<SEC-DOCUMENT>0000313143-21-000010.txt : 20210202
<SEC-HEADER>0000313143-21-000010.hdr.sgml : 20210202
<ACCEPTANCE-DATETIME>20210202062144
ACCESSION NUMBER:		0000313143-21-000010
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		66
CONFORMED PERIOD OF REPORT:	20201226
FILED AS OF DATE:		20210202
DATE AS OF CHANGE:		20210202

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HAEMONETICS CORP
		CENTRAL INDEX KEY:			0000313143
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				042882273
		STATE OF INCORPORATION:			MA
		FISCAL YEAR END:			0403

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-14041
		FILM NUMBER:		21578947

	BUSINESS ADDRESS:	
		STREET 1:		125 SUMMER STREET
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02110
		BUSINESS PHONE:		7818487100

	MAIL ADDRESS:	
		STREET 1:		125 SUMMER STREET
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02110
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>hae-20201226.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:dcc831a0-a182-47d6-a94e-5adaefe7bce2,g:c7d71817-1258-4da0-86ec-9eebc508e513,d:b1e23e354c9c424096b27d04c70f5a5a--><html xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:srt="http://fasb.org/srt/2019-01-31" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:hae="http://www.haemonetics.com/20201226" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>hae-20201226</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80L2ZyYWc6ZmRiZTI4NjMzMDBkNDAwYjk2ZWFjN2JiOTAwZjA5NTEvdGFibGU6NDA5NWI4NTZlZmIwNDBlZmEzOWMzMzk0MGZhMzhkYTYvdGFibGVyYW5nZTo0MDk1Yjg1NmVmYjA0MGVmYTM5YzMzOTQwZmEzOGRhNl8wLTEtMS0xLTA_2c8e4d6e-42d2-4d72-8984-c3f97be6bafa">0000313143</ix:nonNumeric><ix:nonNumeric contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" format="ixt:datemonthday" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80L2ZyYWc6ZmRiZTI4NjMzMDBkNDAwYjk2ZWFjN2JiOTAwZjA5NTEvdGFibGU6NDA5NWI4NTZlZmIwNDBlZmEzOWMzMzk0MGZhMzhkYTYvdGFibGVyYW5nZTo0MDk1Yjg1NmVmYjA0MGVmYTM5YzMzOTQwZmEzOGRhNl8xLTEtMS0xLTA_8af779f3-7863-4046-8410-5296454406ad">4/3</ix:nonNumeric><ix:nonNumeric contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80L2ZyYWc6ZmRiZTI4NjMzMDBkNDAwYjk2ZWFjN2JiOTAwZjA5NTEvdGFibGU6NDA5NWI4NTZlZmIwNDBlZmEzOWMzMzk0MGZhMzhkYTYvdGFibGVyYW5nZTo0MDk1Yjg1NmVmYjA0MGVmYTM5YzMzOTQwZmEzOGRhNl8yLTEtMS0xLTA_712b495b-5ae5-493e-af3a-00434ae77c5b">false</ix:nonNumeric><ix:nonNumeric contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80L2ZyYWc6ZmRiZTI4NjMzMDBkNDAwYjk2ZWFjN2JiOTAwZjA5NTEvdGFibGU6NDA5NWI4NTZlZmIwNDBlZmEzOWMzMzk0MGZhMzhkYTYvdGFibGVyYW5nZTo0MDk1Yjg1NmVmYjA0MGVmYTM5YzMzOTQwZmEzOGRhNl8zLTEtMS0xLTA_254f6297-6837-42ab-a9eb-cd21da73546c">2021</ix:nonNumeric><ix:nonNumeric contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80L2ZyYWc6ZmRiZTI4NjMzMDBkNDAwYjk2ZWFjN2JiOTAwZjA5NTEvdGFibGU6NDA5NWI4NTZlZmIwNDBlZmEzOWMzMzk0MGZhMzhkYTYvdGFibGVyYW5nZTo0MDk1Yjg1NmVmYjA0MGVmYTM5YzMzOTQwZmEzOGRhNl80LTEtMS0xLTA_0c2b3b41-b014-45ac-999f-11879f635432">Q3</ix:nonNumeric><ix:nonFraction unitRef="usd" contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yMi9mcmFnOjY1ODlmZjVkZTIzMDQ5YTdhZTMwMTA0YjVlYjQ3Y2JiL3RhYmxlOmY4YzkxY2I3N2I0ZTQzOGM5OWNiY2Y5MWY5MGEyYmY0L3RhYmxlcmFuZ2U6ZjhjOTFjYjc3YjRlNDM4Yzk5Y2JjZjkxZjkwYTJiZjRfMC0xLTEtMS0w_7678ac3d-df46-4f0a-9a45-4d8f6a20a901">2,525</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yMi9mcmFnOjY1ODlmZjVkZTIzMDQ5YTdhZTMwMTA0YjVlYjQ3Y2JiL3RhYmxlOmY4YzkxY2I3N2I0ZTQzOGM5OWNiY2Y5MWY5MGEyYmY0L3RhYmxlcmFuZ2U6ZjhjOTFjYjc3YjRlNDM4Yzk5Y2JjZjkxZjkwYTJiZjRfMC0yLTEtMS0w_23f0fd68-56c9-4649-ad1c-011f7781e57d">3,824</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yMi9mcmFnOjY1ODlmZjVkZTIzMDQ5YTdhZTMwMTA0YjVlYjQ3Y2JiL3RhYmxlOmY4YzkxY2I3N2I0ZTQzOGM5OWNiY2Y5MWY5MGEyYmY0L3RhYmxlcmFuZ2U6ZjhjOTFjYjc3YjRlNDM4Yzk5Y2JjZjkxZjkwYTJiZjRfMS0xLTEtMS0w_f0281538-9afc-42bc-b568-ef970600e21c">309,951</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yMi9mcmFnOjY1ODlmZjVkZTIzMDQ5YTdhZTMwMTA0YjVlYjQ3Y2JiL3RhYmxlOmY4YzkxY2I3N2I0ZTQzOGM5OWNiY2Y5MWY5MGEyYmY0L3RhYmxlcmFuZ2U6ZjhjOTFjYjc3YjRlNDM4Yzk5Y2JjZjkxZjkwYTJiZjRfMS0yLTEtMS0w_627f1dd7-ce21-4c49-88ab-c7bcbf4b69ad">296,942</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yMi9mcmFnOjY1ODlmZjVkZTIzMDQ5YTdhZTMwMTA0YjVlYjQ3Y2JiL3RhYmxlOmY4YzkxY2I3N2I0ZTQzOGM5OWNiY2Y5MWY5MGEyYmY0L3RhYmxlcmFuZ2U6ZjhjOTFjYjc3YjRlNDM4Yzk5Y2JjZjkxZjkwYTJiZjRfMi0xLTEtMS0w_d01d6b4b-23ec-4657-bf89-3005ddf8ceda">0.01</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yMi9mcmFnOjY1ODlmZjVkZTIzMDQ5YTdhZTMwMTA0YjVlYjQ3Y2JiL3RhYmxlOmY4YzkxY2I3N2I0ZTQzOGM5OWNiY2Y5MWY5MGEyYmY0L3RhYmxlcmFuZ2U6ZjhjOTFjYjc3YjRlNDM4Yzk5Y2JjZjkxZjkwYTJiZjRfMi0yLTEtMS0w_4e53cea3-e63c-4637-ab0f-8a4cb1e34f90">0.01</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yMi9mcmFnOjY1ODlmZjVkZTIzMDQ5YTdhZTMwMTA0YjVlYjQ3Y2JiL3RhYmxlOmY4YzkxY2I3N2I0ZTQzOGM5OWNiY2Y5MWY5MGEyYmY0L3RhYmxlcmFuZ2U6ZjhjOTFjYjc3YjRlNDM4Yzk5Y2JjZjkxZjkwYTJiZjRfMy0xLTEtMS0w_061a90e3-63e2-4b79-9598-e20118904687">150,000,000</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yMi9mcmFnOjY1ODlmZjVkZTIzMDQ5YTdhZTMwMTA0YjVlYjQ3Y2JiL3RhYmxlOmY4YzkxY2I3N2I0ZTQzOGM5OWNiY2Y5MWY5MGEyYmY0L3RhYmxlcmFuZ2U6ZjhjOTFjYjc3YjRlNDM4Yzk5Y2JjZjkxZjkwYTJiZjRfMy0yLTEtMS0w_34ec690f-0ef6-4700-b6f1-de024420f637">150,000,000</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yMi9mcmFnOjY1ODlmZjVkZTIzMDQ5YTdhZTMwMTA0YjVlYjQ3Y2JiL3RhYmxlOmY4YzkxY2I3N2I0ZTQzOGM5OWNiY2Y5MWY5MGEyYmY0L3RhYmxlcmFuZ2U6ZjhjOTFjYjc3YjRlNDM4Yzk5Y2JjZjkxZjkwYTJiZjRfNC0xLTEtMS0w_09e861bb-8a5f-4605-aade-db0e52ac4a32">50,817,233</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yMi9mcmFnOjY1ODlmZjVkZTIzMDQ5YTdhZTMwMTA0YjVlYjQ3Y2JiL3RhYmxlOmY4YzkxY2I3N2I0ZTQzOGM5OWNiY2Y5MWY5MGEyYmY0L3RhYmxlcmFuZ2U6ZjhjOTFjYjc3YjRlNDM4Yzk5Y2JjZjkxZjkwYTJiZjRfNC0yLTEtMS0w_49edae4c-c2fc-4500-93db-6380b0380220">50,322,930</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yMi9mcmFnOjY1ODlmZjVkZTIzMDQ5YTdhZTMwMTA0YjVlYjQ3Y2JiL3RhYmxlOmY4YzkxY2I3N2I0ZTQzOGM5OWNiY2Y5MWY5MGEyYmY0L3RhYmxlcmFuZ2U6ZjhjOTFjYjc3YjRlNDM4Yzk5Y2JjZjkxZjkwYTJiZjRfNS0xLTEtMS0w_bfca9384-95c0-42dc-856b-e4387e8e90c8">50,817,233</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yMi9mcmFnOjY1ODlmZjVkZTIzMDQ5YTdhZTMwMTA0YjVlYjQ3Y2JiL3RhYmxlOmY4YzkxY2I3N2I0ZTQzOGM5OWNiY2Y5MWY5MGEyYmY0L3RhYmxlcmFuZ2U6ZjhjOTFjYjc3YjRlNDM4Yzk5Y2JjZjkxZjkwYTJiZjRfNS0yLTEtMS0w_9a0dcae9-36cc-47c9-842a-20c6b862a65f">50,322,930</ix:nonFraction><ix:nonNumeric contextRef="ib56a8928767949d4bf60e3aee31e1600_I20201226" name="us-gaap:LesseeOperatingLeaseRenewalTerm" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV82NC9mcmFnOjc2OTk3NDk1NTM2NjRmNzlhNjNiMjA4OGEzM2Y2YzcxL3RleHRyZWdpb246NzY5OTc0OTU1MzY2NGY3OWE2M2IyMDg4YTMzZjZjNzFfMzI4_d1261318-cbde-4310-8bac-529fcbd30bd5">P5Y</ix:nonNumeric><ix:nonNumeric contextRef="i6748c368b970432e8ef44eb2755d3755_I20201226" name="us-gaap:LesseeOperatingLeaseRenewalTerm" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV82NC9mcmFnOjc2OTk3NDk1NTM2NjRmNzlhNjNiMjA4OGEzM2Y2YzcxL3RleHRyZWdpb246NzY5OTc0OTU1MzY2NGY3OWE2M2IyMDg4YTMzZjZjNzFfMzY4_fdeb1860-c6a9-478a-81ce-84942fec66c9">P4Y</ix:nonNumeric><ix:nonNumeric contextRef="ib56a8928767949d4bf60e3aee31e1600_I20201226" format="ixt-sec:durwordsen" name="us-gaap:LesseeOperatingLeaseTermOfContract" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV82Ny9mcmFnOjNjMzQ0OGI4NDNiYzQxMWU4ZGNkNmI4NDY1ZTJjZjVjL3RleHRyZWdpb246M2MzNDQ4Yjg0M2JjNDExZThkY2Q2Yjg0NjVlMmNmNWNfMTQy_2bae1474-c5f6-4a91-aa0c-1d757b5c7c29">15 years, 6 months, 30 days</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="hae-20201226.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i6fffe38395d44814afad719145493df5_I20210129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-01-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-31</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b515458914540b58a5b339208b5c6aa_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2cb16a2f4c824ae1aca4e13fd49fe043_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14a5e6c117e3421f99e4b603faf5fa43_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icab8382823bd48c2b8bbd759d1c6a1fa_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1efb1864b5d4f41a6d229d84f58d0e1_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6dd2f02aa774a31a839f57971d93f2e_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98d0d3136b6e4534bd099c082763c527_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07f570d9a0854ee48af28be5af08a344_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07cbfd44a12f4311afb21d55a472de13_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3694a6c7d953431dbcadb946b1f414c2_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e7c8087bac9435c9d82d1fedfbff52e_I20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31fa2bd3032a476cb1c1b205b1125b8d_I20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2fb46a5a8af4e3188ae02ca82d7f05e_I20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i371aab8c0d604c439b36e469dfeb7ae1_I20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8de24c4e5ca9457ba67c9faa95840867_I20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb62b5f06b724ac49c887e404027a4ab_D20200628-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-28</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c87b6d14b0e4daf97ae63c97329dc5f_D20200628-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-28</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53c39140b1904bbe8f3f81c2a2ec9a42_D20200628-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-28</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3cade1e4d1894ebcbacdb9ac1d8529d3_D20200628-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-28</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib49fa4ce64654900825a35f23c5fe8a0_D20200628-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-28</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b695da1c7ae4c91ad9625021564f186_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11d7a90961554152b7611178522b5b4b_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86938e4e5827482b8bb6a25573904ac1_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0809a2c180d446f385e5eb23f3c7098a_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32fa3388584544f9a03ffc1d8057d360_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b2f8ac7c8044d99a51a1c40cfc06202_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7bb87bf0127e4aafa52d782d9e0aa0ee_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i593e5b9ceb9240d1888435f827c761eb_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00bd6a8c6c87470d94b98154b4ed663c_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb893eb36e724d78b750bf760d6e530a_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0c3ea92ba584163a7dfa754dd67152c_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4bfeea1c445b4bbfac0cf8cc2616054f_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0dd7da6b8cfa47a1852a89e52d0d489d_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13923cc91bcd4918b0cd47b138b0c826_I20190330"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id87d83aa2a9a48168fe6363c8adf8a60_I20190330"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie49c0793891c4f9b9446cafe5a44063b_I20190330"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4294e77e77b744d1a79deeae24bc95c9_I20190330"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief541fbd0adf409c9514798c114d14d4_I20190330"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-03-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79fce91b6c7e4ee895ae77d545ae7cac_D20190331-20190629"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-31</xbrli:startDate><xbrli:endDate>2019-06-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab444088a1f343aab3754df7e9900053_D20190331-20190629"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-31</xbrli:startDate><xbrli:endDate>2019-06-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58aa4c71425b490eabe0528109268325_D20190331-20190629"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-31</xbrli:startDate><xbrli:endDate>2019-06-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i856b92cb87d749768e7bc9dd5dd377bb_D20190331-20190629"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-31</xbrli:startDate><xbrli:endDate>2019-06-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifeab2898c30e44abac79ea28e3a13d7b_D20190331-20190629"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-31</xbrli:startDate><xbrli:endDate>2019-06-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44d85e61a03348ac976af3cd59985a40_I20190629"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i977ae884714349048379a8f918f47155_I20190629"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28e2deb2f39545f994371185aa291fd9_I20190629"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifcc6781b9c184013b3ebcc9dd2da2e75_I20190629"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib446da48c08e4f9e9211152ee5dc9758_I20190629"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-06-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3be29de096b43b59d76094a1a86ec73_D20190630-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-06-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b7a68038f8b43a9ad82e2d31b79cdad_D20190630-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-06-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11e5dd1a63a349b98dfe50b20ed69371_D20190630-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-06-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4718bcfebbe44fb8dd41c9d91c87ba9_D20190630-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-06-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a8dccbf5b0e46dd9089c29ee8278a27_D20190630-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-06-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie63b3633289a4dc68fd18c6df9378c99_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if08c7a9f75a04b27aee3f352a3ac162a_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i960c732942cc46598e20801270314713_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f49655e125c49c2893f2cfe850a84c4_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if62547d494fe448f98e6b8c907702474_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8048eb98c0f42aeb56fecb8379edd69_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib55ff0c99eb34464a7e8eda801ade4ca_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32d0e40ce5a64e91b5d91a3c4c9fa8ad_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i357f065f29714ef2a554cacc02892fb9_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f2c9eca9e304ad9b69f801a97fc5dd6_I20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb4f07ff3cbf4479a1d29d55b7330f7a_I20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c64ccfff7864e46907e03a928ba5c42_I20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i591c8e13af6e49d391c4c0e273d6a551_I20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic35a4df7f44a40e5a674e72ae5bf6205_I20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i025a500d449145cdaf09b62761336e4d_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:A2020ProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0527d982aa5d4b1493f2febb15dfb36f_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:A2020ProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd11a684655c47febfdbc8b572773803_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:A2020ProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36f501133aca4e94a40d5f53c2932604_D20200329-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:A2020ProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a5c7d523f2145b6aa5ffec1153cb69c_D20190331-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:A2020ProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-31</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47a6d93cd53549d89b47e663b9deba14_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:A2020ProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2cacfe431b9c4c0fb8e8aef0b6153a74_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:A2020ProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if349602212e14b36bbf1334f02910da3_D20200329-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:A2018ProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93496a66e90a4df78a56e3d1ea9032d5_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:A2018ProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5424d4d3c7a46febf9cc99a77e86fdd_D20190331-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:A2018ProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-31</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i260b34151c1f4ffeb7f29c12973c0d99_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:A2018ProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06e550e92ba749fcb6ba3ce3f7d5cab2_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:A2020ProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6f164270add4f63b852149f39adb6dd_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:A2018ProgramandPriorProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9df13005acd43968fa8aa9997a94054_D20200329-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:A2020ProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id2f1e7afc3e94b0ebd50a8b6ea8db521_D20200329-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:A2018ProgramandPriorProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b7ebb1b437c46a0a817c9861b363798_D20200329-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad3aa8dfa6b948e5b3115795d08f59c8_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:A2018ProgramandPriorProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if591715db6554c7c88829b6f6ea5dd52_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01fc03287b95423b9e72f9953bf2f534_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e978d21bd9d46c78c1bd4f9805a8a0a_D20200329-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib21731e2375545a08b98875f7a4af110_D20190331-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-31</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c902e8ff2a544848d52e4275e2b7ba6_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c6375b4134b4ca68ab871618f059116_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ad87d4f1d5749fda7366051a2f43f16_D20200329-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11ffc79a4ee6438fbd8ff28e0c4be5bb_D20190331-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-31</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee4e2e1969f04310b8b24c6665e635f3_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85a5e4e16a244429b43d7873d0c5a1f8_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8987e6d81b9e45c09d60428f5014e56f_D20200329-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9d7c28c8e164a01a59f0e2d04a596f1_D20190331-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-31</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a367bb123554012a9834d85df459f46_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:PlasmaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2c7bdc34da3493493cc0abe3dc3def5_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:PlasmaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4eb9c47f2f9244e0b383fb7b25f6b0d4_D20200329-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:PlasmaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0091dd1f9204cdd979ec26f0ee2b0ae_D20190331-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:PlasmaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-31</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6cfe5b5730064f93b6ecea7bc136d73f_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:BloodCenterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic275845b82014295bb8e14b72d0cb7a2_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:BloodCenterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4648a84bbe144e499e5f0bbff9596c82_D20200329-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:BloodCenterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2fa6549b61284e39986bb1296676dc1a_D20190331-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:BloodCenterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-31</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id93717bc785844afbedbb40fafa0d6e6_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:HospitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d1a57ec025045cbb23779fa6fc0cb2e_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:HospitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib19f3255f7c4488593f3252f04fa0abf_D20200329-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:HospitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id42b45b3282241f0b4410893d0379aae_D20190331-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:HospitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-31</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05d2add01f7948cdbe05379d9edfa6cd_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if68e3d2fce814080a6a5a599e4100f7d_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f207c5c248843fd8e07e9437fa7102e_D20200329-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7b79856e7224f109a59af542be47303_D20190331-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-31</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8271c898b4eb4b14baafd85359156c86_D20210117-20210117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:CardivaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-17</xbrli:startDate><xbrli:endDate>2021-01-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72cd9e5107234d5fbbe3ac8fc02e2137_I20210117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:CardivaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07195ff1642e4aeb86c955b7bd7ec0ee_D20210113-20210113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="hae:AssetAcquisitionAxis">hae:HASIntellectualPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-13</xbrli:startDate><xbrli:endDate>2021-01-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c4663f05df4454e9e234b6de7661db7_D20200401-20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:EnicorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7337ad8ffd7f4d8cb8646e0073515fc1_I20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:EnicorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e7fc74b32564f649453438d72e04947_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:EnicorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f13c7f15fc44cdf96efa179ac88e167_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:EnicorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b8aa32b413b4a499e81cb8f98426327_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:EnicorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e187811cd3e42c390dd4993b5e2ed41_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:EnicorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ad4c63952854d498ed7b2fe9fb419e8_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:EnicorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icef6f3884c5247499558f7349ee73936_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:EnicorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7aab4b31eac44a489a14bcde8ce8f4eb_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:EnicorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i394c4dad38e046eabd38f765e09e2e8d_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:EnicorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied6e581caf26486bbb484a11ddea3e51_D20200629-20200629"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hae:FajardoPuertoRicoManufacturingOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-06-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i231ee71df4ce422fbe1694ee337e10ea_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hae:FajardoPuertoRicoManufacturingOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieacf3aef0a2a44ffa6d41b7518483e60_I20200629"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hae:FajardoPuertoRicoManufacturingOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie18de39654bc43fabcb2d7cea0396838_D20200701-20200701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hae:USBloodDonorManagementSoftwareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c5c92e739704d5ebb1fc26b36eb5d62_I20200701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hae:USBloodDonorManagementSoftwareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e00d646e9b74bf58ee6a91734e5d466_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hae:USBloodDonorManagementSoftwareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3858043e51c64ee89cd1d79087a6f765_D20200918-20200918"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hae:InlogHoldingsFranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-18</xbrli:startDate><xbrli:endDate>2020-09-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90c03c90eadf4fd4868c3d27ca9208b1_I20200918"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hae:InlogHoldingsFranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6bd93e1c908460891c53b736309cb36_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hae:InlogHoldingsFranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i241ec033d3e44caf9ae5188ed0acd523_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2020-06-28</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib56a8928767949d4bf60e3aee31e1600_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">hae:ManufacturingSpaceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6748c368b970432e8ef44eb2755d3755_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">hae:ManufacturingSpaceSecondRenewalTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c25c1d4590644eb8b651796c671219c_I20180615"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4426464d081b45bb8839adced8fe2873_I20180615"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5d1fce0362544e68a49594cab3a1aa8_D20180615-20180615"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-06-15</xbrli:startDate><xbrli:endDate>2018-06-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9a17518f7194d808968c5442709d4d4_D20180615-20180615"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-06-15</xbrli:startDate><xbrli:endDate>2018-06-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd1b9a587aec4cdca6306687ea65c1a4_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4842b0c162ea46978645dd51b56a0764_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i075eaab3aa4549bb8d0f597beca1bd0f_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i466af82608da4d9bb01882ff1ee71a02_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a806c141f624127aa55c8379bed5731_D20200329-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3351e34989d1461db1163f69c1e631aa_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7435ba41f5b744d59c3211f1c1551e27_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea5e92752773469e8e60c7fb366f08c0_D20200329-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42839168f30747d5b099bb2d4f81d4c3_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86142ccd878c41b5b3b0b89e198e3ffa_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="swap"><xbrli:measure>hae:swap</xbrli:measure></xbrli:unit><xbrli:context id="i6b04360cbc954a42813ee3db68494774_I20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23f7882051074260b7b16d0028b875ea_I20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22efb3fabcf04d79ba596b48595d8ac1_I20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d31dcad300f4873901a0cff3c146b47_D20200329-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice57ced2f272477c986a2ba3d175843c_D20200329-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">hae:NetRevenuesCostOfGoodsSoldAndSellingGeneralAndAdministrativeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0f1b457527f4847a6ebea6d12d49745_D20200329-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">hae:OtherIncomeExpenseNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie07432d269194a38a5b973923e71f52b_D20200329-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa58cfb640b3424280402bd198a7e951_D20200329-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">hae:OtherIncomeExpenseNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d8c09f0cf9042d3ab0ab835a3cfb875_D20200329-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">hae:OtherIncomeExpenseNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iecb24d1198e0473ab5ff26bece23c571_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief8dcb9ed5df46338245fba90826a4a3_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ab86f680653471e898cddf1c4abb3b3_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74b77438f0884283bdfb63acbb121963_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i758e348315a24c3baee3f7984ecfe945_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7af1564b75c420894f80854a774c2d3_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i961d5a6a04ff4db6a9d0a9bbac6be95e_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9656f96940b412198f0ace7941ec4e7_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09705bf4b4c04d018ba1ef2118f58a80_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d30c35c0167492082c7bb18a3980991_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e657827ea664680a8857cfd8b096cb9_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0b611ab7cea40329891cbc0d9cdf3fc_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iafe5dcd8b8f34d0ba81608d6c14c3841_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i110e3cdb79b447caadd705ad58eb1b5d_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7030b986c4a7457991f4240d9857700b_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i997562bcb47249f98a7209c0a94eb2bc_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c5d0e8a5be946c1bcf0fc6bd7dd684d_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26592b211dab480aa8decca198bc3e17_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i588cb2bb68f741b69393f24addb9f2de_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9d15f27861f44938c5187801f43c5d9_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16890a24a13b44bab1e3d254125196c3_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3f2a0af4b1b470aaa1b1fd8223858e3_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a99a6573bad464bacf1a667a155cf4c_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia02b0b01fd264d638c0c2628fc697f93_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie276656bb33a45a487bf62990df0f609_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a4ac71d84054665bcf305a9df5b7ddf_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hae:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d3d12a07ab54dd3a6c5ac15a7096a2b_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hae:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2e4f6aff6eb4677970da26827668a01_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1ddfbfc3ba244e7833e4eac1cbf3b2d_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i216d245bc1864b20940d046e5608b9e0_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3e33f79fd854ca19ec85d864af74f63_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf86edce1a1b42fbb8cfd4d66d94a959_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45f6ab924d174fe997e8ffab01ef2a19_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib783ce7f3af1414a917dfb19f3fd67f6_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3bfc2d6751964174b4757e882148e033_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8d95a735afe423c94c8eeae0f71dc33_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iffada09cc3634b0e9958607425101e7e_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b3615436e53401aaf2becfa502d691c_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if932a0aaa03f451f9dad61e387eabc93_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab5f44f15bc94d6daa33cc2caabfaf8a_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iecf4e5d38e474810bfe38afc5d4ff6a7_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e02337377ab4f1ba4536388c0003177_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hae:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">hae:RevenueBasedPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4bca110ee0c94411a74ee374c176ca00_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">hae:RegulatoryBasedPaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hae:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06f5f1e7b5734a368db7c1b4554453ea_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hae:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54c62f100cf84a5b86024a6964d52097_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hae:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52cd92f3abc349f2a9cd1e1c9b9229e3_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hae:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3f7a3bec94a478ca2a052a1fdea5f49_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hae:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>hae:segment</xbrli:measure></xbrli:unit><xbrli:context id="i86b9b10063b34ad7b052ae6b08484c65_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6bb939bdb4e84a4cb2451ad2848d0fab_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c7f2e0a659245f486464f52663463fe_D20200329-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i019e1c4459504344b5dfa26c7a9c0f8d_D20190331-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-31</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82de2706ab9a438d881b82d726f54fab_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:PlasmaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d107d1d05864d96b46812133da26150_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:PlasmaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f67e87ff2f840db91e6f9c559b88649_D20200329-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:PlasmaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0bd53f6c3550495599acfaf8cba39d05_D20190331-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:PlasmaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-31</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05aef9efca8d40999e7e0b591e687fcd_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:BloodCenterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib02855b3bb664c3d929e1fe1f3d95081_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:BloodCenterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1aec235f150e4c96ab0033513856af19_D20200329-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:BloodCenterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1cc5c0e6c3114948a0b3b81b9e13dbb3_D20190331-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:BloodCenterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-31</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c22cd4ab0ee4facb5feb0c32ce1dcb8_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:HospitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2da01bba3bcc4743a21c2cd6815ea493_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:HospitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35b2d1e5a36a40f9a3630df7618c1971_D20200329-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:HospitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87d70737be684026888e909a4d46800b_D20190331-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:HospitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-31</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c9e183b328f4417a77301e1291a4315_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib94e4c38bb47467fa41d2b3dd7377cf5_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d46cacfa2ca4634b761fcb1de68c22e_D20200329-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1791b14ab6944fc9f18b6f33b05c26e_D20190331-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-31</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26227889e9a545ad95431135a52ce953_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hae:PlasmaProductsandServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idedb7dce764d40518eed1fa0384c56e9_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hae:PlasmaProductsandServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf184b96fbe0474082337c767ecc2e6f_D20200329-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hae:PlasmaProductsandServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if01e8fdfb1df4aa0be9d813f7d0e93e8_D20190331-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hae:PlasmaProductsandServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-31</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52f5dadf03404a3289fc228ba07b7289_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hae:BloodCenterProductsandServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46410774ee104dd5856f09f41912d660_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hae:BloodCenterProductsandServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc470180227d4a10b1dffb6cb47fb61e_D20200329-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hae:BloodCenterProductsandServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ad919a0f8eb4d72afcee6d577854416_D20190331-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hae:BloodCenterProductsandServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-31</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87710fdfb6e84d9f8daaca0e1a6929bb_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hae:HospitalProductsandServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8bb31ac20c2428391e3f927f45c8cd7_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hae:HospitalProductsandServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb446313570e4a9d840e6f2059d39181_D20200329-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hae:HospitalProductsandServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2fa09902b11845b090e32e2378241640_D20190331-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hae:HospitalProductsandServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-31</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7cc83bace6e64ba2819ad07eee146aa5_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5255bf836d2f4c928a7bb2389d05393b_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia77b37ab4b674b69b224543cc8eb45e6_D20200329-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a100d6026814cee86e66f779c21038c_D20190331-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-31</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d172cbd06c7456499c6f9186db5c771_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84a09fec71e2469490c5fced840c534d_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8042aa5ffab48bba95d2e2d9c04f228_D20200329-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17ab8f6f349b4eaba8ad6043c531b88a_D20190331-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-31</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb8358f9ae4143e7bb93e59e7d3a809c_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i479cccf7db0b402f8eb765dc4867033c_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib68f4cb225a84d98b73f7eb16b96435c_D20200329-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d56e00072c84650b763043b36796f33_D20190331-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-31</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4173f578720640508c5f3e2556613126_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie22e69eafcdc47a5a7f6d41ca37a8314_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17cdd867d9784cc8998e9d70ee3105af_D20200329-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96c22dedabc94ec0a58470fce107095e_D20190331-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-31</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c25765c59da42a08a0a21dbace51807_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hae:OtherCountryorRegionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i787564a0a009410b9c7377c8d5563e2a_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hae:OtherCountryorRegionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idfb3207a7e164364a10c64478573dec0_D20200329-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hae:OtherCountryorRegionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77f79023d32b40a3bb1a8b511a7fe783_D20190331-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hae:OtherCountryorRegionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-31</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73c6d04f09054f72ad3f93b0ac709dbf_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5abcf57b0bd45828a4b667e017ea34b_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd033b9d4b7c4a79acde034ff7bf773d_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e613855a20241cbb5aca346a957c8d5_D20200329-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1674f32a21e4d63a2bd245596b5d47c_D20200329-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64fb8a3c1c5d42e99e7b38ba5b2f180f_D20200329-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie870c34971924054809e87e40bb33672_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6309acd9935545568cbf73841d4a4e9c_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98ca0312f088468c8e6ea90d58d30441_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ib1e23e354c9c424096b27d04c70f5a5a_1"></div><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xL2ZyYWc6ZDA3OWU4MGYyZDRlNGVmZjlhMGJlMDYzOGFjYTBiYTUvdGV4dHJlZ2lvbjpkMDc5ZTgwZjJkNGU0ZWZmOWEwYmUwNjM4YWNhMGJhNV8xODY3_6f3b1b72-0e23-4a35-8b01-1f551bf57a39">10-Q</ix:nonNumeric> </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.840%"><tr><td style="width:1.0%"></td><td style="width:3.738%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.062%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:14pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xL2ZyYWc6ZDA3OWU4MGYyZDRlNGVmZjlhMGJlMDYzOGFjYTBiYTUvdGFibGU6NDE0YThiMTY0Mjg0NDA0OTk5ZGUwNDhjYWMwY2YzMDUvdGFibGVyYW5nZTo0MTRhOGIxNjQyODQ0MDQ5OTlkZTA0OGNhYzBjZjMwNV8wLTAtMS0xLTA_bd689b30-8d43-41c8-8cdd-ee3f5335d998">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended: <ix:nonNumeric contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xL2ZyYWc6ZDA3OWU4MGYyZDRlNGVmZjlhMGJlMDYzOGFjYTBiYTUvdGV4dHJlZ2lvbjpkMDc5ZTgwZjJkNGU0ZWZmOWEwYmUwNjM4YWNhMGJhNV8xMjM_4a292f1e-d2b8-4253-b8ff-6ed5fa9f2c60">December 26, 2020</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:144%">OR</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.840%"><tr><td style="width:1.0%"></td><td style="width:3.738%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.062%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xL2ZyYWc6ZDA3OWU4MGYyZDRlNGVmZjlhMGJlMDYzOGFjYTBiYTUvdGFibGU6OTQ2MTg4ZGI2NDcxNDA1NmE5YTI3NDI2ZmUyYzM3NGYvdGFibGVyYW5nZTo5NDYxODhkYjY0NzE0MDU2YTlhMjc0MjZmZTJjMzc0Zl8wLTAtMS0xLTA_ff310773-e90f-4964-b463-fa3a07372b3a">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xL2ZyYWc6ZDA3OWU4MGYyZDRlNGVmZjlhMGJlMDYzOGFjYTBiYTUvdGV4dHJlZ2lvbjpkMDc5ZTgwZjJkNGU0ZWZmOWEwYmUwNjM4YWNhMGJhNV8xODY4_210fe1fd-7496-423f-a2c4-05a976b85c27">001-14041</ix:nonNumeric> </span></div><div style="margin-top:16pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xL2ZyYWc6ZDA3OWU4MGYyZDRlNGVmZjlhMGJlMDYzOGFjYTBiYTUvdGV4dHJlZ2lvbjpkMDc5ZTgwZjJkNGU0ZWZmOWEwYmUwNjM4YWNhMGJhNV8xODY5_a7182630-fcbe-4547-ac08-9d83afffabad">HAEMONETICS CORP</ix:nonNumeric>ORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.653%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.972%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.698%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.177%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xL2ZyYWc6ZDA3OWU4MGYyZDRlNGVmZjlhMGJlMDYzOGFjYTBiYTUvdGFibGU6YjY4YjYxMzMwZTQyNDY0YmFiNjk3YjgwMGJjNzZkNjkvdGFibGVyYW5nZTpiNjhiNjEzMzBlNDI0NjRiYWI2OTdiODAwYmM3NmQ2OV8wLTAtMS0xLTA_bbd803e8-8ff8-4a59-9dbd-a7c215c49d1a">Massachusetts</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xL2ZyYWc6ZDA3OWU4MGYyZDRlNGVmZjlhMGJlMDYzOGFjYTBiYTUvdGFibGU6YjY4YjYxMzMwZTQyNDY0YmFiNjk3YjgwMGJjNzZkNjkvdGFibGVyYW5nZTpiNjhiNjEzMzBlNDI0NjRiYWI2OTdiODAwYmM3NmQ2OV8wLTMtMS0xLTA_d73f7bbd-3f0f-4c6e-9078-d0028535a166">04-2882273</ix:nonNumeric></span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xL2ZyYWc6ZDA3OWU4MGYyZDRlNGVmZjlhMGJlMDYzOGFjYTBiYTUvdGFibGU6YjY4YjYxMzMwZTQyNDY0YmFiNjk3YjgwMGJjNzZkNjkvdGFibGVyYW5nZTpiNjhiNjEzMzBlNDI0NjRiYWI2OTdiODAwYmM3NmQ2OV8zLTAtMS0xLTA_6317c296-f190-4204-9e3d-dad2c120f062">125 Summer Street</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xL2ZyYWc6ZDA3OWU4MGYyZDRlNGVmZjlhMGJlMDYzOGFjYTBiYTUvdGFibGU6YjY4YjYxMzMwZTQyNDY0YmFiNjk3YjgwMGJjNzZkNjkvdGFibGVyYW5nZTpiNjhiNjEzMzBlNDI0NjRiYWI2OTdiODAwYmM3NmQ2OV80LTAtMS0xLTA_a14cb21c-f4d6-4129-b42c-edd081b7a486">Boston,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xL2ZyYWc6ZDA3OWU4MGYyZDRlNGVmZjlhMGJlMDYzOGFjYTBiYTUvdGFibGU6YjY4YjYxMzMwZTQyNDY0YmFiNjk3YjgwMGJjNzZkNjkvdGFibGVyYW5nZTpiNjhiNjEzMzBlNDI0NjRiYWI2OTdiODAwYmM3NmQ2OV80LTEtMS0xLTA_c71f0cad-a40a-4216-a77e-46f68e75e2a1">Massachusetts</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xL2ZyYWc6ZDA3OWU4MGYyZDRlNGVmZjlhMGJlMDYzOGFjYTBiYTUvdGFibGU6YjY4YjYxMzMwZTQyNDY0YmFiNjk3YjgwMGJjNzZkNjkvdGFibGVyYW5nZTpiNjhiNjEzMzBlNDI0NjRiYWI2OTdiODAwYmM3NmQ2OV80LTMtMS0xLTA_0def97c1-9fc4-480d-9119-69f949109c09">02110</ix:nonNumeric></span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xL2ZyYWc6ZDA3OWU4MGYyZDRlNGVmZjlhMGJlMDYzOGFjYTBiYTUvdGV4dHJlZ2lvbjpkMDc5ZTgwZjJkNGU0ZWZmOWEwYmUwNjM4YWNhMGJhNV8xODcw_eadfd0fc-f21e-4bd9-841f-952f0eaad3d3">781</ix:nonNumeric>)&#160;<ix:nonNumeric contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xL2ZyYWc6ZDA3OWU4MGYyZDRlNGVmZjlhMGJlMDYzOGFjYTBiYTUvdGV4dHJlZ2lvbjpkMDc5ZTgwZjJkNGU0ZWZmOWEwYmUwNjM4YWNhMGJhNV8xODYz_5fa63407-a76c-4d3b-9e39-2acc2df43f60">848-7100</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section&#160;12(b) of the Act:</span></div><div style="margin-bottom:5pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.695%"><tr><td style="width:1.0%"></td><td style="width:36.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.590%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.759%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.590%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.017%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title of Each Class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Trading Symbol</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of Each Exchange on Which Registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xL2ZyYWc6ZDA3OWU4MGYyZDRlNGVmZjlhMGJlMDYzOGFjYTBiYTUvdGFibGU6ODU3YzRkZGE4MTdiNGNlMjliZGE0OGIxNzA2OTlkNWUvdGFibGVyYW5nZTo4NTdjNGRkYTgxN2I0Y2UyOWJkYTQ4YjE3MDY5OWQ1ZV8xLTAtMS0xLTA_1bc2a359-af24-49c7-b319-e72262f89c21">Common stock, $.01&#160;par value per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xL2ZyYWc6ZDA3OWU4MGYyZDRlNGVmZjlhMGJlMDYzOGFjYTBiYTUvdGFibGU6ODU3YzRkZGE4MTdiNGNlMjliZGE0OGIxNzA2OTlkNWUvdGFibGVyYW5nZTo4NTdjNGRkYTgxN2I0Y2UyOWJkYTQ4YjE3MDY5OWQ1ZV8xLTItMS0xLTA_ea1788a8-88fc-4140-8f54-781c745da86e">HAE</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xL2ZyYWc6ZDA3OWU4MGYyZDRlNGVmZjlhMGJlMDYzOGFjYTBiYTUvdGFibGU6ODU3YzRkZGE4MTdiNGNlMjliZGE0OGIxNzA2OTlkNWUvdGFibGVyYW5nZTo4NTdjNGRkYTgxN2I0Y2UyOWJkYTQ4YjE3MDY5OWQ1ZV8xLTQtMS0xLTA_c7e83262-9260-4705-9f64-0cf21260bb59">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12&#160;months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90&#160;days.  <ix:nonNumeric contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xL2ZyYWc6ZDA3OWU4MGYyZDRlNGVmZjlhMGJlMDYzOGFjYTBiYTUvdGV4dHJlZ2lvbjpkMDc5ZTgwZjJkNGU0ZWZmOWEwYmUwNjM4YWNhMGJhNV8xODY0_2a0898af-44e2-479c-a5c9-50f060c862e4">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">   No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&#160;405 of Regulation&#160;S-T (&#167;232.405 of this chapter) during the preceding 12&#160;months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xL2ZyYWc6ZDA3OWU4MGYyZDRlNGVmZjlhMGJlMDYzOGFjYTBiYTUvdGV4dHJlZ2lvbjpkMDc5ZTgwZjJkNGU0ZWZmOWEwYmUwNjM4YWNhMGJhNV8xODY1_81f8802a-7dfa-4a18-b2b7-9dcc4784fd70">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">   No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule&#160;12b-2 of the Exchange Act.</span></div><div style="margin-bottom:5pt;margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.871%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.943%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.392%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.392%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.189%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.552%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.961%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xL2ZyYWc6ZDA3OWU4MGYyZDRlNGVmZjlhMGJlMDYzOGFjYTBiYTUvdGFibGU6YWQxYWE3YWU1NTg1NGZhMTgxNGI1ZDliZDk2YzljM2MvdGFibGVyYW5nZTphZDFhYTdhZTU1ODU0ZmExODE0YjVkOWJkOTZjOWMzY18wLTAtMS0xLTA_184a884e-11f0-4e08-aaf2-dd90d5392a1e">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated filer&#160; </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer&#160;  </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xL2ZyYWc6ZDA3OWU4MGYyZDRlNGVmZjlhMGJlMDYzOGFjYTBiYTUvdGFibGU6YWQxYWE3YWU1NTg1NGZhMTgxNGI1ZDliZDk2YzljM2MvdGFibGVyYW5nZTphZDFhYTdhZTU1ODU0ZmExODE0YjVkOWJkOTZjOWMzY18xLTYtMS0xLTA_4c1ee18d-ed09-4acb-8504-2fe0258029ae">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xL2ZyYWc6ZDA3OWU4MGYyZDRlNGVmZjlhMGJlMDYzOGFjYTBiYTUvdGFibGU6YWQxYWE3YWU1NTg1NGZhMTgxNGI1ZDliZDk2YzljM2MvdGFibGVyYW5nZTphZDFhYTdhZTU1ODU0ZmExODE0YjVkOWJkOTZjOWMzY18yLTYtMS0xLTA_d2920ccb-bb88-4d34-a7e0-e27ffcf6aa50">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act.)  Yes </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xL2ZyYWc6ZDA3OWU4MGYyZDRlNGVmZjlhMGJlMDYzOGFjYTBiYTUvdGV4dHJlZ2lvbjpkMDc5ZTgwZjJkNGU0ZWZmOWEwYmUwNjM4YWNhMGJhNV8xODY2_3b907941-230e-4785-9547-0dfe5757d8e3">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of shares of $0.01 par value common stock outstanding as of January&#160;29, 2021: <ix:nonFraction unitRef="shares" contextRef="i6fffe38395d44814afad719145493df5_I20210129" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xL2ZyYWc6ZDA3OWU4MGYyZDRlNGVmZjlhMGJlMDYzOGFjYTBiYTUvdGV4dHJlZ2lvbjpkMDc5ZTgwZjJkNGU0ZWZmOWEwYmUwNjM4YWNhMGJhNV8xODYx_b83f92e6-d837-4947-a825-bfd27205742a">50,821,698</ix:nonFraction> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ib1e23e354c9c424096b27d04c70f5a5a_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HAEMONETICS CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:90.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.685%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">PAGE</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1e23e354c9c424096b27d04c70f5a5a_10">PART I. FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1e23e354c9c424096b27d04c70f5a5a_13">ITEM 1. Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib1e23e354c9c424096b27d04c70f5a5a_16">Unaudited Condensed Consolidated Statements of Income and Comprehensive Income - Three and </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib1e23e354c9c424096b27d04c70f5a5a_16">Nine</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib1e23e354c9c424096b27d04c70f5a5a_16"> Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib1e23e354c9c424096b27d04c70f5a5a_16">December</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib1e23e354c9c424096b27d04c70f5a5a_16"> 26, 2020 and </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib1e23e354c9c424096b27d04c70f5a5a_16">December</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib1e23e354c9c424096b27d04c70f5a5a_16"> 28, 2019</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib1e23e354c9c424096b27d04c70f5a5a_16">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib1e23e354c9c424096b27d04c70f5a5a_19">Unaudited Condensed Consolidated Balance Sheet - </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib1e23e354c9c424096b27d04c70f5a5a_19">December </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib1e23e354c9c424096b27d04c70f5a5a_19">26, 2020 and Consolidated Balance Sheet - March 28, 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib1e23e354c9c424096b27d04c70f5a5a_19">4</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib1e23e354c9c424096b27d04c70f5a5a_25">Unaudited Condensed Consolidated Statements of Stockholders' Equity - Three and </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib1e23e354c9c424096b27d04c70f5a5a_25">Nine</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib1e23e354c9c424096b27d04c70f5a5a_25"> Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib1e23e354c9c424096b27d04c70f5a5a_25">December</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib1e23e354c9c424096b27d04c70f5a5a_25"> 26, 2020 and </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib1e23e354c9c424096b27d04c70f5a5a_25">December </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib1e23e354c9c424096b27d04c70f5a5a_25">28, 2019</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib1e23e354c9c424096b27d04c70f5a5a_25">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib1e23e354c9c424096b27d04c70f5a5a_28">Unaudited Condensed Consolidated Statements of Cash Flows - </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib1e23e354c9c424096b27d04c70f5a5a_28">Nine</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib1e23e354c9c424096b27d04c70f5a5a_28"> Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib1e23e354c9c424096b27d04c70f5a5a_28">December</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib1e23e354c9c424096b27d04c70f5a5a_28"> 26, 2020 and </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib1e23e354c9c424096b27d04c70f5a5a_28">December</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib1e23e354c9c424096b27d04c70f5a5a_28"> 28, 2019</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib1e23e354c9c424096b27d04c70f5a5a_28">7</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib1e23e354c9c424096b27d04c70f5a5a_31">Notes to Unaudited Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib1e23e354c9c424096b27d04c70f5a5a_31">8</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1e23e354c9c424096b27d04c70f5a5a_88">ITEM 2. Management's Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib1e23e354c9c424096b27d04c70f5a5a_88">22</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1e23e354c9c424096b27d04c70f5a5a_112">ITEM 3. Quantitative and Qualitative Disclosures about Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib1e23e354c9c424096b27d04c70f5a5a_112">34</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1e23e354c9c424096b27d04c70f5a5a_115">ITEM 4. Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib1e23e354c9c424096b27d04c70f5a5a_115">35</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1e23e354c9c424096b27d04c70f5a5a_118">PART II. OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib1e23e354c9c424096b27d04c70f5a5a_118">36</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1e23e354c9c424096b27d04c70f5a5a_121">ITEM 1. Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib1e23e354c9c424096b27d04c70f5a5a_121">36</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1e23e354c9c424096b27d04c70f5a5a_124">ITEM 1A. Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib1e23e354c9c424096b27d04c70f5a5a_124">36</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1e23e354c9c424096b27d04c70f5a5a_127">ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib1e23e354c9c424096b27d04c70f5a5a_127">36</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1e23e354c9c424096b27d04c70f5a5a_130">ITEM 3. Defaults upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib1e23e354c9c424096b27d04c70f5a5a_130">37</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1e23e354c9c424096b27d04c70f5a5a_133">ITEM 4. Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib1e23e354c9c424096b27d04c70f5a5a_133">37</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1e23e354c9c424096b27d04c70f5a5a_136">ITEM 5. Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib1e23e354c9c424096b27d04c70f5a5a_136">37</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1e23e354c9c424096b27d04c70f5a5a_139">ITEM 6. Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib1e23e354c9c424096b27d04c70f5a5a_139">38</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ib1e23e354c9c424096b27d04c70f5a5a_142">SIGNATURES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib1e23e354c9c424096b27d04c70f5a5a_142">39</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="ib1e23e354c9c424096b27d04c70f5a5a_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div id="ib1e23e354c9c424096b27d04c70f5a5a_13"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1. FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HAEMONETICS CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div><div id="ib1e23e354c9c424096b27d04c70f5a5a_16"></div><div style="margin-bottom:10pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.584%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.186%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMi0xLTEtMS0w_6247e7d1-6478-4331-9457-d7e0cdb1eae8">240,371</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMi0zLTEtMS0w_7e8dc4ea-0865-4f15-b12d-4d16e09e3a2a">258,970</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMi01LTEtMS0w_e7409b68-cb8d-482c-9d42-13319666171e">645,434</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMi03LTEtMS0w_8d01d65c-eddf-4825-b595-61ef081063a3">749,987</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMy0xLTEtMS0w_81d9bf96-6226-4e72-b359-0629e148139b">120,114</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMy0zLTEtMS0w_4cd8586e-699e-49f8-a0a2-fada8665465b">130,920</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMy01LTEtMS0w_dd6371d3-a16c-4887-9d6c-9a73f4cf7248">329,403</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMy03LTEtMS0w_9f400aa4-8362-46f8-a97e-4c1e964d43ee">379,031</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfNC0xLTEtMS0w_912f9c1b-43af-40bb-8ccf-2e50c07f7506">120,257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfNC0zLTEtMS0w_51097d7e-dce5-4c06-9894-d072e65e8eb0">128,050</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfNC01LTEtMS0w_1371b955-d0ca-4d47-87bf-ccbb147cbfd3">316,031</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfNC03LTEtMS0w_62d3f91e-4f51-472c-a51e-08024abadd89">370,956</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfNi0xLTEtMS0w_424c0fe1-9b7e-4fc6-a6a3-6b3af08cf5cd">7,501</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfNi0zLTEtMS0w_08143091-031e-4456-9c85-c5e3dd4c29ab">7,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfNi01LTEtMS0w_d51cab18-a8c3-4fb5-9432-5a73c9d92c3d">22,014</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfNi03LTEtMS0w_59067476-584f-4b1b-870f-093d4b138c2f">21,909</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfNy0xLTEtMS0w_b66a9d32-77db-471d-9c18-a77c22bd7e24">73,446</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfNy0zLTEtMS0w_07c4750c-09ce-46a1-98ed-4516001bcbb0">78,267</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfNy01LTEtMS0w_2cf57dc4-0d31-47e2-8627-9a07b402ba43">214,680</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfNy03LTEtMS0w_7d81f894-1f60-45ca-b0b3-a51eb623dc25">229,189</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherAssetImpairmentCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfOC0xLTEtMS0w_401cd5ce-bd4d-408a-8008-e52806b5da1e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetImpairmentCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfOC0zLTEtMS0w_61d5a0b7-3bd8-41e8-b736-76114e40473a">1,876</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetImpairmentCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfOC01LTEtMS0w_290d8be0-8c97-4a9a-91ef-53f975d22f7d">1,028</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetImpairmentCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfOC03LTEtMS0w_a043d750-5afa-46d4-b24f-290d8919ab31">50,597</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gains on divestitures and sale of assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="hae:GainLossOnDivestitureAndSaleOfAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfOS0xLTEtMS0w_12dc0881-f7a6-42c8-814d-d0bfda4d6e07">1,115</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228" decimals="-3" format="ixt:zerodash" name="hae:GainLossOnDivestitureAndSaleOfAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfOS0zLTEtMS0w_84e77bb0-6ea5-4164-b1f4-60c758f2d5ec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="hae:GainLossOnDivestitureAndSaleOfAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfOS01LTEtMS0w_f3d2af17-5faf-47d8-a8a5-c70556315d06">32,613</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="hae:GainLossOnDivestitureAndSaleOfAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfOS03LTEtMS0w_2cb29542-950b-4ffa-9f7c-2dcd34b8ae47">8,083</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTAtMS0xLTEtMA_c7928fee-9691-4eb0-9645-874857e9331c">79,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTAtMy0xLTEtMA_01d91a01-ac45-4246-9d22-6e71d1bf68e2">87,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTAtNS0xLTEtMA_6bb8d4cf-bf39-4c80-a1b4-17bae6b40ab8">205,109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTAtNy0xLTEtMA_bad2c76e-bfa0-4d2b-92d5-c47c87408e65">293,612</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTEtMS0xLTEtMA_ca3afc5a-f8a4-40e3-bf63-1584a8869c3a">40,425</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTEtMy0xLTEtMA_0228aeb5-1774-4305-9ea5-48cdf2e81f13">40,907</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTEtNS0xLTEtMA_2750fb61-bc4d-4ea6-8312-6e4469e97199">110,922</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTEtNy0xLTEtMA_a8eda6d8-43b0-4ef5-9fde-4908239bff87">77,344</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTItMS0xLTEtMA_50b6c430-0b48-4027-8cc2-ab2605111739">3,051</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTItMy0xLTEtMA_245ed609-e8e0-4e20-869e-cc186333fbcc">3,078</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTItNS0xLTEtMA_d2d8cf80-4ade-4733-974c-927117579f12">10,612</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTItNy0xLTEtMA_d8d6f2c2-9c14-4776-a243-80590af9e95d">12,152</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income before provision for income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTMtMS0xLTEtMA_6331f634-57fa-4a2c-9a2c-630699e60529">37,374</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTMtMy0xLTEtMA_c2822748-defa-4497-92d8-6af6f318a0f7">37,829</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTMtNS0xLTEtMA_d26e4efe-3aa9-41ce-b90e-67fefeac685e">100,310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTMtNy0xLTEtMA_123ca3aa-387d-485d-bad0-0fe75909625a">65,192</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTQtMS0xLTEtMA_95575cd3-bed2-4719-8d03-d96fd76bdcd3">5,492</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTQtMy0xLTEtMA_7567258b-0046-42e7-81b8-622432d112d2">7,934</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTQtNS0xLTEtMA_26c701b1-ae02-43aa-bcd2-8590c91c34f1">9,800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTQtNy0xLTEtMA_e4462d56-ba36-4cee-88e8-9293e0bc78f9">6,290</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTUtMS0xLTEtMA_53c9b6e5-7537-48ed-944d-4f7c4de18f2c">31,882</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTUtMy0xLTEtMA_1a6cd5a6-1a6e-4f91-a33a-dfb75f3425a3">29,895</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTUtNS0xLTEtMA_3a268274-8fc7-4aa3-8a61-ea0e80d11353">90,510</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTUtNy0xLTEtMA_8d01ec91-451e-40d9-9b79-f8af80f85c44">58,902</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share - basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTctMS0xLTEtMA_8fa9d717-da4c-4be3-bdf7-cffd920ea7d7">0.63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTctMy0xLTEtMA_7394a5e3-d3a8-438b-ab4b-be6f27cfa74a">0.59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTctNS0xLTEtMA_f78d5cdc-eca8-4edb-a730-87865c780571">1.79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTctNy0xLTEtMA_d0c6bcdb-f9b3-4232-b295-355950d23293">1.16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share - diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTgtMS0xLTEtMA_082da17b-2295-419d-80b6-e758a44b0eb7">0.62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTgtMy0xLTEtMA_7a0bf7ae-5bee-472e-a836-739c16e59709">0.58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTgtNS0xLTEtMA_0b8cb62c-f339-4c9a-ad8e-10c0a536db1e">1.77</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTgtNy0xLTEtMA_5c7cd8b3-5aae-4b4a-bec7-a6e04ba7bb0b">1.13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average shares outstanding </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMjEtMS0xLTEtMA_4bd87dba-35d7-4dd3-915c-1f23d542f561">50,789</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMjEtMy0xLTEtMA_23684420-4979-49c0-86e5-fc5df9060f52">50,630</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMjEtNS0xLTEtMA_a11ae91a-ae83-48de-87f6-f8892d6d754a">50,634</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMjEtNy0xLTEtMA_f7369501-704f-4a11-97de-c186f4d5d713">50,810</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMjItMS0xLTEtMA_0353f13b-e23e-441c-910b-3d2abc056499">51,363</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMjItMy0xLTEtMA_5a8e2e0c-d178-473b-89e9-2a6b596f4629">51,638</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMjItNS0xLTEtMA_ddf057e2-5345-41c9-be30-9ce7f3f6e066">51,234</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMjItNy0xLTEtMA_f2e3da2d-e4b5-4e3d-b607-f1dee1ada187">51,995</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMjQtMS0xLTEtMA_66cd7e81-0736-43d2-beb1-aa7f44474297">40,496</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMjQtMy0xLTEtMA_20d47858-3633-486e-8466-f7ff066a1b79">32,296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMjQtNS0xLTEtMA_07d0cf7d-f4b0-4cb9-a083-36cc32dcb828">105,787</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMjQtNy0xLTEtMA_c8f64a1d-cf8a-4ebd-86e3-cb30705059e2">55,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:21pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="ib1e23e354c9c424096b27d04c70f5a5a_19"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HAEMONETICS CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited in thousands, except share data)</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:69.721%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.122%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.124%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 28,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMy0xLTEtMS0w_d3b9c242-5950-4050-9e04-bd75c904bb67">189,002</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMy0zLTEtMS0w_cd8ae725-23af-446c-8c61-2a9ff82d6e8c">137,311</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable, less allowance of $2,525 at December 26, 2020 and $3,824 at March 28, 2020</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfNC0xLTEtMS0w_83a7c6a6-a39d-4bcc-8204-66373665b362">146,939</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfNC0zLTEtMS0w_3b402390-ff7c-413d-95c5-b945b7f5c95a">165,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfNS0xLTEtMS0w_8924b742-95e1-4b86-b91a-64fc944eb70a">299,710</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfNS0zLTEtMS0w_888201b6-0404-4d4f-8499-224377d87d84">270,276</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfNi0xLTEtMS0w_cc3a143f-e719-46f2-8d4e-250981210c2e">32,697</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfNi0zLTEtMS0w_7a48ff06-a4ff-47a4-9e17-8a0e0630ab3f">30,845</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfNy0xLTEtMS0w_88deef09-525d-49c5-822c-fc50fdfb510b">668,348</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfNy0zLTEtMS0w_5192fc74-72ad-4232-9c0a-ef8c8b0e6ca1">603,639</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfOC0xLTEtMS0w_38318e47-c312-4afd-a652-7eb6aec3ab22">240,009</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfOC0zLTEtMS0w_a031301c-cc81-4aac-930d-f924616a66a6">253,399</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets, less accumulated amortization of $309,951 at December 26, 2020 and $296,942 at March 28, 2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfOS0xLTEtMS0w_0cda3ce6-1dcc-45aa-836c-40efaf33ae74">119,716</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfOS0zLTEtMS0w_b373b70e-8748-4c48-b19c-5f8e23b60406">133,106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMTAtMS0xLTEtMA_4d72402d-775f-4de5-aa22-11000ce6eb2a">215,508</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMTAtMy0xLTEtMA_a31e3d4e-3620-4b98-8d0e-4cc8f87f69ee">210,652</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMTEtMS0xLTEtMA_cb8c6365-cb81-44d0-8278-09be92eb9482">4,558</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMTEtMy0xLTEtMA_d35bc743-7954-4504-a89e-6a88cdf98cc2">3,930</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMTItMS0xLTEtMA_70ba55f2-d28b-43f4-a99d-85cefba7740e">69,929</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMTItMy0xLTEtMA_a74151cc-63c7-4fde-b833-5f021909e946">62,384</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMTMtMS0xLTEtMA_1fda45ef-65ef-421a-9977-3cfd7cdd1884">1,318,068</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMTMtMy0xLTEtMA_a4926de0-35c2-4769-a2a9-e59ceefee5f9">1,267,110</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Notes payable and current maturities of long-term debt</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMTYtMS0xLTEtMA_24354097-a189-4530-8e11-85b54cab6a36">17,055</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMTYtMy0xLTEtMA_b5f1f57c-647b-4ea8-9412-206aa3342d70">76,980</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMTctMS0xLTEtMA_68c4d11e-c456-4583-8bf3-376cdfba3586">42,979</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMTctMy0xLTEtMA_91d54cd4-79e0-443e-9760-769a0d26dbf2">50,730</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued payroll and related costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMTgtMS0xLTEtMA_294a95d8-eb6f-4609-903c-45b37bdba0ef">35,127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMTgtMy0xLTEtMA_2f8f8373-5e5d-4950-b866-22bfb1e01503">49,471</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMTktMS0xLTEtMA_dd9058ee-ba53-4acf-8965-5ca3ceeec91a">99,223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMTktMy0xLTEtMA_bd5875f3-644b-4d76-964c-5ff9146242d6">97,641</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMjAtMS0xLTEtMA_2e2090ad-3476-48d8-af72-161ac3d1402e">194,384</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMjAtMy0xLTEtMA_3d526e29-ebdc-4612-b0ed-d77adbffbbc7">274,822</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt, net of current maturities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMjEtMS0xLTEtMA_da606ac2-5561-48dc-ab85-37748c5c5838">292,721</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMjEtMy0xLTEtMA_cc81db97-3cfd-4785-b1c5-5fddf871f6a4">305,513</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMjItMS0xLTEtMA_08e80a29-a930-4b92-a3de-d22e3d1a6c98">9,803</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMjItMy0xLTEtMA_17654efb-4a46-4701-9c3c-6398b309ff0e">10,562</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMjMtMS0xLTEtMA_a3a487a6-6a55-4800-827a-7865212f8790">102,008</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMjMtMy0xLTEtMA_150481d0-c6ae-42c5-9a6f-ac4cb29e5542">89,104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock, $0.01 par value; Authorized &#8212; 150,000,000 shares; Issued and outstanding &#8212; 50,817,222 shares at December 26, 2020 and 50,322,930 shares at March 28, 2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMjUtMS0xLTEtMA_e73fdd28-53bb-4aad-8bb7-d5a99a4bdf75">508</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMjUtMy0xLTEtMA_ac897d15-d374-41aa-a052-5f4fc5e5d540">503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMjYtMS0xLTEtMA_e268feea-914d-4450-b3f7-c133c50331df">579,480</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMjYtMy0xLTEtMA_402ea60a-bbbd-4a42-913a-dbe0657a2dd4">553,229</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMjctMS0xLTEtMA_49f4f71f-ab9e-468c-934b-d6645441dcc7">169,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMjctMy0xLTEtMA_d5d2db67-6624-4131-9ab5-e97139ca4a5d">78,512</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMjgtMS0xLTEtMA_655e1689-45c9-4cd6-adcc-4f540432fd02">29,858</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMjgtMy0xLTEtMA_34131a8f-0685-44ba-8c07-b1d0b735eca3">45,135</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMjktMS0xLTEtMA_78dff6a0-6c7c-4c69-8b63-a018a67977fc">719,152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMjktMy0xLTEtMA_bb5ff56c-5fe0-492a-aca4-91ae1fb4185d">587,109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMzAtMS0xLTEtMA_4ab86254-c856-4bc0-9c9b-19e4295f4b63">1,318,068</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMzAtMy0xLTEtMA_5ee724ec-5c97-469e-8451-566eb3cdefc1">1,267,110</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="ib1e23e354c9c424096b27d04c70f5a5a_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HAEMONETICS CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited in thousands)</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:37.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.791%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.294%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.655%"></td><td style="width:0.1%"></td></tr><tr style="height:26pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional<br/>Paid-in Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>Stockholders&#8217; Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Par Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, March 28, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2cb16a2f4c824ae1aca4e13fd49fe043_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMi0xLTEtMS0w_2d80a7c1-2887-43c6-b7a0-b398f8920044">50,323</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cb16a2f4c824ae1aca4e13fd49fe043_I20200328" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMi0zLTEtMS0w_014988d3-7554-453e-b679-441d5e46de14">503</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14a5e6c117e3421f99e4b603faf5fa43_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMi01LTEtMS0w_da184472-1500-4c52-a436-11dd6f023aba">553,229</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icab8382823bd48c2b8bbd759d1c6a1fa_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMi03LTEtMS0w_10ffa66d-aea3-4aea-8b55-98a3e901ff51">78,512</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic1efb1864b5d4f41a6d229d84f58d0e1_I20200328" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMi05LTEtMS0w_7a126ed2-7f35-4f7f-849e-ca164ef895d3">45,135</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMi0xMS0xLTEtMA_cc363dae-01d0-433c-a56b-89bf53e2b996">587,109</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if6dd2f02aa774a31a839f57971d93f2e_D20200329-20200627" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMy0xLTEtMS0w_1b4d2f2c-71d7-4f77-9444-1f19e1b4fd5e">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98d0d3136b6e4534bd099c082763c527_D20200329-20200627" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMy01LTEtMS0w_c4341b58-4add-4507-85ca-4db07787e2a1">2,144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07f570d9a0854ee48af28be5af08a344_D20200329-20200627" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMy0xMS0xLTEtMA_290f6873-c9c4-4299-9b46-0869dcbe2751">2,144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if6dd2f02aa774a31a839f57971d93f2e_D20200329-20200627" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfNC0xLTEtMS0w_2d248aab-24ef-4723-a2e7-5b79ae7ec55d">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6dd2f02aa774a31a839f57971d93f2e_D20200329-20200627" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfNC0zLTEtMS0w_83bf192d-d900-4db6-9b03-357fe01a64f0">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98d0d3136b6e4534bd099c082763c527_D20200329-20200627" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfNC01LTEtMS0w_0af101d0-a6e5-41f8-9bca-1ac7eef91c5a">1,192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07f570d9a0854ee48af28be5af08a344_D20200329-20200627" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfNC0xMS0xLTEtMA_649fce95-5664-4531-9380-9612fd45ea4d">1,193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of restricted stock, net of cancellations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if6dd2f02aa774a31a839f57971d93f2e_D20200329-20200627" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfNi0xLTEtMS0w_a1020844-4e6a-4e3b-bd59-86a138e94e15">298</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6dd2f02aa774a31a839f57971d93f2e_D20200329-20200627" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfNi0zLTEtMS0w_c39b8fd4-3f2e-4474-a6a2-749e38367977">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98d0d3136b6e4534bd099c082763c527_D20200329-20200627" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfNi01LTEtMS0w_3466ab2e-770c-41cd-9a91-950bb1f15d80">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07f570d9a0854ee48af28be5af08a344_D20200329-20200627" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfNi0xMS0xLTEtMA_d9397bd2-90f8-4567-8afb-aaa1744a586c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98d0d3136b6e4534bd099c082763c527_D20200329-20200627" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfNy01LTEtMS0w_e6da5b1a-a93e-456d-b12b-0acca995214c">6,167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07f570d9a0854ee48af28be5af08a344_D20200329-20200627" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfNy0xMS0xLTEtMA_7833b740-48d9-4f4c-aba0-def7d965e65c">6,167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07cbfd44a12f4311afb21d55a472de13_D20200329-20200627" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfOS03LTEtMS0w_b67c4fb7-2131-49fb-9269-e1631a354c79">10,527</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07f570d9a0854ee48af28be5af08a344_D20200329-20200627" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfOS0xMS0xLTEtMA_dc120ebd-3584-423d-9cb7-ce31d10e6440">10,527</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3694a6c7d953431dbcadb946b1f414c2_D20200329-20200627" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMTAtOS0xLTEtMA_b5383c9f-b31c-4279-9640-380bbbf0e609">1,429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07f570d9a0854ee48af28be5af08a344_D20200329-20200627" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMTAtMTEtMS0xLTA_61e2cbd1-e91c-4fba-9720-4f139ea6c25a">1,429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, June 27, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1e7c8087bac9435c9d82d1fedfbff52e_I20200627" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMTEtMS0xLTEtMA_494cd577-b0f2-429a-856a-1cef1ba9b6d0">50,671</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e7c8087bac9435c9d82d1fedfbff52e_I20200627" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMTEtMy0xLTEtMA_aa379bd3-1782-418e-9352-7e1bae7014fd">507</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31fa2bd3032a476cb1c1b205b1125b8d_I20200627" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMTEtNS0xLTEtMA_c5d2c624-602a-4e0a-88a7-23d1c92833b4">562,729</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2fb46a5a8af4e3188ae02ca82d7f05e_I20200627" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMTEtNy0xLTEtMA_c991bb12-10ed-4104-a70d-acae6e3e54fa">89,039</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i371aab8c0d604c439b36e469dfeb7ae1_I20200627" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMTEtOS0xLTEtMA_1c058690-5c7f-4ae2-adcb-fc3f90922ab1">43,706</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8de24c4e5ca9457ba67c9faa95840867_I20200627" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMTEtMTEtMS0xLTA_58cc8c77-31df-4118-b649-a91343b3434b">608,569</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idb62b5f06b724ac49c887e404027a4ab_D20200628-20200926" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMTMtMS0xLTEtMA_c7b56afc-3b4d-4350-a1e0-b82e3ca85833">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb62b5f06b724ac49c887e404027a4ab_D20200628-20200926" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMTMtMy0xLTEtMA_5a2d8c16-8e8b-47df-9e58-0612f9a2f949">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c87b6d14b0e4daf97ae63c97329dc5f_D20200628-20200926" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMTMtNS0xLTEtMA_1994910c-8a17-454d-8735-024b51cb2495">67</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53c39140b1904bbe8f3f81c2a2ec9a42_D20200628-20200926" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMTMtMTEtMS0xLTA_0b988ffa-74ab-4f98-bcb0-0af339491919">67</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of restricted stock, net of cancellations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idb62b5f06b724ac49c887e404027a4ab_D20200628-20200926" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMTUtMS0xLTEtMA_b63f893f-6aff-4c32-98c0-9c92dfafcb5e">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb62b5f06b724ac49c887e404027a4ab_D20200628-20200926" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMTUtMy0xLTEtMA_6287f876-5047-4b94-9d05-47859972192a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c87b6d14b0e4daf97ae63c97329dc5f_D20200628-20200926" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMTUtNS0xLTEtMA_c03fc04c-9db6-4118-aec2-7ea27392a8ee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53c39140b1904bbe8f3f81c2a2ec9a42_D20200628-20200926" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMTUtMTEtMS0xLTA_e93f586b-99e5-4a92-af68-23a7b3da4bb1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c87b6d14b0e4daf97ae63c97329dc5f_D20200628-20200926" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMTYtNS0xLTEtMA_aa326b81-f58c-458b-ad38-82744ca20dd6">5,952</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53c39140b1904bbe8f3f81c2a2ec9a42_D20200628-20200926" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMTYtMTEtMS0xLTA_8d7fa5b8-227a-487c-a92f-27e2dd4fd2ee">5,952</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cade1e4d1894ebcbacdb9ac1d8529d3_D20200628-20200926" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMTgtNy0xLTEtMA_632dfafd-f7aa-4256-8c4a-025250a0fb7e">48,101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53c39140b1904bbe8f3f81c2a2ec9a42_D20200628-20200926" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMTgtMTEtMS0xLTA_763bb87f-bbdb-4dce-92db-c229e5275849">48,101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib49fa4ce64654900825a35f23c5fe8a0_D20200628-20200926" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMTktOS0xLTEtMA_7f2638c8-5220-4507-b303-d6b7ae4bb1a1">5,234</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53c39140b1904bbe8f3f81c2a2ec9a42_D20200628-20200926" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMTktMTEtMS0xLTA_b8a38552-ecb3-4a56-bc32-41340b3e7c49">5,234</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, September 26, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3b695da1c7ae4c91ad9625021564f186_I20200926" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMjAtMS0xLTEtMA_12ac0380-f3c0-41fc-b8ad-03d6370e91e2">50,703</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b695da1c7ae4c91ad9625021564f186_I20200926" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMjAtMy0xLTEtMA_b73389bd-ccf5-4d87-b326-9c1de20118d5">507</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11d7a90961554152b7611178522b5b4b_I20200926" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMjAtNS0xLTEtMA_f150b144-afc4-40fa-a64c-f8428135540f">568,748</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86938e4e5827482b8bb6a25573904ac1_I20200926" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMjAtNy0xLTEtMA_f0767903-7105-47a6-b7a5-13a5aa6990ec">137,140</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0809a2c180d446f385e5eb23f3c7098a_I20200926" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMjAtOS0xLTEtMA_aa27868f-dfa4-424b-991c-98a72686566c">38,472</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32fa3388584544f9a03ffc1d8057d360_I20200926" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMjAtMTEtMS0xLTA_3831feea-743e-44c8-9586-db1229f34ee4">667,923</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3b2f8ac7c8044d99a51a1c40cfc06202_D20200927-20201226" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMjEtMS0xLTEtMA_c0cbd132-add0-470f-b5d9-8cb3cc8580df">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2f8ac7c8044d99a51a1c40cfc06202_D20200927-20201226" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMjEtMy0xLTEtMA_a47d8968-860d-4a78-b543-31c589b9308c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bb87bf0127e4aafa52d782d9e0aa0ee_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMjEtNS0xLTEtMA_013178a7-528c-4e77-8e56-7d0adad64b30">1,868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMjEtMTEtMS0xLTA_55dcb42a-a302-46ac-952a-f052ee887ba7">1,868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3b2f8ac7c8044d99a51a1c40cfc06202_D20200927-20201226" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMjItMS0xLTEtMA_7458aefe-e18f-4081-b432-74943e41741e">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bb87bf0127e4aafa52d782d9e0aa0ee_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMjItNS0xLTEtMA_94c8f7d1-2e52-4620-b0f7-5b95d26001de">2,578</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMjItMTEtMS0xLTA_acf48c02-430a-4c13-ae86-26c4e90d7116">2,578</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of restricted stock, net of cancellations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3b2f8ac7c8044d99a51a1c40cfc06202_D20200927-20201226" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMjQtMS0xLTEtMA_d2dd6f88-7559-42cc-96a4-fc5364ef27e6">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b2f8ac7c8044d99a51a1c40cfc06202_D20200927-20201226" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMjQtMy0xLTEtMA_d647bca3-7929-4f52-b856-7cc07e75ba71">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7bb87bf0127e4aafa52d782d9e0aa0ee_D20200927-20201226" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMjQtNS0xLTEtMA_d850a237-e20b-4af8-9acf-380665be7049">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMjQtMTEtMS0xLTA_05e62502-07e3-4a18-852e-3a2bbf5cdd9e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bb87bf0127e4aafa52d782d9e0aa0ee_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMjUtNS0xLTEtMA_25694dcb-73b0-4e70-8b62-23028da654fa">6,287</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMjUtMTEtMS0xLTA_6fd287dd-af0b-4a6a-9305-2099ca61664b">6,287</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i593e5b9ceb9240d1888435f827c761eb_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMjctNy0xLTEtMA_e68609d9-a6d0-499d-bec8-8ea622e75f8c">31,882</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMjctMTEtMS0xLTA_d62e9233-5514-46dc-8c05-27f96c5c751f">31,882</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00bd6a8c6c87470d94b98154b4ed663c_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMjgtOS0xLTEtMA_bfc1a22b-4451-4e1b-9b17-97c3a6accad8">8,614</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMjgtMTEtMS0xLTA_d4e4b7b2-05ba-497e-b456-9fd232724968">8,614</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, December 26, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifb893eb36e724d78b750bf760d6e530a_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMjktMS0xLTEtMA_0475f0b9-7ac3-45fd-aa7b-ae87256496aa">50,817</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb893eb36e724d78b750bf760d6e530a_I20201226" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMjktMy0xLTEtMA_79550a8f-4bf7-4fe9-be14-79dabe468c1f">508</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0c3ea92ba584163a7dfa754dd67152c_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMjktNS0xLTEtMA_fa49d5f1-9f9e-4615-a47e-caa4a532fdbe">579,480</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bfeea1c445b4bbfac0cf8cc2616054f_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMjktNy0xLTEtMA_7173e1c3-1a8e-4919-af30-74b0fb0b7ee2">169,022</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0dd7da6b8cfa47a1852a89e52d0d489d_I20201226" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMjktOS0xLTEtMA_bb734b77-d961-474e-966d-b76fff2b255c">29,858</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMjktMTEtMS0xLTA_2720518e-908c-4941-8b1f-1c2fd4fa0358">719,152</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:4pt;text-align:center"><span><br/></span></div><div style="margin-top:4pt;text-align:center"><span><br/></span></div><div style="margin-top:4pt;text-align:center"><span><br/></span></div><div style="margin-top:4pt;text-align:center"><span><br/></span></div><div style="margin-top:4pt;text-align:center"><span><br/></span></div><div style="margin-top:4pt;text-align:center"><span><br/></span></div><div style="margin-top:4pt;text-align:center"><span><br/></span></div><div style="margin-top:4pt;text-align:center"><span><br/></span></div><div style="margin-top:4pt;text-align:center"><span><br/></span></div><div style="margin-top:4pt;text-align:center"><span><br/></span></div><div style="margin-top:4pt;text-align:center"><span><br/></span></div><div style="margin-top:4pt;text-align:center"><span><br/></span></div><div style="margin-top:4pt;text-align:center"><span><br/></span></div><div style="margin-top:4pt;text-align:center"><span><br/></span></div><div style="margin-top:4pt;text-align:center"><span><br/></span></div><div style="margin-top:4pt;text-align:center"><span><br/></span></div><div style="margin-top:4pt;text-align:center"><span><br/></span></div><div style="margin-top:4pt;text-align:center"><span><br/></span></div><div style="margin-top:4pt;text-align:center"><span><br/></span></div><div style="margin-top:4pt;text-align:center"><span><br/></span></div><div style="margin-top:4pt;text-align:center"><span><br/></span></div><div style="margin-top:4pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HAEMONETICS CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited in thousands)</span></div><div style="margin-bottom:5pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:37.895%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.808%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.171%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.690%"></td><td style="width:0.1%"></td></tr><tr style="height:26pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional<br/>Paid-in Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>Stockholders&#8217; Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Par Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, March 30, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i13923cc91bcd4918b0cd47b138b0c826_I20190330" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMi0xLTEtMS0w_281c4b1d-d614-4be2-b0d4-e890f31eb33b">51,020</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13923cc91bcd4918b0cd47b138b0c826_I20190330" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMi0zLTEtMS0w_1a5322a0-8048-4429-b716-bfb42ec9cbbf">510</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id87d83aa2a9a48168fe6363c8adf8a60_I20190330" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMi01LTEtMS0w_3ef0604d-6d2d-4fe6-91f9-9494a39972e4">536,320</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie49c0793891c4f9b9446cafe5a44063b_I20190330" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMi03LTEtMS0w_01b599a3-292c-457f-a870-5a1041d4a470">161,418</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4294e77e77b744d1a79deeae24bc95c9_I20190330" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMi05LTEtMS0w_542318d3-41ee-43a2-b050-83436c660536">30,380</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief541fbd0adf409c9514798c114d14d4_I20190330" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMi0xMS0xLTEtMA_fa8f63cd-9608-4d30-99d7-17a001e7274b">667,868</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i79fce91b6c7e4ee895ae77d545ae7cac_D20190331-20190629" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMy0xLTEtMS0w_0d1748cd-ccb9-49ad-b11f-280cc557e038">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fce91b6c7e4ee895ae77d545ae7cac_D20190331-20190629" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMy0zLTEtMS0w_b3ec2fa1-eea1-41d4-a81a-c0a69de66328">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab444088a1f343aab3754df7e9900053_D20190331-20190629" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMy01LTEtMS0w_56795e53-66ec-4287-bcf2-a91f46d0816c">1,830</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58aa4c71425b490eabe0528109268325_D20190331-20190629" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMy0xMS0xLTEtMA_adbcf5b1-b188-4f8a-8762-f06a9fc7ec5e">1,830</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i79fce91b6c7e4ee895ae77d545ae7cac_D20190331-20190629" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfNC0xLTEtMS0w_6980a306-7b2d-46a1-944a-96dd52bd7455">85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fce91b6c7e4ee895ae77d545ae7cac_D20190331-20190629" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfNC0zLTEtMS0w_e5dd5c2d-5a74-4e04-a3bb-9a9cd55e1568">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab444088a1f343aab3754df7e9900053_D20190331-20190629" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfNC01LTEtMS0w_a8186030-3774-4bfb-8eaa-24e9564b97b1">3,634</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58aa4c71425b490eabe0528109268325_D20190331-20190629" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfNC0xMS0xLTEtMA_6174d377-e7ac-4a20-b2ca-0940e73701ca">3,635</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares repurchased</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i79fce91b6c7e4ee895ae77d545ae7cac_D20190331-20190629" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfNS0xLTEtMS0w_270fcc8a-b8cd-4d61-b46f-a3e8d0091f5e">616</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i79fce91b6c7e4ee895ae77d545ae7cac_D20190331-20190629" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfNS0zLTEtMS0w_24787e61-edf6-420e-89d7-b5c5f1fb2093">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab444088a1f343aab3754df7e9900053_D20190331-20190629" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfNS01LTEtMS0w_325128fc-7b31-40ac-a900-a58b4d2b66c0">21,473</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i856b92cb87d749768e7bc9dd5dd377bb_D20190331-20190629" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfNS03LTEtMS0w_691a71ed-0911-47f0-a394-67c1f629f7f3">53,521</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58aa4c71425b490eabe0528109268325_D20190331-20190629" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfNS0xMS0xLTEtMA_db2dd110-621d-4ba0-a614-5e45d243f3d3">75,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of restricted stock, net of cancellations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i79fce91b6c7e4ee895ae77d545ae7cac_D20190331-20190629" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfNi0xLTEtMS0w_7ea6cde7-64dc-4094-bfd2-ce9c706f3137">257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fce91b6c7e4ee895ae77d545ae7cac_D20190331-20190629" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfNi0zLTEtMS0w_c2aa9e8c-42ce-4110-8bc7-e40cbd1c7293">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab444088a1f343aab3754df7e9900053_D20190331-20190629" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfNi01LTEtMS0w_cc491aa0-e5c7-46d1-a1f9-82ffaff4bdc7">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58aa4c71425b490eabe0528109268325_D20190331-20190629" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfNi0xMS0xLTEtMA_1a253b36-da38-4e95-90b4-dc28bfb6ff6a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab444088a1f343aab3754df7e9900053_D20190331-20190629" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfNy01LTEtMS0w_c88f2c98-4304-42dc-9fa1-5cb41cf4afc6">4,730</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58aa4c71425b490eabe0528109268325_D20190331-20190629" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfNy0xMS0xLTEtMA_131ef81e-6a2c-4f49-9830-c6dd51fd6e7e">4,730</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i856b92cb87d749768e7bc9dd5dd377bb_D20190331-20190629" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfOS03LTEtMS0w_aff7eaa3-1714-465f-900e-2d3ca6673775">8,479</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58aa4c71425b490eabe0528109268325_D20190331-20190629" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfOS0xMS0xLTEtMA_4e7ac715-1c75-40f1-a6dd-2292daa24cbc">8,479</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifeab2898c30e44abac79ea28e3a13d7b_D20190331-20190629" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMTAtOS0xLTEtMA_b3ab27f8-943f-4208-b6b2-c1e661c14bc2">3,618</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58aa4c71425b490eabe0528109268325_D20190331-20190629" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMTAtMTEtMS0xLTA_2bc4f5bc-96a9-4e96-8154-d42e22877777">3,618</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, June 29, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i44d85e61a03348ac976af3cd59985a40_I20190629" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMTEtMS0xLTEtMA_d5fe4d39-b263-4b05-86b0-7d9c7049c12d">50,771</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44d85e61a03348ac976af3cd59985a40_I20190629" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMTEtMy0xLTEtMA_7f988a7d-222b-4db5-a907-14ea4e007cea">508</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i977ae884714349048379a8f918f47155_I20190629" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMTEtNS0xLTEtMA_80140d3d-287a-4a52-9e75-2ac28eb53892">525,038</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28e2deb2f39545f994371185aa291fd9_I20190629" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMTEtNy0xLTEtMA_00e1a474-86ec-4e0a-8f92-b0a00082e759">99,418</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifcc6781b9c184013b3ebcc9dd2da2e75_I20190629" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMTEtOS0xLTEtMA_0e54b0cc-b2b3-430c-b944-2c31afe8b9e4">33,998</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib446da48c08e4f9e9211152ee5dc9758_I20190629" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMTEtMTEtMS0xLTA_b90a03fb-4edc-429f-a3ff-f87dca90cb83">590,966</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic3be29de096b43b59d76094a1a86ec73_D20190630-20190928" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMTMtMS0xLTEtMA_c0f41520-422a-4dcf-8322-cf02346cad7b">64</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3be29de096b43b59d76094a1a86ec73_D20190630-20190928" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMTMtMy0xLTEtMA_edf3ca28-5bfa-492f-84c3-655585a7feee">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b7a68038f8b43a9ad82e2d31b79cdad_D20190630-20190928" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMTMtNS0xLTEtMA_b705cd7d-8828-415e-8e85-05cf97762aa8">2,409</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11e5dd1a63a349b98dfe50b20ed69371_D20190630-20190928" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMTMtMTEtMS0xLTA_30527515-7364-4ff6-b72a-8086aa3b0dfe">2,410</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares repurchased</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ic3be29de096b43b59d76094a1a86ec73_D20190630-20190928" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMTQtMS0xLTEtMA_4c8001e7-4800-48a2-912a-23211ac1221f">360</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic3be29de096b43b59d76094a1a86ec73_D20190630-20190928" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMTQtMy0xLTEtMA_fd3777a8-affc-4e7f-9e54-3cc5ad46ae5b">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b7a68038f8b43a9ad82e2d31b79cdad_D20190630-20190928" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMTQtNS0xLTEtMA_33dd4017-1474-496e-9220-0e8e17288491">1,274</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4718bcfebbe44fb8dd41c9d91c87ba9_D20190630-20190928" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMTQtNy0xLTEtMA_9d42c8c7-3fa2-4ea5-a59a-93f378b81812">51,270</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11e5dd1a63a349b98dfe50b20ed69371_D20190630-20190928" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMTQtMTEtMS0xLTA_893e0892-f2b9-4a0a-8adf-1b243f567e96">50,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of restricted stock, net of cancellations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic3be29de096b43b59d76094a1a86ec73_D20190630-20190928" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMTUtMS0xLTEtMA_ca03bf64-be9b-40a9-8aff-68b6b480ab24">133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3be29de096b43b59d76094a1a86ec73_D20190630-20190928" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMTUtMy0xLTEtMA_3501ee28-6a85-48e1-a1f0-4301dd787271">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b7a68038f8b43a9ad82e2d31b79cdad_D20190630-20190928" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMTUtNS0xLTEtMA_6c9a70b3-332d-49cf-9b70-d92af561fa8e">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11e5dd1a63a349b98dfe50b20ed69371_D20190630-20190928" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMTUtMTEtMS0xLTA_b8439e34-9b03-4503-8faa-56924d3a9eed">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b7a68038f8b43a9ad82e2d31b79cdad_D20190630-20190928" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMTYtNS0xLTEtMA_4f1c30e7-6728-4392-8e50-0fd4bfa0ba2c">5,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11e5dd1a63a349b98dfe50b20ed69371_D20190630-20190928" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMTYtMTEtMS0xLTA_3f9e94d7-7de4-48fe-91a6-c2a2bd55383f">5,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4718bcfebbe44fb8dd41c9d91c87ba9_D20190630-20190928" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMTgtNy0xLTEtMA_04a47dd2-2e4e-4068-a2de-7eac18fc09cd">37,486</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11e5dd1a63a349b98dfe50b20ed69371_D20190630-20190928" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMTgtMTEtMS0xLTA_bac408d8-13d4-468a-bb5e-d602afe9da59">37,486</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6a8dccbf5b0e46dd9089c29ee8278a27_D20190630-20190928" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMTktOS0xLTEtMA_8d51b5a3-2b81-4362-a369-6839bd251e86">2,108</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11e5dd1a63a349b98dfe50b20ed69371_D20190630-20190928" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMTktMTEtMS0xLTA_6a7f88d5-5c2b-44ee-9a1d-4d4055876305">2,108</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, September 28, 2019</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie63b3633289a4dc68fd18c6df9378c99_I20190928" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjAtMS0xLTEtMA_563a853c-a872-472b-b0dc-188453b414e8">50,608</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie63b3633289a4dc68fd18c6df9378c99_I20190928" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjAtMy0xLTEtMA_20771231-ca3a-4e82-9ca0-10088d4f6fd5">506</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if08c7a9f75a04b27aee3f352a3ac162a_I20190928" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjAtNS0xLTEtMA_39400e70-c2ee-4bd8-82e7-479ef4a96529">533,720</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i960c732942cc46598e20801270314713_I20190928" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjAtNy0xLTEtMA_d090b9dc-0e1d-41be-af8a-d8b11873cc79">85,634</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5f49655e125c49c2893f2cfe850a84c4_I20190928" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjAtOS0xLTEtMA_e73b87e8-6a70-4a5a-aa75-8591922bca48">36,106</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if62547d494fe448f98e6b8c907702474_I20190928" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjAtMTEtMS0xLTA_29e1e659-129d-466e-bd58-2ee990562bc7">583,754</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib8048eb98c0f42aeb56fecb8379edd69_D20190929-20191228" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjEtMS0xLTEtMA_24c4e56e-1c72-483a-a1cb-bb5988d49cd6">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8048eb98c0f42aeb56fecb8379edd69_D20190929-20191228" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjEtMy0xLTEtMA_76bc7407-1889-4689-93b0-44db3c7a2606">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib55ff0c99eb34464a7e8eda801ade4ca_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjEtNS0xLTEtMA_55a74a76-d65f-4c8e-84a1-70f1e22f7a70">1,537</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjEtMTEtMS0xLTA_4a9fedff-7663-473b-8f3f-11da52059bd4">1,538</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib8048eb98c0f42aeb56fecb8379edd69_D20190929-20191228" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjItMS0xLTEtMA_cb8c5f68-72c2-475c-b0b9-0541990f2048">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8048eb98c0f42aeb56fecb8379edd69_D20190929-20191228" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjItMy0xLTEtMA_b5b2c1cb-707c-49f8-ae2c-b44face9efcf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib55ff0c99eb34464a7e8eda801ade4ca_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjItNS0xLTEtMA_2363e628-c07c-46ef-b95c-80353ad0bd56">1,667</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjItMTEtMS0xLTA_6b10a032-8c61-462e-9555-2eb7423b7b4b">1,667</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares repurchased</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ib8048eb98c0f42aeb56fecb8379edd69_D20190929-20191228" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjMtMS0xLTEtMA_4bd45463-1985-49b5-afc6-18a2bc629472">411</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8048eb98c0f42aeb56fecb8379edd69_D20190929-20191228" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjMtMy0xLTEtMA_6410e662-41d8-478a-a633-c3ce32d5a383">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib55ff0c99eb34464a7e8eda801ade4ca_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjMtNS0xLTEtMA_8aad431f-b77b-447b-a98e-b88e44e5da54">4,335</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i32d0e40ce5a64e91b5d91a3c4c9fa8ad_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjMtNy0xLTEtMA_ab12340f-afb5-494c-9aa8-a45da803a742">45,661</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjMtMTEtMS0xLTA_ec944232-f3e8-4673-b719-6daa64af6d0e">50,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of restricted stock, net of cancellations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib8048eb98c0f42aeb56fecb8379edd69_D20190929-20191228" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjQtMS0xLTEtMA_8f99078d-a642-4ee2-9aeb-3ab0bda96c71">114</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8048eb98c0f42aeb56fecb8379edd69_D20190929-20191228" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjQtMy0xLTEtMA_b0daf32b-8523-4d2a-902e-0197352902f0">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib55ff0c99eb34464a7e8eda801ade4ca_D20190929-20191228" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjQtNS0xLTEtMA_29696537-2998-4e1b-b8fb-976d04d3cee8">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjQtMTEtMS0xLTA_5b3ff0cc-2d92-4456-8dd2-d1bd4946b5cf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib55ff0c99eb34464a7e8eda801ade4ca_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjUtNS0xLTEtMA_c83bb1bd-204e-44f7-833a-489792430c28">5,325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjUtMTEtMS0xLTA_d96a071c-a508-4266-9ea1-11bfa2c223d8">5,325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32d0e40ce5a64e91b5d91a3c4c9fa8ad_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjctNy0xLTEtMA_2b412bf1-f84a-47a5-b9da-b95761e7373a">29,895</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjctMTEtMS0xLTA_9ee28fc2-9869-4224-915a-3de013daa712">29,895</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i357f065f29714ef2a554cacc02892fb9_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjgtOS0xLTEtMA_4effa0c1-670d-4438-8404-550fb30d5d38">2,401</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjgtMTEtMS0xLTA_14e8041c-8d66-409a-8a2d-f403f41a38a2">2,401</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, December 28, 2019</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2f2c9eca9e304ad9b69f801a97fc5dd6_I20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjktMS0xLTEtMA_7770373a-461e-45b0-a1eb-a5e151786133">50,391</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f2c9eca9e304ad9b69f801a97fc5dd6_I20191228" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjktMy0xLTEtMA_bebdfb95-5852-4771-bccc-9318a395ff0c">504</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb4f07ff3cbf4479a1d29d55b7330f7a_I20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjktNS0xLTEtMA_cccde9e7-3a6a-4936-9bf8-d7f847a2fb1b">537,913</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c64ccfff7864e46907e03a928ba5c42_I20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjktNy0xLTEtMA_be5949c0-186f-4e67-847c-2cf0fb2a7655">69,868</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i591c8e13af6e49d391c4c0e273d6a551_I20191228" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjktOS0xLTEtMA_17c7c883-919c-4705-a557-9f7acdfea32e">33,705</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic35a4df7f44a40e5a674e72ae5bf6205_I20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjktMTEtMS0xLTA_f68fca80-da0d-4da2-a706-dd0b1b752c1d">574,580</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:4pt;text-align:center"><span><br/></span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="margin-top:4pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="ib1e23e354c9c424096b27d04c70f5a5a_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HAEMONETICS CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited in thousands) </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:69.721%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.122%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.124%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash Flows from Operating Activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMy0xLTEtMS0w_f14be7c7-9723-45dd-8a92-bd00bc5b28a2">90,510</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMy0zLTEtMS0w_8d01ec91-451e-40d9-9b79-f8af80f85c44">58,902</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-cash items:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfNi0xLTEtMS0w_64d2a936-5874-4a5d-b24d-503db3e8169f">62,377</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfNi0zLTEtMS0w_53705387-433c-4f37-9127-8b81fbfb751e">81,524</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment of assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfNy0xLTEtMS0w_c7a58b94-0041-4bd8-a793-5dc58d40d488">1,028</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfNy0zLTEtMS0w_098edfcb-7b21-4614-9039-9068480f6c25">50,597</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfOC0xLTEtMS0w_583a493e-2137-4648-b6b1-d45807128d98">18,406</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfOC0zLTEtMS0w_ffed898b-0bb2-472c-aefb-e7e72f45b106">15,055</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DeferredOtherTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfOS0xLTEtMS0w_a19e59bb-26ba-4fbf-8fa5-70e25b751cf5">3,953</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DeferredOtherTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfOS0zLTEtMS0w_c758dea7-d2aa-4767-9fd0-46e2a4e7f6b4">4,747</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision for losses on accounts receivable and inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProvisionForLoanLeaseAndOtherLosses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMTAtMS0xLTEtMA_a65bd315-c488-4609-9205-8c6dd0a749b9">2,942</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProvisionForLoanLeaseAndOtherLosses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMTAtMy0xLTEtMA_37dd0a28-770e-42c1-95f8-5cb88aeeaace">2,246</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gains on divestitures and sale of assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="hae:GainLossOnDivestitureAndSaleOfAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMTEtMS0xLTEtMA_c24703f1-e599-44d7-b6aa-947d0eaf5f30">32,613</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="hae:GainLossOnDivestitureAndSaleOfAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMTEtMy0xLTEtMA_45dbbe0f-a231-4d47-82f6-6f91388e45cb">8,083</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-cash operating activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMTItMS0xLTEtMA_8d19500a-49a8-4dd3-b24b-cf1bcdc90f8a">1,351</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMTItMy0xLTEtMA_11daadce-cd40-4b14-8a96-2209113b3c1b">1,945</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMTQtMS0xLTEtMA_79bd87d8-a29e-4fc6-8353-ca69f14e79ce">18,588</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMTQtMy0xLTEtMA_e3ffc046-ec8c-4413-b2a1-15fca22cd0a9">13,807</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMTUtMS0xLTEtMA_65707846-d274-4a04-b365-70a08ce4d200">33,728</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMTUtMy0xLTEtMA_70243606-4590-45e8-98c2-e424dc03f827">68,251</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in prepaid income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInPrepaidTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMTYtMS0xLTEtMA_74890265-2ea4-4cd8-8b5a-e1bd2b5bc581">1,181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMTYtMy0xLTEtMA_0a16b3ae-80a5-4c13-bcb1-039d2a13bab5">273</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in other assets and other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMTctMS0xLTEtMA_4dff906d-0f46-4059-83f8-5b88878cf1d4">2,687</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMTctMy0xLTEtMA_1e458039-301a-49b8-abff-b0914f33a86e">8,829</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMTgtMS0xLTEtMA_cb65dbee-6855-450c-a914-dae65723902e">21,518</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMTgtMy0xLTEtMA_fbfd36de-b4fd-424f-b5d6-e181a98db96c">17,590</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMTktMS0xLTEtMA_7878335a-000e-4117-90b1-c0727cd97a7c">107,258</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMTktMy0xLTEtMA_eb0e2244-7c24-441e-ba38-5018a2a0bd8b">111,811</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash Flows from Investing Activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMjEtMS0xLTEtMA_c0346216-0ad1-4efd-bf40-77368ab9fce1">25,408</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMjEtMy0xLTEtMA_a3bf0c35-7e29-4225-b33b-281c2df59a21">38,112</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMjItMS0xLTEtMA_41f6ba09-45dd-4316-bf8e-cb12823dbf8e">16,606</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMjItMy0xLTEtMA_f086916f-a89b-4123-ac0f-5b518581928b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from divestitures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMjMtMS0xLTEtMA_1324fdf8-34de-4250-9b8b-39e2ee9e952c">44,587</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMjMtMy0xLTEtMA_96ab9062-3a3d-47e6-b66a-67c6a6297cf2">9,808</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from sale of property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMjQtMS0xLTEtMA_7a78e459-5d94-42bc-8d82-e365c48844d0">1,085</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMjQtMy0xLTEtMA_bd4c676d-dfac-41ad-a081-84c288cf7527">16,263</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by (used in) investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMjUtMS0xLTEtMA_1df169bc-855a-4462-8e4e-e74ebe491f74">3,658</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMjUtMy0xLTEtMA_41a1ede4-daf5-4b07-966d-805790331547">12,041</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash Flows from Financing Activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (decrease) increase in short-term loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMjctMS0xLTEtMA_cef00816-7cfb-4add-9500-de36a59ea319">60,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMjctMy0xLTEtMA_1ffc49b9-0fc2-4a26-9b9f-017a58ddb544">30,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayment of term loan borrowings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMjgtMS0xLTEtMA_9415b342-d5f6-4a3a-8967-f6ddb4a6660a">13,125</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMjgtMy0xLTEtMA_14a376a6-a557-4f6d-a5b9-93f3e54bcf8f">8,750</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share repurchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsForRepurchaseOfEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMjktMS0xLTEtMA_184f8bed-0a1d-4d90-8500-23dec01a9c84">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsForRepurchaseOfEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMjktMy0xLTEtMA_25f09f57-ecd6-43c0-9797-948879aa9532">175,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeStockOwnershipPlanESOPCashContributionsToESOP" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMzAtMS0xLTEtMA_a046cfe6-083f-4da4-924b-ebf96f2cc545">4,012</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeStockOwnershipPlanESOPCashContributionsToESOP" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMzAtMy0xLTEtMA_7b81ae51-bfc4-48fc-8dad-f5d730f1e71a">3,368</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMzEtMS0xLTEtMA_780698db-3c3d-45c4-a762-b38838908389">3,838</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMzEtMy0xLTEtMA_c90f1733-6525-4fd3-9386-5bdb369e701b">7,712</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMzItMS0xLTEtMA_a9901bb4-d1f7-41d6-acf3-edd8c89cec6a">32</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMzItMy0xLTEtMA_960363d2-e953-4e1e-8730-7c3e2f10f02c">90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMzMtMS0xLTEtMA_1ec81d00-a08a-4007-96c9-7b87d554bfb8">65,307</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMzMtMy0xLTEtMA_d2f156af-05f0-4a15-acc2-ff7e8aaacdfd">142,580</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of exchange rates on cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMzQtMS0xLTEtMA_e20de9d2-8f1f-454e-a6cf-106fe21cffff">6,082</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMzQtMy0xLTEtMA_9509da19-425a-4155-a3cb-c584d729a378">124</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net Change in Cash and Cash Equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMzUtMS0xLTEtMA_249261c8-3624-4da7-b6c6-cd686d376669">51,691</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMzUtMy0xLTEtMA_0efda6a2-28c0-4fb9-ba95-08d5866e8a9c">42,934</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and Cash Equivalents at Beginning of Period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMzYtMS0xLTEtMA_266ba266-2462-4d5b-935c-e553b9fe84be">137,311</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief541fbd0adf409c9514798c114d14d4_I20190330" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMzYtMy0xLTEtMA_47981fba-b997-417a-a440-cd83e818afe1">169,351</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash and Cash Equivalents at End of Period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMzctMS0xLTEtMA_2c02341e-4075-4d7b-a511-8c61f1d29cd5">189,002</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic35a4df7f44a40e5a674e72ae5bf6205_I20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMzctMy0xLTEtMA_f3ac193d-942f-4da8-8e88-fc07ad0a1a89">126,417</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supplemental Disclosures of Cash Flow Information:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest paid</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMzktMS0xLTEtMA_7efc88c4-7113-4391-b86c-8623fcce0f15">6,070</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMzktMy0xLTEtMA_06878e47-4bda-49bd-a423-6a6b68e676ce">10,739</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income taxes paid</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxesPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfNDAtMS0xLTEtMA_bdcb0d1c-880d-43e1-b84e-d0bd25a55f77">5,612</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxesPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfNDAtMy0xLTEtMA_65357137-900c-4921-952a-848a1e0aec54">9,888</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-Cash Investing and Financing Activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transfers from inventory to fixed assets for placement of Haemonetics equipment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="hae:TransfersFromInventoryToFixedAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfNDItMS0xLTEtMA_8d7a86ff-81bd-473e-8111-b605126bd584">5,878</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="hae:TransfersFromInventoryToFixedAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfNDItMy0xLTEtMA_7b097a66-1415-42fe-a167-1f80be7858d8">10,705</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="ib1e23e354c9c424096b27d04c70f5a5a_31"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HAEMONETICS CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span><br/></span></div><div id="ib1e23e354c9c424096b27d04c70f5a5a_34"></div><ix:nonNumeric contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8zNC9mcmFnOmIxYTE2MDU0NWZhNjQxNDhhOGUxZDE5ZTIxMGJhYzQ0L3RleHRyZWdpb246YjFhMTYwNTQ1ZmE2NDE0OGE4ZTFkMTllMjEwYmFjNDRfMTg1NQ_f3b16e71-fb1f-448e-b084-5b5ad6da6e6c" continuedAt="i3577e572224c4705a472c00733934248" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. BASIS OF PRESENTATION </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements of Haemonetics Corporation (&#8220;Haemonetics&#8221; or the &#8220;Company&#8221;) presented herein have been prepared in accordance with generally accepted accounting principles in the United States of America (&#8220;U.S. GAAP&#8221;) for interim financial information and with the instructions to Form 10-Q and Article&#160;10 of Regulation&#160;S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of the Company's management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included. All intercompany transactions have been eliminated. Operating results for the nine months ended December 26, 2020 are not necessarily indicative of the results that may be expected for the full fiscal year ending April&#160;3, 2021 or any other interim period. The Company has assessed its ability to continue as a going concern. As of December&#160;26, 2020, the Company has concluded that substantial doubt about its ability to continue as a going concern does not exist. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and footnotes included in the annual report on Form 10-K for the fiscal year ended March&#160;28, 2020.</span></div></ix:nonNumeric><div><span><br/></span></div><div><ix:continuation id="i3577e572224c4705a472c00733934248" continuedAt="i9bc47dac6c9c45f7aed81343295ba5bd"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers events or transactions that occur after the balance sheet date but prior to the issuance of the financial statements to provide additional evidence relative to certain estimates or to identify matters that require additional disclosure. Refer to Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i9bc47dac6c9c45f7aed81343295ba5bd"> for information pertaining to acquisitions that were signed or closed subsequent to December&#160;26, 2020. There were no other material recognized or unrecognized subsequent events as of or for the three and nine months ended December&#160;26, 2020.</ix:continuation> </span></div><div><span><br/></span></div><div id="ib1e23e354c9c424096b27d04c70f5a5a_37"></div><ix:nonNumeric contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" name="us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8zNy9mcmFnOjk0ODljZjI5ODNjODQyYzk4MWJkYTZiN2Y5ZmYwMTE5L3RleHRyZWdpb246OTQ4OWNmMjk4M2M4NDJjOTgxYmRhNmI3ZjlmZjAxMTlfMTI5NA_f226f96d-2a39-4305-9699-384a5117e2ea" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2. RECENT ACCOUNTING PRONOUNCEMENTS </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Standards Implemented</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Codification (&#8220;ASC&#8221;) Update No. 2016-13,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments &#8211; Credit Losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;(Topic 326). ASC Update No. 2016-13 is intended to replace the current incurred loss impairment methodology for financial assets measured at amortized cost with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information, including forecasted information, to develop credit loss estimates. The Company adopted ASC Update No. 2016-13 during the first quarter of fiscal 2021. The adoption did not have a material impact on the Company's unaudited condensed consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASC Update No. 2018-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles, Goodwill and Other - Internal-Use Software </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Subtopic 350-40). The new guidance aligns the accounting implementation costs incurred in a cloud computing arrangement that is a service contract with the accounting for internal-use software licenses. The Company adopted ASC Update No. 2018-15 during the first quarter of fiscal 2021. The adoption did not have a material impact on the Company's unaudited condensed consolidated financial statements.</span></div></ix:nonNumeric><div><span><br/></span></div><div id="ib1e23e354c9c424096b27d04c70f5a5a_40"></div><ix:nonNumeric contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RleHRyZWdpb246ZmMwYjM2YjgyNjgzNGVmMThmNTk3M2E4MjcxOGQ0MzFfMzIyNA_00676aa8-0047-4b02-bfdb-bb67bbeb70f9" continuedAt="ic2ee30d8d3c9495b8820acb2eb6605b9" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3. RESTRUCTURING </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On an ongoing basis, the Company reviews the global economy, the healthcare industry, and the markets in which it competes to identify opportunities for efficiencies, enhance commercial capabilities, align its resources and offer its customers better solutions. In order to realize these opportunities, the Company undertakes restructuring-type activities to transform its business.</span></div></ix:nonNumeric><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ic2ee30d8d3c9495b8820acb2eb6605b9" continuedAt="i676346b24ce244118c3e386070be4844"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2019, the Board of Directors of the Company approved a new Operational Excellence Program (the &#8220;2020 Program&#8221;) and delegated authority to the Company's management to determine the detail of the initiatives that will comprise the program. The 2020 Program is designed to improve operational performance and reduce cost principally in our manufacturing and supply chain operations. The Company estimates that it will incur aggregate charges between $<ix:nonFraction unitRef="usd" contextRef="i025a500d449145cdaf09b62761336e4d_I20201226" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RleHRyZWdpb246ZmMwYjM2YjgyNjgzNGVmMThmNTk3M2E4MjcxOGQ0MzFfODQ5_eb4a07ac-ca36-4e6e-88df-5e4ba3d69e83">60</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i0527d982aa5d4b1493f2febb15dfb36f_I20201226" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RleHRyZWdpb246ZmMwYjM2YjgyNjgzNGVmMThmNTk3M2E4MjcxOGQ0MzFfODU2_929ca29d-34d3-42a0-b93a-ebddfcf0c2d8">70</ix:nonFraction> million in connection with the 2020 Program. These charges, the majority of which will result in cash outlays, including severance and other employee costs, will be incurred as the specific actions required to execute these initiatives are identified and approved and are expected to be substantially completed by the end of fiscal 2023. During the three and nine months ended December 26, 2020, the Company incurred $<ix:nonFraction unitRef="usd" contextRef="ibd11a684655c47febfdbc8b572773803_D20200927-20201226" decimals="-5" format="ixt:numdotdecimal" name="hae:RestructuringandRestructuringRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RleHRyZWdpb246ZmMwYjM2YjgyNjgzNGVmMThmNTk3M2E4MjcxOGQ0MzFfMTIyNQ_f809a9d9-e322-484e-a5ec-5345e3a8bb31">3.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i36f501133aca4e94a40d5f53c2932604_D20200329-20201226" decimals="-5" name="hae:RestructuringandRestructuringRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RleHRyZWdpb246ZmMwYjM2YjgyNjgzNGVmMThmNTk3M2E4MjcxOGQ0MzFfMTIzMg_5d89399d-5d2c-4397-bd7d-b07444c05d70">11.1</ix:nonFraction> million, respectively, of restructuring and turnaround costs under this program. During the three and nine months ended December 28, 2019, the Company incurred $<ix:nonFraction unitRef="usd" contextRef="i5a5c7d523f2145b6aa5ffec1153cb69c_D20190331-20191228" decimals="-5" format="ixt:numdotdecimal" name="hae:RestructuringandRestructuringRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RleHRyZWdpb246ZmMwYjM2YjgyNjgzNGVmMThmNTk3M2E4MjcxOGQ0MzFfMTM0OQ_35c1403e-f7b5-44ad-8aa5-a5bc6bc6c0fc"><ix:nonFraction unitRef="usd" contextRef="i47a6d93cd53549d89b47e663b9deba14_D20190929-20191228" decimals="-5" format="ixt:numdotdecimal" name="hae:RestructuringandRestructuringRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RleHRyZWdpb246ZmMwYjM2YjgyNjgzNGVmMThmNTk3M2E4MjcxOGQ0MzFfMTM0OQ_5c0e0810-05c7-438c-b851-68d73271fc56">3.9</ix:nonFraction></ix:nonFraction>&#160;million and $6.8 million, respectively, of restructuring and turnaround costs under this program. Total cumulative charges under this program are $<ix:nonFraction unitRef="usd" contextRef="i2cacfe431b9c4c0fb8e8aef0b6153a74_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RestructuringAndRelatedCostCostIncurredToDate1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RleHRyZWdpb246ZmMwYjM2YjgyNjgzNGVmMThmNTk3M2E4MjcxOGQ0MzFfMTQ1OQ_dcdca477-c2d5-4fb5-a9a5-d1c405c8422b">22.9</ix:nonFraction> million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2018, the Company launched a Complexity Reduction Initiative (the &#8220;2018 Program&#8221;), a company-wide restructuring program designed to improve operational performance and reduce cost, freeing up resources to invest in accelerated growth. During the three months ended December 26, 2020, the Company incurred minimal charges of restructuring and turnaround costs under this program. During the nine months ended December 26, 2020, the Company incurred $<ix:nonFraction unitRef="usd" contextRef="if349602212e14b36bbf1334f02910da3_D20200329-20201226" decimals="-5" format="ixt:numdotdecimal" name="hae:RestructuringandRestructuringRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RleHRyZWdpb246ZmMwYjM2YjgyNjgzNGVmMThmNTk3M2E4MjcxOGQ0MzFfMTg1OQ_6797f85a-3ace-4fcf-8617-1c36adcc931b">0.5</ix:nonFraction> million of restructuring and turnaround costs under this program. During the three and nine months ended December 28, 2019, the Company incurred $<ix:nonFraction unitRef="usd" contextRef="i93496a66e90a4df78a56e3d1ea9032d5_D20190929-20191228" decimals="-5" format="ixt:numdotdecimal" name="hae:RestructuringandRestructuringRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RleHRyZWdpb246ZmMwYjM2YjgyNjgzNGVmMThmNTk3M2E4MjcxOGQ0MzFfMTk1Ng_917cf092-0ea2-4fee-8498-dcf62d83c629">3.9</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ia5424d4d3c7a46febf9cc99a77e86fdd_D20190331-20191228" decimals="-5" format="ixt:numdotdecimal" name="hae:RestructuringandRestructuringRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RleHRyZWdpb246ZmMwYjM2YjgyNjgzNGVmMThmNTk3M2E4MjcxOGQ0MzFfMTk2Mw_ef92edc3-d386-4373-a186-26681a736bb6">6.8</ix:nonFraction>&#160;million, respectively, of restructuring and turnaround costs under this program. Total cumulative charges under this program are $<ix:nonFraction unitRef="usd" contextRef="i260b34151c1f4ffeb7f29c12973c0d99_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RestructuringAndRelatedCostCostIncurredToDate1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RleHRyZWdpb246ZmMwYjM2YjgyNjgzNGVmMThmNTk3M2E4MjcxOGQ0MzFfMjA4Nw_57a789d0-c857-48f5-854d-d2c8f91c5430">58.7</ix:nonFraction> million. The 2018 Program is substantially complete.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" name="us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RleHRyZWdpb246ZmMwYjM2YjgyNjgzNGVmMThmNTk3M2E4MjcxOGQ0MzFfMzIxOQ_2962a5c7-8c69-42c8-9d16-32d43f7e2b79" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity for restructuring reserves related to the 2020 Program and the 2018 Program and prior programs for the nine months ended December 26, 2020, substantially all of which relates to employee severance and other employee costs:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.063%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.501%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020 Program</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018 Program and Prior Programs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 28, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06e550e92ba749fcb6ba3ce3f7d5cab2_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestructuringReserve" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjBiMDlhY2JmZGQxMjQ0OGZhMWQ5ODJmODFjNGE5MDZmL3RhYmxlcmFuZ2U6MGIwOWFjYmZkZDEyNDQ4ZmExZDk4MmY4MWM0YTkwNmZfMS0yLTEtMS0w_57b2fb4e-f627-4b0b-b827-7ab533b33c5f">1,136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6f164270add4f63b852149f39adb6dd_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestructuringReserve" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjBiMDlhY2JmZGQxMjQ0OGZhMWQ5ODJmODFjNGE5MDZmL3RhYmxlcmFuZ2U6MGIwOWFjYmZkZDEyNDQ4ZmExZDk4MmY4MWM0YTkwNmZfMS00LTEtMS0w_10550dd3-999b-48fe-b182-f4b5ba55a520">1,512</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestructuringReserve" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjBiMDlhY2JmZGQxMjQ0OGZhMWQ5ODJmODFjNGE5MDZmL3RhYmxlcmFuZ2U6MGIwOWFjYmZkZDEyNDQ4ZmExZDk4MmY4MWM0YTkwNmZfMS02LTEtMS0w_158aa5ec-9d0d-43ce-9671-0abee503f0a4">2,648</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs incurred, net of reversals</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9df13005acd43968fa8aa9997a94054_D20200329-20200926" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjBiMDlhY2JmZGQxMjQ0OGZhMWQ5ODJmODFjNGE5MDZmL3RhYmxlcmFuZ2U6MGIwOWFjYmZkZDEyNDQ4ZmExZDk4MmY4MWM0YTkwNmZfMi0yLTEtMS0w_17fa48ee-8e60-402e-af08-e1bb8dc3dc66">1,005</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id2f1e7afc3e94b0ebd50a8b6ea8db521_D20200329-20200926" decimals="-3" sign="-" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjBiMDlhY2JmZGQxMjQ0OGZhMWQ5ODJmODFjNGE5MDZmL3RhYmxlcmFuZ2U6MGIwOWFjYmZkZDEyNDQ4ZmExZDk4MmY4MWM0YTkwNmZfMi00LTEtMS0w_f13fdc0e-96d1-4fb9-9eb9-f734dd275fe8">105</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b7ebb1b437c46a0a817c9861b363798_D20200329-20200926" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjBiMDlhY2JmZGQxMjQ0OGZhMWQ5ODJmODFjNGE5MDZmL3RhYmxlcmFuZ2U6MGIwOWFjYmZkZDEyNDQ4ZmExZDk4MmY4MWM0YTkwNmZfMi02LTEtMS0w_5be34103-c333-46dd-ad51-b0a570021610">900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9df13005acd43968fa8aa9997a94054_D20200329-20200926" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsForRestructuring" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjBiMDlhY2JmZGQxMjQ0OGZhMWQ5ODJmODFjNGE5MDZmL3RhYmxlcmFuZ2U6MGIwOWFjYmZkZDEyNDQ4ZmExZDk4MmY4MWM0YTkwNmZfMy0yLTEtMS0w_265b9c38-e030-4ca9-910c-27d657ddc47e">1,546</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id2f1e7afc3e94b0ebd50a8b6ea8db521_D20200329-20200926" decimals="-3" name="us-gaap:PaymentsForRestructuring" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjBiMDlhY2JmZGQxMjQ0OGZhMWQ5ODJmODFjNGE5MDZmL3RhYmxlcmFuZ2U6MGIwOWFjYmZkZDEyNDQ4ZmExZDk4MmY4MWM0YTkwNmZfMy00LTEtMS0w_e846f93d-0587-4001-9bff-7e47dce6c219">887</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b7ebb1b437c46a0a817c9861b363798_D20200329-20200926" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsForRestructuring" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjBiMDlhY2JmZGQxMjQ0OGZhMWQ5ODJmODFjNGE5MDZmL3RhYmxlcmFuZ2U6MGIwOWFjYmZkZDEyNDQ4ZmExZDk4MmY4MWM0YTkwNmZfMy02LTEtMS0w_31262e21-9e5f-4a4b-8d96-4ee63d5a2a9c">2,433</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 26, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cacfe431b9c4c0fb8e8aef0b6153a74_I20201226" decimals="-3" name="us-gaap:RestructuringReserve" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjBiMDlhY2JmZGQxMjQ0OGZhMWQ5ODJmODFjNGE5MDZmL3RhYmxlcmFuZ2U6MGIwOWFjYmZkZDEyNDQ4ZmExZDk4MmY4MWM0YTkwNmZfNS0yLTEtMS0w_53af5df6-09c9-401e-9ba3-47f40b21346f">595</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3aa8dfa6b948e5b3115795d08f59c8_I20201226" decimals="-3" name="us-gaap:RestructuringReserve" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjBiMDlhY2JmZGQxMjQ0OGZhMWQ5ODJmODFjNGE5MDZmL3RhYmxlcmFuZ2U6MGIwOWFjYmZkZDEyNDQ4ZmExZDk4MmY4MWM0YTkwNmZfNS00LTEtMS0w_5a2af002-e0b6-414d-8434-05974c0866e0">520</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestructuringReserve" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjBiMDlhY2JmZGQxMjQ0OGZhMWQ5ODJmODFjNGE5MDZmL3RhYmxlcmFuZ2U6MGIwOWFjYmZkZDEyNDQ4ZmExZDk4MmY4MWM0YTkwNmZfNS02LTEtMS0w_8583be97-7834-4556-af76-95bb3afeab06">1,115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RleHRyZWdpb246ZmMwYjM2YjgyNjgzNGVmMThmNTk3M2E4MjcxOGQ0MzFfMzIzMg_3f7952da-f631-4921-b473-16b4fd208322" continuedAt="i723ec8101e2d466c8568b857f44db4b9" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents the restructuring costs by line item within our accompanying unaudited condensed consolidated statements of income and comprehensive income:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.578%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands) </span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if591715db6554c7c88829b6f6ea5dd52_D20200927-20201226" decimals="-3" sign="-" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjAzYjk1NGQ0NjQ0MTQ4M2ZiYzkxZTA3ODlkOWEwNDg2L3RhYmxlcmFuZ2U6MDNiOTU0ZDQ2NDQxNDgzZmJjOTFlMDc4OWQ5YTA0ODZfMi0xLTEtMS0w_7863ea6a-f763-47b5-be3a-e2ad248b6b41">49</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01fc03287b95423b9e72f9953bf2f534_D20190929-20191228" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjAzYjk1NGQ0NjQ0MTQ4M2ZiYzkxZTA3ODlkOWEwNDg2L3RhYmxlcmFuZ2U6MDNiOTU0ZDQ2NDQxNDgzZmJjOTFlMDc4OWQ5YTA0ODZfMi0zLTEtMS0w_6545a601-d633-477d-af3f-e43da7d09572">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e978d21bd9d46c78c1bd4f9805a8a0a_D20200329-20201226" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjAzYjk1NGQ0NjQ0MTQ4M2ZiYzkxZTA3ODlkOWEwNDg2L3RhYmxlcmFuZ2U6MDNiOTU0ZDQ2NDQxNDgzZmJjOTFlMDc4OWQ5YTA0ODZfMi01LTEtMS0w_8bd181a5-4a39-41b6-a85e-8a419cb131e9">218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib21731e2375545a08b98875f7a4af110_D20190331-20191228" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjAzYjk1NGQ0NjQ0MTQ4M2ZiYzkxZTA3ODlkOWEwNDg2L3RhYmxlcmFuZ2U6MDNiOTU0ZDQ2NDQxNDgzZmJjOTFlMDc4OWQ5YTA0ODZfMi03LTEtMS0w_7ec7cc1b-c97f-4388-8164-3a07f9ed7945">444</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c902e8ff2a544848d52e4275e2b7ba6_D20200927-20201226" decimals="-3" sign="-" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjAzYjk1NGQ0NjQ0MTQ4M2ZiYzkxZTA3ODlkOWEwNDg2L3RhYmxlcmFuZ2U6MDNiOTU0ZDQ2NDQxNDgzZmJjOTFlMDc4OWQ5YTA0ODZfMy0xLTEtMS0w_81ce2ee2-e132-4a10-8e15-f24afcda8d93">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c6375b4134b4ca68ab871618f059116_D20190929-20191228" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjAzYjk1NGQ0NjQ0MTQ4M2ZiYzkxZTA3ODlkOWEwNDg2L3RhYmxlcmFuZ2U6MDNiOTU0ZDQ2NDQxNDgzZmJjOTFlMDc4OWQ5YTA0ODZfMy0zLTEtMS0w_dec1fe1f-f6ee-4418-be27-69b16df23619">139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ad87d4f1d5749fda7366051a2f43f16_D20200329-20201226" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjAzYjk1NGQ0NjQ0MTQ4M2ZiYzkxZTA3ODlkOWEwNDg2L3RhYmxlcmFuZ2U6MDNiOTU0ZDQ2NDQxNDgzZmJjOTFlMDc4OWQ5YTA0ODZfMy01LTEtMS0w_8330de99-6f23-4b0b-8c62-22bb949d922b">108</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ffc79a4ee6438fbd8ff28e0c4be5bb_D20190331-20191228" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjAzYjk1NGQ0NjQ0MTQ4M2ZiYzkxZTA3ODlkOWEwNDg2L3RhYmxlcmFuZ2U6MDNiOTU0ZDQ2NDQxNDgzZmJjOTFlMDc4OWQ5YTA0ODZfMy03LTEtMS0w_31c344d4-1d90-4a7f-9102-781e68c11b19">708</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee4e2e1969f04310b8b24c6665e635f3_D20200927-20201226" decimals="-3" sign="-" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjAzYjk1NGQ0NjQ0MTQ4M2ZiYzkxZTA3ODlkOWEwNDg2L3RhYmxlcmFuZ2U6MDNiOTU0ZDQ2NDQxNDgzZmJjOTFlMDc4OWQ5YTA0ODZfNC0xLTEtMS0w_3ec2effb-6ff4-432a-a810-84bbb0d2a68e">41</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85a5e4e16a244429b43d7873d0c5a1f8_D20190929-20191228" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjAzYjk1NGQ0NjQ0MTQ4M2ZiYzkxZTA3ODlkOWEwNDg2L3RhYmxlcmFuZ2U6MDNiOTU0ZDQ2NDQxNDgzZmJjOTFlMDc4OWQ5YTA0ODZfNC0zLTEtMS0w_bd4426e1-1148-4d26-926b-e560363108bc">476</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8987e6d81b9e45c09d60428f5014e56f_D20200329-20201226" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjAzYjk1NGQ0NjQ0MTQ4M2ZiYzkxZTA3ODlkOWEwNDg2L3RhYmxlcmFuZ2U6MDNiOTU0ZDQ2NDQxNDgzZmJjOTFlMDc4OWQ5YTA0ODZfNC01LTEtMS0w_7030c5bd-a68a-4468-9e20-a8420cd053bd">574</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9d7c28c8e164a01a59f0e2d04a596f1_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjAzYjk1NGQ0NjQ0MTQ4M2ZiYzkxZTA3ODlkOWEwNDg2L3RhYmxlcmFuZ2U6MDNiOTU0ZDQ2NDQxNDgzZmJjOTFlMDc4OWQ5YTA0ODZfNC03LTEtMS0w_aa228d71-4d3f-4d6c-b1aa-073117827921">1,777</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226" decimals="-3" sign="-" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjAzYjk1NGQ0NjQ0MTQ4M2ZiYzkxZTA3ODlkOWEwNDg2L3RhYmxlcmFuZ2U6MDNiOTU0ZDQ2NDQxNDgzZmJjOTFlMDc4OWQ5YTA0ODZfNS0xLTEtMS0w_8b396b74-a770-451d-8a17-e26f0cf5a0f4">92</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjAzYjk1NGQ0NjQ0MTQ4M2ZiYzkxZTA3ODlkOWEwNDg2L3RhYmxlcmFuZ2U6MDNiOTU0ZDQ2NDQxNDgzZmJjOTFlMDc4OWQ5YTA0ODZfNS0zLTEtMS0w_0a8a29fc-3c07-4919-9167-2e2d24ae010c">617</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjAzYjk1NGQ0NjQ0MTQ4M2ZiYzkxZTA3ODlkOWEwNDg2L3RhYmxlcmFuZ2U6MDNiOTU0ZDQ2NDQxNDgzZmJjOTFlMDc4OWQ5YTA0ODZfNS01LTEtMS0w_53e09336-b340-4dba-be23-953538a90761">900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjAzYjk1NGQ0NjQ0MTQ4M2ZiYzkxZTA3ODlkOWEwNDg2L3RhYmxlcmFuZ2U6MDNiOTU0ZDQ2NDQxNDgzZmJjOTFlMDc4OWQ5YTA0ODZfNS03LTEtMS0w_0d355f68-3c38-4e39-bb48-6118e6e46bbf">2,929</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;26, 2020, the Company had a restructuring liability of $<ix:nonFraction unitRef="usd" contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RleHRyZWdpb246ZmMwYjM2YjgyNjgzNGVmMThmNTk3M2E4MjcxOGQ0MzFfMjU5Nw_6d6961ce-52b9-4d85-939b-89182a15803e">1.1</ix:nonFraction> million, of which $<ix:nonFraction unitRef="usd" contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226" decimals="-5" format="ixt:numdotdecimal" name="hae:RestructuringChargesPayableInNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RleHRyZWdpb246ZmMwYjM2YjgyNjgzNGVmMThmNTk3M2E4MjcxOGQ0MzFfMjYxMA_f55b0c97-4bf3-47b5-8753-bfb724567539">0.7</ix:nonFraction> million is payable within the next twelve months. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the restructuring costs included in the table above, the Company also incurred costs that do not constitute restructuring under ASC 420, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Exit and Disposal Cost Obligations,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and which the Company instead refers to as turnaround costs. These costs consist primarily of expenditures directly related to the restructuring actions and include program management costs associated with the 2020 Program and operational performance improvement initiatives.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><ix:continuation id="i676346b24ce244118c3e386070be4844"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below present restructuring and turnaround costs by reportable segment:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="i723ec8101e2d466c8568b857f44db4b9"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.578%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring costs</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands) </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plasma</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a367bb123554012a9834d85df459f46_D20200927-20201226" decimals="-3" sign="-" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMi0xLTEtMS0w_9e4ac43d-8800-4508-a955-8c2253de2cdc">27</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2c7bdc34da3493493cc0abe3dc3def5_D20190929-20191228" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMi0zLTEtMS0w_1a569151-cf14-4a6d-855a-cc8981ee6769">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4eb9c47f2f9244e0b383fb7b25f6b0d4_D20200329-20201226" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMi01LTEtMS0w_9e22c41a-20c7-424f-a067-caf304f64737">454</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0091dd1f9204cdd979ec26f0ee2b0ae_D20190331-20191228" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMi03LTEtMS0w_4d63c8f5-c593-49b0-b115-2255146be16b">552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Center</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cfe5b5730064f93b6ecea7bc136d73f_D20200927-20201226" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMy0xLTEtMS0w_d80dede0-171b-4039-8fc5-c1b9f1b9b34a">66</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic275845b82014295bb8e14b72d0cb7a2_D20190929-20191228" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMy0zLTEtMS0w_6e665467-0fa3-4b9a-8772-31558f3a4453">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4648a84bbe144e499e5f0bbff9596c82_D20200329-20201226" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMy01LTEtMS0w_8e2c9e0d-db94-4c6a-9c16-cd32d06ed80c">240</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fa6549b61284e39986bb1296676dc1a_D20190331-20191228" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMy03LTEtMS0w_6d7b6f78-f122-4843-bc60-3a6e17d9aaa7">154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id93717bc785844afbedbb40fafa0d6e6_D20200927-20201226" decimals="-3" format="ixt:zerodash" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfNC0xLTEtMS0w_812af6be-1092-4f51-9c1c-55da5fc20a64">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d1a57ec025045cbb23779fa6fc0cb2e_D20190929-20191228" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfNC0zLTEtMS0w_f24193a9-4a11-4383-bb71-454f9113df4a">58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib19f3255f7c4488593f3252f04fa0abf_D20200329-20201226" decimals="-3" sign="-" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfNC01LTEtMS0w_a104025c-7bf5-4a83-9ae3-59de9785bebd">18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id42b45b3282241f0b4410893d0379aae_D20190331-20191228" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfNC03LTEtMS0w_088a1631-78eb-4ee9-9d50-76a80cf0e721">295</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i05d2add01f7948cdbe05379d9edfa6cd_D20200927-20201226" decimals="-3" sign="-" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfNS0xLTEtMS0w_6f6e5043-0c34-45bb-b162-cd7caf9a817e">131</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if68e3d2fce814080a6a5a599e4100f7d_D20190929-20191228" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfNS0zLTEtMS0w_7b4efe5a-a325-4562-9406-0d167c4784ea">537</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f207c5c248843fd8e07e9437fa7102e_D20200329-20201226" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfNS01LTEtMS0w_b18ea5c5-4796-4c64-80a2-7116fa5073e8">224</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7b79856e7224f109a59af542be47303_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfNS03LTEtMS0w_35ed0a07-2972-469f-90a5-6724475e9b36">1,928</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226" decimals="-3" sign="-" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfNi0xLTEtMS0w_7238a665-48a9-492c-a2ed-9f2edc1122e2">92</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfNi0zLTEtMS0w_3e76e93e-933e-46ae-8cca-d5ee83225c21">617</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfNi01LTEtMS0w_4c5cdea6-aea2-4501-996d-6cd05642513b">900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfNi03LTEtMS0w_c22b4444-6685-4ff5-b912-e70a1d9c0792">2,929</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Turnaround costs</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands) </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plasma</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a367bb123554012a9834d85df459f46_D20200927-20201226" decimals="-3" name="hae:RestructuringRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMTAtMS0xLTEtMA_2aaae7f5-7e6f-4096-939e-d2b5e075c1ec">431</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2c7bdc34da3493493cc0abe3dc3def5_D20190929-20191228" decimals="-3" name="hae:RestructuringRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMTAtMy0xLTEtMA_ab5feb1b-d1da-48db-ade9-ceeea015b998">108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4eb9c47f2f9244e0b383fb7b25f6b0d4_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="hae:RestructuringRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMTAtNS0xLTEtMA_1b17102e-27a1-4f0f-bc5f-7b40fa6aadf4">1,235</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0091dd1f9204cdd979ec26f0ee2b0ae_D20190331-20191228" decimals="-3" name="hae:RestructuringRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMTAtNy0xLTEtMA_22a51b54-c1f8-4195-a8b9-3410245464d3">187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Center</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cfe5b5730064f93b6ecea7bc136d73f_D20200927-20201226" decimals="-3" name="hae:RestructuringRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMTEtMS0xLTEtMA_31c5dc25-10c6-4144-9c8f-cdb4c9f5cb2f">518</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic275845b82014295bb8e14b72d0cb7a2_D20190929-20191228" decimals="-3" name="hae:RestructuringRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMTEtMy0xLTEtMA_c12f8c89-0809-437d-9cf0-a63f27e56a48">293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4648a84bbe144e499e5f0bbff9596c82_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="hae:RestructuringRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMTEtNS0xLTEtMA_fb5c79c1-e612-4484-9ced-fe2c2200e799">1,024</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fa6549b61284e39986bb1296676dc1a_D20190331-20191228" decimals="-3" name="hae:RestructuringRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMTEtNy0xLTEtMA_802684aa-07ac-4e7f-b271-3caf7c15fc3c">293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id93717bc785844afbedbb40fafa0d6e6_D20200927-20201226" decimals="-3" name="hae:RestructuringRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMTItMS0xLTEtMA_cd3386c7-ebf8-4202-aa45-14153a08eaad">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d1a57ec025045cbb23779fa6fc0cb2e_D20190929-20191228" decimals="-3" format="ixt:zerodash" name="hae:RestructuringRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMTItMy0xLTEtMA_5625eece-4221-4343-937f-2a2d0c03e00c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19f3255f7c4488593f3252f04fa0abf_D20200329-20201226" decimals="-3" name="hae:RestructuringRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMTItNS0xLTEtMA_748a2ea3-a774-4787-84d2-bf2297edc705">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id42b45b3282241f0b4410893d0379aae_D20190331-20191228" decimals="-3" format="ixt:zerodash" name="hae:RestructuringRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMTItNy0xLTEtMA_2e4f8945-50fe-4390-a2d5-4ee768d60b65">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05d2add01f7948cdbe05379d9edfa6cd_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="hae:RestructuringRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMTMtMS0xLTEtMA_38f98390-3325-4439-bf1e-74240583e25c">2,282</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if68e3d2fce814080a6a5a599e4100f7d_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="hae:RestructuringRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMTMtMy0xLTEtMA_221bb0a7-850f-4a16-8070-7651544c0543">6,780</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f207c5c248843fd8e07e9437fa7102e_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="hae:RestructuringRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMTMtNS0xLTEtMA_590545c0-8bda-4217-8ee7-110748462d0c">8,410</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7b79856e7224f109a59af542be47303_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="hae:RestructuringRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMTMtNy0xLTEtMA_7ab03fd8-73f7-407a-b576-d9773b0cf34a">10,173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="hae:RestructuringRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMTQtMS0xLTEtMA_fdca3068-016b-444a-b123-8f4ad7535e44">3,235</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="hae:RestructuringRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMTQtMy0xLTEtMA_6a2050c8-b1d3-400a-9015-7d3290fb65b9">7,181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="hae:RestructuringRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMTQtNS0xLTEtMA_a2159279-61d7-4222-b297-2a29d3e7cef6">10,683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="hae:RestructuringRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMTQtNy0xLTEtMA_6bfcfb7f-bda6-49d8-bb7b-ae2803015a44">10,653</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total restructuring and turnaround costs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="hae:RestructuringandRestructuringRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMTYtMS0xLTEtMA_d19d86db-ec52-4a14-bf3a-a7518510707f">3,143</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="hae:RestructuringandRestructuringRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMTYtMy0xLTEtMA_5d8fd7da-1a69-4d5f-89d3-5865b428aa90">7,798</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="hae:RestructuringandRestructuringRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMTYtNS0xLTEtMA_b9633fea-cce5-4df5-bce2-db0c0c7b5bea">11,583</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="hae:RestructuringandRestructuringRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMTYtNy0xLTEtMA_fc73579b-e235-4060-b944-17b30c271edb">13,582</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="text-align:center"><span><br/></span></div><div id="ib1e23e354c9c424096b27d04c70f5a5a_43"></div><ix:nonNumeric contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RleHRyZWdpb246ZDEyMzJiZDFkNjM1NGY4YzkyOGZkZTcwZTFmMDBlYTlfMzE4Ng_22ebaf26-6844-45b9-bce4-b611731c6245" continuedAt="i78a9b29a24f44ab98731e7b0104fd21d" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4. ACQUISITIONS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cardiva Medical, Inc.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 17, 2021, the Company entered into an Agreement and Plan of Merger with Cardiva Medical, Inc., (&#8220;Cardiva&#8221;), an industry-leading manufacturer of vascular closure systems based in Santa Clara, California. In connection with this acquisition, the Company will pay upfront consideration of $<ix:nonFraction unitRef="usd" contextRef="i8271c898b4eb4b14baafd85359156c86_D20210117-20210117" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RleHRyZWdpb246ZDEyMzJiZDFkNjM1NGY4YzkyOGZkZTcwZTFmMDBlYTlfODI0NjMzNzIxNTMyNQ_a1b4eeb3-60c5-402c-b832-0b2a7cc46c38">475.0</ix:nonFraction>&#160;million in cash, subject to customary working capital and certain other adjustments as of the closing of the transaction, as well as up to $<ix:nonFraction unitRef="usd" contextRef="i72cd9e5107234d5fbbe3ac8fc02e2137_I20210117" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RleHRyZWdpb246ZDEyMzJiZDFkNjM1NGY4YzkyOGZkZTcwZTFmMDBlYTlfODI0NjMzNzIxNTM0MQ_3eaf73ee-cf1e-4f10-8453-c5fd8c74c954">35.0</ix:nonFraction>&#160;million in additional contingent consideration payable over the next two years based on sales growth. The transaction is not subject to a financing contingency, and the Company expects to finance the transaction through a combination of its cash on hand, revolving credit facility and an additional $<ix:nonFraction unitRef="usd" contextRef="i8271c898b4eb4b14baafd85359156c86_D20210117-20210117" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfSecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RleHRyZWdpb246ZDEyMzJiZDFkNjM1NGY4YzkyOGZkZTcwZTFmMDBlYTlfODI0NjMzNzIxNTM1Ng_db5f564a-b252-4828-96fb-2adf2d5b7ea2">150.0</ix:nonFraction>&#160;million term loan anticipated to be borrowed under its existing credit facility. The transaction is expected to close in the fourth quarter of fiscal 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cardiva&#8217;s portfolio includes two catheter-based vascular access site closure devices. The VASCADE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> vascular closure system is designed for &#8220;small-bore&#8221; femoral arterial and venous closure, generally used in interventional cardiology and peripheral vascular procedures. The VASCADE MVP</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> vascular closure system is designed for &#8220;mid-bore&#8221; multi-access femoral venous closure, generally used in electrophysiology procedures, and is the only U.S. Food and Drug Administration (&#8220;FDA&#8221;) approved closure device for use following cardiac ablation procedures requiring two or more access sites within the same vessel. The addition of the VASCADE portfolio to the Hospital business unit includes products with demonstrated benefits and enhances penetration into the large and growing interventional cardiology and electrophysiology markets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HAS Intellectual Property</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, the Company entered into an agreement to acquire certain intellectual property owned by HemoAssay Science and Technology (Suzhou) Co. Ltd., a China-incorporated company, and its affiliates (collectively, &#8220;HemoAssay&#8221;) underlying their HAS viscoelastic diagnostic devices, related assays and disposables. The Company previously entered into exclusive manufacturing and distribution agreements with HemoAssay pursuant to which it has exclusive rights to commercialize HemoAssay&#8217;s HAS devices in China. In connection with the transaction, the Company has agreed to pay up to $<ix:nonFraction unitRef="usd" contextRef="i07195ff1642e4aeb86c955b7bd7ec0ee_D20210113-20210113" decimals="-5" format="ixt:numdotdecimal" name="hae:AssetAcquisitionUpfrontPayment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RleHRyZWdpb246ZDEyMzJiZDFkNjM1NGY4YzkyOGZkZTcwZTFmMDBlYTlfODI0NjMzNzIxNTM3Mg_88378757-7c6e-43ad-9e33-f3e6dd529904">15.0</ix:nonFraction>&#160;million to HemoAssay in contingent consideration based on certain developmental and manufacturing based milestones. These products augment the Company's portfolio of hemostasis analyzers within the Hospital business unit.</span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="i78a9b29a24f44ab98731e7b0104fd21d" continuedAt="i6c1da8226e2b4607be446efd0fdf3566"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">enicor GmbH</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2020, the Company acquired all of the outstanding equity of enicor GmbH (&#8220;enicor&#8221;), the manufacturer of ClotPro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a new generation whole blood coagulation testing system that is currently available in select European and Asia Pacific markets, for total consideration of $<ix:nonFraction unitRef="usd" contextRef="i1c4663f05df4454e9e234b6de7661db7_D20200401-20200401" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RleHRyZWdpb246ZDEyMzJiZDFkNjM1NGY4YzkyOGZkZTcwZTFmMDBlYTlfMjkx_30bea2e5-7e7f-4222-88e9-b67dbdcc7a4c">20.5</ix:nonFraction>&#160;million, which consisted of upfront payments of $<ix:nonFraction unitRef="usd" contextRef="i1c4663f05df4454e9e234b6de7661db7_D20200401-20200401" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RleHRyZWdpb246ZDEyMzJiZDFkNjM1NGY4YzkyOGZkZTcwZTFmMDBlYTlfMzM0_99e73f9d-4d64-459d-8c51-9229fc559079">16.6</ix:nonFraction>&#160;million and the fair value of contingent consideration of $<ix:nonFraction unitRef="usd" contextRef="i7337ad8ffd7f4d8cb8646e0073515fc1_I20200401" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RleHRyZWdpb246ZDEyMzJiZDFkNjM1NGY4YzkyOGZkZTcwZTFmMDBlYTlfMzg3_4f27dda8-106f-49cc-abd7-59bf76196f68">3.9</ix:nonFraction>&#160;million. The contingent consideration, which could total a maximum of $<ix:nonFraction unitRef="usd" contextRef="i7337ad8ffd7f4d8cb8646e0073515fc1_I20200401" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RleHRyZWdpb246ZDEyMzJiZDFkNjM1NGY4YzkyOGZkZTcwZTFmMDBlYTlfNDUy_af75958b-b33e-4fe2-b685-6aa457c99f3d">4.5</ix:nonFraction>&#160;million, consists of payments related to the achievement of certain revenue and regulatory milestones. The acquisition of this viscoelastic diagnostic device augments the Company's portfolio of hemostasis analyzers within the Hospital business unit.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purchase Price Allocation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounted for the acquisition of enicor as a business combination, and in accordance with FASB ASC Topic 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Topic 805</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), recorded the assets acquired and liabilities assumed at their respective fair values as of the acquisition date. The final determination of the fair value of certain assets and liabilities will be completed within the measurement period as required by Topic 805. As of December&#160;26, 2020, the valuation studies necessary to determine the fair market value of the assets acquired and liabilities assumed are preliminary, including the projection of the underlying cash flows used to determine the fair value of the identified tangible, intangible and financial assets and liabilities.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RleHRyZWdpb246ZDEyMzJiZDFkNjM1NGY4YzkyOGZkZTcwZTFmMDBlYTlfMzE4Nw_9ddfba91-40d6-481c-a2c7-43dc0aa52874" continuedAt="i24f83d77c6d24f3a97038505e13ca24e" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following amounts represent the preliminary determination of the fair value of the identifiable assets acquired and liabilities assumed for enicor completed during the first nine months of fiscal 2021:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.888%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.182%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26, 2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e7fc74b32564f649453438d72e04947_I20201226" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RhYmxlOmMzNjNhOGFlZWZiNTRmOWNhZDNjNWE5M2FlZDdhY2I0L3RhYmxlcmFuZ2U6YzM2M2E4YWVlZmI1NGY5Y2FkM2M1YTkzYWVkN2FjYjRfMi0yLTEtMS0w_6756b07e-f4c7-414b-a98e-133fc1c653d7">634</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e7fc74b32564f649453438d72e04947_I20201226" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RhYmxlOmMzNjNhOGFlZWZiNTRmOWNhZDNjNWE5M2FlZDdhY2I0L3RhYmxlcmFuZ2U6YzM2M2E4YWVlZmI1NGY5Y2FkM2M1YTkzYWVkN2FjYjRfMy0yLTEtMS0w_6412aed6-48f4-4b96-a886-c72826d12b47">685</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e7fc74b32564f649453438d72e04947_I20201226" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RhYmxlOmMzNjNhOGFlZWZiNTRmOWNhZDNjNWE5M2FlZDdhY2I0L3RhYmxlcmFuZ2U6YzM2M2E4YWVlZmI1NGY5Y2FkM2M1YTkzYWVkN2FjYjRfNC0yLTEtMS0w_c188042b-ed30-4963-835c-85bf6136398c">289</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e7fc74b32564f649453438d72e04947_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RhYmxlOmMzNjNhOGFlZWZiNTRmOWNhZDNjNWE5M2FlZDdhY2I0L3RhYmxlcmFuZ2U6YzM2M2E4YWVlZmI1NGY5Y2FkM2M1YTkzYWVkN2FjYjRfNS0yLTEtMS0w_f6dac7a0-4155-4e5d-ace2-9b09cc489d7b">14,090</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e7fc74b32564f649453438d72e04947_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RhYmxlOmMzNjNhOGFlZWZiNTRmOWNhZDNjNWE5M2FlZDdhY2I0L3RhYmxlcmFuZ2U6YzM2M2E4YWVlZmI1NGY5Y2FkM2M1YTkzYWVkN2FjYjRfNi0yLTEtMS0w_a84c081f-3ec0-4e50-8d0c-523cbaaf0d3f">8,153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e7fc74b32564f649453438d72e04947_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RhYmxlOmMzNjNhOGFlZWZiNTRmOWNhZDNjNWE5M2FlZDdhY2I0L3RhYmxlcmFuZ2U6YzM2M2E4YWVlZmI1NGY5Y2FkM2M1YTkzYWVkN2FjYjRfNy0yLTEtMS0w_d0ec0c83-b603-4eb4-bab3-6548f6ae203a">23,851</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e7fc74b32564f649453438d72e04947_I20201226" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RhYmxlOmMzNjNhOGFlZWZiNTRmOWNhZDNjNWE5M2FlZDdhY2I0L3RhYmxlcmFuZ2U6YzM2M2E4YWVlZmI1NGY5Y2FkM2M1YTkzYWVkN2FjYjRfOC0yLTEtMS0w_952958dd-4d30-4101-bc79-b5589c0e15d7">289</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration (current)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e7fc74b32564f649453438d72e04947_I20201226" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RhYmxlOmMzNjNhOGFlZWZiNTRmOWNhZDNjNWE5M2FlZDdhY2I0L3RhYmxlcmFuZ2U6YzM2M2E4YWVlZmI1NGY5Y2FkM2M1YTkzYWVkN2FjYjRfOS0yLTEtMS0w_6fbc05b1-34e5-478e-96f0-f3c81e520ddb">504</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration (non-current)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e7fc74b32564f649453438d72e04947_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RhYmxlOmMzNjNhOGFlZWZiNTRmOWNhZDNjNWE5M2FlZDdhY2I0L3RhYmxlcmFuZ2U6YzM2M2E4YWVlZmI1NGY5Y2FkM2M1YTkzYWVkN2FjYjRfMTAtMi0xLTEtMA_e4138326-cdf7-437c-91a4-bcca33dec6c9">3,416</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e7fc74b32564f649453438d72e04947_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RhYmxlOmMzNjNhOGFlZWZiNTRmOWNhZDNjNWE5M2FlZDdhY2I0L3RhYmxlcmFuZ2U6YzM2M2E4YWVlZmI1NGY5Y2FkM2M1YTkzYWVkN2FjYjRfMTEtMi0xLTEtMA_fab7ad45-1ffc-46da-b6c6-ba35e3d8c620">3,036</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities assumed</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e7fc74b32564f649453438d72e04947_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RhYmxlOmMzNjNhOGFlZWZiNTRmOWNhZDNjNWE5M2FlZDdhY2I0L3RhYmxlcmFuZ2U6YzM2M2E4YWVlZmI1NGY5Y2FkM2M1YTkzYWVkN2FjYjRfMTItMi0xLTEtMA_4ce490fb-696f-4185-b3e6-b4f3bb87bddd">7,245</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net assets acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e7fc74b32564f649453438d72e04947_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RhYmxlOmMzNjNhOGFlZWZiNTRmOWNhZDNjNWE5M2FlZDdhY2I0L3RhYmxlcmFuZ2U6YzM2M2E4YWVlZmI1NGY5Y2FkM2M1YTkzYWVkN2FjYjRfMTMtMi0xLTEtMA_81efdfbf-f6bb-4b81-b702-929b537c03b0">16,606</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined the identifiable intangible assets were completed technology, customer relationships and a trademark. The fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using a rate of 20%. The cash flows were based on estimates used to price the transaction, and the discount rates applied were benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The benefits of adding a viscoelastic diagnostic device to the Company&#8217;s portfolio of hemostasis analyzers within the Hospital business unit contributed to an acquisition price in excess of the fair value of net assets acquired for enicor, which resulted in the establishment of goodwill. In addition, the benefits of lower cost manufacturing and complementary sales channels also contributed to the establishment of goodwill for this acquisition. None of the goodwill is expected to be deductible for income tax purposes.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i6c1da8226e2b4607be446efd0fdf3566" continuedAt="ie517a5e952934d37a56581f217e77edc"><ix:continuation id="i24f83d77c6d24f3a97038505e13ca24e"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets acquired consist of the following:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.692%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Amortization Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Completed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f13c7f15fc44cdf96efa179ac88e167_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RhYmxlOjFlYjg1YzkyMTU3YzRhOTliOWQ4ZTUxMTU3NGUyY2IxL3RhYmxlcmFuZ2U6MWViODVjOTIxNTdjNGE5OWI5ZDhlNTExNTc0ZTJjYjFfMS0yLTEtMS0w_7f7a56ce-970b-4447-9cf2-2d39c362a2cd">13,441</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8b8aa32b413b4a499e81cb8f98426327_D20200927-20201226" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RhYmxlOjFlYjg1YzkyMTU3YzRhOTliOWQ4ZTUxMTU3NGUyY2IxL3RhYmxlcmFuZ2U6MWViODVjOTIxNTdjNGE5OWI5ZDhlNTExNTc0ZTJjYjFfMS00LTEtMS0w_86e9638e-d73c-4d1b-b071-8854df8fe58f">10</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e187811cd3e42c390dd4993b5e2ed41_I20201226" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RhYmxlOjFlYjg1YzkyMTU3YzRhOTliOWQ4ZTUxMTU3NGUyY2IxL3RhYmxlcmFuZ2U6MWViODVjOTIxNTdjNGE5OWI5ZDhlNTExNTc0ZTJjYjFfMi0yLTEtMS0w_2c31a630-28ac-4978-b963-22b19b526e6a">347</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6ad4c63952854d498ed7b2fe9fb419e8_D20200927-20201226" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RhYmxlOjFlYjg1YzkyMTU3YzRhOTliOWQ4ZTUxMTU3NGUyY2IxL3RhYmxlcmFuZ2U6MWViODVjOTIxNTdjNGE5OWI5ZDhlNTExNTc0ZTJjYjFfMi00LTEtMS0w_99c89333-b15b-4185-be04-622cc01258d5">10</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademark</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icef6f3884c5247499558f7349ee73936_I20201226" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RhYmxlOjFlYjg1YzkyMTU3YzRhOTliOWQ4ZTUxMTU3NGUyY2IxL3RhYmxlcmFuZ2U6MWViODVjOTIxNTdjNGE5OWI5ZDhlNTExNTc0ZTJjYjFfMy0yLTEtMS0w_dd49a798-1487-40bf-9475-d16685779485">302</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7aab4b31eac44a489a14bcde8ce8f4eb_D20200927-20201226" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RhYmxlOjFlYjg1YzkyMTU3YzRhOTliOWQ4ZTUxMTU3NGUyY2IxL3RhYmxlcmFuZ2U6MWViODVjOTIxNTdjNGE5OWI5ZDhlNTExNTc0ZTJjYjFfMy00LTEtMS0w_e8d138a3-2bba-4e4e-8f5e-5bf97729339d">10</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e7fc74b32564f649453438d72e04947_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RhYmxlOjFlYjg1YzkyMTU3YzRhOTliOWQ4ZTUxMTU3NGUyY2IxL3RhYmxlcmFuZ2U6MWViODVjOTIxNTdjNGE5OWI5ZDhlNTExNTc0ZTJjYjFfNC0yLTEtMS0w_c11e081f-5657-4b44-ab70-71b1f3074ecd">14,090</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i394c4dad38e046eabd38f765e09e2e8d_D20200927-20201226" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RhYmxlOjFlYjg1YzkyMTU3YzRhOTliOWQ4ZTUxMTU3NGUyY2IxL3RhYmxlcmFuZ2U6MWViODVjOTIxNTdjNGE5OWI5ZDhlNTExNTc0ZTJjYjFfNC00LTEtMS0w_190a680a-e8b3-4670-98eb-129754685ab8">10</ix:nonNumeric></span></td></tr></table></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition-Related Costs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of acquisition-related costs incurred associated with the acquisition was $<ix:nonFraction unitRef="usd" contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RleHRyZWdpb246ZDEyMzJiZDFkNjM1NGY4YzkyOGZkZTcwZTFmMDBlYTlfMjg2Mg_69bbc3ed-a24d-441d-8433-ad33ac03162f">0.2</ix:nonFraction>&#160;million for the three and nine months ended December 26, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unaudited Pro Forma Financial Information</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie517a5e952934d37a56581f217e77edc">Enicor had an immaterial impact to the Company's net revenues and net income for the period post acquisition through December&#160;26, 2020. The unaudited estimated pro forma impact of the results of the acquisition of enicor as if it was consummated on March 29, 2020 are immaterial.</ix:continuation> </span></div><div><span><br/></span></div><div id="ib1e23e354c9c424096b27d04c70f5a5a_46"></div><ix:nonNumeric contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" name="us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80Ni9mcmFnOjczOTYwYTdlNjAzMDQyZGE4MWM2ZmVmM2ZjYzc3YWRkL3RleHRyZWdpb246NzM5NjBhN2U2MDMwNDJkYTgxYzZmZWYzZmNjNzdhZGRfMzQ1Nw_c7b730d2-17da-4838-b283-74ecb2116410" continuedAt="if9d17c80bb504e378e98e527464422b3" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5. DIVESTITURES </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fajardo, Puerto Rico Manufacturing Operations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 29, 2020, the Company sold its Fajardo, Puerto Rico, manufacturing operations to GVS, S.p.A (&#8220;GVS&#8221;), a leading provider of advanced filtration solutions for critical applications for $<ix:nonFraction unitRef="usd" contextRef="ied6e581caf26486bbb484a11ddea3e51_D20200629-20200629" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80Ni9mcmFnOjczOTYwYTdlNjAzMDQyZGE4MWM2ZmVmM2ZjYzc3YWRkL3RleHRyZWdpb246NzM5NjBhN2U2MDMwNDJkYTgxYzZmZWYzZmNjNzdhZGRfMjQ4_72ba152b-ad40-4252-b1d3-4511a404f665">15.1</ix:nonFraction>&#160;million ($<ix:nonFraction unitRef="usd" contextRef="ied6e581caf26486bbb484a11ddea3e51_D20200629-20200629" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80Ni9mcmFnOjczOTYwYTdlNjAzMDQyZGE4MWM2ZmVmM2ZjYzc3YWRkL3RleHRyZWdpb246NzM5NjBhN2U2MDMwNDJkYTgxYzZmZWYzZmNjNzdhZGRfMjUy_4f682827-c2e8-4808-86eb-a1acdb8f3c8c">7.8</ix:nonFraction>&#160;million, net of cash transferred). Under the terms of the agreement, Haemonetics retained all intellectual property rights to its proprietary blood filters currently manufactured at its Fajardo facility and GVS acquired certain assets consisting primarily of property, plant and equipment, inventory and cash and has assumed certain related liabilities. In connection with this transaction, the Company and GVS also entered into a long-term supply and development agreement that, among other things, grants GVS exclusive rights to manufacture and supply the blood filters currently produced at the Fajardo facility for Haemonetics. The Company also agreed to provide certain transition services to GVS, generally for a period of up to three months depending on the nature of the service.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of this transaction, Haemonetics recognized a pre-tax impairment charge in its Blood Center business unit of $<ix:nonFraction unitRef="usd" contextRef="ied6e581caf26486bbb484a11ddea3e51_D20200629-20200629" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80Ni9mcmFnOjczOTYwYTdlNjAzMDQyZGE4MWM2ZmVmM2ZjYzc3YWRkL3RleHRyZWdpb246NzM5NjBhN2U2MDMwNDJkYTgxYzZmZWYzZmNjNzdhZGRfMTEyMw_aadaafd3-ca76-4b2b-a824-d4bed212685f">1.0</ix:nonFraction>&#160;million in the first quarter of fiscal 2021 and an incremental loss of $<ix:nonFraction unitRef="usd" contextRef="i231ee71df4ce422fbe1694ee337e10ea_D20200329-20200627" decimals="-5" format="ixt:numdotdecimal" name="hae:DisposalGroupNotDiscontinuedOperationsIncrementalLossOnClosingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80Ni9mcmFnOjczOTYwYTdlNjAzMDQyZGE4MWM2ZmVmM2ZjYzc3YWRkL3RleHRyZWdpb246NzM5NjBhN2U2MDMwNDJkYTgxYzZmZWYzZmNjNzdhZGRfODI0NjMzNzIxMjQ2Mw_c20d92e8-f9dc-4099-9310-ff7a29d00ce4">0.4</ix:nonFraction>&#160;million based on closing adjustments during the third quarter of fiscal 2021, as the carrying value of the assets and liabilities in the asset transfer exceeded the net of the $<ix:nonFraction unitRef="usd" contextRef="ied6e581caf26486bbb484a11ddea3e51_D20200629-20200629" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80Ni9mcmFnOjczOTYwYTdlNjAzMDQyZGE4MWM2ZmVmM2ZjYzc3YWRkL3RleHRyZWdpb246NzM5NjBhN2U2MDMwNDJkYTgxYzZmZWYzZmNjNzdhZGRfMTI5OQ_b12bf4c0-7f78-4eb3-b1ce-ee45e3791382">15.1</ix:nonFraction>&#160;million of cash proceeds and an additional contingent liability of $<ix:nonFraction unitRef="usd" contextRef="ied6e581caf26486bbb484a11ddea3e51_D20200629-20200629" decimals="-5" format="ixt:numdotdecimal" name="hae:DisposalGroupNotDiscontinuedOperationsExpectedCostToSell" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80Ni9mcmFnOjczOTYwYTdlNjAzMDQyZGE4MWM2ZmVmM2ZjYzc3YWRkL3RleHRyZWdpb246NzM5NjBhN2U2MDMwNDJkYTgxYzZmZWYzZmNjNzdhZGRfMTM2MQ_4b899a65-fdff-43f9-9f62-bd4f4cc8727b">1.5</ix:nonFraction>&#160;million. The disposal group consisted of $<ix:nonFraction unitRef="usd" contextRef="ieacf3aef0a2a44ffa6d41b7518483e60_I20200629" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80Ni9mcmFnOjczOTYwYTdlNjAzMDQyZGE4MWM2ZmVmM2ZjYzc3YWRkL3RleHRyZWdpb246NzM5NjBhN2U2MDMwNDJkYTgxYzZmZWYzZmNjNzdhZGRfMTM5Nw_5f9aaecb-8d28-41e3-8715-ebe1679907b0">3.3</ix:nonFraction>&#160;million of inventory, $<ix:nonFraction unitRef="usd" contextRef="ieacf3aef0a2a44ffa6d41b7518483e60_I20200629" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80Ni9mcmFnOjczOTYwYTdlNjAzMDQyZGE4MWM2ZmVmM2ZjYzc3YWRkL3RleHRyZWdpb246NzM5NjBhN2U2MDMwNDJkYTgxYzZmZWYzZmNjNzdhZGRfMTQxNA_13bd7947-11b6-4b5c-a60f-9d18db812d52">7.2</ix:nonFraction>&#160;million of fixed assets, $<ix:nonFraction unitRef="usd" contextRef="ieacf3aef0a2a44ffa6d41b7518483e60_I20200629" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80Ni9mcmFnOjczOTYwYTdlNjAzMDQyZGE4MWM2ZmVmM2ZjYzc3YWRkL3RleHRyZWdpb246NzM5NjBhN2U2MDMwNDJkYTgxYzZmZWYzZmNjNzdhZGRfMTQzNA_944dfa27-cd5f-4351-a754-499c60dc8c98">3.2</ix:nonFraction>&#160;million of other liabilities, and $<ix:nonFraction unitRef="usd" contextRef="ieacf3aef0a2a44ffa6d41b7518483e60_I20200629" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80Ni9mcmFnOjczOTYwYTdlNjAzMDQyZGE4MWM2ZmVmM2ZjYzc3YWRkL3RleHRyZWdpb246NzM5NjBhN2U2MDMwNDJkYTgxYzZmZWYzZmNjNzdhZGRfMTQ2Mw_35a0ba40-14fa-4a33-a111-64790f60111c">0.4</ix:nonFraction>&#160;million of goodwill allocated based on fair value to the business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. Blood Donor Management Software</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 1, 2020, the Company sold certain U.S. blood donor management software solution assets within its Blood Center business unit to the GPI Group (&#8220;GPI&#8221;) for an upfront cash payment of $<ix:nonFraction unitRef="usd" contextRef="ie18de39654bc43fabcb2d7cea0396838_D20200701-20200701" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80Ni9mcmFnOjczOTYwYTdlNjAzMDQyZGE4MWM2ZmVmM2ZjYzc3YWRkL3RleHRyZWdpb246NzM5NjBhN2U2MDMwNDJkYTgxYzZmZWYzZmNjNzdhZGRfMTc1Mw_270ab112-9d18-4307-9a94-07bbdea9be96">14.0</ix:nonFraction>&#160;million ($<ix:nonFraction unitRef="usd" contextRef="ie18de39654bc43fabcb2d7cea0396838_D20200701-20200701" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80Ni9mcmFnOjczOTYwYTdlNjAzMDQyZGE4MWM2ZmVmM2ZjYzc3YWRkL3RleHRyZWdpb246NzM5NjBhN2U2MDMwNDJkYTgxYzZmZWYzZmNjNzdhZGRfMTc1Nw_6e978252-f282-48f4-b1d9-0d83d4c6974f">13.6</ix:nonFraction>&#160;million, net of working capital adjustments) and up to $<ix:nonFraction unitRef="usd" contextRef="ie18de39654bc43fabcb2d7cea0396838_D20200701-20200701" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80Ni9mcmFnOjczOTYwYTdlNjAzMDQyZGE4MWM2ZmVmM2ZjYzc3YWRkL3RleHRyZWdpb246NzM5NjBhN2U2MDMwNDJkYTgxYzZmZWYzZmNjNzdhZGRfMTgwNw_68da6d27-8fdc-4e80-bbc0-4e7d5b750dab">14.0</ix:nonFraction>&#160;million in additional consideration contingent on the achievement of commercial milestones over the twelve month period immediately following the closing of the transaction. The disposal group consisted of $<ix:nonFraction unitRef="usd" contextRef="i2c5c92e739704d5ebb1fc26b36eb5d62_I20200701" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80Ni9mcmFnOjczOTYwYTdlNjAzMDQyZGE4MWM2ZmVmM2ZjYzc3YWRkL3RleHRyZWdpb246NzM5NjBhN2U2MDMwNDJkYTgxYzZmZWYzZmNjNzdhZGRfMjAwNQ_78e24551-17b5-495c-ab9c-65ea522cbe65">1.4</ix:nonFraction>&#160;million of accounts receivable, $<ix:nonFraction unitRef="usd" contextRef="i2c5c92e739704d5ebb1fc26b36eb5d62_I20200701" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80Ni9mcmFnOjczOTYwYTdlNjAzMDQyZGE4MWM2ZmVmM2ZjYzc3YWRkL3RleHRyZWdpb246NzM5NjBhN2U2MDMwNDJkYTgxYzZmZWYzZmNjNzdhZGRfMjAzMg_d16a7908-06ce-45b6-b9da-b921c5b92df2">0.9</ix:nonFraction>&#160;million of intangible assets, other liabilities of $<ix:nonFraction unitRef="usd" contextRef="i2c5c92e739704d5ebb1fc26b36eb5d62_I20200701" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80Ni9mcmFnOjczOTYwYTdlNjAzMDQyZGE4MWM2ZmVmM2ZjYzc3YWRkL3RleHRyZWdpb246NzM5NjBhN2U2MDMwNDJkYTgxYzZmZWYzZmNjNzdhZGRfMjA3OA_4d4ddaa8-66b6-48e1-918e-815a2e49c8a7">1.8</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i2c5c92e739704d5ebb1fc26b36eb5d62_I20200701" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80Ni9mcmFnOjczOTYwYTdlNjAzMDQyZGE4MWM2ZmVmM2ZjYzc3YWRkL3RleHRyZWdpb246NzM5NjBhN2U2MDMwNDJkYTgxYzZmZWYzZmNjNzdhZGRfMjA4NQ_1211ce09-3dec-448b-8b38-81e740c24103">1.4</ix:nonFraction>&#160;million of goodwill allocated based on fair value to the business. The Company recognized an $<ix:nonFraction unitRef="usd" contextRef="ie18de39654bc43fabcb2d7cea0396838_D20200701-20200701" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80Ni9mcmFnOjczOTYwYTdlNjAzMDQyZGE4MWM2ZmVmM2ZjYzc3YWRkL3RleHRyZWdpb246NzM5NjBhN2U2MDMwNDJkYTgxYzZmZWYzZmNjNzdhZGRfMjE3Mw_2a16eef9-18d3-4baa-8e5b-e3bc665b0a2c">11.7</ix:nonFraction>&#160;million gain upon closing of the transaction in the second quarter of fiscal 2021 and an additional $<ix:nonFraction unitRef="usd" contextRef="i4e00d646e9b74bf58ee6a91734e5d466_D20200927-20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80Ni9mcmFnOjczOTYwYTdlNjAzMDQyZGE4MWM2ZmVmM2ZjYzc3YWRkL3RleHRyZWdpb246NzM5NjBhN2U2MDMwNDJkYTgxYzZmZWYzZmNjNzdhZGRfODI0NjMzNzIxMjQ3Nw_70e0db60-52cd-41bf-843f-ba2e9d1eb0c7">1.5</ix:nonFraction>&#160;million gain in the third quarter of fiscal 2021. To the extent the additional contingent consideration is earned and realized in a future period then such amounts will be recorded as additional gains in such future period. The Company also agreed to provide certain transition services to GPI, generally for a period of one to nine months depending on the nature of the service.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inlog Holdings France</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 18, 2020, the Company sold its wholly-owned subsidiary Inlog Holdings France SAS to Ab&#233;nex Capital (&#8220;Ab&#233;nex&#8221;), a private equity firm based in France for $<ix:nonFraction unitRef="usd" contextRef="i3858043e51c64ee89cd1d79087a6f765_D20200918-20200918" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80Ni9mcmFnOjczOTYwYTdlNjAzMDQyZGE4MWM2ZmVmM2ZjYzc3YWRkL3RleHRyZWdpb246NzM5NjBhN2U2MDMwNDJkYTgxYzZmZWYzZmNjNzdhZGRfMjc3NA_fd9c27df-9740-407a-85c0-8236492a97dd">30.5</ix:nonFraction>&#160;million ($<ix:nonFraction unitRef="usd" contextRef="i3858043e51c64ee89cd1d79087a6f765_D20200918-20200918" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80Ni9mcmFnOjczOTYwYTdlNjAzMDQyZGE4MWM2ZmVmM2ZjYzc3YWRkL3RleHRyZWdpb246NzM5NjBhN2U2MDMwNDJkYTgxYzZmZWYzZmNjNzdhZGRfMjc3OA_7984a8ea-6c80-4f32-b20b-0015e73d8b18">24.5</ix:nonFraction>&#160;million, net of cash transferred), of which </span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if9d17c80bb504e378e98e527464422b3">$<ix:nonFraction unitRef="usd" contextRef="i90c03c90eadf4fd4868c3d27ca9208b1_I20200918" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80Ni9mcmFnOjczOTYwYTdlNjAzMDQyZGE4MWM2ZmVmM2ZjYzc3YWRkL3RleHRyZWdpb246NzM5NjBhN2U2MDMwNDJkYTgxYzZmZWYzZmNjNzdhZGRfMjgxNw_640be3f4-cd52-4d8e-a953-12e25d2959b9">29.2</ix:nonFraction>&#160;million was received at closing and $<ix:nonFraction unitRef="usd" contextRef="i90c03c90eadf4fd4868c3d27ca9208b1_I20200918" decimals="-5" format="ixt:numdotdecimal" name="hae:DisposalGroupIncludingDiscontinuedOperationConsiderationToBeReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80Ni9mcmFnOjczOTYwYTdlNjAzMDQyZGE4MWM2ZmVmM2ZjYzc3YWRkL3RleHRyZWdpb246NzM5NjBhN2U2MDMwNDJkYTgxYzZmZWYzZmNjNzdhZGRfMjg0OA_c3d79e3e-2045-422a-b2c9-1e2764fea240">1.3</ix:nonFraction>&#160;million will be received one-year from the closing date. Inlog Holdings France SAS, through its subsidiary In Log SAS, develops and sells blood bank and hospital software solutions used predominantly in France and in several other countries outside of the U.S. The disposal group included $<ix:nonFraction unitRef="usd" contextRef="i90c03c90eadf4fd4868c3d27ca9208b1_I20200918" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80Ni9mcmFnOjczOTYwYTdlNjAzMDQyZGE4MWM2ZmVmM2ZjYzc3YWRkL3RleHRyZWdpb246NzM5NjBhN2U2MDMwNDJkYTgxYzZmZWYzZmNjNzdhZGRfMzEzMg_5013751c-d229-4e55-840f-eb1f84ca0013">2.2</ix:nonFraction>&#160;million of intangible assets, $<ix:nonFraction unitRef="usd" contextRef="i90c03c90eadf4fd4868c3d27ca9208b1_I20200918" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80Ni9mcmFnOjczOTYwYTdlNjAzMDQyZGE4MWM2ZmVmM2ZjYzc3YWRkL3RleHRyZWdpb246NzM5NjBhN2U2MDMwNDJkYTgxYzZmZWYzZmNjNzdhZGRfMzE1Nw_1124204d-ede6-44ae-814d-af9c81e31ac4">2.2</ix:nonFraction>&#160;million accounts receivable, $<ix:nonFraction unitRef="usd" contextRef="i90c03c90eadf4fd4868c3d27ca9208b1_I20200918" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80Ni9mcmFnOjczOTYwYTdlNjAzMDQyZGE4MWM2ZmVmM2ZjYzc3YWRkL3RleHRyZWdpb246NzM5NjBhN2U2MDMwNDJkYTgxYzZmZWYzZmNjNzdhZGRfMzE4MQ_b9ddd127-a4a8-40d4-95a8-7b018059ad25">0.3</ix:nonFraction>&#160;million other assets, $<ix:nonFraction unitRef="usd" contextRef="i90c03c90eadf4fd4868c3d27ca9208b1_I20200918" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80Ni9mcmFnOjczOTYwYTdlNjAzMDQyZGE4MWM2ZmVmM2ZjYzc3YWRkL3RleHRyZWdpb246NzM5NjBhN2U2MDMwNDJkYTgxYzZmZWYzZmNjNzdhZGRfMzE5OA_8b6b20c5-f8cf-499e-8ca5-89a6eb687e82">3.3</ix:nonFraction>&#160;million of liabilities and $<ix:nonFraction unitRef="usd" contextRef="i90c03c90eadf4fd4868c3d27ca9208b1_I20200918" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80Ni9mcmFnOjczOTYwYTdlNjAzMDQyZGE4MWM2ZmVmM2ZjYzc3YWRkL3RleHRyZWdpb246NzM5NjBhN2U2MDMwNDJkYTgxYzZmZWYzZmNjNzdhZGRfMzIyMA_c6c3b46d-1043-4061-918d-ba8b13bda0fb">3.3</ix:nonFraction>&#160;million of goodwill allocated based on the fair value of the business which impacted both the Blood Center and Hospital business units. The Company recognized a gain of $<ix:nonFraction unitRef="usd" contextRef="id6bd93e1c908460891c53b736309cb36_D20200927-20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80Ni9mcmFnOjczOTYwYTdlNjAzMDQyZGE4MWM2ZmVmM2ZjYzc3YWRkL3RleHRyZWdpb246NzM5NjBhN2U2MDMwNDJkYTgxYzZmZWYzZmNjNzdhZGRfMzM4NA_c41d3c4b-ac37-4878-9790-c599be01afd9">19.8</ix:nonFraction>&#160;million upon closing of the transaction in the second quarter of fiscal 2021.</ix:continuation></span></div><div><span><br/></span></div><div id="ib1e23e354c9c424096b27d04c70f5a5a_49"></div><ix:nonNumeric contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80OS9mcmFnOjcwZDk0ZWMzZjk5NjRmMGI4ODYzMWZiZTk0ZGRmNTI3L3RleHRyZWdpb246NzBkOTRlYzNmOTk2NGYwYjg4NjMxZmJlOTRkZGY1MjdfMTcxNA_47162145-2677-4a15-b318-18a6350514d7" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6. INCOME TAXES </span></div><div><span><br/></span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company conducts business globally and reports its results of operations in a number of foreign jurisdictions in addition to the United States. The Company's reported tax rate is impacted by the jurisdictional mix of earnings in any given period as the foreign jurisdictions in which it operates have tax rates that differ from the U.S. statutory tax rate.&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended December 26, 2020, the Company reported income tax expense of $<ix:nonFraction unitRef="usd" contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80OS9mcmFnOjcwZDk0ZWMzZjk5NjRmMGI4ODYzMWZiZTk0ZGRmNTI3L3RleHRyZWdpb246NzBkOTRlYzNmOTk2NGYwYjg4NjMxZmJlOTRkZGY1MjdfNDI4_2ddc7bff-1479-4642-b368-6f42dbfed9ca">5.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80OS9mcmFnOjcwZDk0ZWMzZjk5NjRmMGI4ODYzMWZiZTk0ZGRmNTI3L3RleHRyZWdpb246NzBkOTRlYzNmOTk2NGYwYjg4NjMxZmJlOTRkZGY1MjdfNDM1_ca5534c8-519d-413b-a44b-6a7d2b051737">9.8</ix:nonFraction>&#160;million, respectively, representing effective tax rates of <ix:nonFraction unitRef="number" contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80OS9mcmFnOjcwZDk0ZWMzZjk5NjRmMGI4ODYzMWZiZTk0ZGRmNTI3L3RleHRyZWdpb246NzBkOTRlYzNmOTk2NGYwYjg4NjMxZmJlOTRkZGY1MjdfNDg5_a5454c74-9ac8-4610-bad9-8d61ca59b1b9">14.7</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80OS9mcmFnOjcwZDk0ZWMzZjk5NjRmMGI4ODYzMWZiZTk0ZGRmNTI3L3RleHRyZWdpb246NzBkOTRlYzNmOTk2NGYwYjg4NjMxZmJlOTRkZGY1MjdfNDk2_0af8f8a3-af4b-46a0-a720-ab683b6c9130">9.8</ix:nonFraction>%, respectively. The effective tax rate for the three and nine months ended December 26, 2020 includes discrete tax benefits recognized from excess stock compensation deductions of $<ix:nonFraction unitRef="usd" contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80OS9mcmFnOjcwZDk0ZWMzZjk5NjRmMGI4ODYzMWZiZTk0ZGRmNTI3L3RleHRyZWdpb246NzBkOTRlYzNmOTk2NGYwYjg4NjMxZmJlOTRkZGY1MjdfNjM1_d012dd20-b0e4-415d-bb5d-33cb5a4e9722">1.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80OS9mcmFnOjcwZDk0ZWMzZjk5NjRmMGI4ODYzMWZiZTk0ZGRmNTI3L3RleHRyZWdpb246NzBkOTRlYzNmOTk2NGYwYjg4NjMxZmJlOTRkZGY1MjdfNjQy_4d26c7a4-a1e9-44ad-b318-189c6c227065">5.1</ix:nonFraction>&#160;million, respectively. The effective tax rates were also impacted by the jurisdictional mix of earnings including divestiture transactions. During the nine months ended December 26, 2020, the Company sold its Fajardo, Puerto Rico manufacturing operations, certain U.S. blood donor management software solution assets, and its wholly-owned subsidiary Inlog Holdings France SAS. The tax expense on divestitures, including the associated valuation allowance impacts, were included in the computation of the annual effective tax rate. Refer to Note 5, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Divestitures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for information pertaining to these divestitures. </span></div><div><span><br/></span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended December 28, 2019, the Company reported an income tax provision of $<ix:nonFraction unitRef="usd" contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80OS9mcmFnOjcwZDk0ZWMzZjk5NjRmMGI4ODYzMWZiZTk0ZGRmNTI3L3RleHRyZWdpb246NzBkOTRlYzNmOTk2NGYwYjg4NjMxZmJlOTRkZGY1MjdfMTI2MA_a35ce2ed-bf76-42b1-940b-c154b24761f5">7.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80OS9mcmFnOjcwZDk0ZWMzZjk5NjRmMGI4ODYzMWZiZTk0ZGRmNTI3L3RleHRyZWdpb246NzBkOTRlYzNmOTk2NGYwYjg4NjMxZmJlOTRkZGY1MjdfMTI4MA_9db86f44-8f3c-4552-8ad9-5e3dca69d7d0">6.3</ix:nonFraction>&#160;million, respectively, representing effective tax rates of <ix:nonFraction unitRef="number" contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80OS9mcmFnOjcwZDk0ZWMzZjk5NjRmMGI4ODYzMWZiZTk0ZGRmNTI3L3RleHRyZWdpb246NzBkOTRlYzNmOTk2NGYwYjg4NjMxZmJlOTRkZGY1MjdfMTMzNA_4e0f0c80-3511-4d7f-8d6b-e39eb253bd1f">21.0</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80OS9mcmFnOjcwZDk0ZWMzZjk5NjRmMGI4ODYzMWZiZTk0ZGRmNTI3L3RleHRyZWdpb246NzBkOTRlYzNmOTk2NGYwYjg4NjMxZmJlOTRkZGY1MjdfMTM0MQ_973b1700-1284-4816-b395-30e26f8fbdbd">9.6</ix:nonFraction>%, respectively. The effective tax rate for the nine months ended December 28, 2019 was lower than the U.S. statutory tax rate primarily due to a discrete tax benefit recognized from excess stock compensation deductions of $<ix:nonFraction unitRef="usd" contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80OS9mcmFnOjcwZDk0ZWMzZjk5NjRmMGI4ODYzMWZiZTk0ZGRmNTI3L3RleHRyZWdpb246NzBkOTRlYzNmOTk2NGYwYjg4NjMxZmJlOTRkZGY1MjdfMTUzMg_12fa9ab5-7cc4-4bef-8353-5d35f19e8489">3.1</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80OS9mcmFnOjcwZDk0ZWMzZjk5NjRmMGI4ODYzMWZiZTk0ZGRmNTI3L3RleHRyZWdpb246NzBkOTRlYzNmOTk2NGYwYjg4NjMxZmJlOTRkZGY1MjdfMTUzOQ_820a414f-7414-4ab2-bdd1-33ae6ffd8f1e">12.4</ix:nonFraction>&#160;million, respectively. The effective tax rates were also impacted by the jurisdictional mix of earnings and the impact of the divestiture of the Union, South Carolina facility.</span></div></ix:nonNumeric><div style="margin-bottom:8pt"><span><br/></span></div><div id="ib1e23e354c9c424096b27d04c70f5a5a_55"></div><ix:nonNumeric contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RleHRyZWdpb246NjU1ODE1MTM4MmU3NDMxYjg5YWU1YjNjNmQwNDk4NmFfNzM1_21f79ea1-ea5b-44cd-a04f-137f772d4d2f" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7. EARNINGS PER SHARE </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RleHRyZWdpb246NjU1ODE1MTM4MmU3NDMxYjg5YWU1YjNjNmQwNDk4NmFfNzM3_beff60fa-830a-4025-a262-29d60f108bd2" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of the numerators and denominators of the basic and diluted earnings per share computations. </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.578%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#160;(In thousands, except per share amounts)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic EPS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfMy0xLTEtMS0w_25e1969a-8e42-46a2-86c9-e7bd47f453b1"><ix:nonFraction unitRef="usd" contextRef="i593e5b9ceb9240d1888435f827c761eb_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfMy0xLTEtMS0w_2c8836b8-c96e-4fc9-a8f6-f3306d7f3f9d">31,882</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfMy0zLTEtMS0w_71e8ffb5-836b-4843-8096-33a8f0ce1284">29,895</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfMy01LTEtMS0w_f14be7c7-9723-45dd-8a92-bd00bc5b28a2">90,510</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfMy03LTEtMS0w_9b89c7a6-2ac5-41e5-b2b7-9e84e3c5f3c3">58,902</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfNC0xLTEtMS0w_4bd87dba-35d7-4dd3-915c-1f23d542f561">50,789</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfNC0zLTEtMS0w_23684420-4979-49c0-86e5-fc5df9060f52">50,630</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfNC01LTEtMS0w_a11ae91a-ae83-48de-87f6-f8892d6d754a">50,634</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfNC03LTEtMS0w_f7369501-704f-4a11-97de-c186f4d5d713">50,810</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic income per share</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfNS0xLTEtMS0w_1a37f945-c63e-4a66-a8e6-be30fd0111ad">0.63</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfNS0zLTEtMS0w_ce48a8d3-9fa8-4a00-a4f9-76d734def7a6">0.59</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfNS01LTEtMS0w_6270ae8d-763a-40de-9b13-5448e84ad388">1.79</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfNS03LTEtMS0w_f575fd78-636e-49d7-8ca3-84bcc0e1692e">1.16</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted EPS</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfNy0xLTEtMS0w_758fb82e-a817-4c9b-adb8-294b8207a8fa">31,882</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfNy0zLTEtMS0w_80ae592d-9213-4cd4-a3a7-6462926c56c0">29,895</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfNy01LTEtMS0w_239539a8-4952-48a5-b19c-4fe1fbe4d74f">90,510</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfNy03LTEtMS0w_df105f6a-e705-4260-92da-9e71768c189c">58,902</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted average shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfOC0xLTEtMS0w_4bd87dba-35d7-4dd3-915c-1f23d542f561">50,789</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfOC0zLTEtMS0w_26ace557-9615-4b30-9a46-0f1e7c5eb82c">50,630</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfOC01LTEtMS0w_a11ae91a-ae83-48de-87f6-f8892d6d754a">50,634</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfOC03LTEtMS0w_572cb851-b16a-46b8-b4d4-302c45b58f37">50,810</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net effect of common stock equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfOS0xLTEtMS0w_fa069adc-7fa4-4e97-8431-045294564467">574</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfOS0zLTEtMS0w_6e0b15a3-e39a-4738-8f17-afe35b497433">1,008</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfOS01LTEtMS0w_63d6923c-64db-4575-bea3-90ce50bd8ab3">600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfOS03LTEtMS0w_dc2dab91-66d1-4cad-9480-b64d17aa39e7">1,185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted average shares</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfMTAtMS0xLTEtMA_0353f13b-e23e-441c-910b-3d2abc056499">51,363</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfMTAtMy0xLTEtMA_5a8e2e0c-d178-473b-89e9-2a6b596f4629">51,638</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfMTAtNS0xLTEtMA_ddf057e2-5345-41c9-be30-9ce7f3f6e066">51,234</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfMTAtNy0xLTEtMA_f2e3da2d-e4b5-4e3d-b607-f1dee1ada187">51,995</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted income per share</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfMTEtMS0xLTEtMA_54a5b9e4-5f19-4402-92c4-c82a0c17d2f0">0.62</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfMTEtMy0xLTEtMA_ae9fe9aa-076c-450e-9fcb-5cdfacc0b8f1">0.58</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfMTEtNS0xLTEtMA_d5540280-8a6b-42d4-a99c-476368adab1e">1.77</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfMTEtNy0xLTEtMA_f84e01a5-4e80-4f8f-b448-b3963d98359e">1.13</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is calculated using the Company's weighted-average outstanding common stock. Diluted earnings per share is calculated using its weighted-average outstanding common stock including the dilutive effect of stock awards as determined under the treasury stock method. For the three and nine months ended December 26, 2020, weighted average shares outstanding, assuming dilution, excludes the impact of <ix:nonFraction unitRef="shares" contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RleHRyZWdpb246NjU1ODE1MTM4MmU3NDMxYjg5YWU1YjNjNmQwNDk4NmFfNTMz_08868977-ecac-4cc7-ab40-814baf340798">0.4</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RleHRyZWdpb246NjU1ODE1MTM4MmU3NDMxYjg5YWU1YjNjNmQwNDk4NmFfNTQw_ae06c578-077f-4899-a636-ffdc82942615">0.6</ix:nonFraction>&#160;million anti-dilutive shares, respectively. For both the three and nine months ended December 28, 2019, weighted average shares outstanding, assuming dilution, excludes the impact of <ix:nonFraction unitRef="shares" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RleHRyZWdpb246NjU1ODE1MTM4MmU3NDMxYjg5YWU1YjNjNmQwNDk4NmFfNjg0_a1207fd3-6f56-4a2e-bc01-ad08b8bf5377">0.2</ix:nonFraction>&#160;million anti-dilutive shares.</span></div></ix:nonNumeric><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><div id="ib1e23e354c9c424096b27d04c70f5a5a_58"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:nonNumeric contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81OC9mcmFnOjNjZDkyMjcwZDg3MjRmNTU4YTc1MzM3ZDg5NDRiMTIyL3RleHRyZWdpb246M2NkOTIyNzBkODcyNGY1NThhNzUzMzdkODk0NGIxMjJfMzIxNw_8109fc1a-9e8d-4e03-9858-f0fbc6ddfb0e" continuedAt="ia284b369abe04bb8b4756f0ac4a21963" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8. REVENUE </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's revenue recognition policy is to recognize revenues from product sales, software and services in accordance with ASC Topic 606,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Revenue is recognized when obligations under the terms of a contract with a customer are satisfied; this occurs with the transfer of control of the Company&#8217;s goods or services. The Company considers revenue to be earned when all of the following criteria are met: it has a contract with a customer that creates enforceable rights and obligations; promised products or services are identified; the transaction price, or the consideration it expects to receive for transferring goods or providing services, is determinable and it has transferred control of the promised items to the customer. A promise in a contract to transfer a distinct good or service to the customer is identified as a performance obligation. A contract&#8217;s transaction price is allocated to each performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. Some of the Company&#8217;s contracts have multiple performance obligations. For contracts with multiple performance obligations, the Company allocates the contract&#8217;s transaction price to each performance obligation based on the estimated standalone selling prices of the good or service in the contract. For goods or services for which observable standalone selling prices are not available, the Company uses an expected cost plus a margin approach to estimate the standalone selling price of each performance obligation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;26, 2020, the Company had $<ix:nonFraction unitRef="usd" contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81OC9mcmFnOjNjZDkyMjcwZDg3MjRmNTU4YTc1MzM3ZDg5NDRiMTIyL3RleHRyZWdpb246M2NkOTIyNzBkODcyNGY1NThhNzUzMzdkODk0NGIxMjJfMTYwMw_70df73a3-4149-4a29-86cf-91ee503fec42">17.9</ix:nonFraction> million of its transaction price allocated to remaining performance obligations related to executed contracts with an original duration of one year or more. The Company expects to recognize approximately <ix:nonFraction unitRef="number" contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81OC9mcmFnOjNjZDkyMjcwZDg3MjRmNTU4YTc1MzM3ZDg5NDRiMTIyL3RleHRyZWdpb246M2NkOTIyNzBkODcyNGY1NThhNzUzMzdkODk0NGIxMjJfMTgwMg_92021fb8-fdca-481f-a885-201aeecb731b">59</ix:nonFraction>% of this amount as revenue within the next <ix:nonNumeric contextRef="i241ec033d3e44caf9ae5188ed0acd523_I20201226" format="ixt-sec:durwordsen" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81OC9mcmFnOjNjZDkyMjcwZDg3MjRmNTU4YTc1MzM3ZDg5NDRiMTIyL3RleHRyZWdpb246M2NkOTIyNzBkODcyNGY1NThhNzUzMzdkODk0NGIxMjJfMTg0Nw_841ddd5a-dd5f-42e2-963a-f92230d6a880">twelve months</ix:nonNumeric> and the remaining balance thereafter.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and customer advances and deposits (contract liabilities) on the condensed consolidated balance sheets. The difference in timing between billing and revenue recognition primarily occurs in software licensing arrangements, resulting in contract assets and contract liabilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;26, 2020 and March&#160;28, 2020, the Company had contract assets of $<ix:nonFraction unitRef="usd" contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81OC9mcmFnOjNjZDkyMjcwZDg3MjRmNTU4YTc1MzM3ZDg5NDRiMTIyL3RleHRyZWdpb246M2NkOTIyNzBkODcyNGY1NThhNzUzMzdkODk0NGIxMjJfMjM2Mw_62041a68-782d-4b65-9d25-212350580b6e">5.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81OC9mcmFnOjNjZDkyMjcwZDg3MjRmNTU4YTc1MzM3ZDg5NDRiMTIyL3RleHRyZWdpb246M2NkOTIyNzBkODcyNGY1NThhNzUzMzdkODk0NGIxMjJfMjM3MA_b24ef384-e5e7-4e96-a4a1-c3b64bd2b732">5.0</ix:nonFraction> million, respectively. The change is primarily due to the delay in billings compared to the revenue recognized. Contract assets are classified as other current assets and other long-term assets on the condensed consolidated balance sheets.</span></div></ix:nonNumeric><div><span><br/></span></div><div><ix:continuation id="ia284b369abe04bb8b4756f0ac4a21963" continuedAt="ic90319af9c1c4d25b493fd35309be8e7"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;26, 2020 and March&#160;28, 2020, the Company had contract liabilities of $<ix:nonFraction unitRef="usd" contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81OC9mcmFnOjNjZDkyMjcwZDg3MjRmNTU4YTc1MzM3ZDg5NDRiMTIyL3RleHRyZWdpb246M2NkOTIyNzBkODcyNGY1NThhNzUzMzdkODk0NGIxMjJfMjY2Mw_041e9af7-131d-429f-8352-a01ea0e0c265">16.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81OC9mcmFnOjNjZDkyMjcwZDg3MjRmNTU4YTc1MzM3ZDg5NDRiMTIyL3RleHRyZWdpb246M2NkOTIyNzBkODcyNGY1NThhNzUzMzdkODk0NGIxMjJfMjY3MA_906d3d69-e733-40e4-8013-7e4e7ac5d404">20.8</ix:nonFraction> million, respectively. During the three and nine months ended December 26, 2020, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81OC9mcmFnOjNjZDkyMjcwZDg3MjRmNTU4YTc1MzM3ZDg5NDRiMTIyL3RleHRyZWdpb246M2NkOTIyNzBkODcyNGY1NThhNzUzMzdkODk0NGIxMjJfMjcyNg_8537597f-4ba0-4a18-bfa5-b8df3dc67572">2.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81OC9mcmFnOjNjZDkyMjcwZDg3MjRmNTU4YTc1MzM3ZDg5NDRiMTIyL3RleHRyZWdpb246M2NkOTIyNzBkODcyNGY1NThhNzUzMzdkODk0NGIxMjJfMjczMw_fcb09a95-0562-48b6-bb49-45ca81f27d8f">16.3</ix:nonFraction> million, respectively, of revenue that was included in the above March&#160;28, 2020 contract liability balance. Contract liabilities decreased by an additional $<ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81OC9mcmFnOjNjZDkyMjcwZDg3MjRmNTU4YTc1MzM3ZDg5NDRiMTIyL3RleHRyZWdpb246M2NkOTIyNzBkODcyNGY1NThhNzUzMzdkODk0NGIxMjJfMjg3Mg_65d9f4b2-5850-4031-bc65-805ed953dd37"><ix:nonFraction unitRef="usd" contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81OC9mcmFnOjNjZDkyMjcwZDg3MjRmNTU4YTc1MzM3ZDg5NDRiMTIyL3RleHRyZWdpb246M2NkOTIyNzBkODcyNGY1NThhNzUzMzdkODk0NGIxMjJfMjg3Mg_9fb8dc9c-295e-4e08-9c40-4233653b340a">2.5</ix:nonFraction></ix:nonFraction>&#160;million during the three and nine months ended December 26, 2020 as a result of the sale of certain U.S. blood donor management software solution assets and the Company's wholly-owned subsidiary Inlog Holdings France SAS. Refer to Note 5, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Divestitures</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic90319af9c1c4d25b493fd35309be8e7"> for additional detail. Contract liabilities are classified as other liabilities and other long-term liabilities on the condensed consolidated balance sheets.</ix:continuation> </span></div><div><span><br/></span></div><div id="ib1e23e354c9c424096b27d04c70f5a5a_61"></div><ix:nonNumeric contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" name="us-gaap:InventoryDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV82MS9mcmFnOmI4YzE4ZjYwNDZjZjQzMjg5N2EyZDFiNTgzNGRiOWUyL3RleHRyZWdpb246YjhjMThmNjA0NmNmNDMyODk3YTJkMWI1ODM0ZGI5ZTJfMTkx_a5820338-0f33-423d-b16e-7a0ae07717eb" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9. INVENTORIES </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV82MS9mcmFnOmI4YzE4ZjYwNDZjZjQzMjg5N2EyZDFiNTgzNGRiOWUyL3RleHRyZWdpb246YjhjMThmNjA0NmNmNDMyODk3YTJkMWI1ODM0ZGI5ZTJfMTk1_1422f6b2-505b-4c90-81be-5b1313912f84" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost or market and include the cost of material, labor and manufacturing overhead. Cost is determined using the first-in, first-out method.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:68.944%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.143%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.145%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28, <br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV82MS9mcmFnOmI4YzE4ZjYwNDZjZjQzMjg5N2EyZDFiNTgzNGRiOWUyL3RhYmxlOjAyM2E0NjNjY2I4YTQ1NGE4ZjQ2MGQ0NWI1ODc3OTFmL3RhYmxlcmFuZ2U6MDIzYTQ2M2NjYjhhNDU0YThmNDYwZDQ1YjU4Nzc5MWZfMS0yLTEtMS0w_5d805fa5-80d6-4579-a5ae-97b1f7be2396">74,437</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV82MS9mcmFnOmI4YzE4ZjYwNDZjZjQzMjg5N2EyZDFiNTgzNGRiOWUyL3RhYmxlOjAyM2E0NjNjY2I4YTQ1NGE4ZjQ2MGQ0NWI1ODc3OTFmL3RhYmxlcmFuZ2U6MDIzYTQ2M2NjYjhhNDU0YThmNDYwZDQ1YjU4Nzc5MWZfMS00LTEtMS0w_482d135e-4b00-40e1-afef-0d128e286b21">76,867</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV82MS9mcmFnOmI4YzE4ZjYwNDZjZjQzMjg5N2EyZDFiNTgzNGRiOWUyL3RhYmxlOjAyM2E0NjNjY2I4YTQ1NGE4ZjQ2MGQ0NWI1ODc3OTFmL3RhYmxlcmFuZ2U6MDIzYTQ2M2NjYjhhNDU0YThmNDYwZDQ1YjU4Nzc5MWZfMi0yLTEtMS0w_704aff31-dce0-4849-9187-fdd788fa82eb">22,030</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV82MS9mcmFnOmI4YzE4ZjYwNDZjZjQzMjg5N2EyZDFiNTgzNGRiOWUyL3RhYmxlOjAyM2E0NjNjY2I4YTQ1NGE4ZjQ2MGQ0NWI1ODc3OTFmL3RhYmxlcmFuZ2U6MDIzYTQ2M2NjYjhhNDU0YThmNDYwZDQ1YjU4Nzc5MWZfMi00LTEtMS0w_2e427561-5dce-441b-9d64-15d528d9699a">11,021</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV82MS9mcmFnOmI4YzE4ZjYwNDZjZjQzMjg5N2EyZDFiNTgzNGRiOWUyL3RhYmxlOjAyM2E0NjNjY2I4YTQ1NGE4ZjQ2MGQ0NWI1ODc3OTFmL3RhYmxlcmFuZ2U6MDIzYTQ2M2NjYjhhNDU0YThmNDYwZDQ1YjU4Nzc5MWZfMy0yLTEtMS0w_2b33ed25-27a7-4f6a-888f-a452f1d5ac76">203,243</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV82MS9mcmFnOmI4YzE4ZjYwNDZjZjQzMjg5N2EyZDFiNTgzNGRiOWUyL3RhYmxlOjAyM2E0NjNjY2I4YTQ1NGE4ZjQ2MGQ0NWI1ODc3OTFmL3RhYmxlcmFuZ2U6MDIzYTQ2M2NjYjhhNDU0YThmNDYwZDQ1YjU4Nzc5MWZfMy00LTEtMS0w_d856076f-dace-495a-8fd3-c0ce334c1a02">182,388</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total inventories</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV82MS9mcmFnOmI4YzE4ZjYwNDZjZjQzMjg5N2EyZDFiNTgzNGRiOWUyL3RhYmxlOjAyM2E0NjNjY2I4YTQ1NGE4ZjQ2MGQ0NWI1ODc3OTFmL3RhYmxlcmFuZ2U6MDIzYTQ2M2NjYjhhNDU0YThmNDYwZDQ1YjU4Nzc5MWZfNC0yLTEtMS0w_1ca32271-c54b-4e59-b34f-e50ba77b1990">299,710</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV82MS9mcmFnOmI4YzE4ZjYwNDZjZjQzMjg5N2EyZDFiNTgzNGRiOWUyL3RhYmxlOjAyM2E0NjNjY2I4YTQ1NGE4ZjQ2MGQ0NWI1ODc3OTFmL3RhYmxlcmFuZ2U6MDIzYTQ2M2NjYjhhNDU0YThmNDYwZDQ1YjU4Nzc5MWZfNC00LTEtMS0w_d563b93f-6642-41cb-97e6-1ffb93bc8dc5">270,276</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div><span><br/></span></div><div id="ib1e23e354c9c424096b27d04c70f5a5a_64"></div><ix:nonNumeric contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV82NC9mcmFnOjc2OTk3NDk1NTM2NjRmNzlhNjNiMjA4OGEzM2Y2YzcxL3RleHRyZWdpb246NzY5OTc0OTU1MzY2NGY3OWE2M2IyMDg4YTMzZjZjNzFfMTYxNg_ccd94338-2743-42b9-9ac4-bd5b561ef0db" continuedAt="i61fc3746387b4b96b0ba45b378d6e4e5" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10. LEASES </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lessee Activity</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of fiscal 2021, the Company entered into a lease for manufacturing space in Clinton, PA. The Company's current manufacturing operations in Leetsdale, PA will be relocated. The lease term associated with the new manufacturing facility is 15 years and 7 months and includes two <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV82NC9mcmFnOjc2OTk3NDk1NTM2NjRmNzlhNjNiMjA4OGEzM2Y2YzcxL3RleHRyZWdpb246NzY5OTc0OTU1MzY2NGY3OWE2M2IyMDg4YTMzZjZjNzFfMzI4_d1261318-cbde-4310-8bac-529fcbd30bd5">five</span> year renewal options followed by one <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV82NC9mcmFnOjc2OTk3NDk1NTM2NjRmNzlhNjNiMjA4OGEzM2Y2YzcxL3RleHRyZWdpb246NzY5OTc0OTU1MzY2NGY3OWE2M2IyMDg4YTMzZjZjNzFfMzY4_fdeb1860-c6a9-478a-81ce-84942fec66c9">four</span> year renewal option. During the first quarter of fiscal 2021, the Company recorded a right-of-use asset of $<ix:nonFraction unitRef="usd" contextRef="ib56a8928767949d4bf60e3aee31e1600_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV82NC9mcmFnOjc2OTk3NDk1NTM2NjRmNzlhNjNiMjA4OGEzM2Y2YzcxL3RleHRyZWdpb246NzY5OTc0OTU1MzY2NGY3OWE2M2IyMDg4YTMzZjZjNzFfNDc4_a88873c8-ea96-4fdc-a079-f662411b5d4b">11.3</ix:nonFraction> million and corresponding liabilities of $<ix:nonFraction unitRef="usd" contextRef="ib56a8928767949d4bf60e3aee31e1600_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV82NC9mcmFnOjc2OTk3NDk1NTM2NjRmNzlhNjNiMjA4OGEzM2Y2YzcxL3RleHRyZWdpb246NzY5OTc0OTU1MzY2NGY3OWE2M2IyMDg4YTMzZjZjNzFfNTE0_ae585a27-917d-449b-b8f9-31a829ed205f">15.4</ix:nonFraction> million upon commencement of the lease term in May 2020. In addition, the Company recorded a $<ix:nonFraction unitRef="usd" contextRef="ib56a8928767949d4bf60e3aee31e1600_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV82NC9mcmFnOjc2OTk3NDk1NTM2NjRmNzlhNjNiMjA4OGEzM2Y2YzcxL3RleHRyZWdpb246NzY5OTc0OTU1MzY2NGY3OWE2M2IyMDg4YTMzZjZjNzFfNjAy_8ff30335-6ed4-4d93-a268-4953b354a52c">4.1</ix:nonFraction> </span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i61fc3746387b4b96b0ba45b378d6e4e5"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">million lease incentive receivable associated with this lease agreement which was received during the third quarter of fiscal 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lessor Activity</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets on the Company's balance sheet classified as Haemonetics equipment primarily consists of medical devices installed at customer sites but owned by Haemonetics. These devices are leased to customers under contractual arrangements that typically include an operating or sales-type lease as well as the purchase and consumption of a certain level of disposable products. Sales-type leases are not significant. Contract terms vary by customer and may include options to terminate the contract or options to extend the contract. Where devices are provided under operating lease arrangements, a substantial majority of the entire lease revenue is variable and subject to subsequent non-lease component (disposable products) sales. The allocation of revenue between the lease and non-lease components is based on stand-alone selling prices. Operating lease revenue represents less than 3 percent of the Company's total net sales.</span></div></ix:continuation><div><span><br/></span></div><div id="ib1e23e354c9c424096b27d04c70f5a5a_70"></div><ix:nonNumeric contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83MC9mcmFnOjc1NDg0Y2NjZWE0NjQ4MzViYmRkNTBiY2Q1Yjg4YjBlL3RleHRyZWdpb246NzU0ODRjY2NlYTQ2NDgzNWJiZGQ1MGJjZDViODhiMGVfMTQwNQ_2e218482-caeb-4b2b-afe1-6a57645c7092" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11. NOTES&#160;PAYABLE AND LONG-TERM DEBT </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 15, 2018, the Company entered into a credit agreement with certain lenders which provided for a $<ix:nonFraction unitRef="usd" contextRef="i7c25c1d4590644eb8b651796c671219c_I20180615" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83MC9mcmFnOjc1NDg0Y2NjZWE0NjQ4MzViYmRkNTBiY2Q1Yjg4YjBlL3RleHRyZWdpb246NzU0ODRjY2NlYTQ2NDgzNWJiZGQ1MGJjZDViODhiMGVfMTE0_2b6ec305-65d4-4c34-9682-571208da8e11">350.0</ix:nonFraction> million term loan (the &#8220;Term Loan&#8221;) and a $<ix:nonFraction unitRef="usd" contextRef="i4426464d081b45bb8839adced8fe2873_I20180615" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83MC9mcmFnOjc1NDg0Y2NjZWE0NjQ4MzViYmRkNTBiY2Q1Yjg4YjBlL3RleHRyZWdpb246NzU0ODRjY2NlYTQ2NDgzNWJiZGQ1MGJjZDViODhiMGVfMTUx_a076c77d-6253-45bf-b6c4-db674c9f9519">350.0</ix:nonFraction> million revolving loan (the &#8220;Revolving Credit Facility&#8221; and together with the Term Loan, the &#8220;Credit Facilities&#8221;). The Credit Facilities expire on June 15, 2023. Interest on the Credit Facilities is established using LIBOR plus <ix:nonFraction unitRef="number" contextRef="ic5d1fce0362544e68a49594cab3a1aa8_D20180615-20180615" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83MC9mcmFnOjc1NDg0Y2NjZWE0NjQ4MzViYmRkNTBiY2Q1Yjg4YjBlL3RleHRyZWdpb246NzU0ODRjY2NlYTQ2NDgzNWJiZGQ1MGJjZDViODhiMGVfMzc0_a8302392-6fea-48a0-9136-a77a75bc4bd6">1.13</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="ic9a17518f7194d808968c5442709d4d4_D20180615-20180615" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83MC9mcmFnOjc1NDg0Y2NjZWE0NjQ4MzViYmRkNTBiY2Q1Yjg4YjBlL3RleHRyZWdpb246NzU0ODRjY2NlYTQ2NDgzNWJiZGQ1MGJjZDViODhiMGVfMzc5_05a7f461-7657-429d-b08c-d654423969b5">1.75</ix:nonFraction>%, depending on the Company's leverage ratio. Under the Credit Facilities, the Company is required to maintain certain leverage and interest coverage ratios specified in the credit agreement as well as other customary non-financial affirmative and negative covenants. At December&#160;26, 2020, $<ix:nonFraction unitRef="usd" contextRef="ifd1b9a587aec4cdca6306687ea65c1a4_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83MC9mcmFnOjc1NDg0Y2NjZWE0NjQ4MzViYmRkNTBiY2Q1Yjg4YjBlL3RleHRyZWdpb246NzU0ODRjY2NlYTQ2NDgzNWJiZGQ1MGJjZDViODhiMGVfNjU1_c8b1cb89-2ceb-4ce6-ba64-374b521d69b5">310.6</ix:nonFraction> million was outstanding under the Term Loan with an effective interest rate of <ix:nonFraction unitRef="number" contextRef="ifd1b9a587aec4cdca6306687ea65c1a4_I20201226" decimals="INF" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83MC9mcmFnOjc1NDg0Y2NjZWE0NjQ4MzViYmRkNTBiY2Q1Yjg4YjBlL3RleHRyZWdpb246NzU0ODRjY2NlYTQ2NDgzNWJiZGQ1MGJjZDViODhiMGVfNzI5_2d20ddde-f329-4952-a1da-a5194b4cfe0a">1.4</ix:nonFraction>%. There were no borrowings outstanding on the Revolving Credit Facility. The Company also has $<ix:nonFraction unitRef="usd" contextRef="i4842b0c162ea46978645dd51b56a0764_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83MC9mcmFnOjc1NDg0Y2NjZWE0NjQ4MzViYmRkNTBiY2Q1Yjg4YjBlL3RleHRyZWdpb246NzU0ODRjY2NlYTQ2NDgzNWJiZGQ1MGJjZDViODhiMGVfOTQz_4945c9d6-fd56-43bc-8777-db8069d89189">26.2</ix:nonFraction> million of uncommitted operating lines of credit to fund its global operations under which there were <ix:nonFraction unitRef="usd" contextRef="i4842b0c162ea46978645dd51b56a0764_I20201226" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LongTermDebt" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83MC9mcmFnOjc1NDg0Y2NjZWE0NjQ4MzViYmRkNTBiY2Q1Yjg4YjBlL3RleHRyZWdpb246NzU0ODRjY2NlYTQ2NDgzNWJiZGQ1MGJjZDViODhiMGVfMTA0MA_b1338eca-bdb6-4f1b-9d24-fdcaea79a335">no</ix:nonFraction> outstanding borrowings as of December&#160;26, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has required scheduled principal payments of $<ix:nonFraction unitRef="usd" contextRef="i075eaab3aa4549bb8d0f597beca1bd0f_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83MC9mcmFnOjc1NDg0Y2NjZWE0NjQ4MzViYmRkNTBiY2Q1Yjg4YjBlL3RleHRyZWdpb246NzU0ODRjY2NlYTQ2NDgzNWJiZGQ1MGJjZDViODhiMGVfMTEzNA_90d66632-8729-4b07-beac-25e00fb7ec43">8.7</ix:nonFraction> million during the remainder of fiscal 2021, $<ix:nonFraction unitRef="usd" contextRef="i075eaab3aa4549bb8d0f597beca1bd0f_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83MC9mcmFnOjc1NDg0Y2NjZWE0NjQ4MzViYmRkNTBiY2Q1Yjg4YjBlL3RleHRyZWdpb246NzU0ODRjY2NlYTQ2NDgzNWJiZGQ1MGJjZDViODhiMGVfMTE3NA_426607cf-62f4-4deb-a2f4-20863f98f539">17.5</ix:nonFraction> million during fiscal 2022, $<ix:nonFraction unitRef="usd" contextRef="i075eaab3aa4549bb8d0f597beca1bd0f_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83MC9mcmFnOjc1NDg0Y2NjZWE0NjQ4MzViYmRkNTBiY2Q1Yjg4YjBlL3RleHRyZWdpb246NzU0ODRjY2NlYTQ2NDgzNWJiZGQ1MGJjZDViODhiMGVfMTE5Nw_e43a3d1e-9617-4f7c-9f99-eadfef612d77">214.4</ix:nonFraction> million during fiscal 2023 and $<ix:nonFraction unitRef="usd" contextRef="i075eaab3aa4549bb8d0f597beca1bd0f_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83MC9mcmFnOjc1NDg0Y2NjZWE0NjQ4MzViYmRkNTBiY2Q1Yjg4YjBlL3RleHRyZWdpb246NzU0ODRjY2NlYTQ2NDgzNWJiZGQ1MGJjZDViODhiMGVfMTIyMw_26d2c202-3352-4ca0-b55d-ab4c9ac60691">70.0</ix:nonFraction> million during fiscal 2024. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company was in compliance with the leverage and interest coverage ratios specified in the Credit Facilities as well as all other bank covenants as of December&#160;26, 2020.</span></div></ix:nonNumeric><div><span><br/></span></div><div id="ib1e23e354c9c424096b27d04c70f5a5a_73"></div><ix:nonNumeric contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" name="us-gaap:DerivativesAndFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RleHRyZWdpb246NDkzMGI5ZjM2MzE1NDU1MjgyOTZhYjk0MWVjODM0ZDJfMTE0ODI_d3815b83-443f-4b72-a65c-386abf57016c" continuedAt="ief8ee603edc2490e88b694eab1b8bb9e" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12. FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manufactures, markets and sells its products globally. During the three and nine months ended December 26, 2020, <ix:nonFraction unitRef="number" contextRef="i466af82608da4d9bb01882ff1ee71a02_D20200927-20201226" decimals="3" name="hae:PercentageOfNetSalesGeneratedOutsideOfUs" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RleHRyZWdpb246NDkzMGI5ZjM2MzE1NDU1MjgyOTZhYjk0MWVjODM0ZDJfOTI_6619a9cb-2c6c-482a-9e7e-08cbd113d6ba">38.6</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i7a806c141f624127aa55c8379bed5731_D20200329-20201226" decimals="3" name="hae:PercentageOfNetSalesGeneratedOutsideOfUs" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RleHRyZWdpb246NDkzMGI5ZjM2MzE1NDU1MjgyOTZhYjk0MWVjODM0ZDJfOTk_68725329-6917-435a-b8e6-c643dfd01735">40.7</ix:nonFraction>%, respectively, of the Company's sales were generated outside the U.S., generally in foreign currencies. The Company also incurs certain manufacturing, marketing and selling costs in international markets in local currency.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accordingly, earnings and cash flows are exposed to market risk from changes in foreign currency exchange rates relative to the U.S. Dollar, the Company's reporting currency. The Company has a program in place that is designed to mitigate the exposure to changes in foreign currency exchange rates. That program includes the use of derivative financial instruments to minimize, for a period of time, the impact on its financial results from changes in foreign exchange rates. The Company utilizes foreign currency forward contracts to hedge the anticipated cash flows from transactions denominated in foreign currencies, primarily the Japanese Yen and the Euro, and to a lesser extent the Swiss Franc, Australian Dollar, Canadian Dollar and the Mexican Peso. This does not eliminate the impact of the volatility of foreign exchange rates. However, because the Company generally enters into forward contracts one year out, rates are fixed for a <ix:nonNumeric contextRef="i7a806c141f624127aa55c8379bed5731_D20200329-20201226" format="ixt-sec:durwordsen" name="us-gaap:AverageRemainingMaturityOfForeignCurrencyDerivatives1" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RleHRyZWdpb246NDkzMGI5ZjM2MzE1NDU1MjgyOTZhYjk0MWVjODM0ZDJfODI0NjMzNzIxOTg2Mg_564a33b9-6c0a-4006-b9ff-b306310de4a1">one-year</ix:nonNumeric> period, thereby facilitating financial planning and resource allocation.</span></div></ix:nonNumeric><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ief8ee603edc2490e88b694eab1b8bb9e" continuedAt="i7aedcfceec554fb784f9a679f52665ca"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Designated Foreign Currency Hedge Contracts</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the Company's designated foreign currency hedge contracts as of December&#160;26, 2020 and March&#160;28, 2020 were cash flow hedges under ASC 815, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASC 815&#8221;). The Company records the effective portion of any change in the fair value of designated foreign currency hedge contracts in other comprehensive income until the related third-party transaction occurs. Once the related third-party transaction occurs, the Company reclassifies the effective portion of any related gain or loss on the designated foreign currency hedge contracts to earnings. In the event the hedged forecasted transaction does not occur, or it becomes probable that it will not occur, the Company would reclassify the amount of any gain or loss on the related cash flow hedge to earnings at that time. The Company had designated foreign currency hedge contracts outstanding in the contract amount of $<ix:nonFraction unitRef="usd" contextRef="i3351e34989d1461db1163f69c1e631aa_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RleHRyZWdpb246NDkzMGI5ZjM2MzE1NDU1MjgyOTZhYjk0MWVjODM0ZDJfMjI2Ng_0501fdb8-d131-4321-afc4-fa5aa8810fe6">78.8</ix:nonFraction> million as of December&#160;26, 2020 and $<ix:nonFraction unitRef="usd" contextRef="i7435ba41f5b744d59c3211f1c1551e27_I20200328" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RleHRyZWdpb246NDkzMGI5ZjM2MzE1NDU1MjgyOTZhYjk0MWVjODM0ZDJfMjI4Mg_2854d416-46c5-4a6b-9a21-5f607bb60a08">93.8</ix:nonFraction> million as of March&#160;28, 2020. At December&#160;26, 2020, a loss of $<ix:nonFraction unitRef="usd" contextRef="iea5e92752773469e8e60c7fb366f08c0_D20200329-20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RleHRyZWdpb246NDkzMGI5ZjM2MzE1NDU1MjgyOTZhYjk0MWVjODM0ZDJfMjMxMg_11907d2d-ad07-4edd-a7f8-72d599927cb0">1.4</ix:nonFraction> million, net of tax, will be reclassified to earnings within the next twelve months. Substantially all currency cash flow hedges outstanding as of December&#160;26, 2020 mature within twelve months.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-Designated Foreign Currency Contracts</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages its exposure to changes in foreign currency on a consolidated basis to take advantage of offsetting transactions and balances. It uses foreign currency forward contracts as a part of its strategy to manage exposure related to foreign currency denominated monetary assets and liabilities. These foreign currency forward contracts are entered into for periods consistent with currency transaction exposures, generally one month. They are not designated as cash flow or fair value hedges under ASC 815. These forward contracts are marked-to-market with changes in fair value recorded to earnings. The Company had non-designated foreign currency hedge contracts under ASC 815 outstanding in the contract amount of $<ix:nonFraction unitRef="usd" contextRef="i42839168f30747d5b099bb2d4f81d4c3_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RleHRyZWdpb246NDkzMGI5ZjM2MzE1NDU1MjgyOTZhYjk0MWVjODM0ZDJfMzIzOA_fa351e2e-5c9f-4da9-8156-b4d9147b7046">90.5</ix:nonFraction> million as of December&#160;26, 2020 and $<ix:nonFraction unitRef="usd" contextRef="i86142ccd878c41b5b3b0b89e198e3ffa_I20200328" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RleHRyZWdpb246NDkzMGI5ZjM2MzE1NDU1MjgyOTZhYjk0MWVjODM0ZDJfMzI1NA_b7118669-4ab3-483a-afd1-7942bb303103">98.0</ix:nonFraction> million as of March&#160;28, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Rate Swaps</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 15, 2018, the Company entered into Credit Facilities which provided for a $<ix:nonFraction unitRef="usd" contextRef="i7c25c1d4590644eb8b651796c671219c_I20180615" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RleHRyZWdpb246NDkzMGI5ZjM2MzE1NDU1MjgyOTZhYjk0MWVjODM0ZDJfMzM3MQ_2b6ec305-65d4-4c34-9682-571208da8e11">350.0</ix:nonFraction> million Term Loan and a $<ix:nonFraction unitRef="usd" contextRef="i4426464d081b45bb8839adced8fe2873_I20180615" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RleHRyZWdpb246NDkzMGI5ZjM2MzE1NDU1MjgyOTZhYjk0MWVjODM0ZDJfMzM5MA_a076c77d-6253-45bf-b6c4-db674c9f9519">350.0</ix:nonFraction> million Revolving Credit Facility. Under the terms of the Credit Facilities, interest is established using LIBOR plus <ix:nonFraction unitRef="number" contextRef="ic5d1fce0362544e68a49594cab3a1aa8_D20180615-20180615" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RleHRyZWdpb246NDkzMGI5ZjM2MzE1NDU1MjgyOTZhYjk0MWVjODM0ZDJfMzUwMw_a8302392-6fea-48a0-9136-a77a75bc4bd6">1.13</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="ic9a17518f7194d808968c5442709d4d4_D20180615-20180615" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RleHRyZWdpb246NDkzMGI5ZjM2MzE1NDU1MjgyOTZhYjk0MWVjODM0ZDJfMzUwOA_05a7f461-7657-429d-b08c-d654423969b5">1.75</ix:nonFraction>%. As a result, the Company's earnings and cash flows are exposed to interest rate risk from changes to LIBOR. Part of the Company's interest rate risk management strategy includes the use of interest rate swaps to mitigate its exposure to changes in variable interest rates. The Company's objective in using interest rate swaps is to add stability to interest expense and to manage and reduce the risk inherent in interest rate fluctuations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the Company entered into <ix:nonFraction unitRef="swap" contextRef="i6b04360cbc954a42813ee3db68494774_I20180831" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DerivativeNumberOfInstrumentsHeld" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RleHRyZWdpb246NDkzMGI5ZjM2MzE1NDU1MjgyOTZhYjk0MWVjODM0ZDJfMzk5NA_dcb09137-2ffb-4e9d-a343-7bdcf0dd3ab2">two</ix:nonFraction> interest rate swap agreements (the &#8220;Swaps&#8221;) to pay an average fixed rate of <ix:nonFraction unitRef="number" contextRef="i6b04360cbc954a42813ee3db68494774_I20180831" decimals="INF" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RleHRyZWdpb246NDkzMGI5ZjM2MzE1NDU1MjgyOTZhYjk0MWVjODM0ZDJfNDA3Mw_b67b5c6e-658b-4ef5-99be-f371467761bb">2.80</ix:nonFraction>% on a total notional value of $<ix:nonFraction unitRef="usd" contextRef="i6b04360cbc954a42813ee3db68494774_I20180831" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RleHRyZWdpb246NDkzMGI5ZjM2MzE1NDU1MjgyOTZhYjk0MWVjODM0ZDJfNDEwNQ_6161e6b4-9c14-4bb0-8232-8a0869d66e42">241.9</ix:nonFraction> million of debt. As a result of the Swaps, <ix:nonFraction unitRef="number" contextRef="i23f7882051074260b7b16d0028b875ea_I20180831" decimals="INF" name="hae:DerivativePercentofDebtExposed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RleHRyZWdpb246NDkzMGI5ZjM2MzE1NDU1MjgyOTZhYjk0MWVjODM0ZDJfNDE0Mw_0dd3f9ce-a2fa-4465-9727-1dcaf768a9fb">70</ix:nonFraction>% of the Term Loan previously exposed to interest rate risk from changes in LIBOR is now fixed at a rate of <ix:nonFraction unitRef="number" contextRef="i23f7882051074260b7b16d0028b875ea_I20180831" decimals="INF" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RleHRyZWdpb246NDkzMGI5ZjM2MzE1NDU1MjgyOTZhYjk0MWVjODM0ZDJfNDI1Mg_0ce9ee9d-ef58-47bb-94db-ba6d867e21d5">4.05</ix:nonFraction>%. The Swaps mature on June 15, 2023. The Company designated the Swaps as cash flow hedges of variable interest rate risk associated with $<ix:nonFraction unitRef="usd" contextRef="i22efb3fabcf04d79ba596b48595d8ac1_I20180831" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RleHRyZWdpb246NDkzMGI5ZjM2MzE1NDU1MjgyOTZhYjk0MWVjODM0ZDJfNDM5MQ_85f83b9e-2572-4ed0-b57a-3495b75cfb11">345.6</ix:nonFraction>&#160;million of indebtedness. For the nine months ended December 26, 2020, a gain of $<ix:nonFraction unitRef="usd" contextRef="i0d31dcad300f4873901a0cff3c146b47_D20200329-20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RleHRyZWdpb246NDkzMGI5ZjM2MzE1NDU1MjgyOTZhYjk0MWVjODM0ZDJfNDQzMw_9d59e489-977c-476b-808e-0a6705780972">0.3</ix:nonFraction>&#160;million, net of tax, was recorded in accumulated other comprehensive loss to recognize the effective portion of the fair value of the Swaps that qualify as cash flow hedges. </span></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i7aedcfceec554fb784f9a679f52665ca" continuedAt="i8475bfabee66472e9667a5deab4fc0f8"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Trade Receivables</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, the Company grants trade credit to its customers on normal credit terms. In an effort to reduce its credit risk, the Company (i) establishes credit limits for all customers, (ii) performs ongoing credit evaluations of customers&#8217; financial condition, (iii) monitors the payment history and aging of customers&#8217; receivables, and (iv) monitors open orders against an individual customer&#8217;s outstanding receivable balance.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's allowance for credit losses is maintained for trade accounts receivable based on the expected collectability, the historical collection experience, the length of time an account is outstanding, the financial position of the customer and information provided by credit rating services. Effective March 29, 2020, the Company adopted Update No. 2016-13,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments &#8211; Credit Losses&#160;(Topic 326)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> which requires consideration of events or circumstances indicating historic collection rates may not be indicative of future collectability. For example, potential adverse changes to customer liquidity from new macroeconomic events such as the COVID-19 pandemic must be taken into consideration. To date, the Company has not experienced significant customer payment defaults, or identified other significant collectability concerns as a result of the pandemic.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" name="us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RleHRyZWdpb246NDkzMGI5ZjM2MzE1NDU1MjgyOTZhYjk0MWVjODM0ZDJfMTE0NzE_7464bb16-5b72-4321-9583-96950da6147b" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a rollforward of the allowance for credit losses:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.684%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.231%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.231%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.231%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.526%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32fa3388584544f9a03ffc1d8057d360_I20200926" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOjZhZTg3ZDc0NDNlNjQ0MTE5Mjg5Yzc2MjNiMGE5YjU2L3RhYmxlcmFuZ2U6NmFlODdkNzQ0M2U2NDQxMTkyODljNzYyM2IwYTliNTZfMi0xLTEtMS0w_e97c4e5c-d5a3-4a54-91b7-a40af2f36eca">2,699</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if62547d494fe448f98e6b8c907702474_I20190928" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOjZhZTg3ZDc0NDNlNjQ0MTE5Mjg5Yzc2MjNiMGE5YjU2L3RhYmxlcmFuZ2U6NmFlODdkNzQ0M2U2NDQxMTkyODljNzYyM2IwYTliNTZfMi0zLTEtMS0w_fa200e4a-54d3-4f47-bb17-9d70ddc28505">4,108</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOjZhZTg3ZDc0NDNlNjQ0MTE5Mjg5Yzc2MjNiMGE5YjU2L3RhYmxlcmFuZ2U6NmFlODdkNzQ0M2U2NDQxMTkyODljNzYyM2IwYTliNTZfMi01LTEtMS0w_fd97e759-06cf-4731-b9a9-b5ebab50ac31">3,824</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief541fbd0adf409c9514798c114d14d4_I20190330" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOjZhZTg3ZDc0NDNlNjQ0MTE5Mjg5Yzc2MjNiMGE5YjU2L3RhYmxlcmFuZ2U6NmFlODdkNzQ0M2U2NDQxMTkyODljNzYyM2IwYTliNTZfMi03LTEtMS0w_64ee2b1c-87a9-4f11-bde8-0fd5a41830b0">3,937</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Credit (gain) loss</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOjZhZTg3ZDc0NDNlNjQ0MTE5Mjg5Yzc2MjNiMGE5YjU2L3RhYmxlcmFuZ2U6NmFlODdkNzQ0M2U2NDQxMTkyODljNzYyM2IwYTliNTZfMy0xLTEtMS0w_168fc7b1-2744-4e09-988a-6c8544629f04">95</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228" decimals="-3" sign="-" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOjZhZTg3ZDc0NDNlNjQ0MTE5Mjg5Yzc2MjNiMGE5YjU2L3RhYmxlcmFuZ2U6NmFlODdkNzQ0M2U2NDQxMTkyODljNzYyM2IwYTliNTZfMy0zLTEtMS0w_069dec00-5499-44d2-939a-93f03d702c44">229</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOjZhZTg3ZDc0NDNlNjQ0MTE5Mjg5Yzc2MjNiMGE5YjU2L3RhYmxlcmFuZ2U6NmFlODdkNzQ0M2U2NDQxMTkyODljNzYyM2IwYTliNTZfMy01LTEtMS0w_c80dc678-fed9-4547-98ed-469532be24a3">838</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" sign="-" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOjZhZTg3ZDc0NDNlNjQ0MTE5Mjg5Yzc2MjNiMGE5YjU2L3RhYmxlcmFuZ2U6NmFlODdkNzQ0M2U2NDQxMTkyODljNzYyM2IwYTliNTZfMy03LTEtMS0w_e7486a6b-d038-4180-bb5b-6fd9614b52e8">515</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Write-offs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOjZhZTg3ZDc0NDNlNjQ0MTE5Mjg5Yzc2MjNiMGE5YjU2L3RhYmxlcmFuZ2U6NmFlODdkNzQ0M2U2NDQxMTkyODljNzYyM2IwYTliNTZfNC0xLTEtMS0w_e6d0de40-a67f-47b1-8e22-8742da89720d">79</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOjZhZTg3ZDc0NDNlNjQ0MTE5Mjg5Yzc2MjNiMGE5YjU2L3RhYmxlcmFuZ2U6NmFlODdkNzQ0M2U2NDQxMTkyODljNzYyM2IwYTliNTZfNC0zLTEtMS0w_1d313ed1-2afd-4859-85f5-fb7fa7fc67d1">240</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOjZhZTg3ZDc0NDNlNjQ0MTE5Mjg5Yzc2MjNiMGE5YjU2L3RhYmxlcmFuZ2U6NmFlODdkNzQ0M2U2NDQxMTkyODljNzYyM2IwYTliNTZfNC01LTEtMS0w_18960eed-13a5-42d0-bd96-d3c1d0e9aa7d">461</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOjZhZTg3ZDc0NDNlNjQ0MTE5Mjg5Yzc2MjNiMGE5YjU2L3RhYmxlcmFuZ2U6NmFlODdkNzQ0M2U2NDQxMTkyODljNzYyM2IwYTliNTZfNC03LTEtMS0w_cc24bdea-78c0-439b-927b-884a6caee279">355</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOjZhZTg3ZDc0NDNlNjQ0MTE5Mjg5Yzc2MjNiMGE5YjU2L3RhYmxlcmFuZ2U6NmFlODdkNzQ0M2U2NDQxMTkyODljNzYyM2IwYTliNTZfNS0xLTEtMS0w_d6a669d8-782a-40b0-b609-dee6bab3b375">2,525</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic35a4df7f44a40e5a674e72ae5bf6205_I20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOjZhZTg3ZDc0NDNlNjQ0MTE5Mjg5Yzc2MjNiMGE5YjU2L3RhYmxlcmFuZ2U6NmFlODdkNzQ0M2U2NDQxMTkyODljNzYyM2IwYTliNTZfNS0zLTEtMS0w_f9141981-2a9f-4729-819e-2d153f55d49a">4,097</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOjZhZTg3ZDc0NDNlNjQ0MTE5Mjg5Yzc2MjNiMGE5YjU2L3RhYmxlcmFuZ2U6NmFlODdkNzQ0M2U2NDQxMTkyODljNzYyM2IwYTliNTZfNS01LTEtMS0w_b60dab05-d5cd-45bf-a093-ffa2841cd315">2,525</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic35a4df7f44a40e5a674e72ae5bf6205_I20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOjZhZTg3ZDc0NDNlNjQ0MTE5Mjg5Yzc2MjNiMGE5YjU2L3RhYmxlcmFuZ2U6NmFlODdkNzQ0M2U2NDQxMTkyODljNzYyM2IwYTliNTZfNS03LTEtMS0w_7662b7b1-5bc5-4f4b-b243-5b6509e940f5">4,097</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value of Derivative Instruments</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RleHRyZWdpb246NDkzMGI5ZjM2MzE1NDU1MjgyOTZhYjk0MWVjODM0ZDJfMTE0ODM_1f93f7ff-f070-41bd-9c25-31996de67462" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the effect of the Company's derivative instruments designated as cash flow hedges and those not designated as hedging instruments under ASC 815 in its condensed consolidated statements of income and comprehensive income for the nine months ended December&#160;26, 2020:</span></div><div><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:23.422%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.493%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.500%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.203%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amount of Gain<br/>(Loss) Recognized<br/>in Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amount of Gain (Loss) Reclassified<br/>from Accumulated Other Comprehensive Loss into<br/>Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Location in<br/>Condensed Consolidated Statements of Income and Comprehensive Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amount of Gain (Loss) Excluded from<br/>Effectiveness<br/>Testing</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Location in<br/>Condensed Consolidated Statements of Income and Comprehensive Income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated foreign currency hedge contracts, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice57ced2f272477c986a2ba3d175843c_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmYzMDcxMTUwMzVkNzQyNjRhZDAxMmU5ZDlhYWNiMjZlL3RhYmxlcmFuZ2U6ZjMwNzExNTAzNWQ3NDI2NGFkMDEyZTlkOWFhY2IyNmVfMS0yLTEtMS0w_56fedb99-33fb-4042-a636-232601b51d04">1,378</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ice57ced2f272477c986a2ba3d175843c_D20200329-20201226" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmYzMDcxMTUwMzVkNzQyNjRhZDAxMmU5ZDlhYWNiMjZlL3RhYmxlcmFuZ2U6ZjMwNzExNTAzNWQ3NDI2NGFkMDEyZTlkOWFhY2IyNmVfMS00LTEtMS0w_fa384cc0-26ac-45b6-8e24-c228c54cf9ae">1,538</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues, COGS and SG&amp;A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia0f1b457527f4847a6ebea6d12d49745_D20200329-20201226" decimals="-3" sign="-" name="us-gaap:GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmYzMDcxMTUwMzVkNzQyNjRhZDAxMmU5ZDlhYWNiMjZlL3RhYmxlcmFuZ2U6ZjMwNzExNTAzNWQ3NDI2NGFkMDEyZTlkOWFhY2IyNmVfMS04LTEtMS0w_f2dd5431-9474-4f03-9027-b39fa12fb451">671</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other expense, net</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated foreign currency hedge contracts</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie07432d269194a38a5b973923e71f52b_D20200329-20201226" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmYzMDcxMTUwMzVkNzQyNjRhZDAxMmU5ZDlhYWNiMjZlL3RhYmxlcmFuZ2U6ZjMwNzExNTAzNWQ3NDI2NGFkMDEyZTlkOWFhY2IyNmVfMi0yLTEtMS0w_f75f9bfd-d1f1-4931-abac-7f59cf5fd4de">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie07432d269194a38a5b973923e71f52b_D20200329-20201226" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmYzMDcxMTUwMzVkNzQyNjRhZDAxMmU5ZDlhYWNiMjZlL3RhYmxlcmFuZ2U6ZjMwNzExNTAzNWQ3NDI2NGFkMDEyZTlkOWFhY2IyNmVfMi00LTEtMS0w_cab9ef16-e412-49ac-bfea-6eb221ce80a8">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa58cfb640b3424280402bd198a7e951_D20200329-20201226" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmYzMDcxMTUwMzVkNzQyNjRhZDAxMmU5ZDlhYWNiMjZlL3RhYmxlcmFuZ2U6ZjMwNzExNTAzNWQ3NDI2NGFkMDEyZTlkOWFhY2IyNmVfMi04LTEtMS0w_31d813da-a5d2-4ea4-98ba-d79d0459d432">5,218</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other expense, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated interest rate swaps, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d8c09f0cf9042d3ab0ab835a3cfb875_D20200329-20201226" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmYzMDcxMTUwMzVkNzQyNjRhZDAxMmU5ZDlhYWNiMjZlL3RhYmxlcmFuZ2U6ZjMwNzExNTAzNWQ3NDI2NGFkMDEyZTlkOWFhY2IyNmVfMy0yLTEtMS0w_3c2f10ac-a6de-4d43-83d5-21f5d4b84e0a">2,996</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d8c09f0cf9042d3ab0ab835a3cfb875_D20200329-20201226" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmYzMDcxMTUwMzVkNzQyNjRhZDAxMmU5ZDlhYWNiMjZlL3RhYmxlcmFuZ2U6ZjMwNzExNTAzNWQ3NDI2NGFkMDEyZTlkOWFhY2IyNmVfMy00LTEtMS0w_fdfe5738-8ea1-4c28-9973-db6fe25826cf">3,326</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d31dcad300f4873901a0cff3c146b47_D20200329-20201226" decimals="-3" format="ixt:zerodash" name="us-gaap:GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmYzMDcxMTUwMzVkNzQyNjRhZDAxMmU5ZDlhYWNiMjZlL3RhYmxlcmFuZ2U6ZjMwNzExNTAzNWQ3NDI2NGFkMDEyZTlkOWFhY2IyNmVfMy04LTEtMS0w_c39db3a3-f763-48cb-a186-2a9be6cb694d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did not have fair value hedges or net investment hedges outstanding as of December&#160;26, 2020 or March&#160;28, 2020. As of December&#160;26, 2020, <ix:nonFraction unitRef="usd" contextRef="iecb24d1198e0473ab5ff26bece23c571_I20201226" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DeferredTaxAssetsDerivativeInstruments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RleHRyZWdpb246NDkzMGI5ZjM2MzE1NDU1MjgyOTZhYjk0MWVjODM0ZDJfNjQ1NA_0b62babb-c86e-41fe-9c9b-ccc0ec884c26">no</ix:nonFraction> material deferred tax assets were recognized for designated foreign currency hedges.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 815 requires all derivative instruments to be recognized at their fair values as either assets or liabilities on the balance sheet. The Company determines the fair value of its derivative instruments using the framework prescribed by ASC 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements and Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, by considering the estimated amount it would receive or pay to sell or transfer these instruments at the reporting date and by taking into account current interest rates, currency exchange rates, current interest rate curves, interest rate volatilities, the creditworthiness of the counterparty for assets, and its creditworthiness for liabilities. In certain instances, the Company may utilize financial models to measure fair value. Generally, it uses inputs that include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; other observable inputs for the asset or liability; and inputs derived principally from, or corroborated by, observable market data by correlation or other means. As of December&#160;26, 2020, the Company has classified its derivative </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i8475bfabee66472e9667a5deab4fc0f8" continuedAt="ief56e3b30ee14caaa029e2262494c54b"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">assets and liabilities within Level 2 of the fair value hierarchy prescribed by ASC 815, as discussed below, because these observable inputs are available for substantially the full term of its derivative instruments.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RleHRyZWdpb246NDkzMGI5ZjM2MzE1NDU1MjgyOTZhYjk0MWVjODM0ZDJfMTE0ODA_bb8c5318-f4ee-4d36-9570-a89e38b7548f" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the fair value of the Company's derivative instruments as they appear in its condensed consolidated balance sheets as of December&#160;26, 2020 and March&#160;28, 2020:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.250%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.859%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.863%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Location in Condensed Consolidated<br/>Balance Sheets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief8dcb9ed5df46338245fba90826a4a3_I20201226" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmEwNzY2ZDU2ODQ5MTQ2NTE4MDNkMDg0ZDIwNDhjYWQ2L3RhYmxlcmFuZ2U6YTA3NjZkNTY4NDkxNDY1MTgwM2QwODRkMjA0OGNhZDZfMy00LTEtMS0w_d5212bc6-72fc-4297-966f-5e3199cdbc83">191</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ab86f680653471e898cddf1c4abb3b3_I20200328" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmEwNzY2ZDU2ODQ5MTQ2NTE4MDNkMDg0ZDIwNDhjYWQ2L3RhYmxlcmFuZ2U6YTA3NjZkNTY4NDkxNDY1MTgwM2QwODRkMjA0OGNhZDZfMy02LTEtMS0w_38996b92-4e60-49b2-91b8-fc86d79c6f49">839</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74b77438f0884283bdfb63acbb121963_I20201226" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmEwNzY2ZDU2ODQ5MTQ2NTE4MDNkMDg0ZDIwNDhjYWQ2L3RhYmxlcmFuZ2U6YTA3NjZkNTY4NDkxNDY1MTgwM2QwODRkMjA0OGNhZDZfNC00LTEtMS0w_06f2b89b-36b3-409e-b783-338b88089af9">69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i758e348315a24c3baee3f7984ecfe945_I20200328" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmEwNzY2ZDU2ODQ5MTQ2NTE4MDNkMDg0ZDIwNDhjYWQ2L3RhYmxlcmFuZ2U6YTA3NjZkNTY4NDkxNDY1MTgwM2QwODRkMjA0OGNhZDZfNC02LTEtMS0w_3497e216-8199-4a19-a21e-1183a435ec0b">377</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7af1564b75c420894f80854a774c2d3_I20201226" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmEwNzY2ZDU2ODQ5MTQ2NTE4MDNkMDg0ZDIwNDhjYWQ2L3RhYmxlcmFuZ2U6YTA3NjZkNTY4NDkxNDY1MTgwM2QwODRkMjA0OGNhZDZfNi00LTEtMS0w_029a9267-d542-4a82-b019-0eacd42963fe">260</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i961d5a6a04ff4db6a9d0a9bbac6be95e_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmEwNzY2ZDU2ODQ5MTQ2NTE4MDNkMDg0ZDIwNDhjYWQ2L3RhYmxlcmFuZ2U6YTA3NjZkNTY4NDkxNDY1MTgwM2QwODRkMjA0OGNhZDZfNi02LTEtMS0w_8102342f-7ed3-4d18-ab58-16444e69bd8c">1,216</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9656f96940b412198f0ace7941ec4e7_I20201226" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmEwNzY2ZDU2ODQ5MTQ2NTE4MDNkMDg0ZDIwNDhjYWQ2L3RhYmxlcmFuZ2U6YTA3NjZkNTY4NDkxNDY1MTgwM2QwODRkMjA0OGNhZDZfOC00LTEtMS0w_2d46ec3e-6563-4e87-9ac2-62354ddab893">919</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09705bf4b4c04d018ba1ef2118f58a80_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmEwNzY2ZDU2ODQ5MTQ2NTE4MDNkMDg0ZDIwNDhjYWQ2L3RhYmxlcmFuZ2U6YTA3NjZkNTY4NDkxNDY1MTgwM2QwODRkMjA0OGNhZDZfOC02LTEtMS0w_b3c23a2d-d08a-4562-ac31-ce169d0ee13c">1,854</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d30c35c0167492082c7bb18a3980991_I20201226" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmEwNzY2ZDU2ODQ5MTQ2NTE4MDNkMDg0ZDIwNDhjYWQ2L3RhYmxlcmFuZ2U6YTA3NjZkNTY4NDkxNDY1MTgwM2QwODRkMjA0OGNhZDZfOS00LTEtMS0w_089f4991-da93-4c00-a6fb-93e058231e80">206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e657827ea664680a8857cfd8b096cb9_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmEwNzY2ZDU2ODQ5MTQ2NTE4MDNkMDg0ZDIwNDhjYWQ2L3RhYmxlcmFuZ2U6YTA3NjZkNTY4NDkxNDY1MTgwM2QwODRkMjA0OGNhZDZfOS02LTEtMS0w_7ceff04d-e961-478a-8dba-4b4debfba960">1,435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated interest rate swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0b611ab7cea40329891cbc0d9cdf3fc_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmEwNzY2ZDU2ODQ5MTQ2NTE4MDNkMDg0ZDIwNDhjYWQ2L3RhYmxlcmFuZ2U6YTA3NjZkNTY4NDkxNDY1MTgwM2QwODRkMjA0OGNhZDZfMTAtNC0xLTEtMA_e0fd50ba-b9fa-4ce2-8c5f-11a5957ed4e3">5,697</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafe5dcd8b8f34d0ba81608d6c14c3841_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmEwNzY2ZDU2ODQ5MTQ2NTE4MDNkMDg0ZDIwNDhjYWQ2L3RhYmxlcmFuZ2U6YTA3NjZkNTY4NDkxNDY1MTgwM2QwODRkMjA0OGNhZDZfMTAtNi0xLTEtMA_60e2762f-3609-4046-812c-6197d53f81e3">5,581</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i110e3cdb79b447caadd705ad58eb1b5d_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmEwNzY2ZDU2ODQ5MTQ2NTE4MDNkMDg0ZDIwNDhjYWQ2L3RhYmxlcmFuZ2U6YTA3NjZkNTY4NDkxNDY1MTgwM2QwODRkMjA0OGNhZDZfMTEtNC0xLTEtMA_9bc37697-5a33-4313-b906-4424603022b6">6,323</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7030b986c4a7457991f4240d9857700b_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmEwNzY2ZDU2ODQ5MTQ2NTE4MDNkMDg0ZDIwNDhjYWQ2L3RhYmxlcmFuZ2U6YTA3NjZkNTY4NDkxNDY1MTgwM2QwODRkMjA0OGNhZDZfMTEtNi0xLTEtMA_f87e2fbf-d877-4c41-b9ad-eb8aae6886e0">9,475</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7af1564b75c420894f80854a774c2d3_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmEwNzY2ZDU2ODQ5MTQ2NTE4MDNkMDg0ZDIwNDhjYWQ2L3RhYmxlcmFuZ2U6YTA3NjZkNTY4NDkxNDY1MTgwM2QwODRkMjA0OGNhZDZfMTItNC0xLTEtMA_5ad05da6-268f-4d97-b983-ab555a559762">13,145</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i961d5a6a04ff4db6a9d0a9bbac6be95e_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmEwNzY2ZDU2ODQ5MTQ2NTE4MDNkMDg0ZDIwNDhjYWQ2L3RhYmxlcmFuZ2U6YTA3NjZkNTY4NDkxNDY1MTgwM2QwODRkMjA0OGNhZDZfMTItNi0xLTEtMA_96d0a1c8-c804-4276-8e53-79e944d7e3de">18,345</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Fair Value Measurements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the exit price that would be received from the sale of an asset or paid to transfer a liability, using assumptions that market participants would use in pricing an asset or liability. The fair value guidance establishes the following three-level hierarchy used for measuring fair value:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 &#8212; Inputs to the valuation methodology are quoted market prices for identical assets or liabilities.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 &#8212; Inputs to the valuation methodology are other observable inputs, including quoted market prices for similar assets or liabilities and market-corroborated inputs.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 &#8212; Inputs to the valuation methodology are unobservable inputs based on management&#8217;s best estimate of inputs market participants would use in pricing the asset or liability at the measurement date, including assumptions about risk.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's money market funds carried at fair value are classified within Level 1 of the fair value hierarchy because they are valued using quoted market prices.</span></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ief56e3b30ee14caaa029e2262494c54b" continuedAt="i54987b162ba04ceb8bf4e2ec7f99e138"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value Measured on a Recurring Basis</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RleHRyZWdpb246NDkzMGI5ZjM2MzE1NDU1MjgyOTZhYjk0MWVjODM0ZDJfMTE0Njc_8f9495c9-f96b-44a3-b197-0127e80aea7a" continuedAt="ie97c97fed3414994b5ef9d1a5a67c2dd" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and financial liabilities measured at fair value on a recurring basis consist of the following as of December&#160;26, 2020 and March&#160;28, 2020.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.533%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 26, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i997562bcb47249f98a7209c0a94eb2bc_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMy0yLTEtMS0w_bfda9ccd-4210-439b-aefb-354a83d794c5">79,773</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c5d0e8a5be946c1bcf0fc6bd7dd684d_I20201226" decimals="-3" format="ixt:zerodash" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMy00LTEtMS0w_c75cba9d-dbc1-46bb-94f8-4008cacb9abb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26592b211dab480aa8decca198bc3e17_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMy04LTEtMS0w_18d728f2-05bd-4a26-ac5c-40a3e23f3ab8">79,773</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i588cb2bb68f741b69393f24addb9f2de_I20201226" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfNC0yLTEtMS0w_66bf5f97-935b-412d-8b51-be77645f0910">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief8dcb9ed5df46338245fba90826a4a3_I20201226" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfNC00LTEtMS0w_d5212bc6-72fc-4297-966f-5e3199cdbc83">191</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9d15f27861f44938c5187801f43c5d9_I20201226" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfNC04LTEtMS0w_87b35c55-9112-4a45-a437-95873a39a0df">191</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16890a24a13b44bab1e3d254125196c3_I20201226" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfNS0yLTEtMS0w_02deb8ec-c089-49de-bce2-a9e0b99a2791">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74b77438f0884283bdfb63acbb121963_I20201226" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfNS00LTEtMS0w_06f2b89b-36b3-409e-b783-338b88089af9">69</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3f2a0af4b1b470aaa1b1fd8223858e3_I20201226" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfNS04LTEtMS0w_a85fc796-c310-4871-9666-977a886e5375">69</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i997562bcb47249f98a7209c0a94eb2bc_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfNy0yLTEtMS0w_d3387dc8-099d-4a45-9ba3-e7090caf0e30">79,773</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c5d0e8a5be946c1bcf0fc6bd7dd684d_I20201226" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfNy00LTEtMS0w_e43ee4b5-65ad-49fb-a115-fab867e2bdd8">260</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26592b211dab480aa8decca198bc3e17_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfNy04LTEtMS0w_6725bf25-f5ec-43b4-a2dc-220bb8c4f9e7">80,033</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i588cb2bb68f741b69393f24addb9f2de_I20201226" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfOS0yLTEtMS0w_2198bd82-f370-4d58-b221-9c2a723ca13b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9656f96940b412198f0ace7941ec4e7_I20201226" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfOS00LTEtMS0w_2d46ec3e-6563-4e87-9ac2-62354ddab893">919</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9d15f27861f44938c5187801f43c5d9_I20201226" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfOS04LTEtMS0w_1e45e138-9b74-474c-8292-91d3da675323">919</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16890a24a13b44bab1e3d254125196c3_I20201226" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMTAtMi0xLTEtMA_5684fb65-2f5e-478b-a1f2-a3d5df48de3f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d30c35c0167492082c7bb18a3980991_I20201226" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMTAtNC0xLTEtMA_089f4991-da93-4c00-a6fb-93e058231e80">206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3f2a0af4b1b470aaa1b1fd8223858e3_I20201226" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMTAtOC0xLTEtMA_8240cb14-7001-4b91-97b0-1c532b5d5f75">206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a99a6573bad464bacf1a667a155cf4c_I20201226" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMTEtMi0xLTEtMA_d3bbfe6d-3580-48a5-8336-2bf76c934cf5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia02b0b01fd264d638c0c2628fc697f93_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMTEtNC0xLTEtMA_3bc8ff9a-2de6-496e-8c69-541fcf174a0e">12,020</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie276656bb33a45a487bf62990df0f609_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMTEtOC0xLTEtMA_afe1c904-983e-43f5-8e6b-c72a75270687">12,020</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a4ac71d84054665bcf305a9df5b7ddf_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMTItNi0xLTEtMA_6e14b893-c0ed-48be-a2af-9e5b20de9d1c">3,920</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d3d12a07ab54dd3a6c5ac15a7096a2b_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMTItOC0xLTEtMA_2979dc8e-39e0-400e-8705-2590deee6f92">3,920</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i997562bcb47249f98a7209c0a94eb2bc_I20201226" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMTMtMi0xLTEtMA_777ea8cd-f3a9-4145-bda2-35960c7f1656">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c5d0e8a5be946c1bcf0fc6bd7dd684d_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMTMtNC0xLTEtMA_9c74e659-4a1e-4582-a5ca-c883f3fb56bc">13,145</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2e4f6aff6eb4677970da26827668a01_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMTMtNi0xLTEtMA_0d830919-4e89-446b-81e6-8bf46aec9e4c">3,920</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26592b211dab480aa8decca198bc3e17_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMTMtOC0xLTEtMA_d81fc245-cc8d-4b91-84c9-63895b37af16">17,065</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="21" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of March 28, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1ddfbfc3ba244e7833e4eac1cbf3b2d_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMTgtMi0xLTEtMA_0764fa1a-99d2-44dd-86a4-bb7491b1e895">44,564</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i216d245bc1864b20940d046e5608b9e0_I20200328" decimals="-3" format="ixt:zerodash" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMTgtNC0xLTEtMA_5e28a728-7c05-47d8-b31b-0175b55e5985">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3e33f79fd854ca19ec85d864af74f63_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMTgtOC0xLTEtMA_1d56a52e-1e9e-4fa4-8c37-e0caf058b435">44,564</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf86edce1a1b42fbb8cfd4d66d94a959_I20200328" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMTktMi0xLTEtMA_fea6c17a-010b-4858-905a-320d481bdc18">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45f6ab924d174fe997e8ffab01ef2a19_I20200328" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMTktNC0xLTEtMA_20d92d83-545e-45f7-b635-807dc7576afe">839</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib783ce7f3af1414a917dfb19f3fd67f6_I20200328" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMTktOC0xLTEtMA_0254ad64-8953-4fc8-83ae-94fc1e1520ce">839</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bfc2d6751964174b4757e882148e033_I20200328" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMjAtMi0xLTEtMA_aaf0ff7c-fea7-4015-8053-9ef5b0ee9e09">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8d95a735afe423c94c8eeae0f71dc33_I20200328" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMjAtNC0xLTEtMA_786e8092-dc17-4cbf-84fd-99fd89a43423">377</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffada09cc3634b0e9958607425101e7e_I20200328" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMjAtOC0xLTEtMA_6a3af108-9213-4fd9-a444-124ab7b9a3e8">377</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1ddfbfc3ba244e7833e4eac1cbf3b2d_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMjItMi0xLTEtMA_f4669525-994c-4032-a71d-929755a653d5">44,564</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i216d245bc1864b20940d046e5608b9e0_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMjItNC0xLTEtMA_83708281-954c-4101-b7f3-a2d9ea893bbb">1,216</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3e33f79fd854ca19ec85d864af74f63_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMjItOC0xLTEtMA_fcb7d877-253d-40fc-a5af-27ca37856aed">45,780</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf86edce1a1b42fbb8cfd4d66d94a959_I20200328" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMjQtMi0xLTEtMA_c303ccb5-e232-4572-8e35-38d9ebb2cc40">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45f6ab924d174fe997e8ffab01ef2a19_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMjQtNC0xLTEtMA_71b0013d-a026-49da-ba34-f51d6c8fa6fc">1,854</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib783ce7f3af1414a917dfb19f3fd67f6_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMjQtOC0xLTEtMA_6179c9ed-e391-4166-b09e-bef4fa6be9d7">1,854</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bfc2d6751964174b4757e882148e033_I20200328" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMjUtMi0xLTEtMA_471fdbf6-6ca3-47d3-9b12-47b2a0e3774f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3615436e53401aaf2becfa502d691c_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMjUtNC0xLTEtMA_d5607647-5d31-4794-b668-6399bc785a92">1,435</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffada09cc3634b0e9958607425101e7e_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMjUtOC0xLTEtMA_8fcafa2e-4404-4ad8-ad62-ba8f9bdad89b">1,435</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if932a0aaa03f451f9dad61e387eabc93_I20200328" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMjYtMi0xLTEtMA_3e972d91-45d1-4490-b7c2-2d80e0069b90">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab5f44f15bc94d6daa33cc2caabfaf8a_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMjYtNC0xLTEtMA_6c98cac0-1405-42e6-b316-a71a9865a7b1">15,056</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecf4e5d38e474810bfe38afc5d4ff6a7_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMjYtOC0xLTEtMA_a9dc364e-281a-486b-9530-b4416cd1135e">15,056</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1ddfbfc3ba244e7833e4eac1cbf3b2d_I20200328" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMjctMi0xLTEtMA_5a148859-87d9-4a73-8dae-7e5bffe9881d">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i216d245bc1864b20940d046e5608b9e0_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMjctNC0xLTEtMA_ea2ace8b-791e-40d0-acea-ab42c9c31558">18,345</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3e33f79fd854ca19ec85d864af74f63_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMjctOC0xLTEtMA_eb3f601e-0d06-4576-a615-8e05bb839a15">18,345</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign currency hedge contracts - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of foreign currency hedge contracts was measured using significant other observable inputs and valued by reference to over-the-counter quoted market prices for similar instruments. The Company does not believe that the fair value of these derivative instruments differs significantly from the amount that could be realized upon settlement or maturity, or that the changes in fair value will have a significant effect on its results of operations, financial condition or cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest rate swaps - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of interest rate swaps are measured using the present value of expected future cash flows using market-based observable inputs, including credit risk and interest rate yield curves. The Company does not believe that the fair values of these derivative instruments differ significantly from the amounts that could be realized upon settlement or maturity, or that the changes in fair value will have a significant effect on its results of operations, financial condition or cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent consideration</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The fair value of contingent consideration liabilities is based on significant unobservable inputs, including management estimates and assumptions, and is measured based on the probability-weighted present value of the payments expected to be made. Accordingly, the fair value of contingent consideration has been classified as level 3 within the fair value hierarchy. <ix:continuation id="ie97c97fed3414994b5ef9d1a5a67c2dd" continuedAt="i62a0e63c9522405ab707e728b865a232">The recurring level 3 fair value measurements of contingent consideration liabilities include the following significant unobservable inputs:</ix:continuation></span></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i54987b162ba04ceb8bf4e2ec7f99e138"><div style="margin-bottom:6pt"><ix:continuation id="i62a0e63c9522405ab707e728b865a232" continuedAt="ib20e612770bd4deb8bb5ac2bf568c579"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:21.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.664%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.550%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value at</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Valuation </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Technique</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Input</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Range</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue-based payments</span></td><td colspan="3" style="padding:0 1pt"></td><td rowspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td rowspan="2" style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e02337377ab4f1ba4536388c0003177_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOjc0Mjc4YjY5YjA1ZDRhYmZhMzA4MDYwYzU3MWE0YzY5L3RhYmxlcmFuZ2U6NzQyNzhiNjliMDVkNGFiZmEzMDgwNjBjNTcxYTRjNjlfMi0yLTEtMS0w_803f8512-f438-414f-8b66-9d63c394410a">1,920</ix:nonFraction>&#160;</span></td><td rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted cash flow</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7e02337377ab4f1ba4536388c0003177_I20201226" decimals="4" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOjc0Mjc4YjY5YjA1ZDRhYmZhMzA4MDYwYzU3MWE0YzY5L3RhYmxlcmFuZ2U6NzQyNzhiNjliMDVkNGFiZmEzMDgwNjBjNTcxYTRjNjlfMi04LTEtMS0w_d79748ab-bef1-4799-b2f9-3c4ce3d41e06">8.5</ix:nonFraction>%</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected year of payment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 - 2023</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Regulatory-based payment</span></td><td colspan="3" style="padding:0 1pt"></td><td rowspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td rowspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bca110ee0c94411a74ee374c176ca00_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOjc0Mjc4YjY5YjA1ZDRhYmZhMzA4MDYwYzU3MWE0YzY5L3RhYmxlcmFuZ2U6NzQyNzhiNjliMDVkNGFiZmEzMDgwNjBjNTcxYTRjNjlfNC0yLTEtMS0w_c111b783-9274-4ca7-b566-48af6c4b2c3a">2,000</ix:nonFraction>&#160;</span></td><td rowspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted cash flow</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4bca110ee0c94411a74ee374c176ca00_I20201226" decimals="4" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOjc0Mjc4YjY5YjA1ZDRhYmZhMzA4MDYwYzU3MWE0YzY5L3RhYmxlcmFuZ2U6NzQyNzhiNjliMDVkNGFiZmEzMDgwNjBjNTcxYTRjNjlfNC04LTEtMS0w_72cd93cd-2f6d-41a1-b45a-58db057bfd7a">4.9</ix:nonFraction>%</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of payment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0% - 100%</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected year of payment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 - 2023</span></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;26, 2020, the maximum potential contingent consideration that the Company could be required to pay is $<ix:nonFraction unitRef="usd" contextRef="i7337ad8ffd7f4d8cb8646e0073515fc1_I20200401" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RleHRyZWdpb246NDkzMGI5ZjM2MzE1NDU1MjgyOTZhYjk0MWVjODM0ZDJfMTA5NzE_793d39f3-d085-4645-8c8a-add66e31cfa4">4.5</ix:nonFraction>&#160;million. The fair value of contingent consideration associated with acquisitions was $<ix:nonFraction unitRef="usd" contextRef="i3d3d12a07ab54dd3a6c5ac15a7096a2b_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RleHRyZWdpb246NDkzMGI5ZjM2MzE1NDU1MjgyOTZhYjk0MWVjODM0ZDJfMTEwNTE_fe46c86b-14c8-4cc9-8aed-644bcc78260e">3.9</ix:nonFraction>&#160;million at December&#160;26, 2020. As of December&#160;26, 2020, $<ix:nonFraction unitRef="usd" contextRef="i06f5f1e7b5734a368db7c1b4554453ea_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RleHRyZWdpb246NDkzMGI5ZjM2MzE1NDU1MjgyOTZhYjk0MWVjODM0ZDJfMTEwNzE_29dff645-c669-4aa6-bc85-b87c54bc4b0c">0.5</ix:nonFraction>&#160;million was included in other liabilities and $<ix:nonFraction unitRef="usd" contextRef="i54c62f100cf84a5b86024a6964d52097_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RleHRyZWdpb246NDkzMGI5ZjM2MzE1NDU1MjgyOTZhYjk0MWVjODM0ZDJfMTExMjA_5adbee42-1955-422a-814b-d141f6d1fc03">3.4</ix:nonFraction>&#160;million was included in other long-term liabilities on the condensed consolidated balance sheet.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A <ix:continuation id="ib20e612770bd4deb8bb5ac2bf568c579" continuedAt="i2bcb9d89d22049c1a5e9afabaf811bf3">reconciliation of the change in the fair value of contingent consideration is included in the following table:</ix:continuation></span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><ix:continuation id="i2bcb9d89d22049c1a5e9afabaf811bf3"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.677%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.393%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 28, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52cd92f3abc349f2a9cd1e1c9b9229e3_I20200328" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmJjZDdkNWIzYTBjYjQxODY5MThiODQzMDIwODU2Nzg5L3RhYmxlcmFuZ2U6YmNkN2Q1YjNhMGNiNDE4NjkxOGI4NDMwMjA4NTY3ODlfMS0yLTEtMS0w_d52a4eee-e883-4287-8d52-e987a3ea4229">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition date fair value of contingent consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3f7a3bec94a478ca2a052a1fdea5f49_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="hae:ContingentConsiderationAcquisitionDateFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmJjZDdkNWIzYTBjYjQxODY5MThiODQzMDIwODU2Nzg5L3RhYmxlcmFuZ2U6YmNkN2Q1YjNhMGNiNDE4NjkxOGI4NDMwMjA4NTY3ODlfMi0yLTEtMS0w_c2b1cd20-1dca-43c0-aa51-4a11767b29ef">3,920</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 26, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d3d12a07ab54dd3a6c5ac15a7096a2b_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmJjZDdkNWIzYTBjYjQxODY5MThiODQzMDIwODU2Nzg5L3RhYmxlcmFuZ2U6YmNkN2Q1YjNhMGNiNDE4NjkxOGI4NDMwMjA4NTY3ODlfNC0yLTEtMS0w_3f6250fe-0c4f-4014-9857-13e8b896ab35">3,920</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Fair Value Disclosures</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Term Loan, which is carried at amortized cost, accounts receivable and accounts payable approximate fair value.</span></div></ix:continuation><div><span><br/></span></div><div id="ib1e23e354c9c424096b27d04c70f5a5a_79"></div><ix:nonNumeric contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83OS9mcmFnOjdiOTQyYmQ5OTJiYTQyMWU5MjMyYjEwZTExNDU2YTU3L3RleHRyZWdpb246N2I5NDJiZDk5MmJhNDIxZTkyMzJiMTBlMTE0NTZhNTdfNTU5_a14f9430-2c8d-4622-b243-4bde17f78aa2" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13. COMMITMENTS AND CONTINGENCIES</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a party to various legal proceedings and claims arising out of the ordinary course of its business. The Company believes there are no proceedings or claims pending against it the ultimate resolution of which could have a material adverse effect on the financial condition or results of operations. At each reporting period, the Company evaluates whether or not a potential loss amount or a potential range of loss is probable and reasonably estimable under ASC 450,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for all matters. Legal costs are expensed as incurred.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of fiscal 2021, the Company received a subpoena from the U.S. Attorney&#8217;s Office for the District of Massachusetts. The subpoena requests certain documents regarding the Company&#8217;s apheresis and autotransfusion devices and disposables, including documents relating to product complaints and adverse event reporting, regulatory clearances and product design changes, among other matters. The Company is fully cooperating with this inquiry.</span></div></ix:nonNumeric><div><span><br/></span></div><div id="ib1e23e354c9c424096b27d04c70f5a5a_82"></div><ix:nonNumeric contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RleHRyZWdpb246NDgyNDUzNzYxYzRhNDE2ODg2NzE1ZTcxMjk5NzFiZjBfMjcwOQ_f88821cc-e952-4ab8-9b43-610bcdd9d65e" continuedAt="ida2ef68d96fe4775ba3c2de89853879d" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14. SEGMENT AND ENTERPRISE-WIDE INFORMATION </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines its reportable segments by first identifying its operating segments, and then by assessing whether any components of these segments constitute a business for which discrete financial information is available and where segment management regularly reviews the operating results of that component. Historically, the Company's operating segments were based primarily on geography. Effective as of March 31, 2019, the Company completed the transition of its operating structure to three global business units and accordingly, reorganized its reporting structure to align with its <ix:nonFraction unitRef="segment" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfOperatingSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RleHRyZWdpb246NDgyNDUzNzYxYzRhNDE2ODg2NzE1ZTcxMjk5NzFiZjBfNjA5_6bbb84f9-eda1-44e6-9af4-486270aeb0ee">three</ix:nonFraction> global business units and the information that will be regularly reviewed by the Company's chief operating decision maker.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the reorganization, the Company's reportable segments are as follows: </span></div><div style="margin-top:7pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Plasma</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Blood Center</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Hospital</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management measures and evaluates the operating segments based on operating income. Management excludes certain corporate expenses from segment operating income. In addition, certain amounts that management considers to be non-</span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ida2ef68d96fe4775ba3c2de89853879d" continuedAt="iddcef453176243c19b726a8f960f1804"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">recurring or non-operational are excluded from segment operating income because management evaluates the operating results of the segments excluding such items. These items include restructuring and turnaround costs, deal amortization, gains on divestitures and sale of assets, asset impairments and other related charges, accelerated depreciation and related costs, costs related to compliance with the European Union Medical Device Regulation, transaction costs and certain legal charges. Although these amounts are excluded from segment operating income, as applicable, they are included in the reconciliations that follow. Management measures and evaluates the Company's net revenues and operating income using internally derived standard currency exchange rates that remain constant from year to year; therefore, segment information is presented on this basis.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" name="us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RleHRyZWdpb246NDgyNDUzNzYxYzRhNDE2ODg2NzE1ZTcxMjk5NzFiZjBfMjcxMQ_f8a1397d-030c-4e76-a49a-929a3d8ce30d" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selected information by reportable segment is presented below:</span></div><div style="margin-bottom:5pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.578%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plasma</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a367bb123554012a9834d85df459f46_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="hae:NetRevenuesBeforeForeignExchangeImpact" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmI4NmQ1MGE1ZjNiMDQyOGRiZGY0NzEyYzE1ZWY1OWYzL3RhYmxlcmFuZ2U6Yjg2ZDUwYTVmM2IwNDI4ZGJkZjQ3MTJjMTVlZjU5ZjNfMy0xLTEtMS0w_70b1d2fb-b20c-4596-a4f1-bf65a68ba1e0">102,154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2c7bdc34da3493493cc0abe3dc3def5_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="hae:NetRevenuesBeforeForeignExchangeImpact" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmI4NmQ1MGE1ZjNiMDQyOGRiZGY0NzEyYzE1ZWY1OWYzL3RhYmxlcmFuZ2U6Yjg2ZDUwYTVmM2IwNDI4ZGJkZjQ3MTJjMTVlZjU5ZjNfMy0zLTEtMS0w_526b62c7-da27-4e5c-bbfe-409815d7c12f">120,997</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4eb9c47f2f9244e0b383fb7b25f6b0d4_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="hae:NetRevenuesBeforeForeignExchangeImpact" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmI4NmQ1MGE1ZjNiMDQyOGRiZGY0NzEyYzE1ZWY1OWYzL3RhYmxlcmFuZ2U6Yjg2ZDUwYTVmM2IwNDI4ZGJkZjQ3MTJjMTVlZjU5ZjNfMy01LTEtMS0w_023fd283-f35e-48b5-b6c9-c65f9f1f42b0">249,587</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0091dd1f9204cdd979ec26f0ee2b0ae_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="hae:NetRevenuesBeforeForeignExchangeImpact" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmI4NmQ1MGE1ZjNiMDQyOGRiZGY0NzEyYzE1ZWY1OWYzL3RhYmxlcmFuZ2U6Yjg2ZDUwYTVmM2IwNDI4ZGJkZjQ3MTJjMTVlZjU5ZjNfMy03LTEtMS0w_9ac0fa06-03eb-4c67-95e8-d74760ec59db">348,141</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Center</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cfe5b5730064f93b6ecea7bc136d73f_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="hae:NetRevenuesBeforeForeignExchangeImpact" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmI4NmQ1MGE1ZjNiMDQyOGRiZGY0NzEyYzE1ZWY1OWYzL3RhYmxlcmFuZ2U6Yjg2ZDUwYTVmM2IwNDI4ZGJkZjQ3MTJjMTVlZjU5ZjNfNC0xLTEtMS0w_e69bde2e-98d1-4007-8ba7-fb09fb3942b4">80,417</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic275845b82014295bb8e14b72d0cb7a2_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="hae:NetRevenuesBeforeForeignExchangeImpact" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmI4NmQ1MGE1ZjNiMDQyOGRiZGY0NzEyYzE1ZWY1OWYzL3RhYmxlcmFuZ2U6Yjg2ZDUwYTVmM2IwNDI4ZGJkZjQ3MTJjMTVlZjU5ZjNfNC0zLTEtMS0w_92411182-8032-435d-bfca-0210259785b8">85,314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4648a84bbe144e499e5f0bbff9596c82_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="hae:NetRevenuesBeforeForeignExchangeImpact" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmI4NmQ1MGE1ZjNiMDQyOGRiZGY0NzEyYzE1ZWY1OWYzL3RhYmxlcmFuZ2U6Yjg2ZDUwYTVmM2IwNDI4ZGJkZjQ3MTJjMTVlZjU5ZjNfNC01LTEtMS0w_8af94eb6-6a15-4f25-b065-536cfb708fc1">234,446</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fa6549b61284e39986bb1296676dc1a_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="hae:NetRevenuesBeforeForeignExchangeImpact" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmI4NmQ1MGE1ZjNiMDQyOGRiZGY0NzEyYzE1ZWY1OWYzL3RhYmxlcmFuZ2U6Yjg2ZDUwYTVmM2IwNDI4ZGJkZjQ3MTJjMTVlZjU5ZjNfNC03LTEtMS0w_343ed17a-de9e-4880-a071-2595e2f0c6e1">246,977</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id93717bc785844afbedbb40fafa0d6e6_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="hae:NetRevenuesBeforeForeignExchangeImpact" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmI4NmQ1MGE1ZjNiMDQyOGRiZGY0NzEyYzE1ZWY1OWYzL3RhYmxlcmFuZ2U6Yjg2ZDUwYTVmM2IwNDI4ZGJkZjQ3MTJjMTVlZjU5ZjNfNS0xLTEtMS0w_64f457b9-8b8b-42db-93ec-75f19ffeddef">52,334</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d1a57ec025045cbb23779fa6fc0cb2e_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="hae:NetRevenuesBeforeForeignExchangeImpact" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmI4NmQ1MGE1ZjNiMDQyOGRiZGY0NzEyYzE1ZWY1OWYzL3RhYmxlcmFuZ2U6Yjg2ZDUwYTVmM2IwNDI4ZGJkZjQ3MTJjMTVlZjU5ZjNfNS0zLTEtMS0w_b0afa49e-cc2d-443e-9b80-0a21a1e6118b">50,753</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19f3255f7c4488593f3252f04fa0abf_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="hae:NetRevenuesBeforeForeignExchangeImpact" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmI4NmQ1MGE1ZjNiMDQyOGRiZGY0NzEyYzE1ZWY1OWYzL3RhYmxlcmFuZ2U6Yjg2ZDUwYTVmM2IwNDI4ZGJkZjQ3MTJjMTVlZjU5ZjNfNS01LTEtMS0w_f8246b9b-e78a-42f4-be20-5a891ff3a507">148,927</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id42b45b3282241f0b4410893d0379aae_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="hae:NetRevenuesBeforeForeignExchangeImpact" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmI4NmQ1MGE1ZjNiMDQyOGRiZGY0NzEyYzE1ZWY1OWYzL3RhYmxlcmFuZ2U6Yjg2ZDUwYTVmM2IwNDI4ZGJkZjQ3MTJjMTVlZjU5ZjNfNS03LTEtMS0w_5c01b674-8fac-4535-b231-5660ac59fa05">147,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues by business unit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="hae:NetRevenuesBeforeForeignExchangeImpact" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmI4NmQ1MGE1ZjNiMDQyOGRiZGY0NzEyYzE1ZWY1OWYzL3RhYmxlcmFuZ2U6Yjg2ZDUwYTVmM2IwNDI4ZGJkZjQ3MTJjMTVlZjU5ZjNfNi0xLTEtMS0w_516c9133-cd84-4b11-a23a-febf1d0b48fd">234,905</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="hae:NetRevenuesBeforeForeignExchangeImpact" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmI4NmQ1MGE1ZjNiMDQyOGRiZGY0NzEyYzE1ZWY1OWYzL3RhYmxlcmFuZ2U6Yjg2ZDUwYTVmM2IwNDI4ZGJkZjQ3MTJjMTVlZjU5ZjNfNi0zLTEtMS0w_25d354bf-fca4-4c11-ac70-ded4bb6e3df5">257,064</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="hae:NetRevenuesBeforeForeignExchangeImpact" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmI4NmQ1MGE1ZjNiMDQyOGRiZGY0NzEyYzE1ZWY1OWYzL3RhYmxlcmFuZ2U6Yjg2ZDUwYTVmM2IwNDI4ZGJkZjQ3MTJjMTVlZjU5ZjNfNi01LTEtMS0w_61a032ba-f68c-4a88-a24b-ec82cd7043f7">632,960</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="hae:NetRevenuesBeforeForeignExchangeImpact" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmI4NmQ1MGE1ZjNiMDQyOGRiZGY0NzEyYzE1ZWY1OWYzL3RhYmxlcmFuZ2U6Yjg2ZDUwYTVmM2IwNDI4ZGJkZjQ3MTJjMTVlZjU5ZjNfNi03LTEtMS0w_89f264b2-1818-4ac9-b6a8-854fbf00e061">742,720</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86b9b10063b34ad7b052ae6b08484c65_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="hae:NetRevenuesBeforeForeignExchangeImpact" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmI4NmQ1MGE1ZjNiMDQyOGRiZGY0NzEyYzE1ZWY1OWYzL3RhYmxlcmFuZ2U6Yjg2ZDUwYTVmM2IwNDI4ZGJkZjQ3MTJjMTVlZjU5ZjNfNy0xLTEtMS0w_544f9ac6-5d57-497c-8bfe-933e781a8f6e">4,972</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bb939bdb4e84a4cb2451ad2848d0fab_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="hae:NetRevenuesBeforeForeignExchangeImpact" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmI4NmQ1MGE1ZjNiMDQyOGRiZGY0NzEyYzE1ZWY1OWYzL3RhYmxlcmFuZ2U6Yjg2ZDUwYTVmM2IwNDI4ZGJkZjQ3MTJjMTVlZjU5ZjNfNy0zLTEtMS0w_c569f428-9dfe-4066-8906-9b552c588c9b">5,197</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c7f2e0a659245f486464f52663463fe_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="hae:NetRevenuesBeforeForeignExchangeImpact" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmI4NmQ1MGE1ZjNiMDQyOGRiZGY0NzEyYzE1ZWY1OWYzL3RhYmxlcmFuZ2U6Yjg2ZDUwYTVmM2IwNDI4ZGJkZjQ3MTJjMTVlZjU5ZjNfNy01LTEtMS0w_73b94d34-2a5b-4537-8e9e-1cb2ea3435e2">15,396</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i019e1c4459504344b5dfa26c7a9c0f8d_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="hae:NetRevenuesBeforeForeignExchangeImpact" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmI4NmQ1MGE1ZjNiMDQyOGRiZGY0NzEyYzE1ZWY1OWYzL3RhYmxlcmFuZ2U6Yjg2ZDUwYTVmM2IwNDI4ZGJkZjQ3MTJjMTVlZjU5ZjNfNy03LTEtMS0w_b3a2c5f3-6011-4aca-99a3-a67fe6cca324">15,339</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226" decimals="-3" name="hae:EffectofExchangeRateonRevenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmI4NmQ1MGE1ZjNiMDQyOGRiZGY0NzEyYzE1ZWY1OWYzL3RhYmxlcmFuZ2U6Yjg2ZDUwYTVmM2IwNDI4ZGJkZjQ3MTJjMTVlZjU5ZjNfOC0xLTEtMS0w_e08e2ac6-4f5e-4086-b409-25542c453b41">494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228" decimals="-3" sign="-" format="ixt:numdotdecimal" name="hae:EffectofExchangeRateonRevenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmI4NmQ1MGE1ZjNiMDQyOGRiZGY0NzEyYzE1ZWY1OWYzL3RhYmxlcmFuZ2U6Yjg2ZDUwYTVmM2IwNDI4ZGJkZjQ3MTJjMTVlZjU5ZjNfOC0zLTEtMS0w_77d9a918-e367-4495-8efb-e7c28e17fc55">3,291</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" sign="-" format="ixt:numdotdecimal" name="hae:EffectofExchangeRateonRevenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmI4NmQ1MGE1ZjNiMDQyOGRiZGY0NzEyYzE1ZWY1OWYzL3RhYmxlcmFuZ2U6Yjg2ZDUwYTVmM2IwNDI4ZGJkZjQ3MTJjMTVlZjU5ZjNfOC01LTEtMS0w_c8675203-b7cb-4a1f-81d5-1cd567122889">2,922</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" sign="-" format="ixt:numdotdecimal" name="hae:EffectofExchangeRateonRevenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmI4NmQ1MGE1ZjNiMDQyOGRiZGY0NzEyYzE1ZWY1OWYzL3RhYmxlcmFuZ2U6Yjg2ZDUwYTVmM2IwNDI4ZGJkZjQ3MTJjMTVlZjU5ZjNfOC03LTEtMS0w_86b6930d-18f7-4868-9f69-0d8160975fdc">8,072</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmI4NmQ1MGE1ZjNiMDQyOGRiZGY0NzEyYzE1ZWY1OWYzL3RhYmxlcmFuZ2U6Yjg2ZDUwYTVmM2IwNDI4ZGJkZjQ3MTJjMTVlZjU5ZjNfOS0xLTEtMS0w_d38d962d-23d8-472d-ac80-fdd5b6282bc8">240,371</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmI4NmQ1MGE1ZjNiMDQyOGRiZGY0NzEyYzE1ZWY1OWYzL3RhYmxlcmFuZ2U6Yjg2ZDUwYTVmM2IwNDI4ZGJkZjQ3MTJjMTVlZjU5ZjNfOS0zLTEtMS0w_1c021815-f40a-4edb-8f08-7d5c03e3814f">258,970</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmI4NmQ1MGE1ZjNiMDQyOGRiZGY0NzEyYzE1ZWY1OWYzL3RhYmxlcmFuZ2U6Yjg2ZDUwYTVmM2IwNDI4ZGJkZjQ3MTJjMTVlZjU5ZjNfOS01LTEtMS0w_affdbae9-f303-4393-bab0-e978260a802c">645,434</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmI4NmQ1MGE1ZjNiMDQyOGRiZGY0NzEyYzE1ZWY1OWYzL3RhYmxlcmFuZ2U6Yjg2ZDUwYTVmM2IwNDI4ZGJkZjQ3MTJjMTVlZjU5ZjNfOS03LTEtMS0w_86903600-b7f3-4d6e-8ff9-fcb9264dbf5a">749,987</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> Reflects revenue for service, maintenance and parts</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.847%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.871%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plasma</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82de2706ab9a438d881b82d726f54fab_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMy0xLTEtMS0w_5f9ee776-b088-4b88-9933-1391e12331f2">52,673</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d107d1d05864d96b46812133da26150_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMy0zLTEtMS0w_c3fe82f1-7a74-4ea8-a69c-0fd261cce0d8">59,343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f67e87ff2f840db91e6f9c559b88649_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMy01LTEtMS0w_e2ea0f01-cd8f-4a97-9a88-d59781a8e16f">129,846</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bd53f6c3550495599acfaf8cba39d05_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMy03LTEtMS0w_3c0b5456-5f13-47a0-a89a-b5092adc1567">169,844</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Center</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05aef9efca8d40999e7e0b591e687fcd_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfNC0xLTEtMS0w_bc9e714d-9e1e-4d33-a5ab-3eb1a3da2c8b">36,424</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib02855b3bb664c3d929e1fe1f3d95081_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfNC0zLTEtMS0w_afb96c28-97ab-41d4-a738-b7d71c4dbb10">42,197</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1aec235f150e4c96ab0033513856af19_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfNC01LTEtMS0w_61ca8ecc-dc16-4330-8109-1545250a7ebd">108,926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cc5c0e6c3114948a0b3b81b9e13dbb3_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfNC03LTEtMS0w_19a46b14-c0e5-4f8d-b899-70572f684901">121,124</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c22cd4ab0ee4facb5feb0c32ce1dcb8_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfNS0xLTEtMS0w_052876f9-0cc1-45ad-8ea0-8cd8eb6e5b63">22,430</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2da01bba3bcc4743a21c2cd6815ea493_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfNS0zLTEtMS0w_8ff37bc7-da66-48b9-9dff-5c51df8b2702">20,593</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35b2d1e5a36a40f9a3630df7618c1971_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfNS01LTEtMS0w_d4755b8a-9ea2-4769-b75a-6a2761425d06">61,672</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87d70737be684026888e909a4d46800b_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfNS03LTEtMS0w_b8cbce86-267c-4573-8770-5c10a355d518">60,360</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c9e183b328f4417a77301e1291a4315_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfNi0xLTEtMS0w_da23710a-e687-4235-930f-7457aaf7a206">111,527</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib94e4c38bb47467fa41d2b3dd7377cf5_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfNi0zLTEtMS0w_5503d744-2a62-4eec-8013-0ae90c6d57b3">122,133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d46cacfa2ca4634b761fcb1de68c22e_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfNi01LTEtMS0w_ad18a8e9-4805-4fcb-ab2e-5dfba157bf89">300,444</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1791b14ab6944fc9f18b6f33b05c26e_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfNi03LTEtMS0w_b49df896-543f-44fd-b0cf-490791d56368">351,328</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Corporate expenses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i05d2add01f7948cdbe05379d9edfa6cd_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="hae:CorporateOperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfNy0xLTEtMS0w_f1695dfd-22e3-4663-991a-1b51dd0d36d2">63,202</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if68e3d2fce814080a6a5a599e4100f7d_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="hae:CorporateOperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfNy0zLTEtMS0w_0e964f62-4fa2-4826-9d7a-337ea675cc4c">63,080</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f207c5c248843fd8e07e9437fa7102e_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="hae:CorporateOperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfNy01LTEtMS0w_d0dd5627-7fc1-42cc-bd6d-9ac0b39afa1e">185,005</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id7b79856e7224f109a59af542be47303_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="hae:CorporateOperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfNy03LTEtMS0w_0e4b990e-fff2-42ca-b442-665849cdf0d2">188,363</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Effect of exchange rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="hae:EffectofExchangeRatesonOperatingIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfOC0xLTEtMS0w_dfec3e63-188c-4a91-89c1-93afa805eea0">4,286</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="hae:EffectofExchangeRatesonOperatingIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfOC0zLTEtMS0w_8bce7622-a887-4716-8903-7d2a73f40d30">2,521</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="hae:EffectofExchangeRatesonOperatingIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfOC01LTEtMS0w_5bb4af4c-ff8c-4c14-8272-8c3dcf748e86">8,644</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="hae:EffectofExchangeRatesonOperatingIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfOC03LTEtMS0w_327f2b43-1d7f-4f0b-bc4c-a02103d22539">7,791</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Deal amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentForAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfOS0xLTEtMS0w_1be6ef3a-f129-432c-93d8-a48cbef67e9c">7,805</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentForAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfOS0zLTEtMS0w_13d92351-06d9-4699-9c3d-1d5a424c2480">5,772</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentForAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfOS01LTEtMS0w_9de26929-47ad-43c3-810d-730b624ad36f">24,204</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentForAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfOS03LTEtMS0w_7e0353c4-26f2-4450-a246-87e9726f7228">17,681</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Restructuring and turnaround costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="hae:RestructuringandTurnaroundCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMTAtMS0xLTEtMA_0716ac2d-1f8f-4621-8465-9710507e4ee8">3,143</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="hae:RestructuringandTurnaroundCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMTAtMy0xLTEtMA_158e172e-283e-494d-a489-b970f47db88f">7,798</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="hae:RestructuringandTurnaroundCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMTAtNS0xLTEtMA_54a26a88-c0af-4c73-a15a-3d4a9641bdbe">11,583</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="hae:RestructuringandTurnaroundCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMTAtNy0xLTEtMA_f7814ba2-d1c8-4ea8-9f76-a02798c142e2">13,582</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Transaction costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226" decimals="-3" format="ixt:zerodash" name="hae:OperatingExpensesTransactionCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMTEtMS0xLTEtNjkw_71c7237c-451f-4fbb-91fc-17928cbee8ea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228" decimals="-3" format="ixt:zerodash" name="hae:OperatingExpensesTransactionCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMTEtMy0xLTEtNzA1_b0da7fc1-b56b-4eb3-99be-c0596dc6f627">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="hae:OperatingExpensesTransactionCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMTEtNS0xLTEtNjk5_6245612f-5c0a-4b14-b4e0-4b322eca471c">3,063</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" format="ixt:zerodash" name="hae:OperatingExpensesTransactionCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMTEtNy0xLTEtNzEw_58fad534-52bb-48ca-951b-5e27ee376884">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;PCS2 accelerated depreciation and related costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestructuringReserveAcceleratedDepreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMTItMS0xLTEtMA_dfa3bc07-25d5-4071-8c06-33d8f796aaa4">1,146</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestructuringReserveAcceleratedDepreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMTItMy0xLTEtMA_55a8a5ab-8dc2-4c2d-bb58-57e46ba770b5">6,649</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestructuringReserveAcceleratedDepreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMTItNS0xLTEtMA_584c3e31-b430-4e44-800a-2bc3c0e85de1">3,332</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestructuringReserveAcceleratedDepreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMTItNy0xLTEtMA_a681c98f-e5cd-4fb9-89f7-8d2153476ee3">18,708</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;European Medical Device Regulation costs and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="hae:EuropeanMedicalDeviceRegulationCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMTMtMS0xLTEtMA_4f1972b6-9fa6-4fbb-b8e4-b84562088b6a">1,207</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228" decimals="-3" name="hae:EuropeanMedicalDeviceRegulationCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMTMtMy0xLTEtMA_4b99d318-9b19-4031-8fb8-15a8aa5454c5">448</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="hae:EuropeanMedicalDeviceRegulationCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMTMtNS0xLTEtMA_dbdc0aa0-15b9-41b6-84cf-dc542674a013">2,696</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" name="hae:EuropeanMedicalDeviceRegulationCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMTMtNy0xLTEtMA_4e4cc4e1-2518-40dc-b6d8-2f929c5ab00d">304</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Impairment of assets and other related charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226" decimals="-3" format="ixt:zerodash" name="hae:AssetImpairmentAndOtherRelatedCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMTQtMS0xLTEtMA_97ac0b69-7127-4dee-9b0d-cadb067193a6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228" decimals="-3" format="ixt:zerodash" name="hae:AssetImpairmentAndOtherRelatedCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMTQtMy0xLTEtMA_681ecf1d-c7b1-4afb-8aaa-310e54ae2bad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" name="hae:AssetImpairmentAndOtherRelatedCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMTQtNS0xLTEtMA_d7e3c4ba-3988-473d-9dab-6e251ad58455">896</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="hae:AssetImpairmentAndOtherRelatedCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMTQtNy0xLTEtMA_91573531-da94-4944-9f5f-8a22cf9a5f12">51,220</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Gains on divestitures and sale of assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GainLossOnDispositionOfAssets1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMTUtMS0xLTEtMA_7c537550-ecdc-4515-b2da-cefd2abe55cc">1,115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228" decimals="-3" format="ixt:zerodash" name="us-gaap:GainLossOnDispositionOfAssets1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMTUtMy0xLTEtMA_d6b4cb7c-66dc-4d0d-b8a4-67e9581bd934">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GainLossOnDispositionOfAssets1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMTUtNS0xLTEtMA_187a1596-3f2f-4d9c-9103-a5435d379d70">32,613</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GainLossOnDispositionOfAssets1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMTUtNy0xLTEtMA_dbf2070c-5841-4bb2-af15-08f945c98e04">8,083</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMTYtMS0xLTEtMA_b2bd9a6e-1297-4c94-a065-255a4e9124dc">40,425</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMTYtMy0xLTEtMA_f5b67842-3170-4798-b39c-77a0cda28de7">40,907</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMTYtNS0xLTEtMA_88b7b439-332f-4be0-89ad-143b50eb396b">110,922</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMTYtNy0xLTEtMA_311fa3d1-b097-4bd6-9805-c4bbc22ce969">77,344</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="24" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> Reflects shared service expenses including quality and regulatory, customer and field service, research and development, manufacturing and supply chain, as well as other corporate support functions.</span></div></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" name="us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RleHRyZWdpb246NDgyNDUzNzYxYzRhNDE2ODg2NzE1ZTcxMjk5NzFiZjBfMjY5OA_398ce147-da15-421e-b260-ea1fdca98de7" continuedAt="ibf04a1ee3b5f400fbe3f7cac45363dff" escape="true">Management reviews revenue based on the reportable segments noted above.&#160;Although these reportable segments are primarily product-based, they differ from the Company&#8217;s product line revenues for Plasma products and services and Blood Center products and services.&#160;Specifically, the Blood Center reportable segment includes plasma products utilized for collection in blood centers primarily for transfusion purposes.&#160;Additionally, product line revenues also include service revenues which are excluded from the reportable segments.</ix:nonNumeric></span></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="iddcef453176243c19b726a8f960f1804"><ix:continuation id="ibf04a1ee3b5f400fbe3f7cac45363dff"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues by product line are as follows:</span></div><div style="margin-bottom:5pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.578%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plasma products and services</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26227889e9a545ad95431135a52ce953_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmM2YThlMzczZTQwYTQ1OTQ4M2U0ZTkyYTRiZjJmZWJjL3RhYmxlcmFuZ2U6YzZhOGUzNzNlNDBhNDU5NDgzZTRlOTJhNGJmMmZlYmNfMi0xLTEtMS0w_5e7ffbde-a70f-4bd6-b038-0e2e729b5710">123,510</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idedb7dce764d40518eed1fa0384c56e9_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmM2YThlMzczZTQwYTQ1OTQ4M2U0ZTkyYTRiZjJmZWJjL3RhYmxlcmFuZ2U6YzZhOGUzNzNlNDBhNDU5NDgzZTRlOTJhNGJmMmZlYmNfMi0zLTEtMS0w_bfe55d89-0da9-4343-ad32-4dbe36c45641">141,231</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf184b96fbe0474082337c767ecc2e6f_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmM2YThlMzczZTQwYTQ1OTQ4M2U0ZTkyYTRiZjJmZWJjL3RhYmxlcmFuZ2U6YzZhOGUzNzNlNDBhNDU5NDgzZTRlOTJhNGJmMmZlYmNfMi01LTEtMS0w_e537ffda-7dec-4f31-babf-c8ba1a7bde11">309,933</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if01e8fdfb1df4aa0be9d813f7d0e93e8_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmM2YThlMzczZTQwYTQ1OTQ4M2U0ZTkyYTRiZjJmZWJjL3RhYmxlcmFuZ2U6YzZhOGUzNzNlNDBhNDU5NDgzZTRlOTJhNGJmMmZlYmNfMi03LTEtMS0w_606d6050-01e8-43cd-823b-ba8ce3137333">406,825</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Center products and services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52f5dadf03404a3289fc228ba07b7289_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmM2YThlMzczZTQwYTQ1OTQ4M2U0ZTkyYTRiZjJmZWJjL3RhYmxlcmFuZ2U6YzZhOGUzNzNlNDBhNDU5NDgzZTRlOTJhNGJmMmZlYmNfMy0xLTEtMS0w_ae0f6f78-1221-4c92-ad9c-f937d10889aa">62,787</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46410774ee104dd5856f09f41912d660_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmM2YThlMzczZTQwYTQ1OTQ4M2U0ZTkyYTRiZjJmZWJjL3RhYmxlcmFuZ2U6YzZhOGUzNzNlNDBhNDU5NDgzZTRlOTJhNGJmMmZlYmNfMy0zLTEtMS0w_ea3962e2-fe5f-4e22-b0b5-7328c0443360">66,126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc470180227d4a10b1dffb6cb47fb61e_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmM2YThlMzczZTQwYTQ1OTQ4M2U0ZTkyYTRiZjJmZWJjL3RhYmxlcmFuZ2U6YzZhOGUzNzNlNDBhNDU5NDgzZTRlOTJhNGJmMmZlYmNfMy01LTEtMS0w_bb6ed9ff-c6be-4f3e-a8f1-8b248eda5a87">182,687</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad919a0f8eb4d72afcee6d577854416_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmM2YThlMzczZTQwYTQ1OTQ4M2U0ZTkyYTRiZjJmZWJjL3RhYmxlcmFuZ2U6YzZhOGUzNzNlNDBhNDU5NDgzZTRlOTJhNGJmMmZlYmNfMy03LTEtMS0w_66229921-bea0-494c-8c3d-1cc3f715ab26">191,648</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospital products and services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87710fdfb6e84d9f8daaca0e1a6929bb_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmM2YThlMzczZTQwYTQ1OTQ4M2U0ZTkyYTRiZjJmZWJjL3RhYmxlcmFuZ2U6YzZhOGUzNzNlNDBhNDU5NDgzZTRlOTJhNGJmMmZlYmNfNC0xLTEtMS0w_8b2bf0e6-63b0-4050-9a48-269f91407021">54,074</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8bb31ac20c2428391e3f927f45c8cd7_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmM2YThlMzczZTQwYTQ1OTQ4M2U0ZTkyYTRiZjJmZWJjL3RhYmxlcmFuZ2U6YzZhOGUzNzNlNDBhNDU5NDgzZTRlOTJhNGJmMmZlYmNfNC0zLTEtMS0w_0aec7d0d-f8ea-4b23-96c0-13d585146b2c">51,613</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb446313570e4a9d840e6f2059d39181_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmM2YThlMzczZTQwYTQ1OTQ4M2U0ZTkyYTRiZjJmZWJjL3RhYmxlcmFuZ2U6YzZhOGUzNzNlNDBhNDU5NDgzZTRlOTJhNGJmMmZlYmNfNC01LTEtMS0w_9d7c1b78-e03b-4c2e-b002-4e87adf6501d">152,814</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fa09902b11845b090e32e2378241640_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmM2YThlMzczZTQwYTQ1OTQ4M2U0ZTkyYTRiZjJmZWJjL3RhYmxlcmFuZ2U6YzZhOGUzNzNlNDBhNDU5NDgzZTRlOTJhNGJmMmZlYmNfNC03LTEtMS0w_75953bb9-ddd2-45f3-9d7f-cc6f36394b8f">151,514</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmM2YThlMzczZTQwYTQ1OTQ4M2U0ZTkyYTRiZjJmZWJjL3RhYmxlcmFuZ2U6YzZhOGUzNzNlNDBhNDU5NDgzZTRlOTJhNGJmMmZlYmNfNS0xLTEtMS0w_c2db2b6d-e82c-48c4-8c86-1bee415ec79d">240,371</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmM2YThlMzczZTQwYTQ1OTQ4M2U0ZTkyYTRiZjJmZWJjL3RhYmxlcmFuZ2U6YzZhOGUzNzNlNDBhNDU5NDgzZTRlOTJhNGJmMmZlYmNfNS0zLTEtMS0w_306f349e-38c0-4b87-b642-4a8f393972ea">258,970</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmM2YThlMzczZTQwYTQ1OTQ4M2U0ZTkyYTRiZjJmZWJjL3RhYmxlcmFuZ2U6YzZhOGUzNzNlNDBhNDU5NDgzZTRlOTJhNGJmMmZlYmNfNS01LTEtMS0w_f1e099b6-efae-472b-a62a-e9e1afdb07a7">645,434</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmM2YThlMzczZTQwYTQ1OTQ4M2U0ZTkyYTRiZjJmZWJjL3RhYmxlcmFuZ2U6YzZhOGUzNzNlNDBhNDU5NDgzZTRlOTJhNGJmMmZlYmNfNS03LTEtMS0w_ed3bd2a5-5007-4264-9ee4-c09232a7e941">749,987</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues generated in the Company's principle operating regions on a reported basis are as follows:</span></div><div style="margin-bottom:5pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.303%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.578%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cc83bace6e64ba2819ad07eee146aa5_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjRlMTRjZjk5MTQ1NTRmZjJhOWQ5N2NmYzUyYzRmNDliL3RhYmxlcmFuZ2U6NGUxNGNmOTkxNDU1NGZmMmE5ZDk3Y2ZjNTJjNGY0OWJfMi0xLTEtMS0w_ef1e65df-d1e9-41e0-855d-da5392a7855f">147,607</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5255bf836d2f4c928a7bb2389d05393b_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjRlMTRjZjk5MTQ1NTRmZjJhOWQ5N2NmYzUyYzRmNDliL3RhYmxlcmFuZ2U6NGUxNGNmOTkxNDU1NGZmMmE5ZDk3Y2ZjNTJjNGY0OWJfMi0zLTEtMS0w_3ef3447e-e684-4999-a13f-b2a3d99e1c40">167,238</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia77b37ab4b674b69b224543cc8eb45e6_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjRlMTRjZjk5MTQ1NTRmZjJhOWQ5N2NmYzUyYzRmNDliL3RhYmxlcmFuZ2U6NGUxNGNmOTkxNDU1NGZmMmE5ZDk3Y2ZjNTJjNGY0OWJfMi01LTEtMS0w_63642879-1047-4cb1-bb9a-a0ef0984ea2e">382,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a100d6026814cee86e66f779c21038c_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjRlMTRjZjk5MTQ1NTRmZjJhOWQ5N2NmYzUyYzRmNDliL3RhYmxlcmFuZ2U6NGUxNGNmOTkxNDU1NGZmMmE5ZDk3Y2ZjNTJjNGY0OWJfMi03LTEtMS0w_a8e026fe-5504-46bf-a214-02b2904138b5">485,493</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d172cbd06c7456499c6f9186db5c771_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjRlMTRjZjk5MTQ1NTRmZjJhOWQ5N2NmYzUyYzRmNDliL3RhYmxlcmFuZ2U6NGUxNGNmOTkxNDU1NGZmMmE5ZDk3Y2ZjNTJjNGY0OWJfMy0xLTEtMS0w_9426c073-0c89-4c0a-9639-0307a0be00ad">20,854</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84a09fec71e2469490c5fced840c534d_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjRlMTRjZjk5MTQ1NTRmZjJhOWQ5N2NmYzUyYzRmNDliL3RhYmxlcmFuZ2U6NGUxNGNmOTkxNDU1NGZmMmE5ZDk3Y2ZjNTJjNGY0OWJfMy0zLTEtMS0w_40bbba88-ea69-46b5-ba47-25da2e5a5292">19,268</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8042aa5ffab48bba95d2e2d9c04f228_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjRlMTRjZjk5MTQ1NTRmZjJhOWQ5N2NmYzUyYzRmNDliL3RhYmxlcmFuZ2U6NGUxNGNmOTkxNDU1NGZmMmE5ZDk3Y2ZjNTJjNGY0OWJfMy01LTEtMS0w_5b6f5ebf-92c1-412d-8390-2773558d2dc6">57,330</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17ab8f6f349b4eaba8ad6043c531b88a_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjRlMTRjZjk5MTQ1NTRmZjJhOWQ5N2NmYzUyYzRmNDliL3RhYmxlcmFuZ2U6NGUxNGNmOTkxNDU1NGZmMmE5ZDk3Y2ZjNTJjNGY0OWJfMy03LTEtMS0w_8631b7e5-7e0f-4d05-ba4c-634d99563c7e">55,111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb8358f9ae4143e7bb93e59e7d3a809c_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjRlMTRjZjk5MTQ1NTRmZjJhOWQ5N2NmYzUyYzRmNDliL3RhYmxlcmFuZ2U6NGUxNGNmOTkxNDU1NGZmMmE5ZDk3Y2ZjNTJjNGY0OWJfNC0xLTEtMS0w_ba5f9352-065d-4f52-9552-26ea0d2b2b48">41,874</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i479cccf7db0b402f8eb765dc4867033c_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjRlMTRjZjk5MTQ1NTRmZjJhOWQ5N2NmYzUyYzRmNDliL3RhYmxlcmFuZ2U6NGUxNGNmOTkxNDU1NGZmMmE5ZDk3Y2ZjNTJjNGY0OWJfNC0zLTEtMS0w_41f4398a-c092-4106-997e-4e103b8d7ebc">40,984</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib68f4cb225a84d98b73f7eb16b96435c_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjRlMTRjZjk5MTQ1NTRmZjJhOWQ5N2NmYzUyYzRmNDliL3RhYmxlcmFuZ2U6NGUxNGNmOTkxNDU1NGZmMmE5ZDk3Y2ZjNTJjNGY0OWJfNC01LTEtMS0w_da8edef1-de6e-437f-bb97-79113e207660">123,541</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d56e00072c84650b763043b36796f33_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjRlMTRjZjk5MTQ1NTRmZjJhOWQ5N2NmYzUyYzRmNDliL3RhYmxlcmFuZ2U6NGUxNGNmOTkxNDU1NGZmMmE5ZDk3Y2ZjNTJjNGY0OWJfNC03LTEtMS0w_a33f4359-b338-4d93-9cfc-61b8c3b0016d">115,811</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4173f578720640508c5f3e2556613126_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjRlMTRjZjk5MTQ1NTRmZjJhOWQ5N2NmYzUyYzRmNDliL3RhYmxlcmFuZ2U6NGUxNGNmOTkxNDU1NGZmMmE5ZDk3Y2ZjNTJjNGY0OWJfNS0xLTEtMS0w_5123ebe0-2df8-4ca1-bb33-fe890af02fd6">29,050</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie22e69eafcdc47a5a7f6d41ca37a8314_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjRlMTRjZjk5MTQ1NTRmZjJhOWQ5N2NmYzUyYzRmNDliL3RhYmxlcmFuZ2U6NGUxNGNmOTkxNDU1NGZmMmE5ZDk3Y2ZjNTJjNGY0OWJfNS0zLTEtMS0w_7de69b6d-eb4e-4c5d-aea1-cad9b503317f">29,436</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17cdd867d9784cc8998e9d70ee3105af_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjRlMTRjZjk5MTQ1NTRmZjJhOWQ5N2NmYzUyYzRmNDliL3RhYmxlcmFuZ2U6NGUxNGNmOTkxNDU1NGZmMmE5ZDk3Y2ZjNTJjNGY0OWJfNS01LTEtMS0w_4f71d74e-9b9a-42bd-b191-70612a579e96">77,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96c22dedabc94ec0a58470fce107095e_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjRlMTRjZjk5MTQ1NTRmZjJhOWQ5N2NmYzUyYzRmNDliL3RhYmxlcmFuZ2U6NGUxNGNmOTkxNDU1NGZmMmE5ZDk3Y2ZjNTJjNGY0OWJfNS03LTEtMS0w_f8d5af3d-3a55-42d4-b867-a96723d3465c">88,269</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c25765c59da42a08a0a21dbace51807_D20200927-20201226" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjRlMTRjZjk5MTQ1NTRmZjJhOWQ5N2NmYzUyYzRmNDliL3RhYmxlcmFuZ2U6NGUxNGNmOTkxNDU1NGZmMmE5ZDk3Y2ZjNTJjNGY0OWJfNi0xLTEtMS0w_71c52af7-a635-43da-b0d4-7626bd2aba40">986</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i787564a0a009410b9c7377c8d5563e2a_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjRlMTRjZjk5MTQ1NTRmZjJhOWQ5N2NmYzUyYzRmNDliL3RhYmxlcmFuZ2U6NGUxNGNmOTkxNDU1NGZmMmE5ZDk3Y2ZjNTJjNGY0OWJfNi0zLTEtMS0w_dab17360-1360-43dd-9ea5-80db38788eea">2,044</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfb3207a7e164364a10c64478573dec0_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjRlMTRjZjk5MTQ1NTRmZjJhOWQ5N2NmYzUyYzRmNDliL3RhYmxlcmFuZ2U6NGUxNGNmOTkxNDU1NGZmMmE5ZDk3Y2ZjNTJjNGY0OWJfNi01LTEtMS0w_73e9f30a-bdd4-4322-9637-a6c789f55af8">4,361</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77f79023d32b40a3bb1a8b511a7fe783_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjRlMTRjZjk5MTQ1NTRmZjJhOWQ5N2NmYzUyYzRmNDliL3RhYmxlcmFuZ2U6NGUxNGNmOTkxNDU1NGZmMmE5ZDk3Y2ZjNTJjNGY0OWJfNi03LTEtMS0w_505ec618-e537-4b91-9b7a-d94623c5076c">5,303</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjRlMTRjZjk5MTQ1NTRmZjJhOWQ5N2NmYzUyYzRmNDliL3RhYmxlcmFuZ2U6NGUxNGNmOTkxNDU1NGZmMmE5ZDk3Y2ZjNTJjNGY0OWJfNy0xLTEtMS0w_05f1566a-f5ad-44be-8926-e0b88b3461a2">240,371</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjRlMTRjZjk5MTQ1NTRmZjJhOWQ5N2NmYzUyYzRmNDliL3RhYmxlcmFuZ2U6NGUxNGNmOTkxNDU1NGZmMmE5ZDk3Y2ZjNTJjNGY0OWJfNy0zLTEtMS0w_8320b608-1097-4f44-aa5a-07b1b58dbadf">258,970</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjRlMTRjZjk5MTQ1NTRmZjJhOWQ5N2NmYzUyYzRmNDliL3RhYmxlcmFuZ2U6NGUxNGNmOTkxNDU1NGZmMmE5ZDk3Y2ZjNTJjNGY0OWJfNy01LTEtMS0w_14c1f9cb-0c06-4ed4-b2d2-58432983ac92">645,434</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjRlMTRjZjk5MTQ1NTRmZjJhOWQ5N2NmYzUyYzRmNDliL3RhYmxlcmFuZ2U6NGUxNGNmOTkxNDU1NGZmMmE5ZDk3Y2ZjNTJjNGY0OWJfNy03LTEtMS0w_9061e593-7332-42b6-8304-1bacb3a71285">749,987</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div style="margin-top:7pt"><span><br/></span></div><div id="ib1e23e354c9c424096b27d04c70f5a5a_85"></div><ix:nonNumeric contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84NS9mcmFnOjk0ZjI1YTIxMDQyMTQ1MTg4NTkxNTg2ZWNiZDNmMTM3L3RleHRyZWdpb246OTRmMjVhMjEwNDIxNDUxODg1OTE1ODZlY2JkM2YxMzdfODM_35214fe2-8083-469a-bf69-343bd642d2b1" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15. ACCUMULATED OTHER COMPREHENSIVE LOSS </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84NS9mcmFnOjk0ZjI1YTIxMDQyMTQ1MTg4NTkxNTg2ZWNiZDNmMTM3L3RleHRyZWdpb246OTRmMjVhMjEwNDIxNDUxODg1OTE1ODZlY2JkM2YxMzdfODY_58120724-cd49-4ff4-9fb8-b3aca249ec2c" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of Accumulated Other Comprehensive Loss are as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:38.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.164%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.164%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.164%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.168%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Defined Benefit Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Unrealized Gain/Loss on Derivatives</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 28, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73c6d04f09054f72ad3f93b0ac709dbf_I20200328" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84NS9mcmFnOjk0ZjI1YTIxMDQyMTQ1MTg4NTkxNTg2ZWNiZDNmMTM3L3RhYmxlOjhiMzZkNDM2YmYyNDRkOGRiOGNmOTg3M2FhMjY3OThmL3RhYmxlcmFuZ2U6OGIzNmQ0MzZiZjI0NGQ4ZGI4Y2Y5ODczYWEyNjc5OGZfMS0yLTEtMS0w_7aa084ff-46c7-4b06-8e1e-06ad0e1140a6">31,100</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id5abcf57b0bd45828a4b667e017ea34b_I20200328" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84NS9mcmFnOjk0ZjI1YTIxMDQyMTQ1MTg4NTkxNTg2ZWNiZDNmMTM3L3RhYmxlOjhiMzZkNDM2YmYyNDRkOGRiOGNmOTg3M2FhMjY3OThmL3RhYmxlcmFuZ2U6OGIzNmQ0MzZiZjI0NGQ4ZGI4Y2Y5ODczYWEyNjc5OGZfMS00LTEtMS0w_46dc2175-9f52-4d81-a06d-0308ab2f5541">209</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd033b9d4b7c4a79acde034ff7bf773d_I20200328" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84NS9mcmFnOjk0ZjI1YTIxMDQyMTQ1MTg4NTkxNTg2ZWNiZDNmMTM3L3RhYmxlOjhiMzZkNDM2YmYyNDRkOGRiOGNmOTg3M2FhMjY3OThmL3RhYmxlcmFuZ2U6OGIzNmQ0MzZiZjI0NGQ4ZGI4Y2Y5ODczYWEyNjc5OGZfMS02LTEtMS0w_93aa28f5-da3a-4b45-8e6d-bce2e70ee9c4">13,826</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84NS9mcmFnOjk0ZjI1YTIxMDQyMTQ1MTg4NTkxNTg2ZWNiZDNmMTM3L3RhYmxlOjhiMzZkNDM2YmYyNDRkOGRiOGNmOTg3M2FhMjY3OThmL3RhYmxlcmFuZ2U6OGIzNmQ0MzZiZjI0NGQ4ZGI4Y2Y5ODczYWEyNjc5OGZfMS04LTEtMS0w_34131a8f-0685-44ba-8c07-b1d0b735eca3">45,135</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e613855a20241cbb5aca346a957c8d5_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84NS9mcmFnOjk0ZjI1YTIxMDQyMTQ1MTg4NTkxNTg2ZWNiZDNmMTM3L3RhYmxlOjhiMzZkNDM2YmYyNDRkOGRiOGNmOTg3M2FhMjY3OThmL3RhYmxlcmFuZ2U6OGIzNmQ0MzZiZjI0NGQ4ZGI4Y2Y5ODczYWEyNjc5OGZfMi0yLTEtMS0w_d38eee8e-4d58-45cd-856b-adb1c138ff9e">12,031</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1674f32a21e4d63a2bd245596b5d47c_D20200329-20201226" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84NS9mcmFnOjk0ZjI1YTIxMDQyMTQ1MTg4NTkxNTg2ZWNiZDNmMTM3L3RhYmxlOjhiMzZkNDM2YmYyNDRkOGRiOGNmOTg3M2FhMjY3OThmL3RhYmxlcmFuZ2U6OGIzNmQ0MzZiZjI0NGQ4ZGI4Y2Y5ODczYWEyNjc5OGZfMi00LTEtMS0w_e8ed2d31-8d1b-426c-a7d6-d30772a4238f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64fb8a3c1c5d42e99e7b38ba5b2f180f_D20200329-20201226" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84NS9mcmFnOjk0ZjI1YTIxMDQyMTQ1MTg4NTkxNTg2ZWNiZDNmMTM3L3RhYmxlOjhiMzZkNDM2YmYyNDRkOGRiOGNmOTg3M2FhMjY3OThmL3RhYmxlcmFuZ2U6OGIzNmQ0MzZiZjI0NGQ4ZGI4Y2Y5ODczYWEyNjc5OGZfMi02LTEtMS0w_0fef3068-9e87-4e70-8522-d3f13cf4218c">1,618</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84NS9mcmFnOjk0ZjI1YTIxMDQyMTQ1MTg4NTkxNTg2ZWNiZDNmMTM3L3RhYmxlOjhiMzZkNDM2YmYyNDRkOGRiOGNmOTg3M2FhMjY3OThmL3RhYmxlcmFuZ2U6OGIzNmQ0MzZiZjI0NGQ4ZGI4Y2Y5ODczYWEyNjc5OGZfMi04LTEtMS0w_f4f4e4bf-1903-4089-bab9-7cf2878611aa">10,413</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e613855a20241cbb5aca346a957c8d5_D20200329-20201226" decimals="-3" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84NS9mcmFnOjk0ZjI1YTIxMDQyMTQ1MTg4NTkxNTg2ZWNiZDNmMTM3L3RhYmxlOjhiMzZkNDM2YmYyNDRkOGRiOGNmOTg3M2FhMjY3OThmL3RhYmxlcmFuZ2U6OGIzNmQ0MzZiZjI0NGQ4ZGI4Y2Y5ODczYWEyNjc5OGZfMy0yLTEtMS0w_dfc707e7-9fbc-4b67-aac4-084b7646e629">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1674f32a21e4d63a2bd245596b5d47c_D20200329-20201226" decimals="-3" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84NS9mcmFnOjk0ZjI1YTIxMDQyMTQ1MTg4NTkxNTg2ZWNiZDNmMTM3L3RhYmxlOjhiMzZkNDM2YmYyNDRkOGRiOGNmOTg3M2FhMjY3OThmL3RhYmxlcmFuZ2U6OGIzNmQ0MzZiZjI0NGQ4ZGI4Y2Y5ODczYWEyNjc5OGZfMy00LTEtMS0w_87446b40-d38e-423c-9d7b-d64fd595d85b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64fb8a3c1c5d42e99e7b38ba5b2f180f_D20200329-20201226" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84NS9mcmFnOjk0ZjI1YTIxMDQyMTQ1MTg4NTkxNTg2ZWNiZDNmMTM3L3RhYmxlOjhiMzZkNDM2YmYyNDRkOGRiOGNmOTg3M2FhMjY3OThmL3RhYmxlcmFuZ2U6OGIzNmQ0MzZiZjI0NGQ4ZGI4Y2Y5ODczYWEyNjc5OGZfMy02LTEtMS0w_df992240-9ee5-44d5-884e-ab70634c9634">4,864</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84NS9mcmFnOjk0ZjI1YTIxMDQyMTQ1MTg4NTkxNTg2ZWNiZDNmMTM3L3RhYmxlOjhiMzZkNDM2YmYyNDRkOGRiOGNmOTg3M2FhMjY3OThmL3RhYmxlcmFuZ2U6OGIzNmQ0MzZiZjI0NGQ4ZGI4Y2Y5ODczYWEyNjc5OGZfMy04LTEtMS0w_aaa0c112-788c-4580-951b-47aa511a440b">4,864</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e613855a20241cbb5aca346a957c8d5_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84NS9mcmFnOjk0ZjI1YTIxMDQyMTQ1MTg4NTkxNTg2ZWNiZDNmMTM3L3RhYmxlOjhiMzZkNDM2YmYyNDRkOGRiOGNmOTg3M2FhMjY3OThmL3RhYmxlcmFuZ2U6OGIzNmQ0MzZiZjI0NGQ4ZGI4Y2Y5ODczYWEyNjc5OGZfNC0yLTEtMS0w_9b974bf6-53ea-468b-a28d-0e836c3bbec2">12,031</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1674f32a21e4d63a2bd245596b5d47c_D20200329-20201226" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84NS9mcmFnOjk0ZjI1YTIxMDQyMTQ1MTg4NTkxNTg2ZWNiZDNmMTM3L3RhYmxlOjhiMzZkNDM2YmYyNDRkOGRiOGNmOTg3M2FhMjY3OThmL3RhYmxlcmFuZ2U6OGIzNmQ0MzZiZjI0NGQ4ZGI4Y2Y5ODczYWEyNjc5OGZfNC00LTEtMS0w_6398e89e-2915-442c-9ae6-226d78ade077">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64fb8a3c1c5d42e99e7b38ba5b2f180f_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84NS9mcmFnOjk0ZjI1YTIxMDQyMTQ1MTg4NTkxNTg2ZWNiZDNmMTM3L3RhYmxlOjhiMzZkNDM2YmYyNDRkOGRiOGNmOTg3M2FhMjY3OThmL3RhYmxlcmFuZ2U6OGIzNmQ0MzZiZjI0NGQ4ZGI4Y2Y5ODczYWEyNjc5OGZfNC02LTEtMS0w_361dab03-662e-4fd3-9513-716276e0e6c4">3,246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84NS9mcmFnOjk0ZjI1YTIxMDQyMTQ1MTg4NTkxNTg2ZWNiZDNmMTM3L3RhYmxlOjhiMzZkNDM2YmYyNDRkOGRiOGNmOTg3M2FhMjY3OThmL3RhYmxlcmFuZ2U6OGIzNmQ0MzZiZjI0NGQ4ZGI4Y2Y5ODczYWEyNjc5OGZfNC04LTEtMS0w_4a7b7b8f-dd8f-4f32-a033-a8bb1065258c">15,277</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 26, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie870c34971924054809e87e40bb33672_I20201226" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84NS9mcmFnOjk0ZjI1YTIxMDQyMTQ1MTg4NTkxNTg2ZWNiZDNmMTM3L3RhYmxlOjhiMzZkNDM2YmYyNDRkOGRiOGNmOTg3M2FhMjY3OThmL3RhYmxlcmFuZ2U6OGIzNmQ0MzZiZjI0NGQ4ZGI4Y2Y5ODczYWEyNjc5OGZfNS0yLTEtMS0w_650727ce-e93c-4a54-82d2-7b35f1fc9a94">19,069</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6309acd9935545568cbf73841d4a4e9c_I20201226" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84NS9mcmFnOjk0ZjI1YTIxMDQyMTQ1MTg4NTkxNTg2ZWNiZDNmMTM3L3RhYmxlOjhiMzZkNDM2YmYyNDRkOGRiOGNmOTg3M2FhMjY3OThmL3RhYmxlcmFuZ2U6OGIzNmQ0MzZiZjI0NGQ4ZGI4Y2Y5ODczYWEyNjc5OGZfNS00LTEtMS0w_b8f074ad-5e7a-4be2-89c9-58d8dfd1f7cd">209</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98ca0312f088468c8e6ea90d58d30441_I20201226" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84NS9mcmFnOjk0ZjI1YTIxMDQyMTQ1MTg4NTkxNTg2ZWNiZDNmMTM3L3RhYmxlOjhiMzZkNDM2YmYyNDRkOGRiOGNmOTg3M2FhMjY3OThmL3RhYmxlcmFuZ2U6OGIzNmQ0MzZiZjI0NGQ4ZGI4Y2Y5ODczYWEyNjc5OGZfNS02LTEtMS0w_c0caff7f-5227-455b-9982-2eaec3545054">10,580</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84NS9mcmFnOjk0ZjI1YTIxMDQyMTQ1MTg4NTkxNTg2ZWNiZDNmMTM3L3RhYmxlOjhiMzZkNDM2YmYyNDRkOGRiOGNmOTg3M2FhMjY3OThmL3RhYmxlcmFuZ2U6OGIzNmQ0MzZiZjI0NGQ4ZGI4Y2Y5ODczYWEyNjc5OGZfNS04LTEtMS0w_a2ec7e48-bc20-48be-9aac-e11e60af33ee">29,858</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> Presented net of income taxes, the amounts of which are insignificant.</span></div></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div><span><br/></span></div><div id="ib1e23e354c9c424096b27d04c70f5a5a_88"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2. MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations (&#8220;MD&amp;A&#8221;) should be read in conjunction with both our interim condensed consolidated financial statements and notes thereto which appear elsewhere in this Quarterly Report on Form 10-Q and our annual consolidated financial statements, notes thereto and the MD&amp;A contained in our Annual Report on Form 10-K for the fiscal year ended March&#160;28, 2020. The following discussion may contain forward-looking statements and should be read in conjunction with the &#8220;Cautionary Statement Regarding Forward-Looking Information&#8221; in this discussion.</span></div><div><span><br/></span></div><div id="ib1e23e354c9c424096b27d04c70f5a5a_91"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Introduction</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Haemonetics is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions to customers to help improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets including blood and plasma component collection, the surgical suite, and hospital transfusion services. When used in this report, the terms &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our&#8221; and &#8220;the Company&#8221; mean Haemonetics.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We view our operations and manage our business in three principal reporting segments: Plasma, Blood Center and Hospital. For that purpose, &#8220;Plasma&#8221; includes plasma collection devices and disposables, plasma donor management software, and anticoagulant and saline sold to plasma customers. &#8220;Blood Center&#8221; includes blood collection and processing devices and disposables for red cells, platelets and whole blood. &#8220;Hospital&#8221;, which is comprised of Hemostasis Management, Cell Salvage and Transfusion Management products, includes devices and methodologies for measuring coagulation characteristics of blood, surgical blood salvage systems, specialized blood cell processing systems and disposables and blood transfusion management software.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that Plasma and Hospital have growth potential, while Blood Center competes in challenging markets which require us to manage the business differently, including reducing costs, shrinking the scope of the current product line, and evaluating opportunities to exit unfavorable customer contracts.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Developments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cardiva Medical, Inc.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 17, 2021, we entered into an Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;) with Cardiva Medical, Inc., (&#8220;Cardiva&#8221;), an industry-leading manufacturer of vascular closure systems based in Santa Clara, California. In connection with this acquisition, we will pay upfront consideration of $475.0 million in cash, subject to customary working capital and certain other adjustments as of the closing of the transaction, as well as up to $35.0 million in additional contingent consideration payable over the next two years based on sales growth. The transaction is not subject to a financing contingency, and we expect to finance the transaction through a combination of our cash on hand, revolving credit facility and an additional $150.0 million term loan anticipated to be borrowed under our existing credit facility. The transaction is expected to close in the fourth quarter of fiscal 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cardiva&#8217;s portfolio includes two catheter-based vascular access site closure devices. The VASCADE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> vascular closure system is designed for &#8220;small-bore&#8221; femoral arterial and venous closure, generally used in interventional cardiology and peripheral vascular procedures. The VASCADE MVP</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> vascular closure system is designed for &#8220;mid-bore&#8221; multi-access femoral venous closure, generally used in electrophysiology procedures, and is the only U.S. Food and Drug Administration (&#8220;FDA&#8221;) approved closure device for use following cardiac ablation procedures requiring two or more access sites within the same vessel. The addition of the VASCADE portfolio to our Hospital business unit includes products with demonstrated benefits and enhances penetration into the large and growing interventional cardiology and electrophysiology markets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HAS Intellectual Property</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, we entered into an agreement to acquire certain intellectual property owned by HemoAssay Science and Technology (Suzhou) Co. Ltd., a China-incorporated company, and its affiliates (collectively, &#8220;HemoAssay&#8221;) underlying their HAS viscoelastic diagnostic devices, related assays and disposables. We previously entered into exclusive manufacturing and distribution agreements with HemoAssay pursuant to which we have exclusive rights to commercialize HemoAssay&#8217;s HAS devices in China. In connection with the transaction, we have agreed to pay up to $15.0 million to HemoAssay in contingent consideration based on certain developmental and manufacturing based milestones. These products augment our portfolio of hemostasis analyzers within the Hospital business unit.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">enicor GmbH</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2020, we acquired enicor GmbH (&#8220;enicor&#8221;), the manufacturer of ClotPro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a new generation whole blood coagulation testing system that is currently available in select European and Asia Pacific markets, for total consideration of $20.5 million, which consisted of upfront payments of $16.6 million and the fair value of contingent consideration of $3.9 million. The contingent consideration, which could total a maximum of $4.5 million, consists of payments related to the achievement of certain revenue and regulatory milestones. The acquisition of this viscoelastic diagnostic device augments the Company's portfolio of hemostasis analyzers within the Hospital business unit. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to the Unaudited Condensed Consolidated Financial Statements in this Quarterly Report on Form 10-Q for additional information.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Persona</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 2, 2020, we received FDA 510(k) clearance for our NexSys PCS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> with Persona technology. NexSys PCS with Persona technology uses a percent plasma nomogram that customizes plasma collection based on an individual donor's body composition. The new, proprietary Persona technology strengthens the NexSys PCS value proposition and reinforces our commitment to supporting the plasma industry.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">COVID-19</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to closely manage the impacts of the COVID-19 pandemic on our business results of operations and financial condition. The progression of the COVID-19 pandemic during fiscal 2021 significantly impacted our financial results. While the duration and additional implications remain uncertain, the full extent of the impact will depend on future developments that are highly uncertain and cannot be accurately predicted, including new information that may emerge concerning COVID-19, the actions taken to contain it or treat its impact and the economic impact on local, regional, national and international markets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our priorities continue to be the safety of our employees and business continuity while continuing to invest in growth opportunities. Our manufacturing and supply chain remain operational without significant disruptions and we continue to operate in all of our markets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the pace and timing of the recovery is uncertain, we remain confident in the long term strength of the end markets that we serve across our three business units. For additional information regarding the expected impacts to our business units and the various risks posed by the COVID-19 pandemic, refer to Results of Operations within Management's Discussion and Analysis and Risk Factors contained in this Quarterly Report on Form 10-Q.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Divestitures</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fajardo, Puerto Rico Manufacturing Operations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 29, 2020, we sold our Fajardo, Puerto Rico, manufacturing operations to GVS, S.p.A (&#8220;GVS&#8221;), a leading provider of advanced filtration solutions for critical applications for $15.1&#160;million ($7.8&#160;million, net of cash transferred). Under the terms of the agreement, Haemonetics retained all intellectual property rights to its proprietary blood filters currently manufactured at its Fajardo facility and GVS acquired certain assets consisting primarily of property, plant and equipment, inventory and cash and has assumed certain related liabilities. In addition, the two parties entered into a long-term supply and development agreement that, among other things, grants GVS exclusive rights to manufacture and supply the blood filters currently produced at the Fajardo facility for Haemonetics. This divestiture will allow Haemonetics to utilize GVS' experience and scale in filtration to deliver reliable, cost-efficient products to its customers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. Blood Donor Management Software</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 1, 2020, we sold certain U.S. blood donor management software solution assets within our Blood Center business unit to the GPI Group for an upfront cash payment of $14.0 million ($13.6 million, net of working capital adjustments) and recognized a $13.2 million gain on the sale. In addition to the cash received upon closing, we may also receive up to an additional $14.0 million, contingent upon the achievement of certain performance measures. This divestiture better positions Haemonetics for sustainable growth by enabling the Company to focus on its core capabilities while delivering quality products and services where it brings distinct value. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inlog Holdings France</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 18, 2020, we sold our wholly-owned subsidiary Inlog Holdings France SAS to Ab&#233;nex Capital (&#8220;Ab&#233;nex&#8221;), a private equity firm based in France for $30.5 million ($24.5 million, net of cash transferred) and recognized a gain of $19.8 million. Inlog Holdings France SAS, through its subsidiary In Log SAS, develops and sells blood bank and hospital software solutions used predominantly in France and in several other countries outside of the U.S. This divestiture and the sale of our U.S. blood donor management software better position us to focus on our growth segments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 5, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Divestitures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to the Unaudited Condensed Consolidated Financial Statements in this Quarterly Report on Form 10-Q for additional information pertaining to these divestitures.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring Program</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2019, our Board of Directors approved a new Operational Excellence Program (the &#8220;2020 Program&#8221;) and delegated authority to management to determine the detail of the initiatives that will comprise the program. The 2020 Program is designed to improve operational performance and reduce cost principally in our manufacturing and supply chain operations. We estimate that we will incur aggregate charges between $60 million and $70 million in connection with the 2020 Program. These charges, the majority of which will result in cash outlays, including severance and other employee costs, will be incurred as the specific actions required to execute these initiatives are identified and approved and are expected to be substantially completed by the end of fiscal 2023. Savings from the 2020 Program are targeted to reach $80 million to $90 million on an annualized basis once the program is completed. During the three and nine months ended December 26, 2020, we incurred $3.1 million and $11.1 million, respectively, of restructuring and turnaround costs under this program.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Summary</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.411%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Increase/<br/>(Decrease)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Increase/<br/>(Decrease)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240,371&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258,970&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(7.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">645,434&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">749,987&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(13.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross profit</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,050&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316,031&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">370,956&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(14.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">% of net revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">50.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">49.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">49.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">49.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,832&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(8.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205,109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293,612&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(30.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,425&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,907&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,922&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,344&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">43.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">% of net revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">16.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">15.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other expense, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,051)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,078)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,612)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,152)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(12.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income before provision for income taxes</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,374&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,829&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,192&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">53.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,492&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,934&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(30.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,290&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">55.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">% of pre-tax income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">14.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">9.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,882&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,895&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,510&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,902&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">53.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">% of net revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">11.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">14.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share - basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">54.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share - diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">56.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues decreased 7.2% and 13.9% during the three and nine months ended December 26, 2020, respectively, as compared with the same periods of fiscal 2020. Without the effect of foreign exchange, net revenues decreased 8.5% and 14.5% during the three and nine months ended December 26, 2020, respectively, as compared with the same periods of fiscal 2020. Revenue decreases in Plasma due to the COVID-19 pandemic primarily drove the overall decrease in revenue during the three and nine months ended December 26, 2020. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating income decreased during the three months ended December 26, 2020, as compared with the same period of fiscal 2020, due to the impact of the COVID-19 pandemic on revenue and gross margin, net of savings in operating expenses from cost containment actions taken to offset these negative effects. Operating income increased during the nine months ended December 26, 2020, as compared with the same period of fiscal 2020, due to the gains on divestitures, incremental savings from the 2020 Program and the absence of impairment charges associated with the divestiture of our plasma liquid solutions operations in the prior year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management's Use of Non-GAAP Measures</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management uses non-GAAP financial measures, in addition to financial measures in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;), to monitor the financial performance of the business, make informed business decisions, establish budgets and forecast future results. These non-GAAP financial measures should be considered supplemental to, and not a substitute for, our reported financial results prepared in accordance with U.S. GAAP. Constant currency growth, a non-GAAP financial measure, measures the change in revenue between the current and prior year periods using a constant currency conversion rate. We have provided this non-GAAP financial measure because we believe it provides meaningful information regarding our results on a consistent and comparable basis for the periods presented.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><div id="ib1e23e354c9c424096b27d04c70f5a5a_94"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div id="ib1e23e354c9c424096b27d04c70f5a5a_97"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESULTS OF OPERATIONS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Revenues by Geography</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:36.491%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.651%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reported growth</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Currency impact</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Constant currency growth</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,608&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167,238&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,763&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,732&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240,371&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258,970&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Constant currency growth, a non-GAAP financial measure, measures the change in revenue between the current and prior year periods using a constant currency. See &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Management's Use of Non-GAAP Measures.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8221;</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:36.491%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.651%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reported growth</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Currency impact</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Constant currency growth</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382,601&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485,493&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262,833&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264,494&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">645,434&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">749,987&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Constant currency growth, a non-GAAP financial measure, measures the change in revenue between the current and prior year periods using a constant currency. See &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Management's Use of Non-GAAP Measures.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8221;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal operations are in the U.S, Europe, Japan and other parts of Asia. Our products are marketed in approximately 85 countries around the world through a combination of our direct sales force, independent distributors and agents. Our revenue generated outside the U.S. was 38.6% and 40.7%, respectively, of total net revenues during the three and nine months ended December 26, 2020, as compared with 35.4% and 35.3%, respectively, during the three and nine months ended December 28, 2019. International sales are generally conducted in local currencies, primarily Japanese Yen, Euro, Chinese Yuan and Australian Dollars. Our results of operations are impacted by changes in foreign exchange rates, particularly in the value of the Yen, Euro and Australian Dollar relative to the U.S.&#160;Dollar. We have placed foreign currency hedges to mitigate our exposure to foreign currency fluctuations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please see the section entitled &#8220;Foreign Exchange&#8221; in this discussion for a more complete explanation of how foreign currency affects our business and our strategy for managing this exposure.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Revenues by Business Unit</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:36.491%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.651%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reported growth</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Currency impact</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Constant currency growth </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plasma</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,934&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,420&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Center</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,920&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospital </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,651&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,266&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,866&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,873&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240,371&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258,970&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Constant currency growth, a non-GAAP financial measure, measures the change in revenue between the current and prior year periods using a constant currency. See &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Management's Use of Non-GAAP Measures.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8221;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Hospital revenue includes Hemostasis Management revenue of $28.5 million and $24.7 million during the three months ended December 26, 2020 and December&#160;28, 2019, respectively. Hemostasis Management revenue increased 15.2% in the third quarter of fiscal 2021, as compared with the same period of fiscal 2020. Without the effect of foreign exchange, Hemostasis Management revenue increased 14.2% in the third quarter of fiscal 2021, as compared with the same period of fiscal 2020.</span></div><div><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:36.491%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.651%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reported growth</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Currency impact</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Constant currency growth </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plasma</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248,553&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346,767&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Center</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233,622&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241,196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospital </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148,468&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,665&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,791&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,359&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">645,434&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">749,987&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Constant currency growth, a non-GAAP financial measure, measures the change in revenue between the current and prior year periods using a constant currency. See &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Management's Use of Non-GAAP Measures.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8221;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> Hospital revenue includes Hemostasis Management revenue of $78.5 million and $73.9 million during the nine months ended December 26, 2020 and December&#160;28, 2019, respectively. Hemostasis Management revenue increased 6.2% in the first nine months of fiscal 2021, as compared with the same period of fiscal 2020. Without the effect of foreign exchange, Hemostasis Management revenue increased 7.7% in the first nine months of fiscal 2021, as compared with the same period of fiscal 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Plasma</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plasma revenue decreased 15.4% and 28.3% during the three and nine months ended December 26, 2020, respectively, as compared with the same periods of fiscal 2020. Without the effect of foreign exchange, Plasma revenue decreased 15.6% and 28.3% during the three and nine months ended December 26, 2020, respectively, as compared with the same periods of fiscal 2020. This revenue decrease during the three and nine months ended December 26, 2020 was driven by a decline in the volume of plasma disposables, primarily in the U.S., due to the COVID-19 pandemic and declines in plasma liquid solutions as a result of certain strategic exits within our liquid solutions business. Additionally, declines in software revenue due to a one time favorable impact in the prior year period also contributed to the decrease during the nine months ended December 26, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we experienced growth rate improvements during the three months ended December 26, 2020 compared with the second quarter of fiscal 2021, the timing of plasma collection recovery remains uncertain and we anticipate a continued negative impact from COVID-19 on our fiscal 2021 Plasma results. We continue to view the impacts of the pandemic on plasma collection as temporary and remain confident in the strength of the plasma end market growth as the long-term global demand for plasma-derived pharmaceuticals is expected to continue.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Blood Center</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blood Center revenue decreased 3.0% and 3.1% during the three and nine months ended December 26, 2020, respectively, as compared with the same periods of fiscal 2020. Without the effect of foreign exchange, Blood Center revenue decreased 5.7% and 5.1% during the three and nine months ended December 26, 2020, respectively, as compared with the same periods of fiscal 2020. These decreases were primarily driven by continued declines in whole blood disposables and the divestiture of certain blood donor management software solution assets, partially offset by increases in apheresis revenue, including distributor stocking orders in the first quarter of fiscal 2021, despite certain customers conversions to alternative sources of supply. The expected impact of the loss of this apheresis business is an incremental revenue decline of approximately $17.0 million in fiscal 2021 as compared with fiscal 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we have not yet experienced the reversal of the large stocking orders made by distributors and blood collectors during the first quarter of fiscal 2021 in response to the COVID-19 pandemic, we may experience a partial reversal in future periods.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hospital</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hospital revenue increased 4.7% and 0.5% during the three and nine months ended December 26, 2020, respectively, as compared with the same periods of fiscal 2020. Without the effect of foreign exchange, Hospital revenue increased 3.1% and 0.9% during the three and nine months ended December 26, 2020, respectively, as compared with the same periods of fiscal 2020. The increase during the three and nine months ended December 26, 2020 was primarily due to an increase in TEG disposables revenue in the U.S. and equipment sales in Europe. These increases were partially offset by declines in Cell Salvage revenue. The divestiture of certain blood bank and hospital software solution assets also contributed to the decline during the three months ended December 26, 2020. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended December 26, 2020, revenue in the Hospital business unit was negatively impacted by COVID-19. We experienced these declines primarily in China and the U.S. However, we had consistent improvement in the second and third quarters of fiscal 2021 in both markets as restrictions in China eased and hospitals in the U.S. experienced an increase in procedure volume. We believe that the demand for our hospital products is inherently strong and that procedure volumes will continue to improve with a return to normal levels in future periods.</span></div><div><span><br/></span></div><div id="ib1e23e354c9c424096b27d04c70f5a5a_100"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Gross Profit</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.209%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.581%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Increase/<br/>(Decrease)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Increase/<br/>(Decrease)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,257&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,050&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316,031&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">370,956&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% of net revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit decreased 6.1% and 14.8% during the three and nine months ended December 26, 2020, respectively, as compared with the same periods of fiscal 2020. Without the effect of foreign exchange, gross profit decreased 8.4% and 15.6% during the three and nine months ended December 26, 2020, respectively, as compared with the same periods of fiscal 2020. The decrease in gross profit margin during the three and nine months ended December 26, 2020 was primarily driven by decreased volumes, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">unfavorable product mix, higher operational costs and the impact of the COVID-19 pandemic and recent divestitures. The decline was partially offset by productivity savings from the 2020 Program and lower depreciation expense.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Expenses</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.209%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.581%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Increase/<br/>(Decrease)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Increase/<br/>(Decrease)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,501&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,014&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,909&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% of net revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,446&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,267&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214,680&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229,189&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% of net revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,876&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,028&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,597&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% of net revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gains on divestitures and sale of assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,115)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/m</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32,613)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,083)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/m</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% of net revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,832&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205,109&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293,612&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% of net revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses increased 7.2% and 0.5% during the three and nine months ended December 26, 2020, respectively, as compared with the same periods of fiscal 2020. Without the effect of foreign exchange, research and development expenses increased 6.9% and 0.6% during the three and nine months ended December 26, 2020, respectively, as compared with the same periods of fiscal 2020. The increase during the three and nine months ended December 26, 2020 was due to continued investments, primarily in our Hospital Business unit as well as increased spend related to a recent acquisition. The increases were partially offset by cost savings primarily related to the 2020 Program.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, General and Administrative</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses decreased 6.2% and 6.3% during the three and nine months ended December 26, 2020, respectively, as compared with the same periods of fiscal 2020. Without the effect of foreign exchange, selling, general, and administrative expenses decreased 7.3% and 6.5% during the three and nine months ended December 26, 2020, respectively, as compared with the same periods of fiscal 2020. These decreases were due to cost containment actions taken to offset the negative effects related to the COVID-19 pandemic, a reduction in variable compensation and incremental productivity savings from the 2020 Program. These decreases were partially offset by continued investments and higher transaction costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impairment of assets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognized impairment charges of $1.0 million during the nine months ended December 26, 2020 in connection with the sale of our Fajardo, Puerto Rico, manufacturing operations. There were no impairments recognized during the three months ended December 26, 2020.  During the nine months ended December 28, 2019 we recognized  $50.6 million of impairment charges primarily in connection with the sale of our Union, South Carolina facility. During the three months ended December 28, 2019, we recognized an additional $1.9 million of other asset impairments.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gains on divestitures</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognized gains on divestitures of $1.1 million and $32.6 million, respectively, during the three and nine months ended December 26, 2020. Refer to Note 5, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Divestitures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to the Unaudited Condensed Consolidated Financial Statements in this Quarterly Report on Form 10-Q for additional information pertaining to these divestitures. We recognized gains on sale of assets of $8.1 million during the nine months ended December 28, 2019 due to the sale of assets associated with our Braintree corporate headquarters. There were no gains on sale of assets during the three months ended December 28, 2019.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest and Other Expense, Net</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense from our $350.0 million term loan and $350.0 million revolving loan constitutes the majority of our interest and other expenses. During the three and nine months ended December 26, 2020, our interest expense associated with this debt declined by $1.6 million and $4.8 million, respectively, despite higher loan balances in the current year period due to a decrease in the effective interest rate. The effective interest rate on total debt outstanding as of December&#160;26, 2020 was 1.4%.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conduct business globally and report our results of operations in a number of foreign jurisdictions in addition to the United States. Our reported tax rate is impacted by the jurisdictional mix of earnings in any given period as the foreign jurisdictions in which we operate have tax rates that differ from the U.S. statutory tax rate.  &#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended December 26, 2020, we reported income tax expense of $5.5 million and $9.8 million, respectively, representing effective tax rates of 14.7% and 9.8%, respectively. The effective tax rate for the three and nine months ended December 26, 2020 includes discrete tax benefits recognized from excess stock compensation deductions of $1.0 million and $5.1 million, respectively. The effective tax rates were also impacted by the jurisdictional mix of earnings including divestiture transactions. During the three and nine months ended December 26, 2020, we sold our Fajardo, Puerto Rico manufacturing operations, certain U.S. blood donor management software solution assets, and our wholly-owned subsidiary Inlog Holdings France SAS. The tax expense on divestitures, including the associated valuation allowance impacts, were included in the computation of the annual effective tax rate. Refer to Note 5, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Divestitures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to the Unaudited Condensed Consolidated Financial Statements in this Quarterly Report on Form 10-Q for information pertaining to these divestitures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended December 28, 2019, we reported an income tax provision of $7.9 million and $6.3 million, respectively, representing effective tax rates of 21.0% and 9.6%, respectively. The effective tax rate for the three and nine months ended December 28, 2019 was lower than the U.S. statutory tax rate primarily due to a discrete tax benefit recognized from excess stock compensation deductions of $3.1 million and $12.4 million, respectively. The effective tax rates were also impacted by the jurisdictional mix of earnings and the impact of the divestiture of the Union, South Carolina facility in the first quarter of fiscal 2020.</span></div><div><span><br/></span></div><div id="ib1e23e354c9c424096b27d04c70f5a5a_103"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table contains certain key performance indicators we believe depict our liquidity and cash flow position:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:68.944%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.143%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.145%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash &amp; cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189,002&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,311&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Working capital</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473,964&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328,817&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current ratio</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(120,774)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(245,182)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Days sales outstanding (DSO)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory turnover</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net debt position is the sum of cash and cash equivalents less total debt.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2019, our Board of Directors approved the 2020 Program. We estimate that we will incur aggregate charges between $60 million and $70 million in connection with the 2020 Program. These charges, the majority of which will result in cash outlays, including severance and other employee costs, will be incurred as the specific actions required to execute these initiatives are identified and approved and are expected to be substantially completed by the end of fiscal 2023. During the three and nine months ended December 26, 2020, we incurred $3.1 million and $11.1 million, respectively, of restructuring and turnaround costs under this program. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary sources of liquidity are cash and cash equivalents, internally generated cash flow from operations, our revolving credit line and proceeds from employee stock option exercises. We believe these sources are sufficient to fund our cash requirements over at least the next twelve months. Our expected cash outlays relate primarily to acquisitions, investments, capital expenditures, including production of the NexSys PCS and the build out of our new manufacturing facility in Clinton, PA, cash payments under the loan agreement and restructuring and turnaround initiatives.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;26, 2020, we had $189.0 million in cash and cash equivalents, the majority of which is held in the U.S. or in countries from which it can be repatriated to the U.S. On June 15, 2018, we entered into a five-year credit agreement which provided for a $350.0 million term loan and a $350.0 million revolving loan (together with the term loan, the &#8220;Credit Facilities&#8221;). Interest on the term loan and revolving loan is established using LIBOR plus 1.13% - 1.75%, depending on our leverage ratio. Under the Credit Facilities, we are required to maintain certain leverage and interest coverage ratios specified in the credit agreement as well as other customary non-financial affirmative and negative covenants. At December&#160;26, 2020, $310.6 million was outstanding under the term loan with an effective interest rate of 1.4%. There were no borrowings outstanding on the revolving loan. We also had $26.2 million of uncommitted operating lines of credit to fund our global operations under which there were no outstanding borrowings as of December&#160;26, 2020. We expect to finance the Cardiva acquisition through a combination of cash on hand, revolving credit facility and an additional $150.0 million term loan under our existing credit facility. The transaction is expected to close in the fourth quarter of fiscal 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have scheduled principal payments of $8.7 million required during the remainder of fiscal 2021. We were in compliance with the leverage and interest coverage ratios specified in the credit agreement as well as all other bank covenants as of December&#160;26, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to manage the ongoing impacts of the COVID-19 pandemic. While the duration and impacts of the pandemic remain uncertain, we have been successful in preserving cash by implementing a number of actions including restricting travel, reducing certain compensation-related items and non-essential spending and delaying hiring. Our capital allocation strategy continues to prioritize organic investments followed by inorganic opportunities and share repurchases. Our commitment to our shareholders will continue to be an important element of our capital allocation strategy, however, our priority will be focused on providing the appropriate levels of funding across our organization and ensuring that we are well positioned to address any challenges that may arise over the course of the pandemic.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2019, our Board of Directors authorized the repurchase of up to $500.0 million of Haemonetics common shares over the next two years. As of December&#160;26, 2020, the total remaining authorization for repurchases of the Company's common stock under the share repurchase program was $325.0 million. We do not expect to make additional share repurchases prior to the expiration of the share repurchase program in May 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Flows</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:53.966%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.143%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.143%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.146%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Increase/<br/>(Decrease)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating activities</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,258&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,811&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,553)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,658&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,041)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,699&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing activities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65,307)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142,580)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,273&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash and cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,082&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(124)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in cash and cash equivalents</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,691&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42,934)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The balance sheet is affected by spot exchange rates used to translate local currency amounts into U.S. Dollars. In accordance with U.S. GAAP, we have removed the effect of foreign currency throughout our cash flow statement, except for its effect on our cash and cash equivalents.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by operating activities decreased by $4.6 million during the nine months ended December 26, 2020, as compared with the nine months ended December 28, 2019. The decrease in cash provided by operating activities was primarily the result of a reduction in net income, as adjusted for depreciation, amortization and other non-cash charges compared with the prior year period. A decrease in working capital as compared with the prior year period due to lower inventory growth, primarily related to NexSys PCS devices, a decline in the build of accounts receivable due to lower sales and improved collection timing, and a large payment to a key service provider in the prior year period, partially offset this decrease.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by investing activities increased by $15.7 million during the nine months ended December 26, 2020, as compared with the nine months ended December 28, 2019. The&#160;increase in cash provided by investing activities was primarily the result of cash received from divestitures. This was partially offset by the cash paid for an acquisition during fiscal 2021 and proceeds received related to the divestiture of our plasma liquid solutions operations and Braintree headquarter facility in the prior year period, as well as a reduction in capital expenditures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in financing activities decreased by $77.3 million during the nine months ended December 26, 2020, as compared with the nine months ended December 28, 2019, primarily due to a decrease in share repurchases compared with the prior year period, partially offset by a reduction in borrowings on our revolving credit facility, net of payments, during fiscal 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentration of Credit Risk</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Concentrations of credit risk with respect to trade accounts receivable are generally limited due to our large number of customers and their diversity across many geographic areas. Certain markets and industries, however, can expose us to concentrations of credit risk. For example, in the Plasma business unit, sales are concentrated with several large customers. As a result, accounts receivable extended to any one of these biopharmaceutical customers can be significant at any point in time. In addition, a portion of our trade accounts receivable outside the U.S. include sales to government-owned or supported healthcare systems in several countries, which are subject to payment delays and local economic conditions. Payment is dependent upon the financial stability and creditworthiness of those countries' national economies. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have not incurred significant losses on receivables. We continually evaluate all receivables for potential collection risks associated with the availability of government funding and reimbursement practices. If the financial condition of customers or the countries' healthcare systems deteriorate such that their ability to make payments is uncertain, allowances may be required in future periods.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inflation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not believe that inflation had a significant impact on our results of operations for the periods presented. Historically, we believe we have been able to mitigate the effects of inflation by improving our manufacturing and purchasing efficiencies, by increasing employee productivity and by adjusting the selling prices of products. We continue to monitor inflation pressures generally and raw materials indices that may affect our procurement and production costs. Increases in the price of petroleum derivatives could result in corresponding increases in our costs to procure plastic raw materials.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Exchange</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and nine months ended December 26, 2020, 38.6% and 40.7%, respectively, of our sales were generated outside the U.S., generally in foreign currencies, yet our reporting currency is the U.S. Dollar. We also incur certain manufacturing, marketing and selling costs in international markets in local currency. Our primary foreign currency exposures relate to sales denominated in Euro, Japanese Yen, Chinese Yuan and Australian Dollars. We also have foreign currency exposure related to manufacturing and other operational costs denominated in Swiss Francs, Canadian Dollars, Mexican Pesos and Malaysian Ringgit. The Yen, Euro, Yuan and Australian Dollar sales exposure is partially mitigated by costs and expenses for foreign operations and sourcing products denominated in foreign currencies.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since our foreign currency denominated Yen, Euro, Yuan and Australian Dollar sales exceed the foreign currency denominated costs, whenever the U.S. Dollar strengthens relative to the Yen, Euro, Yuan or Australian Dollar, there is an adverse effect on our results of operations and, conversely, whenever the U.S. Dollar weakens relative to the Yen, Euro, Yuan or Australian Dollar, there is a positive effect on our results of operations. For Swiss Francs, Canadian Dollars Mexican Pesos and Malaysian Ringgit our primary cash flows relate to product costs or costs and expenses of local operations. Whenever the U.S. Dollar strengthens relative to these foreign currencies, there is a positive effect on our results of operations. Conversely, whenever the U.S. Dollar weakens relative to these currencies, there is an adverse effect on our results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a program in place that is designed to mitigate our exposure to changes in foreign currency exchange rates. That program includes the use of derivative financial instruments to minimize, for a period of time, the unforeseen impact on our financial results from changes in foreign exchange rates. We utilize forward foreign currency contracts to hedge the anticipated cash flows from transactions denominated in foreign currencies, primarily Japanese Yen and Euro, and to a lesser extent Swiss Francs, Australian Dollars, Canadian Dollars and Mexican Pesos. This does not eliminate the volatility of foreign exchange rates, but because we generally enter into forward contracts one year out, rates are fixed for a one-year period, thereby facilitating financial planning and resource allocation. These contracts are designated as cash flow hedges. The final impact of </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">currency fluctuations on the results of operations is dependent on the local currency amounts hedged and the actual local currency results.</span></div><div><span><br/></span></div><div id="ib1e23e354c9c424096b27d04c70f5a5a_106"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Standards to be Implemented</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020,the Securities and Exchange Commission (&#8220;SEC&#8221;) issued a final rule that amends the financial statement requirements for acquisitions and dispositions of businesses. The amendments primarily relate to disclosures required by&#160;Rule 3-05 and Article 11&#160;of Regulation S-X and modifies the tests provided in Rule 1-02(w) of Regulation S-X used to determine whether a subsidiary or an acquired or disposed business is significant and modifies the number of years of audited financial statements required for acquisitions with significance levels greater than specified percentages. The amendments are effective for annual periods beginning after January 1, 2021 but early adoption is permitted. We plan to early adopt the amendments during the fourth quarter of fiscal 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASC Update No. 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The new guidance will improve consistent application of and simplify the accounting for income taxes by removing certain exceptions to the general principals in Topic 740. ASC Update No. 2019-12 is effective for annual periods beginning after December 15, 2020, and is applicable to us in fiscal 2022. We are in the process of determining the effect that the adoption will have on our financial position and results of operations.</span></div><div><span><br/></span></div><div id="ib1e23e354c9c424096b27d04c70f5a5a_109"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cautionary Statement Regarding Forward-Looking Information</span></div><div><span><br/></span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain statements that we make from time to time, including statements contained in this Quarterly Report on Form 10-Q and incorporated by reference into this report, constitute &#8220;forward looking-statements&#8221; within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.&#160;Forward-looking statements do not relate strictly to historical or current facts and reflect management&#8217;s assumptions, views, plans, objectives and projections about the future. Forward-looking statements may be identified by the use of words such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;expects,&#8221; &#8220;plans,&#8221; &#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;estimates,&#8221; &#8220;projects,&#8221; &#8220;predicts,&#8221; &#8220;potential&#8221; and other words of similar meaning in conjunction with, among other things: discussions of future operations; expected operating results and financial performance; impacts of the COVID-19 pandemic; the Company&#8217;s strategy for growth; product development, commercialization and anticipated performance and benefits; regulatory approvals; impact of planned acquisitions or dispositions, including the Company's pending acquisition of Cardiva; market position and expenditures.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because forward-looking statements are based on current beliefs, expectations and assumptions regarding future events, they are subject to uncertainties, risks and changes that are difficult to predict and many of which are outside of the Company's control. Investors should realize that if underlying assumptions prove inaccurate, or known or unknown risks or uncertainties materialize, the Company&#8217;s actual results and financial condition could vary materially from expectations and projections expressed or implied in its forward-looking statements. Investors are therefore cautioned not to rely on these forward-looking statements. </span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are some important factors that could cause our actual results to differ from our expectations in any forward-looking statements. For further discussion of these and other factors, see Item 1A. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in our most recent Annual Report on Form 10-K.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The effect of the ongoing COVID-19 pandemic, or outbreaks of communicable diseases, on our business, financial conditions and results of operations, which may be heightened if the pandemic and various government responses to it continue for an extended period of time; </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Failure to achieve our long-term strategic and financial-improvement goals;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Demand for and market acceptance risks for new and existing products, including material reductions in purchasing from or loss of a significant customer; </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Product quality or safety concerns, leading to product recalls, withdrawals, regulatory action by the FDA (or similar non-U.S. regulatory agencies), reputational damage, declining sales or litigation;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Security breaches of our information technology systems or our products, which could impair our ability to conduct business or compromise sensitive information of the Company or its customers, suppliers and other business partners, or of customers' patients;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Pricing pressures resulting from trends toward health care cost containment, including the continued consolidation among health care providers and other market participants; </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The continuity, availability and pricing of plastic and other raw materials, finished goods and components used in the manufacturing of our products (including those purchased from sole-source suppliers) and the related continuity of our manufacturing and distribution;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to develop new products or enhancements on commercially acceptable terms or at all;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to obtain the anticipated benefits of restructuring programs that we have or may undertake, including the Operational Excellence Program; </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The potential that the expected strategic benefits and opportunities from the Company's pending acquisition of Cardiva and any other planned or completed acquisition or divestiture by the Company may not be realized or may take longer to realize than expected;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of enhanced requirements to obtain regulatory approval in the U.S. and around the world, including the EU MDR and the associated timing and cost of product approval, and</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to comply with established and developing U.S. and foreign legal and regulatory requirements, including the U.S. Foreign Corrupt Practices Act, or FCPA, and similar laws in other jurisdictions, as well as U.S. and foreign export and import restrictions and tariffs;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to execute and realize anticipated benefits from our investments in emerging economies;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to retain and attract key personnel;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Costs and risks associated with product liability and other litigation claims;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to meet our debt obligations, including from the increased amount of debt we anticipate incurring to fund our pending acquisition of Cardiva, and raise additional capital when desired on terms reasonably acceptable to us;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The potential effect of foreign currency fluctuations and interest rate fluctuations on our net sales, expenses, and resulting margins;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact of changes in U.S. and international tax laws;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Market conditions impacting our stock price and/or share repurchase program, and the possibility that our share repurchase program may be delayed, suspended or discontinued; and</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to protect intellectual property and the outcome of patent litigation.</span></div><div><span><br/></span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investors should understand that it is not possible to predict or identify all such factors and should not consider the risks described above and in Item 1A. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in our Annual Report on Form 10-K to be a complete statement of all potential risks and uncertainties. The Company does not undertake to publicly update any forward-looking statement that may be made from time to time, whether as a result of new information or future events or developments.</span></div><div style="margin-bottom:8pt"><span><br/></span></div><div id="ib1e23e354c9c424096b27d04c70f5a5a_112"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our exposure relative to market risk is due to foreign exchange risk and interest rate risk.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Exchange Risk</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See the section above entitled Foreign Exchange for a discussion of how foreign currency affects our business. It is our policy to minimize, for a period of time, the unforeseen impact on our financial results of fluctuations in foreign exchange rates by using derivative financial instruments known as forward contracts to hedge anticipated cash flows from forecasted foreign currency denominated sales and costs. We do not use the financial instruments for speculative or trading activities. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate the change in the fair value of all forward contracts assuming both a 10% strengthening and weakening of the U.S. Dollar relative to all other major currencies. In the event of a 10% strengthening of the U.S. Dollar, the change in fair value of all forward contracts would result in a $12.0 million increase in the fair value of the forward contracts; whereas a 10% weakening of the U.S. Dollar would result in a $13.7 million decrease of the fair value of the forward contracts.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our exposure to changes in interest rates is associated with borrowings under our Credit Facilities, all of which is variable rate debt. Total outstanding debt under our Credit Facilities as of December&#160;26, 2020 was $310.6 million with an interest rate of 1.4% based on prevailing LIBOR rates. An increase of 100 basis points in LIBOR rates would result in additional annual interest expense of $0.8 million. On August 21, 2018, we entered into two interest rate swap agreements to effectively convert $241.9 million of borrowings under our Credit Facilities from a variable rate to a fixed rate. These interest rate swaps are intended to mitigate the exposure to fluctuations in interest rates and qualify for hedge accounting treatment as cash flow hedges.</span></div><div><span><br/></span></div><div id="ib1e23e354c9c424096b27d04c70f5a5a_115"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONTROLS AND PROCEDURES</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted an evaluation, as of December&#160;26, 2020, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer (our principal executive officer and principal financial officer, respectively) regarding the effectiveness of the design and operation of our disclosure controls and procedures as defined in Rule 13a-15 of the Exchange Act. Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures are effective as of December&#160;26, 2020. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Changes in Internal Control Over Financial Reporting</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting during the&#160;three and nine months ended December 26, 2020&#160;that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><div id="ib1e23e354c9c424096b27d04c70f5a5a_118"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II &#8212; OTHER INFORMATION</span></div><div style="margin-top:6pt"><span><br/></span></div><div id="ib1e23e354c9c424096b27d04c70f5a5a_121"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1. Legal Proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information with respect to this Item may be found in Note 13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the Unaudited Condensed Consolidated Financial Statements in this Quarterly Report on Form 10-Q, which is incorporated herein by reference.  </span></div><div><span><br/></span></div><div id="ib1e23e354c9c424096b27d04c70f5a5a_124"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1A. Risk Factors</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no material changes from the Risk Factors previously disclosed in our Annual Report on Form 10-K for the fiscal year ended March&#160;28, 2020.</span></div><div><span><br/></span></div><div id="ib1e23e354c9c424096b27d04c70f5a5a_127"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2. Issuer Purchases of Equity Securities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2019, our Board of Directors authorized the repurchase of up to $500 million of Haemonetics common shares over the next two years. We had no share repurchases during the nine months ended December 26, 2020. The total remaining authorization for repurchases of our common stock under the share repurchase program was $325 million as of December&#160;26, 2020. We do not expect to make additional share repurchases prior to the expiration of the share repurchase program in May 2021.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><div id="ib1e23e354c9c424096b27d04c70f5a5a_130"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;3. Defaults Upon Senior Securities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div><span><br/></span></div><div id="ib1e23e354c9c424096b27d04c70f5a5a_133"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;4. Mine Safety Disclosures</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div><span><br/></span></div><div id="ib1e23e354c9c424096b27d04c70f5a5a_136"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;5. Other Information</span></div><div><span><br/></span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><div id="ib1e23e354c9c424096b27d04c70f5a5a_139"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Item&#160;6. Exhibits</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.029%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/313143/000031314319000035/exhibit31-restatedarticles.htm">3.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restated Articles of Organization of Haemonetics Corporation, reflecting Articles of Amendment dated August 23, 1993, August 21, 2006, July 26, 2018 and July 25, 2019 (filed as Exhibit 3.1 to the Company&#8217;s Form 8-K dated July 29, 2019 and incorporated herein by reference).</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/313143/000031314320000052/by-lawsasamended62920.htm">3.2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By-Laws of the Company, as amended through June 29, 2020 (filed as Exhibit 3.1 to the Company&#8217;s Form 8-K dated June 30, 2020 and incorporated herein by reference).</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex101-firstamendmenttoclin.htm">10.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Amendment to Industrial Lease Agreement, dated as of October 1, 2020, by and between Clinton Commerce III, LLC and the Company.</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex102-12thamendmenttoleets.htm">10.2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Twelfth Amendment to Agreement of Lease, dated as of May 22, 2020, by and between The Buncher Company and the Company.*</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex103-13thamendmenttoleets.htm">10.3</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thirteenth Amendment to Agreement of Lease, dated as of December 21, 2020, by and between The Buncher Company and the Company.*</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex104-agreementandplanofme.htm">10.4</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Agreement and Plan of Merger, dated as of January 17, 2021, by and among the Company, Concordia Merger Sub, Inc., Cardiva Medical, Inc. and Fortis Advisors LLC, as the Seller Representative.*</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="haeq3dec2021ex311.htm">31.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification pursuant to Section&#160;302 of Sarbanes-Oxley Act of 2002, of Christopher A. Simon, President and Chief Executive Officer of the Company.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="haeq3dec2021ex312.htm">31.2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification pursuant to Section&#160;302 of Sarbanes-Oxley of 2002, of William Burke, Executive Vice President, Chief Financial Officer of the Company.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="haeq3dec2021ex321.htm">32.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification Pursuant to 18 United States Code Section&#160;1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, of Christopher A. Simon, President and Chief Executive Officer of the Company.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="haeq3dec2021ex322.htm">32.2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification Pursuant to 18 United States Code Section&#160;1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, of William Burke, Executive Vice President, Chief Financial Officer of the Company.</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101**</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following materials from Haemonetics Corporation on Form&#160;10-Q for the quarter ended December 26, 2020, formatted in inline Extensible Business Reporting Language (XBRL) includes: (i)&#160;Condensed Consolidated Statements of Income and Comprehensive Income, (ii)&#160;Condensed Consolidated Balance Sheets, (iii)&#160;Condensed Consolidated Statements of Cash Flows, and (iv)&#160;Notes to Condensed Consolidated Financial Statements.</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document and contained in Exhibit 101).</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________________________</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">                                                                                                                                                   </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:3.738%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.329%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Certain portions of this exhibit are considered confidential and have been omitted as permitted under SEC rules and regulations.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In accordance with Rule&#160;406T of Regulation&#160;S-T, the XBRL-related information in Exhibit&#160;101 to this Form 10-Q is deemed not filed or part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act, is deemed not filed for the purposes of section 18 of the Exchange Act, and otherwise is not subject to liability under these sections.</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><div id="ib1e23e354c9c424096b27d04c70f5a5a_142"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:35.649%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.024%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.213%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.714%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HAEMONETICS CORPORATION</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Christopher A. Simon &#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Christopher A. Simon,<br/>President and Chief Executive Officer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ William Burke</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">William Burke, Executive Vice President, Chief Financial Officer</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:8pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ex101-firstamendmenttoclin.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="iba38b41f78f641e6b771048ff2a19fbe_1"></div><div style="min-height:64.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:139%">Exhibit 10.1</font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">FIRST AMENDMENT TO LEASE AGREEMENT</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">THIS FIRST AMENDMENT TO LEASE AGREEMENT (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) is entered into this 1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> day of October, 2020, by and between CLINTON COMMERCE III, LLC, a Pennsylvania limited liability company (&#34;Landlord&#34;), and HAEMONETICS CORPORATION, a Massachusetts corporation (&#34;Tenant&#34;).</font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WITNESSETH&#58;</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, Landlord and Tenant entered into that certain Industrial Lease Agreement dated as of May 22, 2020 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Lease</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) relating to approximately 202,817 rentable square feet in an industrial building commonly known as Building III of Clinton Commerce Park, with an address of 1300 Clifford Ball Drive, Clinton, PA 15026 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Building</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;)&#59;</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, Landlord has requested and the Tenant has agreed to amend and modify the Lease in conjunction with a pending sale of the Building and the property on which the Building is located to STAG as set forth herein&#59;</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, Landlord and Tenant hereby agree that this Amendment is contingent upon Landlord closing on the sale of the Building to STAG (as defined below), or its successors or assigns on or before November 30, 2020. If the sale to STAG does not occur on or before November 30, 2020, then this First Amendment shall be of no force or effect.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">NOW, THEREFORE, in consideration of the mutual covenants contained herein, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereby agree as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt;text-decoration:underline">Amendment to Section 1.01(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Section 1.01(j) of the Lease is hereby deleted in its entirety.</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt;text-decoration:underline">Amendment to Section 2.02(d). Section 2.02(d) of the Lease is hereby deleted in its entirety</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9pt;text-decoration:underline">Amendment to Section 2.02(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Each of the first two paragraphs of Section 2.02(c) of the Lease is hereby deleted in its entirety. The third paragraph of Section 2.02(c) is hereby amended as follows&#58;</font></div><div style="margin-bottom:9pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Upon completion of the Tenant Improvements, Tenant, at its sole cost and expense, will provide Landlord and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">STAG INDUSTRIAL HOLDINGS, LLC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, a Delaware limited liability company (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">STAG</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), anticipated successor in interest to Landlord, whose address is&#160;&#160;&#160;&#160;c&#47;o STAG Industrial Management, LLC One Federal Street, 23rd Floor, Boston, Massachusetts, 02110, Attention&#58; Seth A. Malamut, Esq., Associate General Counsel, and whose email address is smalamut&#64;stagindustrial.com, with (i) a complete list of all subcontractors, vendors and&#47;or material suppliers contracted for the Tenant Improvements, (ii) final lien waivers from all such  subcontractors, vendors or materials suppliers whose contract amount exceeds $25,000.00 and who has a right to file a mechanic&#8217;s lien against the Premises, (iii) as-built drawings documenting the Tenant Improvements, and (iii) a copy of the certificate of </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">-1-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:64.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">occupancy (or other certificates acceptable to STAG evidencing inspection and acceptance of the Tenant Improvements by appropriate government authorities).&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Amendment to Section 6.02(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Section 6.02(a) of the Lease is hereby deleted in its entirety and replaced with the following&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;If Tenant desires utilities or building services in addition to those identified above, then Landlord shall cooperate with Tenant&#8217;s efforts to obtain such additional utilities or services. In the event Landlord is able to and does furnish such additional utilities or services the costs thereof (which shall be deemed to mean the cost that Tenant would have incurred had Tenant contracted directly with the utility company or service provider) shall be borne by Tenant, who shall reimburse Landlord monthly for the same as Additional Rent. Landlord acknowledges that the Tenant intends to upgrade the electric capacity to the Premises from 1200 amp service to 3000 amp service, which shall be done at Tenant&#8217;s cost.&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Amendment to Section 11.01(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Section 11.01(c) of the Lease is hereby deleted in its entirety and replaced with the following&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;If Tenant shall make any assignment or sublease, with Landlord's consent, for a rental in excess of the rent payable under this Lease and any sublease costs incurred by Tenant including tenant improvement allowances and brokerage commissions , Tenant shall pay to Landlord fifty percent (50%) of any such excess rental upon receipt.&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Amendment to Section 13.02(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Section 13.02(d) of the Lease is hereby deleted in its entirety and replaced with the following&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Landlord may terminate this Lease and recover from Tenant the costs set forth in (a) above and an amount equal to (i) the present value of the excess, if any, discounted at the Prime Rate, of (A) the Minimum Annual Rent, Additional Rent and all other sums that would have been payable hereunder by Tenant for the Remaining Term, less (B) the aggregate reasonable rental value of the Premises for the Remaining Term, as determined by two real estate brokers licensed in the State of Pennsylvania who has at least ten (10) years of experience&#59; one chosen by the Landlord and one chosen by the Tenant (and a third chosen by the two if the two brokers are unable to reach agreement)&#59; and (ii) Landlord&#8217;s reasonable costs to relet the Premises, including but not limited to removal of Tenant Improvements, removal and&#47;or disposal of Tenant Property, demolition, market rate leasing commissions, and tenant improvements for replacement tenant(s) but specifically excluding any tenant improvements for a replacement tenant in excess of Eight Dollars ($8.00) per square foot&#59; and (iii) the unamortized portion of the first Four Million and 00&#47;100 Dollars ($4,000,000.00) of costs associated with the Tenant Improvements, up to $20 per square foot. The cost of such real estate brokers shall be part of the costs due from the Tenant. Landlord and Tenant acknowledge and agree that the payment of the amount set forth in this clause above shall not be deemed a penalty, but shall merely constitute payment of liquidated damages, it being understood that actual damages to Landlord are  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;-2-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:64.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">extremely difficult, if not impossible, to ascertain. It is expressly agreed and understood that all of Tenant's liabilities and obligations set forth in this subsection (d) shall survive termination of this Lease.&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Amendment to Section 13.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The first paragraph of Section 13.03 of the Lease is hereby deleted in its entirety and replaced with the following&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Landlord shall be in default if it fails to perform any term, condition, covenant or obligation required under this Lease for a period of thirty (30) days after written notice thereof from Tenant to Landlord&#59; provided, however, that if the term, condition, covenant or obligation to be performed by Landlord is such that it cannot reasonably be performed within thirty (30) days, Landlord shall not be in default if Landlord commences such performance within said thirty (30) day period and thereafter diligently undertakes to cure the same. Upon the occurrence of Landlord&#8217;s failure to commence and diligently pursue a cure to Landlord&#8217;s default, Tenant may sue for injunctive relief or to recover damages for any loss directly resulting from such default. The provisions of this Section 13.03 are in addition to the offset rights of Tenant otherwise set forth in this Lease for the failure of the Landlord with respect to its obligations of Maintenance and Repair as set forth herein.&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Amendment to Exhibit A-1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The parties hereto agree that Exhibit A-1 (Property Description) is hereby replaced in its entirety with Exhibit A-1 attached to this Amendment.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Amendments to Exhibit E-1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27.68pt">Section 3(ii) of Exhibit E-1 (Form of Lender SNDA) is hereby amended by deleting the following words therefrom&#58;  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;provided, further, the Lender shall not be subject to any right of offset for funds related to the Tenant Improvement Allowance that were disbursed to the Lessor prior to the Lender&#8217;s receipt of a notice from Tenant of a default by the Lessor which Tenant is required to deliver to the Lender under Section 10 hereof&#59;&#8221;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt">Section 12 of Exhibit E-1 (Form of Lender SNDA) is hereby amended by deleting the following words therefrom&#58;</font></div><div style="margin-bottom:12pt;padding-left:40.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;(except this shall not limit the Tenant&#8217;s right of offset with respect to the Tenant Improvement Allowance)&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Contingency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  In the event Landlord does not close on the sale of the Building to STAG, or its successors or assigns on or before November 30, 2020, this Amendment shall be null and void and of no further force and effect.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Full Force &#38; Effect</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Landlord and Tenant represent to each other that as of the date hereof (i) the Lease is in full force and effect, (ii) there are no existing claims, defenses or offsets </font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;-3-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:64.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">which either party has against the other, and (iii) there exist no current or continuing defaults under the Lease by Landlord or Tenant.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Authority to Execute</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Landlord and Tenant each represent and warrant to the other party that the individual executing this Amendment on its behalf is duly authorized and has legal capacity to execute and deliver this Amendment on behalf of such party. Each party represents and warrants to the other that the execution and delivery of this Amendment and the performance of such party&#8217;s obligations hereunder have been duly authorized and that this Amendment is a valid and legal agreement binding on such party and enforceable in accordance with its terms.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Defined Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. All capitalized terms used but not otherwise defined herein shall have the meaning ascribed thereto in the Lease.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Entirety of Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  To the extent not previously modified or further modified by this First Amendment to Lease, all provisions and terms of the Lease shall remain unchanged and in full force and effect.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">SIGNATURES ON FOLLOWING PAGE</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;-4-</font></div></div></div><div id="iba38b41f78f641e6b771048ff2a19fbe_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, Landlord and Tenant have executed this First Amendment to Lease as of the day and year first above written.</font></div><div><font><br></font></div><div style="margin-bottom:0.12pt;padding-left:220.5pt"><font><br></font></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.310%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.156%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.156%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.171%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.12pt;padding-left:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">LANDLORD&#58; </font></div><div style="padding-left:4.5pt"><font><br></font></div><div style="margin-bottom:0.12pt;text-indent:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">CLINTON COMMERCE  III, LLC</font></div><div style="margin-bottom:0.12pt"><font><br></font></div><div style="margin-bottom:0.12pt;padding-left:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58; Al. Neyer, LLC, its Manager</font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Stephanie P. Gaither</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Printed&#58;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Stephanie P. Gaither</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Executive Vice President &#38; CFO</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">This is an acknowledgment certificate&#59; no oath or affirmation was administered to the signer with regard to this notarial act.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">STATE OF OHIO&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#125;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#125; SS&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">COUNTY OF HAMILTON&#160;&#160;&#160;&#160;&#125;</font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Before me, a Notary Public in and for said County and State, personally appeared Stephanie P. Gaither, by me known and by me known to be the Executive Vice President &#38; CFO of Al. Neyer, LLC, the Manager of Clinton Commerce III, LLC, who acknowledged the execution of the foregoing First Amendment to Lease on behalf of said limited liability companies.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WITNESS my hand and Notarial Seal this 29th day of September, 2020.</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Anne E. Pielage</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notary Public</font></td></tr></table></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">My Commission Expires&#58;&#160;&#160;&#160;&#160;6-15-2025</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">My County of Residence&#58;&#160;&#160;&#160;&#160;Hamilton</font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(SIGNATURES CONTINUED ON THE FOLLOWING PAGE)</font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">-5-</font></div></div></div><div id="iba38b41f78f641e6b771048ff2a19fbe_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.029%"><tr><td style="width:1.0%"></td><td style="width:5.435%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.847%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.741%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.020%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.12pt;text-indent:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">TENANT&#58;</font></div><div style="margin-bottom:0.12pt;text-indent:4.5pt"><font><br></font></div><div style="margin-bottom:0.12pt;text-indent:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">HAEMONETICS CORPORATION</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; William P. Burke</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Printed&#58;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">William P. Burke</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">CFO</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">STATE OF MASSACHUSETTS&#160;&#160;&#160;&#160;)</font></div><div style="padding-left:144pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">) SS&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">COUNTY OF BRISTOL&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;)</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Before me, a Notary Public in and for said County and State, personally appeared William P. Burke, by me known and by me known to be the CFO of Haemonetics Corporation, who acknowledged the execution of the foregoing Office Lease on behalf of said corporation.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WITNESS my hand and Notarial Seal this 1st day of October, 2020.</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.029%"><tr><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Sheryl A. Larkin</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notary Public</font></td></tr></table></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">My Commission Expires&#58; February 5, 2027</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">My County of Residence&#58; Bristol</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">-6-</font></div></div></div><div id="iba38b41f78f641e6b771048ff2a19fbe_10"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT A-1</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">PROPERTY DESCRIPTION (corrected)</font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">All that certain lease parcel, situate in Findlay Township, Allegheny County, Pennsylvania, more particularly bound and described as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Beginning at a point on the cul-de-sac for Clifford Ball Drive, 80.00 feet wide&#59; thence from said point of beginning by a line through lands now or formerly of The County of Allegheny the following N 53&#176; 05&#8217; 20&#8221; W a distance of 699.25 feet to a point on the easterly right of way line of Camp Meeting Road, 33.00 feet wide&#59; thence by the easterly right of way line of Camp Meeting Road in a northwesterly direction by a curve bearing to the left having a radius of 324.50 feet through an arc distance of 70.02 feet to a point of tangency&#59; thence continuing by same N 37&#176; 04&#8217; 05&#8221; W a distance of 44.50 feet to a point&#59; thence by a line through lands now or formerly of The County of Allegheny the following six (6) courses and distances&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">N 36&#176; 58&#8217; 15&#8221; E a distance of 889.20 feet&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">S 53&#176; 01&#8217; 45&#8221; E a distance of 28.54 feet&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">N 36&#176; 58&#8217; 15&#8221; E a distance of 108.42 feet&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">S 53&#176; 01&#8217; 45&#8221; E a distance of 676.00 feet&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">S 36&#176; 58&#8217; 15&#8221; W a distance of 823.23 feet&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">S 06&#176; 44&#8217; 44&#8221; E a distance of 177.19 feet to a point on the northeasterly right of way line of said Clifford Ball Drive&#59;</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">thence in a northwesterly direction by a curve bearing to the left having a radius of 80.00 feet through an arc distance of 91.50 feet, also having a chord bearing of S 50&#176; 29&#8217; 15&#8221; W and a chord distance of 86.60 feet, to a point, at the point of beginning.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Containing an area of 740,988 square feet or 17.011 acres.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">-7-</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>ex102-12thamendmenttoleets.htm
<DESCRIPTION>EX-10.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i072b4c47ffb14923b2acbb0c08e8e470_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:139%">CERTAIN INFORMATION HAS BEEN OMITTED FROM THIS DOCUMENT BECAUSE IT IS (I) NOT MATERIAL, AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. OMISSIONS ARE MARKED &#91;***&#93;.</font></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:139%">Exhibit 10.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">TWELFTH AMENDMENT TO AGREEMENT OF LEASE </font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">DATED THIS 22</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">nd</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> DAY OF MAY, 2020</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">BY AND BETWEEN </font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;THE BUNCHER COMPANY, as Landlord, a Pennsylvania corporation having its principal office in the City of Pittsburgh, Allegheny County, Pennsylvania,</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">AND</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;HAEMONETICS CORPORATION, as Tenant, a Massachusetts corporation having its principal place of business in the City of Boston, Suffolk County, Massachusetts.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;WHEREAS, the parties hereto have entered into that certain Agreement of Lease dated July 17, 1990&#59; as amended by First Amendment to Agreement of Lease dated April 30, 1991&#59; by Second Amendment to Agreement of Lease dated October 18, 2000&#59; by Third Amendment to Agreement of Lease dated March 23, 2004&#59; by Fourth Amendment to Agreement of Lease dated March 12, 2008&#59; by Fifth Amendment to Agreement of Lease dated October 1, 2008&#59; by Sixth Amendment to Agreement of Lease made as of January 8, 2010&#59; by Seventh Amendment to Agreement of Lease made as of March 31, 2011&#59; by letter agreement dated January 27, 2012&#59; along with the renewal letter dated June 8, 2010, exercising the renewal option for the Fourth Renewal Term pursuant to paragraph 3 of the Sixth Amendment to Agreement of Lease&#59; by Eighth Amendment to Agreement of Lease dated February 26, 2013&#59; by Ninth Amendment to Agreement of Lease dated March 12, 2014&#59; by Tenth Amendment to Agreement of Lease dated as of May 31, 2017&#59; and by Eleventh Amendment to Agreement of Lease dated as of March 2, 2018 (hereinafter collectively the &#8220;Lease&#8221;)&#59;</font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;WHEREAS, the &#8220;Leased Premises&#8221; covered by the Lease is 89,177 agreed-upon rentable square feet of space in Buncher Commerce Park, Leetsdale Borough, Allegheny County, Pennsylvania, which is allocated as follows&#58; (a) 81,929 agreed-upon rentable square feet of space in Buildings 18 and 18A&#59; (b) 5,672 agreed-upon rentable square feet of space in the Parking Area&#59; (c) 809 agreed-upon rentable square feet of space in the Building 18 Expansion Space&#59; and (d) 767 agreed-upon rentable square feet of space in the Building 18 Second Expansion Space&#59; </font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;WHEREAS, all terms defined in the Lease and used therein shall have the same meaning herein as in the Lease unless otherwise provided herein&#59; and </font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;WHEREAS, the parties hereto desire to amend the Lease to (i) extend the term of the Lease for six (6) additional months (the &#8220;Fourth Extended Term&#8221;)&#59; (ii) restate the monthly rental for the Leased Premises during the Third Extended Term and to establish the monthly rental during the Fourth Extended Term&#59; and (iii) amend existing Lease </font></div><div style="height:22.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">provisions and to incorporate additional provisions into the Lease to reflect the intentions of the parties.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;NOW, THEREFORE, in consideration of the premises and intending to be legally bound, the parties hereto promise, covenant and agree that the Lease be and is hereby amended as follows&#58; </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;TERM&#58;  The Lease and the term thereof are hereby extended for the Fourth Extended Term to commence immediately following the expiration of the Third Extended Term of the Lease, i.e. July 1, 2021.  The expiration date of the term of the Lease, as extended by the Fourth Extended Term, is hereby changed from June 30, 2021, to December 31, 2021.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;2.&#160;&#160;&#160;&#160;RENT&#58;  Tenant shall pay to Landlord as rental for the Leased Premises the following amounts at the following times&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A.  &#160;&#160;&#160;&#160;Tenant shall continue to pay to Landlord on the first (1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) day of each calendar month during the balance of the Third Extended Term of the Lease until and including June 1, 2021, the amount of $</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#91;***&#93;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> as monthly rental for the Building 18, Building 18A, and the Parking Area portions of the Leased Premises.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">B. &#160;&#160;&#160;&#160;Tenant shall continue to pay to Landlord on the first (1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) day of each calendar month during the balance of the Third Extended Term of the Lease until and including June 1, 2021 as monthly rental for the Building 18 Expansion Space and the Building 18 Second Expansion Space portions of the Leased Premises the amount of $</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#91;***&#93;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, and on July 1, 2021 and continuing on the first (1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) day of each succeeding calendar month during the Fourth Extended Term of the Lease, Tenant shall pay to Landlord as monthly rental for the Building 18 Expansion Space and the Building 18 Second Expansion Space portions of the Leased Premises the amount of $</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#91;***&#93;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">C.&#160;&#160;&#160;&#160;Beginning on July 1, 2021 and continuing on the first (1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) day of each succeeding calendar month thereafter during the Fourth Extended Term of the Lease, Tenant shall pay to Landlord as monthly rental for the Building 18, Building 18A, and the Parking Area portions of the Leased Premises the amount of $</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#91;***&#93;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The monthly rentals as set forth herein shall be payable in advance, without demand, deduction or set off.  All rentals and other amounts payable under the Lease shall be paid to The Buncher Company at P. O. Box 768, Pittsburgh, Pennsylvania 15230-0768 or at such other place or to such other party as may be designated by Landlord in writing.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;If any installment of monthly rental or additional rental becomes overdue for a period in excess of ten (10) business days, Tenant shall pay interest at a monthly rate equal to one percent (1%) accruing from the due date to the date of payment thereof.  Such interest shall constitute additional rental due and payable to Landlord by Tenant.  The interest charge will be in addition to, and not in lieu of, any other remedy Landlord </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:22.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">may have under the Lease.  If there are accrued and unpaid rental amounts, all payments of monthly rental and additional rental shall be applied in such order as Landlord shall determine.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;3.&#160;&#160;&#160;&#160;RENEWAL OPTION&#58;  Effective on the date hereof, paragraph 4 (Renewal Option) of the Eleventh Amendment to Agreement of Lease dated as of March 2, 2018 (the &#8220;Eleventh Amendment&#8221;) is hereby deleted and is of no further force and effect.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;4.&#160;&#160;&#160;&#160;ADDITIONAL TENANT IMPROVEMENT ALLOWANCE&#58; Landlord and Tenant acknowledge and agree that, as of the date of this Twelfth Amendment to Agreement of Lease, the remaining balance of the Additional Tenant Improvement Allowance (as described in paragraph 5 (Tenant Improvement Allowance) of the Eleventh Amendment) that can be applied to the Additional Tenant&#8217;s Work (as defined in the Eleventh Amendment) is $</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#91;***&#93;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The third grammatical sentence of paragraph 5 (Tenant Improvement Allowance) of the Eleventh Amendment is hereby amended to read as follows&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#8220;Any unused amount of the Additional Tenant Improvement Allowance shall be credited against rental in reverse order beginning with the last month of the Fourth Extended Term&#8221;.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Additionally, all language following the third grammatical sentence of said paragraph 5, as amended hereby, is hereby deleted in its entirety and is of no further force and effect.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;5.&#160;&#160;&#160;&#160;CONFESSION OF JUDGMENT&#58;&#160;&#160;&#160;&#160;Tenant hereby restates and ratifies section 17 (Confession of Judgment) of the Agreement of Lease dated July 17, 1990&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;THE FOLLOWING PARAGRAPHS SET FORTH WARRANTS OR AUTHORITY FOR AN ATTORNEY TO CONFESS JUDGMENT AGAINST TENANT IN THE EVENT OF A DEFAULT BY TENANT AS DESCRIBED BELOW. IN GRANTING THESE WARRANTS OF ATTORNEY TO CONFESS JUDGMENT AGAINST TENANT, TENANT HEREBY KNOWINGLY, INTENTIONALLY, AND VOLUNTARILY AND ON THE ADVICE OF SEPARATE COUNSEL OF TENANT, UNCONDITIONALLY WAIVES ANY AND ALL RIGHT THAT TENANT HAS OR MAY HAVE TO PRIOR NOTICE AND OPPORTUNITY FOR A HEARING UNDER THE CONSTITUTION AND LAWS OF THE UNITED STATES AND THE COMMONWEALTH OF PENNSYLVANIA.  USE OF THESE WARRANTS OF ATTORNEY SHALL NOT EXHAUST THE SAME OR THE POWER TO THEREAFTER CONFESS JUDGMENTS, AS A CONTINUING REMEDY, TO BE USED AS OFTEN AS IT MAY BE REQUIRED, AND NOTWITHSTANDING ANY LAW OR RULE TO THE CONTRARY, A REPRODUCED COPY OF THIS INSTRUMENT CERTIFIED BY AN ATTORNEY OF ANY COURT OF RECORD TO BE TRUE AND CORRECT SHALL BE SUFFICIENT EVIDENCE OF THE CONTENTS HEREOF FOR THE PURPOSES HEREINAFTER SET FORTH.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:22.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">FOR VALUE RECEIVED AND FORTHWITH ON EVERY DEFAULT HEREUNDER OR ON ANY AND EVERY BREACH OF COVENANT HEREIN, TENANT HEREBY EMPOWERS ANY ATTORNEY OF ANY COURT OF RECORD WITHIN THE UNITED STATES OR ELSEWHERE TO APPEAR FOR TENANT AND WITH OR WITHOUT DECLARATION FILED, CONFESS JUDGMENT OR A SERIES OF JUDGMENTS AGAINST TENANT AND IN FAVOR OF LANDLORD, ITS SUCCESSORS OR ASSIGNS, AS OF ANY TERM FOR THE FULL SUM DUE BY REASON OF ANY DEFAULT HEREUNDER, INCLUDING UNPAID RENT FOR THE BALANCE OF THE TERM OF THE LEASE, TOGETHER WITH COSTS OF SUIT AND REASONABLE ATTORNEYS&#8217; FEES.  TENANT FURTHER AUTHORIZES THE ISSUANCE OF WRITS OF EXECUTION AS LANDLORD MAY ELECT UPON ANY SUCH JUDGMENT OR JUDGMENTS, WITH RELEASE OF ALL ERRORS AND WITHOUT STAY OF EXECUTION AND INQUISITION, AND EXTENSION UPON ANY LEVY OF REAL ESTATE IS HEREBY WAIVED AND CONDEMNATION AGREED TO AND THE EXEMPTION OF ANY AND ALL PROPERTY FROM LEVY OR SALE BY VIRTUE OF ANY LAW NOW IN FORCE OR HEREINAFTER ENACTED IS ALSO EXPRESSLY WAIVED.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">FOR THE PURPOSE OF OBTAINING POSSESSION OF THE LEASED PREMISES IN THE EVENT OF THE FAILURE OF TENANT TO VACATE THE LEASED PREMISES ON OR BEFORE THE EXPIRATION OF THE TERM OF THE LEASE, AS MAY BE EXTENDED, OR PRIOR TO THE EXPIRATION OF THE TERM OF THE LEASE IN THE EVENT OF DEFAULT, TENANT HEREBY AUTHORIZES AND EMPOWERS ANY ATTORNEY OF ANY COURT OF RECORD WITHIN THE UNITED STATES OR ELSEWHERE, TO APPEAR FOR TENANT AND ALL PERSONS CLAIMING UNDER OR THROUGH TENANT, TO SIGN AN AGREEMENT FOR ENTERING IN ANY COMPETENT COURT AN AMICABLE ACTION IN EJECTMENT FOR POSSESSION OF THE LEASED PREMISES, AND&#47;OR TO APPEAR FOR AND CONFESS JUDGMENT, OR A SERIES OF JUDGMENTS, AGAINST TENANT, AND AGAINST ALL PERSONS CLAIMING UNDER OR THROUGH TENANT IN FAVOR OF LANDLORD, FOR RECOVERY BY LANDLORD OF POSSESSION THEREOF, TOGETHER WITH COSTS OF SUIT AND REASONABLE ATTORNEYS&#8217; FEES, FOR WHICH THE LEASE, OR A COPY THEREOF VERIFIED BY AFFIDAVIT, SHALL BE A SUFFICIENT WARRANT&#59; AND THEREUPON A WRIT OF POSSESSION MAY IMMEDIATELY ISSUE FOR POSSESSION OF THE LEASED PREMISES, WITHOUT ANY PRIOR WRIT OR PROCEEDING WHATSOEVER AND WITHOUT ANY STAY OF EXECUTION.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:47.115%"><tr><td style="width:1.0%"></td><td style="width:19.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.083%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:68.629%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:133%">HAEMONETICS CORPORATION</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:133%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:133%">&#47;s&#47; William P. Burke</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:133%">Name&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:133%">William P. Burke</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:133%">Title&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:133%">CFO</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:22.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;6.&#160;&#160;&#160;&#160;NOTICES&#58;  Section 20 (Notices) of the Agreement of Lease dated July 17, 1990, is hereby made null and void and of no further force and effect and paragraph 7 below shall be given full force and effect.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;7.&#160;&#160;&#160;&#160;NOTICES&#58;  All notices, demands and requests which may be or are required to be given under the Lease shall be given in writing and shall be deemed to have been duly given as of the date sent (a) if mailed by postage prepaid, first class, United States registered or certified mail, return receipt requested, or (b) if deposited with receipt with Federal Express or other nationally recognized overnight courier.  All notices, demands, and requests shall be sent to each of the parties at the following addresses, or to such other addresses as either party hereto may for itself designate in writing from time to time for the purpose of receiving notices hereunder&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">LANDLORD&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;TENANT&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Buncher Company&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Haemonetics Corporation</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Penn Liberty Plaza I&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;125 Summer Street</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1300 Penn Avenue, Suite 300&#160;&#160;&#160;&#160;Boston, Massachusetts 02110</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Pittsburgh, PA 15222-4211&#160;&#160;&#160;&#160;Attention&#58;  SVP, Global Business Services</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">realestategroup&#64;buncher.com</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;With a copy to&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Haemonetics Corporation</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;125 Summer Street</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Boston, Massachusetts 02110</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Attention&#58;&#160; Executive Vice President and General &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;      &#160;&#160;&#160;&#160;Counsel</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;8.&#160;&#160;&#160;&#160;BROKERAGE&#58;  Except as provided below, Landlord and Tenant each hereby warrants to the other that no real estate broker has been involved in this transaction on its behalf and that no finder&#8217;s fees or real estate commissions have been earned by any third party.  Tenant hereby agrees to indemnify Landlord and Landlord hereby agrees to indemnify Tenant for any liability or claims for commissions or fees, including reasonable attorneys&#8217; fees and costs, arising from a breach of this warranty by such party.  The only real estate broker involved in this transaction is Hannah Langolz Wilson Ellis, whose commission or fee with respect to this transaction, if any, shall be paid by Tenant.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;9.&#160;&#160;&#160;&#160;TENANT&#8217;S ACKNOWLEDGMENT&#58;  Tenant hereby acknowledges that as of the date of this Twelfth Amendment to Agreement of Lease, Landlord is not in default </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:22.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">of any of its obligations under the Lease, and Tenant has no claims, counterclaims, offsets or defenses with respect to Landlord&#8217;s obligations under the Lease.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;10.&#160;&#160;&#160;&#160;AUTHORIZATION&#58;  Tenant and Landlord each hereby represent and warrant that it has full authority to enter into, deliver, and perform its obligations hereunder&#59; that the individual executing this Twelfth Amendment to Agreement of Lease on behalf of such party has full authority to legally bind such party&#59; that nothing herein conflicts with either of the party&#8217;s governing documents or any of its commitments or obligations&#59; and that no consent or approval of any third party is required to perform its obligations hereunder.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;11.&#160;&#160;&#160;&#160;NO OTHER MODIFICATIONS&#58;  Except as amended hereby, all terms and conditions of the Lease shall remain in full force and effect and are hereby ratified by Landlord and Tenant.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Signature page follows.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#93;</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:22.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6</font></div><div><font><br></font></div></div></div><div id="i072b4c47ffb14923b2acbb0c08e8e470_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF the parties hereto intending to be legally bound have hereunto set their hands and seals the day and year first above written.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:5.599%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.795%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.586%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.808%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.118%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:133%">ATTEST&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:133%">The BUNCHER COMPANY</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:133%">By&#58;</font></td><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:133%">&#47;s&#47; Joseph M. Jackovic</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:133%">By&#58;</font></td><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:133%">&#47;s&#47; Thomas J. Balestrieri</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Joseph M. Jackovic</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Executive Vice President</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">and Secretary&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:133%">Thomas J. Balestrieri<br>President&#47;CEO</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(Corporate Seal)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;        </font></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:5.599%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.795%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.586%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.808%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.118%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:133%">ATTEST&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:133%">HAEMONETICS CORPORATION</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:133%">By&#58;</font></td><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:133%">&#47;s&#47; Thomas Powers</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:133%">By&#58;</font></td><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:133%">&#47;s&#47; William P. Burke</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Thomas Powers</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Assistant Corporate Secretary</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">William P. Burke</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">CFO</font></div></td></tr></table></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:232%">(Corporate Seal)</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div></div></div><div id="i072b4c47ffb14923b2acbb0c08e8e470_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ACKNOWLEDGMENT</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Commonwealth of MA&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;)</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;) &#160;&#160;&#160;&#160;ss&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">County of Bristol&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;)</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On this 22nd day of May, 2020, before me, a Notary Public, personally appeared William P. Burke, who acknowledged &#91;himself&#47;herself&#93; to be the CFO of HAEMONETICS CORPORATION, a Massachusetts corporation, and that &#91;he&#47;she&#93; as such CFO being authorized to do so, executed the foregoing Twelfth Amendment to Agreement of Lease, including but not limited to paragraph 5, for the purposes therein contained by signing in the name of the corporation by &#91;himself&#47;herself&#93; as CFO.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">      WITNESS my hand and official seal the day and year aforesaid.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:133%">&#47;s&#47; Sheryl A. Larkin</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:133%">Notary Public</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">My Commission Expires&#58; February 5, 2027</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>ex103-13thamendmenttoleets.htm
<DESCRIPTION>EX-10.3
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ife00ae3b03894c53803ca3eed1902f93_1"></div><div style="min-height:49.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:139%">CERTAIN INFORMATION HAS BEEN OMITTED FROM THIS DOCUMENT BECAUSE IT IS (I) NOT MATERIAL, AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. OMISSIONS ARE MARKED &#91;***&#93;.</font></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:139%">Exhibit 10.3</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">THIRTEENTH AMENDMENT TO AGREEMENT OF LEASE </font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">DATED THIS 21</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">st </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">DAY OF DECEMBER, 2020</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">BY AND BETWEEN </font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;THE BUNCHER COMPANY, as Landlord, a Pennsylvania corporation having its principal office in the City of Pittsburgh, Allegheny County, Pennsylvania,</font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">AND</font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;HAEMONETICS CORPORATION, as Tenant, a Massachusetts corporation having its principal place of business in the City of Boston, Suffolk County, Massachusetts.</font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;WHEREAS, the parties hereto have entered into that certain Agreement of Lease dated July 17, 1990&#59; as amended by First Amendment to Agreement of Lease dated April 30, 1991&#59; by Second Amendment to Agreement of Lease dated October 18, 2000&#59; by Third Amendment to Agreement of Lease dated March 23, 2004&#59; by Fourth Amendment to Agreement of Lease dated March 12, 2008&#59; by Fifth Amendment to Agreement of Lease dated October 1, 2008&#59; by Sixth Amendment to Agreement of Lease made as of January 8, 2010&#59; by Seventh Amendment to Agreement of Lease made as of March 31, 2011&#59; by letter agreement dated January 27, 2012&#59; along with the renewal letter dated June 8, 2010, exercising the renewal option for the Fourth Renewal Term pursuant to paragraph 3 of the Sixth Amendment to Agreement of Lease&#59; by Eighth Amendment to Agreement of Lease dated February 26, 2013&#59; by Ninth Amendment to Agreement of Lease dated March 12, 2014&#59; by Tenth Amendment to Agreement of Lease dated as of May 31, 2017&#59; by Eleventh Amendment to Agreement of Lease dated as of March 2, 2018&#59; and by Twelfth Amendment to Agreement of Lease dated May 22, 2020 (hereinafter collectively the &#8220;Lease&#8221;)&#59;</font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;WHEREAS, the &#8220;Leased Premises&#8221; covered by the Lease is 89,177 agreed-upon rentable square feet of space in Buncher Commerce Park, Leetsdale Borough, Allegheny County, Pennsylvania, which is allocated as follows&#58; (a) 81,929 agreed-upon rentable square feet of space in Buildings 18 and 18A&#59; (b) 5,672 agreed-upon rentable square feet of space in the Parking Area&#59; (c) 809 agreed-upon rentable square feet of space in the Building 18 Expansion Space&#59; and (d) 767 agreed-upon rentable square feet of space in the Building 18 Second Expansion Space&#59; </font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;WHEREAS, all terms defined in the Lease and used therein shall have the same meaning herein as in the Lease unless otherwise provided herein&#59; and </font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;WHEREAS, the parties hereto desire to amend the Lease to (i) extend the term of the Lease for three (3) additional months (the &#8220;Fifth Extended Term&#8221;)&#59; (ii) restate the monthly rental for the Leased Premises during the balance of the Third Extended Term, restate the monthly rental during the Fourth Extended Term, and to establish the monthly </font></div><div style="height:22.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">rental during the Fifth Extended Term&#59; and (iii) amend existing Lease provisions and to incorporate additional provisions into the Lease to reflect the intentions of the parties.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;NOW, THEREFORE, in consideration of the premises and intending to be legally bound, the parties hereto promise, covenant and agree that the Lease be and is hereby amended as follows&#58; </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;TERM&#58;  The Lease and the term thereof are hereby extended for the Fifth Extended Term to commence immediately following the expiration of the Fourth Extended Term of the Lease, i.e. January 1, 2022.  The expiration date of the term of the Lease, as extended by the Fifth Extended Term, is hereby changed from December 31, 2021, to March 31, 2022.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.  &#160;&#160;&#160;&#160;RENT&#58;  Effective on the date hereof, paragraph 2 (Rent) of the Twelfth Amendment to Agreement of Lease dated May 22, 2020, shall be null and void and of no further force and effect and the following shall be substituted therefor&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#8220;2.&#160;&#160;&#160;&#160;RENT&#58;  Tenant shall pay to Landlord as rental for the Leased Premises the following amounts at the following times&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A. &#160;&#160;&#160;&#160;Tenant shall continue to pay to Landlord on the first (1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) day of each calendar month during the balance of the Third Extended Term of the Lease until and including June 1, 2021, and then continuing on the first (1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) day of each succeeding calendar month thereafter during the Fourth Extended Term of the Lease until and including December 1, 2021, as monthly rental for the Building 18 Expansion Space and the Building 18 Second Expansion Space portions of the Leased Premises the amount of $</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#91;***&#93;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, and beginning on January 1, 2022 and continuing on the first (1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) day of each </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">succeeding calendar month thereafter during the Fifth Extended Term of the Lease, Tenant shall pay to Landlord as monthly rental for the Building 18 Expansion Space and the Building 18 Second Expansion Space portions of the Leased Premises the amount of $</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#91;***&#93;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">B.  &#160;&#160;&#160;&#160;Tenant shall continue to pay to Landlord on the first (1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) day of each calendar month during the balance of the Third Extended Term of the Lease until and including June 1, 2021, the amount of $</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#91;***&#93;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> as monthly rental for the Building 18, Building 18A, and the Parking Area portions of the Leased Premises.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">C.&#160;&#160;&#160;&#160;Beginning on July 1, 2021 and continuing on the first (1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) day of each succeeding calendar month thereafter during the Fourth Extended Term of the Lease until and including December 1, 2021, Tenant shall pay to Landlord as monthly rental for the Building 18, Building 18A, and the Parking Area portions of the Leased Premises the amount of $</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#91;***&#93;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:22.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.5pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">D.&#160;&#160;&#160;&#160;Beginning on January 1, 2022 and continuing on the first (1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) day of each succeeding calendar month thereafter during the Fifth Extended Term of the Lease, Tenant shall pay to Landlord as monthly rental for the Building 18, Building 18A, and the Parking Area portions of the Leased Premises the amount of $</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#91;***&#93;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The monthly rentals as set forth herein shall be payable in advance, without demand, deduction or set off.  All rentals and other amounts payable under the Lease shall be paid to The Buncher Company at P. O. Box 768, Pittsburgh, Pennsylvania 15230-0768 or at such other place or to such other party as may be designated by Landlord in writing.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;If any installment of monthly rental or additional rental becomes overdue for a period in excess of ten (10) business days, Tenant shall pay interest at a monthly rate equal to one percent (1%) accruing from the due date to the date of payment thereof.  Such interest shall constitute additional rental due and payable to Landlord by Tenant.  The interest charge will be in addition to, and not in lieu of, any other remedy Landlord may have under the Lease.  If there are accrued and unpaid rental amounts, all payments of monthly rental and additional rental shall be applied in such order as Landlord shall determine.&#8221; </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;3.&#160;&#160;&#160;&#160;ADDITIONAL TENANT IMPROVEMENT ALLOWANCE&#58; </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;A.&#160;&#160;&#160;&#160;Landlord and Tenant acknowledge and agree that, as of November 18, 2020, the remaining balance of the Additional Tenant Improvement Allowance (as described in paragraph 5 (Tenant Improvement Allowance) of the Eleventh Amendment to Agreement of Lease dated as of March 2, 2018) that is available to be applied to the Additional Tenant&#8217;s Work (as defined in said Eleventh Amendment) is $</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#91;***&#93;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;B.&#160;&#160;&#160;&#160;The third (3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">rd</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) grammatical paragraph of paragraph 4 (Additional Tenant Improvement Allowance) of the Twelfth Amendment to Agreement of Lease dated May 22, 2020, is hereby amended to read as follows&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#8220;Any unused amount of the Additional Tenant Improvement Allowance shall be credited against rental in reverse order beginning with the last month of the Fifth Extended Term&#8221;.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;4.&#160;&#160;&#160;&#160;CONFESSION OF JUDGMENT&#58;&#160;&#160;&#160;&#160;Tenant hereby restates, ratifies and confirms paragraph 5 (Confession of Judgment) of the Twelfth Amendment to Agreement of Lease dated May 22, 2020&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;THE FOLLOWING PARAGRAPHS SET FORTH WARRANTS OR AUTHORITY FOR AN ATTORNEY TO CONFESS JUDGMENT AGAINST TENANT IN THE EVENT OF A DEFAULT BY TENANT AS DESCRIBED BELOW. IN GRANTING THESE WARRANTS OF ATTORNEY TO CONFESS JUDGMENT AGAINST TENANT, TENANT HEREBY KNOWINGLY, INTENTIONALLY, AND VOLUNTARILY AND ON THE ADVICE OF SEPARATE COUNSEL OF TENANT, UNCONDITIONALLY WAIVES ANY AND ALL </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:22.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.5pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">RIGHT THAT TENANT HAS OR MAY HAVE TO PRIOR NOTICE AND OPPORTUNITY FOR A HEARING UNDER THE CONSTITUTION AND LAWS OF THE UNITED STATES AND THE COMMONWEALTH OF PENNSYLVANIA.  USE OF THESE WARRANTS OF ATTORNEY SHALL NOT EXHAUST THE SAME OR THE POWER TO THEREAFTER CONFESS JUDGMENTS, AS A CONTINUING REMEDY, TO BE USED AS OFTEN AS IT MAY BE REQUIRED, AND NOTWITHSTANDING ANY LAW OR RULE TO THE CONTRARY, A REPRODUCED COPY OF THIS INSTRUMENT CERTIFIED BY AN ATTORNEY OF ANY COURT OF RECORD TO BE TRUE AND CORRECT SHALL BE SUFFICIENT EVIDENCE OF THE CONTENTS HEREOF FOR THE PURPOSES HEREINAFTER SET FORTH.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">FOR VALUE RECEIVED AND FORTHWITH ON EVERY DEFAULT HEREUNDER OR ON ANY AND EVERY BREACH OF COVENANT HEREIN, TENANT HEREBY EMPOWERS ANY ATTORNEY OF ANY COURT OF RECORD WITHIN THE UNITED STATES OR ELSEWHERE TO APPEAR FOR TENANT AND WITH OR WITHOUT DECLARATION FILED, CONFESS JUDGMENT OR A SERIES OF JUDGMENTS AGAINST TENANT AND IN FAVOR OF LANDLORD, ITS SUCCESSORS OR ASSIGNS, AS OF ANY TERM FOR THE FULL SUM DUE BY REASON OF ANY DEFAULT HEREUNDER, INCLUDING UNPAID RENT FOR THE BALANCE OF THE TERM OF THE LEASE, TOGETHER WITH COSTS OF SUIT AND REASONABLE ATTORNEYS&#8217; FEES.  TENANT FURTHER AUTHORIZES THE ISSUANCE OF WRITS OF EXECUTION AS LANDLORD MAY ELECT UPON ANY SUCH JUDGMENT OR JUDGMENTS, WITH RELEASE OF ALL ERRORS AND WITHOUT STAY OF EXECUTION AND INQUISITION, AND EXTENSION UPON ANY LEVY OF REAL ESTATE IS HEREBY WAIVED AND CONDEMNATION AGREED TO AND THE EXEMPTION OF ANY AND ALL PROPERTY FROM LEVY OR SALE BY VIRTUE OF ANY LAW NOW IN FORCE OR HEREINAFTER ENACTED IS ALSO EXPRESSLY WAIVED.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">FOR THE PURPOSE OF OBTAINING POSSESSION OF THE LEASED PREMISES IN THE EVENT OF THE FAILURE OF TENANT TO VACATE THE LEASED PREMISES ON OR BEFORE THE EXPIRATION OF THE TERM OF THE LEASE, AS MAY BE EXTENDED, OR PRIOR TO THE EXPIRATION OF THE TERM OF THE LEASE IN THE EVENT OF DEFAULT, TENANT HEREBY AUTHORIZES AND EMPOWERS ANY ATTORNEY OF ANY COURT OF RECORD WITHIN THE UNITED STATES OR ELSEWHERE, TO APPEAR FOR TENANT AND ALL PERSONS CLAIMING UNDER OR THROUGH TENANT, TO SIGN AN AGREEMENT FOR ENTERING IN ANY COMPETENT COURT AN AMICABLE ACTION IN EJECTMENT FOR POSSESSION OF THE LEASED PREMISES, AND&#47;OR TO APPEAR FOR AND CONFESS JUDGMENT, OR A SERIES OF JUDGMENTS, AGAINST TENANT, AND AGAINST ALL PERSONS CLAIMING UNDER OR THROUGH TENANT IN FAVOR OF LANDLORD, FOR RECOVERY BY LANDLORD OF POSSESSION THEREOF, TOGETHER WITH COSTS OF SUIT AND REASONABLE ATTORNEYS&#8217; FEES, FOR WHICH THE LEASE, OR A COPY THEREOF VERIFIED BY AFFIDAVIT, SHALL BE A SUFFICIENT WARRANT&#59; AND THEREUPON A WRIT OF POSSESSION MAY IMMEDIATELY ISSUE </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:22.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.5pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">FOR POSSESSION OF THE LEASED PREMISES, WITHOUT ANY PRIOR WRIT OR PROCEEDING WHATSOEVER AND WITHOUT ANY STAY OF EXECUTION.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:46.666%"><tr><td style="width:1.0%"></td><td style="width:19.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.083%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:68.629%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:133%">HAEMONETICS CORPORATION</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:133%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:133%">&#47;s&#47; William P. Burke</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:133%">Name&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:133%">William P. Burke</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:133%">Title&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:133%">CFO</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;INTENTIONALLY DELETED. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;6.&#160;&#160;&#160;&#160;BROKERAGE&#58;  Landlord and Tenant each hereby warrants to the other that no real estate broker has been involved in this transaction on its behalf and that no finder's fees or real estate commissions have been earned by any third party.  If either party breaches the foregoing warranty, the breaching party shall indemnify, defend and hold harmless the other for any liability or claims for commissions or fees, including reasonable attorneys&#8217; fees and costs, arising from a breach of this warranty.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;7.&#160;&#160;&#160;&#160;TENANT&#8217;S ACKNOWLEDGMENT&#58;  Tenant hereby acknowledges that as of the date of this Thirteenth Amendment to Agreement of Lease, Landlord is not in default of any of its obligations under the Lease, and Tenant has no claims, counterclaims, offsets or defenses with respect to Landlord&#8217;s obligations under the Lease.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;8.&#160;&#160;&#160;&#160;AUTHORIZATION&#58;  Tenant and Landlord each hereby represent and warrant that it has full authority to enter into, deliver, and perform its obligations hereunder&#59; that the individual executing this Thirteenth Amendment to Agreement of Lease on behalf of such party has full authority to legally bind such party&#59; that nothing herein conflicts with either of the party&#8217;s governing documents or any of its commitments or obligations&#59; and that no consent or approval of any third party is required to perform its obligations hereunder.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;9.&#160;&#160;&#160;&#160;NO OTHER MODIFICATIONS&#58;  Except as amended hereby, all terms and conditions of the Lease shall remain in full force and effect and are hereby ratified by Landlord and Tenant.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#91;Signature page follows&#93;</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:22.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.5pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF the parties hereto intending to be legally bound have hereunto set their hands and seals the day and year first above written.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.142%"><tr><td style="width:1.0%"></td><td style="width:5.599%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.795%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.586%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.808%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.118%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:133%">ATTEST&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:133%">The BUNCHER COMPANY</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:133%">By&#58;</font></td><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:133%">&#47;s&#47; Joseph M. Jackovic</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:133%">By&#58;</font></td><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:133%">&#47;s&#47; David B. Heaton</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Joseph M. Jackovic</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Executive Vice President</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">and Secretary&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">David B. Heaton</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">President&#47;CEO</font></div></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(Corporate Seal)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;        </font></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.142%"><tr><td style="width:1.0%"></td><td style="width:5.599%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.795%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.586%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.808%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.118%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:133%">ATTEST&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:133%">HAEMONETICS CORPORATION</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:133%">By&#58;</font></td><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:133%">&#47;s&#47; Thomas Powers</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:133%">By&#58;</font></td><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:133%">&#47;s&#47; William P. Burke</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Thomas Powers</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Assistant Corporate Secretary</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">William P. Burke</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">CFO</font></div></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(Corporate Seal)</font></div><div style="text-align:justify"><font><br></font></div><div style="height:22.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6</font></div><div><font><br></font></div></div></div><div id="ife00ae3b03894c53803ca3eed1902f93_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ACKNOWLEDGMENT</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Commonwealth of MA&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;)</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;) &#160;&#160;&#160;&#160;ss&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">County of Bristol&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;)</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On this 21st day of December, 2020, before me, a Notary Public, personally appeared William P. Burke, who acknowledged &#91;himself&#47;herself&#93; to be the CFO of HAEMONETICS CORPORATION, a Massachusetts corporation, and that &#91;he&#47;she&#93; as such CFO being authorized to do so, executed the foregoing Thirteenth Amendment to Agreement of Lease, including but not limited to paragraph 4, for the purposes therein contained by signing in the name of the corporation by &#91;himself&#47;herself&#93; as CFO.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">      WITNESS my hand and official seal the day and year aforesaid.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:133%">&#47;s&#47; Sheryl A. Larkin</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:133%">Notary Public</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">My Commission Expires&#58; February 5, 2027</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>5
<FILENAME>ex104-agreementandplanofme.htm
<DESCRIPTION>EX-10.4
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i7ae4bb5e39b04d889fdc79bcea08a102_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CERTAIN INFORMATION HAS BEEN OMITTED FROM THIS DOCUMENT BECAUSE IT IS (I) NOT MATERIAL, AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. OMISSIONS ARE MARKED &#91;***&#93;.</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 10.4</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">EXECUTION VERSION</font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">AGREEMENT AND PLAN OF MERGER     </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">by and among</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">HAEMONETICS CORPORATION&#59;</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CONCORDIA MERGER SUB, INC.&#59;</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CARDIVA MEDICAL, INC.&#59;</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">and</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">FORTIS ADVISORS LLC, as the Seller Representative</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Dated as of January 17, 2021</font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt"><font><br></font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="margin-bottom:10pt"><font><br></font></div></div></div><div id="i7ae4bb5e39b04d889fdc79bcea08a102_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:14.925%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:76.624%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.151%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">T</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ABLE OF </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ONTENTS</font></div><div style="margin-bottom:0.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(CONTINUED)</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECTION 1.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">D</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ESCRIPTION OF </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">T</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">RANSACTION</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Merger of Merger Sub into the Company</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Effect of the Merger</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Closing&#59; Effective Time</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Certificate of Incorporation and Bylaws&#59; Directors and Officers</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Conversion of Shares</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Treatment of Company Options&#59; Treatment of Company Warrants</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.7</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Closing Payments and Estimated Closing Statement</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.8</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Loan Payoff</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.9</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Further Action</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.10</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Closing of the Company&#8217;s Transfer Books</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.11</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exchange&#47;Payment</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.12</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Post-Closing Adjustment to Closing Consideration</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.13</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Working Capital Escrow</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.14</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Appraisal and Dissenters&#8217; Rights</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.15</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Seller Representative</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.16</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Contingent Consideration</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">18</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECTION 2.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">R</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">EPRESENTATIONS AND </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">W</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ARRANTIES OF THE </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">OMPANY</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">21</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Authority&#59; Binding Nature of Agreement</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">21</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Due Incorporation&#59; No Subsidiaries&#59; Etc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">22</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Articles of Incorporation and Bylaws</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">22</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Capitalization, Etc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">22</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Non-Contravention&#59; Consents</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">24</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Financial Statements</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">25</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.7</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Absence of Certain Changes</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">25</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.8</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title to Assets</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">25</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.9</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Real Property&#59; Leasehold</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">26</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.10</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Intellectual Property</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">26</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.11</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Regulatory Matters&#59; Healthcare Laws&#59; Healthcare Permits</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">30</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.12</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Material Contracts</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">32</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.13</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Liabilities</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">34</font></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ii.</font></div><div style="height:22.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div></div><div id="i7ae4bb5e39b04d889fdc79bcea08a102_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:14.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:74.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.394%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">T</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ABLE OF </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ONTENTS</font></div><div style="margin-bottom:0.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(CONTINUED)</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PAGE</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.14</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Compliance with Laws&#59; Permits</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">35</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.15</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Certain Business Practices</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">35</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.16</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Tax Matters</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">36</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.17</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Employee Benefit Plans and Employee Matters</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">38</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.18</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Environmental Matters</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">42</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.19</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Inventory</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">43</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.20</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Accounts Receivable</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">43</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.21</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Suppliers and Customers</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">43</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.22</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Insurance</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">44</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.23</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Legal Proceedings&#59; Orders</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">44</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.24</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Vote Required</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">44</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.25</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Books and Records</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">45</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.26</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Financial Advisor</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">45</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.27</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Bank Accounts&#59; Directors and Officers&#59; Names</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">45</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.28</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Product Liabilities</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">45</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.29</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Product Recalls</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">46</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.30</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Related Party Transactions</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">46</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECTION 3.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">R</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EPRESENTATIONS AND </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">W</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARRANTIES OF </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">P</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ARENT AND </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">M</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ERGER </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UB</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">46</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Due Incorporation&#59; Subsidiaries</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">46</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Authority&#59; Binding Nature of Agreement</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">46</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Non-Contravention&#59; Consents</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">47</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Litigation</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">47</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Merger Sub</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">47</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">No Vote Required</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">47</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.7</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Financing</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">47</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECTION 4.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ERTAIN </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">OVENANTS OF THE </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">OMPANY</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">47</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Access</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">47</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Conduct of the Business of the Company</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">48</font></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">iii.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:22.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt"><font><br></font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="margin-bottom:10pt"><font><br></font></div></div></div><div id="i7ae4bb5e39b04d889fdc79bcea08a102_10"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:15.076%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:73.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.724%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">T</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ABLE OF </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ONTENTS</font></div><div style="margin-bottom:0.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(CONTINUED)</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PAGE</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">No Solicitation</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">50</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notice of Certain Events</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">51</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECTION 5.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">DDITIONAL </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">OVENANTS OF THE </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">P</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ARTIES</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">52</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Stockholder Consent or Approval</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">52</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Regulatory Filings</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">53</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Employee Benefits</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">55</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Indemnification of Officers and Directors</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">56</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Disclosure&#59; Confidentiality</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">57</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Tax Matters</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">57</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.7</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">R&#38;W Insurance</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">58</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.8</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Efforts to Provide Notices</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">58</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECTION 6.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ONDITIONS </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">P</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">RECEDENT TO </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">O</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">BLIGATIONS OF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> P</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ARENT AND </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">M</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ERGER </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">UB</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">59</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Accuracy of Representations and Warranties</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">59</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Performance of Covenants</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">59</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Stockholder Approval</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">59</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">No Restraints</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">59</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">No Governmental Litigation</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">59</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Agreements and Documents</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">59</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.7</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Closing Certificate</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">60</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.8</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Dissenting Shares</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">60</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.9</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Officer&#8217;s Certificate</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">60</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.10</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Good Standing Certificates</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">60</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.11</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Escrow Agreement</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">60</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.12</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">No Company Material Adverse Effect</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">61</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.13</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">HSR Clearance</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">61</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.14</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">R&#38;W Insurance Policy</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">61</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.15</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Termination of 401(k) Plan</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">61</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.16</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Termination and Payment of Severance</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">61</font></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">iv.</font></div><div style="height:22.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt"><font><br></font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="margin-bottom:10pt"><font><br></font></div></div></div><div id="i7ae4bb5e39b04d889fdc79bcea08a102_13"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:14.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:74.380%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.555%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">T</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ABLE OF </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ONTENTS</font></div><div style="margin-bottom:0.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(CONTINUED)</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PAGE</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.17</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Offer Letters and Consulting Agreements</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">61</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECTION 7.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ONDITIONS </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">P</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">RECEDENT TO </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">O</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">BLIGATIONS OF THE </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">OMPANY</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">61</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Accuracy of Representations and Warranties</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">61</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Performance of Covenants</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">61</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Stockholder Approval</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">62</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">No Restraints</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">62</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">No Governmental Litigation</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">62</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Escrow Agreement</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">62</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.7</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Closing Certificate</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">62</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.8</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">HSR Clearance</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">62</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECTION 8.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">T</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ERMINATION</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">62</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Termination</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">62</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Effect of Termination</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">63</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECTION 9.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">M</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ISCELLANEOUS </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">P</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ROVISIONS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">63</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">No Recourse&#59; Non-Survival of Representations, Warranties and Covenants</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">63</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Amendment</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">64</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Expenses</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">64</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Waiver</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">65</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Entire Agreement&#59; Counterparts</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">65</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Applicable Law&#59; Jurisdiction</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">65</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.7</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Assignability</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">66</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.8</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Third Party Beneficiaries</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">66</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.9</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notices</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">66</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.10</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Severability</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">68</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.11</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Knowledge</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">68</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.12</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Conflict of Interest</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">68</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.13</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Attorney-Client Privilege</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">68</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.14</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">No Implied Representations&#59; Non-Reliance</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">69</font></td></tr></table></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">v.</font></div><div style="height:22.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt"><font><br></font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="margin-bottom:10pt"><font><br></font></div></div></div><div id="i7ae4bb5e39b04d889fdc79bcea08a102_16"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:15.076%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:73.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.724%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">T</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ABLE OF </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ONTENTS</font></div><div style="margin-bottom:0.12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(CONTINUED)</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PAGE</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.15</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Specific Performance</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">70</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.16</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Construction</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">70</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.17</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Disclosure Schedule</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">71</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.18</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Waiver of Claims Against Debt Financing Sources</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">71</font></td></tr></table></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:13.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.265%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:80.952%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibits</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exhibit A</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">-</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Definitions</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exhibit B</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">-</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Closing Date Adjustment Illustration</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exhibit C</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">-</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Form of Letter of Transmittal</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exhibit D</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">-</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Form of Escrow Agreement</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exhibit E</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">-</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Form of Written Consent</font></td></tr></table></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">vi.</font></div><div style="height:22.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt"><font><br></font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="margin-bottom:10pt"><font><br></font></div></div></div><div id="i7ae4bb5e39b04d889fdc79bcea08a102_19"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">AGREEMENT AND PLAN OF MERGER</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">This Agreement and Plan of Merger </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(as may be amended from time to time, this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) is made and entered into as of January 17, 2021, by and among&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Haemonetics Corporation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, a Massachusetts corporation (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Parent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Concordia Merger Sub, Inc.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, a Delaware corporation and a wholly owned Subsidiary of Parent (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Merger Sub</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;)&#59;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> Cardiva Medical, Inc.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;)&#59; and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Fortis Advisors LLC,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> a Delaware limited liability company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> as the Seller Representative.  Certain capitalized terms used in this Agreement are defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit&#160;A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">R</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ECITALS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A.&#160;&#160;&#160;&#160;Parent, Merger Sub and the Company intend to effect a merger of Merger Sub into the Company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Merger</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) in accordance with this Agreement and the General Corporation Law of the State of Delaware (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">DGCL</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).  Upon consummation of the Merger, Merger Sub will cease to exist as a separate corporate entity, and the Company will become a wholly owned Subsidiary of Parent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">B.&#160;&#160;&#160;&#160;The respective boards of directors of Parent, Merger Sub and the Company have approved this Agreement and the consummation of the transactions contemplated hereby, including the Merger.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">GREEMENT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The parties to this Agreement, intending to be legally bound, agree as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 1.&#160;&#160;&#160;&#160;D</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ESCRIPTION OF </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">T</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">RANSACTION</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.1&#160;&#160;&#160;&#160;Merger of Merger Sub into the Company. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> Upon the terms and subject to the conditions set forth in this Agreement, at the Effective Time, Merger Sub shall be merged with and into the Company, and the separate existence of Merger Sub shall cease.  The Company will continue as the surviving corporation in the Merger (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Surviving Corporation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.2&#160;&#160;&#160;&#160;Effect of the Merger.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Merger shall have the effects set forth in this Agreement and in the applicable provisions of the DGCL and any applicable provisions in the California Code.  Without limiting the generality of the foregoing, and subject to the DGCL and this Agreement, at the Effective Time, all of the property, rights, privileges, powers and franchises of the Company and Merger Sub shall vest in the Surviving Corporation, and all debts, liabilities and duties of the Company and Merger Sub shall become the debts, liabilities and duties of the Surviving Corporation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.3&#160;&#160;&#160;&#160;Closing&#59; Effective Time.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The consummation of the transactions contemplated by this Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Closing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) shall take place remotely via electronic exchange of closing deliveries on a date to be designated by the Company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Closing Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), which shall be no later than the second Business Day after the satisfaction or waiver of the last to be satisfied or waived of the conditions set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (other than those conditions that by their nature are to be satisfied at the Closing, but subject to the satisfaction or waiver of such conditions), unless another time or place, or both, are agreed to in writing by the Company and Parent.  Subject </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">1.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><br>to the provisions of this Agreement, a certificate of merger satisfying the applicable requirements of the DGCL (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Certificate of Merger</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) shall be duly executed by the Company and, on the Closing Date, concurrently with or immediately following the Closing, delivered to and filed with the Secretary of State of the State of Delaware in accordance with the DGCL.  The Merger shall become effective upon the date and time of the filing of such Certificate of Merger with the Secretary of State of the State of Delaware, or at such later time as may be mutually agreed in writing by the Company and Parent and specified in the Certificate of Merger (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Effective Time</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.4&#160;&#160;&#160;&#160;Certificate of Incorporation and Bylaws&#59; Directors and Officers</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The certificate of incorporation of the Surviving Corporation shall be amended and restated as of the Effective Time to conform to the certificate of incorporation of Merger Sub as in effect immediately prior to the Effective Time, except that the name of the Surviving Corporation shall be &#8220;Cardiva Medical, Inc.&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The bylaws of the Surviving Corporation shall be amended and restated immediately as of the Effective Time to conform to the bylaws of Merger Sub as in effect immediately prior to the Effective Time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The directors and officers of the Surviving Corporation as of the Effective Time shall be the respective individuals who are directors and officers of Merger Sub immediately prior to the Effective Time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.5&#160;&#160;&#160;&#160;Conversion of Shares.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">At the Effective Time, by virtue of the Merger and without any further action on the part of Parent, Merger Sub, the Company or any stockholder of the Company&#58; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">any shares of Company Capital Stock then held by the Company (or held in the Company&#8217;s treasury) shall be canceled and retired and shall cease to exist, and no consideration shall be delivered in exchange therefor&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">any shares of Company Capital Stock then held by Parent, Merger Sub or any other Subsidiary of Parent shall be canceled and retired and shall cease to exist, and no consideration shall be delivered in exchange therefor&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">except as provided in subsections &#8220;1.5(a)&#8221; and &#8220;1.5(b)&#8221; of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and subject to withholdings and adjustments as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.8(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Sections 1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.15&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">each share of Company Common Stock issued and outstanding immediately prior to the Effective Time (except for Dissenting Shares) shall cease to be an existing and issued share of Company Capital Stock, and shall be converted, by virtue of the Merger and without any action on the part of the holders thereof, into the right to receive, without interest, an amount in cash equal to (A) the Per Share Common Closing Consideration, plus (B) the applicable portion of any Post-Closing Consideration, as and when due&#59;</font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(ii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">each share of Series 3 Preferred Stock issued and outstanding immediately prior to the Effective Time (except for Dissenting Shares) shall cease to be an existing and issued share of Company Capital Stock, and shall be converted, by virtue of the Merger and without any action on the part of the holders thereof, into the right to receive, without interest, an amount in cash equal to (A) the Per Share Series 3 Liquidation Amount </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (B) the Per Share Common Closing Consideration, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (C) the applicable portion of any Post-Closing Consideration, as and when due&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(iii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> each share of Series 4 Preferred Stock issued and outstanding immediately prior to the Effective Time (except for Dissenting Shares) shall cease to be an existing and issued share of Company Capital Stock, and shall be converted, by virtue of the Merger and without any action on the part of the holders thereof, into the right to receive, without interest, an amount in cash equal to (A) the Per Share Series 4 Liquidation Amount </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (B) the Per Share Common Closing Consideration, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (C) the applicable portion of any Post-Closing Consideration, as and when due&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(iv)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">each share of Series 5 Preferred Stock issued and outstanding immediately prior to the Effective Time (except for Dissenting Shares) shall cease to be an existing and issued share of Company Capital Stock, and shall be converted, by virtue of the Merger and without any action on the part of the holders thereof, into the right to receive, without interest, an amount in cash equal to (A) the Per Share Series 5 Liquidation Amount </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (B) the Per Share Common Closing Consideration, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (C) the applicable portion of any Post-Closing Consideration, as and when due&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(v)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">each share of Series 6 Preferred Stock issued and outstanding immediately prior to the Effective Time (except for Dissenting Shares) shall cease to be an existing and issued share of Company Capital Stock, and shall be converted, by virtue of the Merger and without any action on the part of the holders thereof, into the right to receive, without interest, an amount in cash equal to (A) the Per Share Series 6 Liquidation Amount </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (B) the Per Share Common Closing Consideration, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (C) the applicable portion of any Post-Closing Consideration, as and when due&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">each share of the common stock, $.0001 par value per share, of Merger Sub issued and outstanding immediately prior to the Effective Time shall cease to be an existing and issued share of Company Capital Stock, and shall be converted, by virtue of the Merger and without any action on the part of its holder into one share of validly issued, fully paid and nonassessable common stock of the Surviving Corporation, such that immediately following the Effective Time, Parent shall become the sole and exclusive owner of all of the issued and outstanding capital stock of the Company as the Surviving Corporation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.6&#160;&#160;&#160;&#160;Treatment of Company Options&#59; Treatment of Company Warrants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Each In-the-Money Option that is outstanding and unexercised immediately prior to the Effective Time shall be canceled at the Effective Time and, in consideration of such cancellation, the holder thereof, subject to withholdings as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Sections 1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, shall be entitled to receive, without interest, a cash payment for each share subject to </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">such In-the-Money Option an amount equal to (i)&#160;the Per Share Common Closing Consideration </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">minus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (ii)&#160;the exercise price per share of such In-the-Money Option, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (iii) the applicable portion of any Post-Closing Consideration, as and when due. The amount of cash each holder of an In-the-Money Option is entitled to receive for all In-the-Money Options held by such holder shall be rounded down to the nearest cent and computed after aggregating cash amounts for all In-the-Money Options held by such holder (such holder&#8217;s &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Closing Options Payout Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">At the Effective Time, each Company Option that is not an In-the-Money Option which is outstanding and unexercised immediately prior to the Effective Time, shall be canceled at the Effective Time without the payment of cash or issuance of other consideration in respect thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Board of Directors of the Company shall adopt such resolutions or take such other actions prior to the Effective Time as may be required to effect the transactions described in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  All cash amounts payable in respect of Employee Options shall be paid pursuant to the Surviving Corporation&#8217;s (or, as applicable, any Affiliate thereof or successor thereto) standard payroll procedures in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.11(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Parent shall cause the Payment Agent to pay all cash amounts payable in respect of Non-Employee Options in accordance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.11(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">As of the Effective Time, by virtue of the Merger and without any action on the part of Parent, Merger Sub or the holder of any Company Warrant, each Company Warrant shall be canceled and treated as follows&#58; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Each Company Common Warrant that is outstanding immediately prior to the Effective Time shall be canceled at the Effective Time and, in consideration of such cancelation, the holder thereof, subject to withholdings and adjustments as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Sections 1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall be entitled to receive, without interest, a cash payment equal to (A) the number of shares of Company Common Stock subject to such Company Common Warrant </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">multiplied by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(B) (1) the Per Share Common Closing Consideration </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">minus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (2) the exercise price per share of Company Common Stock subject to such Company Common Warrant, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (3) the applicable portion of any Post-Closing Consideration, as and when due.  The amount of cash each holder of a Company Common Warrant is entitled to receive for all Company Common Warrants held by such holder shall be rounded down to the nearest cent and computed after aggregating cash amounts for all Company Common Warrants held by such holder&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(ii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Each Company Series 3 Warrant that is outstanding immediately prior to the Effective Time shall be canceled at the Effective Time and, in consideration of such cancelation, the holder thereof, subject to withholdings and adjustments as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Sections 1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, shall be entitled to receive, without interest, a cash payment equal to (A) the number of shares of Series 3 Preferred Stock subject to such Company Series 3 Warrant </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">multiplied by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(B) (1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the Per Share Common Closing Consideration </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">plus </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(2) the Per Share Preferred Warrant Liquidation Amount, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">minus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (3) the exercise price per share of Series 3 Preferred Stock subject to such Company Series 3 Warrant, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (4) the applicable portion of any Post-Closing Consideration, as and when due. The amount of cash each holder of a Company Series&#160;3 Warrant is entitled to receive for all Company Series 3 Warrants held by such holder shall be rounded down </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><br>to the nearest cent and computed after aggregating cash amounts for all Company Series 3 Warrants held by such holder&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(iii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Each Company Series 4 Warrant that is outstanding immediately prior to the Effective Time shall be canceled at the Effective Time and, in consideration of such cancelation, the holder thereof, subject to withholdings and adjustments as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Sections 1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, shall be entitled to receive, without interest, a cash payment equal to (A) the number of shares of Series 4 Preferred Stock subject to such Company Series 4 Warrant </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">multiplied by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(B) (1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the Per Share Common Closing Consideration </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">plus </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(2) the Per Share Preferred Warrant Liquidation Amount, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">minus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (3) the exercise price per share of Series 4 Preferred Stock subject to such Company Series 4 Warrant, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (4) the applicable portion of any Post-Closing Consideration, as and when due. The amount of cash each holder of a Company Series&#160;4&#160;Warrant is entitled to receive for all Company Series 4 Warrants held by such holder shall be rounded down to the nearest cent and computed after aggregating cash amounts for all Company Series 4 Warrants held by such holder&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(iv)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Each Company Series 5 Warrant that is outstanding immediately prior to the Effective Time shall be canceled at the Effective Time and, in consideration of such cancelation, the holder thereof, subject to withholdings and adjustments as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Sections 1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, shall be entitled to receive, without interest, a cash payment equal to (A) the number of shares of Series 5 Preferred Stock subject to such Company Series 5 Warrant </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">multiplied by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(B) (1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the Per Share Common Closing Consideration </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">plus </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(2) the Per Share Preferred Warrant Liquidation Amount, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">minus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (3) the exercise price per share of Series 5 Preferred Stock subject to such Company Series 5 Warrant, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (4) the applicable portion of any Post-Closing Consideration, as and when due. The amount of cash each holder of a Company Series 5 Warrant is entitled to receive for all Company Series 5 Warrants held by such holder shall be rounded down to the nearest cent and computed after aggregating cash amounts for all Company Series 5 Warrants held by such holder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.7&#160;&#160;&#160;&#160;Closing Payments and Estimated Closing Statement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">On the Closing Date, Parent will make, or cause to be made, the following payments, as set forth herein by wire transfer of immediately available funds to the accounts set forth next to each recipient&#8217;s name on the Estimated Closing Statement&#58; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">To the Company&#58; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(1)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the aggregate Closing Options Payout Amount payable in respect of all In-the-Money Options that are Employee Options, as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(2)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the aggregate Carve-Out Plan Amount payable under the Company Carve-Out Plan&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(ii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">To the Payment Agent, by wire transfer of immediately available funds, an aggregate amount in cash (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Closing Payment Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) equal to&#58; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(1)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the Closing Consideration as of the Closing Date, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">minus</font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(2)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the aggregate Closing Options Payout Amount payable in respect of all In-the-Money Options that are Employee Options, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">minus </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(3)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the Escrow Amount, as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.13(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">minus </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(4)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the Seller Representative Reserve, as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.15(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(iii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">To the Escrow Agent, the Escrow Amount, as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.13(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(iv)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">To each Person (if any) identified on the Estimated Closing Statement, the portion of the Estimated Closing Date Transaction Expenses set forth opposite such Person&#8217;s name on the Estimated Closing Statement&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(v)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">To each Person (if any) identified on the Estimated Closing Statement, the portion of the Estimated Closing Date Indebtedness set forth opposite such Person&#8217;s name on the Estimated Closing Statement&#59; and </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(vi)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">To the Seller Representative, the Seller Representative Reserve, as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.15(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Within the later of fourteen (14) days after Closing and the next regularly scheduled payroll after Closing, Parent shall cause the Company through its customary payroll processes or, if applicable, any third party payroll services provider engaged by the Company or successor thereto, to pay to each Carve-Out Plan Participant, the amount set forth next to such Carve-Out Plan Participant&#8217;s name on the Estimated Closing Statement, subject to any required withholding and provided that as a condition to payment, such Carve-Out Plan Participant must have delivered an executed Carve-Out Plan Transmittal Document to the Company, Parent, or another Person designated by Parent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">No less than five (5) Business Days prior to the Closing Date, the Company shall deliver to Parent a spreadsheet (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Estimated Closing Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) setting forth&#58; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the Company&#8217;s good faith estimate of (i) the Closing Working Capital (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Estimated Closing Working Capital</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), (ii) the Closing Cash (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Estimated Closing Cash</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), (iii) the Closing Date Indebtedness (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Estimated Closing Date Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), (iv) the Closing Date Transaction Expenses (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Estimated Closing Date Transaction Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), and (v) the Closing Working Capital Adjustment (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Estimated Closing Working Capital Adjustment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(ii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the name of each holder of Company Capital Stock and Company Options immediately prior to the Effective Time, </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(iii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a designation, with respect to each holder of In-the-Money Options, as to whether such In-the-Money Options are Employee Options or Non-Employee Options, </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(iv)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the number of shares of Company Capital Stock held by each holder thereof immediately prior to the Effective Time (including the number of shares of Company Capital Stock for which Company Options are exercisable), </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(v)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the amount and calculation of the Closing Consideration and the Per Share Common Closing Consideration as of the Closing Date, </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(vi)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the name of each Carve-Out Plan Participant as of immediately prior to Closing, and the portion of the Carve-Out Plan Amount owed to such Carve-Out Plan Participant prior to any withholding,</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(vii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the portion of the Closing Consideration, as of the Closing Date, which each holder of Company Capital Stock, Company Warrants or In-the-Money Options, as applicable, is eligible to receive on the Closing Date under this Agreement (as if no amounts were withheld for the Escrow Fund, the Seller Representative Reserve or Taxes), </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(viii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the Pro Rata Fraction for each Participating Securityholder, </font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(ix)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the portion of the Escrow Amount deposited with respect to each Participating Securityholder in accordance with such Participating Securityholder&#8217;s Pro Rata Fraction, </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(x)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the portion of the Seller Representative Reserve to be contributed on behalf of each Participating Securityholder in accordance with such Participating Securityholder&#8217;s Pro Rata Fraction.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The items prepared for the Estimated Closing Statement under clause (i) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.7(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall be prepared in conformity with GAAP in accordance with the Company&#8217;s historical practices and methodologies and in a manner consistent with the illustrative calculation of Closing Working Capital attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Closing Date Adjustment Illustration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;). Upon the delivery of the Estimated Closing Statement, to the extent reasonably requested by Parent, the Company will make available to Parent and its Representatives the work papers (subject to the execution of customary work paper access letters, if requested) and other books and records used in preparing the Estimated Closing Cash, the Estimated Closing Working Capital, the Estimated Closing Date Indebtedness, the Estimated Closing Date Transaction Expenses, and the Estimated Closing Working Capital Adjustment.  The Estimated Closing Statement shall be delivered to Parent with a certificate of the Chief Executive Officer (or other authorized officer) of the Company certifying that the Estimated Closing Statement is a true and complete statement of the Company&#8217;s determination of the amounts set forth therein.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.8&#160;&#160;&#160;&#160;Loan Payoff.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company shall deliver to Parent prior to or at the Closing, (a) payoff letters for the Closing Date Indebtedness, which shall provide the dollar amount of all Closing Date Indebtedness required to be paid in order to fully pay off such Closing Date Indebtedness as of the Closing and providing for the release (upon such payoff) of all Liens relating to such Indebtedness and (b) drafts of termination statements under the Uniform Commercial Code, releases of intellectual property security interests and other instruments as may reasonably be requested by Parent to release all Liens and guarantees related to such Closing Date Indebtedness. </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.9&#160;&#160;&#160;&#160;Further Action. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> At and after the Effective Time, the officers and directors of the Surviving Corporation shall be authorized to execute and deliver, in the name and behalf of the Company or Merger Sub, any deeds, bills of sale, assignments or assurances and to take and do, in the name and on behalf of the Company or Merger Sub, any other actions and things to vest, perfect or confirm of record or otherwise in the Surviving Corporation any and all right, title and interest in, to and under any of the rights, properties or assets of the Company acquired or to be acquired by the Surviving Corporation as a result of, or in connection with, the Merger.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.10&#160;&#160;&#160;&#160;Closing of the Company&#8217;s Transfer Books.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">At the Effective Time&#58; (a)&#160;all shares of Company Capital Stock outstanding immediately prior to the Effective Time shall automatically be canceled and retired and shall cease to exist, and all holders of certificates representing shares of Company Capital Stock that were outstanding immediately prior to the Effective Time shall cease to have any rights as stockholders of the Company, and each certificate representing any such Company Capital Stock (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company Stock Certificate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) shall thereafter represent the right to receive the consideration referred to in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (or if applicable, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), if any&#59; and (b)&#160;the stock transfer books of the Company shall be closed with respect to all shares of Company Capital Stock outstanding immediately prior to the Effective Time.  No further transfer of any such shares of Company Capital Stock shall be made on such stock transfer books after the Effective Time. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.11&#160;&#160;&#160;&#160;Exchange&#47;Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Prior to the Closing and no later than the Closing Date, Parent shall deposit with the Payment Agent cash in the amount of the Closing Payment Amount in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.7(a)(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  In no event later than one Business Day after the Effective Time, Parent shall cause the Payment Agent to provide (electronically, with respect to any Company Stockholder for whom an email address is listed on the Estimated Closing Statement and who holds electronic, and not physical, Company Stock Certificates, and by physical mail, to any Company Stockholder for whom an email address is not provided or who holds physical Company Stock Certificates), with respect to the Company Stockholders as of immediately prior to the Effective Time, (i) a letter of transmittal in substantially the form attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Letter of Transmittal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) and (ii) instructions for use in effecting the surrender of Company Stock Certificates, if applicable, in exchange for the portion, if any, of the Merger Consideration payable in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (but subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Sections 1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).  Upon submission to the Payment Agent of a duly executed Letter of Transmittal, and with respect to any physical Company Stock Certificates the Company Stock Certificate, the holder of such Company Stock Certificate shall be entitled to receive in exchange therefor the cash amounts payable in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Sections 1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and&#47;or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, as the case may be (subject in each case to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Sections 1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) for each share of Company Capital Stock correctly listed on such duly executed Letter of Transmittal.  No Company Stockholder who holds electronic and not physical Company Stock Certificates shall be required to surrender any Company Stock Certificates in exchange for such Company Stockholder&#8217;s applicable portion of the Merger Consideration but such Company Stockholder shall be required to deliver a duly completed and validly executed Letter of Transmittal to the Payment Agent in order to receive its portion of the Merger Consideration.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font><br></font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i) Within one Business Day following the Effective Time, Parent shall cause the Payment Agent to provide, with respect to each holder of Non-Employee Options as of immediately prior to the Effective Time, an option termination agreement in the form acceptable to Parent (each, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Option Termination Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">and such other customary documents as may reasonably be required by the Payment Agent.  Upon delivery to the Payment Agent of a duly completed and validly executed electronic or physical Option Termination Agreement and such other documents as are reasonably required by the Payment Agent in accordance with the instructions therein, such holder of Non-Employee Options shall be entitled to receive in exchange therefor, and the Parent shall cause the Payment Agent to pay, the cash amounts payable in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (subject in each case to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Sections 1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(ii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Within three Business Days following the Effective Time, Parent shall cause the Surviving Corporation (or any Affiliate thereof or successor thereto) to provide, with respect to each holder of an Employee Option as of immediately prior to the Effective Time, an Option Termination Agreement. Upon delivery to the Surviving Corporation of a duly completed and validly executed electronic or physical Option Termination Agreement in accordance with the instructions therein, such holder of Employee Options shall be entitled to receive in exchange therefor, and Parent shall cause the Surviving Corporation (or any Affiliate thereof or successor thereto) to pay through its customary payroll processes or, if applicable, any third party payroll services provider engaged by the Surviving Corporation or any Affiliate thereof or successor thereto, the cash amounts payable in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Sections 1.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (subject in each case to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Sections 1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), within 10 days after receipt by the Surviving Corporation of the duly completed and validly executed Option Termination Agreement. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(iii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Within one Business Day following the Effective Time, Parent shall cause the Payment Agent to provide, with respect to each holder of Company Warrants as of immediately prior to the Effective Time, a warrant termination agreement in the form acceptable to Parent (each, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Warrant Termination Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) and such other customary documents as may reasonably be required by the Payment Agent. Upon delivery to the Payment Agent of a duly completed and validly executed electronic or physical Warrant Termination Agreement and such other documents as are reasonably required by the Payment Agent in accordance with the instructions therein, such holder of Company Warrants shall be entitled to receive in exchange therefor, and the Parent shall cause the Payment Agent to pay within three Business Days after receipt by the Payment Agent of the duly completed and validly executed Warrant Termination Agreement, the cash amounts payable in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (subject in each case to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Sections 1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Any portion of the amounts payable by the Payment Agent in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that remains undistributed by the Payment Agent to the applicable Participating Securityholders as of (i) the first anniversary of the Effective Time for amounts payable in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, (ii) the first anniversary of the Final Adjustment Amount Determination Date for amounts payable in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, and (iii) the first anniversary of the expiration of the Contingent Consideration Period for amounts payable in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall be delivered to Parent upon demand, and any Participating Securityholders who have not theretofore surrendered the documentation contemplated under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall thereafter look only to Parent for </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">satisfaction of their claims for the cash amounts payable in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Sections 1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Neither Parent nor the Surviving Corporation shall be liable to any Participating Securityholder or other holder or former holder of Company Capital Stock, Company Options or Company Warrants with respect to any amounts properly delivered to any public official pursuant to any applicable abandoned property Law or escheat Law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Each of Parent, the Surviving Corporation, the Payment Agent and the Escrow Agent (each a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Withholding Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) will be entitled to deduct and withhold from the consideration otherwise payable under this Agreement to any Participating Securityholder, the amounts such Withholding Agent is required to deduct and withhold under the Code or any other Tax Law.  If any withholding obligation may be reduced or avoided by any Participating Securityholder providing information or documentation to a Withholding Agent, such Participating Securityholder shall provide such information or documentation to Withholding Agent. At the request of a Participating Securityholder, the Withholding Agent shall use commercially reasonable efforts to cooperate with such Participating Securityholder to reduce or avoid such withholding obligation.  To the extent that amounts are so withheld and properly paid over to the applicable Governmental Entity in accordance with applicable Law, such withheld amounts will be treated as having been paid to the applicable Participating Securityholder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.12&#160;&#160;&#160;&#160;Post-Closing Adjustment to Closing Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Within 90 calendar days following the Closing, Parent shall prepare and deliver to the Seller Representative a written schedule (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Closing Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) setting forth in reasonable detail its calculation of (i) the Closing Working Capital, (ii) the Closing Cash, (iii) the Closing Date Indebtedness, (iv) the Closing Date Transaction Expenses, and (v) the Closing Working Capital Adjustment.  The Closing Statement shall be prepared in conformity with GAAP in accordance with the Company&#8217;s historical practices and methodologies and in a manner consistent with the Closing Date Adjustment Illustration and shall not include any changes in assets or liabilities as a result of purchase accounting adjustments or other changes arising from or resulting as a consequence of the transactions contemplated by this Agreement. Following the Closing, Parent shall provide the Seller Representative and its Representatives reasonable access (including by electronic delivery of documents), during regular business hours, in such a manner as to not interfere with the normal operation of Parent or the Surviving Corporation (subject to the execution of customary work paper access letters, if requested) work papers and books and records relating to the preparation of the Closing Statement solely for the purpose of assisting the Seller Representative in its review of the Closing Statement and the calculations contained therein.  The parties agree that the purpose of preparing the Closing Statement and determining the Closing Working Capital, the Closing Date Indebtedness and the Closing Date Transaction Expenses and the related purchase price adjustment contemplated by this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> is to measure the amount of Closing Cash, Closing Working Capital, Closing Date Indebtedness and Closing Date Transaction Expenses, and such processes are not intended to permit the introduction of new or different judgments, accounting methods, policies, principles, practices, procedures, classifications or estimation methodologies for the purpose of preparing the Closing Statement or determining Closing Cash, Closing Working Capital, Closing Date Indebtedness or Closing Date </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Transaction Expenses&#59;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%"> provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, in each case, that the judgments, accounting methods, policies, principles, practices, procedures, classifications and estimation methodologies used in preparing the Estimated Closing Statement and determining Estimated Closing Cash, Estimated Closing Working Capital, Estimated Closing Date Indebtedness and Estimated Closing Date Transaction Expenses were in conformity with GAAP in accordance with the Company&#8217;s historical practices and methodologies and, as applicable, in a manner consistent with the Closing Date Adjustment Illustration.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If the Seller Representative disagrees with the calculations in the Closing Statement, the Seller Representative shall notify Parent of such disagreement in writing (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Dispute Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) within 30 days after delivery of the Closing Statement.  The Dispute Notice must set forth in reasonable detail any item on the Closing Statement which the Seller Representative believes has not been prepared in accordance with this Agreement and the Seller Representative&#8217;s determination of the amount of such item.  Any item or amount that Seller Representative does not dispute in the Dispute Notice within such 30-day period shall be final, binding and conclusive for all purposes hereunder.  In the event any such Dispute Notice is timely provided, Parent and Seller Representative shall use commercially reasonable efforts for a period of 15 days (or such longer period as they may mutually agree) to resolve any disagreements with respect to the calculations included in the Closing Statement that were disputed in the Dispute Notice.  If, at the end of such period, the Seller Representative and Parent remain unable to resolve the dispute in its entirety, then the unresolved items and amounts thereof in dispute shall be submitted to Grant Thornton LLP, or if such firm cannot or does not accept such engagement, another nationally recognized independent accounting firm, reasonably acceptable to Parent and Seller Representative, which shall not be the independent accountants of Parent or the Company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Dispute Auditor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).  The Dispute Auditor shall determine, based solely on the provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and the related definitions in this Agreement and the written presentations by Seller Representative and Parent, and not by independent review, only those items and amounts that remain then in dispute as set forth in the Dispute Notice.  The Dispute Auditor&#8217;s determination of the Closing Working Capital, the Closing Date Indebtedness and&#47;or the Closing Date Transaction Expenses, as applicable, shall be made within 45 days after the dispute is submitted for its determination and shall be set forth in a written statement delivered to Seller Representative and Parent.  A judgment of a court of competent jurisdiction selected pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;9.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> hereof may be entered upon the Dispute Auditor&#8217;s determination.  The Dispute Auditor shall have exclusive jurisdiction over, and resorting to the Dispute Auditor as provided in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.12(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall be the only recourse and remedy of the parties against one another with respect to, those items and amounts that remain in dispute under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.12(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, and Parent shall not be entitled to seek indemnification or recovery of any attorneys&#8217; fees or other professional fees incurred by Parent in connection with any dispute governed by this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Dispute Auditor shall allocate its fees and expenses between the Parent and Seller Representative (on behalf of the Participating Securityholders) according to the degree to which the positions of the respective parties are not accepted by the Dispute Auditor. In no event shall the decision of the Dispute Auditor assign a value to any item greater than the greatest value for such item claimed by either Parent or Seller Representative or lesser than the smallest value for such item claimed by either Parent or Seller Representative.  Any determinations made by the Dispute Auditor pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall be final, non-appealable and binding on the parties hereto, absent manifest error or fraud. </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If, upon final determination in accordance with the terms of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (the date of such final determination, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Final Adjustment Amount Determination Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), the Adjustment Amount (if any) is a positive number, then the Merger Consideration shall be increased by the Adjustment Amount. If the Adjustment Amount (if any) is a negative number, the Merger Consideration shall be decreased by the Adjustment Amount.  If the Adjustment Amount (if any) is a positive number, within five (5) Business Days after the Final Adjustment Amount Determination Date, Parent shall pay the Adjustment Amount due pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Sections 1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> to the Payment Agent or the Surviving Corporation, as applicable, for further distribution to the applicable Participating Securityholders based on each such holder&#8217;s applicable Pro Rata Fraction of such Adjustment Amount.  If the Adjustment Amount (if any) is a negative number then within five (5) Business Days after the Final Adjustment Amount Determination Date, Parent and the Seller Representative shall deliver joint written instructions to the Escrow Agent directing the Escrow Agent to release to Parent the amount of such shortfall by wire transfer of immediately available funds to an account or accounts designated by Parent in such joint written instructions (it being understood that in no event shall any such recovery be in excess of the then-available amount in the Escrow Fund).  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Adjustment Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the net amount (if disputed, as finally determined in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.12(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), which may be positive or negative, equal to&#58; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(A) the Post-Closing Adjustment Amount (as finally determined in accordance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">minus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (B) the Closing Working Capital Adjustment set forth on the Estimated Closing Statement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(ii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(A) the amount of the Closing Cash (as finally determined in accordance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">minus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (B) the amount of the Estimated Closing Cash&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">plus</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(iii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(A) the Estimated Closing Date Indebtedness </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">minus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (B) the amount of Closing Date Indebtedness (as finally determined in accordance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(iv)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(A) the Estimated Closing Date Transaction Expenses </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">minus </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(B) the amount of Closing Date Transaction Expenses (as finally determined in accordance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Post-Closing Adjustment Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the net amount (if disputed, as finally determined in accordance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) which may be positive or negative (as to the overall net amount and each component used in the calculation of such net amount), equal to&#58; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the amount, if any, by which the Closing Working Capital (as finally determined in accordance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) is less than the Target Working Capital Floor, </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(ii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the amount, if any, by which the Closing Working Capital (as finally determined pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) is greater than the Target Working Capital Ceiling, and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(iii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">zero dollars ($0) if the Closing Working Capital (as finally determined pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) is equal to the Target Working Capital Floor or Target </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Working Capital Ceiling or is an amount that is greater than the Target Working Capital Floor but less than the Target Working Capital Ceiling. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.13&#160;&#160;&#160;&#160;Working Capital Escrow.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">On the Closing Date, Parent shall deliver to the Escrow Agent, as a deposit to the Escrow Fund, cash in an amount equal to $</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;***&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Escrow Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) from the Merger Consideration for the purpose of securing the obligations of the Participating Securityholders under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.  Each Participating Securityholder&#8217;s Pro Rata Fraction of the Escrow Amount shall be withheld from the Closing Consideration otherwise payable to such Participating Securityholder on the Closing Date.  The Escrow Fund shall be held by the Escrow Agent in accordance with the terms of this Agreement and the terms of the Escrow Agreement.  The Escrow Fund shall be held as a trust fund and shall not be subject to any lien, attachment, trustee process or any other judicial process of any creditor of any Person, and shall be held and disbursed solely for the purposes and in accordance with the terms of the Escrow Agreement. Any amounts held in the Escrow Fund following the Final Adjustment Amount Determination Date shall be released to the Payment Agent or the Surviving Corporation, as applicable, for further distribution to the Participating Securityholders in proportion to their respective Pro Rata Fractions no later than five (5) Business Days following the date on which, as applicable, (i) full and final payment is made of any Adjustment Amount payable to Parent pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.12(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> or (ii) a final determination is made pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that no Adjustment Amount is payable to Parent (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Working Capital Escrow Expiration Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Seller Representative shall, within three (3) Business Days after the Working Capital Escrow Expiration Date, as applicable, deliver to the Escrow Agent, Parent and the Payment Agent a written direction and an updated Estimated Closing Statement (which need not be certified by an officer of the Surviving Company) setting forth the portion of any distribution of the Escrow Fund payable to each Participating Securityholder. Each distribution of cash made from the Escrow Fund to the Participating Securityholder shall be made in proportion to the respective Pro Rata Fractions of the Participating Securityholders at the time of such distribution, as set forth in the updated Estimated Closing Statement and the Escrow Agreement. Escrow Fund releases due to the Participating Securityholders in respect of Company Capital Stock, Company Warrants, In-the-Money Options and&#47;or the Carve-Out Plan Amount shall be made to the Payment Agent or the Surviving Corporation, as applicable, for further distribution to the applicable Participating Securityholders based on each such Participating Securityholder&#8217;s applicable Pro Rata Fraction.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Any income, gains, losses and expenses of the Escrow Fund shall be included by Parent as taxable income or loss of Parent, and any income and gains of the Escrow Fund shall be available to Parent as part of the Escrow Fund, but if not paid to Parent in connection with or an Adjustment Amount in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall ultimately be distributable to the Participating Securityholders in accordance with this Agreement and the Escrow Agreement net of any tax liability incurred by Parent in respect thereof, which amount shall be simultaneously paid to Parent by wire transfer of immediately available funds to an account or accounts designated by Parent.</font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The approval of this Agreement by the Company Stockholders, and the acceptance of a portion of the Merger Consideration by the Participating Securityholders, shall constitute approval of the Escrow Agreement and of all of the arrangements relating thereto, including the placement of the Escrow Amount in the Escrow Fund in accordance with the terms hereof and thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.14&#160;&#160;&#160;&#160;Appraisal and Dissenters&#8217; Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding any other provision of this Agreement to the contrary, shares of Company Capital Stock held by a holder who has not voted in favor of the Merger or consented thereto in writing and who has duly and validly made a demand for appraisal of such shares in compliance with Section 262 of the DGCL (any such shares being referred to as &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Dissenting Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; until such time as such holder fails to perfect or otherwise loses such holder&#8217;s appraisal rights under Section 262 of the DGCL with respect to such shares or it is determined that such holder does not have appraisal rights in accordance with the DGCL), will not be converted into or represent the right to receive cash in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, but will be converted into the right to receive such consideration as may be determined to be due with respect to such Dissenting Shares pursuant to the DGCL (and at the Effective Time, such Dissenting Shares shall no longer be outstanding and shall automatically be canceled and shall cease to exist, and such holder shall cease to have any rights with respect thereto, except the rights set forth in Section 262 of the DGCL)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">that if a holder of Dissenting Shares (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Dissenting Stockholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) withdraws or loses such holder&#8217;s demand for such payment and appraisal or becomes ineligible for such payment and appraisal then, as of the later of the Effective Time or the date on which such Dissenting Stockholder withdraws such demand or otherwise becomes ineligible for such payment and appraisal, such holder&#8217;s Dissenting Shares will cease to be Dissenting Shares and will be converted into the right to receive a cash payment determined in accordance with and subject to the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Sections 1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) upon surrender of a Letter of Transmittal and the certificate representing such shares in accordance with the terms of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company shall give Parent&#58;  (i)&#160;prompt notice of&#58;  (A)&#160;any written demand received by the Company prior to the Effective Time to require the Company to purchase shares of Company Capital Stock pursuant to the DGCL, or, if applicable, Chapter 13 of the California Code&#59; (B)&#160;any withdrawal of any such demand and (C) any other demand, notice or instrument delivered to the Company pursuant to the DGCL or, if applicable, Chapter 13 of the California Code&#59; and (ii)&#160;the opportunity to participate in all negotiations and proceedings with respect to any such demand, notice or instrument. Prior to the Closing, neither Parent nor any of its Affiliates (including the Surviving Corporation) shall make or commit to make any payment with respect to any Dissenting Shares or offer to settle or settle any demands with respect to any Dissenting Shares without the prior written consent of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.15&#160;&#160;&#160;&#160;Seller Representative</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In order to efficiently administer certain matters contemplated hereby following the Closing, including any actions that the Seller Representative may, in its sole discretion, determine to be necessary, desirable or appropriate in connection with the matters set </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Sections 1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">1.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the Participating Securityholders, by the adoption of this Agreement, acceptance of consideration under this Agreement and&#47;or the completion and execution of the Participating Securityholders Transmittal Document shall be deemed to have designated Fortis Advisors LLC as the representative of the Participating Securityholders (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Seller Representative</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In the event the Seller Representative becomes unable to perform its responsibilities hereunder or resigns from such position, the Participating Securityholders who hold at least a majority in interest of the Pro Rata Fractions at such time shall be authorized to and shall select another representative to fill such vacancy and such substituted representative shall be deemed to be the Seller Representative for all purposes of this Agreement and the documents delivered pursuant hereto. The immunities and rights to indemnification shall survive the resignation or removal of the Seller Representative or any member of the Advisory Group and the Closing and&#47;or any termination of this Agreement and the Escrow Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By their adoption of this Agreement, acceptance of consideration under this Agreement and&#47;or the delivery of a Participating Securityholder Transmittal Document contemplated by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, and without any further action of any of the Participating Securityholders or the Company, the Participating Securityholders shall be deemed to have agreed, in addition to the foregoing, that&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the Seller Representative shall be appointed and constitute the true and lawful attorney-in-fact and exclusive agent of each Participating Securityholders with full power in his, her or its name and on his, her or its behalf to act according to the terms of this Agreement and in general to do all things and to perform all acts including, without limitation, executing and delivering any agreements, certificates, receipts, instructions, notices or instruments contemplated by or deemed advisable in connection with this Agreement, the Escrow Agreement or the Seller Representative Engagement Agreement&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(ii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the Seller Representative shall have full authority to (A)&#160;execute, deliver, acknowledge, certify and file on behalf of the Participating Securityholders (in the name of any or all of the Participating Securityholders or otherwise) any and all documents that the Seller Representative may, in its sole discretion, determine to be necessary, desirable or appropriate, in such forms and containing such provisions as the Seller Representative may, in its sole discretion, determine to be appropriate, (B)&#160;give and receive notices and other communications relating to this Agreement and the transactions contemplated hereby and thereby (except to the extent that this Agreement contemplates that such notice or communication shall be given or received by the Participating Securityholder individually), (C)&#160;take or refrain from taking any actions (whether by negotiation, settlement, litigation or otherwise) to resolve or settle all matters and disputes arising out of or related to this Agreement and the transactions contemplated hereby and thereby and (D)&#160;engage attorneys, accountants, financial and other advisors, paying agents and other persons necessary or appropriate in the judgment of the Seller Representative for the accomplishment of the foregoing&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify"><font><br></font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(iii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">notwithstanding the foregoing, the Seller Representative shall have no obligation to act on behalf of the Participating Securityholders, except as expressly provided herein, in the Escrow Agreement and in the Seller Representative Engagement Agreement&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(iv)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Parent shall be entitled to rely conclusively on the instructions and decisions given or made by the Seller Representative as to any of the matters described in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, and no party shall have any cause of action against Parent for any action taken by Parent in reliance upon any such instructions or decisions&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(v)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the Seller Representative shall be entitled to&#58; (i) rely upon the Estimated Closing Statement, (ii) rely upon any signature believed by it to be genuine, and (iii) reasonably assume that a signatory has proper authorization to sign on behalf of the applicable Participating Securityholder or other party&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(vi)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">all actions, decisions and instructions of the Seller Representative shall be conclusive and binding upon each of the Participating Securityholders and the Participating Securityholders successors as if expressly confirmed and ratified in writing by Participating Securityholders, all defenses which may be available to any Participating Securityholder to contest, negate or disaffirm the action of the Seller Representative taken in good faith under this Agreement, the Escrow Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">or the Seller Representative Engagement Agreement are waived, and no Participating Securityholder shall have any cause of action against the Seller Representative Group for any action taken, decision made or instruction given by the Seller Representative under this Agreement, the Escrow Agreement or the Seller Representative Engagement Agreement, except for fraud or willful breach of this Agreement on the part of the Seller Representative&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(vii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, and the powers, immunities and rights to indemnification granted to the Seller Representative Group hereunder&#58; (i) are independent and severable, are irrevocable and coupled with an interest, and shall be enforceable notwithstanding any rights or remedies that any Participating Securityholder may have in connection with the transactions contemplated by this Agreement, (ii) shall survive the death, incompetence, bankruptcy or liquidation of any Participating Securityholder and shall be binding on any successor thereto, and (iii) shall survive the delivery of an assignment by any Participating Securityholder of the whole or any fraction of his, her or its interest in the Escrow Amount and Contingent Consideration&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(viii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall be binding upon the executors, heirs, legal representatives successors and assigns of each Participating Securityholder, and any references in this Agreement to a Participating Securityholder or the Participating Securityholders shall mean and include the successors to the Participating Securityholders&#8217; rights hereunder, whether pursuant to testamentary disposition, the laws of descent and distribution or otherwise.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">At the Closing, Parent shall cause to be deposited, in an account designated by the Seller Representative, $500,000</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Seller Representative Reserve</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).  Each Participating Securityholders&#8217; Pro Rata Fraction of the Seller Representative Reserve shall be withheld from the </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Merger Consideration otherwise payable to such Participating Securityholder on the Closing Date.  The Seller Representative Reserve may be applied as the Seller Representative, in its sole discretion, determines to be appropriate to defray, offset, or pay any charges, fees, costs, liabilities, losses, claims, damages, judgments, fines, amounts paid in settlement or expenses (including fees, disbursements and costs of counsel and other skilled professionals and in connection with seeking recovery from insurers) that the Seller Representative incurred in connection with the transactions contemplated by this Agreement, the Escrow Agreement or the Seller Representative Engagement Agreement, including in connection with the matters contemplated by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and the evaluation or defense of any claim for indemnification under this Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Seller Representative Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), or as otherwise determined by the Advisory Group.  The Seller Representative is not providing any investment supervision, recommendations or advice and shall have no responsibility or liability for any loss of principal of the Seller Representative Reserve other than as a result of its gross negligence or willful misconduct.  The Seller Representative is not acting as a withholding agent or in any similar capacity in connection with the Seller Representative Reserve and has no tax reporting or income distribution obligations.  The Participating Securityholders will not receive any interest on the Seller Representative Reserve and assign to the Seller Representative any such interest.  Subject to Advisory Group approval, the Seller Representative may contribute funds to the Seller Representative Reserve from any consideration otherwise distributable to the Participating Securityholders.  The balance of the Seller Representative Reserve held pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.15(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, if any, shall, at the sole discretion of the Seller Representative and at such time to be determined in the sole discretion of the Seller Representative, be deposited with the Payment Agent and distributed to the Participating Securityholders according to each such Participating Securityholder&#8217;s Pro Rata Fraction.  Prior to any such distribution of the Seller Representative Reserve, the Seller Representative shall deliver to Parent and the Payment Agent an updated Estimated Closing Statement (which need not be certified by an officer of the Company) setting forth the portion of the Seller Representative Reserve payable to each Participating Securityholder. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Certain Participating Securityholders have entered into an engagement agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Seller Representative Engagement Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) with the Seller Representative to provide direction to the Seller Representative in connection with its services under this Agreement, the Escrow Agreement and the Seller Representative Engagement Agreement (such Participating Securityholders, including their individual representatives, collectively hereinafter referred to as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Advisory Group</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).  As between the Participating Securityholders and the Seller Representative, neither the Seller Representative nor its members, managers, directors, officers, contractors, agents and employees nor any member of the Advisory Group (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Seller</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Representative Group</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), shall be liable for any act done or omitted hereunder, under the Escrow Agreement or under the Seller Representative Engagement Agreement as Seller Representative while acting in good faith, and any act done or omitted to be done pursuant to the advice of counsel shall be conclusive evidence of such good faith.  The Seller Representative Group shall be indemnified, defended and held harmless and reimbursed by the Participating Securityholders against any Seller Representative Expenses incurred without bad faith, gross negligence or willful misconduct on the part of the Seller Representative and arising out of or in connection with the acceptance or administration of its duties hereunder, under the Escrow Agreement or under the Seller Representative Engagement Agreement and in connection with any Seller Representative Expenses, at the election of the Seller Representative, at any time (i) from </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">17.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the Seller Representative Reserve, to the extent any funds remain in such fund, (ii) following exhaustion of the Seller Representative Reserve, from any distribution of the Escrow Amount and Contingent Consideration otherwise distributable to the Participating Securityholders at the time of distribution, and (iii) directly from the Participating Securityholders according to each Participating Securityholder&#8217;s Pro Rata Fraction&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that no Participating Securityholder shall be liable to the Seller Representative for any amount in excess of the portion of the Merger Consideration actually paid to such Participating Securityholder.  The Participating Securityholders acknowledge that the Seller Representative shall not be required to expend or risk its own funds or otherwise incur any financial liability in the exercise or performance of any of its powers, rights, duties or privileges or pursuant to this Agreement, the Escrow Agreement, the Seller Representative Engagement Agreement or the transactions contemplated hereby or thereby.  Furthermore, the Seller Representative shall not be required to take any action unless the Seller Representative has been provided with funds, security or indemnities which, in its determination, are sufficient to protect the Seller Representative against the costs, expenses and liabilities which may be incurred by the Seller Representative in performing such actions.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.16&#160;&#160;&#160;&#160;Contingent Consideration.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Revenue Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Within 90 days after completion of each of the Measurement Period, the First Contingent Consideration Period and the Second Contingent Consideration Period, Parent will cause to be prepared and delivered to the Seller Representative a certificate (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Revenue Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) setting forth the Achieved Revenue for such period and, with respect to the Revenue Statement delivered following completion of the First Contingent Consideration Period and the Second Contingent Consideration Period, the amount of any Contingent Consideration due and payable by Parent to the Participating Securityholders (in the aggregate) in respect of such period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Defined Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. As used in this Agreement&#58; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Contingent Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means (i) for the First Contingent Consideration Period, an amount equal to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;***&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> the Achieved Revenue for the First Contingent Consideration Period exceeds </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;***&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (such amount, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">First Period Earned Contingent Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), and (ii) for the Second Contingent Consideration Period, an amount equal to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;***&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> the Achieved Revenue for the Second Contingent Consideration Period exceeds </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;***&#93; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(such amount, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Second Period Earned Contingent Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; and, with the First Period Earned Contingent Consideration, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Earned Contingent Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, in no event shall the aggregate of the First Period Earned Contingent Consideration and the Second Period Earned Contingent Consideration exceed Thirty-Five Million Dollars ($35,000,000) (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Maximum Contingent Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;)&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(ii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Achieved Revenue</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the gross revenue, determined in accordance with GAAP, from sales of the Company Products, and any product that is an improvement or modification to a Company Product or that embodies any Company Intellectual </font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">18.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Property or any material Intellectual Property licensed to the Company, (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Revenue Products</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) by the Company or an Affiliate thereof (in the case of sales during the Measurement Period) or by the Surviving Corporation or an Affiliate thereof (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Selling Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), less, in each case to the extent actually incurred or allowed and allocated to such products in accordance with GAAP, consistently applied, returns, allowances for returns, cash discounts, rebates, performance guarantees and fees paid or payable to any group purchasing organization to the extent such fees are in amounts customary in the trade of the Surviving Corporation and its Affiliates&#59; provided that Achieved Revenue outside of the United States will first be determined in the currency in which it is incurred and will then be converted into an amount in United States dollars using the Selling Party&#8217;s customary and usual conversion procedures for the applicable time period and such converted amount will be used in determining the Contingent Consideration&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(iii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">First Contingent Consideration Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the period beginning the first day of the fiscal quarter of Parent during which the Closing Date occurs and ending on the last day of the fourth successive fiscal quarter of Parent thereafter&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(iv)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Second Contingent Consideration Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the period beginning the day immediately following the end of the First Contingent Consideration Period and ending on the last day of the fourth successive fiscal quarter of Parent thereafter (with each of the First Contingent Consideration Period and the Second Contingent Consideration Period being referred to herein as a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Contingent Consideration Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;)&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(v)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Measurement Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the twelve-month period ending on the last day of the last completed calendar quarter preceding the Closing Date (unless the Closing Date is on the last day of a calendar quarter, in which case, such period will be the twelve-month period ending on the Closing Date) (such date, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Measurement Period End Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Dispute of Revenue Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Following delivery of the applicable Revenue Statement, Parent shall give the Seller Representative and its Representatives timely reasonable access to the work papers prepared or reviewed by Parent and its Representatives in connection with the preparation of the applicable Revenue Statement and to such other records and Representatives of Parent and any Selling Party as are reasonably necessary to enable the Seller Representative to verify the accuracy of the applicable Revenue Statement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Revenue Records</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).  Parent shall maintain the Revenue Records until one year after the end of the Second Contingent Consideration Period.  Seller Representative may dispute any amounts reflected on such Revenue Statement by notifying Parent in writing of each disputed item within 30 days after the date on which Seller Representative is given access to the applicable Revenue Records.  If Seller Representative delivers a notice of disagreement within such 30-day period, Seller Representative and Parent shall, during the 15 days following such delivery (or such longer period as they may mutually agree), each use commercially reasonable efforts to reach agreement on the disputed items or amounts in order to finally determine the amounts set forth on such Revenue Statement.  If Seller Representative and Parent are unable to reach agreement concerning any items on such Revenue Statement during such 15-day period, they shall promptly thereafter submit the dispute and all Revenue Records to the Dispute Auditor for resolution pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.12(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The amounts set forth on each Revenue Statement shall be deemed conclusively determined for purposes of this Agreement upon the earlier to occur of (i)&#160;the failure of Seller Representative to </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">19.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">notify Parent of a dispute within 30 days of the date on which Seller Representative is given access to the applicable Revenue Records, (ii)&#160;the mutual written resolution of all disputes by Parent and Seller Representative and (iii)&#160;the resolution of all disputes by the Dispute Auditor pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.12(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Payment Procedures</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Within 10 Business Days of the final determination of the Achieved Revenue for the applicable Contingent Consideration Period in accordance with the last sentence of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.16(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, Parent shall pay to the Payment Agent or the Surviving Corporation (as applicable), and shall cause the Payment Agent or the Surviving Corporation, as applicable, to pay to each Participating Securityholder, by wire transfer of immediately available funds (or by check, as reasonably directed by such person), such person&#8217;s Pro Rata Fraction of the Contingent Consideration for such Contingent Consideration Period (in accordance with the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).  The right of the Participating Securityholders to receive their respective Pro Rata Fractions of any Contingent Consideration shall not be evidenced by any form of certificate or instrument. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The right of any Participating Securityholder to receive such person&#8217;s Pro Rata Fraction of any Contingent Consideration shall not be assignable or transferable except by will, the applicable Laws of intestacy or other operation of applicable Law, without Parent&#8217;s written consent (which shall not be unreasonably withheld, conditioned or delayed but which may be subject to Parent&#8217;s requirement that any costs or expenses related to any such assignment or transfer be borne by the applicable Participating Securityholder) and neither Parent, the Surviving Corporation, the Payment Agent, nor the Seller Representative shall give effect to any purported assignment or transfer made in contravention of this sentence.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Until the end of the Second Contingent Consideration Period, Parent shall, and shall cause each Selling Party to, use commercially reasonable efforts to commercialize and sell Company Products&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that nothing in this clause (i) shall require Parent to commercialize or sell any Company Products outside the United States.  Without limiting the foregoing, at no point during either Contingent Consideration Period shall Parent take, or shall Parent permit any Selling Party to take, directly or indirectly, any action for the primary purpose of avoiding or reducing any of the Earned Contingent Consideration, it being understood that subject to the first sentence of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.16(e)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, Parent shall have sole discretion with regard to all matters relating to the operation of the Surviving Corporation and its Affiliates.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(ii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Until the end of the Second Contingent Consideration Period, in the event of the occurrence of any of the following events, if the Maximum Contingent Consideration has not been paid, then the difference between the Maximum Contingent Consideration and the Contingent Consideration already paid shall be immediately due and payable in full&#58; (A)&#160;Parent or the Surviving Corporation commences any proceeding in bankruptcy or for dissolution, liquidation, winding-up, or other relief under state or federal bankruptcy laws&#59; (B)&#160;any such proceeding is commenced against Parent or the Surviving Corporation, or a receiver or trustee is appointed for Parent or the Surviving Corporation or a substantial part of its respective property, and such proceeding or appointment is not dismissed or discharged within sixty (60) days after its commencement&#59; (C)&#160;Parent or the Surviving Corporation makes an assignment for the benefit of creditors, or petitions or applies to any tribunal for the appointment of a custodian, receiver or </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">20.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">trustee for all or substantially all of its assets or has a receiver, custodian or trustee appointed for all or substantially all of its assets&#59; or (D) a Change of Control is consummated.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Duty to Notify&#59; Information Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  Parent shall deliver a status update to the Seller Representative not less frequently than&#160;once each calendar quarter during either Contingent Consideration Period including the Achieved Revenue as of the end of the applicable quarter and a high-level summary of commercialization activities conducted in such quarter&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that in no case shall Parent be required to provide any such status update before it publicly announces its financial results for the applicable quarter.  Parent shall also provide additional information related to the Achieved Revenue and commercialization activities as reasonably requested by the Seller Representative. The Seller Representative shall not disclose any information included in any such status update except to Company Stockholders who serve on the Seller Representative&#8217;s advisory committee or who have executed a confidentiality agreement on substantially similar terms as those set forth in the Confidentiality Agreement or as necessary to enforce this Agreement or as required by applicable law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(g)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Restrictions on Transfer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Until the earlier to occur of the payment of the Maximum Contingent Consideration and the end of the Second Contingent Consideration Period, if Parent or the Surviving Corporation or an Affiliate thereof sells, assigns, licenses or otherwise transfers rights in or to any Revenue Product to a third party (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Significant Sale</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), then Parent shall either (i) cause such third party in such Significant Sale to assume Parent&#8217;s obligations under this Agreement with respect to the Contingent Consideration, which assumption shall not require any Participating Securityholder&#8217;s or the Seller Representative&#8217;s consent, provided that Parent shall remain liable for all such assumed obligations, or (ii) pay the difference between the Maximum Contingent Consideration and the Earned Contingent Consideration already paid to the Payment Agent for distribution to the Participating Securityholders in accordance with the terms of this Agreement within 20 Business Days following the consummation of such Significant Sale. For the sake of clarity, in no event shall (A) the grant of rights to market, sell, and&#47;or pursue and maintain regulatory clearances with respect to a Revenue Product to a third party distributor, subdistributor or other reseller of Parent or the Surviving Corporation or an Affiliate thereof or (B) the sale of any Revenue Product to a customer or end-user constitute a &#8220;Significant Sale.&#8221;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">R</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">EPRESENTATIONS AND </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">W</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ARRANTIES OF THE </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">OMPANY</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company represents and warrants to Parent and Merger Sub, except as set forth in the Disclosure Schedule, as follows&#58; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.1&#160;&#160;&#160;&#160;Authority&#59; Binding Nature of Agreement.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company has all necessary corporate power and authority to enter into and to perform its obligations under this Agreement and each Transaction Document to which it is a party, and, subject to, in the case of the consummation of the Merger, adoption of this Agreement by the Required Company Stockholder Votes, to consummate the transactions contemplated hereby and thereby.  As of the date of this Agreement, the Board of Directors of the Company (at a meeting duly called and held) has (a)&#160;determined that this Agreement, the Merger and the other Transactions are advisable and fair </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">21.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">and in the best interests of the Company and its stockholders, (b)&#160;authorized, approved and declared advisable the &#8220;agreement of merger&#8221; (as such term is used in Section 251 of the DGCL) contained in this Agreement, the execution, delivery and performance of this Agreement by the Company and the consummation of the Merger, and (c)&#160;recommended the adoption of the &#8220;agreement of merger&#8221; contained in this Agreement by the Company Stockholders and directed that the &#8220;agreement of merger&#8221; contained in this Agreement be submitted for consideration by the Company Stockholders by written consent (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company Board Recommendation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).  This Agreement has been duly executed by the Company, and constitutes the legal, valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, subject to (i)&#160;laws of general application relating to bankruptcy, insolvency and the relief of debtors, and (ii)&#160;rules of law governing specific performance, injunctive relief and other equitable remedies. When each Transaction Document to which the Company is or will be a party has been duly executed and delivered by the Company (assuming due authorization, execution and delivery by each other party thereto), such Transaction Document will constitute a legal and binding obligation of the Company enforceable against it in accordance with its terms, subject to (i)&#160;laws of general application relating to bankruptcy, insolvency and the relief of debtors, and (ii)&#160;rules of law governing specific performance, injunctive relief and other equitable remedies.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.2&#160;&#160;&#160;&#160;Due Incorporation&#59; No Subsidiaries&#59; Etc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company is a corporation duly incorporated, validly existing and in good standing under the laws of the State of Delaware and has all necessary corporate power and authority to own, operate or lease the properties and assets now owned, operated or leased by it and to conduct its business in the manner in which its business has been and is currently being conducted.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company is qualified to do business as a foreign corporation, and is in good standing, under the laws of all states where the nature of its business requires such qualification, except where the failure to be so qualified or in such good standing has not had and could not reasonably be expected to have a Company Material Adverse Effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company does not own, have any interest in any shares or have an ownership interest in any other Person, and it has never owned, had any interest in any shares or had any ownership interest in any other Person.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.3&#160;&#160;&#160;&#160;Articles of Incorporation and Bylaws.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company has delivered or made available to Parent copies of the Company Charter and Company bylaws, including all amendments thereto, as in effect on the date hereof, which organizational documents are in full force and effect. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.4&#160;&#160;&#160;&#160;Capitalization, Etc. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">As of the date of this Agreement, the authorized capital of the Company consists of&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font><br></font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">22.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">121,005,403 shares of Preferred Stock, of which 30,581,046 shares of Series 3 Preferred Stock are issued and outstanding and 191,689 shares of Series 3 Preferred Stock are subject to issuance upon exercise of outstanding Company Warrants, 7,839,461 shares of Series 4 Preferred Stock are issued and outstanding and 72,120 shares of Series 4 Preferred Stock are subject to issuance upon exercise of outstanding Company Warrants, 45,971,053 shares of Series 5 Preferred Stock are issued and outstanding and 3,741,351 shares of Series 3 Preferred Stock are subject to issuance upon exercise of outstanding Company Warrants, and 32,608,683 shares of Series 6 Preferred Stock are issued and outstanding&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(ii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">146,000,000 shares of Company Common Stock, of which 4,548,906 shares are issued and outstanding. 18,478,131 shares of Company Common Stock are reserved for issuance under the Company Option Plan, of which 16,158,947 shares are subject to outstanding stock options under the Company Option Plan and 2,319,184 shares remain available for future grant under the Company Option Plan, and 448,842 shares of Company Common Stock are subject to issuance upon exercise of outstanding Company Warrants. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Except as set forth in Section 2.4(a) above and except for (i)&#160;the Company Options, (ii) the Company Warrants, (iii)&#160;the conversion privileges of the Company Preferred Stock and (iv)&#160;those rights set forth in Part 2.4(b) of the Disclosure Schedule, (A)&#160;there are no other existing options, warrants, calls, rights (including conversion rights, preemptive rights, co-sale rights, rights of first refusal or other similar rights), agreements or commitments of the Company or to which the Company, any Company Stockholder or holder of Company Options or Company Warrants is a party requiring, and there are no securities of the Company outstanding which upon conversion or exchange would require, the issuance, sale or transfer of any additional shares of capital stock or other equity securities of the Company or other securities convertible into, exchangeable for or evidencing the right to subscribe for or purchase shares of Company Capital Stock or other equity securities of the Company, (B)&#160;there are no commitments or obligations, contingent or otherwise, of the Company to&#160;repurchase, redeem or otherwise acquire any shares of Company Capital Stock and (C)&#160;there are no outstanding stock appreciation, phantom stock, profit participation or similar rights with respect to the Company.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Except for those rights set forth in Part 2.4(c) of the Disclosure Schedule, there are no bonds, debentures, notes or other Indebtedness of the Company having the right to vote or consent (or, convertible into, or exchangeable for, securities having the right to vote or consent) on any matters on which the Company Stockholders may vote.  Except as set forth in Part&#160;2.4(c) of the Disclosure Schedule, there are no voting trusts, irrevocable proxies or other Contracts to which the Company, or, to the Company&#8217;s Knowledge, any Company Stockholder or any holder of Company Options or Company Warrants is a party or is bound with respect to the voting or consent of any shares of Company Capital Stock. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">All of the outstanding shares of Company Capital Stock are, and all shares which may be issued pursuant to the exercise of the Company Options and Company Warrants, when issued in accordance with the applicable security, will be (i) duly authorized, validly issued, fully paid and non-assessable, (ii) not subject to any preemptive rights created by statute, the provisions of the Company Charter or Company bylaws, or any agreement to which the Company is a party&#59; and (iii) free of any Encumbrances created by the Company in respect thereof. All of </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">23.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the outstanding shares of Company Capital Stock, the Company Options and the Company Warrants have been issued and granted in all material respects in compliance with all applicable Laws.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Part 2.4(e) of the Disclosure Schedule sets forth (i) the name of each Person that is the registered owner of any shares of Company Capital Stock outstanding as of the date of this Agreement and the number and class of shares owned by such Person&#59; (ii) with respect to each Company Option that is outstanding as of the date of this Agreement&#58; (A) the name of the holder of such Company Option&#59; (B) the total number of shares of Company Common Stock that are subject to such Company Option&#59; (C) the exercise price per share of Company Common Stock purchasable under such Company Option&#59; and (D) whether such Company Option is an Employee Option or a Non-Employee Option&#59; (iii) with respect to each Company Warrant that is outstanding as of the date of this Agreement&#58; (A) the name of the holder of such Company Warrant&#59; (B) the total number and class of shares and class of Company Capital Stock that are subject to such Company Warrant&#59; and (C) the exercise price per share of Company Capital Stock purchasable under such Company Warrant and (iv) with respect to the Company Carve-Out Plan, as of the date of this Agreement&#58; (A) the name of each Carve-Out Plan Participant, (B) the percentage of Net Proceeds that the Board has approved as the Carve-Out Plan Amount, and (C) the percentage of the Carve-Out Plan Amount that each Carve-Out Plan Participant would be entitled to receive after the Effective Time pursuant to the Company Carve-Out Plan, assuming that such Carve-Out Plan Participant were to have complied with all requirements of the Company Carve-Out Plan necessary to receive such amounts at the times and subject to the conditions set forth in the Company Carve-Out Plan. Prior to the Effective Time, the Company will provide to Parent (x) the determination of the aggregate amount of Net Proceeds by the Board of Directors of the Company, and (y) the Company&#8217;s determination (set forth on the Estimated Closing Statement as required by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.7(c)(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) of the amount of the Carve-Out Plan Amount that each Carve-Out Plan Participant is entitled to receive (prior to applicable withholding and taxes) pursuant to the Company Carve-Out Plan as of the Effective Time, assuming that such Carve-Out Plan Participant has complied with all requirements of the Company Carve-Out Plan necessary to receive such amounts as of the Effective Time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Each grant of a Company Option was duly authorized no later than the date on which the grant of such Company Option was by its terms to be effective (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Grant Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) by all necessary corporate action, the award agreement governing such grant was duly executed and delivered by each party thereto, each such grant was made in accordance with the terms of the Company Option Plan and all other applicable legal requirements and the per share exercise price of each Company Option was equal to the fair market value of a share of Common Stock on the applicable Grant Date. No Company Options are treated as non-exempt nonqualified deferred compensation arrangements under Section&#160;409A of the Code and the treasury regulations thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.5&#160;&#160;&#160;&#160;Non-Contravention&#59; Consents.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Except as set forth in Part 2.5 of the Disclosure Schedule, the execution, delivery and performance of this Agreement by the Company and the consummation by the Company of the transactions contemplated by this Agreement will not cause a&#58; (a) violation of any of the provisions of the Company Charter or Company bylaws&#59; (b)&#160;violation by the Company of any Law applicable to the Company&#59; or (c) default (or an event that, with or </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">24.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">without notice or lapse of time or both would constitute a default) on the part of the Company under, or give to others any rights of termination, cancellation or acceleration of any material obligations of the Company pursuant to, any Material Contract, or result in the creation of a Lien on any of the properties or assets of the Company (other than a Permitted Encumbrance).  Except as set forth in Part 2.5 of the Disclosure Schedule and except as may be required by the DGCL or HSR Act, the Company is not required to obtain any Consent from, or submit any filing or notification to, any Governmental Entity or party to a Material Contract at any time prior to the Closing as a result of, or in order to carry out, the execution and delivery of this Agreement, the other Transaction Documents or the consummation by the Company of the Transactions.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.6&#160;&#160;&#160;&#160;Financial Statements.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company has delivered or otherwise made available to Parent or its counsel (a)&#160;the Company&#8217;s audited balance sheet as of December 31, 2018 and December 31, 2019, (b)&#160;the Company&#8217;s audited statement of operations and statement of cash flows for each of the fiscal years ended December 31, 2018 and December 31, 2019, and (c) the Company&#8217;s unaudited balance sheet as of September 30, 2020 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Unaudited Balance Sheet</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), and the unaudited statement of operations and statement of cash flows for the 9 months ended September 30, 2020 (all of the foregoing financial statements of the Company and any notes thereto are hereinafter collectively referred to as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company Financial Statements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;). The Company Financial Statements were prepared in accordance with GAAP applied on a consistent basis throughout the period involved and fairly present in all material respects the financial condition of the Company at the dates therein indicated and the results of operations of the Company for the periods therein specified in accordance with GAAP, except (i)&#160;as may be indicated in the footnotes to such financial statements and (ii)&#160;that the unaudited financial statements do not contain footnotes (none of which, if presented, would materially differ from those in the audited financial statements) and are subject to normal and recurring year-end adjustments (none of which are, individually or in the aggregate, material).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.7&#160;&#160;&#160;&#160;Absence of Certain Changes.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Except as expressly contemplated by this Agreement, between the date of the Unaudited Balance Sheet and the date of this Agreement, there has not occurred&#58;  (a)&#160;any event or occurrence or series of related events or occurrences that has had or could reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect&#59; or (b)&#160;any event or action that would require the consent of Parent pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Sections 4.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> if such event or action occurred during the Pre-Closing Period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.8&#160;&#160;&#160;&#160;Title to Assets.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company has good and valid title to all assets owned by it as of the date of this Agreement, other than Intellectual Property which is covered by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, including all assets (other than capitalized or operating leases) reflected on the Unaudited Balance Sheet (except for assets sold or otherwise disposed of since the date of the Unaudited Balance Sheet in the ordinary course of business).  Except as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Part 2.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of the Disclosure Schedule, (a) all of such assets are owned by the Company free and clear of any Liens (other than Permitted Encumbrances), (b) all of such assets are in good operating condition and repair, and are adequate for the uses to which they are being put as of the date of this Agreement and (c) all of such assets </font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">25.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">are sufficient for the continued conduct of the Company&#8217;s business after the Closing in substantially the same manner as conducted as of the date of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.9&#160;&#160;&#160;&#160;Real Property&#59; Leasehold. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> The Company does not own, and has never owned, any real property, and the Company does not own, and has never owned, any interest in real property, except for the leaseholds created under the real property leases identified in Part 2.9 of the Disclosure Schedule (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Leased Real Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).  The Company is in material compliance with such real property leases and has a valid and subsisting leasehold interest in all Leased Real Property, in each case free and clear of all Liens, other than Permitted Encumbrances.  The Company has not granted any other Person the right to occupy or use any Leased Real Property. There are no written or oral subleases, licenses, concessions, occupancy agreements or other Contracts granting to any other Person the right of use or occupancy of any Leased Real Property or under which the Company is a sublessor of any Leased Real Property.  The Company has not received written notice of (a) default, or intention to terminate or not renew, any real property lease or (b) any eminent domain, condemnation or similar proceeding pending or threatened, against all or any portion of any Leased Real Property.  The use and operation of the Leased Real Property in the conduct of the Company&#8217;s business does not violate in any material respect any Law, covenant, condition, restriction, easement, license, Permit or agreement.  There are no Legal Proceedings pending nor, to the Company&#8217;s Knowledge, threatened against or affecting the Leased Real Property or any portion thereof or interest therein in the nature or in lieu of condemnation or eminent domain proceedings.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.10&#160;&#160;&#160;&#160;Intellectual Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Part 2.10(a) of the Disclosure Schedule sets forth a list of each Company Product.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Part 2.10(b)(i) of the Disclosure Schedule identifies&#58; (i)&#160;each item of Registered IP in which the Company has or purports to have an ownership interest of any nature (whether exclusively, jointly with another Person, or otherwise)&#59; (ii)&#160;the jurisdiction in which such item of Registered IP has been registered or filed and the applicable registration or serial number and filing and registration date&#59; (iii)&#160;any other Person that has an ownership interest in such item of Registered IP and the nature of such ownership interest, and (iv) any unregistered copyrights, trademarks or software that is material to the Company.  To the Company&#8217;s Knowledge, each of the Patents included in the Registered IP that are owned by the Company properly identifies by name each and every inventor of the claims thereof as determined in accordance with the Laws of the jurisdiction in which such Patent is issued or pending.  Each item of Company Intellectual Property is, to the Company&#8217;s Knowledge, valid and enforceable, and in the case of Registered IP, subsisting.  As of the date of this Agreement, no Registered IP that is listed or required to be listed on Part 2.10(b)(i) of the Disclosure Schedule is involved in any interference, opposition, reissue, reexamination, revocation, or equivalent proceeding, in which the scope, validity or enforceability of any such Registered IP is being contested or challenged.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Except as set forth in Part 2.10(c) of the Disclosure Schedule, the Company exclusively owns and has good, valid, and sole title (free and clear of all Liens other than Permitted Encumbrances) to all of the Company Intellectual Property.  The Company Intellectual Property, </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">26.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">together with any Intellectual Property and Intellectual Property Rights licensed to the Company pursuant to an Inbound License constitutes all Intellectual Property and Intellectual Property Rights used in, necessary for or otherwise material to the operation of the business of the Company, other than Off-the-Shelf Software. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">To the Company&#8217;s Knowledge, the Company&#8217;s conduct of the business as currently conducted does not infringe, misappropriate or otherwise violate, and has not infringed, misappropriated or otherwise violated any valid Intellectual Property Rights of others.  Except as set forth in Part 2.10(d) of the Disclosure Schedule, since January 1, 2017, no Person has asserted any written claim (i) challenging or questioning the Company&#8217;s right, interest or title in any of the Company Intellectual Property or (ii) alleging infringement or misappropriation of any Intellectual Property by the Company.  None of the Company Intellectual Property is subject to any pending or outstanding injunction, directive, order, judgment, or other disposition of dispute that adversely restricts the use, transfer, registration or licensing of any such Intellectual Property by the Company, or otherwise adversely affects the validity, scope, use, registrability, or enforceability of any Company Intellectual Property.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">To the Company&#8217;s Knowledge, since January 1, 2017 no Person has infringed or misappropriated, and no Person is currently infringing, misappropriating or otherwise violating any Company Intellectual Property.  The Company has not, since January&#160;1, 2017, asserted any claim that any Person has infringed, misappropriated or otherwise violated any Company Intellectual Property.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Part 2.10(f) of the Disclosure Schedule identifies each Contract pursuant to which any material Intellectual Property or Intellectual Property Rights are licensed to the Company (other than (i)&#160;agreements between the Company and its employees and consultants, (ii)&#160;non-exclusive licenses to commercially available third-party software (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Off-the-Shelf Software</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) or (iii)&#160;non-disclosure agreements entered into in the ordinary course of business consistent with past practice) (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Inbound Licenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).  For the avoidance of doubt, a covenant not to sue granted in favor of the Company and that relates to Intellectual Property shall be considered an Inbound License.  Except with respect to the agreements listed in Part 2.10(f) of the Disclosure Schedule and Off-the-Shelf Software, the Company is not obligated under any contract or other agreement to make any payments by way of royalties, fees, or otherwise to any owner or licensor of, or other claimant to, any Intellectual Property or Intellectual Property Rights.  Except as set forth on Part 2.10(f) of the Disclosure Schedule, all Off-the-Shelf Software used by the Company in the conduct of its business will continue to be available for use by the Surviving Corporation following the consummation of the Transactions without payment of any additional fees by the Surviving Corporation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(g)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Part 2.10(g) of the Disclosure Schedule lists each outbound license of Company Intellectual Property, other than non-exclusive licenses entered into in the ordinary course of business (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Outbound Licenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).  Each Inbound License and Outbound License is valid and enforceable against the Company and the counterparties thereto.  The Company is not, and to the Company&#8217;s Knowledge, no counterparty thereto is in default or other breach of any Inbound License or Outbound License.  For the avoidance of doubt, a covenant not to sue granted by the Company and that relates to Intellectual Property shall be considered an Outbound License.  </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">27.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(h)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company has taken reasonable security measures, including measures against unauthorized disclosure, to protect the secrecy, confidentiality, and value of its trade secrets and other technical information.  To the Company&#8217;s Knowledge, there has been no unauthorized use or disclosure of any of the Company&#8217;s trade secrets or other technical information.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">All current and former employees, contractors, consultants of the Company and any other Persons who have been involved in the development of any Company Intellectual Property for or on behalf of the Company have executed agreements (i) acknowledging the Company&#8217;s exclusive ownership of all Intellectual Property invented, created, or developed by such employee or independent contractor within the scope of his or her employment or engagement with the Company&#59; (ii) granting to the Company a present, irrevocable assignment of any ownership interest such employee or independent contractor may have in or to such Intellectual Property&#59; and (iii) irrevocably waiving any right or interest, including any moral rights, regarding any such Intellectual Property, to the extent permitted by applicable Law (each, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">IP Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).  All such IP Agreements are in the form(s) provided to Parent, and the Company has provided Parent with true and complete copies of all such IP Agreements.  No employee, officer, director, consultant or advisor of the Company (i) has any right, license, and claim or interest whatsoever in or with respect to any Company Intellectual Property, or (ii) to the Company&#8217;s Knowledge, is in material violation of any IP Agreement.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(j)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Except as set forth on Part 2.10(j) of the Disclosure Schedule, no Governmental Entity or academic institution has any right to, ownership of, or right to royalties for or license to any Company Intellectual Property.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(k)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The execution and delivery of this Agreement and the consummation of the transactions contemplated hereby (alone or in combination with any other event), and the compliance with the provisions of this Agreement do not and will not conflict with, alter, or impair, any of the rights of the Company in any Company Intellectual Property or any rights of the Company under agreements identified in Part 2.10(f) of the Disclosure Schedule or the validity, enforceability, use, right to use, ownership, priority, duration, or scope of any Company Intellectual Property or any Intellectual Property or Intellectual Property Rights that the Company uses pursuant to an agreement identified in Part 2.10(f) of the Disclosure Schedule.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(l)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Part 2.10(l)(i) of the Disclosure Schedule identifies each item of Open Source Code used or distributed in connection with each Company Product and the Company Software, including an identification of the license pursuant to which such Open Source Code is used or distributed, identification of the Company Product or Company Software with which such Open Source Code is used or distributed and a description of the manner of use or distribution of such Open Source Code.  Except as set forth in Part 2.10(l)(ii) of the Disclosure Schedule, the Company has not used and no Company Software contains any Open Source Code in a manner that&#58; (i) requires the Company to distribute or disclose the source code of any Company Software&#59; (ii) requires the Company to distribute or make available any Company Software without charge or at a reduced charge&#59; or (iii) provides users the right to decompile, disassemble or otherwise reverse engineer any Company Software&#59; except, in each of the foregoing cases, other than with respect to the Open Source Code itself.  </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">28.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(m)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Except as listed in Part 2.10(m) of the Disclosure Schedule, and except for software (e.g., javascript) which is customarily delivered in source code form in the ordinary course of providing such software (e.g., accompanying a developer&#8217;s kit), the Company has not disclosed or delivered to any Person, or permitted the disclosure or delivery to any escrow agent or other Person of, the source code for any Company Software, other than to consultants and independent contractors pursuant to a non-disclosure and confidentiality agreement and in connection with their work for the Company.  No event has occurred, and no circumstance or condition exists, that (with or without notice or lapse of time, or both) shall result in the disclosure or delivery of the source code for any Company Software by the Company or any escrow agent to any other Person.  Part 2.10(m) of the Disclosure Schedule identifies each Contract pursuant to which Company has deposited, or is or may be required to deposit, with an escrow agent or other Person, the source code for any Company Software.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(n)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Using commercially available tools and procedures, the Company has periodically scanned the Company Software in a manner designed to help ensure that none of the Company Software contains any undocumented &#8220;back door,&#8221; &#8220;drop dead device,&#8221; &#8220;time bomb,&#8221; &#8220;Trojan horse,&#8221; &#8220;virus,&#8221; or &#8220;worm&#8221; (as such terms are commonly understood in the software industry) or any other code designed or intended to have, or capable of performing, any of the following functions&#58;  (i)&#160;disrupting, disabling, harming or otherwise impeding in any manner the operation of, or providing unauthorized access to, a computer system or network or other device on which such code is stored or installed&#59; or (ii)&#160;damaging or destroying any data or file without the user&#8217;s consent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(o)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company is, and at all times during the past six years has been, in compliance with (i) its own website privacy policy and any other external facing policies governing Personal Data in the Company&#8217;s possession or control (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Privacy Policies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;)&#59; (ii) all applicable Privacy Laws&#59; (iii) all Contracts (or portions thereof) to which the Company is a party that contain obligations governing Personal Data&#59; and (iv) the PCI Security Standards Council&#8217;s Payment Card Industry Data Security Standard and all other applicable rules and requirements by the PCI Security Standards Council, card brand, merchant bank, or acquiring bank (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">PCI Requirements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;)&#59; except in each case of (i) through (iv), individually and in the aggregate, as could not reasonably be expected to result in liability material to the Company. The Company has not received any written notices from any Government Entity or Person alleging a violation of any applicable Privacy Laws and, to the Company&#8217;s Knowledge, no circumstance exists that may reasonably lead to any investigation of the Company by any Government Entity with respect to applicable Privacy Laws or require the Company to take any action, including the notification of any Person, with respect to any violation under any applicable Privacy Laws. Except as would not reasonably be expected to result in liability material to the Company, there has been no unauthorized intrusion, ransomware, or breaches of security into any Company systems.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(p)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">At all times during the past six years, the Company has taken commercially reasonable steps (such as, implementing, maintaining, and monitoring compliance with government-issued or industry standard measures with respect to administrative, technical and physical security) designed to protect all Personal Data and confidential information in its possession or control against damage, loss, and against unauthorized access, acquisition, use, modification, disclosure or other misuse. Except as would not reasonably be expected to result in </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">29.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">liability material to the Company, there has been no unauthorized access, use, or disclosure of Personal Data or confidential information in the possession or control of the Company, or, to the Company&#8217;s Knowledge, any of the Company&#8217;s contractors, service providers, or other entities processing the Company&#8217;s Personal Data on the Company&#8217;s behalf. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(q)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company contractually requires all third parties, including vendors, affiliates, and other persons providing services to the Company that have access to or receive Personal Data from or on behalf of the Company to comply with all applicable Privacy Laws, and to take commercially reasonable steps designed to protect Company Personal Data in such third parties&#8217; possession or control against damage, loss, and against unauthorized access, acquisition, use, modification, disclosure or other misuse.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(r)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company has provided notifications to, and has obtained consent from, Persons regarding its processing of Personal Data where such notice or consent is required by applicable Privacy Laws.  The Company has collected all Personal Data in accordance with its Privacy Policies and Privacy Laws, and the Company&#8217;s collection of such Personal Date or any other data from third parties is in accordance with any requirements from such third parties, including written website terms and conditions.  The Company has all permissions necessary to provide all Personal Data to Parent, and, to the Company&#8217;s Knowledge, Parent may use such Personal Data in at least the same manner as Company used such Personal Data prior to the consummation of the transactions contemplated under this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.11&#160;&#160;&#160;&#160;Regulatory Matters&#59; Healthcare Laws&#59; Healthcare Permits.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company and any Person acting on its behalf are, and have been at all times, in compliance in all material respects with all Healthcare Laws and Orders applicable to the operation of the Company&#8217;s business, as well as the terms of and ongoing obligations associated with any applicable Healthcare Permit in each case, regarding the design, development, sale, distribution and promotion of any Company Products in jurisdictions where the Company currently conducts such activities.  The Company has not received any request for information, notice, subpoena, demand letter, administrative inquiry, formal or informal complaint, claim, or other written notice from any Governmental Entity (i) contesting the sale of any Company Product or (ii) otherwise alleging any violation of any Healthcare Laws by the Company with respect to any Company Product.  As of the date of this Agreement, there is no Legal Proceeding or investigation pending, or to the Company&#8217;s Knowledge, threatened against the Company regarding any alleged violation of any Healthcare Law, and, to the Company&#8217;s Knowledge, no facts or circumstances exist that could reasonably be expected to give rise to material liability of the Company under any Healthcare Laws.  Neither the Company nor any of its directors, officers or employees has made any voluntary self-disclosure to any Governmental Entity regarding any potential non-compliance with any Healthcare Law applicable to the business of the Company.  The Company has not been and is not subject to any corrective action plan, corporate integrity agreement, deferred prosecution agreement, consent decree, settlement agreement or similar undertaking with or imposed by any Governmental Entity arising from any alleged violation of any Healthcare Law. The Company is not currently, neither has it been, subject to any continuing reporting obligations pursuant to a settlement agreement or other remedial measure entered into with any Governmental Entity.</font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">30.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">With respect to the Company Products sold or marketed in all applicable jurisdictions, except as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Part 2.11(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of the Disclosure Schedule&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the Company has not received any adverse inspectional finding, data integrity review, investigation, inquiry, penalty, fine, sanction, assessment, request for corrective or remedial action, warning letter, regulatory letter, untitled letter, Form 483, or other compliance or enforcement notice, communication, correspondence, or other notice from any Governmental Entity or any other Person specifically identifying any actual or alleged violation of, or failure to comply with, any applicable regulations or Laws governing the sale and marketing of such Company Products (an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Adverse Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;)&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(ii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the Company is not subject to any obligation or requirement arising under any consent decree, inspection report or warning letter issued by or entered into with the United States Food and Drug Administration (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">FDA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), or any other Governmental Entity with regard to the development, testing, manufacture, clearance or marketing of such Company Products.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company has made available to Parent copies or documentation, to the extent applicable, of any and all material communications and any and all non-routine communications with the FDA and any other Governmental Entity, including but not limited to Adverse Notices. Any Adverse Notice set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Part 2.11(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of the Disclosure Schedule has been closed out by the relevant Governmental Entity or other Person.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">All clinical trials, whether completed or ongoing, that are or have been sponsored or conducted by the Company are listed in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Part 2.11(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of the Disclosure Schedule, and all such clinical trials are being or have been conducted by (or on behalf of) the Company in compliance with all Healthcare Laws in all material respects, including, as applicable, FDA&#8217;s investigational device exemption regulations and good clinical practices requirements. All animal studies conducted by or on behalf of the Company have been conducted in compliance with good laboratory practices set forth in the regulations under 21 C.F.R. Part 58 and all applicable Laws and institutional policies. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Neither the Company nor any Person operating on its behalf has made any false statements on, or omissions from, any applications, notifications, registrations, reports, or other submissions to the FDA or any other Governmental Entity, or made any false statements on, or omissions from, any other material records and documentation prepared or maintained to comply with the requirements of the FDA or any other Governmental Entity or applicable Law.  Neither the Company nor, to the Company&#8217;s Knowledge, any Person operating on its behalf has (i) raised allegations with the Company related to qualifying such person as a relator or potential relator under the Federal False Claims Act&#59; or (ii) caused to be presented a claim for a healthcare item or service that was not provided as claimed, or for a healthcare item or service where such person knew or should have known the claim was false or fraudulent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company has not knowingly or willfully offered, paid, solicited or received any remuneration (including any kickback, bribe, or rebate), directly or indirectly, overtly or covertly, in cash or in kind at any time during the past three years (i) in return for referring any </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">31.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">individual to a person for the furnishing or withholding, or arranging for the furnishing or withholding, of any item or service for which payment may be made in whole or in part by any &#8220;Federal Health Care Program&#8221; as defined in 42 U.S.C. 1320a-7b(f), including Medicare, Medicaid, TRICARE&#47;CHAMPVA and any state health care program (as defined therein) (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Government Healthcare Program</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), as amended from time to time, or any other governmental payment, procurement or non-procurement program, (ii) in return for purchasing, leasing, or ordering or arranging for or recommending purchasing, leasing, or ordering any good, facility, service, or item for which payment may be made in whole or in part by any Government Healthcare Program, or (iii) to influence a patient&#8217;s selection of a particular health care provider practitioner or supplier, unless in each case in (i)-(iii) above such remuneration complies with an applicable exception or safe harbor under applicable Healthcare Laws.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(g)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company is not subject to the Health Insurance Portability and Accountability Act of 1996 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">HIPAA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) and does not receive any &#8220;Protected Health Information&#8221; (as defined by HIPAA) from any entity that is a covered entity or business associate under HIPAA.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.12&#160;&#160;&#160;&#160;Material Contracts.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Part 2.12(a) of the Disclosure Schedule lists each Contract (other than purchase orders) in effect as of the date of this Agreement to which any Company is a party or by which any of its properties or assets are otherwise bound of the following categories (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Material Contracts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;)&#58;  </font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">any Contract or group of related Contracts (except for any offer letters or employment agreements entered into with Company Employees, independent contractors or consultants) that require future payments by or to the Company in excess of $75,000 in any calendar year, in each case to the extent the Contract is not terminable without penalty on 90 days&#8217; or shorter notice&#59;</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(ii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">any acquisition agreement entered into in the five (5) year period preceding the date of this Agreement pursuant to which the Company acquired any operating business or material assets, in each case other than any such Contracts entered into in the ordinary course of business (including pursuant to financing agreements, leases and commercial agreements with suppliers and&#47;or with respect to the sale, distribution or licensing of products by the Company)&#59;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(iii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">any Contract for the sale of any material asset of the Company (other than inventory sales in the ordinary course of business) or the grant of any preferential rights to purchase any such asset or requiring the consent of any party to the transfer thereof&#59;</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(iv)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(A)&#160;any monetary guaranty, surety or performance bond or letter of credit issued or posted, as applicable, by the Company&#59; (B)&#160;any Contract evidencing Indebtedness of the Company or providing for the creation of or granting any Lien upon any of the property or assets of the Company (excluding Permitted Encumbrances)&#59; and (C)&#160;any currency, commodity or other hedging or swap Contract&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(v)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">any Contract under which the Company has made any advance, loan, extension of credit or capital contribution to, or other investment in, any Person (other than the </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">32.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Company and other than extensions of trade credit and other advances under commercial arrangements in the ordinary course of business)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(vi)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(A) any Contract creating or purporting to create any joint venture or any sharing of profits or losses by the Company with any third party&#59; or (B)&#160;any Contract that provides for &#8220;earn-outs&#8221; or other similar contingent payments by or to the Company for the deferred purchase price of property or services&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(vii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">under which any Governmental Entity has any material rights&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(viii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(A)&#160;any Contract containing covenants restricting competition which have, or would have, the effect of limiting the freedom of the Company or, after the Closing, Parent or the Surviving Corporation, to engage in any business or activity in any geographic area or other jurisdiction or with any Person, other than nondisclosure agreements entered into (1)&#160;in the ordinary course of business consistent with past practice or (2)&#160;in connection with this Agreement&#59; (B)&#160;any Contract in which the Company has granted &#8220;exclusivity&#8221; or that requires the Company to deal exclusively with, or grant exclusive rights or rights of first refusal to, any customer, vendor, supplier, distributor, contractor or other Person&#59; (C) any Contract that includes minimum purchase obligations on the part of the Company that exceed $75,000 in any calendar year to the extent the Contract is not terminable without penalty on 90 days&#8217; or shorter notice&#59; or (D)&#160;any Contract containing a &#8220;most-favored-nation&#8221;, &#8220;best pricing&#8221; or other similar term or provision by which another party to such Contract or any other Person is, or could become, entitled to any benefit, right or privilege which, under the terms of such Contract, must be at least as favorable to such party as those offered to another Person&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(ix)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">any Contract involving commitments to make capital expenditures or to contract, purchase or sell assets involving $100,000 or more individually in any calendar year&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(x)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">any lease, sublease, rental or occupancy agreement under which the Company is lessee or lessor of, or owns, uses or operates any leasehold or other interest in any real property&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(xi)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">any Inbound License and any Outbound License&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(xii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">any power of attorney granted by the Company that is currently in effect, except for any power of attorney granted to a professional services firm for the purpose of making any Tax filings or foreign intellectual property filings, in each case, on behalf of the Company&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(xiii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">any collective bargaining agreement or other Contract with any union, labor union, works council, or similar labor entity&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(xiv)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">any Contract relating to the outsourcing or provision of labor or related services (including without limitation the Shelter Plan Service Agreement entered into as of June 10, 2014 between the Company and Offshore International, Inc. and any extensions and amendments thereto) (except for employment agreements entered into in the ordinary course of business)&#59; </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">33.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(xv)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">any offers letter, employment agreement or other Contract with employees, independent contractors or consultants (or similar arrangements) that is not terminable by the Company at-will, without material penalty or without more than 30 days&#8217; notice&#59;   </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(xvi)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">any Contract requiring or otherwise relating to (A)&#160;the right of any Person to return products or (B)&#160;the payment of government rebates, commercial rebates or chargeback claims with respect to the products&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(xvii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">any Contract with any supplier listed or required to be listed as a Top Supplier or otherwise for the purchase of materials, supplies, goods, services, equipment or other assets constituting a sole source of supply&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(xviii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">any Contract with any customer listed or required to be listed as a Top 10 Customer&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(xix)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">any Contract relating to the development, research or manufacturing of any of the Company&#8217;s products, including clinical trial agreements, sponsored research agreements, development agreements, material transfer agreements, contract manufacturing agreements and similar agreements&#59; and </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(xx)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">any other Contract that is material to the Company or the operation of the Company&#8217;s business.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">With respect to each Material Contract listed in Part 2.12(a) of the Disclosure Schedule&#58; (i)&#160;such Material Contract is in full force and effect, is valid and binding on the Company in accordance with its terms and is, to the Company&#8217;s Knowledge, with respect to each party thereto other than the Company, binding and enforceable against such party in accordance with its terms, subject in each case to (A)&#160;laws of general application relating to bankruptcy, insolvency and the relief of debtors, and (B)&#160;rules of Law governing specific performance, injunctive relief and other equitable remedies&#59; and (ii)&#160;the Company is not in material breach or material default of such Material Contract or, with the giving of notice or the giving of notice and passage of time without a cure would be, in material breach or material default of such Material Contract, and to the Company&#8217;s Knowledge no other party to such Material Contract is in material breach or material default of such Material Contract. The Company has delivered or otherwise made available to Parent or its counsel true and complete copy of each such Material Contract. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.13&#160;&#160;&#160;&#160;Liabilities.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">As of the date of this Agreement, the Company has no material liabilities required to be reflected in the Unaudited Balance Sheet under GAAP other than&#58; (a)&#160;those specifically disclosed or adequately reserved in the Unaudited Balance Sheet&#59; (b)&#160;those incurred in the ordinary course of business since the date of the Unaudited Balance Sheet (none of which is a liability for breach of contract, breach of warranty, tort, infringement, violation of Law, </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">34.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><br>or that relates to any cause of action, claim or lawsuit)&#59; and (c)&#160;those incurred pursuant to or in connection with the execution, delivery or performance of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.14&#160;&#160;&#160;&#160;Compliance with Laws&#59; Permits.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Except with respect to Tax matters, which are addressed solely in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and Healthcare matters, which are addressed in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the Company is in compliance with all applicable Laws except as could not reasonably be expected to result in liability material to the Company. The Company has not received any written notices of any violation with respect to such Laws, except for violations that are immaterial, have been cured or are no longer being asserted, or received any request for information, notice, demand letter, administrative inquiry or formal or informal complaint or claim from any Governmental Entity, in each case with respect to any aspect of the Company&#8217;s business.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Part 2.14(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of the Disclosure Schedule lists all current Permits issued to the Company, including the names of the Permits and their respective dates of issuance and expiration (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Necessary Permits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).  All Necessary Permits, including Healthcare Permits required for the Company to conduct its business as currently conducted and as proposed to conducted after the Merger have been obtained by it and have all times been maintained and are valid and in full force and effect.  All fees and charges with respect to such Necessary Permits as of the date hereof have been paid in full.  None of the Necessary Permits will be terminated or suspended as a result of this Agreement, any other Transaction Documents or the Transactions. No event has occurred that, with or without notice or lapse of time or both, could reasonably be expected to result in the cancellation, revocation, suspension, lapse, default or limitation of any Necessary Permit set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Part 2.14(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of the Disclosure Schedule.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.15&#160;&#160;&#160;&#160;Certain Business Practices.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Each of the Company, and to the Company&#8217;s Knowledge, the Company&#8217;s employees or other representatives while acting on the Company&#8217;s behalf (a)&#160;has not used and is not using any funds for any unlawful contributions, unlawful gifts, unlawful entertainment or</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">other unlawful expenses&#59; (b)&#160;has not made any direct or indirect unlawful payments to any foreign or domestic Government Official&#59; (c)&#160;has not violated, aided or abetted the violation of, or conspired to violate, and is not violating, aiding or abetting the violation of, or conspiring to violate, any Anti-Corruption Laws&#59; (d) has not established or maintained, and is not maintaining, any unlawful or unrecorded fund of monies or other properties&#59; (e)&#160;has not made, and is not making, any false or fictitious entries on its accounting books and records&#59; (f)&#160;has not made, and is not making, any bribe, rebate, payoff, influence payment, kickback or other unlawful payment of any nature, and has not paid, and is not paying, any fee, commission or other payment that has not been properly recorded on its accounting books and records as required by the Anti-Corruption Laws&#59; and (g)&#160;has not otherwise given or received anything of value to or from a Government Official, an intermediary for payment to any individual including Government Officials, any political party or customer for the purpose of obtaining or retaining business.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Neither the Company, nor to the Company&#8217;s Knowledge, any Company employee or representative acting on behalf of the Company (i) is a Sanctioned Person, (ii) has violated, aided and abetted the violation of, or conspired to violate any Sanctions Laws or export control laws, or (iii) has been the subject of any investigation, inquiry or enforcement proceedings </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">35.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">by any Governmental Entity regarding, any direct or indirect dealings with any Sanctioned Person or in any Sanctioned Country on behalf of the Company&#59; and, to the Company&#8217;s Knowledge, no such investigation, inquiry or proceedings have been threatened or are pending, and there are no circumstances likely to give rise to any such investigation, inquiry or proceedings in connection with any conduct related to any Sanctions Laws or export control laws.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.16&#160;&#160;&#160;&#160;Tax Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company has filed all income and other material Company Returns that it was required to file under applicable Laws.  All such Company Returns were correct and complete in all material respects.  All Taxes required to be paid by the Company (whether or not shown as owing on a Company Return) have been paid.  There are no Liens for Taxes (other than Permitted Encumbrances) upon any of the assets of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">No audit or other examination of the Company is presently in progress or pending, nor has the Company been notified in writing of any request for such an audit or other examination.  There is no unresolved Tax deficiency outstanding, nor has the Company received written notice of any Tax deficiency assessed or proposed against the Company. The Company has never received a written claim from any Governmental Entity in a jurisdiction in which the Company does not file Company Returns that the Company is or may be subject to taxation by that jurisdiction.  The Company has not (i) waived any statute of limitations beyond the date hereof in respect of any Taxes, (ii) agreed to any extension of time beyond the date hereof with respect to a Tax assessment or deficiency or (iii) requested any written extension of time within which to file a Company Return, in each case, other than in connection with customary extensions of the due date for filing a Company Return obtained in the ordinary course of business.  No power of attorney has been executed by or on behalf of the Company with respect to Taxes that will remain in force following the Closing Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company has withheld and paid all material Taxes required to have been withheld and paid in connection with any amounts paid or owing to any employee, independent contractor, creditor, stockholder, or other third party.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company has not been a United States real property holding corporation within the meaning of Section 897(c)(2) of the Code during the applicable period specified in Section 897(c)(1)(A)(ii) of the Code.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company has not constituted either a &#8220;distributing corporation&#8221; or a &#8220;controlled corporation&#8221; in a distribution of stock intended to be governed in whole or in part by Section 355 or 361 of the Code.  The Company has not consummated or participated in, nor is it currently participating in, any &#8220;reportable transaction&#8221; within the meaning of Section 6707A(c)(1) of the Code and Treasury Regulations Section 1.6011-4(b).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company will not be required to include an item of income in, or exclude an item of deduction from, taxable income for any Tax period (or portion thereof) ending after the Closing as a result of any&#58; (i) change in method of accounting for a Tax period ending prior to the Closing&#59; (ii) &#8220;closing agreement&#8221; as described in Section 7121 of the Code (or any </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">36.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">comparable or similar provisions of applicable Law) executed prior to the Closing&#59; (iii) election pursuant to Section 108(i) of the Code&#59; (iv)&#160;installment sale or open transaction disposition made prior to the Closing&#59; (v)&#160;prepaid amount received or deferred revenue accrued prior to the Closing (other than prepaid amounts received or deferred revenue accrued in the ordinary course of business)&#59; or (vi) use of an improper method of accounting for a taxable period or portion thereof ending prior to the Closing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(g)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company has delivered or made available to Parent complete and accurate copies of all income Company Returns for taxable years ending on or after December&#160;31, 2014, and complete and accurate copies of all audit or examination reports and statements of deficiencies assessed against the Company. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(h)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company is not a party to any agreement with any third party relating to allocating or sharing the payment of, or liability for, Taxes (other than this Agreement and any contract, such as a loan or a lease, entered into in the ordinary course of business the primary purpose of which is unrelated to Taxes).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company has not been a member of an affiliated group filing a U.S. federal income Tax Return.  The Company does not have any Liability for the Taxes of any other Person (i) under Treasury Regulation Section 1.1502-6 (or any similar provision of state, local, or foreign Law)&#59; (ii) as a transferee or successor&#59; or (iii) otherwise by operation of Law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(j)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company has been resident in the United States for Tax purposes and has not, at any time, been treated as a resident of any other country.  The Company does not have a permanent establishment (within the meaning of an applicable Tax treaty) or otherwise have an office or other fixed place of business in a jurisdiction other than the United States. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(k)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company has been classified as a C-corporation for U.S. federal income tax purposes since its formation date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(l)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company has not entered into a closing agreement or other similar agreement with a Governmental Entity relating to Taxes.  No private letter rulings, technical advice memoranda or similar agreements or rulings have been requested, entered into, or issued by any Governmental Entity with respect to the Company.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(m)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Part 2.16(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of the Disclosure Schedule sets forth a true and complete list of elections that have been made (or are pending as of the date hereof) or actions that have been taken (or are pending as of the date hereof) by the Company pursuant to Sections 7001-7005 of the Families First Coronavirus Response Act.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(n)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Part 2.16(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of the Disclosure Schedule sets forth the following (whether occurring or applied for, as applicable, as of the date hereof) by the Company&#58; (i) credits claimed pursuant to Section 2301 of the CARES Act, (ii) payroll and employment taxes deferred pursuant to Section 2302(a) of the CARES Act, (iii) net operating losses carried back pursuant to Section 2303(b) of the CARES Act, (iv) alternative minimum tax credits used pursuant to Section 2305 of the CARES Act, (v) elections made pursuant to Section 2306 of the CARES Act, and (vi) additional depreciation taken pursuant to Section 2307 of the CARES Act.</font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">37.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(o)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Except as set forth in Part 2.16(o) of the Disclosure Schedule, the Company is not a party to any contract or benefit plan that has resulted or could reasonably be expected to result, separately or in the aggregate, in the payment of (i) any &#8220;excess parachute payment&#8221; within the meaning of section 280G of the Code (or any corresponding provisions of state, local or foreign Law) or (ii) any compensation paid or payable for services rendered on or prior to Closing Date that will not be fully tax deductible for federal or state income Tax purposes (including under section 162(m) of the Code).  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.17&#160;&#160;&#160;&#160;Employee Benefit Plans and Employee Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Part 2.17(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of the Disclosure Schedule sets forth a true and complete list of each plan, program, policy, practice, contract, agreement or other arrangement providing for compensation, severance, termination pay, deferred compensation, performance awards, stock or stock-related options or awards, pension, retirement benefits, profit-sharing, savings, disability benefits, medical insurance, dental insurance, health insurance, life insurance, death benefit, other insurance, welfare benefits, fringe benefits or other employee benefits or remuneration of any kind, whether written, unwritten or otherwise, funded or unfunded, including, but not limited to, any &#8220;employee benefit plan&#8221; as defined in Section 3(3) of ERISA, which is or has been maintained, contributed to, or required to be contributed to, by the Company for the benefit of any current or former employee, director, advisor, contractor or consultant, or for which the Company has any liability (excluding from such list option notices, option grants, at-will employment offer letters, the forms of such option notices, option grants, and offer letters, and state-mandated benefit programs such as unemployment insurance) (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).  The Company has not made any plan or commitment to establish any new Company Plan, to modify any Company Plan, or terminate any Company Plan (except to the extent required by law or to conform any such Company Plan to the requirements of any Applicable Law, in each case as previously disclosed to Parent in writing, or as expressly required by this Agreement).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">With respect to each Company Plan, the Company has delivered or otherwise made available to Parent or its counsel a true, correct and complete copy of&#58;  (i) all documents constituting any part of a Company Plan and all amendments thereto, and all trusts and service agreements relating to the administration and recordkeeping of the Company Plan, and written summaries of the terms of all unwritten Company Plans&#59; (ii) the two most recent Annual Reports (Form 5500 Series or otherwise in a form in accordance with applicable Law) including all applicable schedules, if any, for each Company Plan that is subject to such reporting requirements&#59; (iii) the current summary plan description and any material modifications thereto, if any, or any written summary provided to participants with respect to any plan for which no summary plan description exists&#59; (iv) if the Company Plan is funded, the most recent annual and periodic accounting of the Company Plan assets&#59; (v) all communications material to any employee or employees relating to any Company Plan and any proposed Company Plan, in each case, relating to any amendments, terminations, establishments, increases or decreases in benefits, acceleration of payments or vesting schedules or other events which would result in any liability to the Company&#59; (vi) all material, non-routine correspondence to or from any Governmental Entity relating to any Company Plan for the last three years&#59; (vii) all discrimination tests for each Company Plan for the three most recent plan years&#59; and (viii) if such Company Plan is intended to be qualified under Section 401(a) of the Code, the most recent determination letter (or if applicable, </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">38.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><br>advisory or opinion letter) from the IRS, if any, and any pending applications for a determination or opinion letter.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Each Company Plan has been established, maintained and administered in all material respects in accordance with its terms and in all material respects in compliance with all applicable Laws, including but not limited to ERISA or the Code.  No &#8220;prohibited transaction,&#8221; within the meaning of Section 4975 of the Code or Sections 406 and 407 of ERISA, and not otherwise exempt under Section 408 of ERISA, has occurred with respect to any Company Plan that would reasonably be expected to result in any liability.  There are no current actions, suits or claims pending, or, to the Company&#8217;s Knowledge, threatened in writing or reasonably anticipated (other than routine claims for benefits) against any Company Plan or against the assets of any Company Plan.  There are no audits, inquiries or proceedings pending or, to the Company&#8217;s Knowledge, threatened in writing by any Governmental Entity with respect to any Company Plan.  The Company has timely made or otherwise provided for all contributions and other payments required by and due under the terms of each Company Plan.  No event has occurred that could give rise to loss of the tax-qualified or tax-exempt status of any Company Plan.  Neither the Company nor any ERISA Affiliate is subject to any fine, assessment, penalty or other Tax or liability with respect to any Company Plan under Section&#160;502(i) of ERISA or Sections 4975 through 4980 of the Code or otherwise by operation of law or contract.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">No payment or benefit which will or may be made by the Company with respect to any &#8220;disqualified individual&#8221; (as defined in Code Section&#160;280G and the regulations thereunder) could reasonably be expected to be or will be characterized as a &#8220;parachute payment&#8221; within the meaning of Code Section&#160;280G(b)(2).  There is no contract, agreement, plan or arrangement to which the Company is bound to provide a gross-up or otherwise reimburse any employee for excise taxes paid pursuant to Section&#160;4999 of the Code. The execution and delivery of this Agreement and the consummation of the Merger will not result in any acceleration of the time of payment or vesting of any material benefits under any Company Plan. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Each Company Plan that is intended to be qualified under Section 401(a) of the Code is so qualified and has received a currently effective favorable determination letter, or is entitled to rely on an advisory letter or opinion letter, as applicable, from the Internal Revenue Service that such plan is qualified under Section 401(a) of the Code and exempt from federal income tax under Section 501(a) of the Code, and to the Knowledge of the Company nothing has occurred that could reasonably be expected to adversely affect the qualified status of any such Company Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Neither the Company nor any entity or other Person with which the Company is or was, at the relevant time, considered a single employer or under common control with under Section 414(b), (c), (m) or (o) of the Code (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">ERISA Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) currently maintains, sponsors, contributes to, or participates in, or has, within the six (6) years preceding the date of this Agreement, maintained, sponsored, contributed to, participated in, or had any obligations or incurred any liability under any employee benefit plan (i) that was or is subject to Title IV of ERISA or Section 412 of the Code (including any &#8220;defined benefit plan&#8221; within the meaning of Section 3(35) of ERISA), (ii) that was or is a &#8220;multiemployer plan&#8221; within the meaning of Section 3(37) of ERISA, (iii) that was or is a self-insured &#8220;group health plan&#8221; (within the meaning of </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">39.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section&#160;5000(b)(1) of the Code) that provides benefits to employees (other than a medical flexible spending account, health reimbursement arrangement or other similar program, including any such plan pursuant to which a stop-loss policy or contract applies), (iv) that was or is a multiple employer plan or to any plan described in Section&#160;413 of the Code, or (v) that provides, or reflects or represents any liability to provide, post-termination or retiree life insurance, health or other employee welfare benefits to any Person for any reason, except as may be required by the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">COBRA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), or other applicable statute, and the Company has not represented, promised or contracted (whether in oral or written form) to any employee (either individually or to employees as a group) or any other Person that such employee(s) or other Person would be provided with life insurance, health or other employee welfare benefits, except to the extent required by statute. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(g)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company and each ERISA Affiliate has, prior to the date hereof, complied in all material respects with the Patient Protection and Affordable Care Act, as amended, the Health Care and Education Reconciliation Act of 2010, as amended, COBRA, the Family Medical Leave Act of 1993, as amended, the California Family Rights Act of 1993, as amended, the Women&#8217;s Health and Cancer Rights Act of 1998, the Newborns&#8217; and Mothers&#8217; Health Protection Act of 1996, and any similar provisions of foreign or state law applicable to its employees or compliance with those provisions has been delegated to a third-party administrator, and the Company does not have any Knowledge of any non-compliance by such administrator.  Neither the Company nor any ERISA Affiliate has any unsatisfied obligations to any employees or qualified beneficiaries pursuant to COBRA or any state or statutory local law governing health care coverage or extension thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(h)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Except as set forth in Part 2.17(h) of the Disclosure Schedule, neither the execution and delivery of this Agreement nor the consummation of the Transactions or any termination of employment or service in connection therewith will (i) result in any payment (including severance, gratuity, golden parachute, bonus or otherwise), becoming due to any employee, (ii) result in any forgiveness of indebtedness, (iii) increase any benefits otherwise payable by the Company or any ERISA Affiliate, (iv) obligate the Company or any ERISA Affiliate to fund any trust, or (v)&#160;result in the acceleration of the time of payment or vesting of any such benefits except as required under Section&#160;411(d)(3) of the Code.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Each &#8220;nonqualified deferred compensation plan&#8221; (as such term is defined under Section&#160;409A(d)(1) of the Code and the guidance thereunder) under which the Company makes, is obligated to make or promises to make, payments (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">409A Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) complies in both form and operation, with the requirements of Section&#160;409A of the Code and the guidance thereunder.  No compensation shall be includable in the gross income of any current or former employee, director, or consultant of the Company as a result of the operation of Section 409A of the Code and no payment to be made under any 409A Plan is or will be subject to the penalties of Section 409A(a)(1) of the Code.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(j)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company&#58; (i) is and at all times has been in material compliance with all applicable Laws and contractual arrangements, and with any order, ruling, decree, judgment or arbitration award of any arbitrator or any court or other Governmental Entity, respecting employment and employment practices, including but not limited to, payment of wages, hours of </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">40.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">work, non-discrimination, reasonable accommodation, disability rights or benefits, worker classification (including the proper classification of workers as independent contractors and consultants), overtime compensation, child labor, hiring, working conditions, meal and break periods, labor relations, leave of absence requirements, paid sick or family leave, occupational health and safety, privacy, harassment, retaliation, immigration&#59; (ii) has made commercially reasonable efforts to comply with all applicable guidance published by a Governmental Entity, concerning workplace and employee health and safety practices related to the COVID-19 pandemic&#59; (iii) has withheld and reported all amounts required by any Law or contract to be withheld and reported with respect to wages, salaries and other payments to any employee&#59; and (iv) has no liability for any payment to any trust or other fund governed by or maintained by or on behalf of any Governmental Entity with respect to unemployment compensation benefits, social security or other benefits or obligations for any employee (other than routine payments to be made in the normal course of business and consistent with past practice).  The Company has not effectuated a &#8220;mass layoff,&#8221; &#8220;plant closing,&#8221; partial &#8220;plant closing,&#8221; or &#8220;relocation&#8221; (each as defined in the Worker Adjustment and Retraining Notification Act or any similar Laws) affecting any single site of employment or one or more facilities or operating units within any single site of employment or facility of the Company, nor is any such action currently contemplated, planned, or announced. To the Company&#8217;s Knowledge, all employees of the Company classified as exempt under the Fair Labor Standards Act and state and local wage and hour laws are properly classified. All individuals who perform or performed services for the Company and who are characterized and treated by the Company as independent contractors or consultants are properly characterized and treated as independent contractors under all applicable Laws. All employees of the Company located in the United States are legally authorized to work in the United States, and all employees of the Company outside of the United States are legally authorized to work in the country in which they work pursuant to the Laws of such country. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(k)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company is not and has never been a party to or otherwise bound by any collective bargaining agreement, Contract or other agreement or understanding with a labor union or labor organization, or works council or similar body, nor is any such Contract or agreement presently being negotiated, nor, to the Company&#8217;s Knowledge, is there, nor has there been in the last three years, a representation campaign or organizational effort with respect to any of the employees of the Company.  As of the date of this Agreement, there is no pending or, to the Company&#8217;s Knowledge, threatened, labor strike, dispute, walkout, work stoppage, slow-down or lockout involving the Company.  Neither the Company nor any of its Representatives has committed or engaged in any material unfair labor practice in connection with the operation of the business of the Company.  The Company has no duty to bargain with any labor union or labor organization, works council or similar body.  There are no Legal Proceedings pending or, to the Company&#8217;s Knowledge, threatened, relating to any Company Plan, collective bargaining obligation or agreement, wages and hours, leave of absence, plant closing notification, employment statute or regulation, privacy right, labor dispute, workers&#8217; compensation policy, safety, retaliation, harassment, immigration or discrimination matter involving any employee, including charges of unfair labor practices, discrimination, retaliation or harassment complaints or other labor or employment disputes.  All employees of the Company have executed a legally enforceable nondisclosure and confidentiality agreement and arbitration agreement, in each case in the form made available to Parent.  To the Company&#8217;s Knowledge, no employee of Company is in any respect in violation of any material term of any employment Contract, nondisclosure </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">41.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">agreement, common law nondisclosure obligation, fiduciary duty, noncompetition agreement, restrictive covenant or other obligation.  To the Company&#8217;s Knowledge, as of the date of this Agreement, no officer, director or managerial employee or any independent contractor has given notice that such employee or independent contractor intends to terminate his or her employment or engagement with the Company.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(l)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">During the past five (5) years, the Company has not been a party to a settlement agreement with a current or former employee that relates to allegations of harassment, including sexual harassment or sexual misconduct. During the past five (5) years no material claims of harassment, including sexual harassment or sexual misconduct, have been made against&#58; (i) any officer or director of the Company in his or her capacity as an officer or director of the Company, or (ii) any executive or management employee of the Company in his or her capacity as an employee of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(m)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Part 2.17(m)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of the Disclosure Schedule sets forth a correct and complete list of all current employees of the Company as of the date of this Agreement, including any employee who is on a leave of absence of any nature, paid or unpaid, authorized or unauthorized, and sets forth for each such individual the following&#58; job title, work location, name, employing entity, current annual base salary or base wages, current cash bonus target, any other current cash compensation entitlements, &#8220;exempt&#8221; or &#8220;non-exempt&#8221; classification (for employees working in the United States), date of hire, credit service, accrued and unused paid time off and employment status (active or nature of leave of absence). </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Part&#160;2.17(m)(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of the Disclosure Schedule sets forth a correct and complete list of all individual independent contractors or other individual service providers of the Company as of the date of this Agreement and sets forth for such individual the following&#58; name, work location, the fee or compensation schedule, and the applicable term for which such services were or are anticipated to be provided. A list of the employees under a visa or other similar authorization to work in a country other than the employee&#8217;s country of citizenship is set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Part 2.17(k)(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of the Disclosure Schedule.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(n)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Except as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Part 2.17(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of the Disclosure Schedule, no Company Plan is maintained outside the jurisdiction of the United States, or covers any employee residing or working outside the United States.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(o)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> To the Company&#8217;s Knowledge, assignments of inventions, patents and non-solicitation agreements and other restrictive covenants entered into with employees as provided to the Buyer have not been amended and remain in effect and are enforceable.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(p)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">To the Company&#8217;s Knowledge, the employees performing work on behalf of the Company in Mexico who are employed by Maquilas Teta Kawi S.A. de C.V. are compensated and employed consistent with all applicable laws governing wages, benefits and other terms and conditions of employment under Mexico law as it existed as of the signing of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.18&#160;&#160;&#160;&#160;Environmental Matters.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company is in material compliance with all applicable Environmental Laws.  As of the date hereof, the Company has not received any written notices, demand letters or requests for information from any Governmental Entity indicating that </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">42.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the Company is or may be in violation of, or be liable under, any Environmental Law, and the Company is not subject to any pending or, to Company&#8217;s Knowledge, threatened action or investigation by any Governmental Entity under any Environmental Law. To the Company&#8217;s Knowledge, no current or prior owner of any property leased or controlled by the Company has received any written notice from a Governmental Entity during the past two years that alleges that such current or prior owner or the Company is materially violating any Environmental Law.  The Company is in compliance in all material respects with, and has no material liability under, any provisions of leases relating in any way to any Environmental Laws or to the use, management or release of Hazardous Substances under such leases.  All Environmental Permits, if any, required to be obtained by the Company under any Environmental Law in connection with its operations as they are currently being conducted, including those relating to the management of Hazardous Substances, have been obtained by the Company, are in full force and effect, and the Company is in material compliance with the terms thereof.  The Company has not disposed of or released any Hazardous Substances on, in or under any real property that could reasonably be expected to require remediation under Environmental Laws.  The Company has delivered or otherwise made available to Parent or its counsel copies of any environmental investigation, study, test, audit, review or other analysis in its possession in relation to the current or prior business of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.19&#160;&#160;&#160;&#160;Inventory.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> All inventory of the Company, whether or not reflected in the Unaudited Balance Sheet, consists of a quality and quantity usable and salable inventory in the ordinary course of business consistent with past practice, except for obsolete, damaged, defective or slow-moving items that have been written off or written down to fair market value or for which adequate reserves have been established. All such inventory is owned by the Company free and clear of all Liens, and no inventory is held on a consignment basis. The quantities of each item of inventory (whether raw materials, work-in-process or finished goods) are not excessive but are reasonable in the present circumstances of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.20&#160;&#160;&#160;&#160;Accounts Receivable.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> All accounts and notes receivable of the Company represent sales actually made or services provided in the ordinary course of business consistent with past practices or valid claims as to which full performance has been rendered by the Company.  All of the accounts and notes receivable of the Company are collectible in full in accordance with their terms at their recorded amounts.  No counter claims, defenses, offsetting claims or adjustments with respect to the accounts or notes receivable of the Company are pending or, to the Company&#8217;s knowledge, threatened.  All of the accounts and notes receivable of the Company relate solely to sales of goods or services to customers of the Company, none of whom are Affiliates of the Company.  The accounts and notes receivable at Closing do not reflect any changes in discounts, rebates or other benefits offered to customers.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.21&#160;&#160;&#160;&#160;Suppliers and Customers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Part 2.21(a)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of the Disclosure Schedule sets forth a true, correct and complete list of the top 10 suppliers for materials, products or services of the business of the Company based on the amount spent by the Company with such suppliers for the 12-month period ended December 31, 2020 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Top Suppliers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Part 2.21(a)(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of the Disclosure Schedule sets forth a true, correct and complete list of the top 25</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">customers based on the revenue the Company </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">43.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">derived from such customers for the 12-month period ended December 31, 2020 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Top Customers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; and the top 10 of such customers based on such revenue, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Top 10 Customers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company has not received any written notice to the effect that any Top Supplier or Top Customer will, intends to, or is considering terminating, cancelling, discontinuing, reducing, changing the terms (whether related to payment, price or otherwise) of, or otherwise adversely modifying its direct or indirect business with the Company, and there are no outstanding or, to the Company&#8217;s Knowledge, threatened disputes with any Top Supplier or Top Customer.  The Company has not received any written notice from, and has no Knowledge that any Top Supplier or Top Customer is or will be the subject of any voluntary or involuntary bankruptcy, insolvency or other similar proceeding.  Attached to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Part 2.21(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of the Disclosure Schedule are the Company&#8217;s standard form(s) of customer agreements.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.22&#160;&#160;&#160;&#160;Insurance.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> All insurance policies and bonds maintained by or for the benefit of the Company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Insurance Policies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) are in full force and effect and all premiums due and payable under such Insurance Policies have been paid on a timely basis, and, with regard to Insurance Policies on a retrospective or audited premium basis (or any similar basis to the foregoing), no additional amounts will be due in excess of 10% of the stated annual initial premium.  As of the date of this Agreement, there is no claim pending under any of the Company&#8217;s Insurance Policies as to which coverage has been questioned, denied or disputed by the underwriters of such policies.  The Company is in compliance in all material respects with the terms of such policies.  The Company is in compliance with all terms of such Insurance Policies and has not received any written notice of any threatened termination of, or material premium increase with respect to, any of such policies.  None of the Insurance Policies are issued by a captive insurer or, other than workers&#8217; compensation, are on a fronting or similar basis.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.23&#160;&#160;&#160;&#160;Legal Proceedings&#59; Orders.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Except as set forth in Part 2.23 of the Disclosure Schedule, as of the date of this Agreement, there is no pending Legal Proceeding, and, to the Company&#8217;s Knowledge, no Person has threatened in writing to commence any Legal Proceeding&#58;  (a) that involves the Company or any of the assets owned or used by the Company or any Person whose liability the Company has retained or assumed, either contractually or by operation of law&#59; or (b) that challenges, or that may have the effect of preventing, delaying, making illegal or otherwise interfering with, the Merger or any of the other transactions contemplated by this Agreement and the other Transaction Documents.  As of the date of this Agreement, there is no Order resulting from a Legal Proceeding against the Company to which the Company is subject.  To the Company&#8217;s Knowledge, no officer or other employee of the Company is subject to any Order that prohibits such officer or other employee from engaging in or continuing any conduct, activity or practice relating to the Company&#8217;s business.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.24&#160;&#160;&#160;&#160;Vote Required.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Except as set forth in Part 2.24 of the Disclosure Schedule, the adoption of this Agreement and approval of the Merger&#58; (a) requires the affirmative votes of the holders of a majority of the shares of Company Common Stock and Company Preferred Stock (on an as-converted to common stock basis) outstanding on the applicable record date, voting together as a single class, and (b) may require the affirmative votes of (i) the holders of a majority of the shares of Company Common Stock outstanding on the applicable record date, and (ii) the holders of a majority of the shares of Company Preferred Stock outstanding on the applicable record date, </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">44.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">voting together as a single class on an as-converted to common stock basis (together, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Required Company Stockholder Votes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;). The Required Company Stockholder Votes are the only votes of the holders of any of the Company Capital Stock necessary to adopt this Agreement and the Transaction Documents, approve the Merger and consummate the Merger and the other Transactions.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.25&#160;&#160;&#160;&#160;Books and Records.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  All minute books, stock record and other books, records and accounts of the Company, all of which have been made available to Parent, are true, correct and complete and have been maintained in accordance with good business practice and all applicable Laws.  The minute books of the Company contain accurate and complete records of all meetings, and actions taken by written consent of, the Company Stockholders, the Board of the Directors of the Company and any committees of the Board of the Directors of the Company, and no meeting, or action taken by written consent, of any such Company Stockholders, Board of Directors or committee has been held for which minutes have not been prepared and are not contained in such minute books. At the Closing, all of those books and records will be in the possession of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.26&#160;&#160;&#160;&#160;Financial Advisor. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> Except as set forth in Part 2.26 of the Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage or finder&#8217;s fee in connection with the Merger or any of the other transactions contemplated by this Agreement based upon arrangements made by or on behalf of the Company. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.27&#160;&#160;&#160;&#160;Bank Accounts&#59; Directors and Officers&#59; Names.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  Part 2.27 of the Disclosure Schedule sets forth a true and complete list of the name and address of each bank with which the Company has an account or safe deposit box, the account number for each such account and the names of all persons authorized to draw thereon or have access thereto. Part 2.27 of the Disclosure Schedule lists the directors and officers (or equivalents) of the Company. The Company has not used any name or names under which it has invoiced account debtors, maintained records concerning its assets or otherwise conducted its business, other than its current legal name.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.28&#160;&#160;&#160;&#160;Product Liabilities.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Except as set forth in Part 2.28(a) of the Disclosure Schedule, the Company has not suffered, experienced, incurred, received notice of, or become the subject of, or been threatened to be the subject of, any (i) material product return or warranty claim based on failures of any Company Products or, had they been resolved as desired by the claimant or customer seeking to make such returns, could reasonably have resulted in a material liability, (ii) claim or allegation of personal injury, death, or property or economic damages, any claim for punitive or exemplary damages, any claim for contribution or indemnification, or any claim for injunctive relief in connection with the design, manufacture, marketing, sale, distribution, servicing or use of any Company Products, (iii) request by any customer for indemnification with respect to any claim asserted against the customer by any employee of the Company, or (iv) Legal Proceedings involving any Company Products before, or brought by, a Governmental Entity alleging a violation of any Laws governing the use, manufacture, packaging, labeling, advertising, promotion, distribution, storage, development, processing, transportation or sale of such Company Products.</font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">45.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">All Company Products previously and currently sold, marketed or distributed by the Company (i) comply and complied, as applicable, in all respects with all (A) applicable manufacturing and product specifications disclosed to customers of such Company Products by the Company, (B) applicable industry and trade-association standards, and (C) Laws applicable to such sale, marketing, advertising, promotion or distribution, including all Laws governing the use, manufacture, packaging, labeling, distribution, storage, development, processing, or transportation of such Company Products and (ii) are free from latent or patent defects and have contained and contain, as applicable, adequate warnings, presented in a reasonably prominent manner, in accordance with applicable Laws and, with industry practice with respect to its contents and use as of the time of such sale. The Company&#8217;s quality management system is in compliance with the general safety and performance requirements as set out by applicable Law and the actual scientific standard. </font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.29&#160;&#160;&#160;&#160;Product Recalls.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  Except as set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Part 2.29</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of the Disclosure Schedule, there have been no, and, to the Company&#8217;s Knowledge, there exist no facts that could reasonably cause any, (a) product recalls, return programs, customer notifications or withdrawals, or (b) investigations, requests for product recalls or withdrawals by any Governmental Entity or by any customers of the Company, in each case relating to any Company Products (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Product Recalls</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).  Any Product Recalls initiated before the Closing Date have been completed in accordance with all applicable Laws and Orders and have been resolved to the satisfaction of the applicable Governmental Entity. No Person or Governmental Entity has alleged that any Company Products are defective or unsafe or fail to meet any standards or requirements promulgated by a Governmental Entity.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.30&#160;&#160;&#160;&#160;Related Party Transactions.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Except as set forth in Part 2.30 of the Disclosure Schedule, there are no material Contracts, commitments or transactions with, or obligations of the Company, to officers, directors, stockholders or employees of the Company other than (a) for payment of salaries, wages and bonuses for services rendered, (b) reimbursement of customary and reasonable expenses incurred on behalf of the Company, (c) benefits due under Company Plans and fringe benefits not required to be listed on Part 2.17(a) of the Disclosure Schedule, (d) agreements relating to outstanding Company Options, and (e) in respect of Company Capital Stock.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">R</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">EPRESENTATIONS AND </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">W</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ARRANTIES OF </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">P</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ARENT AND</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> M</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ERGER</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">UB</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Parent and Merger Sub represent and warrant to the Company as follows&#58;</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">3.1&#160;&#160;&#160;&#160;Due Incorporation&#59; Subsidiaries.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  Parent is a corporation duly incorporated, validly existing and in good standing under the laws of the Commonwealth of Massachusetts.  Merger Sub is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">3.2&#160;&#160;&#160;&#160;Authority&#59; Binding Nature of Agreement.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Parent and Merger Sub have the absolute and unrestricted right, power and authority to perform their obligations under this Agreement and the other Transaction Documents to which Parent or Merger Sub is a party, and the execution, delivery and performance by Parent and Merger Sub of this Agreement and the other Transaction Documents to which Parent or Merger Sub is a party have been duly authorized </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">46.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">by all necessary action on the part of Parent, Merger Sub and their respective boards of directors.  This Agreement constitutes the legal, valid and binding obligation of Parent and Merger Sub, enforceable against them in accordance with its terms, subject to (a) laws of general application relating to bankruptcy, insolvency and the relief of debtors and (b) rules of law governing specific performance, injunctive relief and other equitable remedies.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">3.3&#160;&#160;&#160;&#160;Non-Contravention&#59; Consents.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The execution and delivery of this Agreement by Parent and Merger Sub and the consummation by Parent and Merger Sub of the transactions contemplated by this Agreement will not&#58; (a)&#160;conflict with or cause a violation of any of the provisions of the certificate of incorporation or bylaws of Parent or Merger Sub, (b)&#160;conflict with or cause a violation by Parent or Merger Sub of any Law applicable to Parent or Merger Sub or (c)&#160;result in any breach, or constitute a default on the part of Parent or Merger Sub under any material Contract of Parent or Merger Sub.  Except as may be required by the DGCL or HSR Act, neither Parent nor Merger Sub is required to obtain any Consent from, or submit and filing or notification to, any Governmental Entity or party to a material Contract of Parent or Merger Sub at any time prior to the Closing in connection with, or in order to carry out, the execution and delivery of this Agreement or the consummation of the Merger.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">3.4&#160;&#160;&#160;&#160;Litigation.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">As of the date of this Agreement, there is no Legal Proceeding pending (or, to the knowledge of Parent or Merger Sub, being threatened) against Parent or Merger Sub challenging or that may have the effect of preventing, delaying, making illegal or otherwise interfering with, the Merger.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">3.5&#160;&#160;&#160;&#160;Merger Sub.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Merger Sub (a) was formed solely for the purpose of engaging in the transactions contemplated by this Agreement, (b) has engaged in no other business activities and (c) has conducted its operations only as contemplated by this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">3.6&#160;&#160;&#160;&#160;No Vote Required.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">No vote or other action of the stockholders of Parent or Merger Sub is required by applicable Law, the certificate of incorporation or bylaws (or similar charter or organizational documents) of Parent or Merger Sub or otherwise in order for Parent and Merger Sub to consummate the Merger and the transactions contemplated by this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">3.7&#160;&#160;&#160;&#160;Financing.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Parent has and will have, from and after the Closing, sufficient cash, available lines of credit or other sources of immediately available funds on hand (without restrictions on drawdown that would delay payment of the Purchase Price) to consummate the transactions contemplated by this Agreement, including the payment of all amounts payable by or on behalf of Parent under this Agreement or otherwise as a result of the transactions contemplated by this Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ERTAIN </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">OVENANTS OF THE </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">OMPANY</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">4.1&#160;&#160;&#160;&#160;Access.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">During the period from the date of this Agreement through the earlier of the Effective Time or the termination of this Agreement pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;8.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Pre-Closing Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), the Company shall (a) upon reasonable advance notice to the Company, provide Parent and Parent&#8217;s Representatives with reasonable access during normal business hours to the Company&#8217;s personnel, facilities and existing books and records&#59; (b) furnish Parent and its </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">47.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Representatives with such financial, operating and other data and information related to the Company as Parent or any of its Representatives may reasonably request&#59; and (c) instruct the Representatives of the Company to cooperate with Parent and Parent&#8217;s Representatives in their investigation of the Company&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">that any such access pursuant to clause (a) shall be conducted at Parent&#8217;s sole cost and expense, under the supervision of appropriate personnel of the Company and in such a manner as to maintain the confidentiality of this Agreement and the transactions contemplated hereby in accordance with the terms hereof and not to interfere unreasonably with the normal operation of the business of the Company.  Nothing herein shall require the Company to disclose any information to Parent, its Affiliates or Representatives if such disclosure would, in the Company&#8217;s reasonable discretion (a) jeopardize any attorney-client or other legal privilege or (b) contravene any applicable Law, fiduciary duty or binding agreement entered into prior to the date of this Agreement (including any confidentiality agreement to which the Company is a party).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">4.2&#160;&#160;&#160;&#160;Conduct of the Business of the Company. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">During the Pre-Closing Period, except (w) as set forth in Part 4.2 of the Disclosure Schedule, (x) to comply with the Company&#8217;s obligations under this Agreement or in connection with a COVID-19 Response, (y) as necessary to ensure that the Company complies with applicable Laws and contractual obligations, or (z) with Parent&#8217;s consent (which shall not be unreasonably withheld, conditioned or delayed)&#58; (i) the Company shall use commercially reasonable efforts to (A) carry on its ordinary course of business, (B) preserve substantially intact their present business organization, and (C) preserve their material relationships with suppliers, distributors, licensors, licensees and others to whom the Company has contractual obligations&#59; and (ii) except as set forth in Part 4.2 of the Disclosure Schedule, the Company shall not&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:700;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">amend the Company Charter, Company bylaws and other charter and organizational documents of the Company&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">split, combine, subdivide or reclassify any of its capital stock or issue or authorize the issuance of any other securities in respect of, in lieu of or in substitution for shares of its capital stock&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">issue, sell, pledge, grant, create a Lien upon, or authorize the issuance, sale, pledge, grant or creation of a Lien upon, any shares of Company Capital Stock or securities convertible into, or subscriptions, rights, warrants or options to acquire, or other agreements or commitments of any character obligating it to issue any such shares or other convertible securities (other than the issuance of Company Common Stock in respect of any conversion of Company Preferred Stock or the exercise of Company Options or Company Warrants outstanding on the date of this Agreement)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">merge or consolidate with or into any other Person or enter into or adopt any plan or agreement of complete or partial liquidation, restructuring or dissolution, or file a voluntary petition in bankruptcy or commence a voluntary legal procedure for reorganization, restructuring, arrangement, adjustment, release or composition of Indebtedness in bankruptcy or other similar Laws now or hereafter in effect&#59;</font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">48.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">make any loans, advances, guarantees or capital contributions to or in any Person (other than business-related advances to its employees in the ordinary course of business consistent with past practice) or incur any indebtedness for borrowed money (other than borrowings under existing lines of credit, letters of credit or similar arrangements issued for the benefit of suppliers or manufacturers), or guarantee any such indebtedness, or issue or sell any debt securities or guarantee any debt securities of others&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">make any capital expenditures, capital additions or capital improvements, in excess of $25,000 in the aggregate per month, for each full or partial calendar month in the Pre-Closing Period (other than in accordance with the budget for capital expenditures previously made available to Parent)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(g)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">knowingly waive any right of the Company under any Material Contract&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(h)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">acquire or agree to acquire by merging or consolidating with, or by purchasing a portion of the stock or (other than in the ordinary course of business) assets of, or by any other manner, any business or any entity&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">sell, assign, transfer, grant a Lien upon, pledge, encumber or otherwise dispose of, abandon, invalidate, dedicate to the public domain, lease or exclusively license or sublicense any Company Intellectual Property or other properties or assets of the Company which are material to the Company&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(j)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i) enter into any Contract that would constitute a Material Contract or lease, sublease, or other rental or occupancy agreement relating to the leasing, use, or occupancy of any real property or otherwise granting a right in any real property&#59; (ii) amend in any material respect any Material Contract or accelerate, cancel or terminate any Material Contract, or (iii) request, decline, or grant any consent or waiver, in each case, in connection with any material provision of any Material Contract, in each case other than to extent such action is expressly set forth in Part 4.2(b) of the Disclosure Schedule or is in furtherance of an action that is expressly permitted by other subsections of this Section 4.2(a) (e.g. capital expenditures within the limit permitted under subclause (f) above) and does not result in any action that would not be permitted under other subsections of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4.2(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(k)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">make any material change in any accounting method or practice of the Company, except as required by GAAP or as disclosed in the notes to the Company Financial Statements&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(l)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">make or change any material election in respect of Taxes, adopt or change any accounting method in respect of Taxes, settle any claim or assessment in respect of Taxes, or consent to any extension or waiver of the limitation period applicable to any claim or assessment in respect of Taxes (other than pursuant to customary extensions of the due date for filing Tax Returns obtained in the ordinary course of business of no more than seven months), incur any Taxes outside of the ordinary course of business other than Transaction Payroll Taxes incurred in connection with the Transactions, surrender the right to any Tax refund, enter into any agreement </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">49.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">with any Governmental Entity with respect to any Tax or Company Returns, or file any amended Company Returns&#59; </font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(m)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i) adopt, establish, enter into, amend or terminate any Company Plan or any plan, agreement, program, policy, trust, fund or other arrangement that would be a Company Plan if it were in existence as of the date of this Agreement (except for amendments determined by the Company in good faith to be required to comply with applicable Law), (ii) increase the compensation or fringe benefits of, or grant any bonus or any bonus opportunity to, any current or former employee, director, officer, independent contractor or consultant of the Company other than in the ordinary course of business consistent with past practice, (iii) accelerate the vesting or payment of any compensation or benefit for any current or former employee, officer, director, independent contractor or consultant (except in the ordinary course of business), (iv) grant any severance or termination pay to any current or former director, officer, employee, independent contractor or consultant of the Company (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">that the Company may make severance or termination payments to employees in the ordinary course of business and in accordance with the terms of any Material Contract disclosed in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Part 2.12(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of the Disclosure Schedule between the Company and such employees in effect on the date of this Agreement or as required by applicable local statutory Laws), or (v) terminate the employment of any key employee or executive other than for cause under applicable local law, provided that the Company may terminate employees in the ordinary course of business&#59;</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(n)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">hire or promote any person as or to (as the case may be) an officer or hire or promote any employee below officer level except to fill a vacancy in the ordinary course of business&#59;</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(o)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">waive, release, assign, compromise, commence, settle or agree to settle any Legal Proceeding, other than waivers, releases, compromises or settlements in the ordinary course of business consistent with past practice that (i) involve only the payment of monetary damages not in excess of $100,000 individually or $500,000 in the aggregate and (ii) do not include the imposition of equitable relief on, or the admission of wrongdoing by, the Company&#59; or </font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(p)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">agree or commit to take any of the actions described in clauses&#160;&#8220;(a)&#8221; through &#8220;(p)&#8221; of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Nothing herein shall require the Company to obtain consent from Parent to do any of the foregoing if obtaining such consent might reasonably be expected to violate applicable Law, including Antitrust Law. Notwithstanding anything to the contrary in this Agreement, nothing contained herein shall give to Parent, directly or indirectly, the right to control or direct the operations of the Company prior to the Closing Date, and prior to the Closing Date, each of Parent and the Company shall exercise, consistent with the terms and conditions hereof, complete control and supervision of its respective operations.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">4.3&#160;&#160;&#160;&#160;No Solicitation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company will immediately cease and cause to be terminated any discussions with any Person that relate to any Acquisition Proposal existing as of the date hereof.  </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">50.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">During the Pre-Closing Period, the Company shall not and shall cause its Representatives not to, directly or indirectly, (i) solicit, initiate, knowingly encourage, facilitate or continue inquiries regarding the submission of any Acquisition Proposal by any Person or (ii) participate in any discussions or negotiations regarding, or furnish to any Person any non-public information with respect to, or take any other action intended or reasonably expected to facilitate the making of any inquiry or proposal to the Company that constitutes or is reasonably expected to lead to, any Acquisition Proposal by any Person.  The Company shall immediately cease and cause to be terminated, and shall cause its Affiliates and all of its and their Representatives to immediately cease and cause to be terminated, all existing discussions or negotiations with any Persons conducted heretofore with respect to, or that is reasonably expected to lead to, an Acquisition Proposal.  For purposes hereof, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Acquisition Proposal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean any inquiry, proposal, offer or indication of interest from any Person (other than Parent or any of its Affiliates or Representatives) concerning (i) a merger, consolidation, liquidation, recapitalization, share exchange or other business combination transaction involving the Company&#59; (ii) the issuance or acquisition of shares of capital stock or other equity securities of the Company (other than the issuance of Company Common Stock in respect of any conversion of Company Preferred Stock or the exercise of Company Options or Company Warrants outstanding on the date of this Agreement)&#59; or (iii) the sale, lease, exchange or other disposition of any significant portion of the Company&#8217;s properties or (except in the Company&#8217;s ordinary course of business) assets. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Neither the Board of Directors of the Company nor any committee thereof shall (i) withdraw or modify in a manner materially adverse to Parent or Merger Sub, the Company Board Recommendation, (ii) approve or recommend any Acquisition Proposal or (iii) cause the Company to enter into any letter of intent, agreement in principle, acquisition agreement or other similar agreement with respect to any Acquisition Proposal.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In addition to the obligations of the Company set forth in paragraphs (a) and (b) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the Company promptly (and in all events within three (3) Business Days) shall notify Parent of the material terms of any Acquisition Proposal received by the Company.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">4.4&#160;&#160;&#160;&#160;Notice of Certain Events.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">From the date hereof until the Closing, the Company shall promptly upon the Company&#8217;s Knowledge thereof notify Parent in writing of&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> any fact, circumstance, event or action the existence, occurrence or taking of which has resulted in, or could reasonably be expected to result in, the failure of the condition set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 6.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> to be satisfied at Closing&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(ii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">any notice or other communication received by the Company from any Person alleging that the consent of such Person is or may be required in connection with the transactions contemplated by this Agreement&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(iii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">any Legal Proceeding commenced or, to the Company&#8217;s Knowledge, threatened against, relating to or involving or otherwise affecting the Company that, if pending on </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">51.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the date of this Agreement, would have been required to have been disclosed pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.23</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Parent&#8217;s receipt of information pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall not operate as a waiver or otherwise affect any representation, warranty or agreement given or made by the Company in this Agreement (including </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.1(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) and shall not be deemed to amend or supplement the Disclosure Schedule.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 5.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">DDITIONAL </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">OVENANTS OF THE </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">P</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ARTIES</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">5.1&#160;&#160;&#160;&#160;Stockholder Consent or Approval</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Immediately following the execution and delivery of this Agreement, the Company shall deliver to Parent written consents of the Company Stockholders in the form attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit E</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Written Consent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) collectively constituting the Required Company Stockholder Votes, together with a certificate from the Chief Executive Officer of the Company certifying that such Written Consents constitute the Required Company Stockholder Votes.  The Company shall use commercially reasonable efforts to obtain and deliver to Parent Written Consents from the Company Stockholders that were not signatories to the Required Company Stockholder Votes and shall, within 10 Business Days after the date of this Agreement, in accordance with the Company Charter and the Company&#8217;s bylaws and the applicable requirements of the DGCL (including Sections 228 and 262 of the DGCL), and, if applicable, the California Code, (i) prepare an information statement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Information Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), and (ii) cause a copy of the Information Statement, together with the Written Consent and Company Board Recommendation, to be delivered to the physical or electronic address on record for each Company Stockholder who is entitled to vote upon adoption of this Agreement and who did not already do so as of the time of the mailing of the Information Statement. The Information Statement shall (i) include a statement to the effect that the Board of Directors of the Company unanimously determined that the Merger is advisable in accordance with Section 251(b) of the DGCL and in the best interests of the Company Stockholders and unanimously approved and adopted this Agreement, the Merger and the other transactions contemplated hereby, (ii) provide the Company Stockholders to whom it is sent with notice of the actions taken in the Written Consent, including the approval and adoption of this Agreement, the Merger and the other transactions contemplated hereby in accordance with Section 228(e) of the DGCL and the bylaws of the Company and (iii) notify such Company Stockholders of their dissent and appraisal rights pursuant to Section 262 of the DGCL. The Information Statement shall include therewith a copy of Section 262 of Delaware Law and all such other information as Parent shall reasonably request. All materials submitted to the Company Stockholders in accordance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.1(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall be subject to Parent&#8217;s advance review and reasonable approval. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Prior to the Closing Date, the Company shall (i) secure from any Person who is a &#8220;disqualified individual&#8221;, as defined in Section 280G of the Code, and who has a right to any payments and&#47;or benefits or potential right to any payments and&#47;or benefits in connection with the consummation of the Merger that would be deemed to constitute &#8220;parachute payments&#8221; pursuant to Section 280G of the Code, a waiver of such Person&#8217;s rights to any such payments and&#47;or benefits applicable to such Person to the extent that all remaining payments and&#47;or benefits </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">52.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">applicable to such Person shall not be deemed to be &#8220;parachute payments&#8221; pursuant to Section 280G of the Code (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Waived 280G Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) and (ii) submit for approval by the Company Stockholders the Waived 280G Benefits, to the extent and in the manner required under Sections 280G(b)(5)(A)(ii) and 280G(b)(5)(B) of the Code and the treasury regulations thereunder, including Q-7 of Section 1.280G-1 of such Treasury Regulations.  Prior to such solicitation, all waiver and stockholder approval materials, including the calculations prepared by the Company or the Company&#8217;s advisors to determine the Waived 280G Benefits, shall be subject to prior review by Parent, and such review shall not be unreasonably withheld or delayed.  The Company shall not pay any of the Waived 280G Benefits if such payment is not approved by the Company Stockholders as contemplated above.  Prior to the Closing Date, the Company shall deliver to Parent evidence satisfactory to Parent that a vote of the Company Stockholders was received in conformance with Section 280G of the Code and the regulations thereunder, or that such requisite stockholder approval has not been obtained with respect to the Waived 280G Benefits, and, as a consequence, the Waived 280G Benefits have not been and shall not be made or provided.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">5.2&#160;&#160;&#160;&#160;Regulatory Filings. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">As promptly as practicable after execution and delivery of this Agreement, Parent, Merger Sub and the Company shall each use commercially reasonable efforts, and cooperate with each other party hereto, to take, or cause to be taken, all actions, and to do, or cause to be done, all things necessary, appropriate or desirable to consummate the transactions contemplated by this Agreement, including and in no event later than eight (8) Business Days after the date of this Agreement, to make or cause to be made all filings and submissions required under the HSR Act or other Laws applicable to the consummation of the transactions contemplated by this Agreement.  The parties shall cooperate in good faith in connection with such filings and submissions and shall promptly comply with any requests for additional information relating thereto from any Governmental Entity, including requests for production of documents and production of witnesses for interviews or depositions by any Governmental Entities.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Parent shall diligently assist and cooperate with the Company in preparing and filing all documents required to be submitted by the Company and&#47;or its respective Affiliates to any Governmental Entities in connection with the transactions contemplated by this Agreement and in obtaining any Governmental Entity or third party consents, waivers, authorizations or approvals which may be required to be obtained by the Company in connection with the transactions contemplated by this Agreement (which assistance and cooperation shall include timely furnishing to the Company and&#47;or its respective Representatives, all information concerning Parent and its Affiliates that counsel to the Company reasonably determines is required to be included in such documents or would be helpful in obtaining such required consent, waiver, authorization or approval). Each of the parties shall have the right to review in advance, and to the extent practicable each will consult the other on any filing made with, or other material communications submitted to, any third party and&#47;or any Governmental Entity in connection with the transactions contemplated by this Agreement. Subject to applicable Laws relating to the exchange of information, each party shall, to the extent practicable, give the other party reasonable advance notice of all material communications with any Governmental Entity and consider in good faith the views of the other party in connection with any analysis, appearance, presentation, memorandum, brief, argument, opinion, proposal or other communication to be made or submitted </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">53.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">in connection with any such request, inquiry, investigation, action, or legal proceeding, and each party shall have the right to attend or participate in material conferences, meetings and telephone or other communications between the other parties and a Governmental Entity concerning the Transactions, unless prohibited by such Governmental Entity. Materials required to be provided pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.2(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> may be redacted (i) to remove references concerning the valuation of the Company or other bidders for the Company, (ii) as necessary to comply with contractual arrangements (iii) as necessary to address attorney-client or other privilege concerns, and (iv) to remove material that is unrelated to the contemplated transactions. Each party, as each deems advisable and necessary, shall be entitled to designate any competitively sensitive material provided to the other under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;5.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> as &#8220;Antitrust Counsel Only Material.&#8221; Such materials and the information contained therein shall be given only to the outside antitrust counsel of the recipient and will not be disclosed by such outside antitrust counsel to Representatives of the recipient unless express written permission is obtained in advance from the source of the materials or its legal counsel.  Parent shall be responsible for all filing fees under the HSR Act and all other Laws or regulations applicable to Parent and&#47;or its Affiliates.  The parties shall cause the filings under the HSR Act to be considered for grant of &#8220;early termination.&#8221; No party shall commit to or agree with any Governmental Entity to stay, toll, or extend any applicable waiting period under the HSR Act, or pull and refile under the HSR Act, without the prior written consent of the other parties.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Without limiting the generality of anything contained in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and subject to any limitations under applicable Laws, Parent agrees to, and to cause its controlled Affiliates to, use commercially reasonable efforts to eliminate each and every impediment that is asserted by any Governmental Entity so as to enable the parties hereto to consummate the transactions contemplated under this Agreement promptly and, in any event, prior to the End Date.  Nothing in this Agreement, including this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, obligates Parent, or any of its Subsidiaries or Affiliates, to (a) propose, negotiate, commit to or effect, by consent decree, hold separate orders, or otherwise, (i) the sale, divesture, licensing, encumbrance, or disposition of any of Parent&#8217;s or its Subsidiaries&#8217; or Affiliates&#8217; assets, properties or businesses, or of the Company&#8217;s properties or businesses to be acquired pursuant to this Agreement, or (ii) the imposition of any obligations, restraints, commitments, or other conditions upon the operation or conduct of any assets, businesses, or operations of Parent, any of its Subsidiaries or Affiliates, or of the Company&#8217;s properties or businesses to be acquired pursuant to this Agreement, or (b) defend through litigation on the merits or otherwise any claim asserted in court by any party in order to avoid entry of, or to have vacated or terminated, any decree, order or judgment (whether temporary, preliminary or permanent) that would prevent the Closing from occurring prior to the End Date. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Prior to the Closing Date, Parent shall not, and shall cause its Affiliates not to, acquire or agree to acquire by merging or consolidating with, or by purchasing a substantial portion of the assets of or equity in, or by any other manner, any Person or portion thereof, or otherwise acquire or agree to acquire any assets, if the entering into of an agreement relating to or the consummation of such acquisition, merger or consolidation would reasonably be expected to (i) impose any material delay in the obtaining of, or increase the risk of not obtaining, any authorizations, consents, Orders, declarations or approvals of any Governmental Entity necessary to consummate the transactions contemplated by this Agreement or the expiration or termination of any applicable waiting period, (ii) increase the risk of any Governmental Entity entering an </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">54.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><br>Order prohibiting the consummation of the Transactions or (iii) materially delay the consummation of the Transactions.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">5.3&#160;&#160;&#160;&#160;Employee Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Parent agrees that from and after the Effective Time, Parent and its Affiliates shall assume and honor accrued wages and related employment obligations (including bonuses and commissions) of the Company.  For a period of not less than twelve (12) months following the Effective Time, Parent shall provide or shall cause to be provided, to current employees of the Company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company Employees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) (i) base salary and target incentive compensation opportunities (excluding equity, phantom equity, and change in control compensation) comparable in the aggregate to those in effect with respect to such Company Employees immediately prior to the Effective Time&#59; and (ii) benefits programs (excluding defined benefit and retiree health) that are comparable in the aggregate to those provided to such Company Employees immediately before the Effective Time&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">that the foregoing shall not diminish any obligation of the Surviving Corporation pursuant to any employment or similar agreement between the Company and any Company Employee in existence as of the Closing Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For all purposes under the employee benefit plans of Parent and its Affiliates providing benefits to any Company Employees after the Effective Time (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">New Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), each Company Employee shall be credited with his or her years of service with the Company before the Effective Time, to the same extent as such Company Employee was entitled, before the Effective Time, to credit for such service under any similar Company Plans.  In addition, and without limiting the generality of the foregoing&#58; (i) each Company Employee shall be immediately eligible to participate, without any waiting time, in any and all New Plans&#59; and (ii) for purposes of each New Plan providing medical, dental, pharmaceutical and&#47;or vision benefits to any Company Employee, Parent shall cause all pre-existing condition exclusions, waiting periods and actively-at-work requirements of such New Plan to be waived for such employee and his or her covered dependents, and Parent shall cause any eligible expenses incurred by such employee and his or her covered dependents during the portion of the plan year of the Company Plan in which such Company Employee participated immediately before the Effective Time ending on the date such employee&#8217;s participation in the corresponding New Plan begins to be taken into account under such New Plan for purposes of satisfying all deductible, coinsurance and maximum out-of-pocket requirements applicable to such employee and his or her covered dependents for the applicable plan year as if such amounts had been paid in accordance with such New Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Nothing contained herein, express or implied, (i) is intended to confer upon any Company Employee any right to continued employment for any period or continued receipt of any specific employee benefit, or shall constitute an amendment to or any other modification of any benefit plan, (ii) shall alter or limit Parent&#8217;s or the Company&#8217;s or their Affiliates&#8217; ability to amend, modify or terminate any particular benefit plan, program, agreement or arrangement or (iii) is intended to confer upon any individual (including employees, retirees or dependents or beneficiaries of employees or retirees) any right as a third party beneficiary of this Agreement.  Notwithstanding any other provision in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, Parent&#8217;s and its Affiliates&#8217; obligations under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall not limit Parent&#8217;s and its Affiliates&#8217; right, in their sole discretion, to </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">55.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">furlough, temporarily layoff, terminate the employment of, or reduce the hours or benefits of, any employee because of, in whole or in part, COVID-19 pandemic related circumstances.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">5.4&#160;&#160;&#160;&#160;Indemnification of Officers and Directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If the Merger is consummated, then from the Effective Time until the sixth anniversary of the date on which the Effective Time occurs, the Surviving Corporation shall, and Parent shall cause the Surviving Corporation to, fulfill and honor all rights to indemnification by the Company existing in favor of those Persons who are directors and officers of the Company as of the date of this Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">D&#38;O Indemnified Persons</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) for their acts and omissions occurring prior to the Effective Time, as provided in the Company Charter and the Company&#8217;s bylaws (in each case, as in effect as of the date of this Agreement) and as provided in the indemnification agreements between the Company and such D&#38;O Indemnified Persons (as in effect as of the date of this Agreement) in the forms made available by the Company to Parent prior to the date of this Agreement, to the fullest extent available under applicable Law, and any claim made requesting indemnification pursuant to such indemnification rights shall continue to be subject to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.4(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and the indemnification rights provided under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.4(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> until disposition of such claim.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If the Merger is consummated, then from the Effective Time until the sixth anniversary of the date on which the Effective Time occurs, the Surviving Corporation shall maintain in effect, for the benefit of the D&#38;O Indemnified Persons with respect to their acts and omissions occurring prior to the Effective Time, the six-year &#8220;tail&#8221; policy for the existing directors and officers liability insurance that the Company shall purchase as of the effective time (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Tail D&#38;O Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that in no event shall Parent be required to expend in any one year an amount in excess of 150% of the annual premium currently payable by the Company with respect to such current policy.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In the event that Parent, the Company or the Surviving Corporation or any of their respective successors or assigns (i) consolidates with or merges into any other Person and shall not be the continuing or surviving corporation or Entity of such consolidation or merger or (ii) transfers all or substantially all of its properties and assets to any Person, then, and in each such case, Parent shall ensure that the successors and assigns of Parent, the Company or the Surviving Corporation, as the case may be, shall assume the obligations set forth in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall survive the consummation of the Merger and are (i) intended to be for the benefit of, and will be enforceable by, each of the D&#38;O Indemnified Persons and their successors, assigns and heirs and (ii) in addition to, and not in substitution for, any other rights to indemnification or contribution that any such D&#38;O Indemnified Person may have by Contract or otherwise.  This </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> may not be amended, altered or repealed after the Effective Time without the prior written consent of the affected D&#38;O Indemnified Person.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding anything contained in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, any indemnification agreement, the Company Charter or the Company&#8217;s bylaws, no such D&#38;O Indemnified Person will have any right of indemnification from the Surviving Corporation or its </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">56.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><br>successors or Acquiror pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> with respect to any damages incurred if such D&#38;O Indemnified Person committed Fraud.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">5.5&#160;&#160;&#160;&#160;Disclosure&#59; Confidentiality</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">During the Pre-Closing Period, neither the Company nor its Affiliates, on the one hand, nor Parent or any of its Affiliates, on the other hand, shall issue (and each shall cause its Representatives not to issue) any press release or make any public statement regarding this Agreement or the Merger, or regarding any of the other transactions contemplated by this Agreement, without the prior written consent of the other party hereto.  Notwithstanding the foregoing, but subject to the terms and conditions of the Confidentiality Agreement, each party hereto shall be allowed to disclose the terms of this Agreement, the Transaction Documents and the Transactions as required under applicable securities or other Laws or the rules of any national securities exchange or interdealer quotation service.  Notwithstanding anything to the contrary contained herein, the Debt Financing Sources may issue customary announcements and make other customary communications, including preparation and distribution of marketing materials, in connection with the Debt Financing&#59; provided, that the recipients of such information and any other information contemplated to be provided by the Debt Financing Sources agree to customary confidentiality arrangements, including &#8220;click through&#8221; confidentiality agreements and confidentially provisions contained in customary bank books and offering memoranda.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Each of Parent, and, prior to the Closing, the Company and their respective controlled Affiliates shall comply with, and shall cause its respective Representatives to comply with, all of its respective obligations under the Confidentiality Agreement which shall survive the termination of this Agreement in accordance with the terms set forth therein.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">5.6&#160;&#160;&#160;&#160;Tax Matters. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Transfer Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Parent on the one hand and the Participating Securityholders on the other hand shall each be responsible for and pay fifty percent (50%) of all stock transfer Taxes, real property transfer or mortgage Taxes, sales Taxes, documentary stamp Taxes, recording charges and other similar Taxes, if any, arising from the Contemplated Transactions and Parent shall prepare and file all necessary Tax Returns and other documentation in connection with such Taxes and Seller Representative shall cooperate as necessary in filing any such Tax Returns.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Cooperation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Parent and the Seller Representative agree to furnish or cause to be furnished to the other, upon reasonable request, such information and assistance in such party&#8217;s possession (including the possession of any Affiliate) relating to Taxes, including access to books and records, as is reasonably necessary for the filing of all Company Returns by Parent, or the Participating Securityholders.  Parent shall retain all books and records in its possession with respect to Taxes for a period of at least seven years following the Closing Date. Notwithstanding anything to the contrary in this Agreement, the Seller Representative shall have no obligation to prepare or file any Tax Returns.</font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">57.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Tax Treatment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  For all applicable Tax purposes, the parties to this Agreement agree to, and no party shall take any action or filing position inconsistent with, the following Tax treatment of the items specified below&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Seller Representative Reserve shall be treated as having been received and voluntarily set aside by the Participating Securityholders on the Closing Date, and no Tax withholding or information reporting shall be required in connection with the subsequent distribution of any portion of the Seller Representative Reserve to the Participating Securityholders.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(ii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Except for amounts paid in respect of In-the-Money Options (which are addressed in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.6(d)(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) and amounts received by a Participating Securityholder in the taxable year of such Participating Securityholder in which the Closing occurs, (A)&#160;the rights of the Participating Securityholders to the amounts held in the Escrow Account shall be treated as deferred contingent purchase price eligible for installment treatment under Section 453 of the Code and any corresponding provision of Applicable Law, as appropriate, and (B)&#160;if and to the extent any amount is released to the Participating Securityholders, interest may be imputed on such amount if required by Section 483 or 1274 of the Code.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(iii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Any payments made in respect of In-the-Money Options pursuant to this Agreement (A) shall be treated as compensation paid by the Company as and when received by the holder thereof to whom such payment is due (which, for the avoidance of doubt, shall be when released in respect of such In-the-Money Options in the case of amounts released from the Escrow Account or any amounts paid pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), and (B) shall be net of any Taxes withheld pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.11(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">All Tax allocation, sharing, receivable or indemnity agreements involving the Company shall be terminated prior to the Closing Date, such that, after the Closing, neither Parent, the Company, the Surviving Corporation, nor any of their Affiliates, shall be bound thereby or have any liability thereunder. For the avoidance of doubt, this provision shall not apply to customary agreements entered into in the ordinary course of business (such as a loan or a lease) the primary purpose of which is not Taxes.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">5.7&#160;&#160;&#160;&#160;R&#38;W Insurance.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  Parent and Merger Sub acknowledge and agree that (a) Parent may obtain the R&#38;W Insurance Policy, which if obtained shall be bound as of the date hereof and be in full force and effect upon Closing, (b) Parent shall be responsible for all fees, expenses and premiums relating to the R&#38;W Insurance Policy, and (c) if an R&#38;W Insurance Policy is obtained, Parent shall provide a copy to the Company prior to the date of this Agreement and shall not amend, waive or terminate the subrogation provisions contained in the R&#38;W Insurance Policy in a manner adverse to the Company or the Participating Securityholders, without the prior written consent of the Company prior to Closing, or the Seller Representative after Closing (such consent not to be unreasonably withheld, conditioned or delayed).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">5.8&#160;&#160;&#160;&#160;Efforts to Provide Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Company will use commercially reasonable efforts to give any required notices to and make any required filings in connection with the matters set forth in item (c)3. on Part 2.5 of the Disclosure Schedule and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 6.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, and Parent will cooperate with the Company in all reasonable respects in connection therewith.</font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">58.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 6.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ONDITIONS </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">P</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">RECEDENT TO </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">O</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">BLIGATIONS OF </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">P</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ARENT AND </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">M</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ERGER </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">UB</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The obligations of Parent and Merger Sub to effect the Merger and otherwise consummate the transactions contemplated by this Agreement are subject to the satisfaction (or waiver by Parent), at or prior to the Closing, of each of the following conditions&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.1&#160;&#160;&#160;&#160;Accuracy of Representations and Warranties.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  The Specified Representations that are qualified by materiality or Company Material Adverse Effect shall be true and correct in all respects as of the date of this Agreement and as of the Closing Date with the same effect as though made on and as of the Closing (except to the extent expressly made as of an earlier date, in which case such representations and warranties shall be true and correct in all respects as of such earlier date). The Specified Representations that are not qualified by materiality or Company Material Adverse Effect shall be true and correct in all material respects as of the date of this Agreement and as of the Closing Date with the same effect as though made on and as of the Closing (except to the extent expressly made as of an earlier date, in which case such representations and warranties shall be true and correct in all material respects as of such earlier date). The other representations and warranties of the Company set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall be true and correct (without giving effect to any limitation as to materiality or Company Material Adverse Effect set forth therein) as of the date of this Agreement and of the Closing Date with the same effect as though made on and as of the Closing (except to the extent expressly made as of an earlier date, in which case such representations and warranties shall be true and correct as of such earlier date), except where the failure of such representations and warranties to be true and correct could not reasonably be expected, individually or in the aggregate, to have a Company Material Adverse Effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.2&#160;&#160;&#160;&#160;Performance of Covenants.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company shall have performed and complied with, in all material respects, all of its covenants contained in this Agreement (other than </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">)at or before the Closing (to the extent that such covenants require performance by the Company at or before the Closing).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.3&#160;&#160;&#160;&#160;Stockholder Approval.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Agreement shall have been duly adopted by the Required Company Stockholder Votes. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.4&#160;&#160;&#160;&#160;No Restraints.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">No Order enjoining, preventing or prohibiting the consummation of the Merger by Parent shall have been issued by any court of competent jurisdiction or other Governmental Entity and remain in effect, and no Law shall have been enacted since the date of this Agreement that, in each case, makes consummation of the Merger by Parent or Merger Sub illegal.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.5&#160;&#160;&#160;&#160;No Governmental Litigation. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> There shall not be pending before any court of competent jurisdiction any lawsuit or other Legal Proceeding challenging the Merger that has been commenced by a Governmental Entity.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.6&#160;&#160;&#160;&#160;Agreements and Documents.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Parent shall have received the following agreements and documents, each of which shall be in full force and effect&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the Certificate of Merger, executed by the Company&#59; and</font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">59.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i) a notice to the IRS, in accordance with the requirements of Treasury Regulation Section 1.897-2(h)(2) dated as of the Closing Date, together with written authorization for Parent to deliver such notice to the IRS on behalf of the Company after the Closing and (ii)&#160;a certification that the shares of Company Capital Stock are not &#8220;United States real property interests&#8221; as defined in Section 897(c) of the Code prepared in accordance with the Treasury Regulations under Sections 897 and 1445 of the Code (for purposes of satisfying Parent&#8217;s obligations under Treasury Regulation Section 1.1445-2(c)(3)), in each case, validly executed by a duly authorized officer of the Company&#59;</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;Reserved&#59;&#93;</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;Reserved&#59;&#93;</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;Reserved&#59;&#93;</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;Reserved&#59;&#93;</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(g)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;Reserved&#59;&#93; and</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(h)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">written resignations of all officers and directors of the Company effective as of the Effective Time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.7&#160;&#160;&#160;&#160;Closing Certificate</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">An authorized officer of the Company shall have delivered to Parent a certificate to the effect that each of the conditions specified above in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Sections 6.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">6.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> is satisfied in all respects.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.8&#160;&#160;&#160;&#160;Dissenting Shares.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Dissenting Shares shall not constitute more than 10% of the Company Capital Stock outstanding on the applicable record date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.9&#160;&#160;&#160;&#160;Officer&#8217;s Certificate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Company shall have delivered to Parent a certificate of the Chief Executive Officer (or other authorized officer) of the Company certifying (a) that attached thereto are true and complete copies of all resolutions adopted by the Board of Directors of the Company (i) authorizing the execution, delivery and performance of this Agreement and the Transaction Documents and the consummation of the Transactions and (ii) with respect to the Company Carve-Out Plan, setting forth the determination of the aggregate amount of Net Proceeds by the Board of Directors of the Company&#59; (b) that the resolutions described in clause (a) are in full force and effect and are all the resolutions adopted in connection with the matters described in clause (a) and the items set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.4(e)(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#59; and (c) the names of the officers of the Company authorized to sign this Agreement, the Transaction Documents and the other documents to be delivered hereunder and thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.10&#160;&#160;&#160;&#160;Good Standing Certificates</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Company shall have delivered to Parent a good standing certificate (or its equivalent) from the secretary of state or similar Governmental Entity of the jurisdiction under the Laws in which the Company is organized.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.11&#160;&#160;&#160;&#160;Escrow Agreement.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Seller Representative shall have executed and delivered the Escrow Agreement.</font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">60.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.12&#160;&#160;&#160;&#160;No Company Material Adverse Effect</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Since the date of this Agreement, there shall not have occurred any Company Material Adverse Effect other than a Company Material Adverse Effect that is capable of being cured and has been cured to Parent&#8217;s satisfaction as of the Closing Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.13&#160;&#160;&#160;&#160;HSR Clearance.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The waiting period (and any extensions thereof) applicable to the consummation of the transactions contemplated by this Agreement under the HSR Act shall have expired or been terminated.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.14&#160;&#160;&#160;&#160;R&#38;W Insurance Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If Parent elects to procure the R&#38;W Insurance Policy pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the R&#38;W Insurance Policy shall be in full force and effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.15&#160;&#160;&#160;&#160;Termination of 401(k) Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The board of directors of the Company shall have adopted a resolution terminating the Company&#8217;s existing 401(k) plan contingent upon the Closing and effective as of the day immediately prior to the Closing Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.16&#160;&#160;&#160;&#160;Termination and Payment of Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Each of the Persons identified on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Schedule 6.6(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall have resigned or been terminated as employees of the Company conditioned on and effective as of the Effective Time, and such resignation or termination shall have been deemed to constitute an event pursuant to which such Persons are entitled severance under their existing agreements with the Company (such severance, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Specified Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.17&#160;&#160;&#160;&#160;Offer Letters and Consulting Agreements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. No individual identified on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Schedule6.17(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall have revoked the consulting agreement from Parent that was executed by such individual simultaneously with the execution and delivery of this Agreement. No individual identified on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Schedule 6.17(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall have revoked the offer letter or restrictive covenant agreement from Parent in each case that was executed by such individual simultaneously with the execution and delivery of this Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 7.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ONDITIONS </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">P</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">RECEDENT TO </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">O</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">BLIGATIONS OF THE </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">OMPANY</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The obligation of the Company to effect the Merger and otherwise consummate the transactions contemplated by this Agreement is subject to the satisfaction (or waiver by the Company), at or prior to the Closing, of the following conditions&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7.1&#160;&#160;&#160;&#160;Accuracy of Representations and Warranties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The representations and warranties of Parent and Merger Sub set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall be true and correct in all material respects as of the date of this Agreement and as of the Closing Date with the same effect as though made on and as of the Closing (except to the extent expressly made as of an earlier date, in which case such representations and warranties shall be true and correct in all respects as of such earlier date).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7.2&#160;&#160;&#160;&#160;Performance of Covenants.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Parent and Merger Sub shall have performed and complied with, in all material respects, all of their agreements, covenants and conditions contained in this Agreement and each Transaction Document to be performed or complied with by it at or before the Closing (to the extent that such agreements, covenants or conditions require performance by Parent or Merger Sub at or before the Closing).</font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">61.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7.3&#160;&#160;&#160;&#160;Stockholder Approval.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Agreement shall have been duly adopted by the Required Company Stockholder Votes.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7.4&#160;&#160;&#160;&#160;No Restraints.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">No Order enjoining, preventing or prohibiting the consummation of the Merger by the Company shall have been issued by any court of competent jurisdiction and remain in effect, and no Law shall have been enacted since the date of this Agreement that, in each case, makes consummation of the Merger by the Company illegal.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7.5&#160;&#160;&#160;&#160;No Governmental Litigation.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">There shall not be pending or threatened before any court of competent jurisdiction any lawsuit or other Legal Proceeding challenging the Merger that&#160;has been commenced by a Governmental Entity.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7.6&#160;&#160;&#160;&#160;Escrow Agreement.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Parent shall have executed and delivered to the Company the Escrow Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7.7&#160;&#160;&#160;&#160;Closing Certificate.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">An authorized officer of Parent and Merger Sub shall have delivered to Company a certificate to the effect that each of the conditions specified above in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Sections 7.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">7.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> is satisfied in all respects.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7.8&#160;&#160;&#160;&#160;HSR Clearance.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The waiting period (and any extensions thereof) applicable to the consummation of the transactions contemplated by this Agreement under the HSR Act shall have expired or been terminated.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 8.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">T</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ERMINATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">8.1&#160;&#160;&#160;&#160;Termination.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Agreement may be terminated prior to the Effective Time (whether before or after the adoption of this Agreement by the Required Company Stockholder Votes)&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">by mutual written consent of Parent and the Company&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">by either Parent or the Company if the Merger shall not have been consummated by the End Date&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">that a party shall not be permitted to terminate this Agreement pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> if the failure to consummate the Merger by the End Date is primarily attributable to a breach or failure on the part of such party to perform any representation, warranty, covenant or agreement in this Agreement required to be performed by such party at or prior to the Effective Time as set forth in this Agreement&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">by either Parent or the Company if a court of competent jurisdiction shall have issued a final and nonappealable Order having the effect of permanently restraining, enjoining or otherwise prohibiting the Merger&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">that a party shall not be permitted to terminate this Agreement pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.1(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> if such party did not use commercially reasonable efforts to have such Order vacated prior to its becoming final and nonappealable&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">by Parent, if the Company shall have materially breached or materially failed to perform any of its representations, warranties, covenants or agreements contained in this Agreement, which material breach or failure to perform (i) would give rise to the failure of a </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">62.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">condition set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 6.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 6.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and (ii) cannot be or has not been cured within 30 calendar days following receipt by the Company of written notice of such material breach or failure to perform&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">by the Company, if Parent or Merger Sub shall have materially breached or materially failed to perform any of their respective representations, warranties, covenants or agreements contained in this Agreement, which material breach or failure to perform (i) would give rise to the failure of a condition set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 7.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 7.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and (ii) cannot be or has not been cured within 30 calendar days following receipt by Parent of written notice of such material breach or failure to perform&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">by Parent, by written notice to the Company if, immediately following the execution of this Agreement, the Company has not obtained the Required Company Stockholder Votes and has not delivered to Parent Written Consents constituting the Required Company Stockholder Votes.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">8.2&#160;&#160;&#160;&#160;Effect of Termination. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> In the event of the termination of this Agreement as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, this Agreement shall be of no further force or effect&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">that no such termination shall relieve any party from any liability for any Damages for Willful Breach of this Agreement before such termination&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.5(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall survive the termination of this Agreement and shall remain in full force and effect.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Section 9.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">M</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ISCELLANEOUS </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">P</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ROVISIONS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.1&#160;&#160;&#160;&#160;No Recourse&#59; Non-Survival of Representations, Warranties and Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">All representations and warranties and all covenants and obligations of the Company set forth in this Agreement (other than those covenants and agreements that by their terms apply or are to be performed in whole or in part (but only to the extent of such part) at or after the Closing (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Post-Closing Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;)) shall terminate at the Closing (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Expiration Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) and it is the intention of the parties hereto, to the extent permitted by applicable Law, that the Expiration Date supersede any applicable statutes of limitations with respect to such representations, warranties and covenants, provided, that (i) nothing herein shall relieve any Person from any liability or damages resulting from such Person&#8217;s Fraud (it being understood that no Person shall be liable for any Fraud committed by any other Person), and (ii) each Post-Closing Covenant shall survive until such covenant is performed or otherwise expires in accordance with its terms.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Parent (on behalf of itself, its Affiliates (including, from and after the Closing, the Company) and its and its Affiliates&#8217; Representatives, collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Parent Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; and each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Parent Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) hereby waives, from and after the Closing, any and all rights, claims and causes of action which any Parent Party may have against the Company or any of the Participating Securityholders, any of its or their respective Affiliates or any of its or their Representatives (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Seller Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) arising out of, relating to or otherwise resulting from the Transactions&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that such waiver shall not limit the liability of any Participating Securityholder for any Fraud committed by that Participating Securityholder. Parent </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">63.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(on behalf of the Parent Parties) agrees that, from and after the Closing, under no circumstances will the Seller Parties have any liability or responsibility to any of the Parent Parties for any losses or other liabilities relating to or arising from any actual or alleged breach of any representation or warranty or any covenant or agreement to have been performed prior to the Closing set forth in this Agreement (or any Exhibit, Schedule or certificate delivered hereunder), including by virtue of or based upon any alleged misrepresentation or inaccuracy in or breach of any of the representations or warranties or covenants or obligations set forth in this Agreement that are to be performed prior to the Closing, any certificate, instrument, opinion or other documents delivered hereunder, the ownership, operation, management, use or control of the business of the Company prior to the Closing, any of their respective assets, or any actions or omissions at or prior to the Closing, whether by the enforcement of any assessment or by any legal or equitable proceeding, or by virtue of any statute, regulation or other applicable Law, except for any claim of Fraud with respect to the representations and warranties in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement. From and after the Closing, the Parent Parties shall have no recourse of any kind to the Seller Parties under any Theory of Liability, for any action or inaction of any of the Seller Parties, in each case prior to the Closing&#59; except for any claim of Fraud with respect to the representations and warranties in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement. In no event shall any Participating Securityholder be liable in connection with the transactions contemplated under this Agreement for any damages, losses or other liabilities (a) in excess of such Participating Securityholder&#8217;s pro rata portion of such amounts based on the portion of Merger Consideration actually received by such Participating Securityholder compared to the total Merger Consideration or (b) in excess of the amount of Merger Consideration actually received by such Participating Securityholder under this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.2&#160;&#160;&#160;&#160;Amendment.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Agreement may be amended with the approval of the respective boards of directors of the Company (or the Seller Representative following the Closing) and Parent at any time (whether before or after the adoption of this Agreement by the Required Company Stockholder Votes)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">that after any such adoption of this Agreement by the Required Company Stockholder Votes, no amendment shall be made which by Law requires further approval of the Company Stockholders without the further approval of such Company Stockholders&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that this Agreement shall not be amended, modified or supplemented in any manner that would adversely affect the rights of any Debt Financing Source Parties under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and&#47;or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (in each case, together with any related definitions and other provisions of this Agreement to the extent an amendment, modification or supplement thereto would serve to modify the substance or provision of any such sections) (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Debt Financing Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) without the prior written consent of the Debt Financing Sources.  This Agreement may not be amended except by an instrument in writing signed on behalf of the Company and Parent (prior to the Closing) or Parent and the Seller Representative (after the Closing) (and, in the case of the Debt Financing Provisions, the Debt Financing Sources).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.3&#160;&#160;&#160;&#160;Expenses.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">All fees and expenses incurred in connection with this Agreement, the Transaction Documents and the Transactions shall be paid by the party incurring such expenses, whether or not the Merger is consummated, except that all (a) filing fees payable under or pursuant to the HSR Act (and any other government regulation) shall be paid by Parent, and (b) fees and expenses of the Payment Agent and the Escrow Agent shall be paid by Parent.</font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">64.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.4&#160;&#160;&#160;&#160;Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">No failure on the part of any party to exercise any power, right, privilege or remedy under this Agreement, and no delay on the part of any party in exercising any power, right, privilege or remedy under this Agreement, shall operate as a waiver of such power, right, privilege or remedy&#59; and no single or partial exercise of any such power, right, privilege or remedy shall preclude any other or further exercise thereof or of any other power, right, privilege or remedy.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">No party shall be deemed to have waived any claim arising out of this Agreement, or any power, right, privilege or remedy under this Agreement, unless the waiver of such claim, power, right, privilege or remedy is expressly set forth in a written instrument duly executed and delivered on behalf of such party&#59; and any such waiver shall not be applicable or have any effect except in the specific instance in which it is given.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.5&#160;&#160;&#160;&#160;Entire Agreement&#59; Counterparts.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Agreement (together with the Disclosure Schedule and Exhibits which are intended to be and hereby are specifically made a part of this Agreement), the Transaction Documents and the Confidentiality Agreement constitute the entire agreement and supersede all prior agreements and understandings, both written and oral, among or between any of the parties with respect to the subject matter hereof and thereof&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">that the Confidentiality Agreement shall not be superseded, shall survive any termination of this Agreement and shall continue in full force and effect until the earlier to occur of (a) the Effective Time and (b) the date on which the Confidentiality Agreement expires in accordance with its terms or is validly terminated by the parties thereto.  This Agreement may be executed in several counterparts, each of which shall be deemed an original and all of which shall constitute one and the same instrument.  This Agreement may be executed by facsimile or electronic transmission, each of which shall be deemed an original.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.6&#160;&#160;&#160;&#160;Applicable Law&#59; Jurisdiction.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware, regardless of the laws that might otherwise govern under applicable principles of conflicts of laws thereof.  Except as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, in any action between any of the parties arising out of or relating to this Agreement or any of the Transactions&#58; (a)&#160;each of the parties irrevocably and unconditionally consents and submits to the exclusive jurisdiction and venue of the state and federal courts located in Delaware&#59; (b) if any such action is commenced in a state court, then, subject to applicable Law, no party shall object to the removal of such action to any federal court located in Delaware&#59; and (c) each of the parties irrevocably waives the right to trial by jury.  Notwithstanding anything to the contrary herein and without limiting </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, (i) no party hereto nor its controlled Affiliates shall bring or support any action or causes of action (whether in contract or in tort or otherwise, or whether at law (including at common law or by statute) or in equity) against the Debt Financing Source Parties (in each case, in such capacity) in any way relating to this Agreement or any of the Transactions, including any dispute arising out of or relating in any way to the Debt Financing or the performance thereof, in any forum other than the Supreme Court of the State of New York, County of New York or, if under applicable Law exclusive jurisdiction is vested in the federal courts, the United States District Court for the Southern District of New York (and appellate courts thereof), (ii) all claims, crossclaims, third party-claims or causes of action (whether in contract or in tort or otherwise, or whether at law (including at common law or by statute) or in equity) against any of </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">65.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the Debt Financing Source Parties (in each case, in such capacity) in any way relating to this Agreement or any of the Transactions, including any dispute arising out of or relating in any way to the Debt Financing or the performance thereof, shall be exclusively governed by, and construed in accordance with, the internal Laws of the State of New York, without giving effect to principles or rules of choice or conflict of Laws to the extent such principles or rules would require or permit the application of Laws of another jurisdiction and (iii) each party HERETO hereby irrevocably and unconditionally waives and shall cause its Affiliates to waive any right such party may have to a trial by jury in respect of any litigation (whether in contract or in tort or otherwise, or whether at law (including at common law or by statute) or in equity) directly or indirectly arising out of or relating in any way to this Agreement and&#47;or the Transactions, including any dispute arising out of or relating in any way to the Debt Financing or the performance thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.7&#160;&#160;&#160;&#160;Assignability.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Agreement shall be binding upon, and shall be enforceable by and inure solely to the benefit of, the parties hereto and their respective successors and assigns&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that, neither this Agreement nor any of the rights hereunder may be assigned (whether by merger, consolidation, sale or otherwise) by the Company (prior to the Effective Time) or Parent without the prior written consent of the other party, and any attempted assignment of this Agreement or any of such rights without such consent shall be void and of no effect (except that Parent may assign this Agreement or any such rights to an Affiliate without the prior written consent of the Company (prior to the Effective Time) or the Seller Representative (at or after the Effective Time))&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that Parent and the Surviving Corporation may assign this Agreement as a whole without such consent in connection with the acquisition (whether by merger, consolidation, sale or otherwise) of Parent or the Surviving Corporation or of that part of Parent&#8217;s or the Surviving Corporation&#8217;s business to which this Agreement relates, as long as Parent provides written notice to the Company (prior to the Effective Time) or the Seller Representative (at or after the Effective Time) of such assignment and the assignee thereof agrees in writing to assume and be bound as Parent and the Surviving Corporation hereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.8&#160;&#160;&#160;&#160;Third Party Beneficiaries.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Except as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, nothing in this Agreement, express or implied, is intended to or shall confer upon any Person (other than the parties hereto) any right, benefit or remedy of any nature whatsoever under or by reason of this Agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that the Debt Financing Source Parties are intended third-party beneficiaries of the Debt Financing Provisions and such provisions shall be enforceable by each Financing Source.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.9&#160;&#160;&#160;&#160;Notices.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Any notice or other communication required or permitted to be delivered to any party under this Agreement shall be in writing and shall be deemed properly delivered, given and received (a) upon receipt when delivered by hand, (b) upon transmission, if sent by electronic transmission (in each case with receipt verified by electronic confirmation), or (c) one Business Day after being sent by courier or express delivery service, provided that in each case the notice or other communication is sent to the address set forth beneath the name of such party below (or to such other address as such party shall have specified in a written notice given to the </font></div><div style="margin-bottom:0.1pt;text-align:justify"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:justify"><font><br></font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">66.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">other parties hereto), provided that with respect to notices deliverable to the Seller Representative, such notices shall be delivered solely via email or facsimile&#58;</font></div><div style="margin-bottom:10pt;padding-left:90pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">if to Parent or Merger Sub&#58;</font></div><div style="margin-bottom:0.1pt;padding-left:90pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">Haemonetics Corporation</font></div><div style="margin-bottom:0.1pt;padding-left:90pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">125 Summer Street</font></div><div style="margin-bottom:0.1pt;padding-left:90pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">Boston, Massachusetts 02110</font></div><div style="margin-bottom:0.1pt;padding-left:90pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">Attn&#58; Michelle Basil, General Counsel</font></div><div style="margin-bottom:12pt;padding-left:90pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">Email&#58; </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#91;***&#93;</font></div><div style="margin-bottom:10pt;padding-left:90pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">with a copy to&#58;</font></div><div style="padding-left:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">DLA Piper LLP</font></div><div style="margin-bottom:0.12pt;padding-left:90pt;text-indent:-0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">33 Arch Street, 26th Floor</font></div><div style="margin-bottom:0.12pt;padding-left:90pt;text-indent:-0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">Boston, Massachusetts 02110</font></div><div style="margin-bottom:0.12pt;padding-left:90pt;text-indent:-0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">Attn&#58; Adam Ghander</font></div><div style="margin-bottom:12pt;padding-left:90pt;text-indent:-0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">Email&#58; adam.ghander&#64;dlapiper.com&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;padding-left:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">if to the Company (prior to Closing)&#58;</font></div><div style="margin-bottom:0.12pt;padding-left:90pt;text-indent:-0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">Cardiva Medical, Inc.</font></div><div style="margin-bottom:0.12pt;padding-left:90pt;text-indent:-0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">1615 Wyatt Drive</font></div><div style="margin-bottom:0.12pt;padding-left:90pt;text-indent:-0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">Santa Clara, CA&#160; 95054</font></div><div style="margin-bottom:0.12pt;padding-left:90pt;text-indent:-0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">Attn&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#91;***&#93;</font></div><div style="margin-bottom:12pt;padding-left:90pt;text-indent:-0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">Email&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#91;***&#93;</font></div><div style="margin-bottom:12pt;padding-left:90pt;text-indent:-0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">or the Seller Representative (after the Closing)&#58;</font></div><div style="margin-bottom:0.12pt;padding-left:90pt;text-indent:-0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">Fortis Advisors LLC</font></div><div style="margin-bottom:0.12pt;padding-left:90pt;text-indent:-0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">Facsimile </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#91;***&#93;</font></div><div style="margin-bottom:0.12pt;padding-left:90pt;text-indent:-0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">E-mail&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#91;***&#93;</font></div><div style="margin-bottom:0.12pt;padding-left:90pt;text-indent:-0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">Attention&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#91;***&#93;</font></div><div style="margin-bottom:0.12pt;padding-left:1.08pt;text-indent:-0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:133%"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">in the case of notices to the Company (prior to Closing) or to the Seller Representative (after the Closing), with a copy to (which shall not constitute notice)&#58;</font></div><div style="padding-left:85.5pt;text-indent:0.18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Cooley LLP</font></div><div style="padding-left:85.5pt;text-indent:0.18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3175 Hanover Street</font></div><div style="padding-left:85.5pt;text-indent:0.18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Palo Alto, CA 94304</font></div><div style="margin-bottom:0.1pt;padding-left:85.5pt;text-indent:0.18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">Attention&#58; Mark Weeks&#59; Josh Seidenfeld&#59; Anne Lieberman&#160;&#160;&#160;&#160;</font></div><div style="padding-left:85.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">E-mail&#58; mweeks&#64;cooley.com&#59; jseidenfeld&#64;cooley.com&#59; </font></div><div style="padding-left:90pt"><font><br></font></div><div style="margin-bottom:0.1pt"><font><br></font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">67.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="padding-left:0.18pt;text-indent:81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">alieberman&#64;cooley.com &#160;&#160;&#160;&#160; </font></div><div style="padding-left:108pt;text-indent:-36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.10&#160;&#160;&#160;&#160;Severability.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Any term or provision of this Agreement that is invalid or unenforceable in any situation in any jurisdiction shall not affect the validity or enforceability of the remaining terms and provisions hereof or the validity or enforceability of the offending term or provision in any other situation or in any other jurisdiction.  If the final judgment of a court of competent jurisdiction declares that any term or provision hereof is invalid or unenforceable, the parties hereto agree that the court making such determination shall have the power to limit the term or provision, to delete specific words or phrases, or to replace any invalid or unenforceable term or provision with a term or provision that is valid and enforceable and that comes closest to expressing the intention of the invalid or unenforceable term or provision, and this Agreement shall be enforceable as so modified.  In the event such court does not exercise the power granted to it in the prior sentence, the parties hereto agree to replace such invalid or unenforceable term or provision with a valid and enforceable term or provision that will achieve, to the extent possible, the economic, business and other purposes of such invalid or unenforceable term.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.11&#160;&#160;&#160;&#160;Knowledge. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Knowledge</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; of the Company shall mean the actual knowledge of a fact or other matter, after reasonable inquiry of the direct reports with operational responsibility for the matters in question, of the Knowledge Individuals.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.12&#160;&#160;&#160;&#160;Conflict of Interest.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If the Seller Representative so desires, acting on behalf of the Participating Securityholders and without the need for any consent or waiver by the Company or Parent, Cooley LLP (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Cooley</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) shall be permitted to represent the Participating Securityholders after the Closing in connection with any matter, including without limitation, anything related to the Transactions, any other agreements referenced herein or any disagreement or dispute relating thereto.  Without limiting the generality of the foregoing, after the Closing, Cooley shall be permitted to represent the Participating Securityholders, any of their agents and Affiliates, or any one or more of them, in connection with any negotiation, transaction or dispute (including any litigation, arbitration or other adversary proceeding) with Parent, the Company or any of their agents or Affiliates under or relating to this Agreement, any transaction contemplated by this Agreement, and any related matter, such as claims or disputes arising under other agreements entered into in connection with this Agreement, including with respect to any indemnification claims.  Upon and after the Closing, the Company shall cease to have any attorney-client relationship with Cooley, unless and to the extent Cooley is specifically engaged in writing by the Company to represent the Company after the Closing and either such engagement involves no conflict of interest with respect to the Participating Securityholders or the Seller Representative consents in writing at the time to such engagement.  Any such representation of the Company by Cooley after the Closing shall not affect the foregoing provisions hereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.13&#160;&#160;&#160;&#160;Attorney-Client Privilege.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Parent, Participating Securityholders and the Company agree that any attorney-client privilege, attorney work-product protection, and the expectation of client confidence attaching as a result of counsel&#8217;s (whether external or internal) representation of the Company in connection with the Transactions, and all information and documents covered by such privilege or protection (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Covered Materials</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), shall belong to and be controlled by the Seller Representative, and not by the Parent or the Company, following the Closing, and may be waived only by the Seller Representative, and not the Company, and shall not pass to or be claimed</font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">68.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> or used by Parent or the Company. Absent the consent of the Seller Representative, neither Parent nor the Company shall have a right to access the Covered Materials following the Closing and, in the event Parent or the Company accesses Covered Materials in violation of this sentence, such access will not waive or otherwise affect the rights of the Seller Representative with respect to the related privilege or protection. Notwithstanding the foregoing, if a dispute arises between Parent or the Company, on the one hand, and a third party other than (and unaffiliated with) the Participating Securityholders and the Seller Representative, on the other hand, after the Closing, then the Company may assert such attorney-client privilege to prevent disclosure to such Covered Materials&#59; and provided, further, that Parent and the Company may not waive such privilege without the prior written consent of the Seller Representative.  The foregoing shall not extend to (i) any communication unrelated to this Agreement, any of the Transaction Documents or the Transactions, (ii) communications among any of the Company Stockholders, the Seller Representative or the Company, on the one hand, and any Person other than Cooley or the Company&#8217;s other legal counsel, on the other hand, or (iii) any post-Closing communications between the Company and Cooley and its other legal counsel.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.14&#160;&#160;&#160;&#160;No Implied Representations&#59; Non-Reliance.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The parties acknowledge that, except as expressly provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, none of the parties hereto has made or is making any representations or warranties whatsoever, implied or otherwise&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that nothing in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall limit Parent&#8217;s right to seek any remedy on account of Fraud. Parent hereby acknowledges and agrees that&#58; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Parent has conducted its own independent investigation, review and analysis of the business, results of operations, prospects, condition (financial or otherwise) or assets of the Company, and acknowledges that it has been provided adequate access to the personnel, properties, assets, premises, books and records, and other documents and data of the Company for such purpose. Parent acknowledges and agrees that&#58; (i) in making its decision to enter into this Agreement and the other Transaction Documents and to consummate the Transactions, Parent has relied solely upon its own investigation and the express representations and warranties of the Company set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement (including, and subject to, the related portions of the Disclosure Schedule) and disclaims reliance on any other representations and warranties of any kind or nature express or implied (including, but not limited to, any relating to the future or historical financial condition, results of operations, assets or liabilities or prospects of the Company)&#59; and (ii) none of the Company Stockholders, the Company or any other Person has made any representation or warranty as to a Company Stockholder, the Company or the accuracy or completeness of any information regarding the Company furnished or made available to Parent and its Representatives, except as expressly set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement (including, and subject to, the related portions of the Disclosure Schedule). </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In connection with the due diligence investigation of the Company by Parent and its Affiliates, stockholders and&#47;or Representatives, Parent and its Affiliates, stockholders and Representatives have received and may continue to receive after the date hereof from the Company and its Affiliates, stockholders and Representatives certain estimates, projections, forecasts and other forward-looking information, as well as certain business plan information, regarding the Company and its businesses and operations. Parent hereby acknowledges that there are uncertainties inherent in attempting to make such estimates, </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">69.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">projections, forecasts and other forward-looking statements, as well as in such business plans, and that Parent will have no claim against any of the Company, or any of its Affiliates, stockholders, directors, officers, employees, consultants, agents, representatives or advisors, or any other Person, with respect thereto, including as to the accuracy or completeness of any information provided. Accordingly, Parent hereby acknowledges and agrees that, except for the representations and warranties expressly set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement (including, and subject to, the related portions of the Disclosure Schedule), neither the Company, nor any of its Affiliates, stockholders, directors, officers, employees, consultants, agents, representatives or advisors has made or is making any express or implied representation or warranty with respect to such estimates, projections, forecasts, forward-looking statements or business plans.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.15&#160;&#160;&#160;&#160;Specific Performance. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The parties agree that irreparable damage for which monetary damages, even if available, would not be an adequate remedy, would occur in the event that the parties do not perform their obligations under the provisions of this Agreement in accordance with its specified terms or otherwise breach such provisions. The parties acknowledge and agree that (a) the parties shall be entitled to an injunction or injunctions, specific performance, or other equitable relief, to prevent breaches of this Agreement and to enforce specifically the terms and provisions hereof in the courts described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> without proof of damages or otherwise, this being in addition to any other remedy to which they are entitled under this Agreement or at law or in equity and (b) the right of specific performance is an integral part of the Transactions and without that right, none of the Company, Parent or Merger Sub would have entered into this Agreement. The right to specific enforcement hereunder shall include the right of the Company to cause Parent to consummate the Merger, and to consummate the other transactions contemplated by this Agreement, on the terms and subject to the conditions set forth in this Agreement. Each of the parties agrees that it will not oppose the granting of an injunction, specific performance and other equitable relief on the basis that the other parties have an adequate remedy at law or an award of specific performance is not an appropriate remedy for any reason at law or equity. The parties acknowledge and agree that any party seeking an Order to prevent breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement in accordance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall not be required to provide any bond or other security in connection with any such Order.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.16&#160;&#160;&#160;&#160;Construction  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For purposes of this Agreement, whenever the context requires&#58; the singular number shall include the plural, and vice versa&#59; the masculine gender shall include the feminine and neuter genders&#59; the feminine gender shall include the masculine and neuter genders&#59; and the neuter gender shall include masculine and feminine genders.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The parties hereto agree that any rule of construction to the effect that ambiguities are to be resolved against the drafting party shall not be applied in the construction or interpretation of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">As used in this Agreement, the words &#8220;include&#8221; and &#8220;including,&#8221; and variations thereof, shall not be deemed to be terms of limitation, but rather shall be deemed to be followed by the words &#8220;without limitation.&#8221;</font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">70.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Except as otherwise indicated, all references in this Agreement to &#8220;Sections,&#8221; &#8220;Exhibits&#8221; and &#8220;Schedules&#8221; are intended to refer to Sections of this Agreement and Exhibits or Schedules to this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The bold-faced headings contained in this Agreement are for convenience of reference only, shall not be deemed to be a part of this Agreement and shall not be referred to in connection with the construction or interpretation of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">All references to materials being &#8220;furnished,&#8221; &#8220;provided,&#8221; &#8220;delivered,&#8221; or &#8220;made available&#8221; by the Company means documents posted and accessible to Parent and its advisors in the Venue Hub electronic data room for &#8220;Project Cardiva&#8221; hosted by Donnelley Financial Solutions no less than 24 hours before the date of this Agreement and remained so posted and accessible continuously through the Closing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.17&#160;&#160;&#160;&#160;Disclosure Schedule.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Disclosure Schedule has been arranged, for purposes of convenience only, as separate Parts corresponding to the subsections of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement. The representations and warranties contained in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement are subject to (a)&#160;the exceptions and disclosures set forth in the part of the Disclosure Schedule corresponding to the particular subsection of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> in which such representation and warranty appears&#59; (b) any exceptions or disclosures explicitly cross-referenced in such part of the Disclosure Schedule by reference to another part of the Disclosure Schedule&#59; and (c)&#160;any exception or disclosure set forth in any other part of the Disclosure Schedule to the extent it is reasonably apparent that such exception or disclosure is intended to qualify such representation and warranty.  No reference to or disclosure of any item or other matter in the Disclosure Schedule shall be construed as an admission or indication that such item or other matter is material (nor shall it establish a standard of materiality for any purpose whatsoever) or that such item or other matter is required to be referred to or disclosed in the Disclosure Schedule.  The information set forth in the Disclosure Schedule is disclosed solely for the purposes of this Agreement, and no information set forth therein shall be deemed to be an admission by any party hereto to any third party of any matter whatsoever, including of any violation of Law or breach of any agreement.  The Disclosure Schedule and the information and disclosures contained therein are intended only to qualify and limit the representations, warranties and covenants of the Company contained in this Agreement.  Nothing in the Disclosure Schedule is intended to broaden the scope of any representation or warranty contained in this Agreement or create any covenant.  Matters reflected in the Disclosure Schedule are not necessarily limited to matters required by the Agreement to be reflected in the Disclosure Schedule.  Such additional matters are set forth for informational purposes and do not necessarily include other matters of a similar nature.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.18&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Waiver of Claims Against Debt Financing Sources.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding anything herein to the contrary, the Company (and its directors, officers, employees, equityholders, Representatives, advisors and Affiliates (in each case, in such capacity)) and the Seller Representative (and its directors, officers, employees, equityholders, Representatives, advisors and Affiliates (in each case, in such capacity)) each hereby waives any rights or claims against any of the Debt Financing Source Parties (in each case, in such capacity), in any way relating to this Agreement or any of the Transactions, including any dispute arising out of or relating in any way to the Debt Financing, whether at law, in equity, in contract, in tort or otherwise.  Nothing in this </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">71.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall in any way limit or modify the rights of Parent or Merger Sub under this Agreement or any Debt Financing Source&#8217;s obligations to Parent as may be mutually agreed by Parent and the Debt Financing Sources.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#91;Signature Page Follows&#93;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">72.</font></div></div></div><div id="i7ae4bb5e39b04d889fdc79bcea08a102_22"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">I</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">N</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> W</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ITNESS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> W</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">HEREOF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the parties have caused this Agreement to be executed as of the date first above written.</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.916%"><tr><td style="width:1.0%"></td><td style="width:18.867%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.867%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.847%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.019%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">HAEMONETICS CORPORATION</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Christopher A. Simon</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Christopher A. Simon</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">President and Chief Executive Officer</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">CONCORDIA MERGER SUB, INC.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Stewart Strong</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Stewart Strong</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">President</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">CARDIVA MEDICAL, INC.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; John Russell</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">John Russell</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">CEO</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Seller Representative</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Ryan Simkin</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Ryan Simkin</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Managing Director</font></td></tr></table></div><div style="margin-bottom:12pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:12pt"><font><br></font></div><div style="margin-bottom:6pt;margin-top:12pt"><font><br></font></div></div></div><div id="i7ae4bb5e39b04d889fdc79bcea08a102_25"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:133%">EXHIBIT A</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:133%">C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">ERTAIN </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:133%">D</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">EFINITIONS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For purposes of the Agreement (including this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">)&#58; </font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">409A Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.17(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Accrued Dividends</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning given to such term in Article 2, Section (a) of the Company Charter. </font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Accrued Pre-Closing Income Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means an amount (which shall not be less than zero ($0) dollars with respect to the Company in any jurisdiction or tax regime) equal to the aggregate amount of any accrued and unpaid Income Taxes of the Company for any Pre-Closing Tax Period (whether or not yet due and payable), determined (i) except as required under applicable Law or otherwise provided in this definition, in accordance with the past practices (including reporting positions, elections and accounting methods) of the Company in preparing Company Returns, (ii) by including (A) in taxable income, any adjustment pursuant to Section 481 of the Code (or any corresponding or similar provision of state, local or non-U.S. Law) (B) the sum of the installment payments, if any, of the Company due (or to become due in any future period) under Section 965(h) of the Code and (C) any Taxes payable in any Straddle Period pursuant to Sections 951 and 951A of the Code by a direct, indirect or constructive shareholder of the Company that are attributable to the Pre-Closing Tax Period portion of such Straddle Period, (iii)&#160;by including as deductions against taxable income all Transaction Deductions in the Pre-Closing Tax Period to the maximum extent permitted by applicable Law and (iv) subject to clause (ii) above, by excluding any deferred Income Tax assets and liabilities. In the case of any Straddle Period, Accrued Pre-Closing Income Taxes shall include an amount equal to the Pre-Closing Tax Period portion of such Taxes, determined on a closing of the books basis&#59; provided that exemptions, allowances or deductions that are calculated on an annual basis (including, but not limited to, depreciation and amortization deductions) shall be apportioned on a per diem basis.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Achieved Revenue</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.16(b)(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Acquisition Proposal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4.3(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Adjustment Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.12(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement. </font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Adverse Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.11(b)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean, with respect to any specified Person, any other Person that, directly or indirectly, through one or more intermediaries, controls, is controlled by or is under common control with such specified Person (but excluding, with respect to the Company, any portfolio </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A-1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">companies of venture capital or investment funds that are Company Stockholders, which portfolio companies may otherwise be deemed to be &#8220;under common control with&#8221; the Company).</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Aggregate Exercise Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the aggregate exercise price of all In-the-Money Options and all Company Warrants that will receive Merger Consideration, in each case outstanding as of immediately prior to the Effective Time, as set forth on the Estimated Closing Statement. </font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Aggregate Liquidation Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the sum of the Aggregate Series 3 Liquidation Amount, the Aggregate Series 4 Liquidation Amount, the Aggregate Series 5 Liquidation Amount, the Aggregate Series 6 Liquidation Amount, and the Aggregate Preferred Warrant Liquidation Amount.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Aggregate Preferred Warrant Liquidation Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the Per Share Preferred Warrant Liquidation Amount, multiplied by the number of shares of Series 3 Preferred Stock, Series 4 Preferred Stock, and Series 5 Preferred Stock issuable pursuant to Company Warrants as of immediately prior to the Effective Time. </font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Aggregate Series 3 Liquidation Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the Per Share Series 3 Liquidation Amount, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">multiplied by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> the number of shares of Series 3 Preferred Stock outstanding as of immediately prior to the Effective Time.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Aggregate Series 4 Liquidation Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the Per Share Series 4 Liquidation Amount, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">multiplied by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> the number of shares of Series 4 Preferred Stock outstanding as of immediately prior to the Effective Time.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Aggregate Series 5 Liquidation Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the Per Share Series 5 Liquidation Amount, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">multiplied by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> the number of shares of Series 5 Preferred Stock outstanding as of immediately prior to the Effective Time.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Aggregate Series 6 Liquidation Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the Per Share Series 6 Liquidation Amount, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">multiplied by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> the number of shares of Series 6 Preferred Stock outstanding as of immediately prior to the Effective Time.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in the preamble of this Agreement.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Anti-Corruption Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the Foreign Corrupt Practices Act of 1977, as amended, the Anti-Kickback Act of 1986 or any applicable Laws of similar effect, including the U.K. Bribery Act of 2010, and the related regulations and published interpretations thereunder.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Antitrust Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean any Law designed or intended to prohibit, restrict, or regulate actions having the purpose or effect of monopolization or restraint of trade or lessening competition through merger or acquisition, including the HSR Act, the Sherman Act, as amended, the Clayton Act, as amended, the Federal Trade Commission Act, as amended, and similar foreign competition Laws.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Base</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Purchase Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean $475,000,000.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A-2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Business Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall mean any day that is not a Saturday, a Sunday or other day on which banks are required or authorized by Law to be closed in Santa Clara, California.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">California Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the California Corporations Code.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">CARES Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the Coronavirus, Aid, Relief, and Economic Security Act (H.R. 748) (together with all amendments thereto and the statutes, rules and regulations promulgated thereunder and any successor to such statutes, rules or regulations, as in effect on the date hereof).</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Carve-Out Plan Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the aggregate amount of Bonus Amounts (as defined in the Company Carve-Out Plan) owed to Carve-Out Plan Participants under the Company Carve-Out Plan in connection with Closing, subject to the terms and conditions of the Company Carve-Out Plan.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Carve-Out Plan Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means each Eligible Employee (as defined in the Company Carve-Out Plan) who has complied with the terms and conditions of the Company Carve-Out Plan and is entitled to a Bonus Amount (as defined in the Company Carve-Out Plan) at the times set forth in the Company Carve-Out Plan. </font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Carve-Out Plan Pool</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the Bonus Pool established by the Board of Directors of the Company under the Company Carve-Out Plan.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Carve-Out Plan Transmittal Document</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means a document with respect to each Carve-Out Plan Participant including an acknowledgment of that participant&#8217;s relevant percentage of the Net Proceeds as defined in the Company Carve-Out Plan and a release of claims, in a form to be mutually agreed by the Company and Parent prior to Closing.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Cash</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean, the aggregate amount of unrestricted cash and cash equivalents held by the Company, as determined in accordance with GAAP, consistently applied, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">less </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;the aggregate amount of outstanding checks or drafts of the Company that have not posted, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (b)&#160;the aggregate amount of checks received by the Company that have not been posted. </font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Certificate of Merger</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Change of Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means with respect to Parent or Surviving Corporation, (a) a merger or consolidation of such entity with an unaffiliated third party that results in the voting securities of such entity outstanding immediately prior thereto, or any securities into which such voting securities have been converted or exchanged, ceasing to represent more than 50% of the combined voting power of the surviving entity or the parent of the surviving entity immediately after such merger or consolidation, (b) a transaction or series of related transactions in which an unaffiliated third party, together with its Affiliates, becomes the beneficial owner of more than 50% of the combined voting power of the outstanding securities of such entity or (c) the sale or other transfer to an unaffiliated third party of all or substantially all of such entity&#8217;s business that pertain to this Agreement. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Closing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall have the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A-3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Closing Cash</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the Cash immediately prior to the Closing on the Closing Date.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Closing Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean an amount of cash equal to the Base Purchase Price, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">plus </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a) the Estimated Closing Cash, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">plus </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b) the amount, if any, by which the Estimated Closing Working Capital is greater than the Target Working Capital Ceiling, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">minus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (c) the amount, if any, by which the Estimated Closing Working Capital is less than the Target Working Capital Floor&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">minus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (d) the Estimated Closing Date Indebtedness, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">minus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (e) the Estimated Closing Date Transaction Expenses, minus (f) the Carve-Out Plan Amount.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Closing Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Closing Date Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the unpaid Indebtedness of the Company immediately before the Closing&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that (a) any item included in Closing Date Indebtedness shall not be included in &#8220;Current Liabilities&#8221; or &#8220;Closing Date Transaction Expenses&#8221; and (b) any item included in &#8220;Current Liabilities&#8221; or &#8220;Closing Date Transaction Expenses&#8221; shall not be included in &#8220;Closing Date Indebtedness.&#8221; For the avoidance of doubt, Closing Date Indebtedness shall not include the Carve-Out Plan Pool.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Closing Date Transaction Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall mean, except to the extent included in Closing Date Indebtedness, (a) all unpaid fees, costs and expenses accrued, incurred or otherwise payable by the Company at or prior to the Closing in connection with the Transactions, including any of the foregoing that are payable in connection with the negotiation, documentation and execution of this Agreement and the other Transaction Documents or the consummation of the Transactions, including the Tail D&#38;O Policy, and (b) any change of control payment, transaction bonus, special cash bonus, commission, severance (including the Specified Severance), other bonus, or other similar payment or benefit of any kind payable by any member of the Company contingent upon the consummation of the Merger&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that Closing Date Transaction Expenses shall not include the Carve-Out Plan Pool, any Transaction Payroll Taxes or any severance payments made to employees who are terminated after the Closing or any fees, costs and expenses payable by Parent or the Merger Sub or any of their respective Affiliates pursuant to the terms of this Agreement (or any financing related to the transactions contemplated by this Agreement), any filing fees under the HSR Act or any other Laws or regulations&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided, further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that (i) any item included in Closing Date Transaction Expenses shall not be included in &#8220;Closing Date Indebtedness&#8221; or &#8220;Current Liabilities&#8221; and (ii) any item included in &#8220;Closing Date Indebtedness&#8221; or &#8220;Current Liabilities&#8221; shall not be included in Closing Date Transaction Expenses. </font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Closing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Options Payout Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.6(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Closing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Payment Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.7(a)(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Closing Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.12(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Closing Working Capital</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean (a) the Current Assets </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">minus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (b) the Current Liabilities, determined as of immediately prior to the Closing on the Closing Date. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A-4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:133%">Closing Working Capital Adjustment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">&#8221; shall mean (a) the amount (expressed as a negative number), if any, by which the Closing Working Capital is less than the Target Working Capital Floor, (b) the amount (expressed as a positive number), if any, by which the amount of Closing Working Capital is greater than the Target Working Capital Ceiling, and (c)&#160;zero dollars ($0) if the Closing Working Capital is equal to the Target Working Capital Floor or Target Working Capital Ceiling or is an amount that is greater than the Target Working Capital Floor but less than the Target Working Capital Ceiling.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">COBRA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.17(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the Internal Revenue Code of 1986, as amended.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall have the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">meaning set forth in the preamble to this Agreement.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company Board Recommendation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company Capital Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean, collectively, the Company Common Stock and the Company Preferred Stock.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company Carve-Out Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the Third Amended and Restated Employee Retention Plan of the Company established by the Board of Directors of the Company effective as of January 17, 2021. </font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company Charter</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the Company&#8217;s Certificate of Incorporation, as in effect as of the date of this Agreement or immediately prior to the Effective Time, as the case may be.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company Common Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the Common Stock of the Company.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company Employees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall have the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.3(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company Financial Statements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company Intellectual Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall mean all Intellectual Property and Intellectual Property Rights owned or purported to be owned, in whole or in part, by the Company.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company Material Adverse Effect</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean any change, development, circumstance, effect, event or fact that, either alone or in combination with any other changes, developments, circumstances, events or facts, has had, or could reasonably be expected to have, a material adverse effect upon (i) the assets, liabilities, financial condition or existing operations, business condition, prospects or the results of operations of the Company or (ii) the Company&#8217;s ability to perform its obligations hereunder&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">that none of the following (individually or in combination) shall be deemed to constitute, or shall be taken into account in determining whether there has been, a Company Material Adverse Effect&#58;  (a)&#160;any adverse effect resulting from general business or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A-5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:3pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">economic conditions, except to the extent such general business or economic conditions have a disproportionate effect on the Company as compared to any of the other companies in the Company&#8217;s industry, in which case only the incremental disproportionate adverse impact may be taken into account in determining whether there has occurred a Company Material Adverse Effect&#59; (b)&#160;any adverse effect resulting from conditions generally affecting any industry or industry sector in which the Company operates, except to the extent such adverse effect has a disproportionate effect on the Company as compared to any of the other companies in the Company&#8217;s industry or industry sector, in which case only the incremental disproportionate adverse impact may be taken into account in determining whether there has occurred a Company Material Adverse Effect&#59; (c)&#160;any adverse effect resulting from changes in regulatory, legislative or political conditions in the United States or any other country or region in the world, except to the extent such change in regulatory, legislative or political condition has a disproportionate effect on the Company as compared to any of the other companies in the Company&#8217;s industry, in which case only the incremental disproportionate adverse impact may be taken into account in determining whether there has occurred a Company Material Adverse Effect&#59; (d) any geopolitical conditions, global pandemic, epidemic or disease outbreak (including the disease that is causing the 2019 novel coronavirus outbreak (officially named &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">COVID-19</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) and which was declared a pandemic on March 11, 2020 by the World Health Organization), outbreak of hostilities, acts of war, sabotage, cyber attacks, terrorism or military actions (including any escalation or general worsening of any such hostilities, acts of war, sabotage, cyber attacks, terrorism or military actions) or pandemic in the United States or any other country or region in the world, except to the extent such conditions or actions has a disproportionate effect on the Company as compared to any of the other companies in the Company&#8217;s industry or geographies in which the Company operates, in which case only the incremental disproportionate adverse impact may be taken into account in determining whether there has occurred a Company Material Adverse Effect&#59;&#59; (e) any adverse effect resulting from the announcement, execution or delivery of the Agreement or the pendency or consummation of the Transactions, including any disruption in (or loss of) supplier, service provider, partner or similar relationships or any loss of employees&#59; (f)&#160;any adverse effect resulting from any change in accounting requirements or principles or any change in applicable Laws or the interpretation thereof&#59; (g)&#160;any adverse effect resulting from (i)&#160;any action taken by the Company at Parent&#8217;s direction, (ii)&#160;any action referred to in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> taken by the Company with Parent&#8217;s consent, (iii)&#160;the failure to take any action referred to in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that was not taken by the Company because Parent withheld its consent&#59; (h) the failure of the Company to meet internal expectations or projections (provided, that the underlying cause of such failure may, to the extent applicable, be taken into account, to the extent that any such underlying cause is not otherwise excluded from this definition of Company Material Adverse Effect)&#59; (i)&#160;any adverse effect resulting from any breach by Parent of any provision of this Agreement or the taking of any other action by Parent&#59; or (j) the availability or cost of equity, debt or other financing to Parent.</font></div><div style="margin-bottom:3pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean an option to purchase a share of Company Common Stock.</font></div><div style="margin-bottom:3pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company Option Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the Company&#8217;s Amended and Restated 2014 Equity Incentive Plan. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall have the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.17(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A-6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company Preferred Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the Series 3 Preferred Stock, the Series 4 Preferred Stock, the Series 5 Preferred Stock and the Series 6 Preferred Stock.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company Product</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the products and services currently licensed, sold or distributed by the Company, or by any predecessor of the Company (excluding any third-party products distributed along with the Company&#8217;s products or services).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company Returns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall mean any return, statement, report, tax filing or form (including estimated Tax returns and reports, withholding Tax returns and reports, any schedule or attachment, and information returns and reports) filed or required to be filed by the Company with a Governmental Entity with respect to Taxes, including any amendments thereof. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company Series 3 Warrant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean a Company Warrant to acquire shares of Series 3 Preferred Stock.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company Series 4 Warrant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean a Company Warrant to acquire shares of Series 4 Preferred Stock.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company Series 5 Warrant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean a Company Warrant to acquire shares of Series 5 Preferred Stock.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company Software</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means any proprietary software of the Company that constitutes Company Intellectual Property or which is used in any Company Product.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company Stock Certificate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall have the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company Stockholders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the holders of Company Capital Stock.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company Warrant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean any warrant to acquire shares of Company Capital Stock.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Confidentiality Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean that certain Non-Disclosure Agreement, dated as of October 8, 2020, by and between Parent and the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Consent(s)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean any consent, approval, clearance or waiver.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Contingent Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.16(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Contingent Consideration Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.16(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Contract</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means any legally binding agreement, contract, subcontract, settlement agreement, lease, instrument, note, option, warranty, license, sublicense, insurance policy or legally binding commitment, arrangement, obligation or undertaking of any nature, including all amendments to any of the foregoing.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A-7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Cooley</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">COVID-19 pandemic</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the COVID-19 pandemic, and any evolutions or mutations thereof or related or associated epidemics, pandemics or disease outbreaks.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">COVID-19 Response</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean any workforce reduction, social distancing measure, office closure or safety measure adopted in response to any Law, directive, guideline or recommendation promulgated by any Governmental Entity, including the Centers for Disease Control and Prevention, in each case, arising out of or otherwise related to the COVID-19 pandemic.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:133%">Current Assets</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">&#8221; means the aggregate amount of current assets of the Company (as determined in accordance with GAAP in accordance with the Company&#8217;s historical practices and methodologies and in a manner consistent with the Closing Date Adjustment Illustration (including the line item current asset accounts set forth therein)). </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Current Liabilities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means all current liabilities of the Company (as determined in accordance with GAAP in accordance with the Company&#8217;s historical practices and methodologies and in a manner consistent with the Closing Date Adjustment Illustration, including the line item current liability accounts set forth therein)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that (a) any item included in Current Liabilities shall not be included in &#8220;Closing Date Indebtedness&#8221; or &#8220;Closing Date Transaction Expenses&#8221; and (b) any item included in &#8220;Closing Date Indebtedness&#8221; or &#8220;Closing Date Transaction Expenses&#8221; shall not be included in Current Liabilities.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">D&#38;O Indemnified Persons</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.4(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Damages</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means any loss, damage, injury, liability, claim, settlement, judgment, award, fine, penalty, Tax, fee, charge, cost or expense of any nature (including reasonable and documented out-of-pocket costs of investigation).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Debt Commitment Letter</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means that certain Commitment Letter, dated as of January 17, 2021 (as amended, restated, amended and restated, supplemented and&#47;or otherwise modified from time to time), by and among, Parent, Citibank, N.A., JPMorgan Chase Bank, N.A. and U.S. Bank National Association.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Debt Financing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean any debt financing sought by Parent, Merger Sub or any of their Affiliates in connection with the Transactions, including, without limitation, pursuant to the Debt Commitment Letter or a borrowing of revolving loans under the Parent Credit Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Debt Financing Source Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean any Debt Financing Source or any of their respective directors, officers, employees, equityholders, Representatives, counsels, advisors and Affiliates.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Debt Financing Sources</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the Persons (other than Parent and Merger Sub) that have committed to provide or otherwise entered into agreements in connection with the Debt </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A-8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Financing, and any joinder agreements or credit agreements entered into pursuant thereto or relating thereto together with their Affiliates, officers, directors, employees and representatives involved in the Debt Financing and their successors and assigns.   </font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Disclosure Schedule</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the disclosure schedule that has been prepared by the Company and delivered to Parent and Merger Sub on the date of the Agreement.  The contents of each of the Contracts and other documents referred to in the Disclosure Schedule shall be deemed to be incorporated and referred to in the Disclosure Schedule as though set forth in full therein.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Dispute Auditor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.12(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Dispute Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.12(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Dissenting Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.14(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Dissenting Stockholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.14(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Effective Time</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall have the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Employee Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean each In-the-Money Option that was granted to the holder in the holder&#8217;s capacity as an employee service provider of the Company for applicable employment Tax purposes.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">End Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean April 17, 2021.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Entity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall mean any corporation (including any nonprofit corporation), general partnership, limited partnership, limited liability partnership, joint venture, estate, trust, company (including any limited liability company or joint stock company), firm or other enterprise, association, organization or entity.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Environmental Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean any Law relating to (a) the protection, preservation or restoration of the environment (including, air, water vapor, surface water, groundwater, drinking water supply, surface land, subsurface land, plant and animal life or any other natural resource)&#59; (b) the exposure to, or the use, storage, recycling, treatment, generation, transportation, processing, handling, labeling, production, release or disposal of, any Hazardous Substances&#59; or (c) safety issues (including human and occupational safety and health), in each case as amended and as in effect on the date hereof.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Environmental Permit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean any Permit issued pursuant to any Environmental Laws.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">ERISA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the Employee Retirement Income Security Act of 1974, as amended.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">ERISA Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.17(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A-9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Escrow Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean PNC Bank, National Association, a national banking association.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Escrow Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean an escrow agreement in substantially the form attached to this Agreement as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit D</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Escrow Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.13(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Estimated Closing Date Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.7(c)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Estimated Closing Date Transaction Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.7(c)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Estimated</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Closing Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.7(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Estimated</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Closing Working Capital</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.7(c)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Estimated</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Closing Working Capital Adjustment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.7(c)(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">FDA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.11(b)(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Final Adjustment Amount Determination Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.12(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">First Contingent Consideration Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.16(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Fraud</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means actual common law fraud under the State of Delaware (and not constructive fraud, or negligent or reckless misrepresentation) in the making of a representation or warranty contained in this Agreement, in each case made by such party with intent to deceive the other party and on which the other party reasonably relied.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Fully Diluted Share Number</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">sum</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of (a) the aggregate number of shares of Company Common Stock outstanding immediately prior to the Effective Time, (b) the aggregate number of shares of Company Common Stock issuable upon the conversion, in accordance with the terms of the Company Charter, of shares of the Company Preferred Stock outstanding as of immediately prior to the Effective Time, (c) the aggregate number of shares of Company Common Stock underlying In-the-Money Options outstanding as of immediately prior to the Effective Time, and (d) the aggregate number of shares of Company Common Stock underlying the Company Warrants outstanding as of immediately prior to the Effective Time. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">GAAP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean United States generally accepted accounting principles.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A-10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:3pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Government Official</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean (a)&#160;any officer or employee of any Governmental Entity, (b)&#160;any person acting in an official capacity on behalf of a Governmental Entity, (c)&#160;any officer or employee of a Person that is majority or wholly owned by a Governmental Entity, or (d)&#160;any officer or employee of a public international organization, such as the World Bank or the United Nations.</font></div><div style="margin-bottom:3pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Governmental Entity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean any national, federal, regional, state, provincial, local, or foreign or other governmental authority or instrumentality, legislative body, court, administrative agency, regulatory body, commission or instrumentality, including any multinational authority having governmental or quasi-governmental powers, or any other industry self-regulatory authority.</font></div><div style="margin-bottom:3pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Government Healthcare Program</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.11(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font></div><div style="margin-bottom:3pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Hazardous Substance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean any substance listed, defined, designated or classified as hazardous, toxic, radioactive, dangerous, or a &#8220;pollutant&#8221; or &#8220;contaminant&#8221; or otherwise regulated, under any Environmental Law.  It shall include any substance for which exposure is regulated by any Governmental Entity or any Environmental Law, including any toxic waste, pollutant, contaminant, hazardous substance, toxic substance, hazardous waste, special waste, petroleum or any derivative or by-product thereof, radon, radioactive material, asbestos, or asbestos containing material, urea formaldehyde foam insulation, lead, mold, mold spores and mycotoxins or polychlorinated biphenyls or other similar substances.</font></div><div style="margin-bottom:3pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Healthcare Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means any federal, state, local or foreign Law, Permit or similar right granted under any of the foregoing, relating in each of the foregoing cases to (a) the provision of healthcare items and services, including&#58; Title XVIII of the Social Security Act, 42 U.S.C. &#167;&#167; 1395-1395lll (the &#8220;Medicare Statute&#8221;)&#59; Title XIX of the Social Security Act, 42 U.S.C. &#167;&#167; 1396-1396w-5 (the &#8220;Medicaid Statute&#8221;)&#59; the Federal Health Care Program Anti-Kickback Statute, 42 U.S.C. &#167; 1320a-7b(b) (the &#8220;Federal Anti-Kickback Statute&#8221;)&#59; the civil False Claims Act, 31 U.S.C. &#167;&#167;&#160;3729-3733 (the &#8220;Federal False Claims Act&#8221;)&#59; the criminal False Claims Act (18 U.S.C. &#167; 287)&#59; the Civil Monetary Penalties Law, 42 U.S.C. &#167;&#167;&#160;1320a-7a and 1320a-7b (the &#8220;Civil Monetary Penalties Law&#8221;)&#59; the Exclusions Law, 42 U.S.C. &#167; 1320a 7&#59; the Health Insurance Portability and Accountability Act of 1996, as amended&#59; the Patient Protection and Affordable Care Act of 2010 and the Health Care and Education Reconciliation Act of 2010&#59; the Federal Health Care Fraud Law, 18 U.S.C. &#167; 1347&#59; TRICARE, 10 U.S.C. &#167; 1071&#59; the Federal Food, Drug, and Cosmetic Act (21 U.S.C. &#167; 301 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">et seq.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">)&#59; the Physician Payments Sunshine Act or any similar law governing the disclosure or reporting of financial relationships with entities that provide healthcare items or services&#59; any similar state and local Laws that address the subject matter of any of the foregoing&#59;  (b) the design, development, testing, manufacture, packaging, storing, handling, labeling, marketing, advertising, offering for sale and importing and exporting of medical products, including the United States Federal Food, Drug, and Cosmetic Act, 21 U.S.C. ch. 9, et seq., the Federal Trade Commission Act and Laws and regulations promulgated under the Medical Device Directive in the European Union, including those relating to establishment registration, investigational use, premarket clearance, marketing approval, CE marking, international standards for quality management systems as adopted by the International Organization for Standardization (ISO) (including ISO 13485) or other authorization to market a product, quality systems </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A-11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">regulations, ISO requirements, current Good Manufacturing Practice (cGMP) and Quality System Regulation (QSR) (21 C.F.R. Part 820), good clinical practices, good laboratory practices, labeling, advertising, record keeping and filing of required reports and security&#59; and (c) any and all amendments or modifications made from time to time to the Healthcare Laws referenced in subsection (a) above.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Healthcare Permits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means all Permits or other similar authorizations to permit the Company to carry on its business as currently conducted and market its products in accordance with Healthcare Laws.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">HIPAA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.11(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">HSR Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the Hart-Scott-Rodino Anti-Trust Improvements Act of 1976, as amended.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">In-the-Money Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means any Company Option that has an exercise price per share that is less than the Per Share Common Closing Consideration.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Inbound Licenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.10(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Income Tax</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means any Tax that is imposed on or measured by net income, however determined.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means (a) any obligation of the Company for the payment of principal, interest, penalties, fees or other liabilities of the Company for borrowed money and collection costs thereof, incurred or assumed, (b)&#160;any obligation of the Company evidenced by bonds, debentures, notes or other similar instruments, (c)&#160;any reimbursement obligation of the Company with respect to letters of credit, surety bonds, performance bonds or other guarantees of contractual performance (in each case, solely to the extent actually drawn upon or otherwise not contingent), bankers&#8217; acceptances or similar facilities, (d) the Accrued Pre-Closing Income Taxes, (e) any Indebtedness of third parties secured by a Lien on assets owned or acquired by the Company, (f) any indebtedness and liabilities and related costs or obligations of the Company under any interest rate protection agreements, foreign currency exchange agreements, forward contracts or other interest, exchange rate or commodity hedging or swap agreements, (g) any capital or finance leases (other than operating leases) of the Company in the Company Financial Statements or required to be capitalized in accordance with GAAP, (h) &#91;Reserved&#93;, (i) any deferred payroll Taxes, as permitted under the CARES Act or any other law, intended to address the consequences of COVID-19, (j) all unpaid severance obligations (including the employer portion of any applicable payroll Taxes), (k) the total redemption amount of all outstanding shareholder loans and loan notes (if any) of any Company, and (l) any obligation of the type referred to in clauses (a)&#160;through (k)&#160;of another Person the payment of which the Company has guaranteed or for which the Company is responsible or liable, directly or indirectly, jointly or severally, as obligor or guarantor, but excluding any capital leases. For the avoidance of doubt, Indebtedness shall not include any deferred revenue or any Taxes other than the Accrued Pre-Closing Income Taxes and the payroll Taxes in items (i) and (j).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A-12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Information Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.1(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Insurance Policies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.22</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Intellectual Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means any and all ideas, concepts, discoveries, inventions, improvements, developments, technologies, works of authorship, trade secrets, software and firmware (such as, for example, computer programs, applications, libraries, routines, utilities, functions and components), tools, algorithms, processes, techniques, know-how, data, databases, plans, analyses, models, prototypes, specifications, designs, interfaces, circuits, layouts, mask works, domain names, trademarks, documentation and records, whether or not it may be patented, copyrighted or otherwise protected.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Intellectual Property Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means any and all intellectual and proprietary rights of any kind, including patent rights, copyright rights, mask work rights, trademark rights, trade secret rights, domain names, rights in social media, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">sui generis</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> database rights and other rights in Intellectual Property (including any disclosure thereof and application therefor), throughout the world, including all goodwill associated therewith and the right to sue for and collect damages for past, present and future infringement, misappropriation or other violation thereof. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">&#8220;IP Agreement&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall have the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.10(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">IRS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall mean the Internal Revenue Service.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Knowledge</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Knowledge Individuals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the following Persons&#58; John Russell, Lisa Garrett, and Justin Ballotta. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean any federal, state, local, municipal, foreign or other law, statute, constitution, principle of common law, rule, regulation, directive, ruling, writ, Order, decree, injunction, requirement, compliance agreement or settlement agreement issued, enacted, adopted, promulgated, implemented or otherwise put into effect by or under the authority of any Governmental Entity.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Leased Real Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Legal Proceeding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean any action, claim, charge, dispute, suit, litigation, arbitration, proceeding (including any civil, criminal, administrative, investigative or appellate proceeding), hearing, inquiry, audit, examination or investigation commenced, brought, conducted or heard by or before, or otherwise involving any court or other Governmental Entity or any arbitrator or arbitration panel.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Letter of Transmittal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.11(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A-13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Liability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means any liability, obligation or commitment of any nature whatsoever, asserted or unasserted, known or unknown, absolute or contingent, accrued or unaccrued, matured or unmatured or otherwise.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Lien</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Liens</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean all mortgages, encumbrances, security interests, claims, charges or pledges.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Material Contracts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.12(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Merger</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall have the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">meaning set forth in the recitals of this Agreement.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Merger Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall mean (a) the Closing Consideration plus (b) the Post-Closing Consideration.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Merger Sub</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall have the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">meaning set forth in the preamble of this Agreement.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Necessary Permits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall have the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.14(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Net Proceeds</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning ascribed to such term in the Company Carve-Out Plan.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">New Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall have the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.3(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Non-Employee Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean each In-the-Money Option that was granted to the holder other than in the holder&#8217;s capacity as an employee service provider to the Company for applicable employment Tax purposes. </font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Open Source Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means any software or program that is licensed or distributed pursuant to any open source, community source, freeware, shareware or public license or distribution model, including without limitation any software or program licensed or distributed under any of the following licenses or distribution models&#58; GNU General Public License (GPL) or Lesser&#47;Library GPL (LGPL), BSD License, Apache License and other licenses listed at www.opensource.org.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Order</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means any decree, ruling, order, judgment, writ, award, injunction, stipulation or consent of or by, or settlement agreement with, a Governmental Entity.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">ordinary course of business</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means, with respect to the Company, the ordinary course of business consistent with the Company&#8217;s past practice&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that, deviations from such ordinary course of business consistent with the Company&#8217;s past practice shall not be deemed outside the &#8220;ordinary course of business&#8221; to the extent such deviations were reasonably necessary with respect to actions taken prior to the date of this Agreement, or, are reasonably necessary with respect to actions taken after the date of this Agreement, in each case, in connection with a COVID-19 Response.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Outbound Licenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.10(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A-14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Parent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall have the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">meaning set forth in the preamble of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Parent Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means that certain Credit Agreement, dated as of June 15, 2018 (as amended, restated, amended and restated, supplemented or otherwise modified from time to time), by and among, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">inter alios</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, Parent, the lenders from time to time party thereto and JPMorgan Chase Bank, N.A., as administrative agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Participating Securityholder Transmittal Document</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means each Letter of Transmittal, each Carve-Out Plan Transmittal Document, each Option Termination Agreement and each Warrant Termination Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Participating Securityholders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the Carve-Out Plan Participants and the holders of shares of Company Capital Stock, Company Warrants and&#47;or In-the-Money Options outstanding as of immediately prior to the Effective Time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Patents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean all patents and patent applications (including provisional applications), including all divisionals, continuations, substitutions, continuations-in-part, re-examinations, re-issues, additions, renewals, extensions, confirmations, registrations, any confirmation patent or registration patent or patent of addition based on any such patent, patent term extensions, and supplemental protection certificates or requests for continued examinations, foreign counterparts, and the like of any of the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Payment Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means PNC Bank, National Association, a national banking association.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">PCI Requirements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.10(o)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Per Share Common Closing Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean an amount in cash equal to the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">quotient</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of (a) the amount equal to&#58; (i) the Closing Consideration, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (ii) the Aggregate Exercise Amount, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">minus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (iii) the Aggregate Liquidation Amount, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">divided by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (b) the Fully Diluted Share Number.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Per Share Series 3 Liquidation Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean, with respect to each share of Series 3 Preferred Stock, an amount equal to $1.875, plus the amount of Accrued Dividends accrued but unpaid with respect to such share of Series 3 Preferred Stock pursuant to the Company Charter.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Per Share Preferred Warrant Liquidation Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean $1.875.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Per Share Series 4 Liquidation Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean, with respect to each share of Series 4 Preferred Stock, an amount equal to $1.875, plus the amount of Accrued Dividends accrued but unpaid with respect to such share of Series 4 Preferred Stock pursuant to the Company Charter.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A-15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Per Share Series 5 Liquidation Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean, with respect to each share of Series 5 Preferred Stock, an amount equal to $1.875, plus the amount of Accrued Dividends accrued but unpaid with respect to such share of Series 5 Preferred Stock pursuant to the Company Charter.</font></div><div style="margin-bottom:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Per Share Series 6 Liquidation Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean, with respect to each share of Series 6 Preferred Stock, an amount equal to $2.5875, plus the amount of Accrued Dividends accrued but unpaid with respect to such share of Series 6 Preferred Stock pursuant to the Company Charter.</font></div><div style="margin-bottom:1pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Permit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means any permit, license, premarket approval (PMA), franchise, clearance, approval, authorization, registration, certificate, waiver, variance and similar right obtained, or required to be obtained, from a Governmental Entity.</font></div><div style="margin-bottom:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Permitted Encumbrances</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean&#58; (a) liens for current Taxes not yet delinquent or that are being contested in good faith by appropriate proceedings for which adequate reserves have been established in accordance with GAAP&#59; (b)&#160;statutory or common law liens to secure obligations to landlords, lessors or renters under leases or rental agreements arising in the ordinary course of business securing amounts that are not delinquent or past due or being contested in good faith by appropriate proceedings&#59; (c)&#160;deposits or pledges made in connection with, or to secure payment of, workers&#8217; compensation, unemployment insurance or similar programs mandated by applicable Law or governmental regulations&#59; (d)&#160;statutory or common law liens in favor of carriers, warehousemen, mechanics and materialmen arising in the ordinary course of business securing amounts that are not delinquent or past due or being contested in good faith by appropriate proceedings&#59; (e) nonexclusive licenses of Intellectual Property granted to customers in the ordinary course of business&#59; (f)&#160;easements, reservations, rights-of-way, restrictions and other similar liens affecting real property not interfering in any material respect with the ordinary conduct of the business of the Company or the value or usefulness of such real property&#59; and (g) nonexclusive licenses of Intellectual Property Rights granted in the ordinary course of business.</font></div><div style="margin-bottom:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean any individual, Entity or Governmental Entity.</font></div><div style="margin-bottom:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Personal Data</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means all data, in the Company&#8217;s possession or control, relating to one or more individual(s) that is personally identifying or as that term is otherwise defined under governing Law.</font></div><div style="margin-bottom:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Post-Closing Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means&#58; (a) any amount that becomes payable by Parent for distribution to the Participating Securityholders pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.12&#59;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and (b)&#160;any Contingent Consideration that becomes payable for distribution pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:133%">Post-Closing Tax Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:133%">&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">shall mean any taxable period beginning after the Closing Date, and the portion of any Straddle Period beginning after the Closing Date.</font></div><div style="margin-bottom:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Pre-Closing Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall have the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;4.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font></div><div style="margin-bottom:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Privacy Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means all applicable Laws governing the processing, privacy or security of Personal Data and all applicable regulations issued by a Governmental Entity thereunder, such as, to the extent applicable, the EU General Data Protection Regulation (EU) 2016&#47;679 and all laws implementing it, HIPAA, Section 5 of the Federal Trade Commission Act, the FTC Red Flag Rules, the CAN SPAM Act and associated regulations set forth in 16 C.F.R. Part 316, the Children&#8217;s Online Privacy Protection Act, state social security number protection laws, state data breach notification laws, state data privacy laws such as the California Consumer Privacy Act, as </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A-16</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">amended, state data security laws, state consumer protection Laws, and laws governing requirements for website and mobile application privacy policies and practices, or outbound commercial communications (including email marketing, telemarketing and text messaging), tracking and marketing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Privacy Policies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.10(o)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Pro Rata Fraction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean, with respect to each Participating Securityholder, the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">quotient</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (expressed as a percentage and rounded to four decimal places) of&#58; (a) the amount of Closing Consideration payable to such Participating Securityholder in respect of shares of Company Capital Stock, Company Warrants and&#47;or In-the-Money Options, in each case outstanding as of immediately prior to the Effective Time, and to such Participating Securityholder under the Company Carve-Out Plan (in each case, as if no amounts were withheld for the Escrow Fund, the Seller Representative Reserve or Taxes), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">divided by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (b) the aggregate amount of Closing Consideration payable to all Participating Securityholders in respect of shares of Company Capital Stock, Company Warrants and&#47;or In-the-Money Options, in each case outstanding as of immediately prior to the Effective Time, and under the Company Carve-Out Plan (in each case, as if no amounts were withheld for the Escrow Fund, the Seller Representative Reserve or Taxes).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Product Recalls</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.29</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">R&#38;W Insurance Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means that certain Representations and Warranties Insurance Policy, dated as of the date hereof, for the benefit of Parent and its Affiliates with respect to the representations and warranties set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement and other customary matters in connection with the transactions contemplated by this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Registered IP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean all Intellectual Property that is registered, filed, or issued under the authority of any Governmental Entity, including all patents, registered copyrights, registered mask works, registered trademarks, domain names, social media accounts and all applications for any of the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Regulatory Authority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means any federal, national, or multinational governmental health regulatory agency or authority within a regulatory jurisdiction, with the authority to grant approvals, licenses, registrations or authorizations necessary for the development, manufacture, use, and sale of a medical device.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Representatives</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean, with respect to any Person, such Person&#8217;s directors, officers or other employees, consultants or other agents including its financial, legal or accounting advisors.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Required Company Stockholder Votes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.24</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Revenue Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.16(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A-17</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Sanctioned Country</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means any country or territory with which dealings are broadly restricted, prohibited, or made sanctionable under any Sanctions Law (currently, Cuba, Iran, North Korea, Syria, and the Crimea Region).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Sanctioned Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means any Person with whom dealings are restricted or prohibited under the Sanctions Laws of the United States, the United Kingdom, the European Union, any member state of the European Union, or the United Nations, including (a) any Person identified in any list of sanctioned Persons maintained by (i) the United States Department of Treasury&#8217;s Office of Foreign Assets Control (including the Specially Designated Nationals and Blocked Persons List, Foreign Sanctions Evaders List, or Sectoral Sanctions Identifications List), the United States Department of Commerce&#8217;s Bureau of Industry and Security, or the United States Department of State&#59; (ii) Her Majesty&#8217;s Treasury of the United Kingdom&#59; (iii) any committee of the United Nations Security Council&#59; or (iv) the European Union&#59; (b) any Person located, organized, or resident in, organized in, or a Governmental Entity or government instrumentality of, any Sanctioned Country and (c) any Person directly or indirectly 50% or more owned or otherwise controlled by, or acting for the benefit or on behalf of, a Person described in (a) or (b).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Sanctions Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means all applicable Laws concerning economic sanctions, including embargoes, export restrictions, the ability to make or receive international payments, the freezing or blocking of assets of targeted Persons, the ability to engage in transactions with specified persons or countries, or the ability to take an ownership interest in assets of specified Persons or located in a specified country, including any Laws threatening to impose economic sanctions on any person for engaging in proscribed behavior.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Second Contingent Consideration Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.16(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Seller Representative</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall have the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.15(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Seller Representative Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall have the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.15(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Seller Representative Reserve</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall have the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.15(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Series 3 Preferred Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the Series 3 Preferred Stock of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Series 4 Preferred Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the Series 4 Preferred Stock of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Series 5 Preferred Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the Series 5 Preferred Stock of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Series 6 Preferred Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the Series 6 Preferred Stock of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Specified Representations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the representations and warranties set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Authority&#59; Binding Nature of Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Due Incorporation&#59; No </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A-18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Subsidiaries&#59; Etc.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Certificate of Incorporation and Bylaws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.4(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Capitalization, Etc.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Title to Assets</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.26</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Financial Advisor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Straddle Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean a taxable period beginning on or prior to the Closing Date and ending after the Closing Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Subsidiary&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall mean, with respect to any Person, any partnership, limited liability company, corporation or other business entity of which (a) if a corporation, a majority of the total voting power of shares of capital stock entitled (without regard to the occurrence of any contingency) to vote in the election of directors, managers, or trustees thereof is at the time owned or controlled, directly or indirectly, by that Person or one or more of the other Subsidiaries of that Person or a combination thereof, or (b) if a partnership, limited liability company or other business entity, a majority of the partnership or other similar ownership interests thereof is at the time owned or controlled, directly or indirectly, by that Person or one or more Subsidiaries of that Person or a combination thereof. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Surviving Corporation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall have the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Target Working Capital Ceiling</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means an amount equal to $</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;***&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Target Working Capital Floor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means an amount equal to $</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;***&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Tax</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">or</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall mean all federal, state, local, foreign and other income, gross receipts, sales, use, production, ad valorem, transfer, franchise, registration, profits, license, lease, service, use, withholding, payroll, employment, unemployment, estimated, excise, severance, environmental, stamp, occupation, premium, property (real or personal), real property gains, windfall profits, custom duties or other taxes of any kind whatsoever, together with any interest or any penalty, addition to tax or additional amount imposed by any Governmental Entity responsible for the imposition of any such tax (domestic or foreign).</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Theory of Liability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean any claims, obligations, liabilities, causes of action, or proceedings (in each case, whether in contract or in tort, at Law or in equity, or pursuant to Law) that may be based upon, in respect of, arise under, out or by reason of, be connected with, or relate in any manner to, this Agreement or any other Transaction Documents, or the negotiation, execution, performance, termination or breach (whether intentional, willful, negligent or otherwise) of this Agreement or any other Transaction Document, including any representation or warranty made in, in connection with, or as an inducement to enter into, this Agreement and including theories of equity, agency, control, instrumentality, alter ego, domination, sham, single business enterprise, piercing the veil, unfairness, undercapitalization or otherwise.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Top Customers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.21(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Top Suppliers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.21(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Transaction Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean this Agreement, the Certificate of Merger, the Escrow Agreement and all other agreements, instruments and certificates expressly contemplated </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A-19</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">by this Agreement to be executed and delivered by any party in connection with the consummation of the transactions contemplated by this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Transaction Payroll Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the employer portion of any payroll or employment Taxes incurred or accrued with respect to any bonuses, Company Option exercises, payments in respect of Employee Options or other compensatory payments made in connection with the transactions contemplated by this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Transactions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the Merger and the other transactions contemplated by this Agreement and the other Transaction Documents.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Unaudited Balance Sheet</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Waived 280G Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Willful Breach</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means a material breach that is a consequence of an act taken by the breaching party, or the failure by the breaching party to take an act it is required to take under this Agreement, in each case with actual knowledge that the taking of, or the failure to take, such act would, or would be reasonably expected to, cause a breach of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Withholding Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.11(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Working Capital Escrow Expiration Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;1.13(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A-20</font></div></div></div><div id="i7ae4bb5e39b04d889fdc79bcea08a102_28"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>6
<FILENAME>haeq3dec2021ex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i30961bed2bff42d4a869b964b8db9cf8_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:18pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT 31.1</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Christopher A. Simon, certify that&#58;</font></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of Haemonetics Corporation&#59; </font></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.24pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.24pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.24pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;2, 2021 </font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:39.309%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.728%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.728%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.796%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.739%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Christopher A. Simon</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Christopher A. Simon, President and Chief Executive Officer</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>7
<FILENAME>haeq3dec2021ex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i7913ae4a77ac4fa78764368132638f6c_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:18pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT 31.2</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, William Burke, certify that&#58;</font></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of Haemonetics Corporation&#59; </font></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.24pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.24pt"> Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.24pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:6pt;padding-left:54pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;2, 2021</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:39.309%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.728%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.728%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.796%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.739%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; William Burke</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">William Burke, Executive Vice President, Chief Financial Officer</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>8
<FILENAME>haeq3dec2021ex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i75ea3c7061d64c7e89fca4302687bca7_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT 32.1</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certification Pursuant To</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18 USC. Section&#160;1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As Adopted Pursuant To</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;906 of the Sarbanes&#47;Oxley Act of 2002</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of Haemonetics Corporation (the &#8220;Company&#8221;) on Form 10-Q for the period ended December&#160;26, 2020 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Christopher A. Simon, President and Chief Executive Officer of the Company, certify, pursuant to Section&#160;1350 of Chapter&#160;63 of Title 18, United States Code, that this Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;2, 2021 </font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.477%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.477%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.634%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.297%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Christopher A. Simon</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Christopher A. Simon,&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section&#160;906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section&#160;906, has been provided to Haemonetics and will be retained by Haemonetics and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>9
<FILENAME>haeq3dec2021ex322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ibc9a7b06bb6a41efb2271c3f2c158518_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT 32.2</font></div><div style="margin-top:12pt;text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certification Pursuant To</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18 USC. Section&#160;1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As Adopted Pursuant To</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section&#160;906 of the Sarbanes&#47;Oxley Act of 2002</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of Haemonetics Corporation (the &#8220;Company&#8221;) on Form 10-Q for the period ended December&#160;26, 2020 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, William Burke, Executive Vice President, Chief Financial Officer of the Company, certify, pursuant to Section&#160;1350 of Chapter&#160;63 of Title 18, United States Code, that this Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;2, 2021 </font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.477%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.477%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.634%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.297%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; William Burke</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">William Burke,&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, Chief Financial Officer</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section&#160;906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section&#160;906, has been provided to Haemonetics and will be retained by Haemonetics and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>10
<FILENAME>hae-20201226.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:dcc831a0-a182-47d6-a94e-5adaefe7bce2,g:c7d71817-1258-4da0-86ec-9eebc508e513-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:hae="http://www.haemonetics.com/20201226" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.haemonetics.com/20201226">
  <xs:import namespace="http://fasb.org/srt/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2017-01-31" schemaLocation="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hae-20201226_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hae-20201226_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hae-20201226_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hae-20201226_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="DOCUMENTANDENTITYINFORMATION" roleURI="http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION">
        <link:definition>0001001 - Document - DOCUMENT AND ENTITY INFORMATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOME" roleURI="http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOME">
        <link:definition>1001002 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETS" roleURI="http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS">
        <link:definition>1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSParentheticals" roleURI="http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParentheticals">
        <link:definition>1003004 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" roleURI="http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
        <link:definition>1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BASISOFPRESENTATION" roleURI="http://www.haemonetics.com/role/BASISOFPRESENTATION">
        <link:definition>2101101 - Disclosure - BASIS OF PRESENTATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RECENTACCOUNTINGPRONOUNCEMENTS" roleURI="http://www.haemonetics.com/role/RECENTACCOUNTINGPRONOUNCEMENTS">
        <link:definition>2102102 - Disclosure - RECENT ACCOUNTING PRONOUNCEMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURING" roleURI="http://www.haemonetics.com/role/RESTRUCTURING">
        <link:definition>2103103 - Disclosure - RESTRUCTURING</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURINGTables" roleURI="http://www.haemonetics.com/role/RESTRUCTURINGTables">
        <link:definition>2304301 - Disclosure - RESTRUCTURING (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURINGNarrativeDetails" roleURI="http://www.haemonetics.com/role/RESTRUCTURINGNarrativeDetails">
        <link:definition>2405401 - Disclosure - RESTRUCTURING (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails" roleURI="http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails">
        <link:definition>2406402 - Disclosure - RESTRUCTURING (Schedule of Restructuring Reserve by Type of Cost) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails" roleURI="http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails">
        <link:definition>2407403 - Disclosure - RESTRUCTURING (Schedule of Restructuring and Related Costs) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITION" roleURI="http://www.haemonetics.com/role/ACQUISITION">
        <link:definition>2108104 - Disclosure - ACQUISITION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONTables" roleURI="http://www.haemonetics.com/role/ACQUISITIONTables">
        <link:definition>2309302 - Disclosure - ACQUISITION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONDetails" roleURI="http://www.haemonetics.com/role/ACQUISITIONDetails">
        <link:definition>2410404 - Disclosure - ACQUISITION (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DIVESTITURE" roleURI="http://www.haemonetics.com/role/DIVESTITURE">
        <link:definition>2111105 - Disclosure - DIVESTITURE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DIVESTITUREDetails" roleURI="http://www.haemonetics.com/role/DIVESTITUREDetails">
        <link:definition>2412405 - Disclosure - DIVESTITURE (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXES" roleURI="http://www.haemonetics.com/role/INCOMETAXES">
        <link:definition>2113106 - Disclosure - INCOME TAXES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESDetails" roleURI="http://www.haemonetics.com/role/INCOMETAXESDetails">
        <link:definition>2414406 - Disclosure - INCOME TAXES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHAREEPS" roleURI="http://www.haemonetics.com/role/EARNINGSPERSHAREEPS">
        <link:definition>2115107 - Disclosure - EARNINGS PER SHARE ("EPS")</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHAREEPSTables" roleURI="http://www.haemonetics.com/role/EARNINGSPERSHAREEPSTables">
        <link:definition>2316303 - Disclosure - EARNINGS PER SHARE ("EPS") (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHAREEPSScheduleofEarningsPerShareReconciliationDetails" roleURI="http://www.haemonetics.com/role/EARNINGSPERSHAREEPSScheduleofEarningsPerShareReconciliationDetails">
        <link:definition>2417407 - Disclosure - EARNINGS PER SHARE ("EPS") (Schedule of Earnings Per Share Reconciliation) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUE" roleURI="http://www.haemonetics.com/role/REVENUE">
        <link:definition>2118108 - Disclosure - REVENUE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUEDetails" roleURI="http://www.haemonetics.com/role/REVENUEDetails">
        <link:definition>2419408 - Disclosure - REVENUE (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUEDetails_1" roleURI="http://www.haemonetics.com/role/REVENUEDetails_1">
        <link:definition>2419408 - Disclosure - REVENUE (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORIES" roleURI="http://www.haemonetics.com/role/INVENTORIES">
        <link:definition>2120109 - Disclosure - INVENTORIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORIESTables" roleURI="http://www.haemonetics.com/role/INVENTORIESTables">
        <link:definition>2321304 - Disclosure - INVENTORIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORIESScheduleofInventoriesDetails" roleURI="http://www.haemonetics.com/role/INVENTORIESScheduleofInventoriesDetails">
        <link:definition>2422409 - Disclosure - INVENTORIES (Schedule of Inventories) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASES" roleURI="http://www.haemonetics.com/role/LEASES">
        <link:definition>2123110 - Disclosure - LEASES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESDetails" roleURI="http://www.haemonetics.com/role/LEASESDetails">
        <link:definition>2424410 - Disclosure - LEASES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NOTESPAYABLEANDLONGTERMDEBT" roleURI="http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBT">
        <link:definition>2125111 - Disclosure - NOTES&#160;PAYABLE AND LONG-TERM DEBT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NOTESPAYABLEANDLONGTERMDEBTDetails" roleURI="http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTDetails">
        <link:definition>2426411 - Disclosure - NOTES&#160;PAYABLE AND LONG-TERM DEBT (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASURES" roleURI="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURES">
        <link:definition>2127112 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASURES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESTables" roleURI="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESTables">
        <link:definition>2328305 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASURES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAllowanceforcreditlossesDetails" roleURI="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAllowanceforcreditlossesDetails">
        <link:definition>2429412 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Allowance for credit losses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails" roleURI="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails">
        <link:definition>2430413 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASURES (Schedule of Effect of Derivative Instruments Designated as Cash Flow Hedges and Those Not Designated as Hedging Instruments) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESSchedulesofDerivativesDetails" roleURI="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESSchedulesofDerivativesDetails">
        <link:definition>2431414 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASURES (Schedules of Derivatives) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails" roleURI="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails">
        <link:definition>2432415 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASURES (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIES" roleURI="http://www.haemonetics.com/role/COMMITMENTSANDCONTINGENCIES">
        <link:definition>2133113 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTANDENTERPRISEWIDEINFORMATION" roleURI="http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATION">
        <link:definition>2134114 - Disclosure - SEGMENT AND ENTERPRISE-WIDE INFORMATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTANDENTERPRISEWIDEINFORMATIONTables" roleURI="http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONTables">
        <link:definition>2335306 - Disclosure - SEGMENT AND ENTERPRISE-WIDE INFORMATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTANDENTERPRISEWIDEINFORMATIONDetails" roleURI="http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails">
        <link:definition>2436416 - Disclosure - SEGMENT AND ENTERPRISE-WIDE INFORMATION (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCUMULATEDOTHERCOMPREHENSIVELOSS" roleURI="http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS">
        <link:definition>2137115 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCUMULATEDOTHERCOMPREHENSIVELOSSTables" roleURI="http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables">
        <link:definition>2338307 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCUMULATEDOTHERCOMPREHENSIVELOSSDetails" roleURI="http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSDetails">
        <link:definition>2439417 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="hae_AssetAcquisitionDomain" abstract="true" name="AssetAcquisitionDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hae_RestructuringChargesPayableInNextTwelveMonths" abstract="false" name="RestructuringChargesPayableInNextTwelveMonths" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hae_PercentageOfNetSalesGeneratedOutsideOfUs" abstract="false" name="PercentageOfNetSalesGeneratedOutsideOfUs" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="hae_CardivaMember" abstract="true" name="CardivaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hae_HospitalMember" abstract="true" name="HospitalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hae_PlasmaProductsandServicesMember" abstract="true" name="PlasmaProductsandServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hae_USBloodDonorManagementSoftwareMember" abstract="true" name="USBloodDonorManagementSoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hae_BloodCenterMember" abstract="true" name="BloodCenterMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hae_DisposalGroupNotDiscontinuedOperationsIncrementalLossOnClosingAdjustments" abstract="false" name="DisposalGroupNotDiscontinuedOperationsIncrementalLossOnClosingAdjustments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hae_ManufacturingSpaceSecondRenewalTermMember" abstract="true" name="ManufacturingSpaceSecondRenewalTermMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hae_TransfersFromInventoryToFixedAssets" abstract="false" name="TransfersFromInventoryToFixedAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hae_RegulatoryBasedPaymentsMember" abstract="true" name="RegulatoryBasedPaymentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hae_AssetAcquisitionAxis" abstract="true" name="AssetAcquisitionAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="hae_CorporateOperatingExpenses" abstract="false" name="CorporateOperatingExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hae_DisposalGroupIncludingDiscontinuedOperationConsiderationToBeReceived" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationConsiderationToBeReceived" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hae_NonCashItemsAbstract" abstract="true" name="NonCashItemsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="hae_RestructuringRelatedCosts" abstract="false" name="RestructuringRelatedCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hae_ContingentConsiderationMember" abstract="true" name="ContingentConsiderationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hae_RevenueBasedPaymentsMember" abstract="true" name="RevenueBasedPaymentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hae_NetRevenuesBeforeForeignExchangeImpact" abstract="false" name="NetRevenuesBeforeForeignExchangeImpact" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hae_AssetImpairmentAndOtherRelatedCharges" abstract="false" name="AssetImpairmentAndOtherRelatedCharges" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hae_DisposalGroupNotDiscontinuedOperationsExpectedCostToSell" abstract="false" name="DisposalGroupNotDiscontinuedOperationsExpectedCostToSell" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hae_AssetAcquisitionUpfrontPayment" abstract="false" name="AssetAcquisitionUpfrontPayment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hae_InlogHoldingsFranceMember" abstract="true" name="InlogHoldingsFranceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hae_RestructuringandTurnaroundCosts" abstract="false" name="RestructuringandTurnaroundCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hae_NetRevenuesCostOfGoodsSoldAndSellingGeneralAndAdministrativeExpenseMember" abstract="true" name="NetRevenuesCostOfGoodsSoldAndSellingGeneralAndAdministrativeExpenseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hae_RestructuringandRestructuringRelatedCosts" abstract="false" name="RestructuringandRestructuringRelatedCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hae_OtherCountryorRegionMember" abstract="true" name="OtherCountryorRegionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hae_EffectofExchangeRatesonOperatingIncome" abstract="false" name="EffectofExchangeRatesonOperatingIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hae_GainLossOnDivestitureAndSaleOfAssets" abstract="false" name="GainLossOnDivestitureAndSaleOfAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hae_DerivativePercentofDebtExposed" abstract="false" name="DerivativePercentofDebtExposed" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="hae_BloodCenterProductsandServicesMember" abstract="true" name="BloodCenterProductsandServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hae_A2020ProgramMember" abstract="true" name="A2020ProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hae_FajardoPuertoRicoManufacturingOperationsMember" abstract="true" name="FajardoPuertoRicoManufacturingOperationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hae_A2018ProgramMember" abstract="true" name="A2018ProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hae_ManufacturingSpaceMember" abstract="true" name="ManufacturingSpaceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hae_OperatingExpensesTransactionCosts" abstract="false" name="OperatingExpensesTransactionCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hae_HASIntellectualPropertyMember" abstract="true" name="HASIntellectualPropertyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hae_PlasmaMember" abstract="true" name="PlasmaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hae_EnicorMember" abstract="true" name="EnicorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hae_HospitalProductsandServicesMember" abstract="true" name="HospitalProductsandServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hae_EffectofExchangeRateonRevenues" abstract="false" name="EffectofExchangeRateonRevenues" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hae_A2018ProgramandPriorProgramsMember" abstract="true" name="A2018ProgramandPriorProgramsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hae_ContingentConsiderationAcquisitionDateFairValue" abstract="false" name="ContingentConsiderationAcquisitionDateFairValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hae_OtherIncomeExpenseNetMember" abstract="true" name="OtherIncomeExpenseNetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hae_EuropeanMedicalDeviceRegulationCosts" abstract="false" name="EuropeanMedicalDeviceRegulationCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>11
<FILENAME>hae-20201226_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:dcc831a0-a182-47d6-a94e-5adaefe7bce2,g:c7d71817-1258-4da0-86ec-9eebc508e513-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION" xlink:type="simple" xlink:href="hae-20201226.xsd#DOCUMENTANDENTITYINFORMATION"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="hae-20201226.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOME"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2a5f4dcd-652a-4dcb-bdfe-b0086d1644af" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_e640ac00-29c9-4658-98d0-4ae42fb3d639" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2a5f4dcd-652a-4dcb-bdfe-b0086d1644af" xlink:to="loc_us-gaap_OperatingIncomeLoss_e640ac00-29c9-4658-98d0-4ae42fb3d639" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_182859e3-3e5a-4d4d-ab1c-d4f5fbd08fd3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2a5f4dcd-652a-4dcb-bdfe-b0086d1644af" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_182859e3-3e5a-4d4d-ab1c-d4f5fbd08fd3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_587198a4-4aad-4782-a3d8-867fc53a0137" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9245bd52-a515-4c98-83ca-313c911bcc48" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_587198a4-4aad-4782-a3d8-867fc53a0137" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9245bd52-a515-4c98-83ca-313c911bcc48" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_5ec7ee09-d912-458c-bb99-13c643f7af35" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_587198a4-4aad-4782-a3d8-867fc53a0137" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_5ec7ee09-d912-458c-bb99-13c643f7af35" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_19ce1b85-bedc-4cdd-9ece-3e91ac098638" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_7b10dc1b-3059-40b2-91ae-2c653c9a70bc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_19ce1b85-bedc-4cdd-9ece-3e91ac098638" xlink:to="loc_us-gaap_GrossProfit_7b10dc1b-3059-40b2-91ae-2c653c9a70bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_7daa25c7-0071-4262-9d6c-356e32e6a1ec" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_19ce1b85-bedc-4cdd-9ece-3e91ac098638" xlink:to="loc_us-gaap_OperatingExpenses_7daa25c7-0071-4262-9d6c-356e32e6a1ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_045b89eb-43c4-48d6-983c-7c484ff385e4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c7e01d35-e34f-4bea-8533-6812e89e0b9f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_045b89eb-43c4-48d6-983c-7c484ff385e4" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c7e01d35-e34f-4bea-8533-6812e89e0b9f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_b6efa994-2d7d-4c57-87fa-039bbfd1e3f0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_045b89eb-43c4-48d6-983c-7c484ff385e4" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_b6efa994-2d7d-4c57-87fa-039bbfd1e3f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_240a79eb-3223-4ef8-9dda-7b890ee4232e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_408fecd5-dbde-4468-a7bf-ca2d089a5dd0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_240a79eb-3223-4ef8-9dda-7b890ee4232e" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_408fecd5-dbde-4468-a7bf-ca2d089a5dd0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_dcb4aa76-3540-4e89-9e50-b13d4350216d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_240a79eb-3223-4ef8-9dda-7b890ee4232e" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_dcb4aa76-3540-4e89-9e50-b13d4350216d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetImpairmentCharges_1a64e94b-1eda-41e1-bab8-5f83827e21b4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetImpairmentCharges"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_240a79eb-3223-4ef8-9dda-7b890ee4232e" xlink:to="loc_us-gaap_OtherAssetImpairmentCharges_1a64e94b-1eda-41e1-bab8-5f83827e21b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_GainLossOnDivestitureAndSaleOfAssets_b1b2d76e-11ab-40c6-b184-b16144df0d54" xlink:href="hae-20201226.xsd#hae_GainLossOnDivestitureAndSaleOfAssets"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_240a79eb-3223-4ef8-9dda-7b890ee4232e" xlink:to="loc_hae_GainLossOnDivestitureAndSaleOfAssets_b1b2d76e-11ab-40c6-b184-b16144df0d54" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="hae-20201226.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_08bf5c7f-15fc-4dca-b661-1e9a73dee534" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_387c3738-11a6-4ab3-a1b9-41c27ff7a247" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_08bf5c7f-15fc-4dca-b661-1e9a73dee534" xlink:to="loc_us-gaap_LongTermDebtCurrent_387c3738-11a6-4ab3-a1b9-41c27ff7a247" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_7834216f-48ec-4389-b300-5c5b06a9f4fb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_08bf5c7f-15fc-4dca-b661-1e9a73dee534" xlink:to="loc_us-gaap_AccountsPayableCurrent_7834216f-48ec-4389-b300-5c5b06a9f4fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_76a1534f-d8f1-440b-8d6b-39bd9f916524" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_08bf5c7f-15fc-4dca-b661-1e9a73dee534" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_76a1534f-d8f1-440b-8d6b-39bd9f916524" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_18c28993-d60d-49a6-8482-899354f502f7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_08bf5c7f-15fc-4dca-b661-1e9a73dee534" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_18c28993-d60d-49a6-8482-899354f502f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a5a7251c-d4f7-466b-af1c-abd6db535ba7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_4fd1a9a5-dee0-423c-bc3a-729f0d292329" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_a5a7251c-d4f7-466b-af1c-abd6db535ba7" xlink:to="loc_us-gaap_CommonStockValue_4fd1a9a5-dee0-423c-bc3a-729f0d292329" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_3ffbcd14-2e57-4cee-b304-8090ed224603" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_a5a7251c-d4f7-466b-af1c-abd6db535ba7" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_3ffbcd14-2e57-4cee-b304-8090ed224603" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_66dee06c-d6b2-43c4-beee-3cf8ac584630" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_a5a7251c-d4f7-466b-af1c-abd6db535ba7" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_66dee06c-d6b2-43c4-beee-3cf8ac584630" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_97373f1e-c45a-4a00-b6f1-fef9822cd99c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_a5a7251c-d4f7-466b-af1c-abd6db535ba7" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_97373f1e-c45a-4a00-b6f1-fef9822cd99c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_f73116bd-a379-4896-af24-bc9a4d76370f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_28fa7da9-5266-4f66-b090-3e95592b18de" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_f73116bd-a379-4896-af24-bc9a4d76370f" xlink:to="loc_us-gaap_AssetsCurrent_28fa7da9-5266-4f66-b090-3e95592b18de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_956189e5-27ef-41a6-b1ea-d605ac8fabef" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_f73116bd-a379-4896-af24-bc9a4d76370f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_956189e5-27ef-41a6-b1ea-d605ac8fabef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_579f8417-11fc-4294-8cf0-ad6155cb0602" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_f73116bd-a379-4896-af24-bc9a4d76370f" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_579f8417-11fc-4294-8cf0-ad6155cb0602" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_206e0e41-6401-46d1-b173-bd3e0a9acdf3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_f73116bd-a379-4896-af24-bc9a4d76370f" xlink:to="loc_us-gaap_Goodwill_206e0e41-6401-46d1-b173-bd3e0a9acdf3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8dcdd5ab-45f0-4758-9d44-d1c560c88601" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_f73116bd-a379-4896-af24-bc9a4d76370f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8dcdd5ab-45f0-4758-9d44-d1c560c88601" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_ceb43c79-916b-43ad-84c6-92fd6bb651fe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_f73116bd-a379-4896-af24-bc9a4d76370f" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_ceb43c79-916b-43ad-84c6-92fd6bb651fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_7ecac3ca-1e43-4819-8a62-ea37c02408be" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_529a67e3-4a1a-42ec-bc3d-2f941399e4c3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_7ecac3ca-1e43-4819-8a62-ea37c02408be" xlink:to="loc_us-gaap_LiabilitiesCurrent_529a67e3-4a1a-42ec-bc3d-2f941399e4c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_4eb0156f-ce61-4eca-87ef-89179c55f560" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_7ecac3ca-1e43-4819-8a62-ea37c02408be" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_4eb0156f-ce61-4eca-87ef-89179c55f560" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_2b77b406-d996-4a0e-85ef-53f7f894c65a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_7ecac3ca-1e43-4819-8a62-ea37c02408be" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_2b77b406-d996-4a0e-85ef-53f7f894c65a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e6bfbe98-61f0-4d2a-9675-9fca3bab2c9d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_7ecac3ca-1e43-4819-8a62-ea37c02408be" xlink:to="loc_us-gaap_StockholdersEquity_e6bfbe98-61f0-4d2a-9675-9fca3bab2c9d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_0c4e192e-be54-4c40-9b98-526662190da1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_7ecac3ca-1e43-4819-8a62-ea37c02408be" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_0c4e192e-be54-4c40-9b98-526662190da1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_538f483b-e3e8-49c3-aa99-26fc6ff2443d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_892c3df3-ecaa-470c-b75b-46e43449a972" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_538f483b-e3e8-49c3-aa99-26fc6ff2443d" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_892c3df3-ecaa-470c-b75b-46e43449a972" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_9b868d84-feaa-484d-8dcc-36c4c832f8aa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_538f483b-e3e8-49c3-aa99-26fc6ff2443d" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_9b868d84-feaa-484d-8dcc-36c4c832f8aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_a26340f7-88dc-48bc-94e6-fd4ad57ee072" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_538f483b-e3e8-49c3-aa99-26fc6ff2443d" xlink:to="loc_us-gaap_InventoryNet_a26340f7-88dc-48bc-94e6-fd4ad57ee072" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_c1f0870c-c612-4ce9-9427-b93e01822253" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_538f483b-e3e8-49c3-aa99-26fc6ff2443d" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_c1f0870c-c612-4ce9-9427-b93e01822253" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParentheticals" xlink:type="simple" xlink:href="hae-20201226.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSParentheticals"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParentheticals" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="hae-20201226.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="hae-20201226.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f0cc8aa8-90b7-4811-8a4b-e9b659ea6f14" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ae00c32c-d4e7-4bd3-b04b-dd5ea9f09f3f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f0cc8aa8-90b7-4811-8a4b-e9b659ea6f14" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ae00c32c-d4e7-4bd3-b04b-dd5ea9f09f3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_199ffee2-169e-4e97-a6d8-0a78b3ee23ef" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f0cc8aa8-90b7-4811-8a4b-e9b659ea6f14" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_199ffee2-169e-4e97-a6d8-0a78b3ee23ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_564f0ff6-02e8-4460-9fbf-9d1ce2dfc561" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f0cc8aa8-90b7-4811-8a4b-e9b659ea6f14" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_564f0ff6-02e8-4460-9fbf-9d1ce2dfc561" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_33f2a2a8-8e25-4c3e-9757-6cbe100bb059" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f0cc8aa8-90b7-4811-8a4b-e9b659ea6f14" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_33f2a2a8-8e25-4c3e-9757-6cbe100bb059" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_cd4984c0-b4cf-42ef-9f41-03a07c2c2178" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_8fd6fb1d-5b25-4de1-8a5c-9555d05f0901" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_cd4984c0-b4cf-42ef-9f41-03a07c2c2178" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_8fd6fb1d-5b25-4de1-8a5c-9555d05f0901" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_8cf7316e-eb37-4137-8e6b-af91fd617028" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_cd4984c0-b4cf-42ef-9f41-03a07c2c2178" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_8cf7316e-eb37-4137-8e6b-af91fd617028" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP_8fa0ad09-ec07-452d-b118-90aef6c359da" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_cd4984c0-b4cf-42ef-9f41-03a07c2c2178" xlink:to="loc_us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP_8fa0ad09-ec07-452d-b118-90aef6c359da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_8984e140-a48f-455e-9c6c-ab2674e69adb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_cd4984c0-b4cf-42ef-9f41-03a07c2c2178" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_8984e140-a48f-455e-9c6c-ab2674e69adb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_12db66ba-d97f-4e2d-97db-ab5fda44f3b7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_cd4984c0-b4cf-42ef-9f41-03a07c2c2178" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_12db66ba-d97f-4e2d-97db-ab5fda44f3b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfEquity_6bcf76c4-e978-4896-8122-4ad4d08d4f88" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForRepurchaseOfEquity"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_cd4984c0-b4cf-42ef-9f41-03a07c2c2178" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfEquity_6bcf76c4-e978-4896-8122-4ad4d08d4f88" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e6731398-4125-4293-ba93-0bf47210e82f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_71aa561d-4293-418e-b277-c54c607d0a14" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e6731398-4125-4293-ba93-0bf47210e82f" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_71aa561d-4293-418e-b277-c54c607d0a14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_392bbe47-5b24-4a7d-9bfa-dc6d83d64421" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e6731398-4125-4293-ba93-0bf47210e82f" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_392bbe47-5b24-4a7d-9bfa-dc6d83d64421" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_55c7b8a7-776b-42b2-9ed8-f27a300afeb1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e6731398-4125-4293-ba93-0bf47210e82f" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_55c7b8a7-776b-42b2-9ed8-f27a300afeb1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_acba1e94-eefc-4a8f-96e6-26e2f1c86b8a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e6731398-4125-4293-ba93-0bf47210e82f" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_acba1e94-eefc-4a8f-96e6-26e2f1c86b8a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c491ea57-34d0-4afd-bdd7-3da7d976c9e5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_790aacac-b34a-4d4a-a3ff-56423bc8c075" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c491ea57-34d0-4afd-bdd7-3da7d976c9e5" xlink:to="loc_us-gaap_NetIncomeLoss_790aacac-b34a-4d4a-a3ff-56423bc8c075" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_b955c63a-6d35-47f6-b417-ee1cec5267e7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c491ea57-34d0-4afd-bdd7-3da7d976c9e5" xlink:to="loc_us-gaap_DepreciationAndAmortization_b955c63a-6d35-47f6-b417-ee1cec5267e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_48547a0c-eef2-4039-bdee-f50ade9efe29" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c491ea57-34d0-4afd-bdd7-3da7d976c9e5" xlink:to="loc_us-gaap_AssetImpairmentCharges_48547a0c-eef2-4039-bdee-f50ade9efe29" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_9aae3dcf-bce8-417b-ae49-3af24cd40db7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c491ea57-34d0-4afd-bdd7-3da7d976c9e5" xlink:to="loc_us-gaap_ShareBasedCompensation_9aae3dcf-bce8-417b-ae49-3af24cd40db7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredOtherTaxExpenseBenefit_15ec01b3-57c7-47d5-9290-f33c3225b007" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredOtherTaxExpenseBenefit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c491ea57-34d0-4afd-bdd7-3da7d976c9e5" xlink:to="loc_us-gaap_DeferredOtherTaxExpenseBenefit_15ec01b3-57c7-47d5-9290-f33c3225b007" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForLoanLeaseAndOtherLosses_b21e80e6-6d54-41a1-b0cf-232aa4cafc22" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProvisionForLoanLeaseAndOtherLosses"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c491ea57-34d0-4afd-bdd7-3da7d976c9e5" xlink:to="loc_us-gaap_ProvisionForLoanLeaseAndOtherLosses_b21e80e6-6d54-41a1-b0cf-232aa4cafc22" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_f0129b86-b5fc-478a-ae7c-ec772050cb2f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c491ea57-34d0-4afd-bdd7-3da7d976c9e5" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_f0129b86-b5fc-478a-ae7c-ec772050cb2f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_c3db8ff9-c496-4e64-a4aa-f8e0ccc27de3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c491ea57-34d0-4afd-bdd7-3da7d976c9e5" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_c3db8ff9-c496-4e64-a4aa-f8e0ccc27de3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_3d15b768-8623-464f-8b5f-6e7828ff8393" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c491ea57-34d0-4afd-bdd7-3da7d976c9e5" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_3d15b768-8623-464f-8b5f-6e7828ff8393" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_10ac5fbd-06af-4ea6-9dbc-11350dce9a13" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c491ea57-34d0-4afd-bdd7-3da7d976c9e5" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_10ac5fbd-06af-4ea6-9dbc-11350dce9a13" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_14de8d88-7e45-45a8-9515-f48a1312156f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c491ea57-34d0-4afd-bdd7-3da7d976c9e5" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_14de8d88-7e45-45a8-9515-f48a1312156f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_a79bccf2-f37b-4301-b762-48f6ee3016c9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c491ea57-34d0-4afd-bdd7-3da7d976c9e5" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_a79bccf2-f37b-4301-b762-48f6ee3016c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_GainLossOnDivestitureAndSaleOfAssets_9d88830d-c8e1-495f-b89f-a4bcb367ae5d" xlink:href="hae-20201226.xsd#hae_GainLossOnDivestitureAndSaleOfAssets"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c491ea57-34d0-4afd-bdd7-3da7d976c9e5" xlink:to="loc_hae_GainLossOnDivestitureAndSaleOfAssets_9d88830d-c8e1-495f-b89f-a4bcb367ae5d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/BASISOFPRESENTATION" xlink:type="simple" xlink:href="hae-20201226.xsd#BASISOFPRESENTATION"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/BASISOFPRESENTATION" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/RECENTACCOUNTINGPRONOUNCEMENTS" xlink:type="simple" xlink:href="hae-20201226.xsd#RECENTACCOUNTINGPRONOUNCEMENTS"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/RECENTACCOUNTINGPRONOUNCEMENTS" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/RESTRUCTURING" xlink:type="simple" xlink:href="hae-20201226.xsd#RESTRUCTURING"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/RESTRUCTURING" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/RESTRUCTURINGTables" xlink:type="simple" xlink:href="hae-20201226.xsd#RESTRUCTURINGTables"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/RESTRUCTURINGTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/RESTRUCTURINGNarrativeDetails" xlink:type="simple" xlink:href="hae-20201226.xsd#RESTRUCTURINGNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/RESTRUCTURINGNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails" xlink:type="simple" xlink:href="hae-20201226.xsd#RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails" xlink:type="simple" xlink:href="hae-20201226.xsd#RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_hae_RestructuringandRestructuringRelatedCosts_d326daf7-c278-43dd-a3dc-a366289735d0" xlink:href="hae-20201226.xsd#hae_RestructuringandRestructuringRelatedCosts"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_RestructuringRelatedCosts_43589f3f-c54c-444a-be9b-b516b9d2462c" xlink:href="hae-20201226.xsd#hae_RestructuringRelatedCosts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hae_RestructuringandRestructuringRelatedCosts_d326daf7-c278-43dd-a3dc-a366289735d0" xlink:to="loc_hae_RestructuringRelatedCosts_43589f3f-c54c-444a-be9b-b516b9d2462c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_b7edf59b-5340-45d5-ba95-71db787d64c2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hae_RestructuringandRestructuringRelatedCosts_d326daf7-c278-43dd-a3dc-a366289735d0" xlink:to="loc_us-gaap_RestructuringCharges_b7edf59b-5340-45d5-ba95-71db787d64c2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/ACQUISITION" xlink:type="simple" xlink:href="hae-20201226.xsd#ACQUISITION"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/ACQUISITION" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/ACQUISITIONTables" xlink:type="simple" xlink:href="hae-20201226.xsd#ACQUISITIONTables"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/ACQUISITIONTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/ACQUISITIONDetails" xlink:type="simple" xlink:href="hae-20201226.xsd#ACQUISITIONDetails"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/ACQUISITIONDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_bafe8a6d-fd51-4740-adff-4fd0e9c81cb2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_a50de26e-69ee-4e20-b02a-0d43e4977289" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_bafe8a6d-fd51-4740-adff-4fd0e9c81cb2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_a50de26e-69ee-4e20-b02a-0d43e4977289" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_6d95a953-e6b6-49b7-a8f7-b41c2109c673" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_bafe8a6d-fd51-4740-adff-4fd0e9c81cb2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_6d95a953-e6b6-49b7-a8f7-b41c2109c673" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_25604420-f6ea-44f7-8fe9-517c3226f25d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_bafe8a6d-fd51-4740-adff-4fd0e9c81cb2" xlink:to="loc_us-gaap_Goodwill_25604420-f6ea-44f7-8fe9-517c3226f25d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_ae518ea1-241f-4d20-af86-4876c8d81ecb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_bafe8a6d-fd51-4740-adff-4fd0e9c81cb2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_ae518ea1-241f-4d20-af86-4876c8d81ecb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_e27da292-c28b-4dc6-ade9-6a051dcf4b7b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_bafe8a6d-fd51-4740-adff-4fd0e9c81cb2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_e27da292-c28b-4dc6-ade9-6a051dcf4b7b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_865858fd-673e-4343-94fc-2a5be5540fa1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_955e1de5-14e9-49a6-83fa-35e1203bbe96" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_865858fd-673e-4343-94fc-2a5be5540fa1" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_955e1de5-14e9-49a6-83fa-35e1203bbe96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_90bb0b50-592b-4b8b-8ba5-85a131f87987" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_865858fd-673e-4343-94fc-2a5be5540fa1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_90bb0b50-592b-4b8b-8ba5-85a131f87987" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_4c166b04-2c84-469d-9041-7813d3b66b35" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_865858fd-673e-4343-94fc-2a5be5540fa1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_4c166b04-2c84-469d-9041-7813d3b66b35" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_b6392f63-270d-4f6c-9563-9c3f2e250c23" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_865858fd-673e-4343-94fc-2a5be5540fa1" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_b6392f63-270d-4f6c-9563-9c3f2e250c23" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/DIVESTITURE" xlink:type="simple" xlink:href="hae-20201226.xsd#DIVESTITURE"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/DIVESTITURE" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/DIVESTITUREDetails" xlink:type="simple" xlink:href="hae-20201226.xsd#DIVESTITUREDetails"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/DIVESTITUREDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/INCOMETAXES" xlink:type="simple" xlink:href="hae-20201226.xsd#INCOMETAXES"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/INCOMETAXES" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/INCOMETAXESDetails" xlink:type="simple" xlink:href="hae-20201226.xsd#INCOMETAXESDetails"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/INCOMETAXESDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/EARNINGSPERSHAREEPS" xlink:type="simple" xlink:href="hae-20201226.xsd#EARNINGSPERSHAREEPS"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/EARNINGSPERSHAREEPS" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/EARNINGSPERSHAREEPSTables" xlink:type="simple" xlink:href="hae-20201226.xsd#EARNINGSPERSHAREEPSTables"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/EARNINGSPERSHAREEPSTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/EARNINGSPERSHAREEPSScheduleofEarningsPerShareReconciliationDetails" xlink:type="simple" xlink:href="hae-20201226.xsd#EARNINGSPERSHAREEPSScheduleofEarningsPerShareReconciliationDetails"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/EARNINGSPERSHAREEPSScheduleofEarningsPerShareReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_fd6d67a1-a8de-4b7c-81eb-d741ec25a059" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_cb4ec2d4-1adb-4091-b81b-4e22c74efd2c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_fd6d67a1-a8de-4b7c-81eb-d741ec25a059" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_cb4ec2d4-1adb-4091-b81b-4e22c74efd2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a5d9feb4-c0d8-40e5-b135-633bd6121aff" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_fd6d67a1-a8de-4b7c-81eb-d741ec25a059" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a5d9feb4-c0d8-40e5-b135-633bd6121aff" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/REVENUE" xlink:type="simple" xlink:href="hae-20201226.xsd#REVENUE"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/REVENUE" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/REVENUEDetails" xlink:type="simple" xlink:href="hae-20201226.xsd#REVENUEDetails"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/REVENUEDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/REVENUEDetails_1" xlink:type="simple" xlink:href="hae-20201226.xsd#REVENUEDetails_1"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/REVENUEDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/INVENTORIES" xlink:type="simple" xlink:href="hae-20201226.xsd#INVENTORIES"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/INVENTORIES" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/INVENTORIESTables" xlink:type="simple" xlink:href="hae-20201226.xsd#INVENTORIESTables"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/INVENTORIESTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/INVENTORIESScheduleofInventoriesDetails" xlink:type="simple" xlink:href="hae-20201226.xsd#INVENTORIESScheduleofInventoriesDetails"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/INVENTORIESScheduleofInventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_f63e9571-7cfa-4202-bbae-a5d88dbf31db" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_e1077945-52ec-418b-8e0a-84ac42a36eb8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_f63e9571-7cfa-4202-bbae-a5d88dbf31db" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_e1077945-52ec-418b-8e0a-84ac42a36eb8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_f89af4e8-215a-483f-976c-e21e0b5d35bb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_f63e9571-7cfa-4202-bbae-a5d88dbf31db" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_f89af4e8-215a-483f-976c-e21e0b5d35bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_8807f219-2781-4958-90b2-fd79522f0ab5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_f63e9571-7cfa-4202-bbae-a5d88dbf31db" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_8807f219-2781-4958-90b2-fd79522f0ab5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/LEASES" xlink:type="simple" xlink:href="hae-20201226.xsd#LEASES"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/LEASES" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/LEASESDetails" xlink:type="simple" xlink:href="hae-20201226.xsd#LEASESDetails"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/LEASESDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBT" xlink:type="simple" xlink:href="hae-20201226.xsd#NOTESPAYABLEANDLONGTERMDEBT"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBT" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTDetails" xlink:type="simple" xlink:href="hae-20201226.xsd#NOTESPAYABLEANDLONGTERMDEBTDetails"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURES" xlink:type="simple" xlink:href="hae-20201226.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASURES"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURES" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESTables" xlink:type="simple" xlink:href="hae-20201226.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESTables"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAllowanceforcreditlossesDetails" xlink:type="simple" xlink:href="hae-20201226.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAllowanceforcreditlossesDetails"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAllowanceforcreditlossesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails" xlink:type="simple" xlink:href="hae-20201226.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESSchedulesofDerivativesDetails" xlink:type="simple" xlink:href="hae-20201226.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESSchedulesofDerivativesDetails"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESSchedulesofDerivativesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails" xlink:type="simple" xlink:href="hae-20201226.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="simple" xlink:href="hae-20201226.xsd#COMMITMENTSANDCONTINGENCIES"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATION" xlink:type="simple" xlink:href="hae-20201226.xsd#SEGMENTANDENTERPRISEWIDEINFORMATION"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATION" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONTables" xlink:type="simple" xlink:href="hae-20201226.xsd#SEGMENTANDENTERPRISEWIDEINFORMATIONTables"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails" xlink:type="simple" xlink:href="hae-20201226.xsd#SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS" xlink:type="simple" xlink:href="hae-20201226.xsd#ACCUMULATEDOTHERCOMPREHENSIVELOSS"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables" xlink:type="simple" xlink:href="hae-20201226.xsd#ACCUMULATEDOTHERCOMPREHENSIVELOSSTables"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSDetails" xlink:type="simple" xlink:href="hae-20201226.xsd#ACCUMULATEDOTHERCOMPREHENSIVELOSSDetails"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_cea3a22a-e819-4d9f-866d-086bb894d10a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_96d6e88a-376b-4c25-8d8d-1d856b3d953e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_cea3a22a-e819-4d9f-866d-086bb894d10a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_96d6e88a-376b-4c25-8d8d-1d856b3d953e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_7cc7272e-6865-498a-8100-396b48a3fe1c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_cea3a22a-e819-4d9f-866d-086bb894d10a" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_7cc7272e-6865-498a-8100-396b48a3fe1c" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>12
<FILENAME>hae-20201226_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:dcc831a0-a182-47d6-a94e-5adaefe7bce2,g:c7d71817-1258-4da0-86ec-9eebc508e513-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION" xlink:type="simple" xlink:href="hae-20201226.xsd#DOCUMENTANDENTITYINFORMATION"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION" xlink:type="extended" id="if027ecb9139241a9badb707418342d1e_DOCUMENTANDENTITYINFORMATION"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="hae-20201226.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOME"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOME" xlink:type="extended" id="i352249f2261441a992bd979f7956a8cf_CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOME"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="hae-20201226.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended" id="ib9ef19aa60164d44b7a041abf49d0aee_CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParentheticals" xlink:type="simple" xlink:href="hae-20201226.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSParentheticals"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParentheticals" xlink:type="extended" id="i5079534afa5d493cbac57b1f3eee20d8_CONDENSEDCONSOLIDATEDBALANCESHEETSParentheticals"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="hae-20201226.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended" id="if6da7a9e99b44307b645d84882eee960_CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ecacfcb4-b509-4ded-b006-b182ffc61bc2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a41d6314-a70f-4b93-a12b-e7c1e77d6cce" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ecacfcb4-b509-4ded-b006-b182ffc61bc2" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a41d6314-a70f-4b93-a12b-e7c1e77d6cce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_26904038-cdca-4093-8f88-3f3a6f0e9cd5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a41d6314-a70f-4b93-a12b-e7c1e77d6cce" xlink:to="loc_us-gaap_SharesIssued_26904038-cdca-4093-8f88-3f3a6f0e9cd5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_19f06525-9427-45e6-a939-80b3b1a82fed" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a41d6314-a70f-4b93-a12b-e7c1e77d6cce" xlink:to="loc_us-gaap_StockholdersEquity_19f06525-9427-45e6-a939-80b3b1a82fed" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_96db0ab4-545b-4962-8a62-c0e606f32b51" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a41d6314-a70f-4b93-a12b-e7c1e77d6cce" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_96db0ab4-545b-4962-8a62-c0e606f32b51" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_a43cdf27-b7fe-4132-94ee-8e85d40548fc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a41d6314-a70f-4b93-a12b-e7c1e77d6cce" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_a43cdf27-b7fe-4132-94ee-8e85d40548fc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3e88c37a-04ec-41b3-a14e-cbac6f2092ce" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a41d6314-a70f-4b93-a12b-e7c1e77d6cce" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3e88c37a-04ec-41b3-a14e-cbac6f2092ce" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_bf44b70d-f623-43f3-8797-caebbc0ed4a3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a41d6314-a70f-4b93-a12b-e7c1e77d6cce" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_bf44b70d-f623-43f3-8797-caebbc0ed4a3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_12d99330-f184-45f2-ac9b-7b96c243b6b6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a41d6314-a70f-4b93-a12b-e7c1e77d6cce" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_12d99330-f184-45f2-ac9b-7b96c243b6b6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_60454318-fbdd-41d8-90fc-fa20e5c3f1c3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a41d6314-a70f-4b93-a12b-e7c1e77d6cce" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_60454318-fbdd-41d8-90fc-fa20e5c3f1c3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_b0463caa-d678-408d-82a5-3b6a1b2c3028" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a41d6314-a70f-4b93-a12b-e7c1e77d6cce" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_b0463caa-d678-408d-82a5-3b6a1b2c3028" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_3b0e2f32-8e79-4803-82d3-6dbb6a738e4f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a41d6314-a70f-4b93-a12b-e7c1e77d6cce" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_3b0e2f32-8e79-4803-82d3-6dbb6a738e4f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4c2ad8e7-b0ff-490f-9254-b61de2f6e610" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a41d6314-a70f-4b93-a12b-e7c1e77d6cce" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4c2ad8e7-b0ff-490f-9254-b61de2f6e610" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0d81cfa8-803f-40d5-94a5-52d8712889a5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a41d6314-a70f-4b93-a12b-e7c1e77d6cce" xlink:to="loc_us-gaap_NetIncomeLoss_0d81cfa8-803f-40d5-94a5-52d8712889a5" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_306582be-2fe5-431a-a925-b79ca1990a8a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a41d6314-a70f-4b93-a12b-e7c1e77d6cce" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_306582be-2fe5-431a-a925-b79ca1990a8a" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_14627e93-c4f6-4c07-ada8-7cbdc1fa063b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_d4b57277-0ddc-472a-b9a7-654fc472922c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_e4eabd83-9eb9-4f77-a15c-965e2fca2499" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_ecacfcb4-b509-4ded-b006-b182ffc61bc2" xlink:to="loc_us-gaap_StatementTable_e4eabd83-9eb9-4f77-a15c-965e2fca2499" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_7720febd-512f-40b5-9a05-c6ec9c178848" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_e4eabd83-9eb9-4f77-a15c-965e2fca2499" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_7720febd-512f-40b5-9a05-c6ec9c178848" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_7720febd-512f-40b5-9a05-c6ec9c178848_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7720febd-512f-40b5-9a05-c6ec9c178848" xlink:to="loc_us-gaap_EquityComponentDomain_7720febd-512f-40b5-9a05-c6ec9c178848_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_25062988-23dc-4e57-a49f-72a98363fbe7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7720febd-512f-40b5-9a05-c6ec9c178848" xlink:to="loc_us-gaap_EquityComponentDomain_25062988-23dc-4e57-a49f-72a98363fbe7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_58faff7b-f1d8-40d1-a98f-bee287ae8e36" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_25062988-23dc-4e57-a49f-72a98363fbe7" xlink:to="loc_us-gaap_CommonStockMember_58faff7b-f1d8-40d1-a98f-bee287ae8e36" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_f7b98f84-334e-4f8e-ac6f-dd8065c0fea3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_25062988-23dc-4e57-a49f-72a98363fbe7" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_f7b98f84-334e-4f8e-ac6f-dd8065c0fea3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_e7dca7cb-b1ef-4e86-b5c3-ea51999d908d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_25062988-23dc-4e57-a49f-72a98363fbe7" xlink:to="loc_us-gaap_RetainedEarningsMember_e7dca7cb-b1ef-4e86-b5c3-ea51999d908d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_fd908a19-7f69-42f8-a2c9-758d49da0eff" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_25062988-23dc-4e57-a49f-72a98363fbe7" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_fd908a19-7f69-42f8-a2c9-758d49da0eff" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="hae-20201226.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended" id="i8cd3bc1c26fa496f8b0aeccf1f275820_CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/BASISOFPRESENTATION" xlink:type="simple" xlink:href="hae-20201226.xsd#BASISOFPRESENTATION"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/BASISOFPRESENTATION" xlink:type="extended" id="i01679d56ce89468a9eb991a66a0b930b_BASISOFPRESENTATION"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/RECENTACCOUNTINGPRONOUNCEMENTS" xlink:type="simple" xlink:href="hae-20201226.xsd#RECENTACCOUNTINGPRONOUNCEMENTS"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/RECENTACCOUNTINGPRONOUNCEMENTS" xlink:type="extended" id="i8e81298eb59c4bf391231e064c364d38_RECENTACCOUNTINGPRONOUNCEMENTS"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/RESTRUCTURING" xlink:type="simple" xlink:href="hae-20201226.xsd#RESTRUCTURING"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/RESTRUCTURING" xlink:type="extended" id="ibab93edb368740d5814f687f3ecde6dd_RESTRUCTURING"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/RESTRUCTURINGTables" xlink:type="simple" xlink:href="hae-20201226.xsd#RESTRUCTURINGTables"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/RESTRUCTURINGTables" xlink:type="extended" id="i8a18aa4be1634314b0820539ae8d4c3d_RESTRUCTURINGTables"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/RESTRUCTURINGNarrativeDetails" xlink:type="simple" xlink:href="hae-20201226.xsd#RESTRUCTURINGNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/RESTRUCTURINGNarrativeDetails" xlink:type="extended" id="icabb178b177a42edb33301d817898492_RESTRUCTURINGNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_f498ef9d-c7d4-499b-99c3-52f895b05608" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_a94cf790-8fb9-4124-b3b6-ef8c608d44d3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f498ef9d-c7d4-499b-99c3-52f895b05608" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_a94cf790-8fb9-4124-b3b6-ef8c608d44d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_RestructuringandRestructuringRelatedCosts_c72f6750-0721-4566-9844-da9d1da70df3" xlink:href="hae-20201226.xsd#hae_RestructuringandRestructuringRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f498ef9d-c7d4-499b-99c3-52f895b05608" xlink:to="loc_hae_RestructuringandRestructuringRelatedCosts_c72f6750-0721-4566-9844-da9d1da70df3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_34ae08e5-a895-4982-aa81-0d380915529d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f498ef9d-c7d4-499b-99c3-52f895b05608" xlink:to="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_34ae08e5-a895-4982-aa81-0d380915529d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_2a73a210-9221-4123-9ed0-3ea8185a64c7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f498ef9d-c7d4-499b-99c3-52f895b05608" xlink:to="loc_us-gaap_RestructuringReserve_2a73a210-9221-4123-9ed0-3ea8185a64c7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_RestructuringChargesPayableInNextTwelveMonths_c1faa4d5-969c-4d22-8a5a-cecf9eeb1dec" xlink:href="hae-20201226.xsd#hae_RestructuringChargesPayableInNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f498ef9d-c7d4-499b-99c3-52f895b05608" xlink:to="loc_hae_RestructuringChargesPayableInNextTwelveMonths_c1faa4d5-969c-4d22-8a5a-cecf9eeb1dec" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_RestructuringRelatedCosts_a91ebd3d-db7b-4527-8605-e7996044cb57" xlink:href="hae-20201226.xsd#hae_RestructuringRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f498ef9d-c7d4-499b-99c3-52f895b05608" xlink:to="loc_hae_RestructuringRelatedCosts_a91ebd3d-db7b-4527-8605-e7996044cb57" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_76c91248-93f9-46de-a59b-c91502325241" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f498ef9d-c7d4-499b-99c3-52f895b05608" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_76c91248-93f9-46de-a59b-c91502325241" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_72e939e4-9f70-43a8-99ed-80c79320cd6f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_76c91248-93f9-46de-a59b-c91502325241" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_72e939e4-9f70-43a8-99ed-80c79320cd6f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_72e939e4-9f70-43a8-99ed-80c79320cd6f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_72e939e4-9f70-43a8-99ed-80c79320cd6f" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_72e939e4-9f70-43a8-99ed-80c79320cd6f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_baace393-84dc-49ef-850f-49cfe5cb9cdb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_72e939e4-9f70-43a8-99ed-80c79320cd6f" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_baace393-84dc-49ef-850f-49cfe5cb9cdb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_410f29e3-e55a-4e73-a970-bf5f85e714a1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_baace393-84dc-49ef-850f-49cfe5cb9cdb" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_410f29e3-e55a-4e73-a970-bf5f85e714a1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_0c783631-7504-4454-9de1-d5bcfc211373" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_76c91248-93f9-46de-a59b-c91502325241" xlink:to="loc_us-gaap_RestructuringPlanAxis_0c783631-7504-4454-9de1-d5bcfc211373" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_0c783631-7504-4454-9de1-d5bcfc211373_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_0c783631-7504-4454-9de1-d5bcfc211373" xlink:to="loc_us-gaap_RestructuringPlanDomain_0c783631-7504-4454-9de1-d5bcfc211373_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_92c07ca8-cf4b-47fd-9933-74c4022e6112" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_0c783631-7504-4454-9de1-d5bcfc211373" xlink:to="loc_us-gaap_RestructuringPlanDomain_92c07ca8-cf4b-47fd-9933-74c4022e6112" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_A2020ProgramMember_692c9749-ada4-4c26-9838-57a192fc88ac" xlink:href="hae-20201226.xsd#hae_A2020ProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_92c07ca8-cf4b-47fd-9933-74c4022e6112" xlink:to="loc_hae_A2020ProgramMember_692c9749-ada4-4c26-9838-57a192fc88ac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_A2018ProgramMember_d6f66fed-27b3-45dd-ab6b-7efd0d00268f" xlink:href="hae-20201226.xsd#hae_A2018ProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_92c07ca8-cf4b-47fd-9933-74c4022e6112" xlink:to="loc_hae_A2018ProgramMember_d6f66fed-27b3-45dd-ab6b-7efd0d00268f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6e2956df-8542-4d49-8687-41190eb75d9b" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_76c91248-93f9-46de-a59b-c91502325241" xlink:to="loc_srt_RangeAxis_6e2956df-8542-4d49-8687-41190eb75d9b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6e2956df-8542-4d49-8687-41190eb75d9b_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_6e2956df-8542-4d49-8687-41190eb75d9b" xlink:to="loc_srt_RangeMember_6e2956df-8542-4d49-8687-41190eb75d9b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a525a9d2-18c9-4d2c-9591-5017a0b3600d" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_6e2956df-8542-4d49-8687-41190eb75d9b" xlink:to="loc_srt_RangeMember_a525a9d2-18c9-4d2c-9591-5017a0b3600d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_5642e3fd-e479-4725-93df-822e9de6c980" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a525a9d2-18c9-4d2c-9591-5017a0b3600d" xlink:to="loc_srt_MinimumMember_5642e3fd-e479-4725-93df-822e9de6c980" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b8da0ff8-4a99-44a9-9574-437d505d4dbf" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a525a9d2-18c9-4d2c-9591-5017a0b3600d" xlink:to="loc_srt_MaximumMember_b8da0ff8-4a99-44a9-9574-437d505d4dbf" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails" xlink:type="simple" xlink:href="hae-20201226.xsd#RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails" xlink:type="extended" id="i03778536db5744888bb0f168a1c9eb76_RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_eda6c633-e335-4743-a423-3f9ef9403aac" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_d5fe9bd8-6cc1-4683-8d6a-e5cae48a6d1f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_eda6c633-e335-4743-a423-3f9ef9403aac" xlink:to="loc_us-gaap_RestructuringReserveRollForward_d5fe9bd8-6cc1-4683-8d6a-e5cae48a6d1f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_8cf10a95-858d-469a-9937-ee8fc982c07f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_d5fe9bd8-6cc1-4683-8d6a-e5cae48a6d1f" xlink:to="loc_us-gaap_RestructuringReserve_8cf10a95-858d-469a-9937-ee8fc982c07f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_46d838af-e6a5-462a-91e9-b08a61823269" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_d5fe9bd8-6cc1-4683-8d6a-e5cae48a6d1f" xlink:to="loc_us-gaap_RestructuringCharges_46d838af-e6a5-462a-91e9-b08a61823269" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_f6b1c728-97ad-4eaf-8723-93ac4445e80e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_d5fe9bd8-6cc1-4683-8d6a-e5cae48a6d1f" xlink:to="loc_us-gaap_PaymentsForRestructuring_f6b1c728-97ad-4eaf-8723-93ac4445e80e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_94cec370-82ec-49ab-b352-ed733933d3f9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_ea008bd9-7f3b-4962-875c-35daea700ebf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_eda6c633-e335-4743-a423-3f9ef9403aac" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_ea008bd9-7f3b-4962-875c-35daea700ebf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_fcd444ff-68ea-4808-9d3b-cb40ddb77bdf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_ea008bd9-7f3b-4962-875c-35daea700ebf" xlink:to="loc_us-gaap_RestructuringPlanAxis_fcd444ff-68ea-4808-9d3b-cb40ddb77bdf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_fcd444ff-68ea-4808-9d3b-cb40ddb77bdf_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_fcd444ff-68ea-4808-9d3b-cb40ddb77bdf" xlink:to="loc_us-gaap_RestructuringPlanDomain_fcd444ff-68ea-4808-9d3b-cb40ddb77bdf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_c482078e-db79-452d-af35-32f5d965f592" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_fcd444ff-68ea-4808-9d3b-cb40ddb77bdf" xlink:to="loc_us-gaap_RestructuringPlanDomain_c482078e-db79-452d-af35-32f5d965f592" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_A2020ProgramMember_bc852142-1ed9-45c8-b658-56aa19f28dbd" xlink:href="hae-20201226.xsd#hae_A2020ProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_c482078e-db79-452d-af35-32f5d965f592" xlink:to="loc_hae_A2020ProgramMember_bc852142-1ed9-45c8-b658-56aa19f28dbd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_A2018ProgramMember_e97f3603-8673-41f4-93e6-0e1fa6ed0c5f" xlink:href="hae-20201226.xsd#hae_A2018ProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_c482078e-db79-452d-af35-32f5d965f592" xlink:to="loc_hae_A2018ProgramMember_e97f3603-8673-41f4-93e6-0e1fa6ed0c5f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_A2018ProgramandPriorProgramsMember_a9c8e545-3278-4de0-9430-e5ec223d161a" xlink:href="hae-20201226.xsd#hae_A2018ProgramandPriorProgramsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_c482078e-db79-452d-af35-32f5d965f592" xlink:to="loc_hae_A2018ProgramandPriorProgramsMember_a9c8e545-3278-4de0-9430-e5ec223d161a" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails" xlink:type="simple" xlink:href="hae-20201226.xsd#RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails" xlink:type="extended" id="ib49f64a8308a40418ec853f722cb7785_RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_443baa8b-4948-4e4d-b410-b992518d580c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_c20174f8-b6d1-4daf-a6ac-3ebc798e6c03" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_443baa8b-4948-4e4d-b410-b992518d580c" xlink:to="loc_us-gaap_RestructuringCharges_c20174f8-b6d1-4daf-a6ac-3ebc798e6c03" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_RestructuringRelatedCosts_8e7d5113-4077-4882-9257-9e3bd694bbe6" xlink:href="hae-20201226.xsd#hae_RestructuringRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_443baa8b-4948-4e4d-b410-b992518d580c" xlink:to="loc_hae_RestructuringRelatedCosts_8e7d5113-4077-4882-9257-9e3bd694bbe6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_RestructuringandRestructuringRelatedCosts_a3c86043-e823-4bba-bdfc-214c07d4efc2" xlink:href="hae-20201226.xsd#hae_RestructuringandRestructuringRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_443baa8b-4948-4e4d-b410-b992518d580c" xlink:to="loc_hae_RestructuringandRestructuringRelatedCosts_a3c86043-e823-4bba-bdfc-214c07d4efc2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f894168b-dd20-486d-8ab4-1a1a98dc7242" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_443baa8b-4948-4e4d-b410-b992518d580c" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f894168b-dd20-486d-8ab4-1a1a98dc7242" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_6f097e47-b9ea-4114-9c57-870ad59045e1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f894168b-dd20-486d-8ab4-1a1a98dc7242" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_6f097e47-b9ea-4114-9c57-870ad59045e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_6f097e47-b9ea-4114-9c57-870ad59045e1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_6f097e47-b9ea-4114-9c57-870ad59045e1" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_6f097e47-b9ea-4114-9c57-870ad59045e1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ca47f29f-b642-40e3-bc59-dc062df9137c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_6f097e47-b9ea-4114-9c57-870ad59045e1" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ca47f29f-b642-40e3-bc59-dc062df9137c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_f00834ec-257e-40a7-9226-b5ee337c9a4b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ca47f29f-b642-40e3-bc59-dc062df9137c" xlink:to="loc_us-gaap_CostOfSalesMember_f00834ec-257e-40a7-9226-b5ee337c9a4b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_a030fdb6-e8b1-49e5-add4-f4c75692e6e3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ca47f29f-b642-40e3-bc59-dc062df9137c" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_a030fdb6-e8b1-49e5-add4-f4c75692e6e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_7dd8f6f1-c3dd-4bb0-90ee-8cdbc6f7f4e2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ca47f29f-b642-40e3-bc59-dc062df9137c" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_7dd8f6f1-c3dd-4bb0-90ee-8cdbc6f7f4e2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_c18bf501-ada4-4ed6-b20e-b0a508259d15" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f894168b-dd20-486d-8ab4-1a1a98dc7242" xlink:to="loc_srt_ConsolidationItemsAxis_c18bf501-ada4-4ed6-b20e-b0a508259d15" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_c18bf501-ada4-4ed6-b20e-b0a508259d15_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_c18bf501-ada4-4ed6-b20e-b0a508259d15" xlink:to="loc_srt_ConsolidationItemsDomain_c18bf501-ada4-4ed6-b20e-b0a508259d15_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_a927b954-d4ff-4799-af8c-2cfcab7ee94c" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_c18bf501-ada4-4ed6-b20e-b0a508259d15" xlink:to="loc_srt_ConsolidationItemsDomain_a927b954-d4ff-4799-af8c-2cfcab7ee94c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_fe42a686-2f97-4b69-8332-6e1d6a3d09c0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_a927b954-d4ff-4799-af8c-2cfcab7ee94c" xlink:to="loc_us-gaap_CorporateNonSegmentMember_fe42a686-2f97-4b69-8332-6e1d6a3d09c0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_6792ec26-c8a8-4ced-af8d-e0bbcbf93467" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f894168b-dd20-486d-8ab4-1a1a98dc7242" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_6792ec26-c8a8-4ced-af8d-e0bbcbf93467" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6792ec26-c8a8-4ced-af8d-e0bbcbf93467_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6792ec26-c8a8-4ced-af8d-e0bbcbf93467" xlink:to="loc_us-gaap_SegmentDomain_6792ec26-c8a8-4ced-af8d-e0bbcbf93467_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_bd3a562a-a01b-4df2-a454-7fd96db959c2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6792ec26-c8a8-4ced-af8d-e0bbcbf93467" xlink:to="loc_us-gaap_SegmentDomain_bd3a562a-a01b-4df2-a454-7fd96db959c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_BloodCenterMember_94305463-8986-4702-9b85-548dfe6e3bec" xlink:href="hae-20201226.xsd#hae_BloodCenterMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_bd3a562a-a01b-4df2-a454-7fd96db959c2" xlink:to="loc_hae_BloodCenterMember_94305463-8986-4702-9b85-548dfe6e3bec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_HospitalMember_53d6896f-724f-4cbc-a53e-4b1fb68a7ccc" xlink:href="hae-20201226.xsd#hae_HospitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_bd3a562a-a01b-4df2-a454-7fd96db959c2" xlink:to="loc_hae_HospitalMember_53d6896f-724f-4cbc-a53e-4b1fb68a7ccc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_PlasmaMember_0952a3c1-dc0a-4aa8-86c4-ba41f1cb981d" xlink:href="hae-20201226.xsd#hae_PlasmaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_bd3a562a-a01b-4df2-a454-7fd96db959c2" xlink:to="loc_hae_PlasmaMember_0952a3c1-dc0a-4aa8-86c4-ba41f1cb981d" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/ACQUISITION" xlink:type="simple" xlink:href="hae-20201226.xsd#ACQUISITION"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/ACQUISITION" xlink:type="extended" id="ic1e6af0193d346219e080cc94420d32a_ACQUISITION"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/ACQUISITIONTables" xlink:type="simple" xlink:href="hae-20201226.xsd#ACQUISITIONTables"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/ACQUISITIONTables" xlink:type="extended" id="ib17c3e2d73054ee4afcd9f5d4aa9a66c_ACQUISITIONTables"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/ACQUISITIONDetails" xlink:type="simple" xlink:href="hae-20201226.xsd#ACQUISITIONDetails"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/ACQUISITIONDetails" xlink:type="extended" id="ib7500ad7413c47918d88c035f0e835a4_ACQUISITIONDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_b6b7020e-40af-4081-afb7-2fe01143998d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_0fafb014-69c3-41b6-925c-f2d6286549b4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b6b7020e-40af-4081-afb7-2fe01143998d" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_0fafb014-69c3-41b6-925c-f2d6286549b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_6dade145-43f9-4224-8627-f5399104fdbf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b6b7020e-40af-4081-afb7-2fe01143998d" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_6dade145-43f9-4224-8627-f5399104fdbf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_a6fa9a57-466c-49cc-a6ae-87e1040cc64d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b6b7020e-40af-4081-afb7-2fe01143998d" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_a6fa9a57-466c-49cc-a6ae-87e1040cc64d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_7b39ea8b-17be-424b-a0e7-853d0210309a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b6b7020e-40af-4081-afb7-2fe01143998d" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_7b39ea8b-17be-424b-a0e7-853d0210309a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_AssetAcquisitionUpfrontPayment_ebec3b4e-6cdf-4051-afcd-8ca70ed5947f" xlink:href="hae-20201226.xsd#hae_AssetAcquisitionUpfrontPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b6b7020e-40af-4081-afb7-2fe01143998d" xlink:to="loc_hae_AssetAcquisitionUpfrontPayment_ebec3b4e-6cdf-4051-afcd-8ca70ed5947f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_b84b2b2c-f6be-4c36-931c-ea254f25f9b4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b6b7020e-40af-4081-afb7-2fe01143998d" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_b84b2b2c-f6be-4c36-931c-ea254f25f9b4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_f6f4cfa2-d6cf-4fa7-8830-785f3d26799c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b6b7020e-40af-4081-afb7-2fe01143998d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_f6f4cfa2-d6cf-4fa7-8830-785f3d26799c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_198a0ea5-d07c-433c-b830-aa8e57099cf1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b6b7020e-40af-4081-afb7-2fe01143998d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_198a0ea5-d07c-433c-b830-aa8e57099cf1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_0a22362b-dec0-4239-81bc-2f53427f8765" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b6b7020e-40af-4081-afb7-2fe01143998d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_0a22362b-dec0-4239-81bc-2f53427f8765" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_928c77a1-c15b-4286-982b-f347c80305a1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b6b7020e-40af-4081-afb7-2fe01143998d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_928c77a1-c15b-4286-982b-f347c80305a1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_67f24cef-b6d0-4a92-8445-7bdb5d1e3e10" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b6b7020e-40af-4081-afb7-2fe01143998d" xlink:to="loc_us-gaap_Goodwill_67f24cef-b6d0-4a92-8445-7bdb5d1e3e10" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_1816895d-4f11-4122-a005-0f886ed816a3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b6b7020e-40af-4081-afb7-2fe01143998d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_1816895d-4f11-4122-a005-0f886ed816a3" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_f32c67a6-706b-4468-9896-ee1c45199c21" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b6b7020e-40af-4081-afb7-2fe01143998d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_f32c67a6-706b-4468-9896-ee1c45199c21" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_7d52c82a-004a-4a4b-9609-bc4c9303a405" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b6b7020e-40af-4081-afb7-2fe01143998d" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_7d52c82a-004a-4a4b-9609-bc4c9303a405" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_d5460471-202f-43c0-a3c0-a9dd6b236a31" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b6b7020e-40af-4081-afb7-2fe01143998d" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_d5460471-202f-43c0-a3c0-a9dd6b236a31" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_2c107fce-0eb9-4300-a4df-0fdc98e9478d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b6b7020e-40af-4081-afb7-2fe01143998d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_2c107fce-0eb9-4300-a4df-0fdc98e9478d" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_d61415df-251b-4234-bfbe-85d9bad731f3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b6b7020e-40af-4081-afb7-2fe01143998d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_d61415df-251b-4234-bfbe-85d9bad731f3" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_1b8d4bbb-ca17-4785-9c02-105a1398e70d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b6b7020e-40af-4081-afb7-2fe01143998d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_1b8d4bbb-ca17-4785-9c02-105a1398e70d" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_169a521f-81cc-4e97-be08-e439501dcb69" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b6b7020e-40af-4081-afb7-2fe01143998d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_169a521f-81cc-4e97-be08-e439501dcb69" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_95b782ba-506b-4fd3-b044-91b09b8b27f9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b6b7020e-40af-4081-afb7-2fe01143998d" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_95b782ba-506b-4fd3-b044-91b09b8b27f9" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed_279c9739-ad5a-4f2e-b709-fe55e6c97f00" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b6b7020e-40af-4081-afb7-2fe01143998d" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed_279c9739-ad5a-4f2e-b709-fe55e6c97f00" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_98954cb8-bc12-4ee0-983d-65d97a4b7914" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b6b7020e-40af-4081-afb7-2fe01143998d" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_98954cb8-bc12-4ee0-983d-65d97a4b7914" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_68010d25-7883-4c58-b507-7c5a578365d6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_98954cb8-bc12-4ee0-983d-65d97a4b7914" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_68010d25-7883-4c58-b507-7c5a578365d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_68010d25-7883-4c58-b507-7c5a578365d6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_68010d25-7883-4c58-b507-7c5a578365d6" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_68010d25-7883-4c58-b507-7c5a578365d6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_13cc9a1c-df56-4cba-88a5-c74e51111723" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_68010d25-7883-4c58-b507-7c5a578365d6" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_13cc9a1c-df56-4cba-88a5-c74e51111723" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EnicorMember_d2aa72f3-5c4f-4dad-914f-e9ea15a6497c" xlink:href="hae-20201226.xsd#hae_EnicorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_13cc9a1c-df56-4cba-88a5-c74e51111723" xlink:to="loc_hae_EnicorMember_d2aa72f3-5c4f-4dad-914f-e9ea15a6497c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_CardivaMember_dcf66604-f35f-476e-b5f9-4adf262a68a7" xlink:href="hae-20201226.xsd#hae_CardivaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_13cc9a1c-df56-4cba-88a5-c74e51111723" xlink:to="loc_hae_CardivaMember_dcf66604-f35f-476e-b5f9-4adf262a68a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_988d5221-cb26-44b2-af4f-bd300b031fb3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_98954cb8-bc12-4ee0-983d-65d97a4b7914" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_988d5221-cb26-44b2-af4f-bd300b031fb3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_988d5221-cb26-44b2-af4f-bd300b031fb3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_988d5221-cb26-44b2-af4f-bd300b031fb3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_988d5221-cb26-44b2-af4f-bd300b031fb3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_83e31946-d146-4d05-a41b-686614e98b2c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_988d5221-cb26-44b2-af4f-bd300b031fb3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_83e31946-d146-4d05-a41b-686614e98b2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_5f0ed48a-efbf-4c70-81fb-af2f78cf3887" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_83e31946-d146-4d05-a41b-686614e98b2c" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_5f0ed48a-efbf-4c70-81fb-af2f78cf3887" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_ebfe8116-b585-461f-a424-53f5a3bc22c9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_83e31946-d146-4d05-a41b-686614e98b2c" xlink:to="loc_us-gaap_CustomerRelationshipsMember_ebfe8116-b585-461f-a424-53f5a3bc22c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_5501e118-1124-4f4b-8038-645566c5f024" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_83e31946-d146-4d05-a41b-686614e98b2c" xlink:to="loc_us-gaap_TrademarksMember_5501e118-1124-4f4b-8038-645566c5f024" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_5d56e3f6-9134-46bf-8b4b-ff77ff036e2e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_98954cb8-bc12-4ee0-983d-65d97a4b7914" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_5d56e3f6-9134-46bf-8b4b-ff77ff036e2e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_5d56e3f6-9134-46bf-8b4b-ff77ff036e2e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_5d56e3f6-9134-46bf-8b4b-ff77ff036e2e" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_5d56e3f6-9134-46bf-8b4b-ff77ff036e2e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_e51aad8c-281d-4b78-8d9f-192acc3b705c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_5d56e3f6-9134-46bf-8b4b-ff77ff036e2e" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_e51aad8c-281d-4b78-8d9f-192acc3b705c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_c3a5141e-4b14-4b64-8c80-cc919ac9f51c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_e51aad8c-281d-4b78-8d9f-192acc3b705c" xlink:to="loc_us-gaap_SubsequentEventMember_c3a5141e-4b14-4b64-8c80-cc919ac9f51c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_AssetAcquisitionAxis_15dd029e-fb29-4ea1-bd17-f9161c61644f" xlink:href="hae-20201226.xsd#hae_AssetAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_98954cb8-bc12-4ee0-983d-65d97a4b7914" xlink:to="loc_hae_AssetAcquisitionAxis_15dd029e-fb29-4ea1-bd17-f9161c61644f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_AssetAcquisitionDomain_15dd029e-fb29-4ea1-bd17-f9161c61644f_default" xlink:href="hae-20201226.xsd#hae_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_hae_AssetAcquisitionAxis_15dd029e-fb29-4ea1-bd17-f9161c61644f" xlink:to="loc_hae_AssetAcquisitionDomain_15dd029e-fb29-4ea1-bd17-f9161c61644f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_AssetAcquisitionDomain_f081cc78-3783-4a4f-ba72-dde7afa8ca27" xlink:href="hae-20201226.xsd#hae_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_hae_AssetAcquisitionAxis_15dd029e-fb29-4ea1-bd17-f9161c61644f" xlink:to="loc_hae_AssetAcquisitionDomain_f081cc78-3783-4a4f-ba72-dde7afa8ca27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_HASIntellectualPropertyMember_28996d98-35f9-4633-bb88-eccb7955eab6" xlink:href="hae-20201226.xsd#hae_HASIntellectualPropertyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hae_AssetAcquisitionDomain_f081cc78-3783-4a4f-ba72-dde7afa8ca27" xlink:to="loc_hae_HASIntellectualPropertyMember_28996d98-35f9-4633-bb88-eccb7955eab6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/DIVESTITURE" xlink:type="simple" xlink:href="hae-20201226.xsd#DIVESTITURE"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/DIVESTITURE" xlink:type="extended" id="i1b5992814ef44696b1e8a56cbc6b9041_DIVESTITURE"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/DIVESTITUREDetails" xlink:type="simple" xlink:href="hae-20201226.xsd#DIVESTITUREDetails"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/DIVESTITUREDetails" xlink:type="extended" id="i2b284525bde84a6db7e73a1da4ae011f_DIVESTITUREDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_36d4d99a-ab58-4e68-aa75-614fb536266f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_a5ee4fef-7338-4d7b-b505-c187f98d48ca" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_36d4d99a-ab58-4e68-aa75-614fb536266f" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_a5ee4fef-7338-4d7b-b505-c187f98d48ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_7e16eb09-0ee7-4c6f-94b9-993a22d24efb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_36d4d99a-ab58-4e68-aa75-614fb536266f" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_7e16eb09-0ee7-4c6f-94b9-993a22d24efb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_de2553ac-cddd-48d0-b2f6-484bb990ccca" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_36d4d99a-ab58-4e68-aa75-614fb536266f" xlink:to="loc_us-gaap_AssetImpairmentCharges_de2553ac-cddd-48d0-b2f6-484bb990ccca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DisposalGroupNotDiscontinuedOperationsIncrementalLossOnClosingAdjustments_4cc9bac0-bded-4ad4-a472-4ee65fb8c778" xlink:href="hae-20201226.xsd#hae_DisposalGroupNotDiscontinuedOperationsIncrementalLossOnClosingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_36d4d99a-ab58-4e68-aa75-614fb536266f" xlink:to="loc_hae_DisposalGroupNotDiscontinuedOperationsIncrementalLossOnClosingAdjustments_4cc9bac0-bded-4ad4-a472-4ee65fb8c778" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DisposalGroupNotDiscontinuedOperationsExpectedCostToSell_c79c9ea9-bffa-41a9-be3f-ada4beba2fa4" xlink:href="hae-20201226.xsd#hae_DisposalGroupNotDiscontinuedOperationsExpectedCostToSell"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_36d4d99a-ab58-4e68-aa75-614fb536266f" xlink:to="loc_hae_DisposalGroupNotDiscontinuedOperationsExpectedCostToSell_c79c9ea9-bffa-41a9-be3f-ada4beba2fa4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_a05ecbc1-13ea-46b7-98b5-2a6a7380283b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_36d4d99a-ab58-4e68-aa75-614fb536266f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_a05ecbc1-13ea-46b7-98b5-2a6a7380283b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_a75017bb-b1a3-43cf-86c6-e273d0dde341" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_36d4d99a-ab58-4e68-aa75-614fb536266f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_a75017bb-b1a3-43cf-86c6-e273d0dde341" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_5ab18d75-350e-41d0-a1f4-b005d6f1f1a3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_36d4d99a-ab58-4e68-aa75-614fb536266f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_5ab18d75-350e-41d0-a1f4-b005d6f1f1a3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_2c5edfc5-853a-4804-8f99-2f08e6ef527d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_36d4d99a-ab58-4e68-aa75-614fb536266f" xlink:to="loc_us-gaap_Goodwill_2c5edfc5-853a-4804-8f99-2f08e6ef527d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_f6b99512-a34f-405e-8baf-7fecf32c08ed" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_36d4d99a-ab58-4e68-aa75-614fb536266f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_f6b99512-a34f-405e-8baf-7fecf32c08ed" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_8ba06b7e-7b2f-4198-9035-e823e704006f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_36d4d99a-ab58-4e68-aa75-614fb536266f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_8ba06b7e-7b2f-4198-9035-e823e704006f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_346c585f-6b6f-4dd2-ab2b-2505d3295d2f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_36d4d99a-ab58-4e68-aa75-614fb536266f" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_346c585f-6b6f-4dd2-ab2b-2505d3295d2f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_03fc00f9-f1b5-498b-a400-2139db0e8a41" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_36d4d99a-ab58-4e68-aa75-614fb536266f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_03fc00f9-f1b5-498b-a400-2139db0e8a41" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_d7b1ea5b-946e-4107-b278-4c464ee343c7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_36d4d99a-ab58-4e68-aa75-614fb536266f" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_d7b1ea5b-946e-4107-b278-4c464ee343c7" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_ee916f03-db97-4cbe-9c61-e69ae0558c32" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_36d4d99a-ab58-4e68-aa75-614fb536266f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_ee916f03-db97-4cbe-9c61-e69ae0558c32" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DisposalGroupIncludingDiscontinuedOperationConsiderationToBeReceived_3c36631f-3119-44b8-99c7-5200c9dd4010" xlink:href="hae-20201226.xsd#hae_DisposalGroupIncludingDiscontinuedOperationConsiderationToBeReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_36d4d99a-ab58-4e68-aa75-614fb536266f" xlink:to="loc_hae_DisposalGroupIncludingDiscontinuedOperationConsiderationToBeReceived_3c36631f-3119-44b8-99c7-5200c9dd4010" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_1e243146-5537-4dcb-9362-b9bf81b44ed2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_36d4d99a-ab58-4e68-aa75-614fb536266f" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_1e243146-5537-4dcb-9362-b9bf81b44ed2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_ab51096a-e465-4963-8236-26c9d51158d3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_1e243146-5537-4dcb-9362-b9bf81b44ed2" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_ab51096a-e465-4963-8236-26c9d51158d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ab51096a-e465-4963-8236-26c9d51158d3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_ab51096a-e465-4963-8236-26c9d51158d3" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ab51096a-e465-4963-8236-26c9d51158d3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c5bc8741-2117-40c2-bf31-a9dbb2ff18c2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_ab51096a-e465-4963-8236-26c9d51158d3" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c5bc8741-2117-40c2-bf31-a9dbb2ff18c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_FajardoPuertoRicoManufacturingOperationsMember_8c151440-a8c4-4129-bf36-780898b77ad3" xlink:href="hae-20201226.xsd#hae_FajardoPuertoRicoManufacturingOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c5bc8741-2117-40c2-bf31-a9dbb2ff18c2" xlink:to="loc_hae_FajardoPuertoRicoManufacturingOperationsMember_8c151440-a8c4-4129-bf36-780898b77ad3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_USBloodDonorManagementSoftwareMember_adcefcc7-2533-4bc5-95d6-d9ddd5c72a3a" xlink:href="hae-20201226.xsd#hae_USBloodDonorManagementSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c5bc8741-2117-40c2-bf31-a9dbb2ff18c2" xlink:to="loc_hae_USBloodDonorManagementSoftwareMember_adcefcc7-2533-4bc5-95d6-d9ddd5c72a3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_InlogHoldingsFranceMember_b6384b4e-8266-4398-a0da-1d2f58550a68" xlink:href="hae-20201226.xsd#hae_InlogHoldingsFranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c5bc8741-2117-40c2-bf31-a9dbb2ff18c2" xlink:to="loc_hae_InlogHoldingsFranceMember_b6384b4e-8266-4398-a0da-1d2f58550a68" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_4c69073d-a8de-4923-aca2-30197a6b730d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_1e243146-5537-4dcb-9362-b9bf81b44ed2" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_4c69073d-a8de-4923-aca2-30197a6b730d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_4c69073d-a8de-4923-aca2-30197a6b730d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_4c69073d-a8de-4923-aca2-30197a6b730d" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_4c69073d-a8de-4923-aca2-30197a6b730d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_a9798296-6b88-461f-9cd5-8978743c627a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_4c69073d-a8de-4923-aca2-30197a6b730d" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_a9798296-6b88-461f-9cd5-8978743c627a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_706948c3-12e1-40f9-b7d2-49ed72815e91" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_a9798296-6b88-461f-9cd5-8978743c627a" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_706948c3-12e1-40f9-b7d2-49ed72815e91" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_0d83f936-e742-4eaa-8dd9-c39810106028" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_1e243146-5537-4dcb-9362-b9bf81b44ed2" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_0d83f936-e742-4eaa-8dd9-c39810106028" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_0d83f936-e742-4eaa-8dd9-c39810106028_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_0d83f936-e742-4eaa-8dd9-c39810106028" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_0d83f936-e742-4eaa-8dd9-c39810106028_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_7b8f5a7a-c131-4e2b-9248-dcf4bd51cf21" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_0d83f936-e742-4eaa-8dd9-c39810106028" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_7b8f5a7a-c131-4e2b-9248-dcf4bd51cf21" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_fb7c1d30-580c-4bf0-a92e-ceb8df146c8c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_7b8f5a7a-c131-4e2b-9248-dcf4bd51cf21" xlink:to="loc_us-gaap_SubsequentEventMember_fb7c1d30-580c-4bf0-a92e-ceb8df146c8c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/INCOMETAXES" xlink:type="simple" xlink:href="hae-20201226.xsd#INCOMETAXES"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/INCOMETAXES" xlink:type="extended" id="i9c49528a4ad54ee484ee8afd8cf3667c_INCOMETAXES"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/INCOMETAXESDetails" xlink:type="simple" xlink:href="hae-20201226.xsd#INCOMETAXESDetails"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/INCOMETAXESDetails" xlink:type="extended" id="i1e7c3134469a401bbc211d070c6a2a4b_INCOMETAXESDetails"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/EARNINGSPERSHAREEPS" xlink:type="simple" xlink:href="hae-20201226.xsd#EARNINGSPERSHAREEPS"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/EARNINGSPERSHAREEPS" xlink:type="extended" id="icabb521c853c4f6bb8a4314219822c86_EARNINGSPERSHAREEPS"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/EARNINGSPERSHAREEPSTables" xlink:type="simple" xlink:href="hae-20201226.xsd#EARNINGSPERSHAREEPSTables"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/EARNINGSPERSHAREEPSTables" xlink:type="extended" id="i01278ff127314c2998af014e67c10e24_EARNINGSPERSHAREEPSTables"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/EARNINGSPERSHAREEPSScheduleofEarningsPerShareReconciliationDetails" xlink:type="simple" xlink:href="hae-20201226.xsd#EARNINGSPERSHAREEPSScheduleofEarningsPerShareReconciliationDetails"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/EARNINGSPERSHAREEPSScheduleofEarningsPerShareReconciliationDetails" xlink:type="extended" id="i6ccf0ee396eb4be18dfa5e0e3da41afb_EARNINGSPERSHAREEPSScheduleofEarningsPerShareReconciliationDetails"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/REVENUE" xlink:type="simple" xlink:href="hae-20201226.xsd#REVENUE"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/REVENUE" xlink:type="extended" id="i3762fd4fd5274a1282bd8292fda4ec71_REVENUE"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/REVENUEDetails" xlink:type="simple" xlink:href="hae-20201226.xsd#REVENUEDetails"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/REVENUEDetails" xlink:type="extended" id="ib7f285d1c10141a8b17d7d2d38dde7b6_REVENUEDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_ef6c35d5-0d8d-499b-9423-4b5bb9be8c77" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_0b8ad975-a92c-422a-b7b6-56b9536e266e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_ef6c35d5-0d8d-499b-9423-4b5bb9be8c77" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_0b8ad975-a92c-422a-b7b6-56b9536e266e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_14fc84e4-c1ec-4a6c-9801-8c175684530d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_ef6c35d5-0d8d-499b-9423-4b5bb9be8c77" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_14fc84e4-c1ec-4a6c-9801-8c175684530d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_4a9e7cd9-038f-47a2-88ff-a65d8280ed9e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_14fc84e4-c1ec-4a6c-9801-8c175684530d" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_4a9e7cd9-038f-47a2-88ff-a65d8280ed9e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/REVENUEDetails_1" xlink:type="simple" xlink:href="hae-20201226.xsd#REVENUEDetails_1"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/REVENUEDetails_1" xlink:type="extended" id="i0fbd6c15e3614599a1dbd0022b50d8d1_REVENUEDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_ef6c35d5-0d8d-499b-9423-4b5bb9be8c77" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_0b8ad975-a92c-422a-b7b6-56b9536e266e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_ef6c35d5-0d8d-499b-9423-4b5bb9be8c77" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_0b8ad975-a92c-422a-b7b6-56b9536e266e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_14fc84e4-c1ec-4a6c-9801-8c175684530d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_ef6c35d5-0d8d-499b-9423-4b5bb9be8c77" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_14fc84e4-c1ec-4a6c-9801-8c175684530d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/INVENTORIES" xlink:type="simple" xlink:href="hae-20201226.xsd#INVENTORIES"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/INVENTORIES" xlink:type="extended" id="ide84e2fea2bd4f50880839a30301cb96_INVENTORIES"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/INVENTORIESTables" xlink:type="simple" xlink:href="hae-20201226.xsd#INVENTORIESTables"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/INVENTORIESTables" xlink:type="extended" id="i4bee45464763463ba14a784b595b668a_INVENTORIESTables"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/INVENTORIESScheduleofInventoriesDetails" xlink:type="simple" xlink:href="hae-20201226.xsd#INVENTORIESScheduleofInventoriesDetails"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/INVENTORIESScheduleofInventoriesDetails" xlink:type="extended" id="if5c3cc9f04b14c2f86dbfd1716264cfe_INVENTORIESScheduleofInventoriesDetails"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/LEASES" xlink:type="simple" xlink:href="hae-20201226.xsd#LEASES"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/LEASES" xlink:type="extended" id="i69c29bbb627b4036b6a3f8bd96a83cf6_LEASES"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/LEASESDetails" xlink:type="simple" xlink:href="hae-20201226.xsd#LEASESDetails"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/LEASESDetails" xlink:type="extended" id="ieff2ea13a2ed4c4eb450204ca3d4b904_LEASESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_fe543621-760d-4e5e-865e-38a1e267b560" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_1180e0ba-20ec-40cf-8b15-b8f45281c744" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fe543621-760d-4e5e-865e-38a1e267b560" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_1180e0ba-20ec-40cf-8b15-b8f45281c744" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_655a2c52-67c9-4679-8c6b-5f768b439495" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fe543621-760d-4e5e-865e-38a1e267b560" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_655a2c52-67c9-4679-8c6b-5f768b439495" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_2f96f6d9-27f9-4057-afd1-81c6b75a876c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fe543621-760d-4e5e-865e-38a1e267b560" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_2f96f6d9-27f9-4057-afd1-81c6b75a876c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_dd71f9ce-1544-42f9-9ca8-81338893729a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fe543621-760d-4e5e-865e-38a1e267b560" xlink:to="loc_us-gaap_OperatingLeaseLiability_dd71f9ce-1544-42f9-9ca8-81338893729a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_711dba16-b8a6-41ec-b3c9-504a381f0848" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fe543621-760d-4e5e-865e-38a1e267b560" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_711dba16-b8a6-41ec-b3c9-504a381f0848" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_0647b524-1ed5-4d0e-97ff-532ca068f3ab" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fe543621-760d-4e5e-865e-38a1e267b560" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_0647b524-1ed5-4d0e-97ff-532ca068f3ab" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_75d58ef6-e069-44b0-b0e4-6034ae1bd341" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_0647b524-1ed5-4d0e-97ff-532ca068f3ab" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_75d58ef6-e069-44b0-b0e4-6034ae1bd341" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_75d58ef6-e069-44b0-b0e4-6034ae1bd341_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_75d58ef6-e069-44b0-b0e4-6034ae1bd341" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_75d58ef6-e069-44b0-b0e4-6034ae1bd341_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_256ae936-5931-4447-a5e4-0525ca18abc6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_75d58ef6-e069-44b0-b0e4-6034ae1bd341" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_256ae936-5931-4447-a5e4-0525ca18abc6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_ManufacturingSpaceMember_3c8d99c7-6ff6-45ef-86ed-dc9d7b46c5b9" xlink:href="hae-20201226.xsd#hae_ManufacturingSpaceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_256ae936-5931-4447-a5e4-0525ca18abc6" xlink:to="loc_hae_ManufacturingSpaceMember_3c8d99c7-6ff6-45ef-86ed-dc9d7b46c5b9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_ManufacturingSpaceSecondRenewalTermMember_81a8b198-9ce3-4ff4-a574-ddcead797bb6" xlink:href="hae-20201226.xsd#hae_ManufacturingSpaceSecondRenewalTermMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_256ae936-5931-4447-a5e4-0525ca18abc6" xlink:to="loc_hae_ManufacturingSpaceSecondRenewalTermMember_81a8b198-9ce3-4ff4-a574-ddcead797bb6" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBT" xlink:type="simple" xlink:href="hae-20201226.xsd#NOTESPAYABLEANDLONGTERMDEBT"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBT" xlink:type="extended" id="i7141292a262841d08c0d45da52a76d9e_NOTESPAYABLEANDLONGTERMDEBT"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTDetails" xlink:type="simple" xlink:href="hae-20201226.xsd#NOTESPAYABLEANDLONGTERMDEBTDetails"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTDetails" xlink:type="extended" id="i4f0d5116c0a049da820d4cce6c4f9079_NOTESPAYABLEANDLONGTERMDEBTDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_59800d62-3d7a-4f6d-81cb-0c8a3e570f5c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_eb46fda6-83bf-4371-9bb1-2037a97cd746" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_59800d62-3d7a-4f6d-81cb-0c8a3e570f5c" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_eb46fda6-83bf-4371-9bb1-2037a97cd746" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_add0667b-9d96-496e-87d3-842841622b09" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_59800d62-3d7a-4f6d-81cb-0c8a3e570f5c" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_add0667b-9d96-496e-87d3-842841622b09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_2de3b621-2a23-42e6-a7ea-d6b0f1d9ad8e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_59800d62-3d7a-4f6d-81cb-0c8a3e570f5c" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_2de3b621-2a23-42e6-a7ea-d6b0f1d9ad8e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_6276a79e-f8ce-417a-9a89-5fb3de2cb863" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_59800d62-3d7a-4f6d-81cb-0c8a3e570f5c" xlink:to="loc_us-gaap_LongTermDebt_6276a79e-f8ce-417a-9a89-5fb3de2cb863" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_cda3cccd-a668-47e8-a45a-1582b9787832" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_59800d62-3d7a-4f6d-81cb-0c8a3e570f5c" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_cda3cccd-a668-47e8-a45a-1582b9787832" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_b79e3ddf-78b4-4020-85bf-e05ceebb2e19" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_59800d62-3d7a-4f6d-81cb-0c8a3e570f5c" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_b79e3ddf-78b4-4020-85bf-e05ceebb2e19" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_5e39c26a-767c-4917-ab53-85931059560f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_59800d62-3d7a-4f6d-81cb-0c8a3e570f5c" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_5e39c26a-767c-4917-ab53-85931059560f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_44c57621-c5eb-4a0e-8a70-403205a33009" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_59800d62-3d7a-4f6d-81cb-0c8a3e570f5c" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_44c57621-c5eb-4a0e-8a70-403205a33009" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_1619afd8-2492-4a82-9720-f16a9b7e0aef" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_59800d62-3d7a-4f6d-81cb-0c8a3e570f5c" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_1619afd8-2492-4a82-9720-f16a9b7e0aef" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_e0add28a-efac-4171-affe-3fdcd1e2e7c9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_59800d62-3d7a-4f6d-81cb-0c8a3e570f5c" xlink:to="loc_us-gaap_DebtInstrumentTable_e0add28a-efac-4171-affe-3fdcd1e2e7c9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_0097a92e-3144-49e4-be99-e9d37a9ed904" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e0add28a-efac-4171-affe-3fdcd1e2e7c9" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_0097a92e-3144-49e4-be99-e9d37a9ed904" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_0097a92e-3144-49e4-be99-e9d37a9ed904_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_0097a92e-3144-49e4-be99-e9d37a9ed904" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_0097a92e-3144-49e4-be99-e9d37a9ed904_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_ccb6c9d2-c448-4b6a-a5d6-ccefe4ecf892" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_0097a92e-3144-49e4-be99-e9d37a9ed904" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_ccb6c9d2-c448-4b6a-a5d6-ccefe4ecf892" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_7ff10cc3-cd2b-450a-b5fa-da4ef572be3d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_ccb6c9d2-c448-4b6a-a5d6-ccefe4ecf892" xlink:to="loc_us-gaap_LongTermDebtMember_7ff10cc3-cd2b-450a-b5fa-da4ef572be3d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember_133b0826-dc85-4b6d-9535-01e637333f14" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MediumTermNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtMember_7ff10cc3-cd2b-450a-b5fa-da4ef572be3d" xlink:to="loc_us-gaap_MediumTermNotesMember_133b0826-dc85-4b6d-9535-01e637333f14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_3eef0573-1e1d-4aa5-baa2-fb27b3a9771e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtMember_7ff10cc3-cd2b-450a-b5fa-da4ef572be3d" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_3eef0573-1e1d-4aa5-baa2-fb27b3a9771e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_71605c0e-34d8-48d3-98e5-e4d09ebd6c88" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtMember_7ff10cc3-cd2b-450a-b5fa-da4ef572be3d" xlink:to="loc_us-gaap_LineOfCreditMember_71605c0e-34d8-48d3-98e5-e4d09ebd6c88" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_028c57d7-5d83-4908-9991-35358e1cc8e5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e0add28a-efac-4171-affe-3fdcd1e2e7c9" xlink:to="loc_us-gaap_VariableRateAxis_028c57d7-5d83-4908-9991-35358e1cc8e5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_028c57d7-5d83-4908-9991-35358e1cc8e5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_028c57d7-5d83-4908-9991-35358e1cc8e5" xlink:to="loc_us-gaap_VariableRateDomain_028c57d7-5d83-4908-9991-35358e1cc8e5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_dac890b6-65ee-4024-8d7f-115755282cbc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_028c57d7-5d83-4908-9991-35358e1cc8e5" xlink:to="loc_us-gaap_VariableRateDomain_dac890b6-65ee-4024-8d7f-115755282cbc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_90b22c7a-7439-4670-ab49-c07c4f62706a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_dac890b6-65ee-4024-8d7f-115755282cbc" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_90b22c7a-7439-4670-ab49-c07c4f62706a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d7206e70-49fa-4bae-8a1b-39b29cf62623" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e0add28a-efac-4171-affe-3fdcd1e2e7c9" xlink:to="loc_srt_RangeAxis_d7206e70-49fa-4bae-8a1b-39b29cf62623" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d7206e70-49fa-4bae-8a1b-39b29cf62623_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_d7206e70-49fa-4bae-8a1b-39b29cf62623" xlink:to="loc_srt_RangeMember_d7206e70-49fa-4bae-8a1b-39b29cf62623_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0957b6da-0a20-4685-9ad5-442f76aa85b6" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_d7206e70-49fa-4bae-8a1b-39b29cf62623" xlink:to="loc_srt_RangeMember_0957b6da-0a20-4685-9ad5-442f76aa85b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_5313734f-ef99-4c82-868c-12c1a087dcbd" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_0957b6da-0a20-4685-9ad5-442f76aa85b6" xlink:to="loc_srt_MinimumMember_5313734f-ef99-4c82-868c-12c1a087dcbd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4cead233-63d4-4954-9b75-fcdbcc821999" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_0957b6da-0a20-4685-9ad5-442f76aa85b6" xlink:to="loc_srt_MaximumMember_4cead233-63d4-4954-9b75-fcdbcc821999" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAxis_7c54f8f6-2d01-4b28-a6f7-323a6b8be587" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ExtinguishmentOfDebtAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e0add28a-efac-4171-affe-3fdcd1e2e7c9" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAxis_7c54f8f6-2d01-4b28-a6f7-323a6b8be587" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_7c54f8f6-2d01-4b28-a6f7-323a6b8be587_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAxis_7c54f8f6-2d01-4b28-a6f7-323a6b8be587" xlink:to="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_7c54f8f6-2d01-4b28-a6f7-323a6b8be587_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_31cf45fd-24a6-48a0-a076-90713f1cb959" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAxis_7c54f8f6-2d01-4b28-a6f7-323a6b8be587" xlink:to="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_31cf45fd-24a6-48a0-a076-90713f1cb959" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_a7f2f3ac-e0b8-4521-95e0-aaeb7c0b17c5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_31cf45fd-24a6-48a0-a076-90713f1cb959" xlink:to="loc_us-gaap_LongTermDebtMember_a7f2f3ac-e0b8-4521-95e0-aaeb7c0b17c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember_11b811b3-f22b-4791-935d-6a79cf49d9cc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MediumTermNotesMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_21d96463-d586-44ee-97ec-f156557e1209" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_bb55f6f8-fccf-423b-8f85-d09b2198efe9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_b77f0ff9-fb6f-4426-8a07-0ccb357b0be8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e0add28a-efac-4171-affe-3fdcd1e2e7c9" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_b77f0ff9-fb6f-4426-8a07-0ccb357b0be8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_b77f0ff9-fb6f-4426-8a07-0ccb357b0be8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_b77f0ff9-fb6f-4426-8a07-0ccb357b0be8" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_b77f0ff9-fb6f-4426-8a07-0ccb357b0be8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_a14e8238-c204-4721-876e-d31e40e5459a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_b77f0ff9-fb6f-4426-8a07-0ccb357b0be8" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_a14e8238-c204-4721-876e-d31e40e5459a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_cb2c119c-8ab0-4fbf-9e77-3c9a0101f3bd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_a14e8238-c204-4721-876e-d31e40e5459a" xlink:to="loc_us-gaap_SubsequentEventMember_cb2c119c-8ab0-4fbf-9e77-3c9a0101f3bd" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURES" xlink:type="simple" xlink:href="hae-20201226.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASURES"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURES" xlink:type="extended" id="i479f69e7a71742e4a4fdfe47acd03bdb_FINANCIALINSTRUMENTSANDFAIRVALUEMEASURES"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESTables" xlink:type="simple" xlink:href="hae-20201226.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESTables"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESTables" xlink:type="extended" id="i6f845d914082460c8a816686bf355537_FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESTables"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAllowanceforcreditlossesDetails" xlink:type="simple" xlink:href="hae-20201226.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAllowanceforcreditlossesDetails"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAllowanceforcreditlossesDetails" xlink:type="extended" id="iaa1e4bbc569c47f6987f24acc7ec327c_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAllowanceforcreditlossesDetails"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails" xlink:type="simple" xlink:href="hae-20201226.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails" xlink:type="extended" id="iee55e742ea8f4b7ab35d3426202fedb2_FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6603fa1a-0b5c-412a-ac20-cff548b3b18c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_67cbdaf4-73c5-4722-b22f-f34616bdaca6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6603fa1a-0b5c-412a-ac20-cff548b3b18c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_67cbdaf4-73c5-4722-b22f-f34616bdaca6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_d75f4615-a0ff-4c65-9b83-a4c8a7b36110" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6603fa1a-0b5c-412a-ac20-cff548b3b18c" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_d75f4615-a0ff-4c65-9b83-a4c8a7b36110" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet_38eb7249-6a53-4d71-8a39-4a420e8f0bf3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6603fa1a-0b5c-412a-ac20-cff548b3b18c" xlink:to="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet_38eb7249-6a53-4d71-8a39-4a420e8f0bf3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_677fa7e5-7116-4957-98be-0d4d197097eb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6603fa1a-0b5c-412a-ac20-cff548b3b18c" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_677fa7e5-7116-4957-98be-0d4d197097eb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_93b74f35-dee0-4e27-95f0-e549a2030cdd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_677fa7e5-7116-4957-98be-0d4d197097eb" xlink:to="loc_us-gaap_HedgingDesignationAxis_93b74f35-dee0-4e27-95f0-e549a2030cdd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_93b74f35-dee0-4e27-95f0-e549a2030cdd_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_93b74f35-dee0-4e27-95f0-e549a2030cdd" xlink:to="loc_us-gaap_HedgingDesignationDomain_93b74f35-dee0-4e27-95f0-e549a2030cdd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_096ebaee-5b79-4833-a1cb-acb0fe175a9b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_93b74f35-dee0-4e27-95f0-e549a2030cdd" xlink:to="loc_us-gaap_HedgingDesignationDomain_096ebaee-5b79-4833-a1cb-acb0fe175a9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_cb72f676-99c6-4e64-8301-d73e5fc34a91" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_096ebaee-5b79-4833-a1cb-acb0fe175a9b" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_cb72f676-99c6-4e64-8301-d73e5fc34a91" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_68e933d8-fbf4-4382-a144-89fded2e57f7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_096ebaee-5b79-4833-a1cb-acb0fe175a9b" xlink:to="loc_us-gaap_NondesignatedMember_68e933d8-fbf4-4382-a144-89fded2e57f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_c8588da3-6904-4c57-907b-46c80b280db2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_677fa7e5-7116-4957-98be-0d4d197097eb" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_c8588da3-6904-4c57-907b-46c80b280db2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_c8588da3-6904-4c57-907b-46c80b280db2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_c8588da3-6904-4c57-907b-46c80b280db2" xlink:to="loc_us-gaap_HedgingRelationshipDomain_c8588da3-6904-4c57-907b-46c80b280db2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_cad6352e-faa7-4546-b5c3-a0e402b4dc44" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_c8588da3-6904-4c57-907b-46c80b280db2" xlink:to="loc_us-gaap_HedgingRelationshipDomain_cad6352e-faa7-4546-b5c3-a0e402b4dc44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_9ea356f0-8e45-4cb6-983f-da08279dd059" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_cad6352e-faa7-4546-b5c3-a0e402b4dc44" xlink:to="loc_us-gaap_CashFlowHedgingMember_9ea356f0-8e45-4cb6-983f-da08279dd059" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_962cf01f-6c38-421a-9159-f05898aa4aa8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_cad6352e-faa7-4546-b5c3-a0e402b4dc44" xlink:to="loc_us-gaap_InterestRateSwapMember_962cf01f-6c38-421a-9159-f05898aa4aa8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_4694a744-f889-46af-bf38-5efd5b55d38e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_677fa7e5-7116-4957-98be-0d4d197097eb" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_4694a744-f889-46af-bf38-5efd5b55d38e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_4694a744-f889-46af-bf38-5efd5b55d38e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4694a744-f889-46af-bf38-5efd5b55d38e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_4694a744-f889-46af-bf38-5efd5b55d38e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f9aa7d99-422d-4153-9bb5-e94f2b25c6e4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4694a744-f889-46af-bf38-5efd5b55d38e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f9aa7d99-422d-4153-9bb5-e94f2b25c6e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_613991ba-a159-45eb-bd00-2cfc3585cf00" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f9aa7d99-422d-4153-9bb5-e94f2b25c6e4" xlink:to="loc_us-gaap_ForeignExchangeContractMember_613991ba-a159-45eb-bd00-2cfc3585cf00" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_29683312-0d70-408a-8415-2829056233f5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_677fa7e5-7116-4957-98be-0d4d197097eb" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_29683312-0d70-408a-8415-2829056233f5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_29683312-0d70-408a-8415-2829056233f5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_29683312-0d70-408a-8415-2829056233f5" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_29683312-0d70-408a-8415-2829056233f5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_d321bd06-bee4-4701-a891-1799694a8545" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_29683312-0d70-408a-8415-2829056233f5" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_d321bd06-bee4-4701-a891-1799694a8545" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_NetRevenuesCostOfGoodsSoldAndSellingGeneralAndAdministrativeExpenseMember_546b82b4-402e-4bef-bd98-b45e4ad1be2d" xlink:href="hae-20201226.xsd#hae_NetRevenuesCostOfGoodsSoldAndSellingGeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d321bd06-bee4-4701-a891-1799694a8545" xlink:to="loc_hae_NetRevenuesCostOfGoodsSoldAndSellingGeneralAndAdministrativeExpenseMember_546b82b4-402e-4bef-bd98-b45e4ad1be2d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_OtherIncomeExpenseNetMember_a9758848-33c6-4cf5-bdf7-deb85cc8dc10" xlink:href="hae-20201226.xsd#hae_OtherIncomeExpenseNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d321bd06-bee4-4701-a891-1799694a8545" xlink:to="loc_hae_OtherIncomeExpenseNetMember_a9758848-33c6-4cf5-bdf7-deb85cc8dc10" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESSchedulesofDerivativesDetails" xlink:type="simple" xlink:href="hae-20201226.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESSchedulesofDerivativesDetails"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESSchedulesofDerivativesDetails" xlink:type="extended" id="i2831ae4813f9475e92a22d27050723a6_FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESSchedulesofDerivativesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ba768439-7dcb-4202-82c8-024d1d9ba05f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_a47e0d75-6038-4665-9aaf-b9ad737e93d8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ba768439-7dcb-4202-82c8-024d1d9ba05f" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_a47e0d75-6038-4665-9aaf-b9ad737e93d8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_397a3ba1-4516-48b3-8caf-964814a9a3c0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_a47e0d75-6038-4665-9aaf-b9ad737e93d8" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_397a3ba1-4516-48b3-8caf-964814a9a3c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_6412a815-48fb-4b22-84d7-2e6b91e71e3e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_a47e0d75-6038-4665-9aaf-b9ad737e93d8" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_6412a815-48fb-4b22-84d7-2e6b91e71e3e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_eff67284-bb90-4220-95e7-390883dd18fe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_a47e0d75-6038-4665-9aaf-b9ad737e93d8" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_eff67284-bb90-4220-95e7-390883dd18fe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_e46c2d3a-fa96-445a-a5a0-01afcba33963" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ba768439-7dcb-4202-82c8-024d1d9ba05f" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_e46c2d3a-fa96-445a-a5a0-01afcba33963" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_ff6ed0a8-0113-4406-8839-20a155ae9a79" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_e46c2d3a-fa96-445a-a5a0-01afcba33963" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_ff6ed0a8-0113-4406-8839-20a155ae9a79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_c4a776f4-7990-4b0d-927b-fc935bde61b6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_e46c2d3a-fa96-445a-a5a0-01afcba33963" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_c4a776f4-7990-4b0d-927b-fc935bde61b6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_7d2a51fb-1487-4c18-9de9-e398c9499107" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ba768439-7dcb-4202-82c8-024d1d9ba05f" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_7d2a51fb-1487-4c18-9de9-e398c9499107" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_33505315-9905-4c91-b582-a1d0558264e4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ba768439-7dcb-4202-82c8-024d1d9ba05f" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_33505315-9905-4c91-b582-a1d0558264e4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d1ff66c9-6e38-4f39-94db-a555801aba38" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_33505315-9905-4c91-b582-a1d0558264e4" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d1ff66c9-6e38-4f39-94db-a555801aba38" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_d1ff66c9-6e38-4f39-94db-a555801aba38_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d1ff66c9-6e38-4f39-94db-a555801aba38" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_d1ff66c9-6e38-4f39-94db-a555801aba38_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_ce11dd19-61ef-4ce8-9a06-a14e0846c370" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d1ff66c9-6e38-4f39-94db-a555801aba38" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_ce11dd19-61ef-4ce8-9a06-a14e0846c370" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_3c740d8d-2692-4e40-9b57-74f6cf06dafb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_ce11dd19-61ef-4ce8-9a06-a14e0846c370" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_3c740d8d-2692-4e40-9b57-74f6cf06dafb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f9efe0c2-eb1a-4b7c-9f95-07de1822530e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_33505315-9905-4c91-b582-a1d0558264e4" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f9efe0c2-eb1a-4b7c-9f95-07de1822530e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f9efe0c2-eb1a-4b7c-9f95-07de1822530e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f9efe0c2-eb1a-4b7c-9f95-07de1822530e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f9efe0c2-eb1a-4b7c-9f95-07de1822530e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_0c7fea24-2b9c-4eba-b0b2-2ad6a7bcdd93" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f9efe0c2-eb1a-4b7c-9f95-07de1822530e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_0c7fea24-2b9c-4eba-b0b2-2ad6a7bcdd93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_c5f89e0c-7d48-4cfe-b2a4-ec28dab26b51" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0c7fea24-2b9c-4eba-b0b2-2ad6a7bcdd93" xlink:to="loc_us-gaap_ForeignExchangeContractMember_c5f89e0c-7d48-4cfe-b2a4-ec28dab26b51" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_93c9d520-a87f-49cd-81bd-e9ae7999281c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0c7fea24-2b9c-4eba-b0b2-2ad6a7bcdd93" xlink:to="loc_us-gaap_InterestRateSwapMember_93c9d520-a87f-49cd-81bd-e9ae7999281c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_ContingentConsiderationMember_580fd43a-e30b-401e-a24d-b74b5244fee4" xlink:href="hae-20201226.xsd#hae_ContingentConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0c7fea24-2b9c-4eba-b0b2-2ad6a7bcdd93" xlink:to="loc_hae_ContingentConsiderationMember_580fd43a-e30b-401e-a24d-b74b5244fee4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_44b36215-3c20-4c9e-bb79-2e7e9096542e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_33505315-9905-4c91-b582-a1d0558264e4" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_44b36215-3c20-4c9e-bb79-2e7e9096542e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_44b36215-3c20-4c9e-bb79-2e7e9096542e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_44b36215-3c20-4c9e-bb79-2e7e9096542e" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_44b36215-3c20-4c9e-bb79-2e7e9096542e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_6246f256-1a65-4e8a-a49f-59c2986c1dc3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_44b36215-3c20-4c9e-bb79-2e7e9096542e" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_6246f256-1a65-4e8a-a49f-59c2986c1dc3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember_9497043f-7ad6-4548-8533-971483fdca59" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6246f256-1a65-4e8a-a49f-59c2986c1dc3" xlink:to="loc_us-gaap_OtherCurrentAssetsMember_9497043f-7ad6-4548-8533-971483fdca59" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_deb0012e-6b7b-4ecf-8f0c-a6d3924026e4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6246f256-1a65-4e8a-a49f-59c2986c1dc3" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_deb0012e-6b7b-4ecf-8f0c-a6d3924026e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_6dcf15fe-1f3a-4653-91c4-39f8fd079384" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6246f256-1a65-4e8a-a49f-59c2986c1dc3" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_6dcf15fe-1f3a-4653-91c4-39f8fd079384" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_e9387925-5ddc-4893-bf48-a86bc4f2937b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_33505315-9905-4c91-b582-a1d0558264e4" xlink:to="loc_us-gaap_HedgingDesignationAxis_e9387925-5ddc-4893-bf48-a86bc4f2937b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_e9387925-5ddc-4893-bf48-a86bc4f2937b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_e9387925-5ddc-4893-bf48-a86bc4f2937b" xlink:to="loc_us-gaap_HedgingDesignationDomain_e9387925-5ddc-4893-bf48-a86bc4f2937b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_4c1d785e-f2fc-4992-a08f-c5140035b095" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_e9387925-5ddc-4893-bf48-a86bc4f2937b" xlink:to="loc_us-gaap_HedgingDesignationDomain_4c1d785e-f2fc-4992-a08f-c5140035b095" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_b950d3cc-bb11-4ac0-877f-6689c51e5a54" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_4c1d785e-f2fc-4992-a08f-c5140035b095" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_b950d3cc-bb11-4ac0-877f-6689c51e5a54" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_e8e4ab9e-602a-43ec-93ff-3c44b4fcc532" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_4c1d785e-f2fc-4992-a08f-c5140035b095" xlink:to="loc_us-gaap_NondesignatedMember_e8e4ab9e-602a-43ec-93ff-3c44b4fcc532" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ec5dc463-12fd-43b2-aa32-2bf09218bf22" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_33505315-9905-4c91-b582-a1d0558264e4" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ec5dc463-12fd-43b2-aa32-2bf09218bf22" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ec5dc463-12fd-43b2-aa32-2bf09218bf22_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ec5dc463-12fd-43b2-aa32-2bf09218bf22" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ec5dc463-12fd-43b2-aa32-2bf09218bf22_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fb07f4d8-8491-410e-890a-cec59c16d3f0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ec5dc463-12fd-43b2-aa32-2bf09218bf22" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fb07f4d8-8491-410e-890a-cec59c16d3f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_73c31abd-b12d-4483-91a0-664455c57f8c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fb07f4d8-8491-410e-890a-cec59c16d3f0" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_73c31abd-b12d-4483-91a0-664455c57f8c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_4d3e61da-2d5a-46ed-a5a0-89eeb89ab1da" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fb07f4d8-8491-410e-890a-cec59c16d3f0" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_4d3e61da-2d5a-46ed-a5a0-89eeb89ab1da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_fd5026df-8b2b-4e20-a865-f2037ca7b9b3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fb07f4d8-8491-410e-890a-cec59c16d3f0" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_fd5026df-8b2b-4e20-a865-f2037ca7b9b3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_adbab90a-2430-4984-91a3-6c5a65049491" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_33505315-9905-4c91-b582-a1d0558264e4" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_adbab90a-2430-4984-91a3-6c5a65049491" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_adbab90a-2430-4984-91a3-6c5a65049491_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_adbab90a-2430-4984-91a3-6c5a65049491" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_adbab90a-2430-4984-91a3-6c5a65049491_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_79676504-9f42-4b6c-ad92-1f5c5d5a528d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_adbab90a-2430-4984-91a3-6c5a65049491" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_79676504-9f42-4b6c-ad92-1f5c5d5a528d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_RegulatoryBasedPaymentsMember_2dda8dba-e4fb-4bfa-8ca2-bd576c954a21" xlink:href="hae-20201226.xsd#hae_RegulatoryBasedPaymentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_79676504-9f42-4b6c-ad92-1f5c5d5a528d" xlink:to="loc_hae_RegulatoryBasedPaymentsMember_2dda8dba-e4fb-4bfa-8ca2-bd576c954a21" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_RevenueBasedPaymentsMember_45bddd1d-422c-4a31-98b8-e1c8c9a0ff18" xlink:href="hae-20201226.xsd#hae_RevenueBasedPaymentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_79676504-9f42-4b6c-ad92-1f5c5d5a528d" xlink:to="loc_hae_RevenueBasedPaymentsMember_45bddd1d-422c-4a31-98b8-e1c8c9a0ff18" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_c961bb98-8895-44fd-bfc0-d1eef723fb8b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_33505315-9905-4c91-b582-a1d0558264e4" xlink:to="loc_us-gaap_ValuationTechniqueAxis_c961bb98-8895-44fd-bfc0-d1eef723fb8b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_c961bb98-8895-44fd-bfc0-d1eef723fb8b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationTechniqueAxis_c961bb98-8895-44fd-bfc0-d1eef723fb8b" xlink:to="loc_us-gaap_ValuationTechniqueDomain_c961bb98-8895-44fd-bfc0-d1eef723fb8b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_cb3901f8-0b2e-46f4-8d1b-ee74df9fa8ea" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationTechniqueAxis_c961bb98-8895-44fd-bfc0-d1eef723fb8b" xlink:to="loc_us-gaap_ValuationTechniqueDomain_cb3901f8-0b2e-46f4-8d1b-ee74df9fa8ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_67e21594-2bd7-4719-b438-8ca51043d71e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationTechniqueDomain_cb3901f8-0b2e-46f4-8d1b-ee74df9fa8ea" xlink:to="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_67e21594-2bd7-4719-b438-8ca51043d71e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails" xlink:type="simple" xlink:href="hae-20201226.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails" xlink:type="extended" id="i04b1e9bbab7042e588d908f84fa3c5ce_FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_0d7c0f4f-59d4-4631-a724-d6a7ea9592f3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_PercentageOfNetSalesGeneratedOutsideOfUs_e284ef7b-a1a6-44df-a4bf-7d2eeca60ef2" xlink:href="hae-20201226.xsd#hae_PercentageOfNetSalesGeneratedOutsideOfUs"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_0d7c0f4f-59d4-4631-a724-d6a7ea9592f3" xlink:to="loc_hae_PercentageOfNetSalesGeneratedOutsideOfUs_e284ef7b-a1a6-44df-a4bf-7d2eeca60ef2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AverageRemainingMaturityOfForeignCurrencyDerivatives1_124838db-77c9-416e-b1f1-6c208790d966" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AverageRemainingMaturityOfForeignCurrencyDerivatives1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_0d7c0f4f-59d4-4631-a724-d6a7ea9592f3" xlink:to="loc_us-gaap_AverageRemainingMaturityOfForeignCurrencyDerivatives1_124838db-77c9-416e-b1f1-6c208790d966" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet_aaac7b1d-53b6-43a6-bbc1-ca71de568ab9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_0d7c0f4f-59d4-4631-a724-d6a7ea9592f3" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet_aaac7b1d-53b6-43a6-bbc1-ca71de568ab9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_171069cc-191e-4401-aeef-1b5afd4bf37f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_0d7c0f4f-59d4-4631-a724-d6a7ea9592f3" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_171069cc-191e-4401-aeef-1b5afd4bf37f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet_418ed34c-0ff1-4123-bb90-9c731efaa4fd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_0d7c0f4f-59d4-4631-a724-d6a7ea9592f3" xlink:to="loc_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet_418ed34c-0ff1-4123-bb90-9c731efaa4fd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_2548fd75-d62b-487d-a8b3-9b2a64b2e103" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_0d7c0f4f-59d4-4631-a724-d6a7ea9592f3" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_2548fd75-d62b-487d-a8b3-9b2a64b2e103" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_1ce3cc67-d25c-4056-9fdc-fc8cb79e9cee" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_0d7c0f4f-59d4-4631-a724-d6a7ea9592f3" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_1ce3cc67-d25c-4056-9fdc-fc8cb79e9cee" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_2e0f3a3e-7ce8-4441-86ac-69e1ee5927aa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_0d7c0f4f-59d4-4631-a724-d6a7ea9592f3" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_2e0f3a3e-7ce8-4441-86ac-69e1ee5927aa" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNumberOfInstrumentsHeld_5b0ae45a-270a-445a-a67d-0cc401fc68a3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeNumberOfInstrumentsHeld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_0d7c0f4f-59d4-4631-a724-d6a7ea9592f3" xlink:to="loc_us-gaap_DerivativeNumberOfInstrumentsHeld_5b0ae45a-270a-445a-a67d-0cc401fc68a3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DerivativePercentofDebtExposed_9e8a9f29-417d-4421-9304-1b9023ff9559" xlink:href="hae-20201226.xsd#hae_DerivativePercentofDebtExposed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_0d7c0f4f-59d4-4631-a724-d6a7ea9592f3" xlink:to="loc_hae_DerivativePercentofDebtExposed_9e8a9f29-417d-4421-9304-1b9023ff9559" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_f2bfc44d-e18d-4942-8bce-d997227666d9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_0d7c0f4f-59d4-4631-a724-d6a7ea9592f3" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_f2bfc44d-e18d-4942-8bce-d997227666d9" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_5461c4ad-bcd9-47a6-a4eb-c2cc16bb68c3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_0d7c0f4f-59d4-4631-a724-d6a7ea9592f3" xlink:to="loc_us-gaap_DerivativeNotionalAmount_5461c4ad-bcd9-47a6-a4eb-c2cc16bb68c3" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_879c7c46-21e0-404e-9a57-a54de20bafc9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_0d7c0f4f-59d4-4631-a724-d6a7ea9592f3" xlink:to="loc_us-gaap_LongTermDebt_879c7c46-21e0-404e-9a57-a54de20bafc9" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_9a173d68-8922-4e9e-9776-b2cb6089ab7e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_0d7c0f4f-59d4-4631-a724-d6a7ea9592f3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_9a173d68-8922-4e9e-9776-b2cb6089ab7e" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsDerivativeInstruments_8537f58c-e86e-4345-84b5-1e795832885e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsDerivativeInstruments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_0d7c0f4f-59d4-4631-a724-d6a7ea9592f3" xlink:to="loc_us-gaap_DeferredTaxAssetsDerivativeInstruments_8537f58c-e86e-4345-84b5-1e795832885e" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_91d5acd6-db14-4b6e-a83b-102998191eb1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_0d7c0f4f-59d4-4631-a724-d6a7ea9592f3" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_91d5acd6-db14-4b6e-a83b-102998191eb1" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_55d7ba2c-40b7-419a-aa00-fa6b55b7796d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_0d7c0f4f-59d4-4631-a724-d6a7ea9592f3" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_55d7ba2c-40b7-419a-aa00-fa6b55b7796d" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_ContingentConsiderationAcquisitionDateFairValue_ca892b6f-d677-4674-a6b5-60b1305aa5bc" xlink:href="hae-20201226.xsd#hae_ContingentConsiderationAcquisitionDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_0d7c0f4f-59d4-4631-a724-d6a7ea9592f3" xlink:to="loc_hae_ContingentConsiderationAcquisitionDateFairValue_ca892b6f-d677-4674-a6b5-60b1305aa5bc" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_26d1ad7c-971c-475d-99f3-7f322b5f73e3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_0d7c0f4f-59d4-4631-a724-d6a7ea9592f3" xlink:to="loc_us-gaap_DerivativeTable_26d1ad7c-971c-475d-99f3-7f322b5f73e3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_db47abff-88d9-4fc0-9cc4-d4c02b197ef4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_26d1ad7c-971c-475d-99f3-7f322b5f73e3" xlink:to="loc_us-gaap_HedgingDesignationAxis_db47abff-88d9-4fc0-9cc4-d4c02b197ef4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_db47abff-88d9-4fc0-9cc4-d4c02b197ef4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_db47abff-88d9-4fc0-9cc4-d4c02b197ef4" xlink:to="loc_us-gaap_HedgingDesignationDomain_db47abff-88d9-4fc0-9cc4-d4c02b197ef4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_52d8aced-fee6-48d9-a907-0038d2bc3308" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_db47abff-88d9-4fc0-9cc4-d4c02b197ef4" xlink:to="loc_us-gaap_HedgingDesignationDomain_52d8aced-fee6-48d9-a907-0038d2bc3308" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_910a79bb-1952-4f8b-8394-8896089d1137" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_52d8aced-fee6-48d9-a907-0038d2bc3308" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_910a79bb-1952-4f8b-8394-8896089d1137" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_97727b18-1e40-4a2e-9be4-080a5b36dfeb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_52d8aced-fee6-48d9-a907-0038d2bc3308" xlink:to="loc_us-gaap_NondesignatedMember_97727b18-1e40-4a2e-9be4-080a5b36dfeb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_4e5fd725-4663-4ff5-b5a5-5d21458f56c5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_26d1ad7c-971c-475d-99f3-7f322b5f73e3" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_4e5fd725-4663-4ff5-b5a5-5d21458f56c5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_4e5fd725-4663-4ff5-b5a5-5d21458f56c5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_4e5fd725-4663-4ff5-b5a5-5d21458f56c5" xlink:to="loc_us-gaap_HedgingRelationshipDomain_4e5fd725-4663-4ff5-b5a5-5d21458f56c5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_2baa98f3-3381-4b9a-8b10-0bc3247afb7e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_4e5fd725-4663-4ff5-b5a5-5d21458f56c5" xlink:to="loc_us-gaap_HedgingRelationshipDomain_2baa98f3-3381-4b9a-8b10-0bc3247afb7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_3bb389bb-1abc-4a68-a286-b52823ada253" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_2baa98f3-3381-4b9a-8b10-0bc3247afb7e" xlink:to="loc_us-gaap_ForeignExchangeContractMember_3bb389bb-1abc-4a68-a286-b52823ada253" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_55726ad5-0005-4a82-8016-b7f1220da642" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_2baa98f3-3381-4b9a-8b10-0bc3247afb7e" xlink:to="loc_us-gaap_CashFlowHedgingMember_55726ad5-0005-4a82-8016-b7f1220da642" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_1b5f4be2-2674-42ff-9a7e-6b4a817f902c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_2baa98f3-3381-4b9a-8b10-0bc3247afb7e" xlink:to="loc_us-gaap_InterestRateSwapMember_1b5f4be2-2674-42ff-9a7e-6b4a817f902c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_9edd7d6f-1c06-4ac7-8794-275991a5e8f5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_26d1ad7c-971c-475d-99f3-7f322b5f73e3" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_9edd7d6f-1c06-4ac7-8794-275991a5e8f5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9edd7d6f-1c06-4ac7-8794-275991a5e8f5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9edd7d6f-1c06-4ac7-8794-275991a5e8f5" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9edd7d6f-1c06-4ac7-8794-275991a5e8f5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5c8ea9d7-b89d-40fa-b6a3-24d305814a48" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9edd7d6f-1c06-4ac7-8794-275991a5e8f5" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5c8ea9d7-b89d-40fa-b6a3-24d305814a48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_245fba20-7c75-4a0d-a85b-1dc230c29307" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5c8ea9d7-b89d-40fa-b6a3-24d305814a48" xlink:to="loc_us-gaap_ForeignExchangeContractMember_245fba20-7c75-4a0d-a85b-1dc230c29307" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_547a6159-3ea9-47a7-9241-1300abeedac2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5c8ea9d7-b89d-40fa-b6a3-24d305814a48" xlink:to="loc_us-gaap_InterestRateSwapMember_547a6159-3ea9-47a7-9241-1300abeedac2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_ContingentConsiderationMember_a5230a27-8b69-4110-b42e-211dc1baa3c0" xlink:href="hae-20201226.xsd#hae_ContingentConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5c8ea9d7-b89d-40fa-b6a3-24d305814a48" xlink:to="loc_hae_ContingentConsiderationMember_a5230a27-8b69-4110-b42e-211dc1baa3c0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_7da1c67a-4d0f-49b9-abd5-3b8f76f1a09e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_26d1ad7c-971c-475d-99f3-7f322b5f73e3" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_7da1c67a-4d0f-49b9-abd5-3b8f76f1a09e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_7da1c67a-4d0f-49b9-abd5-3b8f76f1a09e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_7da1c67a-4d0f-49b9-abd5-3b8f76f1a09e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_7da1c67a-4d0f-49b9-abd5-3b8f76f1a09e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_98d24340-fbdd-487d-a36e-4b5b44fabf20" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_7da1c67a-4d0f-49b9-abd5-3b8f76f1a09e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_98d24340-fbdd-487d-a36e-4b5b44fabf20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_OtherIncomeExpenseNetMember_67cfb3f1-ff34-4ae2-882f-782f5a4409e5" xlink:href="hae-20201226.xsd#hae_OtherIncomeExpenseNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_98d24340-fbdd-487d-a36e-4b5b44fabf20" xlink:to="loc_hae_OtherIncomeExpenseNetMember_67cfb3f1-ff34-4ae2-882f-782f5a4409e5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_19a1449c-34ad-4eb3-b609-438fadc13ebd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_26d1ad7c-971c-475d-99f3-7f322b5f73e3" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_19a1449c-34ad-4eb3-b609-438fadc13ebd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_19a1449c-34ad-4eb3-b609-438fadc13ebd_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_19a1449c-34ad-4eb3-b609-438fadc13ebd" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_19a1449c-34ad-4eb3-b609-438fadc13ebd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_efd83056-6d4b-4d24-b5f8-f618b5bd99f0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_19a1449c-34ad-4eb3-b609-438fadc13ebd" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_efd83056-6d4b-4d24-b5f8-f618b5bd99f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember_916068e4-642f-4493-9201-8655f84bc472" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MediumTermNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_efd83056-6d4b-4d24-b5f8-f618b5bd99f0" xlink:to="loc_us-gaap_MediumTermNotesMember_916068e4-642f-4493-9201-8655f84bc472" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_77cf73b1-98fc-4690-96a4-ce6718f6d93b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_efd83056-6d4b-4d24-b5f8-f618b5bd99f0" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_77cf73b1-98fc-4690-96a4-ce6718f6d93b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_ff08a47c-9bce-4a6e-91cc-5042b8e6455d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_26d1ad7c-971c-475d-99f3-7f322b5f73e3" xlink:to="loc_us-gaap_VariableRateAxis_ff08a47c-9bce-4a6e-91cc-5042b8e6455d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_ff08a47c-9bce-4a6e-91cc-5042b8e6455d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_ff08a47c-9bce-4a6e-91cc-5042b8e6455d" xlink:to="loc_us-gaap_VariableRateDomain_ff08a47c-9bce-4a6e-91cc-5042b8e6455d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_2721b12d-b5ee-4024-8a55-696147bc850c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_ff08a47c-9bce-4a6e-91cc-5042b8e6455d" xlink:to="loc_us-gaap_VariableRateDomain_2721b12d-b5ee-4024-8a55-696147bc850c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_670b0dcb-2e97-4ced-a06f-d2895105703f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_2721b12d-b5ee-4024-8a55-696147bc850c" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_670b0dcb-2e97-4ced-a06f-d2895105703f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_9e22656b-4649-4367-b1cb-6b353b4617c8" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_26d1ad7c-971c-475d-99f3-7f322b5f73e3" xlink:to="loc_srt_RangeAxis_9e22656b-4649-4367-b1cb-6b353b4617c8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9e22656b-4649-4367-b1cb-6b353b4617c8_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_9e22656b-4649-4367-b1cb-6b353b4617c8" xlink:to="loc_srt_RangeMember_9e22656b-4649-4367-b1cb-6b353b4617c8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_819d092c-ee08-4da7-aca3-13ab28ef5661" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_9e22656b-4649-4367-b1cb-6b353b4617c8" xlink:to="loc_srt_RangeMember_819d092c-ee08-4da7-aca3-13ab28ef5661" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_8a8b5752-ac67-4acb-b199-0ff6918e63de" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_819d092c-ee08-4da7-aca3-13ab28ef5661" xlink:to="loc_srt_MinimumMember_8a8b5752-ac67-4acb-b199-0ff6918e63de" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5d43eeaa-b92c-4acf-9c8c-7058c7c3b8cc" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_819d092c-ee08-4da7-aca3-13ab28ef5661" xlink:to="loc_srt_MaximumMember_5d43eeaa-b92c-4acf-9c8c-7058c7c3b8cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_c7104477-770b-4e5a-baf3-25cd690c46bc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_26d1ad7c-971c-475d-99f3-7f322b5f73e3" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_c7104477-770b-4e5a-baf3-25cd690c46bc" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_c7104477-770b-4e5a-baf3-25cd690c46bc_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_c7104477-770b-4e5a-baf3-25cd690c46bc" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_c7104477-770b-4e5a-baf3-25cd690c46bc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_45bc7042-4b2d-4cad-b5b5-202f00fec76c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_c7104477-770b-4e5a-baf3-25cd690c46bc" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_45bc7042-4b2d-4cad-b5b5-202f00fec76c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_42a58428-fd0b-4740-b5a2-5e3aba3da01b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_45bc7042-4b2d-4cad-b5b5-202f00fec76c" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_42a58428-fd0b-4740-b5a2-5e3aba3da01b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_6b583260-9a58-409e-99ce-2d64ef0ab7b6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_26d1ad7c-971c-475d-99f3-7f322b5f73e3" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_6b583260-9a58-409e-99ce-2d64ef0ab7b6" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_6b583260-9a58-409e-99ce-2d64ef0ab7b6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_6b583260-9a58-409e-99ce-2d64ef0ab7b6" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_6b583260-9a58-409e-99ce-2d64ef0ab7b6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_fb852330-871e-4d9a-a64a-7399fe44ddf0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_6b583260-9a58-409e-99ce-2d64ef0ab7b6" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_fb852330-871e-4d9a-a64a-7399fe44ddf0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_03c096ae-b7a4-459a-882c-28574db1e3f6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_fb852330-871e-4d9a-a64a-7399fe44ddf0" xlink:to="loc_us-gaap_OtherLiabilitiesMember_03c096ae-b7a4-459a-882c-28574db1e3f6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_e51568c3-aa2b-422f-9571-8ab55a142ba1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_fb852330-871e-4d9a-a64a-7399fe44ddf0" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_e51568c3-aa2b-422f-9571-8ab55a142ba1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1d8f66f6-2032-4fd1-a379-e575538428c6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_26d1ad7c-971c-475d-99f3-7f322b5f73e3" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1d8f66f6-2032-4fd1-a379-e575538428c6" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1d8f66f6-2032-4fd1-a379-e575538428c6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1d8f66f6-2032-4fd1-a379-e575538428c6" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1d8f66f6-2032-4fd1-a379-e575538428c6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_757ac86a-38bf-4188-a8be-19a035d2ecfd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1d8f66f6-2032-4fd1-a379-e575538428c6" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_757ac86a-38bf-4188-a8be-19a035d2ecfd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EnicorMember_e5e0fb43-c7ec-4f5e-857f-ce26a70c365e" xlink:href="hae-20201226.xsd#hae_EnicorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_757ac86a-38bf-4188-a8be-19a035d2ecfd" xlink:to="loc_hae_EnicorMember_e5e0fb43-c7ec-4f5e-857f-ce26a70c365e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="simple" xlink:href="hae-20201226.xsd#COMMITMENTSANDCONTINGENCIES"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="extended" id="i299b57cb87fb4567bddbeb13ce193d0b_COMMITMENTSANDCONTINGENCIES"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATION" xlink:type="simple" xlink:href="hae-20201226.xsd#SEGMENTANDENTERPRISEWIDEINFORMATION"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATION" xlink:type="extended" id="if47b44180c9e40a6bb13a4e45e9b1c90_SEGMENTANDENTERPRISEWIDEINFORMATION"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONTables" xlink:type="simple" xlink:href="hae-20201226.xsd#SEGMENTANDENTERPRISEWIDEINFORMATIONTables"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONTables" xlink:type="extended" id="i1c3a710212614f928d159b9637e37834_SEGMENTANDENTERPRISEWIDEINFORMATIONTables"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails" xlink:type="simple" xlink:href="hae-20201226.xsd#SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails" xlink:type="extended" id="ie5757dc8c814443d9ad607d2e551dd67_SEGMENTANDENTERPRISEWIDEINFORMATIONDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_f2ffc2b6-b57b-41c7-a9fe-a65d3c6f247b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_NetRevenuesBeforeForeignExchangeImpact_ab6357e2-91e6-48d9-b2f8-918a555c1ba4" xlink:href="hae-20201226.xsd#hae_NetRevenuesBeforeForeignExchangeImpact"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f2ffc2b6-b57b-41c7-a9fe-a65d3c6f247b" xlink:to="loc_hae_NetRevenuesBeforeForeignExchangeImpact_ab6357e2-91e6-48d9-b2f8-918a555c1ba4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EffectofExchangeRateonRevenues_b7df9695-725d-43f2-95b6-edb6bd4d01c5" xlink:href="hae-20201226.xsd#hae_EffectofExchangeRateonRevenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f2ffc2b6-b57b-41c7-a9fe-a65d3c6f247b" xlink:to="loc_hae_EffectofExchangeRateonRevenues_b7df9695-725d-43f2-95b6-edb6bd4d01c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2c1cde13-dfe9-44d9-a9b9-058b20152599" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f2ffc2b6-b57b-41c7-a9fe-a65d3c6f247b" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2c1cde13-dfe9-44d9-a9b9-058b20152599" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_d22a4618-83c3-4b94-b8a9-7d2415385b95" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f2ffc2b6-b57b-41c7-a9fe-a65d3c6f247b" xlink:to="loc_us-gaap_OperatingIncomeLoss_d22a4618-83c3-4b94-b8a9-7d2415385b95" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_CorporateOperatingExpenses_2aac086b-01d9-4924-8111-0aa5071973cf" xlink:href="hae-20201226.xsd#hae_CorporateOperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f2ffc2b6-b57b-41c7-a9fe-a65d3c6f247b" xlink:to="loc_hae_CorporateOperatingExpenses_2aac086b-01d9-4924-8111-0aa5071973cf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EffectofExchangeRatesonOperatingIncome_d3715677-0a8d-44c0-9ac9-fee5c10ab1a5" xlink:href="hae-20201226.xsd#hae_EffectofExchangeRatesonOperatingIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f2ffc2b6-b57b-41c7-a9fe-a65d3c6f247b" xlink:to="loc_hae_EffectofExchangeRatesonOperatingIncome_d3715677-0a8d-44c0-9ac9-fee5c10ab1a5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_7181dde4-007c-4527-bb3e-162710b54075" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f2ffc2b6-b57b-41c7-a9fe-a65d3c6f247b" xlink:to="loc_us-gaap_AdjustmentForAmortization_7181dde4-007c-4527-bb3e-162710b54075" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_RestructuringandTurnaroundCosts_2e598128-4f73-4bb0-801d-04f07daef0b6" xlink:href="hae-20201226.xsd#hae_RestructuringandTurnaroundCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f2ffc2b6-b57b-41c7-a9fe-a65d3c6f247b" xlink:to="loc_hae_RestructuringandTurnaroundCosts_2e598128-4f73-4bb0-801d-04f07daef0b6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_OperatingExpensesTransactionCosts_b37ee14f-2072-40e6-9a38-32684245f18c" xlink:href="hae-20201226.xsd#hae_OperatingExpensesTransactionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f2ffc2b6-b57b-41c7-a9fe-a65d3c6f247b" xlink:to="loc_hae_OperatingExpensesTransactionCosts_b37ee14f-2072-40e6-9a38-32684245f18c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAcceleratedDepreciation_4fc48432-a40d-419e-a427-dfc6dde4ea31" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserveAcceleratedDepreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f2ffc2b6-b57b-41c7-a9fe-a65d3c6f247b" xlink:to="loc_us-gaap_RestructuringReserveAcceleratedDepreciation_4fc48432-a40d-419e-a427-dfc6dde4ea31" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EuropeanMedicalDeviceRegulationCosts_f4e7bc2e-3363-4725-9eb8-2f4a7372012d" xlink:href="hae-20201226.xsd#hae_EuropeanMedicalDeviceRegulationCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f2ffc2b6-b57b-41c7-a9fe-a65d3c6f247b" xlink:to="loc_hae_EuropeanMedicalDeviceRegulationCosts_f4e7bc2e-3363-4725-9eb8-2f4a7372012d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_AssetImpairmentAndOtherRelatedCharges_1f6e8067-6900-4cd5-8faa-e49b71ccd82b" xlink:href="hae-20201226.xsd#hae_AssetImpairmentAndOtherRelatedCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f2ffc2b6-b57b-41c7-a9fe-a65d3c6f247b" xlink:to="loc_hae_AssetImpairmentAndOtherRelatedCharges_1f6e8067-6900-4cd5-8faa-e49b71ccd82b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1_d626d8e6-115b-4380-ab9b-06e859d80440" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f2ffc2b6-b57b-41c7-a9fe-a65d3c6f247b" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets1_d626d8e6-115b-4380-ab9b-06e859d80440" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0e5d8e50-2c69-4056-88fe-92a48e7b9118" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f2ffc2b6-b57b-41c7-a9fe-a65d3c6f247b" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0e5d8e50-2c69-4056-88fe-92a48e7b9118" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_0dd1604c-af04-4e0e-819a-cf005041c1d9" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0e5d8e50-2c69-4056-88fe-92a48e7b9118" xlink:to="loc_srt_ConsolidationItemsAxis_0dd1604c-af04-4e0e-819a-cf005041c1d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_0dd1604c-af04-4e0e-819a-cf005041c1d9_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_0dd1604c-af04-4e0e-819a-cf005041c1d9" xlink:to="loc_srt_ConsolidationItemsDomain_0dd1604c-af04-4e0e-819a-cf005041c1d9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_98fd8207-9b39-4c95-a95f-301ecd6ff700" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_0dd1604c-af04-4e0e-819a-cf005041c1d9" xlink:to="loc_srt_ConsolidationItemsDomain_98fd8207-9b39-4c95-a95f-301ecd6ff700" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_2a89031c-24f5-4234-94da-8ec739ef270a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_98fd8207-9b39-4c95-a95f-301ecd6ff700" xlink:to="loc_us-gaap_OperatingSegmentsMember_2a89031c-24f5-4234-94da-8ec739ef270a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_7f87ef89-e332-41d6-bc0c-df309968148a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_98fd8207-9b39-4c95-a95f-301ecd6ff700" xlink:to="loc_us-gaap_CorporateNonSegmentMember_7f87ef89-e332-41d6-bc0c-df309968148a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_4a96633f-2b94-467d-b552-70490566ebcf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0e5d8e50-2c69-4056-88fe-92a48e7b9118" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_4a96633f-2b94-467d-b552-70490566ebcf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_4a96633f-2b94-467d-b552-70490566ebcf_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_4a96633f-2b94-467d-b552-70490566ebcf" xlink:to="loc_us-gaap_SegmentDomain_4a96633f-2b94-467d-b552-70490566ebcf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_4a669364-a53b-4ff1-a161-5fba36bad434" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_4a96633f-2b94-467d-b552-70490566ebcf" xlink:to="loc_us-gaap_SegmentDomain_4a669364-a53b-4ff1-a161-5fba36bad434" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_PlasmaMember_caeca16a-2b17-49b3-b77b-0ee2fa4a6398" xlink:href="hae-20201226.xsd#hae_PlasmaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_4a669364-a53b-4ff1-a161-5fba36bad434" xlink:to="loc_hae_PlasmaMember_caeca16a-2b17-49b3-b77b-0ee2fa4a6398" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_BloodCenterMember_9b8dafe0-fa10-47ad-a105-0f68dd564016" xlink:href="hae-20201226.xsd#hae_BloodCenterMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_4a669364-a53b-4ff1-a161-5fba36bad434" xlink:to="loc_hae_BloodCenterMember_9b8dafe0-fa10-47ad-a105-0f68dd564016" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_HospitalMember_1c6cdefc-4e64-4122-852f-a5e7bb2eecbc" xlink:href="hae-20201226.xsd#hae_HospitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_4a669364-a53b-4ff1-a161-5fba36bad434" xlink:to="loc_hae_HospitalMember_1c6cdefc-4e64-4122-852f-a5e7bb2eecbc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_e4d63a71-5066-45a1-b64f-a9f875d1e1a5" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0e5d8e50-2c69-4056-88fe-92a48e7b9118" xlink:to="loc_srt_ProductOrServiceAxis_e4d63a71-5066-45a1-b64f-a9f875d1e1a5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e4d63a71-5066-45a1-b64f-a9f875d1e1a5_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_e4d63a71-5066-45a1-b64f-a9f875d1e1a5" xlink:to="loc_srt_ProductsAndServicesDomain_e4d63a71-5066-45a1-b64f-a9f875d1e1a5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_795115c4-f95e-4c0c-96ab-634ead9b3b72" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_e4d63a71-5066-45a1-b64f-a9f875d1e1a5" xlink:to="loc_srt_ProductsAndServicesDomain_795115c4-f95e-4c0c-96ab-634ead9b3b72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_e1c3e92c-858a-4118-a8fd-3c46cb3efea6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_795115c4-f95e-4c0c-96ab-634ead9b3b72" xlink:to="loc_us-gaap_ServiceMember_e1c3e92c-858a-4118-a8fd-3c46cb3efea6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_PlasmaProductsandServicesMember_b69c6a01-6285-4169-a576-91daa02e451b" xlink:href="hae-20201226.xsd#hae_PlasmaProductsandServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_795115c4-f95e-4c0c-96ab-634ead9b3b72" xlink:to="loc_hae_PlasmaProductsandServicesMember_b69c6a01-6285-4169-a576-91daa02e451b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_BloodCenterProductsandServicesMember_6f662a29-1625-46a9-9a7f-f40eec4018f8" xlink:href="hae-20201226.xsd#hae_BloodCenterProductsandServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_795115c4-f95e-4c0c-96ab-634ead9b3b72" xlink:to="loc_hae_BloodCenterProductsandServicesMember_6f662a29-1625-46a9-9a7f-f40eec4018f8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_HospitalProductsandServicesMember_015e6a3e-e7a0-48cd-8e47-7100d1092d9c" xlink:href="hae-20201226.xsd#hae_HospitalProductsandServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_795115c4-f95e-4c0c-96ab-634ead9b3b72" xlink:to="loc_hae_HospitalProductsandServicesMember_015e6a3e-e7a0-48cd-8e47-7100d1092d9c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_4abef3b3-5b93-490f-8ac7-09bd3518b62e" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0e5d8e50-2c69-4056-88fe-92a48e7b9118" xlink:to="loc_srt_StatementGeographicalAxis_4abef3b3-5b93-490f-8ac7-09bd3518b62e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_4abef3b3-5b93-490f-8ac7-09bd3518b62e_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_4abef3b3-5b93-490f-8ac7-09bd3518b62e" xlink:to="loc_srt_SegmentGeographicalDomain_4abef3b3-5b93-490f-8ac7-09bd3518b62e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_8b094d06-36cd-4be4-a064-69e3cc063581" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_4abef3b3-5b93-490f-8ac7-09bd3518b62e" xlink:to="loc_srt_SegmentGeographicalDomain_8b094d06-36cd-4be4-a064-69e3cc063581" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_dee3f38c-5926-467e-9036-cec722c07eb6" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_8b094d06-36cd-4be4-a064-69e3cc063581" xlink:to="loc_country_US_dee3f38c-5926-467e-9036-cec722c07eb6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_JP_18acc3aa-74dc-4f44-8555-89cc98c5830d" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_JP"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_8b094d06-36cd-4be4-a064-69e3cc063581" xlink:to="loc_country_JP_18acc3aa-74dc-4f44-8555-89cc98c5830d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_e4523ec5-8e99-4e64-9ad8-5c6c59e530a7" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_8b094d06-36cd-4be4-a064-69e3cc063581" xlink:to="loc_srt_EuropeMember_e4523ec5-8e99-4e64-9ad8-5c6c59e530a7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaMember_e1ecc216-c723-44fc-9c83-53fdc20bec69" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_AsiaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_8b094d06-36cd-4be4-a064-69e3cc063581" xlink:to="loc_srt_AsiaMember_e1ecc216-c723-44fc-9c83-53fdc20bec69" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_OtherCountryorRegionMember_83aeadd5-d8d3-4b4e-b4a1-e7b93f6759ad" xlink:href="hae-20201226.xsd#hae_OtherCountryorRegionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_8b094d06-36cd-4be4-a064-69e3cc063581" xlink:to="loc_hae_OtherCountryorRegionMember_83aeadd5-d8d3-4b4e-b4a1-e7b93f6759ad" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS" xlink:type="simple" xlink:href="hae-20201226.xsd#ACCUMULATEDOTHERCOMPREHENSIVELOSS"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS" xlink:type="extended" id="i6e5d5a09a5f5467382cc2f417f39c027_ACCUMULATEDOTHERCOMPREHENSIVELOSS"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables" xlink:type="simple" xlink:href="hae-20201226.xsd#ACCUMULATEDOTHERCOMPREHENSIVELOSSTables"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables" xlink:type="extended" id="i350440fae0744db3850821cfa9c13cd5_ACCUMULATEDOTHERCOMPREHENSIVELOSSTables"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSDetails" xlink:type="simple" xlink:href="hae-20201226.xsd#ACCUMULATEDOTHERCOMPREHENSIVELOSSDetails"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSDetails" xlink:type="extended" id="i3aac0e722b3748fcb461cdfe070446b8_ACCUMULATEDOTHERCOMPREHENSIVELOSSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_ec77b6d0-37a2-4053-9f28-5908f045efae" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_1f5758b3-ec84-4803-ae3f-6dfb74b4df50" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_ec77b6d0-37a2-4053-9f28-5908f045efae" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_1f5758b3-ec84-4803-ae3f-6dfb74b4df50" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a16180bc-e003-495a-975a-0119018fa854" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_1f5758b3-ec84-4803-ae3f-6dfb74b4df50" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a16180bc-e003-495a-975a-0119018fa854" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_de5c90dc-5dbb-411e-b867-cdeead68513c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_1f5758b3-ec84-4803-ae3f-6dfb74b4df50" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_de5c90dc-5dbb-411e-b867-cdeead68513c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_1f84a88d-08ae-4133-8c4d-fe466876cacf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_1f5758b3-ec84-4803-ae3f-6dfb74b4df50" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_1f84a88d-08ae-4133-8c4d-fe466876cacf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_27d1028f-b893-4360-9833-80b36f3a50e0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_1f5758b3-ec84-4803-ae3f-6dfb74b4df50" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_27d1028f-b893-4360-9833-80b36f3a50e0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_92cf1eba-e358-4937-a1e8-b27446b86147" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_31e0f6e5-886e-4258-98f0-b754ba800de8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_ec77b6d0-37a2-4053-9f28-5908f045efae" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_31e0f6e5-886e-4258-98f0-b754ba800de8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d91112a3-a1a1-4ef2-b8b3-d025fcc4aeff" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_31e0f6e5-886e-4258-98f0-b754ba800de8" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d91112a3-a1a1-4ef2-b8b3-d025fcc4aeff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d91112a3-a1a1-4ef2-b8b3-d025fcc4aeff_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d91112a3-a1a1-4ef2-b8b3-d025fcc4aeff" xlink:to="loc_us-gaap_EquityComponentDomain_d91112a3-a1a1-4ef2-b8b3-d025fcc4aeff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_70711680-80b8-4a85-a9a9-2c6490b8e05b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d91112a3-a1a1-4ef2-b8b3-d025fcc4aeff" xlink:to="loc_us-gaap_EquityComponentDomain_70711680-80b8-4a85-a9a9-2c6490b8e05b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_8f236a11-664c-4193-8875-80713379b5cb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_70711680-80b8-4a85-a9a9-2c6490b8e05b" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_8f236a11-664c-4193-8875-80713379b5cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_aa05434a-b776-4f18-96fe-f7b8e660041e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_70711680-80b8-4a85-a9a9-2c6490b8e05b" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_aa05434a-b776-4f18-96fe-f7b8e660041e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_0c95c083-4c68-4085-94d7-458567785417" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_70711680-80b8-4a85-a9a9-2c6490b8e05b" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_0c95c083-4c68-4085-94d7-458567785417" xlink:type="arc" order="2"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>13
<FILENAME>hae-20201226_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:dcc831a0-a182-47d6-a94e-5adaefe7bce2,g:c7d71817-1258-4da0-86ec-9eebc508e513-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_b87139d8-5c20-4804-acf0-a03f379b694c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_c70ab4ea-ec9b-4b82-a4b8-7ac364d0c0fd_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_675d2741-609d-4ce9-8111-aa9468c7919b_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal repayments, fiscal 2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Maturities, Repayments of Principal in Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_95bf31ff-7bd2-4c63-8a39-570f654a1326_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognized</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_147bc9fa-0b4f-435b-9848-57e270d46b18_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_62ca5555-8c1b-45c7-9489-3bf92d23ff7a_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_TransfersFromInventoryToFixedAssets_277f0dcf-327f-4e9d-93bf-1779ec5a252e_terseLabel_en-US" xlink:label="lab_hae_TransfersFromInventoryToFixedAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfers from inventory to fixed assets for placement of Haemonetics equipment</link:label>
    <link:label id="lab_hae_TransfersFromInventoryToFixedAssets_label_en-US" xlink:label="lab_hae_TransfersFromInventoryToFixedAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfers from Inventory to Fixed Assets</link:label>
    <link:label id="lab_hae_TransfersFromInventoryToFixedAssets_documentation_en-US" xlink:label="lab_hae_TransfersFromInventoryToFixedAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfers from inventory to fixed assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_TransfersFromInventoryToFixedAssets" xlink:href="hae-20201226.xsd#hae_TransfersFromInventoryToFixedAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_TransfersFromInventoryToFixedAssets" xlink:to="lab_hae_TransfersFromInventoryToFixedAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_5d3b93a6-5a72-4b5f-ad17-f90573d5380e_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on closing of transaction</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:to="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b1786822-149b-4fdf-b7c5-e7edc71126b6_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_6a69ed8e-61b7-4aa9-bd7d-608a0323a1d1_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of goods sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_b44f3b47-193f-4c8e-a921-0b176dd06a42_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceMember_0b95e72e-9642-4b3e-aa13-ec0cfff37421_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service</link:label>
    <link:label id="lab_us-gaap_ServiceMember_label_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceMember" xlink:to="lab_us-gaap_ServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfEquity_6153b154-46db-4ff8-b00d-5f7f7dcd9875_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfEquity" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchases</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfEquity_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForRepurchaseOfEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfEquity" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_892071b4-c1a0-44f2-8a95-718d8a854266_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Loss into Earnings</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_613b80e4-c684-4694-8d01-4c327c17a0ce_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_NetRevenuesBeforeForeignExchangeImpact_b0369102-e674-4eb2-be2f-9833a27bcbfa_terseLabel_en-US" xlink:label="lab_hae_NetRevenuesBeforeForeignExchangeImpact" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenues before foreign exchange impact</link:label>
    <link:label id="lab_hae_NetRevenuesBeforeForeignExchangeImpact_label_en-US" xlink:label="lab_hae_NetRevenuesBeforeForeignExchangeImpact" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Revenues, Before Foreign Exchange Impact</link:label>
    <link:label id="lab_hae_NetRevenuesBeforeForeignExchangeImpact_documentation_en-US" xlink:label="lab_hae_NetRevenuesBeforeForeignExchangeImpact" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Revenues, Before Foreign Exchange Impact</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_NetRevenuesBeforeForeignExchangeImpact" xlink:href="hae-20201226.xsd#hae_NetRevenuesBeforeForeignExchangeImpact"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_NetRevenuesBeforeForeignExchangeImpact" xlink:to="lab_hae_NetRevenuesBeforeForeignExchangeImpact" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_82fd5dbc-800d-47e4-90f6-07820ad7c6d9_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e7b5bdad-fef2-43a6-a7f4-9df10bbb8a88_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted weighted average shares (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_63925db4-45f4-4d46-9fa8-145e765661c1_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_53180ec1-2a6e-4b41-9a7d-cf9cc27a6dab_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of restricted stock, net of cancellations (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_0e305b0d-f820-484f-a3ad-5aa18b86bfed_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_8a841284-1d26-48ea-8312-cfd299753267_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_c021c44d-530c-4672-9af4-51ee10a49970_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MediumTermNotesMember_64e2c118-ef9c-4002-8a4b-8f32993d744b_terseLabel_en-US" xlink:label="lab_us-gaap_MediumTermNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan</link:label>
    <link:label id="lab_us-gaap_MediumTermNotesMember_label_en-US" xlink:label="lab_us-gaap_MediumTermNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medium-term Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MediumTermNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MediumTermNotesMember" xlink:to="lab_us-gaap_MediumTermNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_6d72948c-735a-42de-baf9-eb285886f419_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIBOR</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_5d93ecba-85ef-4ee5-91e7-d9e2a498f6ca_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income/(Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_c8dfbaa2-e54e-4407-8947-e33e6c3f68a0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_bf834faf-d5cc-4ae1-afe6-efbc5285a90b_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_108f8070-1c32-49cf-9544-9f828d214716_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_0c8fcb58-159a-4391-85f9-aa5924d9d11f_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_604397fd-e867-4312-87bf-8f443487e2c6_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_0ebdcbbb-3978-4e3c-ad2d-bbbdc0caefbf_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_fd376001-7f7c-4a8f-8de0-5cab7f88e9cf_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_57f27a4b-a7bc-427c-81c6-f94674ba9409_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_6a0c407f-a7b7-4097-a939-45b20bc089d7_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_b0441992-2e32-4528-a8e3-e19b04bb72ad_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_c349b25b-5f64-4ae4-ada7-9febf87dc21e_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of term loan borrowings</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_FajardoPuertoRicoManufacturingOperationsMember_2809ce26-29df-4eae-a8e9-4fb9c3fa82bc_terseLabel_en-US" xlink:label="lab_hae_FajardoPuertoRicoManufacturingOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fajardo, Puerto Rico Manufacturing Operations [Member]</link:label>
    <link:label id="lab_hae_FajardoPuertoRicoManufacturingOperationsMember_label_en-US" xlink:label="lab_hae_FajardoPuertoRicoManufacturingOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fajardo, Puerto Rico Manufacturing Operations [Member]</link:label>
    <link:label id="lab_hae_FajardoPuertoRicoManufacturingOperationsMember_documentation_en-US" xlink:label="lab_hae_FajardoPuertoRicoManufacturingOperationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fajardo, Puerto Rico Manufacturing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_FajardoPuertoRicoManufacturingOperationsMember" xlink:href="hae-20201226.xsd#hae_FajardoPuertoRicoManufacturingOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_FajardoPuertoRicoManufacturingOperationsMember" xlink:to="lab_hae_FajardoPuertoRicoManufacturingOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_f12a135f-e577-4583-bcab-55cba4253fa5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_876a4339-9cbe-42d2-9e88-d801ba08e7f0_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_8876b05b-a21f-4b27-9c32-2e450f4be6a3_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_08ca29d7-5551-40b0-af2f-26c9919f093c_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_8e9f08cc-277b-4e0b-8444-1c094b559ef2_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_AssetAcquisitionUpfrontPayment_de775415-5dee-4e44-a3f0-0db36c8ea841_terseLabel_en-US" xlink:label="lab_hae_AssetAcquisitionUpfrontPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront payment for intellectual property</link:label>
    <link:label id="lab_hae_AssetAcquisitionUpfrontPayment_label_en-US" xlink:label="lab_hae_AssetAcquisitionUpfrontPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Upfront Payment</link:label>
    <link:label id="lab_hae_AssetAcquisitionUpfrontPayment_documentation_en-US" xlink:label="lab_hae_AssetAcquisitionUpfrontPayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Upfront Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_AssetAcquisitionUpfrontPayment" xlink:href="hae-20201226.xsd#hae_AssetAcquisitionUpfrontPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_AssetAcquisitionUpfrontPayment" xlink:to="lab_hae_AssetAcquisitionUpfrontPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_c4d32803-12a3-4ca2-8ed3-e20ea28d721e_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_4efdf569-8039-442b-ac33-2f05ec957353_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance obligation amount</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_fbc66e76-4de6-490e-b4cf-308f4ce009c3_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEGMENT AND ENTERPRISE-WIDE INFORMATION</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1b0d19f7-0925-4b3e-b8bc-30c79464ccc9_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rates on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_5f461779-dab5-496d-ac5d-031f072ac764_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_2fc0a8de-54b4-49b3-9aa9-c6ec05403fcc_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_d22d3293-b6d5-46a9-926c-900ca9a6e8b3_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_c35652be-05e5-4e30-8cd4-0886d51fe3ff_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_a443c9e2-51b4-4f8b-a802-758ddc296627_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_8d7a2b58-5457-4d96-a9c9-125caf0a5fc8_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_19d74c95-43ca-48d2-8df4-c77568e97878_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_8ad9088a-de3e-4c52-8678-90bd8bdd436f_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_31525807-8f9e-44c6-8a1e-ef3b8c7543c9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_06799dcb-8370-44c8-b29b-045dc2ce230e_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_0c6b02c9-5ab6-4a36-84f8-4b6cbc43d057_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetImpairmentCharges_ba9a8662-e841-4ac4-9118-1b66d1d282f5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_OtherAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetImpairmentCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetImpairmentCharges" xlink:to="lab_us-gaap_OtherAssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_1abb10dc-38e8-4916-8fc5-e0e657da96e7_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected timing of satisfaction</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_db8efc75-9dfc-45f2-8b9f-0c32fb9ca40d_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet_559ddcfd-f163-4596-bde4-02d17ab8a3d8_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of Gain (Loss) Excluded from Effectiveness Testing</link:label>
    <link:label id="lab_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet_label_en-US" xlink:label="lab_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet" xlink:to="lab_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_87d27fa0-de68-4cd7-94fe-88fa58f43693_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_db7a476d-5341-4a20-b31c-a1131b37f8e0_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssued_726d2688-5938-4a71-9713-6fb145b8cdc4_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_68182a19-5159-4b26-b74d-a26ef46f2fb6_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_label_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssued" xlink:to="lab_us-gaap_SharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_ae6c2f19-3c24-4ece-b8d2-88707eafb35b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities [Member]</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesMember" xlink:to="lab_us-gaap_OtherLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_9dc5398a-b351-40ac-a2f4-5b2c2c19f58e_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_660eeb3b-80a7-427f-a41f-561278850c1d_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis" xlink:to="lab_us-gaap_RestructuringPlanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ccd52aa8-155f-410c-b6ff-fb9937e5042e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_d5800d7f-c614-469e-8fbb-b55c89088f85_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted EPS</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNumberOfInstrumentsHeld_474993b2-d56f-4366-9f58-ca13e0d96bcb_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNumberOfInstrumentsHeld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of instruments held</link:label>
    <link:label id="lab_us-gaap_DerivativeNumberOfInstrumentsHeld_label_en-US" xlink:label="lab_us-gaap_DerivativeNumberOfInstrumentsHeld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Number of Instruments Held</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNumberOfInstrumentsHeld" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeNumberOfInstrumentsHeld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNumberOfInstrumentsHeld" xlink:to="lab_us-gaap_DerivativeNumberOfInstrumentsHeld" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_a91165ed-1e14-4051-9cb3-40e48cb236eb_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_af5d0abe-afc1-443f-9ac0-b8e4cdc4f1f7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating (loss) income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_abfd7837-35fc-46fe-b71a-79f63bff6dba_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration (non-current)</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_e87afc84-694e-4841-b0ca-212f5d34db34_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_3987b0f1-df15-4aa9-ba53-e96969581409_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_a047f31b-31ae-49ad-8657-b73920a43c4e_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_66ca7668-ce08-41f2-a3cf-85e836b128a4_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_aa441a39-18dd-4ea6-8251-5e9c42800830_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_77d87d95-9c6c-4087-90c3-dcd8422f0082_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_edcb5e18-48af-4acb-b084-9c781857d274_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic income (loss) per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_3502fc20-db8a-48c8-86e0-9e9874260b49_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVENTORIES</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_b6070533-992c-46b8-b55b-78aebd6d8f32_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_b0f1a9e9-488d-4868-b135-2bcccb6f784a_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsDerivativeInstruments_156639f8-3a56-4234-9b8a-34d73c8084d4_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsDerivativeInstruments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsDerivativeInstruments_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsDerivativeInstruments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Derivative Instruments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsDerivativeInstruments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsDerivativeInstruments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsDerivativeInstruments" xlink:to="lab_us-gaap_DeferredTaxAssetsDerivativeInstruments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_fed7cb2d-8867-43dc-a0ce-b8475b806abd_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_b93c66cc-e1aa-42e2-8d0d-389fc79bd28e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_a3c40dc8-1355-4c16-831b-84a44f31aeb7_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_042e60df-a786-4453-99fc-cb4006577113_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_f1eda258-4805-4c77-ad08-46f596dc8296_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_921598dd-170b-49e4-9cb2-f69f60f48e32_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_label_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentForAmortization" xlink:to="lab_us-gaap_AdjustmentForAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7825914b-aca7-41e3-8d68-b40296df6eb2_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_7b4e3b08-c0fe-462e-bdc3-66e49ec08bda_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_5124ad69-2086-4aae-8035-62f4cc708da2_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_NetRevenuesCostOfGoodsSoldAndSellingGeneralAndAdministrativeExpenseMember_4e2d2a2a-f817-4aaf-b010-4bab2adb832e_terseLabel_en-US" xlink:label="lab_hae_NetRevenuesCostOfGoodsSoldAndSellingGeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenues, COGS and SG&amp;A</link:label>
    <link:label id="lab_hae_NetRevenuesCostOfGoodsSoldAndSellingGeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_hae_NetRevenuesCostOfGoodsSoldAndSellingGeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Revenues Cost Of Goods Sold And Selling General And Administrative Expense [Member]</link:label>
    <link:label id="lab_hae_NetRevenuesCostOfGoodsSoldAndSellingGeneralAndAdministrativeExpenseMember_documentation_en-US" xlink:label="lab_hae_NetRevenuesCostOfGoodsSoldAndSellingGeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Revenues Cost Of Goods Sold And Selling General And Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_NetRevenuesCostOfGoodsSoldAndSellingGeneralAndAdministrativeExpenseMember" xlink:href="hae-20201226.xsd#hae_NetRevenuesCostOfGoodsSoldAndSellingGeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_NetRevenuesCostOfGoodsSoldAndSellingGeneralAndAdministrativeExpenseMember" xlink:to="lab_hae_NetRevenuesCostOfGoodsSoldAndSellingGeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_e427a717-adea-43b0-86d9-a97fa9fb2386_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_4c1f4812-5c16-47c5-955b-1bceb8c9f531_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_d08e805c-6885-454a-8b76-ebd1d9ce1fa1_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:to="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_f286e757-1fb3-4a7e-806f-fd90d9665397_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_8ed05ea2-aefc-437c-8392-0c5a5c2ae956_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACCUMULATED OTHER COMPREHENSIVE LOSS</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_ContingentConsiderationMember_07a8e5e7-4739-400a-87f5-34ad92b2444d_terseLabel_en-US" xlink:label="lab_hae_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration</link:label>
    <link:label id="lab_hae_ContingentConsiderationMember_label_en-US" xlink:label="lab_hae_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration [Member]</link:label>
    <link:label id="lab_hae_ContingentConsiderationMember_documentation_en-US" xlink:label="lab_hae_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_ContingentConsiderationMember" xlink:href="hae-20201226.xsd#hae_ContingentConsiderationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_ContingentConsiderationMember" xlink:to="lab_hae_ContingentConsiderationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_99f2a2ae-d8b5-4f80-a0dd-dad66dcef0d0_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BASIS OF PRESENTATION</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentAssetsMember_d0ecd69c-6025-4369-9c8c-c3d2a32e50e2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets</link:label>
    <link:label id="lab_us-gaap_OtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentAssetsMember" xlink:to="lab_us-gaap_OtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_AssetImpairmentAndOtherRelatedCharges_233127dd-a06d-441d-88ac-96e5bc1cc33a_negatedTerseLabel_en-US" xlink:label="lab_hae_AssetImpairmentAndOtherRelatedCharges" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of assets and related costs</link:label>
    <link:label id="lab_hae_AssetImpairmentAndOtherRelatedCharges_label_en-US" xlink:label="lab_hae_AssetImpairmentAndOtherRelatedCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment and Other Related Charges</link:label>
    <link:label id="lab_hae_AssetImpairmentAndOtherRelatedCharges_documentation_en-US" xlink:label="lab_hae_AssetImpairmentAndOtherRelatedCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment and Other Related Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_AssetImpairmentAndOtherRelatedCharges" xlink:href="hae-20201226.xsd#hae_AssetImpairmentAndOtherRelatedCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_AssetImpairmentAndOtherRelatedCharges" xlink:to="lab_hae_AssetImpairmentAndOtherRelatedCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets1_33d110f0-d691-4f39-94c3-9421fafe3e45_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on sale of assets</link:label>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets1_label_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnDispositionOfAssets1" xlink:to="lab_us-gaap_GainLossOnDispositionOfAssets1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_b264c5a0-e7eb-42b2-8d38-5dd321cf8a5a_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_c0efd447-374c-4bfd-8612-d3a265cb8098_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DIVESTITURE</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_HospitalProductsandServicesMember_5700db9a-a6a6-444e-859b-9127b80ad187_terseLabel_en-US" xlink:label="lab_hae_HospitalProductsandServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hospital products and services</link:label>
    <link:label id="lab_hae_HospitalProductsandServicesMember_label_en-US" xlink:label="lab_hae_HospitalProductsandServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hospital Products and Services [Member]</link:label>
    <link:label id="lab_hae_HospitalProductsandServicesMember_documentation_en-US" xlink:label="lab_hae_HospitalProductsandServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hospital Products and Services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_HospitalProductsandServicesMember" xlink:href="hae-20201226.xsd#hae_HospitalProductsandServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_HospitalProductsandServicesMember" xlink:to="lab_hae_HospitalProductsandServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_EffectofExchangeRatesonOperatingIncome_06975a7e-9f51-46aa-ae97-a68cede3bdc6_terseLabel_en-US" xlink:label="lab_hae_EffectofExchangeRatesonOperatingIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rates</link:label>
    <link:label id="lab_hae_EffectofExchangeRatesonOperatingIncome_label_en-US" xlink:label="lab_hae_EffectofExchangeRatesonOperatingIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rates on Operating Income</link:label>
    <link:label id="lab_hae_EffectofExchangeRatesonOperatingIncome_documentation_en-US" xlink:label="lab_hae_EffectofExchangeRatesonOperatingIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rates on Operating Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EffectofExchangeRatesonOperatingIncome" xlink:href="hae-20201226.xsd#hae_EffectofExchangeRatesonOperatingIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_EffectofExchangeRatesonOperatingIncome" xlink:to="lab_hae_EffectofExchangeRatesonOperatingIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_1a8ec764-355d-4533-909d-193217d8e2b6_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (decrease) increase in short-term loans</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repayments of) Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_258c7a19-528e-416c-bc53-53e31e1c3356_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed assets</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_bb82ce28-1cfd-443e-9a21-79a6353f9adb_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, less allowance of $2,525 at December 26, 2020 and $3,824 at March 28, 2020</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_A2018ProgramMember_14ec3f7b-0183-4d74-b479-242b346ada45_terseLabel_en-US" xlink:label="lab_hae_A2018ProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 Program</link:label>
    <link:label id="lab_hae_A2018ProgramMember_label_en-US" xlink:label="lab_hae_A2018ProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 Program [Member]</link:label>
    <link:label id="lab_hae_A2018ProgramMember_documentation_en-US" xlink:label="lab_hae_A2018ProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 Program [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_A2018ProgramMember" xlink:href="hae-20201226.xsd#hae_A2018ProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_A2018ProgramMember" xlink:to="lab_hae_A2018ProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_46a0ebfd-ec62-426f-a226-a3fb214592cb_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_093d54f3-a7ea-4ddf-9406-4970a13440c6_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work-in-process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet_930d73a2-dd61-4f71-a260-0cf527d49493_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated foreign currency hedge contracts outstanding</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Cash Flow Hedge Derivative at Fair Value, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet" xlink:to="lab_us-gaap_ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_57880261-94f7-4f66-88c3-6cb011e29f40_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_3c17b7ca-a6d7-43d6-ae5f-7662f9f76367_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discrete tax benefit (expense)</link:label>
    <link:label id="lab_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_label_en-US" xlink:label="lab_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Adjustments, Settlements, and Unusual Provisions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions" xlink:to="lab_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_d8061c89-2a4f-408c-8647-1246c6c176a8_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_87769fcd-8e18-434e-8fa2-cdc7e4b810b7_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Renewal term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_f91fed3f-a22c-4236-af28-86060cbd700f_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_bda5f4be-2d18-416f-9117-8b6471bffa60_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_b15a8fbf-c96f-4a3d-a4ad-480e385ca08a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired intangibles</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_d8f64a62-bec0-48a1-95b0-f7e75778c7f4_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements and Changes in Accounting Principles [Abstract]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements and Changes in Accounting Principles [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f093bf36-3827-4e1b-8970-1b089137cfff_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Change in Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_PlasmaMember_365e7311-8f7f-42ac-9cd5-aa7bf823c87d_terseLabel_en-US" xlink:label="lab_hae_PlasmaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plasma</link:label>
    <link:label id="lab_hae_PlasmaMember_label_en-US" xlink:label="lab_hae_PlasmaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plasma [Member]</link:label>
    <link:label id="lab_hae_PlasmaMember_documentation_en-US" xlink:label="lab_hae_PlasmaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plasma [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_PlasmaMember" xlink:href="hae-20201226.xsd#hae_PlasmaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_PlasmaMember" xlink:to="lab_hae_PlasmaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_5eb01623-8c09-4661-8d26-aa7427b81eca_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_e60955d9-0d73-4c67-ba33-0bcd38fe4063_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_e8cc85dc-86f7-4b7c-bc8b-2402e1b4c9f3_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_5083598b-2349-4789-85f2-00086a3ad948_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_0a8a0582-ed26-4ab3-ac81-4523bd48fd6e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercise of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_EnicorMember_490f1aac-3804-4351-a036-50832d0331b1_terseLabel_en-US" xlink:label="lab_hae_EnicorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Enicor</link:label>
    <link:label id="lab_hae_EnicorMember_label_en-US" xlink:label="lab_hae_EnicorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Enicor [Member]</link:label>
    <link:label id="lab_hae_EnicorMember_documentation_en-US" xlink:label="lab_hae_EnicorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Enicor</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EnicorMember" xlink:href="hae-20201226.xsd#hae_EnicorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_EnicorMember" xlink:to="lab_hae_EnicorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_d6f84d8e-f2db-49a7-a9b3-ccbf99cc86b6_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_504b30a0-b824-42c7-a747-0a82287633ee_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_dbc250d9-9992-45d3-b2e7-710f1c59a18b_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_151550f3-4422-4aa4-8a48-bf2baa19245b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration (current)</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_8d6281c1-887f-4185-be62-44d89e38e8eb_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_A2020ProgramMember_e7972a30-22e9-491b-a525-93f10628fdf3_terseLabel_en-US" xlink:label="lab_hae_A2020ProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Program</link:label>
    <link:label id="lab_hae_A2020ProgramMember_label_en-US" xlink:label="lab_hae_A2020ProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Program [Member]</link:label>
    <link:label id="lab_hae_A2020ProgramMember_documentation_en-US" xlink:label="lab_hae_A2020ProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Program [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_A2020ProgramMember" xlink:href="hae-20201226.xsd#hae_A2020ProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_A2020ProgramMember" xlink:to="lab_hae_A2020ProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesAndFairValueTextBlock_d008a58b-b70e-4384-917d-22f2845267a8_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesAndFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DERIVATIVES AND FAIR VALUE MEASUREMENTS</link:label>
    <link:label id="lab_us-gaap_DerivativesAndFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesAndFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives and Fair Value [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesAndFairValueTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativesAndFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesAndFairValueTextBlock" xlink:to="lab_us-gaap_DerivativesAndFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_f9681d28-50b7-463d-a8a8-e68bf41c7938_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_HospitalMember_6179171b-6766-454e-bc04-20f1410904db_terseLabel_en-US" xlink:label="lab_hae_HospitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hospital</link:label>
    <link:label id="lab_hae_HospitalMember_label_en-US" xlink:label="lab_hae_HospitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hospital [Member]</link:label>
    <link:label id="lab_hae_HospitalMember_documentation_en-US" xlink:label="lab_hae_HospitalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hospital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_HospitalMember" xlink:href="hae-20201226.xsd#hae_HospitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_HospitalMember" xlink:to="lab_hae_HospitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_c5aa3d9c-8fd3-4560-beb6-6a521e264ad0_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_63f6bd66-d20f-4ded-8b4b-435c22bf0cb5_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_ed612c42-ce0f-489a-bd63-e83b7d00323a_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_5fea1938-c314-422b-9a2b-151d07772aec_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration, maximum exposure</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_A2018ProgramandPriorProgramsMember_4bd7a800-f00e-49fe-9547-b331bf96ddaf_terseLabel_en-US" xlink:label="lab_hae_A2018ProgramandPriorProgramsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 Program and Prior Programs</link:label>
    <link:label id="lab_hae_A2018ProgramandPriorProgramsMember_label_en-US" xlink:label="lab_hae_A2018ProgramandPriorProgramsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 Program and Prior Programs [Member]</link:label>
    <link:label id="lab_hae_A2018ProgramandPriorProgramsMember_documentation_en-US" xlink:label="lab_hae_A2018ProgramandPriorProgramsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 Program and Prior Programs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_A2018ProgramandPriorProgramsMember" xlink:href="hae-20201226.xsd#hae_A2018ProgramandPriorProgramsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_A2018ProgramandPriorProgramsMember" xlink:to="lab_hae_A2018ProgramandPriorProgramsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_363d4ffc-f288-419e-a47d-0150af2ea188_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_3d0fea45-f591-44eb-bffd-9862acb5c490_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_15c77f1a-b803-44a4-9478-42040215006b_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_0f35ac81-85c1-46e3-8834-197ead7f9a44_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_e92afd34-641c-4742-b9fb-1e0d627cf21e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_ad779c1c-078a-4cdc-89f2-174b7a21e6ee_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effect of Derivative Instruments Designated as Cash Flow Hedges and Those Not Designated as Hedging Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_7edda457-e6bc-4192-8932-f5addda8fd6a_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_5803acea-28e4-41ea-9e2d-0ddaa20e39b3_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes payable and current maturities of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_9130915d-6a7e-4e07-a4fc-fff4f6a278aa_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_638d060a-79b1-408b-96fa-310802b17e22_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_DisposalGroupNotDiscontinuedOperationsExpectedCostToSell_760ff461-d6db-46a4-a2bf-1fe8fda6f719_terseLabel_en-US" xlink:label="lab_hae_DisposalGroupNotDiscontinuedOperationsExpectedCostToSell" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected cost to sell</link:label>
    <link:label id="lab_hae_DisposalGroupNotDiscontinuedOperationsExpectedCostToSell_label_en-US" xlink:label="lab_hae_DisposalGroupNotDiscontinuedOperationsExpectedCostToSell" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operations, Expected Cost To Sell</link:label>
    <link:label id="lab_hae_DisposalGroupNotDiscontinuedOperationsExpectedCostToSell_documentation_en-US" xlink:label="lab_hae_DisposalGroupNotDiscontinuedOperationsExpectedCostToSell" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operations, Expected Cost To Sell</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DisposalGroupNotDiscontinuedOperationsExpectedCostToSell" xlink:href="hae-20201226.xsd#hae_DisposalGroupNotDiscontinuedOperationsExpectedCostToSell"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_DisposalGroupNotDiscontinuedOperationsExpectedCostToSell" xlink:to="lab_hae_DisposalGroupNotDiscontinuedOperationsExpectedCostToSell" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_BloodCenterMember_3ca21fea-f6a7-4e53-8885-7c5b1b0fd417_terseLabel_en-US" xlink:label="lab_hae_BloodCenterMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blood Center</link:label>
    <link:label id="lab_hae_BloodCenterMember_label_en-US" xlink:label="lab_hae_BloodCenterMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blood Center [Member]</link:label>
    <link:label id="lab_hae_BloodCenterMember_documentation_en-US" xlink:label="lab_hae_BloodCenterMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blood Center [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_BloodCenterMember" xlink:href="hae-20201226.xsd#hae_BloodCenterMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_BloodCenterMember" xlink:to="lab_hae_BloodCenterMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_db9f7130-45c1-45b5-ab1a-21729b9bd8e4_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_ContingentConsiderationAcquisitionDateFairValue_91b01601-dd59-4dab-96e2-7cc9c00dda20_terseLabel_en-US" xlink:label="lab_hae_ContingentConsiderationAcquisitionDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration, Acquisition Date Fair Value</link:label>
    <link:label id="lab_hae_ContingentConsiderationAcquisitionDateFairValue_label_en-US" xlink:label="lab_hae_ContingentConsiderationAcquisitionDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration, Acquisition Date Fair Value</link:label>
    <link:label id="lab_hae_ContingentConsiderationAcquisitionDateFairValue_documentation_en-US" xlink:label="lab_hae_ContingentConsiderationAcquisitionDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration, Acquisition Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_ContingentConsiderationAcquisitionDateFairValue" xlink:href="hae-20201226.xsd#hae_ContingentConsiderationAcquisitionDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_ContingentConsiderationAcquisitionDateFairValue" xlink:to="lab_hae_ContingentConsiderationAcquisitionDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_455e729c-26e5-4395-8a30-a6930cf3bcdc_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_34a994ce-bb68-4d46-818a-53b74df6d9fc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_fbd56762-7e57-4f20-b14a-a574e3bdbf7c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of Gain (Loss) Recognized in Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_a04cba48-d268-444b-ba76-7012c2c5c1f8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_8b13ee63-36fe-485f-88b3-a6972aabd987_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_8d6362e4-4007-401d-95cc-503b2217f076_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, allowance</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_889c6825-78f0-4c85-9b09-a1e3adf84377_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_AssetAcquisitionAxis_4275bc27-e335-4ca0-8816-56c6e914945e_terseLabel_en-US" xlink:label="lab_hae_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:label id="lab_hae_AssetAcquisitionAxis_label_en-US" xlink:label="lab_hae_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:label id="lab_hae_AssetAcquisitionAxis_documentation_en-US" xlink:label="lab_hae_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_AssetAcquisitionAxis" xlink:href="hae-20201226.xsd#hae_AssetAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_AssetAcquisitionAxis" xlink:to="lab_hae_AssetAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_EuropeanMedicalDeviceRegulationCosts_238bc088-c637-4a2f-bfa2-b7a873af7643_negatedTerseLabel_en-US" xlink:label="lab_hae_EuropeanMedicalDeviceRegulationCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">European Medical Device Regulation costs and other</link:label>
    <link:label id="lab_hae_EuropeanMedicalDeviceRegulationCosts_label_en-US" xlink:label="lab_hae_EuropeanMedicalDeviceRegulationCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">European Medical Device Regulation Costs</link:label>
    <link:label id="lab_hae_EuropeanMedicalDeviceRegulationCosts_documentation_en-US" xlink:label="lab_hae_EuropeanMedicalDeviceRegulationCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">European Medical Device Regulation Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EuropeanMedicalDeviceRegulationCosts" xlink:href="hae-20201226.xsd#hae_EuropeanMedicalDeviceRegulationCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_EuropeanMedicalDeviceRegulationCosts" xlink:to="lab_hae_EuropeanMedicalDeviceRegulationCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_5e3ce47a-f535-49ab-ac0c-c20a6f0cb547_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and other expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_c7988e65-f35b-4d96-a283-b8c8939abc20_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b886e522-b46a-429d-819a-f54e7f6d7dff_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6fd5a3ec-21f5-4e38-9f5f-18ecc7fd4a79_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance as of March 28, 2020</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_427385f8-cf97-4cbe-83fc-00d6fb60e2b1_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance as of December 26, 2020</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_1d8b3ba9-875f-46df-9b1f-2dc7892f92f9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchased</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_OtherIncomeExpenseNetMember_7830c90b-dad7-45e3-8342-6bad64ac4d04_terseLabel_en-US" xlink:label="lab_hae_OtherIncomeExpenseNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and other expense, net</link:label>
    <link:label id="lab_hae_OtherIncomeExpenseNetMember_label_en-US" xlink:label="lab_hae_OtherIncomeExpenseNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income (Expense), Net [Member]</link:label>
    <link:label id="lab_hae_OtherIncomeExpenseNetMember_documentation_en-US" xlink:label="lab_hae_OtherIncomeExpenseNetMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income (Expense), Net [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_OtherIncomeExpenseNetMember" xlink:href="hae-20201226.xsd#hae_OtherIncomeExpenseNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_OtherIncomeExpenseNetMember" xlink:to="lab_hae_OtherIncomeExpenseNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_3c1fd190-4034-42c6-9ef6-c8149611999e_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_f0db6618-c509-4b5e-926b-3fbfedd2468a_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_50fd7b43-116a-41bd-8a9f-c29bf4cd1d28_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_f996b091-dbd4-4e1d-970e-7aa30adce9bc_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LEASES</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveAcceleratedDepreciation_206f6625-6ef4-4871-86fe-a918106800bf_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveAcceleratedDepreciation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PCS2 accelerated depreciation and related costs</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveAcceleratedDepreciation_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveAcceleratedDepreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Accelerated Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAcceleratedDepreciation" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserveAcceleratedDepreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveAcceleratedDepreciation" xlink:to="lab_us-gaap_RestructuringReserveAcceleratedDepreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_06c591c0-b5a7-497e-a7e2-ea25592679d5_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_14512616-2d65-45d3-99fa-b415a951b7b8_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_a5698368-6ea9-4e0d-8d7e-3c592e30a2ab_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AverageRemainingMaturityOfForeignCurrencyDerivatives1_0d88ca70-7811-4a69-8f00-9e7177cd907a_terseLabel_en-US" xlink:label="lab_us-gaap_AverageRemainingMaturityOfForeignCurrencyDerivatives1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturity period for foreign currency contracts</link:label>
    <link:label id="lab_us-gaap_AverageRemainingMaturityOfForeignCurrencyDerivatives1_label_en-US" xlink:label="lab_us-gaap_AverageRemainingMaturityOfForeignCurrencyDerivatives1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average Remaining Maturity of Foreign Currency Derivatives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AverageRemainingMaturityOfForeignCurrencyDerivatives1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AverageRemainingMaturityOfForeignCurrencyDerivatives1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AverageRemainingMaturityOfForeignCurrencyDerivatives1" xlink:to="lab_us-gaap_AverageRemainingMaturityOfForeignCurrencyDerivatives1" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_DisposalGroupNotDiscontinuedOperationsIncrementalLossOnClosingAdjustments_4e680c03-f617-4dcd-ab63-018f48a2b3ed_terseLabel_en-US" xlink:label="lab_hae_DisposalGroupNotDiscontinuedOperationsIncrementalLossOnClosingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental loss</link:label>
    <link:label id="lab_hae_DisposalGroupNotDiscontinuedOperationsIncrementalLossOnClosingAdjustments_label_en-US" xlink:label="lab_hae_DisposalGroupNotDiscontinuedOperationsIncrementalLossOnClosingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operations, Incremental Loss On Closing Adjustments</link:label>
    <link:label id="lab_hae_DisposalGroupNotDiscontinuedOperationsIncrementalLossOnClosingAdjustments_documentation_en-US" xlink:label="lab_hae_DisposalGroupNotDiscontinuedOperationsIncrementalLossOnClosingAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operations, Incremental Loss On Closing Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DisposalGroupNotDiscontinuedOperationsIncrementalLossOnClosingAdjustments" xlink:href="hae-20201226.xsd#hae_DisposalGroupNotDiscontinuedOperationsIncrementalLossOnClosingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_DisposalGroupNotDiscontinuedOperationsIncrementalLossOnClosingAdjustments" xlink:to="lab_hae_DisposalGroupNotDiscontinuedOperationsIncrementalLossOnClosingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_1b51c984-52bb-4403-af9d-84039b82a94a_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liabilities</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_RegulatoryBasedPaymentsMember_4f599080-4ac9-420b-8b9e-e15130629412_terseLabel_en-US" xlink:label="lab_hae_RegulatoryBasedPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regulatory Based Payments</link:label>
    <link:label id="lab_hae_RegulatoryBasedPaymentsMember_label_en-US" xlink:label="lab_hae_RegulatoryBasedPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regulatory Based Payments [Member]</link:label>
    <link:label id="lab_hae_RegulatoryBasedPaymentsMember_documentation_en-US" xlink:label="lab_hae_RegulatoryBasedPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regulatory Based Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_RegulatoryBasedPaymentsMember" xlink:href="hae-20201226.xsd#hae_RegulatoryBasedPaymentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_RegulatoryBasedPaymentsMember" xlink:to="lab_hae_RegulatoryBasedPaymentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_65d76250-fcd2-4f8e-a761-02ef2f605476_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Financial Assets and Financial Liabilities Measured at Fair Value on a Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_CorporateOperatingExpenses_28851c49-a5ac-4f9c-aeb5-d508535d41c6_negatedLabel_en-US" xlink:label="lab_hae_CorporateOperatingExpenses" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate expenses</link:label>
    <link:label id="lab_hae_CorporateOperatingExpenses_label_en-US" xlink:label="lab_hae_CorporateOperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Operating Expenses</link:label>
    <link:label id="lab_hae_CorporateOperatingExpenses_documentation_en-US" xlink:label="lab_hae_CorporateOperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_CorporateOperatingExpenses" xlink:href="hae-20201226.xsd#hae_CorporateOperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_CorporateOperatingExpenses" xlink:to="lab_hae_CorporateOperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_043ac71a-6da9-4f51-a8fa-3f59902f6623_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flows from Investing Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_87dfa9cb-29f2-4891-8165-382cf917e462_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_CardivaMember_0f333bb9-f20d-41da-9c91-7e0c3eb68aeb_terseLabel_en-US" xlink:label="lab_hae_CardivaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiva</link:label>
    <link:label id="lab_hae_CardivaMember_label_en-US" xlink:label="lab_hae_CardivaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiva [Member]</link:label>
    <link:label id="lab_hae_CardivaMember_documentation_en-US" xlink:label="lab_hae_CardivaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiva</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_CardivaMember" xlink:href="hae-20201226.xsd#hae_CardivaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_CardivaMember" xlink:to="lab_hae_CardivaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksMember_fa5435fe-985a-46b6-a62f-01e45b2c7194_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks</link:label>
    <link:label id="lab_us-gaap_TrademarksMember_label_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksMember" xlink:to="lab_us-gaap_TrademarksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_ccad0c1f-fc07-4044-a6e8-8b67ebd85cd9_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_OtherCountryorRegionMember_041c8647-5645-4db8-bb48-b952a30bf0ef_terseLabel_en-US" xlink:label="lab_hae_OtherCountryorRegionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_hae_OtherCountryorRegionMember_label_en-US" xlink:label="lab_hae_OtherCountryorRegionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Country or Region [Member]</link:label>
    <link:label id="lab_hae_OtherCountryorRegionMember_documentation_en-US" xlink:label="lab_hae_OtherCountryorRegionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Country or Region [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_OtherCountryorRegionMember" xlink:href="hae-20201226.xsd#hae_OtherCountryorRegionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_OtherCountryorRegionMember" xlink:to="lab_hae_OtherCountryorRegionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_e436078e-7143-4857-8214-a2d43a9024e8_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, net of cash transferred</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses, Net of Cash Divested</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AsiaMember_2be7c974-33a2-4827-b7dd-0742c571e7bb_terseLabel_en-US" xlink:label="lab_srt_AsiaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia</link:label>
    <link:label id="lab_srt_AsiaMember_label_en-US" xlink:label="lab_srt_AsiaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaMember" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_AsiaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AsiaMember" xlink:to="lab_srt_AsiaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_a06af8f2-883d-454b-a401-d2702fc69d4d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_ac301ffd-12b2-4686-b228-0be0fbfd8863_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_DisposalGroupIncludingDiscontinuedOperationConsiderationToBeReceived_d0271551-4fa0-4ae8-90e5-dc8fbd1550e1_terseLabel_en-US" xlink:label="lab_hae_DisposalGroupIncludingDiscontinuedOperationConsiderationToBeReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount received one year after closing date</link:label>
    <link:label id="lab_hae_DisposalGroupIncludingDiscontinuedOperationConsiderationToBeReceived_label_en-US" xlink:label="lab_hae_DisposalGroupIncludingDiscontinuedOperationConsiderationToBeReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration To Be Received</link:label>
    <link:label id="lab_hae_DisposalGroupIncludingDiscontinuedOperationConsiderationToBeReceived_documentation_en-US" xlink:label="lab_hae_DisposalGroupIncludingDiscontinuedOperationConsiderationToBeReceived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration To Be Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DisposalGroupIncludingDiscontinuedOperationConsiderationToBeReceived" xlink:href="hae-20201226.xsd#hae_DisposalGroupIncludingDiscontinuedOperationConsiderationToBeReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_DisposalGroupIncludingDiscontinuedOperationConsiderationToBeReceived" xlink:to="lab_hae_DisposalGroupIncludingDiscontinuedOperationConsiderationToBeReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_c99798fd-fcd1-4eea-bc6c-bdaf5e4ea3ea_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_67463aac-9651-4c07-8c74-1d4540da311e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Face amount of debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_1465250a-caa0-46bb-a3da-319fc99dad53_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted income (loss) per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_NonCashItemsAbstract_e44fc342-0ce6-4f35-9a9e-a034701e4131_terseLabel_en-US" xlink:label="lab_hae_NonCashItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash items:</link:label>
    <link:label id="lab_hae_NonCashItemsAbstract_label_en-US" xlink:label="lab_hae_NonCashItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Cash Items [Abstract]</link:label>
    <link:label id="lab_hae_NonCashItemsAbstract_documentation_en-US" xlink:label="lab_hae_NonCashItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Cash Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_NonCashItemsAbstract" xlink:href="hae-20201226.xsd#hae_NonCashItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_NonCashItemsAbstract" xlink:to="lab_hae_NonCashItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember_bde6ef92-8585-44c0-a5ad-316a86de17c0_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Technique, Discounted Cash Flow</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Technique, Discounted Cash Flow [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:to="lab_us-gaap_ValuationTechniqueDiscountedCashFlowMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_f1a14978-9b2c-461d-be26-73b0759a2146_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_ceac5d65-5831-43bb-928e-e5791bb05b9e_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_ad7695e9-0502-4d75-805b-2457f60bfaf6_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_18df69d6-6276-49f0-a52a-01e6b449c50f_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_f6f67526-9082-44e8-af84-95cf6873b70c_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a9b791be-b449-4675-a4e8-d42979920fce_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_e432134f-842c-4a8b-b554-48b3863ba89c_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_60160e48-fd22-49b1-8391-d0aacb9406fd_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_e0660269-86ad-47b4-9399-370ef5577d80_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_ac2a81dc-9fd7-4eca-b062-a9a3638a2df8_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_117a0222-d2a5-4918-9e40-ab2007f841c1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified from Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_BloodCenterProductsandServicesMember_d909b6c7-0040-4eae-b9fa-86a0a8dfa951_terseLabel_en-US" xlink:label="lab_hae_BloodCenterProductsandServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blood Center products and services</link:label>
    <link:label id="lab_hae_BloodCenterProductsandServicesMember_label_en-US" xlink:label="lab_hae_BloodCenterProductsandServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blood Center Products and Services [Member]</link:label>
    <link:label id="lab_hae_BloodCenterProductsandServicesMember_documentation_en-US" xlink:label="lab_hae_BloodCenterProductsandServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blood Center Products and Services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_BloodCenterProductsandServicesMember" xlink:href="hae-20201226.xsd#hae_BloodCenterProductsandServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_BloodCenterProductsandServicesMember" xlink:to="lab_hae_BloodCenterProductsandServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_5ed6df91-154a-47c2-bef0-a7e5607ac2b9_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_71c8cb47-ba40-415b-a2fc-e810f90f95f7_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Fair Value, Gross Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_3cbdae76-7f44-4a4b-8f0c-c042628fd068_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_b27b807d-ae0e-42a1-9482-3db4c189b2ad_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_3c81b805-c19a-43f2-a042-f38712d600da_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_14d4fe4f-9720-48a2-b54c-daf6ccbde675_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_be1ca7cd-9666-40fe-ab0d-bef20b3369f9_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee stock purchase plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_168e49e2-5174-44eb-b217-6f922a3334c6_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets fair value</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_3c066ce3-04b9-4960-8fe9-74a68f587413_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt_d4c9aecc-f7cc-4f81-8daa-29ffdbddd402_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from term loan</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Secured Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_e1214703-2d09-4468-b8aa-c889b7eba385_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_964fcfb4-4198-410c-b54f-e7dd98a173ff_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax asset</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_1d40cb93-ffc8-4651-b6bb-ec872309925b_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_dd89456a-4e4d-410f-90b4-0c8f2a2023f1_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_5a2f9316-40af-4eaa-877e-922915b5e475_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of business units</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_0ebf0897-1813-4434-b366-91d394ec2cd1_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_1c569132-94f0-4ff0-bd04-fcfa7969d39e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_97feb389-1cdb-4a63-b6c0-5a88f5017a63_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flows from Operating Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_7c5e8170-6df8-40a5-826f-048a9a5a2d56_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP_fbbd293b-deb9-4978-8690-d37e40461bb5_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Ownership Plan (ESOP), Cash Contributions to ESOP</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP" xlink:to="lab_us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_9f532ce1-2a4b-4575-84f7-886b9ed09669_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net effect of common stock equivalents (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number Diluted Shares Outstanding Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EuropeMember_d372c90b-fc05-4108-bcef-025b3341133d_terseLabel_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe</link:label>
    <link:label id="lab_srt_EuropeMember_label_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_EuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember" xlink:to="lab_srt_EuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtTypeDomain_cd5218fa-c599-41ba-808c-42963a1b0e45_terseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:to="lab_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_ed71c9b6-a5bf-4165-9c64-d365df2bf263_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_ed477def-953c-4fb0-a59a-920aa07da9a4_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_17e94fac-4b35-4e3a-b665-30ea69c194dd_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_23c81bba-f8f2-481c-967e-cc436b5702cf_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_c6b2c31a-22b3-4175-a6ef-11c720ce56b9_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_acd55f0c-1648-4976-8bea-5fb7da51d05f_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_0805b227-5840-4bbc-a1b0-00d3b0f20dcd_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, less accumulated amortization of $309,951 at December 26, 2020 and $296,942 at March 28, 2020</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_5792e03e-b6c6-4024-b7b6-df1791dcfc58_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_334256c8-2971-4c30-ad6c-bf1592f10871_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount received for divestiture</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_7402cb35-f624-49ff-b628-1b702889f287_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_085cfc4d-7e98-4388-b0ff-7a596b624ee2_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RESTRUCTURING</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_cd29aae7-4d47-4984-a316-e41a6d6563f9_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c114b4de-20bd-4654-b8e0-43bdeb5e2a23_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_98a2961d-2629-4580-bad8-491749a94b7c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_4a6ab615-83b0-4ba3-90fd-a22ee677e203_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_48f02e28-bca6-4ecf-a67a-550ae3b3cc9e_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Disclosures of Cash Flow Information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_5bf366b0-4660-4bc0-ac5c-7a2b34450c31_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_e8e21ca1-dd61-49cf-bf05-055d72095567_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities assumed</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_80739aec-f1bc-41aa-916b-a244ce4ee2f8_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract assets</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNet" xlink:to="lab_us-gaap_ContractWithCustomerAssetNet" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_OperatingExpensesTransactionCosts_fd12fdf8-e024-4659-8da7-c0e28e1f224d_negatedTerseLabel_en-US" xlink:label="lab_hae_OperatingExpensesTransactionCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction costs</link:label>
    <link:label id="lab_hae_OperatingExpensesTransactionCosts_label_en-US" xlink:label="lab_hae_OperatingExpensesTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses, Transaction Costs</link:label>
    <link:label id="lab_hae_OperatingExpensesTransactionCosts_documentation_en-US" xlink:label="lab_hae_OperatingExpensesTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses, Transaction Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_OperatingExpensesTransactionCosts" xlink:href="hae-20201226.xsd#hae_OperatingExpensesTransactionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_OperatingExpensesTransactionCosts" xlink:to="lab_hae_OperatingExpensesTransactionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_HASIntellectualPropertyMember_18b82938-1556-43b0-a682-78d91e0bf43c_terseLabel_en-US" xlink:label="lab_hae_HASIntellectualPropertyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HAS Intellectual Property</link:label>
    <link:label id="lab_hae_HASIntellectualPropertyMember_label_en-US" xlink:label="lab_hae_HASIntellectualPropertyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HAS Intellectual Property [Member]</link:label>
    <link:label id="lab_hae_HASIntellectualPropertyMember_documentation_en-US" xlink:label="lab_hae_HASIntellectualPropertyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HAS Intellectual Property</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_HASIntellectualPropertyMember" xlink:href="hae-20201226.xsd#hae_HASIntellectualPropertyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_HASIntellectualPropertyMember" xlink:to="lab_hae_HASIntellectualPropertyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_ec26eb0c-4149-4564-acc0-71a823ede534_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_5144a935-f9ca-490e-bbbf-3f71b76adbe3_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_da8ab5a9-530b-4c82-b3b2-10ea2e4e4fdd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchased (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_5ba0dd4d-4e08-440b-86f1-a816c89ff79d_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal repayments, fiscal 2022</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Maturities, Repayments of Principal in Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_InlogHoldingsFranceMember_cd99c610-bde4-41d2-9177-723c03e167e2_terseLabel_en-US" xlink:label="lab_hae_InlogHoldingsFranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inlog Holdings France [Member]</link:label>
    <link:label id="lab_hae_InlogHoldingsFranceMember_label_en-US" xlink:label="lab_hae_InlogHoldingsFranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inlog Holdings France [Member]</link:label>
    <link:label id="lab_hae_InlogHoldingsFranceMember_documentation_en-US" xlink:label="lab_hae_InlogHoldingsFranceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inlog Holdings France</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_InlogHoldingsFranceMember" xlink:href="hae-20201226.xsd#hae_InlogHoldingsFranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_InlogHoldingsFranceMember" xlink:to="lab_hae_InlogHoldingsFranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_51e609ed-8371-4630-b6cb-b8ab096cf254_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes paid</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_c376d056-9e8f-498e-9cb3-7ef859aaf559_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic EPS</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_91a28afd-a943-4e66-ab58-96aa24b80938_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring liability</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_73cc921f-4c6c-48b7-9cd9-0b00804e89f9_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at March 28, 2020</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_da2aa216-4494-4de8-98c9-90a5cca3a8c8_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at December 26, 2020</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_770b8f04-7d7c-4a33-8ea2-83b0d3836044_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write-offs</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Writeoff</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_18ea7e5c-30d1-4db4-92c6-c073a0f94e2f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NOTES&#160;PAYABLE AND LONG-TERM DEBT</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFixedInterestRate_090e3ce7-3971-4e02-9d1b-419ae1ef0dca_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative fixed interest rate</link:label>
    <link:label id="lab_us-gaap_DerivativeFixedInterestRate_label_en-US" xlink:label="lab_us-gaap_DerivativeFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Fixed Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFixedInterestRate" xlink:to="lab_us-gaap_DerivativeFixedInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_814e27e4-292c-4375-b4a1-d27831e45f44_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative costs to date</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Cost Incurred to Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_2c69e914-d26c-4919-89c4-8007e198aa92_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage_6f1e329f-8bef-4ef7-80b2-ff3253e4115d_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance obligation percent</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_72ec04ac-a1e4-4768-bb43-bf8e90edadad_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_34d51334-b77b-4e98-ac6b-a4dc339496a2_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_RestructuringChargesPayableInNextTwelveMonths_ad36e84c-6a9e-47bc-b258-0f590e28d85a_terseLabel_en-US" xlink:label="lab_hae_RestructuringChargesPayableInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring liability payable in next twelve months</link:label>
    <link:label id="lab_hae_RestructuringChargesPayableInNextTwelveMonths_label_en-US" xlink:label="lab_hae_RestructuringChargesPayableInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges Payable In Next Twelve Months</link:label>
    <link:label id="lab_hae_RestructuringChargesPayableInNextTwelveMonths_documentation_en-US" xlink:label="lab_hae_RestructuringChargesPayableInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges Payable In Next Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_RestructuringChargesPayableInNextTwelveMonths" xlink:href="hae-20201226.xsd#hae_RestructuringChargesPayableInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_RestructuringChargesPayableInNextTwelveMonths" xlink:to="lab_hae_RestructuringChargesPayableInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_314f761c-419c-44dd-aad4-babe080174e6_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_6f61a63b-dbc4-4741-8b1f-143b0ce10e24_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_2fd000e4-f7ce-4158-bbbb-dce2c52107e0_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_e64a5777-0925-4604-a156-3edec91d6a79_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_5f80514a-675a-4476-a9f9-18308b41f1e8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share Reconciliation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_9eca9a8b-781a-4833-9214-2838c7a4f1ae_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in other assets and other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_c3204761-b1f8-4701-92d6-772c8f03b095_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, net of current maturities</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_0dd662c9-d816-459b-b4ab-d0e0f547c551_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) to be reclassified within the next twelve months</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:to="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_65ecbcd3-231d-4878-bc28-b65448c51238_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_fbcbd044-88a9-473c-a2d8-83995759e556_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_1edaaa78-1143-48e7-b7a5-e2159b3be429_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued payroll and related costs</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_0ef997ad-052d-43e2-89dd-3b75d713b4db_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_7005ae40-2db7-4341-a6e7-39600f21362e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_7f3b2dbf-463d-4a02-93b0-d883adfb892f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_AssetAcquisitionDomain_70fe1c5e-159b-4fd0-ac02-9adc0e9e90e3_terseLabel_en-US" xlink:label="lab_hae_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:label id="lab_hae_AssetAcquisitionDomain_label_en-US" xlink:label="lab_hae_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:label id="lab_hae_AssetAcquisitionDomain_documentation_en-US" xlink:label="lab_hae_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_AssetAcquisitionDomain" xlink:href="hae-20201226.xsd#hae_AssetAcquisitionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_AssetAcquisitionDomain" xlink:to="lab_hae_AssetAcquisitionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_988a43e5-87d5-4f23-8a89-27c7ad42eacb_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RECENT ACCOUNTING PRONOUNCEMENTS</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements and Changes in Accounting Principles [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_62d9696b-25a7-4359-a16b-eb80a95dfa25_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_ManufacturingSpaceSecondRenewalTermMember_b93d51da-9c61-4bef-b85f-0584b78873ea_terseLabel_en-US" xlink:label="lab_hae_ManufacturingSpaceSecondRenewalTermMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing Space, Second Renewal Term [Member]</link:label>
    <link:label id="lab_hae_ManufacturingSpaceSecondRenewalTermMember_label_en-US" xlink:label="lab_hae_ManufacturingSpaceSecondRenewalTermMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing Space, Second Renewal Term [Member]</link:label>
    <link:label id="lab_hae_ManufacturingSpaceSecondRenewalTermMember_documentation_en-US" xlink:label="lab_hae_ManufacturingSpaceSecondRenewalTermMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing Space, Second Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_ManufacturingSpaceSecondRenewalTermMember" xlink:href="hae-20201226.xsd#hae_ManufacturingSpaceSecondRenewalTermMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_ManufacturingSpaceSecondRenewalTermMember" xlink:to="lab_hae_ManufacturingSpaceSecondRenewalTermMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a0269eb4-c186-4a68-a7d5-99c03ef421ea_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAxis_83353d30-3333-4458-8358-e5170818f898_terseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt [Axis]</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAxis_label_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ExtinguishmentOfDebtAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAxis" xlink:to="lab_us-gaap_ExtinguishmentOfDebtAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_2e3f20d6-d4f8-4821-9763-60f659ccc036_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_df42eb53-0487-49b6-b3b8-ffbc174fe003_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selected Information by Business Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_a075f53e-b255-4149-b9f7-9c8a7e567a04_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6860b280-c49c-44c0-9dd7-4c190556deba_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flows from Financing Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_1f4202a1-2236-4bb7-a35b-9ca3438c4928_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_15b6b6f7-b7fb-40d9-a0f5-a1449869d510_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net current period other comprehensive income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_a8c652b1-eb3a-48a7-a043-6d4ea6aff14c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6d873d08-988b-4840-a0bd-32f0613899c1_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_542d1d0f-13e6-4dd3-99f0-88d126a10e4b_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_69fbd96a-90b5-4a42-8f61-8245ee3fd5a3_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt outstanding</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f7b0418a-d098-43d3-aed2-decd114e159a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_206a803c-f8b3-4e63-acf7-ba331f3ce3f4_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_476bac51-c152-4f21-a048-bba7dd1b4596_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value of Derivative Instruments as They Appear in Consolidated Balance Sheets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_2f84e298-d28f-490f-b673-9b59946e96e3_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_034d60c7-4328-49b0-b11a-524583a236f5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_0c48b5d9-dfec-4416-843b-a3f78f3ced62_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_418025ed-1aa6-44b8-b4a6-4e05aad10bcd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit (gain) loss</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueAxis_249e0f4b-a3e8-4566-8aba-a76874aa3fb8_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueAxis_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueAxis" xlink:to="lab_us-gaap_ValuationTechniqueAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_5356f1cc-56c7-4c07-89f5-7ce19f6f82fd_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_62cb1236-1e88-4036-8452-5bd3ef73da0f_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">REVENUE</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f59d977b-b4ac-444f-8fa1-e91af18e3420_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_59ace26f-8406-4fa7-9f8d-dc1b4fb027cd_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liability</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_0098c0c1-e12b-4492-bdba-b52f35e1a3d2_verboseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_73ff7e3c-7e6b-40ec-b13a-5906a409d086_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_e32b5ac9-d828-4f55-9b96-eb16ca54fdf5_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money market funds</link:label>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:to="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_db8df2fa-ce30-4b4f-acdb-1e5de3048aa6_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of restricted stock, net of cancellations</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueDomain_328d5996-ca77-4eec-a66d-0286fa793282_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueDomain_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueDomain" xlink:to="lab_us-gaap_ValuationTechniqueDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_eacd4368-5c37-4196-b92e-cf6be0cc95e9_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal repayments, fiscal 2021</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Maturities, Repayments of Principal in Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_9f1508e7-33b5-4969-87c9-37236015b391_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_63c712ee-6e69-48d7-96b2-5fe7d3e923db_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2444f0d4-ee48-4506-8182-11f42973918e_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_PercentageOfNetSalesGeneratedOutsideOfUs_a86d3af0-e632-4766-b8a6-75417582c011_terseLabel_en-US" xlink:label="lab_hae_PercentageOfNetSalesGeneratedOutsideOfUs" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of sales generated outside the US</link:label>
    <link:label id="lab_hae_PercentageOfNetSalesGeneratedOutsideOfUs_label_en-US" xlink:label="lab_hae_PercentageOfNetSalesGeneratedOutsideOfUs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Net Sales Generated Outside Of The US</link:label>
    <link:label id="lab_hae_PercentageOfNetSalesGeneratedOutsideOfUs_documentation_en-US" xlink:label="lab_hae_PercentageOfNetSalesGeneratedOutsideOfUs" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Net Sales Generated Outside Of The US</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_PercentageOfNetSalesGeneratedOutsideOfUs" xlink:href="hae-20201226.xsd#hae_PercentageOfNetSalesGeneratedOutsideOfUs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_PercentageOfNetSalesGeneratedOutsideOfUs" xlink:to="lab_hae_PercentageOfNetSalesGeneratedOutsideOfUs" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_f6bd47fc-e0d9-4512-86c1-9b83634af2dd_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_b18789bd-4a6c-467e-b6ce-49698374d8f1_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_2d7eb850-1483-4a44-9ab5-08a784a9a1b6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_afd4a385-7379-4c73-adcb-c6c0e413669f_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront payment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_28da7e09-072c-4301-a116-b6413a8ddaec_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_RestructuringandRestructuringRelatedCosts_3bd1f3d0-d046-4cfc-8d40-a9a4b18ca0d5_terseLabel_en-US" xlink:label="lab_hae_RestructuringandRestructuringRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and turnaround costs</link:label>
    <link:label id="lab_hae_RestructuringandRestructuringRelatedCosts_2711ad0d-1a73-4a97-88a1-b81e0e4f2507_totalLabel_en-US" xlink:label="lab_hae_RestructuringandRestructuringRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total restructuring and turnaround costs</link:label>
    <link:label id="lab_hae_RestructuringandRestructuringRelatedCosts_label_en-US" xlink:label="lab_hae_RestructuringandRestructuringRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Restructuring Related Costs</link:label>
    <link:label id="lab_hae_RestructuringandRestructuringRelatedCosts_documentation_en-US" xlink:label="lab_hae_RestructuringandRestructuringRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Restructuring Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_RestructuringandRestructuringRelatedCosts" xlink:href="hae-20201226.xsd#hae_RestructuringandRestructuringRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_RestructuringandRestructuringRelatedCosts" xlink:to="lab_hae_RestructuringandRestructuringRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_8090ceeb-61d3-47d7-a875-aaaee55da076_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_b95d1966-64e2-4f5b-aae8-0ffb0751d20d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_c9fec232-08d3-4d2d-840a-646900f9f27a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_a2f19ddf-2639-4171-a81f-70a21df30bed_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities fair value</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial and Nonfinancial Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_585a2501-b800-4439-82e1-719ee1968bf6_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs incurred, net of reversals</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_ca645fbd-c12b-459c-9e8a-7f4c0b060d6f_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring costs</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_51f236af-e03d-4fad-801f-6fc2c266dd6a_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e169a854-fb15-4b64-9ebe-81a4ca9ee62c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_ManufacturingSpaceMember_92022c9c-11d4-47f6-a753-ed7a9ba594e9_terseLabel_en-US" xlink:label="lab_hae_ManufacturingSpaceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing Space [Member]</link:label>
    <link:label id="lab_hae_ManufacturingSpaceMember_label_en-US" xlink:label="lab_hae_ManufacturingSpaceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing Space [Member]</link:label>
    <link:label id="lab_hae_ManufacturingSpaceMember_documentation_en-US" xlink:label="lab_hae_ManufacturingSpaceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing Space</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_ManufacturingSpaceMember" xlink:href="hae-20201226.xsd#hae_ManufacturingSpaceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_ManufacturingSpaceMember" xlink:to="lab_hae_ManufacturingSpaceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_41f824c6-a633-4f48-9db0-29fce6073294_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration transferred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_6acbefe1-0d33-452e-b750-51e9c0438654_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-cash operating activities</link:label>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_label_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Activities, Cash Flow Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:to="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_18e51f73-5a6c-48f4-85a0-82cd4620e05a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_805a77b0-2237-4c9f-a49c-62acd23f7e26_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_90b2ec6e-2f6c-4f05-b837-86a291d34287_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_6bfd0f08-dcf6-4e64-ae89-d158675eebef_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_8cb87deb-42bd-4e85-a9d5-40921dd4e5e5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_a43de574-5a0c-4b3d-b8ce-1be18e289468_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_a10036d3-d3de-4194-bf9c-897f69bfcfd9_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_17a616f9-d8df-4274-96af-a4426c208146_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_28c0db97-a03d-4df5-a6fd-ea8ca7667d22_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_cb504ef8-d203-40cb-a978-0941fdb02d5d_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring" xlink:to="lab_us-gaap_PaymentsForRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_39d6cd3f-3aa8-4173-b720-5c11307cdd44_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of assets</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_cf0cafdd-74a9-4597-ac48-0bb5b413f56c_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_cc274009-21ef-4de8-bc6e-b64058067268_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7f891c59-2911-41a5-87a3-e3311bb51263_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_e7b6b32b-b616-4ec7-8de9-b040dc4f33ed_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes_f4c2d5f9-2d3c-4827-b4a1-659662087d82_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in prepaid income taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_RevenueBasedPaymentsMember_a932fcdc-6d6a-4ce3-ad90-7dce368d4ca9_terseLabel_en-US" xlink:label="lab_hae_RevenueBasedPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Based Payments</link:label>
    <link:label id="lab_hae_RevenueBasedPaymentsMember_label_en-US" xlink:label="lab_hae_RevenueBasedPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Based Payments [Member]</link:label>
    <link:label id="lab_hae_RevenueBasedPaymentsMember_documentation_en-US" xlink:label="lab_hae_RevenueBasedPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Based Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_RevenueBasedPaymentsMember" xlink:href="hae-20201226.xsd#hae_RevenueBasedPaymentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_RevenueBasedPaymentsMember" xlink:to="lab_hae_RevenueBasedPaymentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_ea9015e0-5b6b-4e85-bcf5-c45fedd017b5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_07a25946-50b7-4a91-b7f1-edfb80898694_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_4339599f-bce4-4512-95f7-dd32cb4d6082_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EARNINGS PER SHARE (EPS)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_a3722b22-36e4-49e3-9a5e-e2b44726cf30_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_country_JP_fd53d306-1684-4931-b63c-55c7ea7fe6f1_terseLabel_en-US" xlink:label="lab_country_JP" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Japan</link:label>
    <link:label id="lab_country_JP_label_en-US" xlink:label="lab_country_JP" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">JAPAN</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_JP" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_JP"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_JP" xlink:to="lab_country_JP" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_d35478f2-5251-48c6-a3e1-fc04f3e9d106_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_13508ab0-f7ec-494a-970a-90ff6232fddd_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_68d95c4e-ce74-4e68-b534-9d7e8efc58e1_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_0df88367-f2f9-449d-bc67-fa72fb30236c_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_e5b70a24-ae71-46be-9175-23858f49f71c_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of goods sold</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_6d1aa2a0-ce96-4c9d-9ab6-c9e33cfe519f_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_d0b554d6-2438-4487-bfda-2ca962764127_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_RestructuringandTurnaroundCosts_e89d8862-97ad-4582-b53e-4dce92b653e2_negatedTerseLabel_en-US" xlink:label="lab_hae_RestructuringandTurnaroundCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and turnaround costs</link:label>
    <link:label id="lab_hae_RestructuringandTurnaroundCosts_label_en-US" xlink:label="lab_hae_RestructuringandTurnaroundCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Turnaround Costs</link:label>
    <link:label id="lab_hae_RestructuringandTurnaroundCosts_documentation_en-US" xlink:label="lab_hae_RestructuringandTurnaroundCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Turnaround Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_RestructuringandTurnaroundCosts" xlink:href="hae-20201226.xsd#hae_RestructuringandTurnaroundCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_RestructuringandTurnaroundCosts" xlink:to="lab_hae_RestructuringandTurnaroundCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_DerivativePercentofDebtExposed_e615ec9b-4e2c-4d00-8ac4-390e92d7cfb2_terseLabel_en-US" xlink:label="lab_hae_DerivativePercentofDebtExposed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt exposed to interest rate risk</link:label>
    <link:label id="lab_hae_DerivativePercentofDebtExposed_label_en-US" xlink:label="lab_hae_DerivativePercentofDebtExposed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Percent of Debt Exposed</link:label>
    <link:label id="lab_hae_DerivativePercentofDebtExposed_documentation_en-US" xlink:label="lab_hae_DerivativePercentofDebtExposed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Percent of Debt Exposed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DerivativePercentofDebtExposed" xlink:href="hae-20201226.xsd#hae_DerivativePercentofDebtExposed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_DerivativePercentofDebtExposed" xlink:to="lab_hae_DerivativePercentofDebtExposed" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_01281d29-f9aa-47f2-a0de-bc40bd22fb6a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_dcd33ca6-df68-4894-a9b6-0c47d3161c88_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACQUISITION</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_38d6a3ee-add5-4df9-9ee0-4b94d50b97b8_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.01 par value; Authorized &#8212; 150,000,000 shares; Issued and outstanding &#8212; 50,817,222 shares at December 26, 2020 and 50,322,930 shares at March 28, 2020</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_38589439-f8c4-46f4-bda5-3b40a8ae51c3_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredOtherTaxExpenseBenefit_d418be4b-5353-49ad-84d5-be62df8daf9e_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredOtherTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax benefit</link:label>
    <link:label id="lab_us-gaap_DeferredOtherTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredOtherTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Other Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredOtherTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredOtherTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredOtherTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredOtherTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_21eaefd3-ac1e-44bb-bac1-4b6cda587f37_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal repayments, fiscal 2020</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Maturities, Repayments of Principal, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_daefa5fb-e159-4cca-b7ac-66e520d24593_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward" xlink:to="lab_us-gaap_RestructuringReserveRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_a0857e62-5a37-479f-ba2b-cce55d861e8c_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from divestitures</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_284d86af-4efb-42e1-b024-8e454a6083a3_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_d589412a-fa5b-44c9-858f-89db7ce3fef0_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_912a72fe-ace6-49b4-bcfa-8f38f22663bf_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents at Beginning of Period</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_ce6bf980-7df0-429a-803d-b822eb70db84_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents at End of Period</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed_86d4dea7-d8a8-48a5-a8c8-fd0a3a104c60_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition related costs incurred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Separately Recognized Transactions, Additional Disclosures, Acquisition Cost Expensed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed" xlink:to="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_1df3ea19-1f0e-46a6-9639-4740979d6ca9_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues by Product Line and Geographic Regions</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Revenue from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForLoanLeaseAndOtherLosses_1a381978-65bb-4e14-81b3-39a608da17d2_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForLoanLeaseAndOtherLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for losses on accounts receivable and inventory</link:label>
    <link:label id="lab_us-gaap_ProvisionForLoanLeaseAndOtherLosses_label_en-US" xlink:label="lab_us-gaap_ProvisionForLoanLeaseAndOtherLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for Loan, Lease, and Other Losses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForLoanLeaseAndOtherLosses" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProvisionForLoanLeaseAndOtherLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForLoanLeaseAndOtherLosses" xlink:to="lab_us-gaap_ProvisionForLoanLeaseAndOtherLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_6e1bbfd4-5566-4e97-9f55-437ee86f52c6_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected cost</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5a73d644-8d7b-4be5-bbbf-cbf21dac16e2_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a10acf95-a5cf-4f5f-a964-688e6c9583d6_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_a384c0cb-0bb4-4ba8-8d79-7fc3045af0c0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_576b1474-aa54-4b09-99d4-fdc1bafb3bdf_terseLabel_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_label_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:to="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_3df1ad88-8dd2-4198-86d3-303aacf9ceb3_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_63977410-f8bb-4610-902c-002b0849f7b2_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_f4ca82ed-5f8e-44a0-bba5-1ac630a00690_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_7450bf3b-3785-4fa0-bd66-eeffc846e075_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ee878126-a3cb-4b52-8625-ca6e133541dd_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_USBloodDonorManagementSoftwareMember_7255cbe3-7483-41ae-a9b4-303ff28be926_terseLabel_en-US" xlink:label="lab_hae_USBloodDonorManagementSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Blood Donor Management Software [Member]</link:label>
    <link:label id="lab_hae_USBloodDonorManagementSoftwareMember_label_en-US" xlink:label="lab_hae_USBloodDonorManagementSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Blood Donor Management Software [Member]</link:label>
    <link:label id="lab_hae_USBloodDonorManagementSoftwareMember_documentation_en-US" xlink:label="lab_hae_USBloodDonorManagementSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Blood Donor Management Software</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_USBloodDonorManagementSoftwareMember" xlink:href="hae-20201226.xsd#hae_USBloodDonorManagementSoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_USBloodDonorManagementSoftwareMember" xlink:to="lab_hae_USBloodDonorManagementSoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_3d983bc9-1b94-4246-814f-6a0f4bd5baed_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_5440b557-25cf-4995-a74a-794e48b7ea61_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_b6f562c4-413a-4c92-a885-efe4d649dfeb_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_6254f520-6b2f-4843-93ab-3b97b5caf8cf_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_de6890f9-b39d-4d62-a3cf-f363ec53ceb4_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Unrealized Gain/Loss on Derivatives</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:to="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet_e73d119a-c52c-4a08-bbeb-c5e7e9e6e8fa_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-designated foreign currency hedge contracts outstanding</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Derivative Instruments Not Designated as Hedging Instruments at Fair Value, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet" xlink:to="lab_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_7c34e8ac-cbd0-46e2-80c7-563b5c2cb410_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_78ad4897-532a-41ef-b585-e227acc33917_periodStartLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_160b09de-16fe-4a8a-94da-c13262f22af0_periodEndLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_EffectofExchangeRateonRevenues_31ffcdb6-d0bd-429f-a933-c70ae9fa01b8_terseLabel_en-US" xlink:label="lab_hae_EffectofExchangeRateonRevenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rates</link:label>
    <link:label id="lab_hae_EffectofExchangeRateonRevenues_label_en-US" xlink:label="lab_hae_EffectofExchangeRateonRevenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Revenues</link:label>
    <link:label id="lab_hae_EffectofExchangeRateonRevenues_documentation_en-US" xlink:label="lab_hae_EffectofExchangeRateonRevenues" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EffectofExchangeRateonRevenues" xlink:href="hae-20201226.xsd#hae_EffectofExchangeRateonRevenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_EffectofExchangeRateonRevenues" xlink:to="lab_hae_EffectofExchangeRateonRevenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_f8b8baac-1807-4aea-b515-49d00fd73440_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_de473c01-e0ec-4551-8dee-45722625fcfc_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_f5714a85-32b6-4b1b-a476-b0e91ee010f5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_81b3bedc-6754-46d5-94a6-082f409a988e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_eff0d40d-cbb9-4051-aae0-7a0acfcd8abe_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anti-dilutive shares (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_38137ab6-b27a-45a7-b35a-40d4f40ada8a_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_PlasmaProductsandServicesMember_71c669eb-36c0-4f4a-bacd-3267f6bc856c_terseLabel_en-US" xlink:label="lab_hae_PlasmaProductsandServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plasma products and services</link:label>
    <link:label id="lab_hae_PlasmaProductsandServicesMember_label_en-US" xlink:label="lab_hae_PlasmaProductsandServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plasma Products and Services [Member]</link:label>
    <link:label id="lab_hae_PlasmaProductsandServicesMember_documentation_en-US" xlink:label="lab_hae_PlasmaProductsandServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plasma Products and Services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_PlasmaProductsandServicesMember" xlink:href="hae-20201226.xsd#hae_PlasmaProductsandServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_PlasmaProductsandServicesMember" xlink:to="lab_hae_PlasmaProductsandServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_RestructuringRelatedCosts_380d1e88-17de-4a27-9081-b101f0bacc74_terseLabel_en-US" xlink:label="lab_hae_RestructuringRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Turnaround costs</link:label>
    <link:label id="lab_hae_RestructuringRelatedCosts_label_en-US" xlink:label="lab_hae_RestructuringRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Related Costs</link:label>
    <link:label id="lab_hae_RestructuringRelatedCosts_documentation_en-US" xlink:label="lab_hae_RestructuringRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_RestructuringRelatedCosts" xlink:href="hae-20201226.xsd#hae_RestructuringRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_RestructuringRelatedCosts" xlink:to="lab_hae_RestructuringRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_bf0f941f-6cfd-400e-918f-84a608e0bf2f_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_cb1dc7ad-7e6f-4c4c-acf3-1c2dbaae445c_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_b98af428-0982-4761-8b90-78be15ea2579_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_7d4eef03-de84-4bc4-b8c5-4d1e1b6b6d32_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_85c63654-7930-47f7-add1-49e7e57b041f_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_e75ad36d-d731-4f9b-adc6-6d073b765124_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_f9b6b1b3-055b-4d7c-9a5a-0bf2922d9f25_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in contract liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_766d0666-81d9-4f1d-8982-c301d3e71f19_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_47ec8b4e-6f08-471f-bf6d-3060a4c596f3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_abb2c2a9-97e3-4de7-a200-99f3b1d39f78_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_e4d5e436-13e6-4151-818d-78767bd06290_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uncommitted Operating Lines of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1fe8e771-d7ed-4d5c-9039-4a75426ca915_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_ec6f046f-ddbe-41b8-915a-45bfd2f28c95_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_28159249-6ba3-49a9-8ce2-8ed901bb9f03_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Amortization Period</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMember_a078fb65-b9a1-4ae1-891c-cecc4315f63b_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facilities</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMember_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMember" xlink:to="lab_us-gaap_LongTermDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_42273b98-c967-4ac3-bf16-c4abdb2e62a8_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_706a49ad-7f4e-471b-8bcb-10ef66819deb_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_f3598f7e-be97-4d88-b65d-a3545a188216_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_3fde189d-41de-48ed-88ff-2866d50f023f_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain" xlink:to="lab_us-gaap_RestructuringPlanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_hae_GainLossOnDivestitureAndSaleOfAssets_4a396700-b8cf-490e-ad1f-357f6813d49e_negatedTerseLabel_en-US" xlink:label="lab_hae_GainLossOnDivestitureAndSaleOfAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains on divestitures and sale of assets</link:label>
    <link:label id="lab_hae_GainLossOnDivestitureAndSaleOfAssets_label_en-US" xlink:label="lab_hae_GainLossOnDivestitureAndSaleOfAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Divestiture and Sale of Assets</link:label>
    <link:label id="lab_hae_GainLossOnDivestitureAndSaleOfAssets_documentation_en-US" xlink:label="lab_hae_GainLossOnDivestitureAndSaleOfAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Divestiture and Sale of Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hae_GainLossOnDivestitureAndSaleOfAssets" xlink:href="hae-20201226.xsd#hae_GainLossOnDivestitureAndSaleOfAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hae_GainLossOnDivestitureAndSaleOfAssets" xlink:to="lab_hae_GainLossOnDivestitureAndSaleOfAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_8b340ee5-f95f-4751-94d8-a971bed490cf_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Assets</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Fair Value, Gross Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_d421ddf0-7991-4bad-bc4b-7d236ae13194_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>14
<FILENAME>hae-20201226_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:dcc831a0-a182-47d6-a94e-5adaefe7bce2,g:c7d71817-1258-4da0-86ec-9eebc508e513-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION" xlink:type="simple" xlink:href="hae-20201226.xsd#DOCUMENTANDENTITYINFORMATION"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_023246c9-78e5-4bd3-910c-77421483d9e9" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_3174589e-9b43-4634-a035-7978d95feda4" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_023246c9-78e5-4bd3-910c-77421483d9e9" xlink:to="loc_dei_DocumentType_3174589e-9b43-4634-a035-7978d95feda4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_25c050af-6c58-4648-bdf4-2bea20ff36e8" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_023246c9-78e5-4bd3-910c-77421483d9e9" xlink:to="loc_dei_DocumentQuarterlyReport_25c050af-6c58-4648-bdf4-2bea20ff36e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_6a27d1a3-1797-4c18-b399-4007a8850b6b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_023246c9-78e5-4bd3-910c-77421483d9e9" xlink:to="loc_dei_DocumentPeriodEndDate_6a27d1a3-1797-4c18-b399-4007a8850b6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_9a934bff-8c01-41de-adb3-afafa9c5104d" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_023246c9-78e5-4bd3-910c-77421483d9e9" xlink:to="loc_dei_DocumentTransitionReport_9a934bff-8c01-41de-adb3-afafa9c5104d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_c76af9b2-7bc6-4f5b-8ae9-f0a511c6826d" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_023246c9-78e5-4bd3-910c-77421483d9e9" xlink:to="loc_dei_EntityFileNumber_c76af9b2-7bc6-4f5b-8ae9-f0a511c6826d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_ecc98560-8854-4951-b965-22da1df3781b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_023246c9-78e5-4bd3-910c-77421483d9e9" xlink:to="loc_dei_EntityRegistrantName_ecc98560-8854-4951-b965-22da1df3781b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_a402bc50-fc61-4132-9a09-ec396c43fa12" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_023246c9-78e5-4bd3-910c-77421483d9e9" xlink:to="loc_dei_EntityCentralIndexKey_a402bc50-fc61-4132-9a09-ec396c43fa12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_dc5d4d10-658a-44a8-af6c-dc9ce4fe1085" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_023246c9-78e5-4bd3-910c-77421483d9e9" xlink:to="loc_dei_CurrentFiscalYearEndDate_dc5d4d10-658a-44a8-af6c-dc9ce4fe1085" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_e5f94e64-e2bd-4d18-983a-77f17be519b9" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_023246c9-78e5-4bd3-910c-77421483d9e9" xlink:to="loc_dei_DocumentFiscalYearFocus_e5f94e64-e2bd-4d18-983a-77f17be519b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_4edd5b80-01c3-4536-84cb-6c5767580adb" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_023246c9-78e5-4bd3-910c-77421483d9e9" xlink:to="loc_dei_DocumentFiscalPeriodFocus_4edd5b80-01c3-4536-84cb-6c5767580adb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_2e478709-90b1-44b9-bf4f-cb84f0db710c" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_023246c9-78e5-4bd3-910c-77421483d9e9" xlink:to="loc_dei_AmendmentFlag_2e478709-90b1-44b9-bf4f-cb84f0db710c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_fd805031-c8e2-4d54-9b2f-4940b0da34c9" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_023246c9-78e5-4bd3-910c-77421483d9e9" xlink:to="loc_dei_EntityIncorporationStateCountryCode_fd805031-c8e2-4d54-9b2f-4940b0da34c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_191dbd75-3cfb-43e2-a01b-81ecb95fafce" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_023246c9-78e5-4bd3-910c-77421483d9e9" xlink:to="loc_dei_EntityTaxIdentificationNumber_191dbd75-3cfb-43e2-a01b-81ecb95fafce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_4ba85d4b-2e42-41dd-8b81-3b7867778f4f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_023246c9-78e5-4bd3-910c-77421483d9e9" xlink:to="loc_dei_EntityAddressAddressLine1_4ba85d4b-2e42-41dd-8b81-3b7867778f4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_125dd6e2-6576-47e2-bb21-6460d0db49af" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_023246c9-78e5-4bd3-910c-77421483d9e9" xlink:to="loc_dei_EntityAddressCityOrTown_125dd6e2-6576-47e2-bb21-6460d0db49af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_2daf37d0-2821-49fe-b9ef-73745839c7e9" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_023246c9-78e5-4bd3-910c-77421483d9e9" xlink:to="loc_dei_EntityAddressStateOrProvince_2daf37d0-2821-49fe-b9ef-73745839c7e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_c2b90ce0-1c2c-437b-9a59-b66c3b6c639c" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_023246c9-78e5-4bd3-910c-77421483d9e9" xlink:to="loc_dei_EntityAddressPostalZipCode_c2b90ce0-1c2c-437b-9a59-b66c3b6c639c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_67132f2d-1d94-494b-97f7-f9a29e20fdb8" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_023246c9-78e5-4bd3-910c-77421483d9e9" xlink:to="loc_dei_CityAreaCode_67132f2d-1d94-494b-97f7-f9a29e20fdb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_89484105-3729-4562-a5a2-548981e8ea5d" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_023246c9-78e5-4bd3-910c-77421483d9e9" xlink:to="loc_dei_LocalPhoneNumber_89484105-3729-4562-a5a2-548981e8ea5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_11f81557-a4a4-4e1c-a46a-3bcc16b9c8a1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_023246c9-78e5-4bd3-910c-77421483d9e9" xlink:to="loc_dei_Security12bTitle_11f81557-a4a4-4e1c-a46a-3bcc16b9c8a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_cdbd7284-7509-4aae-9e97-df6fc972a79f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_023246c9-78e5-4bd3-910c-77421483d9e9" xlink:to="loc_dei_TradingSymbol_cdbd7284-7509-4aae-9e97-df6fc972a79f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_150a1fc2-2e95-4dea-b244-42251ad06214" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_023246c9-78e5-4bd3-910c-77421483d9e9" xlink:to="loc_dei_SecurityExchangeName_150a1fc2-2e95-4dea-b244-42251ad06214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_46494195-105c-4eb4-9eb0-477c8bea0ddf" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_023246c9-78e5-4bd3-910c-77421483d9e9" xlink:to="loc_dei_EntityCurrentReportingStatus_46494195-105c-4eb4-9eb0-477c8bea0ddf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_d50d42e7-10a7-4e82-b2a1-8e48b144143a" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_023246c9-78e5-4bd3-910c-77421483d9e9" xlink:to="loc_dei_EntityInteractiveDataCurrent_d50d42e7-10a7-4e82-b2a1-8e48b144143a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_d7f457be-1333-4d2d-b37f-335a963f8aec" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_023246c9-78e5-4bd3-910c-77421483d9e9" xlink:to="loc_dei_EntityFilerCategory_d7f457be-1333-4d2d-b37f-335a963f8aec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_b2d1573b-3b83-4670-8298-7013afc349ee" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_023246c9-78e5-4bd3-910c-77421483d9e9" xlink:to="loc_dei_EntitySmallBusiness_b2d1573b-3b83-4670-8298-7013afc349ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_cfa1a0f9-236f-4bc9-ab84-35bb12482f44" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_023246c9-78e5-4bd3-910c-77421483d9e9" xlink:to="loc_dei_EntityEmergingGrowthCompany_cfa1a0f9-236f-4bc9-ab84-35bb12482f44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_e3102b64-f4f9-4ec9-99c7-5e4c659f5e67" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_023246c9-78e5-4bd3-910c-77421483d9e9" xlink:to="loc_dei_EntityShellCompany_e3102b64-f4f9-4ec9-99c7-5e4c659f5e67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_285c53ca-9843-4f19-b1e5-4f76143db545" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_023246c9-78e5-4bd3-910c-77421483d9e9" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_285c53ca-9843-4f19-b1e5-4f76143db545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="hae-20201226.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOME"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_284db2cf-e6eb-4399-937a-ff3a4b875708" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7125a83a-628a-4909-aeba-d05dae05932f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_284db2cf-e6eb-4399-937a-ff3a4b875708" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7125a83a-628a-4909-aeba-d05dae05932f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_b2300eab-21b1-47d2-86b2-2ab3b8cae6cb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_284db2cf-e6eb-4399-937a-ff3a4b875708" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_b2300eab-21b1-47d2-86b2-2ab3b8cae6cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_63c331cb-f722-4019-a0e0-b5c52c5295bd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_284db2cf-e6eb-4399-937a-ff3a4b875708" xlink:to="loc_us-gaap_GrossProfit_63c331cb-f722-4019-a0e0-b5c52c5295bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_8ea0036e-768c-4671-a640-00d1bff03f0c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_284db2cf-e6eb-4399-937a-ff3a4b875708" xlink:to="loc_us-gaap_OperatingExpensesAbstract_8ea0036e-768c-4671-a640-00d1bff03f0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_42a1504a-5856-4f14-b04a-42ac7ee7e49a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_8ea0036e-768c-4671-a640-00d1bff03f0c" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_42a1504a-5856-4f14-b04a-42ac7ee7e49a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_63e63a83-27f7-429d-9092-2482689676f9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_8ea0036e-768c-4671-a640-00d1bff03f0c" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_63e63a83-27f7-429d-9092-2482689676f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetImpairmentCharges_b6858df6-4027-4d0e-b852-e690e33faa08" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetImpairmentCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_8ea0036e-768c-4671-a640-00d1bff03f0c" xlink:to="loc_us-gaap_OtherAssetImpairmentCharges_b6858df6-4027-4d0e-b852-e690e33faa08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_GainLossOnDivestitureAndSaleOfAssets_2aa1064b-2dc5-43b6-a2a1-7d3b3ac96e77" xlink:href="hae-20201226.xsd#hae_GainLossOnDivestitureAndSaleOfAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_8ea0036e-768c-4671-a640-00d1bff03f0c" xlink:to="loc_hae_GainLossOnDivestitureAndSaleOfAssets_2aa1064b-2dc5-43b6-a2a1-7d3b3ac96e77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_e33c8dca-8c4e-4362-8425-8755f9da7720" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_8ea0036e-768c-4671-a640-00d1bff03f0c" xlink:to="loc_us-gaap_OperatingExpenses_e33c8dca-8c4e-4362-8425-8755f9da7720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_36b918a9-9a27-4eb5-8004-71943c9a6504" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_284db2cf-e6eb-4399-937a-ff3a4b875708" xlink:to="loc_us-gaap_OperatingIncomeLoss_36b918a9-9a27-4eb5-8004-71943c9a6504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_b4587b56-b7ce-4862-9dcc-a7f43417739f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_284db2cf-e6eb-4399-937a-ff3a4b875708" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_b4587b56-b7ce-4862-9dcc-a7f43417739f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_b9f1216b-9a61-41af-a277-9b28cc6cb77c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_284db2cf-e6eb-4399-937a-ff3a4b875708" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_b9f1216b-9a61-41af-a277-9b28cc6cb77c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_d8b58d4a-8b87-42ec-8f58-a90d562f7100" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_284db2cf-e6eb-4399-937a-ff3a4b875708" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_d8b58d4a-8b87-42ec-8f58-a90d562f7100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6808108b-f185-4048-aaaa-a1ffa8e13038" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_284db2cf-e6eb-4399-937a-ff3a4b875708" xlink:to="loc_us-gaap_NetIncomeLoss_6808108b-f185-4048-aaaa-a1ffa8e13038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_a0397e80-b2b6-444c-9e21-8a1aa9bf50ed" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_284db2cf-e6eb-4399-937a-ff3a4b875708" xlink:to="loc_us-gaap_EarningsPerShareBasic_a0397e80-b2b6-444c-9e21-8a1aa9bf50ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_9f4c09ae-ec92-461a-bc44-f1563cc714b7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_284db2cf-e6eb-4399-937a-ff3a4b875708" xlink:to="loc_us-gaap_EarningsPerShareDiluted_9f4c09ae-ec92-461a-bc44-f1563cc714b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_29cb9b5d-acfd-4972-9591-60b4a4d7e090" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_284db2cf-e6eb-4399-937a-ff3a4b875708" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_29cb9b5d-acfd-4972-9591-60b4a4d7e090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_abc5a8e9-a13d-4793-90e8-ef6c9f6fc0a1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_29cb9b5d-acfd-4972-9591-60b4a4d7e090" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_abc5a8e9-a13d-4793-90e8-ef6c9f6fc0a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b1dc97ab-d2bb-4503-b89d-215aa1a62f77" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_29cb9b5d-acfd-4972-9591-60b4a4d7e090" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b1dc97ab-d2bb-4503-b89d-215aa1a62f77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_53aba9a5-62a8-4ea6-b9ca-bd77eec95609" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_284db2cf-e6eb-4399-937a-ff3a4b875708" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_53aba9a5-62a8-4ea6-b9ca-bd77eec95609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="hae-20201226.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_327d05b6-848a-4322-9f71-4335b4f2eca4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_f0c10d64-be08-4de4-8958-4a84ff484638" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_327d05b6-848a-4322-9f71-4335b4f2eca4" xlink:to="loc_us-gaap_AssetsAbstract_f0c10d64-be08-4de4-8958-4a84ff484638" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_2b155b41-e83d-4204-b0a4-8d50864fdf86" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f0c10d64-be08-4de4-8958-4a84ff484638" xlink:to="loc_us-gaap_AssetsCurrentAbstract_2b155b41-e83d-4204-b0a4-8d50864fdf86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8f22ac76-fe3e-4b43-ad88-8b6fb0570a3e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_2b155b41-e83d-4204-b0a4-8d50864fdf86" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8f22ac76-fe3e-4b43-ad88-8b6fb0570a3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_a10664a4-ddab-4337-a46f-322df3129c85" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_2b155b41-e83d-4204-b0a4-8d50864fdf86" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_a10664a4-ddab-4337-a46f-322df3129c85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_dd2f2d14-d859-47bd-ac4b-35c7218f03ab" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_2b155b41-e83d-4204-b0a4-8d50864fdf86" xlink:to="loc_us-gaap_InventoryNet_dd2f2d14-d859-47bd-ac4b-35c7218f03ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_534c05ce-7da5-4e04-b040-2f54ccc43e9d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_2b155b41-e83d-4204-b0a4-8d50864fdf86" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_534c05ce-7da5-4e04-b040-2f54ccc43e9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_c0a823fd-ef9a-458e-9f41-24419f3f8aca" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_2b155b41-e83d-4204-b0a4-8d50864fdf86" xlink:to="loc_us-gaap_AssetsCurrent_c0a823fd-ef9a-458e-9f41-24419f3f8aca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_39ff5275-14de-48e1-92c4-a867fa8514e0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f0c10d64-be08-4de4-8958-4a84ff484638" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_39ff5275-14de-48e1-92c4-a867fa8514e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2e376b6b-e716-47b8-b6a9-d4a6ebc8d785" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f0c10d64-be08-4de4-8958-4a84ff484638" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2e376b6b-e716-47b8-b6a9-d4a6ebc8d785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_3aed44ec-3efe-4500-aabb-1c241de4dc71" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f0c10d64-be08-4de4-8958-4a84ff484638" xlink:to="loc_us-gaap_Goodwill_3aed44ec-3efe-4500-aabb-1c241de4dc71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_6a0f84ab-19c5-4156-ada5-13c1149f668b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f0c10d64-be08-4de4-8958-4a84ff484638" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_6a0f84ab-19c5-4156-ada5-13c1149f668b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_8bd8072a-f892-459d-ad14-ecd26f14b19a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f0c10d64-be08-4de4-8958-4a84ff484638" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_8bd8072a-f892-459d-ad14-ecd26f14b19a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_f69838da-6b39-4ea5-b892-cde947935ac4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f0c10d64-be08-4de4-8958-4a84ff484638" xlink:to="loc_us-gaap_Assets_f69838da-6b39-4ea5-b892-cde947935ac4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6a322774-c2d6-4c24-bcff-f00e2ce55400" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_327d05b6-848a-4322-9f71-4335b4f2eca4" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6a322774-c2d6-4c24-bcff-f00e2ce55400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_c0db0999-5a26-4c81-9dcf-ba0623b7c9e2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6a322774-c2d6-4c24-bcff-f00e2ce55400" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_c0db0999-5a26-4c81-9dcf-ba0623b7c9e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_8c39b787-608c-4268-bd46-728916a85737" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c0db0999-5a26-4c81-9dcf-ba0623b7c9e2" xlink:to="loc_us-gaap_LongTermDebtCurrent_8c39b787-608c-4268-bd46-728916a85737" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_0977a6f6-2569-4fc0-a4fe-69545c592aaf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c0db0999-5a26-4c81-9dcf-ba0623b7c9e2" xlink:to="loc_us-gaap_AccountsPayableCurrent_0977a6f6-2569-4fc0-a4fe-69545c592aaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_3b0625bb-182b-4b22-885a-7623a67f9e1a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c0db0999-5a26-4c81-9dcf-ba0623b7c9e2" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_3b0625bb-182b-4b22-885a-7623a67f9e1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_d27295a2-b5e8-4968-b3d7-d87c70adfd3b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c0db0999-5a26-4c81-9dcf-ba0623b7c9e2" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_d27295a2-b5e8-4968-b3d7-d87c70adfd3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_94c1f3f9-30eb-407f-b19c-59ae7fb85941" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c0db0999-5a26-4c81-9dcf-ba0623b7c9e2" xlink:to="loc_us-gaap_LiabilitiesCurrent_94c1f3f9-30eb-407f-b19c-59ae7fb85941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_ddd72eb3-f8be-458e-8b31-910d0843610d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6a322774-c2d6-4c24-bcff-f00e2ce55400" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_ddd72eb3-f8be-458e-8b31-910d0843610d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_757ea8be-3279-464e-ac94-22cf2278ea61" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6a322774-c2d6-4c24-bcff-f00e2ce55400" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_757ea8be-3279-464e-ac94-22cf2278ea61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_76eab5d3-4954-4e65-8a9c-0825e1d85eb5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6a322774-c2d6-4c24-bcff-f00e2ce55400" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_76eab5d3-4954-4e65-8a9c-0825e1d85eb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_e485bffa-c216-4df9-aa29-b2fe08ddb520" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6a322774-c2d6-4c24-bcff-f00e2ce55400" xlink:to="loc_us-gaap_StockholdersEquityAbstract_e485bffa-c216-4df9-aa29-b2fe08ddb520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_ef51a91c-ffd8-4cba-9c65-79dc3a5e4ffc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_e485bffa-c216-4df9-aa29-b2fe08ddb520" xlink:to="loc_us-gaap_CommonStockValue_ef51a91c-ffd8-4cba-9c65-79dc3a5e4ffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_5975fedc-e902-40bf-98d0-d7c8848ca74b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_e485bffa-c216-4df9-aa29-b2fe08ddb520" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_5975fedc-e902-40bf-98d0-d7c8848ca74b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_c2403faa-9869-4386-be11-0a6446a8b878" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_e485bffa-c216-4df9-aa29-b2fe08ddb520" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_c2403faa-9869-4386-be11-0a6446a8b878" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f62c03f3-968f-4ef0-a087-a0c4f4457f4e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_e485bffa-c216-4df9-aa29-b2fe08ddb520" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f62c03f3-968f-4ef0-a087-a0c4f4457f4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_b7a93e93-53aa-4042-aaf4-43d20e0b4a6c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_e485bffa-c216-4df9-aa29-b2fe08ddb520" xlink:to="loc_us-gaap_StockholdersEquity_b7a93e93-53aa-4042-aaf4-43d20e0b4a6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_4d7df806-112c-4c1f-93d9-8e3097efb724" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6a322774-c2d6-4c24-bcff-f00e2ce55400" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_4d7df806-112c-4c1f-93d9-8e3097efb724" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParentheticals" xlink:type="simple" xlink:href="hae-20201226.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSParentheticals"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParentheticals" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_7bd350fa-7c6d-4b71-9e6d-c9c14bd25568" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_f4de1086-d60d-4b80-a291-298e035ee0b1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_7bd350fa-7c6d-4b71-9e6d-c9c14bd25568" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_f4de1086-d60d-4b80-a291-298e035ee0b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_bd804d5b-7a68-4290-8f39-ff583391921a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_7bd350fa-7c6d-4b71-9e6d-c9c14bd25568" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_bd804d5b-7a68-4290-8f39-ff583391921a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_d0041137-7583-4c98-871d-6e9fb3629343" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_7bd350fa-7c6d-4b71-9e6d-c9c14bd25568" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_d0041137-7583-4c98-871d-6e9fb3629343" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_a1a91768-596a-4b0d-a68d-e1ff7c04638d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_7bd350fa-7c6d-4b71-9e6d-c9c14bd25568" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_a1a91768-596a-4b0d-a68d-e1ff7c04638d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_c73836fe-e217-496f-9f5f-af23747e3eca" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_7bd350fa-7c6d-4b71-9e6d-c9c14bd25568" xlink:to="loc_us-gaap_CommonStockSharesIssued_c73836fe-e217-496f-9f5f-af23747e3eca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_b0cf3e5a-a070-46b5-b1d4-913dfba34935" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_7bd350fa-7c6d-4b71-9e6d-c9c14bd25568" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_b0cf3e5a-a070-46b5-b1d4-913dfba34935" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="hae-20201226.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_31128934-8cb7-41c6-89ad-e0b833e3b87a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_e4eabd83-9eb9-4f77-a15c-965e2fca2499" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_31128934-8cb7-41c6-89ad-e0b833e3b87a" xlink:to="loc_us-gaap_StatementTable_e4eabd83-9eb9-4f77-a15c-965e2fca2499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_7720febd-512f-40b5-9a05-c6ec9c178848" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e4eabd83-9eb9-4f77-a15c-965e2fca2499" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_7720febd-512f-40b5-9a05-c6ec9c178848" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_25062988-23dc-4e57-a49f-72a98363fbe7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7720febd-512f-40b5-9a05-c6ec9c178848" xlink:to="loc_us-gaap_EquityComponentDomain_25062988-23dc-4e57-a49f-72a98363fbe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_58faff7b-f1d8-40d1-a98f-bee287ae8e36" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_25062988-23dc-4e57-a49f-72a98363fbe7" xlink:to="loc_us-gaap_CommonStockMember_58faff7b-f1d8-40d1-a98f-bee287ae8e36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_f7b98f84-334e-4f8e-ac6f-dd8065c0fea3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_25062988-23dc-4e57-a49f-72a98363fbe7" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_f7b98f84-334e-4f8e-ac6f-dd8065c0fea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_e7dca7cb-b1ef-4e86-b5c3-ea51999d908d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_25062988-23dc-4e57-a49f-72a98363fbe7" xlink:to="loc_us-gaap_RetainedEarningsMember_e7dca7cb-b1ef-4e86-b5c3-ea51999d908d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_fd908a19-7f69-42f8-a2c9-758d49da0eff" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_25062988-23dc-4e57-a49f-72a98363fbe7" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_fd908a19-7f69-42f8-a2c9-758d49da0eff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ecacfcb4-b509-4ded-b006-b182ffc61bc2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e4eabd83-9eb9-4f77-a15c-965e2fca2499" xlink:to="loc_us-gaap_StatementLineItems_ecacfcb4-b509-4ded-b006-b182ffc61bc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a41d6314-a70f-4b93-a12b-e7c1e77d6cce" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ecacfcb4-b509-4ded-b006-b182ffc61bc2" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a41d6314-a70f-4b93-a12b-e7c1e77d6cce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_26904038-cdca-4093-8f88-3f3a6f0e9cd5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a41d6314-a70f-4b93-a12b-e7c1e77d6cce" xlink:to="loc_us-gaap_SharesIssued_26904038-cdca-4093-8f88-3f3a6f0e9cd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_19f06525-9427-45e6-a939-80b3b1a82fed" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a41d6314-a70f-4b93-a12b-e7c1e77d6cce" xlink:to="loc_us-gaap_StockholdersEquity_19f06525-9427-45e6-a939-80b3b1a82fed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_96db0ab4-545b-4962-8a62-c0e606f32b51" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a41d6314-a70f-4b93-a12b-e7c1e77d6cce" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_96db0ab4-545b-4962-8a62-c0e606f32b51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_a43cdf27-b7fe-4132-94ee-8e85d40548fc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a41d6314-a70f-4b93-a12b-e7c1e77d6cce" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_a43cdf27-b7fe-4132-94ee-8e85d40548fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3e88c37a-04ec-41b3-a14e-cbac6f2092ce" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a41d6314-a70f-4b93-a12b-e7c1e77d6cce" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3e88c37a-04ec-41b3-a14e-cbac6f2092ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_bf44b70d-f623-43f3-8797-caebbc0ed4a3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a41d6314-a70f-4b93-a12b-e7c1e77d6cce" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_bf44b70d-f623-43f3-8797-caebbc0ed4a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_12d99330-f184-45f2-ac9b-7b96c243b6b6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a41d6314-a70f-4b93-a12b-e7c1e77d6cce" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_12d99330-f184-45f2-ac9b-7b96c243b6b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_60454318-fbdd-41d8-90fc-fa20e5c3f1c3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a41d6314-a70f-4b93-a12b-e7c1e77d6cce" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_60454318-fbdd-41d8-90fc-fa20e5c3f1c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_b0463caa-d678-408d-82a5-3b6a1b2c3028" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a41d6314-a70f-4b93-a12b-e7c1e77d6cce" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_b0463caa-d678-408d-82a5-3b6a1b2c3028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_3b0e2f32-8e79-4803-82d3-6dbb6a738e4f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a41d6314-a70f-4b93-a12b-e7c1e77d6cce" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_3b0e2f32-8e79-4803-82d3-6dbb6a738e4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4c2ad8e7-b0ff-490f-9254-b61de2f6e610" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a41d6314-a70f-4b93-a12b-e7c1e77d6cce" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4c2ad8e7-b0ff-490f-9254-b61de2f6e610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0d81cfa8-803f-40d5-94a5-52d8712889a5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a41d6314-a70f-4b93-a12b-e7c1e77d6cce" xlink:to="loc_us-gaap_NetIncomeLoss_0d81cfa8-803f-40d5-94a5-52d8712889a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_306582be-2fe5-431a-a925-b79ca1990a8a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a41d6314-a70f-4b93-a12b-e7c1e77d6cce" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_306582be-2fe5-431a-a925-b79ca1990a8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_14627e93-c4f6-4c07-ada8-7cbdc1fa063b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a41d6314-a70f-4b93-a12b-e7c1e77d6cce" xlink:to="loc_us-gaap_SharesIssued_14627e93-c4f6-4c07-ada8-7cbdc1fa063b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_d4b57277-0ddc-472a-b9a7-654fc472922c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a41d6314-a70f-4b93-a12b-e7c1e77d6cce" xlink:to="loc_us-gaap_StockholdersEquity_d4b57277-0ddc-472a-b9a7-654fc472922c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="hae-20201226.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_50f05b06-50b7-4d7d-ad96-817c7e2be697" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_796ae213-b4f9-4c85-bdf0-3474af157136" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_50f05b06-50b7-4d7d-ad96-817c7e2be697" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_796ae213-b4f9-4c85-bdf0-3474af157136" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_436ce1fd-4a8a-4220-a2f2-00b18a505bc2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_796ae213-b4f9-4c85-bdf0-3474af157136" xlink:to="loc_us-gaap_NetIncomeLoss_436ce1fd-4a8a-4220-a2f2-00b18a505bc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_03fafb24-8412-4a94-8bf1-e07deadcfc48" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_796ae213-b4f9-4c85-bdf0-3474af157136" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_03fafb24-8412-4a94-8bf1-e07deadcfc48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_NonCashItemsAbstract_731736b6-5125-4c45-853d-716cf48dbfb8" xlink:href="hae-20201226.xsd#hae_NonCashItemsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_03fafb24-8412-4a94-8bf1-e07deadcfc48" xlink:to="loc_hae_NonCashItemsAbstract_731736b6-5125-4c45-853d-716cf48dbfb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_de2c67a2-5809-48dc-b970-f5acf0496659" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_NonCashItemsAbstract_731736b6-5125-4c45-853d-716cf48dbfb8" xlink:to="loc_us-gaap_DepreciationAndAmortization_de2c67a2-5809-48dc-b970-f5acf0496659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_9c7f1ed9-d9c1-4402-a440-cbdb62ee0e2e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_NonCashItemsAbstract_731736b6-5125-4c45-853d-716cf48dbfb8" xlink:to="loc_us-gaap_AssetImpairmentCharges_9c7f1ed9-d9c1-4402-a440-cbdb62ee0e2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_4887834d-5610-4de8-ba5b-beb871572747" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_NonCashItemsAbstract_731736b6-5125-4c45-853d-716cf48dbfb8" xlink:to="loc_us-gaap_ShareBasedCompensation_4887834d-5610-4de8-ba5b-beb871572747" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredOtherTaxExpenseBenefit_46c82f4a-9a3a-4212-8f8d-2274e92e7c3a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredOtherTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_NonCashItemsAbstract_731736b6-5125-4c45-853d-716cf48dbfb8" xlink:to="loc_us-gaap_DeferredOtherTaxExpenseBenefit_46c82f4a-9a3a-4212-8f8d-2274e92e7c3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForLoanLeaseAndOtherLosses_2f759586-ebbc-4528-98f0-ea29633f5045" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProvisionForLoanLeaseAndOtherLosses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_NonCashItemsAbstract_731736b6-5125-4c45-853d-716cf48dbfb8" xlink:to="loc_us-gaap_ProvisionForLoanLeaseAndOtherLosses_2f759586-ebbc-4528-98f0-ea29633f5045" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_GainLossOnDivestitureAndSaleOfAssets_218853e3-4c18-4eab-b35f-9f6905086fd6" xlink:href="hae-20201226.xsd#hae_GainLossOnDivestitureAndSaleOfAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_NonCashItemsAbstract_731736b6-5125-4c45-853d-716cf48dbfb8" xlink:to="loc_hae_GainLossOnDivestitureAndSaleOfAssets_218853e3-4c18-4eab-b35f-9f6905086fd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_ff0e9c18-c712-46f3-8b62-1d50ae7681c9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_NonCashItemsAbstract_731736b6-5125-4c45-853d-716cf48dbfb8" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_ff0e9c18-c712-46f3-8b62-1d50ae7681c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4c14690c-73a4-477a-b014-b0da521fefc3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_03fafb24-8412-4a94-8bf1-e07deadcfc48" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4c14690c-73a4-477a-b014-b0da521fefc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_d271a1cf-1334-4dcb-8118-6668d902fd5f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4c14690c-73a4-477a-b014-b0da521fefc3" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_d271a1cf-1334-4dcb-8118-6668d902fd5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_2f0d2bca-4ba7-4c26-bfbf-e582e4eecfef" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4c14690c-73a4-477a-b014-b0da521fefc3" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_2f0d2bca-4ba7-4c26-bfbf-e582e4eecfef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_fbf92ea5-3b02-46cc-a654-3ba1a18f1a58" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4c14690c-73a4-477a-b014-b0da521fefc3" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_fbf92ea5-3b02-46cc-a654-3ba1a18f1a58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_659a7803-3525-46d0-8244-3335e2c95197" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4c14690c-73a4-477a-b014-b0da521fefc3" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_659a7803-3525-46d0-8244-3335e2c95197" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_692243ef-1c5d-442a-9832-118af936c87e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4c14690c-73a4-477a-b014-b0da521fefc3" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_692243ef-1c5d-442a-9832-118af936c87e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_76d60c36-010d-48cf-8396-5438695acc23" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_796ae213-b4f9-4c85-bdf0-3474af157136" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_76d60c36-010d-48cf-8396-5438695acc23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ba0593c7-23e0-45d2-afe4-b878c5a22996" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_50f05b06-50b7-4d7d-ad96-817c7e2be697" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ba0593c7-23e0-45d2-afe4-b878c5a22996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_f951b0a1-33d9-41f5-8d47-128085f7517f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ba0593c7-23e0-45d2-afe4-b878c5a22996" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_f951b0a1-33d9-41f5-8d47-128085f7517f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_4fc5e2e0-df70-4ec5-b81d-b32def5d2466" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ba0593c7-23e0-45d2-afe4-b878c5a22996" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_4fc5e2e0-df70-4ec5-b81d-b32def5d2466" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_9ad8621f-fc93-4f4f-a334-8ebae97e4506" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ba0593c7-23e0-45d2-afe4-b878c5a22996" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_9ad8621f-fc93-4f4f-a334-8ebae97e4506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_280e45c4-29d2-4bec-afeb-723d26bb9745" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ba0593c7-23e0-45d2-afe4-b878c5a22996" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_280e45c4-29d2-4bec-afeb-723d26bb9745" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_95a25627-2658-4041-80ee-b41dc08db1d3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_50f05b06-50b7-4d7d-ad96-817c7e2be697" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_95a25627-2658-4041-80ee-b41dc08db1d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7cba5407-bce6-44b4-b6d6-f3d460898512" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_50f05b06-50b7-4d7d-ad96-817c7e2be697" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7cba5407-bce6-44b4-b6d6-f3d460898512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_292456d5-d6b6-4b59-b583-5e4c93ce1848" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7cba5407-bce6-44b4-b6d6-f3d460898512" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_292456d5-d6b6-4b59-b583-5e4c93ce1848" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_fd8e9ee5-a4db-42fc-a006-8a0b70ededa4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7cba5407-bce6-44b4-b6d6-f3d460898512" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_fd8e9ee5-a4db-42fc-a006-8a0b70ededa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfEquity_795edd0b-f53f-4811-992b-f8b019003b19" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForRepurchaseOfEquity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7cba5407-bce6-44b4-b6d6-f3d460898512" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfEquity_795edd0b-f53f-4811-992b-f8b019003b19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP_a2fae194-1b1f-4c75-aff6-dc2de9f3189d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7cba5407-bce6-44b4-b6d6-f3d460898512" xlink:to="loc_us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP_a2fae194-1b1f-4c75-aff6-dc2de9f3189d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_e0f9ef1a-d40f-4c07-bbd4-4428ca882453" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7cba5407-bce6-44b4-b6d6-f3d460898512" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_e0f9ef1a-d40f-4c07-bbd4-4428ca882453" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_6fc26f22-fa9b-416d-910e-1167f8aec2d4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7cba5407-bce6-44b4-b6d6-f3d460898512" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_6fc26f22-fa9b-416d-910e-1167f8aec2d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0014a3b7-f0a4-4389-ab96-d1e834fcd635" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7cba5407-bce6-44b4-b6d6-f3d460898512" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0014a3b7-f0a4-4389-ab96-d1e834fcd635" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d483d792-3cfb-49c5-be2f-d1064c988c74" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_50f05b06-50b7-4d7d-ad96-817c7e2be697" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d483d792-3cfb-49c5-be2f-d1064c988c74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6329f5ce-a348-4201-ba2d-d04a7501f942" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_50f05b06-50b7-4d7d-ad96-817c7e2be697" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6329f5ce-a348-4201-ba2d-d04a7501f942" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b4ee50c5-9ba0-4b6b-b4a4-9219f38ff286" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_50f05b06-50b7-4d7d-ad96-817c7e2be697" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b4ee50c5-9ba0-4b6b-b4a4-9219f38ff286" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3ac84bd5-2398-472f-9955-a4762ae438a0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_50f05b06-50b7-4d7d-ad96-817c7e2be697" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3ac84bd5-2398-472f-9955-a4762ae438a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_7357e2fa-876f-455b-ae59-5fbeef6f7187" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_50f05b06-50b7-4d7d-ad96-817c7e2be697" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_7357e2fa-876f-455b-ae59-5fbeef6f7187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_af2e59f2-3913-4bcc-9314-467a1b3d290b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_7357e2fa-876f-455b-ae59-5fbeef6f7187" xlink:to="loc_us-gaap_InterestPaidNet_af2e59f2-3913-4bcc-9314-467a1b3d290b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_442629a2-5898-4b52-84dc-1ef000dfdb53" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_7357e2fa-876f-455b-ae59-5fbeef6f7187" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_442629a2-5898-4b52-84dc-1ef000dfdb53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_TransfersFromInventoryToFixedAssets_9039f974-d42c-4044-b85e-63e33528c149" xlink:href="hae-20201226.xsd#hae_TransfersFromInventoryToFixedAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_7357e2fa-876f-455b-ae59-5fbeef6f7187" xlink:to="loc_hae_TransfersFromInventoryToFixedAssets_9039f974-d42c-4044-b85e-63e33528c149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/BASISOFPRESENTATION" xlink:type="simple" xlink:href="hae-20201226.xsd#BASISOFPRESENTATION"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/BASISOFPRESENTATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8249d6b1-bfd3-4763-9891-71694904d871" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_b0c30f01-c95d-41ff-ac18-cc024cfb4904" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8249d6b1-bfd3-4763-9891-71694904d871" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_b0c30f01-c95d-41ff-ac18-cc024cfb4904" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/RECENTACCOUNTINGPRONOUNCEMENTS" xlink:type="simple" xlink:href="hae-20201226.xsd#RECENTACCOUNTINGPRONOUNCEMENTS"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/RECENTACCOUNTINGPRONOUNCEMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_254926a1-1cf1-4cf6-8ebf-6e1fd5658745" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_e2031711-7704-4ae5-9925-1435dd8d0a6c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_254926a1-1cf1-4cf6-8ebf-6e1fd5658745" xlink:to="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_e2031711-7704-4ae5-9925-1435dd8d0a6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/RESTRUCTURING" xlink:type="simple" xlink:href="hae-20201226.xsd#RESTRUCTURING"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/RESTRUCTURING" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_aae18a9b-72c2-4a99-8976-7bf987b3a18e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_65ccc032-2f4a-43ee-ab3f-161b55b21696" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_aae18a9b-72c2-4a99-8976-7bf987b3a18e" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_65ccc032-2f4a-43ee-ab3f-161b55b21696" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/RESTRUCTURINGTables" xlink:type="simple" xlink:href="hae-20201226.xsd#RESTRUCTURINGTables"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/RESTRUCTURINGTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_1f449041-8a8a-44a3-837b-a8fdd8e6f25e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_46cebdbf-8ef7-4678-8832-382a5ec9972c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_1f449041-8a8a-44a3-837b-a8fdd8e6f25e" xlink:to="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_46cebdbf-8ef7-4678-8832-382a5ec9972c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_ec0065d6-d5f3-404f-8cc4-4b791a95861c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_1f449041-8a8a-44a3-837b-a8fdd8e6f25e" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_ec0065d6-d5f3-404f-8cc4-4b791a95861c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/RESTRUCTURINGNarrativeDetails" xlink:type="simple" xlink:href="hae-20201226.xsd#RESTRUCTURINGNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/RESTRUCTURINGNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_172a3cc8-b817-42a2-8fd0-7659ec50d7bc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_76c91248-93f9-46de-a59b-c91502325241" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_172a3cc8-b817-42a2-8fd0-7659ec50d7bc" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_76c91248-93f9-46de-a59b-c91502325241" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_72e939e4-9f70-43a8-99ed-80c79320cd6f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_76c91248-93f9-46de-a59b-c91502325241" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_72e939e4-9f70-43a8-99ed-80c79320cd6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_baace393-84dc-49ef-850f-49cfe5cb9cdb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_72e939e4-9f70-43a8-99ed-80c79320cd6f" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_baace393-84dc-49ef-850f-49cfe5cb9cdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_410f29e3-e55a-4e73-a970-bf5f85e714a1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_baace393-84dc-49ef-850f-49cfe5cb9cdb" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_410f29e3-e55a-4e73-a970-bf5f85e714a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_0c783631-7504-4454-9de1-d5bcfc211373" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_76c91248-93f9-46de-a59b-c91502325241" xlink:to="loc_us-gaap_RestructuringPlanAxis_0c783631-7504-4454-9de1-d5bcfc211373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_92c07ca8-cf4b-47fd-9933-74c4022e6112" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_0c783631-7504-4454-9de1-d5bcfc211373" xlink:to="loc_us-gaap_RestructuringPlanDomain_92c07ca8-cf4b-47fd-9933-74c4022e6112" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_A2020ProgramMember_692c9749-ada4-4c26-9838-57a192fc88ac" xlink:href="hae-20201226.xsd#hae_A2020ProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_92c07ca8-cf4b-47fd-9933-74c4022e6112" xlink:to="loc_hae_A2020ProgramMember_692c9749-ada4-4c26-9838-57a192fc88ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_A2018ProgramMember_d6f66fed-27b3-45dd-ab6b-7efd0d00268f" xlink:href="hae-20201226.xsd#hae_A2018ProgramMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_92c07ca8-cf4b-47fd-9933-74c4022e6112" xlink:to="loc_hae_A2018ProgramMember_d6f66fed-27b3-45dd-ab6b-7efd0d00268f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6e2956df-8542-4d49-8687-41190eb75d9b" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_76c91248-93f9-46de-a59b-c91502325241" xlink:to="loc_srt_RangeAxis_6e2956df-8542-4d49-8687-41190eb75d9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a525a9d2-18c9-4d2c-9591-5017a0b3600d" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_6e2956df-8542-4d49-8687-41190eb75d9b" xlink:to="loc_srt_RangeMember_a525a9d2-18c9-4d2c-9591-5017a0b3600d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_5642e3fd-e479-4725-93df-822e9de6c980" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a525a9d2-18c9-4d2c-9591-5017a0b3600d" xlink:to="loc_srt_MinimumMember_5642e3fd-e479-4725-93df-822e9de6c980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b8da0ff8-4a99-44a9-9574-437d505d4dbf" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a525a9d2-18c9-4d2c-9591-5017a0b3600d" xlink:to="loc_srt_MaximumMember_b8da0ff8-4a99-44a9-9574-437d505d4dbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_f498ef9d-c7d4-499b-99c3-52f895b05608" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_76c91248-93f9-46de-a59b-c91502325241" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_f498ef9d-c7d4-499b-99c3-52f895b05608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_a94cf790-8fb9-4124-b3b6-ef8c608d44d3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f498ef9d-c7d4-499b-99c3-52f895b05608" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_a94cf790-8fb9-4124-b3b6-ef8c608d44d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_RestructuringandRestructuringRelatedCosts_c72f6750-0721-4566-9844-da9d1da70df3" xlink:href="hae-20201226.xsd#hae_RestructuringandRestructuringRelatedCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f498ef9d-c7d4-499b-99c3-52f895b05608" xlink:to="loc_hae_RestructuringandRestructuringRelatedCosts_c72f6750-0721-4566-9844-da9d1da70df3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_34ae08e5-a895-4982-aa81-0d380915529d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f498ef9d-c7d4-499b-99c3-52f895b05608" xlink:to="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_34ae08e5-a895-4982-aa81-0d380915529d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_2a73a210-9221-4123-9ed0-3ea8185a64c7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f498ef9d-c7d4-499b-99c3-52f895b05608" xlink:to="loc_us-gaap_RestructuringReserve_2a73a210-9221-4123-9ed0-3ea8185a64c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_RestructuringChargesPayableInNextTwelveMonths_c1faa4d5-969c-4d22-8a5a-cecf9eeb1dec" xlink:href="hae-20201226.xsd#hae_RestructuringChargesPayableInNextTwelveMonths"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f498ef9d-c7d4-499b-99c3-52f895b05608" xlink:to="loc_hae_RestructuringChargesPayableInNextTwelveMonths_c1faa4d5-969c-4d22-8a5a-cecf9eeb1dec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_RestructuringRelatedCosts_a91ebd3d-db7b-4527-8605-e7996044cb57" xlink:href="hae-20201226.xsd#hae_RestructuringRelatedCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_f498ef9d-c7d4-499b-99c3-52f895b05608" xlink:to="loc_hae_RestructuringRelatedCosts_a91ebd3d-db7b-4527-8605-e7996044cb57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails" xlink:type="simple" xlink:href="hae-20201226.xsd#RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_56d65674-4629-4905-9dcc-9b11bb4413c0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_ea008bd9-7f3b-4962-875c-35daea700ebf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_56d65674-4629-4905-9dcc-9b11bb4413c0" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_ea008bd9-7f3b-4962-875c-35daea700ebf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_fcd444ff-68ea-4808-9d3b-cb40ddb77bdf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_ea008bd9-7f3b-4962-875c-35daea700ebf" xlink:to="loc_us-gaap_RestructuringPlanAxis_fcd444ff-68ea-4808-9d3b-cb40ddb77bdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_c482078e-db79-452d-af35-32f5d965f592" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_fcd444ff-68ea-4808-9d3b-cb40ddb77bdf" xlink:to="loc_us-gaap_RestructuringPlanDomain_c482078e-db79-452d-af35-32f5d965f592" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_A2020ProgramMember_bc852142-1ed9-45c8-b658-56aa19f28dbd" xlink:href="hae-20201226.xsd#hae_A2020ProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_c482078e-db79-452d-af35-32f5d965f592" xlink:to="loc_hae_A2020ProgramMember_bc852142-1ed9-45c8-b658-56aa19f28dbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_A2018ProgramMember_e97f3603-8673-41f4-93e6-0e1fa6ed0c5f" xlink:href="hae-20201226.xsd#hae_A2018ProgramMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_c482078e-db79-452d-af35-32f5d965f592" xlink:to="loc_hae_A2018ProgramMember_e97f3603-8673-41f4-93e6-0e1fa6ed0c5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_A2018ProgramandPriorProgramsMember_a9c8e545-3278-4de0-9430-e5ec223d161a" xlink:href="hae-20201226.xsd#hae_A2018ProgramandPriorProgramsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_c482078e-db79-452d-af35-32f5d965f592" xlink:to="loc_hae_A2018ProgramandPriorProgramsMember_a9c8e545-3278-4de0-9430-e5ec223d161a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_eda6c633-e335-4743-a423-3f9ef9403aac" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_ea008bd9-7f3b-4962-875c-35daea700ebf" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_eda6c633-e335-4743-a423-3f9ef9403aac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_d5fe9bd8-6cc1-4683-8d6a-e5cae48a6d1f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_eda6c633-e335-4743-a423-3f9ef9403aac" xlink:to="loc_us-gaap_RestructuringReserveRollForward_d5fe9bd8-6cc1-4683-8d6a-e5cae48a6d1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_8cf10a95-858d-469a-9937-ee8fc982c07f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_d5fe9bd8-6cc1-4683-8d6a-e5cae48a6d1f" xlink:to="loc_us-gaap_RestructuringReserve_8cf10a95-858d-469a-9937-ee8fc982c07f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_46d838af-e6a5-462a-91e9-b08a61823269" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_d5fe9bd8-6cc1-4683-8d6a-e5cae48a6d1f" xlink:to="loc_us-gaap_RestructuringCharges_46d838af-e6a5-462a-91e9-b08a61823269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_f6b1c728-97ad-4eaf-8723-93ac4445e80e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_d5fe9bd8-6cc1-4683-8d6a-e5cae48a6d1f" xlink:to="loc_us-gaap_PaymentsForRestructuring_f6b1c728-97ad-4eaf-8723-93ac4445e80e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_94cec370-82ec-49ab-b352-ed733933d3f9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_d5fe9bd8-6cc1-4683-8d6a-e5cae48a6d1f" xlink:to="loc_us-gaap_RestructuringReserve_94cec370-82ec-49ab-b352-ed733933d3f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails" xlink:type="simple" xlink:href="hae-20201226.xsd#RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_ef4829db-4ecc-42e5-8e32-84cd5e861fed" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f894168b-dd20-486d-8ab4-1a1a98dc7242" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_ef4829db-4ecc-42e5-8e32-84cd5e861fed" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f894168b-dd20-486d-8ab4-1a1a98dc7242" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_6f097e47-b9ea-4114-9c57-870ad59045e1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f894168b-dd20-486d-8ab4-1a1a98dc7242" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_6f097e47-b9ea-4114-9c57-870ad59045e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ca47f29f-b642-40e3-bc59-dc062df9137c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_6f097e47-b9ea-4114-9c57-870ad59045e1" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ca47f29f-b642-40e3-bc59-dc062df9137c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_f00834ec-257e-40a7-9226-b5ee337c9a4b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ca47f29f-b642-40e3-bc59-dc062df9137c" xlink:to="loc_us-gaap_CostOfSalesMember_f00834ec-257e-40a7-9226-b5ee337c9a4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_a030fdb6-e8b1-49e5-add4-f4c75692e6e3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ca47f29f-b642-40e3-bc59-dc062df9137c" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_a030fdb6-e8b1-49e5-add4-f4c75692e6e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_7dd8f6f1-c3dd-4bb0-90ee-8cdbc6f7f4e2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ca47f29f-b642-40e3-bc59-dc062df9137c" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_7dd8f6f1-c3dd-4bb0-90ee-8cdbc6f7f4e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_c18bf501-ada4-4ed6-b20e-b0a508259d15" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f894168b-dd20-486d-8ab4-1a1a98dc7242" xlink:to="loc_srt_ConsolidationItemsAxis_c18bf501-ada4-4ed6-b20e-b0a508259d15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_a927b954-d4ff-4799-af8c-2cfcab7ee94c" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_c18bf501-ada4-4ed6-b20e-b0a508259d15" xlink:to="loc_srt_ConsolidationItemsDomain_a927b954-d4ff-4799-af8c-2cfcab7ee94c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_fe42a686-2f97-4b69-8332-6e1d6a3d09c0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_a927b954-d4ff-4799-af8c-2cfcab7ee94c" xlink:to="loc_us-gaap_CorporateNonSegmentMember_fe42a686-2f97-4b69-8332-6e1d6a3d09c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_6792ec26-c8a8-4ced-af8d-e0bbcbf93467" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f894168b-dd20-486d-8ab4-1a1a98dc7242" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_6792ec26-c8a8-4ced-af8d-e0bbcbf93467" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_bd3a562a-a01b-4df2-a454-7fd96db959c2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6792ec26-c8a8-4ced-af8d-e0bbcbf93467" xlink:to="loc_us-gaap_SegmentDomain_bd3a562a-a01b-4df2-a454-7fd96db959c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_BloodCenterMember_94305463-8986-4702-9b85-548dfe6e3bec" xlink:href="hae-20201226.xsd#hae_BloodCenterMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_bd3a562a-a01b-4df2-a454-7fd96db959c2" xlink:to="loc_hae_BloodCenterMember_94305463-8986-4702-9b85-548dfe6e3bec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_HospitalMember_53d6896f-724f-4cbc-a53e-4b1fb68a7ccc" xlink:href="hae-20201226.xsd#hae_HospitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_bd3a562a-a01b-4df2-a454-7fd96db959c2" xlink:to="loc_hae_HospitalMember_53d6896f-724f-4cbc-a53e-4b1fb68a7ccc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_PlasmaMember_0952a3c1-dc0a-4aa8-86c4-ba41f1cb981d" xlink:href="hae-20201226.xsd#hae_PlasmaMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_bd3a562a-a01b-4df2-a454-7fd96db959c2" xlink:to="loc_hae_PlasmaMember_0952a3c1-dc0a-4aa8-86c4-ba41f1cb981d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_443baa8b-4948-4e4d-b410-b992518d580c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f894168b-dd20-486d-8ab4-1a1a98dc7242" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_443baa8b-4948-4e4d-b410-b992518d580c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_c20174f8-b6d1-4daf-a6ac-3ebc798e6c03" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_443baa8b-4948-4e4d-b410-b992518d580c" xlink:to="loc_us-gaap_RestructuringCharges_c20174f8-b6d1-4daf-a6ac-3ebc798e6c03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_RestructuringRelatedCosts_8e7d5113-4077-4882-9257-9e3bd694bbe6" xlink:href="hae-20201226.xsd#hae_RestructuringRelatedCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_443baa8b-4948-4e4d-b410-b992518d580c" xlink:to="loc_hae_RestructuringRelatedCosts_8e7d5113-4077-4882-9257-9e3bd694bbe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_RestructuringandRestructuringRelatedCosts_a3c86043-e823-4bba-bdfc-214c07d4efc2" xlink:href="hae-20201226.xsd#hae_RestructuringandRestructuringRelatedCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_443baa8b-4948-4e4d-b410-b992518d580c" xlink:to="loc_hae_RestructuringandRestructuringRelatedCosts_a3c86043-e823-4bba-bdfc-214c07d4efc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/ACQUISITION" xlink:type="simple" xlink:href="hae-20201226.xsd#ACQUISITION"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/ACQUISITION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_7600dbd7-e93e-4b40-b762-de5405b8c029" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_7edc6f65-ac36-4e02-8b63-8d489e086bf9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_7600dbd7-e93e-4b40-b762-de5405b8c029" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_7edc6f65-ac36-4e02-8b63-8d489e086bf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/ACQUISITIONTables" xlink:type="simple" xlink:href="hae-20201226.xsd#ACQUISITIONTables"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/ACQUISITIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_41cd386f-4f44-484a-ad01-fabe6f2dd1ff" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_4b02a25d-4741-4681-a8ba-eba9116db979" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_41cd386f-4f44-484a-ad01-fabe6f2dd1ff" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_4b02a25d-4741-4681-a8ba-eba9116db979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/ACQUISITIONDetails" xlink:type="simple" xlink:href="hae-20201226.xsd#ACQUISITIONDetails"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/ACQUISITIONDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_8041590e-203c-44e2-bc21-81eafb98b4bf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_98954cb8-bc12-4ee0-983d-65d97a4b7914" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_8041590e-203c-44e2-bc21-81eafb98b4bf" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_98954cb8-bc12-4ee0-983d-65d97a4b7914" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_68010d25-7883-4c58-b507-7c5a578365d6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_98954cb8-bc12-4ee0-983d-65d97a4b7914" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_68010d25-7883-4c58-b507-7c5a578365d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_13cc9a1c-df56-4cba-88a5-c74e51111723" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_68010d25-7883-4c58-b507-7c5a578365d6" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_13cc9a1c-df56-4cba-88a5-c74e51111723" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EnicorMember_d2aa72f3-5c4f-4dad-914f-e9ea15a6497c" xlink:href="hae-20201226.xsd#hae_EnicorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_13cc9a1c-df56-4cba-88a5-c74e51111723" xlink:to="loc_hae_EnicorMember_d2aa72f3-5c4f-4dad-914f-e9ea15a6497c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_CardivaMember_dcf66604-f35f-476e-b5f9-4adf262a68a7" xlink:href="hae-20201226.xsd#hae_CardivaMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_13cc9a1c-df56-4cba-88a5-c74e51111723" xlink:to="loc_hae_CardivaMember_dcf66604-f35f-476e-b5f9-4adf262a68a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_988d5221-cb26-44b2-af4f-bd300b031fb3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_98954cb8-bc12-4ee0-983d-65d97a4b7914" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_988d5221-cb26-44b2-af4f-bd300b031fb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_83e31946-d146-4d05-a41b-686614e98b2c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_988d5221-cb26-44b2-af4f-bd300b031fb3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_83e31946-d146-4d05-a41b-686614e98b2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_5f0ed48a-efbf-4c70-81fb-af2f78cf3887" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_83e31946-d146-4d05-a41b-686614e98b2c" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_5f0ed48a-efbf-4c70-81fb-af2f78cf3887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_ebfe8116-b585-461f-a424-53f5a3bc22c9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_83e31946-d146-4d05-a41b-686614e98b2c" xlink:to="loc_us-gaap_CustomerRelationshipsMember_ebfe8116-b585-461f-a424-53f5a3bc22c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_5501e118-1124-4f4b-8038-645566c5f024" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_83e31946-d146-4d05-a41b-686614e98b2c" xlink:to="loc_us-gaap_TrademarksMember_5501e118-1124-4f4b-8038-645566c5f024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_5d56e3f6-9134-46bf-8b4b-ff77ff036e2e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_98954cb8-bc12-4ee0-983d-65d97a4b7914" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_5d56e3f6-9134-46bf-8b4b-ff77ff036e2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_e51aad8c-281d-4b78-8d9f-192acc3b705c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_5d56e3f6-9134-46bf-8b4b-ff77ff036e2e" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_e51aad8c-281d-4b78-8d9f-192acc3b705c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_c3a5141e-4b14-4b64-8c80-cc919ac9f51c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_e51aad8c-281d-4b78-8d9f-192acc3b705c" xlink:to="loc_us-gaap_SubsequentEventMember_c3a5141e-4b14-4b64-8c80-cc919ac9f51c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_AssetAcquisitionAxis_15dd029e-fb29-4ea1-bd17-f9161c61644f" xlink:href="hae-20201226.xsd#hae_AssetAcquisitionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_98954cb8-bc12-4ee0-983d-65d97a4b7914" xlink:to="loc_hae_AssetAcquisitionAxis_15dd029e-fb29-4ea1-bd17-f9161c61644f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_AssetAcquisitionDomain_f081cc78-3783-4a4f-ba72-dde7afa8ca27" xlink:href="hae-20201226.xsd#hae_AssetAcquisitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_AssetAcquisitionAxis_15dd029e-fb29-4ea1-bd17-f9161c61644f" xlink:to="loc_hae_AssetAcquisitionDomain_f081cc78-3783-4a4f-ba72-dde7afa8ca27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_HASIntellectualPropertyMember_28996d98-35f9-4633-bb88-eccb7955eab6" xlink:href="hae-20201226.xsd#hae_HASIntellectualPropertyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hae_AssetAcquisitionDomain_f081cc78-3783-4a4f-ba72-dde7afa8ca27" xlink:to="loc_hae_HASIntellectualPropertyMember_28996d98-35f9-4633-bb88-eccb7955eab6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_b6b7020e-40af-4081-afb7-2fe01143998d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_98954cb8-bc12-4ee0-983d-65d97a4b7914" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_b6b7020e-40af-4081-afb7-2fe01143998d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_0fafb014-69c3-41b6-925c-f2d6286549b4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b6b7020e-40af-4081-afb7-2fe01143998d" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_0fafb014-69c3-41b6-925c-f2d6286549b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_6dade145-43f9-4224-8627-f5399104fdbf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b6b7020e-40af-4081-afb7-2fe01143998d" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_6dade145-43f9-4224-8627-f5399104fdbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_a6fa9a57-466c-49cc-a6ae-87e1040cc64d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b6b7020e-40af-4081-afb7-2fe01143998d" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_a6fa9a57-466c-49cc-a6ae-87e1040cc64d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_7b39ea8b-17be-424b-a0e7-853d0210309a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b6b7020e-40af-4081-afb7-2fe01143998d" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_7b39ea8b-17be-424b-a0e7-853d0210309a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_AssetAcquisitionUpfrontPayment_ebec3b4e-6cdf-4051-afcd-8ca70ed5947f" xlink:href="hae-20201226.xsd#hae_AssetAcquisitionUpfrontPayment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b6b7020e-40af-4081-afb7-2fe01143998d" xlink:to="loc_hae_AssetAcquisitionUpfrontPayment_ebec3b4e-6cdf-4051-afcd-8ca70ed5947f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_b84b2b2c-f6be-4c36-931c-ea254f25f9b4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b6b7020e-40af-4081-afb7-2fe01143998d" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_b84b2b2c-f6be-4c36-931c-ea254f25f9b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_f6f4cfa2-d6cf-4fa7-8830-785f3d26799c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b6b7020e-40af-4081-afb7-2fe01143998d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_f6f4cfa2-d6cf-4fa7-8830-785f3d26799c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_198a0ea5-d07c-433c-b830-aa8e57099cf1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b6b7020e-40af-4081-afb7-2fe01143998d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_198a0ea5-d07c-433c-b830-aa8e57099cf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_0a22362b-dec0-4239-81bc-2f53427f8765" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b6b7020e-40af-4081-afb7-2fe01143998d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_0a22362b-dec0-4239-81bc-2f53427f8765" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_928c77a1-c15b-4286-982b-f347c80305a1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b6b7020e-40af-4081-afb7-2fe01143998d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_928c77a1-c15b-4286-982b-f347c80305a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_67f24cef-b6d0-4a92-8445-7bdb5d1e3e10" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b6b7020e-40af-4081-afb7-2fe01143998d" xlink:to="loc_us-gaap_Goodwill_67f24cef-b6d0-4a92-8445-7bdb5d1e3e10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_1816895d-4f11-4122-a005-0f886ed816a3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b6b7020e-40af-4081-afb7-2fe01143998d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_1816895d-4f11-4122-a005-0f886ed816a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_f32c67a6-706b-4468-9896-ee1c45199c21" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b6b7020e-40af-4081-afb7-2fe01143998d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_f32c67a6-706b-4468-9896-ee1c45199c21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_7d52c82a-004a-4a4b-9609-bc4c9303a405" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b6b7020e-40af-4081-afb7-2fe01143998d" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_7d52c82a-004a-4a4b-9609-bc4c9303a405" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_d5460471-202f-43c0-a3c0-a9dd6b236a31" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b6b7020e-40af-4081-afb7-2fe01143998d" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_d5460471-202f-43c0-a3c0-a9dd6b236a31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_2c107fce-0eb9-4300-a4df-0fdc98e9478d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b6b7020e-40af-4081-afb7-2fe01143998d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_2c107fce-0eb9-4300-a4df-0fdc98e9478d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_d61415df-251b-4234-bfbe-85d9bad731f3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b6b7020e-40af-4081-afb7-2fe01143998d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_d61415df-251b-4234-bfbe-85d9bad731f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_1b8d4bbb-ca17-4785-9c02-105a1398e70d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b6b7020e-40af-4081-afb7-2fe01143998d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_1b8d4bbb-ca17-4785-9c02-105a1398e70d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_169a521f-81cc-4e97-be08-e439501dcb69" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b6b7020e-40af-4081-afb7-2fe01143998d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_169a521f-81cc-4e97-be08-e439501dcb69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_95b782ba-506b-4fd3-b044-91b09b8b27f9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b6b7020e-40af-4081-afb7-2fe01143998d" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_95b782ba-506b-4fd3-b044-91b09b8b27f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed_279c9739-ad5a-4f2e-b709-fe55e6c97f00" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b6b7020e-40af-4081-afb7-2fe01143998d" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed_279c9739-ad5a-4f2e-b709-fe55e6c97f00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/DIVESTITURE" xlink:type="simple" xlink:href="hae-20201226.xsd#DIVESTITURE"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/DIVESTITURE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_2dc5b9af-1a1c-4d6a-836c-198117399335" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_c30a3176-93eb-44b2-9de5-1f1d66866c03" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_2dc5b9af-1a1c-4d6a-836c-198117399335" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_c30a3176-93eb-44b2-9de5-1f1d66866c03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/DIVESTITUREDetails" xlink:type="simple" xlink:href="hae-20201226.xsd#DIVESTITUREDetails"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/DIVESTITUREDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_8c4ef11f-2617-4fcf-9afc-3531ab7887bc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_1e243146-5537-4dcb-9362-b9bf81b44ed2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_8c4ef11f-2617-4fcf-9afc-3531ab7887bc" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_1e243146-5537-4dcb-9362-b9bf81b44ed2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_ab51096a-e465-4963-8236-26c9d51158d3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_1e243146-5537-4dcb-9362-b9bf81b44ed2" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_ab51096a-e465-4963-8236-26c9d51158d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c5bc8741-2117-40c2-bf31-a9dbb2ff18c2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_ab51096a-e465-4963-8236-26c9d51158d3" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c5bc8741-2117-40c2-bf31-a9dbb2ff18c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_FajardoPuertoRicoManufacturingOperationsMember_8c151440-a8c4-4129-bf36-780898b77ad3" xlink:href="hae-20201226.xsd#hae_FajardoPuertoRicoManufacturingOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c5bc8741-2117-40c2-bf31-a9dbb2ff18c2" xlink:to="loc_hae_FajardoPuertoRicoManufacturingOperationsMember_8c151440-a8c4-4129-bf36-780898b77ad3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_USBloodDonorManagementSoftwareMember_adcefcc7-2533-4bc5-95d6-d9ddd5c72a3a" xlink:href="hae-20201226.xsd#hae_USBloodDonorManagementSoftwareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c5bc8741-2117-40c2-bf31-a9dbb2ff18c2" xlink:to="loc_hae_USBloodDonorManagementSoftwareMember_adcefcc7-2533-4bc5-95d6-d9ddd5c72a3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_InlogHoldingsFranceMember_b6384b4e-8266-4398-a0da-1d2f58550a68" xlink:href="hae-20201226.xsd#hae_InlogHoldingsFranceMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c5bc8741-2117-40c2-bf31-a9dbb2ff18c2" xlink:to="loc_hae_InlogHoldingsFranceMember_b6384b4e-8266-4398-a0da-1d2f58550a68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_4c69073d-a8de-4923-aca2-30197a6b730d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_1e243146-5537-4dcb-9362-b9bf81b44ed2" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_4c69073d-a8de-4923-aca2-30197a6b730d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_a9798296-6b88-461f-9cd5-8978743c627a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_4c69073d-a8de-4923-aca2-30197a6b730d" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_a9798296-6b88-461f-9cd5-8978743c627a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_706948c3-12e1-40f9-b7d2-49ed72815e91" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_a9798296-6b88-461f-9cd5-8978743c627a" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_706948c3-12e1-40f9-b7d2-49ed72815e91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_0d83f936-e742-4eaa-8dd9-c39810106028" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_1e243146-5537-4dcb-9362-b9bf81b44ed2" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_0d83f936-e742-4eaa-8dd9-c39810106028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_7b8f5a7a-c131-4e2b-9248-dcf4bd51cf21" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_0d83f936-e742-4eaa-8dd9-c39810106028" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_7b8f5a7a-c131-4e2b-9248-dcf4bd51cf21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_fb7c1d30-580c-4bf0-a92e-ceb8df146c8c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_7b8f5a7a-c131-4e2b-9248-dcf4bd51cf21" xlink:to="loc_us-gaap_SubsequentEventMember_fb7c1d30-580c-4bf0-a92e-ceb8df146c8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_36d4d99a-ab58-4e68-aa75-614fb536266f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_1e243146-5537-4dcb-9362-b9bf81b44ed2" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_36d4d99a-ab58-4e68-aa75-614fb536266f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_a5ee4fef-7338-4d7b-b505-c187f98d48ca" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_36d4d99a-ab58-4e68-aa75-614fb536266f" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_a5ee4fef-7338-4d7b-b505-c187f98d48ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_7e16eb09-0ee7-4c6f-94b9-993a22d24efb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_36d4d99a-ab58-4e68-aa75-614fb536266f" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_7e16eb09-0ee7-4c6f-94b9-993a22d24efb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_de2553ac-cddd-48d0-b2f6-484bb990ccca" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_36d4d99a-ab58-4e68-aa75-614fb536266f" xlink:to="loc_us-gaap_AssetImpairmentCharges_de2553ac-cddd-48d0-b2f6-484bb990ccca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DisposalGroupNotDiscontinuedOperationsIncrementalLossOnClosingAdjustments_4cc9bac0-bded-4ad4-a472-4ee65fb8c778" xlink:href="hae-20201226.xsd#hae_DisposalGroupNotDiscontinuedOperationsIncrementalLossOnClosingAdjustments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_36d4d99a-ab58-4e68-aa75-614fb536266f" xlink:to="loc_hae_DisposalGroupNotDiscontinuedOperationsIncrementalLossOnClosingAdjustments_4cc9bac0-bded-4ad4-a472-4ee65fb8c778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DisposalGroupNotDiscontinuedOperationsExpectedCostToSell_c79c9ea9-bffa-41a9-be3f-ada4beba2fa4" xlink:href="hae-20201226.xsd#hae_DisposalGroupNotDiscontinuedOperationsExpectedCostToSell"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_36d4d99a-ab58-4e68-aa75-614fb536266f" xlink:to="loc_hae_DisposalGroupNotDiscontinuedOperationsExpectedCostToSell_c79c9ea9-bffa-41a9-be3f-ada4beba2fa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_a05ecbc1-13ea-46b7-98b5-2a6a7380283b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_36d4d99a-ab58-4e68-aa75-614fb536266f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_a05ecbc1-13ea-46b7-98b5-2a6a7380283b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_a75017bb-b1a3-43cf-86c6-e273d0dde341" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_36d4d99a-ab58-4e68-aa75-614fb536266f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment_a75017bb-b1a3-43cf-86c6-e273d0dde341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_5ab18d75-350e-41d0-a1f4-b005d6f1f1a3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_36d4d99a-ab58-4e68-aa75-614fb536266f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_5ab18d75-350e-41d0-a1f4-b005d6f1f1a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_2c5edfc5-853a-4804-8f99-2f08e6ef527d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_36d4d99a-ab58-4e68-aa75-614fb536266f" xlink:to="loc_us-gaap_Goodwill_2c5edfc5-853a-4804-8f99-2f08e6ef527d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_f6b99512-a34f-405e-8baf-7fecf32c08ed" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_36d4d99a-ab58-4e68-aa75-614fb536266f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_f6b99512-a34f-405e-8baf-7fecf32c08ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_8ba06b7e-7b2f-4198-9035-e823e704006f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_36d4d99a-ab58-4e68-aa75-614fb536266f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_8ba06b7e-7b2f-4198-9035-e823e704006f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_346c585f-6b6f-4dd2-ab2b-2505d3295d2f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_36d4d99a-ab58-4e68-aa75-614fb536266f" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_346c585f-6b6f-4dd2-ab2b-2505d3295d2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_03fc00f9-f1b5-498b-a400-2139db0e8a41" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_36d4d99a-ab58-4e68-aa75-614fb536266f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_03fc00f9-f1b5-498b-a400-2139db0e8a41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_d7b1ea5b-946e-4107-b278-4c464ee343c7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_36d4d99a-ab58-4e68-aa75-614fb536266f" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_d7b1ea5b-946e-4107-b278-4c464ee343c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_ee916f03-db97-4cbe-9c61-e69ae0558c32" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_36d4d99a-ab58-4e68-aa75-614fb536266f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_ee916f03-db97-4cbe-9c61-e69ae0558c32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DisposalGroupIncludingDiscontinuedOperationConsiderationToBeReceived_3c36631f-3119-44b8-99c7-5200c9dd4010" xlink:href="hae-20201226.xsd#hae_DisposalGroupIncludingDiscontinuedOperationConsiderationToBeReceived"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_36d4d99a-ab58-4e68-aa75-614fb536266f" xlink:to="loc_hae_DisposalGroupIncludingDiscontinuedOperationConsiderationToBeReceived_3c36631f-3119-44b8-99c7-5200c9dd4010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/INCOMETAXES" xlink:type="simple" xlink:href="hae-20201226.xsd#INCOMETAXES"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/INCOMETAXES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_4dd61d14-1b94-4685-8b94-63168a6846cd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_6b03fc4c-5af8-405f-842f-86b3d44fe6f3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4dd61d14-1b94-4685-8b94-63168a6846cd" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_6b03fc4c-5af8-405f-842f-86b3d44fe6f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/INCOMETAXESDetails" xlink:type="simple" xlink:href="hae-20201226.xsd#INCOMETAXESDetails"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/INCOMETAXESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_3dcc7cd3-92e5-466c-861f-d761d89eee70" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c8954990-2dcb-4d96-8710-2a676c3c741d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3dcc7cd3-92e5-466c-861f-d761d89eee70" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_c8954990-2dcb-4d96-8710-2a676c3c741d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_04ae456f-ac65-4b65-b8a3-59abeb0d8857" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3dcc7cd3-92e5-466c-861f-d761d89eee70" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_04ae456f-ac65-4b65-b8a3-59abeb0d8857" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_b3ccfd56-5e09-4e67-9862-674cc3a90853" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3dcc7cd3-92e5-466c-861f-d761d89eee70" xlink:to="loc_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_b3ccfd56-5e09-4e67-9862-674cc3a90853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/EARNINGSPERSHAREEPS" xlink:type="simple" xlink:href="hae-20201226.xsd#EARNINGSPERSHAREEPS"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/EARNINGSPERSHAREEPS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_c8f8ef3e-0fca-48c3-ab4a-3ebc50718fe2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_3f54a377-187c-4067-97d5-54dc68ea776d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_c8f8ef3e-0fca-48c3-ab4a-3ebc50718fe2" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_3f54a377-187c-4067-97d5-54dc68ea776d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/EARNINGSPERSHAREEPSTables" xlink:type="simple" xlink:href="hae-20201226.xsd#EARNINGSPERSHAREEPSTables"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/EARNINGSPERSHAREEPSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_e3b4479a-6a05-4652-a2aa-5f3052a179fe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_99851727-b164-4a30-a548-2962a280fbed" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e3b4479a-6a05-4652-a2aa-5f3052a179fe" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_99851727-b164-4a30-a548-2962a280fbed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/EARNINGSPERSHAREEPSScheduleofEarningsPerShareReconciliationDetails" xlink:type="simple" xlink:href="hae-20201226.xsd#EARNINGSPERSHAREEPSScheduleofEarningsPerShareReconciliationDetails"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/EARNINGSPERSHAREEPSScheduleofEarningsPerShareReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_fa94504f-7397-4113-bf39-6ff53b7d1023" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_b9736179-08ac-4725-8d81-92049056c3e0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_fa94504f-7397-4113-bf39-6ff53b7d1023" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_b9736179-08ac-4725-8d81-92049056c3e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_bc8640a6-d187-48dc-be05-ff4fbcdeaf20" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_b9736179-08ac-4725-8d81-92049056c3e0" xlink:to="loc_us-gaap_NetIncomeLoss_bc8640a6-d187-48dc-be05-ff4fbcdeaf20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_fd03e58b-7dfc-4c3b-9076-9490a6366658" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_b9736179-08ac-4725-8d81-92049056c3e0" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_fd03e58b-7dfc-4c3b-9076-9490a6366658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_5eeb021e-9ccb-4cd1-b4b9-d6addac0a2b9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_b9736179-08ac-4725-8d81-92049056c3e0" xlink:to="loc_us-gaap_EarningsPerShareBasic_5eeb021e-9ccb-4cd1-b4b9-d6addac0a2b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_52321e78-cbed-4459-af67-be1e55e05db3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_fa94504f-7397-4113-bf39-6ff53b7d1023" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_52321e78-cbed-4459-af67-be1e55e05db3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6b329eb4-8506-40bb-8d3e-c4d7a1cd221f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_52321e78-cbed-4459-af67-be1e55e05db3" xlink:to="loc_us-gaap_NetIncomeLoss_6b329eb4-8506-40bb-8d3e-c4d7a1cd221f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_9c661ecd-d5b5-4e53-a25e-6aa00b6d38c8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_52321e78-cbed-4459-af67-be1e55e05db3" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_9c661ecd-d5b5-4e53-a25e-6aa00b6d38c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_55bb718f-86c9-4407-afe2-98423791644f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_52321e78-cbed-4459-af67-be1e55e05db3" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_55bb718f-86c9-4407-afe2-98423791644f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_222ba8b6-b777-49f8-9692-00b9d1c266be" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_52321e78-cbed-4459-af67-be1e55e05db3" xlink:to="loc_us-gaap_EarningsPerShareDiluted_222ba8b6-b777-49f8-9692-00b9d1c266be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2e46fb2c-4db9-4d7c-bb4b-1bfaf14a92cc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_52321e78-cbed-4459-af67-be1e55e05db3" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2e46fb2c-4db9-4d7c-bb4b-1bfaf14a92cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/REVENUE" xlink:type="simple" xlink:href="hae-20201226.xsd#REVENUE"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/REVENUE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b264c18c-1e20-4e4e-9c1d-cfaea4937aff" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_f405ee70-bd2f-4284-82bf-fb6e02f54f99" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b264c18c-1e20-4e4e-9c1d-cfaea4937aff" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_f405ee70-bd2f-4284-82bf-fb6e02f54f99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/REVENUEDetails" xlink:type="simple" xlink:href="hae-20201226.xsd#REVENUEDetails"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/REVENUEDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_80fefcf0-eb94-4d63-8eb9-62fe5e00bd39" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_2d47d79c-e2be-40bc-8225-75a3210e273e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_80fefcf0-eb94-4d63-8eb9-62fe5e00bd39" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_2d47d79c-e2be-40bc-8225-75a3210e273e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_d6fe16ad-2c96-4f64-9c03-c4357aefd38a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_80fefcf0-eb94-4d63-8eb9-62fe5e00bd39" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_d6fe16ad-2c96-4f64-9c03-c4357aefd38a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_7ca1d71a-aadd-4ad3-ad85-2be912a5339e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_80fefcf0-eb94-4d63-8eb9-62fe5e00bd39" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_7ca1d71a-aadd-4ad3-ad85-2be912a5339e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_6ec4624d-57ba-4066-9d52-e233d7c0cbc4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_80fefcf0-eb94-4d63-8eb9-62fe5e00bd39" xlink:to="loc_us-gaap_ContractWithCustomerLiability_6ec4624d-57ba-4066-9d52-e233d7c0cbc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_488863eb-0a40-4d7f-add4-81fd8b593bb0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_80fefcf0-eb94-4d63-8eb9-62fe5e00bd39" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_488863eb-0a40-4d7f-add4-81fd8b593bb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_12595e2b-227e-4eda-a8b2-0c213b3f7c6a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_80fefcf0-eb94-4d63-8eb9-62fe5e00bd39" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_12595e2b-227e-4eda-a8b2-0c213b3f7c6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_14fc84e4-c1ec-4a6c-9801-8c175684530d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_80fefcf0-eb94-4d63-8eb9-62fe5e00bd39" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_14fc84e4-c1ec-4a6c-9801-8c175684530d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_4a9e7cd9-038f-47a2-88ff-a65d8280ed9e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_14fc84e4-c1ec-4a6c-9801-8c175684530d" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_4a9e7cd9-038f-47a2-88ff-a65d8280ed9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_ef6c35d5-0d8d-499b-9423-4b5bb9be8c77" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_14fc84e4-c1ec-4a6c-9801-8c175684530d" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_ef6c35d5-0d8d-499b-9423-4b5bb9be8c77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_0b8ad975-a92c-422a-b7b6-56b9536e266e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_ef6c35d5-0d8d-499b-9423-4b5bb9be8c77" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_0b8ad975-a92c-422a-b7b6-56b9536e266e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/REVENUEDetails_1" xlink:type="simple" xlink:href="hae-20201226.xsd#REVENUEDetails_1"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/REVENUEDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/INVENTORIES" xlink:type="simple" xlink:href="hae-20201226.xsd#INVENTORIES"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/INVENTORIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_6afcb49d-900e-457d-ac2c-1f869268528a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_fa7d4074-432e-4244-88d6-85bc496e8636" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_6afcb49d-900e-457d-ac2c-1f869268528a" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_fa7d4074-432e-4244-88d6-85bc496e8636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/INVENTORIESTables" xlink:type="simple" xlink:href="hae-20201226.xsd#INVENTORIESTables"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/INVENTORIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_d6eaafb5-69ab-428b-a3d7-5129c84dedeb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_6b7a43a4-246f-4aae-9964-42238e51e2bc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_d6eaafb5-69ab-428b-a3d7-5129c84dedeb" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_6b7a43a4-246f-4aae-9964-42238e51e2bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/INVENTORIESScheduleofInventoriesDetails" xlink:type="simple" xlink:href="hae-20201226.xsd#INVENTORIESScheduleofInventoriesDetails"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/INVENTORIESScheduleofInventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_6ea8472d-92f3-487e-9c6e-03c7e9d6a03c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_8ff1189f-6b69-4950-9164-2c2dea5f7189" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_6ea8472d-92f3-487e-9c6e-03c7e9d6a03c" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_8ff1189f-6b69-4950-9164-2c2dea5f7189" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_e581e27f-1bee-41bf-9411-d7f8940f9836" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_6ea8472d-92f3-487e-9c6e-03c7e9d6a03c" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_e581e27f-1bee-41bf-9411-d7f8940f9836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_c727e4b6-a1e8-4fe6-9bb8-a3fe3367bd8e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_6ea8472d-92f3-487e-9c6e-03c7e9d6a03c" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_c727e4b6-a1e8-4fe6-9bb8-a3fe3367bd8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_3f264d2a-6116-4ec6-b838-92118f8d5285" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_6ea8472d-92f3-487e-9c6e-03c7e9d6a03c" xlink:to="loc_us-gaap_InventoryNet_3f264d2a-6116-4ec6-b838-92118f8d5285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/LEASES" xlink:type="simple" xlink:href="hae-20201226.xsd#LEASES"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/LEASES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_5a788f4b-51db-4b20-a43c-ef1a97a34ebd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_5c17e17c-fb17-4ff5-a47b-38eb2edd349b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5a788f4b-51db-4b20-a43c-ef1a97a34ebd" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_5c17e17c-fb17-4ff5-a47b-38eb2edd349b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/LEASESDetails" xlink:type="simple" xlink:href="hae-20201226.xsd#LEASESDetails"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/LEASESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_070b0408-8c36-4808-b9d2-a539eb55cea3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_0647b524-1ed5-4d0e-97ff-532ca068f3ab" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_070b0408-8c36-4808-b9d2-a539eb55cea3" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_0647b524-1ed5-4d0e-97ff-532ca068f3ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_75d58ef6-e069-44b0-b0e4-6034ae1bd341" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_0647b524-1ed5-4d0e-97ff-532ca068f3ab" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_75d58ef6-e069-44b0-b0e4-6034ae1bd341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_256ae936-5931-4447-a5e4-0525ca18abc6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_75d58ef6-e069-44b0-b0e4-6034ae1bd341" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_256ae936-5931-4447-a5e4-0525ca18abc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_ManufacturingSpaceMember_3c8d99c7-6ff6-45ef-86ed-dc9d7b46c5b9" xlink:href="hae-20201226.xsd#hae_ManufacturingSpaceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_256ae936-5931-4447-a5e4-0525ca18abc6" xlink:to="loc_hae_ManufacturingSpaceMember_3c8d99c7-6ff6-45ef-86ed-dc9d7b46c5b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_ManufacturingSpaceSecondRenewalTermMember_81a8b198-9ce3-4ff4-a574-ddcead797bb6" xlink:href="hae-20201226.xsd#hae_ManufacturingSpaceSecondRenewalTermMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_256ae936-5931-4447-a5e4-0525ca18abc6" xlink:to="loc_hae_ManufacturingSpaceSecondRenewalTermMember_81a8b198-9ce3-4ff4-a574-ddcead797bb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_fe543621-760d-4e5e-865e-38a1e267b560" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_0647b524-1ed5-4d0e-97ff-532ca068f3ab" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_fe543621-760d-4e5e-865e-38a1e267b560" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_1180e0ba-20ec-40cf-8b15-b8f45281c744" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fe543621-760d-4e5e-865e-38a1e267b560" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_1180e0ba-20ec-40cf-8b15-b8f45281c744" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_655a2c52-67c9-4679-8c6b-5f768b439495" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fe543621-760d-4e5e-865e-38a1e267b560" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_655a2c52-67c9-4679-8c6b-5f768b439495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_2f96f6d9-27f9-4057-afd1-81c6b75a876c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fe543621-760d-4e5e-865e-38a1e267b560" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_2f96f6d9-27f9-4057-afd1-81c6b75a876c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_dd71f9ce-1544-42f9-9ca8-81338893729a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fe543621-760d-4e5e-865e-38a1e267b560" xlink:to="loc_us-gaap_OperatingLeaseLiability_dd71f9ce-1544-42f9-9ca8-81338893729a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_711dba16-b8a6-41ec-b3c9-504a381f0848" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fe543621-760d-4e5e-865e-38a1e267b560" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_711dba16-b8a6-41ec-b3c9-504a381f0848" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBT" xlink:type="simple" xlink:href="hae-20201226.xsd#NOTESPAYABLEANDLONGTERMDEBT"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_0d22a248-c338-4ef7-a760-c2ea6c9253f5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_25e88771-4330-4b79-9abf-b837f3b4894e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0d22a248-c338-4ef7-a760-c2ea6c9253f5" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_25e88771-4330-4b79-9abf-b837f3b4894e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTDetails" xlink:type="simple" xlink:href="hae-20201226.xsd#NOTESPAYABLEANDLONGTERMDEBTDetails"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_924381c7-7842-4a1e-848e-e45dc43d9868" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_e0add28a-efac-4171-affe-3fdcd1e2e7c9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_924381c7-7842-4a1e-848e-e45dc43d9868" xlink:to="loc_us-gaap_DebtInstrumentTable_e0add28a-efac-4171-affe-3fdcd1e2e7c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_0097a92e-3144-49e4-be99-e9d37a9ed904" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e0add28a-efac-4171-affe-3fdcd1e2e7c9" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_0097a92e-3144-49e4-be99-e9d37a9ed904" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_ccb6c9d2-c448-4b6a-a5d6-ccefe4ecf892" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_0097a92e-3144-49e4-be99-e9d37a9ed904" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_ccb6c9d2-c448-4b6a-a5d6-ccefe4ecf892" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_7ff10cc3-cd2b-450a-b5fa-da4ef572be3d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_ccb6c9d2-c448-4b6a-a5d6-ccefe4ecf892" xlink:to="loc_us-gaap_LongTermDebtMember_7ff10cc3-cd2b-450a-b5fa-da4ef572be3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember_133b0826-dc85-4b6d-9535-01e637333f14" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MediumTermNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtMember_7ff10cc3-cd2b-450a-b5fa-da4ef572be3d" xlink:to="loc_us-gaap_MediumTermNotesMember_133b0826-dc85-4b6d-9535-01e637333f14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_3eef0573-1e1d-4aa5-baa2-fb27b3a9771e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtMember_7ff10cc3-cd2b-450a-b5fa-da4ef572be3d" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_3eef0573-1e1d-4aa5-baa2-fb27b3a9771e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_71605c0e-34d8-48d3-98e5-e4d09ebd6c88" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtMember_7ff10cc3-cd2b-450a-b5fa-da4ef572be3d" xlink:to="loc_us-gaap_LineOfCreditMember_71605c0e-34d8-48d3-98e5-e4d09ebd6c88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_028c57d7-5d83-4908-9991-35358e1cc8e5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e0add28a-efac-4171-affe-3fdcd1e2e7c9" xlink:to="loc_us-gaap_VariableRateAxis_028c57d7-5d83-4908-9991-35358e1cc8e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_dac890b6-65ee-4024-8d7f-115755282cbc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_028c57d7-5d83-4908-9991-35358e1cc8e5" xlink:to="loc_us-gaap_VariableRateDomain_dac890b6-65ee-4024-8d7f-115755282cbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_90b22c7a-7439-4670-ab49-c07c4f62706a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_dac890b6-65ee-4024-8d7f-115755282cbc" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_90b22c7a-7439-4670-ab49-c07c4f62706a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d7206e70-49fa-4bae-8a1b-39b29cf62623" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e0add28a-efac-4171-affe-3fdcd1e2e7c9" xlink:to="loc_srt_RangeAxis_d7206e70-49fa-4bae-8a1b-39b29cf62623" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0957b6da-0a20-4685-9ad5-442f76aa85b6" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_d7206e70-49fa-4bae-8a1b-39b29cf62623" xlink:to="loc_srt_RangeMember_0957b6da-0a20-4685-9ad5-442f76aa85b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_5313734f-ef99-4c82-868c-12c1a087dcbd" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_0957b6da-0a20-4685-9ad5-442f76aa85b6" xlink:to="loc_srt_MinimumMember_5313734f-ef99-4c82-868c-12c1a087dcbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4cead233-63d4-4954-9b75-fcdbcc821999" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_0957b6da-0a20-4685-9ad5-442f76aa85b6" xlink:to="loc_srt_MaximumMember_4cead233-63d4-4954-9b75-fcdbcc821999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAxis_7c54f8f6-2d01-4b28-a6f7-323a6b8be587" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ExtinguishmentOfDebtAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e0add28a-efac-4171-affe-3fdcd1e2e7c9" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAxis_7c54f8f6-2d01-4b28-a6f7-323a6b8be587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_31cf45fd-24a6-48a0-a076-90713f1cb959" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAxis_7c54f8f6-2d01-4b28-a6f7-323a6b8be587" xlink:to="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_31cf45fd-24a6-48a0-a076-90713f1cb959" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_a7f2f3ac-e0b8-4521-95e0-aaeb7c0b17c5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_31cf45fd-24a6-48a0-a076-90713f1cb959" xlink:to="loc_us-gaap_LongTermDebtMember_a7f2f3ac-e0b8-4521-95e0-aaeb7c0b17c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember_11b811b3-f22b-4791-935d-6a79cf49d9cc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MediumTermNotesMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_21d96463-d586-44ee-97ec-f156557e1209" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_bb55f6f8-fccf-423b-8f85-d09b2198efe9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_b77f0ff9-fb6f-4426-8a07-0ccb357b0be8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e0add28a-efac-4171-affe-3fdcd1e2e7c9" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_b77f0ff9-fb6f-4426-8a07-0ccb357b0be8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_a14e8238-c204-4721-876e-d31e40e5459a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_b77f0ff9-fb6f-4426-8a07-0ccb357b0be8" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_a14e8238-c204-4721-876e-d31e40e5459a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_cb2c119c-8ab0-4fbf-9e77-3c9a0101f3bd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_a14e8238-c204-4721-876e-d31e40e5459a" xlink:to="loc_us-gaap_SubsequentEventMember_cb2c119c-8ab0-4fbf-9e77-3c9a0101f3bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_59800d62-3d7a-4f6d-81cb-0c8a3e570f5c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e0add28a-efac-4171-affe-3fdcd1e2e7c9" xlink:to="loc_us-gaap_DebtInstrumentLineItems_59800d62-3d7a-4f6d-81cb-0c8a3e570f5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_eb46fda6-83bf-4371-9bb1-2037a97cd746" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_59800d62-3d7a-4f6d-81cb-0c8a3e570f5c" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_eb46fda6-83bf-4371-9bb1-2037a97cd746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_add0667b-9d96-496e-87d3-842841622b09" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_59800d62-3d7a-4f6d-81cb-0c8a3e570f5c" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_add0667b-9d96-496e-87d3-842841622b09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_2de3b621-2a23-42e6-a7ea-d6b0f1d9ad8e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_59800d62-3d7a-4f6d-81cb-0c8a3e570f5c" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_2de3b621-2a23-42e6-a7ea-d6b0f1d9ad8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_6276a79e-f8ce-417a-9a89-5fb3de2cb863" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_59800d62-3d7a-4f6d-81cb-0c8a3e570f5c" xlink:to="loc_us-gaap_LongTermDebt_6276a79e-f8ce-417a-9a89-5fb3de2cb863" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_cda3cccd-a668-47e8-a45a-1582b9787832" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_59800d62-3d7a-4f6d-81cb-0c8a3e570f5c" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_cda3cccd-a668-47e8-a45a-1582b9787832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_b79e3ddf-78b4-4020-85bf-e05ceebb2e19" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_59800d62-3d7a-4f6d-81cb-0c8a3e570f5c" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_b79e3ddf-78b4-4020-85bf-e05ceebb2e19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_5e39c26a-767c-4917-ab53-85931059560f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_59800d62-3d7a-4f6d-81cb-0c8a3e570f5c" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_5e39c26a-767c-4917-ab53-85931059560f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_44c57621-c5eb-4a0e-8a70-403205a33009" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_59800d62-3d7a-4f6d-81cb-0c8a3e570f5c" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_44c57621-c5eb-4a0e-8a70-403205a33009" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_1619afd8-2492-4a82-9720-f16a9b7e0aef" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_59800d62-3d7a-4f6d-81cb-0c8a3e570f5c" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_1619afd8-2492-4a82-9720-f16a9b7e0aef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURES" xlink:type="simple" xlink:href="hae-20201226.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASURES"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_8c73b6d4-fda2-48c7-93d2-47205a8fb209" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesAndFairValueTextBlock_2d0e48be-8e05-40ac-9b93-3ff000948ea0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativesAndFairValueTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_8c73b6d4-fda2-48c7-93d2-47205a8fb209" xlink:to="loc_us-gaap_DerivativesAndFairValueTextBlock_2d0e48be-8e05-40ac-9b93-3ff000948ea0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESTables" xlink:type="simple" xlink:href="hae-20201226.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESTables"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1ac9d703-7853-4126-a0a2-78723a2de38f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_23ed8bd9-205d-4965-9160-df8cb4cc31bc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1ac9d703-7853-4126-a0a2-78723a2de38f" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_23ed8bd9-205d-4965-9160-df8cb4cc31bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_85448167-e1e6-4777-8fbd-f3f1a37c1747" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1ac9d703-7853-4126-a0a2-78723a2de38f" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_85448167-e1e6-4777-8fbd-f3f1a37c1747" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_22890ec5-6ab3-4f85-b930-38c13a48a71a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1ac9d703-7853-4126-a0a2-78723a2de38f" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_22890ec5-6ab3-4f85-b930-38c13a48a71a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_0d562199-d6ce-4cfc-a875-c8f606a3db03" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1ac9d703-7853-4126-a0a2-78723a2de38f" xlink:to="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_0d562199-d6ce-4cfc-a875-c8f606a3db03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAllowanceforcreditlossesDetails" xlink:type="simple" xlink:href="hae-20201226.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAllowanceforcreditlossesDetails"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAllowanceforcreditlossesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_efb02b86-1a4f-42bf-9f94-2a06a98fd54a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_c89798da-58f1-4cd4-96f0-3d1c416b1629" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_efb02b86-1a4f-42bf-9f94-2a06a98fd54a" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_c89798da-58f1-4cd4-96f0-3d1c416b1629" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_5a4c98a4-2005-4bcc-a092-a0018065d2b4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_c89798da-58f1-4cd4-96f0-3d1c416b1629" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_5a4c98a4-2005-4bcc-a092-a0018065d2b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_d0d85419-bb4a-4cb9-a7d0-ae9eaea332fb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_c89798da-58f1-4cd4-96f0-3d1c416b1629" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_d0d85419-bb4a-4cb9-a7d0-ae9eaea332fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_50ba75fb-1208-40e2-a423-bd260cf098db" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_c89798da-58f1-4cd4-96f0-3d1c416b1629" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_50ba75fb-1208-40e2-a423-bd260cf098db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_832d391f-15db-4d19-aad1-16b7acf508e0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_c89798da-58f1-4cd4-96f0-3d1c416b1629" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_832d391f-15db-4d19-aad1-16b7acf508e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails" xlink:type="simple" xlink:href="hae-20201226.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_589ad664-c5c3-47cd-b3d8-7413170d4602" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_677fa7e5-7116-4957-98be-0d4d197097eb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_589ad664-c5c3-47cd-b3d8-7413170d4602" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_677fa7e5-7116-4957-98be-0d4d197097eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_93b74f35-dee0-4e27-95f0-e549a2030cdd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_677fa7e5-7116-4957-98be-0d4d197097eb" xlink:to="loc_us-gaap_HedgingDesignationAxis_93b74f35-dee0-4e27-95f0-e549a2030cdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_096ebaee-5b79-4833-a1cb-acb0fe175a9b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_93b74f35-dee0-4e27-95f0-e549a2030cdd" xlink:to="loc_us-gaap_HedgingDesignationDomain_096ebaee-5b79-4833-a1cb-acb0fe175a9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_cb72f676-99c6-4e64-8301-d73e5fc34a91" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_096ebaee-5b79-4833-a1cb-acb0fe175a9b" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_cb72f676-99c6-4e64-8301-d73e5fc34a91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_68e933d8-fbf4-4382-a144-89fded2e57f7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_096ebaee-5b79-4833-a1cb-acb0fe175a9b" xlink:to="loc_us-gaap_NondesignatedMember_68e933d8-fbf4-4382-a144-89fded2e57f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_c8588da3-6904-4c57-907b-46c80b280db2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_677fa7e5-7116-4957-98be-0d4d197097eb" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_c8588da3-6904-4c57-907b-46c80b280db2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_cad6352e-faa7-4546-b5c3-a0e402b4dc44" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_c8588da3-6904-4c57-907b-46c80b280db2" xlink:to="loc_us-gaap_HedgingRelationshipDomain_cad6352e-faa7-4546-b5c3-a0e402b4dc44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_9ea356f0-8e45-4cb6-983f-da08279dd059" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_cad6352e-faa7-4546-b5c3-a0e402b4dc44" xlink:to="loc_us-gaap_CashFlowHedgingMember_9ea356f0-8e45-4cb6-983f-da08279dd059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_962cf01f-6c38-421a-9159-f05898aa4aa8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_cad6352e-faa7-4546-b5c3-a0e402b4dc44" xlink:to="loc_us-gaap_InterestRateSwapMember_962cf01f-6c38-421a-9159-f05898aa4aa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_4694a744-f889-46af-bf38-5efd5b55d38e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_677fa7e5-7116-4957-98be-0d4d197097eb" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_4694a744-f889-46af-bf38-5efd5b55d38e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f9aa7d99-422d-4153-9bb5-e94f2b25c6e4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4694a744-f889-46af-bf38-5efd5b55d38e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f9aa7d99-422d-4153-9bb5-e94f2b25c6e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_613991ba-a159-45eb-bd00-2cfc3585cf00" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f9aa7d99-422d-4153-9bb5-e94f2b25c6e4" xlink:to="loc_us-gaap_ForeignExchangeContractMember_613991ba-a159-45eb-bd00-2cfc3585cf00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_29683312-0d70-408a-8415-2829056233f5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_677fa7e5-7116-4957-98be-0d4d197097eb" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_29683312-0d70-408a-8415-2829056233f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_d321bd06-bee4-4701-a891-1799694a8545" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_29683312-0d70-408a-8415-2829056233f5" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_d321bd06-bee4-4701-a891-1799694a8545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_NetRevenuesCostOfGoodsSoldAndSellingGeneralAndAdministrativeExpenseMember_546b82b4-402e-4bef-bd98-b45e4ad1be2d" xlink:href="hae-20201226.xsd#hae_NetRevenuesCostOfGoodsSoldAndSellingGeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d321bd06-bee4-4701-a891-1799694a8545" xlink:to="loc_hae_NetRevenuesCostOfGoodsSoldAndSellingGeneralAndAdministrativeExpenseMember_546b82b4-402e-4bef-bd98-b45e4ad1be2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_OtherIncomeExpenseNetMember_a9758848-33c6-4cf5-bdf7-deb85cc8dc10" xlink:href="hae-20201226.xsd#hae_OtherIncomeExpenseNetMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d321bd06-bee4-4701-a891-1799694a8545" xlink:to="loc_hae_OtherIncomeExpenseNetMember_a9758848-33c6-4cf5-bdf7-deb85cc8dc10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6603fa1a-0b5c-412a-ac20-cff548b3b18c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_677fa7e5-7116-4957-98be-0d4d197097eb" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6603fa1a-0b5c-412a-ac20-cff548b3b18c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_67cbdaf4-73c5-4722-b22f-f34616bdaca6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6603fa1a-0b5c-412a-ac20-cff548b3b18c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_67cbdaf4-73c5-4722-b22f-f34616bdaca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_d75f4615-a0ff-4c65-9b83-a4c8a7b36110" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6603fa1a-0b5c-412a-ac20-cff548b3b18c" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_d75f4615-a0ff-4c65-9b83-a4c8a7b36110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet_38eb7249-6a53-4d71-8a39-4a420e8f0bf3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6603fa1a-0b5c-412a-ac20-cff548b3b18c" xlink:to="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet_38eb7249-6a53-4d71-8a39-4a420e8f0bf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESSchedulesofDerivativesDetails" xlink:type="simple" xlink:href="hae-20201226.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESSchedulesofDerivativesDetails"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESSchedulesofDerivativesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_12f3bc07-fa8d-4510-89e9-7506a0a74d5c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_33505315-9905-4c91-b582-a1d0558264e4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_12f3bc07-fa8d-4510-89e9-7506a0a74d5c" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_33505315-9905-4c91-b582-a1d0558264e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d1ff66c9-6e38-4f39-94db-a555801aba38" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_33505315-9905-4c91-b582-a1d0558264e4" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d1ff66c9-6e38-4f39-94db-a555801aba38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_ce11dd19-61ef-4ce8-9a06-a14e0846c370" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d1ff66c9-6e38-4f39-94db-a555801aba38" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_ce11dd19-61ef-4ce8-9a06-a14e0846c370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_3c740d8d-2692-4e40-9b57-74f6cf06dafb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_ce11dd19-61ef-4ce8-9a06-a14e0846c370" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_3c740d8d-2692-4e40-9b57-74f6cf06dafb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f9efe0c2-eb1a-4b7c-9f95-07de1822530e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_33505315-9905-4c91-b582-a1d0558264e4" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f9efe0c2-eb1a-4b7c-9f95-07de1822530e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_0c7fea24-2b9c-4eba-b0b2-2ad6a7bcdd93" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f9efe0c2-eb1a-4b7c-9f95-07de1822530e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_0c7fea24-2b9c-4eba-b0b2-2ad6a7bcdd93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_c5f89e0c-7d48-4cfe-b2a4-ec28dab26b51" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0c7fea24-2b9c-4eba-b0b2-2ad6a7bcdd93" xlink:to="loc_us-gaap_ForeignExchangeContractMember_c5f89e0c-7d48-4cfe-b2a4-ec28dab26b51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_93c9d520-a87f-49cd-81bd-e9ae7999281c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0c7fea24-2b9c-4eba-b0b2-2ad6a7bcdd93" xlink:to="loc_us-gaap_InterestRateSwapMember_93c9d520-a87f-49cd-81bd-e9ae7999281c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_ContingentConsiderationMember_580fd43a-e30b-401e-a24d-b74b5244fee4" xlink:href="hae-20201226.xsd#hae_ContingentConsiderationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0c7fea24-2b9c-4eba-b0b2-2ad6a7bcdd93" xlink:to="loc_hae_ContingentConsiderationMember_580fd43a-e30b-401e-a24d-b74b5244fee4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_44b36215-3c20-4c9e-bb79-2e7e9096542e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_33505315-9905-4c91-b582-a1d0558264e4" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_44b36215-3c20-4c9e-bb79-2e7e9096542e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_6246f256-1a65-4e8a-a49f-59c2986c1dc3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_44b36215-3c20-4c9e-bb79-2e7e9096542e" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_6246f256-1a65-4e8a-a49f-59c2986c1dc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember_9497043f-7ad6-4548-8533-971483fdca59" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6246f256-1a65-4e8a-a49f-59c2986c1dc3" xlink:to="loc_us-gaap_OtherCurrentAssetsMember_9497043f-7ad6-4548-8533-971483fdca59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_deb0012e-6b7b-4ecf-8f0c-a6d3924026e4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6246f256-1a65-4e8a-a49f-59c2986c1dc3" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_deb0012e-6b7b-4ecf-8f0c-a6d3924026e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_6dcf15fe-1f3a-4653-91c4-39f8fd079384" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6246f256-1a65-4e8a-a49f-59c2986c1dc3" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_6dcf15fe-1f3a-4653-91c4-39f8fd079384" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_e9387925-5ddc-4893-bf48-a86bc4f2937b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_33505315-9905-4c91-b582-a1d0558264e4" xlink:to="loc_us-gaap_HedgingDesignationAxis_e9387925-5ddc-4893-bf48-a86bc4f2937b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_4c1d785e-f2fc-4992-a08f-c5140035b095" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_e9387925-5ddc-4893-bf48-a86bc4f2937b" xlink:to="loc_us-gaap_HedgingDesignationDomain_4c1d785e-f2fc-4992-a08f-c5140035b095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_b950d3cc-bb11-4ac0-877f-6689c51e5a54" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_4c1d785e-f2fc-4992-a08f-c5140035b095" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_b950d3cc-bb11-4ac0-877f-6689c51e5a54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_e8e4ab9e-602a-43ec-93ff-3c44b4fcc532" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_4c1d785e-f2fc-4992-a08f-c5140035b095" xlink:to="loc_us-gaap_NondesignatedMember_e8e4ab9e-602a-43ec-93ff-3c44b4fcc532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ec5dc463-12fd-43b2-aa32-2bf09218bf22" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_33505315-9905-4c91-b582-a1d0558264e4" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ec5dc463-12fd-43b2-aa32-2bf09218bf22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fb07f4d8-8491-410e-890a-cec59c16d3f0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ec5dc463-12fd-43b2-aa32-2bf09218bf22" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fb07f4d8-8491-410e-890a-cec59c16d3f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_73c31abd-b12d-4483-91a0-664455c57f8c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fb07f4d8-8491-410e-890a-cec59c16d3f0" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_73c31abd-b12d-4483-91a0-664455c57f8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_4d3e61da-2d5a-46ed-a5a0-89eeb89ab1da" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fb07f4d8-8491-410e-890a-cec59c16d3f0" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_4d3e61da-2d5a-46ed-a5a0-89eeb89ab1da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_fd5026df-8b2b-4e20-a865-f2037ca7b9b3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fb07f4d8-8491-410e-890a-cec59c16d3f0" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_fd5026df-8b2b-4e20-a865-f2037ca7b9b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_adbab90a-2430-4984-91a3-6c5a65049491" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_33505315-9905-4c91-b582-a1d0558264e4" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_adbab90a-2430-4984-91a3-6c5a65049491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_79676504-9f42-4b6c-ad92-1f5c5d5a528d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_adbab90a-2430-4984-91a3-6c5a65049491" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_79676504-9f42-4b6c-ad92-1f5c5d5a528d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_RegulatoryBasedPaymentsMember_2dda8dba-e4fb-4bfa-8ca2-bd576c954a21" xlink:href="hae-20201226.xsd#hae_RegulatoryBasedPaymentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_79676504-9f42-4b6c-ad92-1f5c5d5a528d" xlink:to="loc_hae_RegulatoryBasedPaymentsMember_2dda8dba-e4fb-4bfa-8ca2-bd576c954a21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_RevenueBasedPaymentsMember_45bddd1d-422c-4a31-98b8-e1c8c9a0ff18" xlink:href="hae-20201226.xsd#hae_RevenueBasedPaymentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_79676504-9f42-4b6c-ad92-1f5c5d5a528d" xlink:to="loc_hae_RevenueBasedPaymentsMember_45bddd1d-422c-4a31-98b8-e1c8c9a0ff18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_c961bb98-8895-44fd-bfc0-d1eef723fb8b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_33505315-9905-4c91-b582-a1d0558264e4" xlink:to="loc_us-gaap_ValuationTechniqueAxis_c961bb98-8895-44fd-bfc0-d1eef723fb8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_cb3901f8-0b2e-46f4-8d1b-ee74df9fa8ea" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueAxis_c961bb98-8895-44fd-bfc0-d1eef723fb8b" xlink:to="loc_us-gaap_ValuationTechniqueDomain_cb3901f8-0b2e-46f4-8d1b-ee74df9fa8ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_67e21594-2bd7-4719-b438-8ca51043d71e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ValuationTechniqueDiscountedCashFlowMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueDomain_cb3901f8-0b2e-46f4-8d1b-ee74df9fa8ea" xlink:to="loc_us-gaap_ValuationTechniqueDiscountedCashFlowMember_67e21594-2bd7-4719-b438-8ca51043d71e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ba768439-7dcb-4202-82c8-024d1d9ba05f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_33505315-9905-4c91-b582-a1d0558264e4" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ba768439-7dcb-4202-82c8-024d1d9ba05f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_a47e0d75-6038-4665-9aaf-b9ad737e93d8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ba768439-7dcb-4202-82c8-024d1d9ba05f" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_a47e0d75-6038-4665-9aaf-b9ad737e93d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_397a3ba1-4516-48b3-8caf-964814a9a3c0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_a47e0d75-6038-4665-9aaf-b9ad737e93d8" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_397a3ba1-4516-48b3-8caf-964814a9a3c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_6412a815-48fb-4b22-84d7-2e6b91e71e3e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_a47e0d75-6038-4665-9aaf-b9ad737e93d8" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_6412a815-48fb-4b22-84d7-2e6b91e71e3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_eff67284-bb90-4220-95e7-390883dd18fe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_a47e0d75-6038-4665-9aaf-b9ad737e93d8" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_eff67284-bb90-4220-95e7-390883dd18fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_e46c2d3a-fa96-445a-a5a0-01afcba33963" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ba768439-7dcb-4202-82c8-024d1d9ba05f" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_e46c2d3a-fa96-445a-a5a0-01afcba33963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_ff6ed0a8-0113-4406-8839-20a155ae9a79" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_e46c2d3a-fa96-445a-a5a0-01afcba33963" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_ff6ed0a8-0113-4406-8839-20a155ae9a79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_c4a776f4-7990-4b0d-927b-fc935bde61b6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_e46c2d3a-fa96-445a-a5a0-01afcba33963" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_c4a776f4-7990-4b0d-927b-fc935bde61b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_7d2a51fb-1487-4c18-9de9-e398c9499107" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ba768439-7dcb-4202-82c8-024d1d9ba05f" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_7d2a51fb-1487-4c18-9de9-e398c9499107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails" xlink:type="simple" xlink:href="hae-20201226.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_3f181cc1-204c-405e-859f-2abef458c87e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_26d1ad7c-971c-475d-99f3-7f322b5f73e3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_3f181cc1-204c-405e-859f-2abef458c87e" xlink:to="loc_us-gaap_DerivativeTable_26d1ad7c-971c-475d-99f3-7f322b5f73e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_db47abff-88d9-4fc0-9cc4-d4c02b197ef4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_26d1ad7c-971c-475d-99f3-7f322b5f73e3" xlink:to="loc_us-gaap_HedgingDesignationAxis_db47abff-88d9-4fc0-9cc4-d4c02b197ef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_52d8aced-fee6-48d9-a907-0038d2bc3308" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_db47abff-88d9-4fc0-9cc4-d4c02b197ef4" xlink:to="loc_us-gaap_HedgingDesignationDomain_52d8aced-fee6-48d9-a907-0038d2bc3308" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_910a79bb-1952-4f8b-8394-8896089d1137" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_52d8aced-fee6-48d9-a907-0038d2bc3308" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_910a79bb-1952-4f8b-8394-8896089d1137" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_97727b18-1e40-4a2e-9be4-080a5b36dfeb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_52d8aced-fee6-48d9-a907-0038d2bc3308" xlink:to="loc_us-gaap_NondesignatedMember_97727b18-1e40-4a2e-9be4-080a5b36dfeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_4e5fd725-4663-4ff5-b5a5-5d21458f56c5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_26d1ad7c-971c-475d-99f3-7f322b5f73e3" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_4e5fd725-4663-4ff5-b5a5-5d21458f56c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_2baa98f3-3381-4b9a-8b10-0bc3247afb7e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_4e5fd725-4663-4ff5-b5a5-5d21458f56c5" xlink:to="loc_us-gaap_HedgingRelationshipDomain_2baa98f3-3381-4b9a-8b10-0bc3247afb7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_3bb389bb-1abc-4a68-a286-b52823ada253" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_2baa98f3-3381-4b9a-8b10-0bc3247afb7e" xlink:to="loc_us-gaap_ForeignExchangeContractMember_3bb389bb-1abc-4a68-a286-b52823ada253" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_55726ad5-0005-4a82-8016-b7f1220da642" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_2baa98f3-3381-4b9a-8b10-0bc3247afb7e" xlink:to="loc_us-gaap_CashFlowHedgingMember_55726ad5-0005-4a82-8016-b7f1220da642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_1b5f4be2-2674-42ff-9a7e-6b4a817f902c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_2baa98f3-3381-4b9a-8b10-0bc3247afb7e" xlink:to="loc_us-gaap_InterestRateSwapMember_1b5f4be2-2674-42ff-9a7e-6b4a817f902c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_9edd7d6f-1c06-4ac7-8794-275991a5e8f5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_26d1ad7c-971c-475d-99f3-7f322b5f73e3" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_9edd7d6f-1c06-4ac7-8794-275991a5e8f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5c8ea9d7-b89d-40fa-b6a3-24d305814a48" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9edd7d6f-1c06-4ac7-8794-275991a5e8f5" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5c8ea9d7-b89d-40fa-b6a3-24d305814a48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_245fba20-7c75-4a0d-a85b-1dc230c29307" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5c8ea9d7-b89d-40fa-b6a3-24d305814a48" xlink:to="loc_us-gaap_ForeignExchangeContractMember_245fba20-7c75-4a0d-a85b-1dc230c29307" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_547a6159-3ea9-47a7-9241-1300abeedac2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5c8ea9d7-b89d-40fa-b6a3-24d305814a48" xlink:to="loc_us-gaap_InterestRateSwapMember_547a6159-3ea9-47a7-9241-1300abeedac2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_ContingentConsiderationMember_a5230a27-8b69-4110-b42e-211dc1baa3c0" xlink:href="hae-20201226.xsd#hae_ContingentConsiderationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5c8ea9d7-b89d-40fa-b6a3-24d305814a48" xlink:to="loc_hae_ContingentConsiderationMember_a5230a27-8b69-4110-b42e-211dc1baa3c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_7da1c67a-4d0f-49b9-abd5-3b8f76f1a09e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_26d1ad7c-971c-475d-99f3-7f322b5f73e3" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_7da1c67a-4d0f-49b9-abd5-3b8f76f1a09e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_98d24340-fbdd-487d-a36e-4b5b44fabf20" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_7da1c67a-4d0f-49b9-abd5-3b8f76f1a09e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_98d24340-fbdd-487d-a36e-4b5b44fabf20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_OtherIncomeExpenseNetMember_67cfb3f1-ff34-4ae2-882f-782f5a4409e5" xlink:href="hae-20201226.xsd#hae_OtherIncomeExpenseNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_98d24340-fbdd-487d-a36e-4b5b44fabf20" xlink:to="loc_hae_OtherIncomeExpenseNetMember_67cfb3f1-ff34-4ae2-882f-782f5a4409e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_19a1449c-34ad-4eb3-b609-438fadc13ebd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_26d1ad7c-971c-475d-99f3-7f322b5f73e3" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_19a1449c-34ad-4eb3-b609-438fadc13ebd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_efd83056-6d4b-4d24-b5f8-f618b5bd99f0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_19a1449c-34ad-4eb3-b609-438fadc13ebd" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_efd83056-6d4b-4d24-b5f8-f618b5bd99f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember_916068e4-642f-4493-9201-8655f84bc472" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MediumTermNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_efd83056-6d4b-4d24-b5f8-f618b5bd99f0" xlink:to="loc_us-gaap_MediumTermNotesMember_916068e4-642f-4493-9201-8655f84bc472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_77cf73b1-98fc-4690-96a4-ce6718f6d93b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_efd83056-6d4b-4d24-b5f8-f618b5bd99f0" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_77cf73b1-98fc-4690-96a4-ce6718f6d93b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_ff08a47c-9bce-4a6e-91cc-5042b8e6455d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_26d1ad7c-971c-475d-99f3-7f322b5f73e3" xlink:to="loc_us-gaap_VariableRateAxis_ff08a47c-9bce-4a6e-91cc-5042b8e6455d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_2721b12d-b5ee-4024-8a55-696147bc850c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_ff08a47c-9bce-4a6e-91cc-5042b8e6455d" xlink:to="loc_us-gaap_VariableRateDomain_2721b12d-b5ee-4024-8a55-696147bc850c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_670b0dcb-2e97-4ced-a06f-d2895105703f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_2721b12d-b5ee-4024-8a55-696147bc850c" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_670b0dcb-2e97-4ced-a06f-d2895105703f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_9e22656b-4649-4367-b1cb-6b353b4617c8" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_26d1ad7c-971c-475d-99f3-7f322b5f73e3" xlink:to="loc_srt_RangeAxis_9e22656b-4649-4367-b1cb-6b353b4617c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_819d092c-ee08-4da7-aca3-13ab28ef5661" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_9e22656b-4649-4367-b1cb-6b353b4617c8" xlink:to="loc_srt_RangeMember_819d092c-ee08-4da7-aca3-13ab28ef5661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_8a8b5752-ac67-4acb-b199-0ff6918e63de" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_819d092c-ee08-4da7-aca3-13ab28ef5661" xlink:to="loc_srt_MinimumMember_8a8b5752-ac67-4acb-b199-0ff6918e63de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5d43eeaa-b92c-4acf-9c8c-7058c7c3b8cc" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_819d092c-ee08-4da7-aca3-13ab28ef5661" xlink:to="loc_srt_MaximumMember_5d43eeaa-b92c-4acf-9c8c-7058c7c3b8cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_c7104477-770b-4e5a-baf3-25cd690c46bc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_26d1ad7c-971c-475d-99f3-7f322b5f73e3" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_c7104477-770b-4e5a-baf3-25cd690c46bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_45bc7042-4b2d-4cad-b5b5-202f00fec76c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_c7104477-770b-4e5a-baf3-25cd690c46bc" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_45bc7042-4b2d-4cad-b5b5-202f00fec76c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_42a58428-fd0b-4740-b5a2-5e3aba3da01b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_45bc7042-4b2d-4cad-b5b5-202f00fec76c" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_42a58428-fd0b-4740-b5a2-5e3aba3da01b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_6b583260-9a58-409e-99ce-2d64ef0ab7b6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_26d1ad7c-971c-475d-99f3-7f322b5f73e3" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_6b583260-9a58-409e-99ce-2d64ef0ab7b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_fb852330-871e-4d9a-a64a-7399fe44ddf0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_6b583260-9a58-409e-99ce-2d64ef0ab7b6" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_fb852330-871e-4d9a-a64a-7399fe44ddf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_03c096ae-b7a4-459a-882c-28574db1e3f6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_fb852330-871e-4d9a-a64a-7399fe44ddf0" xlink:to="loc_us-gaap_OtherLiabilitiesMember_03c096ae-b7a4-459a-882c-28574db1e3f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_e51568c3-aa2b-422f-9571-8ab55a142ba1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_fb852330-871e-4d9a-a64a-7399fe44ddf0" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_e51568c3-aa2b-422f-9571-8ab55a142ba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1d8f66f6-2032-4fd1-a379-e575538428c6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_26d1ad7c-971c-475d-99f3-7f322b5f73e3" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1d8f66f6-2032-4fd1-a379-e575538428c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_757ac86a-38bf-4188-a8be-19a035d2ecfd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1d8f66f6-2032-4fd1-a379-e575538428c6" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_757ac86a-38bf-4188-a8be-19a035d2ecfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EnicorMember_e5e0fb43-c7ec-4f5e-857f-ce26a70c365e" xlink:href="hae-20201226.xsd#hae_EnicorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_757ac86a-38bf-4188-a8be-19a035d2ecfd" xlink:to="loc_hae_EnicorMember_e5e0fb43-c7ec-4f5e-857f-ce26a70c365e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_0d7c0f4f-59d4-4631-a724-d6a7ea9592f3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_26d1ad7c-971c-475d-99f3-7f322b5f73e3" xlink:to="loc_us-gaap_DerivativeLineItems_0d7c0f4f-59d4-4631-a724-d6a7ea9592f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_PercentageOfNetSalesGeneratedOutsideOfUs_e284ef7b-a1a6-44df-a4bf-7d2eeca60ef2" xlink:href="hae-20201226.xsd#hae_PercentageOfNetSalesGeneratedOutsideOfUs"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_0d7c0f4f-59d4-4631-a724-d6a7ea9592f3" xlink:to="loc_hae_PercentageOfNetSalesGeneratedOutsideOfUs_e284ef7b-a1a6-44df-a4bf-7d2eeca60ef2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AverageRemainingMaturityOfForeignCurrencyDerivatives1_124838db-77c9-416e-b1f1-6c208790d966" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AverageRemainingMaturityOfForeignCurrencyDerivatives1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_0d7c0f4f-59d4-4631-a724-d6a7ea9592f3" xlink:to="loc_us-gaap_AverageRemainingMaturityOfForeignCurrencyDerivatives1_124838db-77c9-416e-b1f1-6c208790d966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet_aaac7b1d-53b6-43a6-bbc1-ca71de568ab9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_0d7c0f4f-59d4-4631-a724-d6a7ea9592f3" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet_aaac7b1d-53b6-43a6-bbc1-ca71de568ab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_171069cc-191e-4401-aeef-1b5afd4bf37f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_0d7c0f4f-59d4-4631-a724-d6a7ea9592f3" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_171069cc-191e-4401-aeef-1b5afd4bf37f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet_418ed34c-0ff1-4123-bb90-9c731efaa4fd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_0d7c0f4f-59d4-4631-a724-d6a7ea9592f3" xlink:to="loc_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet_418ed34c-0ff1-4123-bb90-9c731efaa4fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_2548fd75-d62b-487d-a8b3-9b2a64b2e103" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_0d7c0f4f-59d4-4631-a724-d6a7ea9592f3" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_2548fd75-d62b-487d-a8b3-9b2a64b2e103" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_1ce3cc67-d25c-4056-9fdc-fc8cb79e9cee" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_0d7c0f4f-59d4-4631-a724-d6a7ea9592f3" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_1ce3cc67-d25c-4056-9fdc-fc8cb79e9cee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_2e0f3a3e-7ce8-4441-86ac-69e1ee5927aa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_0d7c0f4f-59d4-4631-a724-d6a7ea9592f3" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_2e0f3a3e-7ce8-4441-86ac-69e1ee5927aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNumberOfInstrumentsHeld_5b0ae45a-270a-445a-a67d-0cc401fc68a3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeNumberOfInstrumentsHeld"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_0d7c0f4f-59d4-4631-a724-d6a7ea9592f3" xlink:to="loc_us-gaap_DerivativeNumberOfInstrumentsHeld_5b0ae45a-270a-445a-a67d-0cc401fc68a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_DerivativePercentofDebtExposed_9e8a9f29-417d-4421-9304-1b9023ff9559" xlink:href="hae-20201226.xsd#hae_DerivativePercentofDebtExposed"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_0d7c0f4f-59d4-4631-a724-d6a7ea9592f3" xlink:to="loc_hae_DerivativePercentofDebtExposed_9e8a9f29-417d-4421-9304-1b9023ff9559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_f2bfc44d-e18d-4942-8bce-d997227666d9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_0d7c0f4f-59d4-4631-a724-d6a7ea9592f3" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_f2bfc44d-e18d-4942-8bce-d997227666d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_5461c4ad-bcd9-47a6-a4eb-c2cc16bb68c3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_0d7c0f4f-59d4-4631-a724-d6a7ea9592f3" xlink:to="loc_us-gaap_DerivativeNotionalAmount_5461c4ad-bcd9-47a6-a4eb-c2cc16bb68c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_879c7c46-21e0-404e-9a57-a54de20bafc9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_0d7c0f4f-59d4-4631-a724-d6a7ea9592f3" xlink:to="loc_us-gaap_LongTermDebt_879c7c46-21e0-404e-9a57-a54de20bafc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_9a173d68-8922-4e9e-9776-b2cb6089ab7e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_0d7c0f4f-59d4-4631-a724-d6a7ea9592f3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_9a173d68-8922-4e9e-9776-b2cb6089ab7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsDerivativeInstruments_8537f58c-e86e-4345-84b5-1e795832885e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsDerivativeInstruments"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_0d7c0f4f-59d4-4631-a724-d6a7ea9592f3" xlink:to="loc_us-gaap_DeferredTaxAssetsDerivativeInstruments_8537f58c-e86e-4345-84b5-1e795832885e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_91d5acd6-db14-4b6e-a83b-102998191eb1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_0d7c0f4f-59d4-4631-a724-d6a7ea9592f3" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_91d5acd6-db14-4b6e-a83b-102998191eb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_55d7ba2c-40b7-419a-aa00-fa6b55b7796d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_0d7c0f4f-59d4-4631-a724-d6a7ea9592f3" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_55d7ba2c-40b7-419a-aa00-fa6b55b7796d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_ContingentConsiderationAcquisitionDateFairValue_ca892b6f-d677-4674-a6b5-60b1305aa5bc" xlink:href="hae-20201226.xsd#hae_ContingentConsiderationAcquisitionDateFairValue"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_0d7c0f4f-59d4-4631-a724-d6a7ea9592f3" xlink:to="loc_hae_ContingentConsiderationAcquisitionDateFairValue_ca892b6f-d677-4674-a6b5-60b1305aa5bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="simple" xlink:href="hae-20201226.xsd#COMMITMENTSANDCONTINGENCIES"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_79c902b7-f367-4d04-9dae-13d4dc84294e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_0dc0fdc3-5127-4fe3-aa46-40237e198fec" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_79c902b7-f367-4d04-9dae-13d4dc84294e" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_0dc0fdc3-5127-4fe3-aa46-40237e198fec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATION" xlink:type="simple" xlink:href="hae-20201226.xsd#SEGMENTANDENTERPRISEWIDEINFORMATION"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_d278ab1b-df62-4498-92ed-aca95971f6b5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_26ad517e-1b34-42b8-84fc-60ec678071cc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_d278ab1b-df62-4498-92ed-aca95971f6b5" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_26ad517e-1b34-42b8-84fc-60ec678071cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONTables" xlink:type="simple" xlink:href="hae-20201226.xsd#SEGMENTANDENTERPRISEWIDEINFORMATIONTables"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_e6c2fb7d-0fd5-4ace-8c1d-0b24581a03cf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_716dfca2-efb0-48db-80dd-9407cf5ca5c3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_e6c2fb7d-0fd5-4ace-8c1d-0b24581a03cf" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_716dfca2-efb0-48db-80dd-9407cf5ca5c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_643ee6e2-9924-4c56-bc7b-d11b55a13e72" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_e6c2fb7d-0fd5-4ace-8c1d-0b24581a03cf" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_643ee6e2-9924-4c56-bc7b-d11b55a13e72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails" xlink:type="simple" xlink:href="hae-20201226.xsd#SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_bebfdab1-adc4-46e4-b10b-6662b0e69b26" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_3ea6f34a-d6e0-491e-8305-f1ebd9d2f51b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_bebfdab1-adc4-46e4-b10b-6662b0e69b26" xlink:to="loc_us-gaap_NumberOfOperatingSegments_3ea6f34a-d6e0-491e-8305-f1ebd9d2f51b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0e5d8e50-2c69-4056-88fe-92a48e7b9118" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_bebfdab1-adc4-46e4-b10b-6662b0e69b26" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0e5d8e50-2c69-4056-88fe-92a48e7b9118" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_0dd1604c-af04-4e0e-819a-cf005041c1d9" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0e5d8e50-2c69-4056-88fe-92a48e7b9118" xlink:to="loc_srt_ConsolidationItemsAxis_0dd1604c-af04-4e0e-819a-cf005041c1d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_98fd8207-9b39-4c95-a95f-301ecd6ff700" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_0dd1604c-af04-4e0e-819a-cf005041c1d9" xlink:to="loc_srt_ConsolidationItemsDomain_98fd8207-9b39-4c95-a95f-301ecd6ff700" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_2a89031c-24f5-4234-94da-8ec739ef270a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_98fd8207-9b39-4c95-a95f-301ecd6ff700" xlink:to="loc_us-gaap_OperatingSegmentsMember_2a89031c-24f5-4234-94da-8ec739ef270a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_7f87ef89-e332-41d6-bc0c-df309968148a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_98fd8207-9b39-4c95-a95f-301ecd6ff700" xlink:to="loc_us-gaap_CorporateNonSegmentMember_7f87ef89-e332-41d6-bc0c-df309968148a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_4a96633f-2b94-467d-b552-70490566ebcf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0e5d8e50-2c69-4056-88fe-92a48e7b9118" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_4a96633f-2b94-467d-b552-70490566ebcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_4a669364-a53b-4ff1-a161-5fba36bad434" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_4a96633f-2b94-467d-b552-70490566ebcf" xlink:to="loc_us-gaap_SegmentDomain_4a669364-a53b-4ff1-a161-5fba36bad434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_PlasmaMember_caeca16a-2b17-49b3-b77b-0ee2fa4a6398" xlink:href="hae-20201226.xsd#hae_PlasmaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_4a669364-a53b-4ff1-a161-5fba36bad434" xlink:to="loc_hae_PlasmaMember_caeca16a-2b17-49b3-b77b-0ee2fa4a6398" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_BloodCenterMember_9b8dafe0-fa10-47ad-a105-0f68dd564016" xlink:href="hae-20201226.xsd#hae_BloodCenterMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_4a669364-a53b-4ff1-a161-5fba36bad434" xlink:to="loc_hae_BloodCenterMember_9b8dafe0-fa10-47ad-a105-0f68dd564016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_HospitalMember_1c6cdefc-4e64-4122-852f-a5e7bb2eecbc" xlink:href="hae-20201226.xsd#hae_HospitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_4a669364-a53b-4ff1-a161-5fba36bad434" xlink:to="loc_hae_HospitalMember_1c6cdefc-4e64-4122-852f-a5e7bb2eecbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_e4d63a71-5066-45a1-b64f-a9f875d1e1a5" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0e5d8e50-2c69-4056-88fe-92a48e7b9118" xlink:to="loc_srt_ProductOrServiceAxis_e4d63a71-5066-45a1-b64f-a9f875d1e1a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_795115c4-f95e-4c0c-96ab-634ead9b3b72" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_e4d63a71-5066-45a1-b64f-a9f875d1e1a5" xlink:to="loc_srt_ProductsAndServicesDomain_795115c4-f95e-4c0c-96ab-634ead9b3b72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_e1c3e92c-858a-4118-a8fd-3c46cb3efea6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_795115c4-f95e-4c0c-96ab-634ead9b3b72" xlink:to="loc_us-gaap_ServiceMember_e1c3e92c-858a-4118-a8fd-3c46cb3efea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_PlasmaProductsandServicesMember_b69c6a01-6285-4169-a576-91daa02e451b" xlink:href="hae-20201226.xsd#hae_PlasmaProductsandServicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_795115c4-f95e-4c0c-96ab-634ead9b3b72" xlink:to="loc_hae_PlasmaProductsandServicesMember_b69c6a01-6285-4169-a576-91daa02e451b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_BloodCenterProductsandServicesMember_6f662a29-1625-46a9-9a7f-f40eec4018f8" xlink:href="hae-20201226.xsd#hae_BloodCenterProductsandServicesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_795115c4-f95e-4c0c-96ab-634ead9b3b72" xlink:to="loc_hae_BloodCenterProductsandServicesMember_6f662a29-1625-46a9-9a7f-f40eec4018f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_HospitalProductsandServicesMember_015e6a3e-e7a0-48cd-8e47-7100d1092d9c" xlink:href="hae-20201226.xsd#hae_HospitalProductsandServicesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_795115c4-f95e-4c0c-96ab-634ead9b3b72" xlink:to="loc_hae_HospitalProductsandServicesMember_015e6a3e-e7a0-48cd-8e47-7100d1092d9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_4abef3b3-5b93-490f-8ac7-09bd3518b62e" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0e5d8e50-2c69-4056-88fe-92a48e7b9118" xlink:to="loc_srt_StatementGeographicalAxis_4abef3b3-5b93-490f-8ac7-09bd3518b62e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_8b094d06-36cd-4be4-a064-69e3cc063581" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_4abef3b3-5b93-490f-8ac7-09bd3518b62e" xlink:to="loc_srt_SegmentGeographicalDomain_8b094d06-36cd-4be4-a064-69e3cc063581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_dee3f38c-5926-467e-9036-cec722c07eb6" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_8b094d06-36cd-4be4-a064-69e3cc063581" xlink:to="loc_country_US_dee3f38c-5926-467e-9036-cec722c07eb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_JP_18acc3aa-74dc-4f44-8555-89cc98c5830d" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_JP"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_8b094d06-36cd-4be4-a064-69e3cc063581" xlink:to="loc_country_JP_18acc3aa-74dc-4f44-8555-89cc98c5830d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_e4523ec5-8e99-4e64-9ad8-5c6c59e530a7" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_EuropeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_8b094d06-36cd-4be4-a064-69e3cc063581" xlink:to="loc_srt_EuropeMember_e4523ec5-8e99-4e64-9ad8-5c6c59e530a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaMember_e1ecc216-c723-44fc-9c83-53fdc20bec69" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_AsiaMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_8b094d06-36cd-4be4-a064-69e3cc063581" xlink:to="loc_srt_AsiaMember_e1ecc216-c723-44fc-9c83-53fdc20bec69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_OtherCountryorRegionMember_83aeadd5-d8d3-4b4e-b4a1-e7b93f6759ad" xlink:href="hae-20201226.xsd#hae_OtherCountryorRegionMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_8b094d06-36cd-4be4-a064-69e3cc063581" xlink:to="loc_hae_OtherCountryorRegionMember_83aeadd5-d8d3-4b4e-b4a1-e7b93f6759ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_f2ffc2b6-b57b-41c7-a9fe-a65d3c6f247b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0e5d8e50-2c69-4056-88fe-92a48e7b9118" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_f2ffc2b6-b57b-41c7-a9fe-a65d3c6f247b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_NetRevenuesBeforeForeignExchangeImpact_ab6357e2-91e6-48d9-b2f8-918a555c1ba4" xlink:href="hae-20201226.xsd#hae_NetRevenuesBeforeForeignExchangeImpact"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f2ffc2b6-b57b-41c7-a9fe-a65d3c6f247b" xlink:to="loc_hae_NetRevenuesBeforeForeignExchangeImpact_ab6357e2-91e6-48d9-b2f8-918a555c1ba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EffectofExchangeRateonRevenues_b7df9695-725d-43f2-95b6-edb6bd4d01c5" xlink:href="hae-20201226.xsd#hae_EffectofExchangeRateonRevenues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f2ffc2b6-b57b-41c7-a9fe-a65d3c6f247b" xlink:to="loc_hae_EffectofExchangeRateonRevenues_b7df9695-725d-43f2-95b6-edb6bd4d01c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2c1cde13-dfe9-44d9-a9b9-058b20152599" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f2ffc2b6-b57b-41c7-a9fe-a65d3c6f247b" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2c1cde13-dfe9-44d9-a9b9-058b20152599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_d22a4618-83c3-4b94-b8a9-7d2415385b95" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f2ffc2b6-b57b-41c7-a9fe-a65d3c6f247b" xlink:to="loc_us-gaap_OperatingIncomeLoss_d22a4618-83c3-4b94-b8a9-7d2415385b95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_CorporateOperatingExpenses_2aac086b-01d9-4924-8111-0aa5071973cf" xlink:href="hae-20201226.xsd#hae_CorporateOperatingExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f2ffc2b6-b57b-41c7-a9fe-a65d3c6f247b" xlink:to="loc_hae_CorporateOperatingExpenses_2aac086b-01d9-4924-8111-0aa5071973cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EffectofExchangeRatesonOperatingIncome_d3715677-0a8d-44c0-9ac9-fee5c10ab1a5" xlink:href="hae-20201226.xsd#hae_EffectofExchangeRatesonOperatingIncome"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f2ffc2b6-b57b-41c7-a9fe-a65d3c6f247b" xlink:to="loc_hae_EffectofExchangeRatesonOperatingIncome_d3715677-0a8d-44c0-9ac9-fee5c10ab1a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_7181dde4-007c-4527-bb3e-162710b54075" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f2ffc2b6-b57b-41c7-a9fe-a65d3c6f247b" xlink:to="loc_us-gaap_AdjustmentForAmortization_7181dde4-007c-4527-bb3e-162710b54075" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_RestructuringandTurnaroundCosts_2e598128-4f73-4bb0-801d-04f07daef0b6" xlink:href="hae-20201226.xsd#hae_RestructuringandTurnaroundCosts"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f2ffc2b6-b57b-41c7-a9fe-a65d3c6f247b" xlink:to="loc_hae_RestructuringandTurnaroundCosts_2e598128-4f73-4bb0-801d-04f07daef0b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_OperatingExpensesTransactionCosts_b37ee14f-2072-40e6-9a38-32684245f18c" xlink:href="hae-20201226.xsd#hae_OperatingExpensesTransactionCosts"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f2ffc2b6-b57b-41c7-a9fe-a65d3c6f247b" xlink:to="loc_hae_OperatingExpensesTransactionCosts_b37ee14f-2072-40e6-9a38-32684245f18c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAcceleratedDepreciation_4fc48432-a40d-419e-a427-dfc6dde4ea31" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserveAcceleratedDepreciation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f2ffc2b6-b57b-41c7-a9fe-a65d3c6f247b" xlink:to="loc_us-gaap_RestructuringReserveAcceleratedDepreciation_4fc48432-a40d-419e-a427-dfc6dde4ea31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_EuropeanMedicalDeviceRegulationCosts_f4e7bc2e-3363-4725-9eb8-2f4a7372012d" xlink:href="hae-20201226.xsd#hae_EuropeanMedicalDeviceRegulationCosts"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f2ffc2b6-b57b-41c7-a9fe-a65d3c6f247b" xlink:to="loc_hae_EuropeanMedicalDeviceRegulationCosts_f4e7bc2e-3363-4725-9eb8-2f4a7372012d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hae_AssetImpairmentAndOtherRelatedCharges_1f6e8067-6900-4cd5-8faa-e49b71ccd82b" xlink:href="hae-20201226.xsd#hae_AssetImpairmentAndOtherRelatedCharges"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f2ffc2b6-b57b-41c7-a9fe-a65d3c6f247b" xlink:to="loc_hae_AssetImpairmentAndOtherRelatedCharges_1f6e8067-6900-4cd5-8faa-e49b71ccd82b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1_d626d8e6-115b-4380-ab9b-06e859d80440" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f2ffc2b6-b57b-41c7-a9fe-a65d3c6f247b" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets1_d626d8e6-115b-4380-ab9b-06e859d80440" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS" xlink:type="simple" xlink:href="hae-20201226.xsd#ACCUMULATEDOTHERCOMPREHENSIVELOSS"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_7aa41154-941e-47d9-ac6b-35c26a7b6a79" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_47ebfe25-8fd0-4f06-8b01-bd936cc7216b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_7aa41154-941e-47d9-ac6b-35c26a7b6a79" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_47ebfe25-8fd0-4f06-8b01-bd936cc7216b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables" xlink:type="simple" xlink:href="hae-20201226.xsd#ACCUMULATEDOTHERCOMPREHENSIVELOSSTables"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_46f9e981-62d7-41a0-895a-04cccad38853" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_faf96f28-0af4-4a09-bfcf-12ad47ca98cd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_46f9e981-62d7-41a0-895a-04cccad38853" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_faf96f28-0af4-4a09-bfcf-12ad47ca98cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSDetails" xlink:type="simple" xlink:href="hae-20201226.xsd#ACCUMULATEDOTHERCOMPREHENSIVELOSSDetails"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_25ac3f65-f1e6-43eb-ab6f-1a85c537e597" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_31e0f6e5-886e-4258-98f0-b754ba800de8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_25ac3f65-f1e6-43eb-ab6f-1a85c537e597" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_31e0f6e5-886e-4258-98f0-b754ba800de8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d91112a3-a1a1-4ef2-b8b3-d025fcc4aeff" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_31e0f6e5-886e-4258-98f0-b754ba800de8" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d91112a3-a1a1-4ef2-b8b3-d025fcc4aeff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_70711680-80b8-4a85-a9a9-2c6490b8e05b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d91112a3-a1a1-4ef2-b8b3-d025fcc4aeff" xlink:to="loc_us-gaap_EquityComponentDomain_70711680-80b8-4a85-a9a9-2c6490b8e05b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_8f236a11-664c-4193-8875-80713379b5cb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_70711680-80b8-4a85-a9a9-2c6490b8e05b" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_8f236a11-664c-4193-8875-80713379b5cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_aa05434a-b776-4f18-96fe-f7b8e660041e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_70711680-80b8-4a85-a9a9-2c6490b8e05b" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_aa05434a-b776-4f18-96fe-f7b8e660041e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_0c95c083-4c68-4085-94d7-458567785417" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_70711680-80b8-4a85-a9a9-2c6490b8e05b" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_0c95c083-4c68-4085-94d7-458567785417" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_ec77b6d0-37a2-4053-9f28-5908f045efae" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_31e0f6e5-886e-4258-98f0-b754ba800de8" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_ec77b6d0-37a2-4053-9f28-5908f045efae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_1f5758b3-ec84-4803-ae3f-6dfb74b4df50" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_ec77b6d0-37a2-4053-9f28-5908f045efae" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_1f5758b3-ec84-4803-ae3f-6dfb74b4df50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a16180bc-e003-495a-975a-0119018fa854" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_1f5758b3-ec84-4803-ae3f-6dfb74b4df50" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a16180bc-e003-495a-975a-0119018fa854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_de5c90dc-5dbb-411e-b867-cdeead68513c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_1f5758b3-ec84-4803-ae3f-6dfb74b4df50" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_de5c90dc-5dbb-411e-b867-cdeead68513c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_1f84a88d-08ae-4133-8c4d-fe466876cacf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_1f5758b3-ec84-4803-ae3f-6dfb74b4df50" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_1f84a88d-08ae-4133-8c4d-fe466876cacf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_27d1028f-b893-4360-9833-80b36f3a50e0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_1f5758b3-ec84-4803-ae3f-6dfb74b4df50" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_27d1028f-b893-4360-9833-80b36f3a50e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_92cf1eba-e358-4937-a1e8-b27446b86147" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_1f5758b3-ec84-4803-ae3f-6dfb74b4df50" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_92cf1eba-e358-4937-a1e8-b27446b86147" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>hae-20201226_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2017-01-31"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:hae="http://www.haemonetics.com/20201226"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2019-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="hae-20201226.xsd" xlink:type="simple"/>
    <context id="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i6fffe38395d44814afad719145493df5_I20210129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
        </entity>
        <period>
            <instant>2021-01-29</instant>
        </period>
    </context>
    <context id="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
        </entity>
        <period>
            <startDate>2019-03-31</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i6b515458914540b58a5b339208b5c6aa_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="i2cb16a2f4c824ae1aca4e13fd49fe043_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="i14a5e6c117e3421f99e4b603faf5fa43_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="icab8382823bd48c2b8bbd759d1c6a1fa_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="ic1efb1864b5d4f41a6d229d84f58d0e1_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="if6dd2f02aa774a31a839f57971d93f2e_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i98d0d3136b6e4534bd099c082763c527_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i07f570d9a0854ee48af28be5af08a344_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i07cbfd44a12f4311afb21d55a472de13_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i3694a6c7d953431dbcadb946b1f414c2_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i1e7c8087bac9435c9d82d1fedfbff52e_I20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-27</instant>
        </period>
    </context>
    <context id="i31fa2bd3032a476cb1c1b205b1125b8d_I20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-27</instant>
        </period>
    </context>
    <context id="id2fb46a5a8af4e3188ae02ca82d7f05e_I20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-27</instant>
        </period>
    </context>
    <context id="i371aab8c0d604c439b36e469dfeb7ae1_I20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-27</instant>
        </period>
    </context>
    <context id="i8de24c4e5ca9457ba67c9faa95840867_I20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
        </entity>
        <period>
            <instant>2020-06-27</instant>
        </period>
    </context>
    <context id="idb62b5f06b724ac49c887e404027a4ab_D20200628-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i4c87b6d14b0e4daf97ae63c97329dc5f_D20200628-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i53c39140b1904bbe8f3f81c2a2ec9a42_D20200628-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i3cade1e4d1894ebcbacdb9ac1d8529d3_D20200628-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="ib49fa4ce64654900825a35f23c5fe8a0_D20200628-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i3b695da1c7ae4c91ad9625021564f186_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i11d7a90961554152b7611178522b5b4b_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i86938e4e5827482b8bb6a25573904ac1_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i0809a2c180d446f385e5eb23f3c7098a_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i32fa3388584544f9a03ffc1d8057d360_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i3b2f8ac7c8044d99a51a1c40cfc06202_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i7bb87bf0127e4aafa52d782d9e0aa0ee_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i593e5b9ceb9240d1888435f827c761eb_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i00bd6a8c6c87470d94b98154b4ed663c_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="ifb893eb36e724d78b750bf760d6e530a_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="ib0c3ea92ba584163a7dfa754dd67152c_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i4bfeea1c445b4bbfac0cf8cc2616054f_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i0dd7da6b8cfa47a1852a89e52d0d489d_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i13923cc91bcd4918b0cd47b138b0c826_I20190330">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-30</instant>
        </period>
    </context>
    <context id="id87d83aa2a9a48168fe6363c8adf8a60_I20190330">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-30</instant>
        </period>
    </context>
    <context id="ie49c0793891c4f9b9446cafe5a44063b_I20190330">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-30</instant>
        </period>
    </context>
    <context id="i4294e77e77b744d1a79deeae24bc95c9_I20190330">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-30</instant>
        </period>
    </context>
    <context id="ief541fbd0adf409c9514798c114d14d4_I20190330">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
        </entity>
        <period>
            <instant>2019-03-30</instant>
        </period>
    </context>
    <context id="i79fce91b6c7e4ee895ae77d545ae7cac_D20190331-20190629">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-31</startDate>
            <endDate>2019-06-29</endDate>
        </period>
    </context>
    <context id="iab444088a1f343aab3754df7e9900053_D20190331-20190629">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-31</startDate>
            <endDate>2019-06-29</endDate>
        </period>
    </context>
    <context id="i58aa4c71425b490eabe0528109268325_D20190331-20190629">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
        </entity>
        <period>
            <startDate>2019-03-31</startDate>
            <endDate>2019-06-29</endDate>
        </period>
    </context>
    <context id="i856b92cb87d749768e7bc9dd5dd377bb_D20190331-20190629">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-31</startDate>
            <endDate>2019-06-29</endDate>
        </period>
    </context>
    <context id="ifeab2898c30e44abac79ea28e3a13d7b_D20190331-20190629">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-31</startDate>
            <endDate>2019-06-29</endDate>
        </period>
    </context>
    <context id="i44d85e61a03348ac976af3cd59985a40_I20190629">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-29</instant>
        </period>
    </context>
    <context id="i977ae884714349048379a8f918f47155_I20190629">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-29</instant>
        </period>
    </context>
    <context id="i28e2deb2f39545f994371185aa291fd9_I20190629">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-29</instant>
        </period>
    </context>
    <context id="ifcc6781b9c184013b3ebcc9dd2da2e75_I20190629">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-29</instant>
        </period>
    </context>
    <context id="ib446da48c08e4f9e9211152ee5dc9758_I20190629">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
        </entity>
        <period>
            <instant>2019-06-29</instant>
        </period>
    </context>
    <context id="ic3be29de096b43b59d76094a1a86ec73_D20190630-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i6b7a68038f8b43a9ad82e2d31b79cdad_D20190630-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i11e5dd1a63a349b98dfe50b20ed69371_D20190630-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
        </entity>
        <period>
            <startDate>2019-06-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="id4718bcfebbe44fb8dd41c9d91c87ba9_D20190630-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i6a8dccbf5b0e46dd9089c29ee8278a27_D20190630-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="ie63b3633289a4dc68fd18c6df9378c99_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="if08c7a9f75a04b27aee3f352a3ac162a_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i960c732942cc46598e20801270314713_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i5f49655e125c49c2893f2cfe850a84c4_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="if62547d494fe448f98e6b8c907702474_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="ib8048eb98c0f42aeb56fecb8379edd69_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="ib55ff0c99eb34464a7e8eda801ade4ca_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i32d0e40ce5a64e91b5d91a3c4c9fa8ad_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i357f065f29714ef2a554cacc02892fb9_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i2f2c9eca9e304ad9b69f801a97fc5dd6_I20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-28</instant>
        </period>
    </context>
    <context id="icb4f07ff3cbf4479a1d29d55b7330f7a_I20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-28</instant>
        </period>
    </context>
    <context id="i6c64ccfff7864e46907e03a928ba5c42_I20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-28</instant>
        </period>
    </context>
    <context id="i591c8e13af6e49d391c4c0e273d6a551_I20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-28</instant>
        </period>
    </context>
    <context id="ic35a4df7f44a40e5a674e72ae5bf6205_I20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
        </entity>
        <period>
            <instant>2019-12-28</instant>
        </period>
    </context>
    <context id="i025a500d449145cdaf09b62761336e4d_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:A2020ProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i0527d982aa5d4b1493f2febb15dfb36f_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:A2020ProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="ibd11a684655c47febfdbc8b572773803_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:A2020ProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i36f501133aca4e94a40d5f53c2932604_D20200329-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:A2020ProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i5a5c7d523f2145b6aa5ffec1153cb69c_D20190331-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:A2020ProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-31</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i47a6d93cd53549d89b47e663b9deba14_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:A2020ProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i2cacfe431b9c4c0fb8e8aef0b6153a74_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:A2020ProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="if349602212e14b36bbf1334f02910da3_D20200329-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:A2018ProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i93496a66e90a4df78a56e3d1ea9032d5_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:A2018ProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="ia5424d4d3c7a46febf9cc99a77e86fdd_D20190331-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:A2018ProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-31</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i260b34151c1f4ffeb7f29c12973c0d99_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:A2018ProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i06e550e92ba749fcb6ba3ce3f7d5cab2_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:A2020ProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="ia6f164270add4f63b852149f39adb6dd_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:A2018ProgramandPriorProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="ic9df13005acd43968fa8aa9997a94054_D20200329-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:A2020ProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="id2f1e7afc3e94b0ebd50a8b6ea8db521_D20200329-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:A2018ProgramandPriorProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i0b7ebb1b437c46a0a817c9861b363798_D20200329-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="iad3aa8dfa6b948e5b3115795d08f59c8_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hae:A2018ProgramandPriorProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="if591715db6554c7c88829b6f6ea5dd52_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i01fc03287b95423b9e72f9953bf2f534_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i2e978d21bd9d46c78c1bd4f9805a8a0a_D20200329-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="ib21731e2375545a08b98875f7a4af110_D20190331-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-31</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i3c902e8ff2a544848d52e4275e2b7ba6_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i2c6375b4134b4ca68ab871618f059116_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i6ad87d4f1d5749fda7366051a2f43f16_D20200329-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i11ffc79a4ee6438fbd8ff28e0c4be5bb_D20190331-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-31</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="iee4e2e1969f04310b8b24c6665e635f3_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i85a5e4e16a244429b43d7873d0c5a1f8_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i8987e6d81b9e45c09d60428f5014e56f_D20200329-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="ic9d7c28c8e164a01a59f0e2d04a596f1_D20190331-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-31</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i3a367bb123554012a9834d85df459f46_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:PlasmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="ib2c7bdc34da3493493cc0abe3dc3def5_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:PlasmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i4eb9c47f2f9244e0b383fb7b25f6b0d4_D20200329-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:PlasmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="ib0091dd1f9204cdd979ec26f0ee2b0ae_D20190331-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:PlasmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-31</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i6cfe5b5730064f93b6ecea7bc136d73f_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:BloodCenterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="ic275845b82014295bb8e14b72d0cb7a2_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:BloodCenterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i4648a84bbe144e499e5f0bbff9596c82_D20200329-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:BloodCenterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i2fa6549b61284e39986bb1296676dc1a_D20190331-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:BloodCenterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-31</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="id93717bc785844afbedbb40fafa0d6e6_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:HospitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i2d1a57ec025045cbb23779fa6fc0cb2e_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:HospitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="ib19f3255f7c4488593f3252f04fa0abf_D20200329-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:HospitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="id42b45b3282241f0b4410893d0379aae_D20190331-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:HospitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-31</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i05d2add01f7948cdbe05379d9edfa6cd_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="if68e3d2fce814080a6a5a599e4100f7d_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i2f207c5c248843fd8e07e9437fa7102e_D20200329-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="id7b79856e7224f109a59af542be47303_D20190331-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-31</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i8271c898b4eb4b14baafd85359156c86_D20210117-20210117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:CardivaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-17</startDate>
            <endDate>2021-01-17</endDate>
        </period>
    </context>
    <context id="i72cd9e5107234d5fbbe3ac8fc02e2137_I20210117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:CardivaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-17</instant>
        </period>
    </context>
    <context id="i07195ff1642e4aeb86c955b7bd7ec0ee_D20210113-20210113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="hae:AssetAcquisitionAxis">hae:HASIntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-13</startDate>
            <endDate>2021-01-13</endDate>
        </period>
    </context>
    <context id="i1c4663f05df4454e9e234b6de7661db7_D20200401-20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:EnicorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-01</endDate>
        </period>
    </context>
    <context id="i7337ad8ffd7f4d8cb8646e0073515fc1_I20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:EnicorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-01</instant>
        </period>
    </context>
    <context id="i0e7fc74b32564f649453438d72e04947_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:EnicorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i9f13c7f15fc44cdf96efa179ac88e167_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:EnicorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i8b8aa32b413b4a499e81cb8f98426327_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:EnicorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i9e187811cd3e42c390dd4993b5e2ed41_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:EnicorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i6ad4c63952854d498ed7b2fe9fb419e8_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:EnicorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="icef6f3884c5247499558f7349ee73936_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:EnicorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i7aab4b31eac44a489a14bcde8ce8f4eb_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:EnicorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i394c4dad38e046eabd38f765e09e2e8d_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:EnicorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="ied6e581caf26486bbb484a11ddea3e51_D20200629-20200629">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hae:FajardoPuertoRicoManufacturingOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-06-29</endDate>
        </period>
    </context>
    <context id="i231ee71df4ce422fbe1694ee337e10ea_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hae:FajardoPuertoRicoManufacturingOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="ieacf3aef0a2a44ffa6d41b7518483e60_I20200629">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hae:FajardoPuertoRicoManufacturingOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-29</instant>
        </period>
    </context>
    <context id="ie18de39654bc43fabcb2d7cea0396838_D20200701-20200701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hae:USBloodDonorManagementSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-07-01</endDate>
        </period>
    </context>
    <context id="i2c5c92e739704d5ebb1fc26b36eb5d62_I20200701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hae:USBloodDonorManagementSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-01</instant>
        </period>
    </context>
    <context id="i4e00d646e9b74bf58ee6a91734e5d466_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hae:USBloodDonorManagementSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i3858043e51c64ee89cd1d79087a6f765_D20200918-20200918">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hae:InlogHoldingsFranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-18</startDate>
            <endDate>2020-09-18</endDate>
        </period>
    </context>
    <context id="i90c03c90eadf4fd4868c3d27ca9208b1_I20200918">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hae:InlogHoldingsFranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-18</instant>
        </period>
    </context>
    <context id="id6bd93e1c908460891c53b736309cb36_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hae:InlogHoldingsFranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i241ec033d3e44caf9ae5188ed0acd523_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2020-06-28</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="ib56a8928767949d4bf60e3aee31e1600_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">hae:ManufacturingSpaceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i6748c368b970432e8ef44eb2755d3755_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">hae:ManufacturingSpaceSecondRenewalTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i7c25c1d4590644eb8b651796c671219c_I20180615">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-15</instant>
        </period>
    </context>
    <context id="i4426464d081b45bb8839adced8fe2873_I20180615">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-15</instant>
        </period>
    </context>
    <context id="ic5d1fce0362544e68a49594cab3a1aa8_D20180615-20180615">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-06-15</startDate>
            <endDate>2018-06-15</endDate>
        </period>
    </context>
    <context id="ic9a17518f7194d808968c5442709d4d4_D20180615-20180615">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-06-15</startDate>
            <endDate>2018-06-15</endDate>
        </period>
    </context>
    <context id="ifd1b9a587aec4cdca6306687ea65c1a4_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i4842b0c162ea46978645dd51b56a0764_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i075eaab3aa4549bb8d0f597beca1bd0f_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i466af82608da4d9bb01882ff1ee71a02_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i7a806c141f624127aa55c8379bed5731_D20200329-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i3351e34989d1461db1163f69c1e631aa_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i7435ba41f5b744d59c3211f1c1551e27_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="iea5e92752773469e8e60c7fb366f08c0_D20200329-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i42839168f30747d5b099bb2d4f81d4c3_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i86142ccd878c41b5b3b0b89e198e3ffa_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="i6b04360cbc954a42813ee3db68494774_I20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-31</instant>
        </period>
    </context>
    <context id="i23f7882051074260b7b16d0028b875ea_I20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-31</instant>
        </period>
    </context>
    <context id="i22efb3fabcf04d79ba596b48595d8ac1_I20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-31</instant>
        </period>
    </context>
    <context id="i0d31dcad300f4873901a0cff3c146b47_D20200329-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="ice57ced2f272477c986a2ba3d175843c_D20200329-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">hae:NetRevenuesCostOfGoodsSoldAndSellingGeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="ia0f1b457527f4847a6ebea6d12d49745_D20200329-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">hae:OtherIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="ie07432d269194a38a5b973923e71f52b_D20200329-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="iaa58cfb640b3424280402bd198a7e951_D20200329-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">hae:OtherIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i9d8c09f0cf9042d3ab0ab835a3cfb875_D20200329-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">hae:OtherIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="iecb24d1198e0473ab5ff26bece23c571_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="ief8dcb9ed5df46338245fba90826a4a3_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i2ab86f680653471e898cddf1c4abb3b3_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="i74b77438f0884283bdfb63acbb121963_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i758e348315a24c3baee3f7984ecfe945_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="id7af1564b75c420894f80854a774c2d3_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i961d5a6a04ff4db6a9d0a9bbac6be95e_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="ia9656f96940b412198f0ace7941ec4e7_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i09705bf4b4c04d018ba1ef2118f58a80_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="i9d30c35c0167492082c7bb18a3980991_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i2e657827ea664680a8857cfd8b096cb9_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="ie0b611ab7cea40329891cbc0d9cdf3fc_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="iafe5dcd8b8f34d0ba81608d6c14c3841_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="i110e3cdb79b447caadd705ad58eb1b5d_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i7030b986c4a7457991f4240d9857700b_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="i997562bcb47249f98a7209c0a94eb2bc_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i5c5d0e8a5be946c1bcf0fc6bd7dd684d_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i26592b211dab480aa8decca198bc3e17_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i588cb2bb68f741b69393f24addb9f2de_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="if9d15f27861f44938c5187801f43c5d9_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i16890a24a13b44bab1e3d254125196c3_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="ic3f2a0af4b1b470aaa1b1fd8223858e3_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i5a99a6573bad464bacf1a667a155cf4c_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="ia02b0b01fd264d638c0c2628fc697f93_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="ie276656bb33a45a487bf62990df0f609_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i8a4ac71d84054665bcf305a9df5b7ddf_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hae:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i3d3d12a07ab54dd3a6c5ac15a7096a2b_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hae:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="ic2e4f6aff6eb4677970da26827668a01_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="ia1ddfbfc3ba244e7833e4eac1cbf3b2d_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="i216d245bc1864b20940d046e5608b9e0_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="id3e33f79fd854ca19ec85d864af74f63_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="iaf86edce1a1b42fbb8cfd4d66d94a959_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="i45f6ab924d174fe997e8ffab01ef2a19_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="ib783ce7f3af1414a917dfb19f3fd67f6_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="i3bfc2d6751964174b4757e882148e033_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="id8d95a735afe423c94c8eeae0f71dc33_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="iffada09cc3634b0e9958607425101e7e_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="i4b3615436e53401aaf2becfa502d691c_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="if932a0aaa03f451f9dad61e387eabc93_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="iab5f44f15bc94d6daa33cc2caabfaf8a_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="iecf4e5d38e474810bfe38afc5d4ff6a7_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="i7e02337377ab4f1ba4536388c0003177_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hae:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">hae:RevenueBasedPaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i4bca110ee0c94411a74ee374c176ca00_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hae:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">hae:RegulatoryBasedPaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueDiscountedCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i06f5f1e7b5734a368db7c1b4554453ea_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hae:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i54c62f100cf84a5b86024a6964d52097_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hae:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i52cd92f3abc349f2a9cd1e1c9b9229e3_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hae:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="ib3f7a3bec94a478ca2a052a1fdea5f49_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hae:ContingentConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i86b9b10063b34ad7b052ae6b08484c65_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i6bb939bdb4e84a4cb2451ad2848d0fab_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i6c7f2e0a659245f486464f52663463fe_D20200329-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i019e1c4459504344b5dfa26c7a9c0f8d_D20190331-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-31</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i82de2706ab9a438d881b82d726f54fab_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:PlasmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i0d107d1d05864d96b46812133da26150_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:PlasmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i5f67e87ff2f840db91e6f9c559b88649_D20200329-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:PlasmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i0bd53f6c3550495599acfaf8cba39d05_D20190331-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:PlasmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-31</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i05aef9efca8d40999e7e0b591e687fcd_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:BloodCenterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="ib02855b3bb664c3d929e1fe1f3d95081_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:BloodCenterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i1aec235f150e4c96ab0033513856af19_D20200329-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:BloodCenterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i1cc5c0e6c3114948a0b3b81b9e13dbb3_D20190331-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:BloodCenterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-31</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i3c22cd4ab0ee4facb5feb0c32ce1dcb8_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:HospitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i2da01bba3bcc4743a21c2cd6815ea493_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:HospitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i35b2d1e5a36a40f9a3630df7618c1971_D20200329-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:HospitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i87d70737be684026888e909a4d46800b_D20190331-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:HospitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-31</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i7c9e183b328f4417a77301e1291a4315_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="ib94e4c38bb47467fa41d2b3dd7377cf5_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i5d46cacfa2ca4634b761fcb1de68c22e_D20200329-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="ia1791b14ab6944fc9f18b6f33b05c26e_D20190331-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-31</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i26227889e9a545ad95431135a52ce953_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hae:PlasmaProductsandServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="idedb7dce764d40518eed1fa0384c56e9_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hae:PlasmaProductsandServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="idf184b96fbe0474082337c767ecc2e6f_D20200329-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hae:PlasmaProductsandServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="if01e8fdfb1df4aa0be9d813f7d0e93e8_D20190331-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hae:PlasmaProductsandServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-31</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i52f5dadf03404a3289fc228ba07b7289_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hae:BloodCenterProductsandServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i46410774ee104dd5856f09f41912d660_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hae:BloodCenterProductsandServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="idc470180227d4a10b1dffb6cb47fb61e_D20200329-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hae:BloodCenterProductsandServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i9ad919a0f8eb4d72afcee6d577854416_D20190331-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hae:BloodCenterProductsandServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-31</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i87710fdfb6e84d9f8daaca0e1a6929bb_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hae:HospitalProductsandServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="if8bb31ac20c2428391e3f927f45c8cd7_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hae:HospitalProductsandServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="ieb446313570e4a9d840e6f2059d39181_D20200329-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hae:HospitalProductsandServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i2fa09902b11845b090e32e2378241640_D20190331-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hae:HospitalProductsandServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-31</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i7cc83bace6e64ba2819ad07eee146aa5_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i5255bf836d2f4c928a7bb2389d05393b_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="ia77b37ab4b674b69b224543cc8eb45e6_D20200329-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i4a100d6026814cee86e66f779c21038c_D20190331-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-31</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i5d172cbd06c7456499c6f9186db5c771_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i84a09fec71e2469490c5fced840c534d_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="ia8042aa5ffab48bba95d2e2d9c04f228_D20200329-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i17ab8f6f349b4eaba8ad6043c531b88a_D20190331-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-31</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="ieb8358f9ae4143e7bb93e59e7d3a809c_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i479cccf7db0b402f8eb765dc4867033c_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="ib68f4cb225a84d98b73f7eb16b96435c_D20200329-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i0d56e00072c84650b763043b36796f33_D20190331-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-31</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i4173f578720640508c5f3e2556613126_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="ie22e69eafcdc47a5a7f6d41ca37a8314_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i17cdd867d9784cc8998e9d70ee3105af_D20200329-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i96c22dedabc94ec0a58470fce107095e_D20190331-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-31</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i6c25765c59da42a08a0a21dbace51807_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hae:OtherCountryorRegionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i787564a0a009410b9c7377c8d5563e2a_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hae:OtherCountryorRegionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="idfb3207a7e164364a10c64478573dec0_D20200329-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hae:OtherCountryorRegionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i77f79023d32b40a3bb1a8b511a7fe783_D20190331-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hae:OtherCountryorRegionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-31</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i73c6d04f09054f72ad3f93b0ac709dbf_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="id5abcf57b0bd45828a4b667e017ea34b_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="ibd033b9d4b7c4a79acde034ff7bf773d_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="i1e613855a20241cbb5aca346a957c8d5_D20200329-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="if1674f32a21e4d63a2bd245596b5d47c_D20200329-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i64fb8a3c1c5d42e99e7b38ba5b2f180f_D20200329-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="ie870c34971924054809e87e40bb33672_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i6309acd9935545568cbf73841d4a4e9c_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i98ca0312f088468c8e6ea90d58d30441_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="swap">
        <measure>hae:swap</measure>
    </unit>
    <unit id="segment">
        <measure>hae:segment</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80L2ZyYWc6ZmRiZTI4NjMzMDBkNDAwYjk2ZWFjN2JiOTAwZjA5NTEvdGFibGU6NDA5NWI4NTZlZmIwNDBlZmEzOWMzMzk0MGZhMzhkYTYvdGFibGVyYW5nZTo0MDk1Yjg1NmVmYjA0MGVmYTM5YzMzOTQwZmEzOGRhNl8wLTEtMS0xLTA_2c8e4d6e-42d2-4d72-8984-c3f97be6bafa">0000313143</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80L2ZyYWc6ZmRiZTI4NjMzMDBkNDAwYjk2ZWFjN2JiOTAwZjA5NTEvdGFibGU6NDA5NWI4NTZlZmIwNDBlZmEzOWMzMzk0MGZhMzhkYTYvdGFibGVyYW5nZTo0MDk1Yjg1NmVmYjA0MGVmYTM5YzMzOTQwZmEzOGRhNl8xLTEtMS0xLTA_8af779f3-7863-4046-8410-5296454406ad">--04-03</dei:CurrentFiscalYearEndDate>
    <dei:AmendmentFlag
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80L2ZyYWc6ZmRiZTI4NjMzMDBkNDAwYjk2ZWFjN2JiOTAwZjA5NTEvdGFibGU6NDA5NWI4NTZlZmIwNDBlZmEzOWMzMzk0MGZhMzhkYTYvdGFibGVyYW5nZTo0MDk1Yjg1NmVmYjA0MGVmYTM5YzMzOTQwZmEzOGRhNl8yLTEtMS0xLTA_712b495b-5ae5-493e-af3a-00434ae77c5b">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80L2ZyYWc6ZmRiZTI4NjMzMDBkNDAwYjk2ZWFjN2JiOTAwZjA5NTEvdGFibGU6NDA5NWI4NTZlZmIwNDBlZmEzOWMzMzk0MGZhMzhkYTYvdGFibGVyYW5nZTo0MDk1Yjg1NmVmYjA0MGVmYTM5YzMzOTQwZmEzOGRhNl8zLTEtMS0xLTA_254f6297-6837-42ab-a9eb-cd21da73546c">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80L2ZyYWc6ZmRiZTI4NjMzMDBkNDAwYjk2ZWFjN2JiOTAwZjA5NTEvdGFibGU6NDA5NWI4NTZlZmIwNDBlZmEzOWMzMzk0MGZhMzhkYTYvdGFibGVyYW5nZTo0MDk1Yjg1NmVmYjA0MGVmYTM5YzMzOTQwZmEzOGRhNl80LTEtMS0xLTA_0c2b3b41-b014-45ac-999f-11879f635432">Q3</dei:DocumentFiscalPeriodFocus>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yMi9mcmFnOjY1ODlmZjVkZTIzMDQ5YTdhZTMwMTA0YjVlYjQ3Y2JiL3RhYmxlOmY4YzkxY2I3N2I0ZTQzOGM5OWNiY2Y5MWY5MGEyYmY0L3RhYmxlcmFuZ2U6ZjhjOTFjYjc3YjRlNDM4Yzk5Y2JjZjkxZjkwYTJiZjRfMC0xLTEtMS0w_7678ac3d-df46-4f0a-9a45-4d8f6a20a901"
      unitRef="usd">2525000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yMi9mcmFnOjY1ODlmZjVkZTIzMDQ5YTdhZTMwMTA0YjVlYjQ3Y2JiL3RhYmxlOmY4YzkxY2I3N2I0ZTQzOGM5OWNiY2Y5MWY5MGEyYmY0L3RhYmxlcmFuZ2U6ZjhjOTFjYjc3YjRlNDM4Yzk5Y2JjZjkxZjkwYTJiZjRfMC0yLTEtMS0w_23f0fd68-56c9-4649-ad1c-011f7781e57d"
      unitRef="usd">3824000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yMi9mcmFnOjY1ODlmZjVkZTIzMDQ5YTdhZTMwMTA0YjVlYjQ3Y2JiL3RhYmxlOmY4YzkxY2I3N2I0ZTQzOGM5OWNiY2Y5MWY5MGEyYmY0L3RhYmxlcmFuZ2U6ZjhjOTFjYjc3YjRlNDM4Yzk5Y2JjZjkxZjkwYTJiZjRfMS0xLTEtMS0w_f0281538-9afc-42bc-b568-ef970600e21c"
      unitRef="usd">309951000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yMi9mcmFnOjY1ODlmZjVkZTIzMDQ5YTdhZTMwMTA0YjVlYjQ3Y2JiL3RhYmxlOmY4YzkxY2I3N2I0ZTQzOGM5OWNiY2Y5MWY5MGEyYmY0L3RhYmxlcmFuZ2U6ZjhjOTFjYjc3YjRlNDM4Yzk5Y2JjZjkxZjkwYTJiZjRfMS0yLTEtMS0w_627f1dd7-ce21-4c49-88ab-c7bcbf4b69ad"
      unitRef="usd">296942000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yMi9mcmFnOjY1ODlmZjVkZTIzMDQ5YTdhZTMwMTA0YjVlYjQ3Y2JiL3RhYmxlOmY4YzkxY2I3N2I0ZTQzOGM5OWNiY2Y5MWY5MGEyYmY0L3RhYmxlcmFuZ2U6ZjhjOTFjYjc3YjRlNDM4Yzk5Y2JjZjkxZjkwYTJiZjRfMi0xLTEtMS0w_d01d6b4b-23ec-4657-bf89-3005ddf8ceda"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yMi9mcmFnOjY1ODlmZjVkZTIzMDQ5YTdhZTMwMTA0YjVlYjQ3Y2JiL3RhYmxlOmY4YzkxY2I3N2I0ZTQzOGM5OWNiY2Y5MWY5MGEyYmY0L3RhYmxlcmFuZ2U6ZjhjOTFjYjc3YjRlNDM4Yzk5Y2JjZjkxZjkwYTJiZjRfMi0yLTEtMS0w_4e53cea3-e63c-4637-ab0f-8a4cb1e34f90"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yMi9mcmFnOjY1ODlmZjVkZTIzMDQ5YTdhZTMwMTA0YjVlYjQ3Y2JiL3RhYmxlOmY4YzkxY2I3N2I0ZTQzOGM5OWNiY2Y5MWY5MGEyYmY0L3RhYmxlcmFuZ2U6ZjhjOTFjYjc3YjRlNDM4Yzk5Y2JjZjkxZjkwYTJiZjRfMy0xLTEtMS0w_061a90e3-63e2-4b79-9598-e20118904687"
      unitRef="shares">150000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yMi9mcmFnOjY1ODlmZjVkZTIzMDQ5YTdhZTMwMTA0YjVlYjQ3Y2JiL3RhYmxlOmY4YzkxY2I3N2I0ZTQzOGM5OWNiY2Y5MWY5MGEyYmY0L3RhYmxlcmFuZ2U6ZjhjOTFjYjc3YjRlNDM4Yzk5Y2JjZjkxZjkwYTJiZjRfMy0yLTEtMS0w_34ec690f-0ef6-4700-b6f1-de024420f637"
      unitRef="shares">150000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yMi9mcmFnOjY1ODlmZjVkZTIzMDQ5YTdhZTMwMTA0YjVlYjQ3Y2JiL3RhYmxlOmY4YzkxY2I3N2I0ZTQzOGM5OWNiY2Y5MWY5MGEyYmY0L3RhYmxlcmFuZ2U6ZjhjOTFjYjc3YjRlNDM4Yzk5Y2JjZjkxZjkwYTJiZjRfNC0xLTEtMS0w_09e861bb-8a5f-4605-aade-db0e52ac4a32"
      unitRef="shares">50817233</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yMi9mcmFnOjY1ODlmZjVkZTIzMDQ5YTdhZTMwMTA0YjVlYjQ3Y2JiL3RhYmxlOmY4YzkxY2I3N2I0ZTQzOGM5OWNiY2Y5MWY5MGEyYmY0L3RhYmxlcmFuZ2U6ZjhjOTFjYjc3YjRlNDM4Yzk5Y2JjZjkxZjkwYTJiZjRfNC0yLTEtMS0w_49edae4c-c2fc-4500-93db-6380b0380220"
      unitRef="shares">50322930</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yMi9mcmFnOjY1ODlmZjVkZTIzMDQ5YTdhZTMwMTA0YjVlYjQ3Y2JiL3RhYmxlOmY4YzkxY2I3N2I0ZTQzOGM5OWNiY2Y5MWY5MGEyYmY0L3RhYmxlcmFuZ2U6ZjhjOTFjYjc3YjRlNDM4Yzk5Y2JjZjkxZjkwYTJiZjRfNS0xLTEtMS0w_bfca9384-95c0-42dc-856b-e4387e8e90c8"
      unitRef="shares">50817233</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yMi9mcmFnOjY1ODlmZjVkZTIzMDQ5YTdhZTMwMTA0YjVlYjQ3Y2JiL3RhYmxlOmY4YzkxY2I3N2I0ZTQzOGM5OWNiY2Y5MWY5MGEyYmY0L3RhYmxlcmFuZ2U6ZjhjOTFjYjc3YjRlNDM4Yzk5Y2JjZjkxZjkwYTJiZjRfNS0yLTEtMS0w_9a0dcae9-36cc-47c9-842a-20c6b862a65f"
      unitRef="shares">50322930</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="ib56a8928767949d4bf60e3aee31e1600_I20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV82NC9mcmFnOjc2OTk3NDk1NTM2NjRmNzlhNjNiMjA4OGEzM2Y2YzcxL3RleHRyZWdpb246NzY5OTc0OTU1MzY2NGY3OWE2M2IyMDg4YTMzZjZjNzFfMzI4_d1261318-cbde-4310-8bac-529fcbd30bd5">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="i6748c368b970432e8ef44eb2755d3755_I20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV82NC9mcmFnOjc2OTk3NDk1NTM2NjRmNzlhNjNiMjA4OGEzM2Y2YzcxL3RleHRyZWdpb246NzY5OTc0OTU1MzY2NGY3OWE2M2IyMDg4YTMzZjZjNzFfMzY4_fdeb1860-c6a9-478a-81ce-84942fec66c9">P4Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="ib56a8928767949d4bf60e3aee31e1600_I20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV82Ny9mcmFnOjNjMzQ0OGI4NDNiYzQxMWU4ZGNkNmI4NDY1ZTJjZjVjL3RleHRyZWdpb246M2MzNDQ4Yjg0M2JjNDExZThkY2Q2Yjg0NjVlMmNmNWNfMTQy_2bae1474-c5f6-4a91-aa0c-1d757b5c7c29">P15Y6M30D</us-gaap:LesseeOperatingLeaseTermOfContract>
    <dei:DocumentType
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xL2ZyYWc6ZDA3OWU4MGYyZDRlNGVmZjlhMGJlMDYzOGFjYTBiYTUvdGV4dHJlZ2lvbjpkMDc5ZTgwZjJkNGU0ZWZmOWEwYmUwNjM4YWNhMGJhNV8xODY3_6f3b1b72-0e23-4a35-8b01-1f551bf57a39">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xL2ZyYWc6ZDA3OWU4MGYyZDRlNGVmZjlhMGJlMDYzOGFjYTBiYTUvdGFibGU6NDE0YThiMTY0Mjg0NDA0OTk5ZGUwNDhjYWMwY2YzMDUvdGFibGVyYW5nZTo0MTRhOGIxNjQyODQ0MDQ5OTlkZTA0OGNhYzBjZjMwNV8wLTAtMS0xLTA_bd689b30-8d43-41c8-8cdd-ee3f5335d998">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xL2ZyYWc6ZDA3OWU4MGYyZDRlNGVmZjlhMGJlMDYzOGFjYTBiYTUvdGV4dHJlZ2lvbjpkMDc5ZTgwZjJkNGU0ZWZmOWEwYmUwNjM4YWNhMGJhNV8xMjM_4a292f1e-d2b8-4253-b8ff-6ed5fa9f2c60">2020-12-26</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xL2ZyYWc6ZDA3OWU4MGYyZDRlNGVmZjlhMGJlMDYzOGFjYTBiYTUvdGFibGU6OTQ2MTg4ZGI2NDcxNDA1NmE5YTI3NDI2ZmUyYzM3NGYvdGFibGVyYW5nZTo5NDYxODhkYjY0NzE0MDU2YTlhMjc0MjZmZTJjMzc0Zl8wLTAtMS0xLTA_ff310773-e90f-4964-b463-fa3a07372b3a">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xL2ZyYWc6ZDA3OWU4MGYyZDRlNGVmZjlhMGJlMDYzOGFjYTBiYTUvdGV4dHJlZ2lvbjpkMDc5ZTgwZjJkNGU0ZWZmOWEwYmUwNjM4YWNhMGJhNV8xODY4_210fe1fd-7496-423f-a2c4-05a976b85c27">001-14041</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xL2ZyYWc6ZDA3OWU4MGYyZDRlNGVmZjlhMGJlMDYzOGFjYTBiYTUvdGV4dHJlZ2lvbjpkMDc5ZTgwZjJkNGU0ZWZmOWEwYmUwNjM4YWNhMGJhNV8xODY5_a7182630-fcbe-4547-ac08-9d83afffabad">HAEMONETICS CORP</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xL2ZyYWc6ZDA3OWU4MGYyZDRlNGVmZjlhMGJlMDYzOGFjYTBiYTUvdGFibGU6YjY4YjYxMzMwZTQyNDY0YmFiNjk3YjgwMGJjNzZkNjkvdGFibGVyYW5nZTpiNjhiNjEzMzBlNDI0NjRiYWI2OTdiODAwYmM3NmQ2OV8wLTAtMS0xLTA_bbd803e8-8ff8-4a59-9dbd-a7c215c49d1a">MA</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xL2ZyYWc6ZDA3OWU4MGYyZDRlNGVmZjlhMGJlMDYzOGFjYTBiYTUvdGFibGU6YjY4YjYxMzMwZTQyNDY0YmFiNjk3YjgwMGJjNzZkNjkvdGFibGVyYW5nZTpiNjhiNjEzMzBlNDI0NjRiYWI2OTdiODAwYmM3NmQ2OV8wLTMtMS0xLTA_d73f7bbd-3f0f-4c6e-9078-d0028535a166">04-2882273</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xL2ZyYWc6ZDA3OWU4MGYyZDRlNGVmZjlhMGJlMDYzOGFjYTBiYTUvdGFibGU6YjY4YjYxMzMwZTQyNDY0YmFiNjk3YjgwMGJjNzZkNjkvdGFibGVyYW5nZTpiNjhiNjEzMzBlNDI0NjRiYWI2OTdiODAwYmM3NmQ2OV8zLTAtMS0xLTA_6317c296-f190-4204-9e3d-dad2c120f062">125 Summer Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xL2ZyYWc6ZDA3OWU4MGYyZDRlNGVmZjlhMGJlMDYzOGFjYTBiYTUvdGFibGU6YjY4YjYxMzMwZTQyNDY0YmFiNjk3YjgwMGJjNzZkNjkvdGFibGVyYW5nZTpiNjhiNjEzMzBlNDI0NjRiYWI2OTdiODAwYmM3NmQ2OV80LTAtMS0xLTA_a14cb21c-f4d6-4129-b42c-edd081b7a486">Boston,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xL2ZyYWc6ZDA3OWU4MGYyZDRlNGVmZjlhMGJlMDYzOGFjYTBiYTUvdGFibGU6YjY4YjYxMzMwZTQyNDY0YmFiNjk3YjgwMGJjNzZkNjkvdGFibGVyYW5nZTpiNjhiNjEzMzBlNDI0NjRiYWI2OTdiODAwYmM3NmQ2OV80LTEtMS0xLTA_c71f0cad-a40a-4216-a77e-46f68e75e2a1">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xL2ZyYWc6ZDA3OWU4MGYyZDRlNGVmZjlhMGJlMDYzOGFjYTBiYTUvdGFibGU6YjY4YjYxMzMwZTQyNDY0YmFiNjk3YjgwMGJjNzZkNjkvdGFibGVyYW5nZTpiNjhiNjEzMzBlNDI0NjRiYWI2OTdiODAwYmM3NmQ2OV80LTMtMS0xLTA_0def97c1-9fc4-480d-9119-69f949109c09">02110</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xL2ZyYWc6ZDA3OWU4MGYyZDRlNGVmZjlhMGJlMDYzOGFjYTBiYTUvdGV4dHJlZ2lvbjpkMDc5ZTgwZjJkNGU0ZWZmOWEwYmUwNjM4YWNhMGJhNV8xODcw_eadfd0fc-f21e-4bd9-841f-952f0eaad3d3">781</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xL2ZyYWc6ZDA3OWU4MGYyZDRlNGVmZjlhMGJlMDYzOGFjYTBiYTUvdGV4dHJlZ2lvbjpkMDc5ZTgwZjJkNGU0ZWZmOWEwYmUwNjM4YWNhMGJhNV8xODYz_5fa63407-a76c-4d3b-9e39-2acc2df43f60">848-7100</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xL2ZyYWc6ZDA3OWU4MGYyZDRlNGVmZjlhMGJlMDYzOGFjYTBiYTUvdGFibGU6ODU3YzRkZGE4MTdiNGNlMjliZGE0OGIxNzA2OTlkNWUvdGFibGVyYW5nZTo4NTdjNGRkYTgxN2I0Y2UyOWJkYTQ4YjE3MDY5OWQ1ZV8xLTAtMS0xLTA_1bc2a359-af24-49c7-b319-e72262f89c21">Common stock, $.01&#160;par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xL2ZyYWc6ZDA3OWU4MGYyZDRlNGVmZjlhMGJlMDYzOGFjYTBiYTUvdGFibGU6ODU3YzRkZGE4MTdiNGNlMjliZGE0OGIxNzA2OTlkNWUvdGFibGVyYW5nZTo4NTdjNGRkYTgxN2I0Y2UyOWJkYTQ4YjE3MDY5OWQ1ZV8xLTItMS0xLTA_ea1788a8-88fc-4140-8f54-781c745da86e">HAE</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xL2ZyYWc6ZDA3OWU4MGYyZDRlNGVmZjlhMGJlMDYzOGFjYTBiYTUvdGFibGU6ODU3YzRkZGE4MTdiNGNlMjliZGE0OGIxNzA2OTlkNWUvdGFibGVyYW5nZTo4NTdjNGRkYTgxN2I0Y2UyOWJkYTQ4YjE3MDY5OWQ1ZV8xLTQtMS0xLTA_c7e83262-9260-4705-9f64-0cf21260bb59">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xL2ZyYWc6ZDA3OWU4MGYyZDRlNGVmZjlhMGJlMDYzOGFjYTBiYTUvdGV4dHJlZ2lvbjpkMDc5ZTgwZjJkNGU0ZWZmOWEwYmUwNjM4YWNhMGJhNV8xODY0_2a0898af-44e2-479c-a5c9-50f060c862e4">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xL2ZyYWc6ZDA3OWU4MGYyZDRlNGVmZjlhMGJlMDYzOGFjYTBiYTUvdGV4dHJlZ2lvbjpkMDc5ZTgwZjJkNGU0ZWZmOWEwYmUwNjM4YWNhMGJhNV8xODY1_81f8802a-7dfa-4a18-b2b7-9dcc4784fd70">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xL2ZyYWc6ZDA3OWU4MGYyZDRlNGVmZjlhMGJlMDYzOGFjYTBiYTUvdGFibGU6YWQxYWE3YWU1NTg1NGZhMTgxNGI1ZDliZDk2YzljM2MvdGFibGVyYW5nZTphZDFhYTdhZTU1ODU0ZmExODE0YjVkOWJkOTZjOWMzY18wLTAtMS0xLTA_184a884e-11f0-4e08-aaf2-dd90d5392a1e">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xL2ZyYWc6ZDA3OWU4MGYyZDRlNGVmZjlhMGJlMDYzOGFjYTBiYTUvdGFibGU6YWQxYWE3YWU1NTg1NGZhMTgxNGI1ZDliZDk2YzljM2MvdGFibGVyYW5nZTphZDFhYTdhZTU1ODU0ZmExODE0YjVkOWJkOTZjOWMzY18xLTYtMS0xLTA_4c1ee18d-ed09-4acb-8504-2fe0258029ae">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xL2ZyYWc6ZDA3OWU4MGYyZDRlNGVmZjlhMGJlMDYzOGFjYTBiYTUvdGFibGU6YWQxYWE3YWU1NTg1NGZhMTgxNGI1ZDliZDk2YzljM2MvdGFibGVyYW5nZTphZDFhYTdhZTU1ODU0ZmExODE0YjVkOWJkOTZjOWMzY18yLTYtMS0xLTA_d2920ccb-bb88-4d34-a7e0-e27ffcf6aa50">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xL2ZyYWc6ZDA3OWU4MGYyZDRlNGVmZjlhMGJlMDYzOGFjYTBiYTUvdGV4dHJlZ2lvbjpkMDc5ZTgwZjJkNGU0ZWZmOWEwYmUwNjM4YWNhMGJhNV8xODY2_3b907941-230e-4785-9547-0dfe5757d8e3">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i6fffe38395d44814afad719145493df5_I20210129"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xL2ZyYWc6ZDA3OWU4MGYyZDRlNGVmZjlhMGJlMDYzOGFjYTBiYTUvdGV4dHJlZ2lvbjpkMDc5ZTgwZjJkNGU0ZWZmOWEwYmUwNjM4YWNhMGJhNV8xODYx_b83f92e6-d837-4947-a825-bfd27205742a"
      unitRef="shares">50821698</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMi0xLTEtMS0w_6247e7d1-6478-4331-9457-d7e0cdb1eae8"
      unitRef="usd">240371000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMi0zLTEtMS0w_7e8dc4ea-0865-4f15-b12d-4d16e09e3a2a"
      unitRef="usd">258970000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMi01LTEtMS0w_e7409b68-cb8d-482c-9d42-13319666171e"
      unitRef="usd">645434000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMi03LTEtMS0w_8d01d65c-eddf-4825-b595-61ef081063a3"
      unitRef="usd">749987000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMy0xLTEtMS0w_81d9bf96-6226-4e72-b359-0629e148139b"
      unitRef="usd">120114000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMy0zLTEtMS0w_4cd8586e-699e-49f8-a0a2-fada8665465b"
      unitRef="usd">130920000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMy01LTEtMS0w_dd6371d3-a16c-4887-9d6c-9a73f4cf7248"
      unitRef="usd">329403000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMy03LTEtMS0w_9f400aa4-8362-46f8-a97e-4c1e964d43ee"
      unitRef="usd">379031000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfNC0xLTEtMS0w_912f9c1b-43af-40bb-8ccf-2e50c07f7506"
      unitRef="usd">120257000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfNC0zLTEtMS0w_51097d7e-dce5-4c06-9894-d072e65e8eb0"
      unitRef="usd">128050000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfNC01LTEtMS0w_1371b955-d0ca-4d47-87bf-ccbb147cbfd3"
      unitRef="usd">316031000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfNC03LTEtMS0w_62d3f91e-4f51-472c-a51e-08024abadd89"
      unitRef="usd">370956000</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfNi0xLTEtMS0w_424c0fe1-9b7e-4fc6-a6a3-6b3af08cf5cd"
      unitRef="usd">7501000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfNi0zLTEtMS0w_08143091-031e-4456-9c85-c5e3dd4c29ab"
      unitRef="usd">7000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfNi01LTEtMS0w_d51cab18-a8c3-4fb5-9432-5a73c9d92c3d"
      unitRef="usd">22014000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfNi03LTEtMS0w_59067476-584f-4b1b-870f-093d4b138c2f"
      unitRef="usd">21909000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfNy0xLTEtMS0w_b66a9d32-77db-471d-9c18-a77c22bd7e24"
      unitRef="usd">73446000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfNy0zLTEtMS0w_07c4750c-09ce-46a1-98ed-4516001bcbb0"
      unitRef="usd">78267000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfNy01LTEtMS0w_2cf57dc4-0d31-47e2-8627-9a07b402ba43"
      unitRef="usd">214680000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfNy03LTEtMS0w_7d81f894-1f60-45ca-b0b3-a51eb623dc25"
      unitRef="usd">229189000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:OtherAssetImpairmentCharges
      contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfOC0xLTEtMS0w_401cd5ce-bd4d-408a-8008-e52806b5da1e"
      unitRef="usd">0</us-gaap:OtherAssetImpairmentCharges>
    <us-gaap:OtherAssetImpairmentCharges
      contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfOC0zLTEtMS0w_61d5a0b7-3bd8-41e8-b736-76114e40473a"
      unitRef="usd">1876000</us-gaap:OtherAssetImpairmentCharges>
    <us-gaap:OtherAssetImpairmentCharges
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfOC01LTEtMS0w_290d8be0-8c97-4a9a-91ef-53f975d22f7d"
      unitRef="usd">1028000</us-gaap:OtherAssetImpairmentCharges>
    <us-gaap:OtherAssetImpairmentCharges
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfOC03LTEtMS0w_a043d750-5afa-46d4-b24f-290d8919ab31"
      unitRef="usd">50597000</us-gaap:OtherAssetImpairmentCharges>
    <hae:GainLossOnDivestitureAndSaleOfAssets
      contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfOS0xLTEtMS0w_12dc0881-f7a6-42c8-814d-d0bfda4d6e07"
      unitRef="usd">1115000</hae:GainLossOnDivestitureAndSaleOfAssets>
    <hae:GainLossOnDivestitureAndSaleOfAssets
      contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfOS0zLTEtMS0w_84e77bb0-6ea5-4164-b1f4-60c758f2d5ec"
      unitRef="usd">0</hae:GainLossOnDivestitureAndSaleOfAssets>
    <hae:GainLossOnDivestitureAndSaleOfAssets
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfOS01LTEtMS0w_f3d2af17-5faf-47d8-a8a5-c70556315d06"
      unitRef="usd">32613000</hae:GainLossOnDivestitureAndSaleOfAssets>
    <hae:GainLossOnDivestitureAndSaleOfAssets
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfOS03LTEtMS0w_2cb29542-950b-4ffa-9f7c-2dcd34b8ae47"
      unitRef="usd">8083000</hae:GainLossOnDivestitureAndSaleOfAssets>
    <us-gaap:OperatingExpenses
      contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTAtMS0xLTEtMA_c7928fee-9691-4eb0-9645-874857e9331c"
      unitRef="usd">79832000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTAtMy0xLTEtMA_01d91a01-ac45-4246-9d22-6e71d1bf68e2"
      unitRef="usd">87143000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTAtNS0xLTEtMA_6bb8d4cf-bf39-4c80-a1b4-17bae6b40ab8"
      unitRef="usd">205109000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTAtNy0xLTEtMA_bad2c76e-bfa0-4d2b-92d5-c47c87408e65"
      unitRef="usd">293612000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTEtMS0xLTEtMA_ca3afc5a-f8a4-40e3-bf63-1584a8869c3a"
      unitRef="usd">40425000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTEtMy0xLTEtMA_0228aeb5-1774-4305-9ea5-48cdf2e81f13"
      unitRef="usd">40907000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTEtNS0xLTEtMA_2750fb61-bc4d-4ea6-8312-6e4469e97199"
      unitRef="usd">110922000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTEtNy0xLTEtMA_a8eda6d8-43b0-4ef5-9fde-4908239bff87"
      unitRef="usd">77344000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTItMS0xLTEtMA_50b6c430-0b48-4027-8cc2-ab2605111739"
      unitRef="usd">-3051000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTItMy0xLTEtMA_245ed609-e8e0-4e20-869e-cc186333fbcc"
      unitRef="usd">-3078000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTItNS0xLTEtMA_d2d8cf80-4ade-4733-974c-927117579f12"
      unitRef="usd">-10612000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTItNy0xLTEtMA_d8d6f2c2-9c14-4776-a243-80590af9e95d"
      unitRef="usd">-12152000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTMtMS0xLTEtMA_6331f634-57fa-4a2c-9a2c-630699e60529"
      unitRef="usd">37374000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTMtMy0xLTEtMA_c2822748-defa-4497-92d8-6af6f318a0f7"
      unitRef="usd">37829000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTMtNS0xLTEtMA_d26e4efe-3aa9-41ce-b90e-67fefeac685e"
      unitRef="usd">100310000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTMtNy0xLTEtMA_123ca3aa-387d-485d-bad0-0fe75909625a"
      unitRef="usd">65192000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTQtMS0xLTEtMA_95575cd3-bed2-4719-8d03-d96fd76bdcd3"
      unitRef="usd">5492000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTQtMy0xLTEtMA_7567258b-0046-42e7-81b8-622432d112d2"
      unitRef="usd">7934000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTQtNS0xLTEtMA_26c701b1-ae02-43aa-bcd2-8590c91c34f1"
      unitRef="usd">9800000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTQtNy0xLTEtMA_e4462d56-ba36-4cee-88e8-9293e0bc78f9"
      unitRef="usd">6290000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTUtMS0xLTEtMA_53c9b6e5-7537-48ed-944d-4f7c4de18f2c"
      unitRef="usd">31882000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTUtMy0xLTEtMA_1a6cd5a6-1a6e-4f91-a33a-dfb75f3425a3"
      unitRef="usd">29895000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTUtNS0xLTEtMA_3a268274-8fc7-4aa3-8a61-ea0e80d11353"
      unitRef="usd">90510000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTUtNy0xLTEtMA_8d01ec91-451e-40d9-9b79-f8af80f85c44"
      unitRef="usd">58902000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTctMS0xLTEtMA_8fa9d717-da4c-4be3-bdf7-cffd920ea7d7"
      unitRef="usdPerShare">0.63</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTctMy0xLTEtMA_7394a5e3-d3a8-438b-ab4b-be6f27cfa74a"
      unitRef="usdPerShare">0.59</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTctNS0xLTEtMA_f78d5cdc-eca8-4edb-a730-87865c780571"
      unitRef="usdPerShare">1.79</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTctNy0xLTEtMA_d0c6bcdb-f9b3-4232-b295-355950d23293"
      unitRef="usdPerShare">1.16</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTgtMS0xLTEtMA_082da17b-2295-419d-80b6-e758a44b0eb7"
      unitRef="usdPerShare">0.62</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTgtMy0xLTEtMA_7a0bf7ae-5bee-472e-a836-739c16e59709"
      unitRef="usdPerShare">0.58</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTgtNS0xLTEtMA_0b8cb62c-f339-4c9a-ad8e-10c0a536db1e"
      unitRef="usdPerShare">1.77</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMTgtNy0xLTEtMA_5c7cd8b3-5aae-4b4a-bec7-a6e04ba7bb0b"
      unitRef="usdPerShare">1.13</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMjEtMS0xLTEtMA_4bd87dba-35d7-4dd3-915c-1f23d542f561"
      unitRef="shares">50789000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMjEtMy0xLTEtMA_23684420-4979-49c0-86e5-fc5df9060f52"
      unitRef="shares">50630000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMjEtNS0xLTEtMA_a11ae91a-ae83-48de-87f6-f8892d6d754a"
      unitRef="shares">50634000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMjEtNy0xLTEtMA_f7369501-704f-4a11-97de-c186f4d5d713"
      unitRef="shares">50810000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMjItMS0xLTEtMA_0353f13b-e23e-441c-910b-3d2abc056499"
      unitRef="shares">51363000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMjItMy0xLTEtMA_5a8e2e0c-d178-473b-89e9-2a6b596f4629"
      unitRef="shares">51638000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMjItNS0xLTEtMA_ddf057e2-5345-41c9-be30-9ce7f3f6e066"
      unitRef="shares">51234000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMjItNy0xLTEtMA_f2e3da2d-e4b5-4e3d-b607-f1dee1ada187"
      unitRef="shares">51995000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMjQtMS0xLTEtMA_66cd7e81-0736-43d2-beb1-aa7f44474297"
      unitRef="usd">40496000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMjQtMy0xLTEtMA_20d47858-3633-486e-8466-f7ff066a1b79"
      unitRef="usd">32296000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMjQtNS0xLTEtMA_07d0cf7d-f4b0-4cb9-a083-36cc32dcb828"
      unitRef="usd">105787000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xNi9mcmFnOjA1NGNkNjAwZDBkZDRhYzBiNjU5MjZmYzhhYmM4ZGIzL3RhYmxlOjhmNTcwNmY5Y2Y2NDQ3OWZhZjJlNGFkZmE2NjZhYzJmL3RhYmxlcmFuZ2U6OGY1NzA2ZjljZjY0NDc5ZmFmMmU0YWRmYTY2NmFjMmZfMjQtNy0xLTEtMA_c8f64a1d-cf8a-4ebd-86e3-cb30705059e2"
      unitRef="usd">55577000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMy0xLTEtMS0w_d3b9c242-5950-4050-9e04-bd75c904bb67"
      unitRef="usd">189002000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMy0zLTEtMS0w_cd8ae725-23af-446c-8c61-2a9ff82d6e8c"
      unitRef="usd">137311000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfNC0xLTEtMS0w_83a7c6a6-a39d-4bcc-8204-66373665b362"
      unitRef="usd">146939000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfNC0zLTEtMS0w_3b402390-ff7c-413d-95c5-b945b7f5c95a"
      unitRef="usd">165207000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfNS0xLTEtMS0w_8924b742-95e1-4b86-b91a-64fc944eb70a"
      unitRef="usd">299710000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfNS0zLTEtMS0w_888201b6-0404-4d4f-8499-224377d87d84"
      unitRef="usd">270276000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfNi0xLTEtMS0w_cc3a143f-e719-46f2-8d4e-250981210c2e"
      unitRef="usd">32697000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfNi0zLTEtMS0w_7a48ff06-a4ff-47a4-9e17-8a0e0630ab3f"
      unitRef="usd">30845000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfNy0xLTEtMS0w_88deef09-525d-49c5-822c-fc50fdfb510b"
      unitRef="usd">668348000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfNy0zLTEtMS0w_5192fc74-72ad-4232-9c0a-ef8c8b0e6ca1"
      unitRef="usd">603639000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfOC0xLTEtMS0w_38318e47-c312-4afd-a652-7eb6aec3ab22"
      unitRef="usd">240009000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfOC0zLTEtMS0w_a031301c-cc81-4aac-930d-f924616a66a6"
      unitRef="usd">253399000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfOS0xLTEtMS0w_0cda3ce6-1dcc-45aa-836c-40efaf33ae74"
      unitRef="usd">119716000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfOS0zLTEtMS0w_b373b70e-8748-4c48-b19c-5f8e23b60406"
      unitRef="usd">133106000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:Goodwill
      contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMTAtMS0xLTEtMA_4d72402d-775f-4de5-aa22-11000ce6eb2a"
      unitRef="usd">215508000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMTAtMy0xLTEtMA_a31e3d4e-3620-4b98-8d0e-4cc8f87f69ee"
      unitRef="usd">210652000</us-gaap:Goodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMTEtMS0xLTEtMA_cb8c6365-cb81-44d0-8278-09be92eb9482"
      unitRef="usd">4558000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMTEtMy0xLTEtMA_d35bc743-7954-4504-a89e-6a88cdf98cc2"
      unitRef="usd">3930000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMTItMS0xLTEtMA_70ba55f2-d28b-43f4-a99d-85cefba7740e"
      unitRef="usd">69929000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMTItMy0xLTEtMA_a74151cc-63c7-4fde-b833-5f021909e946"
      unitRef="usd">62384000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMTMtMS0xLTEtMA_1fda45ef-65ef-421a-9977-3cfd7cdd1884"
      unitRef="usd">1318068000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMTMtMy0xLTEtMA_a4926de0-35c2-4769-a2a9-e59ceefee5f9"
      unitRef="usd">1267110000</us-gaap:Assets>
    <us-gaap:LongTermDebtCurrent
      contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMTYtMS0xLTEtMA_24354097-a189-4530-8e11-85b54cab6a36"
      unitRef="usd">17055000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMTYtMy0xLTEtMA_b5f1f57c-647b-4ea8-9412-206aa3342d70"
      unitRef="usd">76980000</us-gaap:LongTermDebtCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMTctMS0xLTEtMA_68c4d11e-c456-4583-8bf3-376cdfba3586"
      unitRef="usd">42979000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMTctMy0xLTEtMA_91d54cd4-79e0-443e-9760-769a0d26dbf2"
      unitRef="usd">50730000</us-gaap:AccountsPayableCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMTgtMS0xLTEtMA_294a95d8-eb6f-4609-903c-45b37bdba0ef"
      unitRef="usd">35127000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMTgtMy0xLTEtMA_2f8f8373-5e5d-4950-b866-22bfb1e01503"
      unitRef="usd">49471000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMTktMS0xLTEtMA_dd9058ee-ba53-4acf-8965-5ca3ceeec91a"
      unitRef="usd">99223000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMTktMy0xLTEtMA_bd5875f3-644b-4d76-964c-5ff9146242d6"
      unitRef="usd">97641000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMjAtMS0xLTEtMA_2e2090ad-3476-48d8-af72-161ac3d1402e"
      unitRef="usd">194384000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMjAtMy0xLTEtMA_3d526e29-ebdc-4612-b0ed-d77adbffbbc7"
      unitRef="usd">274822000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMjEtMS0xLTEtMA_da606ac2-5561-48dc-ab85-37748c5c5838"
      unitRef="usd">292721000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMjEtMy0xLTEtMA_cc81db97-3cfd-4785-b1c5-5fddf871f6a4"
      unitRef="usd">305513000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMjItMS0xLTEtMA_08e80a29-a930-4b92-a3de-d22e3d1a6c98"
      unitRef="usd">9803000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMjItMy0xLTEtMA_17654efb-4a46-4701-9c3c-6398b309ff0e"
      unitRef="usd">10562000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMjMtMS0xLTEtMA_a3a487a6-6a55-4800-827a-7865212f8790"
      unitRef="usd">102008000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMjMtMy0xLTEtMA_150481d0-c6ae-42c5-9a6f-ac4cb29e5542"
      unitRef="usd">89104000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:CommonStockValue
      contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMjUtMS0xLTEtMA_e73fdd28-53bb-4aad-8bb7-d5a99a4bdf75"
      unitRef="usd">508000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMjUtMy0xLTEtMA_ac897d15-d374-41aa-a052-5f4fc5e5d540"
      unitRef="usd">503000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMjYtMS0xLTEtMA_e268feea-914d-4450-b3f7-c133c50331df"
      unitRef="usd">579480000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMjYtMy0xLTEtMA_402ea60a-bbbd-4a42-913a-dbe0657a2dd4"
      unitRef="usd">553229000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMjctMS0xLTEtMA_49f4f71f-ab9e-468c-934b-d6645441dcc7"
      unitRef="usd">169022000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMjctMy0xLTEtMA_d5d2db67-6624-4131-9ab5-e97139ca4a5d"
      unitRef="usd">78512000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMjgtMS0xLTEtMA_655e1689-45c9-4cd6-adcc-4f540432fd02"
      unitRef="usd">-29858000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMjgtMy0xLTEtMA_34131a8f-0685-44ba-8c07-b1d0b735eca3"
      unitRef="usd">-45135000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMjktMS0xLTEtMA_78dff6a0-6c7c-4c69-8b63-a018a67977fc"
      unitRef="usd">719152000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMjktMy0xLTEtMA_bb5ff56c-5fe0-492a-aca4-91ae1fb4185d"
      unitRef="usd">587109000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMzAtMS0xLTEtMA_4ab86254-c856-4bc0-9c9b-19e4295f4b63"
      unitRef="usd">1318068000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8xOS9mcmFnOmI2YjdlMWQyZGMyYTQxYTk4N2ZkZTY0MDM5MjI1YjJjL3RhYmxlOjljY2EzMzM4ODZiOTRiY2NhZmM1YmJhMTNmMTg2YzNlL3RhYmxlcmFuZ2U6OWNjYTMzMzg4NmI5NGJjY2FmYzViYmExM2YxODZjM2VfMzAtMy0xLTEtMA_5ee724ec-5c97-469e-8451-566eb3cdefc1"
      unitRef="usd">1267110000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="i2cb16a2f4c824ae1aca4e13fd49fe043_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMi0xLTEtMS0w_2d80a7c1-2887-43c6-b7a0-b398f8920044"
      unitRef="shares">50323000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i2cb16a2f4c824ae1aca4e13fd49fe043_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMi0zLTEtMS0w_014988d3-7554-453e-b679-441d5e46de14"
      unitRef="usd">503000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i14a5e6c117e3421f99e4b603faf5fa43_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMi01LTEtMS0w_da184472-1500-4c52-a436-11dd6f023aba"
      unitRef="usd">553229000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="icab8382823bd48c2b8bbd759d1c6a1fa_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMi03LTEtMS0w_10ffa66d-aea3-4aea-8b55-98a3e901ff51"
      unitRef="usd">78512000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic1efb1864b5d4f41a6d229d84f58d0e1_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMi05LTEtMS0w_7a126ed2-7f35-4f7f-849e-ca164ef895d3"
      unitRef="usd">-45135000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMi0xMS0xLTEtMA_cc363dae-01d0-433c-a56b-89bf53e2b996"
      unitRef="usd">587109000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="if6dd2f02aa774a31a839f57971d93f2e_D20200329-20200627"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMy0xLTEtMS0w_1b4d2f2c-71d7-4f77-9444-1f19e1b4fd5e"
      unitRef="shares">22000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i98d0d3136b6e4534bd099c082763c527_D20200329-20200627"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMy01LTEtMS0w_c4341b58-4add-4507-85ca-4db07787e2a1"
      unitRef="usd">2144000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i07f570d9a0854ee48af28be5af08a344_D20200329-20200627"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMy0xMS0xLTEtMA_290f6873-c9c4-4299-9b46-0869dcbe2751"
      unitRef="usd">2144000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="if6dd2f02aa774a31a839f57971d93f2e_D20200329-20200627"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfNC0xLTEtMS0w_2d248aab-24ef-4723-a2e7-5b79ae7ec55d"
      unitRef="shares">28000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="if6dd2f02aa774a31a839f57971d93f2e_D20200329-20200627"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfNC0zLTEtMS0w_83bf192d-d900-4db6-9b03-357fe01a64f0"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i98d0d3136b6e4534bd099c082763c527_D20200329-20200627"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfNC01LTEtMS0w_0af101d0-a6e5-41f8-9bca-1ac7eef91c5a"
      unitRef="usd">1192000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i07f570d9a0854ee48af28be5af08a344_D20200329-20200627"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfNC0xMS0xLTEtMA_649fce95-5664-4531-9380-9612fd45ea4d"
      unitRef="usd">1193000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="if6dd2f02aa774a31a839f57971d93f2e_D20200329-20200627"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfNi0xLTEtMS0w_a1020844-4e6a-4e3b-bd59-86a138e94e15"
      unitRef="shares">298000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="if6dd2f02aa774a31a839f57971d93f2e_D20200329-20200627"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfNi0zLTEtMS0w_c39b8fd4-3f2e-4474-a6a2-749e38367977"
      unitRef="usd">3000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i98d0d3136b6e4534bd099c082763c527_D20200329-20200627"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfNi01LTEtMS0w_3466ab2e-770c-41cd-9a91-950bb1f15d80"
      unitRef="usd">-3000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i07f570d9a0854ee48af28be5af08a344_D20200329-20200627"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfNi0xMS0xLTEtMA_d9397bd2-90f8-4567-8afb-aaa1744a586c"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i98d0d3136b6e4534bd099c082763c527_D20200329-20200627"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfNy01LTEtMS0w_e6da5b1a-a93e-456d-b12b-0acca995214c"
      unitRef="usd">6167000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i07f570d9a0854ee48af28be5af08a344_D20200329-20200627"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfNy0xMS0xLTEtMA_7833b740-48d9-4f4c-aba0-def7d965e65c"
      unitRef="usd">6167000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="i07cbfd44a12f4311afb21d55a472de13_D20200329-20200627"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfOS03LTEtMS0w_b67c4fb7-2131-49fb-9269-e1631a354c79"
      unitRef="usd">10527000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i07f570d9a0854ee48af28be5af08a344_D20200329-20200627"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfOS0xMS0xLTEtMA_dc120ebd-3584-423d-9cb7-ce31d10e6440"
      unitRef="usd">10527000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3694a6c7d953431dbcadb946b1f414c2_D20200329-20200627"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMTAtOS0xLTEtMA_b5383c9f-b31c-4279-9640-380bbbf0e609"
      unitRef="usd">1429000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i07f570d9a0854ee48af28be5af08a344_D20200329-20200627"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMTAtMTEtMS0xLTA_61e2cbd1-e91c-4fba-9720-4f139ea6c25a"
      unitRef="usd">1429000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:SharesIssued
      contextRef="i1e7c8087bac9435c9d82d1fedfbff52e_I20200627"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMTEtMS0xLTEtMA_494cd577-b0f2-429a-856a-1cef1ba9b6d0"
      unitRef="shares">50671000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i1e7c8087bac9435c9d82d1fedfbff52e_I20200627"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMTEtMy0xLTEtMA_aa379bd3-1782-418e-9352-7e1bae7014fd"
      unitRef="usd">507000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i31fa2bd3032a476cb1c1b205b1125b8d_I20200627"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMTEtNS0xLTEtMA_c5d2c624-602a-4e0a-88a7-23d1c92833b4"
      unitRef="usd">562729000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id2fb46a5a8af4e3188ae02ca82d7f05e_I20200627"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMTEtNy0xLTEtMA_c991bb12-10ed-4104-a70d-acae6e3e54fa"
      unitRef="usd">89039000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i371aab8c0d604c439b36e469dfeb7ae1_I20200627"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMTEtOS0xLTEtMA_1c058690-5c7f-4ae2-adcb-fc3f90922ab1"
      unitRef="usd">-43706000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8de24c4e5ca9457ba67c9faa95840867_I20200627"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMTEtMTEtMS0xLTA_58cc8c77-31df-4118-b649-a91343b3434b"
      unitRef="usd">608569000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="idb62b5f06b724ac49c887e404027a4ab_D20200628-20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMTMtMS0xLTEtMA_c7b56afc-3b4d-4350-a1e0-b82e3ca85833"
      unitRef="shares">2000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="idb62b5f06b724ac49c887e404027a4ab_D20200628-20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMTMtMy0xLTEtMA_5a2d8c16-8e8b-47df-9e58-0612f9a2f949"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i4c87b6d14b0e4daf97ae63c97329dc5f_D20200628-20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMTMtNS0xLTEtMA_1994910c-8a17-454d-8735-024b51cb2495"
      unitRef="usd">67000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i53c39140b1904bbe8f3f81c2a2ec9a42_D20200628-20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMTMtMTEtMS0xLTA_0b988ffa-74ab-4f98-bcb0-0af339491919"
      unitRef="usd">67000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="idb62b5f06b724ac49c887e404027a4ab_D20200628-20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMTUtMS0xLTEtMA_b63f893f-6aff-4c32-98c0-9c92dfafcb5e"
      unitRef="shares">30000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="idb62b5f06b724ac49c887e404027a4ab_D20200628-20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMTUtMy0xLTEtMA_6287f876-5047-4b94-9d05-47859972192a"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i4c87b6d14b0e4daf97ae63c97329dc5f_D20200628-20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMTUtNS0xLTEtMA_c03fc04c-9db6-4118-aec2-7ea27392a8ee"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i53c39140b1904bbe8f3f81c2a2ec9a42_D20200628-20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMTUtMTEtMS0xLTA_e93f586b-99e5-4a92-af68-23a7b3da4bb1"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i4c87b6d14b0e4daf97ae63c97329dc5f_D20200628-20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMTYtNS0xLTEtMA_aa326b81-f58c-458b-ad38-82744ca20dd6"
      unitRef="usd">5952000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i53c39140b1904bbe8f3f81c2a2ec9a42_D20200628-20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMTYtMTEtMS0xLTA_8d7fa5b8-227a-487c-a92f-27e2dd4fd2ee"
      unitRef="usd">5952000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="i3cade1e4d1894ebcbacdb9ac1d8529d3_D20200628-20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMTgtNy0xLTEtMA_632dfafd-f7aa-4256-8c4a-025250a0fb7e"
      unitRef="usd">48101000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i53c39140b1904bbe8f3f81c2a2ec9a42_D20200628-20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMTgtMTEtMS0xLTA_763bb87f-bbdb-4dce-92db-c229e5275849"
      unitRef="usd">48101000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib49fa4ce64654900825a35f23c5fe8a0_D20200628-20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMTktOS0xLTEtMA_7f2638c8-5220-4507-b303-d6b7ae4bb1a1"
      unitRef="usd">5234000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i53c39140b1904bbe8f3f81c2a2ec9a42_D20200628-20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMTktMTEtMS0xLTA_b8a38552-ecb3-4a56-bc32-41340b3e7c49"
      unitRef="usd">5234000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:SharesIssued
      contextRef="i3b695da1c7ae4c91ad9625021564f186_I20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMjAtMS0xLTEtMA_12ac0380-f3c0-41fc-b8ad-03d6370e91e2"
      unitRef="shares">50703000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i3b695da1c7ae4c91ad9625021564f186_I20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMjAtMy0xLTEtMA_b73389bd-ccf5-4d87-b326-9c1de20118d5"
      unitRef="usd">507000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i11d7a90961554152b7611178522b5b4b_I20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMjAtNS0xLTEtMA_f150b144-afc4-40fa-a64c-f8428135540f"
      unitRef="usd">568748000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i86938e4e5827482b8bb6a25573904ac1_I20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMjAtNy0xLTEtMA_f0767903-7105-47a6-b7a5-13a5aa6990ec"
      unitRef="usd">137140000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0809a2c180d446f385e5eb23f3c7098a_I20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMjAtOS0xLTEtMA_aa27868f-dfa4-424b-991c-98a72686566c"
      unitRef="usd">-38472000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i32fa3388584544f9a03ffc1d8057d360_I20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMjAtMTEtMS0xLTA_3831feea-743e-44c8-9586-db1229f34ee4"
      unitRef="usd">667923000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i3b2f8ac7c8044d99a51a1c40cfc06202_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMjEtMS0xLTEtMA_c0cbd132-add0-470f-b5d9-8cb3cc8580df"
      unitRef="shares">22000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i3b2f8ac7c8044d99a51a1c40cfc06202_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMjEtMy0xLTEtMA_a47d8968-860d-4a78-b543-31c589b9308c"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i7bb87bf0127e4aafa52d782d9e0aa0ee_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMjEtNS0xLTEtMA_013178a7-528c-4e77-8e56-7d0adad64b30"
      unitRef="usd">1868000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMjEtMTEtMS0xLTA_55dcb42a-a302-46ac-952a-f052ee887ba7"
      unitRef="usd">1868000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i3b2f8ac7c8044d99a51a1c40cfc06202_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMjItMS0xLTEtMA_7458aefe-e18f-4081-b432-74943e41741e"
      unitRef="shares">50000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i7bb87bf0127e4aafa52d782d9e0aa0ee_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMjItNS0xLTEtMA_94c8f7d1-2e52-4620-b0f7-5b95d26001de"
      unitRef="usd">2578000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMjItMTEtMS0xLTA_acf48c02-430a-4c13-ae86-26c4e90d7116"
      unitRef="usd">2578000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="i3b2f8ac7c8044d99a51a1c40cfc06202_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMjQtMS0xLTEtMA_d2dd6f88-7559-42cc-96a4-fc5364ef27e6"
      unitRef="shares">42000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i3b2f8ac7c8044d99a51a1c40cfc06202_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMjQtMy0xLTEtMA_d647bca3-7929-4f52-b856-7cc07e75ba71"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i7bb87bf0127e4aafa52d782d9e0aa0ee_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMjQtNS0xLTEtMA_d850a237-e20b-4af8-9acf-380665be7049"
      unitRef="usd">-1000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMjQtMTEtMS0xLTA_05e62502-07e3-4a18-852e-3a2bbf5cdd9e"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i7bb87bf0127e4aafa52d782d9e0aa0ee_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMjUtNS0xLTEtMA_25694dcb-73b0-4e70-8b62-23028da654fa"
      unitRef="usd">6287000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMjUtMTEtMS0xLTA_6fd287dd-af0b-4a6a-9305-2099ca61664b"
      unitRef="usd">6287000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="i593e5b9ceb9240d1888435f827c761eb_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMjctNy0xLTEtMA_e68609d9-a6d0-499d-bec8-8ea622e75f8c"
      unitRef="usd">31882000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMjctMTEtMS0xLTA_d62e9233-5514-46dc-8c05-27f96c5c751f"
      unitRef="usd">31882000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i00bd6a8c6c87470d94b98154b4ed663c_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMjgtOS0xLTEtMA_bfc1a22b-4451-4e1b-9b17-97c3a6accad8"
      unitRef="usd">8614000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMjgtMTEtMS0xLTA_d4e4b7b2-05ba-497e-b456-9fd232724968"
      unitRef="usd">8614000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:SharesIssued
      contextRef="ifb893eb36e724d78b750bf760d6e530a_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMjktMS0xLTEtMA_0475f0b9-7ac3-45fd-aa7b-ae87256496aa"
      unitRef="shares">50817000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ifb893eb36e724d78b750bf760d6e530a_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMjktMy0xLTEtMA_79550a8f-4bf7-4fe9-be14-79dabe468c1f"
      unitRef="usd">508000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib0c3ea92ba584163a7dfa754dd67152c_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMjktNS0xLTEtMA_fa49d5f1-9f9e-4615-a47e-caa4a532fdbe"
      unitRef="usd">579480000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4bfeea1c445b4bbfac0cf8cc2616054f_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMjktNy0xLTEtMA_7173e1c3-1a8e-4919-af30-74b0fb0b7ee2"
      unitRef="usd">169022000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0dd7da6b8cfa47a1852a89e52d0d489d_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMjktOS0xLTEtMA_bb734b77-d961-474e-966d-b76fff2b255c"
      unitRef="usd">-29858000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjZiYWNjMDU2MGFlMDQ1Mjk4NDgwZjJiNTJmY2U5OTRjL3RhYmxlcmFuZ2U6NmJhY2MwNTYwYWUwNDUyOTg0ODBmMmI1MmZjZTk5NGNfMjktMTEtMS0xLTA_2720518e-908c-4941-8b1f-1c2fd4fa0358"
      unitRef="usd">719152000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="i13923cc91bcd4918b0cd47b138b0c826_I20190330"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMi0xLTEtMS0w_281c4b1d-d614-4be2-b0d4-e890f31eb33b"
      unitRef="shares">51020000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i13923cc91bcd4918b0cd47b138b0c826_I20190330"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMi0zLTEtMS0w_1a5322a0-8048-4429-b716-bfb42ec9cbbf"
      unitRef="usd">510000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id87d83aa2a9a48168fe6363c8adf8a60_I20190330"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMi01LTEtMS0w_3ef0604d-6d2d-4fe6-91f9-9494a39972e4"
      unitRef="usd">536320000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie49c0793891c4f9b9446cafe5a44063b_I20190330"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMi03LTEtMS0w_01b599a3-292c-457f-a870-5a1041d4a470"
      unitRef="usd">161418000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4294e77e77b744d1a79deeae24bc95c9_I20190330"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMi05LTEtMS0w_542318d3-41ee-43a2-b050-83436c660536"
      unitRef="usd">-30380000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ief541fbd0adf409c9514798c114d14d4_I20190330"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMi0xMS0xLTEtMA_fa8f63cd-9608-4d30-99d7-17a001e7274b"
      unitRef="usd">667868000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i79fce91b6c7e4ee895ae77d545ae7cac_D20190331-20190629"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMy0xLTEtMS0w_0d1748cd-ccb9-49ad-b11f-280cc557e038"
      unitRef="shares">25000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i79fce91b6c7e4ee895ae77d545ae7cac_D20190331-20190629"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMy0zLTEtMS0w_b3ec2fa1-eea1-41d4-a81a-c0a69de66328"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="iab444088a1f343aab3754df7e9900053_D20190331-20190629"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMy01LTEtMS0w_56795e53-66ec-4287-bcf2-a91f46d0816c"
      unitRef="usd">1830000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i58aa4c71425b490eabe0528109268325_D20190331-20190629"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMy0xMS0xLTEtMA_adbcf5b1-b188-4f8a-8762-f06a9fc7ec5e"
      unitRef="usd">1830000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i79fce91b6c7e4ee895ae77d545ae7cac_D20190331-20190629"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfNC0xLTEtMS0w_6980a306-7b2d-46a1-944a-96dd52bd7455"
      unitRef="shares">85000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i79fce91b6c7e4ee895ae77d545ae7cac_D20190331-20190629"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfNC0zLTEtMS0w_e5dd5c2d-5a74-4e04-a3bb-9a9cd55e1568"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="iab444088a1f343aab3754df7e9900053_D20190331-20190629"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfNC01LTEtMS0w_a8186030-3774-4bfb-8eaa-24e9564b97b1"
      unitRef="usd">3634000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i58aa4c71425b490eabe0528109268325_D20190331-20190629"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfNC0xMS0xLTEtMA_6174d377-e7ac-4a20-b2ca-0940e73701ca"
      unitRef="usd">3635000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i79fce91b6c7e4ee895ae77d545ae7cac_D20190331-20190629"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfNS0xLTEtMS0w_270fcc8a-b8cd-4d61-b46f-a3e8d0091f5e"
      unitRef="shares">616000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i79fce91b6c7e4ee895ae77d545ae7cac_D20190331-20190629"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfNS0zLTEtMS0w_24787e61-edf6-420e-89d7-b5c5f1fb2093"
      unitRef="usd">6000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="iab444088a1f343aab3754df7e9900053_D20190331-20190629"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfNS01LTEtMS0w_325128fc-7b31-40ac-a900-a58b4d2b66c0"
      unitRef="usd">21473000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i856b92cb87d749768e7bc9dd5dd377bb_D20190331-20190629"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfNS03LTEtMS0w_691a71ed-0911-47f0-a394-67c1f629f7f3"
      unitRef="usd">53521000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i58aa4c71425b490eabe0528109268325_D20190331-20190629"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfNS0xMS0xLTEtMA_db2dd110-621d-4ba0-a614-5e45d243f3d3"
      unitRef="usd">75000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="i79fce91b6c7e4ee895ae77d545ae7cac_D20190331-20190629"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfNi0xLTEtMS0w_7ea6cde7-64dc-4094-bfd2-ce9c706f3137"
      unitRef="shares">257000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i79fce91b6c7e4ee895ae77d545ae7cac_D20190331-20190629"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfNi0zLTEtMS0w_c2aa9e8c-42ce-4110-8bc7-e40cbd1c7293"
      unitRef="usd">3000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="iab444088a1f343aab3754df7e9900053_D20190331-20190629"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfNi01LTEtMS0w_cc491aa0-e5c7-46d1-a1f9-82ffaff4bdc7"
      unitRef="usd">-3000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i58aa4c71425b490eabe0528109268325_D20190331-20190629"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfNi0xMS0xLTEtMA_1a253b36-da38-4e95-90b4-dc28bfb6ff6a"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="iab444088a1f343aab3754df7e9900053_D20190331-20190629"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfNy01LTEtMS0w_c88f2c98-4304-42dc-9fa1-5cb41cf4afc6"
      unitRef="usd">4730000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i58aa4c71425b490eabe0528109268325_D20190331-20190629"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfNy0xMS0xLTEtMA_131ef81e-6a2c-4f49-9830-c6dd51fd6e7e"
      unitRef="usd">4730000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="i856b92cb87d749768e7bc9dd5dd377bb_D20190331-20190629"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfOS03LTEtMS0w_aff7eaa3-1714-465f-900e-2d3ca6673775"
      unitRef="usd">-8479000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i58aa4c71425b490eabe0528109268325_D20190331-20190629"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfOS0xMS0xLTEtMA_4e7ac715-1c75-40f1-a6dd-2292daa24cbc"
      unitRef="usd">-8479000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ifeab2898c30e44abac79ea28e3a13d7b_D20190331-20190629"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMTAtOS0xLTEtMA_b3ab27f8-943f-4208-b6b2-c1e661c14bc2"
      unitRef="usd">-3618000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i58aa4c71425b490eabe0528109268325_D20190331-20190629"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMTAtMTEtMS0xLTA_2bc4f5bc-96a9-4e96-8154-d42e22877777"
      unitRef="usd">-3618000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:SharesIssued
      contextRef="i44d85e61a03348ac976af3cd59985a40_I20190629"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMTEtMS0xLTEtMA_d5fe4d39-b263-4b05-86b0-7d9c7049c12d"
      unitRef="shares">50771000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i44d85e61a03348ac976af3cd59985a40_I20190629"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMTEtMy0xLTEtMA_7f988a7d-222b-4db5-a907-14ea4e007cea"
      unitRef="usd">508000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i977ae884714349048379a8f918f47155_I20190629"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMTEtNS0xLTEtMA_80140d3d-287a-4a52-9e75-2ac28eb53892"
      unitRef="usd">525038000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i28e2deb2f39545f994371185aa291fd9_I20190629"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMTEtNy0xLTEtMA_00e1a474-86ec-4e0a-8f92-b0a00082e759"
      unitRef="usd">99418000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifcc6781b9c184013b3ebcc9dd2da2e75_I20190629"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMTEtOS0xLTEtMA_0e54b0cc-b2b3-430c-b944-2c31afe8b9e4"
      unitRef="usd">-33998000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib446da48c08e4f9e9211152ee5dc9758_I20190629"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMTEtMTEtMS0xLTA_b90a03fb-4edc-429f-a3ff-f87dca90cb83"
      unitRef="usd">590966000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ic3be29de096b43b59d76094a1a86ec73_D20190630-20190928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMTMtMS0xLTEtMA_c0f41520-422a-4dcf-8322-cf02346cad7b"
      unitRef="shares">64000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ic3be29de096b43b59d76094a1a86ec73_D20190630-20190928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMTMtMy0xLTEtMA_edf3ca28-5bfa-492f-84c3-655585a7feee"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i6b7a68038f8b43a9ad82e2d31b79cdad_D20190630-20190928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMTMtNS0xLTEtMA_b705cd7d-8828-415e-8e85-05cf97762aa8"
      unitRef="usd">2409000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i11e5dd1a63a349b98dfe50b20ed69371_D20190630-20190928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMTMtMTEtMS0xLTA_30527515-7364-4ff6-b72a-8086aa3b0dfe"
      unitRef="usd">2410000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="ic3be29de096b43b59d76094a1a86ec73_D20190630-20190928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMTQtMS0xLTEtMA_4c8001e7-4800-48a2-912a-23211ac1221f"
      unitRef="shares">360000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ic3be29de096b43b59d76094a1a86ec73_D20190630-20190928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMTQtMy0xLTEtMA_fd3777a8-affc-4e7f-9e54-3cc5ad46ae5b"
      unitRef="usd">4000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i6b7a68038f8b43a9ad82e2d31b79cdad_D20190630-20190928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMTQtNS0xLTEtMA_33dd4017-1474-496e-9220-0e8e17288491"
      unitRef="usd">-1274000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="id4718bcfebbe44fb8dd41c9d91c87ba9_D20190630-20190928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMTQtNy0xLTEtMA_9d42c8c7-3fa2-4ea5-a59a-93f378b81812"
      unitRef="usd">51270000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i11e5dd1a63a349b98dfe50b20ed69371_D20190630-20190928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMTQtMTEtMS0xLTA_893e0892-f2b9-4a0a-8adf-1b243f567e96"
      unitRef="usd">50000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="ic3be29de096b43b59d76094a1a86ec73_D20190630-20190928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMTUtMS0xLTEtMA_ca03bf64-be9b-40a9-8aff-68b6b480ab24"
      unitRef="shares">133000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="ic3be29de096b43b59d76094a1a86ec73_D20190630-20190928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMTUtMy0xLTEtMA_3501ee28-6a85-48e1-a1f0-4301dd787271"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i6b7a68038f8b43a9ad82e2d31b79cdad_D20190630-20190928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMTUtNS0xLTEtMA_6c9a70b3-332d-49cf-9b70-d92af561fa8e"
      unitRef="usd">-1000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i11e5dd1a63a349b98dfe50b20ed69371_D20190630-20190928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMTUtMTEtMS0xLTA_b8439e34-9b03-4503-8faa-56924d3a9eed"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i6b7a68038f8b43a9ad82e2d31b79cdad_D20190630-20190928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMTYtNS0xLTEtMA_4f1c30e7-6728-4392-8e50-0fd4bfa0ba2c"
      unitRef="usd">5000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i11e5dd1a63a349b98dfe50b20ed69371_D20190630-20190928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMTYtMTEtMS0xLTA_3f9e94d7-7de4-48fe-91a6-c2a2bd55383f"
      unitRef="usd">5000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="id4718bcfebbe44fb8dd41c9d91c87ba9_D20190630-20190928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMTgtNy0xLTEtMA_04a47dd2-2e4e-4068-a2de-7eac18fc09cd"
      unitRef="usd">37486000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i11e5dd1a63a349b98dfe50b20ed69371_D20190630-20190928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMTgtMTEtMS0xLTA_bac408d8-13d4-468a-bb5e-d602afe9da59"
      unitRef="usd">37486000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6a8dccbf5b0e46dd9089c29ee8278a27_D20190630-20190928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMTktOS0xLTEtMA_8d51b5a3-2b81-4362-a369-6839bd251e86"
      unitRef="usd">-2108000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i11e5dd1a63a349b98dfe50b20ed69371_D20190630-20190928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMTktMTEtMS0xLTA_6a7f88d5-5c2b-44ee-9a1d-4d4055876305"
      unitRef="usd">-2108000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:SharesIssued
      contextRef="ie63b3633289a4dc68fd18c6df9378c99_I20190928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjAtMS0xLTEtMA_563a853c-a872-472b-b0dc-188453b414e8"
      unitRef="shares">50608000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ie63b3633289a4dc68fd18c6df9378c99_I20190928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjAtMy0xLTEtMA_20771231-ca3a-4e82-9ca0-10088d4f6fd5"
      unitRef="usd">506000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if08c7a9f75a04b27aee3f352a3ac162a_I20190928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjAtNS0xLTEtMA_39400e70-c2ee-4bd8-82e7-479ef4a96529"
      unitRef="usd">533720000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i960c732942cc46598e20801270314713_I20190928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjAtNy0xLTEtMA_d090b9dc-0e1d-41be-af8a-d8b11873cc79"
      unitRef="usd">85634000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5f49655e125c49c2893f2cfe850a84c4_I20190928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjAtOS0xLTEtMA_e73b87e8-6a70-4a5a-aa75-8591922bca48"
      unitRef="usd">-36106000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if62547d494fe448f98e6b8c907702474_I20190928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjAtMTEtMS0xLTA_29e1e659-129d-466e-bd58-2ee990562bc7"
      unitRef="usd">583754000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="ib8048eb98c0f42aeb56fecb8379edd69_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjEtMS0xLTEtMA_24c4e56e-1c72-483a-a1cb-bb5988d49cd6"
      unitRef="shares">20000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ib8048eb98c0f42aeb56fecb8379edd69_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjEtMy0xLTEtMA_76bc7407-1889-4689-93b0-44db3c7a2606"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ib55ff0c99eb34464a7e8eda801ade4ca_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjEtNS0xLTEtMA_55a74a76-d65f-4c8e-84a1-70f1e22f7a70"
      unitRef="usd">1537000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjEtMTEtMS0xLTA_4a9fedff-7663-473b-8f3f-11da52059bd4"
      unitRef="usd">1538000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ib8048eb98c0f42aeb56fecb8379edd69_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjItMS0xLTEtMA_cb8c5f68-72c2-475c-b0b9-0541990f2048"
      unitRef="shares">60000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ib8048eb98c0f42aeb56fecb8379edd69_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjItMy0xLTEtMA_b5b2c1cb-707c-49f8-ae2c-b44face9efcf"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ib55ff0c99eb34464a7e8eda801ade4ca_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjItNS0xLTEtMA_2363e628-c07c-46ef-b95c-80353ad0bd56"
      unitRef="usd">1667000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjItMTEtMS0xLTA_6b10a032-8c61-462e-9555-2eb7423b7b4b"
      unitRef="usd">1667000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="ib8048eb98c0f42aeb56fecb8379edd69_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjMtMS0xLTEtMA_4bd45463-1985-49b5-afc6-18a2bc629472"
      unitRef="shares">411000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ib8048eb98c0f42aeb56fecb8379edd69_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjMtMy0xLTEtMA_6410e662-41d8-478a-a633-c3ce32d5a383"
      unitRef="usd">4000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ib55ff0c99eb34464a7e8eda801ade4ca_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjMtNS0xLTEtMA_8aad431f-b77b-447b-a98e-b88e44e5da54"
      unitRef="usd">4335000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i32d0e40ce5a64e91b5d91a3c4c9fa8ad_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjMtNy0xLTEtMA_ab12340f-afb5-494c-9aa8-a45da803a742"
      unitRef="usd">45661000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjMtMTEtMS0xLTA_ec944232-f3e8-4673-b719-6daa64af6d0e"
      unitRef="usd">50000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="ib8048eb98c0f42aeb56fecb8379edd69_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjQtMS0xLTEtMA_8f99078d-a642-4ee2-9aeb-3ab0bda96c71"
      unitRef="shares">114000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="ib8048eb98c0f42aeb56fecb8379edd69_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjQtMy0xLTEtMA_b0daf32b-8523-4d2a-902e-0197352902f0"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="ib55ff0c99eb34464a7e8eda801ade4ca_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjQtNS0xLTEtMA_29696537-2998-4e1b-b8fb-976d04d3cee8"
      unitRef="usd">-1000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjQtMTEtMS0xLTA_5b3ff0cc-2d92-4456-8dd2-d1bd4946b5cf"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ib55ff0c99eb34464a7e8eda801ade4ca_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjUtNS0xLTEtMA_c83bb1bd-204e-44f7-833a-489792430c28"
      unitRef="usd">5325000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjUtMTEtMS0xLTA_d96a071c-a508-4266-9ea1-11bfa2c223d8"
      unitRef="usd">5325000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="i32d0e40ce5a64e91b5d91a3c4c9fa8ad_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjctNy0xLTEtMA_2b412bf1-f84a-47a5-b9da-b95761e7373a"
      unitRef="usd">29895000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjctMTEtMS0xLTA_9ee28fc2-9869-4224-915a-3de013daa712"
      unitRef="usd">29895000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i357f065f29714ef2a554cacc02892fb9_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjgtOS0xLTEtMA_4effa0c1-670d-4438-8404-550fb30d5d38"
      unitRef="usd">2401000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjgtMTEtMS0xLTA_14e8041c-8d66-409a-8a2d-f403f41a38a2"
      unitRef="usd">2401000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:SharesIssued
      contextRef="i2f2c9eca9e304ad9b69f801a97fc5dd6_I20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjktMS0xLTEtMA_7770373a-461e-45b0-a1eb-a5e151786133"
      unitRef="shares">50391000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i2f2c9eca9e304ad9b69f801a97fc5dd6_I20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjktMy0xLTEtMA_bebdfb95-5852-4771-bccc-9318a395ff0c"
      unitRef="usd">504000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="icb4f07ff3cbf4479a1d29d55b7330f7a_I20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjktNS0xLTEtMA_cccde9e7-3a6a-4936-9bf8-d7f847a2fb1b"
      unitRef="usd">537913000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6c64ccfff7864e46907e03a928ba5c42_I20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjktNy0xLTEtMA_be5949c0-186f-4e67-847c-2cf0fb2a7655"
      unitRef="usd">69868000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i591c8e13af6e49d391c4c0e273d6a551_I20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjktOS0xLTEtMA_17c7c883-919c-4705-a557-9f7acdfea32e"
      unitRef="usd">-33705000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic35a4df7f44a40e5a674e72ae5bf6205_I20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yNS9mcmFnOjE1ZjI2M2QxMDg2OTQ2MWFiN2RjYWYwNjdiZGE2MDFhL3RhYmxlOjBiNGMyYjM0OTExYTQwNjliNWJjZjdhZTc4OGU3ZDdlL3RhYmxlcmFuZ2U6MGI0YzJiMzQ5MTFhNDA2OWI1YmNmN2FlNzg4ZTdkN2VfMjktMTEtMS0xLTA_f68fca80-da0d-4da2-a706-dd0b1b752c1d"
      unitRef="usd">574580000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMy0xLTEtMS0w_f14be7c7-9723-45dd-8a92-bd00bc5b28a2"
      unitRef="usd">90510000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMy0zLTEtMS0w_8d01ec91-451e-40d9-9b79-f8af80f85c44"
      unitRef="usd">58902000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationAndAmortization
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfNi0xLTEtMS0w_64d2a936-5874-4a5d-b24d-503db3e8169f"
      unitRef="usd">62377000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfNi0zLTEtMS0w_53705387-433c-4f37-9127-8b81fbfb751e"
      unitRef="usd">81524000</us-gaap:DepreciationAndAmortization>
    <us-gaap:AssetImpairmentCharges
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfNy0xLTEtMS0w_c7a58b94-0041-4bd8-a793-5dc58d40d488"
      unitRef="usd">1028000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfNy0zLTEtMS0w_098edfcb-7b21-4614-9039-9068480f6c25"
      unitRef="usd">50597000</us-gaap:AssetImpairmentCharges>
    <us-gaap:ShareBasedCompensation
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfOC0xLTEtMS0w_583a493e-2137-4648-b6b1-d45807128d98"
      unitRef="usd">18406000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfOC0zLTEtMS0w_ffed898b-0bb2-472c-aefb-e7e72f45b106"
      unitRef="usd">15055000</us-gaap:ShareBasedCompensation>
    <us-gaap:DeferredOtherTaxExpenseBenefit
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfOS0xLTEtMS0w_a19e59bb-26ba-4fbf-8fa5-70e25b751cf5"
      unitRef="usd">-3953000</us-gaap:DeferredOtherTaxExpenseBenefit>
    <us-gaap:DeferredOtherTaxExpenseBenefit
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfOS0zLTEtMS0w_c758dea7-d2aa-4767-9fd0-46e2a4e7f6b4"
      unitRef="usd">-4747000</us-gaap:DeferredOtherTaxExpenseBenefit>
    <us-gaap:ProvisionForLoanLeaseAndOtherLosses
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMTAtMS0xLTEtMA_a65bd315-c488-4609-9205-8c6dd0a749b9"
      unitRef="usd">2942000</us-gaap:ProvisionForLoanLeaseAndOtherLosses>
    <us-gaap:ProvisionForLoanLeaseAndOtherLosses
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMTAtMy0xLTEtMA_37dd0a28-770e-42c1-95f8-5cb88aeeaace"
      unitRef="usd">-2246000</us-gaap:ProvisionForLoanLeaseAndOtherLosses>
    <hae:GainLossOnDivestitureAndSaleOfAssets
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMTEtMS0xLTEtMA_c24703f1-e599-44d7-b6aa-947d0eaf5f30"
      unitRef="usd">32613000</hae:GainLossOnDivestitureAndSaleOfAssets>
    <hae:GainLossOnDivestitureAndSaleOfAssets
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMTEtMy0xLTEtMA_45dbbe0f-a231-4d47-82f6-6f91388e45cb"
      unitRef="usd">8083000</hae:GainLossOnDivestitureAndSaleOfAssets>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMTItMS0xLTEtMA_8d19500a-49a8-4dd3-b24b-cf1bcdc90f8a"
      unitRef="usd">1351000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMTItMy0xLTEtMA_11daadce-cd40-4b14-8a96-2209113b3c1b"
      unitRef="usd">1945000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMTQtMS0xLTEtMA_79bd87d8-a29e-4fc6-8353-ca69f14e79ce"
      unitRef="usd">-18588000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMTQtMy0xLTEtMA_e3ffc046-ec8c-4413-b2a1-15fca22cd0a9"
      unitRef="usd">-13807000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMTUtMS0xLTEtMA_65707846-d274-4a04-b365-70a08ce4d200"
      unitRef="usd">33728000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMTUtMy0xLTEtMA_70243606-4590-45e8-98c2-e424dc03f827"
      unitRef="usd">68251000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidTaxes
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMTYtMS0xLTEtMA_74890265-2ea4-4cd8-8b5a-e1bd2b5bc581"
      unitRef="usd">-1181000</us-gaap:IncreaseDecreaseInPrepaidTaxes>
    <us-gaap:IncreaseDecreaseInPrepaidTaxes
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMTYtMy0xLTEtMA_0a16b3ae-80a5-4c13-bcb1-039d2a13bab5"
      unitRef="usd">273000</us-gaap:IncreaseDecreaseInPrepaidTaxes>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMTctMS0xLTEtMA_4dff906d-0f46-4059-83f8-5b88878cf1d4"
      unitRef="usd">-2687000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMTctMy0xLTEtMA_1e458039-301a-49b8-abff-b0914f33a86e"
      unitRef="usd">8829000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMTgtMS0xLTEtMA_cb65dbee-6855-450c-a914-dae65723902e"
      unitRef="usd">-21518000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMTgtMy0xLTEtMA_fbfd36de-b4fd-424f-b5d6-e181a98db96c"
      unitRef="usd">-17590000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMTktMS0xLTEtMA_7878335a-000e-4117-90b1-c0727cd97a7c"
      unitRef="usd">107258000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMTktMy0xLTEtMA_eb0e2244-7c24-441e-ba38-5018a2a0bd8b"
      unitRef="usd">111811000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMjEtMS0xLTEtMA_c0346216-0ad1-4efd-bf40-77368ab9fce1"
      unitRef="usd">25408000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMjEtMy0xLTEtMA_a3bf0c35-7e29-4225-b33b-281c2df59a21"
      unitRef="usd">38112000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMjItMS0xLTEtMA_41f6ba09-45dd-4316-bf8e-cb12823dbf8e"
      unitRef="usd">16606000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMjItMy0xLTEtMA_f086916f-a89b-4123-ac0f-5b518581928b"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMjMtMS0xLTEtMA_1324fdf8-34de-4250-9b8b-39e2ee9e952c"
      unitRef="usd">44587000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMjMtMy0xLTEtMA_96ab9062-3a3d-47e6-b66a-67c6a6297cf2"
      unitRef="usd">9808000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMjQtMS0xLTEtMA_7a78e459-5d94-42bc-8d82-e365c48844d0"
      unitRef="usd">1085000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMjQtMy0xLTEtMA_bd4c676d-dfac-41ad-a081-84c288cf7527"
      unitRef="usd">16263000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMjUtMS0xLTEtMA_1df169bc-855a-4462-8e4e-e74ebe491f74"
      unitRef="usd">3658000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMjUtMy0xLTEtMA_41a1ede4-daf5-4b07-966d-805790331547"
      unitRef="usd">-12041000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMjctMS0xLTEtMA_cef00816-7cfb-4add-9500-de36a59ea319"
      unitRef="usd">-60000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMjctMy0xLTEtMA_1ffc49b9-0fc2-4a26-9b9f-017a58ddb544"
      unitRef="usd">30000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMjgtMS0xLTEtMA_9415b342-d5f6-4a3a-8967-f6ddb4a6660a"
      unitRef="usd">13125000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMjgtMy0xLTEtMA_14a376a6-a557-4f6d-a5b9-93f3e54bcf8f"
      unitRef="usd">8750000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:PaymentsForRepurchaseOfEquity
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMjktMS0xLTEtMA_184f8bed-0a1d-4d90-8500-23dec01a9c84"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfEquity>
    <us-gaap:PaymentsForRepurchaseOfEquity
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMjktMy0xLTEtMA_25f09f57-ecd6-43c0-9797-948879aa9532"
      unitRef="usd">175000000</us-gaap:PaymentsForRepurchaseOfEquity>
    <us-gaap:EmployeeStockOwnershipPlanESOPCashContributionsToESOP
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMzAtMS0xLTEtMA_a046cfe6-083f-4da4-924b-ebf96f2cc545"
      unitRef="usd">4012000</us-gaap:EmployeeStockOwnershipPlanESOPCashContributionsToESOP>
    <us-gaap:EmployeeStockOwnershipPlanESOPCashContributionsToESOP
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMzAtMy0xLTEtMA_7b81ae51-bfc4-48fc-8dad-f5d730f1e71a"
      unitRef="usd">3368000</us-gaap:EmployeeStockOwnershipPlanESOPCashContributionsToESOP>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMzEtMS0xLTEtMA_780698db-3c3d-45c4-a762-b38838908389"
      unitRef="usd">3838000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMzEtMy0xLTEtMA_c90f1733-6525-4fd3-9386-5bdb369e701b"
      unitRef="usd">7712000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMzItMS0xLTEtMA_a9901bb4-d1f7-41d6-acf3-edd8c89cec6a"
      unitRef="usd">-32000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMzItMy0xLTEtMA_960363d2-e953-4e1e-8730-7c3e2f10f02c"
      unitRef="usd">90000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMzMtMS0xLTEtMA_1ec81d00-a08a-4007-96c9-7b87d554bfb8"
      unitRef="usd">-65307000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMzMtMy0xLTEtMA_d2f156af-05f0-4a15-acc2-ff7e8aaacdfd"
      unitRef="usd">-142580000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMzQtMS0xLTEtMA_e20de9d2-8f1f-454e-a6cf-106fe21cffff"
      unitRef="usd">6082000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMzQtMy0xLTEtMA_9509da19-425a-4155-a3cb-c584d729a378"
      unitRef="usd">-124000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMzUtMS0xLTEtMA_249261c8-3624-4da7-b6c6-cd686d376669"
      unitRef="usd">51691000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMzUtMy0xLTEtMA_0efda6a2-28c0-4fb9-ba95-08d5866e8a9c"
      unitRef="usd">-42934000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMzYtMS0xLTEtMA_266ba266-2462-4d5b-935c-e553b9fe84be"
      unitRef="usd">137311000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ief541fbd0adf409c9514798c114d14d4_I20190330"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMzYtMy0xLTEtMA_47981fba-b997-417a-a440-cd83e818afe1"
      unitRef="usd">169351000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMzctMS0xLTEtMA_2c02341e-4075-4d7b-a511-8c61f1d29cd5"
      unitRef="usd">189002000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ic35a4df7f44a40e5a674e72ae5bf6205_I20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMzctMy0xLTEtMA_f3ac193d-942f-4da8-8e88-fc07ad0a1a89"
      unitRef="usd">126417000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:InterestPaidNet
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMzktMS0xLTEtMA_7efc88c4-7113-4391-b86c-8623fcce0f15"
      unitRef="usd">6070000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfMzktMy0xLTEtMA_06878e47-4bda-49bd-a423-6a6b68e676ce"
      unitRef="usd">10739000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfNDAtMS0xLTEtMA_bdcb0d1c-880d-43e1-b84e-d0bd25a55f77"
      unitRef="usd">5612000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfNDAtMy0xLTEtMA_65357137-900c-4921-952a-848a1e0aec54"
      unitRef="usd">9888000</us-gaap:IncomeTaxesPaidNet>
    <hae:TransfersFromInventoryToFixedAssets
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfNDItMS0xLTEtMA_8d7a86ff-81bd-473e-8111-b605126bd584"
      unitRef="usd">5878000</hae:TransfersFromInventoryToFixedAssets>
    <hae:TransfersFromInventoryToFixedAssets
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8yOC9mcmFnOjFiMjJjZTc3ZTYwODQxY2I4NDE4MzFkYTUyYmQ0YTUzL3RhYmxlOjI0ZjBiMTM2MmYxYTQ2YmRiODI2NjhlODk5YWNiYjFhL3RhYmxlcmFuZ2U6MjRmMGIxMzYyZjFhNDZiZGI4MjY2OGU4OTlhY2JiMWFfNDItMy0xLTEtMA_7b097a66-1415-42fe-a167-1f80be7858d8"
      unitRef="usd">10705000</hae:TransfersFromInventoryToFixedAssets>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8zNC9mcmFnOmIxYTE2MDU0NWZhNjQxNDhhOGUxZDE5ZTIxMGJhYzQ0L3RleHRyZWdpb246YjFhMTYwNTQ1ZmE2NDE0OGE4ZTFkMTllMjEwYmFjNDRfMTg1NQ_f3b16e71-fb1f-448e-b084-5b5ad6da6e6c">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1. BASIS OF PRESENTATION &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited condensed consolidated financial statements of Haemonetics Corporation (&#x201c;Haemonetics&#x201d; or the &#x201c;Company&#x201d;) presented herein have been prepared in accordance with generally accepted accounting principles in the United States of America (&#x201c;U.S. GAAP&#x201d;) for interim financial information and with the instructions to Form 10-Q and Article&#160;10 of Regulation&#160;S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of the Company's management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included. All intercompany transactions have been eliminated. Operating results for the nine months ended December 26, 2020 are not necessarily indicative of the results that may be expected for the full fiscal year ending April&#160;3, 2021 or any other interim period. The Company has assessed its ability to continue as a going concern. As of December&#160;26, 2020, the Company has concluded that substantial doubt about its ability to continue as a going concern does not exist. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and footnotes included in the annual report on Form 10-K for the fiscal year ended March&#160;28, 2020.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers events or transactions that occur after the balance sheet date but prior to the issuance of the financial statements to provide additional evidence relative to certain estimates or to identify matters that require additional disclosure. Refer to Note 4, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisitions&lt;/span&gt; for information pertaining to acquisitions that were signed or closed subsequent to December&#160;26, 2020. There were no other material recognized or unrecognized subsequent events as of or for the three and nine months ended December&#160;26, 2020.</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV8zNy9mcmFnOjk0ODljZjI5ODNjODQyYzk4MWJkYTZiN2Y5ZmYwMTE5L3RleHRyZWdpb246OTQ4OWNmMjk4M2M4NDJjOTgxYmRhNmI3ZjlmZjAxMTlfMTI5NA_f226f96d-2a39-4305-9699-384a5117e2ea">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2. RECENT ACCOUNTING PRONOUNCEMENTS &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Standards Implemented&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Codification (&#x201c;ASC&#x201d;) Update No. 2016-13,&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments &#x2013; Credit Losses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;(Topic 326). ASC Update No. 2016-13 is intended to replace the current incurred loss impairment methodology for financial assets measured at amortized cost with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information, including forecasted information, to develop credit loss estimates. The Company adopted ASC Update No. 2016-13 during the first quarter of fiscal 2021. The adoption did not have a material impact on the Company's unaudited condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASC Update No. 2018-15, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles, Goodwill and Other - Internal-Use Software &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(Subtopic 350-40). The new guidance aligns the accounting implementation costs incurred in a cloud computing arrangement that is a service contract with the accounting for internal-use software licenses. The Company adopted ASC Update No. 2018-15 during the first quarter of fiscal 2021. The adoption did not have a material impact on the Company's unaudited condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RleHRyZWdpb246ZmMwYjM2YjgyNjgzNGVmMThmNTk3M2E4MjcxOGQ0MzFfMzIyNA_00676aa8-0047-4b02-bfdb-bb67bbeb70f9">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;3. RESTRUCTURING &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On an ongoing basis, the Company reviews the global economy, the healthcare industry, and the markets in which it competes to identify opportunities for efficiencies, enhance commercial capabilities, align its resources and offer its customers better solutions. In order to realize these opportunities, the Company undertakes restructuring-type activities to transform its business.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2019, the Board of Directors of the Company approved a new Operational Excellence Program (the &#x201c;2020 Program&#x201d;) and delegated authority to the Company's management to determine the detail of the initiatives that will comprise the program. The 2020 Program is designed to improve operational performance and reduce cost principally in our manufacturing and supply chain operations. The Company estimates that it will incur aggregate charges between $60 million and $70 million in connection with the 2020 Program. These charges, the majority of which will result in cash outlays, including severance and other employee costs, will be incurred as the specific actions required to execute these initiatives are identified and approved and are expected to be substantially completed by the end of fiscal 2023. During the three and nine months ended December 26, 2020, the Company incurred $3.1 million and $11.1 million, respectively, of restructuring and turnaround costs under this program. During the three and nine months ended December 28, 2019, the Company incurred $3.9&#160;million and $6.8 million, respectively, of restructuring and turnaround costs under this program. Total cumulative charges under this program are $22.9 million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal 2018, the Company launched a Complexity Reduction Initiative (the &#x201c;2018 Program&#x201d;), a company-wide restructuring program designed to improve operational performance and reduce cost, freeing up resources to invest in accelerated growth. During the three months ended December 26, 2020, the Company incurred minimal charges of restructuring and turnaround costs under this program. During the nine months ended December 26, 2020, the Company incurred $0.5 million of restructuring and turnaround costs under this program. During the three and nine months ended December 28, 2019, the Company incurred $3.9&#160;million and $6.8&#160;million, respectively, of restructuring and turnaround costs under this program. Total cumulative charges under this program are $58.7 million. The 2018 Program is substantially complete.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity for restructuring reserves related to the 2020 Program and the 2018 Program and prior programs for the nine months ended December 26, 2020, substantially all of which relates to employee severance and other employee costs:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.501%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020 Program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018 Program and Prior Programs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Costs incurred, net of reversals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,546)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(887)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,433)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following presents the restructuring costs by line item within our accompanying unaudited condensed consolidated statements of income and comprehensive income:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 28,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 28,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of goods sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(92)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;26, 2020, the Company had a restructuring liability of $1.1 million, of which $0.7 million is payable within the next twelve months. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to the restructuring costs included in the table above, the Company also incurred costs that do not constitute restructuring under ASC 420, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Exit and Disposal Cost Obligations,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and which the Company instead refers to as turnaround costs. These costs consist primarily of expenditures directly related to the restructuring actions and include program management costs associated with the 2020 Program and operational performance improvement initiatives.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tables below present restructuring and turnaround costs by reportable segment:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restructuring costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plasma&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Blood Center&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(131)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(92)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Turnaround costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plasma&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Blood Center&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total restructuring and turnaround costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,143&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,798&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11,583&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;13,582&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="i025a500d449145cdaf09b62761336e4d_I20201226"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RleHRyZWdpb246ZmMwYjM2YjgyNjgzNGVmMThmNTk3M2E4MjcxOGQ0MzFfODQ5_eb4a07ac-ca36-4e6e-88df-5e4ba3d69e83"
      unitRef="usd">60000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="i0527d982aa5d4b1493f2febb15dfb36f_I20201226"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RleHRyZWdpb246ZmMwYjM2YjgyNjgzNGVmMThmNTk3M2E4MjcxOGQ0MzFfODU2_929ca29d-34d3-42a0-b93a-ebddfcf0c2d8"
      unitRef="usd">70000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <hae:RestructuringandRestructuringRelatedCosts
      contextRef="ibd11a684655c47febfdbc8b572773803_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RleHRyZWdpb246ZmMwYjM2YjgyNjgzNGVmMThmNTk3M2E4MjcxOGQ0MzFfMTIyNQ_f809a9d9-e322-484e-a5ec-5345e3a8bb31"
      unitRef="usd">3100000</hae:RestructuringandRestructuringRelatedCosts>
    <hae:RestructuringandRestructuringRelatedCosts
      contextRef="i36f501133aca4e94a40d5f53c2932604_D20200329-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RleHRyZWdpb246ZmMwYjM2YjgyNjgzNGVmMThmNTk3M2E4MjcxOGQ0MzFfMTIzMg_5d89399d-5d2c-4397-bd7d-b07444c05d70"
      unitRef="usd">11100000</hae:RestructuringandRestructuringRelatedCosts>
    <hae:RestructuringandRestructuringRelatedCosts
      contextRef="i5a5c7d523f2145b6aa5ffec1153cb69c_D20190331-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RleHRyZWdpb246ZmMwYjM2YjgyNjgzNGVmMThmNTk3M2E4MjcxOGQ0MzFfMTM0OQ_35c1403e-f7b5-44ad-8aa5-a5bc6bc6c0fc"
      unitRef="usd">3900000</hae:RestructuringandRestructuringRelatedCosts>
    <hae:RestructuringandRestructuringRelatedCosts
      contextRef="i47a6d93cd53549d89b47e663b9deba14_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RleHRyZWdpb246ZmMwYjM2YjgyNjgzNGVmMThmNTk3M2E4MjcxOGQ0MzFfMTM0OQ_5c0e0810-05c7-438c-b851-68d73271fc56"
      unitRef="usd">3900000</hae:RestructuringandRestructuringRelatedCosts>
    <us-gaap:RestructuringAndRelatedCostCostIncurredToDate1
      contextRef="i2cacfe431b9c4c0fb8e8aef0b6153a74_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RleHRyZWdpb246ZmMwYjM2YjgyNjgzNGVmMThmNTk3M2E4MjcxOGQ0MzFfMTQ1OQ_dcdca477-c2d5-4fb5-a9a5-d1c405c8422b"
      unitRef="usd">22900000</us-gaap:RestructuringAndRelatedCostCostIncurredToDate1>
    <hae:RestructuringandRestructuringRelatedCosts
      contextRef="if349602212e14b36bbf1334f02910da3_D20200329-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RleHRyZWdpb246ZmMwYjM2YjgyNjgzNGVmMThmNTk3M2E4MjcxOGQ0MzFfMTg1OQ_6797f85a-3ace-4fcf-8617-1c36adcc931b"
      unitRef="usd">500000</hae:RestructuringandRestructuringRelatedCosts>
    <hae:RestructuringandRestructuringRelatedCosts
      contextRef="i93496a66e90a4df78a56e3d1ea9032d5_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RleHRyZWdpb246ZmMwYjM2YjgyNjgzNGVmMThmNTk3M2E4MjcxOGQ0MzFfMTk1Ng_917cf092-0ea2-4fee-8498-dcf62d83c629"
      unitRef="usd">3900000</hae:RestructuringandRestructuringRelatedCosts>
    <hae:RestructuringandRestructuringRelatedCosts
      contextRef="ia5424d4d3c7a46febf9cc99a77e86fdd_D20190331-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RleHRyZWdpb246ZmMwYjM2YjgyNjgzNGVmMThmNTk3M2E4MjcxOGQ0MzFfMTk2Mw_ef92edc3-d386-4373-a186-26681a736bb6"
      unitRef="usd">6800000</hae:RestructuringandRestructuringRelatedCosts>
    <us-gaap:RestructuringAndRelatedCostCostIncurredToDate1
      contextRef="i260b34151c1f4ffeb7f29c12973c0d99_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RleHRyZWdpb246ZmMwYjM2YjgyNjgzNGVmMThmNTk3M2E4MjcxOGQ0MzFfMjA4Nw_57a789d0-c857-48f5-854d-d2c8f91c5430"
      unitRef="usd">58700000</us-gaap:RestructuringAndRelatedCostCostIncurredToDate1>
    <us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RleHRyZWdpb246ZmMwYjM2YjgyNjgzNGVmMThmNTk3M2E4MjcxOGQ0MzFfMzIxOQ_2962a5c7-8c69-42c8-9d16-32d43f7e2b79">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity for restructuring reserves related to the 2020 Program and the 2018 Program and prior programs for the nine months ended December 26, 2020, substantially all of which relates to employee severance and other employee costs:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.501%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020 Program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018 Program and Prior Programs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Costs incurred, net of reversals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,546)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(887)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,433)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="i06e550e92ba749fcb6ba3ce3f7d5cab2_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjBiMDlhY2JmZGQxMjQ0OGZhMWQ5ODJmODFjNGE5MDZmL3RhYmxlcmFuZ2U6MGIwOWFjYmZkZDEyNDQ4ZmExZDk4MmY4MWM0YTkwNmZfMS0yLTEtMS0w_57b2fb4e-f627-4b0b-b827-7ab533b33c5f"
      unitRef="usd">1136000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ia6f164270add4f63b852149f39adb6dd_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjBiMDlhY2JmZGQxMjQ0OGZhMWQ5ODJmODFjNGE5MDZmL3RhYmxlcmFuZ2U6MGIwOWFjYmZkZDEyNDQ4ZmExZDk4MmY4MWM0YTkwNmZfMS00LTEtMS0w_10550dd3-999b-48fe-b182-f4b5ba55a520"
      unitRef="usd">1512000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjBiMDlhY2JmZGQxMjQ0OGZhMWQ5ODJmODFjNGE5MDZmL3RhYmxlcmFuZ2U6MGIwOWFjYmZkZDEyNDQ4ZmExZDk4MmY4MWM0YTkwNmZfMS02LTEtMS0w_158aa5ec-9d0d-43ce-9671-0abee503f0a4"
      unitRef="usd">2648000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="ic9df13005acd43968fa8aa9997a94054_D20200329-20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjBiMDlhY2JmZGQxMjQ0OGZhMWQ5ODJmODFjNGE5MDZmL3RhYmxlcmFuZ2U6MGIwOWFjYmZkZDEyNDQ4ZmExZDk4MmY4MWM0YTkwNmZfMi0yLTEtMS0w_17fa48ee-8e60-402e-af08-e1bb8dc3dc66"
      unitRef="usd">1005000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="id2f1e7afc3e94b0ebd50a8b6ea8db521_D20200329-20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjBiMDlhY2JmZGQxMjQ0OGZhMWQ5ODJmODFjNGE5MDZmL3RhYmxlcmFuZ2U6MGIwOWFjYmZkZDEyNDQ4ZmExZDk4MmY4MWM0YTkwNmZfMi00LTEtMS0w_f13fdc0e-96d1-4fb9-9eb9-f734dd275fe8"
      unitRef="usd">-105000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i0b7ebb1b437c46a0a817c9861b363798_D20200329-20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjBiMDlhY2JmZGQxMjQ0OGZhMWQ5ODJmODFjNGE5MDZmL3RhYmxlcmFuZ2U6MGIwOWFjYmZkZDEyNDQ4ZmExZDk4MmY4MWM0YTkwNmZfMi02LTEtMS0w_5be34103-c333-46dd-ad51-b0a570021610"
      unitRef="usd">900000</us-gaap:RestructuringCharges>
    <us-gaap:PaymentsForRestructuring
      contextRef="ic9df13005acd43968fa8aa9997a94054_D20200329-20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjBiMDlhY2JmZGQxMjQ0OGZhMWQ5ODJmODFjNGE5MDZmL3RhYmxlcmFuZ2U6MGIwOWFjYmZkZDEyNDQ4ZmExZDk4MmY4MWM0YTkwNmZfMy0yLTEtMS0w_265b9c38-e030-4ca9-910c-27d657ddc47e"
      unitRef="usd">1546000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="id2f1e7afc3e94b0ebd50a8b6ea8db521_D20200329-20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjBiMDlhY2JmZGQxMjQ0OGZhMWQ5ODJmODFjNGE5MDZmL3RhYmxlcmFuZ2U6MGIwOWFjYmZkZDEyNDQ4ZmExZDk4MmY4MWM0YTkwNmZfMy00LTEtMS0w_e846f93d-0587-4001-9bff-7e47dce6c219"
      unitRef="usd">887000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i0b7ebb1b437c46a0a817c9861b363798_D20200329-20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjBiMDlhY2JmZGQxMjQ0OGZhMWQ5ODJmODFjNGE5MDZmL3RhYmxlcmFuZ2U6MGIwOWFjYmZkZDEyNDQ4ZmExZDk4MmY4MWM0YTkwNmZfMy02LTEtMS0w_31262e21-9e5f-4a4b-8d96-4ee63d5a2a9c"
      unitRef="usd">2433000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve
      contextRef="i2cacfe431b9c4c0fb8e8aef0b6153a74_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjBiMDlhY2JmZGQxMjQ0OGZhMWQ5ODJmODFjNGE5MDZmL3RhYmxlcmFuZ2U6MGIwOWFjYmZkZDEyNDQ4ZmExZDk4MmY4MWM0YTkwNmZfNS0yLTEtMS0w_53af5df6-09c9-401e-9ba3-47f40b21346f"
      unitRef="usd">595000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="iad3aa8dfa6b948e5b3115795d08f59c8_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjBiMDlhY2JmZGQxMjQ0OGZhMWQ5ODJmODFjNGE5MDZmL3RhYmxlcmFuZ2U6MGIwOWFjYmZkZDEyNDQ4ZmExZDk4MmY4MWM0YTkwNmZfNS00LTEtMS0w_5a2af002-e0b6-414d-8434-05974c0866e0"
      unitRef="usd">520000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjBiMDlhY2JmZGQxMjQ0OGZhMWQ5ODJmODFjNGE5MDZmL3RhYmxlcmFuZ2U6MGIwOWFjYmZkZDEyNDQ4ZmExZDk4MmY4MWM0YTkwNmZfNS02LTEtMS0w_8583be97-7834-4556-af76-95bb3afeab06"
      unitRef="usd">1115000</us-gaap:RestructuringReserve>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RleHRyZWdpb246ZmMwYjM2YjgyNjgzNGVmMThmNTk3M2E4MjcxOGQ0MzFfMzIzMg_3f7952da-f631-4921-b473-16b4fd208322">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following presents the restructuring costs by line item within our accompanying unaudited condensed consolidated statements of income and comprehensive income:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 28,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 28,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of goods sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(92)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restructuring costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plasma&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Blood Center&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(131)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(92)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Turnaround costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plasma&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Blood Center&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total restructuring and turnaround costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,143&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,798&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11,583&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;13,582&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:RestructuringCharges
      contextRef="if591715db6554c7c88829b6f6ea5dd52_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjAzYjk1NGQ0NjQ0MTQ4M2ZiYzkxZTA3ODlkOWEwNDg2L3RhYmxlcmFuZ2U6MDNiOTU0ZDQ2NDQxNDgzZmJjOTFlMDc4OWQ5YTA0ODZfMi0xLTEtMS0w_7863ea6a-f763-47b5-be3a-e2ad248b6b41"
      unitRef="usd">-49000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i01fc03287b95423b9e72f9953bf2f534_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjAzYjk1NGQ0NjQ0MTQ4M2ZiYzkxZTA3ODlkOWEwNDg2L3RhYmxlcmFuZ2U6MDNiOTU0ZDQ2NDQxNDgzZmJjOTFlMDc4OWQ5YTA0ODZfMi0zLTEtMS0w_6545a601-d633-477d-af3f-e43da7d09572"
      unitRef="usd">2000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i2e978d21bd9d46c78c1bd4f9805a8a0a_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjAzYjk1NGQ0NjQ0MTQ4M2ZiYzkxZTA3ODlkOWEwNDg2L3RhYmxlcmFuZ2U6MDNiOTU0ZDQ2NDQxNDgzZmJjOTFlMDc4OWQ5YTA0ODZfMi01LTEtMS0w_8bd181a5-4a39-41b6-a85e-8a419cb131e9"
      unitRef="usd">218000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ib21731e2375545a08b98875f7a4af110_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjAzYjk1NGQ0NjQ0MTQ4M2ZiYzkxZTA3ODlkOWEwNDg2L3RhYmxlcmFuZ2U6MDNiOTU0ZDQ2NDQxNDgzZmJjOTFlMDc4OWQ5YTA0ODZfMi03LTEtMS0w_7ec7cc1b-c97f-4388-8164-3a07f9ed7945"
      unitRef="usd">444000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i3c902e8ff2a544848d52e4275e2b7ba6_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjAzYjk1NGQ0NjQ0MTQ4M2ZiYzkxZTA3ODlkOWEwNDg2L3RhYmxlcmFuZ2U6MDNiOTU0ZDQ2NDQxNDgzZmJjOTFlMDc4OWQ5YTA0ODZfMy0xLTEtMS0w_81ce2ee2-e132-4a10-8e15-f24afcda8d93"
      unitRef="usd">-2000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i2c6375b4134b4ca68ab871618f059116_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjAzYjk1NGQ0NjQ0MTQ4M2ZiYzkxZTA3ODlkOWEwNDg2L3RhYmxlcmFuZ2U6MDNiOTU0ZDQ2NDQxNDgzZmJjOTFlMDc4OWQ5YTA0ODZfMy0zLTEtMS0w_dec1fe1f-f6ee-4418-be27-69b16df23619"
      unitRef="usd">139000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i6ad87d4f1d5749fda7366051a2f43f16_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjAzYjk1NGQ0NjQ0MTQ4M2ZiYzkxZTA3ODlkOWEwNDg2L3RhYmxlcmFuZ2U6MDNiOTU0ZDQ2NDQxNDgzZmJjOTFlMDc4OWQ5YTA0ODZfMy01LTEtMS0w_8330de99-6f23-4b0b-8c62-22bb949d922b"
      unitRef="usd">108000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i11ffc79a4ee6438fbd8ff28e0c4be5bb_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjAzYjk1NGQ0NjQ0MTQ4M2ZiYzkxZTA3ODlkOWEwNDg2L3RhYmxlcmFuZ2U6MDNiOTU0ZDQ2NDQxNDgzZmJjOTFlMDc4OWQ5YTA0ODZfMy03LTEtMS0w_31c344d4-1d90-4a7f-9102-781e68c11b19"
      unitRef="usd">708000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="iee4e2e1969f04310b8b24c6665e635f3_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjAzYjk1NGQ0NjQ0MTQ4M2ZiYzkxZTA3ODlkOWEwNDg2L3RhYmxlcmFuZ2U6MDNiOTU0ZDQ2NDQxNDgzZmJjOTFlMDc4OWQ5YTA0ODZfNC0xLTEtMS0w_3ec2effb-6ff4-432a-a810-84bbb0d2a68e"
      unitRef="usd">-41000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i85a5e4e16a244429b43d7873d0c5a1f8_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjAzYjk1NGQ0NjQ0MTQ4M2ZiYzkxZTA3ODlkOWEwNDg2L3RhYmxlcmFuZ2U6MDNiOTU0ZDQ2NDQxNDgzZmJjOTFlMDc4OWQ5YTA0ODZfNC0zLTEtMS0w_bd4426e1-1148-4d26-926b-e560363108bc"
      unitRef="usd">476000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i8987e6d81b9e45c09d60428f5014e56f_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjAzYjk1NGQ0NjQ0MTQ4M2ZiYzkxZTA3ODlkOWEwNDg2L3RhYmxlcmFuZ2U6MDNiOTU0ZDQ2NDQxNDgzZmJjOTFlMDc4OWQ5YTA0ODZfNC01LTEtMS0w_7030c5bd-a68a-4468-9e20-a8420cd053bd"
      unitRef="usd">574000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ic9d7c28c8e164a01a59f0e2d04a596f1_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjAzYjk1NGQ0NjQ0MTQ4M2ZiYzkxZTA3ODlkOWEwNDg2L3RhYmxlcmFuZ2U6MDNiOTU0ZDQ2NDQxNDgzZmJjOTFlMDc4OWQ5YTA0ODZfNC03LTEtMS0w_aa228d71-4d3f-4d6c-b1aa-073117827921"
      unitRef="usd">1777000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjAzYjk1NGQ0NjQ0MTQ4M2ZiYzkxZTA3ODlkOWEwNDg2L3RhYmxlcmFuZ2U6MDNiOTU0ZDQ2NDQxNDgzZmJjOTFlMDc4OWQ5YTA0ODZfNS0xLTEtMS0w_8b396b74-a770-451d-8a17-e26f0cf5a0f4"
      unitRef="usd">-92000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjAzYjk1NGQ0NjQ0MTQ4M2ZiYzkxZTA3ODlkOWEwNDg2L3RhYmxlcmFuZ2U6MDNiOTU0ZDQ2NDQxNDgzZmJjOTFlMDc4OWQ5YTA0ODZfNS0zLTEtMS0w_0a8a29fc-3c07-4919-9167-2e2d24ae010c"
      unitRef="usd">617000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjAzYjk1NGQ0NjQ0MTQ4M2ZiYzkxZTA3ODlkOWEwNDg2L3RhYmxlcmFuZ2U6MDNiOTU0ZDQ2NDQxNDgzZmJjOTFlMDc4OWQ5YTA0ODZfNS01LTEtMS0w_53e09336-b340-4dba-be23-953538a90761"
      unitRef="usd">900000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjAzYjk1NGQ0NjQ0MTQ4M2ZiYzkxZTA3ODlkOWEwNDg2L3RhYmxlcmFuZ2U6MDNiOTU0ZDQ2NDQxNDgzZmJjOTFlMDc4OWQ5YTA0ODZfNS03LTEtMS0w_0d355f68-3c38-4e39-bb48-6118e6e46bbf"
      unitRef="usd">2929000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringReserve
      contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RleHRyZWdpb246ZmMwYjM2YjgyNjgzNGVmMThmNTk3M2E4MjcxOGQ0MzFfMjU5Nw_6d6961ce-52b9-4d85-939b-89182a15803e"
      unitRef="usd">1100000</us-gaap:RestructuringReserve>
    <hae:RestructuringChargesPayableInNextTwelveMonths
      contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RleHRyZWdpb246ZmMwYjM2YjgyNjgzNGVmMThmNTk3M2E4MjcxOGQ0MzFfMjYxMA_f55b0c97-4bf3-47b5-8753-bfb724567539"
      unitRef="usd">700000</hae:RestructuringChargesPayableInNextTwelveMonths>
    <us-gaap:RestructuringCharges
      contextRef="i3a367bb123554012a9834d85df459f46_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMi0xLTEtMS0w_9e4ac43d-8800-4508-a955-8c2253de2cdc"
      unitRef="usd">-27000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ib2c7bdc34da3493493cc0abe3dc3def5_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMi0zLTEtMS0w_1a569151-cf14-4a6d-855a-cc8981ee6769"
      unitRef="usd">4000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i4eb9c47f2f9244e0b383fb7b25f6b0d4_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMi01LTEtMS0w_9e22c41a-20c7-424f-a067-caf304f64737"
      unitRef="usd">454000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ib0091dd1f9204cdd979ec26f0ee2b0ae_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMi03LTEtMS0w_4d63c8f5-c593-49b0-b115-2255146be16b"
      unitRef="usd">552000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i6cfe5b5730064f93b6ecea7bc136d73f_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMy0xLTEtMS0w_d80dede0-171b-4039-8fc5-c1b9f1b9b34a"
      unitRef="usd">66000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ic275845b82014295bb8e14b72d0cb7a2_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMy0zLTEtMS0w_6e665467-0fa3-4b9a-8772-31558f3a4453"
      unitRef="usd">18000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i4648a84bbe144e499e5f0bbff9596c82_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMy01LTEtMS0w_8e2c9e0d-db94-4c6a-9c16-cd32d06ed80c"
      unitRef="usd">240000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i2fa6549b61284e39986bb1296676dc1a_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMy03LTEtMS0w_6d7b6f78-f122-4843-bc60-3a6e17d9aaa7"
      unitRef="usd">154000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="id93717bc785844afbedbb40fafa0d6e6_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfNC0xLTEtMS0w_812af6be-1092-4f51-9c1c-55da5fc20a64"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i2d1a57ec025045cbb23779fa6fc0cb2e_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfNC0zLTEtMS0w_f24193a9-4a11-4383-bb71-454f9113df4a"
      unitRef="usd">58000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ib19f3255f7c4488593f3252f04fa0abf_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfNC01LTEtMS0w_a104025c-7bf5-4a83-9ae3-59de9785bebd"
      unitRef="usd">-18000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="id42b45b3282241f0b4410893d0379aae_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfNC03LTEtMS0w_088a1631-78eb-4ee9-9d50-76a80cf0e721"
      unitRef="usd">295000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i05d2add01f7948cdbe05379d9edfa6cd_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfNS0xLTEtMS0w_6f6e5043-0c34-45bb-b162-cd7caf9a817e"
      unitRef="usd">-131000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="if68e3d2fce814080a6a5a599e4100f7d_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfNS0zLTEtMS0w_7b4efe5a-a325-4562-9406-0d167c4784ea"
      unitRef="usd">537000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i2f207c5c248843fd8e07e9437fa7102e_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfNS01LTEtMS0w_b18ea5c5-4796-4c64-80a2-7116fa5073e8"
      unitRef="usd">224000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="id7b79856e7224f109a59af542be47303_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfNS03LTEtMS0w_35ed0a07-2972-469f-90a5-6724475e9b36"
      unitRef="usd">1928000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfNi0xLTEtMS0w_7238a665-48a9-492c-a2ed-9f2edc1122e2"
      unitRef="usd">-92000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfNi0zLTEtMS0w_3e76e93e-933e-46ae-8cca-d5ee83225c21"
      unitRef="usd">617000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfNi01LTEtMS0w_4c5cdea6-aea2-4501-996d-6cd05642513b"
      unitRef="usd">900000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfNi03LTEtMS0w_c22b4444-6685-4ff5-b912-e70a1d9c0792"
      unitRef="usd">2929000</us-gaap:RestructuringCharges>
    <hae:RestructuringRelatedCosts
      contextRef="i3a367bb123554012a9834d85df459f46_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMTAtMS0xLTEtMA_2aaae7f5-7e6f-4096-939e-d2b5e075c1ec"
      unitRef="usd">431000</hae:RestructuringRelatedCosts>
    <hae:RestructuringRelatedCosts
      contextRef="ib2c7bdc34da3493493cc0abe3dc3def5_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMTAtMy0xLTEtMA_ab5feb1b-d1da-48db-ade9-ceeea015b998"
      unitRef="usd">108000</hae:RestructuringRelatedCosts>
    <hae:RestructuringRelatedCosts
      contextRef="i4eb9c47f2f9244e0b383fb7b25f6b0d4_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMTAtNS0xLTEtMA_1b17102e-27a1-4f0f-bc5f-7b40fa6aadf4"
      unitRef="usd">1235000</hae:RestructuringRelatedCosts>
    <hae:RestructuringRelatedCosts
      contextRef="ib0091dd1f9204cdd979ec26f0ee2b0ae_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMTAtNy0xLTEtMA_22a51b54-c1f8-4195-a8b9-3410245464d3"
      unitRef="usd">187000</hae:RestructuringRelatedCosts>
    <hae:RestructuringRelatedCosts
      contextRef="i6cfe5b5730064f93b6ecea7bc136d73f_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMTEtMS0xLTEtMA_31c5dc25-10c6-4144-9c8f-cdb4c9f5cb2f"
      unitRef="usd">518000</hae:RestructuringRelatedCosts>
    <hae:RestructuringRelatedCosts
      contextRef="ic275845b82014295bb8e14b72d0cb7a2_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMTEtMy0xLTEtMA_c12f8c89-0809-437d-9cf0-a63f27e56a48"
      unitRef="usd">293000</hae:RestructuringRelatedCosts>
    <hae:RestructuringRelatedCosts
      contextRef="i4648a84bbe144e499e5f0bbff9596c82_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMTEtNS0xLTEtMA_fb5c79c1-e612-4484-9ced-fe2c2200e799"
      unitRef="usd">1024000</hae:RestructuringRelatedCosts>
    <hae:RestructuringRelatedCosts
      contextRef="i2fa6549b61284e39986bb1296676dc1a_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMTEtNy0xLTEtMA_802684aa-07ac-4e7f-b271-3caf7c15fc3c"
      unitRef="usd">293000</hae:RestructuringRelatedCosts>
    <hae:RestructuringRelatedCosts
      contextRef="id93717bc785844afbedbb40fafa0d6e6_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMTItMS0xLTEtMA_cd3386c7-ebf8-4202-aa45-14153a08eaad"
      unitRef="usd">4000</hae:RestructuringRelatedCosts>
    <hae:RestructuringRelatedCosts
      contextRef="i2d1a57ec025045cbb23779fa6fc0cb2e_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMTItMy0xLTEtMA_5625eece-4221-4343-937f-2a2d0c03e00c"
      unitRef="usd">0</hae:RestructuringRelatedCosts>
    <hae:RestructuringRelatedCosts
      contextRef="ib19f3255f7c4488593f3252f04fa0abf_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMTItNS0xLTEtMA_748a2ea3-a774-4787-84d2-bf2297edc705"
      unitRef="usd">14000</hae:RestructuringRelatedCosts>
    <hae:RestructuringRelatedCosts
      contextRef="id42b45b3282241f0b4410893d0379aae_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMTItNy0xLTEtMA_2e4f8945-50fe-4390-a2d5-4ee768d60b65"
      unitRef="usd">0</hae:RestructuringRelatedCosts>
    <hae:RestructuringRelatedCosts
      contextRef="i05d2add01f7948cdbe05379d9edfa6cd_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMTMtMS0xLTEtMA_38f98390-3325-4439-bf1e-74240583e25c"
      unitRef="usd">2282000</hae:RestructuringRelatedCosts>
    <hae:RestructuringRelatedCosts
      contextRef="if68e3d2fce814080a6a5a599e4100f7d_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMTMtMy0xLTEtMA_221bb0a7-850f-4a16-8070-7651544c0543"
      unitRef="usd">6780000</hae:RestructuringRelatedCosts>
    <hae:RestructuringRelatedCosts
      contextRef="i2f207c5c248843fd8e07e9437fa7102e_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMTMtNS0xLTEtMA_590545c0-8bda-4217-8ee7-110748462d0c"
      unitRef="usd">8410000</hae:RestructuringRelatedCosts>
    <hae:RestructuringRelatedCosts
      contextRef="id7b79856e7224f109a59af542be47303_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMTMtNy0xLTEtMA_7ab03fd8-73f7-407a-b576-d9773b0cf34a"
      unitRef="usd">10173000</hae:RestructuringRelatedCosts>
    <hae:RestructuringRelatedCosts
      contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMTQtMS0xLTEtMA_fdca3068-016b-444a-b123-8f4ad7535e44"
      unitRef="usd">3235000</hae:RestructuringRelatedCosts>
    <hae:RestructuringRelatedCosts
      contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMTQtMy0xLTEtMA_6a2050c8-b1d3-400a-9015-7d3290fb65b9"
      unitRef="usd">7181000</hae:RestructuringRelatedCosts>
    <hae:RestructuringRelatedCosts
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMTQtNS0xLTEtMA_a2159279-61d7-4222-b297-2a29d3e7cef6"
      unitRef="usd">10683000</hae:RestructuringRelatedCosts>
    <hae:RestructuringRelatedCosts
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMTQtNy0xLTEtMA_6bfcfb7f-bda6-49d8-bb7b-ae2803015a44"
      unitRef="usd">10653000</hae:RestructuringRelatedCosts>
    <hae:RestructuringandRestructuringRelatedCosts
      contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMTYtMS0xLTEtMA_d19d86db-ec52-4a14-bf3a-a7518510707f"
      unitRef="usd">3143000</hae:RestructuringandRestructuringRelatedCosts>
    <hae:RestructuringandRestructuringRelatedCosts
      contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMTYtMy0xLTEtMA_5d8fd7da-1a69-4d5f-89d3-5865b428aa90"
      unitRef="usd">7798000</hae:RestructuringandRestructuringRelatedCosts>
    <hae:RestructuringandRestructuringRelatedCosts
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMTYtNS0xLTEtMA_b9633fea-cce5-4df5-bce2-db0c0c7b5bea"
      unitRef="usd">11583000</hae:RestructuringandRestructuringRelatedCosts>
    <hae:RestructuringandRestructuringRelatedCosts
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80MC9mcmFnOmZjMGIzNmI4MjY4MzRlZjE4ZjU5NzNhODI3MThkNDMxL3RhYmxlOjQwMGE5NGNmMzVjMDRiODFiMWE4YThmOGQ3M2ZmOWEzL3RhYmxlcmFuZ2U6NDAwYTk0Y2YzNWMwNGI4MWIxYThhOGY4ZDczZmY5YTNfMTYtNy0xLTEtMA_fc73579b-e235-4060-b944-17b30c271edb"
      unitRef="usd">13582000</hae:RestructuringandRestructuringRelatedCosts>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RleHRyZWdpb246ZDEyMzJiZDFkNjM1NGY4YzkyOGZkZTcwZTFmMDBlYTlfMzE4Ng_22ebaf26-6844-45b9-bce4-b611731c6245">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;4. ACQUISITIONS&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cardiva Medical, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 17, 2021, the Company entered into an Agreement and Plan of Merger with Cardiva Medical, Inc., (&#x201c;Cardiva&#x201d;), an industry-leading manufacturer of vascular closure systems based in Santa Clara, California. In connection with this acquisition, the Company will pay upfront consideration of $475.0&#160;million in cash, subject to customary working capital and certain other adjustments as of the closing of the transaction, as well as up to $35.0&#160;million in additional contingent consideration payable over the next two years based on sales growth. The transaction is not subject to a financing contingency, and the Company expects to finance the transaction through a combination of its cash on hand, revolving credit facility and an additional $150.0&#160;million term loan anticipated to be borrowed under its existing credit facility. The transaction is expected to close in the fourth quarter of fiscal 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cardiva&#x2019;s portfolio includes two catheter-based vascular access site closure devices. The VASCADE&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; vascular closure system is designed for &#x201c;small-bore&#x201d; femoral arterial and venous closure, generally used in interventional cardiology and peripheral vascular procedures. The VASCADE MVP&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; vascular closure system is designed for &#x201c;mid-bore&#x201d; multi-access femoral venous closure, generally used in electrophysiology procedures, and is the only U.S. Food and Drug Administration (&#x201c;FDA&#x201d;) approved closure device for use following cardiac ablation procedures requiring two or more access sites within the same vessel. The addition of the VASCADE portfolio to the Hospital business unit includes products with demonstrated benefits and enhances penetration into the large and growing interventional cardiology and electrophysiology markets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;HAS Intellectual Property&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2021, the Company entered into an agreement to acquire certain intellectual property owned by HemoAssay Science and Technology (Suzhou) Co. Ltd., a China-incorporated company, and its affiliates (collectively, &#x201c;HemoAssay&#x201d;) underlying their HAS viscoelastic diagnostic devices, related assays and disposables. The Company previously entered into exclusive manufacturing and distribution agreements with HemoAssay pursuant to which it has exclusive rights to commercialize HemoAssay&#x2019;s HAS devices in China. In connection with the transaction, the Company has agreed to pay up to $15.0&#160;million to HemoAssay in contingent consideration based on certain developmental and manufacturing based milestones. These products augment the Company's portfolio of hemostasis analyzers within the Hospital business unit.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;enicor GmbH&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 1, 2020, the Company acquired all of the outstanding equity of enicor GmbH (&#x201c;enicor&#x201d;), the manufacturer of ClotPro&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, a new generation whole blood coagulation testing system that is currently available in select European and Asia Pacific markets, for total consideration of $20.5&#160;million, which consisted of upfront payments of $16.6&#160;million and the fair value of contingent consideration of $3.9&#160;million. The contingent consideration, which could total a maximum of $4.5&#160;million, consists of payments related to the achievement of certain revenue and regulatory milestones. The acquisition of this viscoelastic diagnostic device augments the Company's portfolio of hemostasis analyzers within the Hospital business unit.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Purchase Price Allocation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounted for the acquisition of enicor as a business combination, and in accordance with FASB ASC Topic 805, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Topic 805&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), recorded the assets acquired and liabilities assumed at their respective fair values as of the acquisition date. The final determination of the fair value of certain assets and liabilities will be completed within the measurement period as required by Topic 805. As of December&#160;26, 2020, the valuation studies necessary to determine the fair market value of the assets acquired and liabilities assumed are preliminary, including the projection of the underlying cash flows used to determine the fair value of the identified tangible, intangible and financial assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following amounts represent the preliminary determination of the fair value of the identifiable assets acquired and liabilities assumed for enicor completed during the first nine months of fiscal 2021:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.182%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;23,851&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,245&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16,606&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determined the identifiable intangible assets were completed technology, customer relationships and a trademark. The fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using a rate of 20%. The cash flows were based on estimates used to price the transaction, and the discount rates applied were benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The benefits of adding a viscoelastic diagnostic device to the Company&#x2019;s portfolio of hemostasis analyzers within the Hospital business unit contributed to an acquisition price in excess of the fair value of net assets acquired for enicor, which resulted in the establishment of goodwill. In addition, the benefits of lower cost manufacturing and complementary sales channels also contributed to the establishment of goodwill for this acquisition. None of the goodwill is expected to be deductible for income tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets acquired consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Amortization Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Completed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademark&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;14,090&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisition-Related Costs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amount of acquisition-related costs incurred associated with the acquisition was $0.2&#160;million for the three and nine months ended December 26, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Unaudited Pro Forma Financial Information&lt;/span&gt;&lt;/div&gt;Enicor had an immaterial impact to the Company's net revenues and net income for the period post acquisition through December&#160;26, 2020. The unaudited estimated pro forma impact of the results of the acquisition of enicor as if it was consummated on March 29, 2020 are immaterial.</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i8271c898b4eb4b14baafd85359156c86_D20210117-20210117"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RleHRyZWdpb246ZDEyMzJiZDFkNjM1NGY4YzkyOGZkZTcwZTFmMDBlYTlfODI0NjMzNzIxNTMyNQ_a1b4eeb3-60c5-402c-b832-0b2a7cc46c38"
      unitRef="usd">475000000.0</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i72cd9e5107234d5fbbe3ac8fc02e2137_I20210117"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RleHRyZWdpb246ZDEyMzJiZDFkNjM1NGY4YzkyOGZkZTcwZTFmMDBlYTlfODI0NjMzNzIxNTM0MQ_3eaf73ee-cf1e-4f10-8453-c5fd8c74c954"
      unitRef="usd">35000000.0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:ProceedsFromIssuanceOfSecuredDebt
      contextRef="i8271c898b4eb4b14baafd85359156c86_D20210117-20210117"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RleHRyZWdpb246ZDEyMzJiZDFkNjM1NGY4YzkyOGZkZTcwZTFmMDBlYTlfODI0NjMzNzIxNTM1Ng_db5f564a-b252-4828-96fb-2adf2d5b7ea2"
      unitRef="usd">150000000.0</us-gaap:ProceedsFromIssuanceOfSecuredDebt>
    <hae:AssetAcquisitionUpfrontPayment
      contextRef="i07195ff1642e4aeb86c955b7bd7ec0ee_D20210113-20210113"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RleHRyZWdpb246ZDEyMzJiZDFkNjM1NGY4YzkyOGZkZTcwZTFmMDBlYTlfODI0NjMzNzIxNTM3Mg_88378757-7c6e-43ad-9e33-f3e6dd529904"
      unitRef="usd">15000000.0</hae:AssetAcquisitionUpfrontPayment>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i1c4663f05df4454e9e234b6de7661db7_D20200401-20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RleHRyZWdpb246ZDEyMzJiZDFkNjM1NGY4YzkyOGZkZTcwZTFmMDBlYTlfMjkx_30bea2e5-7e7f-4222-88e9-b67dbdcc7a4c"
      unitRef="usd">20500000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i1c4663f05df4454e9e234b6de7661db7_D20200401-20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RleHRyZWdpb246ZDEyMzJiZDFkNjM1NGY4YzkyOGZkZTcwZTFmMDBlYTlfMzM0_99e73f9d-4d64-459d-8c51-9229fc559079"
      unitRef="usd">16600000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i7337ad8ffd7f4d8cb8646e0073515fc1_I20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RleHRyZWdpb246ZDEyMzJiZDFkNjM1NGY4YzkyOGZkZTcwZTFmMDBlYTlfMzg3_4f27dda8-106f-49cc-abd7-59bf76196f68"
      unitRef="usd">3900000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i7337ad8ffd7f4d8cb8646e0073515fc1_I20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RleHRyZWdpb246ZDEyMzJiZDFkNjM1NGY4YzkyOGZkZTcwZTFmMDBlYTlfNDUy_af75958b-b33e-4fe2-b685-6aa457c99f3d"
      unitRef="usd">4500000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RleHRyZWdpb246ZDEyMzJiZDFkNjM1NGY4YzkyOGZkZTcwZTFmMDBlYTlfMzE4Nw_9ddfba91-40d6-481c-a2c7-43dc0aa52874">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following amounts represent the preliminary determination of the fair value of the identifiable assets acquired and liabilities assumed for enicor completed during the first nine months of fiscal 2021:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.182%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;23,851&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,245&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16,606&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets acquired consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Amortization Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Completed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademark&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;14,090&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="i0e7fc74b32564f649453438d72e04947_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RhYmxlOmMzNjNhOGFlZWZiNTRmOWNhZDNjNWE5M2FlZDdhY2I0L3RhYmxlcmFuZ2U6YzM2M2E4YWVlZmI1NGY5Y2FkM2M1YTkzYWVkN2FjYjRfMi0yLTEtMS0w_6756b07e-f4c7-414b-a98e-133fc1c653d7"
      unitRef="usd">634000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
      contextRef="i0e7fc74b32564f649453438d72e04947_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RhYmxlOmMzNjNhOGFlZWZiNTRmOWNhZDNjNWE5M2FlZDdhY2I0L3RhYmxlcmFuZ2U6YzM2M2E4YWVlZmI1NGY5Y2FkM2M1YTkzYWVkN2FjYjRfMy0yLTEtMS0w_6412aed6-48f4-4b96-a886-c72826d12b47"
      unitRef="usd">685000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i0e7fc74b32564f649453438d72e04947_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RhYmxlOmMzNjNhOGFlZWZiNTRmOWNhZDNjNWE5M2FlZDdhY2I0L3RhYmxlcmFuZ2U6YzM2M2E4YWVlZmI1NGY5Y2FkM2M1YTkzYWVkN2FjYjRfNC0yLTEtMS0w_c188042b-ed30-4963-835c-85bf6136398c"
      unitRef="usd">289000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i0e7fc74b32564f649453438d72e04947_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RhYmxlOmMzNjNhOGFlZWZiNTRmOWNhZDNjNWE5M2FlZDdhY2I0L3RhYmxlcmFuZ2U6YzM2M2E4YWVlZmI1NGY5Y2FkM2M1YTkzYWVkN2FjYjRfNS0yLTEtMS0w_f6dac7a0-4155-4e5d-ace2-9b09cc489d7b"
      unitRef="usd">14090000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:Goodwill
      contextRef="i0e7fc74b32564f649453438d72e04947_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RhYmxlOmMzNjNhOGFlZWZiNTRmOWNhZDNjNWE5M2FlZDdhY2I0L3RhYmxlcmFuZ2U6YzM2M2E4YWVlZmI1NGY5Y2FkM2M1YTkzYWVkN2FjYjRfNi0yLTEtMS0w_a84c081f-3ec0-4e50-8d0c-523cbaaf0d3f"
      unitRef="usd">8153000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="i0e7fc74b32564f649453438d72e04947_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RhYmxlOmMzNjNhOGFlZWZiNTRmOWNhZDNjNWE5M2FlZDdhY2I0L3RhYmxlcmFuZ2U6YzM2M2E4YWVlZmI1NGY5Y2FkM2M1YTkzYWVkN2FjYjRfNy0yLTEtMS0w_d0ec0c83-b603-4eb4-bab3-6548f6ae203a"
      unitRef="usd">23851000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
      contextRef="i0e7fc74b32564f649453438d72e04947_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RhYmxlOmMzNjNhOGFlZWZiNTRmOWNhZDNjNWE5M2FlZDdhY2I0L3RhYmxlcmFuZ2U6YzM2M2E4YWVlZmI1NGY5Y2FkM2M1YTkzYWVkN2FjYjRfOC0yLTEtMS0w_952958dd-4d30-4101-bc79-b5589c0e15d7"
      unitRef="usd">289000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent
      contextRef="i0e7fc74b32564f649453438d72e04947_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RhYmxlOmMzNjNhOGFlZWZiNTRmOWNhZDNjNWE5M2FlZDdhY2I0L3RhYmxlcmFuZ2U6YzM2M2E4YWVlZmI1NGY5Y2FkM2M1YTkzYWVkN2FjYjRfOS0yLTEtMS0w_6fbc05b1-34e5-478e-96f0-f3c81e520ddb"
      unitRef="usd">504000</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i0e7fc74b32564f649453438d72e04947_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RhYmxlOmMzNjNhOGFlZWZiNTRmOWNhZDNjNWE5M2FlZDdhY2I0L3RhYmxlcmFuZ2U6YzM2M2E4YWVlZmI1NGY5Y2FkM2M1YTkzYWVkN2FjYjRfMTAtMi0xLTEtMA_e4138326-cdf7-437c-91a4-bcca33dec6c9"
      unitRef="usd">3416000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i0e7fc74b32564f649453438d72e04947_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RhYmxlOmMzNjNhOGFlZWZiNTRmOWNhZDNjNWE5M2FlZDdhY2I0L3RhYmxlcmFuZ2U6YzM2M2E4YWVlZmI1NGY5Y2FkM2M1YTkzYWVkN2FjYjRfMTEtMi0xLTEtMA_fab7ad45-1ffc-46da-b6c6-ba35e3d8c620"
      unitRef="usd">3036000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i0e7fc74b32564f649453438d72e04947_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RhYmxlOmMzNjNhOGFlZWZiNTRmOWNhZDNjNWE5M2FlZDdhY2I0L3RhYmxlcmFuZ2U6YzM2M2E4YWVlZmI1NGY5Y2FkM2M1YTkzYWVkN2FjYjRfMTItMi0xLTEtMA_4ce490fb-696f-4185-b3e6-b4f3bb87bddd"
      unitRef="usd">7245000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="i0e7fc74b32564f649453438d72e04947_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RhYmxlOmMzNjNhOGFlZWZiNTRmOWNhZDNjNWE5M2FlZDdhY2I0L3RhYmxlcmFuZ2U6YzM2M2E4YWVlZmI1NGY5Y2FkM2M1YTkzYWVkN2FjYjRfMTMtMi0xLTEtMA_81efdfbf-f6bb-4b81-b702-929b537c03b0"
      unitRef="usd">16606000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i9f13c7f15fc44cdf96efa179ac88e167_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RhYmxlOjFlYjg1YzkyMTU3YzRhOTliOWQ4ZTUxMTU3NGUyY2IxL3RhYmxlcmFuZ2U6MWViODVjOTIxNTdjNGE5OWI5ZDhlNTExNTc0ZTJjYjFfMS0yLTEtMS0w_7f7a56ce-970b-4447-9cf2-2d39c362a2cd"
      unitRef="usd">13441000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i8b8aa32b413b4a499e81cb8f98426327_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RhYmxlOjFlYjg1YzkyMTU3YzRhOTliOWQ4ZTUxMTU3NGUyY2IxL3RhYmxlcmFuZ2U6MWViODVjOTIxNTdjNGE5OWI5ZDhlNTExNTc0ZTJjYjFfMS00LTEtMS0w_86e9638e-d73c-4d1b-b071-8854df8fe58f">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i9e187811cd3e42c390dd4993b5e2ed41_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RhYmxlOjFlYjg1YzkyMTU3YzRhOTliOWQ4ZTUxMTU3NGUyY2IxL3RhYmxlcmFuZ2U6MWViODVjOTIxNTdjNGE5OWI5ZDhlNTExNTc0ZTJjYjFfMi0yLTEtMS0w_2c31a630-28ac-4978-b963-22b19b526e6a"
      unitRef="usd">347000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i6ad4c63952854d498ed7b2fe9fb419e8_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RhYmxlOjFlYjg1YzkyMTU3YzRhOTliOWQ4ZTUxMTU3NGUyY2IxL3RhYmxlcmFuZ2U6MWViODVjOTIxNTdjNGE5OWI5ZDhlNTExNTc0ZTJjYjFfMi00LTEtMS0w_99c89333-b15b-4185-be04-622cc01258d5">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="icef6f3884c5247499558f7349ee73936_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RhYmxlOjFlYjg1YzkyMTU3YzRhOTliOWQ4ZTUxMTU3NGUyY2IxL3RhYmxlcmFuZ2U6MWViODVjOTIxNTdjNGE5OWI5ZDhlNTExNTc0ZTJjYjFfMy0yLTEtMS0w_dd49a798-1487-40bf-9475-d16685779485"
      unitRef="usd">302000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i7aab4b31eac44a489a14bcde8ce8f4eb_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RhYmxlOjFlYjg1YzkyMTU3YzRhOTliOWQ4ZTUxMTU3NGUyY2IxL3RhYmxlcmFuZ2U6MWViODVjOTIxNTdjNGE5OWI5ZDhlNTExNTc0ZTJjYjFfMy00LTEtMS0w_e8d138a3-2bba-4e4e-8f5e-5bf97729339d">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i0e7fc74b32564f649453438d72e04947_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RhYmxlOjFlYjg1YzkyMTU3YzRhOTliOWQ4ZTUxMTU3NGUyY2IxL3RhYmxlcmFuZ2U6MWViODVjOTIxNTdjNGE5OWI5ZDhlNTExNTc0ZTJjYjFfNC0yLTEtMS0w_c11e081f-5657-4b44-ab70-71b1f3074ecd"
      unitRef="usd">14090000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i394c4dad38e046eabd38f765e09e2e8d_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RhYmxlOjFlYjg1YzkyMTU3YzRhOTliOWQ4ZTUxMTU3NGUyY2IxL3RhYmxlcmFuZ2U6MWViODVjOTIxNTdjNGE5OWI5ZDhlNTExNTc0ZTJjYjFfNC00LTEtMS0w_190a680a-e8b3-4670-98eb-129754685ab8">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed
      contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80My9mcmFnOmQxMjMyYmQxZDYzNTRmOGM5MjhmZGU3MGUxZjAwZWE5L3RleHRyZWdpb246ZDEyMzJiZDFkNjM1NGY4YzkyOGZkZTcwZTFmMDBlYTlfMjg2Mg_69bbc3ed-a24d-441d-8433-ad33ac03162f"
      unitRef="usd">200000</us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed>
    <us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80Ni9mcmFnOjczOTYwYTdlNjAzMDQyZGE4MWM2ZmVmM2ZjYzc3YWRkL3RleHRyZWdpb246NzM5NjBhN2U2MDMwNDJkYTgxYzZmZWYzZmNjNzdhZGRfMzQ1Nw_c7b730d2-17da-4838-b283-74ecb2116410">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;5. DIVESTITURES &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fajardo, Puerto Rico Manufacturing Operations&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 29, 2020, the Company sold its Fajardo, Puerto Rico, manufacturing operations to GVS, S.p.A (&#x201c;GVS&#x201d;), a leading provider of advanced filtration solutions for critical applications for $15.1&#160;million ($7.8&#160;million, net of cash transferred). Under the terms of the agreement, Haemonetics retained all intellectual property rights to its proprietary blood filters currently manufactured at its Fajardo facility and GVS acquired certain assets consisting primarily of property, plant and equipment, inventory and cash and has assumed certain related liabilities. In connection with this transaction, the Company and GVS also entered into a long-term supply and development agreement that, among other things, grants GVS exclusive rights to manufacture and supply the blood filters currently produced at the Fajardo facility for Haemonetics. The Company also agreed to provide certain transition services to GVS, generally for a period of up to three months depending on the nature of the service.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of this transaction, Haemonetics recognized a pre-tax impairment charge in its Blood Center business unit of $1.0&#160;million in the first quarter of fiscal 2021 and an incremental loss of $0.4&#160;million based on closing adjustments during the third quarter of fiscal 2021, as the carrying value of the assets and liabilities in the asset transfer exceeded the net of the $15.1&#160;million of cash proceeds and an additional contingent liability of $1.5&#160;million. The disposal group consisted of $3.3&#160;million of inventory, $7.2&#160;million of fixed assets, $3.2&#160;million of other liabilities, and $0.4&#160;million of goodwill allocated based on fair value to the business.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;U.S. Blood Donor Management Software&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 1, 2020, the Company sold certain U.S. blood donor management software solution assets within its Blood Center business unit to the GPI Group (&#x201c;GPI&#x201d;) for an upfront cash payment of $14.0&#160;million ($13.6&#160;million, net of working capital adjustments) and up to $14.0&#160;million in additional consideration contingent on the achievement of commercial milestones over the twelve month period immediately following the closing of the transaction. The disposal group consisted of $1.4&#160;million of accounts receivable, $0.9&#160;million of intangible assets, other liabilities of $1.8&#160;million and $1.4&#160;million of goodwill allocated based on fair value to the business. The Company recognized an $11.7&#160;million gain upon closing of the transaction in the second quarter of fiscal 2021 and an additional $1.5&#160;million gain in the third quarter of fiscal 2021. To the extent the additional contingent consideration is earned and realized in a future period then such amounts will be recorded as additional gains in such future period. The Company also agreed to provide certain transition services to GPI, generally for a period of one to nine months depending on the nature of the service.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Inlog Holdings France&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 18, 2020, the Company sold its wholly-owned subsidiary Inlog Holdings France SAS to Ab&#xe9;nex Capital (&#x201c;Ab&#xe9;nex&#x201d;), a private equity firm based in France for $30.5&#160;million ($24.5&#160;million, net of cash transferred), of which &lt;/span&gt;&lt;/div&gt;$29.2&#160;million was received at closing and $1.3&#160;million will be received one-year from the closing date. Inlog Holdings France SAS, through its subsidiary In Log SAS, develops and sells blood bank and hospital software solutions used predominantly in France and in several other countries outside of the U.S. The disposal group included $2.2&#160;million of intangible assets, $2.2&#160;million accounts receivable, $0.3&#160;million other assets, $3.3&#160;million of liabilities and $3.3&#160;million of goodwill allocated based on the fair value of the business which impacted both the Blood Center and Hospital business units. The Company recognized a gain of $19.8&#160;million upon closing of the transaction in the second quarter of fiscal 2021.</us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="ied6e581caf26486bbb484a11ddea3e51_D20200629-20200629"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80Ni9mcmFnOjczOTYwYTdlNjAzMDQyZGE4MWM2ZmVmM2ZjYzc3YWRkL3RleHRyZWdpb246NzM5NjBhN2U2MDMwNDJkYTgxYzZmZWYzZmNjNzdhZGRfMjQ4_72ba152b-ad40-4252-b1d3-4511a404f665"
      unitRef="usd">15100000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="ied6e581caf26486bbb484a11ddea3e51_D20200629-20200629"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80Ni9mcmFnOjczOTYwYTdlNjAzMDQyZGE4MWM2ZmVmM2ZjYzc3YWRkL3RleHRyZWdpb246NzM5NjBhN2U2MDMwNDJkYTgxYzZmZWYzZmNjNzdhZGRfMjUy_4f682827-c2e8-4808-86eb-a1acdb8f3c8c"
      unitRef="usd">7800000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:AssetImpairmentCharges
      contextRef="ied6e581caf26486bbb484a11ddea3e51_D20200629-20200629"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80Ni9mcmFnOjczOTYwYTdlNjAzMDQyZGE4MWM2ZmVmM2ZjYzc3YWRkL3RleHRyZWdpb246NzM5NjBhN2U2MDMwNDJkYTgxYzZmZWYzZmNjNzdhZGRfMTEyMw_aadaafd3-ca76-4b2b-a824-d4bed212685f"
      unitRef="usd">1000000.0</us-gaap:AssetImpairmentCharges>
    <hae:DisposalGroupNotDiscontinuedOperationsIncrementalLossOnClosingAdjustments
      contextRef="i231ee71df4ce422fbe1694ee337e10ea_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80Ni9mcmFnOjczOTYwYTdlNjAzMDQyZGE4MWM2ZmVmM2ZjYzc3YWRkL3RleHRyZWdpb246NzM5NjBhN2U2MDMwNDJkYTgxYzZmZWYzZmNjNzdhZGRfODI0NjMzNzIxMjQ2Mw_c20d92e8-f9dc-4099-9310-ff7a29d00ce4"
      unitRef="usd">400000</hae:DisposalGroupNotDiscontinuedOperationsIncrementalLossOnClosingAdjustments>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="ied6e581caf26486bbb484a11ddea3e51_D20200629-20200629"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80Ni9mcmFnOjczOTYwYTdlNjAzMDQyZGE4MWM2ZmVmM2ZjYzc3YWRkL3RleHRyZWdpb246NzM5NjBhN2U2MDMwNDJkYTgxYzZmZWYzZmNjNzdhZGRfMTI5OQ_b12bf4c0-7f78-4eb3-b1ce-ee45e3791382"
      unitRef="usd">15100000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <hae:DisposalGroupNotDiscontinuedOperationsExpectedCostToSell
      contextRef="ied6e581caf26486bbb484a11ddea3e51_D20200629-20200629"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80Ni9mcmFnOjczOTYwYTdlNjAzMDQyZGE4MWM2ZmVmM2ZjYzc3YWRkL3RleHRyZWdpb246NzM5NjBhN2U2MDMwNDJkYTgxYzZmZWYzZmNjNzdhZGRfMTM2MQ_4b899a65-fdff-43f9-9f62-bd4f4cc8727b"
      unitRef="usd">1500000</hae:DisposalGroupNotDiscontinuedOperationsExpectedCostToSell>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1
      contextRef="ieacf3aef0a2a44ffa6d41b7518483e60_I20200629"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80Ni9mcmFnOjczOTYwYTdlNjAzMDQyZGE4MWM2ZmVmM2ZjYzc3YWRkL3RleHRyZWdpb246NzM5NjBhN2U2MDMwNDJkYTgxYzZmZWYzZmNjNzdhZGRfMTM5Nw_5f9aaecb-8d28-41e3-8715-ebe1679907b0"
      unitRef="usd">3300000</us-gaap:DisposalGroupIncludingDiscontinuedOperationInventory1>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment
      contextRef="ieacf3aef0a2a44ffa6d41b7518483e60_I20200629"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80Ni9mcmFnOjczOTYwYTdlNjAzMDQyZGE4MWM2ZmVmM2ZjYzc3YWRkL3RleHRyZWdpb246NzM5NjBhN2U2MDMwNDJkYTgxYzZmZWYzZmNjNzdhZGRfMTQxNA_13bd7947-11b6-4b5c-a60f-9d18db812d52"
      unitRef="usd">7200000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities
      contextRef="ieacf3aef0a2a44ffa6d41b7518483e60_I20200629"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80Ni9mcmFnOjczOTYwYTdlNjAzMDQyZGE4MWM2ZmVmM2ZjYzc3YWRkL3RleHRyZWdpb246NzM5NjBhN2U2MDMwNDJkYTgxYzZmZWYzZmNjNzdhZGRfMTQzNA_944dfa27-cd5f-4351-a754-499c60dc8c98"
      unitRef="usd">3200000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities>
    <us-gaap:Goodwill
      contextRef="ieacf3aef0a2a44ffa6d41b7518483e60_I20200629"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80Ni9mcmFnOjczOTYwYTdlNjAzMDQyZGE4MWM2ZmVmM2ZjYzc3YWRkL3RleHRyZWdpb246NzM5NjBhN2U2MDMwNDJkYTgxYzZmZWYzZmNjNzdhZGRfMTQ2Mw_35a0ba40-14fa-4a33-a111-64790f60111c"
      unitRef="usd">400000</us-gaap:Goodwill>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="ie18de39654bc43fabcb2d7cea0396838_D20200701-20200701"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80Ni9mcmFnOjczOTYwYTdlNjAzMDQyZGE4MWM2ZmVmM2ZjYzc3YWRkL3RleHRyZWdpb246NzM5NjBhN2U2MDMwNDJkYTgxYzZmZWYzZmNjNzdhZGRfMTc1Mw_270ab112-9d18-4307-9a94-07bbdea9be96"
      unitRef="usd">14000000.0</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="ie18de39654bc43fabcb2d7cea0396838_D20200701-20200701"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80Ni9mcmFnOjczOTYwYTdlNjAzMDQyZGE4MWM2ZmVmM2ZjYzc3YWRkL3RleHRyZWdpb246NzM5NjBhN2U2MDMwNDJkYTgxYzZmZWYzZmNjNzdhZGRfMTc1Nw_6e978252-f282-48f4-b1d9-0d83d4c6974f"
      unitRef="usd">13600000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="ie18de39654bc43fabcb2d7cea0396838_D20200701-20200701"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80Ni9mcmFnOjczOTYwYTdlNjAzMDQyZGE4MWM2ZmVmM2ZjYzc3YWRkL3RleHRyZWdpb246NzM5NjBhN2U2MDMwNDJkYTgxYzZmZWYzZmNjNzdhZGRfMTgwNw_68da6d27-8fdc-4e80-bbc0-4e7d5b750dab"
      unitRef="usd">14000000.0</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet
      contextRef="i2c5c92e739704d5ebb1fc26b36eb5d62_I20200701"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80Ni9mcmFnOjczOTYwYTdlNjAzMDQyZGE4MWM2ZmVmM2ZjYzc3YWRkL3RleHRyZWdpb246NzM5NjBhN2U2MDMwNDJkYTgxYzZmZWYzZmNjNzdhZGRfMjAwNQ_78e24551-17b5-495c-ab9c-65ea522cbe65"
      unitRef="usd">1400000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets
      contextRef="i2c5c92e739704d5ebb1fc26b36eb5d62_I20200701"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80Ni9mcmFnOjczOTYwYTdlNjAzMDQyZGE4MWM2ZmVmM2ZjYzc3YWRkL3RleHRyZWdpb246NzM5NjBhN2U2MDMwNDJkYTgxYzZmZWYzZmNjNzdhZGRfMjAzMg_d16a7908-06ce-45b6-b9da-b921c5b92df2"
      unitRef="usd">900000</us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities
      contextRef="i2c5c92e739704d5ebb1fc26b36eb5d62_I20200701"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80Ni9mcmFnOjczOTYwYTdlNjAzMDQyZGE4MWM2ZmVmM2ZjYzc3YWRkL3RleHRyZWdpb246NzM5NjBhN2U2MDMwNDJkYTgxYzZmZWYzZmNjNzdhZGRfMjA3OA_4d4ddaa8-66b6-48e1-918e-815a2e49c8a7"
      unitRef="usd">1800000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities>
    <us-gaap:Goodwill
      contextRef="i2c5c92e739704d5ebb1fc26b36eb5d62_I20200701"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80Ni9mcmFnOjczOTYwYTdlNjAzMDQyZGE4MWM2ZmVmM2ZjYzc3YWRkL3RleHRyZWdpb246NzM5NjBhN2U2MDMwNDJkYTgxYzZmZWYzZmNjNzdhZGRfMjA4NQ_1211ce09-3dec-448b-8b38-81e740c24103"
      unitRef="usd">1400000</us-gaap:Goodwill>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="ie18de39654bc43fabcb2d7cea0396838_D20200701-20200701"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80Ni9mcmFnOjczOTYwYTdlNjAzMDQyZGE4MWM2ZmVmM2ZjYzc3YWRkL3RleHRyZWdpb246NzM5NjBhN2U2MDMwNDJkYTgxYzZmZWYzZmNjNzdhZGRfMjE3Mw_2a16eef9-18d3-4baa-8e5b-e3bc665b0a2c"
      unitRef="usd">11700000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i4e00d646e9b74bf58ee6a91734e5d466_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80Ni9mcmFnOjczOTYwYTdlNjAzMDQyZGE4MWM2ZmVmM2ZjYzc3YWRkL3RleHRyZWdpb246NzM5NjBhN2U2MDMwNDJkYTgxYzZmZWYzZmNjNzdhZGRfODI0NjMzNzIxMjQ3Nw_70e0db60-52cd-41bf-843f-ba2e9d1eb0c7"
      unitRef="usd">1500000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i3858043e51c64ee89cd1d79087a6f765_D20200918-20200918"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80Ni9mcmFnOjczOTYwYTdlNjAzMDQyZGE4MWM2ZmVmM2ZjYzc3YWRkL3RleHRyZWdpb246NzM5NjBhN2U2MDMwNDJkYTgxYzZmZWYzZmNjNzdhZGRfMjc3NA_fd9c27df-9740-407a-85c0-8236492a97dd"
      unitRef="usd">30500000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="i3858043e51c64ee89cd1d79087a6f765_D20200918-20200918"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80Ni9mcmFnOjczOTYwYTdlNjAzMDQyZGE4MWM2ZmVmM2ZjYzc3YWRkL3RleHRyZWdpb246NzM5NjBhN2U2MDMwNDJkYTgxYzZmZWYzZmNjNzdhZGRfMjc3OA_7984a8ea-6c80-4f32-b20b-0015e73d8b18"
      unitRef="usd">24500000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="i90c03c90eadf4fd4868c3d27ca9208b1_I20200918"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80Ni9mcmFnOjczOTYwYTdlNjAzMDQyZGE4MWM2ZmVmM2ZjYzc3YWRkL3RleHRyZWdpb246NzM5NjBhN2U2MDMwNDJkYTgxYzZmZWYzZmNjNzdhZGRfMjgxNw_640be3f4-cd52-4d8e-a953-12e25d2959b9"
      unitRef="usd">29200000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <hae:DisposalGroupIncludingDiscontinuedOperationConsiderationToBeReceived
      contextRef="i90c03c90eadf4fd4868c3d27ca9208b1_I20200918"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80Ni9mcmFnOjczOTYwYTdlNjAzMDQyZGE4MWM2ZmVmM2ZjYzc3YWRkL3RleHRyZWdpb246NzM5NjBhN2U2MDMwNDJkYTgxYzZmZWYzZmNjNzdhZGRfMjg0OA_c3d79e3e-2045-422a-b2c9-1e2764fea240"
      unitRef="usd">1300000</hae:DisposalGroupIncludingDiscontinuedOperationConsiderationToBeReceived>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets
      contextRef="i90c03c90eadf4fd4868c3d27ca9208b1_I20200918"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80Ni9mcmFnOjczOTYwYTdlNjAzMDQyZGE4MWM2ZmVmM2ZjYzc3YWRkL3RleHRyZWdpb246NzM5NjBhN2U2MDMwNDJkYTgxYzZmZWYzZmNjNzdhZGRfMzEzMg_5013751c-d229-4e55-840f-eb1f84ca0013"
      unitRef="usd">2200000</us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet
      contextRef="i90c03c90eadf4fd4868c3d27ca9208b1_I20200918"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80Ni9mcmFnOjczOTYwYTdlNjAzMDQyZGE4MWM2ZmVmM2ZjYzc3YWRkL3RleHRyZWdpb246NzM5NjBhN2U2MDMwNDJkYTgxYzZmZWYzZmNjNzdhZGRfMzE1Nw_1124204d-ede6-44ae-814d-af9c81e31ac4"
      unitRef="usd">2200000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets
      contextRef="i90c03c90eadf4fd4868c3d27ca9208b1_I20200918"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80Ni9mcmFnOjczOTYwYTdlNjAzMDQyZGE4MWM2ZmVmM2ZjYzc3YWRkL3RleHRyZWdpb246NzM5NjBhN2U2MDMwNDJkYTgxYzZmZWYzZmNjNzdhZGRfMzE4MQ_b9ddd127-a4a8-40d4-95a8-7b018059ad25"
      unitRef="usd">300000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="i90c03c90eadf4fd4868c3d27ca9208b1_I20200918"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80Ni9mcmFnOjczOTYwYTdlNjAzMDQyZGE4MWM2ZmVmM2ZjYzc3YWRkL3RleHRyZWdpb246NzM5NjBhN2U2MDMwNDJkYTgxYzZmZWYzZmNjNzdhZGRfMzE5OA_8b6b20c5-f8cf-499e-8ca5-89a6eb687e82"
      unitRef="usd">3300000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:Goodwill
      contextRef="i90c03c90eadf4fd4868c3d27ca9208b1_I20200918"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80Ni9mcmFnOjczOTYwYTdlNjAzMDQyZGE4MWM2ZmVmM2ZjYzc3YWRkL3RleHRyZWdpb246NzM5NjBhN2U2MDMwNDJkYTgxYzZmZWYzZmNjNzdhZGRfMzIyMA_c6c3b46d-1043-4061-918d-ba8b13bda0fb"
      unitRef="usd">3300000</us-gaap:Goodwill>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="id6bd93e1c908460891c53b736309cb36_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80Ni9mcmFnOjczOTYwYTdlNjAzMDQyZGE4MWM2ZmVmM2ZjYzc3YWRkL3RleHRyZWdpb246NzM5NjBhN2U2MDMwNDJkYTgxYzZmZWYzZmNjNzdhZGRfMzM4NA_c41d3c4b-ac37-4878-9790-c599be01afd9"
      unitRef="usd">19800000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80OS9mcmFnOjcwZDk0ZWMzZjk5NjRmMGI4ODYzMWZiZTk0ZGRmNTI3L3RleHRyZWdpb246NzBkOTRlYzNmOTk2NGYwYjg4NjMxZmJlOTRkZGY1MjdfMTcxNA_47162145-2677-4a15-b318-18a6350514d7">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;6. INCOME TAXES &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company conducts business globally and reports its results of operations in a number of foreign jurisdictions in addition to the United States. The Company's reported tax rate is impacted by the jurisdictional mix of earnings in any given period as the foreign jurisdictions in which it operates have tax rates that differ from the U.S. statutory tax rate.&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three and nine months ended December 26, 2020, the Company reported income tax expense of $5.5 million and $9.8&#160;million, respectively, representing effective tax rates of 14.7% and 9.8%, respectively. The effective tax rate for the three and nine months ended December 26, 2020 includes discrete tax benefits recognized from excess stock compensation deductions of $1.0 million and $5.1&#160;million, respectively. The effective tax rates were also impacted by the jurisdictional mix of earnings including divestiture transactions. During the nine months ended December 26, 2020, the Company sold its Fajardo, Puerto Rico manufacturing operations, certain U.S. blood donor management software solution assets, and its wholly-owned subsidiary Inlog Holdings France SAS. The tax expense on divestitures, including the associated valuation allowance impacts, were included in the computation of the annual effective tax rate. Refer to Note 5, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Divestitures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for information pertaining to these divestitures. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three and nine months ended December 28, 2019, the Company reported an income tax provision of $7.9 million and $6.3&#160;million, respectively, representing effective tax rates of 21.0% and 9.6%, respectively. The effective tax rate for the nine months ended December 28, 2019 was lower than the U.S. statutory tax rate primarily due to a discrete tax benefit recognized from excess stock compensation deductions of $3.1&#160;million and $12.4&#160;million, respectively. The effective tax rates were also impacted by the jurisdictional mix of earnings and the impact of the divestiture of the Union, South Carolina facility.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80OS9mcmFnOjcwZDk0ZWMzZjk5NjRmMGI4ODYzMWZiZTk0ZGRmNTI3L3RleHRyZWdpb246NzBkOTRlYzNmOTk2NGYwYjg4NjMxZmJlOTRkZGY1MjdfNDI4_2ddc7bff-1479-4642-b368-6f42dbfed9ca"
      unitRef="usd">5500000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80OS9mcmFnOjcwZDk0ZWMzZjk5NjRmMGI4ODYzMWZiZTk0ZGRmNTI3L3RleHRyZWdpb246NzBkOTRlYzNmOTk2NGYwYjg4NjMxZmJlOTRkZGY1MjdfNDM1_ca5534c8-519d-413b-a44b-6a7d2b051737"
      unitRef="usd">9800000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80OS9mcmFnOjcwZDk0ZWMzZjk5NjRmMGI4ODYzMWZiZTk0ZGRmNTI3L3RleHRyZWdpb246NzBkOTRlYzNmOTk2NGYwYjg4NjMxZmJlOTRkZGY1MjdfNDg5_a5454c74-9ac8-4610-bad9-8d61ca59b1b9"
      unitRef="number">0.147</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80OS9mcmFnOjcwZDk0ZWMzZjk5NjRmMGI4ODYzMWZiZTk0ZGRmNTI3L3RleHRyZWdpb246NzBkOTRlYzNmOTk2NGYwYjg4NjMxZmJlOTRkZGY1MjdfNDk2_0af8f8a3-af4b-46a0-a720-ab683b6c9130"
      unitRef="number">0.098</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions
      contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80OS9mcmFnOjcwZDk0ZWMzZjk5NjRmMGI4ODYzMWZiZTk0ZGRmNTI3L3RleHRyZWdpb246NzBkOTRlYzNmOTk2NGYwYjg4NjMxZmJlOTRkZGY1MjdfNjM1_d012dd20-b0e4-415d-bb5d-33cb5a4e9722"
      unitRef="usd">1000000.0</us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions>
    <us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80OS9mcmFnOjcwZDk0ZWMzZjk5NjRmMGI4ODYzMWZiZTk0ZGRmNTI3L3RleHRyZWdpb246NzBkOTRlYzNmOTk2NGYwYjg4NjMxZmJlOTRkZGY1MjdfNjQy_4d26c7a4-a1e9-44ad-b318-189c6c227065"
      unitRef="usd">5100000</us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80OS9mcmFnOjcwZDk0ZWMzZjk5NjRmMGI4ODYzMWZiZTk0ZGRmNTI3L3RleHRyZWdpb246NzBkOTRlYzNmOTk2NGYwYjg4NjMxZmJlOTRkZGY1MjdfMTI2MA_a35ce2ed-bf76-42b1-940b-c154b24761f5"
      unitRef="usd">7900000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80OS9mcmFnOjcwZDk0ZWMzZjk5NjRmMGI4ODYzMWZiZTk0ZGRmNTI3L3RleHRyZWdpb246NzBkOTRlYzNmOTk2NGYwYjg4NjMxZmJlOTRkZGY1MjdfMTI4MA_9db86f44-8f3c-4552-8ad9-5e3dca69d7d0"
      unitRef="usd">6300000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80OS9mcmFnOjcwZDk0ZWMzZjk5NjRmMGI4ODYzMWZiZTk0ZGRmNTI3L3RleHRyZWdpb246NzBkOTRlYzNmOTk2NGYwYjg4NjMxZmJlOTRkZGY1MjdfMTMzNA_4e0f0c80-3511-4d7f-8d6b-e39eb253bd1f"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80OS9mcmFnOjcwZDk0ZWMzZjk5NjRmMGI4ODYzMWZiZTk0ZGRmNTI3L3RleHRyZWdpb246NzBkOTRlYzNmOTk2NGYwYjg4NjMxZmJlOTRkZGY1MjdfMTM0MQ_973b1700-1284-4816-b395-30e26f8fbdbd"
      unitRef="number">0.096</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions
      contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80OS9mcmFnOjcwZDk0ZWMzZjk5NjRmMGI4ODYzMWZiZTk0ZGRmNTI3L3RleHRyZWdpb246NzBkOTRlYzNmOTk2NGYwYjg4NjMxZmJlOTRkZGY1MjdfMTUzMg_12fa9ab5-7cc4-4bef-8353-5d35f19e8489"
      unitRef="usd">3100000</us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions>
    <us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV80OS9mcmFnOjcwZDk0ZWMzZjk5NjRmMGI4ODYzMWZiZTk0ZGRmNTI3L3RleHRyZWdpb246NzBkOTRlYzNmOTk2NGYwYjg4NjMxZmJlOTRkZGY1MjdfMTUzOQ_820a414f-7414-4ab2-bdd1-33ae6ffd8f1e"
      unitRef="usd">12400000</us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RleHRyZWdpb246NjU1ODE1MTM4MmU3NDMxYjg5YWU1YjNjNmQwNDk4NmFfNzM1_21f79ea1-ea5b-44cd-a04f-137f772d4d2f">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;7. EARNINGS PER SHARE &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of the numerators and denominators of the basic and diluted earnings per share computations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#160;(In thousands, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 28,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 28,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basic EPS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic income per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;0.63&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;0.59&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1.79&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1.16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Diluted EPS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic weighted average shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net effect of common stock equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted weighted average shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted income per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;0.62&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;0.58&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1.77&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1.13&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic earnings per share is calculated using the Company's weighted-average outstanding common stock. Diluted earnings per share is calculated using its weighted-average outstanding common stock including the dilutive effect of stock awards as determined under the treasury stock method. For the three and nine months ended December 26, 2020, weighted average shares outstanding, assuming dilution, excludes the impact of 0.4 million and 0.6&#160;million anti-dilutive shares, respectively. For both the three and nine months ended December 28, 2019, weighted average shares outstanding, assuming dilution, excludes the impact of 0.2&#160;million anti-dilutive shares.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RleHRyZWdpb246NjU1ODE1MTM4MmU3NDMxYjg5YWU1YjNjNmQwNDk4NmFfNzM3_beff60fa-830a-4025-a262-29d60f108bd2">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of the numerators and denominators of the basic and diluted earnings per share computations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#160;(In thousands, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 28,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 28,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basic EPS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic income per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;0.63&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;0.59&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1.79&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1.16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Diluted EPS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic weighted average shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net effect of common stock equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted weighted average shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted income per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;0.62&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;0.58&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1.77&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1.13&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfMy0xLTEtMS0w_25e1969a-8e42-46a2-86c9-e7bd47f453b1"
      unitRef="usd">31882000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i593e5b9ceb9240d1888435f827c761eb_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfMy0xLTEtMS0w_2c8836b8-c96e-4fc9-a8f6-f3306d7f3f9d"
      unitRef="usd">31882000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfMy0zLTEtMS0w_71e8ffb5-836b-4843-8096-33a8f0ce1284"
      unitRef="usd">29895000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfMy01LTEtMS0w_f14be7c7-9723-45dd-8a92-bd00bc5b28a2"
      unitRef="usd">90510000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfMy03LTEtMS0w_9b89c7a6-2ac5-41e5-b2b7-9e84e3c5f3c3"
      unitRef="usd">58902000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfNC0xLTEtMS0w_4bd87dba-35d7-4dd3-915c-1f23d542f561"
      unitRef="shares">50789000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfNC0zLTEtMS0w_23684420-4979-49c0-86e5-fc5df9060f52"
      unitRef="shares">50630000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfNC01LTEtMS0w_a11ae91a-ae83-48de-87f6-f8892d6d754a"
      unitRef="shares">50634000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfNC03LTEtMS0w_f7369501-704f-4a11-97de-c186f4d5d713"
      unitRef="shares">50810000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfNS0xLTEtMS0w_1a37f945-c63e-4a66-a8e6-be30fd0111ad"
      unitRef="usdPerShare">0.63</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfNS0zLTEtMS0w_ce48a8d3-9fa8-4a00-a4f9-76d734def7a6"
      unitRef="usdPerShare">0.59</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfNS01LTEtMS0w_6270ae8d-763a-40de-9b13-5448e84ad388"
      unitRef="usdPerShare">1.79</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfNS03LTEtMS0w_f575fd78-636e-49d7-8ca3-84bcc0e1692e"
      unitRef="usdPerShare">1.16</us-gaap:EarningsPerShareBasic>
    <us-gaap:NetIncomeLoss
      contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfNy0xLTEtMS0w_758fb82e-a817-4c9b-adb8-294b8207a8fa"
      unitRef="usd">31882000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfNy0zLTEtMS0w_80ae592d-9213-4cd4-a3a7-6462926c56c0"
      unitRef="usd">29895000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfNy01LTEtMS0w_239539a8-4952-48a5-b19c-4fe1fbe4d74f"
      unitRef="usd">90510000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfNy03LTEtMS0w_df105f6a-e705-4260-92da-9e71768c189c"
      unitRef="usd">58902000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfOC0xLTEtMS0w_4bd87dba-35d7-4dd3-915c-1f23d542f561"
      unitRef="shares">50789000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfOC0zLTEtMS0w_26ace557-9615-4b30-9a46-0f1e7c5eb82c"
      unitRef="shares">50630000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfOC01LTEtMS0w_a11ae91a-ae83-48de-87f6-f8892d6d754a"
      unitRef="shares">50634000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfOC03LTEtMS0w_572cb851-b16a-46b8-b4d4-302c45b58f37"
      unitRef="shares">50810000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfOS0xLTEtMS0w_fa069adc-7fa4-4e97-8431-045294564467"
      unitRef="shares">574000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfOS0zLTEtMS0w_6e0b15a3-e39a-4738-8f17-afe35b497433"
      unitRef="shares">1008000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfOS01LTEtMS0w_63d6923c-64db-4575-bea3-90ce50bd8ab3"
      unitRef="shares">600000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfOS03LTEtMS0w_dc2dab91-66d1-4cad-9480-b64d17aa39e7"
      unitRef="shares">1185000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfMTAtMS0xLTEtMA_0353f13b-e23e-441c-910b-3d2abc056499"
      unitRef="shares">51363000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfMTAtMy0xLTEtMA_5a8e2e0c-d178-473b-89e9-2a6b596f4629"
      unitRef="shares">51638000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfMTAtNS0xLTEtMA_ddf057e2-5345-41c9-be30-9ce7f3f6e066"
      unitRef="shares">51234000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfMTAtNy0xLTEtMA_f2e3da2d-e4b5-4e3d-b607-f1dee1ada187"
      unitRef="shares">51995000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfMTEtMS0xLTEtMA_54a5b9e4-5f19-4402-92c4-c82a0c17d2f0"
      unitRef="usdPerShare">0.62</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfMTEtMy0xLTEtMA_ae9fe9aa-076c-450e-9fcb-5cdfacc0b8f1"
      unitRef="usdPerShare">0.58</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfMTEtNS0xLTEtMA_d5540280-8a6b-42d4-a99c-476368adab1e"
      unitRef="usdPerShare">1.77</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RhYmxlOjhiNjBiYTc3MGJhMTRkNWNiOGQ0ZTNlZWQ1ZDE5ZDYzL3RhYmxlcmFuZ2U6OGI2MGJhNzcwYmExNGQ1Y2I4ZDRlM2VlZDVkMTlkNjNfMTEtNy0xLTEtMA_f84e01a5-4e80-4f8f-b448-b3963d98359e"
      unitRef="usdPerShare">1.13</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RleHRyZWdpb246NjU1ODE1MTM4MmU3NDMxYjg5YWU1YjNjNmQwNDk4NmFfNTMz_08868977-ecac-4cc7-ab40-814baf340798"
      unitRef="shares">400000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RleHRyZWdpb246NjU1ODE1MTM4MmU3NDMxYjg5YWU1YjNjNmQwNDk4NmFfNTQw_ae06c578-077f-4899-a636-ffdc82942615"
      unitRef="shares">600000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81NS9mcmFnOjY1NTgxNTEzODJlNzQzMWI4OWFlNWIzYzZkMDQ5ODZhL3RleHRyZWdpb246NjU1ODE1MTM4MmU3NDMxYjg5YWU1YjNjNmQwNDk4NmFfNjg0_a1207fd3-6f56-4a2e-bc01-ad08b8bf5377"
      unitRef="shares">200000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81OC9mcmFnOjNjZDkyMjcwZDg3MjRmNTU4YTc1MzM3ZDg5NDRiMTIyL3RleHRyZWdpb246M2NkOTIyNzBkODcyNGY1NThhNzUzMzdkODk0NGIxMjJfMzIxNw_8109fc1a-9e8d-4e03-9858-f0fbc6ddfb0e">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;8. REVENUE &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's revenue recognition policy is to recognize revenues from product sales, software and services in accordance with ASC Topic 606,&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Revenue is recognized when obligations under the terms of a contract with a customer are satisfied; this occurs with the transfer of control of the Company&#x2019;s goods or services. The Company considers revenue to be earned when all of the following criteria are met: it has a contract with a customer that creates enforceable rights and obligations; promised products or services are identified; the transaction price, or the consideration it expects to receive for transferring goods or providing services, is determinable and it has transferred control of the promised items to the customer. A promise in a contract to transfer a distinct good or service to the customer is identified as a performance obligation. A contract&#x2019;s transaction price is allocated to each performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. Some of the Company&#x2019;s contracts have multiple performance obligations. For contracts with multiple performance obligations, the Company allocates the contract&#x2019;s transaction price to each performance obligation based on the estimated standalone selling prices of the good or service in the contract. For goods or services for which observable standalone selling prices are not available, the Company uses an expected cost plus a margin approach to estimate the standalone selling price of each performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;26, 2020, the Company had $17.9 million of its transaction price allocated to remaining performance obligations related to executed contracts with an original duration of one year or more. The Company expects to recognize approximately 59% of this amount as revenue within the next twelve months and the remaining balance thereafter.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and customer advances and deposits (contract liabilities) on the condensed consolidated balance sheets. The difference in timing between billing and revenue recognition primarily occurs in software licensing arrangements, resulting in contract assets and contract liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;26, 2020 and March&#160;28, 2020, the Company had contract assets of $5.4 million and $5.0 million, respectively. The change is primarily due to the delay in billings compared to the revenue recognized. Contract assets are classified as other current assets and other long-term assets on the condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;26, 2020 and March&#160;28, 2020, the Company had contract liabilities of $16.7 million and $20.8 million, respectively. During the three and nine months ended December 26, 2020, the Company recognized $2.5 million and $16.3 million, respectively, of revenue that was included in the above March&#160;28, 2020 contract liability balance. Contract liabilities decreased by an additional $2.5&#160;million during the three and nine months ended December 26, 2020 as a result of the sale of certain U.S. blood donor management software solution assets and the Company's wholly-owned subsidiary Inlog Holdings France SAS. Refer to Note 5, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Divestitures&lt;/span&gt; for additional detail. Contract liabilities are classified as other liabilities and other long-term liabilities on the condensed consolidated balance sheets.</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81OC9mcmFnOjNjZDkyMjcwZDg3MjRmNTU4YTc1MzM3ZDg5NDRiMTIyL3RleHRyZWdpb246M2NkOTIyNzBkODcyNGY1NThhNzUzMzdkODk0NGIxMjJfMTYwMw_70df73a3-4149-4a29-86cf-91ee503fec42"
      unitRef="usd">17900000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81OC9mcmFnOjNjZDkyMjcwZDg3MjRmNTU4YTc1MzM3ZDg5NDRiMTIyL3RleHRyZWdpb246M2NkOTIyNzBkODcyNGY1NThhNzUzMzdkODk0NGIxMjJfMTgwMg_92021fb8-fdca-481f-a885-201aeecb731b"
      unitRef="number">0.59</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i241ec033d3e44caf9ae5188ed0acd523_I20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81OC9mcmFnOjNjZDkyMjcwZDg3MjRmNTU4YTc1MzM3ZDg5NDRiMTIyL3RleHRyZWdpb246M2NkOTIyNzBkODcyNGY1NThhNzUzMzdkODk0NGIxMjJfMTg0Nw_841ddd5a-dd5f-42e2-963a-f92230d6a880">P12M</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81OC9mcmFnOjNjZDkyMjcwZDg3MjRmNTU4YTc1MzM3ZDg5NDRiMTIyL3RleHRyZWdpb246M2NkOTIyNzBkODcyNGY1NThhNzUzMzdkODk0NGIxMjJfMjM2Mw_62041a68-782d-4b65-9d25-212350580b6e"
      unitRef="usd">5400000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81OC9mcmFnOjNjZDkyMjcwZDg3MjRmNTU4YTc1MzM3ZDg5NDRiMTIyL3RleHRyZWdpb246M2NkOTIyNzBkODcyNGY1NThhNzUzMzdkODk0NGIxMjJfMjM3MA_b24ef384-e5e7-4e96-a4a1-c3b64bd2b732"
      unitRef="usd">5000000.0</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerLiability
      contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81OC9mcmFnOjNjZDkyMjcwZDg3MjRmNTU4YTc1MzM3ZDg5NDRiMTIyL3RleHRyZWdpb246M2NkOTIyNzBkODcyNGY1NThhNzUzMzdkODk0NGIxMjJfMjY2Mw_041e9af7-131d-429f-8352-a01ea0e0c265"
      unitRef="usd">16700000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81OC9mcmFnOjNjZDkyMjcwZDg3MjRmNTU4YTc1MzM3ZDg5NDRiMTIyL3RleHRyZWdpb246M2NkOTIyNzBkODcyNGY1NThhNzUzMzdkODk0NGIxMjJfMjY3MA_906d3d69-e733-40e4-8013-7e4e7ac5d404"
      unitRef="usd">20800000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81OC9mcmFnOjNjZDkyMjcwZDg3MjRmNTU4YTc1MzM3ZDg5NDRiMTIyL3RleHRyZWdpb246M2NkOTIyNzBkODcyNGY1NThhNzUzMzdkODk0NGIxMjJfMjcyNg_8537597f-4ba0-4a18-bfa5-b8df3dc67572"
      unitRef="usd">2500000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81OC9mcmFnOjNjZDkyMjcwZDg3MjRmNTU4YTc1MzM3ZDg5NDRiMTIyL3RleHRyZWdpb246M2NkOTIyNzBkODcyNGY1NThhNzUzMzdkODk0NGIxMjJfMjczMw_fcb09a95-0562-48b6-bb49-45ca81f27d8f"
      unitRef="usd">16300000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81OC9mcmFnOjNjZDkyMjcwZDg3MjRmNTU4YTc1MzM3ZDg5NDRiMTIyL3RleHRyZWdpb246M2NkOTIyNzBkODcyNGY1NThhNzUzMzdkODk0NGIxMjJfMjg3Mg_65d9f4b2-5850-4031-bc65-805ed953dd37"
      unitRef="usd">-2500000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV81OC9mcmFnOjNjZDkyMjcwZDg3MjRmNTU4YTc1MzM3ZDg5NDRiMTIyL3RleHRyZWdpb246M2NkOTIyNzBkODcyNGY1NThhNzUzMzdkODk0NGIxMjJfMjg3Mg_9fb8dc9c-295e-4e08-9c40-4233653b340a"
      unitRef="usd">-2500000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV82MS9mcmFnOmI4YzE4ZjYwNDZjZjQzMjg5N2EyZDFiNTgzNGRiOWUyL3RleHRyZWdpb246YjhjMThmNjA0NmNmNDMyODk3YTJkMWI1ODM0ZGI5ZTJfMTkx_a5820338-0f33-423d-b16e-7a0ae07717eb">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;9. INVENTORIES &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories are stated at the lower of cost or market and include the cost of material, labor and manufacturing overhead. Cost is determined using the first-in, first-out method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.944%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.143%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 28, &lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;299,710&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;270,276&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV82MS9mcmFnOmI4YzE4ZjYwNDZjZjQzMjg5N2EyZDFiNTgzNGRiOWUyL3RleHRyZWdpb246YjhjMThmNjA0NmNmNDMyODk3YTJkMWI1ODM0ZGI5ZTJfMTk1_1422f6b2-505b-4c90-81be-5b1313912f84">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories are stated at the lower of cost or market and include the cost of material, labor and manufacturing overhead. Cost is determined using the first-in, first-out method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.944%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.143%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 28, &lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;299,710&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;270,276&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV82MS9mcmFnOmI4YzE4ZjYwNDZjZjQzMjg5N2EyZDFiNTgzNGRiOWUyL3RhYmxlOjAyM2E0NjNjY2I4YTQ1NGE4ZjQ2MGQ0NWI1ODc3OTFmL3RhYmxlcmFuZ2U6MDIzYTQ2M2NjYjhhNDU0YThmNDYwZDQ1YjU4Nzc5MWZfMS0yLTEtMS0w_5d805fa5-80d6-4579-a5ae-97b1f7be2396"
      unitRef="usd">74437000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV82MS9mcmFnOmI4YzE4ZjYwNDZjZjQzMjg5N2EyZDFiNTgzNGRiOWUyL3RhYmxlOjAyM2E0NjNjY2I4YTQ1NGE4ZjQ2MGQ0NWI1ODc3OTFmL3RhYmxlcmFuZ2U6MDIzYTQ2M2NjYjhhNDU0YThmNDYwZDQ1YjU4Nzc5MWZfMS00LTEtMS0w_482d135e-4b00-40e1-afef-0d128e286b21"
      unitRef="usd">76867000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV82MS9mcmFnOmI4YzE4ZjYwNDZjZjQzMjg5N2EyZDFiNTgzNGRiOWUyL3RhYmxlOjAyM2E0NjNjY2I4YTQ1NGE4ZjQ2MGQ0NWI1ODc3OTFmL3RhYmxlcmFuZ2U6MDIzYTQ2M2NjYjhhNDU0YThmNDYwZDQ1YjU4Nzc5MWZfMi0yLTEtMS0w_704aff31-dce0-4849-9187-fdd788fa82eb"
      unitRef="usd">22030000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV82MS9mcmFnOmI4YzE4ZjYwNDZjZjQzMjg5N2EyZDFiNTgzNGRiOWUyL3RhYmxlOjAyM2E0NjNjY2I4YTQ1NGE4ZjQ2MGQ0NWI1ODc3OTFmL3RhYmxlcmFuZ2U6MDIzYTQ2M2NjYjhhNDU0YThmNDYwZDQ1YjU4Nzc5MWZfMi00LTEtMS0w_2e427561-5dce-441b-9d64-15d528d9699a"
      unitRef="usd">11021000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV82MS9mcmFnOmI4YzE4ZjYwNDZjZjQzMjg5N2EyZDFiNTgzNGRiOWUyL3RhYmxlOjAyM2E0NjNjY2I4YTQ1NGE4ZjQ2MGQ0NWI1ODc3OTFmL3RhYmxlcmFuZ2U6MDIzYTQ2M2NjYjhhNDU0YThmNDYwZDQ1YjU4Nzc5MWZfMy0yLTEtMS0w_2b33ed25-27a7-4f6a-888f-a452f1d5ac76"
      unitRef="usd">203243000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV82MS9mcmFnOmI4YzE4ZjYwNDZjZjQzMjg5N2EyZDFiNTgzNGRiOWUyL3RhYmxlOjAyM2E0NjNjY2I4YTQ1NGE4ZjQ2MGQ0NWI1ODc3OTFmL3RhYmxlcmFuZ2U6MDIzYTQ2M2NjYjhhNDU0YThmNDYwZDQ1YjU4Nzc5MWZfMy00LTEtMS0w_d856076f-dace-495a-8fd3-c0ce334c1a02"
      unitRef="usd">182388000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV82MS9mcmFnOmI4YzE4ZjYwNDZjZjQzMjg5N2EyZDFiNTgzNGRiOWUyL3RhYmxlOjAyM2E0NjNjY2I4YTQ1NGE4ZjQ2MGQ0NWI1ODc3OTFmL3RhYmxlcmFuZ2U6MDIzYTQ2M2NjYjhhNDU0YThmNDYwZDQ1YjU4Nzc5MWZfNC0yLTEtMS0w_1ca32271-c54b-4e59-b34f-e50ba77b1990"
      unitRef="usd">299710000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV82MS9mcmFnOmI4YzE4ZjYwNDZjZjQzMjg5N2EyZDFiNTgzNGRiOWUyL3RhYmxlOjAyM2E0NjNjY2I4YTQ1NGE4ZjQ2MGQ0NWI1ODc3OTFmL3RhYmxlcmFuZ2U6MDIzYTQ2M2NjYjhhNDU0YThmNDYwZDQ1YjU4Nzc5MWZfNC00LTEtMS0w_d563b93f-6642-41cb-97e6-1ffb93bc8dc5"
      unitRef="usd">270276000</us-gaap:InventoryNet>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV82NC9mcmFnOjc2OTk3NDk1NTM2NjRmNzlhNjNiMjA4OGEzM2Y2YzcxL3RleHRyZWdpb246NzY5OTc0OTU1MzY2NGY3OWE2M2IyMDg4YTMzZjZjNzFfMTYxNg_ccd94338-2743-42b9-9ac4-bd5b561ef0db">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;10. LEASES &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Lessee Activity&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of fiscal 2021, the Company entered into a lease for manufacturing space in Clinton, PA. The Company's current manufacturing operations in Leetsdale, PA will be relocated. The lease term associated with the new manufacturing facility is 15 years and 7 months and includes two &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV82NC9mcmFnOjc2OTk3NDk1NTM2NjRmNzlhNjNiMjA4OGEzM2Y2YzcxL3RleHRyZWdpb246NzY5OTc0OTU1MzY2NGY3OWE2M2IyMDg4YTMzZjZjNzFfMzI4_d1261318-cbde-4310-8bac-529fcbd30bd5"&gt;five&lt;/span&gt; year renewal options followed by one &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV82NC9mcmFnOjc2OTk3NDk1NTM2NjRmNzlhNjNiMjA4OGEzM2Y2YzcxL3RleHRyZWdpb246NzY5OTc0OTU1MzY2NGY3OWE2M2IyMDg4YTMzZjZjNzFfMzY4_fdeb1860-c6a9-478a-81ce-84942fec66c9"&gt;four&lt;/span&gt; year renewal option. During the first quarter of fiscal 2021, the Company recorded a right-of-use asset of $11.3 million and corresponding liabilities of $15.4 million upon commencement of the lease term in May 2020. In addition, the Company recorded a $4.1 &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;million lease incentive receivable associated with this lease agreement which was received during the third quarter of fiscal 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Lessor Activity&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets on the Company's balance sheet classified as Haemonetics equipment primarily consists of medical devices installed at customer sites but owned by Haemonetics. These devices are leased to customers under contractual arrangements that typically include an operating or sales-type lease as well as the purchase and consumption of a certain level of disposable products. Sales-type leases are not significant. Contract terms vary by customer and may include options to terminate the contract or options to extend the contract. Where devices are provided under operating lease arrangements, a substantial majority of the entire lease revenue is variable and subject to subsequent non-lease component (disposable products) sales. The allocation of revenue between the lease and non-lease components is based on stand-alone selling prices. Operating lease revenue represents less than 3 percent of the Company's total net sales.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ib56a8928767949d4bf60e3aee31e1600_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV82NC9mcmFnOjc2OTk3NDk1NTM2NjRmNzlhNjNiMjA4OGEzM2Y2YzcxL3RleHRyZWdpb246NzY5OTc0OTU1MzY2NGY3OWE2M2IyMDg4YTMzZjZjNzFfNDc4_a88873c8-ea96-4fdc-a079-f662411b5d4b"
      unitRef="usd">11300000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="ib56a8928767949d4bf60e3aee31e1600_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV82NC9mcmFnOjc2OTk3NDk1NTM2NjRmNzlhNjNiMjA4OGEzM2Y2YzcxL3RleHRyZWdpb246NzY5OTc0OTU1MzY2NGY3OWE2M2IyMDg4YTMzZjZjNzFfNTE0_ae585a27-917d-449b-b8f9-31a829ed205f"
      unitRef="usd">15400000</us-gaap:OperatingLeaseLiability>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ib56a8928767949d4bf60e3aee31e1600_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV82NC9mcmFnOjc2OTk3NDk1NTM2NjRmNzlhNjNiMjA4OGEzM2Y2YzcxL3RleHRyZWdpb246NzY5OTc0OTU1MzY2NGY3OWE2M2IyMDg4YTMzZjZjNzFfNjAy_8ff30335-6ed4-4d93-a268-4953b354a52c"
      unitRef="usd">4100000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83MC9mcmFnOjc1NDg0Y2NjZWE0NjQ4MzViYmRkNTBiY2Q1Yjg4YjBlL3RleHRyZWdpb246NzU0ODRjY2NlYTQ2NDgzNWJiZGQ1MGJjZDViODhiMGVfMTQwNQ_2e218482-caeb-4b2b-afe1-6a57645c7092">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;11. NOTES&#160;PAYABLE AND LONG-TERM DEBT &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 15, 2018, the Company entered into a credit agreement with certain lenders which provided for a $350.0 million term loan (the &#x201c;Term Loan&#x201d;) and a $350.0 million revolving loan (the &#x201c;Revolving Credit Facility&#x201d; and together with the Term Loan, the &#x201c;Credit Facilities&#x201d;). The Credit Facilities expire on June 15, 2023. Interest on the Credit Facilities is established using LIBOR plus 1.13% - 1.75%, depending on the Company's leverage ratio. Under the Credit Facilities, the Company is required to maintain certain leverage and interest coverage ratios specified in the credit agreement as well as other customary non-financial affirmative and negative covenants. At December&#160;26, 2020, $310.6 million was outstanding under the Term Loan with an effective interest rate of 1.4%. There were no borrowings outstanding on the Revolving Credit Facility. The Company also has $26.2 million of uncommitted operating lines of credit to fund its global operations under which there were no outstanding borrowings as of December&#160;26, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has required scheduled principal payments of $8.7 million during the remainder of fiscal 2021, $17.5 million during fiscal 2022, $214.4 million during fiscal 2023 and $70.0 million during fiscal 2024. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company was in compliance with the leverage and interest coverage ratios specified in the Credit Facilities as well as all other bank covenants as of December&#160;26, 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i7c25c1d4590644eb8b651796c671219c_I20180615"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83MC9mcmFnOjc1NDg0Y2NjZWE0NjQ4MzViYmRkNTBiY2Q1Yjg4YjBlL3RleHRyZWdpb246NzU0ODRjY2NlYTQ2NDgzNWJiZGQ1MGJjZDViODhiMGVfMTE0_2b6ec305-65d4-4c34-9682-571208da8e11"
      unitRef="usd">350000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i4426464d081b45bb8839adced8fe2873_I20180615"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83MC9mcmFnOjc1NDg0Y2NjZWE0NjQ4MzViYmRkNTBiY2Q1Yjg4YjBlL3RleHRyZWdpb246NzU0ODRjY2NlYTQ2NDgzNWJiZGQ1MGJjZDViODhiMGVfMTUx_a076c77d-6253-45bf-b6c4-db674c9f9519"
      unitRef="usd">350000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ic5d1fce0362544e68a49594cab3a1aa8_D20180615-20180615"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83MC9mcmFnOjc1NDg0Y2NjZWE0NjQ4MzViYmRkNTBiY2Q1Yjg4YjBlL3RleHRyZWdpb246NzU0ODRjY2NlYTQ2NDgzNWJiZGQ1MGJjZDViODhiMGVfMzc0_a8302392-6fea-48a0-9136-a77a75bc4bd6"
      unitRef="number">0.0113</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ic9a17518f7194d808968c5442709d4d4_D20180615-20180615"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83MC9mcmFnOjc1NDg0Y2NjZWE0NjQ4MzViYmRkNTBiY2Q1Yjg4YjBlL3RleHRyZWdpb246NzU0ODRjY2NlYTQ2NDgzNWJiZGQ1MGJjZDViODhiMGVfMzc5_05a7f461-7657-429d-b08c-d654423969b5"
      unitRef="number">0.0175</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LongTermDebt
      contextRef="ifd1b9a587aec4cdca6306687ea65c1a4_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83MC9mcmFnOjc1NDg0Y2NjZWE0NjQ4MzViYmRkNTBiY2Q1Yjg4YjBlL3RleHRyZWdpb246NzU0ODRjY2NlYTQ2NDgzNWJiZGQ1MGJjZDViODhiMGVfNjU1_c8b1cb89-2ceb-4ce6-ba64-374b521d69b5"
      unitRef="usd">310600000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="ifd1b9a587aec4cdca6306687ea65c1a4_I20201226"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83MC9mcmFnOjc1NDg0Y2NjZWE0NjQ4MzViYmRkNTBiY2Q1Yjg4YjBlL3RleHRyZWdpb246NzU0ODRjY2NlYTQ2NDgzNWJiZGQ1MGJjZDViODhiMGVfNzI5_2d20ddde-f329-4952-a1da-a5194b4cfe0a"
      unitRef="number">0.014</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i4842b0c162ea46978645dd51b56a0764_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83MC9mcmFnOjc1NDg0Y2NjZWE0NjQ4MzViYmRkNTBiY2Q1Yjg4YjBlL3RleHRyZWdpb246NzU0ODRjY2NlYTQ2NDgzNWJiZGQ1MGJjZDViODhiMGVfOTQz_4945c9d6-fd56-43bc-8777-db8069d89189"
      unitRef="usd">26200000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LongTermDebt
      contextRef="i4842b0c162ea46978645dd51b56a0764_I20201226"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83MC9mcmFnOjc1NDg0Y2NjZWE0NjQ4MzViYmRkNTBiY2Q1Yjg4YjBlL3RleHRyZWdpb246NzU0ODRjY2NlYTQ2NDgzNWJiZGQ1MGJjZDViODhiMGVfMTA0MA_b1338eca-bdb6-4f1b-9d24-fdcaea79a335"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
      contextRef="i075eaab3aa4549bb8d0f597beca1bd0f_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83MC9mcmFnOjc1NDg0Y2NjZWE0NjQ4MzViYmRkNTBiY2Q1Yjg4YjBlL3RleHRyZWdpb246NzU0ODRjY2NlYTQ2NDgzNWJiZGQ1MGJjZDViODhiMGVfMTEzNA_90d66632-8729-4b07-beac-25e00fb7ec43"
      unitRef="usd">8700000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i075eaab3aa4549bb8d0f597beca1bd0f_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83MC9mcmFnOjc1NDg0Y2NjZWE0NjQ4MzViYmRkNTBiY2Q1Yjg4YjBlL3RleHRyZWdpb246NzU0ODRjY2NlYTQ2NDgzNWJiZGQ1MGJjZDViODhiMGVfMTE3NA_426607cf-62f4-4deb-a2f4-20863f98f539"
      unitRef="usd">17500000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i075eaab3aa4549bb8d0f597beca1bd0f_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83MC9mcmFnOjc1NDg0Y2NjZWE0NjQ4MzViYmRkNTBiY2Q1Yjg4YjBlL3RleHRyZWdpb246NzU0ODRjY2NlYTQ2NDgzNWJiZGQ1MGJjZDViODhiMGVfMTE5Nw_e43a3d1e-9617-4f7c-9f99-eadfef612d77"
      unitRef="usd">214400000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="i075eaab3aa4549bb8d0f597beca1bd0f_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83MC9mcmFnOjc1NDg0Y2NjZWE0NjQ4MzViYmRkNTBiY2Q1Yjg4YjBlL3RleHRyZWdpb246NzU0ODRjY2NlYTQ2NDgzNWJiZGQ1MGJjZDViODhiMGVfMTIyMw_26d2c202-3352-4ca0-b55d-ab4c9ac60691"
      unitRef="usd">70000000.0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:DerivativesAndFairValueTextBlock
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RleHRyZWdpb246NDkzMGI5ZjM2MzE1NDU1MjgyOTZhYjk0MWVjODM0ZDJfMTE0ODI_d3815b83-443f-4b72-a65c-386abf57016c">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;12. FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company manufactures, markets and sells its products globally. During the three and nine months ended December 26, 2020, 38.6% and 40.7%, respectively, of the Company's sales were generated outside the U.S., generally in foreign currencies. The Company also incurs certain manufacturing, marketing and selling costs in international markets in local currency.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accordingly, earnings and cash flows are exposed to market risk from changes in foreign currency exchange rates relative to the U.S. Dollar, the Company's reporting currency. The Company has a program in place that is designed to mitigate the exposure to changes in foreign currency exchange rates. That program includes the use of derivative financial instruments to minimize, for a period of time, the impact on its financial results from changes in foreign exchange rates. The Company utilizes foreign currency forward contracts to hedge the anticipated cash flows from transactions denominated in foreign currencies, primarily the Japanese Yen and the Euro, and to a lesser extent the Swiss Franc, Australian Dollar, Canadian Dollar and the Mexican Peso. This does not eliminate the impact of the volatility of foreign exchange rates. However, because the Company generally enters into forward contracts one year out, rates are fixed for a one-year period, thereby facilitating financial planning and resource allocation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Designated Foreign Currency Hedge Contracts&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All of the Company's designated foreign currency hedge contracts as of December&#160;26, 2020 and March&#160;28, 2020 were cash flow hedges under ASC 815, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivatives and Hedging &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;ASC 815&#x201d;). The Company records the effective portion of any change in the fair value of designated foreign currency hedge contracts in other comprehensive income until the related third-party transaction occurs. Once the related third-party transaction occurs, the Company reclassifies the effective portion of any related gain or loss on the designated foreign currency hedge contracts to earnings. In the event the hedged forecasted transaction does not occur, or it becomes probable that it will not occur, the Company would reclassify the amount of any gain or loss on the related cash flow hedge to earnings at that time. The Company had designated foreign currency hedge contracts outstanding in the contract amount of $78.8 million as of December&#160;26, 2020 and $93.8 million as of March&#160;28, 2020. At December&#160;26, 2020, a loss of $1.4 million, net of tax, will be reclassified to earnings within the next twelve months. Substantially all currency cash flow hedges outstanding as of December&#160;26, 2020 mature within twelve months.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Non-Designated Foreign Currency Contracts&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company manages its exposure to changes in foreign currency on a consolidated basis to take advantage of offsetting transactions and balances. It uses foreign currency forward contracts as a part of its strategy to manage exposure related to foreign currency denominated monetary assets and liabilities. These foreign currency forward contracts are entered into for periods consistent with currency transaction exposures, generally one month. They are not designated as cash flow or fair value hedges under ASC 815. These forward contracts are marked-to-market with changes in fair value recorded to earnings. The Company had non-designated foreign currency hedge contracts under ASC 815 outstanding in the contract amount of $90.5 million as of December&#160;26, 2020 and $98.0 million as of March&#160;28, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Interest Rate Swaps&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 15, 2018, the Company entered into Credit Facilities which provided for a $350.0 million Term Loan and a $350.0 million Revolving Credit Facility. Under the terms of the Credit Facilities, interest is established using LIBOR plus 1.13% - 1.75%. As a result, the Company's earnings and cash flows are exposed to interest rate risk from changes to LIBOR. Part of the Company's interest rate risk management strategy includes the use of interest rate swaps to mitigate its exposure to changes in variable interest rates. The Company's objective in using interest rate swaps is to add stability to interest expense and to manage and reduce the risk inherent in interest rate fluctuations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the Company entered into two interest rate swap agreements (the &#x201c;Swaps&#x201d;) to pay an average fixed rate of 2.80% on a total notional value of $241.9 million of debt. As a result of the Swaps, 70% of the Term Loan previously exposed to interest rate risk from changes in LIBOR is now fixed at a rate of 4.05%. The Swaps mature on June 15, 2023. The Company designated the Swaps as cash flow hedges of variable interest rate risk associated with $345.6&#160;million of indebtedness. For the nine months ended December 26, 2020, a gain of $0.3&#160;million, net of tax, was recorded in accumulated other comprehensive loss to recognize the effective portion of the fair value of the Swaps that qualify as cash flow hedges. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Trade Receivables&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the ordinary course of business, the Company grants trade credit to its customers on normal credit terms. In an effort to reduce its credit risk, the Company (i) establishes credit limits for all customers, (ii) performs ongoing credit evaluations of customers&#x2019; financial condition, (iii) monitors the payment history and aging of customers&#x2019; receivables, and (iv) monitors open orders against an individual customer&#x2019;s outstanding receivable balance.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's allowance for credit losses is maintained for trade accounts receivable based on the expected collectability, the historical collection experience, the length of time an account is outstanding, the financial position of the customer and information provided by credit rating services. Effective March 29, 2020, the Company adopted Update No. 2016-13,&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments &#x2013; Credit Losses&#160;(Topic 326)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; which requires consideration of events or circumstances indicating historic collection rates may not be indicative of future collectability. For example, potential adverse changes to customer liquidity from new macroeconomic events such as the COVID-19 pandemic must be taken into consideration. To date, the Company has not experienced significant customer payment defaults, or identified other significant collectability concerns as a result of the pandemic.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a rollforward of the allowance for credit losses:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.684%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.231%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.231%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.231%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.526%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.235%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,699&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,108&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,824&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,937&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Credit (gain) loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(95)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(838)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Write-offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(79)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(240)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(461)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(355)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,525&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,097&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,525&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,097&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fair Value of Derivative Instruments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the effect of the Company's derivative instruments designated as cash flow hedges and those not designated as hedging instruments under ASC 815 in its condensed consolidated statements of income and comprehensive income for the nine months ended December&#160;26, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.493%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.203%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amount of Gain&lt;br/&gt;(Loss) Recognized&lt;br/&gt;in Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amount of Gain (Loss) Reclassified&lt;br/&gt;from Accumulated Other Comprehensive Loss into&lt;br/&gt;Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Location in&lt;br/&gt;Condensed Consolidated Statements of Income and Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amount of Gain (Loss) Excluded from&lt;br/&gt;Effectiveness&lt;br/&gt;Testing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Location in&lt;br/&gt;Condensed Consolidated Statements of Income and Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Designated foreign currency hedge contracts, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,538)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenues, COGS and SG&amp;amp;A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(671)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest and other expense, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-designated foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,218)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest and other expense, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Designated interest rate swaps, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,996)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,326)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest and other expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company did not have fair value hedges or net investment hedges outstanding as of December&#160;26, 2020 or March&#160;28, 2020. As of December&#160;26, 2020, no material deferred tax assets were recognized for designated foreign currency hedges.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASC 815 requires all derivative instruments to be recognized at their fair values as either assets or liabilities on the balance sheet. The Company determines the fair value of its derivative instruments using the framework prescribed by ASC 820, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements and Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, by considering the estimated amount it would receive or pay to sell or transfer these instruments at the reporting date and by taking into account current interest rates, currency exchange rates, current interest rate curves, interest rate volatilities, the creditworthiness of the counterparty for assets, and its creditworthiness for liabilities. In certain instances, the Company may utilize financial models to measure fair value. Generally, it uses inputs that include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; other observable inputs for the asset or liability; and inputs derived principally from, or corroborated by, observable market data by correlation or other means. As of December&#160;26, 2020, the Company has classified its derivative &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;assets and liabilities within Level 2 of the fair value hierarchy prescribed by ASC 815, as discussed below, because these observable inputs are available for substantially the full term of its derivative instruments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present the fair value of the Company's derivative instruments as they appear in its condensed consolidated balance sheets as of December&#160;26, 2020 and March&#160;28, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.859%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.863%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Location in Condensed Consolidated&lt;br/&gt;Balance Sheets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Designated foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-designated foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;260&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,216&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Designated foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-designated foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Designated interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Designated interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;13,145&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;18,345&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is defined as the exit price that would be received from the sale of an asset or paid to transfer a liability, using assumptions that market participants would use in pricing an asset or liability. The fair value guidance establishes the following three-level hierarchy used for measuring fair value:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 1 &#x2014; Inputs to the valuation methodology are quoted market prices for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 2 &#x2014; Inputs to the valuation methodology are other observable inputs, including quoted market prices for similar assets or liabilities and market-corroborated inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 3 &#x2014; Inputs to the valuation methodology are unobservable inputs based on management&#x2019;s best estimate of inputs market participants would use in pricing the asset or liability at the measurement date, including assumptions about risk.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's money market funds carried at fair value are classified within Level 1 of the fair value hierarchy because they are valued using quoted market prices.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fair Value Measured on a Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial assets and financial liabilities measured at fair value on a recurring basis consist of the following as of December&#160;26, 2020 and March&#160;28, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Designated foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-designated foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;79,773&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;260&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;80,033&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Designated foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-designated foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Designated interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;13,145&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,920&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;17,065&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="21" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of March 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Designated foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-designated foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;44,564&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,216&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;45,780&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Designated foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-designated foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Designated interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;18,345&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;18,345&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Foreign currency hedge contracts - &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of foreign currency hedge contracts was measured using significant other observable inputs and valued by reference to over-the-counter quoted market prices for similar instruments. The Company does not believe that the fair value of these derivative instruments differs significantly from the amount that could be realized upon settlement or maturity, or that the changes in fair value will have a significant effect on its results of operations, financial condition or cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest rate swaps - &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair values of interest rate swaps are measured using the present value of expected future cash flows using market-based observable inputs, including credit risk and interest rate yield curves. The Company does not believe that the fair values of these derivative instruments differ significantly from the amounts that could be realized upon settlement or maturity, or that the changes in fair value will have a significant effect on its results of operations, financial condition or cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingent consideration&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - The fair value of contingent consideration liabilities is based on significant unobservable inputs, including management estimates and assumptions, and is measured based on the probability-weighted present value of the payments expected to be made. Accordingly, the fair value of contingent consideration has been classified as level 3 within the fair value hierarchy. The recurring level 3 fair value measurements of contingent consideration liabilities include the following significant unobservable inputs:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.988%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value at&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Valuation &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unobservable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Technique&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Range&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue-based payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td rowspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted cash flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.5%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected year of payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021 - 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Regulatory-based payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td rowspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted cash flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Probability of payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0% - 100%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected year of payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021 - 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;26, 2020, the maximum potential contingent consideration that the Company could be required to pay is $4.5&#160;million. The fair value of contingent consideration associated with acquisitions was $3.9&#160;million at December&#160;26, 2020. As of December&#160;26, 2020, $0.5&#160;million was included in other liabilities and $3.4&#160;million was included in other long-term liabilities on the condensed consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the change in the fair value of contingent consideration is included in the following table:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition date fair value of contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,920&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other Fair Value Disclosures&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Term Loan, which is carried at amortized cost, accounts receivable and accounts payable approximate fair value.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativesAndFairValueTextBlock>
    <hae:PercentageOfNetSalesGeneratedOutsideOfUs
      contextRef="i466af82608da4d9bb01882ff1ee71a02_D20200927-20201226"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RleHRyZWdpb246NDkzMGI5ZjM2MzE1NDU1MjgyOTZhYjk0MWVjODM0ZDJfOTI_6619a9cb-2c6c-482a-9e7e-08cbd113d6ba"
      unitRef="number">0.386</hae:PercentageOfNetSalesGeneratedOutsideOfUs>
    <hae:PercentageOfNetSalesGeneratedOutsideOfUs
      contextRef="i7a806c141f624127aa55c8379bed5731_D20200329-20201226"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RleHRyZWdpb246NDkzMGI5ZjM2MzE1NDU1MjgyOTZhYjk0MWVjODM0ZDJfOTk_68725329-6917-435a-b8e6-c643dfd01735"
      unitRef="number">0.407</hae:PercentageOfNetSalesGeneratedOutsideOfUs>
    <us-gaap:AverageRemainingMaturityOfForeignCurrencyDerivatives1
      contextRef="i7a806c141f624127aa55c8379bed5731_D20200329-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RleHRyZWdpb246NDkzMGI5ZjM2MzE1NDU1MjgyOTZhYjk0MWVjODM0ZDJfODI0NjMzNzIxOTg2Mg_564a33b9-6c0a-4006-b9ff-b306310de4a1">P1Y</us-gaap:AverageRemainingMaturityOfForeignCurrencyDerivatives1>
    <us-gaap:ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet
      contextRef="i3351e34989d1461db1163f69c1e631aa_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RleHRyZWdpb246NDkzMGI5ZjM2MzE1NDU1MjgyOTZhYjk0MWVjODM0ZDJfMjI2Ng_0501fdb8-d131-4321-afc4-fa5aa8810fe6"
      unitRef="usd">78800000</us-gaap:ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet>
    <us-gaap:ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet
      contextRef="i7435ba41f5b744d59c3211f1c1551e27_I20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RleHRyZWdpb246NDkzMGI5ZjM2MzE1NDU1MjgyOTZhYjk0MWVjODM0ZDJfMjI4Mg_2854d416-46c5-4a6b-9a21-5f607bb60a08"
      unitRef="usd">93800000</us-gaap:ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet>
    <us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
      contextRef="iea5e92752773469e8e60c7fb366f08c0_D20200329-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RleHRyZWdpb246NDkzMGI5ZjM2MzE1NDU1MjgyOTZhYjk0MWVjODM0ZDJfMjMxMg_11907d2d-ad07-4edd-a7f8-72d599927cb0"
      unitRef="usd">1400000</us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths>
    <us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet
      contextRef="i42839168f30747d5b099bb2d4f81d4c3_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RleHRyZWdpb246NDkzMGI5ZjM2MzE1NDU1MjgyOTZhYjk0MWVjODM0ZDJfMzIzOA_fa351e2e-5c9f-4da9-8156-b4d9147b7046"
      unitRef="usd">90500000</us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet>
    <us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet
      contextRef="i86142ccd878c41b5b3b0b89e198e3ffa_I20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RleHRyZWdpb246NDkzMGI5ZjM2MzE1NDU1MjgyOTZhYjk0MWVjODM0ZDJfMzI1NA_b7118669-4ab3-483a-afd1-7942bb303103"
      unitRef="usd">98000000.0</us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i7c25c1d4590644eb8b651796c671219c_I20180615"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RleHRyZWdpb246NDkzMGI5ZjM2MzE1NDU1MjgyOTZhYjk0MWVjODM0ZDJfMzM3MQ_2b6ec305-65d4-4c34-9682-571208da8e11"
      unitRef="usd">350000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i4426464d081b45bb8839adced8fe2873_I20180615"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RleHRyZWdpb246NDkzMGI5ZjM2MzE1NDU1MjgyOTZhYjk0MWVjODM0ZDJfMzM5MA_a076c77d-6253-45bf-b6c4-db674c9f9519"
      unitRef="usd">350000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ic5d1fce0362544e68a49594cab3a1aa8_D20180615-20180615"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RleHRyZWdpb246NDkzMGI5ZjM2MzE1NDU1MjgyOTZhYjk0MWVjODM0ZDJfMzUwMw_a8302392-6fea-48a0-9136-a77a75bc4bd6"
      unitRef="number">0.0113</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ic9a17518f7194d808968c5442709d4d4_D20180615-20180615"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RleHRyZWdpb246NDkzMGI5ZjM2MzE1NDU1MjgyOTZhYjk0MWVjODM0ZDJfMzUwOA_05a7f461-7657-429d-b08c-d654423969b5"
      unitRef="number">0.0175</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DerivativeNumberOfInstrumentsHeld
      contextRef="i6b04360cbc954a42813ee3db68494774_I20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RleHRyZWdpb246NDkzMGI5ZjM2MzE1NDU1MjgyOTZhYjk0MWVjODM0ZDJfMzk5NA_dcb09137-2ffb-4e9d-a343-7bdcf0dd3ab2"
      unitRef="swap">2</us-gaap:DerivativeNumberOfInstrumentsHeld>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i6b04360cbc954a42813ee3db68494774_I20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RleHRyZWdpb246NDkzMGI5ZjM2MzE1NDU1MjgyOTZhYjk0MWVjODM0ZDJfNDA3Mw_b67b5c6e-658b-4ef5-99be-f371467761bb"
      unitRef="number">0.0280</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i6b04360cbc954a42813ee3db68494774_I20180831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RleHRyZWdpb246NDkzMGI5ZjM2MzE1NDU1MjgyOTZhYjk0MWVjODM0ZDJfNDEwNQ_6161e6b4-9c14-4bb0-8232-8a0869d66e42"
      unitRef="usd">241900000</us-gaap:DerivativeNotionalAmount>
    <hae:DerivativePercentofDebtExposed
      contextRef="i23f7882051074260b7b16d0028b875ea_I20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RleHRyZWdpb246NDkzMGI5ZjM2MzE1NDU1MjgyOTZhYjk0MWVjODM0ZDJfNDE0Mw_0dd3f9ce-a2fa-4465-9727-1dcaf768a9fb"
      unitRef="number">0.70</hae:DerivativePercentofDebtExposed>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i23f7882051074260b7b16d0028b875ea_I20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RleHRyZWdpb246NDkzMGI5ZjM2MzE1NDU1MjgyOTZhYjk0MWVjODM0ZDJfNDI1Mg_0ce9ee9d-ef58-47bb-94db-ba6d867e21d5"
      unitRef="number">0.0405</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:LongTermDebt
      contextRef="i22efb3fabcf04d79ba596b48595d8ac1_I20180831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RleHRyZWdpb246NDkzMGI5ZjM2MzE1NDU1MjgyOTZhYjk0MWVjODM0ZDJfNDM5MQ_85f83b9e-2572-4ed0-b57a-3495b75cfb11"
      unitRef="usd">345600000</us-gaap:LongTermDebt>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="i0d31dcad300f4873901a0cff3c146b47_D20200329-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RleHRyZWdpb246NDkzMGI5ZjM2MzE1NDU1MjgyOTZhYjk0MWVjODM0ZDJfNDQzMw_9d59e489-977c-476b-808e-0a6705780972"
      unitRef="usd">300000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RleHRyZWdpb246NDkzMGI5ZjM2MzE1NDU1MjgyOTZhYjk0MWVjODM0ZDJfMTE0NzE_7464bb16-5b72-4321-9583-96950da6147b">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a rollforward of the allowance for credit losses:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.684%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.231%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.231%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.231%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.526%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.235%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,699&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,108&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,824&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,937&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Credit (gain) loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(95)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(838)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Write-offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(79)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(240)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(461)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(355)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,525&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,097&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,525&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,097&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i32fa3388584544f9a03ffc1d8057d360_I20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOjZhZTg3ZDc0NDNlNjQ0MTE5Mjg5Yzc2MjNiMGE5YjU2L3RhYmxlcmFuZ2U6NmFlODdkNzQ0M2U2NDQxMTkyODljNzYyM2IwYTliNTZfMi0xLTEtMS0w_e97c4e5c-d5a3-4a54-91b7-a40af2f36eca"
      unitRef="usd">2699000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="if62547d494fe448f98e6b8c907702474_I20190928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOjZhZTg3ZDc0NDNlNjQ0MTE5Mjg5Yzc2MjNiMGE5YjU2L3RhYmxlcmFuZ2U6NmFlODdkNzQ0M2U2NDQxMTkyODljNzYyM2IwYTliNTZfMi0zLTEtMS0w_fa200e4a-54d3-4f47-bb17-9d70ddc28505"
      unitRef="usd">4108000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOjZhZTg3ZDc0NDNlNjQ0MTE5Mjg5Yzc2MjNiMGE5YjU2L3RhYmxlcmFuZ2U6NmFlODdkNzQ0M2U2NDQxMTkyODljNzYyM2IwYTliNTZfMi01LTEtMS0w_fd97e759-06cf-4731-b9a9-b5ebab50ac31"
      unitRef="usd">3824000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="ief541fbd0adf409c9514798c114d14d4_I20190330"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOjZhZTg3ZDc0NDNlNjQ0MTE5Mjg5Yzc2MjNiMGE5YjU2L3RhYmxlcmFuZ2U6NmFlODdkNzQ0M2U2NDQxMTkyODljNzYyM2IwYTliNTZfMi03LTEtMS0w_64ee2b1c-87a9-4f11-bde8-0fd5a41830b0"
      unitRef="usd">3937000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOjZhZTg3ZDc0NDNlNjQ0MTE5Mjg5Yzc2MjNiMGE5YjU2L3RhYmxlcmFuZ2U6NmFlODdkNzQ0M2U2NDQxMTkyODljNzYyM2IwYTliNTZfMy0xLTEtMS0w_168fc7b1-2744-4e09-988a-6c8544629f04"
      unitRef="usd">95000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOjZhZTg3ZDc0NDNlNjQ0MTE5Mjg5Yzc2MjNiMGE5YjU2L3RhYmxlcmFuZ2U6NmFlODdkNzQ0M2U2NDQxMTkyODljNzYyM2IwYTliNTZfMy0zLTEtMS0w_069dec00-5499-44d2-939a-93f03d702c44"
      unitRef="usd">-229000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOjZhZTg3ZDc0NDNlNjQ0MTE5Mjg5Yzc2MjNiMGE5YjU2L3RhYmxlcmFuZ2U6NmFlODdkNzQ0M2U2NDQxMTkyODljNzYyM2IwYTliNTZfMy01LTEtMS0w_c80dc678-fed9-4547-98ed-469532be24a3"
      unitRef="usd">838000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOjZhZTg3ZDc0NDNlNjQ0MTE5Mjg5Yzc2MjNiMGE5YjU2L3RhYmxlcmFuZ2U6NmFlODdkNzQ0M2U2NDQxMTkyODljNzYyM2IwYTliNTZfMy03LTEtMS0w_e7486a6b-d038-4180-bb5b-6fd9614b52e8"
      unitRef="usd">-515000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOjZhZTg3ZDc0NDNlNjQ0MTE5Mjg5Yzc2MjNiMGE5YjU2L3RhYmxlcmFuZ2U6NmFlODdkNzQ0M2U2NDQxMTkyODljNzYyM2IwYTliNTZfNC0xLTEtMS0w_e6d0de40-a67f-47b1-8e22-8742da89720d"
      unitRef="usd">79000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOjZhZTg3ZDc0NDNlNjQ0MTE5Mjg5Yzc2MjNiMGE5YjU2L3RhYmxlcmFuZ2U6NmFlODdkNzQ0M2U2NDQxMTkyODljNzYyM2IwYTliNTZfNC0zLTEtMS0w_1d313ed1-2afd-4859-85f5-fb7fa7fc67d1"
      unitRef="usd">240000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOjZhZTg3ZDc0NDNlNjQ0MTE5Mjg5Yzc2MjNiMGE5YjU2L3RhYmxlcmFuZ2U6NmFlODdkNzQ0M2U2NDQxMTkyODljNzYyM2IwYTliNTZfNC01LTEtMS0w_18960eed-13a5-42d0-bd96-d3c1d0e9aa7d"
      unitRef="usd">461000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOjZhZTg3ZDc0NDNlNjQ0MTE5Mjg5Yzc2MjNiMGE5YjU2L3RhYmxlcmFuZ2U6NmFlODdkNzQ0M2U2NDQxMTkyODljNzYyM2IwYTliNTZfNC03LTEtMS0w_cc24bdea-78c0-439b-927b-884a6caee279"
      unitRef="usd">355000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOjZhZTg3ZDc0NDNlNjQ0MTE5Mjg5Yzc2MjNiMGE5YjU2L3RhYmxlcmFuZ2U6NmFlODdkNzQ0M2U2NDQxMTkyODljNzYyM2IwYTliNTZfNS0xLTEtMS0w_d6a669d8-782a-40b0-b609-dee6bab3b375"
      unitRef="usd">2525000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="ic35a4df7f44a40e5a674e72ae5bf6205_I20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOjZhZTg3ZDc0NDNlNjQ0MTE5Mjg5Yzc2MjNiMGE5YjU2L3RhYmxlcmFuZ2U6NmFlODdkNzQ0M2U2NDQxMTkyODljNzYyM2IwYTliNTZfNS0zLTEtMS0w_f9141981-2a9f-4729-819e-2d153f55d49a"
      unitRef="usd">4097000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOjZhZTg3ZDc0NDNlNjQ0MTE5Mjg5Yzc2MjNiMGE5YjU2L3RhYmxlcmFuZ2U6NmFlODdkNzQ0M2U2NDQxMTkyODljNzYyM2IwYTliNTZfNS01LTEtMS0w_b60dab05-d5cd-45bf-a093-ffa2841cd315"
      unitRef="usd">2525000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="ic35a4df7f44a40e5a674e72ae5bf6205_I20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOjZhZTg3ZDc0NDNlNjQ0MTE5Mjg5Yzc2MjNiMGE5YjU2L3RhYmxlcmFuZ2U6NmFlODdkNzQ0M2U2NDQxMTkyODljNzYyM2IwYTliNTZfNS03LTEtMS0w_7662b7b1-5bc5-4f4b-b243-5b6509e940f5"
      unitRef="usd">4097000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RleHRyZWdpb246NDkzMGI5ZjM2MzE1NDU1MjgyOTZhYjk0MWVjODM0ZDJfMTE0ODM_1f93f7ff-f070-41bd-9c25-31996de67462">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the effect of the Company's derivative instruments designated as cash flow hedges and those not designated as hedging instruments under ASC 815 in its condensed consolidated statements of income and comprehensive income for the nine months ended December&#160;26, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.493%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.203%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amount of Gain&lt;br/&gt;(Loss) Recognized&lt;br/&gt;in Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amount of Gain (Loss) Reclassified&lt;br/&gt;from Accumulated Other Comprehensive Loss into&lt;br/&gt;Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Location in&lt;br/&gt;Condensed Consolidated Statements of Income and Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amount of Gain (Loss) Excluded from&lt;br/&gt;Effectiveness&lt;br/&gt;Testing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Location in&lt;br/&gt;Condensed Consolidated Statements of Income and Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Designated foreign currency hedge contracts, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,538)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenues, COGS and SG&amp;amp;A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(671)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest and other expense, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-designated foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,218)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest and other expense, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Designated interest rate swaps, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,996)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,326)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest and other expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="ice57ced2f272477c986a2ba3d175843c_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmYzMDcxMTUwMzVkNzQyNjRhZDAxMmU5ZDlhYWNiMjZlL3RhYmxlcmFuZ2U6ZjMwNzExNTAzNWQ3NDI2NGFkMDEyZTlkOWFhY2IyNmVfMS0yLTEtMS0w_56fedb99-33fb-4042-a636-232601b51d04"
      unitRef="usd">1378000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="ice57ced2f272477c986a2ba3d175843c_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmYzMDcxMTUwMzVkNzQyNjRhZDAxMmU5ZDlhYWNiMjZlL3RhYmxlcmFuZ2U6ZjMwNzExNTAzNWQ3NDI2NGFkMDEyZTlkOWFhY2IyNmVfMS00LTEtMS0w_fa384cc0-26ac-45b6-8e24-c228c54cf9ae"
      unitRef="usd">-1538000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet
      contextRef="ia0f1b457527f4847a6ebea6d12d49745_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmYzMDcxMTUwMzVkNzQyNjRhZDAxMmU5ZDlhYWNiMjZlL3RhYmxlcmFuZ2U6ZjMwNzExNTAzNWQ3NDI2NGFkMDEyZTlkOWFhY2IyNmVfMS04LTEtMS0w_f2dd5431-9474-4f03-9027-b39fa12fb451"
      unitRef="usd">-671000</us-gaap:GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="ie07432d269194a38a5b973923e71f52b_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmYzMDcxMTUwMzVkNzQyNjRhZDAxMmU5ZDlhYWNiMjZlL3RhYmxlcmFuZ2U6ZjMwNzExNTAzNWQ3NDI2NGFkMDEyZTlkOWFhY2IyNmVfMi0yLTEtMS0w_f75f9bfd-d1f1-4931-abac-7f59cf5fd4de"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="ie07432d269194a38a5b973923e71f52b_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmYzMDcxMTUwMzVkNzQyNjRhZDAxMmU5ZDlhYWNiMjZlL3RhYmxlcmFuZ2U6ZjMwNzExNTAzNWQ3NDI2NGFkMDEyZTlkOWFhY2IyNmVfMi00LTEtMS0w_cab9ef16-e412-49ac-bfea-6eb221ce80a8"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet
      contextRef="iaa58cfb640b3424280402bd198a7e951_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmYzMDcxMTUwMzVkNzQyNjRhZDAxMmU5ZDlhYWNiMjZlL3RhYmxlcmFuZ2U6ZjMwNzExNTAzNWQ3NDI2NGFkMDEyZTlkOWFhY2IyNmVfMi04LTEtMS0w_31d813da-a5d2-4ea4-98ba-d79d0459d432"
      unitRef="usd">-5218000</us-gaap:GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="i9d8c09f0cf9042d3ab0ab835a3cfb875_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmYzMDcxMTUwMzVkNzQyNjRhZDAxMmU5ZDlhYWNiMjZlL3RhYmxlcmFuZ2U6ZjMwNzExNTAzNWQ3NDI2NGFkMDEyZTlkOWFhY2IyNmVfMy0yLTEtMS0w_3c2f10ac-a6de-4d43-83d5-21f5d4b84e0a"
      unitRef="usd">-2996000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i9d8c09f0cf9042d3ab0ab835a3cfb875_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmYzMDcxMTUwMzVkNzQyNjRhZDAxMmU5ZDlhYWNiMjZlL3RhYmxlcmFuZ2U6ZjMwNzExNTAzNWQ3NDI2NGFkMDEyZTlkOWFhY2IyNmVfMy00LTEtMS0w_fdfe5738-8ea1-4c28-9973-db6fe25826cf"
      unitRef="usd">-3326000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet
      contextRef="i0d31dcad300f4873901a0cff3c146b47_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmYzMDcxMTUwMzVkNzQyNjRhZDAxMmU5ZDlhYWNiMjZlL3RhYmxlcmFuZ2U6ZjMwNzExNTAzNWQ3NDI2NGFkMDEyZTlkOWFhY2IyNmVfMy04LTEtMS0w_c39db3a3-f763-48cb-a186-2a9be6cb694d"
      unitRef="usd">0</us-gaap:GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet>
    <us-gaap:DeferredTaxAssetsDerivativeInstruments
      contextRef="iecb24d1198e0473ab5ff26bece23c571_I20201226"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RleHRyZWdpb246NDkzMGI5ZjM2MzE1NDU1MjgyOTZhYjk0MWVjODM0ZDJfNjQ1NA_0b62babb-c86e-41fe-9c9b-ccc0ec884c26"
      unitRef="usd">0</us-gaap:DeferredTaxAssetsDerivativeInstruments>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RleHRyZWdpb246NDkzMGI5ZjM2MzE1NDU1MjgyOTZhYjk0MWVjODM0ZDJfMTE0ODA_bb8c5318-f4ee-4d36-9570-a89e38b7548f">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present the fair value of the Company's derivative instruments as they appear in its condensed consolidated balance sheets as of December&#160;26, 2020 and March&#160;28, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.250%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.859%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.863%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Location in Condensed Consolidated&lt;br/&gt;Balance Sheets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Designated foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-designated foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;260&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,216&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivative Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Designated foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-designated foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Designated interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Designated interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;13,145&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;18,345&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ief8dcb9ed5df46338245fba90826a4a3_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmEwNzY2ZDU2ODQ5MTQ2NTE4MDNkMDg0ZDIwNDhjYWQ2L3RhYmxlcmFuZ2U6YTA3NjZkNTY4NDkxNDY1MTgwM2QwODRkMjA0OGNhZDZfMy00LTEtMS0w_d5212bc6-72fc-4297-966f-5e3199cdbc83"
      unitRef="usd">191000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i2ab86f680653471e898cddf1c4abb3b3_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmEwNzY2ZDU2ODQ5MTQ2NTE4MDNkMDg0ZDIwNDhjYWQ2L3RhYmxlcmFuZ2U6YTA3NjZkNTY4NDkxNDY1MTgwM2QwODRkMjA0OGNhZDZfMy02LTEtMS0w_38996b92-4e60-49b2-91b8-fc86d79c6f49"
      unitRef="usd">839000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i74b77438f0884283bdfb63acbb121963_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmEwNzY2ZDU2ODQ5MTQ2NTE4MDNkMDg0ZDIwNDhjYWQ2L3RhYmxlcmFuZ2U6YTA3NjZkNTY4NDkxNDY1MTgwM2QwODRkMjA0OGNhZDZfNC00LTEtMS0w_06f2b89b-36b3-409e-b783-338b88089af9"
      unitRef="usd">69000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i758e348315a24c3baee3f7984ecfe945_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmEwNzY2ZDU2ODQ5MTQ2NTE4MDNkMDg0ZDIwNDhjYWQ2L3RhYmxlcmFuZ2U6YTA3NjZkNTY4NDkxNDY1MTgwM2QwODRkMjA0OGNhZDZfNC02LTEtMS0w_3497e216-8199-4a19-a21e-1183a435ec0b"
      unitRef="usd">377000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="id7af1564b75c420894f80854a774c2d3_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmEwNzY2ZDU2ODQ5MTQ2NTE4MDNkMDg0ZDIwNDhjYWQ2L3RhYmxlcmFuZ2U6YTA3NjZkNTY4NDkxNDY1MTgwM2QwODRkMjA0OGNhZDZfNi00LTEtMS0w_029a9267-d542-4a82-b019-0eacd42963fe"
      unitRef="usd">260000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i961d5a6a04ff4db6a9d0a9bbac6be95e_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmEwNzY2ZDU2ODQ5MTQ2NTE4MDNkMDg0ZDIwNDhjYWQ2L3RhYmxlcmFuZ2U6YTA3NjZkNTY4NDkxNDY1MTgwM2QwODRkMjA0OGNhZDZfNi02LTEtMS0w_8102342f-7ed3-4d18-ab58-16444e69bd8c"
      unitRef="usd">1216000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ia9656f96940b412198f0ace7941ec4e7_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmEwNzY2ZDU2ODQ5MTQ2NTE4MDNkMDg0ZDIwNDhjYWQ2L3RhYmxlcmFuZ2U6YTA3NjZkNTY4NDkxNDY1MTgwM2QwODRkMjA0OGNhZDZfOC00LTEtMS0w_2d46ec3e-6563-4e87-9ac2-62354ddab893"
      unitRef="usd">919000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i09705bf4b4c04d018ba1ef2118f58a80_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmEwNzY2ZDU2ODQ5MTQ2NTE4MDNkMDg0ZDIwNDhjYWQ2L3RhYmxlcmFuZ2U6YTA3NjZkNTY4NDkxNDY1MTgwM2QwODRkMjA0OGNhZDZfOC02LTEtMS0w_b3c23a2d-d08a-4562-ac31-ce169d0ee13c"
      unitRef="usd">1854000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i9d30c35c0167492082c7bb18a3980991_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmEwNzY2ZDU2ODQ5MTQ2NTE4MDNkMDg0ZDIwNDhjYWQ2L3RhYmxlcmFuZ2U6YTA3NjZkNTY4NDkxNDY1MTgwM2QwODRkMjA0OGNhZDZfOS00LTEtMS0w_089f4991-da93-4c00-a6fb-93e058231e80"
      unitRef="usd">206000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i2e657827ea664680a8857cfd8b096cb9_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmEwNzY2ZDU2ODQ5MTQ2NTE4MDNkMDg0ZDIwNDhjYWQ2L3RhYmxlcmFuZ2U6YTA3NjZkNTY4NDkxNDY1MTgwM2QwODRkMjA0OGNhZDZfOS02LTEtMS0w_7ceff04d-e961-478a-8dba-4b4debfba960"
      unitRef="usd">1435000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ie0b611ab7cea40329891cbc0d9cdf3fc_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmEwNzY2ZDU2ODQ5MTQ2NTE4MDNkMDg0ZDIwNDhjYWQ2L3RhYmxlcmFuZ2U6YTA3NjZkNTY4NDkxNDY1MTgwM2QwODRkMjA0OGNhZDZfMTAtNC0xLTEtMA_e0fd50ba-b9fa-4ce2-8c5f-11a5957ed4e3"
      unitRef="usd">5697000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="iafe5dcd8b8f34d0ba81608d6c14c3841_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmEwNzY2ZDU2ODQ5MTQ2NTE4MDNkMDg0ZDIwNDhjYWQ2L3RhYmxlcmFuZ2U6YTA3NjZkNTY4NDkxNDY1MTgwM2QwODRkMjA0OGNhZDZfMTAtNi0xLTEtMA_60e2762f-3609-4046-812c-6197d53f81e3"
      unitRef="usd">5581000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i110e3cdb79b447caadd705ad58eb1b5d_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmEwNzY2ZDU2ODQ5MTQ2NTE4MDNkMDg0ZDIwNDhjYWQ2L3RhYmxlcmFuZ2U6YTA3NjZkNTY4NDkxNDY1MTgwM2QwODRkMjA0OGNhZDZfMTEtNC0xLTEtMA_9bc37697-5a33-4313-b906-4424603022b6"
      unitRef="usd">6323000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i7030b986c4a7457991f4240d9857700b_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmEwNzY2ZDU2ODQ5MTQ2NTE4MDNkMDg0ZDIwNDhjYWQ2L3RhYmxlcmFuZ2U6YTA3NjZkNTY4NDkxNDY1MTgwM2QwODRkMjA0OGNhZDZfMTEtNi0xLTEtMA_f87e2fbf-d877-4c41-b9ad-eb8aae6886e0"
      unitRef="usd">9475000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="id7af1564b75c420894f80854a774c2d3_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmEwNzY2ZDU2ODQ5MTQ2NTE4MDNkMDg0ZDIwNDhjYWQ2L3RhYmxlcmFuZ2U6YTA3NjZkNTY4NDkxNDY1MTgwM2QwODRkMjA0OGNhZDZfMTItNC0xLTEtMA_5ad05da6-268f-4d97-b983-ab555a559762"
      unitRef="usd">13145000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i961d5a6a04ff4db6a9d0a9bbac6be95e_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmEwNzY2ZDU2ODQ5MTQ2NTE4MDNkMDg0ZDIwNDhjYWQ2L3RhYmxlcmFuZ2U6YTA3NjZkNTY4NDkxNDY1MTgwM2QwODRkMjA0OGNhZDZfMTItNi0xLTEtMA_96d0a1c8-c804-4276-8e53-79e944d7e3de"
      unitRef="usd">18345000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RleHRyZWdpb246NDkzMGI5ZjM2MzE1NDU1MjgyOTZhYjk0MWVjODM0ZDJfMTE0Njc_8f9495c9-f96b-44a3-b197-0127e80aea7a">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial assets and financial liabilities measured at fair value on a recurring basis consist of the following as of December&#160;26, 2020 and March&#160;28, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Designated foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-designated foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;79,773&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;260&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;80,033&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Designated foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-designated foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Designated interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;13,145&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,920&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;17,065&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="21" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of March 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Designated foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-designated foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;44,564&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,216&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;45,780&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Designated foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-designated foreign currency hedge contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Designated interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;18,345&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;18,345&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The recurring level 3 fair value measurements of contingent consideration liabilities include the following significant unobservable inputs:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.988%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.664%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value at&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Valuation &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unobservable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Technique&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Range&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue-based payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td rowspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted cash flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.5%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected year of payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021 - 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Regulatory-based payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td rowspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td rowspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discounted cash flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Probability of payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0% - 100%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected year of payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021 - 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;reconciliation of the change in the fair value of contingent consideration is included in the following table:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition date fair value of contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,920&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i997562bcb47249f98a7209c0a94eb2bc_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMy0yLTEtMS0w_bfda9ccd-4210-439b-aefb-354a83d794c5"
      unitRef="usd">79773000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i5c5d0e8a5be946c1bcf0fc6bd7dd684d_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMy00LTEtMS0w_c75cba9d-dbc1-46bb-94f8-4008cacb9abb"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i26592b211dab480aa8decca198bc3e17_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMy04LTEtMS0w_18d728f2-05bd-4a26-ac5c-40a3e23f3ab8"
      unitRef="usd">79773000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i588cb2bb68f741b69393f24addb9f2de_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfNC0yLTEtMS0w_66bf5f97-935b-412d-8b51-be77645f0910"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ief8dcb9ed5df46338245fba90826a4a3_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfNC00LTEtMS0w_d5212bc6-72fc-4297-966f-5e3199cdbc83"
      unitRef="usd">191000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="if9d15f27861f44938c5187801f43c5d9_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfNC04LTEtMS0w_87b35c55-9112-4a45-a437-95873a39a0df"
      unitRef="usd">191000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i16890a24a13b44bab1e3d254125196c3_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfNS0yLTEtMS0w_02deb8ec-c089-49de-bce2-a9e0b99a2791"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i74b77438f0884283bdfb63acbb121963_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfNS00LTEtMS0w_06f2b89b-36b3-409e-b783-338b88089af9"
      unitRef="usd">69000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ic3f2a0af4b1b470aaa1b1fd8223858e3_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfNS04LTEtMS0w_a85fc796-c310-4871-9666-977a886e5375"
      unitRef="usd">69000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i997562bcb47249f98a7209c0a94eb2bc_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfNy0yLTEtMS0w_d3387dc8-099d-4a45-9ba3-e7090caf0e30"
      unitRef="usd">79773000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i5c5d0e8a5be946c1bcf0fc6bd7dd684d_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfNy00LTEtMS0w_e43ee4b5-65ad-49fb-a115-fab867e2bdd8"
      unitRef="usd">260000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i26592b211dab480aa8decca198bc3e17_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfNy04LTEtMS0w_6725bf25-f5ec-43b4-a2dc-220bb8c4f9e7"
      unitRef="usd">80033000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i588cb2bb68f741b69393f24addb9f2de_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfOS0yLTEtMS0w_2198bd82-f370-4d58-b221-9c2a723ca13b"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ia9656f96940b412198f0ace7941ec4e7_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfOS00LTEtMS0w_2d46ec3e-6563-4e87-9ac2-62354ddab893"
      unitRef="usd">919000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="if9d15f27861f44938c5187801f43c5d9_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfOS04LTEtMS0w_1e45e138-9b74-474c-8292-91d3da675323"
      unitRef="usd">919000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i16890a24a13b44bab1e3d254125196c3_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMTAtMi0xLTEtMA_5684fb65-2f5e-478b-a1f2-a3d5df48de3f"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i9d30c35c0167492082c7bb18a3980991_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMTAtNC0xLTEtMA_089f4991-da93-4c00-a6fb-93e058231e80"
      unitRef="usd">206000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ic3f2a0af4b1b470aaa1b1fd8223858e3_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMTAtOC0xLTEtMA_8240cb14-7001-4b91-97b0-1c532b5d5f75"
      unitRef="usd">206000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i5a99a6573bad464bacf1a667a155cf4c_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMTEtMi0xLTEtMA_d3bbfe6d-3580-48a5-8336-2bf76c934cf5"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ia02b0b01fd264d638c0c2628fc697f93_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMTEtNC0xLTEtMA_3bc8ff9a-2de6-496e-8c69-541fcf174a0e"
      unitRef="usd">12020000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ie276656bb33a45a487bf62990df0f609_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMTEtOC0xLTEtMA_afe1c904-983e-43f5-8e6b-c72a75270687"
      unitRef="usd">12020000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i8a4ac71d84054665bcf305a9df5b7ddf_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMTItNi0xLTEtMA_6e14b893-c0ed-48be-a2af-9e5b20de9d1c"
      unitRef="usd">3920000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i3d3d12a07ab54dd3a6c5ac15a7096a2b_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMTItOC0xLTEtMA_2979dc8e-39e0-400e-8705-2590deee6f92"
      unitRef="usd">3920000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i997562bcb47249f98a7209c0a94eb2bc_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMTMtMi0xLTEtMA_777ea8cd-f3a9-4145-bda2-35960c7f1656"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i5c5d0e8a5be946c1bcf0fc6bd7dd684d_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMTMtNC0xLTEtMA_9c74e659-4a1e-4582-a5ca-c883f3fb56bc"
      unitRef="usd">13145000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ic2e4f6aff6eb4677970da26827668a01_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMTMtNi0xLTEtMA_0d830919-4e89-446b-81e6-8bf46aec9e4c"
      unitRef="usd">3920000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i26592b211dab480aa8decca198bc3e17_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMTMtOC0xLTEtMA_d81fc245-cc8d-4b91-84c9-63895b37af16"
      unitRef="usd">17065000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ia1ddfbfc3ba244e7833e4eac1cbf3b2d_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMTgtMi0xLTEtMA_0764fa1a-99d2-44dd-86a4-bb7491b1e895"
      unitRef="usd">44564000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i216d245bc1864b20940d046e5608b9e0_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMTgtNC0xLTEtMA_5e28a728-7c05-47d8-b31b-0175b55e5985"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="id3e33f79fd854ca19ec85d864af74f63_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMTgtOC0xLTEtMA_1d56a52e-1e9e-4fa4-8c37-e0caf058b435"
      unitRef="usd">44564000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="iaf86edce1a1b42fbb8cfd4d66d94a959_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMTktMi0xLTEtMA_fea6c17a-010b-4858-905a-320d481bdc18"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i45f6ab924d174fe997e8ffab01ef2a19_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMTktNC0xLTEtMA_20d92d83-545e-45f7-b635-807dc7576afe"
      unitRef="usd">839000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ib783ce7f3af1414a917dfb19f3fd67f6_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMTktOC0xLTEtMA_0254ad64-8953-4fc8-83ae-94fc1e1520ce"
      unitRef="usd">839000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i3bfc2d6751964174b4757e882148e033_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMjAtMi0xLTEtMA_aaf0ff7c-fea7-4015-8053-9ef5b0ee9e09"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="id8d95a735afe423c94c8eeae0f71dc33_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMjAtNC0xLTEtMA_786e8092-dc17-4cbf-84fd-99fd89a43423"
      unitRef="usd">377000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="iffada09cc3634b0e9958607425101e7e_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMjAtOC0xLTEtMA_6a3af108-9213-4fd9-a444-124ab7b9a3e8"
      unitRef="usd">377000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ia1ddfbfc3ba244e7833e4eac1cbf3b2d_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMjItMi0xLTEtMA_f4669525-994c-4032-a71d-929755a653d5"
      unitRef="usd">44564000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i216d245bc1864b20940d046e5608b9e0_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMjItNC0xLTEtMA_83708281-954c-4101-b7f3-a2d9ea893bbb"
      unitRef="usd">1216000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="id3e33f79fd854ca19ec85d864af74f63_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMjItOC0xLTEtMA_fcb7d877-253d-40fc-a5af-27ca37856aed"
      unitRef="usd">45780000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="iaf86edce1a1b42fbb8cfd4d66d94a959_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMjQtMi0xLTEtMA_c303ccb5-e232-4572-8e35-38d9ebb2cc40"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i45f6ab924d174fe997e8ffab01ef2a19_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMjQtNC0xLTEtMA_71b0013d-a026-49da-ba34-f51d6c8fa6fc"
      unitRef="usd">1854000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ib783ce7f3af1414a917dfb19f3fd67f6_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMjQtOC0xLTEtMA_6179c9ed-e391-4166-b09e-bef4fa6be9d7"
      unitRef="usd">1854000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i3bfc2d6751964174b4757e882148e033_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMjUtMi0xLTEtMA_471fdbf6-6ca3-47d3-9b12-47b2a0e3774f"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i4b3615436e53401aaf2becfa502d691c_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMjUtNC0xLTEtMA_d5607647-5d31-4794-b668-6399bc785a92"
      unitRef="usd">1435000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="iffada09cc3634b0e9958607425101e7e_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMjUtOC0xLTEtMA_8fcafa2e-4404-4ad8-ad62-ba8f9bdad89b"
      unitRef="usd">1435000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="if932a0aaa03f451f9dad61e387eabc93_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMjYtMi0xLTEtMA_3e972d91-45d1-4490-b7c2-2d80e0069b90"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="iab5f44f15bc94d6daa33cc2caabfaf8a_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMjYtNC0xLTEtMA_6c98cac0-1405-42e6-b316-a71a9865a7b1"
      unitRef="usd">15056000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="iecf4e5d38e474810bfe38afc5d4ff6a7_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMjYtOC0xLTEtMA_a9dc364e-281a-486b-9530-b4416cd1135e"
      unitRef="usd">15056000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ia1ddfbfc3ba244e7833e4eac1cbf3b2d_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMjctMi0xLTEtMA_5a148859-87d9-4a73-8dae-7e5bffe9881d"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i216d245bc1864b20940d046e5608b9e0_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMjctNC0xLTEtMA_ea2ace8b-791e-40d0-acea-ab42c9c31558"
      unitRef="usd">18345000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="id3e33f79fd854ca19ec85d864af74f63_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmI3MDFjMTRkOGNhNjQ1YmM5NjM4ZDk2YzhlMWQxNzM3L3RhYmxlcmFuZ2U6YjcwMWMxNGQ4Y2E2NDViYzk2MzhkOTZjOGUxZDE3MzdfMjctOC0xLTEtMA_eb3f601e-0d06-4576-a615-8e05bb839a15"
      unitRef="usd">18345000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i7e02337377ab4f1ba4536388c0003177_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOjc0Mjc4YjY5YjA1ZDRhYmZhMzA4MDYwYzU3MWE0YzY5L3RhYmxlcmFuZ2U6NzQyNzhiNjliMDVkNGFiZmEzMDgwNjBjNTcxYTRjNjlfMi0yLTEtMS0w_803f8512-f438-414f-8b66-9d63c394410a"
      unitRef="usd">1920000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i7e02337377ab4f1ba4536388c0003177_I20201226"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOjc0Mjc4YjY5YjA1ZDRhYmZhMzA4MDYwYzU3MWE0YzY5L3RhYmxlcmFuZ2U6NzQyNzhiNjliMDVkNGFiZmEzMDgwNjBjNTcxYTRjNjlfMi04LTEtMS0w_d79748ab-bef1-4799-b2f9-3c4ce3d41e06"
      unitRef="number">0.085</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i4bca110ee0c94411a74ee374c176ca00_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOjc0Mjc4YjY5YjA1ZDRhYmZhMzA4MDYwYzU3MWE0YzY5L3RhYmxlcmFuZ2U6NzQyNzhiNjliMDVkNGFiZmEzMDgwNjBjNTcxYTRjNjlfNC0yLTEtMS0w_c111b783-9274-4ca7-b566-48af6c4b2c3a"
      unitRef="usd">2000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i4bca110ee0c94411a74ee374c176ca00_I20201226"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOjc0Mjc4YjY5YjA1ZDRhYmZhMzA4MDYwYzU3MWE0YzY5L3RhYmxlcmFuZ2U6NzQyNzhiNjliMDVkNGFiZmEzMDgwNjBjNTcxYTRjNjlfNC04LTEtMS0w_72cd93cd-2f6d-41a1-b45a-58db057bfd7a"
      unitRef="number">0.049</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i7337ad8ffd7f4d8cb8646e0073515fc1_I20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RleHRyZWdpb246NDkzMGI5ZjM2MzE1NDU1MjgyOTZhYjk0MWVjODM0ZDJfMTA5NzE_793d39f3-d085-4645-8c8a-add66e31cfa4"
      unitRef="usd">4500000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i3d3d12a07ab54dd3a6c5ac15a7096a2b_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RleHRyZWdpb246NDkzMGI5ZjM2MzE1NDU1MjgyOTZhYjk0MWVjODM0ZDJfMTEwNTE_fe46c86b-14c8-4cc9-8aed-644bcc78260e"
      unitRef="usd">3900000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i06f5f1e7b5734a368db7c1b4554453ea_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RleHRyZWdpb246NDkzMGI5ZjM2MzE1NDU1MjgyOTZhYjk0MWVjODM0ZDJfMTEwNzE_29dff645-c669-4aa6-bc85-b87c54bc4b0c"
      unitRef="usd">500000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i54c62f100cf84a5b86024a6964d52097_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RleHRyZWdpb246NDkzMGI5ZjM2MzE1NDU1MjgyOTZhYjk0MWVjODM0ZDJfMTExMjA_5adbee42-1955-422a-814b-d141f6d1fc03"
      unitRef="usd">3400000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i52cd92f3abc349f2a9cd1e1c9b9229e3_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmJjZDdkNWIzYTBjYjQxODY5MThiODQzMDIwODU2Nzg5L3RhYmxlcmFuZ2U6YmNkN2Q1YjNhMGNiNDE4NjkxOGI4NDMwMjA4NTY3ODlfMS0yLTEtMS0w_d52a4eee-e883-4287-8d52-e987a3ea4229"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <hae:ContingentConsiderationAcquisitionDateFairValue
      contextRef="ib3f7a3bec94a478ca2a052a1fdea5f49_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmJjZDdkNWIzYTBjYjQxODY5MThiODQzMDIwODU2Nzg5L3RhYmxlcmFuZ2U6YmNkN2Q1YjNhMGNiNDE4NjkxOGI4NDMwMjA4NTY3ODlfMi0yLTEtMS0w_c2b1cd20-1dca-43c0-aa51-4a11767b29ef"
      unitRef="usd">3920000</hae:ContingentConsiderationAcquisitionDateFairValue>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i3d3d12a07ab54dd3a6c5ac15a7096a2b_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83My9mcmFnOjQ5MzBiOWYzNjMxNTQ1NTI4Mjk2YWI5NDFlYzgzNGQyL3RhYmxlOmJjZDdkNWIzYTBjYjQxODY5MThiODQzMDIwODU2Nzg5L3RhYmxlcmFuZ2U6YmNkN2Q1YjNhMGNiNDE4NjkxOGI4NDMwMjA4NTY3ODlfNC0yLTEtMS0w_3f6250fe-0c4f-4014-9857-13e8b896ab35"
      unitRef="usd">3920000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV83OS9mcmFnOjdiOTQyYmQ5OTJiYTQyMWU5MjMyYjEwZTExNDU2YTU3L3RleHRyZWdpb246N2I5NDJiZDk5MmJhNDIxZTkyMzJiMTBlMTE0NTZhNTdfNTU5_a14f9430-2c8d-4622-b243-4bde17f78aa2">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;13. COMMITMENTS AND CONTINGENCIES&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is a party to various legal proceedings and claims arising out of the ordinary course of its business. The Company believes there are no proceedings or claims pending against it the ultimate resolution of which could have a material adverse effect on the financial condition or results of operations. At each reporting period, the Company evaluates whether or not a potential loss amount or a potential range of loss is probable and reasonably estimable under ASC 450,&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingencies, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for all matters. Legal costs are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the third quarter of fiscal 2021, the Company received a subpoena from the U.S. Attorney&#x2019;s Office for the District of Massachusetts. The subpoena requests certain documents regarding the Company&#x2019;s apheresis and autotransfusion devices and disposables, including documents relating to product complaints and adverse event reporting, regulatory clearances and product design changes, among other matters. The Company is fully cooperating with this inquiry.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RleHRyZWdpb246NDgyNDUzNzYxYzRhNDE2ODg2NzE1ZTcxMjk5NzFiZjBfMjcwOQ_f88821cc-e952-4ab8-9b43-610bcdd9d65e">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;14. SEGMENT AND ENTERPRISE-WIDE INFORMATION &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines its reportable segments by first identifying its operating segments, and then by assessing whether any components of these segments constitute a business for which discrete financial information is available and where segment management regularly reviews the operating results of that component. Historically, the Company's operating segments were based primarily on geography. Effective as of March 31, 2019, the Company completed the transition of its operating structure to three global business units and accordingly, reorganized its reporting structure to align with its three global business units and the information that will be regularly reviewed by the Company's chief operating decision maker.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Following the reorganization, the Company's reportable segments are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Plasma&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Blood Center&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Hospital&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Management measures and evaluates the operating segments based on operating income. Management excludes certain corporate expenses from segment operating income. In addition, certain amounts that management considers to be non-&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;recurring or non-operational are excluded from segment operating income because management evaluates the operating results of the segments excluding such items. These items include restructuring and turnaround costs, deal amortization, gains on divestitures and sale of assets, asset impairments and other related charges, accelerated depreciation and related costs, costs related to compliance with the European Union Medical Device Regulation, transaction costs and certain legal charges. Although these amounts are excluded from segment operating income, as applicable, they are included in the reconciliations that follow. Management measures and evaluates the Company's net revenues and operating income using internally derived standard currency exchange rates that remain constant from year to year; therefore, segment information is presented on this basis.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Selected information by reportable segment is presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 28,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 28,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plasma&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;249,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;348,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Blood Center&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net revenues by business unit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234,905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;632,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;742,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,291)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,922)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,072)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;240,371&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;258,970&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;645,434&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;749,987&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt; Reflects revenue for service, maintenance and parts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 28,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 28,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plasma&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Blood Center&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Corporate expenses &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63,202)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63,080)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(185,005)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(188,363)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Effect of exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Deal amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,805)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,772)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,204)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,681)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Restructuring and turnaround costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,143)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,798)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,583)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,582)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Transaction costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,063)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;PCS2 accelerated depreciation and related costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,649)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,332)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,708)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;European Medical Device Regulation costs and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,207)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(448)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,696)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(304)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Impairment of assets and other related charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(896)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51,220)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Gains on divestitures and sale of assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;40,425&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;40,907&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;110,922&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;77,344&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="24" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt; Reflects shared service expenses including quality and regulatory, customer and field service, research and development, manufacturing and supply chain, as well as other corporate support functions.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Management reviews revenue based on the reportable segments noted above.&#160;Although these reportable segments are primarily product-based, they differ from the Company&#x2019;s product line revenues for Plasma products and services and Blood Center products and services.&#160;Specifically, the Blood Center reportable segment includes plasma products utilized for collection in blood centers primarily for transfusion purposes.&#160;Additionally, product line revenues also include service revenues which are excluded from the reportable segments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net revenues by product line are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 28,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 28,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plasma products and services&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;309,933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;406,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Blood Center products and services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hospital products and services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;240,371&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;258,970&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;645,434&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;749,987&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net revenues generated in the Company's principle operating regions on a reported basis are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.303%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 28,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 28,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;382,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;485,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Japan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;240,371&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;258,970&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;645,434&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;749,987&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RleHRyZWdpb246NDgyNDUzNzYxYzRhNDE2ODg2NzE1ZTcxMjk5NzFiZjBfNjA5_6bbb84f9-eda1-44e6-9af4-486270aeb0ee"
      unitRef="segment">3</us-gaap:NumberOfOperatingSegments>
    <us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RleHRyZWdpb246NDgyNDUzNzYxYzRhNDE2ODg2NzE1ZTcxMjk5NzFiZjBfMjcxMQ_f8a1397d-030c-4e76-a49a-929a3d8ce30d">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Selected information by reportable segment is presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 28,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 28,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plasma&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;249,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;348,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Blood Center&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net revenues by business unit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234,905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;632,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;742,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,291)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,922)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,072)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;240,371&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;258,970&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;645,434&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;749,987&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt; Reflects revenue for service, maintenance and parts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 28,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 28,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plasma&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Blood Center&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hospital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Corporate expenses &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63,202)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63,080)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(185,005)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(188,363)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Effect of exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Deal amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,805)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,772)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,204)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,681)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Restructuring and turnaround costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,143)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,798)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,583)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,582)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Transaction costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,063)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;PCS2 accelerated depreciation and related costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,649)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,332)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,708)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;European Medical Device Regulation costs and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,207)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(448)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,696)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(304)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Impairment of assets and other related charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(896)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51,220)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Gains on divestitures and sale of assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;40,425&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;40,907&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;110,922&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;77,344&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="24" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt; Reflects shared service expenses including quality and regulatory, customer and field service, research and development, manufacturing and supply chain, as well as other corporate support functions.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock>
    <hae:NetRevenuesBeforeForeignExchangeImpact
      contextRef="i3a367bb123554012a9834d85df459f46_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmI4NmQ1MGE1ZjNiMDQyOGRiZGY0NzEyYzE1ZWY1OWYzL3RhYmxlcmFuZ2U6Yjg2ZDUwYTVmM2IwNDI4ZGJkZjQ3MTJjMTVlZjU5ZjNfMy0xLTEtMS0w_70b1d2fb-b20c-4596-a4f1-bf65a68ba1e0"
      unitRef="usd">102154000</hae:NetRevenuesBeforeForeignExchangeImpact>
    <hae:NetRevenuesBeforeForeignExchangeImpact
      contextRef="ib2c7bdc34da3493493cc0abe3dc3def5_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmI4NmQ1MGE1ZjNiMDQyOGRiZGY0NzEyYzE1ZWY1OWYzL3RhYmxlcmFuZ2U6Yjg2ZDUwYTVmM2IwNDI4ZGJkZjQ3MTJjMTVlZjU5ZjNfMy0zLTEtMS0w_526b62c7-da27-4e5c-bbfe-409815d7c12f"
      unitRef="usd">120997000</hae:NetRevenuesBeforeForeignExchangeImpact>
    <hae:NetRevenuesBeforeForeignExchangeImpact
      contextRef="i4eb9c47f2f9244e0b383fb7b25f6b0d4_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmI4NmQ1MGE1ZjNiMDQyOGRiZGY0NzEyYzE1ZWY1OWYzL3RhYmxlcmFuZ2U6Yjg2ZDUwYTVmM2IwNDI4ZGJkZjQ3MTJjMTVlZjU5ZjNfMy01LTEtMS0w_023fd283-f35e-48b5-b6c9-c65f9f1f42b0"
      unitRef="usd">249587000</hae:NetRevenuesBeforeForeignExchangeImpact>
    <hae:NetRevenuesBeforeForeignExchangeImpact
      contextRef="ib0091dd1f9204cdd979ec26f0ee2b0ae_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmI4NmQ1MGE1ZjNiMDQyOGRiZGY0NzEyYzE1ZWY1OWYzL3RhYmxlcmFuZ2U6Yjg2ZDUwYTVmM2IwNDI4ZGJkZjQ3MTJjMTVlZjU5ZjNfMy03LTEtMS0w_9ac0fa06-03eb-4c67-95e8-d74760ec59db"
      unitRef="usd">348141000</hae:NetRevenuesBeforeForeignExchangeImpact>
    <hae:NetRevenuesBeforeForeignExchangeImpact
      contextRef="i6cfe5b5730064f93b6ecea7bc136d73f_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmI4NmQ1MGE1ZjNiMDQyOGRiZGY0NzEyYzE1ZWY1OWYzL3RhYmxlcmFuZ2U6Yjg2ZDUwYTVmM2IwNDI4ZGJkZjQ3MTJjMTVlZjU5ZjNfNC0xLTEtMS0w_e69bde2e-98d1-4007-8ba7-fb09fb3942b4"
      unitRef="usd">80417000</hae:NetRevenuesBeforeForeignExchangeImpact>
    <hae:NetRevenuesBeforeForeignExchangeImpact
      contextRef="ic275845b82014295bb8e14b72d0cb7a2_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmI4NmQ1MGE1ZjNiMDQyOGRiZGY0NzEyYzE1ZWY1OWYzL3RhYmxlcmFuZ2U6Yjg2ZDUwYTVmM2IwNDI4ZGJkZjQ3MTJjMTVlZjU5ZjNfNC0zLTEtMS0w_92411182-8032-435d-bfca-0210259785b8"
      unitRef="usd">85314000</hae:NetRevenuesBeforeForeignExchangeImpact>
    <hae:NetRevenuesBeforeForeignExchangeImpact
      contextRef="i4648a84bbe144e499e5f0bbff9596c82_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmI4NmQ1MGE1ZjNiMDQyOGRiZGY0NzEyYzE1ZWY1OWYzL3RhYmxlcmFuZ2U6Yjg2ZDUwYTVmM2IwNDI4ZGJkZjQ3MTJjMTVlZjU5ZjNfNC01LTEtMS0w_8af94eb6-6a15-4f25-b065-536cfb708fc1"
      unitRef="usd">234446000</hae:NetRevenuesBeforeForeignExchangeImpact>
    <hae:NetRevenuesBeforeForeignExchangeImpact
      contextRef="i2fa6549b61284e39986bb1296676dc1a_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmI4NmQ1MGE1ZjNiMDQyOGRiZGY0NzEyYzE1ZWY1OWYzL3RhYmxlcmFuZ2U6Yjg2ZDUwYTVmM2IwNDI4ZGJkZjQ3MTJjMTVlZjU5ZjNfNC03LTEtMS0w_343ed17a-de9e-4880-a071-2595e2f0c6e1"
      unitRef="usd">246977000</hae:NetRevenuesBeforeForeignExchangeImpact>
    <hae:NetRevenuesBeforeForeignExchangeImpact
      contextRef="id93717bc785844afbedbb40fafa0d6e6_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmI4NmQ1MGE1ZjNiMDQyOGRiZGY0NzEyYzE1ZWY1OWYzL3RhYmxlcmFuZ2U6Yjg2ZDUwYTVmM2IwNDI4ZGJkZjQ3MTJjMTVlZjU5ZjNfNS0xLTEtMS0w_64f457b9-8b8b-42db-93ec-75f19ffeddef"
      unitRef="usd">52334000</hae:NetRevenuesBeforeForeignExchangeImpact>
    <hae:NetRevenuesBeforeForeignExchangeImpact
      contextRef="i2d1a57ec025045cbb23779fa6fc0cb2e_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmI4NmQ1MGE1ZjNiMDQyOGRiZGY0NzEyYzE1ZWY1OWYzL3RhYmxlcmFuZ2U6Yjg2ZDUwYTVmM2IwNDI4ZGJkZjQ3MTJjMTVlZjU5ZjNfNS0zLTEtMS0w_b0afa49e-cc2d-443e-9b80-0a21a1e6118b"
      unitRef="usd">50753000</hae:NetRevenuesBeforeForeignExchangeImpact>
    <hae:NetRevenuesBeforeForeignExchangeImpact
      contextRef="ib19f3255f7c4488593f3252f04fa0abf_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmI4NmQ1MGE1ZjNiMDQyOGRiZGY0NzEyYzE1ZWY1OWYzL3RhYmxlcmFuZ2U6Yjg2ZDUwYTVmM2IwNDI4ZGJkZjQ3MTJjMTVlZjU5ZjNfNS01LTEtMS0w_f8246b9b-e78a-42f4-be20-5a891ff3a507"
      unitRef="usd">148927000</hae:NetRevenuesBeforeForeignExchangeImpact>
    <hae:NetRevenuesBeforeForeignExchangeImpact
      contextRef="id42b45b3282241f0b4410893d0379aae_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmI4NmQ1MGE1ZjNiMDQyOGRiZGY0NzEyYzE1ZWY1OWYzL3RhYmxlcmFuZ2U6Yjg2ZDUwYTVmM2IwNDI4ZGJkZjQ3MTJjMTVlZjU5ZjNfNS03LTEtMS0w_5c01b674-8fac-4535-b231-5660ac59fa05"
      unitRef="usd">147602000</hae:NetRevenuesBeforeForeignExchangeImpact>
    <hae:NetRevenuesBeforeForeignExchangeImpact
      contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmI4NmQ1MGE1ZjNiMDQyOGRiZGY0NzEyYzE1ZWY1OWYzL3RhYmxlcmFuZ2U6Yjg2ZDUwYTVmM2IwNDI4ZGJkZjQ3MTJjMTVlZjU5ZjNfNi0xLTEtMS0w_516c9133-cd84-4b11-a23a-febf1d0b48fd"
      unitRef="usd">234905000</hae:NetRevenuesBeforeForeignExchangeImpact>
    <hae:NetRevenuesBeforeForeignExchangeImpact
      contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmI4NmQ1MGE1ZjNiMDQyOGRiZGY0NzEyYzE1ZWY1OWYzL3RhYmxlcmFuZ2U6Yjg2ZDUwYTVmM2IwNDI4ZGJkZjQ3MTJjMTVlZjU5ZjNfNi0zLTEtMS0w_25d354bf-fca4-4c11-ac70-ded4bb6e3df5"
      unitRef="usd">257064000</hae:NetRevenuesBeforeForeignExchangeImpact>
    <hae:NetRevenuesBeforeForeignExchangeImpact
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmI4NmQ1MGE1ZjNiMDQyOGRiZGY0NzEyYzE1ZWY1OWYzL3RhYmxlcmFuZ2U6Yjg2ZDUwYTVmM2IwNDI4ZGJkZjQ3MTJjMTVlZjU5ZjNfNi01LTEtMS0w_61a032ba-f68c-4a88-a24b-ec82cd7043f7"
      unitRef="usd">632960000</hae:NetRevenuesBeforeForeignExchangeImpact>
    <hae:NetRevenuesBeforeForeignExchangeImpact
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmI4NmQ1MGE1ZjNiMDQyOGRiZGY0NzEyYzE1ZWY1OWYzL3RhYmxlcmFuZ2U6Yjg2ZDUwYTVmM2IwNDI4ZGJkZjQ3MTJjMTVlZjU5ZjNfNi03LTEtMS0w_89f264b2-1818-4ac9-b6a8-854fbf00e061"
      unitRef="usd">742720000</hae:NetRevenuesBeforeForeignExchangeImpact>
    <hae:NetRevenuesBeforeForeignExchangeImpact
      contextRef="i86b9b10063b34ad7b052ae6b08484c65_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmI4NmQ1MGE1ZjNiMDQyOGRiZGY0NzEyYzE1ZWY1OWYzL3RhYmxlcmFuZ2U6Yjg2ZDUwYTVmM2IwNDI4ZGJkZjQ3MTJjMTVlZjU5ZjNfNy0xLTEtMS0w_544f9ac6-5d57-497c-8bfe-933e781a8f6e"
      unitRef="usd">4972000</hae:NetRevenuesBeforeForeignExchangeImpact>
    <hae:NetRevenuesBeforeForeignExchangeImpact
      contextRef="i6bb939bdb4e84a4cb2451ad2848d0fab_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmI4NmQ1MGE1ZjNiMDQyOGRiZGY0NzEyYzE1ZWY1OWYzL3RhYmxlcmFuZ2U6Yjg2ZDUwYTVmM2IwNDI4ZGJkZjQ3MTJjMTVlZjU5ZjNfNy0zLTEtMS0w_c569f428-9dfe-4066-8906-9b552c588c9b"
      unitRef="usd">5197000</hae:NetRevenuesBeforeForeignExchangeImpact>
    <hae:NetRevenuesBeforeForeignExchangeImpact
      contextRef="i6c7f2e0a659245f486464f52663463fe_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmI4NmQ1MGE1ZjNiMDQyOGRiZGY0NzEyYzE1ZWY1OWYzL3RhYmxlcmFuZ2U6Yjg2ZDUwYTVmM2IwNDI4ZGJkZjQ3MTJjMTVlZjU5ZjNfNy01LTEtMS0w_73b94d34-2a5b-4537-8e9e-1cb2ea3435e2"
      unitRef="usd">15396000</hae:NetRevenuesBeforeForeignExchangeImpact>
    <hae:NetRevenuesBeforeForeignExchangeImpact
      contextRef="i019e1c4459504344b5dfa26c7a9c0f8d_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmI4NmQ1MGE1ZjNiMDQyOGRiZGY0NzEyYzE1ZWY1OWYzL3RhYmxlcmFuZ2U6Yjg2ZDUwYTVmM2IwNDI4ZGJkZjQ3MTJjMTVlZjU5ZjNfNy03LTEtMS0w_b3a2c5f3-6011-4aca-99a3-a67fe6cca324"
      unitRef="usd">15339000</hae:NetRevenuesBeforeForeignExchangeImpact>
    <hae:EffectofExchangeRateonRevenues
      contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmI4NmQ1MGE1ZjNiMDQyOGRiZGY0NzEyYzE1ZWY1OWYzL3RhYmxlcmFuZ2U6Yjg2ZDUwYTVmM2IwNDI4ZGJkZjQ3MTJjMTVlZjU5ZjNfOC0xLTEtMS0w_e08e2ac6-4f5e-4086-b409-25542c453b41"
      unitRef="usd">494000</hae:EffectofExchangeRateonRevenues>
    <hae:EffectofExchangeRateonRevenues
      contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmI4NmQ1MGE1ZjNiMDQyOGRiZGY0NzEyYzE1ZWY1OWYzL3RhYmxlcmFuZ2U6Yjg2ZDUwYTVmM2IwNDI4ZGJkZjQ3MTJjMTVlZjU5ZjNfOC0zLTEtMS0w_77d9a918-e367-4495-8efb-e7c28e17fc55"
      unitRef="usd">-3291000</hae:EffectofExchangeRateonRevenues>
    <hae:EffectofExchangeRateonRevenues
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmI4NmQ1MGE1ZjNiMDQyOGRiZGY0NzEyYzE1ZWY1OWYzL3RhYmxlcmFuZ2U6Yjg2ZDUwYTVmM2IwNDI4ZGJkZjQ3MTJjMTVlZjU5ZjNfOC01LTEtMS0w_c8675203-b7cb-4a1f-81d5-1cd567122889"
      unitRef="usd">-2922000</hae:EffectofExchangeRateonRevenues>
    <hae:EffectofExchangeRateonRevenues
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmI4NmQ1MGE1ZjNiMDQyOGRiZGY0NzEyYzE1ZWY1OWYzL3RhYmxlcmFuZ2U6Yjg2ZDUwYTVmM2IwNDI4ZGJkZjQ3MTJjMTVlZjU5ZjNfOC03LTEtMS0w_86b6930d-18f7-4868-9f69-0d8160975fdc"
      unitRef="usd">-8072000</hae:EffectofExchangeRateonRevenues>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmI4NmQ1MGE1ZjNiMDQyOGRiZGY0NzEyYzE1ZWY1OWYzL3RhYmxlcmFuZ2U6Yjg2ZDUwYTVmM2IwNDI4ZGJkZjQ3MTJjMTVlZjU5ZjNfOS0xLTEtMS0w_d38d962d-23d8-472d-ac80-fdd5b6282bc8"
      unitRef="usd">240371000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmI4NmQ1MGE1ZjNiMDQyOGRiZGY0NzEyYzE1ZWY1OWYzL3RhYmxlcmFuZ2U6Yjg2ZDUwYTVmM2IwNDI4ZGJkZjQ3MTJjMTVlZjU5ZjNfOS0zLTEtMS0w_1c021815-f40a-4edb-8f08-7d5c03e3814f"
      unitRef="usd">258970000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmI4NmQ1MGE1ZjNiMDQyOGRiZGY0NzEyYzE1ZWY1OWYzL3RhYmxlcmFuZ2U6Yjg2ZDUwYTVmM2IwNDI4ZGJkZjQ3MTJjMTVlZjU5ZjNfOS01LTEtMS0w_affdbae9-f303-4393-bab0-e978260a802c"
      unitRef="usd">645434000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmI4NmQ1MGE1ZjNiMDQyOGRiZGY0NzEyYzE1ZWY1OWYzL3RhYmxlcmFuZ2U6Yjg2ZDUwYTVmM2IwNDI4ZGJkZjQ3MTJjMTVlZjU5ZjNfOS03LTEtMS0w_86903600-b7f3-4d6e-8ff9-fcb9264dbf5a"
      unitRef="usd">749987000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="i82de2706ab9a438d881b82d726f54fab_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMy0xLTEtMS0w_5f9ee776-b088-4b88-9933-1391e12331f2"
      unitRef="usd">52673000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i0d107d1d05864d96b46812133da26150_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMy0zLTEtMS0w_c3fe82f1-7a74-4ea8-a69c-0fd261cce0d8"
      unitRef="usd">59343000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5f67e87ff2f840db91e6f9c559b88649_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMy01LTEtMS0w_e2ea0f01-cd8f-4a97-9a88-d59781a8e16f"
      unitRef="usd">129846000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i0bd53f6c3550495599acfaf8cba39d05_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMy03LTEtMS0w_3c0b5456-5f13-47a0-a89a-b5092adc1567"
      unitRef="usd">169844000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i05aef9efca8d40999e7e0b591e687fcd_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfNC0xLTEtMS0w_bc9e714d-9e1e-4d33-a5ab-3eb1a3da2c8b"
      unitRef="usd">36424000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib02855b3bb664c3d929e1fe1f3d95081_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfNC0zLTEtMS0w_afb96c28-97ab-41d4-a738-b7d71c4dbb10"
      unitRef="usd">42197000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i1aec235f150e4c96ab0033513856af19_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfNC01LTEtMS0w_61ca8ecc-dc16-4330-8109-1545250a7ebd"
      unitRef="usd">108926000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i1cc5c0e6c3114948a0b3b81b9e13dbb3_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfNC03LTEtMS0w_19a46b14-c0e5-4f8d-b899-70572f684901"
      unitRef="usd">121124000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3c22cd4ab0ee4facb5feb0c32ce1dcb8_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfNS0xLTEtMS0w_052876f9-0cc1-45ad-8ea0-8cd8eb6e5b63"
      unitRef="usd">22430000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i2da01bba3bcc4743a21c2cd6815ea493_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfNS0zLTEtMS0w_8ff37bc7-da66-48b9-9dff-5c51df8b2702"
      unitRef="usd">20593000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i35b2d1e5a36a40f9a3630df7618c1971_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfNS01LTEtMS0w_d4755b8a-9ea2-4769-b75a-6a2761425d06"
      unitRef="usd">61672000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i87d70737be684026888e909a4d46800b_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfNS03LTEtMS0w_b8cbce86-267c-4573-8770-5c10a355d518"
      unitRef="usd">60360000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i7c9e183b328f4417a77301e1291a4315_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfNi0xLTEtMS0w_da23710a-e687-4235-930f-7457aaf7a206"
      unitRef="usd">111527000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib94e4c38bb47467fa41d2b3dd7377cf5_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfNi0zLTEtMS0w_5503d744-2a62-4eec-8013-0ae90c6d57b3"
      unitRef="usd">122133000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5d46cacfa2ca4634b761fcb1de68c22e_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfNi01LTEtMS0w_ad18a8e9-4805-4fcb-ab2e-5dfba157bf89"
      unitRef="usd">300444000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia1791b14ab6944fc9f18b6f33b05c26e_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfNi03LTEtMS0w_b49df896-543f-44fd-b0cf-490791d56368"
      unitRef="usd">351328000</us-gaap:OperatingIncomeLoss>
    <hae:CorporateOperatingExpenses
      contextRef="i05d2add01f7948cdbe05379d9edfa6cd_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfNy0xLTEtMS0w_f1695dfd-22e3-4663-991a-1b51dd0d36d2"
      unitRef="usd">63202000</hae:CorporateOperatingExpenses>
    <hae:CorporateOperatingExpenses
      contextRef="if68e3d2fce814080a6a5a599e4100f7d_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfNy0zLTEtMS0w_0e964f62-4fa2-4826-9d7a-337ea675cc4c"
      unitRef="usd">63080000</hae:CorporateOperatingExpenses>
    <hae:CorporateOperatingExpenses
      contextRef="i2f207c5c248843fd8e07e9437fa7102e_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfNy01LTEtMS0w_d0dd5627-7fc1-42cc-bd6d-9ac0b39afa1e"
      unitRef="usd">185005000</hae:CorporateOperatingExpenses>
    <hae:CorporateOperatingExpenses
      contextRef="id7b79856e7224f109a59af542be47303_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfNy03LTEtMS0w_0e4b990e-fff2-42ca-b442-665849cdf0d2"
      unitRef="usd">188363000</hae:CorporateOperatingExpenses>
    <hae:EffectofExchangeRatesonOperatingIncome
      contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfOC0xLTEtMS0w_dfec3e63-188c-4a91-89c1-93afa805eea0"
      unitRef="usd">4286000</hae:EffectofExchangeRatesonOperatingIncome>
    <hae:EffectofExchangeRatesonOperatingIncome
      contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfOC0zLTEtMS0w_8bce7622-a887-4716-8903-7d2a73f40d30"
      unitRef="usd">2521000</hae:EffectofExchangeRatesonOperatingIncome>
    <hae:EffectofExchangeRatesonOperatingIncome
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfOC01LTEtMS0w_5bb4af4c-ff8c-4c14-8272-8c3dcf748e86"
      unitRef="usd">8644000</hae:EffectofExchangeRatesonOperatingIncome>
    <hae:EffectofExchangeRatesonOperatingIncome
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfOC03LTEtMS0w_327f2b43-1d7f-4f0b-bc4c-a02103d22539"
      unitRef="usd">7791000</hae:EffectofExchangeRatesonOperatingIncome>
    <us-gaap:AdjustmentForAmortization
      contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfOS0xLTEtMS0w_1be6ef3a-f129-432c-93d8-a48cbef67e9c"
      unitRef="usd">7805000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfOS0zLTEtMS0w_13d92351-06d9-4699-9c3d-1d5a424c2480"
      unitRef="usd">5772000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfOS01LTEtMS0w_9de26929-47ad-43c3-810d-730b624ad36f"
      unitRef="usd">24204000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfOS03LTEtMS0w_7e0353c4-26f2-4450-a246-87e9726f7228"
      unitRef="usd">17681000</us-gaap:AdjustmentForAmortization>
    <hae:RestructuringandTurnaroundCosts
      contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMTAtMS0xLTEtMA_0716ac2d-1f8f-4621-8465-9710507e4ee8"
      unitRef="usd">3143000</hae:RestructuringandTurnaroundCosts>
    <hae:RestructuringandTurnaroundCosts
      contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMTAtMy0xLTEtMA_158e172e-283e-494d-a489-b970f47db88f"
      unitRef="usd">7798000</hae:RestructuringandTurnaroundCosts>
    <hae:RestructuringandTurnaroundCosts
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMTAtNS0xLTEtMA_54a26a88-c0af-4c73-a15a-3d4a9641bdbe"
      unitRef="usd">11583000</hae:RestructuringandTurnaroundCosts>
    <hae:RestructuringandTurnaroundCosts
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMTAtNy0xLTEtMA_f7814ba2-d1c8-4ea8-9f76-a02798c142e2"
      unitRef="usd">13582000</hae:RestructuringandTurnaroundCosts>
    <hae:OperatingExpensesTransactionCosts
      contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMTEtMS0xLTEtNjkw_71c7237c-451f-4fbb-91fc-17928cbee8ea"
      unitRef="usd">0</hae:OperatingExpensesTransactionCosts>
    <hae:OperatingExpensesTransactionCosts
      contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMTEtMy0xLTEtNzA1_b0da7fc1-b56b-4eb3-99be-c0596dc6f627"
      unitRef="usd">0</hae:OperatingExpensesTransactionCosts>
    <hae:OperatingExpensesTransactionCosts
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMTEtNS0xLTEtNjk5_6245612f-5c0a-4b14-b4e0-4b322eca471c"
      unitRef="usd">3063000</hae:OperatingExpensesTransactionCosts>
    <hae:OperatingExpensesTransactionCosts
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMTEtNy0xLTEtNzEw_58fad534-52bb-48ca-951b-5e27ee376884"
      unitRef="usd">0</hae:OperatingExpensesTransactionCosts>
    <us-gaap:RestructuringReserveAcceleratedDepreciation
      contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMTItMS0xLTEtMA_dfa3bc07-25d5-4071-8c06-33d8f796aaa4"
      unitRef="usd">1146000</us-gaap:RestructuringReserveAcceleratedDepreciation>
    <us-gaap:RestructuringReserveAcceleratedDepreciation
      contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMTItMy0xLTEtMA_55a8a5ab-8dc2-4c2d-bb58-57e46ba770b5"
      unitRef="usd">6649000</us-gaap:RestructuringReserveAcceleratedDepreciation>
    <us-gaap:RestructuringReserveAcceleratedDepreciation
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMTItNS0xLTEtMA_584c3e31-b430-4e44-800a-2bc3c0e85de1"
      unitRef="usd">3332000</us-gaap:RestructuringReserveAcceleratedDepreciation>
    <us-gaap:RestructuringReserveAcceleratedDepreciation
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMTItNy0xLTEtMA_a681c98f-e5cd-4fb9-89f7-8d2153476ee3"
      unitRef="usd">18708000</us-gaap:RestructuringReserveAcceleratedDepreciation>
    <hae:EuropeanMedicalDeviceRegulationCosts
      contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMTMtMS0xLTEtMA_4f1972b6-9fa6-4fbb-b8e4-b84562088b6a"
      unitRef="usd">1207000</hae:EuropeanMedicalDeviceRegulationCosts>
    <hae:EuropeanMedicalDeviceRegulationCosts
      contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMTMtMy0xLTEtMA_4b99d318-9b19-4031-8fb8-15a8aa5454c5"
      unitRef="usd">448000</hae:EuropeanMedicalDeviceRegulationCosts>
    <hae:EuropeanMedicalDeviceRegulationCosts
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMTMtNS0xLTEtMA_dbdc0aa0-15b9-41b6-84cf-dc542674a013"
      unitRef="usd">2696000</hae:EuropeanMedicalDeviceRegulationCosts>
    <hae:EuropeanMedicalDeviceRegulationCosts
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMTMtNy0xLTEtMA_4e4cc4e1-2518-40dc-b6d8-2f929c5ab00d"
      unitRef="usd">304000</hae:EuropeanMedicalDeviceRegulationCosts>
    <hae:AssetImpairmentAndOtherRelatedCharges
      contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMTQtMS0xLTEtMA_97ac0b69-7127-4dee-9b0d-cadb067193a6"
      unitRef="usd">0</hae:AssetImpairmentAndOtherRelatedCharges>
    <hae:AssetImpairmentAndOtherRelatedCharges
      contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMTQtMy0xLTEtMA_681ecf1d-c7b1-4afb-8aaa-310e54ae2bad"
      unitRef="usd">0</hae:AssetImpairmentAndOtherRelatedCharges>
    <hae:AssetImpairmentAndOtherRelatedCharges
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMTQtNS0xLTEtMA_d7e3c4ba-3988-473d-9dab-6e251ad58455"
      unitRef="usd">896000</hae:AssetImpairmentAndOtherRelatedCharges>
    <hae:AssetImpairmentAndOtherRelatedCharges
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMTQtNy0xLTEtMA_91573531-da94-4944-9f5f-8a22cf9a5f12"
      unitRef="usd">51220000</hae:AssetImpairmentAndOtherRelatedCharges>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMTUtMS0xLTEtMA_7c537550-ecdc-4515-b2da-cefd2abe55cc"
      unitRef="usd">1115000</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMTUtMy0xLTEtMA_d6b4cb7c-66dc-4d0d-b8a4-67e9581bd934"
      unitRef="usd">0</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMTUtNS0xLTEtMA_187a1596-3f2f-4d9c-9103-a5435d379d70"
      unitRef="usd">32613000</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMTUtNy0xLTEtMA_dbf2070c-5841-4bb2-af15-08f945c98e04"
      unitRef="usd">8083000</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:OperatingIncomeLoss
      contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMTYtMS0xLTEtMA_b2bd9a6e-1297-4c94-a065-255a4e9124dc"
      unitRef="usd">40425000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMTYtMy0xLTEtMA_f5b67842-3170-4798-b39c-77a0cda28de7"
      unitRef="usd">40907000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMTYtNS0xLTEtMA_88b7b439-332f-4be0-89ad-143b50eb396b"
      unitRef="usd">110922000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjkxOTI1ZDhhNGU5NDRhNTViZjNiYTQ1MDZhMDY4ZDM3L3RhYmxlcmFuZ2U6OTE5MjVkOGE0ZTk0NGE1NWJmM2JhNDUwNmEwNjhkMzdfMTYtNy0xLTEtMA_311fa3d1-b097-4bd6-9805-c4bbc22ce969"
      unitRef="usd">77344000</us-gaap:OperatingIncomeLoss>
    <us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RleHRyZWdpb246NDgyNDUzNzYxYzRhNDE2ODg2NzE1ZTcxMjk5NzFiZjBfMjY5OA_398ce147-da15-421e-b260-ea1fdca98de7">Management reviews revenue based on the reportable segments noted above.&#160;Although these reportable segments are primarily product-based, they differ from the Company&#x2019;s product line revenues for Plasma products and services and Blood Center products and services.&#160;Specifically, the Blood Center reportable segment includes plasma products utilized for collection in blood centers primarily for transfusion purposes.&#160;Additionally, product line revenues also include service revenues which are excluded from the reportable segments.&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net revenues by product line are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 28,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 28,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plasma products and services&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;309,933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;406,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Blood Center products and services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hospital products and services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;240,371&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;258,970&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;645,434&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;749,987&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net revenues generated in the Company's principle operating regions on a reported basis are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.303%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 28,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 28,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;382,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;485,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Japan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;240,371&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;258,970&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;645,434&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;749,987&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i26227889e9a545ad95431135a52ce953_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmM2YThlMzczZTQwYTQ1OTQ4M2U0ZTkyYTRiZjJmZWJjL3RhYmxlcmFuZ2U6YzZhOGUzNzNlNDBhNDU5NDgzZTRlOTJhNGJmMmZlYmNfMi0xLTEtMS0w_5e7ffbde-a70f-4bd6-b038-0e2e729b5710"
      unitRef="usd">123510000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idedb7dce764d40518eed1fa0384c56e9_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmM2YThlMzczZTQwYTQ1OTQ4M2U0ZTkyYTRiZjJmZWJjL3RhYmxlcmFuZ2U6YzZhOGUzNzNlNDBhNDU5NDgzZTRlOTJhNGJmMmZlYmNfMi0zLTEtMS0w_bfe55d89-0da9-4343-ad32-4dbe36c45641"
      unitRef="usd">141231000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idf184b96fbe0474082337c767ecc2e6f_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmM2YThlMzczZTQwYTQ1OTQ4M2U0ZTkyYTRiZjJmZWJjL3RhYmxlcmFuZ2U6YzZhOGUzNzNlNDBhNDU5NDgzZTRlOTJhNGJmMmZlYmNfMi01LTEtMS0w_e537ffda-7dec-4f31-babf-c8ba1a7bde11"
      unitRef="usd">309933000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if01e8fdfb1df4aa0be9d813f7d0e93e8_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmM2YThlMzczZTQwYTQ1OTQ4M2U0ZTkyYTRiZjJmZWJjL3RhYmxlcmFuZ2U6YzZhOGUzNzNlNDBhNDU5NDgzZTRlOTJhNGJmMmZlYmNfMi03LTEtMS0w_606d6050-01e8-43cd-823b-ba8ce3137333"
      unitRef="usd">406825000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i52f5dadf03404a3289fc228ba07b7289_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmM2YThlMzczZTQwYTQ1OTQ4M2U0ZTkyYTRiZjJmZWJjL3RhYmxlcmFuZ2U6YzZhOGUzNzNlNDBhNDU5NDgzZTRlOTJhNGJmMmZlYmNfMy0xLTEtMS0w_ae0f6f78-1221-4c92-ad9c-f937d10889aa"
      unitRef="usd">62787000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i46410774ee104dd5856f09f41912d660_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmM2YThlMzczZTQwYTQ1OTQ4M2U0ZTkyYTRiZjJmZWJjL3RhYmxlcmFuZ2U6YzZhOGUzNzNlNDBhNDU5NDgzZTRlOTJhNGJmMmZlYmNfMy0zLTEtMS0w_ea3962e2-fe5f-4e22-b0b5-7328c0443360"
      unitRef="usd">66126000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idc470180227d4a10b1dffb6cb47fb61e_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmM2YThlMzczZTQwYTQ1OTQ4M2U0ZTkyYTRiZjJmZWJjL3RhYmxlcmFuZ2U6YzZhOGUzNzNlNDBhNDU5NDgzZTRlOTJhNGJmMmZlYmNfMy01LTEtMS0w_bb6ed9ff-c6be-4f3e-a8f1-8b248eda5a87"
      unitRef="usd">182687000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9ad919a0f8eb4d72afcee6d577854416_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmM2YThlMzczZTQwYTQ1OTQ4M2U0ZTkyYTRiZjJmZWJjL3RhYmxlcmFuZ2U6YzZhOGUzNzNlNDBhNDU5NDgzZTRlOTJhNGJmMmZlYmNfMy03LTEtMS0w_66229921-bea0-494c-8c3d-1cc3f715ab26"
      unitRef="usd">191648000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i87710fdfb6e84d9f8daaca0e1a6929bb_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmM2YThlMzczZTQwYTQ1OTQ4M2U0ZTkyYTRiZjJmZWJjL3RhYmxlcmFuZ2U6YzZhOGUzNzNlNDBhNDU5NDgzZTRlOTJhNGJmMmZlYmNfNC0xLTEtMS0w_8b2bf0e6-63b0-4050-9a48-269f91407021"
      unitRef="usd">54074000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if8bb31ac20c2428391e3f927f45c8cd7_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmM2YThlMzczZTQwYTQ1OTQ4M2U0ZTkyYTRiZjJmZWJjL3RhYmxlcmFuZ2U6YzZhOGUzNzNlNDBhNDU5NDgzZTRlOTJhNGJmMmZlYmNfNC0zLTEtMS0w_0aec7d0d-f8ea-4b23-96c0-13d585146b2c"
      unitRef="usd">51613000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieb446313570e4a9d840e6f2059d39181_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmM2YThlMzczZTQwYTQ1OTQ4M2U0ZTkyYTRiZjJmZWJjL3RhYmxlcmFuZ2U6YzZhOGUzNzNlNDBhNDU5NDgzZTRlOTJhNGJmMmZlYmNfNC01LTEtMS0w_9d7c1b78-e03b-4c2e-b002-4e87adf6501d"
      unitRef="usd">152814000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2fa09902b11845b090e32e2378241640_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmM2YThlMzczZTQwYTQ1OTQ4M2U0ZTkyYTRiZjJmZWJjL3RhYmxlcmFuZ2U6YzZhOGUzNzNlNDBhNDU5NDgzZTRlOTJhNGJmMmZlYmNfNC03LTEtMS0w_75953bb9-ddd2-45f3-9d7f-cc6f36394b8f"
      unitRef="usd">151514000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmM2YThlMzczZTQwYTQ1OTQ4M2U0ZTkyYTRiZjJmZWJjL3RhYmxlcmFuZ2U6YzZhOGUzNzNlNDBhNDU5NDgzZTRlOTJhNGJmMmZlYmNfNS0xLTEtMS0w_c2db2b6d-e82c-48c4-8c86-1bee415ec79d"
      unitRef="usd">240371000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmM2YThlMzczZTQwYTQ1OTQ4M2U0ZTkyYTRiZjJmZWJjL3RhYmxlcmFuZ2U6YzZhOGUzNzNlNDBhNDU5NDgzZTRlOTJhNGJmMmZlYmNfNS0zLTEtMS0w_306f349e-38c0-4b87-b642-4a8f393972ea"
      unitRef="usd">258970000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmM2YThlMzczZTQwYTQ1OTQ4M2U0ZTkyYTRiZjJmZWJjL3RhYmxlcmFuZ2U6YzZhOGUzNzNlNDBhNDU5NDgzZTRlOTJhNGJmMmZlYmNfNS01LTEtMS0w_f1e099b6-efae-472b-a62a-e9e1afdb07a7"
      unitRef="usd">645434000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOmM2YThlMzczZTQwYTQ1OTQ4M2U0ZTkyYTRiZjJmZWJjL3RhYmxlcmFuZ2U6YzZhOGUzNzNlNDBhNDU5NDgzZTRlOTJhNGJmMmZlYmNfNS03LTEtMS0w_ed3bd2a5-5007-4264-9ee4-c09232a7e941"
      unitRef="usd">749987000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7cc83bace6e64ba2819ad07eee146aa5_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjRlMTRjZjk5MTQ1NTRmZjJhOWQ5N2NmYzUyYzRmNDliL3RhYmxlcmFuZ2U6NGUxNGNmOTkxNDU1NGZmMmE5ZDk3Y2ZjNTJjNGY0OWJfMi0xLTEtMS0w_ef1e65df-d1e9-41e0-855d-da5392a7855f"
      unitRef="usd">147607000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5255bf836d2f4c928a7bb2389d05393b_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjRlMTRjZjk5MTQ1NTRmZjJhOWQ5N2NmYzUyYzRmNDliL3RhYmxlcmFuZ2U6NGUxNGNmOTkxNDU1NGZmMmE5ZDk3Y2ZjNTJjNGY0OWJfMi0zLTEtMS0w_3ef3447e-e684-4999-a13f-b2a3d99e1c40"
      unitRef="usd">167238000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia77b37ab4b674b69b224543cc8eb45e6_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjRlMTRjZjk5MTQ1NTRmZjJhOWQ5N2NmYzUyYzRmNDliL3RhYmxlcmFuZ2U6NGUxNGNmOTkxNDU1NGZmMmE5ZDk3Y2ZjNTJjNGY0OWJfMi01LTEtMS0w_63642879-1047-4cb1-bb9a-a0ef0984ea2e"
      unitRef="usd">382600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4a100d6026814cee86e66f779c21038c_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjRlMTRjZjk5MTQ1NTRmZjJhOWQ5N2NmYzUyYzRmNDliL3RhYmxlcmFuZ2U6NGUxNGNmOTkxNDU1NGZmMmE5ZDk3Y2ZjNTJjNGY0OWJfMi03LTEtMS0w_a8e026fe-5504-46bf-a214-02b2904138b5"
      unitRef="usd">485493000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5d172cbd06c7456499c6f9186db5c771_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjRlMTRjZjk5MTQ1NTRmZjJhOWQ5N2NmYzUyYzRmNDliL3RhYmxlcmFuZ2U6NGUxNGNmOTkxNDU1NGZmMmE5ZDk3Y2ZjNTJjNGY0OWJfMy0xLTEtMS0w_9426c073-0c89-4c0a-9639-0307a0be00ad"
      unitRef="usd">20854000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i84a09fec71e2469490c5fced840c534d_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjRlMTRjZjk5MTQ1NTRmZjJhOWQ5N2NmYzUyYzRmNDliL3RhYmxlcmFuZ2U6NGUxNGNmOTkxNDU1NGZmMmE5ZDk3Y2ZjNTJjNGY0OWJfMy0zLTEtMS0w_40bbba88-ea69-46b5-ba47-25da2e5a5292"
      unitRef="usd">19268000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia8042aa5ffab48bba95d2e2d9c04f228_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjRlMTRjZjk5MTQ1NTRmZjJhOWQ5N2NmYzUyYzRmNDliL3RhYmxlcmFuZ2U6NGUxNGNmOTkxNDU1NGZmMmE5ZDk3Y2ZjNTJjNGY0OWJfMy01LTEtMS0w_5b6f5ebf-92c1-412d-8390-2773558d2dc6"
      unitRef="usd">57330000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i17ab8f6f349b4eaba8ad6043c531b88a_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjRlMTRjZjk5MTQ1NTRmZjJhOWQ5N2NmYzUyYzRmNDliL3RhYmxlcmFuZ2U6NGUxNGNmOTkxNDU1NGZmMmE5ZDk3Y2ZjNTJjNGY0OWJfMy03LTEtMS0w_8631b7e5-7e0f-4d05-ba4c-634d99563c7e"
      unitRef="usd">55111000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieb8358f9ae4143e7bb93e59e7d3a809c_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjRlMTRjZjk5MTQ1NTRmZjJhOWQ5N2NmYzUyYzRmNDliL3RhYmxlcmFuZ2U6NGUxNGNmOTkxNDU1NGZmMmE5ZDk3Y2ZjNTJjNGY0OWJfNC0xLTEtMS0w_ba5f9352-065d-4f52-9552-26ea0d2b2b48"
      unitRef="usd">41874000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i479cccf7db0b402f8eb765dc4867033c_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjRlMTRjZjk5MTQ1NTRmZjJhOWQ5N2NmYzUyYzRmNDliL3RhYmxlcmFuZ2U6NGUxNGNmOTkxNDU1NGZmMmE5ZDk3Y2ZjNTJjNGY0OWJfNC0zLTEtMS0w_41f4398a-c092-4106-997e-4e103b8d7ebc"
      unitRef="usd">40984000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib68f4cb225a84d98b73f7eb16b96435c_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjRlMTRjZjk5MTQ1NTRmZjJhOWQ5N2NmYzUyYzRmNDliL3RhYmxlcmFuZ2U6NGUxNGNmOTkxNDU1NGZmMmE5ZDk3Y2ZjNTJjNGY0OWJfNC01LTEtMS0w_da8edef1-de6e-437f-bb97-79113e207660"
      unitRef="usd">123541000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0d56e00072c84650b763043b36796f33_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjRlMTRjZjk5MTQ1NTRmZjJhOWQ5N2NmYzUyYzRmNDliL3RhYmxlcmFuZ2U6NGUxNGNmOTkxNDU1NGZmMmE5ZDk3Y2ZjNTJjNGY0OWJfNC03LTEtMS0w_a33f4359-b338-4d93-9cfc-61b8c3b0016d"
      unitRef="usd">115811000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4173f578720640508c5f3e2556613126_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjRlMTRjZjk5MTQ1NTRmZjJhOWQ5N2NmYzUyYzRmNDliL3RhYmxlcmFuZ2U6NGUxNGNmOTkxNDU1NGZmMmE5ZDk3Y2ZjNTJjNGY0OWJfNS0xLTEtMS0w_5123ebe0-2df8-4ca1-bb33-fe890af02fd6"
      unitRef="usd">29050000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie22e69eafcdc47a5a7f6d41ca37a8314_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjRlMTRjZjk5MTQ1NTRmZjJhOWQ5N2NmYzUyYzRmNDliL3RhYmxlcmFuZ2U6NGUxNGNmOTkxNDU1NGZmMmE5ZDk3Y2ZjNTJjNGY0OWJfNS0zLTEtMS0w_7de69b6d-eb4e-4c5d-aea1-cad9b503317f"
      unitRef="usd">29436000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i17cdd867d9784cc8998e9d70ee3105af_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjRlMTRjZjk5MTQ1NTRmZjJhOWQ5N2NmYzUyYzRmNDliL3RhYmxlcmFuZ2U6NGUxNGNmOTkxNDU1NGZmMmE5ZDk3Y2ZjNTJjNGY0OWJfNS01LTEtMS0w_4f71d74e-9b9a-42bd-b191-70612a579e96"
      unitRef="usd">77602000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i96c22dedabc94ec0a58470fce107095e_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjRlMTRjZjk5MTQ1NTRmZjJhOWQ5N2NmYzUyYzRmNDliL3RhYmxlcmFuZ2U6NGUxNGNmOTkxNDU1NGZmMmE5ZDk3Y2ZjNTJjNGY0OWJfNS03LTEtMS0w_f8d5af3d-3a55-42d4-b867-a96723d3465c"
      unitRef="usd">88269000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6c25765c59da42a08a0a21dbace51807_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjRlMTRjZjk5MTQ1NTRmZjJhOWQ5N2NmYzUyYzRmNDliL3RhYmxlcmFuZ2U6NGUxNGNmOTkxNDU1NGZmMmE5ZDk3Y2ZjNTJjNGY0OWJfNi0xLTEtMS0w_71c52af7-a635-43da-b0d4-7626bd2aba40"
      unitRef="usd">986000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i787564a0a009410b9c7377c8d5563e2a_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjRlMTRjZjk5MTQ1NTRmZjJhOWQ5N2NmYzUyYzRmNDliL3RhYmxlcmFuZ2U6NGUxNGNmOTkxNDU1NGZmMmE5ZDk3Y2ZjNTJjNGY0OWJfNi0zLTEtMS0w_dab17360-1360-43dd-9ea5-80db38788eea"
      unitRef="usd">2044000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idfb3207a7e164364a10c64478573dec0_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjRlMTRjZjk5MTQ1NTRmZjJhOWQ5N2NmYzUyYzRmNDliL3RhYmxlcmFuZ2U6NGUxNGNmOTkxNDU1NGZmMmE5ZDk3Y2ZjNTJjNGY0OWJfNi01LTEtMS0w_73e9f30a-bdd4-4322-9637-a6c789f55af8"
      unitRef="usd">4361000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i77f79023d32b40a3bb1a8b511a7fe783_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjRlMTRjZjk5MTQ1NTRmZjJhOWQ5N2NmYzUyYzRmNDliL3RhYmxlcmFuZ2U6NGUxNGNmOTkxNDU1NGZmMmE5ZDk3Y2ZjNTJjNGY0OWJfNi03LTEtMS0w_505ec618-e537-4b91-9b7a-d94623c5076c"
      unitRef="usd">5303000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjRlMTRjZjk5MTQ1NTRmZjJhOWQ5N2NmYzUyYzRmNDliL3RhYmxlcmFuZ2U6NGUxNGNmOTkxNDU1NGZmMmE5ZDk3Y2ZjNTJjNGY0OWJfNy0xLTEtMS0w_05f1566a-f5ad-44be-8926-e0b88b3461a2"
      unitRef="usd">240371000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i47db47b4ac42495eb564dec317455a1b_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjRlMTRjZjk5MTQ1NTRmZjJhOWQ5N2NmYzUyYzRmNDliL3RhYmxlcmFuZ2U6NGUxNGNmOTkxNDU1NGZmMmE5ZDk3Y2ZjNTJjNGY0OWJfNy0zLTEtMS0w_8320b608-1097-4f44-aa5a-07b1b58dbadf"
      unitRef="usd">258970000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjRlMTRjZjk5MTQ1NTRmZjJhOWQ5N2NmYzUyYzRmNDliL3RhYmxlcmFuZ2U6NGUxNGNmOTkxNDU1NGZmMmE5ZDk3Y2ZjNTJjNGY0OWJfNy01LTEtMS0w_14c1f9cb-0c06-4ed4-b2d2-58432983ac92"
      unitRef="usd">645434000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i204e8d9698904871aad5bc655af74aa6_D20190331-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84Mi9mcmFnOjQ4MjQ1Mzc2MWM0YTQxNjg4NjcxNWU3MTI5OTcxYmYwL3RhYmxlOjRlMTRjZjk5MTQ1NTRmZjJhOWQ5N2NmYzUyYzRmNDliL3RhYmxlcmFuZ2U6NGUxNGNmOTkxNDU1NGZmMmE5ZDk3Y2ZjNTJjNGY0OWJfNy03LTEtMS0w_9061e593-7332-42b6-8304-1bacb3a71285"
      unitRef="usd">749987000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84NS9mcmFnOjk0ZjI1YTIxMDQyMTQ1MTg4NTkxNTg2ZWNiZDNmMTM3L3RleHRyZWdpb246OTRmMjVhMjEwNDIxNDUxODg1OTE1ODZlY2JkM2YxMzdfODM_35214fe2-8083-469a-bf69-343bd642d2b1">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;15. ACCUMULATED OTHER COMPREHENSIVE LOSS &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of Accumulated Other Comprehensive Loss are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.168%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Defined Benefit Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Unrealized Gain/Loss on Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of March 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(31,100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(209)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(13,826)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(45,135)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,618)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current period other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(19,069)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(209)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(10,580)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(29,858)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt; Presented net of income taxes, the amounts of which are insignificant.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84NS9mcmFnOjk0ZjI1YTIxMDQyMTQ1MTg4NTkxNTg2ZWNiZDNmMTM3L3RleHRyZWdpb246OTRmMjVhMjEwNDIxNDUxODg1OTE1ODZlY2JkM2YxMzdfODY_58120724-cd49-4ff4-9fb8-b3aca249ec2c">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of Accumulated Other Comprehensive Loss are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.168%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Defined Benefit Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Unrealized Gain/Loss on Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of March 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(31,100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(209)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(13,826)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(45,135)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,618)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current period other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(19,069)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(209)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(10,580)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(29,858)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt; Presented net of income taxes, the amounts of which are insignificant.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i73c6d04f09054f72ad3f93b0ac709dbf_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84NS9mcmFnOjk0ZjI1YTIxMDQyMTQ1MTg4NTkxNTg2ZWNiZDNmMTM3L3RhYmxlOjhiMzZkNDM2YmYyNDRkOGRiOGNmOTg3M2FhMjY3OThmL3RhYmxlcmFuZ2U6OGIzNmQ0MzZiZjI0NGQ4ZGI4Y2Y5ODczYWEyNjc5OGZfMS0yLTEtMS0w_7aa084ff-46c7-4b06-8e1e-06ad0e1140a6"
      unitRef="usd">-31100000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="id5abcf57b0bd45828a4b667e017ea34b_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84NS9mcmFnOjk0ZjI1YTIxMDQyMTQ1MTg4NTkxNTg2ZWNiZDNmMTM3L3RhYmxlOjhiMzZkNDM2YmYyNDRkOGRiOGNmOTg3M2FhMjY3OThmL3RhYmxlcmFuZ2U6OGIzNmQ0MzZiZjI0NGQ4ZGI4Y2Y5ODczYWEyNjc5OGZfMS00LTEtMS0w_46dc2175-9f52-4d81-a06d-0308ab2f5541"
      unitRef="usd">-209000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ibd033b9d4b7c4a79acde034ff7bf773d_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84NS9mcmFnOjk0ZjI1YTIxMDQyMTQ1MTg4NTkxNTg2ZWNiZDNmMTM3L3RhYmxlOjhiMzZkNDM2YmYyNDRkOGRiOGNmOTg3M2FhMjY3OThmL3RhYmxlcmFuZ2U6OGIzNmQ0MzZiZjI0NGQ4ZGI4Y2Y5ODczYWEyNjc5OGZfMS02LTEtMS0w_93aa28f5-da3a-4b45-8e6d-bce2e70ee9c4"
      unitRef="usd">-13826000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i6b515458914540b58a5b339208b5c6aa_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84NS9mcmFnOjk0ZjI1YTIxMDQyMTQ1MTg4NTkxNTg2ZWNiZDNmMTM3L3RhYmxlOjhiMzZkNDM2YmYyNDRkOGRiOGNmOTg3M2FhMjY3OThmL3RhYmxlcmFuZ2U6OGIzNmQ0MzZiZjI0NGQ4ZGI4Y2Y5ODczYWEyNjc5OGZfMS04LTEtMS0w_34131a8f-0685-44ba-8c07-b1d0b735eca3"
      unitRef="usd">-45135000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i1e613855a20241cbb5aca346a957c8d5_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84NS9mcmFnOjk0ZjI1YTIxMDQyMTQ1MTg4NTkxNTg2ZWNiZDNmMTM3L3RhYmxlOjhiMzZkNDM2YmYyNDRkOGRiOGNmOTg3M2FhMjY3OThmL3RhYmxlcmFuZ2U6OGIzNmQ0MzZiZjI0NGQ4ZGI4Y2Y5ODczYWEyNjc5OGZfMi0yLTEtMS0w_d38eee8e-4d58-45cd-856b-adb1c138ff9e"
      unitRef="usd">12031000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="if1674f32a21e4d63a2bd245596b5d47c_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84NS9mcmFnOjk0ZjI1YTIxMDQyMTQ1MTg4NTkxNTg2ZWNiZDNmMTM3L3RhYmxlOjhiMzZkNDM2YmYyNDRkOGRiOGNmOTg3M2FhMjY3OThmL3RhYmxlcmFuZ2U6OGIzNmQ0MzZiZjI0NGQ4ZGI4Y2Y5ODczYWEyNjc5OGZfMi00LTEtMS0w_e8ed2d31-8d1b-426c-a7d6-d30772a4238f"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i64fb8a3c1c5d42e99e7b38ba5b2f180f_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84NS9mcmFnOjk0ZjI1YTIxMDQyMTQ1MTg4NTkxNTg2ZWNiZDNmMTM3L3RhYmxlOjhiMzZkNDM2YmYyNDRkOGRiOGNmOTg3M2FhMjY3OThmL3RhYmxlcmFuZ2U6OGIzNmQ0MzZiZjI0NGQ4ZGI4Y2Y5ODczYWEyNjc5OGZfMi02LTEtMS0w_0fef3068-9e87-4e70-8522-d3f13cf4218c"
      unitRef="usd">-1618000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84NS9mcmFnOjk0ZjI1YTIxMDQyMTQ1MTg4NTkxNTg2ZWNiZDNmMTM3L3RhYmxlOjhiMzZkNDM2YmYyNDRkOGRiOGNmOTg3M2FhMjY3OThmL3RhYmxlcmFuZ2U6OGIzNmQ0MzZiZjI0NGQ4ZGI4Y2Y5ODczYWEyNjc5OGZfMi04LTEtMS0w_f4f4e4bf-1903-4089-bab9-7cf2878611aa"
      unitRef="usd">10413000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i1e613855a20241cbb5aca346a957c8d5_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84NS9mcmFnOjk0ZjI1YTIxMDQyMTQ1MTg4NTkxNTg2ZWNiZDNmMTM3L3RhYmxlOjhiMzZkNDM2YmYyNDRkOGRiOGNmOTg3M2FhMjY3OThmL3RhYmxlcmFuZ2U6OGIzNmQ0MzZiZjI0NGQ4ZGI4Y2Y5ODczYWEyNjc5OGZfMy0yLTEtMS0w_dfc707e7-9fbc-4b67-aac4-084b7646e629"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="if1674f32a21e4d63a2bd245596b5d47c_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84NS9mcmFnOjk0ZjI1YTIxMDQyMTQ1MTg4NTkxNTg2ZWNiZDNmMTM3L3RhYmxlOjhiMzZkNDM2YmYyNDRkOGRiOGNmOTg3M2FhMjY3OThmL3RhYmxlcmFuZ2U6OGIzNmQ0MzZiZjI0NGQ4ZGI4Y2Y5ODczYWEyNjc5OGZfMy00LTEtMS0w_87446b40-d38e-423c-9d7b-d64fd595d85b"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i64fb8a3c1c5d42e99e7b38ba5b2f180f_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84NS9mcmFnOjk0ZjI1YTIxMDQyMTQ1MTg4NTkxNTg2ZWNiZDNmMTM3L3RhYmxlOjhiMzZkNDM2YmYyNDRkOGRiOGNmOTg3M2FhMjY3OThmL3RhYmxlcmFuZ2U6OGIzNmQ0MzZiZjI0NGQ4ZGI4Y2Y5ODczYWEyNjc5OGZfMy02LTEtMS0w_df992240-9ee5-44d5-884e-ab70634c9634"
      unitRef="usd">-4864000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84NS9mcmFnOjk0ZjI1YTIxMDQyMTQ1MTg4NTkxNTg2ZWNiZDNmMTM3L3RhYmxlOjhiMzZkNDM2YmYyNDRkOGRiOGNmOTg3M2FhMjY3OThmL3RhYmxlcmFuZ2U6OGIzNmQ0MzZiZjI0NGQ4ZGI4Y2Y5ODczYWEyNjc5OGZfMy04LTEtMS0w_aaa0c112-788c-4580-951b-47aa511a440b"
      unitRef="usd">-4864000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i1e613855a20241cbb5aca346a957c8d5_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84NS9mcmFnOjk0ZjI1YTIxMDQyMTQ1MTg4NTkxNTg2ZWNiZDNmMTM3L3RhYmxlOjhiMzZkNDM2YmYyNDRkOGRiOGNmOTg3M2FhMjY3OThmL3RhYmxlcmFuZ2U6OGIzNmQ0MzZiZjI0NGQ4ZGI4Y2Y5ODczYWEyNjc5OGZfNC0yLTEtMS0w_9b974bf6-53ea-468b-a28d-0e836c3bbec2"
      unitRef="usd">12031000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if1674f32a21e4d63a2bd245596b5d47c_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84NS9mcmFnOjk0ZjI1YTIxMDQyMTQ1MTg4NTkxNTg2ZWNiZDNmMTM3L3RhYmxlOjhiMzZkNDM2YmYyNDRkOGRiOGNmOTg3M2FhMjY3OThmL3RhYmxlcmFuZ2U6OGIzNmQ0MzZiZjI0NGQ4ZGI4Y2Y5ODczYWEyNjc5OGZfNC00LTEtMS0w_6398e89e-2915-442c-9ae6-226d78ade077"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i64fb8a3c1c5d42e99e7b38ba5b2f180f_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84NS9mcmFnOjk0ZjI1YTIxMDQyMTQ1MTg4NTkxNTg2ZWNiZDNmMTM3L3RhYmxlOjhiMzZkNDM2YmYyNDRkOGRiOGNmOTg3M2FhMjY3OThmL3RhYmxlcmFuZ2U6OGIzNmQ0MzZiZjI0NGQ4ZGI4Y2Y5ODczYWEyNjc5OGZfNC02LTEtMS0w_361dab03-662e-4fd3-9513-716276e0e6c4"
      unitRef="usd">3246000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84NS9mcmFnOjk0ZjI1YTIxMDQyMTQ1MTg4NTkxNTg2ZWNiZDNmMTM3L3RhYmxlOjhiMzZkNDM2YmYyNDRkOGRiOGNmOTg3M2FhMjY3OThmL3RhYmxlcmFuZ2U6OGIzNmQ0MzZiZjI0NGQ4ZGI4Y2Y5ODczYWEyNjc5OGZfNC04LTEtMS0w_4a7b7b8f-dd8f-4f32-a033-a8bb1065258c"
      unitRef="usd">15277000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ie870c34971924054809e87e40bb33672_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84NS9mcmFnOjk0ZjI1YTIxMDQyMTQ1MTg4NTkxNTg2ZWNiZDNmMTM3L3RhYmxlOjhiMzZkNDM2YmYyNDRkOGRiOGNmOTg3M2FhMjY3OThmL3RhYmxlcmFuZ2U6OGIzNmQ0MzZiZjI0NGQ4ZGI4Y2Y5ODczYWEyNjc5OGZfNS0yLTEtMS0w_650727ce-e93c-4a54-82d2-7b35f1fc9a94"
      unitRef="usd">-19069000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i6309acd9935545568cbf73841d4a4e9c_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84NS9mcmFnOjk0ZjI1YTIxMDQyMTQ1MTg4NTkxNTg2ZWNiZDNmMTM3L3RhYmxlOjhiMzZkNDM2YmYyNDRkOGRiOGNmOTg3M2FhMjY3OThmL3RhYmxlcmFuZ2U6OGIzNmQ0MzZiZjI0NGQ4ZGI4Y2Y5ODczYWEyNjc5OGZfNS00LTEtMS0w_b8f074ad-5e7a-4be2-89c9-58d8dfd1f7cd"
      unitRef="usd">-209000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i98ca0312f088468c8e6ea90d58d30441_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84NS9mcmFnOjk0ZjI1YTIxMDQyMTQ1MTg4NTkxNTg2ZWNiZDNmMTM3L3RhYmxlOjhiMzZkNDM2YmYyNDRkOGRiOGNmOTg3M2FhMjY3OThmL3RhYmxlcmFuZ2U6OGIzNmQ0MzZiZjI0NGQ4ZGI4Y2Y5ODczYWEyNjc5OGZfNS02LTEtMS0w_c0caff7f-5227-455b-9982-2eaec3545054"
      unitRef="usd">-10580000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV84NS9mcmFnOjk0ZjI1YTIxMDQyMTQ1MTg4NTkxNTg2ZWNiZDNmMTM3L3RhYmxlOjhiMzZkNDM2YmYyNDRkOGRiOGNmOTg3M2FhMjY3OThmL3RhYmxlcmFuZ2U6OGIzNmQ0MzZiZjI0NGQ4ZGI4Y2Y5ODczYWEyNjc5OGZfNS04LTEtMS0w_a2ec7e48-bc20-48be-9aac-e11e60af33ee"
      unitRef="usd">-29858000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140454139227656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DOCUMENT AND ENTITY INFORMATION - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Jan. 29, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 26,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-14041<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">HAEMONETICS CORP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000313143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--04-03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">MA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">04-2882273<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">125 Summer Street<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Boston,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">781<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">848-7100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, $.01&#160;par value per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">HAE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,821,698<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 13<br> -Subsection a-13<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1-<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140454070543352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">$ 240,371<span></span>
</td>
<td class="nump">$ 258,970<span></span>
</td>
<td class="nump">$ 645,434<span></span>
</td>
<td class="nump">$ 749,987<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of goods sold</a></td>
<td class="nump">120,114<span></span>
</td>
<td class="nump">130,920<span></span>
</td>
<td class="nump">329,403<span></span>
</td>
<td class="nump">379,031<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">120,257<span></span>
</td>
<td class="nump">128,050<span></span>
</td>
<td class="nump">316,031<span></span>
</td>
<td class="nump">370,956<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">7,501<span></span>
</td>
<td class="nump">7,000<span></span>
</td>
<td class="nump">22,014<span></span>
</td>
<td class="nump">21,909<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">73,446<span></span>
</td>
<td class="nump">78,267<span></span>
</td>
<td class="nump">214,680<span></span>
</td>
<td class="nump">229,189<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetImpairmentCharges', window );">Impairment of assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,876<span></span>
</td>
<td class="nump">1,028<span></span>
</td>
<td class="nump">50,597<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hae_GainLossOnDivestitureAndSaleOfAssets', window );">Gains on divestitures and sale of assets</a></td>
<td class="num">(1,115)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(32,613)<span></span>
</td>
<td class="num">(8,083)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">79,832<span></span>
</td>
<td class="nump">87,143<span></span>
</td>
<td class="nump">205,109<span></span>
</td>
<td class="nump">293,612<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">40,425<span></span>
</td>
<td class="nump">40,907<span></span>
</td>
<td class="nump">110,922<span></span>
</td>
<td class="nump">77,344<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Interest and other expense, net</a></td>
<td class="num">(3,051)<span></span>
</td>
<td class="num">(3,078)<span></span>
</td>
<td class="num">(10,612)<span></span>
</td>
<td class="num">(12,152)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before provision for income taxes</a></td>
<td class="nump">37,374<span></span>
</td>
<td class="nump">37,829<span></span>
</td>
<td class="nump">100,310<span></span>
</td>
<td class="nump">65,192<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">5,492<span></span>
</td>
<td class="nump">7,934<span></span>
</td>
<td class="nump">9,800<span></span>
</td>
<td class="nump">6,290<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 31,882<span></span>
</td>
<td class="nump">$ 29,895<span></span>
</td>
<td class="nump">$ 90,510<span></span>
</td>
<td class="nump">$ 58,902<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic income (loss) per share (in dollars per share)</a></td>
<td class="nump">$ 0.63<span></span>
</td>
<td class="nump">$ 0.59<span></span>
</td>
<td class="nump">$ 1.79<span></span>
</td>
<td class="nump">$ 1.16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted income (loss) per share (in dollars per share)</a></td>
<td class="nump">$ 0.62<span></span>
</td>
<td class="nump">$ 0.58<span></span>
</td>
<td class="nump">$ 1.77<span></span>
</td>
<td class="nump">$ 1.13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average shares outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">50,789<span></span>
</td>
<td class="nump">50,630<span></span>
</td>
<td class="nump">50,634<span></span>
</td>
<td class="nump">50,810<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">51,363<span></span>
</td>
<td class="nump">51,638<span></span>
</td>
<td class="nump">51,234<span></span>
</td>
<td class="nump">51,995<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income</a></td>
<td class="nump">$ 40,496<span></span>
</td>
<td class="nump">$ 32,296<span></span>
</td>
<td class="nump">$ 105,787<span></span>
</td>
<td class="nump">$ 55,577<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_GainLossOnDivestitureAndSaleOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) on Divestiture and Sale of Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_GainLossOnDivestitureAndSaleOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e557-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1337-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=117327953&amp;loc=d3e4984-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=SL5780133-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=117327953&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1252-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109238882&amp;loc=d3e38679-109324<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The charge against earnings resulting from the write down of long lived assets other than goodwill due to the difference between the carrying value and lower fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130543-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=68048583&amp;loc=d3e3636-108311<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1448-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140454070479528">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 189,002<span></span>
</td>
<td class="nump">$ 137,311<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, less allowance of $2,525 at December 26, 2020 and $3,824 at March 28, 2020</a></td>
<td class="nump">146,939<span></span>
</td>
<td class="nump">165,207<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories, net</a></td>
<td class="nump">299,710<span></span>
</td>
<td class="nump">270,276<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">32,697<span></span>
</td>
<td class="nump">30,845<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">668,348<span></span>
</td>
<td class="nump">603,639<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">240,009<span></span>
</td>
<td class="nump">253,399<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets, less accumulated amortization of $309,951 at December 26, 2020 and $296,942 at March 28, 2020</a></td>
<td class="nump">119,716<span></span>
</td>
<td class="nump">133,106<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">215,508<span></span>
</td>
<td class="nump">210,652<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax asset</a></td>
<td class="nump">4,558<span></span>
</td>
<td class="nump">3,930<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long-term assets</a></td>
<td class="nump">69,929<span></span>
</td>
<td class="nump">62,384<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">1,318,068<span></span>
</td>
<td class="nump">1,267,110<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Notes payable and current maturities of long-term debt</a></td>
<td class="nump">17,055<span></span>
</td>
<td class="nump">76,980<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">42,979<span></span>
</td>
<td class="nump">50,730<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued payroll and related costs</a></td>
<td class="nump">35,127<span></span>
</td>
<td class="nump">49,471<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other liabilities</a></td>
<td class="nump">99,223<span></span>
</td>
<td class="nump">97,641<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">194,384<span></span>
</td>
<td class="nump">274,822<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, net of current maturities</a></td>
<td class="nump">292,721<span></span>
</td>
<td class="nump">305,513<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liability</a></td>
<td class="nump">9,803<span></span>
</td>
<td class="nump">10,562<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">102,008<span></span>
</td>
<td class="nump">89,104<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Total stockholders&#8217; equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.01 par value; Authorized &#8212; 150,000,000 shares; Issued and outstanding &#8212; 50,817,222 shares at December 26, 2020 and 50,322,930 shares at March 28, 2020</a></td>
<td class="nump">508<span></span>
</td>
<td class="nump">503<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">579,480<span></span>
</td>
<td class="nump">553,229<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">169,022<span></span>
</td>
<td class="nump">78,512<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(29,858)<span></span>
</td>
<td class="num">(45,135)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">719,152<span></span>
</td>
<td class="nump">587,109<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 1,318,068<span></span>
</td>
<td class="nump">$ 1,267,110<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130549-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118952595&amp;loc=d3e4428-111522<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=118952595&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6801-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=116821951&amp;loc=d3e31931-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77989000&amp;loc=SL49117168-202975<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116846819&amp;loc=d3e3927-108312<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140454070222776">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Parentheticals) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Accounts receivable, allowance</a></td>
<td class="nump">$ 2,525<span></span>
</td>
<td class="nump">$ 3,824<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Intangible assets, amortization</a></td>
<td class="nump">$ 309,951<span></span>
</td>
<td class="nump">$ 296,942<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">150,000,000<span></span>
</td>
<td class="nump">150,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">50,817,233<span></span>
</td>
<td class="nump">50,322,930<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">50,817,233<span></span>
</td>
<td class="nump">50,322,930<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=118936363&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118955202&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140454139812024">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income/(Loss)</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Mar. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 30, 2019</a></td>
<td class="nump">$ 667,868<span></span>
</td>
<td class="nump">$ 510<span></span>
</td>
<td class="nump">$ 536,320<span></span>
</td>
<td class="nump">$ 161,418<span></span>
</td>
<td class="num">$ (30,380)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Employee stock purchase plan</a></td>
<td class="nump">1,830<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">1,830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">3,635<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">3,634<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Shares repurchased (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(616)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Shares repurchased</a></td>
<td class="num">(75,000)<span></span>
</td>
<td class="num">$ (6)<span></span>
</td>
<td class="num">(21,473)<span></span>
</td>
<td class="num">(53,521)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock, net of cancellations (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">257<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock, net of cancellations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">4,730<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,730<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="num">(8,479)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,479)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(3,618)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,618)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Jun. 29, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,771<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 29, 2019</a></td>
<td class="nump">590,966<span></span>
</td>
<td class="nump">$ 508<span></span>
</td>
<td class="nump">525,038<span></span>
</td>
<td class="nump">99,418<span></span>
</td>
<td class="num">(33,998)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Mar. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 30, 2019</a></td>
<td class="nump">667,868<span></span>
</td>
<td class="nump">$ 510<span></span>
</td>
<td class="nump">536,320<span></span>
</td>
<td class="nump">161,418<span></span>
</td>
<td class="num">(30,380)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">58,902<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Dec. 28, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,391<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 28, 2019</a></td>
<td class="nump">574,580<span></span>
</td>
<td class="nump">$ 504<span></span>
</td>
<td class="nump">537,913<span></span>
</td>
<td class="nump">69,868<span></span>
</td>
<td class="num">(33,705)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Jun. 29, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,771<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 29, 2019</a></td>
<td class="nump">590,966<span></span>
</td>
<td class="nump">$ 508<span></span>
</td>
<td class="nump">525,038<span></span>
</td>
<td class="nump">99,418<span></span>
</td>
<td class="num">(33,998)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">2,410<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">2,409<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Shares repurchased (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(360)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Shares repurchased</a></td>
<td class="num">(50,000)<span></span>
</td>
<td class="num">$ (4)<span></span>
</td>
<td class="nump">1,274<span></span>
</td>
<td class="num">(51,270)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock, net of cancellations (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock, net of cancellations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">37,486<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,486<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(2,108)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,108)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Sep. 28, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,608<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Sep. 28, 2019</a></td>
<td class="nump">583,754<span></span>
</td>
<td class="nump">$ 506<span></span>
</td>
<td class="nump">533,720<span></span>
</td>
<td class="nump">85,634<span></span>
</td>
<td class="num">(36,106)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Employee stock purchase plan</a></td>
<td class="nump">1,538<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">1,537<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">1,667<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">1,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Shares repurchased (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(411)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Shares repurchased</a></td>
<td class="num">(50,000)<span></span>
</td>
<td class="num">$ (4)<span></span>
</td>
<td class="num">(4,335)<span></span>
</td>
<td class="num">(45,661)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock, net of cancellations (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock, net of cancellations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">5,325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">29,895<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,895<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">2,401<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,401<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Dec. 28, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,391<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 28, 2019</a></td>
<td class="nump">574,580<span></span>
</td>
<td class="nump">$ 504<span></span>
</td>
<td class="nump">537,913<span></span>
</td>
<td class="nump">69,868<span></span>
</td>
<td class="num">(33,705)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Mar. 28, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,323<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 28, 2020</a></td>
<td class="nump">587,109<span></span>
</td>
<td class="nump">$ 503<span></span>
</td>
<td class="nump">553,229<span></span>
</td>
<td class="nump">78,512<span></span>
</td>
<td class="num">(45,135)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Employee stock purchase plan</a></td>
<td class="nump">2,144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">1,193<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">1,192<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock, net of cancellations (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">298<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock, net of cancellations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">6,167<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,167<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">10,527<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,527<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">1,429<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,429<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Jun. 27, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,671<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 27, 2020</a></td>
<td class="nump">608,569<span></span>
</td>
<td class="nump">$ 507<span></span>
</td>
<td class="nump">562,729<span></span>
</td>
<td class="nump">89,039<span></span>
</td>
<td class="num">(43,706)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Mar. 28, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,323<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 28, 2020</a></td>
<td class="nump">587,109<span></span>
</td>
<td class="nump">$ 503<span></span>
</td>
<td class="nump">553,229<span></span>
</td>
<td class="nump">78,512<span></span>
</td>
<td class="num">(45,135)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">90,510<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">15,277<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Dec. 26, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,817<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 26, 2020</a></td>
<td class="nump">719,152<span></span>
</td>
<td class="nump">$ 508<span></span>
</td>
<td class="nump">579,480<span></span>
</td>
<td class="nump">169,022<span></span>
</td>
<td class="num">(29,858)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Jun. 27, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,671<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 27, 2020</a></td>
<td class="nump">608,569<span></span>
</td>
<td class="nump">$ 507<span></span>
</td>
<td class="nump">562,729<span></span>
</td>
<td class="nump">89,039<span></span>
</td>
<td class="num">(43,706)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">67<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock, net of cancellations (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock, net of cancellations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">5,952<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,952<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">48,101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">5,234<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,234<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Sep. 26, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,703<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Sep. 26, 2020</a></td>
<td class="nump">667,923<span></span>
</td>
<td class="nump">$ 507<span></span>
</td>
<td class="nump">568,748<span></span>
</td>
<td class="nump">137,140<span></span>
</td>
<td class="num">(38,472)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Employee stock purchase plan</a></td>
<td class="nump">1,868<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,868<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">2,578<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">2,578<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock, net of cancellations (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock, net of cancellations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">6,287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">31,882<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,882<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">8,614<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,614<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Dec. 26, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,817<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 26, 2020</a></td>
<td class="nump">$ 719,152<span></span>
</td>
<td class="nump">$ 508<span></span>
</td>
<td class="nump">$ 579,480<span></span>
</td>
<td class="nump">$ 169,022<span></span>
</td>
<td class="num">$ (29,858)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118258462&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=118258462&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116855982&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118951672&amp;loc=d3e1436-108581<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140454069840344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash Flows from Operating Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 90,510<span></span>
</td>
<td class="nump">$ 58,902<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hae_NonCashItemsAbstract', window );"><strong>Non-cash items:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">62,377<span></span>
</td>
<td class="nump">81,524<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment of assets</a></td>
<td class="nump">1,028<span></span>
</td>
<td class="nump">50,597<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation expense</a></td>
<td class="nump">18,406<span></span>
</td>
<td class="nump">15,055<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredOtherTaxExpenseBenefit', window );">Deferred tax benefit</a></td>
<td class="num">(3,953)<span></span>
</td>
<td class="num">(4,747)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForLoanLeaseAndOtherLosses', window );">Provision for losses on accounts receivable and inventory</a></td>
<td class="nump">2,942<span></span>
</td>
<td class="num">(2,246)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hae_GainLossOnDivestitureAndSaleOfAssets', window );">Gains on divestitures and sale of assets</a></td>
<td class="num">(32,613)<span></span>
</td>
<td class="num">(8,083)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingActivitiesCashFlowStatement', window );">Other non-cash operating activities</a></td>
<td class="nump">1,351<span></span>
</td>
<td class="nump">1,945<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Change in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Change in accounts receivable</a></td>
<td class="nump">18,588<span></span>
</td>
<td class="nump">13,807<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Change in inventories</a></td>
<td class="num">(33,728)<span></span>
</td>
<td class="num">(68,251)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidTaxes', window );">Change in prepaid income taxes</a></td>
<td class="nump">1,181<span></span>
</td>
<td class="num">(273)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Change in other assets and other liabilities</a></td>
<td class="nump">2,687<span></span>
</td>
<td class="num">(8,829)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Change in accounts payable and accrued expenses</a></td>
<td class="num">(21,518)<span></span>
</td>
<td class="num">(17,590)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">107,258<span></span>
</td>
<td class="nump">111,811<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash Flows from Investing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="num">(25,408)<span></span>
</td>
<td class="num">(38,112)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisition</a></td>
<td class="num">(16,606)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from divestitures</a></td>
<td class="nump">44,587<span></span>
</td>
<td class="nump">9,808<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from sale of property, plant and equipment</a></td>
<td class="nump">1,085<span></span>
</td>
<td class="nump">16,263<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="nump">3,658<span></span>
</td>
<td class="num">(12,041)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash Flows from Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt', window );">Net (decrease) increase in short-term loans</a></td>
<td class="num">(60,000)<span></span>
</td>
<td class="nump">30,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayment of term loan borrowings</a></td>
<td class="num">(13,125)<span></span>
</td>
<td class="num">(8,750)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfEquity', window );">Share repurchases</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(175,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP', window );">Proceeds from employee stock purchase plan</a></td>
<td class="nump">4,012<span></span>
</td>
<td class="nump">3,368<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">3,838<span></span>
</td>
<td class="nump">7,712<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other</a></td>
<td class="num">(32)<span></span>
</td>
<td class="nump">90<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(65,307)<span></span>
</td>
<td class="num">(142,580)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rates on cash and cash equivalents</a></td>
<td class="nump">6,082<span></span>
</td>
<td class="num">(124)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net Change in Cash and Cash Equivalents</a></td>
<td class="nump">51,691<span></span>
</td>
<td class="num">(42,934)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents at Beginning of Period</a></td>
<td class="nump">137,311<span></span>
</td>
<td class="nump">169,351<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents at End of Period</a></td>
<td class="nump">189,002<span></span>
</td>
<td class="nump">126,417<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental Disclosures of Cash Flow Information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="nump">6,070<span></span>
</td>
<td class="nump">10,739<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes paid</a></td>
<td class="nump">5,612<span></span>
</td>
<td class="nump">9,888<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hae_TransfersFromInventoryToFixedAssets', window );">Transfers from inventory to fixed assets for placement of Haemonetics equipment</a></td>
<td class="nump">$ 5,878<span></span>
</td>
<td class="nump">$ 10,705<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_GainLossOnDivestitureAndSaleOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) on Divestiture and Sale of Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_GainLossOnDivestitureAndSaleOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_NonCashItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non-Cash Items [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_NonCashItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_TransfersFromInventoryToFixedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Transfers from inventory to fixed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_TransfersFromInventoryToFixedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredOtherTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other deferred income tax expense (benefit) pertaining to income (loss) from continuing operations. For example, but not limited to, acquisition-date income tax benefits or expenses recognized from changes in the acquirer's valuation allowance for its previously existing deferred tax assets resulting from a business combination and adjustments to beginning-of-year balance of a valuation allowance because of a change in circumstance causing a change in judgment about the realizability of the related deferred tax asset in future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredOtherTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the amount of cash contributions during the period made by the entity to the Employee Stock Ownership Plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 40<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109244661&amp;loc=d3e17540-113929<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of consideration paid in advance for income and other taxes that provide economic benefits in future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingActivitiesCashFlowStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingActivitiesCashFlowStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForLoanLeaseAndOtherLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related loan transactions, lease transactions, credit loss from transactions other than loan and lease transactions, and other loss based on assessment of uncollectability from the counterparty to reduce the account to their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118936363&amp;loc=SL6953423-111524<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.11)<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForLoanLeaseAndOtherLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140454065819880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PRESENTATION<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">BASIS OF PRESENTATION</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. BASIS OF PRESENTATION </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements of Haemonetics Corporation (&#8220;Haemonetics&#8221; or the &#8220;Company&#8221;) presented herein have been prepared in accordance with generally accepted accounting principles in the United States of America (&#8220;U.S. GAAP&#8221;) for interim financial information and with the instructions to Form 10-Q and Article&#160;10 of Regulation&#160;S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of the Company's management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included. All intercompany transactions have been eliminated. Operating results for the nine months ended December 26, 2020 are not necessarily indicative of the results that may be expected for the full fiscal year ending April&#160;3, 2021 or any other interim period. The Company has assessed its ability to continue as a going concern. As of December&#160;26, 2020, the Company has concluded that substantial doubt about its ability to continue as a going concern does not exist. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and footnotes included in the annual report on Form 10-K for the fiscal year ended March&#160;28, 2020.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers events or transactions that occur after the balance sheet date but prior to the issuance of the financial statements to provide additional evidence relative to certain estimates or to identify matters that require additional disclosure. Refer to Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions</span> for information pertaining to acquisitions that were signed or closed subsequent to December&#160;26, 2020. There were no other material recognized or unrecognized subsequent events as of or for the three and nine months ended December&#160;26, 2020.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140454067345032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RECENT ACCOUNTING PRONOUNCEMENTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>New Accounting Pronouncements and Changes in Accounting Principles [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">RECENT ACCOUNTING PRONOUNCEMENTS</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2. RECENT ACCOUNTING PRONOUNCEMENTS </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Standards Implemented</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Codification (&#8220;ASC&#8221;) Update No. 2016-13,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments &#8211; Credit Losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;(Topic 326). ASC Update No. 2016-13 is intended to replace the current incurred loss impairment methodology for financial assets measured at amortized cost with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information, including forecasted information, to develop credit loss estimates. The Company adopted ASC Update No. 2016-13 during the first quarter of fiscal 2021. The adoption did not have a material impact on the Company's unaudited condensed consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASC Update No. 2018-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles, Goodwill and Other - Internal-Use Software </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Subtopic 350-40). The new guidance aligns the accounting implementation costs incurred in a cloud computing arrangement that is a service contract with the accounting for internal-use software licenses. The Company adopted ASC Update No. 2018-15 during the first quarter of fiscal 2021. The adoption did not have a material impact on the Company's unaudited condensed consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140454067279416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">RESTRUCTURING</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3. RESTRUCTURING </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On an ongoing basis, the Company reviews the global economy, the healthcare industry, and the markets in which it competes to identify opportunities for efficiencies, enhance commercial capabilities, align its resources and offer its customers better solutions. In order to realize these opportunities, the Company undertakes restructuring-type activities to transform its business.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2019, the Board of Directors of the Company approved a new Operational Excellence Program (the &#8220;2020 Program&#8221;) and delegated authority to the Company's management to determine the detail of the initiatives that will comprise the program. The 2020 Program is designed to improve operational performance and reduce cost principally in our manufacturing and supply chain operations. The Company estimates that it will incur aggregate charges between $60 million and $70 million in connection with the 2020 Program. These charges, the majority of which will result in cash outlays, including severance and other employee costs, will be incurred as the specific actions required to execute these initiatives are identified and approved and are expected to be substantially completed by the end of fiscal 2023. During the three and nine months ended December 26, 2020, the Company incurred $3.1 million and $11.1 million, respectively, of restructuring and turnaround costs under this program. During the three and nine months ended December 28, 2019, the Company incurred $3.9&#160;million and $6.8 million, respectively, of restructuring and turnaround costs under this program. Total cumulative charges under this program are $22.9 million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2018, the Company launched a Complexity Reduction Initiative (the &#8220;2018 Program&#8221;), a company-wide restructuring program designed to improve operational performance and reduce cost, freeing up resources to invest in accelerated growth. During the three months ended December 26, 2020, the Company incurred minimal charges of restructuring and turnaround costs under this program. During the nine months ended December 26, 2020, the Company incurred $0.5 million of restructuring and turnaround costs under this program. During the three and nine months ended December 28, 2019, the Company incurred $3.9&#160;million and $6.8&#160;million, respectively, of restructuring and turnaround costs under this program. Total cumulative charges under this program are $58.7 million. The 2018 Program is substantially complete.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity for restructuring reserves related to the 2020 Program and the 2018 Program and prior programs for the nine months ended December 26, 2020, substantially all of which relates to employee severance and other employee costs:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.063%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.501%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020 Program</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018 Program and Prior Programs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 28, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,136&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,512&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,648&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs incurred, net of reversals</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,005&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,546)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(887)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,433)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 26, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">595&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">520&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,115&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents the restructuring costs by line item within our accompanying unaudited condensed consolidated statements of income and comprehensive income:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.578%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands) </span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">444&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">708&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">476&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">574&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,777&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(92)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">617&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">900&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,929&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;26, 2020, the Company had a restructuring liability of $1.1 million, of which $0.7 million is payable within the next twelve months. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the restructuring costs included in the table above, the Company also incurred costs that do not constitute restructuring under ASC 420, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Exit and Disposal Cost Obligations,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and which the Company instead refers to as turnaround costs. These costs consist primarily of expenditures directly related to the restructuring actions and include program management costs associated with the 2020 Program and operational performance improvement initiatives.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below present restructuring and turnaround costs by reportable segment:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.578%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring costs</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands) </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plasma</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">454&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">552&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Center</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(131)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">537&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,928&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(92)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">617&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">900&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,929&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Turnaround costs</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands) </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plasma</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">431&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,235&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Center</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,024&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,282&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,780&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,410&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,235&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,181&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,683&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,653&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total restructuring and turnaround costs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,143</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,798</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,583</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13,582</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI http://asc.fasb.org/topic&amp;trid=2175745<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140454065861096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITION<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">ACQUISITION</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4. ACQUISITIONS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cardiva Medical, Inc.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 17, 2021, the Company entered into an Agreement and Plan of Merger with Cardiva Medical, Inc., (&#8220;Cardiva&#8221;), an industry-leading manufacturer of vascular closure systems based in Santa Clara, California. In connection with this acquisition, the Company will pay upfront consideration of $475.0&#160;million in cash, subject to customary working capital and certain other adjustments as of the closing of the transaction, as well as up to $35.0&#160;million in additional contingent consideration payable over the next two years based on sales growth. The transaction is not subject to a financing contingency, and the Company expects to finance the transaction through a combination of its cash on hand, revolving credit facility and an additional $150.0&#160;million term loan anticipated to be borrowed under its existing credit facility. The transaction is expected to close in the fourth quarter of fiscal 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cardiva&#8217;s portfolio includes two catheter-based vascular access site closure devices. The VASCADE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> vascular closure system is designed for &#8220;small-bore&#8221; femoral arterial and venous closure, generally used in interventional cardiology and peripheral vascular procedures. The VASCADE MVP</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> vascular closure system is designed for &#8220;mid-bore&#8221; multi-access femoral venous closure, generally used in electrophysiology procedures, and is the only U.S. Food and Drug Administration (&#8220;FDA&#8221;) approved closure device for use following cardiac ablation procedures requiring two or more access sites within the same vessel. The addition of the VASCADE portfolio to the Hospital business unit includes products with demonstrated benefits and enhances penetration into the large and growing interventional cardiology and electrophysiology markets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HAS Intellectual Property</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, the Company entered into an agreement to acquire certain intellectual property owned by HemoAssay Science and Technology (Suzhou) Co. Ltd., a China-incorporated company, and its affiliates (collectively, &#8220;HemoAssay&#8221;) underlying their HAS viscoelastic diagnostic devices, related assays and disposables. The Company previously entered into exclusive manufacturing and distribution agreements with HemoAssay pursuant to which it has exclusive rights to commercialize HemoAssay&#8217;s HAS devices in China. In connection with the transaction, the Company has agreed to pay up to $15.0&#160;million to HemoAssay in contingent consideration based on certain developmental and manufacturing based milestones. These products augment the Company's portfolio of hemostasis analyzers within the Hospital business unit.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">enicor GmbH</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2020, the Company acquired all of the outstanding equity of enicor GmbH (&#8220;enicor&#8221;), the manufacturer of ClotPro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a new generation whole blood coagulation testing system that is currently available in select European and Asia Pacific markets, for total consideration of $20.5&#160;million, which consisted of upfront payments of $16.6&#160;million and the fair value of contingent consideration of $3.9&#160;million. The contingent consideration, which could total a maximum of $4.5&#160;million, consists of payments related to the achievement of certain revenue and regulatory milestones. The acquisition of this viscoelastic diagnostic device augments the Company's portfolio of hemostasis analyzers within the Hospital business unit.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purchase Price Allocation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounted for the acquisition of enicor as a business combination, and in accordance with FASB ASC Topic 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Topic 805</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), recorded the assets acquired and liabilities assumed at their respective fair values as of the acquisition date. The final determination of the fair value of certain assets and liabilities will be completed within the measurement period as required by Topic 805. As of December&#160;26, 2020, the valuation studies necessary to determine the fair market value of the assets acquired and liabilities assumed are preliminary, including the projection of the underlying cash flows used to determine the fair value of the identified tangible, intangible and financial assets and liabilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following amounts represent the preliminary determination of the fair value of the identifiable assets acquired and liabilities assumed for enicor completed during the first nine months of fiscal 2021:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.888%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.182%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26, 2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">634&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">685&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,090&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">23,851</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration (current)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration (non-current)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,416&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,036&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities assumed</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,245</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net assets acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16,606</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined the identifiable intangible assets were completed technology, customer relationships and a trademark. The fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using a rate of 20%. The cash flows were based on estimates used to price the transaction, and the discount rates applied were benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The benefits of adding a viscoelastic diagnostic device to the Company&#8217;s portfolio of hemostasis analyzers within the Hospital business unit contributed to an acquisition price in excess of the fair value of net assets acquired for enicor, which resulted in the establishment of goodwill. In addition, the benefits of lower cost manufacturing and complementary sales channels also contributed to the establishment of goodwill for this acquisition. None of the goodwill is expected to be deductible for income tax purposes.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets acquired consist of the following:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.692%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Amortization Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Completed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,441&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademark</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14,090</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition-Related Costs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of acquisition-related costs incurred associated with the acquisition was $0.2&#160;million for the three and nine months ended December 26, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unaudited Pro Forma Financial Information</span></div>Enicor had an immaterial impact to the Company's net revenues and net income for the period post acquisition through December&#160;26, 2020. The unaudited estimated pro forma impact of the results of the acquisition of enicor as if it was consummated on March 29, 2020 are immaterial.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140454065953528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DIVESTITURE<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock', window );">DIVESTITURE</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5. DIVESTITURES </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fajardo, Puerto Rico Manufacturing Operations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 29, 2020, the Company sold its Fajardo, Puerto Rico, manufacturing operations to GVS, S.p.A (&#8220;GVS&#8221;), a leading provider of advanced filtration solutions for critical applications for $15.1&#160;million ($7.8&#160;million, net of cash transferred). Under the terms of the agreement, Haemonetics retained all intellectual property rights to its proprietary blood filters currently manufactured at its Fajardo facility and GVS acquired certain assets consisting primarily of property, plant and equipment, inventory and cash and has assumed certain related liabilities. In connection with this transaction, the Company and GVS also entered into a long-term supply and development agreement that, among other things, grants GVS exclusive rights to manufacture and supply the blood filters currently produced at the Fajardo facility for Haemonetics. The Company also agreed to provide certain transition services to GVS, generally for a period of up to three months depending on the nature of the service.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of this transaction, Haemonetics recognized a pre-tax impairment charge in its Blood Center business unit of $1.0&#160;million in the first quarter of fiscal 2021 and an incremental loss of $0.4&#160;million based on closing adjustments during the third quarter of fiscal 2021, as the carrying value of the assets and liabilities in the asset transfer exceeded the net of the $15.1&#160;million of cash proceeds and an additional contingent liability of $1.5&#160;million. The disposal group consisted of $3.3&#160;million of inventory, $7.2&#160;million of fixed assets, $3.2&#160;million of other liabilities, and $0.4&#160;million of goodwill allocated based on fair value to the business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. Blood Donor Management Software</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 1, 2020, the Company sold certain U.S. blood donor management software solution assets within its Blood Center business unit to the GPI Group (&#8220;GPI&#8221;) for an upfront cash payment of $14.0&#160;million ($13.6&#160;million, net of working capital adjustments) and up to $14.0&#160;million in additional consideration contingent on the achievement of commercial milestones over the twelve month period immediately following the closing of the transaction. The disposal group consisted of $1.4&#160;million of accounts receivable, $0.9&#160;million of intangible assets, other liabilities of $1.8&#160;million and $1.4&#160;million of goodwill allocated based on fair value to the business. The Company recognized an $11.7&#160;million gain upon closing of the transaction in the second quarter of fiscal 2021 and an additional $1.5&#160;million gain in the third quarter of fiscal 2021. To the extent the additional contingent consideration is earned and realized in a future period then such amounts will be recorded as additional gains in such future period. The Company also agreed to provide certain transition services to GPI, generally for a period of one to nine months depending on the nature of the service.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inlog Holdings France</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 18, 2020, the Company sold its wholly-owned subsidiary Inlog Holdings France SAS to Ab&#233;nex Capital (&#8220;Ab&#233;nex&#8221;), a private equity firm based in France for $30.5&#160;million ($24.5&#160;million, net of cash transferred), of which </span></div>$29.2&#160;million was received at closing and $1.3&#160;million will be received one-year from the closing date. Inlog Holdings France SAS, through its subsidiary In Log SAS, develops and sells blood bank and hospital software solutions used predominantly in France and in several other countries outside of the U.S. The disposal group included $2.2&#160;million of intangible assets, $2.2&#160;million accounts receivable, $0.3&#160;million other assets, $3.3&#160;million of liabilities and $3.3&#160;million of goodwill allocated based on the fair value of the business which impacted both the Blood Center and Hospital business units. The Company recognized a gain of $19.8&#160;million upon closing of the transaction in the second quarter of fiscal 2021.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2122178<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140454067420840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6. INCOME TAXES </span></div><div><span><br/></span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company conducts business globally and reports its results of operations in a number of foreign jurisdictions in addition to the United States. The Company's reported tax rate is impacted by the jurisdictional mix of earnings in any given period as the foreign jurisdictions in which it operates have tax rates that differ from the U.S. statutory tax rate.&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended December 26, 2020, the Company reported income tax expense of $5.5 million and $9.8&#160;million, respectively, representing effective tax rates of 14.7% and 9.8%, respectively. The effective tax rate for the three and nine months ended December 26, 2020 includes discrete tax benefits recognized from excess stock compensation deductions of $1.0 million and $5.1&#160;million, respectively. The effective tax rates were also impacted by the jurisdictional mix of earnings including divestiture transactions. During the nine months ended December 26, 2020, the Company sold its Fajardo, Puerto Rico manufacturing operations, certain U.S. blood donor management software solution assets, and its wholly-owned subsidiary Inlog Holdings France SAS. The tax expense on divestitures, including the associated valuation allowance impacts, were included in the computation of the annual effective tax rate. Refer to Note 5, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Divestitures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for information pertaining to these divestitures. </span></div><div><span><br/></span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended December 28, 2019, the Company reported an income tax provision of $7.9 million and $6.3&#160;million, respectively, representing effective tax rates of 21.0% and 9.6%, respectively. The effective tax rate for the nine months ended December 28, 2019 was lower than the U.S. statutory tax rate primarily due to a discrete tax benefit recognized from excess stock compensation deductions of $3.1&#160;million and $12.4&#160;million, respectively. The effective tax rates were also impacted by the jurisdictional mix of earnings and the impact of the divestiture of the Union, South Carolina facility.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140454065946808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE ("EPS")<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">EARNINGS PER SHARE (EPS)</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7. EARNINGS PER SHARE </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of the numerators and denominators of the basic and diluted earnings per share computations. </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.578%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#160;(In thousands, except per share amounts)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic EPS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,882&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,895&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,510&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,902&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,789&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,630&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,634&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,810&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic income per share</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.63</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.59</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.79</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.16</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted EPS</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,882&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,895&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,510&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,902&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted average shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,789&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,630&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,634&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,810&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net effect of common stock equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">574&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,008&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,185&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted average shares</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,363&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,638&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,234&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,995&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted income per share</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.62</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.58</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.77</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is calculated using the Company's weighted-average outstanding common stock. Diluted earnings per share is calculated using its weighted-average outstanding common stock including the dilutive effect of stock awards as determined under the treasury stock method. For the three and nine months ended December 26, 2020, weighted average shares outstanding, assuming dilution, excludes the impact of 0.4 million and 0.6&#160;million anti-dilutive shares, respectively. For both the three and nine months ended December 28, 2019, weighted average shares outstanding, assuming dilution, excludes the impact of 0.2&#160;million anti-dilutive shares.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140454067508408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">REVENUE</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8. REVENUE </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's revenue recognition policy is to recognize revenues from product sales, software and services in accordance with ASC Topic 606,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Revenue is recognized when obligations under the terms of a contract with a customer are satisfied; this occurs with the transfer of control of the Company&#8217;s goods or services. The Company considers revenue to be earned when all of the following criteria are met: it has a contract with a customer that creates enforceable rights and obligations; promised products or services are identified; the transaction price, or the consideration it expects to receive for transferring goods or providing services, is determinable and it has transferred control of the promised items to the customer. A promise in a contract to transfer a distinct good or service to the customer is identified as a performance obligation. A contract&#8217;s transaction price is allocated to each performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. Some of the Company&#8217;s contracts have multiple performance obligations. For contracts with multiple performance obligations, the Company allocates the contract&#8217;s transaction price to each performance obligation based on the estimated standalone selling prices of the good or service in the contract. For goods or services for which observable standalone selling prices are not available, the Company uses an expected cost plus a margin approach to estimate the standalone selling price of each performance obligation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;26, 2020, the Company had $17.9 million of its transaction price allocated to remaining performance obligations related to executed contracts with an original duration of one year or more. The Company expects to recognize approximately 59% of this amount as revenue within the next twelve months and the remaining balance thereafter.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and customer advances and deposits (contract liabilities) on the condensed consolidated balance sheets. The difference in timing between billing and revenue recognition primarily occurs in software licensing arrangements, resulting in contract assets and contract liabilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;26, 2020 and March&#160;28, 2020, the Company had contract assets of $5.4 million and $5.0 million, respectively. The change is primarily due to the delay in billings compared to the revenue recognized. Contract assets are classified as other current assets and other long-term assets on the condensed consolidated balance sheets.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;26, 2020 and March&#160;28, 2020, the Company had contract liabilities of $16.7 million and $20.8 million, respectively. During the three and nine months ended December 26, 2020, the Company recognized $2.5 million and $16.3 million, respectively, of revenue that was included in the above March&#160;28, 2020 contract liability balance. Contract liabilities decreased by an additional $2.5&#160;million during the three and nine months ended December 26, 2020 as a result of the sale of certain U.S. blood donor management software solution assets and the Company's wholly-owned subsidiary Inlog Holdings France SAS. Refer to Note 5, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Divestitures</span> for additional detail. Contract liabilities are classified as other liabilities and other long-term liabilities on the condensed consolidated balance sheets.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140454065922504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">INVENTORIES</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9. INVENTORIES </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost or market and include the cost of material, labor and manufacturing overhead. Cost is determined using the first-in, first-out method.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:68.944%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.143%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.145%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28, <br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,437&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,867&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,030&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,021&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203,243&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182,388&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total inventories</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">299,710</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">270,276</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140454067479432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">LEASES</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10. LEASES </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lessee Activity</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of fiscal 2021, the Company entered into a lease for manufacturing space in Clinton, PA. The Company's current manufacturing operations in Leetsdale, PA will be relocated. The lease term associated with the new manufacturing facility is 15 years and 7 months and includes two <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV82NC9mcmFnOjc2OTk3NDk1NTM2NjRmNzlhNjNiMjA4OGEzM2Y2YzcxL3RleHRyZWdpb246NzY5OTc0OTU1MzY2NGY3OWE2M2IyMDg4YTMzZjZjNzFfMzI4_d1261318-cbde-4310-8bac-529fcbd30bd5">five</span> year renewal options followed by one <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmIxZTIzZTM1NGM5YzQyNDA5NmIyN2QwNGM3MGY1YTVhL3NlYzpiMWUyM2UzNTRjOWM0MjQwOTZiMjdkMDRjNzBmNWE1YV82NC9mcmFnOjc2OTk3NDk1NTM2NjRmNzlhNjNiMjA4OGEzM2Y2YzcxL3RleHRyZWdpb246NzY5OTc0OTU1MzY2NGY3OWE2M2IyMDg4YTMzZjZjNzFfMzY4_fdeb1860-c6a9-478a-81ce-84942fec66c9">four</span> year renewal option. During the first quarter of fiscal 2021, the Company recorded a right-of-use asset of $11.3 million and corresponding liabilities of $15.4 million upon commencement of the lease term in May 2020. In addition, the Company recorded a $4.1 </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">million lease incentive receivable associated with this lease agreement which was received during the third quarter of fiscal 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lessor Activity</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets on the Company's balance sheet classified as Haemonetics equipment primarily consists of medical devices installed at customer sites but owned by Haemonetics. These devices are leased to customers under contractual arrangements that typically include an operating or sales-type lease as well as the purchase and consumption of a certain level of disposable products. Sales-type leases are not significant. Contract terms vary by customer and may include options to terminate the contract or options to extend the contract. Where devices are provided under operating lease arrangements, a substantial majority of the entire lease revenue is variable and subject to subsequent non-lease component (disposable products) sales. The allocation of revenue between the lease and non-lease components is based on stand-alone selling prices. Operating lease revenue represents less than 3 percent of the Company's total net sales.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140454162268920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTES&#160;PAYABLE AND LONG-TERM DEBT<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">NOTES&#160;PAYABLE AND LONG-TERM DEBT</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11. NOTES&#160;PAYABLE AND LONG-TERM DEBT </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 15, 2018, the Company entered into a credit agreement with certain lenders which provided for a $350.0 million term loan (the &#8220;Term Loan&#8221;) and a $350.0 million revolving loan (the &#8220;Revolving Credit Facility&#8221; and together with the Term Loan, the &#8220;Credit Facilities&#8221;). The Credit Facilities expire on June 15, 2023. Interest on the Credit Facilities is established using LIBOR plus 1.13% - 1.75%, depending on the Company's leverage ratio. Under the Credit Facilities, the Company is required to maintain certain leverage and interest coverage ratios specified in the credit agreement as well as other customary non-financial affirmative and negative covenants. At December&#160;26, 2020, $310.6 million was outstanding under the Term Loan with an effective interest rate of 1.4%. There were no borrowings outstanding on the Revolving Credit Facility. The Company also has $26.2 million of uncommitted operating lines of credit to fund its global operations under which there were no outstanding borrowings as of December&#160;26, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has required scheduled principal payments of $8.7 million during the remainder of fiscal 2021, $17.5 million during fiscal 2022, $214.4 million during fiscal 2023 and $70.0 million during fiscal 2024. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company was in compliance with the leverage and interest coverage ratios specified in the Credit Facilities as well as all other bank covenants as of December&#160;26, 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140454067456152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASURES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesAndFairValueTextBlock', window );">DERIVATIVES AND FAIR VALUE MEASUREMENTS</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12. FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manufactures, markets and sells its products globally. During the three and nine months ended December 26, 2020, 38.6% and 40.7%, respectively, of the Company's sales were generated outside the U.S., generally in foreign currencies. The Company also incurs certain manufacturing, marketing and selling costs in international markets in local currency.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accordingly, earnings and cash flows are exposed to market risk from changes in foreign currency exchange rates relative to the U.S. Dollar, the Company's reporting currency. The Company has a program in place that is designed to mitigate the exposure to changes in foreign currency exchange rates. That program includes the use of derivative financial instruments to minimize, for a period of time, the impact on its financial results from changes in foreign exchange rates. The Company utilizes foreign currency forward contracts to hedge the anticipated cash flows from transactions denominated in foreign currencies, primarily the Japanese Yen and the Euro, and to a lesser extent the Swiss Franc, Australian Dollar, Canadian Dollar and the Mexican Peso. This does not eliminate the impact of the volatility of foreign exchange rates. However, because the Company generally enters into forward contracts one year out, rates are fixed for a one-year period, thereby facilitating financial planning and resource allocation.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Designated Foreign Currency Hedge Contracts</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the Company's designated foreign currency hedge contracts as of December&#160;26, 2020 and March&#160;28, 2020 were cash flow hedges under ASC 815, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASC 815&#8221;). The Company records the effective portion of any change in the fair value of designated foreign currency hedge contracts in other comprehensive income until the related third-party transaction occurs. Once the related third-party transaction occurs, the Company reclassifies the effective portion of any related gain or loss on the designated foreign currency hedge contracts to earnings. In the event the hedged forecasted transaction does not occur, or it becomes probable that it will not occur, the Company would reclassify the amount of any gain or loss on the related cash flow hedge to earnings at that time. The Company had designated foreign currency hedge contracts outstanding in the contract amount of $78.8 million as of December&#160;26, 2020 and $93.8 million as of March&#160;28, 2020. At December&#160;26, 2020, a loss of $1.4 million, net of tax, will be reclassified to earnings within the next twelve months. Substantially all currency cash flow hedges outstanding as of December&#160;26, 2020 mature within twelve months.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-Designated Foreign Currency Contracts</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages its exposure to changes in foreign currency on a consolidated basis to take advantage of offsetting transactions and balances. It uses foreign currency forward contracts as a part of its strategy to manage exposure related to foreign currency denominated monetary assets and liabilities. These foreign currency forward contracts are entered into for periods consistent with currency transaction exposures, generally one month. They are not designated as cash flow or fair value hedges under ASC 815. These forward contracts are marked-to-market with changes in fair value recorded to earnings. The Company had non-designated foreign currency hedge contracts under ASC 815 outstanding in the contract amount of $90.5 million as of December&#160;26, 2020 and $98.0 million as of March&#160;28, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Rate Swaps</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 15, 2018, the Company entered into Credit Facilities which provided for a $350.0 million Term Loan and a $350.0 million Revolving Credit Facility. Under the terms of the Credit Facilities, interest is established using LIBOR plus 1.13% - 1.75%. As a result, the Company's earnings and cash flows are exposed to interest rate risk from changes to LIBOR. Part of the Company's interest rate risk management strategy includes the use of interest rate swaps to mitigate its exposure to changes in variable interest rates. The Company's objective in using interest rate swaps is to add stability to interest expense and to manage and reduce the risk inherent in interest rate fluctuations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the Company entered into two interest rate swap agreements (the &#8220;Swaps&#8221;) to pay an average fixed rate of 2.80% on a total notional value of $241.9 million of debt. As a result of the Swaps, 70% of the Term Loan previously exposed to interest rate risk from changes in LIBOR is now fixed at a rate of 4.05%. The Swaps mature on June 15, 2023. The Company designated the Swaps as cash flow hedges of variable interest rate risk associated with $345.6&#160;million of indebtedness. For the nine months ended December 26, 2020, a gain of $0.3&#160;million, net of tax, was recorded in accumulated other comprehensive loss to recognize the effective portion of the fair value of the Swaps that qualify as cash flow hedges. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Trade Receivables</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, the Company grants trade credit to its customers on normal credit terms. In an effort to reduce its credit risk, the Company (i) establishes credit limits for all customers, (ii) performs ongoing credit evaluations of customers&#8217; financial condition, (iii) monitors the payment history and aging of customers&#8217; receivables, and (iv) monitors open orders against an individual customer&#8217;s outstanding receivable balance.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's allowance for credit losses is maintained for trade accounts receivable based on the expected collectability, the historical collection experience, the length of time an account is outstanding, the financial position of the customer and information provided by credit rating services. Effective March 29, 2020, the Company adopted Update No. 2016-13,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments &#8211; Credit Losses&#160;(Topic 326)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> which requires consideration of events or circumstances indicating historic collection rates may not be indicative of future collectability. For example, potential adverse changes to customer liquidity from new macroeconomic events such as the COVID-19 pandemic must be taken into consideration. To date, the Company has not experienced significant customer payment defaults, or identified other significant collectability concerns as a result of the pandemic.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a rollforward of the allowance for credit losses:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.684%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.231%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.231%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.231%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.526%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.235%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,699</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,108</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,824</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,937</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Credit (gain) loss</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(838)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">515&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Write-offs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(240)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(461)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(355)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,525</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,097</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,525</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,097</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value of Derivative Instruments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the effect of the Company's derivative instruments designated as cash flow hedges and those not designated as hedging instruments under ASC 815 in its condensed consolidated statements of income and comprehensive income for the nine months ended December&#160;26, 2020:</span></div><div><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:23.422%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.493%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.203%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amount of Gain<br/>(Loss) Recognized<br/>in Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amount of Gain (Loss) Reclassified<br/>from Accumulated Other Comprehensive Loss into<br/>Earnings</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Location in<br/>Condensed Consolidated Statements of Income and Comprehensive Income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amount of Gain (Loss) Excluded from<br/>Effectiveness<br/>Testing</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Location in<br/>Condensed Consolidated Statements of Income and Comprehensive Income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated foreign currency hedge contracts, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,378&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,538)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues, COGS and SG&amp;A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(671)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other expense, net</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated foreign currency hedge contracts</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,218)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other expense, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated interest rate swaps, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,996)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,326)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did not have fair value hedges or net investment hedges outstanding as of December&#160;26, 2020 or March&#160;28, 2020. As of December&#160;26, 2020, no material deferred tax assets were recognized for designated foreign currency hedges.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 815 requires all derivative instruments to be recognized at their fair values as either assets or liabilities on the balance sheet. The Company determines the fair value of its derivative instruments using the framework prescribed by ASC 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements and Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, by considering the estimated amount it would receive or pay to sell or transfer these instruments at the reporting date and by taking into account current interest rates, currency exchange rates, current interest rate curves, interest rate volatilities, the creditworthiness of the counterparty for assets, and its creditworthiness for liabilities. In certain instances, the Company may utilize financial models to measure fair value. Generally, it uses inputs that include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; other observable inputs for the asset or liability; and inputs derived principally from, or corroborated by, observable market data by correlation or other means. As of December&#160;26, 2020, the Company has classified its derivative </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">assets and liabilities within Level 2 of the fair value hierarchy prescribed by ASC 815, as discussed below, because these observable inputs are available for substantially the full term of its derivative instruments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the fair value of the Company's derivative instruments as they appear in its condensed consolidated balance sheets as of December&#160;26, 2020 and March&#160;28, 2020:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.250%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.438%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.859%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.863%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Location in Condensed Consolidated<br/>Balance Sheets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">839&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">377&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">260</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,216</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">919&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,854&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,435&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated interest rate swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,697&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,581&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,323&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,475&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13,145</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18,345</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Fair Value Measurements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the exit price that would be received from the sale of an asset or paid to transfer a liability, using assumptions that market participants would use in pricing an asset or liability. The fair value guidance establishes the following three-level hierarchy used for measuring fair value:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 &#8212; Inputs to the valuation methodology are quoted market prices for identical assets or liabilities.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 &#8212; Inputs to the valuation methodology are other observable inputs, including quoted market prices for similar assets or liabilities and market-corroborated inputs.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 &#8212; Inputs to the valuation methodology are unobservable inputs based on management&#8217;s best estimate of inputs market participants would use in pricing the asset or liability at the measurement date, including assumptions about risk.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's money market funds carried at fair value are classified within Level 1 of the fair value hierarchy because they are valued using quoted market prices.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value Measured on a Recurring Basis</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and financial liabilities measured at fair value on a recurring basis consist of the following as of December&#160;26, 2020 and March&#160;28, 2020.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.533%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 26, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,773&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,773&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">79,773</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">260</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">80,033</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">919&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">919&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,020&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,020&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,920&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,920&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13,145</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,920</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17,065</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="21" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of March 28, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,564&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,564&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">839&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">839&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">377&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">377&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">44,564</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,216</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">45,780</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,854&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,854&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,435&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,435&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,056&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,056&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18,345</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18,345</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign currency hedge contracts - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of foreign currency hedge contracts was measured using significant other observable inputs and valued by reference to over-the-counter quoted market prices for similar instruments. The Company does not believe that the fair value of these derivative instruments differs significantly from the amount that could be realized upon settlement or maturity, or that the changes in fair value will have a significant effect on its results of operations, financial condition or cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest rate swaps - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of interest rate swaps are measured using the present value of expected future cash flows using market-based observable inputs, including credit risk and interest rate yield curves. The Company does not believe that the fair values of these derivative instruments differ significantly from the amounts that could be realized upon settlement or maturity, or that the changes in fair value will have a significant effect on its results of operations, financial condition or cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent consideration</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The fair value of contingent consideration liabilities is based on significant unobservable inputs, including management estimates and assumptions, and is measured based on the probability-weighted present value of the payments expected to be made. Accordingly, the fair value of contingent consideration has been classified as level 3 within the fair value hierarchy. The recurring level 3 fair value measurements of contingent consideration liabilities include the following significant unobservable inputs:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:21.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.517%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.988%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.550%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value at</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Valuation </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Technique</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Input</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Range</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue-based payments</span></td><td colspan="3" style="padding:0 1pt"/><td rowspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td rowspan="2" style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,920&#160;</span></td><td rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted cash flow</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5%</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected year of payment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 - 2023</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Regulatory-based payment</span></td><td colspan="3" style="padding:0 1pt"/><td rowspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td rowspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td rowspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted cash flow</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9%</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of payment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0% - 100%</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected year of payment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 - 2023</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;26, 2020, the maximum potential contingent consideration that the Company could be required to pay is $4.5&#160;million. The fair value of contingent consideration associated with acquisitions was $3.9&#160;million at December&#160;26, 2020. As of December&#160;26, 2020, $0.5&#160;million was included in other liabilities and $3.4&#160;million was included in other long-term liabilities on the condensed consolidated balance sheet.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the change in the fair value of contingent consideration is included in the following table:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.677%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.393%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 28, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition date fair value of contingent consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,920&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 26, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,920</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Fair Value Disclosures</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Term Loan, which is carried at amortized cost, accounts receivable and accounts payable approximate fair value.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesAndFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivatives and fair value of assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -URI http://asc.fasb.org/topic&amp;trid=2155941<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI http://asc.fasb.org/topic&amp;trid=2229140<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesAndFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140454168873608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13. COMMITMENTS AND CONTINGENCIES</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a party to various legal proceedings and claims arising out of the ordinary course of its business. The Company believes there are no proceedings or claims pending against it the ultimate resolution of which could have a material adverse effect on the financial condition or results of operations. At each reporting period, the Company evaluates whether or not a potential loss amount or a potential range of loss is probable and reasonably estimable under ASC 450,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for all matters. Legal costs are expensed as incurred.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of fiscal 2021, the Company received a subpoena from the U.S. Attorney&#8217;s Office for the District of Massachusetts. The subpoena requests certain documents regarding the Company&#8217;s apheresis and autotransfusion devices and disposables, including documents relating to product complaints and adverse event reporting, regulatory clearances and product design changes, among other matters. The Company is fully cooperating with this inquiry.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140454065881576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND ENTERPRISE-WIDE INFORMATION<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">SEGMENT AND ENTERPRISE-WIDE INFORMATION</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14. SEGMENT AND ENTERPRISE-WIDE INFORMATION </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines its reportable segments by first identifying its operating segments, and then by assessing whether any components of these segments constitute a business for which discrete financial information is available and where segment management regularly reviews the operating results of that component. Historically, the Company's operating segments were based primarily on geography. Effective as of March 31, 2019, the Company completed the transition of its operating structure to three global business units and accordingly, reorganized its reporting structure to align with its three global business units and the information that will be regularly reviewed by the Company's chief operating decision maker.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the reorganization, the Company's reportable segments are as follows: </span></div><div style="margin-top:7pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Plasma</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Blood Center</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Hospital</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management measures and evaluates the operating segments based on operating income. Management excludes certain corporate expenses from segment operating income. In addition, certain amounts that management considers to be non-</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">recurring or non-operational are excluded from segment operating income because management evaluates the operating results of the segments excluding such items. These items include restructuring and turnaround costs, deal amortization, gains on divestitures and sale of assets, asset impairments and other related charges, accelerated depreciation and related costs, costs related to compliance with the European Union Medical Device Regulation, transaction costs and certain legal charges. Although these amounts are excluded from segment operating income, as applicable, they are included in the reconciliations that follow. Management measures and evaluates the Company's net revenues and operating income using internally derived standard currency exchange rates that remain constant from year to year; therefore, segment information is presented on this basis.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selected information by reportable segment is presented below:</span></div><div style="margin-bottom:5pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.578%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plasma</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,997&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249,587&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348,141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Center</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,417&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234,446&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246,977&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,334&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,753&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148,927&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues by business unit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234,905&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257,064&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">632,960&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">742,720&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,972&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,197&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,339&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,291)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,922)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,072)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">240,371</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">258,970</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">645,434</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">749,987</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> Reflects revenue for service, maintenance and parts</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:5pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.847%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.871%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plasma</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,673&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,343&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129,846&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,844&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Center</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,424&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,197&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,926&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,430&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,593&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,672&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,360&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,527&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,133&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300,444&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351,328&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Corporate expenses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63,202)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63,080)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(185,005)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(188,363)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Effect of exchange rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,286&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,521&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,644&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,791&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Deal amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,805)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,772)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,204)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,681)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Restructuring and turnaround costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,143)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,798)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,583)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,582)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Transaction costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,063)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;PCS2 accelerated depreciation and related costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,146)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,649)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,332)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,708)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;European Medical Device Regulation costs and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,207)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(448)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,696)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(304)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Impairment of assets and other related charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(896)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51,220)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Gains on divestitures and sale of assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,613&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,083&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">40,425</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">40,907</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">110,922</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">77,344</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="24" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> Reflects shared service expenses including quality and regulatory, customer and field service, research and development, manufacturing and supply chain, as well as other corporate support functions.</span></div></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management reviews revenue based on the reportable segments noted above.&#160;Although these reportable segments are primarily product-based, they differ from the Company&#8217;s product line revenues for Plasma products and services and Blood Center products and services.&#160;Specifically, the Blood Center reportable segment includes plasma products utilized for collection in blood centers primarily for transfusion purposes.&#160;Additionally, product line revenues also include service revenues which are excluded from the reportable segments.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues by product line are as follows:</span></div><div style="margin-bottom:5pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.578%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plasma products and services</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,510&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,231&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309,933&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406,825&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Center products and services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,787&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182,687&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191,648&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospital products and services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,074&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,613&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152,814&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151,514&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">240,371</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">258,970</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">645,434</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">749,987</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues generated in the Company's principle operating regions on a reported basis are as follows:</span></div><div style="margin-bottom:5pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.303%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.578%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,607&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167,238&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382,600&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485,493&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,854&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,268&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,330&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,874&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,984&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,541&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,811&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,050&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,436&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,269&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">986&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,044&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,361&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,303&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">240,371</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">258,970</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">645,434</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">749,987</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140454067523960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCUMULATED OTHER COMPREHENSIVE LOSS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">ACCUMULATED OTHER COMPREHENSIVE LOSS</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15. ACCUMULATED OTHER COMPREHENSIVE LOSS </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of Accumulated Other Comprehensive Loss are as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:38.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.164%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.164%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.164%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.168%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Defined Benefit Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Unrealized Gain/Loss on Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 28, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(31,100)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(209)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(13,826)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(45,135)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,031&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,618)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,413&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,864&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,864&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,031&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,246&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,277&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 26, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(19,069)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(209)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(10,580)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(29,858)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> Presented net of income taxes, the amounts of which are insignificant.</span></div></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140454065856072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock', window );">Schedule of Restructuring Reserve by Type of Cost</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity for restructuring reserves related to the 2020 Program and the 2018 Program and prior programs for the nine months ended December 26, 2020, substantially all of which relates to employee severance and other employee costs:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.063%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.501%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020 Program</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018 Program and Prior Programs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 28, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,136&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,512&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,648&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs incurred, net of reversals</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,005&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,546)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(887)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,433)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 26, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">595&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">520&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,115&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Schedule of Restructuring and Related Costs</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents the restructuring costs by line item within our accompanying unaudited condensed consolidated statements of income and comprehensive income:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.578%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands) </span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">444&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">708&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">476&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">574&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,777&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(92)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">617&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">900&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,929&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.578%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring costs</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands) </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plasma</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">454&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">552&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Center</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(131)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">537&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,928&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(92)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">617&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">900&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,929&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Turnaround costs</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands) </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plasma</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">431&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,235&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Center</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,024&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,282&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,780&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,410&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,235&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,181&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,683&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,653&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total restructuring and turnaround costs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,143</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,798</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,583</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13,582</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140454065941000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITION (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Schedule of Business Acquisitions, by Acquisition</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following amounts represent the preliminary determination of the fair value of the identifiable assets acquired and liabilities assumed for enicor completed during the first nine months of fiscal 2021:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.888%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.182%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26, 2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">634&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">685&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,090&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">23,851</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration (current)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration (non-current)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,416&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,036&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities assumed</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,245</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net assets acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16,606</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets acquired consist of the following:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.692%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Amortization Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Completed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,441&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademark</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14,090</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1486-128463<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140454149060504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE ("EPS") (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings Per Share Reconciliation</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of the numerators and denominators of the basic and diluted earnings per share computations. </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.578%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#160;(In thousands, except per share amounts)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic EPS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,882&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,895&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,510&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,902&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,789&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,630&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,634&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,810&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic income per share</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.63</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.59</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.79</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.16</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted EPS</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,882&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,895&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,510&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,902&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted average shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,789&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,630&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,634&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,810&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net effect of common stock equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">574&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,008&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,185&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted average shares</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,363&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,638&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,234&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,995&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted income per share</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.62</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.58</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.77</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140454067462840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventories</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost or market and include the cost of material, labor and manufacturing overhead. Cost is determined using the first-in, first-out method.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:68.944%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.143%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.145%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28, <br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,437&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,867&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,030&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,021&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203,243&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182,388&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total inventories</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">299,710</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">270,276</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140454065885000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASURES (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Schedule of Effect of Derivative Instruments Designated as Cash Flow Hedges and Those Not Designated as Hedging Instruments</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the effect of the Company's derivative instruments designated as cash flow hedges and those not designated as hedging instruments under ASC 815 in its condensed consolidated statements of income and comprehensive income for the nine months ended December&#160;26, 2020:</span></div><div><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:23.422%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.493%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.500%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.203%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amount of Gain<br/>(Loss) Recognized<br/>in Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amount of Gain (Loss) Reclassified<br/>from Accumulated Other Comprehensive Loss into<br/>Earnings</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Location in<br/>Condensed Consolidated Statements of Income and Comprehensive Income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amount of Gain (Loss) Excluded from<br/>Effectiveness<br/>Testing</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Location in<br/>Condensed Consolidated Statements of Income and Comprehensive Income</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated foreign currency hedge contracts, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,378&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,538)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues, COGS and SG&amp;A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(671)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other expense, net</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated foreign currency hedge contracts</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,218)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other expense, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated interest rate swaps, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,996)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,326)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Schedule of Fair Value of Derivative Instruments as They Appear in Consolidated Balance Sheets</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the fair value of the Company's derivative instruments as they appear in its condensed consolidated balance sheets as of December&#160;26, 2020 and March&#160;28, 2020:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.250%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.438%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.859%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.863%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Location in Condensed Consolidated<br/>Balance Sheets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 28, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">839&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">377&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">260</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,216</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivative Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">919&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,854&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,435&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated interest rate swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,697&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,581&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,323&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,475&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13,145</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18,345</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Financial Assets and Financial Liabilities Measured at Fair Value on a Recurring Basis</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and financial liabilities measured at fair value on a recurring basis consist of the following as of December&#160;26, 2020 and March&#160;28, 2020.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.533%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 26, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,773&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,773&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">79,773</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">260</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">80,033</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">919&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">919&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,020&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,020&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,920&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,920&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13,145</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,920</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17,065</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="21" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of March 28, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,564&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,564&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">839&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">839&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">377&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">377&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">44,564</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,216</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">45,780</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,854&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,854&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-designated foreign currency hedge contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,435&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,435&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designated interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,056&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,056&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18,345</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18,345</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>The recurring level 3 fair value measurements of contingent consideration liabilities include the following significant unobservable inputs:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:21.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.517%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.988%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.550%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value at</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Valuation </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Technique</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Input</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Range</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue-based payments</span></td><td colspan="3" style="padding:0 1pt"/><td rowspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td rowspan="2" style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,920&#160;</span></td><td rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted cash flow</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5%</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected year of payment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 - 2023</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Regulatory-based payment</span></td><td colspan="3" style="padding:0 1pt"/><td rowspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td rowspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td rowspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discounted cash flow</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9%</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of payment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0% - 100%</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected year of payment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 - 2023</span></td></tr></table>reconciliation of the change in the fair value of contingent consideration is included in the following table:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.677%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.393%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 28, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition date fair value of contingent consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,920&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 26, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,920</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock', window );">Accounts Receivable, Allowance for Credit Loss</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a rollforward of the allowance for credit losses:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.684%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.231%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.231%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.231%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.526%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.235%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,699</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,108</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,824</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,937</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Credit (gain) loss</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(838)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">515&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Write-offs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(240)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(461)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(355)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,525</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,097</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,525</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,097</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=119407570&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4E<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624181-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5618551-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140454067885944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND ENTERPRISE-WIDE INFORMATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock', window );">Selected Information by Business Segment</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selected information by reportable segment is presented below:</span></div><div style="margin-bottom:5pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.578%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plasma</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,997&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249,587&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348,141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Center</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,417&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234,446&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246,977&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,334&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,753&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148,927&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues by business unit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234,905&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257,064&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">632,960&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">742,720&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,972&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,197&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,339&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,291)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,922)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,072)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">240,371</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">258,970</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">645,434</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">749,987</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> Reflects revenue for service, maintenance and parts</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:5pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.847%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.871%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plasma</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,673&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,343&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129,846&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,844&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Center</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,424&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,197&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,926&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,430&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,593&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,672&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,360&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,527&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,133&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300,444&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351,328&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Corporate expenses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63,202)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63,080)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(185,005)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(188,363)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Effect of exchange rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,286&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,521&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,644&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,791&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Deal amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,805)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,772)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,204)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,681)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Restructuring and turnaround costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,143)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,798)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,583)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,582)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Transaction costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,063)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;PCS2 accelerated depreciation and related costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,146)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,649)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,332)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,708)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;European Medical Device Regulation costs and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,207)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(448)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,696)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(304)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Impairment of assets and other related charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(896)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51,220)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Gains on divestitures and sale of assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,613&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,083&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">40,425</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">40,907</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">110,922</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">77,344</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="24" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> Reflects shared service expenses including quality and regulatory, customer and field service, research and development, manufacturing and supply chain, as well as other corporate support functions.</span></div></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock', window );">Schedule of Revenues by Product Line and Geographic Regions</a></td>
<td class="text">Management reviews revenue based on the reportable segments noted above.&#160;Although these reportable segments are primarily product-based, they differ from the Company&#8217;s product line revenues for Plasma products and services and Blood Center products and services.&#160;Specifically, the Blood Center reportable segment includes plasma products utilized for collection in blood centers primarily for transfusion purposes.&#160;Additionally, product line revenues also include service revenues which are excluded from the reportable segments.<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues by product line are as follows:</span></div><div style="margin-bottom:5pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.578%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plasma products and services</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,510&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,231&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309,933&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406,825&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Center products and services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,787&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182,687&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191,648&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospital products and services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,074&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,613&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152,814&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151,514&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">240,371</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">258,970</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">645,434</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">749,987</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues generated in the Company's principle operating regions on a reported basis are as follows:</span></div><div style="margin-bottom:5pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.303%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.578%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,607&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167,238&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382,600&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485,493&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,854&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,268&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,330&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,874&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,984&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,541&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,811&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,050&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,436&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,269&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">986&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,044&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,361&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,303&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">240,371</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">258,970</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">645,434</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">749,987</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material.  An entity may also provide subtotals of geographic information about groups of countries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e9038-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140454065979896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of Accumulated Other Comprehensive Loss are as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:38.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.164%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.164%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.164%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.168%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Defined Benefit Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Unrealized Gain/Loss on Derivatives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 28, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(31,100)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(209)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(13,826)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(45,135)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,031&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,618)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,413&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from Accumulated Other Comprehensive Loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,864&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,864&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period other comprehensive income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,031&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,246&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,277&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 26, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(19,069)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(209)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(10,580)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(29,858)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> Presented net of income taxes, the amounts of which are insignificant.</span></div></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140454069970040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING (Narrative) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hae_RestructuringandRestructuringRelatedCosts', window );">Restructuring and turnaround costs</a></td>
<td class="nump">$ 3,143<span></span>
</td>
<td class="nump">$ 7,798<span></span>
</td>
<td class="nump">$ 11,583<span></span>
</td>
<td class="nump">$ 13,582<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring liability</a></td>
<td class="nump">1,115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,648<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hae_RestructuringChargesPayableInNextTwelveMonths', window );">Restructuring liability payable in next twelve months</a></td>
<td class="nump">700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hae_RestructuringRelatedCosts', window );">Turnaround costs</a></td>
<td class="nump">3,235<span></span>
</td>
<td class="nump">7,181<span></span>
</td>
<td class="nump">10,683<span></span>
</td>
<td class="nump">10,653<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=hae_A2020ProgramMember', window );">2020 Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hae_RestructuringandRestructuringRelatedCosts', window );">Restructuring and turnaround costs</a></td>
<td class="nump">3,100<span></span>
</td>
<td class="nump">3,900<span></span>
</td>
<td class="nump">11,100<span></span>
</td>
<td class="nump">3,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1', window );">Cumulative costs to date</a></td>
<td class="nump">22,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring liability</a></td>
<td class="nump">595<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">595<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,136<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=hae_A2020ProgramMember', window );">2020 Program | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Expected cost</a></td>
<td class="nump">60,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=hae_A2020ProgramMember', window );">2020 Program | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Expected cost</a></td>
<td class="nump">70,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=hae_A2018ProgramMember', window );">2018 Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hae_RestructuringandRestructuringRelatedCosts', window );">Restructuring and turnaround costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,900<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="nump">$ 6,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1', window );">Cumulative costs to date</a></td>
<td class="nump">$ 58,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 58,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_RestructuringChargesPayableInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring Charges Payable In Next Twelve Months</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_RestructuringChargesPayableInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_RestructuringRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring Related Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_RestructuringRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_RestructuringandRestructuringRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring and Restructuring Related Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_RestructuringandRestructuringRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of costs incurred to date for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostCostIncurredToDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostExpectedCost1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount expected to be recognized in earnings for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostExpectedCost1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=hae_A2020ProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=hae_A2020ProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=hae_A2018ProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=hae_A2018ProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140454069935064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING (Schedule of Restructuring Reserve by Type of Cost) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance at March 28, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,648<span></span>
</td>
<td class="nump">$ 2,648<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Costs incurred, net of reversals</a></td>
<td class="num">$ (92)<span></span>
</td>
<td class="nump">$ 617<span></span>
</td>
<td class="nump">900<span></span>
</td>
<td class="nump">900<span></span>
</td>
<td class="nump">$ 2,929<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,433)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance at December 26, 2020</a></td>
<td class="nump">1,115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=hae_A2020ProgramMember', window );">2020 Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance at March 28, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,136<span></span>
</td>
<td class="nump">1,136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Costs incurred, net of reversals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,546)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance at December 26, 2020</a></td>
<td class="nump">595<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">595<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=hae_A2018ProgramandPriorProgramsMember', window );">2018 Program and Prior Programs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance at March 28, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,512<span></span>
</td>
<td class="nump">1,512<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Costs incurred, net of reversals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(105)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (887)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance at December 26, 2020</a></td>
<td class="nump">$ 520<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 520<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=hae_A2020ProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=hae_A2020ProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=hae_A2018ProgramandPriorProgramsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=hae_A2018ProgramandPriorProgramsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140454069503416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING (Schedule of Restructuring and Related Costs) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring costs</a></td>
<td class="num">$ (92)<span></span>
</td>
<td class="nump">$ 617<span></span>
</td>
<td class="nump">$ 900<span></span>
</td>
<td class="nump">$ 900<span></span>
</td>
<td class="nump">$ 2,929<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hae_RestructuringRelatedCosts', window );">Turnaround costs</a></td>
<td class="nump">3,235<span></span>
</td>
<td class="nump">7,181<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,683<span></span>
</td>
<td class="nump">10,653<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hae_RestructuringandRestructuringRelatedCosts', window );">Total restructuring and turnaround costs</a></td>
<td class="nump">3,143<span></span>
</td>
<td class="nump">7,798<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,583<span></span>
</td>
<td class="nump">13,582<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=hae_BloodCenterMember', window );">Blood Center</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring costs</a></td>
<td class="nump">66<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">240<span></span>
</td>
<td class="nump">154<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hae_RestructuringRelatedCosts', window );">Turnaround costs</a></td>
<td class="nump">518<span></span>
</td>
<td class="nump">293<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,024<span></span>
</td>
<td class="nump">293<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=hae_HospitalMember', window );">Hospital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18)<span></span>
</td>
<td class="nump">295<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hae_RestructuringRelatedCosts', window );">Turnaround costs</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=hae_PlasmaMember', window );">Plasma</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring costs</a></td>
<td class="num">(27)<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">454<span></span>
</td>
<td class="nump">552<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hae_RestructuringRelatedCosts', window );">Turnaround costs</a></td>
<td class="nump">431<span></span>
</td>
<td class="nump">108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,235<span></span>
</td>
<td class="nump">187<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring costs</a></td>
<td class="num">(131)<span></span>
</td>
<td class="nump">537<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">224<span></span>
</td>
<td class="nump">1,928<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hae_RestructuringRelatedCosts', window );">Turnaround costs</a></td>
<td class="nump">2,282<span></span>
</td>
<td class="nump">6,780<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,410<span></span>
</td>
<td class="nump">10,173<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of goods sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring costs</a></td>
<td class="num">(41)<span></span>
</td>
<td class="nump">476<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">574<span></span>
</td>
<td class="nump">1,777<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring costs</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">108<span></span>
</td>
<td class="nump">708<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, general and administrative expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring costs</a></td>
<td class="num">$ (49)<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 218<span></span>
</td>
<td class="nump">$ 444<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_RestructuringRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring Related Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_RestructuringRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_RestructuringandRestructuringRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring and Restructuring Related Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_RestructuringandRestructuringRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=hae_BloodCenterMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=hae_BloodCenterMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=hae_HospitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=hae_HospitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=hae_PlasmaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=hae_PlasmaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140454074521816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITION (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 17, 2021</div></th>
<th class="th"><div>Jan. 13, 2021</div></th>
<th class="th"><div>Apr. 01, 2020</div></th>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 215,508<span></span>
</td>
<td class="nump">$ 210,652<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed', window );">Acquisition related costs incurred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | HAS Intellectual Property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hae_AssetAcquisitionUpfrontPayment', window );">Upfront payment for intellectual property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=hae_EnicorMember', window );">Enicor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Upfront payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Contingent consideration, maximum exposure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">634<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther', window );">Other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">685<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">289<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,090<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,153<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,851<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther', window );">Other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">289<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent', window );">Contingent consideration (current)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">504<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Contingent consideration (non-current)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,416<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Total liabilities assumed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,245<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Net assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,606<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Acquired intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,090<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted-Average Amortization Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=hae_EnicorMember', window );">Enicor | Technology-Based Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Acquired intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,441<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted-Average Amortization Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=hae_EnicorMember', window );">Enicor | Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Acquired intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 347<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted-Average Amortization Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=hae_EnicorMember', window );">Enicor | Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Acquired intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 302<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted-Average Amortization Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=hae_CardivaMember', window );">Cardiva | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Upfront payment</a></td>
<td class="nump">$ 475,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">35,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSecuredDebt', window );">Proceeds from term loan</a></td>
<td class="nump">$ 150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_AssetAcquisitionUpfrontPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition, Upfront Payment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_AssetAcquisitionUpfrontPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116821951&amp;loc=d3e31917-109318<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=116868840&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=116868840&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=116868840&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=116868840&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For transactions that are recognized separately from the acquisition of assets and assumptions of liabilities in the business combination, such as related to pre-existing relationships with the acquiree, this element represents the disclosure of the amount of acquisition related costs which have been expensed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77989000&amp;loc=SL49117168-202975<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from amounts received from issuance of long-term debt that is wholly or partially secured by collateral. Excludes proceeds from tax exempt secured debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_AssetAcquisitionAxis=hae_HASIntellectualPropertyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_AssetAcquisitionAxis=hae_HASIntellectualPropertyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=hae_EnicorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=hae_EnicorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=hae_CardivaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=hae_CardivaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140454070507432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DIVESTITURE (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 18, 2020</div></th>
<th class="th"><div>Jul. 01, 2020</div></th>
<th class="th"><div>Jun. 29, 2020</div></th>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from divestitures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44,587<span></span>
</td>
<td class="nump">$ 9,808<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment of assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,028<span></span>
</td>
<td class="nump">$ 50,597<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 215,508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 215,508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 210,652<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=hae_FajardoPuertoRicoManufacturingOperationsMember', window );">Fajardo, Puerto Rico Manufacturing Operations [Member] | Disposal Group, Disposed of by Sale, Not Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from divestitures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested', window );">Proceeds, net of cash transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment of assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hae_DisposalGroupNotDiscontinuedOperationsIncrementalLossOnClosingAdjustments', window );">Incremental loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hae_DisposalGroupNotDiscontinuedOperationsExpectedCostToSell', window );">Expected cost to sell</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1', window );">Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment', window );">Fixed assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities', window );">Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=hae_USBloodDonorManagementSoftwareMember', window );">U.S. Blood Donor Management Software [Member] | Disposal Group, Disposed of by Sale, Not Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from divestitures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested', window );">Proceeds, net of cash transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities', window );">Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain on closing of transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=hae_InlogHoldingsFranceMember', window );">Inlog Holdings France [Member] | Disposal Group, Disposed of by Sale, Not Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from divestitures</a></td>
<td class="nump">$ 30,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested', window );">Proceeds, net of cash transferred</a></td>
<td class="nump">24,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">3,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet', window );">Accounts receivable</a></td>
<td class="nump">2,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets', window );">Intangible assets</a></td>
<td class="nump">2,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain on closing of transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets', window );">Other assets</a></td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Liabilities</a></td>
<td class="nump">3,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Amount received for divestiture</a></td>
<td class="nump">29,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hae_DisposalGroupIncludingDiscontinuedOperationConsiderationToBeReceived', window );">Amount received one year after closing date</a></td>
<td class="nump">$ 1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_DisposalGroupIncludingDiscontinuedOperationConsiderationToBeReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Consideration To Be Received</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_DisposalGroupIncludingDiscontinuedOperationConsiderationToBeReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_DisposalGroupNotDiscontinuedOperationsExpectedCostToSell">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Not Discontinued Operations, Expected Cost To Sell</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_DisposalGroupNotDiscontinuedOperationsExpectedCostToSell</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_DisposalGroupNotDiscontinuedOperationsIncrementalLossOnClosingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Not Discontinued Operations, Incremental Loss On Closing Adjustments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_DisposalGroupNotDiscontinuedOperationsIncrementalLossOnClosingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as inventory attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77989000&amp;loc=SL49117168-202975<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the cash inflow during the period from the sale of a component of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=hae_FajardoPuertoRicoManufacturingOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=hae_FajardoPuertoRicoManufacturingOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=hae_USBloodDonorManagementSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=hae_USBloodDonorManagementSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=hae_InlogHoldingsFranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=hae_InlogHoldingsFranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140454065850728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">$ 5,492<span></span>
</td>
<td class="nump">$ 7,934<span></span>
</td>
<td class="nump">$ 9,800<span></span>
</td>
<td class="nump">$ 6,290<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Reported tax rate</a></td>
<td class="nump">14.70%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">9.80%<span></span>
</td>
<td class="nump">9.60%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions', window );">Discrete tax benefit (expense)</a></td>
<td class="num">$ (1,000)<span></span>
</td>
<td class="num">$ (3,100)<span></span>
</td>
<td class="num">$ (5,100)<span></span>
</td>
<td class="num">$ (12,400)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109238882&amp;loc=d3e38679-109324<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) to previously recorded tax expense. Includes, but is not limited to, significant settlements of income tax disputes, and unusual tax positions or infrequent actions taken by the entity, including tax assessment reversal, and IRS tax settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=117330534&amp;loc=d3e28511-109314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=117330534&amp;loc=d3e28446-109314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140454070007048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE ("EPS") (Schedule of Earnings Per Share Reconciliation) (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="6">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Jun. 29, 2019</div></th>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Basic EPS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 31,882<span></span>
</td>
<td class="nump">$ 48,101<span></span>
</td>
<td class="nump">$ 10,527<span></span>
</td>
<td class="nump">$ 29,895<span></span>
</td>
<td class="nump">$ 37,486<span></span>
</td>
<td class="num">$ (8,479)<span></span>
</td>
<td class="nump">$ 90,510<span></span>
</td>
<td class="nump">$ 58,902<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares (in shares)</a></td>
<td class="nump">50,789<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,630<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,634<span></span>
</td>
<td class="nump">50,810<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic income (loss) per share (in dollars per share)</a></td>
<td class="nump">$ 0.63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.79<span></span>
</td>
<td class="nump">$ 1.16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Diluted EPS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 31,882<span></span>
</td>
<td class="nump">$ 48,101<span></span>
</td>
<td class="nump">$ 10,527<span></span>
</td>
<td class="nump">$ 29,895<span></span>
</td>
<td class="nump">$ 37,486<span></span>
</td>
<td class="num">$ (8,479)<span></span>
</td>
<td class="nump">$ 90,510<span></span>
</td>
<td class="nump">$ 58,902<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Net effect of common stock equivalents (in shares)</a></td>
<td class="nump">574<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,008<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600<span></span>
</td>
<td class="nump">1,185<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted average shares (in shares)</a></td>
<td class="nump">51,363<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,638<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,234<span></span>
</td>
<td class="nump">51,995<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted income (loss) per share (in dollars per share)</a></td>
<td class="nump">$ 0.62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.77<span></span>
</td>
<td class="nump">$ 1.13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive shares (in shares)</a></td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600<span></span>
</td>
<td class="nump">200<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1337-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=117327953&amp;loc=d3e4984-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=SL5780133-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=117327953&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1252-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1448-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140454069013096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Performance obligation amount</a></td>
<td class="nump">$ 17.9<span></span>
</td>
<td class="nump">$ 17.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Performance obligation percent</a></td>
<td class="nump">59.00%<span></span>
</td>
<td class="nump">59.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract assets</a></td>
<td class="nump">$ 5.4<span></span>
</td>
<td class="nump">$ 5.4<span></span>
</td>
<td class="nump">$ 5.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract liabilities</a></td>
<td class="nump">16.7<span></span>
</td>
<td class="nump">16.7<span></span>
</td>
<td class="nump">$ 20.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized</a></td>
<td class="nump">2.5<span></span>
</td>
<td class="nump">16.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Decrease in contract liabilities</a></td>
<td class="num">$ (2.5)<span></span>
</td>
<td class="num">$ (2.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2020-06-28', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2020-06-28</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Expected timing of satisfaction</a></td>
<td class="text">12 months<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130549-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118944033&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=118944033&amp;loc=SL49130533-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118944033&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118944033&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2020-06-28">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2020-06-28</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140454067945224">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVENTORIES (Schedule of Inventories) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 74,437<span></span>
</td>
<td class="nump">$ 76,867<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work-in-process</a></td>
<td class="nump">22,030<span></span>
</td>
<td class="nump">11,021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">203,243<span></span>
</td>
<td class="nump">182,388<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories, net</a></td>
<td class="nump">$ 299,710<span></span>
</td>
<td class="nump">$ 270,276<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116846819&amp;loc=d3e3927-108312<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140454074534424">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">$ 240,009<span></span>
</td>
<td class="nump">$ 253,399<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=hae_ManufacturingSpaceMember', window );">Manufacturing Space [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">15 years 6 months 30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Renewal term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating Lease, Right-of-Use Asset</a></td>
<td class="nump">$ 11,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating Lease, Liability</a></td>
<td class="nump">15,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">$ 4,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=hae_ManufacturingSpaceSecondRenewalTermMember', window );">Manufacturing Space, Second Renewal Term [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Renewal term</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=hae_ManufacturingSpaceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=hae_ManufacturingSpaceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=hae_ManufacturingSpaceSecondRenewalTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=hae_ManufacturingSpaceSecondRenewalTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140454069131512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>NOTES&#160;PAYABLE AND LONG-TERM DEBT (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 15, 2018</div></th>
<th class="th"><div>Dec. 26, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LongTermDebtMember', window );">Credit Facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear', window );">Principal repayments, fiscal 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,700,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">Principal repayments, fiscal 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">Principal repayments, fiscal 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">214,400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">Principal repayments, fiscal 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember', window );">Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount of debt</a></td>
<td class="nump">$ 350,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 310,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.40%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">$ 350,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | LIBOR | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest rate</a></td>
<td class="nump">1.13%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | LIBOR | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest rate</a></td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Uncommitted Operating Lines of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,200,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the remainder of the fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LongTermDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LongTermDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140454067186056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Allowance for credit losses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward', window );"><strong>Accounts Receivable, Allowance for Credit Loss [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Beginning balance</a></td>
<td class="nump">$ 2,699<span></span>
</td>
<td class="nump">$ 4,108<span></span>
</td>
<td class="nump">$ 3,824<span></span>
</td>
<td class="nump">$ 3,937<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Credit (gain) loss</a></td>
<td class="num">(95)<span></span>
</td>
<td class="nump">229<span></span>
</td>
<td class="num">(838)<span></span>
</td>
<td class="nump">515<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs', window );">Write-offs</a></td>
<td class="num">(79)<span></span>
</td>
<td class="num">(240)<span></span>
</td>
<td class="num">(461)<span></span>
</td>
<td class="num">(355)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Ending balance</a></td>
<td class="nump">$ 2,525<span></span>
</td>
<td class="nump">$ 4,097<span></span>
</td>
<td class="nump">$ 2,525<span></span>
</td>
<td class="nump">$ 4,097<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=119407570&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=118936363&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=119407570&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118955202&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of direct write-downs of accounts receivable charged against the allowance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=119407570&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=119407570&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140454145264488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASURES (Schedule of Effect of Derivative Instruments Designated as Cash Flow Hedges and Those Not Designated as Hedging Instruments) (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 26, 2020 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cash Flow Hedging | Net revenues, COGS and SG&amp;A</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax', window );">Amount of Gain (Loss) Recognized in Accumulated Other Comprehensive Loss</a></td>
<td class="nump">$ 1,378<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Loss into Earnings</a></td>
<td class="num">(1,538)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cash Flow Hedging | Interest and other expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet', window );">Amount of Gain (Loss) Excluded from Effectiveness Testing</a></td>
<td class="num">(671)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax', window );">Amount of Gain (Loss) Recognized in Accumulated Other Comprehensive Loss</a></td>
<td class="nump">300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet', window );">Amount of Gain (Loss) Excluded from Effectiveness Testing</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Interest Rate Swap | Interest and other expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax', window );">Amount of Gain (Loss) Recognized in Accumulated Other Comprehensive Loss</a></td>
<td class="num">(2,996)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Loss into Earnings</a></td>
<td class="num">(3,326)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument | Foreign Exchange Contract</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax', window );">Amount of Gain (Loss) Recognized in Accumulated Other Comprehensive Loss</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Loss into Earnings</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument | Foreign Exchange Contract | Interest and other expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet', window );">Amount of Gain (Loss) Excluded from Effectiveness Testing</a></td>
<td class="num">$ (5,218)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624177-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net gain (loss) relating to components of the gain (loss) on the fair value hedging instrument excluded from the assessment of fair value hedge effectiveness. Recognized in earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624171-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 25<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109977999&amp;loc=d3e76258-113986<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109978405&amp;loc=d3e80720-113993<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=hae_NetRevenuesCostOfGoodsSoldAndSellingGeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=hae_NetRevenuesCostOfGoodsSoldAndSellingGeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=hae_OtherIncomeExpenseNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=hae_OtherIncomeExpenseNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140454073103112">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASURES (Schedules of Derivatives) (Details) - Fair Value, Recurring [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Mar. 28, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Money market funds</a></td>
<td class="nump">$ 79,773<span></span>
</td>
<td class="nump">$ 44,564<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets fair value</a></td>
<td class="nump">80,033<span></span>
</td>
<td class="nump">45,780<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities fair value</a></td>
<td class="nump">17,065<span></span>
</td>
<td class="nump">18,345<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Money market funds</a></td>
<td class="nump">79,773<span></span>
</td>
<td class="nump">44,564<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets fair value</a></td>
<td class="nump">79,773<span></span>
</td>
<td class="nump">44,564<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Money market funds</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets fair value</a></td>
<td class="nump">260<span></span>
</td>
<td class="nump">1,216<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities fair value</a></td>
<td class="nump">13,145<span></span>
</td>
<td class="nump">18,345<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Inputs, Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities fair value</a></td>
<td class="nump">3,920<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative Assets</a></td>
<td class="nump">260<span></span>
</td>
<td class="nump">1,216<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative Liabilities</a></td>
<td class="nump">13,145<span></span>
</td>
<td class="nump">18,345<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Foreign Exchange Contract | Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative Assets</a></td>
<td class="nump">191<span></span>
</td>
<td class="nump">839<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative Liabilities</a></td>
<td class="nump">919<span></span>
</td>
<td class="nump">1,854<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Foreign Exchange Contract | Designated as Hedging Instrument | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Foreign Exchange Contract | Designated as Hedging Instrument | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">839<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,854<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Foreign Exchange Contract | Not Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative Assets</a></td>
<td class="nump">69<span></span>
</td>
<td class="nump">377<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative Liabilities</a></td>
<td class="nump">206<span></span>
</td>
<td class="nump">1,435<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Foreign Exchange Contract | Not Designated as Hedging Instrument | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Foreign Exchange Contract | Not Designated as Hedging Instrument | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">377<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Foreign Exchange Contract | Other Current Assets | Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">839<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Foreign Exchange Contract | Other Current Assets | Designated as Hedging Instrument | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative Assets</a></td>
<td class="nump">191<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Foreign Exchange Contract | Other Current Assets | Not Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">377<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Foreign Exchange Contract | Other Current Assets | Not Designated as Hedging Instrument | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative Assets</a></td>
<td class="nump">69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Foreign Exchange Contract | Other Current Liabilities | Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,854<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Foreign Exchange Contract | Other Current Liabilities | Designated as Hedging Instrument | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative Liabilities</a></td>
<td class="nump">919<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Foreign Exchange Contract | Other Current Liabilities | Not Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,435<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Foreign Exchange Contract | Other Current Liabilities | Not Designated as Hedging Instrument | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative Liabilities</a></td>
<td class="nump">206<span></span>
</td>
<td class="nump">1,435<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Interest Rate Swap | Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative Liabilities</a></td>
<td class="nump">12,020<span></span>
</td>
<td class="nump">15,056<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Interest Rate Swap | Designated as Hedging Instrument | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Interest Rate Swap | Designated as Hedging Instrument | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative Liabilities</a></td>
<td class="nump">12,020<span></span>
</td>
<td class="nump">15,056<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Interest Rate Swap | Other Current Liabilities | Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,581<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Interest Rate Swap | Other Current Liabilities | Designated as Hedging Instrument | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative Liabilities</a></td>
<td class="nump">5,697<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Interest Rate Swap | Other Noncurrent Liabilities | Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,475<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Interest Rate Swap | Other Noncurrent Liabilities | Designated as Hedging Instrument | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative Liabilities</a></td>
<td class="nump">6,323<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Contingent Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities fair value</a></td>
<td class="nump">3,920<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Contingent Consideration | Regulatory Based Payments | Valuation Technique, Discounted Cash Flow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities fair value</a></td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Derivative fixed interest rate</a></td>
<td class="nump">4.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Contingent Consideration | Revenue Based Payments | Valuation Technique, Discounted Cash Flow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities fair value</a></td>
<td class="nump">$ 1,920<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Derivative fixed interest rate</a></td>
<td class="nump">8.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Contingent Consideration | Fair Value, Inputs, Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities fair value</a></td>
<td class="nump">$ 3,920<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Contingent Consideration | Other Current Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities fair value</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118948506&amp;loc=SL51823488-111719<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118948506&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624163-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFixedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fixed interest rate related to the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFixedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=hae_ContingentConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=hae_ContingentConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=hae_RegulatoryBasedPaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=hae_RegulatoryBasedPaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=hae_RevenueBasedPaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=hae_RevenueBasedPaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140454139522920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASURES (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 15, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 26, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 26, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 01, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 28, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 31, 2018 </div>
<div>USD ($) </div>
<div>swap</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=hae_EnicorMember', window );">Enicor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Contingent consideration, maximum exposure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,065,000<span></span>
</td>
<td class="nump">$ 17,065,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,345,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember', window );">Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount of debt</a></td>
<td class="nump">$ 350,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 310,600,000<span></span>
</td>
<td class="nump">$ 310,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">$ 350,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | LIBOR | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest rate</a></td>
<td class="nump">1.13%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | LIBOR | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest rate</a></td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Exchange Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hae_PercentageOfNetSalesGeneratedOutsideOfUs', window );">Percentage of sales generated outside the US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.60%<span></span>
</td>
<td class="nump">40.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AverageRemainingMaturityOfForeignCurrencyDerivatives1', window );">Maturity period for foreign currency contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=hae_ContingentConsiderationMember', window );">Contingent Consideration | Fair Value, Recurring [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,920,000<span></span>
</td>
<td class="nump">$ 3,920,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hae_ContingentConsiderationAcquisitionDateFairValue', window );">Contingent Consideration, Acquisition Date Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,920,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=hae_ContingentConsiderationMember', window );">Contingent Consideration | Fair Value, Recurring [Member] | Other Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,400,000<span></span>
</td>
<td class="nump">3,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=hae_ContingentConsiderationMember', window );">Contingent Consideration | Fair Value, Recurring [Member] | Other Current Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNumberOfInstrumentsHeld', window );">Number of instruments held | swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Derivative fixed interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.80%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 241,900,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Interest Rate Swap | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hae_DerivativePercentofDebtExposed', window );">Debt exposed to interest rate risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Derivative fixed interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.05%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Foreign Exchange Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsDerivativeInstruments', window );">Deferred income tax expense (benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Foreign Exchange Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet', window );">Designated foreign currency hedge contracts outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78,800,000<span></span>
</td>
<td class="nump">78,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cash Flow Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths', window );">Gain (loss) to be reclassified within the next twelve months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 345,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax', window );">Amount of Gain (Loss) Recognized in Accumulated Other Comprehensive Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Interest Rate Swap | Interest and other expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax', window );">Amount of Gain (Loss) Recognized in Accumulated Other Comprehensive Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,996,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument | Foreign Exchange Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet', window );">Non-designated foreign currency hedge contracts outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90,500,000<span></span>
</td>
<td class="nump">90,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 98,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax', window );">Amount of Gain (Loss) Recognized in Accumulated Other Comprehensive Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_ContingentConsiderationAcquisitionDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingent Consideration, Acquisition Date Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_ContingentConsiderationAcquisitionDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_DerivativePercentofDebtExposed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derivative, Percent of Debt Exposed</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_DerivativePercentofDebtExposed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_PercentageOfNetSalesGeneratedOutsideOfUs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage Of Net Sales Generated Outside Of The US</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_PercentageOfNetSalesGeneratedOutsideOfUs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AverageRemainingMaturityOfForeignCurrencyDerivatives1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average period remaining before foreign currency exchange rate derivatives mature or expire, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AverageRemainingMaturityOfForeignCurrencyDerivatives1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=112277219&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsDerivativeInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from derivative instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=117330534&amp;loc=d3e28680-109314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsDerivativeInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFixedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fixed interest rate related to the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFixedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNumberOfInstrumentsHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of derivative instruments of a particular group held by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5579245-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5580258-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNumberOfInstrumentsHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of all foreign currency derivatives designated as cash flow hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(b),(c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of all foreign currency derivatives not designated as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=117331979&amp;loc=d3e41228-113958<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109978405&amp;loc=d3e80720-113993<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=hae_EnicorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=hae_EnicorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=hae_ContingentConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=hae_ContingentConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=hae_OtherIncomeExpenseNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=hae_OtherIncomeExpenseNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140454139162776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND ENTERPRISE-WIDE INFORMATION (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 26, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 28, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 26, 2020 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Dec. 28, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of business units | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hae_NetRevenuesBeforeForeignExchangeImpact', window );">Net revenues before foreign exchange impact</a></td>
<td class="nump">$ 234,905<span></span>
</td>
<td class="nump">$ 257,064<span></span>
</td>
<td class="nump">$ 632,960<span></span>
</td>
<td class="nump">$ 742,720<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hae_EffectofExchangeRateonRevenues', window );">Effect of exchange rates</a></td>
<td class="nump">494<span></span>
</td>
<td class="num">(3,291)<span></span>
</td>
<td class="num">(2,922)<span></span>
</td>
<td class="num">(8,072)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">240,371<span></span>
</td>
<td class="nump">258,970<span></span>
</td>
<td class="nump">645,434<span></span>
</td>
<td class="nump">749,987<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating (loss) income</a></td>
<td class="nump">40,425<span></span>
</td>
<td class="nump">40,907<span></span>
</td>
<td class="nump">110,922<span></span>
</td>
<td class="nump">77,344<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hae_EffectofExchangeRatesonOperatingIncome', window );">Effect of exchange rates</a></td>
<td class="nump">4,286<span></span>
</td>
<td class="nump">2,521<span></span>
</td>
<td class="nump">8,644<span></span>
</td>
<td class="nump">7,791<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization</a></td>
<td class="nump">7,805<span></span>
</td>
<td class="nump">5,772<span></span>
</td>
<td class="nump">24,204<span></span>
</td>
<td class="nump">17,681<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hae_RestructuringandTurnaroundCosts', window );">Restructuring and turnaround costs</a></td>
<td class="num">(3,143)<span></span>
</td>
<td class="num">(7,798)<span></span>
</td>
<td class="num">(11,583)<span></span>
</td>
<td class="num">(13,582)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hae_OperatingExpensesTransactionCosts', window );">Transaction costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,063)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveAcceleratedDepreciation', window );">PCS2 accelerated depreciation and related costs</a></td>
<td class="num">(1,146)<span></span>
</td>
<td class="num">(6,649)<span></span>
</td>
<td class="num">(3,332)<span></span>
</td>
<td class="num">(18,708)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hae_EuropeanMedicalDeviceRegulationCosts', window );">European Medical Device Regulation costs and other</a></td>
<td class="num">(1,207)<span></span>
</td>
<td class="num">(448)<span></span>
</td>
<td class="num">(2,696)<span></span>
</td>
<td class="num">(304)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hae_AssetImpairmentAndOtherRelatedCharges', window );">Impairment of assets and related costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(896)<span></span>
</td>
<td class="num">(51,220)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets1', window );">Gain on sale of assets</a></td>
<td class="nump">1,115<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">32,613<span></span>
</td>
<td class="nump">8,083<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">147,607<span></span>
</td>
<td class="nump">167,238<span></span>
</td>
<td class="nump">382,600<span></span>
</td>
<td class="nump">485,493<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_JP', window );">Japan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">20,854<span></span>
</td>
<td class="nump">19,268<span></span>
</td>
<td class="nump">57,330<span></span>
</td>
<td class="nump">55,111<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">41,874<span></span>
</td>
<td class="nump">40,984<span></span>
</td>
<td class="nump">123,541<span></span>
</td>
<td class="nump">115,811<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaMember', window );">Asia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">29,050<span></span>
</td>
<td class="nump">29,436<span></span>
</td>
<td class="nump">77,602<span></span>
</td>
<td class="nump">88,269<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=hae_OtherCountryorRegionMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">986<span></span>
</td>
<td class="nump">2,044<span></span>
</td>
<td class="nump">4,361<span></span>
</td>
<td class="nump">5,303<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hae_NetRevenuesBeforeForeignExchangeImpact', window );">Net revenues before foreign exchange impact</a></td>
<td class="nump">4,972<span></span>
</td>
<td class="nump">5,197<span></span>
</td>
<td class="nump">15,396<span></span>
</td>
<td class="nump">15,339<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=hae_PlasmaProductsandServicesMember', window );">Plasma products and services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">123,510<span></span>
</td>
<td class="nump">141,231<span></span>
</td>
<td class="nump">309,933<span></span>
</td>
<td class="nump">406,825<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=hae_BloodCenterProductsandServicesMember', window );">Blood Center products and services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">62,787<span></span>
</td>
<td class="nump">66,126<span></span>
</td>
<td class="nump">182,687<span></span>
</td>
<td class="nump">191,648<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=hae_HospitalProductsandServicesMember', window );">Hospital products and services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">54,074<span></span>
</td>
<td class="nump">51,613<span></span>
</td>
<td class="nump">152,814<span></span>
</td>
<td class="nump">151,514<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=hae_PlasmaMember', window );">Plasma</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hae_NetRevenuesBeforeForeignExchangeImpact', window );">Net revenues before foreign exchange impact</a></td>
<td class="nump">102,154<span></span>
</td>
<td class="nump">120,997<span></span>
</td>
<td class="nump">249,587<span></span>
</td>
<td class="nump">348,141<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=hae_BloodCenterMember', window );">Blood Center</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hae_NetRevenuesBeforeForeignExchangeImpact', window );">Net revenues before foreign exchange impact</a></td>
<td class="nump">80,417<span></span>
</td>
<td class="nump">85,314<span></span>
</td>
<td class="nump">234,446<span></span>
</td>
<td class="nump">246,977<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=hae_HospitalMember', window );">Hospital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hae_NetRevenuesBeforeForeignExchangeImpact', window );">Net revenues before foreign exchange impact</a></td>
<td class="nump">52,334<span></span>
</td>
<td class="nump">50,753<span></span>
</td>
<td class="nump">148,927<span></span>
</td>
<td class="nump">147,602<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating (loss) income</a></td>
<td class="nump">111,527<span></span>
</td>
<td class="nump">122,133<span></span>
</td>
<td class="nump">300,444<span></span>
</td>
<td class="nump">351,328<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Plasma</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating (loss) income</a></td>
<td class="nump">52,673<span></span>
</td>
<td class="nump">59,343<span></span>
</td>
<td class="nump">129,846<span></span>
</td>
<td class="nump">169,844<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Blood Center</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating (loss) income</a></td>
<td class="nump">36,424<span></span>
</td>
<td class="nump">42,197<span></span>
</td>
<td class="nump">108,926<span></span>
</td>
<td class="nump">121,124<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Hospital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating (loss) income</a></td>
<td class="nump">22,430<span></span>
</td>
<td class="nump">20,593<span></span>
</td>
<td class="nump">61,672<span></span>
</td>
<td class="nump">60,360<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hae_CorporateOperatingExpenses', window );">Corporate expenses</a></td>
<td class="num">$ (63,202)<span></span>
</td>
<td class="num">$ (63,080)<span></span>
</td>
<td class="num">$ (185,005)<span></span>
</td>
<td class="num">$ (188,363)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_AssetImpairmentAndOtherRelatedCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Impairment and Other Related Charges</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_AssetImpairmentAndOtherRelatedCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_CorporateOperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Corporate Operating Expenses</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_CorporateOperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_EffectofExchangeRateonRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effect of Exchange Rate on Revenues</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_EffectofExchangeRateonRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_EffectofExchangeRatesonOperatingIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effect of Exchange Rates on Operating Income</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_EffectofExchangeRatesonOperatingIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_EuropeanMedicalDeviceRegulationCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>European Medical Device Regulation Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_EuropeanMedicalDeviceRegulationCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_NetRevenuesBeforeForeignExchangeImpact">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Revenues, Before Foreign Exchange Impact</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_NetRevenuesBeforeForeignExchangeImpact</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_OperatingExpensesTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Expenses, Transaction Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_OperatingExpensesTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hae_RestructuringandTurnaroundCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring and Turnaround Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hae_RestructuringandTurnaroundCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hae_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveAcceleratedDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accelerated depreciation charged against earnings associated with exit from or disposal of business activities or restructuring plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveAcceleratedDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130543-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_JP">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_JP</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=hae_OtherCountryorRegionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=hae_OtherCountryorRegionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=hae_PlasmaProductsandServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=hae_PlasmaProductsandServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=hae_BloodCenterProductsandServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=hae_BloodCenterProductsandServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=hae_HospitalProductsandServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=hae_HospitalProductsandServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=hae_PlasmaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=hae_PlasmaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=hae_BloodCenterMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=hae_BloodCenterMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=hae_HospitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=hae_HospitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140454070169416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCUMULATED OTHER COMPREHENSIVE LOSS (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="6">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Jun. 29, 2019</div></th>
<th class="th"><div>Dec. 26, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Balance as of March 28, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (45,135)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (45,135)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,413<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,864<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net current period other comprehensive income</a></td>
<td class="nump">$ 8,614<span></span>
</td>
<td class="nump">$ 5,234<span></span>
</td>
<td class="nump">1,429<span></span>
</td>
<td class="nump">$ 2,401<span></span>
</td>
<td class="num">$ (2,108)<span></span>
</td>
<td class="num">$ (3,618)<span></span>
</td>
<td class="nump">15,277<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Balance as of December 26, 2020</a></td>
<td class="num">(29,858)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(29,858)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign Currency</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Balance as of March 28, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(31,100)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(31,100)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,031<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net current period other comprehensive income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,031<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Balance as of December 26, 2020</a></td>
<td class="num">(19,069)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19,069)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Defined Benefit Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Balance as of March 28, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(209)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(209)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net current period other comprehensive income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Balance as of December 26, 2020</a></td>
<td class="num">(209)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(209)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Net Unrealized Gain/Loss on Derivatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Balance as of March 28, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (13,826)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,826)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,618)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,864<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net current period other comprehensive income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,246<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Balance as of December 26, 2020</a></td>
<td class="num">$ (10,580)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (10,580)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AOCIAttributableToParentNetOfTaxRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669686-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118951672&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118951672&amp;loc=d3e1436-108581<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17B<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL34724394-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118951672&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>61
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M[S-VA?9H9?D4]^F"<.3[L#)*S@X'Y",\1V9Q?>YP2<HNR *6TK"D@,NPFL-
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M\9#991+#Q33V>J+ NRCPP2@\*@.YKIP:@K+F;AJ+V.,V:Q<61\SW;.8NC-.
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M&AWP4.5M57:,7+D#?RX-7!^NF<$%3Y4-@.<+*<UKQ]XAU5^&P7]02P,$%
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MU1+04_+C!^=K.]5HHQ*00S5:KP3D!I+\Z!IM5 )RJ$8+2$ .U6B=[1!P!DE
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M4?S2P% >#<-8#'T)P) +A>U*E#P&AH SQJ6@]BE1P X1@6AJSQ= 0R*I\-T
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M16^QBN,QB)$>8N0#FRBK*@N^B!%,TVBL4")[1VIN>'6Y=)L^T:I+0^[L24Q
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MXW@OUCE7C@2Y;X0+1)PHY\IG)")=]6&+&;&X1*DD&!N@% _(ZA&J8[WY4+(
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M"'DM21CVW44L/6!</$*V"Y*PLVU FQPKO-<H3I2@T>7& Q$^C]E*V@S.A['
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MI3(/\J)D<R<YNX%D6*)F$O,, H%[XZ-@>Z W)Z/A60;'($$YC')491B1I2H
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M+]_(("_/G=T*QZN!QA<QU+@;SBG#15D$A[<*^\+EF]NO;Q>?;S]_^?3V?!(
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MR((<Z4.U?]I_YE^EK]N'Y>E_!!]Q"F&R:%IAZS1[@:]JE[Z[TTVP=?S67=J
M+^=X6>+[@QPOP/N5M:&[80/]/S\N_PM02P,$%     @ M3)"4E;;R<FP!
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M+)F,(M#AU1 65NU\IZ9X4=_WTRT]M% [ ?J_5LH>%LY _W2;_P102P,$%
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MK-!\ <_G%DXW7]A ]XO*^;]02P,$%     @ M3)"4AB:I8?- @  M@4  !D
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M,E?:D<X;TX\>C0\@?ZZUVR]\@NZIGO\!4$L#!!0    ( +4R0E)W+0+(9 0
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M_6].3SLT+$#[F=9N,6$#W6/Q[%]02P,$%     @ M3)"4H@LNLG1$P  !D
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M>#ZVN3AV2V#5!#RYM @0IGB1K7'.C"7[EFIQ"^1:PJ;A2S*)QCD+\5""1V.
M>CH:;>+;@KL'#E/MZ$H\"ZNX)H#B:K7"X^RG@5 CQ+[D%'D+Z(0PY*):[")<
MC$UAAT%LGE('(/2<]O_-2]"-^,8=(1?5G 4!S)GTX.]X,'DQ,&DE>#H1@S."
MTZ== E']WFG(^>?:7/\=]D.K/Q23WH36&H^&_Z84(=U^]Q1H#@>C9T#4$R1&
M4-J<P=_1N+<?D=1D\V/RDY#,*8"Q@9A$PS,L4'J#J#>D#^-H !]XYJ[D?%7[
M"]U4FE$#QI7)ZD$7'(@YFG)"9KRB*!#RY1L8BI?/^-RZCJ$KJ:F56^5I68?5
MR"$+&%PN5]P*HS5<I,0,2+=]D$E>MZ0<3_SP-9*6:.TB1"W4O 1?0H<-NW=%
M,XI@P7N<4E2L(V!I'>+C;$AW62JR;[BG?OK6!=->A7.O75+D.V55GP^H@.LG
M)C5S/@QT6<Y+VY;L6C-<9V/E_HM7WI$"(Y?#4="=S#V=?#'H\9SC1B[D!38Y
M'[R8\S+;SBY5,[ ^5ZK:DU,ZGG' DNM6FK.WB;4C @\NE[4?N<Y0K<'0K.44
M"A?J*6]V1/$8^]&S,X-Z'*OZ/-=<!@16C-('Z;Z1R'M/)O(@.[,2:8 _.VS;
MZ$Y+K$CX( C*;HAB./$CW2"H6XX!XJ@196@;2T^H*1B1S2NR?#'!';M7<E6>
MNG^VW0FCMK*PTZ'W)F^;=W3FQ8D46U^;^W0HSB;1V=E@1_WMOGQ)!O.3,>.&
MGU^:L?Q<2+7!QX!?3KTUK^-NU!T,PM3[(KY#4IQIF\^_RS_FU_#S,PFR4ED_
MPFW>>,3;-&!!BOJJ88/;C_/_!]$$AO/?4)(JJ_JO>F=1]W3DS&P#BOV^40V'
MT>ATN,.HW)>_8U0(X,+/O[LI"-["SP''C.4:_(ZBLW'W_\2P&+QMO_E=.1BX
M-9_V-;!1U!V=;CXV6&/@U?+JZCG^CC?Q2W#3=^<D/.BMXBL']O @85?-BU'3
M98,I7J^<X>6$F"Y3F+7*CV':L>M'/(\(MJJTJO'DKTQ"N:C5VB')UE+-JIV=
M;SV;X;ED():KO,-KDT0YKC&J3*FC5J[ S_%26\JY&C$=7@0@%$IUOV.H_;H4
MW2JD5J5LJ-4W[[E<]#?B\0K=R@47P%0M)[G4*JANW 37E@);VS0#N^M&#-W]
M:FX]'0BYBKC2;G5,ZL_=ZBL_/,OA-@>GG@*'P1FY:XV$;#UJ!>KG-MC+#<'N
M:0E/&X+]?VH).Y-46U2(=PUNM,,"@!QRW(*DPRT.[FAY^,SA(H"UKB491)[&
MN3S?A2:\?'Q/OPBDMMF&60:7&&QMH]P37\I$;?PJ:#MJ[-0"-LBF2F4A;(97
MJ<O$P4W@-MC,EEOC4C\M&+L,J^B]]\.U29NP]IF=>1,"<C#0GU6!]",<_.R1
M[)V*%YG^JU1<<(D;:F??\)F5\_QJ,S#!(M#!QCWE@/#*N7_)+C_NC%Z)[[GY
M)^\>_VYD5IUXP]H]L&"\: 6+S?$"DLD?F^O1^6JWN]=RP\Z$EO/F%:[5I=N/
MW>Z^_#S9:UW*![TLE\$UA)U[7 4.'^R"V$-G0(F_;P<.<SBL+[UN]2N>LJ3-
M&V4R!MI\!X5!P.$@N(XG6^[1/]%=/@ROXB(Q9ZM)_7N1S5H?EAL^-Z6U866J
M&\'/MEB!8SH=R_ ZK&Q<MWGBYS [5:B;3&XT@M"/MOJT'QT[H,\-F%\#O/-Z
M)_BD:4]VN)BXJ"0)IGG2P?+;+NW+D:T>7WC>=A?>MHS<?1_=:#5 WLP+2I'X
MN\VH]=H5Q7__'DR97ZX@T#]P@R4X+FK[)?!)\-OLI<KG] MTRR=>_#/MZFWU
M(_=S_FUW/9Q_(0_[, =0 &%Y!E.[G;/1 > 1^M4Y/Q1F1;_TGIJB,$OZN%"0
M3W(< -_/#/BT>\ %JI_^?_A?4$L#!!0    ( +4R0E(OSV)K% 0  ) (   9
M    >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;*U636\B1Q#]*R4BY60!QO:N
ML\%(&#N)I6!;BS<Y1#DT,S5,:WNZQ_T!]K_/JQZ8Q5'6IQR _JAZKZKZ53?3
MG?-?0\T<Z:4Q-EP-ZAC;3Z-1*&IN5!BZEBUV*N<;%3'UFU%H/:LR.S5F-!F/
M/XP:I>U@-LUKCWXV=2D:;?G14TA-H_SK-1NWNQJ<#@X+G_6FCK(PFDU;M>$5
MQR_MH\=LU*.4NF$;M+/DN;H:S$\_79^+?3;X0_,N'(U),ED[]U4F=^758"P!
ML>$B"H+"SY87;(P (8SG/>:@IQ3'X_$!_9><.W)9J\ +9_[49:RO!I<#*KE2
MR<3/;O<;[_.Y$+S"F9"_:=?97DP&5*007;-W1@2-MMVO>MG7X<CA<OP=A\G>
M89+C[HARE#<JJMG4NQUYL0::#'*JV1O!:2N'LHH>NQI^<;9X6"[OGI:W]T\K
MFM_?T.+A_NGN_M?;^\7=[6HZBJ 0PU&QA[ONX";?@?N)EL[&.M"M+;E\ZS]"
M:'U\DT-\UY-W 6^X&-+DPPE-QI/Q.WAG?;YG&>_L>_FZIM$1JHJ!E"UI@7"U
MW; M- >ZT:$P+B3/]-=\':*':/Y^A_6\9SW/K.?_5Y7?ASL]&]*[D/14,U)K
M6F5?22-3:I6/KQ0=;977+@4RO%&&6N\*YA(5Z,I1&*4;#+T.6"-T,;F*(M"<
MAQ7:E@J7?&!9UJCA.L&00QB^H5RST;Q%0>&)6BI\K'M#YOR!"]>++)':X H)
M$:B9#UVET72,S@_.I-S"X-S5NJ@E!E-2K;; )K'R&LFH<LL2&E<5>I[@($ 5
MPL;I8K]P8.J O,""(@@F;CBO9!U9S".Q H/GUGE1!N)#P<J3C'7(C[?*)- &
MQ,.2HR!:%Z70+D)<0@<AH9*-2S;*]O&65Y"<4&<;'!!*LU9KP_D0<+D&9S$%
M49 JR$9"0WF:KQ9T?C$^>:O;$ZJ$P!BI!8J!/'[/QUNX(#I'^?D%=0Y<D@*?
M+9+W7 [I)GE)45*+M?8E/2?H1-*I4+=0  )]=_HV><\%XR8%%*[R=>O8*JJ\
M:[+1E^%*BAB=M_SZXP^7D].//P=ZJ"I=<(Y2C-!FT>LB:VNI0D#!4^ 8]RKJ
M43T_)Y8,"O81ZJ#2%:GK78_\?'D(?A]:SZ=:T5W0G:A5B@ZM;$.5\EM2\A;1
M='NE#JT+4F%4$84Q*8,>$QF5=1"S@,N$L O00;R'.Z37W18>WY1S(D$F>#OI
M&L,*(1QH#T@E@MQ8*FH1!"* 7*3MLJ3ZL_Q7,U?)&&G#O6QAO].QE@.4HWU.
MVK\._^O.&AV]$@W[37X+@_22C=V#T:_VS^V\>V6^F7=O]5+Y#9H5ET@%U_'P
MX\6 ?/?^=9/HVOSFK!VDT.1AC;\,[,4 ^Y5#+^PG0M#_"9G] U!+ P04
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M*7"'H@/X?5:CD/<;$C#\E^'T/U!+ P04    " "U,D)2NZS$(%L#   @!P
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M8;K_U4O!&]6J4.V<-FM*E\ : 3OMGN1_UJC>-_/F[:#[LJ. P#$GU[![WO=
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M3:\F"F)$1=\>/*;]BTM85@:E==SGX!.!.%GY1G(G6_8TR8,S;XA7 K31NK2
M<$O<VXMD-B:-T0^%^PJ2)/&-Q*N20)>H,*E;J@?%,X8HGD$4YI#A[P$_>TA)
M !NA\-1([\!+_*#4U/#HRPCB:TL<H0Z3: Q)-H4T2U!36991_AFC_-.()B1;
MTON,S;[11[\]_YDI+^X34O"XSG[(9B&Y;3@A9ADA3NB7TC--&=Q*)!7ND"/T
MF4X!J61)"!$:O->VK>G,__Q3SB+V"Z0Y'LD<VP8>L3MM6HU$"5R*D9XTSH Q
MHF?&\GVO.$/2LC.*&]UY;?UO&$KBB+I&F/O>P6+J)%&>G9*4$D6SF-H6UDNC
M@:ADH"IZ&CXQQ0*6,Y@&61Y"'B01TAP&418/=,7[G%D0Y3V28)K'^T%ZL#//
M&I#[EDT*%26Q#Y7-?#G82_M0,0[8=YOBY.C:U BS\9=#BR$[Y?H;U+ ZW#]O
M^FO7DWE_><5OPZ96%J18HVOX.L,6:/H+83]QNO67L)5V>*7SPPKOT,*0 ;Y?
M:^T.$THPW,KG_P!02P,$%     @ M3)"4OU0%$2& P  A@<  !D   !X;"]W
M;W)K<VAE971S+W-H965T,C,N>&UL?55+;]LX$/XK R&'!'"CIQTGL W8[CY\
M:.MMW.UAL0=:&ME$*%(EJ3CIK]\A):MNU_%%(N?Y?9SA<')0^LGL$2V\5$*:
M:;"WMGX(0Y/OL6+F5M4H25,J73%+6[T+3:V1%=ZI$F$21:.P8EP&LXF7K?5L
MHAHKN,2U!M-4%=.O"Q3J, WBX"CXS'=[ZP3A;%*S'3ZB_5*O->W"/DK!*Y2&
M*PD:RVDPCQ\6F;/W!G]S/)B3-3@F6Z6>W&953(/( 4*!N741&/V><8E"N$ $
MXUL7,^A3.L?3]3'Z[YX[<=DR@TLEOO+"[J?!.( "2]8(^UD=_L2.S]#%RY4P
M_@N'UG88!9 WQJJJ<R8$%9?MG[UTYW#B,'[+(>D<$H^[3>11OF>6S29:'4 [
M:XKF%IZJ]R9P7+JB/%I-6DY^=C9?_O5E];C:K#Y]A.L-VPHT-Y/04F2G#_,N
MRJ*-DKP1Y1X^*&GW!GZ3!18_^X>$J(>5'&$MDHL!WV-^"\EH $F41!?BI3W-
MU,=+WXBW: Q)C(&EJK9<,M<1!OZ9;XW5U!C_7DB1]2DRGR)[(\4CW9>B$0BJ
MA#[=//_6<,-]N@%L7T\%YX[Y<HK-'J%4@BX2ESM@E6JD-70UZ#H:E!8LZ6DM
M.#4*W3#J3HNZZN@Z7,Z@9%S#,Q,-'B6\(&=><E=]8,8@!64.I\8"F"Q D(H+
M HW&Z9N*Y#0/ "7/Z9>KJA:4JH"BT0Z93\.UL2") 51M;U"VDIN<"5?4^ &N
M5Y(L56,HA;D!*CE66]1]V6$EGPF8(B)7,$HS^$1Q*5NCM2/; 1V-A[#6-*2T
M?1U +9A3$68D_'7E#)/Q/86R3.[X"<$X&T3W$?RA5''@0L!X$ ]3V"A+^'X]
M@RM(TL%X&/^"X/187)(E\23Z3I53O>E8=7ORUYW'#0RC[(*95/)=;YH.LGA$
MIU*B=A@L>^D3OI(R2D<=VG/5N8*[09(-X2/:,VSBT6 4C<X<2F_C@5']CCUS
M;+K_56WNFQ"^^NF'Q;OY,['9H9-KR[^WQ-:HN2K<W>OZQ&*^ETJHG2MM3$RS
M&.((EG[>T0E3#[=7=,]K VEVY[0;S0IZD?03I%'B!9[^U;&4\=E!$9[,1@J]
M\R^ (8($NQV3O;1_9.;M;/UAWKY0'YC><1H; DMRC6[OA@'H=NJW&ZMJ/VFW
MRA(/O]S30XG:&9"^5,H>-RY!__3._@-02P,$%     @ M3)"4BH<\<I" P
M40<  !D   !X;"]W;W)K<VAE971S+W-H965T,C0N>&ULG55+;^,X#/XKA#&'
M%C#B1UY.D01(IMF='J8(DN[.83 'Q69BH;;DD>2D^^^7DI(T!9H<YF)2$OGQ
M(TU1XX-4K[I$-/!65T)/@M*8YB&*=%YBS71'-BCH9"M5S0PMU2[2C4)6.*>Z
MBM(X'D0UXR*8CMW>4DW'LC45%[A4H-NZ9NJ_.5;R, F2X+2QXKO2V(UH.F[8
M#M=H_FF6BE;1&:7@-0K-I0"%VTDP2Q[F/6OO#/[E>- 7.MA,-E*^VL53,0EB
M2P@KS(U%8"3V^!6KR@(1C=]'S. <TCI>ZB?TOUSNE,N&:?PJJQ^\,.4DR (H
M<,O:RJSDX1L>\^E;O%Q6VGWAX&U[@P#R5AM9'YV)0<V%E^SM6(<+ARR^XI >
M'5+'VP=R+!^98=.QD@=0UIK0K.)2==Y$C@O[4]9&T2DG/S-=S%;/3\]_KV&Y
M6,'ZVVRU@+M@L5P']W#WPC85ZOMQ9"B0-8_R(^C<@Z970$?P70I3:EB( HN/
M_A$1/+-,3RSGZ4W 1\P[D Y"2.,TOH'7/6?==7C=:UDS);C8:5BB@G7)%,+/
MV48;14WRZP9^[XS?<_B]*_AKNCM%6R'(+7P2:X6Y%#FO.+.=^5E];\+;B_J@
M&Y;C)*";J%'M,9B^E A;6=$MHVA@[+^#1LD]+U #HPMT&=,2,^0@VAH5,U*1
MB2BHG86D)O,;1Q/J>9[[4UZU!@O 4T8-9:1=1KFLF]8X:-V!EU(A?N@!>*84
M/N[</0G"EZTF:!T"ON78F M(5LM6&'T/]/.QWM"^;8#W11;>.)D[TM3'\$R#
MC0OBA_ %NDF892DIZ2C,1GU21G'83V)2^EDXBE/XX:XQT6-[*LP./1D-_3@<
M9B,K!MW8BYX5&3G[8,<@[PE\@;@SZ#K1'Y%(.D,OD@$\'DOY!PQ]M,,?\+2!
M<+NE>6C_+06LJ1%HPN2O@+];OF<54L&A/^Q!$L9Q!H,X)BW)^F>^5\,F89=R
M)3'H9E:D-FP2CD;OOI\7*/4%RGR!AKY 7?CL$D878X[:=N>&N:9$J$_\Q#OO
MGM^+F1^3[^;^L?G.U(X+#15NR37N#/L!*#_ _<+(Q@W-C30T@IU:TIN'RAK0
M^59*<UK8 .=7=/H_4$L#!!0    ( +4R0E(/#<ZMV0(  +P%   9    >&PO
M=V]R:W-H965T<R]S:&5E=#(U+GAM;'U436_B,!#]*Z.HAU9*27 HT J02C^T
M'-JMH-L>5GLPR818=6S6=J#]]SM.(&6ETDLR]LQ[\V$_C[;:O-D"T<%[*94=
M!X5SZZLHLFF!);<=O49%GER;DCM:FE5DUP9Y5H-*&;$X[D<E%RJ8C.J])S,9
MZ<I)H?#)@*W*DIN/*4J]'0?=8+\Q%ZO"^8UH,EKS%2[0_5H_&5I%+4LF2E16
M: 4&\W%PW;V:]GQ\'? B<&L/;/"=++5^\XM9-@YB7Q!*3)UGX/3;X U*Z8FH
MC+\[SJ!-Z8&']I[]ONZ=>EERBS=:OHK,%>-@&$"&.:^DF^OM#]SU<^'Y4BUM
M_85M$YNP -+*.EWNP%1!*53SY^^[.1P AO$1 -L!6%UWDZBN\I8[/AD9O07C
MHXG-&W6K-9J*$\H?RL(9\@K"N<GL\>7N\?GG?':W@--GOI1HST:1(V;OC](=
MR[1A84=8+N%!*U=8N%,99O_C(ZJH+8OMRYJR;PEO,>T ZX? 8A9_PY>T;28U
M7W*L3;5!Y;3Y@%MA4ZEM91!^7R^M,W0O_GR3H==FZ-49>D<R+$@N6241= [[
M; +M5[/\ELBK\,JN>8KC@&1FT6PPF!PP J?2K>,.,^ .7(% RD+C$Z?:.M"&
M+HAY(T%SE8%0J:PRK.,:=TYNAT9P&8+D2PKW<25754ZSJ(Q0*] ;- 5IO ,W
M'B,LW73"T 6DK)7U(9XP%\:Z<Z'"G46JAQ)=H0EX.E,4HRM+[/8,Z$2Q7%*9
M_E0?N$D+8,,0YGS;EF/A! :]L)<,O-$/A_T!O)*F*<'YVN@4K07&PCB)H=L-
M8]:%>Z$$W?T,5EIGY(R3D/42Z Y9F R'\*P=ES2!S]F= +N\# ?=V%N#.&2#
M/GQU^-&!HDHTJ_K=L#3 2KE&7.UN^S1=-XK\#&_>->IU)90%B3E!X\[@(@#3
MO!7-PNEUK<^E=J3VVO2C1^,#R)]K[?8+GZ!]L"?_ %!+ P04    " "U,D)2
MV&3\4BH'  !Z%@  &0   'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6RM6%M3
MX[@2_BNJG+-[0I4AOL1VS )5)L L59"=(C#[L'4>%$>.=<:V,I8,Y-^?;CEV
M[ P)@=T76]?NKUM]D\Y>1/%=)HPI\IJEN3SO)4HM3P<#&24LH_)$+%D.,[$H
M,JJ@6RP&<EDP.M>;LG1@FZ8WR"C/>Q=G>NQK<7$F2I7RG'TMB"RSC!:K2Y:*
ME_.>U:L''O@B43@PN#A;T@6;,O6T_%I ;]!0F?.,Y9*+G!0L/N^%UNFEC^OU
M@F^<O<A6FZ D,R&^8^=V?MXS$1!+6:20 H7?,QNS-$5" ./'FF:O88D;V^V:
M^HV6'6294<G&(OV3SU5RWAOUR)S%M$S5@WCYG:WE<9%>)%*IO^1EO=;LD:B4
M2F3KS8 @XWGUIZ]K/1RRP5YOL#7NBI%&>445O3@KQ LI<#50PX865>\&<#S'
M0YFJ F8Y[%,7-[>3<#*^#>_([63Z^/!T?SUYG))P<D5NPML'\BV\>[HF]]?A
M].GA>DKZCW26,GET-E# &RD,HC6?RXJ/O8-/0.Y%KA))KO,YFW?W#P!S ]RN
M@5_:>PE>L>B$V)Y!;-,V]]!S&D4XFIZSDU[!GRF:"+G-I2I*L#PE"<WGY'<V
M7_!\04*T(*XXD^2*RR@5LBP8^2N<P7*PKO_N03%L4 PUBN$.%%-PNGF9,B)B
M<AW'8+K8VH'MBDF^R*EB<T(E&5.9D!MP,HV75= ?$R$9F0BUM;@6J47NK3/=
M"Q;CQ:E<THB=]R @2%8\L][%8\)(+%+ @?05V@O1LXA8P21KQ,+>6&1+FJ_^
M(\&5&B%Y2\AY!W>$0L8H9+(14FDA<Q"RNSA9"]DF5X+Y%22<CLG(<F&&<!B,
M!(SF$G9!2XJ4SS4)J>!7;0.T/(]$QC1#:(!("88FC59/0(#4$N6@)9)5QL[0
MV$'U$<MFP+8VUU/2O\T1=BF!G#PB82;*7.OD"\31[6[_3DA8],"BE$K)8PXT
M[T1$=5C;N?SZ-4I+9!\7(NNL;YD"@(:XE4.D*0J61ZM*K:@&;=+2(#FKSHJ^
MDG\3RW#\$?S[EN$ZHR,R@<F"/;.\9+!T_,>7J=;/],NO-%O^%N)*S[>.P,P4
M QM0>E: E@K"7I>H\HK!1.3'\\-1 =U?_S6R+?NW3JOO&K8U>I];2WY>+RV@
M2^0+76Z+W+>-(/".L.48CNV]3WX#:4] <)N X!X<$&XH+\@WFI9L3U  NP<7
M7)%PN62TP.,>MVWZDJ8TCQB98L9XT^?WXCG8YV7M]-HG8D3^7",_R.^ICA8K
M0ALY]GCJ;"V5SH-ZKU;0EMOI [NG1900>[3#$]M^,FZ8=508:NKA#AY=^NU3
M"J4$<*<?<3_RAS:O:AH,3E- /PPL^(Z<X,.>\R9!+R".[P-%VS.UE]N6UT9^
MQ^F,ISKS_1WXZ88,< FL0/,:N<._*46;KFUZ0'/HN.]X^1X2KN$%/GS=D748
MD53DBV.8S#ID/(@6#@F,H>^BG(YA#75C9#C0V!,:O"8T>(>'!IZ# W":KJU,
MF_IFL'6 Y)Y1K%L@0ZI.1($*&5,,* 2=^))*_F9XV(OI[?"PP4$WX.)FL*VT
MK 6N'3007-& FR$X'0&X;"J)30 ZW/U/=KKQ=EB ))<2:_VWUW^'/ JUT3E4
MN!"PX&[S';) #)4&FKD?&+[O[,A8Z\F/N%2]&4- N_U1%ZKW@N^WFBV\52S8
M8!V9ANDX'5/Z".XVJ<KUN_W/XD>';[??\=A&9;:!Q[S5A3BOP((P(FCK@MQ4
M98-Z7?UWC "65]^V)(V;UU.6;YB>NS:SK=SP>:,:#@W7&^XPJO7D9XP*,TJ[
M_=E#P6S2;K<05\FE@]<U_)'YCQA6E4U^'OFL'%4FZ?8.-3#7,%UON]N!5F6"
M-X9:81GB(#8J*WS*Q0QCJKY4;46HGT/8(XN2G/\HL3Y<EHH\4+!L"/&Z7#_&
MIXPY6=)556ZAIM!B\6*+MPFLL)J[5CU8R3DZ<7\A7POQ/[C&P;(5EF=@W&M2
MR-LBQ_AS@-FB3*D2Q:K+#\.+89H'L1N>!)K=K#*/59N7^0MPLDSS4#Q;.JN+
M85#REFMN#B6,?I1<<JU_K/^V:MEH5\2H L XT4J'8K*UK2;=8O_SZ=4A9$^A
MX#>%@K^W4 @CK4Z)Z9UQ;3T&"3%;:O9X<1U#SN6*X,WQK:2_E_XA=P)(UY#
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MV\:&PZ:-5]A8)S:N89SM^0:;YW8LY"*W.R]VE1>[-R\+_";O/]&U?\]N<7I
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M!96_!<UY_0EV#=8=@,66"UHTQG(&15;NO_%KDX@# ^G';( : Z0:^"<,O,;
MZSN"WQCX?0V"QB#H.Z6P,0CKW.^356?Z#@L\&C*Z ZQ"2V_515VNVEHF."LK
M9LT%D[]FTDZ,9I/YX^QI_/@TN__]-W QE\Q-MSD!= EFA NV78@MR\H5P&4J
MG^18D!2,*1?\,[BX(P)GN;RZ!$_S.W#QZ3/X!+(2/*[IEDL#/G2$G&,UDK-H
MYG.[GP\Z,1\/_*"E6',P*5.2&NSO[/;AK^PG=OO$8N_(W+8)1F\)OD56AW=D
M<050^ 4@%[F&^8S[F,>5.4Q,Z;";S\G&.OKD?9.?_N_)'^72:\GJU?Z\4V0]
M8F3%PH:6G+ 7 O[Z+O'@7I""_VT9S6]'\^O1_%ZC+2K.F_B\=Q+63JH^_C*Z
M3-#0>3FLL8X)872,N=,QB>L>8R8],%,=@Q*4M*"C5 1M*@)K*AZWK,2,;F6R
M3^9A[R$X&-=#7J D0@=%,(9*E#H(NF'L*7$:48%G#C1L PWM@5*!<ZF8:N<3
M/1(0Z@F OC+KL0Z*HB16$J"#( RT!!A07A C<P*B-@&1-0&W.:6RP9-2$&99
M0W'K+C[#BDW:T9*/6+&)EK@P5,JD0Z!:)!V"?'4M&MP$OKE T.T4VWWW8FQ<
M'(X<J!&,#2"4*"R;&$#01;X2Z"]<'4=Z\&X"K9%^HWR3R05IH09$G3-T!BK"
M3JN@]Q%D;+P<9LY5ZZ1# I6-!LRE6O"I 822X$25.IF$=IWLQ4=?&]E7H]0A
MJOP9(%!CHLW-<82=^D&[_#WDF!?8QHI.7V!X#A9V[1S:^WE?%D8Z?5"D5D@'
M^6J%#)! *Y$."H(3N@4[I8'Q^VD8Z]/SH!JF#H*NMMX,(.UU9VI"Q=&)2#N5
M@W:9&U.VH4SNQ&S;DTY.D'L&1J*NJ2-[4^_)R,;+<4/3:F5 !9["VXD!A#0%
M,X!@@F)SK5"G.@B]FY6-B^/YQ>H>PH *HUAMD094[$/UO<2 @BZ,3@@VZC0/
MV36O9@]=@I5\B>2 T]RZ@^X4!OGGH&C7[Y&]W_>EJ+X%N?0UANH@/PK5JNF@
M(-(8:MCQ1-&);H(Z14+V+4^51<P6ZSJE*7DA.=T4\OW?ELE.?E!TCLIU(H#L
M(M"W<GI?OM36FZ%W>XE:N!Y:,36 (O=49^E4 -E58$YR^6CU!:Q(29C<M5:)
MQ6F1E9G, :X.; %YW9"2$VX[>^F$PCN'4'B=4'@?(A2-EZ,#&%^IT]@ 4NH]
M,4&T-V@#R/?5'9US<!Q;$+:J#\ZYC&!;BOUA5_NT/9S_6A])*\]OX?48&IY/
MX/5T?_3>N=__$_ #LU56<I"3I1S*O8HDZ=C^<'U_(^BF/@Q^ID+0HKY<$YP2
M5@'D[TM*Q=M--4#[%\?H/U!+ P04    " "U,D)28:M<_I<%  "<&0  &0
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MKE]0OZ\8DT\W^C2\_4-F^A]02P,$%     @ M3)"4L['HL&D!0  01H  !D
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M&J">+QB3^XDVJ#Y6AG\ 4$L#!!0    ( +4R0E+RWU2+3P0  /@0   9
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M*#9\"4^E_87-SC;V'$C64O&L &L%&66[?_)6)*(""-HU@*  !'\!_*@&$!8
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M+$B*UYF:\>U7LDO("DQX)NT_V)9SH] #R5HJGN_ 6D%.67G$#[M"[ %@? *
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MM;"G*[W[(\),T/=3SM73P.POJOUD[S]02P,$%     @ M3)"4I"$'N0M P
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M=@,]7TAI'B?60/6]9/@/4$L#!!0    ( +4R0E+%#H=*90@  "<Z   9
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MZE_59<Y_5)_DAT6+-BL?:NFC_KP^G_JA[_/CX;,I@6TEA%1B8[45H-@$*-
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MN L,<< 0QS'4/<FXC:&0A;MMD&W$ ME2FW%@%<=9U2?#*I/]13LW>L:>1.-
M-.Z :-R&U2[/4)/MV !FW 7,.,",NX(9MREE;1@SV0X0(,8/![%-BF'%- ><
M\9XXXX SWA]G(_X&4@D@E7!!*@&D$HY(-1)O@9  "(GW0^@F*_M\U0G C^B)
M'V$<+CG C[#9HG:AWV##?;]%;B"0<$$@ 002K@@D&OHWJG8WW5!,"=Y22PG
MD'@_AKHD6:=O.P$H$CU1) !%PD%E)6P4[<(?-=D^Q@1621>LDL JZ:JJDC:K
M=C>,FFP'""R3AV59IV\\"523/:DF@6JR/]5&\@W$DL9I.'YRA8GZWW*F<S):
MY'FMWOH8J5=[)(%\4O54%_ D<3QU4]?O7D](0)'$3Z(.H&ZW+ ;"R;"?S@J
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M&)1K&EC7])F*!-USDEK\,RQU#5OVO.L8-CL-:1-11!*>03+S%>RP"U4+6^?
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MD5=9W$%+M(:E4M,8-1V]%3-5?=\?#.KVZI-'CFM&#KV!A;:!H6U@I^T)83T
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M&C>0[$@38N2!S@Q$Y"OCIC32+8_0M9%&W*4_!7\#G=+MIS#)J:VL (Q3MP$
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M%*5<-7593ASW>.)>-4:O_M<L.\B\>&C[%E,\9 6 3)RK,5QPHYO6])_HKU\
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M6P7'#&Q,S"H!L55PS$L;$_-+0.P7'//*QL1,$Q";!B]S!_]-]'4)L7+P,G>
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MT-NCWOZ=>L=TK4)\]CS6^/QW4IUN]X;GX^_+Q\G."W7'V<'OL<4O4$L#!!0
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M2P$"% ,4    " "U,D)2>2['0.T    K @  $0              @ &O
M9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " "U,D)2F5R<(Q &  "<)P
M$P              @ '+ 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0
M   ( +4R0E)_V3*S304  '(5   8              " @0P(  !X;"]W;W)K
M<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " "U,D)2,C9)PQ0&   @&
M&               @(&/#0  >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L!
M A0#%     @ M3)"4C/CM943!@  IA8  !@              ("!V1,  'AL
M+W=O<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0    ( +4R0E)?N94>_ (
M #X(   8              " @2(:  !X;"]W;W)K<VAE971S+W-H965T-"YX
M;6Q02P$"% ,4    " "U,D)2XFN@=2,+   520  &               @(%4
M'0  >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%     @ M3)"4M2)
M<GAX!P  Q1T  !@              ("!K2@  'AL+W=O<FMS:&5E=',O<VAE
M970V+GAM;%!+ 0(4 Q0    ( +4R0E)>7?R>]00  %(+   8
M  " @5LP  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4    " "U
M,D)2BK60AD,$  #-"0  &               @(&&-0  >&PO=V]R:W-H965T
M<R]S:&5E=#@N>&UL4$L! A0#%     @ M3)"4D+4"IF7"   +1<  !@
M         ("!_SD  'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0
M   ( +4R0E(O)BKI.PL  ,D<   9              " @<Q"  !X;"]W;W)K
M<VAE971S+W-H965T,3 N>&UL4$L! A0#%     @ M3)"4@^PC3WC!@  "!$
M !D              ("!/DX  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q0
M2P$"% ,4    " "U,D)25MO)R; $   -#   &0              @(%850
M>&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    ( +4R0E*Q@*]\
MZ ,  ,8)   9              " @3]:  !X;"]W;W)K<VAE971S+W-H965T
M,3,N>&UL4$L! A0#%     @ M3)"4CP5_;Z/!@  71$  !D
M ("!7EX  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"% ,4    " "U
M,D)2&)JEA\T"  "V!0  &0              @($D90  >&PO=V]R:W-H965T
M<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    ( +4R0E)W+0+(9 0  *0)   9
M          " @2AH  !X;"]W;W)K<VAE971S+W-H965T,38N>&UL4$L! A0#
M%     @ M3)"4E*^A'=.!   . H  !D              ("!PVP  'AL+W=O
M<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4    " "U,D)2B"RZR=$3   &
M0   &0              @(%(<0  >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM
M;%!+ 0(4 Q0    ( +4R0E(OSV)K% 0  ) (   9              " @5"%
M  !X;"]W;W)K<VAE971S+W-H965T,3DN>&UL4$L! A0#%     @ M3)"4O"H
MD(R/"0  <1@  !D              ("!FXD  'AL+W=O<FMS:&5E=',O<VAE
M970R,"YX;6Q02P$"% ,4    " "U,D)2NZS$(%L#   @!P  &0
M    @(%ADP  >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    (
M +4R0E*!'?!WS 0  *$+   9              " @?.6  !X;"]W;W)K<VAE
M971S+W-H965T,C(N>&UL4$L! A0#%     @ M3)"4OU0%$2& P  A@<  !D
M             ("!]IL  'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"
M% ,4    " "U,D)2*ASQRD(#  !1!P  &0              @(&SGP  >&PO
M=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    ( +4R0E(/#<ZMV0(
M +P%   9              " @2RC  !X;"]W;W)K<VAE971S+W-H965T,C4N
M>&UL4$L! A0#%     @ M3)"4MAD_%(J!P  >A8  !D              ("!
M/*8  'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q02P$"% ,4    " "U,D)2
MWHO:0E<'  !;$0  &0              @(&=K0  >&PO=V]R:W-H965T<R]S
M:&5E=#(W+GAM;%!+ 0(4 Q0    ( +4R0E)2NT<2: ,  !4'   9
M      " @2NU  !X;"]W;W)K<VAE971S+W-H965T,C@N>&UL4$L! A0#%
M  @ M3)"4J5&ZGDA!   WQ$  !D              ("!RK@  'AL+W=O<FMS
M:&5E=',O<VAE970R.2YX;6Q02P$"% ,4    " "U,D)2-<]^A-,#  "'#P
M&0              @($BO0  >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+
M 0(4 Q0    ( +4R0E+^;15F(@4  .X8   9              " @2S!  !X
M;"]W;W)K<VAE971S+W-H965T,S$N>&UL4$L! A0#%     @ M3)"4F&K7/Z7
M!0  G!D  !D              ("!A<8  'AL+W=O<FMS:&5E=',O<VAE970S
M,BYX;6Q02P$"% ,4    " "U,D)2SL>BP:0%  !!&@  &0
M@(%3S   >&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    ( +4R
M0E((9EU"XP(  +@(   9              " @2[2  !X;"]W;W)K<VAE971S
M+W-H965T,S0N>&UL4$L! A0#%     @ M3)"4O+?5(M/!   ^!   !D
M         ("!2-4  'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6Q02P$"% ,4
M    " "U,D)2N]/:&VL#  !R"P  &0              @('.V0  >&PO=V]R
M:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4 Q0    ( +4R0E*7ROC:A (  %$&
M   9              " @7#=  !X;"]W;W)K<VAE971S+W-H965T,S<N>&UL
M4$L! A0#%     @ M3)"4BEBDP7U @  9@D  !D              ("!*^
M 'AL+W=O<FMS:&5E=',O<VAE970S."YX;6Q02P$"% ,4    " "U,D)2ZSA@
MU; #  !;#@  &0              @(%7XP  >&PO=V]R:W-H965T<R]S:&5E
M=#,Y+GAM;%!+ 0(4 Q0    ( +4R0E*0A![D+0,  (X)   9
M  " @3[G  !X;"]W;W)K<VAE971S+W-H965T-# N>&UL4$L! A0#%     @
MM3)"4@,I;DD9!   .Q$  !D              ("!HNH  'AL+W=O<FMS:&5E
M=',O<VAE970T,2YX;6Q02P$"% ,4    " "U,D)2Q0Z'2F4(   G.@  &0
M            @('R[@  >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4
M Q0    ( +4R0E(!E_E>5@<  &4E   9              " @8[W  !X;"]W
M;W)K<VAE971S+W-H965T-#,N>&UL4$L! A0#%     @ M3)"4N+G"O?L"
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M96QS+RYR96QS4$L! A0#%     @ M3)"4CS1!\07!    AX   \
M     ( !S! ! 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( +4R0E*X-L3<
MJ0$  "X;   :              "  1 5 0!X;"]?<F5L<R]W;W)K8F]O:RYX
M;6PN<F5L<U!+ 0(4 Q0    ( +4R0E)3V2LIL@$  %,;   3
M  "  ?$6 0!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     U #4 :@X  -08
$ 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>274</ContextCount>
  <ElementCount>315</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>69</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>6</UnitCount>
  <MyReports>
    <Report instance="hae-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - DOCUMENT AND ENTITY INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION</Role>
      <ShortName>DOCUMENT AND ENTITY INFORMATION</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="hae-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOME</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="hae-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="hae-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParentheticals</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="hae-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="hae-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="hae-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - BASIS OF PRESENTATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/BASISOFPRESENTATION</Role>
      <ShortName>BASIS OF PRESENTATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="hae-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2102102 - Disclosure - RECENT ACCOUNTING PRONOUNCEMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/RECENTACCOUNTINGPRONOUNCEMENTS</Role>
      <ShortName>RECENT ACCOUNTING PRONOUNCEMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="hae-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2103103 - Disclosure - RESTRUCTURING</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/RESTRUCTURING</Role>
      <ShortName>RESTRUCTURING</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="hae-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2108104 - Disclosure - ACQUISITION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/ACQUISITION</Role>
      <ShortName>ACQUISITION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="hae-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2111105 - Disclosure - DIVESTITURE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/DIVESTITURE</Role>
      <ShortName>DIVESTITURE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="hae-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2113106 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/INCOMETAXES</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="hae-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2115107 - Disclosure - EARNINGS PER SHARE ("EPS")</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/EARNINGSPERSHAREEPS</Role>
      <ShortName>EARNINGS PER SHARE ("EPS")</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="hae-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2118108 - Disclosure - REVENUE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/REVENUE</Role>
      <ShortName>REVENUE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="hae-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2120109 - Disclosure - INVENTORIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/INVENTORIES</Role>
      <ShortName>INVENTORIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="hae-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2123110 - Disclosure - LEASES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/LEASES</Role>
      <ShortName>LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="hae-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2125111 - Disclosure - NOTES??PAYABLE AND LONG-TERM DEBT</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBT</Role>
      <ShortName>NOTES??PAYABLE AND LONG-TERM DEBT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="hae-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2127112 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASURES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURES</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASURES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="hae-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2133113 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/COMMITMENTSANDCONTINGENCIES</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="hae-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2134114 - Disclosure - SEGMENT AND ENTERPRISE-WIDE INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATION</Role>
      <ShortName>SEGMENT AND ENTERPRISE-WIDE INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="hae-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2137115 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS</Role>
      <ShortName>ACCUMULATED OTHER COMPREHENSIVE LOSS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="hae-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2304301 - Disclosure - RESTRUCTURING (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/RESTRUCTURINGTables</Role>
      <ShortName>RESTRUCTURING (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/RESTRUCTURING</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="hae-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2309302 - Disclosure - ACQUISITION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/ACQUISITIONTables</Role>
      <ShortName>ACQUISITION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/ACQUISITION</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="hae-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2316303 - Disclosure - EARNINGS PER SHARE ("EPS") (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/EARNINGSPERSHAREEPSTables</Role>
      <ShortName>EARNINGS PER SHARE ("EPS") (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/EARNINGSPERSHAREEPS</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="hae-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2321304 - Disclosure - INVENTORIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/INVENTORIESTables</Role>
      <ShortName>INVENTORIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/INVENTORIES</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="hae-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2328305 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASURES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESTables</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASURES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURES</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="hae-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2335306 - Disclosure - SEGMENT AND ENTERPRISE-WIDE INFORMATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONTables</Role>
      <ShortName>SEGMENT AND ENTERPRISE-WIDE INFORMATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATION</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="hae-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2338307 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables</Role>
      <ShortName>ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="hae-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2405401 - Disclosure - RESTRUCTURING (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/RESTRUCTURINGNarrativeDetails</Role>
      <ShortName>RESTRUCTURING (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/RESTRUCTURINGTables</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="hae-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2406402 - Disclosure - RESTRUCTURING (Schedule of Restructuring Reserve by Type of Cost) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails</Role>
      <ShortName>RESTRUCTURING (Schedule of Restructuring Reserve by Type of Cost) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/RESTRUCTURINGTables</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="hae-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2407403 - Disclosure - RESTRUCTURING (Schedule of Restructuring and Related Costs) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails</Role>
      <ShortName>RESTRUCTURING (Schedule of Restructuring and Related Costs) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/RESTRUCTURINGTables</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="hae-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2410404 - Disclosure - ACQUISITION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/ACQUISITIONDetails</Role>
      <ShortName>ACQUISITION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/ACQUISITIONTables</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="hae-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2412405 - Disclosure - DIVESTITURE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/DIVESTITUREDetails</Role>
      <ShortName>DIVESTITURE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/DIVESTITURE</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="hae-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2414406 - Disclosure - INCOME TAXES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/INCOMETAXESDetails</Role>
      <ShortName>INCOME TAXES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/INCOMETAXES</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="hae-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2417407 - Disclosure - EARNINGS PER SHARE ("EPS") (Schedule of Earnings Per Share Reconciliation) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/EARNINGSPERSHAREEPSScheduleofEarningsPerShareReconciliationDetails</Role>
      <ShortName>EARNINGS PER SHARE ("EPS") (Schedule of Earnings Per Share Reconciliation) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/EARNINGSPERSHAREEPSTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="hae-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2419408 - Disclosure - REVENUE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/REVENUEDetails</Role>
      <ShortName>REVENUE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/REVENUE</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="hae-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2422409 - Disclosure - INVENTORIES (Schedule of Inventories) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/INVENTORIESScheduleofInventoriesDetails</Role>
      <ShortName>INVENTORIES (Schedule of Inventories) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/INVENTORIESTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="hae-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2424410 - Disclosure - LEASES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/LEASESDetails</Role>
      <ShortName>LEASES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/LEASES</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="hae-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2426411 - Disclosure - NOTES??PAYABLE AND LONG-TERM DEBT (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTDetails</Role>
      <ShortName>NOTES??PAYABLE AND LONG-TERM DEBT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBT</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="hae-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2429412 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Allowance for credit losses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAllowanceforcreditlossesDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Allowance for credit losses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="hae-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2430413 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASURES (Schedule of Effect of Derivative Instruments Designated as Cash Flow Hedges and Those Not Designated as Hedging Instruments) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASURES (Schedule of Effect of Derivative Instruments Designated as Cash Flow Hedges and Those Not Designated as Hedging Instruments) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="hae-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2431414 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASURES (Schedules of Derivatives) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESSchedulesofDerivativesDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASURES (Schedules of Derivatives) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="hae-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2432415 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASURES (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASURES (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="hae-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2436416 - Disclosure - SEGMENT AND ENTERPRISE-WIDE INFORMATION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails</Role>
      <ShortName>SEGMENT AND ENTERPRISE-WIDE INFORMATION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="hae-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2439417 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSDetails</Role>
      <ShortName>ACCUMULATED OTHER COMPREHENSIVE LOSS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="hae-20201226.htm">hae-20201226.htm</File>
    <File>ex101-firstamendmenttoclin.htm</File>
    <File>ex102-12thamendmenttoleets.htm</File>
    <File>ex103-13thamendmenttoleets.htm</File>
    <File>ex104-agreementandplanofme.htm</File>
    <File>hae-20201226.xsd</File>
    <File>hae-20201226_cal.xml</File>
    <File>hae-20201226_def.xml</File>
    <File>hae-20201226_lab.xml</File>
    <File>hae-20201226_pre.xml</File>
    <File>haeq3dec2021ex311.htm</File>
    <File>haeq3dec2021ex312.htm</File>
    <File>haeq3dec2021ex321.htm</File>
    <File>haeq3dec2021ex322.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2017-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>67
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "hae-20201226.htm": {
   "axisCustom": 1,
   "axisStandard": 24,
   "contextCount": 274,
   "dts": {
    "calculationLink": {
     "local": [
      "hae-20201226_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "hae-20201226_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml",
      "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "hae-20201226.htm"
     ]
    },
    "labelLink": {
     "local": [
      "hae-20201226_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "hae-20201226_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-ref-2019-01-31.xml",
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "hae-20201226.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd",
      "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-parts-codification-2019-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 432,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2019-01-31": 15,
    "http://xbrl.sec.gov/dei/2019-01-31": 5,
    "total": 20
   },
   "keyCustom": 20,
   "keyStandard": 295,
   "memberCustom": 23,
   "memberStandard": 44,
   "nsprefix": "hae",
   "nsuri": "http://www.haemonetics.com/20201226",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - DOCUMENT AND ENTITY INFORMATION",
     "role": "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION",
     "shortName": "DOCUMENT AND ENTITY INFORMATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2108104 - Disclosure - ACQUISITION",
     "role": "http://www.haemonetics.com/role/ACQUISITION",
     "shortName": "ACQUISITION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2111105 - Disclosure - DIVESTITURE",
     "role": "http://www.haemonetics.com/role/DIVESTITURE",
     "shortName": "DIVESTITURE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2113106 - Disclosure - INCOME TAXES",
     "role": "http://www.haemonetics.com/role/INCOMETAXES",
     "shortName": "INCOME TAXES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2115107 - Disclosure - EARNINGS PER SHARE (\"EPS\")",
     "role": "http://www.haemonetics.com/role/EARNINGSPERSHAREEPS",
     "shortName": "EARNINGS PER SHARE (\"EPS\")",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2118108 - Disclosure - REVENUE",
     "role": "http://www.haemonetics.com/role/REVENUE",
     "shortName": "REVENUE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2120109 - Disclosure - INVENTORIES",
     "role": "http://www.haemonetics.com/role/INVENTORIES",
     "shortName": "INVENTORIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2123110 - Disclosure - LEASES",
     "role": "http://www.haemonetics.com/role/LEASES",
     "shortName": "LEASES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2125111 - Disclosure - NOTES\u00a0PAYABLE AND LONG-TERM DEBT",
     "role": "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBT",
     "shortName": "NOTES\u00a0PAYABLE AND LONG-TERM DEBT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativesAndFairValueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2127112 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASURES",
     "role": "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURES",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASURES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativesAndFairValueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2133113 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "role": "http://www.haemonetics.com/role/COMMITMENTSANDCONTINGENCIES",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME",
     "role": "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOME",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2134114 - Disclosure - SEGMENT AND ENTERPRISE-WIDE INFORMATION",
     "role": "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATION",
     "shortName": "SEGMENT AND ENTERPRISE-WIDE INFORMATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2137115 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS",
     "role": "http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS",
     "shortName": "ACCUMULATED OTHER COMPREHENSIVE LOSS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2304301 - Disclosure - RESTRUCTURING (Tables)",
     "role": "http://www.haemonetics.com/role/RESTRUCTURINGTables",
     "shortName": "RESTRUCTURING (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2309302 - Disclosure - ACQUISITION (Tables)",
     "role": "http://www.haemonetics.com/role/ACQUISITIONTables",
     "shortName": "ACQUISITION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2316303 - Disclosure - EARNINGS PER SHARE (\"EPS\") (Tables)",
     "role": "http://www.haemonetics.com/role/EARNINGSPERSHAREEPSTables",
     "shortName": "EARNINGS PER SHARE (\"EPS\") (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2321304 - Disclosure - INVENTORIES (Tables)",
     "role": "http://www.haemonetics.com/role/INVENTORIESTables",
     "shortName": "INVENTORIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2328305 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASURES (Tables)",
     "role": "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESTables",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASURES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2335306 - Disclosure - SEGMENT AND ENTERPRISE-WIDE INFORMATION (Tables)",
     "role": "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONTables",
     "shortName": "SEGMENT AND ENTERPRISE-WIDE INFORMATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2338307 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)",
     "role": "http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables",
     "shortName": "ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "hae:RestructuringandRestructuringRelatedCosts",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405401 - Disclosure - RESTRUCTURING (Narrative) (Details)",
     "role": "http://www.haemonetics.com/role/RESTRUCTURINGNarrativeDetails",
     "shortName": "RESTRUCTURING (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "ibd11a684655c47febfdbc8b572773803_D20200927-20201226",
      "decimals": "-5",
      "lang": "en-US",
      "name": "hae:RestructuringandRestructuringRelatedCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS",
     "role": "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "i6b515458914540b58a5b339208b5c6aa_I20200328",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406402 - Disclosure - RESTRUCTURING (Schedule of Restructuring Reserve by Type of Cost) (Details)",
     "role": "http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails",
     "shortName": "RESTRUCTURING (Schedule of Restructuring Reserve by Type of Cost) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "i0b7ebb1b437c46a0a817c9861b363798_D20200329-20200926",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:PaymentsForRestructuring",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407403 - Disclosure - RESTRUCTURING (Schedule of Restructuring and Related Costs) (Details)",
     "role": "http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails",
     "shortName": "RESTRUCTURING (Schedule of Restructuring and Related Costs) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "i6cfe5b5730064f93b6ecea7bc136d73f_D20200927-20201226",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410404 - Disclosure - ACQUISITION (Details)",
     "role": "http://www.haemonetics.com/role/ACQUISITIONDetails",
     "shortName": "ACQUISITION (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromDivestitureOfBusinesses",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412405 - Disclosure - DIVESTITURE (Details)",
     "role": "http://www.haemonetics.com/role/DIVESTITUREDetails",
     "shortName": "DIVESTITURE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "ied6e581caf26486bbb484a11ddea3e51_D20200629-20200629",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromDivestitureOfBusinesses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414406 - Disclosure - INCOME TAXES (Details)",
     "role": "http://www.haemonetics.com/role/INCOMETAXESDetails",
     "shortName": "INCOME TAXES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226",
      "decimals": "3",
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417407 - Disclosure - EARNINGS PER SHARE (\"EPS\") (Schedule of Earnings Per Share Reconciliation) (Details)",
     "role": "http://www.haemonetics.com/role/EARNINGSPERSHAREEPSScheduleofEarningsPerShareReconciliationDetails",
     "shortName": "EARNINGS PER SHARE (\"EPS\") (Schedule of Earnings Per Share Reconciliation) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "i2fddb9c91fae4d52a80014124cbc196a_D20200927-20201226",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419408 - Disclosure - REVENUE (Details)",
     "role": "http://www.haemonetics.com/role/REVENUEDetails",
     "shortName": "REVENUE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "i6b515458914540b58a5b339208b5c6aa_I20200328",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2422409 - Disclosure - INVENTORIES (Schedule of Inventories) (Details)",
     "role": "http://www.haemonetics.com/role/INVENTORIESScheduleofInventoriesDetails",
     "shortName": "INVENTORIES (Schedule of Inventories) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "ie63b4144671b45fbbe67bb51fcf3fcbf_I20201226",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424410 - Disclosure - LEASES (Details)",
     "role": "http://www.haemonetics.com/role/LEASESDetails",
     "shortName": "LEASES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "ib56a8928767949d4bf60e3aee31e1600_I20201226",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "i075eaab3aa4549bb8d0f597beca1bd0f_I20201226",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426411 - Disclosure - NOTES\u00a0PAYABLE AND LONG-TERM DEBT (Details)",
     "role": "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTDetails",
     "shortName": "NOTES\u00a0PAYABLE AND LONG-TERM DEBT (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "i075eaab3aa4549bb8d0f597beca1bd0f_I20201226",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": null,
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parentheticals)",
     "role": "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParentheticals",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parentheticals)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "i32fa3388584544f9a03ffc1d8057d360_I20200926",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429412 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Allowance for credit losses (Details)",
     "role": "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAllowanceforcreditlossesDetails",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS - Allowance for credit losses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "i32fa3388584544f9a03ffc1d8057d360_I20200926",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "ice57ced2f272477c986a2ba3d175843c_D20200329-20201226",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430413 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASURES (Schedule of Effect of Derivative Instruments Designated as Cash Flow Hedges and Those Not Designated as Hedging Instruments) (Details)",
     "role": "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASURES (Schedule of Effect of Derivative Instruments Designated as Cash Flow Hedges and Those Not Designated as Hedging Instruments) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "ice57ced2f272477c986a2ba3d175843c_D20200329-20201226",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "i26592b211dab480aa8decca198bc3e17_I20201226",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431414 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASURES (Schedules of Derivatives) (Details)",
     "role": "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESSchedulesofDerivativesDetails",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASURES (Schedules of Derivatives) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "i26592b211dab480aa8decca198bc3e17_I20201226",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "i7337ad8ffd7f4d8cb8646e0073515fc1_I20200401",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432415 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASURES (Narrative) (Details)",
     "role": "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASURES (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:DerivativesAndFairValueTextBlock",
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "i466af82608da4d9bb01882ff1ee71a02_D20200927-20201226",
      "decimals": "3",
      "lang": "en-US",
      "name": "hae:PercentageOfNetSalesGeneratedOutsideOfUs",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2436416 - Disclosure - SEGMENT AND ENTERPRISE-WIDE INFORMATION (Details)",
     "role": "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails",
     "shortName": "SEGMENT AND ENTERPRISE-WIDE INFORMATION (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "i6b515458914540b58a5b339208b5c6aa_I20200328",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439417 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE LOSS (Details)",
     "role": "http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSDetails",
     "shortName": "ACCUMULATED OTHER COMPREHENSIVE LOSS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "i13923cc91bcd4918b0cd47b138b0c826_I20190330",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesIssued",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "role": "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "i79fce91b6c7e4ee895ae77d545ae7cac_D20190331-20190629",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - BASIS OF PRESENTATION",
     "role": "http://www.haemonetics.com/role/BASISOFPRESENTATION",
     "shortName": "BASIS OF PRESENTATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2102102 - Disclosure - RECENT ACCOUNTING PRONOUNCEMENTS",
     "role": "http://www.haemonetics.com/role/RECENTACCOUNTINGPRONOUNCEMENTS",
     "shortName": "RECENT ACCOUNTING PRONOUNCEMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2103103 - Disclosure - RESTRUCTURING",
     "role": "http://www.haemonetics.com/role/RESTRUCTURING",
     "shortName": "RESTRUCTURING",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "hae-20201226.htm",
      "contextRef": "if5927f1db89749ba99ed5b14bb232b63_D20200329-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 69,
   "tag": {
    "country_JP": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "JAPAN",
        "terseLabel": "Japan"
       }
      }
     },
     "localname": "JP",
     "nsuri": "http://xbrl.sec.gov/country/2017-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "verboseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2017-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "hae_A2018ProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2018 Program [Member]",
        "label": "2018 Program [Member]",
        "terseLabel": "2018 Program"
       }
      }
     },
     "localname": "A2018ProgramMember",
     "nsuri": "http://www.haemonetics.com/20201226",
     "presentation": [
      "http://www.haemonetics.com/role/RESTRUCTURINGNarrativeDetails",
      "http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_A2018ProgramandPriorProgramsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2018 Program and Prior Programs [Member]",
        "label": "2018 Program and Prior Programs [Member]",
        "terseLabel": "2018 Program and Prior Programs"
       }
      }
     },
     "localname": "A2018ProgramandPriorProgramsMember",
     "nsuri": "http://www.haemonetics.com/20201226",
     "presentation": [
      "http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_A2020ProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2020 Program [Member]",
        "label": "2020 Program [Member]",
        "terseLabel": "2020 Program"
       }
      }
     },
     "localname": "A2020ProgramMember",
     "nsuri": "http://www.haemonetics.com/20201226",
     "presentation": [
      "http://www.haemonetics.com/role/RESTRUCTURINGNarrativeDetails",
      "http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_AssetAcquisitionAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Acquisition",
        "label": "Asset Acquisition [Axis]",
        "terseLabel": "Asset Acquisition [Axis]"
       }
      }
     },
     "localname": "AssetAcquisitionAxis",
     "nsuri": "http://www.haemonetics.com/20201226",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "hae_AssetAcquisitionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Acquisition",
        "label": "Asset Acquisition [Domain]",
        "terseLabel": "Asset Acquisition [Domain]"
       }
      }
     },
     "localname": "AssetAcquisitionDomain",
     "nsuri": "http://www.haemonetics.com/20201226",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_AssetAcquisitionUpfrontPayment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Acquisition, Upfront Payment",
        "label": "Asset Acquisition, Upfront Payment",
        "terseLabel": "Upfront payment for intellectual property"
       }
      }
     },
     "localname": "AssetAcquisitionUpfrontPayment",
     "nsuri": "http://www.haemonetics.com/20201226",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hae_AssetImpairmentAndOtherRelatedCharges": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Impairment and Other Related Charges",
        "label": "Asset Impairment and Other Related Charges",
        "negatedTerseLabel": "Impairment of assets and related costs"
       }
      }
     },
     "localname": "AssetImpairmentAndOtherRelatedCharges",
     "nsuri": "http://www.haemonetics.com/20201226",
     "presentation": [
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hae_BloodCenterMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Blood Center [Member]",
        "label": "Blood Center [Member]",
        "terseLabel": "Blood Center"
       }
      }
     },
     "localname": "BloodCenterMember",
     "nsuri": "http://www.haemonetics.com/20201226",
     "presentation": [
      "http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails",
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_BloodCenterProductsandServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Blood Center Products and Services [Member]",
        "label": "Blood Center Products and Services [Member]",
        "terseLabel": "Blood Center products and services"
       }
      }
     },
     "localname": "BloodCenterProductsandServicesMember",
     "nsuri": "http://www.haemonetics.com/20201226",
     "presentation": [
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_CardivaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cardiva",
        "label": "Cardiva [Member]",
        "terseLabel": "Cardiva"
       }
      }
     },
     "localname": "CardivaMember",
     "nsuri": "http://www.haemonetics.com/20201226",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_ContingentConsiderationAcquisitionDateFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Consideration, Acquisition Date Fair Value",
        "label": "Contingent Consideration, Acquisition Date Fair Value",
        "terseLabel": "Contingent Consideration, Acquisition Date Fair Value"
       }
      }
     },
     "localname": "ContingentConsiderationAcquisitionDateFairValue",
     "nsuri": "http://www.haemonetics.com/20201226",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hae_ContingentConsiderationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Consideration",
        "label": "Contingent Consideration [Member]",
        "terseLabel": "Contingent Consideration"
       }
      }
     },
     "localname": "ContingentConsiderationMember",
     "nsuri": "http://www.haemonetics.com/20201226",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESSchedulesofDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_CorporateOperatingExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate Operating Expenses",
        "label": "Corporate Operating Expenses",
        "negatedLabel": "Corporate expenses"
       }
      }
     },
     "localname": "CorporateOperatingExpenses",
     "nsuri": "http://www.haemonetics.com/20201226",
     "presentation": [
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hae_DerivativePercentofDebtExposed": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative, Percent of Debt Exposed",
        "label": "Derivative, Percent of Debt Exposed",
        "terseLabel": "Debt exposed to interest rate risk"
       }
      }
     },
     "localname": "DerivativePercentofDebtExposed",
     "nsuri": "http://www.haemonetics.com/20201226",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "hae_DisposalGroupIncludingDiscontinuedOperationConsiderationToBeReceived": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Consideration To Be Received",
        "label": "Disposal Group, Including Discontinued Operation, Consideration To Be Received",
        "terseLabel": "Amount received one year after closing date"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsiderationToBeReceived",
     "nsuri": "http://www.haemonetics.com/20201226",
     "presentation": [
      "http://www.haemonetics.com/role/DIVESTITUREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hae_DisposalGroupNotDiscontinuedOperationsExpectedCostToSell": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Not Discontinued Operations, Expected Cost To Sell",
        "label": "Disposal Group, Not Discontinued Operations, Expected Cost To Sell",
        "terseLabel": "Expected cost to sell"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationsExpectedCostToSell",
     "nsuri": "http://www.haemonetics.com/20201226",
     "presentation": [
      "http://www.haemonetics.com/role/DIVESTITUREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hae_DisposalGroupNotDiscontinuedOperationsIncrementalLossOnClosingAdjustments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Not Discontinued Operations, Incremental Loss On Closing Adjustments",
        "label": "Disposal Group, Not Discontinued Operations, Incremental Loss On Closing Adjustments",
        "terseLabel": "Incremental loss"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationsIncrementalLossOnClosingAdjustments",
     "nsuri": "http://www.haemonetics.com/20201226",
     "presentation": [
      "http://www.haemonetics.com/role/DIVESTITUREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hae_EffectofExchangeRateonRevenues": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effect of Exchange Rate on Revenues",
        "label": "Effect of Exchange Rate on Revenues",
        "terseLabel": "Effect of exchange rates"
       }
      }
     },
     "localname": "EffectofExchangeRateonRevenues",
     "nsuri": "http://www.haemonetics.com/20201226",
     "presentation": [
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hae_EffectofExchangeRatesonOperatingIncome": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effect of Exchange Rates on Operating Income",
        "label": "Effect of Exchange Rates on Operating Income",
        "terseLabel": "Effect of exchange rates"
       }
      }
     },
     "localname": "EffectofExchangeRatesonOperatingIncome",
     "nsuri": "http://www.haemonetics.com/20201226",
     "presentation": [
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hae_EnicorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Enicor",
        "label": "Enicor [Member]",
        "terseLabel": "Enicor"
       }
      }
     },
     "localname": "EnicorMember",
     "nsuri": "http://www.haemonetics.com/20201226",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_EuropeanMedicalDeviceRegulationCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "European Medical Device Regulation Costs",
        "label": "European Medical Device Regulation Costs",
        "negatedTerseLabel": "European Medical Device Regulation costs and other"
       }
      }
     },
     "localname": "EuropeanMedicalDeviceRegulationCosts",
     "nsuri": "http://www.haemonetics.com/20201226",
     "presentation": [
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hae_FajardoPuertoRicoManufacturingOperationsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fajardo, Puerto Rico Manufacturing Operations",
        "label": "Fajardo, Puerto Rico Manufacturing Operations [Member]",
        "terseLabel": "Fajardo, Puerto Rico Manufacturing Operations [Member]"
       }
      }
     },
     "localname": "FajardoPuertoRicoManufacturingOperationsMember",
     "nsuri": "http://www.haemonetics.com/20201226",
     "presentation": [
      "http://www.haemonetics.com/role/DIVESTITUREDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_GainLossOnDivestitureAndSaleOfAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOME": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (Loss) on Divestiture and Sale of Assets",
        "label": "Gain (Loss) on Divestiture and Sale of Assets",
        "negatedTerseLabel": "Gains on divestitures and sale of assets"
       }
      }
     },
     "localname": "GainLossOnDivestitureAndSaleOfAssets",
     "nsuri": "http://www.haemonetics.com/20201226",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hae_HASIntellectualPropertyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "HAS Intellectual Property",
        "label": "HAS Intellectual Property [Member]",
        "terseLabel": "HAS Intellectual Property"
       }
      }
     },
     "localname": "HASIntellectualPropertyMember",
     "nsuri": "http://www.haemonetics.com/20201226",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_HospitalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hospital [Member]",
        "label": "Hospital [Member]",
        "terseLabel": "Hospital"
       }
      }
     },
     "localname": "HospitalMember",
     "nsuri": "http://www.haemonetics.com/20201226",
     "presentation": [
      "http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails",
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_HospitalProductsandServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hospital Products and Services [Member]",
        "label": "Hospital Products and Services [Member]",
        "terseLabel": "Hospital products and services"
       }
      }
     },
     "localname": "HospitalProductsandServicesMember",
     "nsuri": "http://www.haemonetics.com/20201226",
     "presentation": [
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_InlogHoldingsFranceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inlog Holdings France",
        "label": "Inlog Holdings France [Member]",
        "terseLabel": "Inlog Holdings France [Member]"
       }
      }
     },
     "localname": "InlogHoldingsFranceMember",
     "nsuri": "http://www.haemonetics.com/20201226",
     "presentation": [
      "http://www.haemonetics.com/role/DIVESTITUREDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_ManufacturingSpaceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Manufacturing Space",
        "label": "Manufacturing Space [Member]",
        "terseLabel": "Manufacturing Space [Member]"
       }
      }
     },
     "localname": "ManufacturingSpaceMember",
     "nsuri": "http://www.haemonetics.com/20201226",
     "presentation": [
      "http://www.haemonetics.com/role/LEASESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_ManufacturingSpaceSecondRenewalTermMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Manufacturing Space, Second Renewal Term",
        "label": "Manufacturing Space, Second Renewal Term [Member]",
        "terseLabel": "Manufacturing Space, Second Renewal Term [Member]"
       }
      }
     },
     "localname": "ManufacturingSpaceSecondRenewalTermMember",
     "nsuri": "http://www.haemonetics.com/20201226",
     "presentation": [
      "http://www.haemonetics.com/role/LEASESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_NetRevenuesBeforeForeignExchangeImpact": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Revenues, Before Foreign Exchange Impact",
        "label": "Net Revenues, Before Foreign Exchange Impact",
        "terseLabel": "Net revenues before foreign exchange impact"
       }
      }
     },
     "localname": "NetRevenuesBeforeForeignExchangeImpact",
     "nsuri": "http://www.haemonetics.com/20201226",
     "presentation": [
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hae_NetRevenuesCostOfGoodsSoldAndSellingGeneralAndAdministrativeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Revenues Cost Of Goods Sold And Selling General And Administrative Expense",
        "label": "Net Revenues Cost Of Goods Sold And Selling General And Administrative Expense [Member]",
        "terseLabel": "Net revenues, COGS and SG&amp;A"
       }
      }
     },
     "localname": "NetRevenuesCostOfGoodsSoldAndSellingGeneralAndAdministrativeExpenseMember",
     "nsuri": "http://www.haemonetics.com/20201226",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_NonCashItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-Cash Items [Abstract]",
        "label": "Non-Cash Items [Abstract]",
        "terseLabel": "Non-cash items:"
       }
      }
     },
     "localname": "NonCashItemsAbstract",
     "nsuri": "http://www.haemonetics.com/20201226",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "hae_OperatingExpensesTransactionCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Expenses, Transaction Costs",
        "label": "Operating Expenses, Transaction Costs",
        "negatedTerseLabel": "Transaction costs"
       }
      }
     },
     "localname": "OperatingExpensesTransactionCosts",
     "nsuri": "http://www.haemonetics.com/20201226",
     "presentation": [
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hae_OtherCountryorRegionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Country or Region [Member]",
        "label": "Other Country or Region [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherCountryorRegionMember",
     "nsuri": "http://www.haemonetics.com/20201226",
     "presentation": [
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_OtherIncomeExpenseNetMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Income (Expense), Net [Member]",
        "label": "Other Income (Expense), Net [Member]",
        "terseLabel": "Interest and other expense, net"
       }
      }
     },
     "localname": "OtherIncomeExpenseNetMember",
     "nsuri": "http://www.haemonetics.com/20201226",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_PercentageOfNetSalesGeneratedOutsideOfUs": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage Of Net Sales Generated Outside Of The US",
        "label": "Percentage Of Net Sales Generated Outside Of The US",
        "terseLabel": "Percentage of sales generated outside the US"
       }
      }
     },
     "localname": "PercentageOfNetSalesGeneratedOutsideOfUs",
     "nsuri": "http://www.haemonetics.com/20201226",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "hae_PlasmaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plasma [Member]",
        "label": "Plasma [Member]",
        "terseLabel": "Plasma"
       }
      }
     },
     "localname": "PlasmaMember",
     "nsuri": "http://www.haemonetics.com/20201226",
     "presentation": [
      "http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails",
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_PlasmaProductsandServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plasma Products and Services [Member]",
        "label": "Plasma Products and Services [Member]",
        "terseLabel": "Plasma products and services"
       }
      }
     },
     "localname": "PlasmaProductsandServicesMember",
     "nsuri": "http://www.haemonetics.com/20201226",
     "presentation": [
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_RegulatoryBasedPaymentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regulatory Based Payments",
        "label": "Regulatory Based Payments [Member]",
        "terseLabel": "Regulatory Based Payments"
       }
      }
     },
     "localname": "RegulatoryBasedPaymentsMember",
     "nsuri": "http://www.haemonetics.com/20201226",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESSchedulesofDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_RestructuringChargesPayableInNextTwelveMonths": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring Charges Payable In Next Twelve Months",
        "label": "Restructuring Charges Payable In Next Twelve Months",
        "terseLabel": "Restructuring liability payable in next twelve months"
       }
      }
     },
     "localname": "RestructuringChargesPayableInNextTwelveMonths",
     "nsuri": "http://www.haemonetics.com/20201226",
     "presentation": [
      "http://www.haemonetics.com/role/RESTRUCTURINGNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hae_RestructuringRelatedCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails": {
       "order": 1.0,
       "parentTag": "hae_RestructuringandRestructuringRelatedCosts",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring Related Costs",
        "label": "Restructuring Related Costs",
        "terseLabel": "Turnaround costs"
       }
      }
     },
     "localname": "RestructuringRelatedCosts",
     "nsuri": "http://www.haemonetics.com/20201226",
     "presentation": [
      "http://www.haemonetics.com/role/RESTRUCTURINGNarrativeDetails",
      "http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hae_RestructuringandRestructuringRelatedCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring and Restructuring Related Costs",
        "label": "Restructuring and Restructuring Related Costs",
        "terseLabel": "Restructuring and turnaround costs",
        "totalLabel": "Total restructuring and turnaround costs"
       }
      }
     },
     "localname": "RestructuringandRestructuringRelatedCosts",
     "nsuri": "http://www.haemonetics.com/20201226",
     "presentation": [
      "http://www.haemonetics.com/role/RESTRUCTURINGNarrativeDetails",
      "http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hae_RestructuringandTurnaroundCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring and Turnaround Costs",
        "label": "Restructuring and Turnaround Costs",
        "negatedTerseLabel": "Restructuring and turnaround costs"
       }
      }
     },
     "localname": "RestructuringandTurnaroundCosts",
     "nsuri": "http://www.haemonetics.com/20201226",
     "presentation": [
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hae_RevenueBasedPaymentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue Based Payments",
        "label": "Revenue Based Payments [Member]",
        "terseLabel": "Revenue Based Payments"
       }
      }
     },
     "localname": "RevenueBasedPaymentsMember",
     "nsuri": "http://www.haemonetics.com/20201226",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESSchedulesofDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hae_TransfersFromInventoryToFixedAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transfers from inventory to fixed assets.",
        "label": "Transfers from Inventory to Fixed Assets",
        "terseLabel": "Transfers from inventory to fixed assets for placement of Haemonetics equipment"
       }
      }
     },
     "localname": "TransfersFromInventoryToFixedAssets",
     "nsuri": "http://www.haemonetics.com/20201226",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hae_USBloodDonorManagementSoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "U.S. Blood Donor Management Software",
        "label": "U.S. Blood Donor Management Software [Member]",
        "terseLabel": "U.S. Blood Donor Management Software [Member]"
       }
      }
     },
     "localname": "USBloodDonorManagementSoftwareMember",
     "nsuri": "http://www.haemonetics.com/20201226",
     "presentation": [
      "http://www.haemonetics.com/role/DIVESTITUREDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_AsiaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asia [Member]",
        "terseLabel": "Asia"
       }
      }
     },
     "localname": "AsiaMember",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r126",
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails",
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails",
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Europe [Member]",
        "terseLabel": "Europe"
       }
      }
     },
     "localname": "EuropeMember",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTDetails",
      "http://www.haemonetics.com/role/RESTRUCTURINGNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTDetails",
      "http://www.haemonetics.com/role/RESTRUCTURINGNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r135",
      "r210",
      "r213",
      "r336",
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTDetails",
      "http://www.haemonetics.com/role/RESTRUCTURINGNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTDetails",
      "http://www.haemonetics.com/role/RESTRUCTURINGNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r136",
      "r210",
      "r214",
      "r338",
      "r339",
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]",
        "terseLabel": "AOCI Attributable to Parent, Net of Tax [Roll Forward]"
       }
      }
     },
     "localname": "AOCIAttributableToParentNetOfTaxRollForward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock": {
     "auth_ref": [
      "r148"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss [Table Text Block]",
        "terseLabel": "Accounts Receivable, Allowance for Credit Loss"
       }
      }
     },
     "localname": "AccountsReceivableAllowanceForCreditLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r19",
      "r30",
      "r138",
      "r139",
      "r211"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, less allowance of $2,525 at December 26, 2020 and $3,824 at March 28, 2020"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "auth_ref": [
      "r63",
      "r67",
      "r68",
      "r218",
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "terseLabel": "Defined Benefit Plans"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": {
     "auth_ref": [
      "r67",
      "r75",
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]",
        "terseLabel": "Net Unrealized Gain/Loss on Derivatives"
       }
      }
     },
     "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r65",
      "r66",
      "r67"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "periodEndLabel": "Balance as of December 26, 2020",
        "periodStartLabel": "Balance as of March 28, 2020",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSDetails",
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r64",
      "r67",
      "r68",
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income/(Loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r61",
      "r67",
      "r68",
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Foreign Currency"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Weighted-Average Amortization Period"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r31"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentForAmortization": {
     "auth_ref": [
      "r101",
      "r161"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.",
        "label": "Amortization",
        "terseLabel": "Amortization"
       }
      }
     },
     "localname": "AdjustmentForAmortization",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r220",
      "r221",
      "r224",
      "r225"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "auth_ref": [
      "r141",
      "r143",
      "r144",
      "r147"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAllowanceforcreditlossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r36",
      "r141",
      "r143"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, allowance"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParentheticals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]",
        "terseLabel": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableRollforward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAllowanceforcreditlossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": {
     "auth_ref": [
      "r146"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Writeoff",
        "negatedTerseLabel": "Write-offs"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAllowanceforcreditlossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Anti-dilutive shares (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/EARNINGSPERSHAREEPSScheduleofEarningsPerShareReconciliationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AssetImpairmentCharges": {
     "auth_ref": [
      "r101",
      "r163"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
        "label": "Asset Impairment Charges",
        "terseLabel": "Impairment of assets"
       }
      }
     },
     "localname": "AssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.haemonetics.com/role/DIVESTITUREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r128",
      "r322",
      "r329"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r20",
      "r21",
      "r58"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "verboseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r296"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "terseLabel": "Assets fair value"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESSchedulesofDerivativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Fair Value Disclosure [Abstract]",
        "verboseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESSchedulesofDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AverageRemainingMaturityOfForeignCurrencyDerivatives1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Average period remaining before foreign currency exchange rate derivatives mature or expire, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Average Remaining Maturity of Foreign Currency Derivatives",
        "terseLabel": "Maturity period for foreign currency contracts"
       }
      }
     },
     "localname": "AverageRemainingMaturityOfForeignCurrencyDerivatives1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESSchedulesofDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r273",
      "r278"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESSchedulesofDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r244",
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r252",
      "r253",
      "r256"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Consideration transferred"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh": {
     "auth_ref": [
      "r259"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.",
        "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High",
        "terseLabel": "Contingent consideration, maximum exposure"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r251",
      "r254",
      "r258"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent": {
     "auth_ref": [
      "r251",
      "r255"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/ACQUISITIONDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Liability, Current",
        "terseLabel": "Contingent consideration (current)"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent": {
     "auth_ref": [
      "r251",
      "r255"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/ACQUISITIONDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Liability, Noncurrent",
        "terseLabel": "Contingent consideration (non-current)"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r260"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "ACQUISITION"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": {
     "auth_ref": [
      "r247"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/ACQUISITIONDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets",
        "totalLabel": "Total assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther": {
     "auth_ref": [
      "r247"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/ACQUISITIONDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther": {
     "auth_ref": [
      "r247"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/ACQUISITIONDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other",
        "terseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "auth_ref": [
      "r231",
      "r247"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/ACQUISITIONDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "terseLabel": "Deferred tax liability"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r247"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/ACQUISITIONDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r246",
      "r247"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Acquired intangibles"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "auth_ref": [
      "r246",
      "r247"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/ACQUISITIONDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of inventory recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "auth_ref": [
      "r247"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/ACQUISITIONDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities",
        "totalLabel": "Total liabilities assumed"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r246",
      "r247"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net",
        "terseLabel": "Net assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r246",
      "r247"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/ACQUISITIONDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed": {
     "auth_ref": [
      "r243"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For transactions that are recognized separately from the acquisition of assets and assumptions of liabilities in the business combination, such as related to pre-existing relationships with the acquiree, this element represents the disclosure of the amount of acquisition related costs which have been expensed.",
        "label": "Business Combination, Separately Recognized Transactions, Additional Disclosures, Acquisition Cost Expensed",
        "terseLabel": "Acquisition related costs incurred"
       }
      }
     },
     "localname": "BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r17",
      "r45",
      "r103"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "periodEndLabel": "Cash and Cash Equivalents at End of Period",
        "periodStartLabel": "Cash and Cash Equivalents at Beginning of Period",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r97",
      "r306"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net Change in Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths": {
     "auth_ref": [
      "r294"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.",
        "label": "Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months",
        "terseLabel": "Gain (loss) to be reclassified within the next twelve months"
       }
      }
     },
     "localname": "CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedging"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r189",
      "r190"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/COMMITMENTSANDCONTINGENCIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r29"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParentheticals"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r29"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r29"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r29",
      "r197"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r29"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.01 par value; Authorized \u2014 150,000,000 shares; Issued and outstanding \u2014 50,817,222 shares at December 26, 2020 and 50,322,930 shares at March 28, 2020"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r71",
      "r73",
      "r74"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "terseLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerAssetNet": {
     "auth_ref": [
      "r204",
      "r206",
      "r211"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss",
        "terseLabel": "Contract assets"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/REVENUEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r204",
      "r205",
      "r211"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "terseLabel": "Contract liabilities"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/REVENUEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r212"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "terseLabel": "Revenue recognized"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/REVENUEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r134"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails",
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of goods sold"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of goods sold"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r250"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer Relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r196"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "NOTES\u00a0PAYABLE AND LONG-TERM DEBT"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBT"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Interest rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r308",
      "r309"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Face amount of debt"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "auth_ref": [
      "r53",
      "r194",
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "terseLabel": "Effective interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r54",
      "r106",
      "r198",
      "r199",
      "r200",
      "r201",
      "r307",
      "r308",
      "r309",
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r235"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred tax asset"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r232",
      "r235"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred tax liability"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredOtherTaxExpenseBenefit": {
     "auth_ref": [
      "r109",
      "r238",
      "r239",
      "r240"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other deferred income tax expense (benefit) pertaining to income (loss) from continuing operations. For example, but not limited to, acquisition-date income tax benefits or expenses recognized from changes in the acquirer's valuation allowance for its previously existing deferred tax assets resulting from a business combination and adjustments to beginning-of-year balance of a valuation allowance because of a change in circumstance causing a change in judgment about the realizability of the related deferred tax asset in future periods.",
        "label": "Deferred Other Tax Expense (Benefit)",
        "terseLabel": "Deferred tax benefit"
       }
      }
     },
     "localname": "DeferredOtherTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsDerivativeInstruments": {
     "auth_ref": [
      "r229",
      "r236",
      "r237"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from derivative instruments.",
        "label": "Deferred Tax Assets, Derivative Instruments",
        "verboseLabel": "Deferred income tax expense (benefit)"
       }
      }
     },
     "localname": "DeferredTaxAssetsDerivativeInstruments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r101",
      "r165"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESSchedulesofDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r59",
      "r60",
      "r276",
      "r320"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Fair Value, Gross Asset",
        "terseLabel": "Derivative Assets"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESSchedulesofDerivativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "auth_ref": [
      "r59",
      "r60",
      "r276",
      "r320"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Fair Value, Gross Liability",
        "terseLabel": "Derivative Liabilities"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESSchedulesofDerivativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFixedInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed interest rate related to the interest rate derivative.",
        "label": "Derivative, Fixed Interest Rate",
        "terseLabel": "Derivative fixed interest rate"
       }
      }
     },
     "localname": "DerivativeFixedInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESSchedulesofDerivativesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r274",
      "r277",
      "r282",
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESSchedulesofDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r271",
      "r274",
      "r282"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r271",
      "r274",
      "r282",
      "r286",
      "r287",
      "r290",
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet": {
     "auth_ref": [
      "r280",
      "r285"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net",
        "terseLabel": "Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Loss into Earnings"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r267",
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Notional amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeNumberOfInstrumentsHeld": {
     "auth_ref": [
      "r267",
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of derivative instruments of a particular group held by the entity.",
        "label": "Derivative, Number of Instruments Held",
        "terseLabel": "Number of instruments held"
       }
      }
     },
     "localname": "DerivativeNumberOfInstrumentsHeld",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r110",
      "r266",
      "r268",
      "r269",
      "r271",
      "r272",
      "r279",
      "r282",
      "r288",
      "r289",
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesAndFairValueTextBlock": {
     "auth_ref": [
      "r295",
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivatives and fair value of assets and liabilities.",
        "label": "Derivatives and Fair Value [Text Block]",
        "terseLabel": "DERIVATIVES AND FAIR VALUE MEASUREMENTS"
       }
      }
     },
     "localname": "DerivativesAndFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Designated as Hedging Instrument"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESSchedulesofDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued Operations and Disposal Groups [Abstract]",
        "terseLabel": "Discontinued Operations and Disposal Groups [Abstract]"
       }
      }
     },
     "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DIVESTITUREDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DIVESTITUREDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r164",
      "r172"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that has been sold. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]",
        "terseLabel": "Disposal Group, Disposed of by Sale, Not Discontinued Operations"
       }
      }
     },
     "localname": "DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DIVESTITUREDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet": {
     "auth_ref": [
      "r0",
      "r1",
      "r9",
      "r170"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DIVESTITUREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Consideration",
        "terseLabel": "Amount received for divestiture"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DIVESTITUREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets": {
     "auth_ref": [
      "r0",
      "r1",
      "r9",
      "r170"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Intangible Assets",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DIVESTITUREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1": {
     "auth_ref": [
      "r0",
      "r1",
      "r9",
      "r170"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as inventory attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Inventory",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationInventory1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DIVESTITUREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets": {
     "auth_ref": [
      "r0",
      "r1",
      "r9",
      "r170"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as other assets attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Other Assets",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DIVESTITUREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities": {
     "auth_ref": [
      "r0",
      "r1",
      "r9",
      "r170"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as other liabilities attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Other Liabilities",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DIVESTITUREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r0",
      "r1",
      "r9",
      "r170"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Property, Plant and Equipment",
        "terseLabel": "Fixed assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DIVESTITUREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": {
     "auth_ref": [
      "r15",
      "r174"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]",
        "terseLabel": "DIVESTITURE"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DIVESTITURE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DIVESTITUREDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r77",
      "r113",
      "r117",
      "r118",
      "r119",
      "r120",
      "r123",
      "r326",
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "verboseLabel": "Basic income (loss) per share (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOME",
      "http://www.haemonetics.com/role/EARNINGSPERSHAREEPSScheduleofEarningsPerShareReconciliationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic [Abstract]",
        "terseLabel": "Basic EPS"
       }
      }
     },
     "localname": "EarningsPerShareBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/EARNINGSPERSHAREEPSScheduleofEarningsPerShareReconciliationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r77",
      "r113",
      "r117",
      "r118",
      "r119",
      "r120",
      "r123",
      "r326",
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "verboseLabel": "Diluted income (loss) per share (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOME",
      "http://www.haemonetics.com/role/EARNINGSPERSHAREEPSScheduleofEarningsPerShareReconciliationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted [Abstract]",
        "verboseLabel": "Diluted EPS"
       }
      }
     },
     "localname": "EarningsPerShareDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/EARNINGSPERSHAREEPSScheduleofEarningsPerShareReconciliationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r124"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "EARNINGS PER SHARE (EPS)"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/EARNINGSPERSHAREEPS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r306"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Effect of exchange rates on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r108",
      "r233",
      "r234"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Reported tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued payroll and related costs"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOwnershipPlanESOPCashContributionsToESOP": {
     "auth_ref": [
      "r226"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the amount of cash contributions during the period made by the entity to the Employee Stock Ownership Plan (ESOP).",
        "label": "Employee Stock Ownership Plan (ESOP), Cash Contributions to ESOP",
        "terseLabel": "Proceeds from employee stock purchase plan"
       }
      }
     },
     "localname": "EmployeeStockOwnershipPlanESOPCashContributionsToESOP",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r197"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSDetails",
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ExtinguishmentOfDebtAxis": {
     "auth_ref": [
      "r195"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information pertaining to the debt extinguished including the amount of gain (loss), the income tax effect on the gain (loss), and the amount of gain (loss), net or the related income tax, by debt instrument.",
        "label": "Extinguishment of Debt [Axis]",
        "terseLabel": "Extinguishment of Debt [Axis]"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ExtinguishmentOfDebtTypeDomain": {
     "auth_ref": [
      "r195"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of debt extinguished.",
        "label": "Extinguishment of Debt, Type [Domain]",
        "terseLabel": "Extinguishment of Debt, Type [Domain]"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESSchedulesofDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r296",
      "r297",
      "r298",
      "r303"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESSchedulesofDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r216",
      "r217",
      "r219",
      "r297",
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESSchedulesofDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r296",
      "r297",
      "r300",
      "r301",
      "r304"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESSchedulesofDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r216",
      "r217",
      "r219",
      "r297",
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESSchedulesofDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r216",
      "r217",
      "r219",
      "r297",
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESSchedulesofDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r216",
      "r217",
      "r219",
      "r297",
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESSchedulesofDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESSchedulesofDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESSchedulesofDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r302",
      "r304"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value, Recurring [Member]"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESSchedulesofDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r160"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "terseLabel": "Intangible assets, amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParentheticals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r156",
      "r158",
      "r160",
      "r162",
      "r321"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r156",
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r160"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "terseLabel": "Intangible assets, less accumulated amortization of $309,951 at December 26, 2020 and $296,942 at March 28, 2020"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet": {
     "auth_ref": [
      "r275"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of all foreign currency derivatives designated as cash flow hedging instruments.",
        "label": "Foreign Currency Cash Flow Hedge Derivative at Fair Value, Net",
        "terseLabel": "Designated foreign currency hedge contracts outstanding"
       }
      }
     },
     "localname": "ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet": {
     "auth_ref": [
      "r265"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of all foreign currency derivatives not designated as hedging instruments.",
        "label": "Foreign Currency Derivative Instruments Not Designated as Hedging Instruments at Fair Value, Net",
        "terseLabel": "Non-designated foreign currency hedge contracts outstanding"
       }
      }
     },
     "localname": "ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignExchangeContractMember": {
     "auth_ref": [
      "r216",
      "r284"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange Contract [Member]",
        "terseLabel": "Foreign Exchange Contract"
       }
      }
     },
     "localname": "ForeignExchangeContractMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESSchedulesofDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet": {
     "auth_ref": [
      "r281",
      "r291"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net gain (loss) relating to components of the gain (loss) on the fair value hedging instrument excluded from the assessment of fair value hedge effectiveness. Recognized in earnings.",
        "label": "Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, Net",
        "terseLabel": "Amount of Gain (Loss) Excluded from Effectiveness Testing"
       }
      }
     },
     "localname": "GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnDispositionOfAssets1": {
     "auth_ref": [
      "r101"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.",
        "label": "Gain (Loss) on Disposition of Assets",
        "terseLabel": "Gain on sale of assets"
       }
      }
     },
     "localname": "GainLossOnDispositionOfAssets1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfBusiness": {
     "auth_ref": [
      "r101",
      "r263"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.",
        "label": "Gain (Loss) on Disposition of Business",
        "terseLabel": "Gain on closing of transaction"
       }
      }
     },
     "localname": "GainLossOnSaleOfBusiness",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DIVESTITUREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r153",
      "r154"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/ACQUISITIONDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      },
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONDetails",
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.haemonetics.com/role/DIVESTITUREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r271",
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESSchedulesofDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESSchedulesofDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income before provision for income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DIVESTITUREDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DIVESTITUREDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r1",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r10",
      "r12",
      "r13",
      "r14",
      "r172",
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DIVESTITUREDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r169"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESSchedulesofDerivativesDetails",
      "http://www.haemonetics.com/role/RESTRUCTURINGNarrativeDetails",
      "http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESSchedulesofDerivativesDetails",
      "http://www.haemonetics.com/role/RESTRUCTURINGNarrativeDetails",
      "http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r242"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r105",
      "r127",
      "r241"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Provision for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOME",
      "http://www.haemonetics.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r104"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Income taxes paid"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Change in accounts payable and accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Change in accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "auth_ref": [
      "r100"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "verboseLabel": "Decrease in contract liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/REVENUEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Change in inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Change in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedLabel": "Change in other assets and other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidTaxes": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of consideration paid in advance for income and other taxes that provide economic benefits in future periods.",
        "label": "Increase (Decrease) in Prepaid Taxes",
        "negatedTerseLabel": "Change in prepaid income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidTaxes",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r95",
      "r98",
      "r104"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r283"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest Rate Swap"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESSchedulesofDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]",
        "terseLabel": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r152"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "terseLabel": "INVENTORIES"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INVENTORIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r37",
      "r151"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/INVENTORIESScheduleofInventoriesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INVENTORIESScheduleofInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r18",
      "r57",
      "r150"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.haemonetics.com/role/INVENTORIESScheduleofInventoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories, net",
        "totalLabel": "Inventories, net"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.haemonetics.com/role/INVENTORIESScheduleofInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r39",
      "r151"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/INVENTORIESScheduleofInventoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INVENTORIESScheduleofInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r38",
      "r151"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/INVENTORIESScheduleofInventoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work-in-process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INVENTORIESScheduleofInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsFairValueDisclosure": {
     "auth_ref": [
      "r296"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.",
        "label": "Investments, Fair Value Disclosure",
        "terseLabel": "Money market funds"
       }
      }
     },
     "localname": "InvestmentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESSchedulesofDerivativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/LEASESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/LEASESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Renewal Term",
        "terseLabel": "Renewal term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/LEASESDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Lease term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/LEASESDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "LEASES"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/LEASES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r35",
      "r324",
      "r332"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r296"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure",
        "terseLabel": "Liabilities fair value"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESSchedulesofDerivativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Fair Value Disclosure [Abstract]",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESSchedulesofDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation": {
     "auth_ref": [
      "r0",
      "r1",
      "r9",
      "r11",
      "r170"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DIVESTITUREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r49"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Uncommitted Operating Lines of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "LIBOR"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r27",
      "r193",
      "r323",
      "r330"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "terseLabel": "Debt outstanding"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Current Maturities",
        "terseLabel": "Notes payable and current maturities of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r112",
      "r191"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Long-term Debt, Maturities, Repayments of Principal in Year Four",
        "terseLabel": "Principal repayments, fiscal 2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r112",
      "r191"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Long-term Debt, Maturities, Repayments of Principal in Year Three",
        "terseLabel": "Principal repayments, fiscal 2022"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r112",
      "r191"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Long-term Debt, Maturities, Repayments of Principal in Year Two",
        "terseLabel": "Principal repayments, fiscal 2021"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": {
     "auth_ref": [
      "r112"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the remainder of the fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Long-term Debt, Maturities, Repayments of Principal, Remainder of Fiscal Year",
        "terseLabel": "Principal repayments, fiscal 2020"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt arrangement having an initial term longer than one year or beyond the normal operating cycle, if longer.",
        "label": "Long-term Debt [Member]",
        "terseLabel": "Credit Facilities"
       }
      }
     },
     "localname": "LongTermDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt, net of current maturities"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r54"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r54",
      "r192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MediumTermNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instruments with maturities ranging from five to ten years.",
        "label": "Medium-term Notes [Member]",
        "terseLabel": "Term Loan"
       }
      }
     },
     "localname": "MediumTermNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r97"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash Flows from Financing Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r97"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by (used in) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash Flows from Investing Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r97",
      "r99",
      "r102"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash Flows from Operating Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r69",
      "r72",
      "r76",
      "r102",
      "r122",
      "r325",
      "r334"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOME": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income",
        "totalLabel": "Net income",
        "verboseLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOME",
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.haemonetics.com/role/EARNINGSPERSHAREEPSScheduleofEarningsPerShareReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Accounting Pronouncements and Changes in Accounting Principles [Abstract]",
        "terseLabel": "New Accounting Pronouncements and Changes in Accounting Principles [Abstract]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.",
        "label": "New Accounting Pronouncements and Changes in Accounting Principles [Text Block]",
        "terseLabel": "RECENT ACCOUNTING PRONOUNCEMENTS"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RECENTACCOUNTINGPRONOUNCEMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Not Designated as Hedging Instrument"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESSchedulesofDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of business units"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Operating (loss) income",
        "totalLabel": "Operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOME",
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r311"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "verboseLabel": "Operating Lease, Liability"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/LEASESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r310"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating Lease, Right-of-Use Asset"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/LEASESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r126",
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r16",
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "BASIS OF PRESENTATION"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/BASISOFPRESENTATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAssetImpairmentCharges": {
     "auth_ref": [
      "r101",
      "r168"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOME": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The charge against earnings resulting from the write down of long lived assets other than goodwill due to the difference between the carrying value and lower fair value.",
        "label": "Other Asset Impairment Charges",
        "terseLabel": "Impairment of assets"
       }
      }
     },
     "localname": "OtherAssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other long-term assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r67",
      "r75"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "terseLabel": "Other comprehensive income (loss) before reclassifications"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r70",
      "r73",
      "r75",
      "r197"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive income (loss)",
        "totalLabel": "Net current period other comprehensive income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSDetails",
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax": {
     "auth_ref": [
      "r62",
      "r65",
      "r293"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).",
        "label": "Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax",
        "terseLabel": "Amount of Gain (Loss) Recognized in Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESScheduleofEffectofDerivativeInstrumentsDesignatedasCashFlowHedgesandThoseNotDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentAssetsMember": {
     "auth_ref": [
      "r273",
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current assets.",
        "label": "Other Current Assets [Member]",
        "terseLabel": "Other Current Assets"
       }
      }
     },
     "localname": "OtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESSchedulesofDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current liabilities.",
        "label": "Other Current Liabilities [Member]",
        "terseLabel": "Other Current Liabilities"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails",
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESSchedulesofDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r22",
      "r23",
      "r51"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesMember": {
     "auth_ref": [
      "r273",
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other liabilities.",
        "label": "Other Liabilities [Member]",
        "terseLabel": "Other Liabilities [Member]"
       }
      }
     },
     "localname": "OtherLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "terseLabel": "Other Noncurrent Liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESSchedulesofDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Interest and other expense, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherOperatingActivitiesCashFlowStatement": {
     "auth_ref": [],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).",
        "label": "Other Operating Activities, Cash Flow Statement",
        "terseLabel": "Other non-cash operating activities"
       }
      }
     },
     "localname": "OtherOperatingActivitiesCashFlowStatement",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfEquity": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common and preferred stock.",
        "label": "Payments for Repurchase of Equity",
        "negatedTerseLabel": "Share repurchases"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfEquity",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRestructuring": {
     "auth_ref": [
      "r96",
      "r177"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.",
        "label": "Payments for Restructuring",
        "negatedLabel": "Payments"
       }
      }
     },
     "localname": "PaymentsForRestructuring",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r87",
      "r257"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Upfront payment"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedTerseLabel": "Acquisition"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Capital expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r20",
      "r43",
      "r44"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.",
        "label": "Proceeds from Divestiture of Businesses",
        "terseLabel": "Proceeds from divestitures"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.haemonetics.com/role/DIVESTITUREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested": {
     "auth_ref": [
      "r85"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the cash inflow during the period from the sale of a component of the entity.",
        "label": "Proceeds from Divestiture of Businesses, Net of Cash Divested",
        "terseLabel": "Proceeds, net of cash transferred"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinessesNetOfCashDivested",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DIVESTITUREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSecuredDebt": {
     "auth_ref": [
      "r90"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from amounts received from issuance of long-term debt that is wholly or partially secured by collateral. Excludes proceeds from tax exempt secured debt.",
        "label": "Proceeds from Issuance of Secured Debt",
        "terseLabel": "Proceeds from term loan"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSecuredDebt",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r91",
      "r94",
      "r111"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfShortTermDebt": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Proceeds from (Repayments of) Short-term Debt",
        "terseLabel": "Net (decrease) increase in short-term loans"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.",
        "label": "Proceeds from Sale of Property, Plant, and Equipment",
        "terseLabel": "Proceeds from sale of property, plant and equipment"
       }
      }
     },
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r89",
      "r223"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from exercise of stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r46",
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Property, Plant and Equipment, Type [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/LEASESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r25",
      "r26",
      "r167",
      "r333"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.haemonetics.com/role/LEASESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r25",
      "r166"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Property, Plant and Equipment, Type [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/LEASESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r78",
      "r145"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "negatedTerseLabel": "Credit (gain) loss"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSAllowanceforcreditlossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProvisionForLoanLeaseAndOtherLosses": {
     "auth_ref": [
      "r100",
      "r140",
      "r327"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense related loan transactions, lease transactions, credit loss from transactions other than loan and lease transactions, and other loss based on assessment of uncollectability from the counterparty to reduce the account to their net realizable value.",
        "label": "Provision for Loan, Lease, and Other Losses",
        "terseLabel": "Provision for losses on accounts receivable and inventory"
       }
      }
     },
     "localname": "ProvisionForLoanLeaseAndOtherLosses",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r67",
      "r68",
      "r75"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "negatedTerseLabel": "Amounts reclassified from Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r130",
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues.",
        "label": "Reconciliation of Revenue from Segments to Consolidated [Table Text Block]",
        "terseLabel": "Schedule of Revenues by Product Line and Geographic Regions"
       }
      }
     },
     "localname": "ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "negatedLabel": "Repayment of term loan borrowings"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r227",
      "r341"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]",
        "terseLabel": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r188"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "RESTRUCTURING"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RESTRUCTURING"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringAndRelatedCostCostIncurredToDate1": {
     "auth_ref": [
      "r176",
      "r178",
      "r184",
      "r187"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of costs incurred to date for the specified restructuring cost.",
        "label": "Restructuring and Related Cost, Cost Incurred to Date",
        "terseLabel": "Cumulative costs to date"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostCostIncurredToDate1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RESTRUCTURINGNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedCostExpectedCost1": {
     "auth_ref": [
      "r176",
      "r178",
      "r184",
      "r187"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount expected to be recognized in earnings for the specified restructuring cost.",
        "label": "Restructuring and Related Cost, Expected Cost",
        "terseLabel": "Expected cost"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostExpectedCost1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RESTRUCTURINGNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r101",
      "r175",
      "r181",
      "r186"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails": {
       "order": 2.0,
       "parentTag": "hae_RestructuringandRestructuringRelatedCosts",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Costs incurred, net of reversals",
        "verboseLabel": "Restructuring costs"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails",
      "http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RESTRUCTURINGNarrativeDetails",
      "http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails",
      "http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by individual restructuring plan.",
        "label": "Restructuring Plan [Axis]",
        "terseLabel": "Restructuring Plan [Axis]"
       }
      }
     },
     "localname": "RestructuringPlanAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RESTRUCTURINGNarrativeDetails",
      "http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the individual restructuring plans.",
        "label": "Restructuring Plan [Domain]",
        "terseLabel": "Restructuring Plan [Domain]"
       }
      }
     },
     "localname": "RestructuringPlanDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RESTRUCTURINGNarrativeDetails",
      "http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r177",
      "r182"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Balance at December 26, 2020",
        "periodStartLabel": "Balance at March 28, 2020",
        "terseLabel": "Restructuring liability"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RESTRUCTURINGNarrativeDetails",
      "http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveAcceleratedDepreciation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accelerated depreciation charged against earnings associated with exit from or disposal of business activities or restructuring plan.",
        "label": "Restructuring and Related Cost, Accelerated Depreciation",
        "negatedTerseLabel": "PCS2 accelerated depreciation and related costs"
       }
      }
     },
     "localname": "RestructuringReserveAcceleratedDepreciation",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Restructuring Reserve [Roll Forward]",
        "terseLabel": "Restructuring Reserve [Roll Forward]"
       }
      }
     },
     "localname": "RestructuringReserveRollForward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r32",
      "r202",
      "r331"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r209",
      "r210"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Net revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOME",
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r215"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "REVENUE"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/REVENUE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r207"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "terseLabel": "Performance obligation amount"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/REVENUEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/REVENUEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": {
     "auth_ref": [
      "r208"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period",
        "terseLabel": "Expected timing of satisfaction"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/REVENUEDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": {
     "auth_ref": [
      "r208"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in CCYY-MM-DD format.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/REVENUEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about expected timing for satisfying remaining performance obligation.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/REVENUEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationPercentage": {
     "auth_ref": [
      "r208"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Percentage",
        "terseLabel": "Performance obligation percent"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationPercentage",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/REVENUEDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r67"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r244",
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": {
     "auth_ref": [
      "r244",
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
     "auth_ref": [
      "r274",
      "r282",
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Effect of Derivative Instruments Designated as Cash Flow Hedges and Those Not Designated as Hedging Instruments"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "auth_ref": [
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "terseLabel": "Schedule of Fair Value of Derivative Instruments as They Appear in Consolidated Balance Sheets"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Earnings Per Share Reconciliation"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/EARNINGSPERSHAREEPSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r296",
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Financial Assets and Financial Liabilities Measured at Fair Value on a Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r24",
      "r40",
      "r41",
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of Inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INVENTORIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r179",
      "r180",
      "r183"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RESTRUCTURINGNarrativeDetails",
      "http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringReservebyTypeofCostDetails",
      "http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r179",
      "r180",
      "r183"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "terseLabel": "Schedule of Restructuring and Related Costs"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RESTRUCTURINGTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": {
     "auth_ref": [
      "r177",
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.",
        "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]",
        "terseLabel": "Schedule of Restructuring Reserve by Type of Cost"
       }
      }
     },
     "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RESTRUCTURINGTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock": {
     "auth_ref": [
      "r79",
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material.  An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]",
        "terseLabel": "Selected Information by Business Segment"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r125",
      "r128",
      "r129",
      "r131",
      "r155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails",
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "SEGMENT AND ENTERPRISE-WIDE INFORMATION"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r82",
      "r149"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [
      "r84"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "Selling, general and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RESTRUCTURINGNarrativeDetails",
      "http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ServiceMember": {
     "auth_ref": [
      "r213"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.",
        "label": "Service [Member]",
        "terseLabel": "Service"
       }
      }
     },
     "localname": "ServiceMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r197"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares, Issued",
        "periodEndLabel": "Balance (in shares)",
        "periodStartLabel": "Balance (in shares)"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r2",
      "r128",
      "r155",
      "r171",
      "r178",
      "r187",
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/RESTRUCTURINGScheduleofRestructuringandRelatedCostsDetails",
      "http://www.haemonetics.com/role/SEGMENTANDENTERPRISEWIDEINFORMATIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r56",
      "r197"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSSDetails",
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r28",
      "r29",
      "r197",
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Employee stock purchase plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r28",
      "r29",
      "r197",
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures",
        "terseLabel": "Issuance of restricted stock, net of cancellations (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r28",
      "r29",
      "r197",
      "r202",
      "r222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "terseLabel": "Exercise of stock options (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r28",
      "r29",
      "r197",
      "r202"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Employee stock purchase plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r197",
      "r202"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.",
        "label": "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures",
        "terseLabel": "Issuance of restricted stock, net of cancellations"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r56",
      "r197",
      "r202"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r28",
      "r29",
      "r197",
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "negatedTerseLabel": "Shares repurchased (in shares)"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "auth_ref": [
      "r28",
      "r29",
      "r197",
      "r202"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Value",
        "negatedTerseLabel": "Shares repurchased"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r29",
      "r33",
      "r34",
      "r142"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]",
        "terseLabel": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r203"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "ACCUMULATED OTHER COMPREHENSIVE LOSS"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACCUMULATEDOTHERCOMPREHENSIVELOSS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONDetails",
      "http://www.haemonetics.com/role/DIVESTITUREDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONDetails",
      "http://www.haemonetics.com/role/DIVESTITUREDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONDetails",
      "http://www.haemonetics.com/role/DIVESTITUREDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental Disclosures of Cash Flow Information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions": {
     "auth_ref": [
      "r228",
      "r230"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) to previously recorded tax expense. Includes, but is not limited to, significant settlements of income tax disputes, and unusual tax positions or infrequent actions taken by the entity, including tax assessment reversal, and IRS tax settlement.",
        "label": "Tax Adjustments, Settlements, and Unusual Provisions",
        "negatedTerseLabel": "Discrete tax benefit (expense)"
       }
      }
     },
     "localname": "TaxAdjustmentsSettlementsAndUnusualProvisions",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "auth_ref": [
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.",
        "label": "Technology-Based Intangible Assets [Member]",
        "terseLabel": "Technology-Based Intangible Assets"
       }
      }
     },
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TrademarksMember": {
     "auth_ref": [
      "r249"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.",
        "label": "Trademarks [Member]",
        "terseLabel": "Trademarks"
       }
      }
     },
     "localname": "TrademarksMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/ACQUISITIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationTechniqueAxis": {
     "auth_ref": [
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by valuation approach and technique.",
        "label": "Valuation Approach and Technique [Axis]",
        "terseLabel": "Valuation Approach and Technique [Axis]"
       }
      }
     },
     "localname": "ValuationTechniqueAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESSchedulesofDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ValuationTechniqueDiscountedCashFlowMember": {
     "auth_ref": [
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation technique calculating present value of future cash flows.",
        "label": "Valuation Technique, Discounted Cash Flow [Member]",
        "terseLabel": "Valuation Technique, Discounted Cash Flow"
       }
      }
     },
     "localname": "ValuationTechniqueDiscountedCashFlowMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESSchedulesofDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationTechniqueDomain": {
     "auth_ref": [
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation approach and technique.",
        "label": "Valuation Approach and Technique [Domain]",
        "terseLabel": "Valuation Approach and Technique [Domain]"
       }
      }
     },
     "localname": "ValuationTechniqueDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESSchedulesofDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASURESNarrativeDetails",
      "http://www.haemonetics.com/role/NOTESPAYABLEANDLONGTERMDEBTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/EARNINGSPERSHAREEPSScheduleofEarningsPerShareReconciliationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number Diluted Shares Outstanding Adjustment",
        "terseLabel": "Net effect of common stock equivalents (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/EARNINGSPERSHAREEPSScheduleofEarningsPerShareReconciliationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r116",
      "r120"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/EARNINGSPERSHAREEPSScheduleofEarningsPerShareReconciliationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Diluted weighted average shares (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOME",
      "http://www.haemonetics.com/role/EARNINGSPERSHAREEPSScheduleofEarningsPerShareReconciliationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted average shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r115",
      "r120"
     ],
     "calculation": {
      "http://www.haemonetics.com/role/EARNINGSPERSHAREEPSScheduleofEarningsPerShareReconciliationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Weighted average shares (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOME",
      "http://www.haemonetics.com/role/EARNINGSPERSHAREEPSScheduleofEarningsPerShareReconciliationDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 6
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3044-108585"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4297-108586"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(1)(i))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(n)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04.(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "http://asc.fasb.org/topic&trid=2122394"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1448-109256"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1505-109256"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1252-109256"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=SL5780133-109256"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1337-109256"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117327953&loc=d3e4984-109258"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8721-108599"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8813-108599"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8906-108599"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8906-108599"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8924-108599"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8475-108599"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9031-108599"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9038-108599"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=118952595&loc=d3e4428-111522"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=118952595&loc=d3e4531-111522"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=118936363&loc=SL6953423-111524"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=118936363&loc=d3e5074-111524"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=118955202&loc=SL82895884-210446"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919249-210447"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919249-210447"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919249-210447"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919249-210447"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919249-210447"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=68048583&loc=d3e3636-108311"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/subtopic&trid=2122178"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116846819&loc=d3e3927-108312"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=77989000&loc=SL49117168-202975"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2420-110228"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2443-110228"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "http://asc.fasb.org/topic&trid=2175745"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6031897-161870"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6036836-161870"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=7516071&loc=d3e13374-112631"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118944033&loc=SL49130531-203044"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118944033&loc=SL49130532-203044"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118944033&loc=SL49130533-203044"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130556-203045"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130556-203045"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130543-203045"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6801-107765"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130545-203045"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130549-203045"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130549-203045"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118944142&loc=SL49130690-203046-203046"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118944142&loc=SL49130690-203046-203046"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6904-107765"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116855982&loc=d3e4534-113899"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=SL79508275-113901"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=118258462&loc=d3e11149-113907"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=118258462&loc=d3e11178-113907"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=109244661&loc=d3e17540-113929"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=117330534&loc=d3e28511-109314"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=117330534&loc=d3e28680-109314"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6911-107765"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=117330534&loc=d3e28446-109314"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116821951&loc=d3e31917-109318"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116821951&loc=d3e31931-109318"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32698-109319"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=109238882&loc=d3e38679-109324"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116868840&loc=d3e2207-128464"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116869197&loc=d3e4845-128472"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=77890550&loc=d3e5227-128473"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=77890550&loc=d3e5263-128473"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=77890550&loc=d3e5333-128473"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "b",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=117331979&loc=d3e41228-113958"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579240-113959"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579245-113959"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579245-113959"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5580258-113959"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41620-113959"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41620-113959"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41638-113959"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624181-113959"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41641-113959"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41678-113959"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=116861445&loc=SL5629052-113961"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109977999&loc=d3e76258-113986"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109977999&loc=d3e76258-113986"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109978405&loc=d3e80720-113993"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=112277219&loc=d3e80748-113994"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "http://asc.fasb.org/topic&trid=2229140"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "820",
   "URI": "http://asc.fasb.org/topic&trid=2155941"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28541-108399"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28551-108399"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918673-209980"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918673-209980"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=SL51823488-111719"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.11)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=117419784&loc=SL117783719-158441"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=117419784&loc=SL117783719-158441"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=6589523&loc=d3e617274-123014"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=6590653&loc=d3e638233-123024"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r342": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r343": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r344": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-13"
  },
  "r345": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1-"
  },
  "r346": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r347": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i),(j),(k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e637-108580"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e681-108580"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669686-108580"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL34724394-108580"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e557-108580"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118951672&loc=d3e1436-108581"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3179-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3179-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3367-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3367-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3521-108585"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>68
<FILENAME>0000313143-21-000010-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000313143-21-000010-xbrl.zip
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MPP"$AG$ 2=C8]D'Y9/:G\_Y=K7ZB[:^"5_"*^_R6]@4Q$.OX@IT+M ,\UDT
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M Y#0H%=*Y..*]5D$B[4H317T)8;TO+%),,:]/K.)O()^^"/.XLA2&TQ!'ZA
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M =,"\43(+JAV[N:$],GD\OYF[_;0]>FF[&*VR4_.8Y_Y#/B9-1SJ=HI0F3-
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M%LWQ4_RI=RT82JVIB,H5K*$U43<OF&BR8:9J:*J9=PO->>\!X0-J#>42R=$
M9=ZN-P%GL-WPL=FMU0"L;@@W!;S,KVUA3.1(,>,BTZ&-+JA?L]MB=> 'T C3
M!(57BI\N, #=@UJS6Q=6MJ-H=89!]AFX<Z6IY#0W=25_IPI/:+R^JFCV!(5J
MNBFLI]G5Q, $ LHY&*:41:;<'&(-537Q[$J0H0$,0T#2$_M?H!KVHYEF-\7A
MRM $>/7?:DTZ 69&+S*7:A/-4+<CQ0JH=S'#D9P])HP-592J0@H!Z53#T TS
M8SFR&N3D>JY/8AC89%,3I4M(>/\-XZ E0-9Y4[V\%B*H &22-ZR#)L67'*>Z
MM)[ C%9;B!/5T2(#F[HPT'.+MJE3/J:.%ECU#MCM:U%[370')E-I$N\O-7"G
MU+0-N@C@%9*DZ4:-G)>\H04FU'!: ()*T]2ATXX!<I=Z>/4W'R$UYX8@W?1S
M+'M'ZP?=-*<KO$S^Z\ "M:6ATS*_!J#9J&C-KJ%.W6?DZJ520T%8!@.A&^ ]
M8;Z;Y'Q'DUIF]12$*2 =19+!.BHC ",<;.D-K@%H80126\RKW=S\)+G?N!8N
MK%;#)/30&=;\ P6LM:;+ ^*>H7>_7DS71#I#;4GN;%:<#B'"3Y56%EI;HHE5
M!\D-)H2Q04NK":U5(ZK!E^HW4"T9C)]*!*F%WSX=5,\$&W(CDG-^QEP45MJ+
MPL)BCT@AGSV$)"O,#**$#!+F]WJJ4'&Y-!VF)?SUOZ[S18]7%QKHYIP<T_AI
M?2)[8H#0=$T"ZXFZ<JG!\+-%AI)?9LC%F\CMEJH3S!PI8[(<<\/!.:.U8 FF
M@02"FD-#HZ[+VM0XH/2(B29ZP&FGUT!_(Q>N8 5LZNC5S!@4LDOS1N47U.MS
M;R8_[O]K5FD05D(6W4C7/KCGO(O%9NQ1S$_37\Y<+Q[Y]N34"VB8U&@^;C0)
M1](W/Z@6R^5#=,\3L&*)FX*7GGN1//>]Q%WR[J1X<GR\\G6I6%[=]!ZPQ\72
M\?[&H1X=%X\J)VN!W2-""&( 4>.1'?R^=;(U70>Y&$YZ6AG]8.79C'R?]Q<B
M=('23R7(^TBV%87G,CG+C7!N]5T^%$*6&_7^PJA+..8<%1_ATZ7T7VSS0NE_
M/IG=?MXHG5[HF,G\Q_0_N_)\W[.'&'=Z/HZ^\V6"]TJ'V;:'_!&8*Q4Y!OG#
MMRP.?<]EZ1A>.$G>,+<MK)G^_N9RK:$O,G&/G(AGWR9^R\T^ML ?W<<_>/5;
MX*_YI/IH95R!.!TU972J*<,!*B6VW0Y!%?+X@>?_^: /*MP:C'T17GP;>B+&
M\?Y@#YF+D :65%F/^^'=-"#H!B9D *U]_]T&GE;7Y"8F-P6"BP69""7#/_@?
M8QXGL2S *5.(,-DEXO32BT0D6T;OE1E0XO4TS8C@9V]=E!B"1&'L/0[?NB@N
MHME<*&M,"3#V#O/Z@)/GBUPFT*T)1B>-(HZ1[069'>KX=@S#Z@84'6:*V):(
MWWBQ*",-H\'ZT1CFXA*T KQ-QA'&C3G<&R4I%3B A(^Q+"CTZW+2Y="&PLC2
M;^F/!L>Z8#[F0$>4!Q3)A); 3B.JL$%X$P"37<HB"I"=X(F,(X]'Q>4L*<SR
M)"->+(-X*<%SMC[;8ATA<&P0)P2[D"N6O:,:4EXN?TS6)T,!P%PG+XFYWY_F
MDN7Y*E*1P#A10"[^3#,^1^,(:$91840N*IXN!TD]D/"\Q<"@=!?SWC"L3?TO
M]E??(AF79$\^E#@7-A^& 0>9BP%$5LK_I8X8LS]9T^MQG(0=W_[39MJFY*1<
M.63F&$LS@U8$DYV\5"*4]TLERH-E"AB#,<>K$T#SLGVLF[]\;.D="[-W-Y0J
MY?):-\ \"ZOS2;\*IOI6*KL'%:Q>OR) -Y%%.5.?[+)38%_]L >6YSS--C5Y
M=(OZ]:6.&OQT7P2<WD3A>/3;IZ.#LYZ8XD4G'+Y4M%_<2<0[I<<5NEMXQ<\(
MRTZ\19OW7)1]98;RN<CT:HSH<Q'H%5KBYR+5K$$7SV -R9TQY0%?XB5E'5B@
M>1B41&O!KSR@A>9S8<SHWZJW>)<'K!/?B4(^7EW5RM#_I1K*5S5-[?[A\%&"
M:^SL7@C:NRHL3?&E5;W<*+NSH\C&Q'R9ZRJ6[90,&U ZH<_D'0>]*/P.KP;0
M"6VF>,%MZ-^F.:\>0,"K<&U9Z48D6_7XP/;[LOJ2 -GWQ))<9M#V.:?=C'Q/
M6 ?;BT45^>GF#;>C0&S+8#D/D2)&6PG%K&!RF@^)VX6QJ%+O\F$ _)RE0_;'
M/0TD2*K# OWYGMWS?+IO+<(-(&\8T[L\KO G#J>0JR\)PXK#@.(W["0)8023
M. T6HJ&+*F0QU4F(Q$5/M-UA,]QP3G=?@+J241,D &VP9&-'K@6T_[/ K'MY
M!']>V$%@#Y >-Z'_)Q[B K9,]7TOQBMR<&ME.D YOG1W*AY1+?]P 7 !-[.
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ME8\*K'QR4OK]MX.3,^05AZ8NO.U-6<.+P&EH^(#Z ^25P#1@FL^J)8)6EM
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MKVV#X$4<W3E+R5PQRELL$A0RD-JY3,$>YF%,*?,24P/=6US+%B@5/9PDS!7
M=K< /]U)7Y[F1P0J' R*##-A9V/@@2L=M*9G>"G@">A([NPO/[)'*3H."7Z6
M?COFP10/ #M%9A;9>?B-'1V"-N0O*<U=>BH?5*JEW1(T0NR@(VCS4.&B[KI$
M.$S^,8^2*:DA:"9@@KE_-P&=+O>F,ST%DMQ%'J87P63?B?P8 X;T]X(8V.JG
MY^\+Y@KI/,NE4@][HA^BO<"D;'<B4R+!0@%Z(9%2?.M3HBE8*A& >RKMS&X@
M@3&.[S&:'EW  6<&7.4S)#"K0/Q[ F,"6\- X"!XQ0R _G6'\7X_(G=("1V4
MAC!1J0@JT2M-(8$A9+:!3%$ )MLH(]FHV8::2@:X9]((&D4_%?:\F9?7$F!&
M*HDE@]L?\NA&@)9)/2#-DX"AO[3T09C@<]\3$X;)$\@3*;M@VH6;$U(484KX
M7= S&-08R*E1D@^11<C,B$E NJ?FH!169ALKFL3W<)T2LI8HD*DS'X\!76*U
M5+4(\<E=5U1-78%I.\#W8IK'_TY4J[HRR-/J=0,O]FE-YNAMK>TPH]6QS$MY
MWUMK-LTKK5W3GRNK[4502UM)K5D<%;BIS>#]KT%XYPOW1BPD#A;4+9TVV*71
M["8<Y@[)JU,C[E%\O;"3J\TD78UAC#!K5.8D:9B80LVW.2;GQ_W(ZTGAG^4Y
M';#M[W7-\I]^_M;1CLR1Q$LGM]SS4U.4TTIE^I9FA3I8/CJ+J9B'FDQVTR!&
M*[&,W0X.]*Z#R7<3#IRO3C'%_$LZ[=BNOI:59N3^BI4F&(/1B!-&.>- \4?Z
MQS[;7M/>;"1I<CEUFK+>^5(*]3N1<I7OJ$&0-0GH0M5LT?P87Y#%0OU(0 ^$
M<\,QE$Z#)0^ONH%XQD*%1[-TE>SZK\^AO=Q]2'.G5UX8>B^KVOV59JAFMALZ
M52K"FBA_=NM?6FENZ@/'Y4H#U"TH"'\QP7S@J1L,$/4//+QX-^?.:_ 4UBLJ
MK_W/B7LSVDPB\WO2-BQKTC QJ#7:7UA'L[0OEM:YL)FM._#"<B[8E699$ ;;
MS+28UG4N3,MPKO$=T]I,<QS3:NO76!5)L3]C/-.^:$;;=K(XNHUW5YA^J0HG
M::RN-[1NTV'GUVD;S8:'=LTRSG6L.0-X%;'?%\0 ,00 MIY#J?$8# KI*'B#
M!L;\1YNFW;PNP!CP2H;]^"=6O+DTF]VVHUE&4U; ,27Z6OW2J.DXLJTCO1PL
MYM5MVWH3GZ4#==N 2[J0  !7FG&IVP!'PH)GSQ>U?!SEO,ZCG.6J:*_O*.=9
MC9QE?+D 7;_0,I.#Q?O 4+4TK+%WJ:.-Z%@&/&F;#FHQZ76G W:NV\ZL&I@'
MT'HP-MUV7;=(Z4&9;<=PNE01$#LUM2NR/O@2NX*ULAVP!3:]E5U:+;-]I6M-
ML*'0LJ.WV_9U\U)K&QJL6;!<H.R_RI[9%V@E %&F__-"ZZ(5 ["VUM)Q2OA[
MQ[Q"_$QY)5!K.%2;:MX$V@6TJ1H^!P/:Q6E9>DNO@Y&#CN<Z(E+')B9T;^,O
MAD/T@E>6_C]=P]+KTAX")E>&<P'3!,,&8-"6 1D0&:O;U!4>-)"E66A$ 4#'
M,NO=&HQ0,SO7<L(&# '4M&3I1"RY:#0,M/;7<PX%20$C@&VUR%M8>LVTZ@II
MZ"V9!\_@A:.(!6_L;J-AU P$K5\:=;U=2^E,F"%%R/S#LT9*QJ[5,6U=/C?:
MDHZ9_WOSZ4A(ADNMV45^UW1P4W6B+$T>&8Z.#WRV=9VY:Z23U WH2@HAO9IL
M=0ZB6".1KYF7,W]KM!?=K]XB 59>\0&^(R8J@)C7-T!!;]HZE1.@VHR=#JBO
M9*Z**=JR.S;%GV;7P8)]34U6\&(-HXDROA0\D"VP=<O0[7P\:R_&-0@?4&MH
METB.!BA%N]X$G"&J@,9VMU8#L*8E R@(C[^TI5*JF>+]T$P6&UT08[O;8G7@
M!] (2R3(<!J;+C$  Y=:LUN7UJJC&76&U\$R<.=:4\MI  VE?J>RE6@$ONAH
M/B2%:J8MK9#=->3$) +:.2AXRB);[5.QAJ[;N)\NR=  AB$@%2/^+U -QS%L
MNYOB<&49$KS^3[VFC*F=T8O,CMY$=>YVE%@!]2[F.)*S:X2QI<OZFT@A()UN
M6:9E9RQ'5H.<7"^,20P#VV8;LH0;">\_81ZT=LD&;^J7UU($-8!,\H;U797X
M4DA75U8(F-%J2W&BXJ!DJ%)7 ".W.HXQXV,: H)U[(#]NY8U9>5P8'JT)O'^
MT@"WI*=]T-1"O$J29EHU<@)Y@P5,J*%: ():TS9AT(X%<I?&GO5W8<=RYASI
M9IYC.5]:V9BV/5N:9O)?!Q;H+0.-_^+JA+11,YI=2Y\%]LC52ZV&@G ?#(1N
M@1?"V_F*\QU#69G5*@@JH!PNR6 =C1& D8&*\JIK %J:@;(6BV8WIY\D]QNW
MPH759IB$'@;#6L9@@(W6+,PB[EEF]\O%;+5F,K26%!9D%7<1(OS4*4(SV@I-
MK*9,X00AC!U:1DU:K1I1#5KJ?X)IR6 \*!%D%G[_;?_H3+(A-R.E\W/NHK#2
M7Q26EJ%$"O7L,219X680)620=+_7,X.*8>=LFHZ,>W[>YLL1KRX,L,TY.:;Y
M4YRG1F* T"RV@[BLKET:,/TL6-/RX9H*@F5M$64ZP<V1,2;/L3 =U!FC!:&L
M 1((9@X=S7IUF#]6U>]X5;W_L:I^O%]=PUBFX1;:8^FZI,ZB(S-K$!&A7;N"
MM;EMXCIA+D2C2&\Q3%NYS;Q>@:>?5\;YVDPRG%&5\5*MPW.#7:P(R<>Q.$U_
M.7.]>.SSZ:D7$#FIT^))6!*.E4SL'Q8/#P]1+!+ )G%3\$IBBB0Q>XE[S[N3
MXLGQ\<K7I6)Y==?O@#TNEHZK&X=Z>%P\K)RL!7:/""&) 42-QSSX8^MD:Z:!
M+N9BGE;&WUAYOF26+P9+9XY Z>=2F"J2;46EZ$S.<C-<L/OE REDN5E7EV9=
MPCGGJ/@$3>^E_W*?%TK_\^G\"<Y&Z?1"YTQQ:DS_LRO/]ST^PJ3-\TGT5=PG
M>*]TFFT^$D_ 7&7(,6T!VC*(G#R7I7-XX21YP]QV\+-%[T^7:PUSF8E[%$0\
M57"S^%V@%[&A<[ R IP[K65UO0F+_WKQQ9;"6#6-P]4WC2SS'[JE?5%IINR^
M-$NZ+:,2)^YX%'',%%:IA3(]F?(0 \HF\IDJ,-N+PJ_P:LACUA,B8%YP&_JW
M:3%C#R#@A\RXNF$0T/<J>F+(_8&Z]2)!#E HHK_%6!TZQAST_!A8E-"+945/
M2H>FD02/ IG4CPG4,EV-DO]E=K3P<M<!<'G5'V8ER2)Q$U)>CISF5*:+RD;X
M7':2&3^(V"@ %N-5B0'6)46\AZ$/__%H1 669R2BQ'A !TQHS_/IHQL1Z_O<
M&\7T+C\5^!-G6\A=] 4,XC"@-0$'18()3N-TIX0H(]-78LKHCN1' B@5GBOL
M9;8*D#V=VGO)(CKZ3KW,-FT#$15MIM4P3:.IYY*)LD)W:>+<+.$XEA+*LUM8
MLQ*50&2L")&(==)["[F;)W%Z P#DB4]\:D1W  :D'6$/B,OEU:^%O/]"7E]1
MY4!SI'!A;=4)WD%(_PP'@U@D)&0DMGACC-+0(A&/J0#N[#9#EB?\G:'?BQP=
MKT[D5_O<M/B:EQOD2L;?O!V-Q!CH+503I9,JGUMR<$"E+2?),(S06F#=;60C
M52Y&B^-[$#U(OH]%!"9DM"0D.!9Q2VYU9A5UP7)YMYZ+=VG$-]&?)/**XZ/D
M%DVV,M=8LA_O?DCC>#_N62U@&#O7.H<8B/XP5[$>4_%\KY\HX51&.U>->9H)
MYPU>/J)T2E=]B)*D.Z<Y9%R3[$V.1K,"TZG#P9L_--$(T^BC\):^H+7H2E!9
M(_'OB1?)/-H'6;"L)J]8%TY6ZD+;9";M^+?,NM$P:J03=EHJ]EM?C)/\MY&D
M-N0_>:#2,&7J[?P55^5WY>4--),D9O>6>,T5.%8)GO.7_&;6\BG-U]-\ 8W@
MG'H)C-%?BX<GY3.;;CI.(E2=&S'+]LY=I%A++C^.%E[$T<+!&SA:^+5+/J.-
M9P)M/%>]4F>(]]2G_VY%>[GBD 8>;QH+<JX>+GD"5QJR6. M:1D=3NG)%!8G
MJE8#[X'?HKO&,,C35XEYKD.&DZ-B>;_R(X<,!\6#D_6V[1\#M5(J'IT<;!QL
M>;]X<'RX>;#EXG%I\P<M!\7*467SI"T7RY7-@RU7B^7R>C1XW><WFN/HMK.Q
M?<=7,V^J_3#_B=M7=&;UFIJ^[FWYA\[7#A?/5=)-YM=VM)(_5/LSC,5XR%KX
M593^U_#6Z[^K,XEWR?,ZOP7$SXOL0O D#'[D9&TEYY<(ML'#QY>S4_$=K7EA
M>RJZW'&#T/\2O\K>B01^5BM(7BJ^N&JQ11_60SR:KI<1]4R^[WU(]BK;\,+$
M))-CLF@UW;Q')#9ZOOR<D]NN99\3M&%)O_/8A,%5_S/U[X?VV3X6]!\+^H\%
M_8N*Z=[K@O[U)Z*^IJ8?B_I7M\!SAN&(QZP3WHDH_EC/OW5V;R)5]ITO>^[7
MF%\1_&MQ[,4)IN?D5P%J0?RQ\'TRNJ]4HA>V\LUG43_16O>%S'1Q&?QQ*?75
M98X<_ECF"!+;<__8\@:B5.*BVBM5CT_V^P?5XU*USZM"N.634F5P4OW7_M;/
M9YL<53:5:_(T&5C?=Q=S:<1O+#FV%HY&87 'RB\+5;:TQVYY_8#1>)ZI;6I/
M[]$$6?F%Q_A'R[$^ERQ,@H12;,\C")!"?V,4>6-*LVJ>IKH(4RG'2?IEFO2#
M;FG1WI[ 2RELA!G^K!UBR,DZDY[O]0N8<XQW0C AC8_'@F,J\F+05&!WPS!_
M;\%EE! Z]$:Q\ >T7!EB:5K\_:1ZIA+=,&4-XAK$:,7>#N+3XG',^\-)+!)*
MLI;! ?C?PBRC6HXFY.H(?^(@^&T2S ''(7H"\^M4LOA_9#:U&T(H6U#)Z<)=
MN)SSF,L5LQLTO0GEF#/?&U&17OI2:E:*N9!]C6<\@6FHS^BDF>@)]]2-(OQD
M"$+SY%>7 C[*:L?GYH\MOT]FH !,_JW=G9"G&6EBY6A*J9#R*S&#@=?W\,L1
M>'UK*2.2(W>Q\/SS4>2%'*X<%TM'/U22H5(MGI16O_[A(X"G ;M_O#;8G]T?
M>8N[:/G-)1L,R=1G6I$UZ:M@&]U<>G>WVN=\ZM/?AO[%!KHUQ8]MJ8NF^.5Y
M#\RNO)W3$+V(OC-X0+''T1,M[FEM]X1+^P<6LGN]T)W"CV$R\C__/U!+ P04
M    " "U,D)2%A&[M0Y\ 0"V@0T '@   &5X,3 T+6%G<F5E;65N=&%N9'!L
M86YO9FUE+FAT;>R]ZW+;2)8N^O\\!7;5G-Y2!Z72U9=R[XJ@)=FM&5E62*JN
M,[].)(FDA#((L'&1S'GZO2Z9B00(D)0M&6 6)J*G+(D$\K)RY;I\ZUO_^%^G
MGT]N__OJS+O/IJ%W]?O[B_,3[Z>=7W[YX_#DEU].;T^]?]Y^NO".=O?VO=M$
M1&F0!7$DPE]^.;O\R?OI/LMFO_[RR^/CX^[CX6Z<W/UR>_T+/NKHES".4[GK
M9_Y/O_T#?P/_7PK_M__G'_]K9\<[C<?Y5$:9-TZDR*3OY6D0W7E_^#+]XNWL
MJ$^=Q+-Y$MS=9][!WL&^]T><? D>!/\]"[)0_J:?\X]?^.=__$(O^<<H]N>_
M_<,/'KS _S\_!:^%/!J-CN7AV]'>D?_FS=N)/W[]=C268N^-V-\[^/_W89"_
MP,?Y.VDV#^7_^6D:1#OW$M__Z^N#6?;N,?"S^U_W]_;^WY_*GQ/)'7QT%&=9
M/(6_SS+X^R2.,AA' L_E?_+C%U]2_O*!^;+^P#@.X^37G_?H_][A7W8F8AJ$
M\U__]VTPE:EW*1^]ZW@JHO\]2&&#=E*9!!/^8!K\C_QU?Q_&3C\^JLG <\(@
MDGIR^P<XHY.SZ]OA^:5W?OGA\_6GX>WYYTOOG\,;[_W9V:7W^=/Y[>W9J??A
M^O,G[_:?YS<>R,WOG\XN;^'O)\/?;\Z\\UL/?KUUONU=?K[UX %GU^?#BX$W
MO#R%W\*O__C\^\4I?-P[^?SIZNSV_/;\7V<7_PWON/[TX?<+[_R#$C_XW>GY
MS<G%YYNSTUU\\\T-C.7&&UZ?P6.O_PN&\;>?W^Z_^_O?_P[_/7RW6UYA:VTS
M^37;$6%P%_U*8O3L*WNPULJ>?;T/1D'F[>_M'CUUK#4BU,$)_G]G)[^3P/SK
M[!HWJW' B]+^SIK#&$ZR3-::^0]ZT)]YF@63.?\JB'QX[J^'KY8=\"X\NC3]
M'RT,PX_79V>D&?#D7UT,07M\\#Z=77\\N_;P_S9Q4J.Y)R+?$],XNMO$\?]S
M>/;I\R4HW9,;4+_75Y^O2<'_[>?CM^\V<3XGGR]A&J?G0RU8-[^_'\#5=;*[
MN5,:PGS^A1,Z/3_!BW.C9P.G91.'#:;/+5@QP]-_G=]\OK[Q+BY.!IY(O>Q>
M>C<R#&7B7<M9(E,8I,B"![F)DSPEBQMF%4^\_Q11+I*YM_]Z0$9V?^$Z_.BE
MGLGW?\WVE68Q>XJ_)C*D@]+H/:FW[!5?$:,T#O.L^2L_=EI/=^^*1ZSG?1X9
M[_,^T6^=B3NY,P+O^,N.F,#9^E6$CV*>_M2VA\JBEXE1*(L=3'R9[(#Z"L4L
ME;_J?[SS@W06BOFO041*B+[T[D$F63 6H9+O+)X5P][=XZ%G,*C,U\]7?]ZE
M/_V2^35_.]I]>W#<^.>]W?WFKRYY[.M7NZ\.CI[]L<>[^\?-W[2?^@LM!"\&
MK&HZ$]'_^>GPIT)&?#^([G[=\_9I5_3SEGST8/85/VQKF%!.LII=629!K[IQ
MFY&PW&KQ_<%!$WKY\/W%&;HW+S.&]1;@I,T%^'QY"Z[>S9K*$V3[QQA"ZPU^
M"]R(V_/+W\].MRLZ</5!*ITY=4XK%^'^,>O*YSJ[W_K1-;7(DU1#&W;KS=D)
M!9GVBXC?\RN\EDSRELXPA^]N3J[/KVAIVU-E!VWJ<GKY]?#R9D@2]F1ET*&C
M<U0[M_W2B=D\A= PJ]W]E]($;4SGDTSN9()>N?K733[R@BB+*?QP$D]A8G.7
M)NRJ5!ZXM$EGDXD<9RB5*(4LF2[-SU4A/'1IDT["& $"% [W6"*#!^GA.UR:
MIJNR>.32)IW@0"8PE$RB5CR/QG$RBQ.!L4O*$KZ?A^(Q95D]#1*0U3A)Z2^?
M)_ ]F:0N+<>!HS)[[-(FG<01C"5%"061O;D7B>R%L/.SVM]]Y=(FW2+6CU!_
M((/*G?$^SU!O*FU9^XD_1)*(*'-*7@\=E=?7+FV2,CJ]*S%'F>0K_"S-@BDE
MT/6?;S+XD4&H[LS]V%$!?>/2)EW$(D+IC"<3EZ;UVE'9>^O2)GW(D^Q>)MYP
MC/>W2S-[XZCX[>^YM$OZ]E5Q264L_NWG-P?[K]^E7*LR ?E\'\=?G#(=G15/
MIW(Y9U_']R*ZDW_[^>CU.V5 NC0_9Z70J=S-59QF.UI3#GW$DI)WG<7&>SD!
MYSOP)8<O79I[Y;IS2$2=RNQ042?*H9@%F0C!OQXG\:-+,]QW-=BS[U1:9SB;
M)2)(000QS',:I"E!$U-E4GK7^%FG+,G*_CDDF$[E;I;7'3DP07?ET*GT#5B*
M&0P4[4=WC<9-]VN6(Z</-ADY7;]CUS\&,MS@Y5]=G]V<7=Y2,?4-%;S_&/AT
M@RW=YEH,KZ^'E[?G9S<((K_]YUFK*_&#:F+J7_[YT]7P\K_= Y$?N E/.W +
M13[,L_LX";(Y0RK>!Q&.V[L469X08&UXETCG\M7.RJ93\<C37);QDBRCES&6
M.H!%&8@DD H+=):-7\Q::64KW<2H';@%-!_B.$*9+D/VNC1?9Z72J=BD"HX'
M_T.B..AUXX9,RRT0^64<[6 0*!$/8#V:VQN#0=(Q?.Z!FR') [< Y1^"2$3C
M0(0%!M<M*703A7O@%DQ\. +U-R;7&DO#1!!Y)X3]Z65Q Z;E%B+\%EFP$=XS
M3%/9*\--F)9;L/!K";?Q51+/8$ J GDA12KOX]!W:9X'KQR51K=0XN=1ANB)
M<99;8NG2!-V50Z>2,M?R+@]%%B=S[Y/(&%:&NO&?H"ZS^[%(I'=A. .L7U[)
M9!JX=8\?NHG+/7 ,.@YB"E\$K<D1G[%C0NAJP-$M</A%($9!&&2!6[[T84UT
M\1=B1_ZM&RU3?N""$!%K$#0W\5$?/#C8/9YUB%?\VYB^7_=,W]_-]/WZU0LP
M?1_M'A^MQ\G]I,?N'KY=CS^\9_JVM43/]%T[AI[I^QL@F3W3]P\:28?,KGH4
M_-7PXUF=V;_9F]FA96]T2MP"X\3361@(3/D]!MF]%;AQ,5KC:M;%K1I!G7A^
MCWUT99IZ5QBR"<:.^<W."J-3L)Q;\55'N5V:UJ&SJ1:GX#AG<#O'<RF]]S*2
MDR#SKD)X&G,WZC^Y*)V;7KG:*)U. 73.HH<@B2.$*HK013D\<C:SXA1.YSQ"
M#'><. 6&.'*3:>=@]\ I4,YP/(YSY%.^EF,9/&"NP*7IN2N%3D%R;O+9+ RD
MZLQQDJ=9/'7M+G96$IV"VIQ':9Y@/-&E21VY6D%UX!;"1MXQ,G8L)8Y81;(_
M8Y[?+5WHK#PZE5SY5YQ)L O_G0>)=*I@P%WY<RJ10G3Q9!&"<Q(GOELZT-7\
MR8%3^9.BK'GH/P1I[%2[57=ET*DLRGL1??%TH&99*TO%X"2F;J6:W153I](I
MX+CX^3CS'"T4<%<*G4JF:"D$DU&$H5L2Z"KHX="IE,HU5L-(W[L223;GYE>"
M&K/UPMBE:2UGYS[<)';N]:B07XB=>V\]K,6/8N=>;RU>B)U[O;4HL7.WN0I7
M[:X"B$/K@O"IU4-Q_?'LNM7IW[0Y_=_?N\?+OO'78@.BT2U>]@;N:YOXVJ7I
M.BN43D$/_IK- IR53:>@"7\ANN$C-UO>'[K%PGX19,&=<RW/G)4]IW )GV1R
M)Q.T%EV:E;.RYQ0>X3+VW(5EN2J!3J$1%"(FNG-I4ALO>LNS&4>;E,W8@*Z2
M9]>WP_/+OW!7S7^=70XO;_OVHJZV%]UX?=@P+;?"V,/Q6*9]\&4#IN56I/HD
MC@AC%4^\[%X61$?J9R3E$I%;U>PUC![?R!+\9YYFP63.OPHB7T;9KX>OEG'#
M/I$WN.G)/W#-%)'P$B;A%URCCI(4_]BO?1LE\OY>SXD,PW[[9G?O]:MOHD0^
MUM]\7N[BP]VW>\U__G9*Y-<'/25R3XG<4R+WE,@=8M'M*9$=VLP.+7N3;^88
M4L.[B<-@'&3.9<>/W>Q6=>06,N,R1JYCNP/OV8-K&*'C_0V7Q.7IHF/WTD7#
M-K,$IZ?GN*[#B[]PHJ1#&:,7*GM9;R&&UUCYXU[&Z-A-KMECMS)&-UD\_H+]
MGV6BP;M>G'C#V2R)'T3HTE2=%4BG4DE6,]X/08BD=R[-[MA-TL]CMUSF:I<"
MMT303=J28[><YO/(E],HF,!@,&J#WK,F=2*&)\/WY-*DC]TL_3IVJ]KA-$C'
M89SFB30U7Y, ,_(!C"QS"N5Q[";ZZ-BM$@A'6UHY*WQ.53]<_^WGPS?O_O"<
MY(D_=K-OU?&N4SR+9Y-)G&2IE\7(%?\ =[''.1>WU.&FR^+R%,LK]U(L[>87
M+CG'<O/7S2Q<GYV<G2*GUNWG5A?A<YN+\/[B_*/BF/O\H<U5\%K.,KTLN=J:
MA?+MUNB]'+G:FLF6-J?_<N1J#*%LRRQXN^%F0?VT7KF59AR.Q^ =C><8Q[R6
MLT1BHI$BFQS._$,DX#RYQA#NK&PZE7&\D@GX3U/TW0FD%C_(2+B&3W-5$IW*
M.]I@#"<1&*Y*H5.IQ\L8KN@T2T30*\%-F-8KM]*+('X?X0I.(B0V%:'G)K&?
ML[+H5&;1$.PJT$4\SJ?.E2ZX*HE.I1E/PCA%\F<LH6%4D%.)QE=N5G*]<BO1
M>!JD&+=!.;RY%XE;P1IG1="I;FX*!/FWG]\<[+]^E_;Z<+.FM;OO5&>WCW'L
M>S>9X,8,EBSVFG$#IK6[[U2.Y2P=)_&CFTU!W!5!IU(IE['F^D- +CR#VZ3+
M))7>V60BQVX)Y:87_3<*I5-9E7_>7'LGH13.H7/=E3^G\BD+"''O"OEXG"J4
M<5<4G<JMW,ID&D2FHO!H;W_KR[9W%0JG<BON"J-3R15;&#&[<B7F4Z*?F'@W
M$D;Y5[BNOX\RVB6&:%JBX*&9(+IG<?YV%N?#GL69A[V[QT-_,HWST>[K5\?/
MS[=\M'OXYB5HG(^/UQML3^-L*Z6>QKEV##V-<T_CO,[HVAE)A^R^GL:Y2^;V
M[KY3"*#/DXE,O M)/!?D,"%?7QX2'*, JKDTY8UWY)>7?+_N2[[[DN^^Y/ME
M2[Y;)Q?NVU'V-\.ZTWK=5_UN_JR=E4VGH"I_A:I?9R71*7R*ZU6_K]SD77_=
M5_UNQ,2<%3^GD"E_C:I?9V71*6"*TT!Z5R70J5B_Z]6^K@JA4]6^[N+F-UW\
MEJ>5WKB75OI!$)PFWM!/YY>43W PCK[I1Z%^6F_<BJ-;2&F7IN6L\#D5*.>Z
M38R1NRJ&F]Z3;[DY\-8]<Z!5&O'SFY.SBXOAY=GGW__*0)//_SJ_08B%@S;1
MINN#^FF]=<LFHGS%.,Z35+6ANXRCG9L\>0@>1%@#.!A8: .%GGRQC&^KA/C.
MBJ]35M5P*B/?N>#RD:.BYQ3>X.SK3$:I8Y@K5R7/*8S!'R* L;@THU=N-M-^
MZQ:XX RLOD06"5W=MSC'TL"92!P#O+@JDTZ!#(:S60@#P2KW"_'($OF?>1*D
M?C!V+L+FJD0Z!3H8IBD,0(P"U[JXOWKEJ/@Y!3>XO0\2) %*LKGW7D9R$HP#
MD;A6&^*J*#I%,NY@]VQG!<\M0G$F/G/P"M[TYNV-XN=44N6_HO@QE/Z=6W _
M9V7/J8S(21Q-P",FI,DY!F9DZE9RQ%DQ="H[,LRR.(GD?.<D#)"-]"H)'H)0
M]BIQ Z;UUC'F\,O8.Y_.0 []*IJA@#Q<RS!P#J!?TY+P&YERE_/;NL.<VQ/G
MO@AQ[JN>.!>&_?;-[M[K5]_$FWNLO_F\!+>'NV_W7H(W]_7!4<^;V_/F]KRY
M/6]N=ZA6>]Y<AS:S0\O>Z$0Y!?ZYF<DQUM![%N.72_-[[69KQ+>.=;M!LN8L
MR9W#]K@K?DZ!>TZ#=!S&:9Y([V9\+_T\=$L)NLET"%+H%,:' >#$MQF*8)IZ
MPSL1@%[T3N4H\SX$$5S.R'MS$^>)8P",.@EM/:;9S5Y+A[M';PZ?/;ASL'OP
M AV<WNSMOCT^>,Z84<<EF<?ERW&<4"KBUQPD,,%/8671?3 *GH2F_TYOJ_<%
M7[A4C#;4&[JDB7=<FLRIG 0196=2)RT@+8'O7=HTIR10<Q6>BDQZ0Q];DU(;
MU_,PS)%/>,'A=4TT3US:3:=$\T.<3-'9X*991&&4P..F0995*-9=D\E3E[;1
M29E<2C+LFCB>N;2#3HKC'PDH11E13\%::6P]5M&5)_]P9%?00[M> MKU=H.@
M73\(G+$>K&7X\?KL[!,V&1Q>GGI7%\-+!-I\.KO^>';]C2<.G89@,O_Q1ZX>
M>7!['Z3%S4QL85>AB%!/?I+)'9B2;?+^;8G4FXJY-Y*>0!8IZ7N3))YZ&;S$
MRV+Z[\#+< Y_^_G-P<'>NQ<>+3WQUP!LZF"\QNHNF#QM+"*MS/Z[;2_ Q?0E
M;3*=*EC.(()EA%6&_?Y/$>4BF7O[KP?>P=[!_L ;S>FS8AI'=W_[^?C-N[8P
M9DS2+B0,1((QD<+=G<SBLL/=QM(./.%]$FDJQO=Y"IY7"@:2&9BWU4F9O!))
M1P22D?UMBA28@+!A?B"TLKO)1P/O/!KOMBU5IV#7/,).E02*#J/W>!^'X=R+
M'R,XOS#@-( ))-1YDO>VHX)7+'%GA*]-V?-.!$C> XJ>C_Y1A^5N*[N7W;Q@
M3^(IN*/SS@@4'=$VI0J<W PM.O\A2.,D]2XN3@9MKHXM4F$P#3+066&@ROY!
MR'[@]M4O6,NKDWIXMFYD&()JM"O?'N2N1TV11!!Y8S&C(_$_L'I@MTU3#\P-
M--[8]K7L=UAF'_-D_-?VYK9&[OQO/^^_VGLW;'/]F\,-'79*KU]FQ=:KM3@[
M.;\=7JQ;:]$9Y[>A 'J797#Q_[,A-;#,0M+L>%;5E8.>D\1?Q9[DMA'"F_*G
M"]\9OT<>EOW%[MZF/.HN7*:HO,08;7/J6OT89/<+JD[MQT<9R42$MDN(-(.X
M"Z1:,TS6P@_F&NKN^I]^/+GHPNK#S?/[#)9Q'$=I/IWRFJKU9!DIG8S'( R]
ML10IQ63DUR#-\&(37BIG(L'EU\:DQ+@#7/R#A=-$SQC!=3&5Z[@XWZJX.Z:
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M]I2UWW]@C^-]5%O>@PA!V<VXS(RJN\J@XN]3YQW7UT&6*GW-6CJ.9#$26)G
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M$N^$<J+0H8L)OF84: _9M4_G&^<ANSV5? U[KZ?HY!<R@),X#.-'4UWU?5G
ME:1I=?1F3\U=81YSQC3I5EV",!08*L/,&:OQ6,ZR2K&;SLM$W4S,\+)XM];D
M#+]'%_(S+S*&U[MOUC%[%E4V*MB=HUV<P@->PW"W*]TP I>0+:)6$;&$-,7[
MFI'>19&DK]CWEY2VV'CITIG3L2A3/+HB$K7BSK<,)3AWQD9:)HE>95ZEV:#5
M5RE.;9Q*4XEX*?FG2O]4-X05^N3)X:RB>'-M?2?F W>"8.VGN_IPCFON>1_.
MZ<,Y?3C'A7".55&TZ512'65\,ZV^P+:J=/;Y)O>LOK1N*^;8U7 R"4)TM P%
M;EV+K>VGN'7@2E6LL&]PZI99F[OUYF[]1%_4[/T>:_6Y+-47WW;13LNWANU\
MRO@=LLK3WBSOS?+>+._-\MXL[^;:M&N6LU$&FGE_S^X$2];#+%MQI7)B;AT;
M:;E5YHYCT&G/H.6LS0*;^5.->^^1O^EHQD:M2W=3-M5@_7,E(7Y #F+IVG8C
M";%P/'Y, D+K_[JP0>U=L+ QZ]X!2_? (8^K=[AZAZMWN'J'JW>XNKDV+N5!
MVD2IC3OIZPRQ\JF,'*T:%.N:;MV4X(Z47W=5^77$".O^\K1[=WJ=+52S5JA=
M,YY8'Q,D@XF()3M(3<^?6@VF'&>K$&!93Q\=?D%4+X5-@B1%3SA"+SP55B>)
M,ILD%B,XX*&U7JW9^15J67T2=<M2P?P01*4V&)KOZ[34!X*XV%T06MVVJ6V?
M1_'JK-H=^746E/,$)S'1Q>).E6N1KF HL>_$)K5_:RSM]))SI!7>XBN*XFB^
MXI:@.CBD#,:Z-P6/@)VR").DKUI;<-24]Q0[U,GIC/LC6#U&.[][K4:@%EE_
MPSC^XL51.+=V<6+93GUQVN(JOG6Q.*VEM4Q!:M*):E/%BCR@EH?!M&B$XT38
MOG4.CZZZC*V;@EU=EI8]Z.XZ$6T;0<_9S:/-"*O?R0CKI0PH3:ZLD4A= BNZ
M[X2!1F.LLCE--QJO^!E!'=8O&J@@"DY>#8V.D\6\>AU7EKF\J"E-."];S\2F
ME8]"!!5@!R+L3#;+DS074?&$(NPB1G TXTCZ17^R"_&(8Y'I^%Z*#']T149E
M)V7T#-/>("9V#]-: 1W4!-**'IS<E/W.@(>ZRL*+ "\\&S@Y&FXGX$+4++:"
M7_&EGX\SPUF'@_8F23RMZ5]2=*32)J7E1Q;@G34TRJ"4!B+<S<**(<]VF>YD
M<:!%JT+L2ZA+"EA7W8JO=*P][YS[2#Q:;XA!=]SQK!3U6(*/9S9O\1 3L?=H
MOEHU%MT: VJ3;6H;RMXWKLGB% >K.[U76E;2YU>]:>$]NY[JWZ3Z*C)Z:_4&
M+>X)CP;A2V/3$S*TT&4229SC)*,^9^,8E2V&^];K:L]P*MP&LPO\I?J=PRZ[
MI;[)%)_70H4PL33FK\K0UZTU^3*AOIVQZCE:B=%_Q-]3CSBX5,[PI,SK7"?K
M&R!E VN@]#8U"GWB,E@APF&E&+O!>8RDC'@<3TL3N-,8[:#IGKJ*TVQ'MP*P
MPLFP4*8YM*V8^@8FSC8P44#IMWO>6(0R\D7"H/@R4-KT!B[!+&?48+S44-(4
M&&+'VJ32%AWQS'#.0)5X:!7Z.9S$+?QT)RV,A589G; P4IEEJG5Q1DUAK)O!
MEQFVT:#*0Q&.\] D(W3*L[&]N\D]E9O#%UF/)9V?MX*'FL\T-WO?>E@ZF,4V
M[TN:NRL1]%6S2[RV\3JA"^3C<'C5A$^N]H($ RN+$P).SQ(<M6Y9.I79?>S#
M+M\%ZC?X1+!IHD@F;+ZEF6DIO[ *EG(]#T/XIVDJJMLH8I(AB,9A[G./0D8X
M$QV>[A":D"L9A &U#BUW^D2O#+Z"/9MAFKEJ3VC>FA:NI7ZP2 (:']F@<:(>
M15_#)^.4T(C!Y5)IK*S8RK2<YJ"LO&V;[GH?UE(<17_P!DV!"PVC+_\ZM:5=
M4 4K2!\M'MWX<QL,;^#U, N#;]\>>#[<]?#A1-[EV)A\I/'?]S'XMP/NXD)^
MC]IC0:86;U.&+6432XXBM!-#C\TP==C45)<&";:L'@5L8"%D7#V@J#)XA*,!
M-LR,.MW2=%5'=JH=-DV\MZT/LI"J1FS4N!.EO]R[G#IVT,DIIRL7SUD<8I&*
MZ?*1PPQ2D@ML])N:5B+UFPA+B7N8R(< M&#C2[3S:>DL%C,11)QIP^H!I0NP
M,II. 4H<&Z25D?'$*@)8>9VO$N;53RWHQ:6JSXQ\I>(SG]3]T\VIG8'2D=:!
MK3]?W0QZ6CG$5M':Z,B"5$]!-^2)M#Q?"IN5+K3&C5Z^R6O>;*0XBA)_M(VT
MWHA\=K)G*'>9JI$!3>7G)M$428J8^<$$=0R,_L_<OR.M-;"5.]](V$XZ!D,F
MD-18&I1@, OYW^KZ&O!(0-WAO\<AGECB6M5A0LE=P<A%+]UR-<=]U:'"<5MG
MZKL7':.8]A_[Y&^S^._O]=G?9UO,NL--_5[;<DX:5)YNCM=NGM(NMQH4M_%+
M*BYJSMVDN?*478&RNEK5_M#67(N?91VV^/L%;;;XD?K+I.%SM78#M4#_8;X-
MM8RHM'K[;E_'E;1/-RF*SR=+#' _2,E.3HL=*QG9051_G0^6/--XK; WQM51
MG7+T^W1Q.D9[\,'=#?*<!ND,[GSO,L9CT8D(CZI./BRQ4]C.;.V6*?>H/!]O
M"F<(0T;+PD48= C@(;I9[**.?+P/QO=+1&($@Y/HG8-'0P8OA]ZMT,RBFBHE
MM+1W5/MXH\?\$LJY5.ED)! G DLQ-'/2 %N^G!J.22QYW+Y:/74N*HNI-H;>
M<[BW [N#UCSB>$TX:H( [8$W"K@[.\X+U.88E"&^A^"^8:CMZI3:P9(_Q9V'
M*1#PP NBNK)7AH".#@@=\4;P_6\B*_BN92=VG902#5!/"I9T_YAE<$NW8PCC
M"#L2J$]P?Z$Y)?BF>9;38TD!;'.F"0SJ!XYJV9IA$8]0HY@H(.8W:BC>3KH=
MU:;Y];M&V4FXU]@P 3?,B I/8IFJLRCCN"C%RR,-Z="3(QQP(388[\#D;R(S
M)CKF,>61^KQ/8LG7KTYA:5HV^+I^DA$HZIF69>P[?F0R@?LXB3(X 1<75P,4
M\$!-:!(D4UC&""69LI9*JID9A#_#Q'&LXT7$@4$^4$HFQO%=!%H+5].7,TG7
MKFW$X4L&-CU$+>](HS .E#(I8I\CJ9SAA=<1=&4AGJ;!+=V_4X:Y'X#AU85+
MI7([J)&9[O.L5V%SD/K=UU$_=1^0IDDY:##IPU%K^&;58)\OX5X(+).K]O+3
MJ;'BN.#G1_.5RJGHU#Z:E\X1!UX'"DQ_CZ&<.NUC:NY87UEJ"!1\R7BH5:\U
M@K7\RO[V8*ON][=NLJGLS!BE.A6^N<V/CFTSJZ3-4TO[XLV(NKT\H2*+@ZK:
M7BDKTVFNK!+ ;M6FHA%C_&B&DX!23.B?R#HC,XX0)D'J!SSQE)(?'%PV0+U.
M'U5VG]ZV3!ZCKE\%4Z)('E;PS.*RP"^5[:4*EHJ)Y%=M!I8V#;$P Y6H2;&(
MO\C05!\F# &L;]3(!FPOJF-PGCM09*1,#5*':.G ,9%JZ:?2-[Y5D6+".N2,
M2.2TK52Q7 =KJ55+HVY*75AGMJZ&N%E9C3;&,I7R"UU]T\B$"CFW/8ZUVTR0
MY0P.4B3GJ3K%WD1**T4.QVLBJ4.Q"/E/X(A@T1]EXM0@.!H7*6.#H6KLX= .
MWQ&Z;5-R=\4^MXOQ:E:>\+^8FBWC]4M[0A%@'2 =R>Q1*B]KI2>\A6T )3QV
MHL_ZTDK0;16WL'2R+SGO'%M!$9U!2O5#E7[ -QI=HE*!["T5? :5.>]B&""*
M513 E$;":\=D@NLW+%X-:7"'5L>#"'-3<D 1D#L"1J+.$;Q*_ O0:_Q9TVJ1
M/DUE;CR\<LT#?*I^31&=@NE.ZPWI%,;];&]0X9S2=9NR#5>_B"7[I_M'L'U_
MI1J^BN)H!PQG*4(&VB">1$6TM$^HQ%ISQXL1;A=F"H();KQ,DIBK6!*1^TL@
MG'WZ]K?]?1?3MYU)VW23LPMCDN1AT)&KN)4->3W\R(;$8+IA5G",T$?C(38Q
MTH7EYKA#)R.)Z_.]="'(R NY.-JM@(SO;8RH"&4M(;M&/AVI.AB^5&J[-IN[
M"2QQC#H7IM/"BW8]E0Q=-81(WHGJ$%:\':1]Y=O7??W""JA0U(1,U./M6DKB
M[$GT/U6\K6@8M.?G<G/"1:WS%72Z +UEZK9:#O,E$.B%\"RZ"9,\(9? ,+^I
M@KLGE&^E*HD1*VB2Q3E>USG^*HF]:Y$)[T-24'[0=[[CA%<4#*NX%SSE2_/G
M)LO#!3I_Q@&F]%5TNLS3KKH0V$7 ?I#@X3-(*NM/E 4-I6+:5D.IR<FG]W&2
M34B1(GHI404%$RYKMYLAB <1L,\Q =%.V8_5Z4#*Y?,_,?B*#J_&2!>1&7KA
MDBEN!1@[PNG0V4FS./8Y5A<L.-XF"6^B2"/-0D\0554< 7N[4PQ<S5TE2]1Z
M?8"7.42#VTV2ADY:< O'N/45VG^'0'GNR@"*2M?SD@;34 K2S60JAT7@I1[)
MT\W;T ZMM!S WM:0!Y5?,M8?J#-]3PP\^>\<E'X6_^WGXS?OW.D.U$E%L37D
M^L.F*FA]I:]]!KKOC[<>8]Q^Z?5Y(GX>]C)/VXU-O%^W"M9"%L3:K&@$M%.M
M0L<6>Q:VO-;.Z--N*]3"[J]6DO?*M%>F/T*9EB6POI:GZQIR\Y54M[74.F5:
MW9*.+IZOYK5S2=5W(X^UW765U1MUWZ,O'S917=96JW9+0DEMMJA?8 V7J\W:
M-71)?;9O*;M2?-Q-SME.AMR7A_5:7ZYGCK_W2F -=WEE )ZTKDI_8JJ/8.;%
MWA#BF'@NXNDLCE":---$I735)#V+;V_WT?T?N=O%?4L<:2*:#RCO;.#:30'7
M_N)]UC,7I(0++U#AMR#=<"BJR_XAC+&/NS.'XJ]Q*GJ(_=./PT(E1L.).)%!
M2)R9<.VX<RRZ>2[^1R:QY\=A*!)PO?YC;QM/1W\>?LAYT%;1RML!+37U][Z0
MI'E1]P]<+"1I:3$;E#+QK:2$2K1HA9Z@W%F@1WFVGG6D7ONL)/CM-B4X;+H&
MJE-G[*0K 9QNLO]_+M,KU90.5'C];0 P([CA$Z0Z*Y] R.N VR2B!V7.BU'Z
M__$R\]Y?,Q+S=O_=W__^=_CO8:L;T&$:([W570F;;1==DVIK=6I8BU.J#%#8
M]:*O3;I6];?B:N@-N:7RJ\L1K0X 'K4B6[:VIA"CMOK"UC.L-$P9EFG_8T2A
MME]-32,M)(E8V1XI7E2'BMC%TFK%:&@DJAZL5!FQ5@'G(@.4]7?K@<6Z+A\(
M*>,L0<9'K)ZHM)A@+KD_K0: 82"Q""?+8+<4Z2=^64K-8%[N]O5G[JLV@/JO
M3*DQ3B17W:N?K^#H4'7/X@"1:C=(1TB[XC>T%BA:;"Q?O[KU&5I=#>F%BT48
ME;8VZY?:%%-1)2_^#ZAX6JZ>B.8XGB%GD/E*D-CD$PNG"_D O;"P4QMJD<J+
MQ/6S$<>*%N: G64F.57+^*JZ=J96)% L#4HP%I?9.IO*YMB84L0N5!:@L%'?
M'E%?1:Z6?[/6M-TB1G3FX(@LBFJ0UDAK=VVW>E\*009!TJVB<5?\NVZR@]\N
M+PHUI>?9/;(:;1TV5Z6N)U$+U\-2][%2O5II26L*.%4)JN);A&LKG_D$2%K&
MZ[_%J8U(2E_;/V,)5^4DT'U'N;$Q%Z%6[VRBF*TV6V.NIT2;J8KTJ[BURX8)
MF1N6SI"KC.)=MINKCR07FA2YL7GM-ZQA*E2(+^OLAA56PUKNDJ)81GYJFQ#>
M3&902R>ZSEXN="<V)I^]$LHP2XG38%T+2E/YK>ZOK9MI#[SS: >>O?,ICF31
M=KO*3BJ2![GS.<^\JQ!$K>K'T$9TNV1^+?]M62&]*YJ]FP1"Q' ?C>,IB 'Q
M5 X\.#?:@3+T>#4ZR69489+UHH(>43#B*^TG/YSHW>+4XN$>*"VL7T\_T@B6
MOJRHD+=8PE,B$JOYWH BY,&$5+?NX=O,OTB.:IW5MHGURAV@@L-^D%.F9!C)
M0K/H[5M+LZ[9\J&JTPDXI6Y7$$73^7+>0,5IN%B9Q5<76XN*PDV#*4Q*1#+.
M4]V>NA"IE^6E:%:$?=+RM_U#%Y.6G;F\NDG5<<NV21(_8._4A7BH"JEJRXL,
M,:59!D9QJ+X3JDVML"WSQA2!>O!2W:5YXK'=519D1(-?&FJ-SA+<5@2_IMO2
MH+%XI]J=%*U7-5]FT;.6G(I0C*7F>5^,?M>$,9<&2!6?N5HH_+<[+>V/FL1Y
M"'LD@E1P(/(T2%/2:H;H^1J?TVK!DCO\/]W,95_&&1Z$%'2":KXT+VB]'RSZ
MY)*NT=V'X/&)2.9T^A,VG&L=0I/T$8I4# R.V#2^>HA5(Z*)>(B3BBZ*N8<>
MRJ6O58'=)0T%5S_,S]'L@%^ V@G\<,X>(R;;IQ1H1YO#2'Q!M$5#)P-Y"HY9
MH1RT?7GPZL!02'\\N?"V#,>5^BYS8R42C"#5J (&T\D0ISKBI,%I[!V(9GK8
M)"GD!:4X"$8\"OXYD(H@3%47X F%'1(K51E2_JN!KTYM=4)J3*6FFW:UVE[+
MWF#J8X+A; N\2&%O>YRF=11UKEAX>\/M@^]&MJ.@2#F"O#_(A,\$#(08^548
MDL-.^$ FDAM+##X9P,B&N6VMTE*RMTSKOKCFM<M,FSTNV48BU04RMF3$](M<
MULO4PAFLX& ++>/K\.#99*+BC+@$@Z;GZ,2U[C@'HXCSS-+M.K0@<K@Q809C
M0N3B]%%HL"U$\9FQYBB47\&5M5IUE^*CYE,L]* 8E;B7IZY-.&0!G%E27(EM
M-IS-;I9RFUZ"[98H" KYF(L5EFU1,+9$]Z^CPE_IP)W$#47]1#RF*IC7<,E8
MI@7W1U1Q:3J\A:V!9Q'C?G@-2#!/ PJ++/\2<F12\%J=!(8@:&>GI!%T +R$
M.EC4$L426]/CE -/HW2S/GG$@]H56I1&TKE&<8QDS4?(JGN":A9\!^IA+:]$
M8TUF8#WD3);:]77ZWM3L&NUR.F]9"]CIY4+ZZ_W]=@V-;BY0VV'S#J_+8<^7
MWK0TK:J=;6[_D6)*(U+6CO N9*9N1N(&P>:3*J)%00H&,% W+.-'X553\?Z7
M8B>[N1U6 JQ5#?>LA38]'JDN\*_#:NQUW1'DA/)DS([@&5X!L&2F,\3C4>OS
M>*+_/E1_QX<8C!!;?<J(\JLIA%D2Q 4(J6QPDNWU[YSR?]97,$J3)^-[M.U6
MQ03KO%YLS<VUUA9@X^1>S/" [Q\:EDP0'[!%HT# LWW)[N'6>WN*RK[E0)\)
MV*D9X_^V3K:M:"?_86#6+5$,^(L]:$LK5.>X?_L,:%BFYI?*+V:8H<DC3.7B
MVIH<#"&2F'#C#H8L#)Z&D>82'?[%EO&5=:B?[JYW96^\0A;!9\N=YR(-=)]0
MD\'A9!*$F/G%=@&E1$TM*F=;2?)4?)$<XYU.N1R*?D.+JXSYNDDL>@P4.)XP
M: X1:"$]5OV+4&<TY?HUJ?-1LOLXSY1S@,NA#XV*1IN-9%%P)UETW*0":R&1
MK5X[CMPZW<P,G6,O6)\/E$309P#KA/D5'QSK($5UAJ85MNJ="C3 4LH'R>F,
M^[=CR&\TKY1%&&52J CJ,*M[J=RK@&<]_'8JYOA-TC=8"8,@FW$B&>5G?'X5
M5(@D%MQ0=@KQ)0DA450&*(8CK71H%16%;]?S2?O:^>4PE",782@M+:8)@G?:
MUTA;1]OU88--#!L<M2LR:P"8E/,C_'B6U:(>!A7T5#D3:/6H+T&<;'P[ 0RD
M*<J07V$,-OQJ.3S4#FZ<QF-V3:Q>BW+*#@IEXBQ(Y0?$>,&H_(<@C>$Y%Q<G
M!%F^M^(AJBOU.L/H;OU6YPS4OESK!QFJ*)+<A*[9>-3IK#S2B&S$D\3)E,Q)
M= CQ/!-L6C?IYC--^ L\32D7$W$"3!EO:Z@6AB?%(67SL=H&R[2FXL\X88 V
MIK7@9:EQ*6MJB334A/ Q17E #DYJ DO%F".3ND]EB,ZMB#BV43GE\-$)IM;H
M@0\"4__S(KN?YB.%X/2K7ZS1-2.Y9,4);X6-5'65>G,1OZ_T66K%6DQPA<$#
MNU3)'TRG& T)5(Y0@0@($@8.?L2!WJ();4JQ!ZFKM4@EDL+%59G:\-3Z*:@8
MQU121\I8-[(D33KW/B9Q/C-ST"58EM*GD)A57=R\  M56HZHC&[6 ;V?J[K_
ME[SME23/.4FQM-:P]FHO>=-@G733MNM*#F*@, ,<ML.#IVO\"HX4%:Y<K;%U
M/2+']M;1\4UVF$#I\"EJ(7P_L.L,03W*NYBB(1CWH$"],\R5G3SVS7J^N%)G
M,^R#JY!P5CD#I0.3G"OW0O$XR4.D@8F32,YAR6' 8T5Y_74<YBF!4NY4G'AE
M%;.*2A,ER"Q^E!B.]T"Y#/#N8_1IZD5"U0W&BW\;29C A*P ' :E,BGF%J_D
MT($WP3B1O1L_[<=T96-]^QU?L9:A1-#!,6%95?1N8$Y<&(#^4@6WRK%1D$.E
M!TVL3[\=9F#E9N$GRD/-\/=V]V&=I$C+68IT03_&B3Y\ B]H58]9$^ KJ_G:
MVA1=4%PK+&?1G> JE>(;E,!QYO1NYO$EA<NT.FP8<]+,I#Y9+ M^!;SBOT3Q
M8RC].ZF%<:XX>4("TJESM9YCK$J.Z)SJVR:QZYM67CH&?,>I24I5(IV@L8Y_
M<(!\8+J#X_E/M4[$H+]!4%C0.155>(:QE<9@$KN4]K8RUD8SD%:DRQ[SB. @
MC%5"M"@BBYLL[ZSH)U.?P3 E8?#O+0U@9KT*!Y:=3MJ5TN.M)Z56K4"1<"V-
MM+B <([*/REGY9<:D* U@H? SQ'/O3W W+;*(:OT:B(G"69JF U#?*DF7K8>
M[R6M'[S,RB@/5 *5-25ZQG?&?[)DE<  L*</I9PK97<YD:)(S+!-!_R0!.0G
MX:T!!X-&QPO^3)M$:?13?>A)69NK.AWHLF.FI4 .J(@8V@H9$BI2-L 4-*W4
M'1V^XA,SHFM+BR-4DUC"8?^9^W=VB6*SGZR*,ZD"*;VWOV/,Q"=?,3.T.*.[
MG5!.U(72G.VHR9[TN:Y2KNO8Q5Q7EVR.;AH=4:5 <L%S6\,FB6*+1U4;Z4^S
M+DSI#-RQ\BN^B!@95 T*:<$@&E2JGA<,_;^R3=O-AH$EVFBX_A&%E(5\%R;(
MH@&7G?(GX0=%M6J[1\K%&BL3S)@/5/JJ3(?Z+1>IAC\I =2W-5B#XR08Z59-
MF]"7H>5*0MR#B.%Y<_O@$]6KR)E76<6A!-'^9!I&-U%A8O57--BB*EF+*DHF
M[+.!\)6$@'Q?)0-.'=MNGMHU DG6068(+G*^THFF;60MW<C>-F".TN+SM.V4
MOL@3S&6%@52^ :,FT7.040XC'6@8*7U?@)T*CAW(5YKFB-M%3T2H1V$. ^OF
MT6Y%NU>ED\PUA9]:O*?6Y$<S/@(?"[>DLINVBHK/<=2LN!/X\K>UQ3)OQ$AP
M<?/0$T8!&T DCA317(_@T/!4+@V?YV/TI!"> /(83"P;!X8Q"9*IBLCB+4!L
ME!8%!&O+9;83]V28,+M;J:]AB6&-F+B7B31\AIQ/K(>F+HCD\()G*R8X1N7%
MV9".^C5F+8^1USCVD> @NZ]-*=5')W^,B-6+?JO%SD^.RGIPB7J/ L,HYI)>
M@_1SY=W=/ I."===ZL6)5 3?B7THE>&VU&!;7T*>'K\V_@6Q8R8BIV)@+,'%
M1 <ZM/K E^(SZB:S"0EKW^F8]N^F^E\L9.Z-]S6-=UHZ3+QA\FE=B,D=4ML6
M14'+%()!$Q6V(*HF?.),DD@S D=B&UTJ&:(_)XE\B-G4XM![/D.34E6Q&^!0
MI6^$C. 0CR5]K1J^L!@Z& ,C_4 'J%=>?WAGDFYLP,TW1VE)KY7U%AFXBR@=
M7XKL?L TJ3.927!\!MY(1%^2?):-*= :!O_. ]\@:E8.N[0XVHPI7"DV/ J.
MDL)\KAN=A>E ^A<TD37]WLJ!* WY>!^'!EHTL7JX5+.Z!AA6">L4_95/8JI:
MP@&42/M,/9E#.K=7NLXHW<7C:)QB3M)2]@416LC0#(9V6,$BECT&3).FC-!<
M!VU1D#$391NJF-2$NDHD=RM@6\K*6@<9A-WKE2-&_-'T16L.ZQ $:U9&I;_-
MG8+TO9R]*]6C@N(0.!%,3V'RK818#8G99D*Q/GW[E$GTK0R?*V#$;O*Z#K-R
M:5PI),P>B&(4XYZ!&DY6<"F7^9,;;9&!]Q_'>WL#F,U?UH/<L.(%^!%>T)$B
MAC5:U!D5U=BB;NDTE[6LZW/32W+3KS8Z-_VJ2V68M138S]X9<?DQT+%)#+1+
M?RFL:@U(5;J(J2*D)T*"Y@-D34AEAL0;.#D.>]UC7V5$QTC\_^,X1:B,;BH0
M2-,V _X6BF"*T68Q%?05#7EA; W^1G<7I/8!B"<SD")\IVFZ8;%&\&MUU\.I
M =_00!B,G\-W;,Q.^B4(T36&*4[ I((5$*%IBUCU55,IOS!C[S@F;XZT3!"!
MIP<Z;'L5RL[T5'@.-_BYPG?%ZJTH:M^XLH)V>WOHZ)!\$&%NP&\JF6#:>>(I
MH-!I-4946RBR:5;(F3JC73!#2%$A*:91R1;9H[)^RP5:2U5NP)3-#*31 ;(@
M @^3>^*D^0Q4,CGW!%"/I_!K7YBL.V(%Q](*,6G 3ZF@4(6M=%,6G1[0/8)
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M\'4Y'<4^TZ'-S8?.HTP24!>]EN\[7GT+@C418F]ZA-CS$:\3YS$## B4#E9
M@NB/DF";3X'*04R R;.9UG 5O'HG-:%VG[6:Z( FW-:P":U/:!N\X602A,Q0
M@<@44',Z:3067&[/^L_/$]V,83$KNXT/TZ@,(N_#SY[$R2S6,+JFEW4Z,XJY
M79P)9MGF7=A#Y&9+J32(\^2T1Q5<I0:)&;@,M\0"G\#7_:WBL>[^HQM*D90V
M7X14RISB\Y'8G%E2L#H_RY.(V9[C1T&L;A,BN52_A^%1Z2>19E&_N1$WGK,Q
M77>Y(%I/!?]!*A(&N#$_BDT5?4<8^%F>C.\%P\"3.Q%9_.G6.C"6E)Y*O)^&
M%64,6A!V)#%@LRPA=N#)$O$E$#=\UP@P<_X72"JZMA>B9W&>H6VNG_U[1)6[
ME(56Y?$3<G]J:X-I][!3,!)O$PXJ(,/"["NWWV3'*E)5!N#V95918H$V++_;
M5WY/GNI#71)U QDMU@I?EJ>HH?DM1*L,TQ]+T QJW\G!*[CJ"?9:I.9Y1XHQ
MJK'1#&#P.O.H%T(/;"GAICM>1N]F/#%9L2(4W?JJE7P/=0I&$H322#:??5^8
M=C 3T)1PP/X-"C'C<CT%]E"7+VN!K$)PY<5C4 BJ],]0[>*G0E%Y?HR04TV"
M2:CDIC?2_4S&K&/N?#?;FW3RG*V7\VE]V58?-#P"P12)M^&X8)F%@7R1O8"X
M]:?BO5[@H'E;9'#9^,>7P)_!VC 36U$7SO7B3#O424GLO@ANN\?_W2O*M:/R
M"PYQZTM44HK9HPP?Y,X4OFJPLLL5&/VL\+"@(T!U(0=;8O37#"F]3'?&DC6R
M9=6AE/X KDO-V\3"PP>%PX/N[: $\=7>PGK3LM^_K; X/G4X[FZ&9T&6O#-0
MZCB##@C5MBLHX7$'M=M2E##W<L83TRFX_J[WP1A3=JN.2BA@8<P5TO4[W>ZC
MN?(?PR_E7Z<480CG1=,]+OM/#5'?8YQ\\68"FT<751P4H'H(Y"-7DEG<876O
M:* 7X*<)NUA@V7391E/A-F:31&K+Q&>WK?K2PCS4V:52>(8LM43:S0:+OMA8
MC,EKL90NZ0'W>ZZI$O)$C-?:MP[GQO58KWEA.Z$MO;*88YT[\8O912EJO%X.
M-F[H(;'(7,)MR#Y!Q4%9S\1'\LM&4DO5%=XJ1L:DZ 0S*G@X5!'^XL9CG_H8
M=;@20\EQ1=T24%=NJ<?C89)3.B_PH<-2O1>[9*C,]#W?2(K*/=K*A[I&/-42
MPKS/)PT/4\H)71R<QE@7Y!=<;6JL-/W#O1VT3V8*,]JLE>SM'=A)DOUCGG+A
M:[+UH77DEJY="N/HCAO<DR]'AM.<=FJ:JT@^C7%[P N,=6E$BIM@Z719^\D)
M5DNEW,H8/RRJ?>-*V\-\NDH& DS2J):+6)F-CS9!::MF"3G2,E65U2@MRW;"
M6C948GFD(_S5(2-ICDPBPQ',(VX44+7X]-?]X]+^T9+R$9PE8-5B%L-RO--\
M- TR>WUTHF3AD"H9U-?Q,/>##/OWT:5"66Z*BUL%Y]VT)Q3C*IL\2/F]-6J5
M=E41%=2*&(G%XGX;^@4?Y<4O]^VVTBD39@"8Q:DLND45M?M%'R0!:\/R3Q%5
MCW*ARDZDJ(X(0NP%'#=)MK7;/9JB!DWQMD=3/-MB\EVL%2DYTEIW52Y=93J\
MR(W+/#W%$>$KBXR"3$:V2L01(FDOCS&M6-[--X65&L,7+']BG6KN=?&3=;$C
M/GX7FX\MDP--6WUELNK=8&O8W_/>(U  -<*II5'(2BPSPAB*T:8Z(DN5K,I3
MU(!13/ 0=80F4>SF9E8/]:NM<<N\]B5/%!L/&0H!FRU=UWO5PF"V,/!@=G#;
M[H*K"#.>]+R!5WH>,<2I@:W14A+T_6.0*-:E"2?5["Q?T6B>6:BV&*,VOI?C
M+_1F*WS"#&P<$-+A9OC;]L#^J9E(K4 '-XBT8:I8)?1;#5)?;GC::9''+@[[
M;8KZMG(FB!9,;\URH@SR/KE)249<VXHC W^QL-OI2MJ.$F>7)GSU=<=B1+X1
M2ZS%$&-ZT[/W_)=M%UG:MY7MG:UM6_N<KK]QW'B&- AJ,:5F.-#R%=EE606%
MJH^,=;5=J%ZOV(TFS00WT>:P+Z*;S559_LK D.BRJC;ST.8THC I!LLV?&FP
M>62I,]W,D8";/KF-'/CVP=V<HR3"2TK<:FG1+*?R<D4YQPUZ==-RU1?.:B9'
MCJRBF==-/ZQFW=8"4A/B.(FDMMBM55BVV]MTVV@:=1[E8-GELG 9#8@0?175
M'N4BY&2BEH-J.S!\P*#%^BE-$4'*J0+X'=:\F5LA2(VUXHIAW<7>'<LNII,8
M=@1<P+;M:5>@(=W$JOY.^9-O2I@,*G'\JEE+UF@Y!9?%@W5#\<5'8#;\;'C4
M0BE97UV]G(P7?=$[PTTU#FEGD/R'=TK=4Q8_6GG=T0+'9;=+ZO32&Z#^ DI?
M><%X*8?!E%-=C/!+Y%U,W<.9*7@&/Y@<A+JC5AG[/' ]8/%%4JO%TF]GZ%MG
M-2E@10 [*,BCF;=5_32PF6&U\SU+ L+RJV@X62 /,7=AI 0&+(;.MFBF[%5\
M"D&F (6D;],,FQG0AED610%VMOWVS>A']PIN.Q"R#KGNU'VJVCA.L1[>B81-
M,$HV<_M93C$P63CN1,D"?4K)RW.:+WU-]S-?8)HX^T&E VBGQZJ&R";.9NUE
M>/7Q\RDU/:32OA7\ JI?:*9XI$7 R56=6P:CF5]G=TU:^4R-7V[^0 @7JZ]H
MSXL.*%:LI\J3&2#U>!@R;^'64&VW3I8L"W%QO]FQJKVF B>IFSR/1/0ER6<9
M^W.H5>$$ZGP$MNN&&\A7>O$Q("3B3CX;%,X?',5 3E0?D313CO]$XDQ#^_$A
M.)!L#VR]5X,W7I4]IM2,US>\VFO,DEOZ:M\Y85<&3JFD%!#X8WB9J=3I.HM&
M3P.%#U."+12A:>82$+C$A%)FJKAW4-2#6;/!I_"KR;]2/7%AB:>PRLI_!8U'
MK=)] ]<(OL)MN/5J;]N&F.![]<HH DM<RY,G",(4;E>JXK=</GV1CF0D)P'-
M$!0PY9E2[N<.VKCH5$QUDJEV(JGU T;,K5BXF2PC8;':#D2:&Q^;K>ESRLTZ
M\V"OSRD_7P\7I0,F7#%,QFAQJ#&D'H;Z5,.ID!P"NE<ML5E@!X44VVJEK%/6
M>S@?6OC<UNDVDF7<"[@<\"-X421QR.HO2O,I]71U);HRZ:!QLA2:G+,[<DF(
M!-ZT\XC*NTF17N-3V@V];)ID-#$$E_P W?]8D"61IZK+\7)>>KQ1J3QC@OXR
MU_-C7WL6, 3<:6*!2L7'TSS;4NO2Q6RP,#EDR]*UPL#ZI83"\^YA#79"^&KH
MT5EGA+GMW9OV.'"-4]\0U5N.*\K)SE"/[(,LRX(LS-E&I!*E*$2E\XQNM6M,
MTK( CB1&1S R,,M'L 2HVZ,HSLFJ1O5>-/X!T<S#K)8]0&U8%4(MPM0:@,_)
M#7A28&D<*Q=1+WZ1OUQ\RLEA.BEIMJ+QS.Z2WHU%I@8-V!!C+X1HM<;,)T:1
M4=6OJTHZP:QT_.HFB\=?= [S\3[VN*&X C36CL7D=83N HLK@?DE[L\(#^'V
MUE_EF(#" @_3!%.8>$]C@Z 2J+A\AZ<!R"9H#82$I QFQLD6<$[EIIY4'EEJ
MI80N9KF< ;X[EE7@)G_2R.5H;DL/.% ;I_4;[(&[#;,'KB5VN=.9\LB[54FR
MEI,O5G2E!NA+X5&5*XS7C(7HN,6W1&LF:_O5=:Q)&,A&VAWR3-.!YLJJ=%K3
MV<E4-4ACB+]V1RL454Q(!T<L\<E[!Y^ZH\7@-S!G@DW 8&[ 3.E"H8^*@I5N
M*F4J88:"LTBDTNT5UK9)=4;<JQUL'5E-QL=PG]X)/EIU'>IKN]\T!^\9 D"O
MFE7P#SJ=L@J#40QM26:]X!-B!,.@0IQ46C?5#M1N'1V&!E"0(]3?6@8*NQ 1
M/"''GB$,N9*$UHY&UF+H5&2P:#NZ5K.>!N077Z6+=0LJ_G50!6>6R2V,?ZSB
M_;7RAD6<O'LI]A1$XQHN\0#C=(LLOEO#;?KH'9)VX6>5<H$YPKWZ168#4D\4
MXOO;ST>OWVD,-MM=I@0ND7<YF&ED@802*<#&1(I5EE^Q6D^9E8X3A.N-K)_M
MR&O*@AE_G^9%87N_K=8J-''UVD$R>1;'\.".V $=D-"&9$%&-49:OR[LAU(K
M3S%@9F@+1W?@)TVX-^$JDV:GQ0:&.K]VL-L]TP8,F#:[%YQ=79_=G%W>#F_/
M/U_>>,/+TU;Q>'^TN1;#Z^OAY>WYV8WW^8-W^\^S5E?BI,V5^/SI:GCYWYO6
MO;09XJD=V$2;"5P'_R@2O%72 H9(OU;-D&_RT4 [P2)=="I/V;?&$KV;\;WT
M<X24"WTCIL_>Q*Q%!7JPN]^D.8<Y^-QX>7.HZSWG(;U+D:G:16-"6(BTMN6
M<@AH>1J_?ZPN8\E=GCD4J*?&40%*]#'1)8>EF%24FT^O,I2)Q LCG;=%TV;O
M-![G4X4>LBDW!9L: ^X\4B!;3-I=<^76F5QD?)($P_?]>%:"AA8#4K&E:QW/
MJ(GQ>/^*B3V5L$TZ[\%&XJK.T\JX5:VGAY6JP.I@&#O[/D8T"?SQE$!%<;+
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M+3U:E?6G'7M4@R]]VAN&Z@I0OHO,T3_]=H:B:MC"1-78>D2$<SEN@T%39*_
M2T=8J.-2&-<\L<Z"PX=2B9"J>U05&=)L^U;6U:KICS2O4YAO%VJDB5:UH="+
MJUD51/01[YLB@F55=^9F^\U6-U?BDEXK%= .^'>5Q^B&>RL8\YIQ'L0V3QZ
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MU#&2#.L_6^<RN8VDR;WNFZ# )#$192WG;AXUKNWVI8F@/B<\07;%U4Z>[+4
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MI[#(/R2()0HRRMSY[<Y7G+$2P"RA_)@[YUY"U\BAN_+;\2S0LFD@-6OTC/3
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M*1C+>>40R>A6\ R]F2,&,-R^SJB:W3E=8GCFV RP%80_OL2JD$QYS.3DU\;
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MGAWI2$S.-%M?-*/^U(UO3Z%63]MIE>#ET,[XE&[(*\A<++H@@.#.!H!8N7Z
MYPJ[XLY\1*#J&Y8YD"HH,%6B0Q3:&UC^LL<WN'#CN*IJ?/,$?YFD8>QOA"E8
M26%H_'9;\A&EV!L6;X.@5'Y55RT)UVFRTA#'&5IJWAHKMR,9G&,:-V*4?3.
MU-%M]S8H!8ZQ+$L'L1 RG\Y$HY:9I%8M0"61@'JO3X=LP]>%=&S\^\L7B9M/
MI>U<I$4&CAS* B6QVQM#&_B*,DWB+J'#+>=6?:\1SBA,Y(A_?.),T)WOO^=4
M9[WU2$9*TQ[+TI[NVC94!:;U(UJ3*B4'%^SDQ2DM!F'Z1<9\D84NP^$SI4\I
M'=6Z%]+V3GO&EQ%"(Y$IGO#!TEF)YN2C!$=KSL4_H#H>4BMVW,Z-=#X^1;Q^
MZW)(G&F_N;)4V,U-^UGC1_H@)66JOBZ=0F [#9F5BH4)#&RC$-@8,7#ZD.TR
MG-*;TG:9[G[Q1DYSB+;',UZG/3%#LU!9W!05<7R_V6-A$O$S/D/*HWK'#>7A
MM0:&L5)5TWN ?D/(B!1WJCM6<:9Z.>8RK0)SP(JK:2!!/:HE=C/)%79R*<.B
MU525&?5S7K7 A%)FS9WG[(0+CS?E'>95234EP0&[=[EP%@\=X9[U;E,U1-K?
M 9G$1D0X<7\R8_#+/4-JC W@._?^YNYJ VV>,9^W;A'2[Y7L&[E0(IV++_R2
M9^6LW52EY;K:6*DUCB6Z>XGDA)="JRNJ&&_+1;N>4RZF.34$NZ_- W$?):M]
MK\'*8Y%TUZ)?#&?D-MWXI^=K'0N ?II+/UIMG&7I^PH19B1=WJ34 U-4: HF
M3[21928;H"+N>X1Y[#7KJ4IRG?K6&5W%<GME!&JP%AO#>"QS[BAS/OVNRYS3
M(C6T!"AF#?HESO:PQDZ0E1X^*=M"0736+Z52CXIOWN]Q/.3 G[[5FZ9/Z4[\
M663Z^+#D0\BY<=J[#Q08L6?0IW^O7#@#GK^M<,B1GW>=UB%*6.7,=5$0L=T@
M70A!/SRSUET 1@UZ )1:\+I\.-LE5>?"P?+,1?>-$3X1K)T0*# ; 6G_[$Y&
MJ,<0&!S4D=W41)BVBGP#Y2T\LH4ZS95JS^2Q!E,5Q0YH1PI)CNW]3/,%1<%#
ML">5\F53@:LDX;8:XC8YTVFA-)UQN5O>KM<-NO780R;QEB*"VX74*J1!Y*K.
MLF6U[L<"8"#=*K34&2)"#TC/E.ST3ZW;PC>XTFLA=='&J:R\<KZ"IB)M.D@X
MI+PF]54&/,#&C1TEAS38'TN2H B?B"'?G*TE^ *#0-U(?O;D0N9XCTP28FOT
M<)2LNLVH.@7 DYU]&B[6%[NS*;1=D5E>CCC*%&<%*2R*F!J:.&.H;<*XK_6:
MN2VLW\M\:[?&<.%/7O&[-MK?J[QN<.U5VQ!>BUUKUF($F()I:A,#K_"9+_PZ
MI+F[K4XR&Z\[)R=7<BE[YQX%S:SK=FV*88;]1MB-"6K29:G%59 1=S.W*QW^
M/Y, IV7RYIY][<%9:Q?E.]MR@_ZBL](6P[WLRCRC19@CDA\]KS%P'\I32&5J
M?D(BK)FB*-TZR#"0,_R>N;7F0!=E"1?9BR!S.<_*; 7%0);YI9N[M0K2 ;YS
M8J#=GCLONGDR6[NU!5B1)]0D@+2;#NW79(0U#9UH^"K:LJN@M]E;9L=R:N5?
M)WEF=2S9357<J AAOF7[2TQKH(&60!Y\;*!V)<D&=B$7?@68TC=07UHQ,)?^
M=Q=&TJ9&7:%B9;V@FS.TTX\K^S/==4#%%&(RDW_5[%O"/"T6K;/."ZL2.Y8C
M<L87(+V,95O=O_!]YBJI;DOF^:>%P[6FC#U6NN6U\"YI7@@'?[/515%GU$O'
MX<=1&8>OTW1H,>GO2L:-_$)%L,S#F']KM]$?CNQ]3/>%;*I;KC&D;B[K,KOS
M?F8GQ:# NL $ZV%(R:P#E1B_*,/\ZVK%Y/PDMR-B!<Z_7/N, :5*V %?,U,C
MKOLY_0K%3O=C(WU8[G%*VMG$8]Z:':T?C*O+R6@+[+&MN.DNN: ?.)N[:56O
MMT]4Z3T)'^BU)863U(&L/T VEH3P6,NP"GXO?XSQGT?V>K^#H@]72SC72;%U
MNR51<$V&^F $^0=Z4U3.9AB6MPH&OZ%!%R4KN ))*8?KK$"8]:%P8?\G:>RY
M',:^,%[R?[=E-KMXDLR>/KEX[JS!]A:-[Q&(!23AJQ4BN,R=6:0+RYWHB?MQ
M<>[/+9/"IU^AT4+\7%39M]5IA"/; S*V;R+_L7JUJWKU[!BK5Q,R0-.U/Q3_
M-YZD<6C'C9TPV4,!FD0GHJ>-+<>=>G>IDSCJ$L.X!\J+(O&VS6?:?6:I#G^K
MB)3?6;EG<:[))IB^J9S%@=?8=%T8<\@I_$K7%('C[=GG\_A$]<#I,"OLRD*+
MU.3GT8"V:L>935["[HNAJU#ZQIO$%H7E=[10K]T+S]!LS@0#?45, >?0/8\L
M+3+5LENT>KQ?JSES98GRP#[/92%_(,:,S]5F]DF_$:T[$SY)WFSE34KC4_/N
M7^CQ#$*#8)QV=]O$QE%R;;!WS,1#N>D&K9WDR&6<LG67O#N^Q?,]K1ZMP>R_
M>BZ>S%[+EX[LU7T/B?%N9!01B8*S)G6[EX'RRB4J0! #JNSR^*@=MV0",4-:
M!'4/Q'7^AO;/9DC1[X,HJZ*)[5_54^H,W(0Z")*\P^1_'<"=1[,.I[L,.YZO
M.JHC<KM:V-];&>MX!-6^#\4)2FWV&AH-W>2>;:C<?>C;]JBTVK\L2SV"#VE&
MW/:T:34+[/YXXUXEDU#/F=F_HSP\IF$9A!Y17KZ?JJSKR=(L2!&;$R^S#MC7
M2S7KP&CDS-!/H9EJ6)FB\J[!!HV>;A^==_@+<!G"9<]*8HDQ3'?1&3!/RR]U
MN]DNB-7).5@W&=7&1+33?33/*%T-H#XK 0,'KP%"W:+EQ/T9$DZ!A%^5 &QO
M :[_>UMR\E6N&Z"F\!FV0N\/?83,&.;0]-8ISB' =3/@S0?2*7IZR:^6V2J%
MCKQ6^/O+"@ 1SQ]WQ0 B]^F@JSKX>U*W<UXJ<$58V*!BT6 Y1:$B$\C3G![\
MSXTQB!CO6IG0)1M"5(SMI#\UI/.>"-?2O5)F/8C"@E&F:V)TX>1YD^%0;S/M
M?B,*7%!AD\=!@QL;Q=&(C#X;,_B_B"0<ZQP>E+EX'\F_#J-=7]HNSYINB%!G
M*Q$>E@STW\K4>9'XQ4]I00;PTW66::'^+Y>7'XR)E=,C]38"Q;M(BT30>+PT
MW7K\9^L&10K@"$+OO:V Q.;1#9RGV]9U^.XN^)[[WR+K3-SX0YZ454D?8D "
M,28$74"$V;IA5P:N$GYW2]E ]'@Y@XVCL5S!%997%"G&D>KA8S)_1S+_^3$F
M\P\TF1A^P(D6E"M4D4%PIU*4*:)(3$L*V(US9)QK8)OP%L,;T?98,_]7'PE+
M3-<LXYCHB=5K@NP9MN.1LGX^=LJ\[K!M!]WJ1['J_Y'-\98KM=W@ K"3-6N+
M)XJ;!:A\N:R!3%M23I0!,=/D]O_$&Y GV*W 'PY*\ _[8:CO=L[LU*>4%!,.
M.9NQO\=!Q9"&09=B/RA,,I";B=G&A)+=VT DXJX=G*"1A%$_*.DI <8RW(TF
M-H-7U-V %'A@V!'2S'^^">(<^5J'E5A-@U9"(GS$^<-%Y5RQ6L0B4.:HMT+M
M_3"Y\KU$R@6I-BI33J4Z9B??(?;7(4D9T@=/^:?[\G-'<H),,3NWC[[*\^FJ
MI H3'<R%H#S5\5#JB7BKVU(#?EVFZ\R'I_I-R6+EM2Y7;(TEUZA7=%TR5)2-
M^[K)E35]LMQQ[S.P:R'(E">< G6<<PRA_M(;FWU#EG%7WHU/ 6C=V#2+B0X,
MBS\$XDR#_PU*,01]8]; JE&-"_]'WS/X:U9?95::IYJ+*,8<U-QT&?HC5N"6
MYHD^9M0SZ$[N"4*>>2P=+5.RRI30B= 0?0P$G2V]B>LR*S)ECADZ- #TWE#=
MD'0!OM"_&# ^.%(%""0UVJ9M-LPD+3H8C63[NAF=4+7YC*H;AV>S-Z(VTFA^
MU/S110KOJUF&CG(Z@M%P0?$9#LK$J]YKLC3D68MTTX1D*M(<%5H$V4?8QS\@
M@ACLZ**0P[+.;BJ5N^5';@3$NVGH#)4L9VV!G>(2=*?R>Y+#GK"A/YY8^L5H
M+.U\.F<R9C^IZ?J@4E4'3N"^E0QA=([N4UI(!O_L,8L!MU-G(GQ#;FB#N KE
MK<6V7XX+WB&W1/BX7/UV4M/ALIS\K+T8*[?D&]_QT99%>NML8<3+TR3A]U?Y
M:FM_IH0BWI!@COYG7LGP.CKH>N!W%N8%[9"-5MZ\EZOOP[,EL3B,%8H)U_"D
M'!(8:)],!4'3-:3G%I:*_[?5*@=V4&ZYZ-R2PRQB&R,Q)+SQ>48,75A)/05Q
MX,4V6EB0+R=V#<DW2"2/F<7TDNI(CEU3ZJ7FHG>S2Q<>G;VN:A10\8V0-#M9
MGOKXTSVT.[?RYKJKQQ6-3'_-8[/+FMI-6.L+[I)0'Z^K,K<[+] FRPBR@=?7
MN>,7?[.@_92S7D%+K0'$I2PJ7"E3T!.A9E5]8<]&),CDEJN'W%(TB!@T"F&C
MNVJU2HSX@I>M4-VB\+#=Y:9GMO-O2/N8O3E1TB(=$S,(]YWPW%#$IA;AIA%F
M!RVA\H4INM=+L?=%$TW5(WDE>TP0W"SO\0H0>WSU4);[JC.9H:1ZY4QKV<T8
M;*^E0.W<TS:3'#A']4,;#H_/;:FHML/+(94/?6K>O$8C)_CR Q=K$FF]0WF/
M9"*5X-O# P>:Z]@#ESU89_K#8[+@0&J+"<DM[B?5I\&:N@#\"NW9;P[]8=E/
M$@)#\/$I+2EP<.M8R51(@ 8+OWL 4 SVT!. 1JQW:3@'B8:HKV#$8J^A*JC0
M9'1@O)8R;J-P&Y5RLB*JB4VV":A'Y71 _4$=HX\UUATUUA>/-=9O-ID]M:/
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MO2N.FYC'ZMA_/7MYC-6QR1P+U02/!4]\YXQB1+ 1SH1J%W5XCX-L(/_KI0'
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M_^.E5=5#B#>H6V2W<+TI41#1H7Z#5WWQY-5C4WDGO8^7MZ(&ST5>+]HUP@<
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M:F9AZAN 0\L7AY6UP.N2XF&06W@MWOQO$+%1NW.N5<E/+<5%:HTT'=<)'"1
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MP&5-]@S'L[5,6;X:&!;L>8U$JFE>ZM9MO?@XF9D<V$^8^;BD$I0%Q=$YSM?
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M'JM:AA$0L;8RL#-;I'37G3E.*0/' 3$2A,I!5.JFQ;?$[QXN#PRL+T2+:.]
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M8ZI6G>VW6\?MK>FB[:,>-P9R2EH=-71H<Y28,IG-*<%)HY_9'ZPP!IB4D6?
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MV\2S.!"J7DKH007Q'&E$C^M)=4R5U4B8-[-UTS"LTAP!E) 'H1%>A#FSJW$
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MWUII YZ'(B0,V"(1*"P(Y/M@D@)&P!**3/!$,CFUEZF!/,1@%!J'%-)8BE*
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MUV[UG&*^'=J+036A_3.#X9J3* 0X\-I&8"9RH#SH%41UX1W:BP$:U;2145%
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M'(IC5EM/@TI4":8)A" 2ZG<C,2VSB5L(3H50=CRN_ ,ZX2VV2F_RL32[N=N
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M$*7""@,$^0BS=V0B'ISC)9! E04M5 =QSY@/ JDG1I' .YFB(YXS'VGPSI1
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M'YV*/\J/,KE.GI79'SW$Z$FA/ZA9,G[( !?]]=KCS_-Z.>SE9;;&,T)SH!S
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MMO 4&SQ1.6(CP5BB!<:(VB:F710V$6TY8MW@EVR#GQ3-F"%):L6A=,  9,:
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M4PN>6&E"E)(S?3U*JC)#989;F,$Z1"1:6YHX<FL=+VUIDXK&Y$L4?$IF^/M
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M=-3;CE!8W8K*G^QQ:6S1[?QZWH\=9KJ= JA93GLGYJ.5=1\-CGMA*08-WKY
MTS6_0 Q:1$EMYB;4UALE;>(^"&.TL$C^W)Z]54_S>R_*ARH=345'5U1TT95'
MI(B!&W!,<D!'!&CI"*A0>EN@\92%M75!NDK=[(-V!9 G"6(>(O+?&Y5/? +P
MN.S2-O;]KT<SXQ3F:Q.IWG0%'\ZHMQ1='@V.\_*-MOYSWCO[7,ES6O+\?$V>
M*AFMK2HG&LP!!B=*.U@%%*/%2(CRT1;RO.G(5>:LS%F9<Q',:92R46O,833/
M031JKHS5R5"=\K\),0]?M)+JK*2Z._9(-:%( L^DJI4%M(*!B4H LY[IZ 37
MAF529:)+>"762JR56)^&6#,868B.)6X$BF0,<D5I]D8M,S0%4XFU%<0Z]E8)
MB=2BPAS@1U\F]EK(^R #1VQ^IC3+)&O6UHWIXBW*8^75RJN55Q]\WU.=YGHO
ME:;.>*J14.YX=+YDEK-@"TCO)M;I3WLJP\[,L!-'MB0*=,1[<,SQTBHAOS*(
MP#RG-D7M3,2U=<Z[QLQRME,9KC)<ZQAN"H)SB#)8U)[HB,E$PRBE@L4H@C=*
MZ.HYMH'7)L^LG<D^(D\N>XVE SHS9<9D2I"T"MX:XITNTW(,Z1IY<X1=]1UK
M^7Q]YVSE\TM=:7 U;+Q,$&GFB70&IP^?('*Y%!,@Y7DEPN#<'<>E2+&8QWP1
MSUUD)D1BI$/NA E*$H.6VA+=JZNV;)*3B]PPP_0,\T7JY/C9=]2=R;0+3Q)F
MEX?DO919P. 3:,X8^$081^EM4&YM7>*<6K[<'RM+E/SY; C@I@>]*/0WW9TJ
M^.<"_K$0&T/BWC(-PJ4,?L,R^-%SD$((+:Q*,69'X6:Z5<5^Q?Y:3SIEI29<
M)YVQ;XT-FD46.'7*^&##/; _71A=:>$1:6'BX-LI(GQ0 ;3.W)#=@P@Z:@'Y
M7Y-12C)K]=HZZR*Y62Y=J6%EJ6&F<KUJX6KA:N$GM_ 4VSNE481 K>26HW%&
MAQ0%<8S$( U7M&[OR[2]3XKHG BF!!6@N$3 E"0XE:-_3;2TECN2+=WL[W1>
MG5X?GQN>5QO0"S&L,QQ/"']>#4'OSF)8H$9YQWSV_<LKJ 0U!4']/JE)HM>$
MT*@ \Y_YBV5@:.8GQAFEUE/&:%I;YW*6Z>RUV5I;$+LH4?$.N-:^\0]"ZUA$
M3*7+J+(:;$HEFU,E,%$@<.^%#2AM%&YM_>8!0L5J6[&Z6 WP@;F"%<YSA/.$
M^,=Y"$AHJ1U4.3@P,H)AC ").E+%M$9#U]9IEZF9SP0KKMN[!P=45#N?HG,1
M,3F=GPKJ33#4:^6LF7OT7_$\3SR/MV<3D'GM%?"4_6B,5H 5QH+AB2OM--6T
M5+$50%=_>GFP7%M,+X.5IF'<A>NME7'G&1!-Z*O:\$BT89"8,X"VU+?9D( Z
MACP)J:*132N;_.RU@W*?5Q9H.6@H7;9*%NCP>L#[14)HM]./9^4;OKSC^-C.
MG!ZZ?*S5!G'UK@30U]?V:MZV\=$.0],-\.?!,,7>V7G57J<EKS=?Y8-:PEV2
M""X:!TBLR=R5$DCMLGDUL9G#<OC'>8MF -9^GTN<U%D!_1B 'L=_7! :(],@
MK1: .E*P-)%2%$I#4%HQ1>>7XUGAW,+(8IXB;07VDP)[0JB5WEA%' ?.60 T
M/H%QBD PS.8@@R:K;TW>KBVYVXKI.@^A6JE::=D3';_$X2#8T5'=*Y_:"9[L
M&Z"1F\@Q;Y&$ XK\12=K04C#,&2?*,9P#>T6^<+/,*T17%&DFW%PL3]J]+=.
M_%1>Q^>5Y%B/>*J5JI66,:7IWN=P&^']^>CL)/;/1@>#C;RHY>+L\2O;"]O]
ME_:T=V:/&U)L./'E!"6^CO\Y[XUZ9W$_#C_T?+QP)EY'/WC7;SZE'N--[S,<
M3L;7F&@98Z9 JE(%R0T#G?U"(.G_L_?N36TD2?OH5^G@[#EG-D+EJ?ME]@TB
M&,!>]C> ;? [Q_['45>0+216$L;XTY^LEH2$ 1L9 2U4&[-8M^ZNJJQ\ZLFL
MK,S 7;+86>K7UL6-FW@%#1J-!@6SBY2*E);=T"XKZS*MK%<.(.9<BSPHI$+D
MB.L4D8%I@3RUU 4AF&:I>4MKR96WXK]<K2BIO3BLVG7%S=6*?BK^_2*E(J4B
MI=614D./!<$"-*WX7/CV7'S[Z$J]%6ZY"H$B&GE$'$N-+ T1J6@]T<ECX\/:
M.E,MKJ_GS"ZZVVC=+0B[#%)JJ).D(.Q]$/9*?('U'.N@$6&!(RZU1<Z)B(+$
MU*9H@LTEK1H'L:L57K _/([].K"@'X]C=]#^$JL.S/P25E#<ZD5*14I%2D5*
M14I+<:+%ZN"]2\+AR&4(!FOCJ8E14Z4M50^2=JBF#YNS[&%*GNM@W4/[M9#H
MN4CTY]FBA3H(XH1EB#I-$&>2(LND05(SXP(5)&J9TY(2O(":A46M&ZC6"[!]
MBUHW0JUG;6-I5=*@W$AXZA#G,2)C24 \<"R$5B!.T2B]7M ^;S-,X9N+9/YI
M.SF_1:LZB*?#>.+ +J:Z566M6E IM%^HH+H\I41O3(01)7-,,D:UL3QXJ5,@
MVLN0 +JT-Y,Z]/?*VU,_=W2(J&#2/)CT:6,VRX6 %48+YI'5BB*N )<<#AX1
MK;E@CA,>=9VA1]Z 2<M3171>K7SB/8"'19>F0?#=ZS//W?WE!-7K?/#7$;44
M85XT>$ZWDRE6BE!&D+?,(D!*BHRW&(%X@>;Q)%,0&3R7N?YR0<Z"G,N,G EK
MKZQ)2EC,'54V1I:8H*"QGDAJ%\%%"ZC>%U1GTVX;P*VH,/(4[&/N@D::YA(8
MRL3$K9&"&@!5QEJ*7@^*+\!:@+4 ZV, JY'8*T8-I]YS*8R.%&M,J,*,<$58
M =9& .N4K09LL#-@V^.8?8[$1623MBAH1XA6S'L%P*I%2[+K!0T*KA9<+;CZ
MR_V>9^]') XD1T1"A>?&@\G/$O4I:H&MYI[?#JR_6$"F(.Q]$'9FWS8JYK2*
M.<,H\%=NA476*H&T,,10ZKSE.I=K:Y$;7 )S9R,L"%<0KCG]GL<DEU1P%;CA
M*7*N$U!'Z;0W6"E,N?H!P!5<>T0_Y\S&-3611.#XB% #U%'*B%P0&H&%;@P6
M$J!-@4VNP287A3N6:/.K0M@^.>WT+F*LZKH2U:362G7:L=W[1)RO3$GR&S?9
MG<9<1V>TQXE3&YV0*7JGF3(Q!#DY@&BHJ4.$"+U7M8F)#.L?O1Y+\#4(L)R6
MF0]8MV=WWRG0^2@ 38G/N^^: 6$DWN43,R;O(!D?<J#?HG)_/'SQ\2<(!%P9
M%+A.I!X+ NH\/[<B0 & >0%@ZI-3$I@3QRK'VYA\6LX@PQS8CCPXYI6E$LL%
MU*0H^O\\]5^(E+ W)CK&N>1611V#U9C8$+FW=]#_^2RJ @T/# TS^Z!"6 42
ME2A(D1#W.B+-+4$*)Q(I3<HJG,L/"Z8*/*P./-SK"%>1<)%PD?"32WB.)9ZK
MX+ARW'I.N1&9XG-8H1E1'!8(XLH2OVQ+_*Q?E5N38D@)*2D9XHHYI!-+B)!@
M!<7"N,!':_SUX/NFXL-JY8;<_AK[OCVH*^B.W)N]TU(HMU&NR_K+_9%4)N(J
M9X;F@ZV=*Y5QG?8B28T4]?G,D/#(86<0%IP8@Q/%>9M;WMMK67)S-42)'\3S
M>-]*846M%Z+64U^D$X[ZO/N@L/*(FZ21C11TF_-D?30Q^=3$RF!%MY^G5[$H
M^"(4?,:C2)ED45*-?*W@,B;D#"S>&C/!;, NB+S9T)+RWA[%HM[+X#,J4BI2
M*E)Z!MZYLE0NA O/INIQ!%O,*-)>$E@K:41&"(%H=(I3YD#HKGEKY6K%%8[<
M.U4_3B(*PVKEK[W]4,DC>MW>3D?_NNNM0-!<$+0[ZV7C+G#!)4/$: 'FN!/(
M)B\1T98Z+ZGABJZM<W(].*BD %P^C7VLX+Y;U+54\OLE;9TZSR0G.$I)$2=!
M(ZZT158RACSSD=$@+-,,M+7HZO/4U<=VF14U7J :S[C(M+6!,Y*04RIGZ(0_
MUNB(G-:1\RB"%1S4N,68**K\+%49P!I'CGT45O)HB!/!$,L\]R99?5GTOJAR
M,U5YNB);1RCC. %K=ID_<X^,M1I9+C(R,PMV/*BR !.^4.CET>52PF 9I#0/
MXCZZ$[4@[B)MH!FG:?2&<\HH2BR"$205 QY%#)+!PF)JDX2EM4XFC&\H9[[,
M"<Z7Q&&:=P]RLO,<K-B/@V&_[8<QC.(66U4W#O,7/O^BT[$EBK%148QO+^55
M_VSCW/9#793A9:^?8GMX5MRM\X+7FUEWJT[&8*4# J2BB,=(@2Y&AYAUV 5K
MI%=D;9V0ZRZ<LIV[G$K]Q.>IBT(_A$+/A#/B8!.C#FE!&>*!6F0PC0@$IYB@
M\#KA!1RM+NK<7,MB 6[9RY1Z1;&?5+%GPQB--%(PA:@Q8&5$XI#3R2&CP+[@
M@8%UH&]2[+D3[!6=;K1/ITBI2*E(J3G1B[]RB*>LE0]!@F=<<L*Q3($\HL&
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M1F"<"^)8#5@56#Z:XI!/Q/G@#4[:YB!2)II4);>X/I8WSJ.H]8.I]92"$!)
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MF:);Q)(88CY5F@3B#BMD)! AC86J)2IX9CZTA?D"T@.6B.S%1V2_;'=MUS]
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MX $S^UQOALQ  !I>G,:9TK.U^Z^.8\N>V]P4=S8 00SN#80K'#VC;X^>>8)
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MW^U4SZ+:9&M\#!:M,8O[-():@,T1C:L!9A2&4-\UGV;LG0T[L+C.>J8&\0M
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ML"I@(Q1=6W_P?$@%QPJ.-1O':#1*!TI<,(%+K[2'ESP9C875%MN?E7 J./8
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M_(RZKM)6&E38S\[)Z.1%2]'& '358>FW^(RO=O*=T=#V@6/\C=OG#R +KU;
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M&''INW5AQ">3$1?5B,?'A^,*PV5QVAM<@I5(?/BX'07LGAQB?MRN#S%+WRS
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M;H%*58CJ##1MN.-1,3R!55KATR+XU,P(SS5-E7:69+D61'B5$2E OU"1Q$J
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MY9?''S[AA,>3(DF^VH 3CWO4*2(8K!UU-3KD1P5\' V/?/2N?P*/>?Z_Q3C
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MY4-?Q&5[A)")WI )R+K1V-GC@/6?U_HF*":+$#(H#8%2*T_A]05Z4]Y=1EN
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M!WTRFWUP-;:L-;TDX8#W3!=5Y'>H%Q,01)O^#W\5:YDE*><U46PPU":! 5G
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MVB_JLJ<2A-)5G]OG055C9U3-=5I3-#M)I[VW8'5/LXCH75Z1#X[JAI55_6.
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M^LV%3#$X8Q!CR2&..456,HDHHQ(3)TC(56A(FZF;&?Q-K'E5P+& X])S,I:
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M1(3@[QFA&Q"#\3@PP-'GAD5,83,N:, C)<Q#%>9G]OR5W#ZMW/;]>U=8(0M
M4'T/_ 77B@P_XH'A"' @P-'S ()?O/$>Y-TK<=UB<7VN3@!*DI]$DCL-[!/;
MM6S8IHC[#)OS,,./[1C4,*5A[',[)O3%&YOHE#[DGEUULG]OY_\=3[)2 W&,
MD@M15DDU*T3M_9? ]%U 8,_.\[?L.+]-2,+=^B4ORY/L*"FG>9G@Y$YBB6,E
M44BU%E+]UG?\W="V7-LV#1%&LE^ ;00TXD8HXHCR0-AV&,HJ '*SZ[^J+MX9
M87YBMU_)\=/(<6=Q1$X P.N&AN.@'$=F9 0>9P9>VV%[)(A\:RM+$I4D#_"Z
M/R7.3R+.O5  \5Q.;-\QK)C&(,Y^:/C$M QN,\N.+->/7//%&XOJ#KG9)D!)
M\\Y(\W-F_2MI?EQI[BGG(*:F:X:&[3%B(!0;/ 9+V_1BG]FA[PF3X=6=YI(F
MGZI;P..(HKM4%.>-,K1$WF>Y;N@ER(M(%$:]AE<64#K*9T$J-)QZ^VF53U_A
M)I1YFD1:NZBO M?6$>N;35%G6^!\.5FV-&9R[:961':%X6MA^!_]0$E P8?B
MCC (]5V#A3XSN.G8!@5=S 1H7A:%+]XP4V?T9J2D%9S-13TW)+H;/EM2\*W@
M^Q'A^SG[92CX?@3X[G7HM@/']1@U8+-,@[F^9P06>-6NR\TPXM2+A"OAVU]2
MM:;@6\'WQG%*P?>00J,*OA\.W[UXJ.<%H'<MW[ LC(<&PC0\GT<&859@FP*@
MW GPGA3 ;WJS!8K";X7?&P<JA=]#"H8K_'X$_.[,;XN0F%L1,0(3HR=!Y!B^
M9]I&",HWI#04L*LOWKBN;K&;U7 *OA\C<D_9TV7S1<G%(V^//?+L%3;H=7M.
M]4J6ZR47XC62U;!&!!^_/E]>"ASAQ9N7Y+LGX2I_):;2 ,]2$5:E5HYY(8"?
M1"'["HFF73>>1J0SW KMGQG,O;IJNA7+VMR\N-*U<%8"[44A/X@3D<Y'T>%[
MI>!%.):?1>)"I/D4$WUU#68^BWG_[N-R-IVF5UCEF&2ZQDOM4J0I_K>N@@SS
M8IICUR_YQ;RHM'B62;$L1W.ID-O?<=[W%0=>G_^]EN;C&4PV"7N\\N;_@N+[
M-XN#/#XC?5W.:4\--;-\!+_A>D<U&#%,TKIIVDG\"38EFXD?BWQR*LYQ;\JS
M_!"(BEB 2=AG\/8?TCS\/$Q=DXJ?/EW]^7LT#2ASCH_.84[POG__^/+'OZ!O
MCM[2DZ-S>OSO6_(G///A[\_V\;\_@@[Z(?[P]Q_V">@+WPL%8:X1<6(;C!)A
M!-0Q#<%)'(7<E^$:N4L)D#$Z0)4>Q";C1 CP"&+8Y#@05NR&/&2VY5A1'+_0
M!"CP*>Q*5<P  S[PC)\+6?];B(M$7);X7]P6#8$BPNQ@D 'X(_(]LC1(6+U7
M6I9C:3 /\@LQJE7$05J-\]GY&!\IES\$HJY-"[ V"N!?^"F/9F%ER'?I^-B5
M%B5Q#$(7 UO(5Q_F$Y"%*YFVY;XNVV<TY-]VLB4:-=K'E)<3WGZAR62N\:#^
M!9@IC[1#F B\8.G7FH6<3L$BBA$UTRLYK<5';RZL 2MXS_3:)&85</R_0"B<
M(4@R8A[:>$FF!7+,4(Y9]JB"WZSPLH)X5N)7IS/ GW(^N0/03SA$/;GEY !C
M+V_G-$?6^:>7XP2!L4"PE5^).G(OV;31#?Q:!#WXL.%"7MLJ7X.W%M@:]&%T
MY**FNJG'+I.H&K=&<N_!QJ@PNT=X + QJVY_I*?&:XH_?^*+!%E*KE&O]^^X
M:&<S!:DT@D+PSP:/8;*O>'K)K\H7WR^L:9)DQC4:7E_^[?M0_WMM[QJ@C4(1
M V00UZ',"HD?N'A#:^P[9DP\S--8_MQ7T6>#RNU85)T !%>+<H.BP!%$TC2_
M+%_=RK @H.= \X;]D-[-7Z0=2Q>MQ3F;-=+4LJXT?!$)^+04K]H?7D=)"=AQ
M]2K)Y.3E0]>--WA-M\,CL][EQLAMQF\^'LF/KMGJ]6<V&YG$N?5C<T1N_>RN
M8?V1[=)[C7KW9[9U^SO57+=OKMY*HWXEL6HK\J>\!WC'\S7YJZRIAHK-K&IY
M2.IL7 BA?8#OC4OM;08FPJTKO+EKM^:R#I08QZ@C;J7%H%A9#O@JJ>!EX2J5
MN^_1_L]G,&A4WBC*7!8?7R.NL]V;?B1",0G VJ>.+LTG]&L?BP*W2LAN4])K
M*4G\QX"3W2:68KNG9KO=RNY>CN!W!47N&=(?WFGD<M+<]S1R0.>-#R^^<2AU
M/<\7/G9)YI%O,XL0R^8V'EC9UN->>C</"!_"''!VOR?5^+")\K_]TIP'8#4.
M_']TQK_LQGGDY /]XVR<PC,POU\O\0SRY S&H;_A&>/5'V>?DC___GGRY^\_
M_WW]//*/?_\<G[S#N/)Q>GST YY!VL='YS#.I_3D[.?Q\;N?)Q\F?Z9_3([C
M#TES%GEJ7OYE"S>.@T@8W#7C^C0R,"W/, 45+O4#VR7FBS>$6KI-;O;G>-"1
MX*[D;"@<W!\<!*<O<*-0N Z+F&D33XB(Q!PDAH6V(_S'O290X> 3X^"_<QP,
M8F';D><;9L1]@UG,,GAD48-%@;"<D-D.(X"#C.C4(@H'%0[N.0[&Q&.![\2!
M,)G+3(]:EANZCBO"D HG?MR+%14./C$.DCD."ML"@S#BA@N[8; 8+UKD06R$
M7L )=\%2)'B]HNGKOO7@"FV%@PH'AXV#L4F$%T=Q0**8<6X&PH\\8L5N9 K?
M$M[C7D6I</")<=":XZ!C.I%CVJ:!&PSV8!@9H.," $,O%!:Q7,NRL$C.T;TE
M1<Y;BH/[T-GRZ\E=JH_E;6AFT]B.>!2;%C,9MZCGQR$@5L!--W#A-Q7E&Q":
M7?6B?%R8L1.[G@%;1K!C P7OU@^-V+?<B)B>YW/^XHU#==>[6?*K>FCMC( S
MAQ'3=9D0Q&119'NV$YM^S- RB1S'5.&K00EX%[X2W/(=*J@1"SLVF*#4",S
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M0+ 8/_ B'.,E[=JJ5]T_47QVW\.O@X^NOEPG[]D*G<ADL>F;-HM=RB,K]JW
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MNP #)P<XQ?@-N/W\/,OK'VNMCS9<W<28XU@WHC$C[7<,&L*7 8P 11:()[Z
M7,DV.9VK(,\=ZC&J(@EF=2RM)7$C>1W9IK.BG/&:]G7P G9(QD.ZP67:1'TJ
MD4\FHFCB2MH"!:0UA MNPURP>9+.MS@?UZSZ]JURIG4847HATL G?0,?_M!-
MOSZ@6V[BSTWXEI>B+EK0Z/9%LM4/P'L$^"]9HYM+T3NEF<E K82Z#OOD><L\
M6,CQS/A?/+CI(>IR7!P$_(@L 3'1WDV"GX8P77#S#Z9%DFJD/A:6G-6 "NJ5
M^6+FVK;^6^>)XWY=][P/T[P"V%6VV?H;@GB;P5"U^50C0!>57PAV ]9676"Z
M#M=B6+Z.= +X\0N>I-)M3_ 8$3%9>SM#I<";A(TRX=I'<$UC0-A&R>MU'D%>
M-?D+B]$,:H[L%EK:HP#YK;*JSP':0 C 40V@^!1Q1LX<D-H<AY@#Y&/L5<9H
M;X4E?-X:^>WCM85UV[>[*<WDX8H$+EC9EV0RF]3AF/[\FYG+2<XGW"J8QGKB
MX1BCX360Q7-P!!4CLEE[HBSW) >M?0T-^P&CVAJ$#;I;Q;6H69O"S4GL_Y:/
M J#:$"#IDX@QQI1KQSEX_4S7GE@<'R$"O1F@:!CTMXS/P-\ CCV<)SX=]A./
MNE2LTRY[9[5\)H2"7DPLZ3)R5 [ ZCD UM[D *PI2Q\!MH"QAF<GG'T8 I*"
M<7<25KEL;]$S[PH1B@1C)#\>'6@V,5]^_DX+4\$+&5Y'D4>#_5A\.07_ZN/A
MZ?"V9_-F7.VV-?S=RR<;]>AZVW<P4(7Y<^"[RU/;)D$DRR?Y><$;0Z\^-((9
M+4M9F;MR]3%9<I%$& ^0F2I@2@1Y=%5GIM7$K4T5L#IU&3(H$E%A!&+)S,!'
M%MEYA24C4O?T%E-;<OA\,VIC&DF=@0ZN/(X!ASBIVN!%.9NV.3TX6+..]EQO
M6]R]-3'M\.2_[X\,XF_)[+^6[%%;TK!S[=E3>M7/P$C _ RK^4%CNSBPEL'4
MF(#1FF>+F5M%E]]]+<^KRW\.VXSPFO& 9\XQQ[(7,;WYGJB..?3.O[1>Y0),
MNIZIJ/.ONW<U\\'D2<Q.P<%A*#YGT+YU,YFF[3UR\-P$S?Q9UAC\M:,;S])4
M [.B<08Z"M4GP9&8BDP*7CRKFNCS/.&BEEO,0AW#%F!<O!V[/N?E&1Z-!C+.
MC#/$G9CBZ2&NJI_U@NYASQ*KQ\6D;3#M,-(+Y(6!,_QJ2\>F B1L\F7Y9Y'5
M\:DZRSNI,,@-LHT>9%6V:VH]-0'?RW$3FK_#.]-<GM*#YR-IIVOUL6L3)Y+Q
MY?E?AA0]QNQ? ,"\J%. ^M(1B";:'PL,J=;GRP)X)K\2;1I8*P7-<WBR7&=%
MM7] J,.SSPOP$M$&;[*H%A*/ZASDFR%*A$O@B7!<^Y^2/^<R!G1&=9+/JKY<
M8%BSF$T[(;Q<E/CZ<1D?X,"_S:*&M&$'*2[ZO Z1 G?6'GF53'KY$&#P8-["
M%49'>@(M32%)12!)G$0HU(W_G.:X47CDWVJ\=BPAPZ!U]IH4/!@%,[11NHJ\
MK-5<G;NZX'N7=2KJ<F<*Y:@I@I#O:/,!6O1MCHL6!YR+YP4O,-JM%4GY&>,$
M91WK7XJC*+*->[V\$J<)(G2IF?][>YF/K.>!EVH_PBSSHERL5OFZ>[DM#+:F
MAC]*4'H3!/A!Y*#]R/\&YLIU[>,,6!\V/@ESW. >O'0,,(0%86[:+!,:]7M>
MC4RG1BE9MES]&ISV3!/XQKO_GNK:Z6@Z.IA'N>%/O60SK4TQJVM5ZB WCR[0
M84+#)FW/7+N:%'2C0M0B:*[P:<^RP$_PB(;4!5EM6/3E-^[(6_B3WM9RRB2F
M.KE8%& 1?#?2?I.91EW91X-.\X,KO5^O 3+?B"6"_/(CPN[0"J&E[P;4@6=<
M) 89N^AR+^@/ ]>&0T/[Q;PJH&5WI# W><H2(;2)P-:T30!8@5MD-+:9E\Q0
M;Y(+\5!^6B\.%6@F ZZUZ03TD?4S'+/BRMFD]Z(VG)LF/, Y207[ODOU:HIG
M+O$$K9!*?_' 5>H"H]8%M0*6QX6=8=<_D 6%H&.A+;*8S-=#,#TO==#S'$U
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M^MI6Q<Q[PLS4U!E]6&/QK6?FO:YY)/:(J9K'36<:[1I;F:.[;T!3G*4XZ_Z
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M7"'0?#S0Z\E/^56]^A9&1%/4"^JF+@^JRQ3___:NM#EM+&O_%557NL:9 HS
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M0*2I!'XBK#$@(SU/E(K=MEC7D(Y!IL;<-X@* =:CR']EQ%=ME?GPX1O\QRA
MLF5K51N:V$[=Y],@E$PU+$ 8,=R"?($F#%P6V"E#+X*CL:$9N4V-W>0@TI^(
M)]BSBHBT:,_@(M(1J\T)V. C+]7P$RS#QV*'HX2B#X[B$%@JY:B ??,]16VP
M8WR\A]# ?,;:T%VPJYHS@G4"=[&;(=NZ,8&'00S:%75))-:0Z4+'N,&$+"]B
MVI"Q.W,YX'X2IRD]DC?_WX*TX+JTH.#0C4<:!GY/^\L"Q^O["0:W$$0##B<$
M W*H(3#&'GI9 3;+7XD6!D,Q2=4TP:X%'W<CY[-W6S@LST9P-?^5@%A!,J3U
M)WA@;SI-6]'!Z[]X"GPQE05] EX=X\4C(:7%L8G?%A/:#AI$"RU^,G<HV,B"
M@.Y:5L8WC*:R1<]&\B#L:W3SEV(=Y)\61M0T)^@ #=E=;]JM3K$S4B)^#,R=
M69;%V/NF;+4_PUI,W-I+@"\&20D'8>X* GT]*Z?%JUM]J8GH(\B?V:[>M6U=
M[;0;![N[Z]0-NE:MJVNUV+N1P3HDBV]-#MUON,^M>4RWLYYMHU\PV/F9DP<G
MF#RX3]?H:MWT?3NJNT_72?W0KMG5HX^'MEG?Z01>Z4F:'FWW8'.2#SC)KLP,
MV:9CW/H@N)5O[R.Z7G[#.Q8^<')%Q]K!8]XBES.(WKY[TA+*UW3./S @<'.<
MF^-\_N.\GU&W+C..3TU*QN,9,<&",<>;#HJ5+JML[M5:G<7#0S<]-:^*(ERW
MMG\+,,6&(EX316SMU#J=]AKT6*V+_NQ2CNW>^G/3Q#/5=5_;O45S;3JMEGY)
M6VZKUMQQYTF/S0TM_8;<3FWWX&!=^N'61<8+1OIC^4@OHXEK:[=3:S?W5J=Y
M_X4<J[O3JG7VFYMS?=QSW0/?>._IVSF?&V%@:; Q)V;$LQ[MS 7%_#?-C)M;
M<_^RH68V-LE4?WZMN;_$%OW-)=W1M)^+P[.YGJ5?SVZMU=Q=%[-^I6UY2N^R
MOEK4%O;C*1!)A4E!8QM.WH]S+&#4>WPMZ,^/=PZKS:,=%WSO6T"@'^TLGC52
MOR'E5T;*6^"#'K3G&P1K1L9W_>@&,^;',&.P-5%&)SOI2(&F#5+L>55ZMEHZ
MH08)RU],':JLPA8([&FD'GQL"0IEYG+_QO'&V'"=<H\TM5++3!]L/W:\?A^(
MK6C9HP_\X^CHK.@#2]38P+8HX[;JB;?F=Z31D]KQ-<0 P1^D>C!BC0;4 <G2
MY$-8DGY:5'RCRIA8L1Z-^8 _,W5O<45UB!EXS;.V=ZR.Y#O.KC?-.QXUWTR\
MI)CG?:>I]]P%:P_>OMO*L7/'0GB@KB4"Q<%V/V[ERP0P($+JI2F.M$S/_R-/
M,VF\]W$P(PX\)=@7H$_@1JN=C%L[L=&/5J4A?V9WRNT_UE#QAG-4VM5U>=Y!
M]7G-/$4/7>1AC8'!=0/WX#H;U:P3T.V).$^U@*?PU570QQYZ3T]5UTVM E@Q
M(*XCIH1S4$#F*/Q+O\H E-*WR7 ^V*$C6$99,(9MU02F(,3ST=V\/"T29^91
MHV9?Z5M-]")F]@L[\A*! XH'@U1E>BX\G^1]9R@*X[U*M!UW-=%V5D(8!A6I
M?I01EC!T.U8;^K-*0_8[]&HJ16+E^A>)1$'900[7$UI+\WSA=P-YPC0#"AB7
MH-0$ E@2E9 5Y'RL9OPR?)#Y94M,50Q:I2[AT$O'G@ >F5'8J8TA@8]^GR $
M" * C93G:UB$Z7FL%0+&;MXOZXDJ(*#UTO=2VBY & MU_=Y>,:WXV<B[5CE.
MV-*2LWVU=U"2%4H#=CAUN38,2E2->J6)IT86 Y"C1J6H5=#WBA'&G&;=.$(=
M5+0B"[K.>9!^6]:T]>J5SB+EK2"?E8[3AKQ)X#R90 4X4+P@7U6:5TCC#,Z&
M)!N"!94I8^H1/!*9405^!8,0(3J#X(T%"8G.)"54&L9#&".6P5!A6_EDA.B-
MR%4-YUC +(#MOJE,#+G(SU,"OK(@&A#T"D0?8L[D!$/17[3=!DZ/A\][B+E1
MT_+VC(5W#P&A$%X!X2AJVH),E/5(S=$,5!G*ELU&"2O $P56JSQ%L+-8S* 4
M@:W'D09H@!WT@G@"LF3L]55._K5UAH+NE8*)AC"7B&GA9?2(20PZA?8"9,,^
MJ?3\HP6- !C"1WA)\^\7D8Q 4Q> 88P[HN0@8+U#A$B(4+C4XVN$I("S3/.)
M3)T'C19FHSZ!YMVDA#>"LE%.RH"6U01&B<'U>G\(W6GKFS!(^+[9#5=P^C'B
MK,!_>5=PS&?R:3*R4>_A/_))K.>9:[PK1/LJ0)"8$,"G >N<+IH.'DG'K.XO
M#N,K%3^,9L8ZL+D&*D(("(,8:E-+".S&>?'BTAG]4'!3B*_5E1?F& 3Q"+'5
M?)#LITF<"6Z,Y4LA7R%R4!KW@X)#"!#ER@M"?0%PU@7]%*@HA-(6C'N(5$+O
M3!+4_GU<6G<P=9V&!,KB)39P)_H2*VC15QGJ7:H12'/"\?(RD4IZC1HSPP [
M!:F-ZX-@,=<8Z4D);:5GH;NA^9*30<C:?=5,L&K]U8T&(9'[:BUV+H$+PDF!
MUNDAK<L>"/W-*Y$\0S85IA.*9>)ZRRP?"/7(O3%"$WC ?L/Y)0 *2U .(Y[N
M=0$36@)X(N&)E .4.63\91WFH]\J%LA@3^@0(90=K*@,M4F^!YN0^$\EP*-]
M$IKD/I')2>]I3%,-\WFE91S:D!0JTJ9Q"FX# X(&@LHJWRGQ/N\@!L5'&)-Z
MQ7@8*7H4EN8GEO40)Q09R@M1S/OT[ *'2,*2!)\4@RPJL$ M7%("($9]Q99T
M:KD_?5**$Y4E<:AR\/K@EZX$L1G8//1M,&FPD<%^B5F@!/;3*"A*,,>$3T4K
M(5<M0]PN>P]KP:X?)6)\(@'LU5IS-=<^'/FZO=_8_9D^OM-L[/U< 6]-*&!D
MG!!^7H$</&W*U"SR#:+IR#OQUXW*1$B0P83^E8[+"^Z\%?DO$"<97KUOK%6+
MGVMBO&K6UHS(!!E$&O18S UMZ2(L:"G_P/AG&EUY)FM QB^QJ" ( ZGSH8!1
M!/9+Q/AO0#5Y$M><?WI !&AK_K\"C79,AA#\(Q?$U".TL#V$("R2' 6ZYI6:
M__MVD&16KG%(VHA=TN5X#%-KO+@.P"S[B!CP<"?'7N3YUE)JSF?U'26[<Z;2
MF(W$SQ[:B_BA<_BM89!Q:)YVQSN>OS<Y)[.#P(XC:7%.(I472U!M&&9)Q1[2
MAS$5Y2'\Z*  89[9YBP!KIC\J>;EBP"S7,@E,U1@;_!^9X^A-L$*7?!,#?X_
M C[6.&T60\))P'>&\&HD?(!(LQ*NFUX/7-S,<FH"ZXKY0O2?T$M54^FU:ON!
MP%=!B](WR$Z8M\9K!;;E(ZQ/0 &O[K0^]G@7\]5=V$IC(9(0,JE)6^@(L0NO
MQ$D5TR F/ DW>X&_/^!2TQEZ"63ZQ,,.Z?@'+A#]Q\HUW(N0UD(":"?3LY$
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MA_^PO<:^KG>GN/Z'(V<+'RT^. (34%F5_8TAUZJ\K5$?9::K1'UO#&_5! >
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M 0I3=:G9-+K@K2EXTQTLQ;[T+\PVM(!?G"5!+]_8'\]'<Z=E&T'R'>2;&!+
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M.Z]&IM**-PSL< 5+UB*GX/1#+QAO>&DYO#16 L?BJQ[\ 0IYZ,V4%1HWH(#
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M(M,>4L=U\9-NR\06#) !3U^N^GGMK54\$,,=%5"7M6*DZ#5.CI2936G>^T,
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MD")H<JY:6C[QQJC).2(Q;E4 E_1 D0)^5EZP%L>4KE6;)\W\\VD%&2SC*K6
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MI;0H,$9C+A(C@R:6)XS/O%8L57'W'H:T#!_TC\.'0KHOQH6%B>R\B^)NT-9
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M+GO#X2BW%1E66-F+D309X17$ZW[W7V@Q3=JY.LU"<&@]6X=6C\SH.^=(26(
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M$Q&8$XF&3D/H:POX\N3W\E!\)OY[<O'^XO3RY!^GKT].S]Z<7[P[NCH]/]M
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MP!!!]VX3BJ2TKL7_+UUL.SRRF( )DC(X(N6DK4? -4O9@)I67+DJ#<XWP'I
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M>>79? 03I.-/?G*)^0[+&BS5AFA'*9$Q*6*S]P2D"X;%F"R_?Q*_R0%Z/>S
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M W.DZM1L/:/=4K"R_'7Y$?P4_OV/_P-02P,$%     @ M3)"4M4VUI6EQ
M:! ( !0   !H864M,C R,#$R,C9?;&%B+GAM;-2]ZW+CN)8F^G^> F?WQ'15
MA-'%"TB">[I[PNET5CDB*YW'F;7WS*DXH<#59I<L>I-R5KJ??@!>),J2*( "
M:79?LFR+Y%KK@_AA 5B7?_U?WQ^7X)LHRBQ?_=M?_'_Q_@+$BN4\6]W_VU]^
M^_H!XK_\KW__;__M7_\?"/_WN[N/X'W.GA_%:@VN"D'6@H,_L_4#^#L7Y1]
M%ODC^'M>_)%](Q#^>W735?[T4F3W#VL0>('_^M/BKYPQ'/K$@\3' 40)CR%)
MD8 1X41(D5 F@HO[O[*$)S[V$^@'$8:(JQMP+!A,A: L\K"(_+!ZZ#);_?%7
M_0\EI0#*N%59_?IO?WE8KY_^^M-/?_[YY[]\I\7R7_+B_J? \\*?VJO_TES^
M?>_Z/\/J:C]-TY^J3S>7EMFA"]5C_9_^]Z\?O[ '\4A@MBK79,6T@#+[:UG]
M\6/.R+K"_*1>X.@5^C?87@;UGQ0^,/3_Y7O)__+O_PV &HXB7XH[(8'^[V]W
M-T=%IC_I*WY:B7L]LI]%D>7\RYH4ZX^$BJ72OGK:^N5)_-M?RNSQ:2G:OST4
M0AY^[+(H=IZJM4RUEGZLM?RG8\)^.D-]1_JN]W5UH%QE[B=7.O9A^LF9NE\5
M/XCQ%>Z(.5OE^@MUO>)3?7<WHLY6?7R-77TM\C593O"UV(KIJ+S4?_BH?FK$
MZ ?UD&DEIZ'NCJKB^UJLN*C9<N?1(./_]A?UT^*YA/>$/"T^D*SX&UD^BYO5
MT_.Z_"B^B67XJWBDHEA0G/AARC&,6.!!A#T$"9-J4O-"&28IC5/$%NO-UWLA
M5O"W+ZTFE3AC67^QL'=]Y+TM1)D_%VP[XSTN#TUC:@;3<Q[^:44>1?E$FAN4
MPMHYJ&WX=ZTJJ'2] +6V%Z#2%X3_^M/6OO/P74Z)VO+-  ._U]K^_T>1R]F.
M7DOM1>3%:TQR9H/)S@M:X2%)22N#FJ<H</ST)[%<E^U?H/X+]/S&V?@G$W$_
M[7T'+HO6'%*P$T/37/$3RY4G];2&.Z.D/4]KN]>Y]=>G1EVI\A>0%UP4RF,^
M8-;>5_N2_\=SN=9N<_DUO^0\TYX?67XF&;]979&G3!'<EP=2".W'\:O\\4FL
MRLH]O!/_>,[*;"V^B.);QD0]U]P)EM^OJJ=4"B]8XA&*!(&"I10BJEQIHOZ%
M"6%AC+C'/,EM^&=LA>=&8I4ML#(&L(XU0'S7/PL[)AM]N,WH<$Z#.#*G7GZ^
MN;H W5'\3%ZJ9>IE4:@+A?Y9TRU3JU:UHI)Y :[R<@TZ-KGCW*F =TG<H^L\
M*?M/-0*OIY#)Y Z;AS[FJWNUR'I\+^CZ5[)^+M2317DGGNJ7I;R5GXMLQ;(G
MLKQ9_1]!B@_J#5W$2<2#!/DP]E(.$1,IQ+[O0T)2%&.6I'Y*;2:705K,;<;8
MJ B*C>(70&8E4W\*O,#2^1TV,F;SP.AXCTSN6G^HQO01: LNP-:&"["U N02
M; <E6P%M"="FN"/VLY!TR=;#%)F4@L_"ZC6OGO>P861YE:_6!6'KOV?KARO%
MZOFC*#YFA&;+;/URIQ8'JV?1\/-_"KY((RI#7TJ84!XHEHQ#B$F8PBCQ9!PA
MXH=!;,.2=N+G1H^-@HH<6PWM^- 2?#,B' _2D1FP5;P^;&E5OP ;Y341UH#?
MG0;<FO:&X>:2[RPUF)3HAJ'SFN$&/F48M;W/RJ>\),N?B_SY22V*EL_ZO$_]
M59F\SI0D?OLDBLHOO5T_B.*R+,6Z7/@HH2R5!'H428C"B,(4(ZPH3@2)QU%,
M?6Q#<</4F!O55:H!4NEF1W(#A\&,[,8'=V32:PT E075XKVV 72- !LK+D ]
M$I?](V'-?N<!Z9(%!VHR*1N>A]9K5CSS:0-7R0WM*@_SZKDHE'^YB -&(O4_
M$#.?0A2Q!*8(IS"D,@UX$$J9D,5Z<TYU>DFV)\**U8Z<N[E\^ZI#-\!JY<!R
MJZ_ENG8?2\-%ZUD(C;TBW2IW 1KU'*XRCYKN= FY+V7:]>%1*_<6?\>OM'O!
M'XA8?"W(JI3*+?B@-+I9*;]*#<;+U_Q#]EWP9H(-DD1ZG$D8!HGR<T3*8:K>
M=.@G22I81((H$"9^CJ&\N3DT&Y7K@*ZL51JL<R"UVHVS4^VB/RW50ZJ=]ER"
M7XAXS%=BG;$2Z/W,I\>^%V/0V/2SQPB(CTPEK\"^Z8)=:7S*GQF$(F^B^*J9
M<THT=P2__5?X7\YG;4N0&@HG.EQ/,7,0U*$NID^9A*(M36KYVO:V8=[9SR1;
M?<S+\G;UA2S%K7SW7&8K49:+B(<T#4D,(Y($$-%(0L+]!,K4BY*01R'VC%C[
ME*"YT;76$^0KP)9YJ5='BH?7>A0(ZSW5M /7S&ES =G(?%NA]8-6\D<-6KW
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M&=Q_NZF.'TD4^TF20DZHFE'2F*M5>L2A%_K22P+"DAC9-!%PKZ+5A#)Q0P)
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M$-F*;?0/'3OM9H&)OQ%F$\9\QWGDN46;<K$WHGJ5TAJ['??7?]NYH08!M"B
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MT>VME<[/]0M\C Y9M?TB^>-R_L]G6>[4Z(A*"C.6D7.ID].8D+E4) $XPQE
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M"C+^ES&R%/"WN%%?_;FGM>3S,D;4+'O]W2R[_[O\<4:YR#+3X#3.$39)H#G
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MYWPIR]2?VMKH^T[SNK^X? MC.XH:CEQ@.GHM#G_[DR^>17E:7N/VVV7<!NG
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M80N-UT82%P<=MYF$+09'#26L+^RI*M!PV<?ET_-V\TG^D(ND[GP&I2*DH +
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M.8H!! 4!%*H,T!@A@G,BLAC.MJLM7;P1[KNAPS)ALUAYDNOYJA%G/S45 >;
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M$RPRHJ,Z3HL"(*G7J33/!8 )SA4MB/YWIUJ2<P--C5(O9R_V$G8[B[,=0_I
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MY!5I]R86[IAY;6'A,/RX#2S<<3EJ7]'C%FX<]TCE[*O4WT-]^P?Y17V66R-
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M-KSW:[K<5-TTXQF*%4X0USR8IZE>G2,,B& 0)$1QF<,B30CJDWEA,_C4F/+
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M/T:Y_G+S\7J[7<_9\]9L5]VOOFK>6FX_2SV&46!OE>%D1<YB5"! :6;X!1)
MB%YB*\%C1A5+F7#J(N,P]M38QI@>M6TWV_25]5>1MM^\W$TA]Y"J*)>IL:.C
M0( ')B?/6#OS50_4?+*7R_"C<ED/7%XS6Y];]&UNKA?\I0#(/Y_GVY>;U?>G
MU;+,L#(]&U.A8BJPB9=$ E!,]-]RD8(4IM2L%+ED3A6=G:--C<LJ&Z.]D;VZ
M878#;,=/WF +S$C.B/7H*&Z!A-_.X5T#CMPAW,+WXT[@-A?UY8X5_\?C:J&O
MV%2WG^4I*0H40Z"P.0/-]=\(3#B ,&$0F[:9IGO!:DL7MH3Q>@@GEM@-%.X[
M?V_&J&0*:SM+<<'B+V4UP];Q9/,$I IQBA,I0*:PD3&A$#!&,Q!3GJ>00I@3
MZ%ZU, S8\4H4WE'](W?L!'8"Q0)ED*F4@;3 &4#*H"CR'$BI%,<HE[#(7,L,
M?& 8OJ; %X*VKZHAF 1^/[6-^]]1_;8Z'4'[?&6=0\3O>^IHE)%?3N>\/'XC
MG?UDS\X/\^5\*S_-?TCQ<;G5\SW7,UFIB?]&_VNUOEG0S>:S_EJ\7QE-E)F4
MN,!QD@.:<G.^E"4ZJ$TRP&DNXS3-4"R$4V\'M_&G%N96YH/2_FCO0*WY;U2)
MM ]1Z41DO(C^7OGAVIK!<9;LZ"8@]H&YR#_L[KT3^H'GM3N"HPGC]C_HA\]1
MAX.>MW%O+?;[W;O%:B7>KY:K]6]T21_*R/]NI;9_Z)=:W8:Y2+*,,YF" N%4
MK^FI--T+D%G3*Y5@)DEBE0%D.^#4^.[W/]_].2K-CDJ[H[WA46/YY;;-_;#O
M)K40B 9FL;<$T[X;F6]01^I)9@.NGZ9D+@!UM":SNLUH#<I<G&JW*7.ZKE_(
M>B_YXW*U6#V\O*.;$Z^%Z@N>"H)3Q@F(&4$ )2@'.$8*Y!0JQ$3&J'0*5*U&
MG1I=[XT&I=7'L9);'&H'O5WTZ1W0P&Q]&<O+7.T<93J!Y#.VM!MXU(C2"8O7
M<:3;Q;T5L%;?Y6[3N-X[NGN4<GN]%"<K'=^]Z!^>5ANZ^'6]>G[:Z%LLGDUB
MC_E,U:-<BGV+\K)*:Y8A!%F6%2 I,PV)R3DL$ 4%01)A5DB:QR[4-I+=4R/'
MQH.H<N$JVCD1M;V(]F[497*.B_>QOA9VM#O!R0Y,W 'FN8_$V)BH>Q8K&\7T
ML67/QIR/$P)JHP[?,XV+ZY7:<UG44);L+\I;7XO_>MYLC=EUN,=RE>6):6P4
MIQ0@3A) ,<Z 5!*)'!&A)'/*X+(:=FIODP^KM9P_+*,;HZFRY(Y'EY90VU&\
M?P #,W3+X.@UCM'>[C.G30'";C<$O29FV8T\;DZ6$QI'Z5AN5WL3H=KKC7P4
M>IBYFM-=N%\*C*RE.&R8J__M^;L4G^5VEB<94ED"0<X2'6)CE *24@92TRHR
MXU1A[I25ZMF^J9&?29BD=9OKVO3!JE*#YL^.*-]P5@(SZFG5J)945-N[9ONB
M\>^H57GM8ID8&U0DR@?Z@46A!IGXUB)0/O"U$'WR,LS@F/57.E\:?0!]4R.
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MW6L<'7 >O&:K!3!SW(RV<#@?9;T%'*KOV:9F3;G9?J7S<H%=\!1)3#G@3$"
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MZX?44G;96DB:4FDN2:%*TGOOH_69RWO?,Y-P45EL1"]S G/,. (\PPP4)<.
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MFR=L_W20=%SZ>Q;;=@#K]L9?"=?$K[P+4A,0P0 H42MD.\S,6PK;'^=%S>O
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MX:V?^R5;@Z1HDAP,\N$-\F$Y MXS8D':P*1D4O@.3TA6T; >4)I/8G8@X":
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M$4V#]#(9H*Z*Z[,IH3UU>ZL)NJJZ:L!;6I>_I;4.4>&&[G!G%\B<<8(X"I9
MUM&5R\-TU>W[_0%Q@[VS%@CK F9+=&ZNO7:AN33[3TN] TO1&1](X@&7N:*"
M!.L2X4QY]"9*I%)E!]Z0SG[/P%N 9R<:; "@Y7K*%#YCK#S\NLS48%QTDDMQ
MK1(^>.<5T=Q;(L%K$EQ$SR09 ^BH*$VKU&&\0%-/G37K%J5VHX'7=O/CS<'[
M@X^'1V=_.3HZ/^OJ>L?#AU:]P_$"_1U=U+C%V4E^-QS[<1SZT:?)];"A6^@)
M;A)5H33Z+A7P@J-MRX;A9T(%F3G$56/_.BB66H.X78W3]<'_+:N91D:3EB0
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MJ8 2UA$?'%I]!E;('),6M?H9KTEBO]-I]@S,2IIK(*=XE#/$.7K*W]!E'E_
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M%;5<N<36F1NV5L>%U22\GC/M;3SXCD3?''B62\T[;H)3951LSD0:YXC/%CV
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M(8%I27 Y4.*5M(0[S3VW-(<Z58E;TMNH?=H$34\Z >U!<Z_+>MU(9/)$(F4
MX#@.1\/K_H5;YZ8Z>&E%>[@3_[4-9_9.*BI+>Y%R(LB8*-V<'=$Y*Q%,8I17
M"9OVY9Q=+[H;;H,S0N/R)=1Z=!$,5\0FRS#HH=)1I:. *FF^%ZEJU AN@HP?
M.6G;:Z&!/,1'F%]'SJ5H<!"BU9)Z31*ZF:4G1"Q#I!7)6>80$_C,JT#H 15M
M068'[4ZZ$O76./D*TS#I""F/ICA_O"I= $_R0DBSDZOY;.['Y4A[(;!!3E2
MLH&8E%%0403B:!GKB&+R6FBM595&LQM1V6_2M![2ZJFJ"22N%-Q  03*62GZ
M*:</,3$22H.EI'U*/E+/0Y6A\"NIZ3<76@]9NXN^200MHY9;$2DND!UC20RE
M58Q4COBL,7P!5F9O4Y7"7AS'1W2U9:^J.%.[:*():#W<Y740W$&0Q"JJB:0A
MX%H30*),QK.8.&=5;M$T[%#MI.$77:I-A-T$5E;NTTOY/-FL[TZA!BYJS2 F
MDE2YV0!*$,\5$.T]I4$G8>/^G*L?T]N6V>H2?_M08 -!XC/^Y'.,#I0*H1QT
ME,8DI4R5&A0I<.*LY,(XIJ6L8O4VI+,M)ZTZ+CM2V/9XG)3N?!7=MP'G/'@;
M- G&H"/BLB5..TYP3;G$(M<Z[.6@9$E/O\T=:^*K"P4TL0,?C.?#5(@??H4S
MB%?3Q7VKHV^E/!]2:?![.+G\<G6MM:>G'@>7I1_"@(/4.7 ,IA)&/>AM1!(P
M "(L9)^9](['*A,H.J&^WYZ--5&Z?^4V?'9U>O37HX^_'VUQ '7SEUV=(JVD
MI*.CH%/X"N,KN-;M> &AOPWGGP_1\<(H87J7 ^%:1F8C8< I.F"RY"Y8(C%[
M\-()XW,5#V5-^G8U:S]XS=W!;"X=6L"4GKBE6P6W&#SQD$D.&BC/2F97)6FV
M+H']AJXUT/382%515?MV:/OS\$</Z-@JU3RG7A=.EF;(,5,"BRL_20MB\5.B
M>0;<\FA(HH]%V;%Q.H4RF HW7-QO\V1Z6:YLGH31\.+Z-B]/TB3C(@$>H"1S
M(L*=*V*41X^ EFZ757SYM:A['69I$QP]8Y8Z5%(#>8RUF,)OQJ+-"Q@DG8%I
MGPB/3A.9M42[3@6)4BCC(2=AJTR[V)#.?O-KS:!Q2\4U@,N5<BM-;$I'/1,]
M2X9YXGU:C"T0Q">K"*XXQ[A70K@JAO EHOK-G.T#<9VII%%XW727^3[0$*7F
M,A%E@B^5Y9JXI#B:="$PV*4QQ,<C(ZKAZY:J?E-G?0%L.Z6TCK!;XQTG%^/A
M_T :2&NM%A (]9*6E$H98Y$PGF$YV:"<"*%*F=EF9/:;&.L=@[NIK0%0+F8"
M^1F\A>M_C\<OKSG&E5-E,"[G!IU92&C?;>"$1LY$$-E$7<7;VY#.?L>.[ .6
M-177Q*G#6N[LS0R@\^%EN>F<S_"[LXQ"*$V!KJ?3RARM!$DB@XANB([$6<27
MC<PH;:42M,I]F&[([W=D2#-12[=J;L#L[LSUV=Q/YV_]_'KPO?0.3$R(0V$S
MD<9S8FW&G4>K9+FED.J$/]VRT43":*] ['HM;(^*GV%-O+_M/P=91Z&2(C19
MC#V=*WT^N2 RJ!!<@#+&L,GU\'ZCT?&UTU6O>BULAX:?81W@'PPGB0UHL#XY
MHT@Y?B>2<T^""9HH'9P2&KC6;>X*2P9>^7ZP)0"[7@?;H.'5'(T.'C4GW^)P
M=, J'8\^INWV@/37'=@__HBO.#\Y/=ZR*^C=7W?7N^\9BCIKVK<<>+FB9Y'V
M.0;I$G&TC#E3)A$?$=TL6^VXMHK7.7MZ@:;=$S)/'GVOO,&;)*G!&$MPY)=+
MB1Y=TL2J$*738+70>^*WD>J3KM#Q-+W2D1H:-J7W5N[6_66>/J."7:G83^8E
M_"0-WN>@B'8^E&*B0+Q(ABC&'?JU^'*H,FBYHG6YZTUR^Y+#JVE9:(^:D>A@
MO!1>$B[+)!R/>G>NM"7A7%A0#'BH4JV[+H'M6IU-4/-\ZY@.U?,Z+-!=CY0;
MUH<PVZ59\7I/KF"MUN=D'QX2>"L-QSV09PPXK%G,>P!"133@DO;XR2NS8;>/
M/O5_?/ (TJ$?S3["_"2?H@*G7V$VL#DS9MUBCI?#@$M14N[G$!YY J^RP1]6
MY?I9TMJU6YL@Y5EOJ1N5-)"$N>7H;Y/IWX_+I/$(LT<L@;)H:$TF+$"9(10R
MAO6,D62R=9)F9RM[X\_3UG>GX\HPZT@I+>'LW7 \G.'&468K/V(I&FY !DT\
M TO*T 'B0K#H5F000IN0;)4\WAJT]=W.N#+..E)*2S@KI7DB<RT3]T0SIHF$
MJ$FPPJ*HT$1GFS P5E4!M6YU9,7Y=I61LZF8.[LPW+V3_O[HX&RK;./R#[MR
ML5?1T9$'_;Y4T,SN[E-Z8VV6 6.VA"%<X)1@M!4)9.:=\4)"J%(S\I",G6=E
MXMX(L.S^/[ZX?OA="*DB,\!,)#DP@P8L*V32!(+Q8^"0DI"N2G;C9;+Z]8]W
MP,&3R93=2;_A /YZ36X?IC_\^VXM1<V0^Q%0J*&!2FJ)C0(MO<7/@BO#HY5P
M$)2*X*NTPJIA,-Y?5Q7.XG3XY>XHGVI$I^*2,$B*R$1Q4S0Y$R5X]%3;+'Q%
M:[&2IJ9,Q28(6&TJ=I=[ VXFAF1H\>;?/XW\N(R5//KOJ^&7Q;C)[^?XB$59
MDE%)6<B: -6+^8R4! J2:"JD!Q;0]E49/[X&;7U#JB,<3.HJI66<%8;>3DJM
MQ( K[<'A:E1.,&1)&ER-R!)57$7/K ^Q2GIF#=KZQ5GG>%@7;ULJI^<YQ!_\
M^*K4TEQ-T8\[^^(C?(#2*FH@HDV+R;(ZHZ"D@M(:"A))T243I([J23/55;.%
MGWM^HR#95HF3CB7:'"K.2B__= IC^,./SF%ZN63*,F\#<QCW1Q#%U9<H)2-)
M2N@4).-,"(_MT'HP>>:%_>9^]XN;+F3>P':V>N=_?UM F$%)H3DC1M-46B$"
MK@O\(*QGP#5Z!KK*7< ?T-4OTFJY2UTJHQEL/4Q$E)5RDF_N] P8LQ1H\ B#
M4J=-(YK=P,ILR"P5MRP:6>5V\X]):]$AWQ():^2'=E!+HT"[9YD'6BG/HRIS
M'DO_3&T<!LLZ$)6-MD$*)UV54X<?T-6B$:L'L6T5T@"^'C%2FK>>Y-]GL.@X
M,>#9Z:R3(]QD5R:UE^ZLB1%<)CH8Y:W150I=7J2JW^/1FMCJ3AG-(>ONSG1*
MAF7T( E3LM36(2\N>HML"&&M$X:[*N7ES]#3[Y'I_M"TG0*:N+3^;/2SZ(C#
M6 J>E5-@C]%MN1,7!%I>1:47EF5J996.]"\1U6__CIJ8ZDP5#1^_?3PY/SK[
M=/"?!V_>'QU\?/O^Y.-OYT>G']X>O3G?XC#NI:=U=32W-L4='=2]A3!?4>-!
M$^>>2TLB&A($5L8-"C%&(@>OH^-*Y"J^Z&IR=K4Z#Y]Z=\C,%5AK#"-2"$ID
M0 ?/^9!+%8K)(DCK9)7"L6?HZ3>8ZP )CTU,%W)_G=9E^Q/_-1ZZ!UM3LS;@
M&: Y+D6)V8FQDA.)&QC!308(2)6B%,E9767WKV=RCL?XK*O+F]LI Z ^)6X]
M@5QFIC%< #YGW*USB@GW:\ PLQ:'CVAITM1L@H!5IF87>3<09;V?C"_P:9>%
ME=MS1DJ=\8XCT:QX^ XD"> < 9<$_@"2HW52CRN(Z1\T.VGX<?9G5W$W")GE
M^5&, ;?FQ$F4N''+H#WQ*FD2(Y(I(6;K^#Y T\)A_NYJ_@%NMI!Y(\@Y7W*Q
M/!,T.3,:HR Q\4"DHIX$E3U)'KT^97@ 4:>J]PDI;2%F&P6OP,P.TFX +Q\@
M#:\N"P\?)W.8+9E@0@1JN28I6E5DDHA30J&200LCA,BLRNZTDIK^4;.+BB==
MR[L!T)S"U\GHZW!\<8CO'L[?^;A(6]X4LP!DJHP@#%AI@.T5"=YSD@,W07B'
M 6*M]DO/4]7S:5>W(.I._@V J60]3_(U)S>R89JJ2'$;EPE-LDV". L* X9$
M'82DHZT2,CXEI>>#K&YALZ.D&\#*7_UT6 *$TYM6CY3;J$SI,I&L0(>/6N*<
M0\6B];3 8D1F:B#E,2']FI>N0ZB=Q-P83)9>7O+1.AHTT:I<CZ9<$EMZE#.F
MC%+<\EBGK\M34OIU9W93[0LXV4+.#2 %+6R:C(_'^,3@QW\_P16"1!1^WA^_
M.3E=6DEDB/-H/#%2+ I&*/%!.A*IB3)K;FB=YN]K4=<.GK:!P-. JF-]] BR
MV70^./7CB_^_O"_KC2O'TGR?7S&8=W9S7X#! +)3SG3#:25D9S7F23@D#^V8
MDB-<$2&GW;^^#T,*698BY%@N=:D<H*LZ7:Z*>Y:/9R'/<GW0LI/<UA5].I"_
MUA&0>1"1J1!E2$2UE;OTRM&/W@$0_>D^>'[XZKCQRU!^Z7!!]J#]&]#R8!PE
M=L XU#V0EA*] +5(5\OB+( W#\KAC]/_F.;A"(W=U_D!XAM9Z[]/II-/5^N2
M?*,$I?"Z$. #&:OD)?.VK@.520#W+J>=FNIWTOL/7QY9\X?H;3:$$,?6/GR]
M0[BN?1=2*695KC?21K,0G6$EY4BQE11AIQVZNVG_[I?'R4@&T_[!0NP@J#S]
M6DOZKB:+C]7MG97J!J^;"Y/1Q1?+9";-Z2@] UL<4U*!C3ZB\4W&\V\C:-S"
MRJ&SUD'$WBE\[KQ7*)&*-B4SJ6L)GP<*?KFS+' G5!$I!M.DVN!QLL;-0H91
M_0YX.E /':!JPUTBN"*+HG.&/'JFC10L&"0V *-+/ J2WO\/#X-#*OKG#X3[
M2+T#W&QYL!+1T[\4*[)>0[M 3"B3F05' ;T..:0FUVD[/! ._9PE10Y66\6R
M\:1^C;6E$A,KPEAC' K)6RU<W_4Y:Y!'EQB-*;9XBJI285JJR'RA>"USRM)$
M\ 2_)GS^[-%E?^;>7<4%_NN*SO+IEYL&[)4SB,X57DI@)=;AT5I:2D.Y8SRE
MJ"A.Y1&;/"MMH6?<%H2AHZ\AA-Z!N=O QHT; *'12^59DIR2$$=VVSN++"N!
MFJ/1IDU3U%:*QG6:@^C[YQ@Z0/C]H>C&PJ8HDQ AD4 B)<.ECNA%1\%H"L %
M%T6U&:^XD9KNT'.(IA_'SP%B[P [/QKF-[<]829XSK.53&4'Q(;-M:TTTL'R
MH- X7DR3D&L+/>-N&A[:>PTA].ZP0R$CGGR:74V7%QBU+9G2%Z\(_EJ1;$*,
M@G1>ZV)=RDXWF0FVC:">2LX/U/:C"#I0]!U Z&XX?IMS7-_&OIC-Y[._:D8"
MG^EOEM\NZ,!Q:UUDE/!1;A3(3GN7%?-:>BTLY89M<J-]B.RI-&<8J#5340?P
M^U%>+V Q6;PC6B"?3>^6&H@+F5'%VB(MH6Z4E&@9. 26;>2%4G9HM!Q@5P)[
M>GEO8>$&4DT'D+M[1W=AI:MW6,B*3W6-!DDI@ _,E*@RRA2];3/1^ X1/3W+
M#&2Q#A5Q!_#X41ZKTB1<+"O23RFZ3,O)%_P#YZFJZ ->I PJI9096.LI?4'/
M0!M@PG@9@_/.JR8M6GM1V=/-4PO;-*22.D#@#X\(4*= +B>X.,?/\*URNS@K
M?\PGTS3Y#)?7ZY))?V?EU621X/+_(LPO(ITVE7-ASD==*_)X7=E9&'*3$&.4
M*-J$:4<2WE...;PA;*[*YP7=U]/*X/N_9A<&54C2 G/642(?A&,0#86L=6PJ
M-\%87D:&ZRVQ.T'4_4TA>IC*GB4L"6=XH74RK@:VR6!D&GBM8ZQEC5Q);D I
MWBC=/8C<G:#I_][0W%MMSQ&<KV97\PMA18"2/9,ZU"$;7K+@R#L482%$AQRP
M#Z-9J=T)FN%O#<V]E=;QP*17K]^>O'WY^N3-Z[?OWI__^?OIV_?O3M[^\NKD
M]?D_3M[\>?K[Z<F[/\\/VJ6V\T\/-3SI,%X&&Z$TGWR!FJU\Q^?B9)I_P_QA
M,OUP4A.9%; V3-GQR:EHLV8E V&)_LB"RK(^H9&1\R4VJE,Y@N;C4_/UI^L'
M7\%D_@^XO+H[D"QSU#Z2O:?XF.P])!9B4$R5PLGH:X_09'[\SP@;^_GC:5#V
M,$D?4%U_ W.X>K8\9);<GA]X:M.XB:\.#*2 NDV%*TJ=*3/10EH&G$#LO),*
MZJ6U;Q(AC6@@WZ6/F*\NL=:T;B#B5YA,W\P6B]?3=P0)O*Y^?369 @4J</D'
MSLML_HG^</>(*LP^U@G7W.3ZG&3J.G/.<O$IZI24:--'/3@GS]<$[X/C!Q4R
MHP*B@^3J)P+8POAL,:G(V."RO-':"^L8"K3D!9UCY 0S*ZH(4"X)IYNT] S,
MQ]B/Y%V>AJ9@Z.HLW/*R6F-01;^>13^I1?90)9[/IN>8KN9U!]7J\7?EYN\8
M ND#QV28A5A73WG#*';C3/DD%&@/3K2ICQV2B[%?[<<^!T\-A Y.P4E*M4YK
M03PA29]8.;F\G/U5O=RKV?RZRJ;ZQ'M<\FQL;3QEV=97[%02 ^\,2[Y8;D'E
MR)L4"AQ&[M@E!>/@^@E4^_S3T.O_?"T7"O#22BZDA@4IY.!YYT-^_8D3V/TE
MTD%VBR5R&;UE G1MWZI5[B5H)H$@&WS)1C=QOR-FMW</\R^SJ[@L5Y</C_SY
M[/*2=/@7S/-%\L$%GX$97P2=[*Q9L(5<4Q9)"QN%E4WN2/>F]/EFI_O@\(&]
M;JK0'F*-G1B\,*!3\$!"X_4>-"9R0#Q(^C<N/+<FR]AD_.YNY(V+S<88.0B1
M>RGL8!A^IE,YRY22SI=#[>SZ,EG43/8A;Q>99\IF"24Q:B"AQ<# 9<X  P*"
M4K+$%A!\C*AQ+RF>%GB#*6=_N(5KN$WQ RPQOW]BX_>?\\F2$M&RN# \@C,E
M,B&Y9YHCG2<M%8M96IX*)]$V@>">=(Y[9="C.3Q,A<\-J!=>R:R"*$R8')G.
M!": +!C)T$$JAGML\K@\H)=NEO'W",N]%':DESZ=YAYR^W?KF[U9N:Z#GVV^
MZ?X%%Y,/TWJ*8/$2%A]?D3QKL(\+F.;W'V<+?#M;WOTOW60"/_Q$XYN"$7AY
MZH?SD;75P2V&\0&RM9HEDQ33+F465?;,::&$XUE;WJA]IH,BI@T/L2^^W5!P
MCI<K["T^3CZ_^/9Z2MC"V]>I-_4C])<OOFWZL?/)XI_7'?+6N0(.#7-"U%Y0
MXUBHY38D5S*&C@>'32*JIV/Q^=Z;[(/\[85574&H@PN7&];7QK#BH ZI"2HZ
M791A&9$SC9*X,!1LH-$!)%<\Y2:36#:3TR%H.P#/;'!-=HG'F[$W/%B,@,A,
MW9JKO5(,:NTYI,@+"F<@-#'-VP@:%Y-#*/NG^#E \AT@Z'M<=_(PKKN=>.1D
ML75$94ATSI"\BE>D^^P4FI*4AB#:^/F?TM8;K@X!P0/O.ZQ&.@#9VQGE 6NN
M;EBP'H.J$4F)13.MO"01:>(C%,H9)!I7FE2Z;:!EW(O@)B Z5N(=@&;_0&)E
MU),WWF=0S(8Z\"W5H("[R+1-GD?I>8Y/E_+]E-P."R7[B]6>  D=X'T#&^N5
MLI3)*2.1%0#'M-&6Q9K5 4?-9=0YZ2;OMULI>FX9QOYPV!SM':F;#D!V]WZ/
M&%HOP$)0IMZ.>]2F/@!28.%581FXER[DS-OL -A(31<AW;&:G@TM]@ZP<W<,
MSKN_X/.:"RM3X:(PFY1G6@I@09C "C<^>  -T&0,]F9RNHCE!D;/ (+O #[;
MXH.5<=8V:' 4C!;OZPH^*"P6XLI@R28:DU6K\7O;B>JP>/]YQ&8':;4KA+Z<
M35?7Z'<&29= !S?7;6%29J:%477NJF$8=)%1FF2Q21#V&%']Q6&'J7XKIH[4
M0P>8>C6;(Z7AIU_3Q[K';,W0.B47*@01@1)Q,MRZSI.)F7-&ACTIXPW9]R8U
M'X]2U0NJCE7^K)4F.H#5%DN_.GHR6*^4D&2_5U.)/#!/HF+2R\"-E4J5)GN8
M'J&IPWZA_ESI4#KM%Y[KC<Y*"CI<% $CUIT,!"7P03#A0JANPQO]E #MP9<.
MIOO=,'6 (D9$U4? B[>X/,<O.+W"Q<O98GE6?IW-\N+=[#*?3/,[O*3_S8=?
M<8ISN*3_X"1_FDPGM12B'M33KY]QNECO$*74*WIY/>T2F8Y(D4D.GD4R^AJR
MB"CO/];?+S$;E* N@7<(0&9C:VMDB)XM/^+\6IXW/) 8UEOZ@C/>:\^4J@]V
MJ1ABHSB6,5)LD7Q.XGZ@MPETCWQBW(N/-C :2J(=>,1'8Y WMS,#K>6J@ #&
MHZE+9R0%I$EREDHQVD<5A6^TE6<7\L8>]/TLPK@&FNX OZNC^'+VB;[_D0[B
MBKLJVC^G<X3+R7]A7K-X-KT[F&T^6=3'[:LZW>&/52W[B]H"C>_A*TDYQ0Q%
M,Z>2J2/?)(M2%E:4ML+27R5HLD6H 2^]Y,S#06[6E_X[. */2OD<TR4L%I,R
MP?R*%'22TM6GJ\M:?G'V\O7KZ7)VX\=N]P?,YA4>Y- NLC.%.#8,>"GDRNK,
MJ^@5 YT\N*BL>! <M#?Z1S#4<5'#,(>A"R1T<"+6+%<VJVV83:L@3K^FRZM\
MPWR=<;&X&7FU'@:T:BZY97]*_X7*N_(8G=2!6:B36;(3S(,*3(.6''WAL329
M@#,D$QT_&0V#_-$T_OP'X]RV8RWN]F$]8:/;YN^.U92V@Q0Z:" 3LJB8N&,%
M?&;:",Y\P,"<X18X.)U;;4D=K8%LWYEM]%]X.Z,H\,$(MPNE##>*O%D(=8Q%
MHHP_FE75:>:&_L'J-D^F@W'0853? +</'LI& 4 'X<PMXR^^W;"YVKTZ7^V
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M+>L^(+0:CEHO[2?S*KN3:5Z]3)[C9?W&RX\P_T!IJB@6/;>.V< YTRD;Y@L
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M0QHE*+]_>_ET,-@AF/+]'8)I;T#C< D6URL8+)_3'H=3D])MPBO[]":4]V)
M5-0]A4RJ*X,*D)^FTGK60RDHO!XJF%=\N<ZY!A3W,*M3Z0HJS9J/Z:-$[D1;
MK%92^)6HK6(KA>1&D@,R)'R?!0K25%E*PGYJ6I^Q/4?B4A<-PC6H;U1B12F3
M2G&B=G3+&[%*YM@BE ;K%0W^BH$$D7VQ/8AO9]N=@G&\,S >M@^/-E'\9+;:
M //3>>[)F,9Y,)6"H,JM+CBQ.K<(<ZHJ";_<B 66$-V2QU))-Z?TOJU;FED>
M=AY185+<$5VK2GWRN*T=*BM<Y5B, I4C2:*-\ ;X^G0"!589"H&-7Z"D&4,B
M6'L'\.+,DJ5/%"\"OLG.P'?)PE=3KBI/511<2%,L$.44PV*W%'K+8N()U!L>
MM]=^'J[8$&G3A@HSUI5[V(*G=+<4!JJ>T\?7.RQ>U.5^ D(8B.5:'/4_?\")
MG0'<DB]#*#<A06ONNF+S7[;B[BM8DC*Y3I+*4.37TN86K;FV#M\GM&9*T3Y4
M5._CL+T'FJ2(8.2O>]*UX;A6 K]=0#L)1;6T:S]8E7&[K#&(^3SB0?B4X,>C
MINLY4_(&5+UW<$^^^:N'Z-?!?*<680<O9!'F-Q3%8H8T5PQ%?+F.TA59$<Z^
MHNK8J%Z7IG&L8)TV=IGH_0M4F>?2.?" WM(LUEA&T#<AT3:O8 ]QC,QKB=CQ
M?ZJA%Y,/?JXDFNXG6E4D?GMA_Z\EUN^5W,\5EF58)DH$&2UJ:7F<2$!4U EZ
MN=29 ;^AC!O*-)]S?8'IMS@7.T%?A;5Z51+V%;8P&A?8T,*2T![$95V68A-#
M1TLX+7S:M[@TLE6.\,!1\L[4B63KGMD+RNF[MP8ZQ]2=&N2+)@8=/,4A;/Q^
M=(VO9LA\LIAJ-05*?P6?U-OJIF9%R$NEYX!?9YD.5,COH!?1]IO4!NVO.]7;
M<AZ[:P>![R V6(+,PWY:KQE.N!^S.=;.Z7Q$)]%K7OCT=>K\<K&6CW'6@6FA
M-XJ7%D:+'R>8JDK%YR-9>)M\HY,I93>LBNKS:-19'W0/A^WC@SZ==3L<4"<6
MZNMC\+8_!N\XL?FM/VSWN\,'/W?;T3=]Z[6/>L<[I/47A^"@?30\_,W51JBV
M_[21[?BHA<@A FS)BS>-?F/1H&:&4:^\9='=*PE$%O=A$<#WQ\\7?]DBS)/E
M_*@]7SHU;-Q#?CU3T"WFM_;8PL3GY?0 :=+_W7IMX,'A>#$Q_A,CV-\4>M;P
MW7[3Y9/!,I5*,E\!7F024G9U"TE%6TCL8UA=_87LY^W==F0_)Z?V/H6M;"Q#
M-]"Y_R>!9\>7AVOEZ%/*ZWLW)DL=KHR.PG'<%#;N4*YXSZ?L[JH)CY'\*K?9
MY)%KE_7?< G47T<]^Q]02P,$%     @ M3)"4BP,).\/"   X2H  !4   !H
M865Q,V1E8S(P,C%E>#,Q,BYH=&WM6FUO&S<2_GZ_@E70U ;T+MFR9,= 8CN(
M@5Z2"]2F]^E [7(EPMSEEN1*5G_]/4.N7BS)9R=M4]G7?'"TR^%PAO/PF2&Y
M9]]=?K@8_OOC%9NX5+&//[WY\?J"56J-QN?.1:-Q.;QD[X;__)%UZ\T6&QJ>
M6>FDSKAJ-*[>5UAEXEP^:#1FLUE]UJEK,VX,/S5(5;>AM+:B'KNX<GY&;_!7
M\/C\'V??U6KL4D=%*C+'(B.X$S$KK,S&[',L[ VKU4JI"YW/C1Q/'&LWVRWV
M69L;.>6AW4FGQ/E"SUDC/)\U_"!G(QW/S\]B.64R?E61O7ZKPT67]WH\ZB:\
M=]([[G:.3UJ=]G'G)#F._M."D0V(AS[6S95X54EE5IL(&G_0;==[1[D[G<G8
M30:M9O/[BA<]/TMTYC">0?_P,ZC95L;-&/J<S@>M$VARXM;5N)+C;.!=K 15
M"_%(*VT&+YK^WRFUU!*>2C4?_#"4J;#LO9BQ3SKEV0]5B[#4K# R"8)6_B9@
M(P;QC[/@0@]ZE,S$PJ56N_E]L"(6D3:<XCHHLE@8DJJ<7_WR[OK-]9!U6O7V
M7=]V>W6<__D^='?X4#F_N/HTO'Y[??%Z>/WA_7Z;>EUEGZ52DJ?L36%N1)5%
MPCB9S)F;</?RQ=')Z2,=.,UY'&/-U)1(W!JD)"*8N4&-WOQ%3K;J"Q^^_>@;
MT]*L']$T7+,)GPIFQ%2*&=C&3:1EOQ;<.*!]CO>Y-H[IC+W5)F6M9NU?3"?L
M'1>ISH23D045F;Q<)(A2_Y0]_3"U]RY,;[A%<!"&=,YN,CU3(AYCB?AHE3&*
M-4S(-!('1N R8SR;LR)SIA#P *G$9Q4$C[,43T9RQ1(>X95A.I6..1WDM@0R
M$0EKN9F32,IO!,9=TVGQ+H8Q&%+YE(0Q2""2!BD(8AFZ,\^?;#:1T839@OZL
M^L^$$:42<B"55B%74=J;23>!@S87D3>0].8P3<=P<XIN,1O-UZ?!0_#I([#S
M=! H6"(SQ)C@LHII%?"#.)K-6KO,$M"(YPK\CE010R=PLQ; *C GB7IRA)T0
M2TA6:@7)$@UV8VB@/O856)4D"@4!X% #+'XXZ^V)N)VP1.F978#4B+&T#N6;
M8YQ>!KMA974-:W9AS):USP1NW;V#V_!.;%Z^.&FW>J>V!%19&1!!Z"21>/11
MNV;<"(\/Q%N.E* X,@%0CI2T$Q(GL13D2 1)S[&TD=*V0#^B3:-5 $IN="1B
MO+;L +B(!8 6@G]U&TUX-A;L-1CI4Z&$??FB==P\11E=:QT=B$/?OW44AZ?P
MB &%R0)*:1!&W+4&W@ F,NC!T5@Y4')GH 0#D;.;D(8$Y?>O+Y^.NGL$4WZX
M1S!M=VD>+H7%1@7!\CGM83A5*=U&O+"/[T)Y;R2 BG*DD$EU8:  _#25UK,>
MI$3F]5#!O.++=<XU0G$/LS*5KJ!2+?F8&B6X$[98K63LMZ"V&%D92VXD.2!#
MPO=9("--A:4D[)>F]1G;<R3VN# (FT_?*4=%*:-"<:)VN.6-6"5S] BEP7I%
M@U\C08)@7_07\=>S[5[!>+0W,.[7CWO;*'XT6VV!^?$\]VA,8QU,94Q0Y59G
MG%B=6\"<JDK"+S?Q DM M^0CJ:2;4WK?-2RM+ \[CZBP*.Z(KE6E/GG<E@[E
M!78Y%E&@<B2*M(F] ;X^'8L,588"L-$B<EHQ)(+:.X 7*TOF/E$\"_A&>P/?
M)0NSJRE7A><JBJY($E2(<HJXV!V5WK*:> 3WAL?=Q9_'*SJ"-VTH,4>Z</=;
M\)CAEL*"RN?DX0T/&RT*<[\"19B(Y68<^I\^XN*]0=R2,$,HMR%!F^ZR9/,M
M.W'W!31)J5Q'46$H\FMY<X?65%N']Q%MFA+8!T7E00X[N*=+ @2#P#:D2\.Q
M61+^O(".$K)B:==AL&K"[;+((.KSB!>QSPE^/DJ^GC,E;X0J#P\VY*N_>XI^
M'\SW:A=V]$QV8?Y$,5ZLD.J*H8@OUU&Z(BO"V1>4'5OEZ](TCA+6:6.7F=Z_
M@,HTE<X)#^@=W48:=02UQ1*V>04'P#&8UQ*QXW\JHA>+3_Q:2)CN%UJ11?Y\
MX?#O/=:?E=U?*]1EJ!,E0$:[6MH?1U( %66"7NYU9H+?4,8-=9K/N;["]&><
MBZ.@+\):N2T)!PL[&(W'Z&C%DM#NQ659EZ*+H4LE+ N?]BWV1K9( 0_,DG>F
M3"0[#\V>44[?OTW0:Z3NQ( OJ@BZ\!0'V/@#Z1)?U9#Y9#;5:BHH_65\7)ZK
MFY(519HK/1=HG4UTH$)^![U VQ]2&]2_&@.5>^]FE_>VWQH-;\7(H/J8A[.T
M=M5?:S_DX$@[I],!W3ZON>P3UYGS.\52?H3U)DP-SBB>6S%8_#A%DLH5GP]D
MYDWRG4ZGE-=0#Y5WT-!97F[W^_63HP[=;SM,G(L7ZLNK[[J_^FZX>+NMTZ]W
MFOU[FYOUUE>UM>N]]LD>:?V?4W!4[_6/_W"U+:CM/&YF&SYJ(7) @,UY]JK2
MJ2PZE,MDT,YO6>ON9PBT<C9A$<#W[<G3?V 1ELER?92>+YWJ5S:07ZX4N,7\
MJ1Y;F/BTG.Z"(/W?NY\*W#L/SR:X_\?0]9\%/6G<;GS6<G4KHH*.AMC/V#.Q
MCP85*E5C578QD2)A;Y>I_D/85?T-[Z?MW6YX/R6G#CZ&,VQ@<@N=AP]X_&S"
MZ$':\"7B5KF\NY1>&+WQI62NPZ>B@W ;-Q5;WTZN*-"G[>:J"Q^!!PNWW>6!
MSRW+O^'C3_\9ZOE_ 5!+ P04    " "U,D)2,2']'5$%   N%P  %0   &AA
M97$S9&5C,C R,65X,S(Q+FAT;>58VV[;.!!]WZ^8*N@-D'6S8B>V:R!U4B1
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M;\_^!5!+ 0(4 Q0    ( +4R0E+V77CJQAD  /RN   >              "
M 0    !E>#$P,2UF:7)S=&%M96YD;65N='1O8VQI;BYH=&U02P$"% ,4
M" "U,D)2Q,\YQGD;  "DN   '@              @ $"&@  97@Q,#(M,3)T
M:&%M96YD;65N='1O;&5E=',N:'1M4$L! A0#%     @ M3)"4I@AX:)/&0
M>*D  !X              ( !MS4  &5X,3 S+3$S=&AA;65N9&UE;G1T;VQE
M971S+FAT;5!+ 0(4 Q0    ( +4R0E(6$;NU#GP! +:!#0 >
M  "  4)/  !E>#$P-"UA9W)E96UE;G1A;F1P;&%N;V9M92YH=&U02P$"% ,4
M    " "U,D)2=W4B_A<% @#0I!D $               @ &,RP$ :&%E+3(P
M,C Q,C(V+FAT;5!+ 0(4 Q0    ( +4R0E(VR>WAAPT  /"#   0
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M &AA92TR,#(P,3(R-E]P<F4N>&UL4$L! A0#%     @ M3)"4HC697(""
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I97$S9&5C,C R,65X,S(R+FAT;5!+!08     #@ . , #  !@K04    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
